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CD109 function in human keratinocytes is linked to a psoriasis-like phenotype
IV Litvinov,1,2 AA Bizet,2 Y Binamer,1 DA Jones,3 D Sasseville1 and A Philip2 1 Division of
Dermatology, McGill University, Montreal, QC, Canada, 2 Department of Plastic Surgery,
McGill University, Montreal, QC, Canada and 3 Department of Dermatology, Harvard
University, Boston, MA
TGF-β is an important cytokine that negatively regulates keratinocyte proliferation. Deregulation of
TGF-β signaling has been reported in psoriasis, where despite increased expression of TGF-β, pso-
riatic keratinocytes continue to hyperproliferate. Recently, we have identified CD109, a glycosyl
phosphatidylinositol (GPI)-anchored protein, as a novel co-receptor and negative regulator of TGF-
β signaling. In the current work, we demonstrate that release of CD109 from the cell surface or addi-
tion of CD109 protein results in downregulation of TGF-β signaling and TGF-β receptor expression
in human keratinocytes. Moreover, these effects are associated with an increase in phospho-STAT3
levels, enhanced total STAT3 and Bcl-2 expression and an increase in cell growth and survival, sug-
gesting that released/soluble CD109 regulates keratinocyte function by inducing a psoriasis-like
phenotype. Analysis of CD109 expression in psoriasis patients reveals that CD109 protein expres-
sion is markedly decreased in psoriatic epidermis while CD109 mRNA remains unchanged as
compared to adjacent normal skin, raising the possibility that CD109 release is enhanced in psori-
atic keratinocytes. Furthermore, psoriatic epidermis displays decreased expression of TGF-β recep-
tors, consistent with the results obtained in-vitro in keratinocytes with CD109 release or addition
of CD109 recombinant protein. Together our findings link aberrant CD109 expression and function
to a psoriasis-like phenotype in human keratinocytes.
003
TWEAKing the inflammatory cascade: The TWEAK/Fn14 pathway as a potential therapeutic
target for cutaneous lupus
K Blecher,1 A Friedman,1,2 J Wen,1 Y Xia,1 J Michaelson,3 L Burkly3 and C Putterman1,4 1 Albert
Einstein College of Medicine, Bronx, NY, 2 Division of Dermatology, Albert Einstein College of
Medicine, Bronx, NY, 3 Biogen Idec, Cambridge, MA and 4 Division of Rheumatology, Albert
Einstein College of Medicine, Bronx, NY
TNF-like weak inducer of apoptosis (TWEAK), a member of the TNF superfamily, regulates inflam-
matory pathways and modulates tissue regeneration through its receptor, FGF-inducible molecule
14 (Fn14). In chronic inflammatory disease states, such as lupus erythematosus (LE), persistent
TWEAK/Fn14 activation promotes tissue damage and impedes endogenous repair mechanisms. This
dysregulated and pathogenic response has recently been implicated in lupus nephritis, but its role
in cutaneous lupus has yet to be elucidated. The development of cutaneous lesions in MRL/lpr mice,
a substrain predisposed to the development of systemic LE, and MRL/lpr mice with an additional
Fn14 knockout (MRL/lpr Fn14KO) were investigated and compared to control mice (MRL/MpJ).
Lesion scoring was based on erythema, scaling, alopecia, lesion thickness, and percent of body
surface area involved, and histopathologic correlation was reviewed. Cutaneous involvement in
MRL/lpr mice was consistently scored higher as compared to MRL/lprFn14KO mice (4.38 vs. 0.866
respectively, p=0.0259). There was so significant difference between control (MRL/MpJ) and
MRL/lprFn14KO mice (0.158 vs. 0.866, p=0.3482). Histology and immunohistochemistry of exam-
ined tissue was in concert with these findings. These data implicate the TWEAK/Fn14 pathway in
the pathogenesis of cutaneous LE lesions. This provides promising evidence that inhibition of
TWEAK/Fn14 may be therefore protective in LE, and may have a potential role in treatment.
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Enforced RORγt expression in haematopoietic stem cells increases regulatory T cell number,
which reduces immunoreactivity and attenuates hypersensitivity in vivo
Y Fujisawa, Y Kawachi, Y Ishitsuka and F Otsuka Dermatology, University of Tsukuba, Tsukuba,
Japan
The retinoic acid receptor-related orphan receptor γt (RORγt) is a key transcription factor involved
in the generation of T-helper 17 (Th17) cells, which mediate tissue inflammation and autoimmu-
nity. However, recent studies indicated that less than half of all RORγt+ Tαβ cells express IL-17,
while the others are Foxp3+ Tαβ cells expressing IL-10. To examine the role of RORγt in T cell dif-
ferentiation, mice were reconstituted with RORγt cDNA-transduced haematopoietic stem cells.
While the number of Th17 cells increased with the reduction in Th1 cell number in transplanted
mice, peripheral blood Foxp3+ Tαβ cell number also increased, which attenuated the severity of
contact hypersensitivity on skin exposed to 2,4-dinitrofluorobenzene. The number of non-trans-
duced Foxp3+ regulatory T cells (Treg cells) also increased in these mice, suggesting that the enforced
expression of RORγt in haematopoietic stem cells induces differentiation of Th17 cells and results
in an increase in Foxp3+ Treg cell number to limit self-tissue damage.
004
The effect of neuropeptides on the expression of nitric oxide synthase.
R Sondhi,2,1 Y Ee,1 SC Geen,1 AR Shalita1 and W Lee1 1 Dermatology, SUNY-Downstate Med
Ctr, Brooklyn, NY and 2 Physiology & Pharmacology, SUNY- Downstate Med Ctr, Brooklyn,
NY
Nitric oxide (NO) is an important signaling messenger with a broad range of functions in both the
central and peripheral nervous systems. In the skin, NO is involved in vasodilation, melanogene-
sis, and immune/inflammatory processes. NO is synthesized from L-arginine by 3 isoforms of NO
synthase (NOS) – neuronal NOS (nNOS), inducible NOS (iNOS), and endothelial NOS (eNOS). Ker-
atinocytes constitutively express nNOS and can be induced to express iNOS by inflammatory
cytokines. Preliminary studies using human immortalized keratinocytes (hTERT) demonstrates that
iNOS is induced in a time- and dose-dependent manner by UVB and cytokines such as CGRP, sub-
stance P, and VIP. To extend these findings, we selected primary cortical neurons as a primary cul-
ture paradigm with cellular lineage distinct from keratinocytes. Expression of all NOS isoforms fol-
lowing neuropeptide treatment (24 vs. 48 hrs) was assessed by Western blot. Primary cortical neurons
were treated in vitro with the nociceptive neurotransmitter substance P or bicyclic monoterpene
diols (BMTd) reported to increase NO levels in neural crest-derived cells and compared to neurons
that received brain-derived neurotrophic factor (BDNF, 100ng/μl), a growth factor known to increase
nNOS. BMTd is known to increase nitric oxide levels in both melanoma and neuronal cells. Com-
pared to BDNF control, 0.1-3 mM BMTd and 1-50 nM substance P selectively upregulated iNOS
at the protein level while have less of an effect on nNOS or eNOS. Our results provide additional
support for the involvement of iNOS upregulation in the development and testing of agents of inter-
est, which may specifically modulate NO-related pathways.
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Small S100 molecules from the psoriasis susceptibility locus (PSORS4) prime the skin for
inflammation
R Wolf,1,5 F Mascia,1 C Cataisson,1 A Dharamsi,1 Z Howard,3 V Bliskovski,1 J Winston,1
L Feigenbaum,4 U Lichti,1 T Ruzicka,5 T Chavakis2,6 and SH Yuspa1 1 Laboratory of Cancer
Biology and Genetics, NIH, Bethesda, MD, 2 Experimental Immunology Branch, NIH,
Bethesda, MD, 3 Laboratory of Molecular Immunoregulation, NIH, Frederick, MD, 4
Laboratory Animal Sciences Program, NIH, Frederick, MD, 5 Department of Dermatology and
Allergology, Ludwig-Maximilian University, Munich, Germany and 6 Department of Medicine
and Institute of Physiology, University of Technology, Dresden, Germany
Psoriasis is genetically linked to small molecules of the human S100A7/A15 subfamily encoded
within the psoriasis susceptibility locus at chromosome 1q21. Inflammation-prone psoriatic skin is
characterized by constitutively elevated levels of S100A7/A15 in epidermis. Here we report that
bitransgenic mice expressing elevated levels of mS100A7A15 by skin keratinocytes are primed for
an exaggerated inflammatory response when challenged by exogenous stimuli (Koebner phenom-
enon). Inflammation-prone transgenic skin is infiltrated with immune cells and expresses elevated
levels of Th1 and Th17 proinflammatory molecules linked to the pathogenesis of psoriasis, which
are further amplified upon challenge. Both, inflammation priming and amplification require
mS100A7A15 ligand and the receptor of advanced glycated end products (RAGE). mS100A7A15
potentiates inflammation directly as a chemoattractant further enhancing the inflammatory infiltrate
in skin from bitransgenic mice. This study models a functional mechanism for a psoriasis candidate
gene and emphasizes the link between the epidermal and immune compartments as a patho-
genetic model for inflammation priming. Thus, targeting S100A7A15-RAGE may be a novel thera-
peutic approach for treatment of susceptibility and inflammation in psoriasis.
006
Identification of a novel pro-inflammatory human skin-homing Vγ9Vδ2 T cell subset and its
role in the pathogenesis of psoriasis
U Laggner,1 P Di Meglio,1 GK Perea,1 C Hundhausen,1 KE Lacy,1 N Ali,1 CH Smith,1 AC Hayday,2
BJ Nickoloff3 and FO Nestle1 1 Dermatology, King’s College London, London, United Kingdom,
2 DIIID, King’s College London, London, United Kingdom and 3 Pathology, Loyola University
Medical Center, Maywood, IL
γδ T cells are key players in murine skin immunology where they mediate rapid tissue responses
and immuno-regulation. The role of δγ cells in human skin under tissue homeostasis and inflam-
mation is less well established. In this study we aimed to elucidate the role of Vγ9Vδ2 T cells in skin
immunosurveillance and in the skin pathology psoriasis. Peripheral blood mononuclear cells (PBMCs)
of psoriasis patients and healthy controls were assessed by flow cytometry. Vγ9Vδ2 T cells in skin
were investigated by immunofluorescence analysis. Skin suction blister techniques were used to
show skin homing and multi cytokine bead array as well as real time qPCR were employed for analy-
sis of cytokine production. We found a distinct subset of Vγ9Vδ2 T cells in peripheral blood which
expressed the skin homing marker cutaneous lymphocyte antigen (CLA). This cell subset was rap-
idly and specifically recruited into perturbed human skin. Investigating the potential implication of
Vγ9Vδ2T cells in psoriasis pathogenesis we found a highly significant decrease of Vγ9Vδ2T cells in
psoriasis patients (n=66) compared to healthy controls (n=34). This decrease was significantly asso-
ciated with increased disease severity and was rescued by successful anti-psoriatic therapy. Vγ9Vδ2
T cells were present in psoriatic lesions but not in healthy skin indicating a redistribution of CLA+
Vγ9Vδ2 T cells from the blood during skin inflammation. Functional analysis revealed that
CLA+Vγ9Vδ2 produced psoriasis-relevant Th1/TH17 cytokines and pro-inflammatory chemokines
upon activation. Supernatant of stimulated CLA+Vγ9Vδ2 T cells led to potent activation of ker-
atinocytes. Here we identify a novel skin-homing CLA+Vγ9Vδ2 T cell subset with a pro-inflamma-
tory cytokine profile involved in skin immune surveillance and establish its clinical relevance in
psoriasis.
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Genome-wide expression profiling of five mouse models identifies similarities and differences
with human psoriasis
WR Swindell,1 A Johnston,2 S Carbajal,3 G Han,4 C Wohn,5 J Lu,6 X Xing,2 RP Nair,2 JJ Voorhees,2
JT Elder,2 X Wang,4 S Sano,7 EP Prens,5 J DiGiovanni,3 MR Pittelkow,6 NL Ward8 and
JE Gudjonsson2 1 Dept. of Genetics, Harvard Medical School, Boston, MA, 2 Dept. of
Dermatology, Univ. of Michigan, Ann Arbor, MI, 3 Div.of Pharmacology & Toxicology, The
Univ. of Texas at Austin, Austin, TX, 4 Dept. of Pathology, Otolaryngology & Dermatology,
Univ. of Colorado, Denver, CO, 5 Depts. of Dermatology, Rheumatology & Immunology,
Erasmus MC, Rotterdam, Netherlands, 6 Dept. of Dermatology, Mayo Clinic, Rochester, MN,
7 Dept. of Dermatology, Kochi Medical School, Okocho, Japan and 8 Dept. of Dermatology,
Case Western, Cleveland, OH
Development of a suitable mouse model would facilitate the investigation of mechanisms under-
lying human psoriasis and development of therapeutic treatments. However, no single model reca-
pitulates all features of the human disease, and standardized validation criteria for psoriasis mouse
models have not been widely applied. In this study, whole-genome transcriptional profiling was
used to compare gene expression patterns manifested by human psoriatic skin lesions with those
that occur in five psoriasis mouse models (K5-Tie2, imiquimod, K14-AREG, K5-Stat3C and K5-
TGFbeta1). The cutaneous gene expression profiles associated with each mouse phenotype exhib-
ited statistically significant similarity to psoriasis in humans. For all five models, correspondence to
the human disease was strong with respect to genes involved in epidermal development and kera-
tinization. Immune and inflammation-associated gene expression, in contrast, was more variable
between models as compared to the human disease. These findings support the value of all five
models as research tools, each with identifiable areas of convergence to and divergence from the
human disease. Additionally, the approach used in this paper provides an objective and quantita-
tive method for evaluation of proposed mouse models of psoriasis, which can be strategically applied
in future studies.
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Anti-inflammatory activity of water chestnut (Trapa japonica Flerov.)
J Kim,1 S Lee,1 M Oh,1 B Kim,1 H Kim,1 B Choi2 and J Lee1 1 R&D Center of Skin Science and
Cosmetics, Enprani, Incheon, Republic of Korea and 2 SN Biotech Co., Ltd, Yongin, Republic
of Korea
The water chestnut (Trapa japonica Flerov.) is an annual aquatic plant that is found in lakes and
ponds in various parts of the world, including Korea, Japan, China, India, and North America. Most
studies on water chestnut have focused on its taxonomy and ecology, but its biological activity
have rarely been studied. In this study, we elucidated the biological effects of the crude water extract
from water chestnut on the production of inflammatory mediators in macrophages. The water
chestnut extract dose-dependantly (0.001~0.01 %) inhibited LPS-induced NO production and sup-
pressed LPS-induced protein and the mRNA expression of the inducible nitric oxide synthase (iNOS)
gene in RAW264.7 cells. But there was no effect on LPS-induced protein and the mRNA expres-
sion of clyclooxlygenase-2 (COX-2). Using the cytokine array assay (protein chip assay), it showed
that water chestnut extracts had the ability to inhibit LPS-induced the protein expression of pro-
inflammatory cytokine. Human skin primary irritation tests were performed on the normal skin
(upper back) of 20 volunteers to determine if any material in water chestnut extracts had irritation
or sensitization potential. We also investigative the protective effect of this extract in sodium lauryl
sulfate (SLS)-induced irritant human skin, it was reduced SLS-induced skin erythema and improve
barrier regeneration. Based on these results, we suggest that water chestnut extracts is a promising
candidate anti-inflammatory agent with potential for use in skin care cosmetics or in the treatment
of skin diseases such as acne and atopic dermatitis.
017
Clinical and laboratory markers of sclerotic-type chronic graft versus host disease
KJ Martires,1 K Baird,2 SM Steinberg,3 L Grkovic,4 K Williams,4 F Hakim,4 SZ Pavletic4 and
EW Cowen1 1 Dermatology, NCI NIH, Bethesda, MD, 2 Pediatric Oncology, NCI NIH,
Bethesda, MD, 3 Biostatistics and Data Management, NCI NIH, Bethesda, MD and 4
Experimental Transplantation and Immunology, NCI NIH, Bethesda, MD
Sclerotic-type cutaneous chronic graft-versus-host disease (ScGVHD) resembles morphea, sys-
temic sclerosis, or eosinophilic fasciitis, and may lead to significant functional disability. Risk fac-
tors and clinical markers of ScGVHD are largely unknown. In this cross-sectional study, 206 patients
with a history of chronic GVHD (cGVHD) following hematopoietic stem cell transplantation (HCT)
underwent systematic clinical and laboratory evaluation by an interdisciplinary team at the NIH.
ScGVHD was identified by skin biopsy and clinical exam (body surface area (BSA)). Patients with
ScGVHD were compared to patients with cGVHD without fibrosis. Pediatric patients (17) were
excluded from survival analysis. 109 (52.9%) patients had ScGVHD. The median BSA involvement
was 37.1%. In univariate analyses, ScGVHD was associated with higher platelet levels (p<0.001),
higher CRP (p<0.001), and higher C3 (p<0.001) and C4 (p<0.001) levels. Serum levels of eosinophils,
CD4 T cells, CD8 T cells, and B cells were not significantly related to the presence of fibrosis. In
univariate analysis, total body irradiation (TBI) was associated with the later development of ScGVHD.
67% of patients receiving TBI during conditioning developed ScGVHD compared to 44% who did
not receive TBI (p=0.002). No autoimmune markers, including ANA and RF, were associated with
skin fibrosis. Lung function values (FEV1 and DLCO) also had no relationship to skin fibrosis, how-
ever, decreased FVC was associated with fibrosis (p= 0.013). Among patients with ScGVHD, higher
BSA sclerotic skin involvement was associated with poorer overall survival (p=0.015). In conclu-
sion, complement, platelet levels, and TBI were associated with ScGVHD, suggesting that TBI used
in myeloablative conditioning may be a risk factor for ScGVHD. For patients with ScGVHD, the
extent of skin involvement assessed by BSA was associated with poorer overall survival.
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Dermal-type macrophages can be integrated into a collagen-fibroblast scaffold
N Bechetoille,1 H Vachon,2 T Fontaine,2 V André-Frei1 and CG Mueller2 1 BASF Beauty Care
Solutions France, Lyon, France and 2 CNRS, Laboratory of Therapeutic Immunology and
Chemistry, IBMC, University Louis Pasteur, Strasbourg, France
The reconstruction of human skin in vitro by a three-dimensional skin culture system has already
been significantly improved by incorporating Langerhans cells and dermal dendritic cells. Yet, skin
culture systems still suffer from the lack of the third immune cell subtype, i.e. dermal macrophages.
Monocyte-derived dermal-type macrophages (MDdM) were seeded into dermis equivalents and cul-
tured for 1 additional week without adding exogenous cytokines. Their phenotypic stability and
distribution within the 3D culture were analyzed by immunolabelling on histological sections. After
1 week inside the dermis equivalent, MDdM expressed CD14, CD163, CD209 and HLA-DR and
lacked CD1a/c. In addition, MDdM released IL-10, but no TNFα, when stimulated by LPS. We suc-
cessfully integrated stable and functional MDdM into dermis equivalents. Because there is increas-
ing evidence that dermal macrophages and dendritic cells co-exist in a dynamic equilibrium, our
model opens the possibility of studying the relationship and potential cross-talk between the two
cell types. Such interactions between dermal macrophages and dendritic cells need to be clarified
in certain infectious diseases, where they elicit particular immune responses in reaction to bacter-
ial or viral pathogens. Finally, with the aim of finding new treatments for inflammatory skin diseases,
we wish to use our model to find ways to specifically target dermal macrophages and stimulate
their release of anti-inflammatory IL-10.
014
Identification of IL-4 regulated keratinocyte genes relevant in the pathogenesis of atopic der-
matitis
L Bao1 and LS Chan1,2 1 Dermatology, Univ of Illinois, Chicago, IL and 2 Med Service, Jesse
Brown VA Med Center, Chicago, IL
An important role of IL-4 in atopic dermatitis (AD) is suggested by the facts that AD is characterized
by early up-regulation of Th2-type cytokines such as IL-4 in the skin and that overexpressing IL-4 in
basal keratinocytes resulted in an animal model of AD. How IL-4 influences the cutaneous immune
milieu via keratinocytes, a dominant epidermal cell type that participates in various immune
responses, is unclear. In this study we aim at identifying keratinocyte genes regulated by IL-4 that
may play key roles in the pathophysiology of AD. HaCat cells were treated with vehicle or IL-4 at
various doses for 24 hours, and PCR gene array on inflammation/autoimmunity was performed three
times for differential expression analysis. Genes with at least 2-fold up-regulation or down-regula-
tion by IL-4 and with a P-value of less than 0.05 were identified. Of all the genes examined, 32 and
53 genes are up- and down-regulated, respectively. Specifically related to AD, chemokines CCL3L1,
CCL8, CCL24, CCL25, CCL26, CXCL6 and CXCL16, which are involved in the recruitment of dif-
ferent inflammatory cells to the skin, are up-regulated. Pro-inflammatory factors, such as IL-19, IL-
20, IL-12RB2, IL-25, IL-31RA, OSMR and nitric oxide synthase 2, are also up-regulated. In addi-
tion, IL-4 up-regulates VEGFA, a pro-angiogenic factor. By contrast, S100s and IL-1R1, which play
key roles in the regulation of filaggrin and ceramide production respectively, CXCL14, an impor-
tant antimicrobial factor, TNF-alpha, and lymphotoxin-beta, an IgE suppressor, are down-regu-
lated. Toll-like receptors 1 & 6 (TLR1 & TLR6), which serve as TLR2 co-receptors, are down-regu-
lated by IL-4. Both CCL17 and IL-18 are down-regulated in the array, consistent with the reported
lower than normal levels of CCL17 and IL-18 present in AD patients under 10 years old. Detailed
examination of keratinocyte genes regulated by IL-4 will delineate their specific roles in chemo-
taxis, inflammation, angiogenesis, skin barrier, and antimicrobial production, which are important
for AD pathogenesis.
018
Role of IL-13 in the cytokine network of psoriasis
M Riblett, X Xing, J Kochkodan, AM Guzman, JJ Voorhees, A Johnston and JE Gudjonsson
Department of Dermatology, University of Michigan, Ann Arbor, MI
Recent genetic studies have shown that a nonsynonymous coding variant in the IL13 gene (rs20541)
contributes to increased risk of psoriasis. Although IL-13 has traditionally been classified as a Th2
cytokine, its role in psoriasis is unknown. IL13 mRNA (n=38, p<0.01) and protein levels (n=12,
p<0.01) were increased in lesional psoriatic compared to uninvolved skin. Flow cytometric analy-
sis of lesional skin lymphocytes demonstrated that the IL-13 was derived from CD4 and CD8+ T-
cells (2-3% of total). There was increased expression of both chains of the IL-13 receptor (IL-4R and
IL13-Rα1) in lesional compared to uninvolved psoriatic skin (n=38, p<0.0001, p<0.05, respectively)
whereas IL13RA2, a soluble inhibitor of IL-13, was decreased (n=38, p<0.05). Using cytokine-stim-
ulated post-confluent NHKs we observed a dose-dependent induction of IL4R and IL13RA1 with
IFN-γ and IL-22 (>3-fold, p<0.01). Immunohistochemistry and fluorescent microscopy was confir-
matory demonstrating increased staining for IL-4R and IL-13Rα1 in psoriatic epidermis with foci of
co-localization limited to a few cells within the inflammatory infiltrate. These cells corresponded
to monocytes as confirmed by flow cytometry. IL-13 (1-10ng/ml) increased expression of IL12B and
TNF in TNF-α stimulated, IFN-γ primed, monocytes (6-fold and 2-fold respectively, p<0.05, n=9)
with increased secretion of IL-23 (3-fold, p<0.05, n=10) and IL-12 (1.2-fold, p<0.05, n=10). In con-
trast to IL-4 (20ng/ml), which showed no effect, IL-13 (20ng/ml) synergized with IFN-γ in the induc-
tion of CXCL9 and CXCL10 by NHKs (IFN-γ+IL-13 vs. IFN-γ alone, p<0.01, p=0.08, respectively
n=6). Our results suggest that IL-13 does not play a traditionally Th2 immunosuppressive role in pso-
riasis but instead acts both on the epidermis and the inflammatory infiltrate leading to shifts in the
polarization of the infiltrate towards the Th1/Th17 axis through its activity on cytokine and chemokine
production by both the epidermis and the inflammatory infiltrate.
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IL-33 is produced by normal human keratinocytes with environmental and inflammatory stim-
uli: A novel “alarmin” in the skin
J Meephansan,1 M Komine,1,2 H Tsuda,1 S Yano,3 S Tominaga2 and M Ohtsuki1 1 Dermatology,
Jichi Medical University, Shimotsuke, Japan, 2 Biochemistry, Jichi Medical University,
Shimotsuke, Japan and 3 Dermatology, International University of Health and Welfare,
Ohtawara, Japan
IL-33 is a newly identified member of IL-1 family, and its constitutive nuclear expression has been
reported in endothelial cells and epidermal keratinocytes in the skin, and is believed to be released
when the cells are exposed to danger signals that lead to cell damage. However, its production in
cultured keratinocytes has not been reported. We examined the effect of ultraviolet B (UVB), mechan-
ical stretch, and the administration of IFNγ and/or TNFα, the environmental and inflammatory stim-
uli, on cultured normal human keratinocytes (NHKs) whether they could induce IL-33 production.
Cultured NHKs were stimulated by the above mentioned stimuli, the cells were harvested, and
then ELISA, real-time PCR and western blotting were performed. UVB and cyclic mechanical stretch-
ing induced the expression of IL-33 at both protein and mRNA levels. IFNγ induced IL-33 expres-
sion in a time- and dose- dependent manner at protein and mRNA levels, but TNFα did not. IL-33
produced from NHKs stimulated by IFNγ was 33kDa pro-form at low concentration and short incu-
bation time up to 12 hours, but 20kDa smaller form appeared at high concentration and longer
incubation for 20 hours with IFNγ. The intensity of 20kDa band increased when cells were incu-
bated with the combination of IFNγ and TNFα. This 20kDa band was also detected when cells were
stimulated by UVB and by mechanical stretching. The 20kDa form corresponded to the calpain-
digested mature IL-33. The induction of IL-33 by UVB or IFNγ was suppressed by the addition of
inhibitors for ERK or p38, and the induction by mechanical stretching was suppressed by the addi-
tion of ERK inhibitor. This study demonstrated for the first time that NHKs produced proIL-33 and
mature IL-33 by the stimulation with IFNγ or UVB, which may serve as danger signals when epi-
dermis was exposed to external stimuli or severe inflammation.
008
Human β-defensin-2 enhances IFN-γ and IL-10 production and suppresses IL-17 production
in T cells: Its roles in psoriasis
N Kanda,1 M Kamata,2 Y Tada,2 T Ishikawa,1 S Sato2 and S Watanabe1 1 Dermatology, Teikyo
University School of Medicine, Tokyo, Japan and 2 Dermatology, Faculty of Medicine,
University of Tokyo, Tokyo, Japan
Psoriasis is an inflammatory dermatosis characterized by the enhanced expression of human β-
defensin-2 (hBD-2) in keratinocytes and the infiltration of T cells producing cytokines which up- or
down-regulate hBD-2 expression. We examined serum levels of hBD-2 and cytokines in psoriasis
patients and analyzed the effects of hBD-2 on cytokine production in human peripheral blood T
cells. Serum hBD-2 levels in patients were higher than those in controls, and correlated with pso-
riasis area and severity index, IFN-γ and IL-10 levels, and inversely correlated with IL-17 levels. IFN-
γ, IL-17, IL-22, TNF-α, IL-6, and IL-1β enhanced while IL-10, IL-4, and IL-13 suppressed hBD-2
secretion from keratinocytes. hBD-2 enhanced the secretion and mRNA levels of IFN-γ, TNF-α, IL-
10, IL-1β, IL-6, and IL-22,while reduced those of IL-17 in CD3/CD28-stimulated T cells. hBD-2
induced phosphorylation of JNK, ERK, and Akt in T cells, and the inhibitors of these signals atten-
uated the hBD-2-induced production of IFN-γ, TNF-α, IL-10, IL-1β, IL-6, and IL-22. hBD-2 sup-
pressed the phosphorylation of STAT3 and enhanced SOCS3 expression in CD3/CD28-stimulated
T cells. siRNA against SOCS3 reversed the hBD-2-induced suppression of IL-17 production and
STAT3 phosphorylation. JNK and MEK inhibitors suppressed the hBD-2-induced expression of SOCS3.
In conclusion, hBD-2 may act as a T cell stimulator by enhancing IFN-γ, TNF-α, IL-1β, IL-6, or IL-
22 production via activation of JNK, MEK/ERK, and PI-3K/Akt, while it acts as a regulator by sup-
pressing IL-17 production via SOCS3 induction or stimulating IL-10 production. These effects of
hBD-2 may contribute to the cross-talk between keratinocytes and T cells in psoriasis lesions.
009
Cutaneous expression of neutrophil elastase in relation to IgA autoantibodies to nonapep-
tides of gliadin and tissue transglutaminase in dermatitis herpetiformis
M Dmochowski,1 J Gornowicz,1 A Seraszek,2 E Kaczmarek2 and M Bowszyc-Dmochowska1 1
Dermatology, University School of Medicine, Poznan, Poland and 2 Bioinformatics and
Computational Biology, University School of Medicine, Poznan, Poland
Neutrophil elastase seems to be one of enzymes responsible for degradation of the dermal-epider-
mal junction (DEJ) in dermatitis herpetiformis (DH) leading to the formation of an intra-lamina lucida
separation, the pathological hallmark of the full-blown disease. Neutrophils are activated by an
engagement of their CD89 receptors by IgA autoantibodies. Here, we examined whether in DH
lesional skin the expression of NE is related to the IgA autoantibodies to nonapetides of gliadin (IgA
npG) and tissue transglutaminase (IgA tTG). Altogether, 31 current DH patients, 27 current bullous
pemphigoid (BP) control patients and 24 healthy individuals were studied. The intensity of NE expres-
sion, visualized with immunohistochemical streptavidin-peroxidase technique on paraffin-embed-
ded sections, was measured using quantitative digital morphometry and levels of serum IgA npG
and IgA tTG were evaluated with ELISA. The mean intensity of expression of NE was significantly
higher in DH than in BP (p=0.0001). There was a significant correlation between levels of IgA npG
and IgA tTG in DH (r=+0.4698; p=0.0077) but there was no such a correlation in healthy individ-
uals. There were no correlations between intensity of expression of NE and levels of either IgA npG
or IgA tTG in DH. Thus, it seems that the production of IgA npG takes place in a coordinated way
with the production of IgA tTG when patients show cutaneous lesions of DH. Nevertheless, it is
hypothesized that IgA npG and IgA tTG, regardless of the issue of their diagnostic significance,
have lesser importance as far as cutaneous pathology of DH, mediated by DEJ-degrading NE released
from IgA autoimmunity-activated neutrophils, is concerned.
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Epidermal ablation of Dlx3 is linked to barrier disruption and a skin inflammation
J Hwang,1 R Kita,1 H Kwon,2 E Choi,3 S Lee,4 MC Udey2 and MI Morasso1 1 Developmental Skin
Biology Section, NIAMS, NIH, Bethesda, MD, 2 Dermatology Branch, NCI, NIH, Bethesda,
MD, 3 Department of Dermatology, Yonsei University Wonju College of Medicine, Wonju,
Republic of Korea and 4 Department of Dermatology, Yonsei University College of Medicine,
Seoul, Republic of Korea
Dlx3 is a homeodomain transcription factor that regulates epidermal development and terminal
differentiation of keratinocytes. Here we demonstrate the pivotal role of Dlx3 in cutaneous home-
ostasis, showing that its ablation in epidermis is linked to barrier disruption, abnormal keratinocyte
differentiation, epidermal hyperplasia and inflammation. Gene expression analyses showed up-reg-
ulation of cytokines, chemokines, proteinases, and antimicrobacterial peptides. Leukocyte infiltra-
tion was prominent and development of a systemic inflammatory response was observed as vari-
ous proinflammatory cytokines were up-regulated in the sera of K14cre;Dlx3Kin/f mice. Subsequent
flow cytometric analysis revealed significant increases in T cells, Langerhans cells, and neutrophils
in the skin of K14cre;Dlx3Kin/f mice. Additionally, we found that the gene expression signature of
the K14cre;Dlx3Kin/f skin was similar to that of the human inflammatory skin disease, psoriasis.
These results indicate that Dlx3 regulatory function is essential for normal barrier formation in murine
skin and that epidermal deletion of Dlx3 is also associated with development of an inflammatory
response. This model may facilitate elucidation of mechanisms that causally link perturbations of
barrier function to inflammation that occur in several common human skin diseases.
011
Cytokine aberrations in a mouse model of psoriatic arthritis
M Yamamoto and S Sano Kochi Medical School, Kochi University, Nankoku, Japan
Psoriatic arthritis (PsA) is a seronegative, chronic inflammatory joint disease associated with psori-
asis. Joint involvements of PsA lead to devastating quality of life. However, the underlying patho-
mechanism of PsA still remains unknown because of scantiness of biopsy specimens or no relevant
animal models of PsA. A majority of PsA patients are affected with involvements in the distal joints
of the fingers and toes, which are often overlaid with skin and nail lesions. This finding strongly sug-
gests that psoriatic skin lesion is spatially associated with joint involvement. Dysregulated cytokine
expression and signaling are major contributors of autoimmune diseases including psoriasis and
psoriatic arthritis. The gp 130F759/F759 knock-in mice (F759), in which Y759 of gp130 was mutated
to phenylalanine, showed persistent Stat3 activation due to impaired SOCS3-dependent negative
regulation. F759 homozygous mice demonstrated enhanced IL-6-Stat3 signaling and spontaneously
developed rheumatoid arthritis-like symptoms by 1 year of age. K5.Stat3C transgenic mice, in which
Stat3 is constitutively activated in keratinocytes, developed psoriasis-like skin lesions following
wounding stimuli or topical TPA treatment. To induce skin lesion in F759 mice, we crossed them
with K5.Stat3C mice. Strikingly, K5.Stat3C:F759 homozygous mice spontaneously developed scaly
erythema and swelling in the digits of the hind paws from as early as 3 weeks of age, and some of
them showed stiffness in the joints together with nail involvements over time. Histologically,
K5.Stat3C:F759 homozygous mice demonstrated acanthosis, inflammatory cell infiltrates and dif-
fuse edema in the dermis. Also, enthesitis underlying the skin lesion was present, resembling human
PsA. The digit lesions demonstrated increased transcriptional levels of Th17 cytokines, and other
proinflammatory cytokines. These results strongly suggested that Stat3 activation linked skin lesion
to its adjacent joints in PsA.
012
Involvement of the CXCL10/CXCR3 axis in the mechanism responsible for cutaneous reverse
passive Arthus reaction
S Noda, Y Asano, Y Tada, M Sugaya, T Kadono and S Sato Dermatology, University of Tokyo,
Tokyo, Japan
The deposition of immune complexes (IC) induces an acute inflammatory response with tissue injury,
such as vasculitis. IC-induced inflammation is mediated by inflammatory cell infiltration, a process
regulated by expression of multiple adhesion molecules, chemokines, and its receptors. CXCL10,
a chemokine secreted from cells stimulated with interferons, and its receptor, CXCR3, are reported
to play an important role in various inflammatory diseases, including rheumatoid arthritis, trans-
plant rejection, psoriasis, and lichen planus, via recruiting effector cells into sites of tissue inflam-
mation. The classical experimental model for IC-mediated tissue injury is the Arthus reaction, which
is characterized by edema, hemorrhage, and neutrophil infiltration. To assess the role of the
CXCL10/CXCR3 axis in this pathogenetic process, the cutaneous reverse passive Arthus reaction
was examined in mice lacking CXCL10 (CXCL10-/-), or CXCR3 (CXCR3-/-). Concretely, chicken
egg albumin was injected intravenously and immediately thereafter rabbit IgG anti-chicken egg albu-
min antibodies were injected intradermally. Subsequently, skin tissues were harvested 4 or 8 hours
later and assessed. Edema and hemorrhage, which peaked 4 and 8 hours after IC challenge, respec-
tively, were significantly reduced in CXCL10-/- and CXCR3-/- mice as compared with wild-type lit-
termates. Reduced neutrophil, but not mast cell, infiltration was also observed for both mutant mice.
Both edema and neutrophil infiltration were much greater inhibited in CXCL10-/- mice than in
CXCR3-/- mice. Furthermore, several cutaneous cytokine productions were inhibited at mRNA lev-
els in the both knockout mice, which paralleled the reductions in cutaneous inflammation. These
results indicate that the CXCL10/CXCR3 axis contributes to the mechanism responsible for cuta-
neous Arthus reaction by regulating neutrophil recruitment and suggest that the CXCL10/CXCR3
axis are one of the potential therapeutic targets for human IC-mediated diseases, such as vasculitis.
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Genome-wide expression profiling of five mouse models identifies similarities and differences
with human psoriasis
WR Swindell,1 A Johnston,2 S Carbajal,3 G Han,4 C Wohn,5 J Lu,6 X Xing,2 RP Nair,2 JJ Voorhees,2
JT Elder,2 X Wang,4 S Sano,7 EP Prens,5 J DiGiovanni,3 MR Pittelkow,6 NL Ward8 and
JE Gudjonsson2 1 Dept. of Genetics, Harvard Medical School, Boston, MA, 2 Dept. of
Dermatology, Univ. of Michigan, Ann Arbor, MI, 3 Div.of Pharmacology & Toxicology, The
Univ. of Texas at Austin, Austin, TX, 4 Dept. of Pathology, Otolaryngology & Dermatology,
Univ. of Colorado, Denver, CO, 5 Depts. of Dermatology, Rheumatology & Immunology,
Erasmus MC, Rotterdam, Netherlands, 6 Dept. of Dermatology, Mayo Clinic, Rochester, MN,
7 Dept. of Dermatology, Kochi Medical School, Okocho, Japan and 8 Dept. of Dermatology,
Case Western, Cleveland, OH
Development of a suitable mouse model would facilitate the investigation of mechanisms under-
lying human psoriasis and development of therapeutic treatments. However, no single model reca-
pitulates all features of the human disease, and standardized validation criteria for psoriasis mouse
models have not been widely applied. In this study, whole-genome transcriptional profiling was
used to compare gene expression patterns manifested by human psoriatic skin lesions with those
that occur in five psoriasis mouse models (K5-Tie2, imiquimod, K14-AREG, K5-Stat3C and K5-
TGFbeta1). The cutaneous gene expression profiles associated with each mouse phenotype exhib-
ited statistically significant similarity to psoriasis in humans. For all five models, correspondence to
the human disease was strong with respect to genes involved in epidermal development and kera-
tinization. Immune and inflammation-associated gene expression, in contrast, was more variable
between models as compared to the human disease. These findings support the value of all five
models as research tools, each with identifiable areas of convergence to and divergence from the
human disease. Additionally, the approach used in this paper provides an objective and quantita-
tive method for evaluation of proposed mouse models of psoriasis, which can be strategically applied
in future studies.
015
Anti-inflammatory activity of water chestnut (Trapa japonica Flerov.)
J Kim,1 S Lee,1 M Oh,1 B Kim,1 H Kim,1 B Choi2 and J Lee1 1 R&D Center of Skin Science and
Cosmetics, Enprani, Incheon, Republic of Korea and 2 SN Biotech Co., Ltd, Yongin, Republic
of Korea
The water chestnut (Trapa japonica Flerov.) is an annual aquatic plant that is found in lakes and
ponds in various parts of the world, including Korea, Japan, China, India, and North America. Most
studies on water chestnut have focused on its taxonomy and ecology, but its biological activity
have rarely been studied. In this study, we elucidated the biological effects of the crude water extract
from water chestnut on the production of inflammatory mediators in macrophages. The water
chestnut extract dose-dependantly (0.001~0.01 %) inhibited LPS-induced NO production and sup-
pressed LPS-induced protein and the mRNA expression of the inducible nitric oxide synthase (iNOS)
gene in RAW264.7 cells. But there was no effect on LPS-induced protein and the mRNA expres-
sion of clyclooxlygenase-2 (COX-2). Using the cytokine array assay (protein chip assay), it showed
that water chestnut extracts had the ability to inhibit LPS-induced the protein expression of pro-
inflammatory cytokine. Human skin primary irritation tests were performed on the normal skin
(upper back) of 20 volunteers to determine if any material in water chestnut extracts had irritation
or sensitization potential. We also investigative the protective effect of this extract in sodium lauryl
sulfate (SLS)-induced irritant human skin, it was reduced SLS-induced skin erythema and improve
barrier regeneration. Based on these results, we suggest that water chestnut extracts is a promising
candidate anti-inflammatory agent with potential for use in skin care cosmetics or in the treatment
of skin diseases such as acne and atopic dermatitis.
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Clinical and laboratory markers of sclerotic-type chronic graft versus host disease
KJ Martires,1 K Baird,2 SM Steinberg,3 L Grkovic,4 K Williams,4 F Hakim,4 SZ Pavletic4 and
EW Cowen1 1 Dermatology, NCI NIH, Bethesda, MD, 2 Pediatric Oncology, NCI NIH,
Bethesda, MD, 3 Biostatistics and Data Management, NCI NIH, Bethesda, MD and 4
Experimental Transplantation and Immunology, NCI NIH, Bethesda, MD
Sclerotic-type cutaneous chronic graft-versus-host disease (ScGVHD) resembles morphea, sys-
temic sclerosis, or eosinophilic fasciitis, and may lead to significant functional disability. Risk fac-
tors and clinical markers of ScGVHD are largely unknown. In this cross-sectional study, 206 patients
with a history of chronic GVHD (cGVHD) following hematopoietic stem cell transplantation (HCT)
underwent systematic clinical and laboratory evaluation by an interdisciplinary team at the NIH.
ScGVHD was identified by skin biopsy and clinical exam (body surface area (BSA)). Patients with
ScGVHD were compared to patients with cGVHD without fibrosis. Pediatric patients (17) were
excluded from survival analysis. 109 (52.9%) patients had ScGVHD. The median BSA involvement
was 37.1%. In univariate analyses, ScGVHD was associated with higher platelet levels (p<0.001),
higher CRP (p<0.001), and higher C3 (p<0.001) and C4 (p<0.001) levels. Serum levels of eosinophils,
CD4 T cells, CD8 T cells, and B cells were not significantly related to the presence of fibrosis. In
univariate analysis, total body irradiation (TBI) was associated with the later development of ScGVHD.
67% of patients receiving TBI during conditioning developed ScGVHD compared to 44% who did
not receive TBI (p=0.002). No autoimmune markers, including ANA and RF, were associated with
skin fibrosis. Lung function values (FEV1 and DLCO) also had no relationship to skin fibrosis, how-
ever, decreased FVC was associated with fibrosis (p= 0.013). Among patients with ScGVHD, higher
BSA sclerotic skin involvement was associated with poorer overall survival (p=0.015). In conclu-
sion, complement, platelet levels, and TBI were associated with ScGVHD, suggesting that TBI used
in myeloablative conditioning may be a risk factor for ScGVHD. For patients with ScGVHD, the
extent of skin involvement assessed by BSA was associated with poorer overall survival.
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Dermal-type macrophages can be integrated into a collagen-fibroblast scaffold
N Bechetoille,1 H Vachon,2 T Fontaine,2 V André-Frei1 and CG Mueller2 1 BASF Beauty Care
Solutions France, Lyon, France and 2 CNRS, Laboratory of Therapeutic Immunology and
Chemistry, IBMC, University Louis Pasteur, Strasbourg, France
The reconstruction of human skin in vitro by a three-dimensional skin culture system has already
been significantly improved by incorporating Langerhans cells and dermal dendritic cells. Yet, skin
culture systems still suffer from the lack of the third immune cell subtype, i.e. dermal macrophages.
Monocyte-derived dermal-type macrophages (MDdM) were seeded into dermis equivalents and cul-
tured for 1 additional week without adding exogenous cytokines. Their phenotypic stability and
distribution within the 3D culture were analyzed by immunolabelling on histological sections. After
1 week inside the dermis equivalent, MDdM expressed CD14, CD163, CD209 and HLA-DR and
lacked CD1a/c. In addition, MDdM released IL-10, but no TNFα, when stimulated by LPS. We suc-
cessfully integrated stable and functional MDdM into dermis equivalents. Because there is increas-
ing evidence that dermal macrophages and dendritic cells co-exist in a dynamic equilibrium, our
model opens the possibility of studying the relationship and potential cross-talk between the two
cell types. Such interactions between dermal macrophages and dendritic cells need to be clarified
in certain infectious diseases, where they elicit particular immune responses in reaction to bacter-
ial or viral pathogens. Finally, with the aim of finding new treatments for inflammatory skin diseases,
we wish to use our model to find ways to specifically target dermal macrophages and stimulate
their release of anti-inflammatory IL-10.
014
Identification of IL-4 regulated keratinocyte genes relevant in the pathogenesis of atopic der-
matitis
L Bao1 and LS Chan1,2 1 Dermatology, Univ of Illinois, Chicago, IL and 2 Med Service, Jesse
Brown VA Med Center, Chicago, IL
An important role of IL-4 in atopic dermatitis (AD) is suggested by the facts that AD is characterized
by early up-regulation of Th2-type cytokines such as IL-4 in the skin and that overexpressing IL-4 in
basal keratinocytes resulted in an animal model of AD. How IL-4 influences the cutaneous immune
milieu via keratinocytes, a dominant epidermal cell type that participates in various immune
responses, is unclear. In this study we aim at identifying keratinocyte genes regulated by IL-4 that
may play key roles in the pathophysiology of AD. HaCat cells were treated with vehicle or IL-4 at
various doses for 24 hours, and PCR gene array on inflammation/autoimmunity was performed three
times for differential expression analysis. Genes with at least 2-fold up-regulation or down-regula-
tion by IL-4 and with a P-value of less than 0.05 were identified. Of all the genes examined, 32 and
53 genes are up- and down-regulated, respectively. Specifically related to AD, chemokines CCL3L1,
CCL8, CCL24, CCL25, CCL26, CXCL6 and CXCL16, which are involved in the recruitment of dif-
ferent inflammatory cells to the skin, are up-regulated. Pro-inflammatory factors, such as IL-19, IL-
20, IL-12RB2, IL-25, IL-31RA, OSMR and nitric oxide synthase 2, are also up-regulated. In addi-
tion, IL-4 up-regulates VEGFA, a pro-angiogenic factor. By contrast, S100s and IL-1R1, which play
key roles in the regulation of filaggrin and ceramide production respectively, CXCL14, an impor-
tant antimicrobial factor, TNF-alpha, and lymphotoxin-beta, an IgE suppressor, are down-regu-
lated. Toll-like receptors 1 & 6 (TLR1 & TLR6), which serve as TLR2 co-receptors, are down-regu-
lated by IL-4. Both CCL17 and IL-18 are down-regulated in the array, consistent with the reported
lower than normal levels of CCL17 and IL-18 present in AD patients under 10 years old. Detailed
examination of keratinocyte genes regulated by IL-4 will delineate their specific roles in chemo-
taxis, inflammation, angiogenesis, skin barrier, and antimicrobial production, which are important
for AD pathogenesis.
018
Role of IL-13 in the cytokine network of psoriasis
M Riblett, X Xing, J Kochkodan, AM Guzman, JJ Voorhees, A Johnston and JE Gudjonsson
Department of Dermatology, University of Michigan, Ann Arbor, MI
Recent genetic studies have shown that a nonsynonymous coding variant in the IL13 gene (rs20541)
contributes to increased risk of psoriasis. Although IL-13 has traditionally been classified as a Th2
cytokine, its role in psoriasis is unknown. IL13 mRNA (n=38, p<0.01) and protein levels (n=12,
p<0.01) were increased in lesional psoriatic compared to uninvolved skin. Flow cytometric analy-
sis of lesional skin lymphocytes demonstrated that the IL-13 was derived from CD4 and CD8+ T-
cells (2-3% of total). There was increased expression of both chains of the IL-13 receptor (IL-4R and
IL13-Rα1) in lesional compared to uninvolved psoriatic skin (n=38, p<0.0001, p<0.05, respectively)
whereas IL13RA2, a soluble inhibitor of IL-13, was decreased (n=38, p<0.05). Using cytokine-stim-
ulated post-confluent NHKs we observed a dose-dependent induction of IL4R and IL13RA1 with
IFN-γ and IL-22 (>3-fold, p<0.01). Immunohistochemistry and fluorescent microscopy was confir-
matory demonstrating increased staining for IL-4R and IL-13Rα1 in psoriatic epidermis with foci of
co-localization limited to a few cells within the inflammatory infiltrate. These cells corresponded
to monocytes as confirmed by flow cytometry. IL-13 (1-10ng/ml) increased expression of IL12B and
TNF in TNF-α stimulated, IFN-γ primed, monocytes (6-fold and 2-fold respectively, p<0.05, n=9)
with increased secretion of IL-23 (3-fold, p<0.05, n=10) and IL-12 (1.2-fold, p<0.05, n=10). In con-
trast to IL-4 (20ng/ml), which showed no effect, IL-13 (20ng/ml) synergized with IFN-γ in the induc-
tion of CXCL9 and CXCL10 by NHKs (IFN-γ+IL-13 vs. IFN-γ alone, p<0.01, p=0.08, respectively
n=6). Our results suggest that IL-13 does not play a traditionally Th2 immunosuppressive role in pso-
riasis but instead acts both on the epidermis and the inflammatory infiltrate leading to shifts in the
polarization of the infiltrate towards the Th1/Th17 axis through its activity on cytokine and chemokine
production by both the epidermis and the inflammatory infiltrate.
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IL-33 is produced by normal human keratinocytes with environmental and inflammatory stim-
uli: A novel “alarmin” in the skin
J Meephansan,1 M Komine,1,2 H Tsuda,1 S Yano,3 S Tominaga2 and M Ohtsuki1 1 Dermatology,
Jichi Medical University, Shimotsuke, Japan, 2 Biochemistry, Jichi Medical University,
Shimotsuke, Japan and 3 Dermatology, International University of Health and Welfare,
Ohtawara, Japan
IL-33 is a newly identified member of IL-1 family, and its constitutive nuclear expression has been
reported in endothelial cells and epidermal keratinocytes in the skin, and is believed to be released
when the cells are exposed to danger signals that lead to cell damage. However, its production in
cultured keratinocytes has not been reported. We examined the effect of ultraviolet B (UVB), mechan-
ical stretch, and the administration of IFNγ and/or TNFα, the environmental and inflammatory stim-
uli, on cultured normal human keratinocytes (NHKs) whether they could induce IL-33 production.
Cultured NHKs were stimulated by the above mentioned stimuli, the cells were harvested, and
then ELISA, real-time PCR and western blotting were performed. UVB and cyclic mechanical stretch-
ing induced the expression of IL-33 at both protein and mRNA levels. IFNγ induced IL-33 expres-
sion in a time- and dose- dependent manner at protein and mRNA levels, but TNFα did not. IL-33
produced from NHKs stimulated by IFNγ was 33kDa pro-form at low concentration and short incu-
bation time up to 12 hours, but 20kDa smaller form appeared at high concentration and longer
incubation for 20 hours with IFNγ. The intensity of 20kDa band increased when cells were incu-
bated with the combination of IFNγ and TNFα. This 20kDa band was also detected when cells were
stimulated by UVB and by mechanical stretching. The 20kDa form corresponded to the calpain-
digested mature IL-33. The induction of IL-33 by UVB or IFNγ was suppressed by the addition of
inhibitors for ERK or p38, and the induction by mechanical stretching was suppressed by the addi-
tion of ERK inhibitor. This study demonstrated for the first time that NHKs produced proIL-33 and
mature IL-33 by the stimulation with IFNγ or UVB, which may serve as danger signals when epi-
dermis was exposed to external stimuli or severe inflammation.
008
Human β-defensin-2 enhances IFN-γ and IL-10 production and suppresses IL-17 production
in T cells: Its roles in psoriasis
N Kanda,1 M Kamata,2 Y Tada,2 T Ishikawa,1 S Sato2 and S Watanabe1 1 Dermatology, Teikyo
University School of Medicine, Tokyo, Japan and 2 Dermatology, Faculty of Medicine,
University of Tokyo, Tokyo, Japan
Psoriasis is an inflammatory dermatosis characterized by the enhanced expression of human β-
defensin-2 (hBD-2) in keratinocytes and the infiltration of T cells producing cytokines which up- or
down-regulate hBD-2 expression. We examined serum levels of hBD-2 and cytokines in psoriasis
patients and analyzed the effects of hBD-2 on cytokine production in human peripheral blood T
cells. Serum hBD-2 levels in patients were higher than those in controls, and correlated with pso-
riasis area and severity index, IFN-γ and IL-10 levels, and inversely correlated with IL-17 levels. IFN-
γ, IL-17, IL-22, TNF-α, IL-6, and IL-1β enhanced while IL-10, IL-4, and IL-13 suppressed hBD-2
secretion from keratinocytes. hBD-2 enhanced the secretion and mRNA levels of IFN-γ, TNF-α, IL-
10, IL-1β, IL-6, and IL-22,while reduced those of IL-17 in CD3/CD28-stimulated T cells. hBD-2
induced phosphorylation of JNK, ERK, and Akt in T cells, and the inhibitors of these signals atten-
uated the hBD-2-induced production of IFN-γ, TNF-α, IL-10, IL-1β, IL-6, and IL-22. hBD-2 sup-
pressed the phosphorylation of STAT3 and enhanced SOCS3 expression in CD3/CD28-stimulated
T cells. siRNA against SOCS3 reversed the hBD-2-induced suppression of IL-17 production and
STAT3 phosphorylation. JNK and MEK inhibitors suppressed the hBD-2-induced expression of SOCS3.
In conclusion, hBD-2 may act as a T cell stimulator by enhancing IFN-γ, TNF-α, IL-1β, IL-6, or IL-
22 production via activation of JNK, MEK/ERK, and PI-3K/Akt, while it acts as a regulator by sup-
pressing IL-17 production via SOCS3 induction or stimulating IL-10 production. These effects of
hBD-2 may contribute to the cross-talk between keratinocytes and T cells in psoriasis lesions.
009
Cutaneous expression of neutrophil elastase in relation to IgA autoantibodies to nonapep-
tides of gliadin and tissue transglutaminase in dermatitis herpetiformis
M Dmochowski,1 J Gornowicz,1 A Seraszek,2 E Kaczmarek2 and M Bowszyc-Dmochowska1 1
Dermatology, University School of Medicine, Poznan, Poland and 2 Bioinformatics and
Computational Biology, University School of Medicine, Poznan, Poland
Neutrophil elastase seems to be one of enzymes responsible for degradation of the dermal-epider-
mal junction (DEJ) in dermatitis herpetiformis (DH) leading to the formation of an intra-lamina lucida
separation, the pathological hallmark of the full-blown disease. Neutrophils are activated by an
engagement of their CD89 receptors by IgA autoantibodies. Here, we examined whether in DH
lesional skin the expression of NE is related to the IgA autoantibodies to nonapetides of gliadin (IgA
npG) and tissue transglutaminase (IgA tTG). Altogether, 31 current DH patients, 27 current bullous
pemphigoid (BP) control patients and 24 healthy individuals were studied. The intensity of NE expres-
sion, visualized with immunohistochemical streptavidin-peroxidase technique on paraffin-embed-
ded sections, was measured using quantitative digital morphometry and levels of serum IgA npG
and IgA tTG were evaluated with ELISA. The mean intensity of expression of NE was significantly
higher in DH than in BP (p=0.0001). There was a significant correlation between levels of IgA npG
and IgA tTG in DH (r=+0.4698; p=0.0077) but there was no such a correlation in healthy individ-
uals. There were no correlations between intensity of expression of NE and levels of either IgA npG
or IgA tTG in DH. Thus, it seems that the production of IgA npG takes place in a coordinated way
with the production of IgA tTG when patients show cutaneous lesions of DH. Nevertheless, it is
hypothesized that IgA npG and IgA tTG, regardless of the issue of their diagnostic significance,
have lesser importance as far as cutaneous pathology of DH, mediated by DEJ-degrading NE released
from IgA autoimmunity-activated neutrophils, is concerned.
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Epidermal ablation of Dlx3 is linked to barrier disruption and a skin inflammation
J Hwang,1 R Kita,1 H Kwon,2 E Choi,3 S Lee,4 MC Udey2 and MI Morasso1 1 Developmental Skin
Biology Section, NIAMS, NIH, Bethesda, MD, 2 Dermatology Branch, NCI, NIH, Bethesda,
MD, 3 Department of Dermatology, Yonsei University Wonju College of Medicine, Wonju,
Republic of Korea and 4 Department of Dermatology, Yonsei University College of Medicine,
Seoul, Republic of Korea
Dlx3 is a homeodomain transcription factor that regulates epidermal development and terminal
differentiation of keratinocytes. Here we demonstrate the pivotal role of Dlx3 in cutaneous home-
ostasis, showing that its ablation in epidermis is linked to barrier disruption, abnormal keratinocyte
differentiation, epidermal hyperplasia and inflammation. Gene expression analyses showed up-reg-
ulation of cytokines, chemokines, proteinases, and antimicrobacterial peptides. Leukocyte infiltra-
tion was prominent and development of a systemic inflammatory response was observed as vari-
ous proinflammatory cytokines were up-regulated in the sera of K14cre;Dlx3Kin/f mice. Subsequent
flow cytometric analysis revealed significant increases in T cells, Langerhans cells, and neutrophils
in the skin of K14cre;Dlx3Kin/f mice. Additionally, we found that the gene expression signature of
the K14cre;Dlx3Kin/f skin was similar to that of the human inflammatory skin disease, psoriasis.
These results indicate that Dlx3 regulatory function is essential for normal barrier formation in murine
skin and that epidermal deletion of Dlx3 is also associated with development of an inflammatory
response. This model may facilitate elucidation of mechanisms that causally link perturbations of
barrier function to inflammation that occur in several common human skin diseases.
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Cytokine aberrations in a mouse model of psoriatic arthritis
M Yamamoto and S Sano Kochi Medical School, Kochi University, Nankoku, Japan
Psoriatic arthritis (PsA) is a seronegative, chronic inflammatory joint disease associated with psori-
asis. Joint involvements of PsA lead to devastating quality of life. However, the underlying patho-
mechanism of PsA still remains unknown because of scantiness of biopsy specimens or no relevant
animal models of PsA. A majority of PsA patients are affected with involvements in the distal joints
of the fingers and toes, which are often overlaid with skin and nail lesions. This finding strongly sug-
gests that psoriatic skin lesion is spatially associated with joint involvement. Dysregulated cytokine
expression and signaling are major contributors of autoimmune diseases including psoriasis and
psoriatic arthritis. The gp 130F759/F759 knock-in mice (F759), in which Y759 of gp130 was mutated
to phenylalanine, showed persistent Stat3 activation due to impaired SOCS3-dependent negative
regulation. F759 homozygous mice demonstrated enhanced IL-6-Stat3 signaling and spontaneously
developed rheumatoid arthritis-like symptoms by 1 year of age. K5.Stat3C transgenic mice, in which
Stat3 is constitutively activated in keratinocytes, developed psoriasis-like skin lesions following
wounding stimuli or topical TPA treatment. To induce skin lesion in F759 mice, we crossed them
with K5.Stat3C mice. Strikingly, K5.Stat3C:F759 homozygous mice spontaneously developed scaly
erythema and swelling in the digits of the hind paws from as early as 3 weeks of age, and some of
them showed stiffness in the joints together with nail involvements over time. Histologically,
K5.Stat3C:F759 homozygous mice demonstrated acanthosis, inflammatory cell infiltrates and dif-
fuse edema in the dermis. Also, enthesitis underlying the skin lesion was present, resembling human
PsA. The digit lesions demonstrated increased transcriptional levels of Th17 cytokines, and other
proinflammatory cytokines. These results strongly suggested that Stat3 activation linked skin lesion
to its adjacent joints in PsA.
012
Involvement of the CXCL10/CXCR3 axis in the mechanism responsible for cutaneous reverse
passive Arthus reaction
S Noda, Y Asano, Y Tada, M Sugaya, T Kadono and S Sato Dermatology, University of Tokyo,
Tokyo, Japan
The deposition of immune complexes (IC) induces an acute inflammatory response with tissue injury,
such as vasculitis. IC-induced inflammation is mediated by inflammatory cell infiltration, a process
regulated by expression of multiple adhesion molecules, chemokines, and its receptors. CXCL10,
a chemokine secreted from cells stimulated with interferons, and its receptor, CXCR3, are reported
to play an important role in various inflammatory diseases, including rheumatoid arthritis, trans-
plant rejection, psoriasis, and lichen planus, via recruiting effector cells into sites of tissue inflam-
mation. The classical experimental model for IC-mediated tissue injury is the Arthus reaction, which
is characterized by edema, hemorrhage, and neutrophil infiltration. To assess the role of the
CXCL10/CXCR3 axis in this pathogenetic process, the cutaneous reverse passive Arthus reaction
was examined in mice lacking CXCL10 (CXCL10-/-), or CXCR3 (CXCR3-/-). Concretely, chicken
egg albumin was injected intravenously and immediately thereafter rabbit IgG anti-chicken egg albu-
min antibodies were injected intradermally. Subsequently, skin tissues were harvested 4 or 8 hours
later and assessed. Edema and hemorrhage, which peaked 4 and 8 hours after IC challenge, respec-
tively, were significantly reduced in CXCL10-/- and CXCR3-/- mice as compared with wild-type lit-
termates. Reduced neutrophil, but not mast cell, infiltration was also observed for both mutant mice.
Both edema and neutrophil infiltration were much greater inhibited in CXCL10-/- mice than in
CXCR3-/- mice. Furthermore, several cutaneous cytokine productions were inhibited at mRNA lev-
els in the both knockout mice, which paralleled the reductions in cutaneous inflammation. These
results indicate that the CXCL10/CXCR3 axis contributes to the mechanism responsible for cuta-
neous Arthus reaction by regulating neutrophil recruitment and suggest that the CXCL10/CXCR3
axis are one of the potential therapeutic targets for human IC-mediated diseases, such as vasculitis.
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Erlotinib-stimulated epidermal hyperplasia is mediated by IL-1
NL Ward,2 N Bhagavathula,1 CM Loyd,2 S Dawes,2 A Johnston,1 J Varani1 and JT Elder1 1 Univ of
Michigan, Ann Arbor, MI and 2 Case Western Univ, Cleveland, OH
Skin rash is a dose-limiting toxicity of EGFR tyrosine kinase inhibitors (RTKI). We reported (SID 2010)
that Erlotinib (Erl) treatment of K5tTA:TetOSTek/Tie2 bigenic mice (KC-Tie2 mice, 10 mg/kg IP daily
for 28d from postnatal day p10) markedly increased epidermal thickness that was not seen in lit-
termate controls. Similar Erl-induced increases in epidermal thickness were inhibited by the IL-1
receptor antagonist anakinra in human skin organ cultures (HSOC). In an effort to confirm this
result in mice, we treated KC-Tie2 mice and littermate controls with saline, Erl (10mg/kg IP), anakinra
(100mg/kg IP), or both, daily for 28 d from p10. Erl significantly increased epidermal thickness in
KC-Tie2 mice (53.8+/-3.2 vs 35.4 +/- 2.2 um vs. saline control, n = 11 - 13, p = 0.00014, mean +/-
SEM), which was abrogated by anakinra (36.2 +/- 5.6, n = 7, p = 0.0085), with no effect in con-
trols. Erl-mediated increases in epidermal thickness were accompanied by 1.9 and 1.4-fold increases
in CD4+ T-cells and F4/80+ macrophages (p=0.026 and 0.039, respectively). Whereas Erl dose-
dependently inhibited human KC monolayer proliferation (>95% at 120 nM), 8-day HSOC devel-
oped acanthosis in response to Erl (125 +/- 9 vs 79 +/- 4 um, mean +/- SEM, n = 27, p < 0.0001)
that was prevented by anakinra (89 +/- 6 um, n = 8, p = 0.048). Erl-induced elaboration of MMP-
1 by HSOC (37.6 +/- 4.1 vs. 18.3 +/- 2.6, p = 0.0002) was also abrogated by anakinra (10.6 +/- 2.5,
p < 0.00001 vs Erl). These results might be explained by influx and/or activation of inflammatory
cells by KC-derived cytokines, as EGFR-RTKI treatment induces CCL2 in cultured KC (AJP165:303).
By ELISA, we confirmed that Erl increases CCL2 in HSOC supernatants (9.8 +/- 2.0 vs 2.9 +/- 0.3
ng/ml, n = 13, p < 0.03), and this increase was also inhibited by anakinra (6.5 +/- 2.4 ng/ml, n = 9,
p < 0.05). Taken together, these results support an IL-1-mediated pro-inflammatory effect of EGFR-
RTKI in mouse and human skin, triggered at least in part by up-regulation of CCL2.
027
IL-17C is overexpressed in psoriasis skin and contributes to cytokine-driven inflammation
CS Chen,1 PM Al-Attar,1 W Fu,2 CM Loyd,2 M Riblett,1 X Xing,1 JJ Voorhees,1 JT Elder,1 NL Ward,2
JE Gudjonsson1 and A Johnston1 1 Dermatology, University of Michigan, Ann Arbor, MI and 2
Dermatology, Case Western Reserve University, Cleveland, OH
Interleukin (IL)-17C is a novel IL-17 family member: it shares 26% homology with IL-17A but uti-
lizes a novel receptor (IL17RE) and is functionally distinct. Given the pro-inflammatory nature of
IL-17A, we evaluated IL-17 family expression in psoriasis skin by QRT-PCR. IL-17C was the most
strongly upregulated (30-fold, p<0.01) transcript in lesional psoriatic (PP) versus normal (NN) skin
with IL-17C >17A >17F >17E >17B >17D, and IL-17C was increased 5-fold (p<0.04) in PP skin
versus uninvolved (PN) skin by ELISA. Moreover, IL-17C was one of the first transcripts to be sig-
nificantly decreased during effective treatment of psoriasis with the anti-TNF-α agent etanercept
(n=8, p=0.0181). Using normal human KC (NHK) we determined that IL-17C is significantly induced
by IL-1α, IL-17A or TNF-α (14-, 160-, and 14-fold respectively, all p<0.02) and TNF-α-induced
expression of IL-17C was significantly abrogated by pharmacological inhibitors of NF-κB, PI3K, p38,
Src, and JNK. IL-17RE was expressed by human epidermis and NHK, and IL-17C dose-dependently
induced IL-20, IL-24, CCL20 and CXCL1 mRNA by NHK, which was sensitive to inhibition of MEK1/2,
p38 and JNK signaling. In addition to its expression by keratinocytes, IL-17C mRNA was also expressed
by activated blood monocytes, but not T cells. As IL-17C was overexpressed in lesional psoriasis
skin and is implicated in skin inflammation, we expressed murine IL-17C in the basal layer of mouse
epidermal keratinocytes using an inducible K5-tTA/Tetos-Il17c system. By three months of age,
bitransgenic mice showed dramatically elevated (10,000-fold) expression of Il17c mRNA, had ery-
thema and scaling at sites of injury and at the histological level, demonstrated acanthosis of non-
injured skin. Our results suggest that IL-17C may be part of a positive feedback loop involving TNF-
α, lymphocytes and KC and has an important role in maintaining inflammation in psoriatic lesions.
029
Primary ceramide deficiency in keratinocytes leads to gene alterations linked to dermatitis
K Nakajima,1 M Terao,2 H Azukizawa,2 I Katayama,2 J Takeda3 and S Sano1 1 Department of
Dermatology, Kochi Medical School, Kochi University, Kochi, Japan, 2 Department of
Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan and 3
Department of Social and Environmental Medicine, Osaka University Graduate School of
Medicine, Osaka, Japan
Impaired skin barrier is associated with inflammatory skin disorders including atopic dermatitis (AD)
and psoriasis. We have studied the role of epidermal ceramide by using keratinocytes-specific Sptlc
deficient mice (K5.SPT-KO), which lacked serine palmitoyltransferase (SPT), a rate-limiting enzyme
for ceramide biosynthesis. K5.SPT-KO mice exhibited barrier disruption from two weeks of age and
developed skin lesions with hyperkeratosis, epidermal hyperplasia, and dermal inflammation. To
examine whether ceramide deficiency itself affected gene expression within keratinocytes, we per-
formed an array analysis on primary cultured keratinocytes of newborn K5.SPT-KO mice. Tran-
scriptional profiling revealed that increased expression of thymic stromal lymphopoietin (TSLP,
ratio=4.2), amphiregulin (Areg, 3.2), and aquaporin 3 (Aqp3, 3.0). Interestingly, these three mole-
cules are associated with the pathogenesis of AD and psoriasis. Since no skin lesion except for skin
dehydration was found in newborn KO mice, the up-regulation of these genes in keratinocytes was
primary consequences of constitutive ceramide deficiency. AQP3 and AR were increased in the
lesional skin of K5.SPT KO mice. Langerhans cells (LCs) in the epidermis of K5.SPT-KO mice appeared
mature and increased numbers of langerin+ dendritic cells were found in the skin-draining lymph
nodes of K5.SPT-KO mice. This might be consistent with recent notion that local increase of TSLP
was directly associated with LC activation. Strikingly, acute barrier disruption by tape stripping led
to up-regulation of AQP3 and AR as well as activation of LCs in hairless mice. We suggested that
primary ceramide deficiency in keratinocytes and/or barrier disruption resulted in increased expres-
sion of AQP3, AR, and TSLP, which may contribute to development of dermatitis.
028
Oxazolone induced atopic dermatitis murine model may be useful to screen TSLP inhibitors
N Yoon,1,2 M Jung,1,2 D Kim,1,2 H Lee1,2 and E Choi1,2 1 Dermatology, Yonsei University Wonju
College of Medicine, Wonju, Republic of Korea and 2 Healthy Woods Skin Center, Yanggu,
Republic of Korea
Thymic stromal lymphopoietin(TSLP) is an epithelial cell-derived cytokine expressed in the skin,
gut, lung and thymus, and closely concerned with IL-7. TSLP plays an important role in shaping the
immune response, in a pathogenesis of asthma and atopic dermatitis(AD). TSLP is overexpressed in
the keratinocytes of AD skin lesions, which triggers a mechanism underlying the progression from
AD to asthma (so-called ‘allergic march’). In addition to early protection of the skin barrier defect
on AD, a selective inhibition of epidermal and systemic TSLP might be a key blocking progression
from AD to Asthma. So, an easy and useful in vivo model to screen novel TSLP inhibitors is needed.
Therefore, we evaluated TSLP and other epidermal permeability markers in the oxazolone induced
atopic dermatitis like model, which represents Th2 immunophenotype and abnormal keratinocyte
differentiation. TSLP in keratinocytes was remarkably overexpressed in oxazolone induced AD model,
compared with its control. After topical steroid application once a day for 10 days, epidermal TSLP
expression was markedly decreased, compared with vehicle application. AD like skin lesions and
basal TEWL increases in AD model were significantly improved by topical steroid, compared with
vehicle. Topical steroid also improved the stratum corneum hydration and the epidermal differen-
tiation markers; for example, filaggrin, loricrin and involucrin in the AD model. Also, the CRTH2
immunostaining that represents Th2 lymphocytes and the expression of antimicrobial peptide(AMP)
at both the mRNA and protein level decreased in the AD model. Our result shows that TSLP expres-
sion is proportional to skin barrier impairment in oxazolone induced AD murine model; this model
may be a good screening model to search the novel TSLP inhibitors in vivo.
026
Early tissue responses in psoriasis to the anti-TNF-α biologic etanercept suggest reduced IL-
17R expression and signaling
AM Guzman,1 A Johnston,1 X Xing,1 L Maier,1 F Wang,1 S Kang,2 G Fisher1 and JE Gudjonsson1 1
Dermatology, University of Michigan, Ann Arbor, MI and 2 Dermatology, Johns Hopkins
Medicine, Baltimore, MD
Anti-TNF-α therapy has made a significant impact on the treatment of psoriasis, arthritis and Crohn’s
disease. Despite being designed to neutralize TNF-α activity, the mechanism of action of these agents
in the resolution of psoriasis remains unclear. We hypothesized that the mechanism of action of
etanercept involves early tissue responses which precede changes in T-cell numbers, keratinocyte
differentiation and proliferation. To test our hypothesis, we analyzed mRNA expression by QRT-PCR
and tissue cytokine and phosphoprotein expression using multiplexed bead arrays using skin biop-
sies from chronic plaque psoriasis patients (n=8) receiving 50mg etanercept (Enbrel®) twice weekly.
Skin biopsies were obtained before treatment and on day1, day3 and day7 post-treatment and imme-
diately snap-frozen. We found that CXCL11, IL12A, IL12B mRNA were suppressed by 72%, 66%,
49% respectively, and tissue levels of the T-cell chemokine CCL27 was suppressed by 36% after 1
day of treatment. Strikingly, IL17A, IL22 and IFN-g mRNA and protein showed no significant changes
in the first week of treatment; however, there was a 2.5-fold down-regulation of IL17RC mRNA
(p<0.05) after day 1, although IL22RA and IL10RB were unchanged. Phospho-GSK3a/b and phos-
pho-ERK1/2 were reduced by 50% and 64% respectively on d1, however we detected no change
in the levels of phospho-STAT3. These results suggest that the early responses of psoriasis plaques
to etanercept may be due to decreased IL-17A activity, not from lowered Th17 cytokine expression,
as the lesions are still rich in IL-17A and IL-22, and activated STAT3, but from diminished tissue
responsiveness to IL-17A as a result of the decreased expression of IL17RC which encodes one sub-
unit of the IL-17A receptor, thus blunting responses to Th17 cytokines and breaking a potentially
self-sustaining cycle which contributes to the maintenance of psoriasis lesions.
030
Effect of norepinephrine (NE) on lipopolysaccaride (LPS) induction of cytokine/chemokine
expression by murine bone marrow (BM)-derived dendritic cells (DCs)
LL Stohl, M Manni, W Ding and RD Granstein Weill Cornell Medical College, New York, NY
DCs play important roles in immune responses and the transition between innate and acquired
immunity. DC maturation is initiated when signals bind to toll-like receptors (TLRs), triggering expres-
sion of costimulatory molecules and cytokines/chemokines. The symphathetic nervous system (SNS)
is involved in stress and immune modulation. SNS fibers innervate lymphoid organs, skin and vas-
culature, and alter immune cell functions via adrenergic receptors (ARs). Murine BMDCs express
ARs and NE, a SNS transmitter (also produced by keratinocytes and melanocytes), decreases pro-
duction of IL-12 and potentiates IL-10 production from stimulation with bacterial TLR agonists. NE
also inhibits IL-6 and TNFα production induced by TLR2 stimulation. We have now further delin-
eated the role of NE on LPS (a TLR4 agonist)-induced DC cytokine/chemokine production. BALB/c
BMDCs were purified from BM cultured for 9 d in granulocyte-macrophage colony-stimulating fac-
tor by magnetic sorting using CD11c beads. BMDCs were treated with NE (10-8M to 10-5M) +/- LPS
for 6 or 24 h, supernatants collected and protein content assessed by ELISA. NE dramatically inhib-
ited LPS induction of IL-6, TNFα, CCL3 and CCL5 production at both timepoints. The specific β2-
adrenergic agonist salbuterol also inhibited LPS-induced secretion of IL-6, TNFα and CCL3. BMDCs
were subsequently treated with NE and LPS in the presence or absence of α- and β-AR antagonists.
Propranolol (non-specific β1/β2 antagonist) and ICI 118,151 (β2-specific) significantly blocked the
NE effect while phentolamine (non-specific α) did not, indicating the NE effect is primarily medi-
ated by β2-ARs. A more complex pattern was observed for CCL5 inhibition and may involve more
than one receptor subtype. Real-time RT-PCR revealed mRNA levels of each gene were also inhib-
ited by NE, although with different kinetics, indicating that decreased levels of protein observed
were due in part to a decrease in transcription. NE released by the SNS may mediate immunologic
effects of stress through effects on DCs.
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Heterogeneity in the inflammatory network in chronic plaque psoriasis
WR Swindell,1 X Xing,2 C Chen,2 RP Nair,2 JJ Voorhees,2 JT Elder,2 A Johnston2 and JE Gudjonsson2
1 Department of Genetics, Harvard University, Boston, MA and 2 Department of
Dermatology, University of Michigan, Ann Arbor, MI
The clinical features of psoriasis, characterized by sharply demarcated scaly erythematous plaques,
are typically so distinctive that a diagnosis can easily be made on clinical grounds alone. However,
there can be great variability in the way that the disease responds to treatments, and this may reflect
heterogeneity of inflammatory network structure among individual patients. In this study, whole-
genome transcriptional profiling was used to characterize inflammatory network heterogeneity
among 62 patients with stable chronic plaque psoriasis, based upon expression signatures from
inflammatory subsets and keratinocyte-derived cytokine signatures. A consistent feature in all patients
was a heightened gene expression signature for keratinocytes (100% of subjects), with concomi-
tantly heightened signatures for CD4+ T cells (> 95%) and dendritic cells (> 90%). A prominent
macrophage signature was also observed in most patients (60%), along with a surprisingly strong
signature for gamma-delta T-cells (>80%). The significance of neutrophil and NK cell signatures
varied among individual patients (26% and 30%, respectively). The presence of these immune cell
subsets was confirmed by immunohistochemistry. Cytokine signatures common to all patients
included those of the IL-20 family of cytokines (IL-19, IL-20, IL-22 and IL-24), IL-1α and IFN-γ
(>98%), whereas 80% and 72% had significant TNF-α and IL-17A signatures, respectively. Inter-
estingly 30-40% of patients had significant IFN-α and IL-13 signatures, whereas the IL-4 response
was weak and only observed in fewer than 20% of patients. Taken together, our data delineate cen-
tral cellular and cytokine pathways shared among nearly all patients with chronic plaque psoriasis,
and define variable points of the inflammatory network structure, which could shape clinical course
and treatment response.
020
MHC class II restricted CD4+ T lymphocytes directed against melanocyte antigens: Tyrosi-
nase, Tyrosinase Related Protein 2 and MART-1 in Vitiligo
A Singh,1 P Sharma,2 HK Kar,2 MK Tembhre,3 S Gupta,3 VK Sharma,3 RS Gokhale4,1 and R Rani1 1
Immungenetics Lab, National Institute of Immunology, New Delhi, India, 2 Department of
Dermatology, Dr. Ram Manohar Lohia Hospital, New Delhi, India, 3 Department of
Dermatology, All India Institute of Medical Sciences, New Delhi, India and 4 Systems Biology
Group, Institute of Genomics and Integrative Biology, New Delhi, India
Vitiligo, a depigmenting disorder of the skin characterized by milky white lesions, is thought to result
from an autoimmune mediated destruction of melanocytes in the epidermis. HLA Class I restricted
CD8+ Cytotoxic T lymphocytes (CTL) specific for melanocyte differentiation antigens like gp100,
MART-1 and tyrosinase have been demonstrated in vitiligo patients supporting the concept of autoim-
mune destruction of melanocytes, however, there is a missing link. For the precursor CTLs to become
effector CTLs, help is required from HLA Class II restricted T helper cells, which play a crucial role
in orchestrating the cascade of immune responses. Presence of melanocyte specific CD4+ T helper
cells has not been demonstrated so far in vitiligo. We demonstrate for the first time melanocyte spe-
cific, HLA class-II restricted memory CD4+ T cells in peripheral circulation of vitiligo patients using
Enzyme-linked immonospot (ELISPOT) assay. T cell responses to nine peptides derived from five
melanocyte enzymes and differentiation antigens, tyrosinase, Tyrosinase related protein 2 (TRP2),
TRP-1, MART-1 and gp100 and recombinant human tyrosinase (rTyr) were tested in 37 vitiligo
patients with progressive disease using IFN-γ ELISPOT assay. 77% of patients showed MHC class-
II restricted positive IFN-γ response directed against at least one of the auto-antigenic peptides or
rTyr tested in vitro. Peptides TRP2 391-405 (p<0.001), MART-1 26-40 (p<0.04) and rTyr (p<0.04)
induced significantly higher number of IFN-γ producing CD4+ memory T cells in HLA class-II
restricted manner. Our results emphasize the role of CD4+ T cells as important players in the induc-
tion of autoimmune responses in vitiligo.
021
Lymphaniogenic process in the Keratin-14-IL-4-transgenic mouse model of atopic dermatitis
parallels the evolution of skin inflammation
VY Shi,1 L Bao,1 H Zhang,1 JR Tian,1 R Zhu1 and LS Chan1,2 1 Dermatology, University of Illinois,
Chicago, IL and 2 Jesse Brown VA Medical Center, Chicago, IL
The studies of keratin-14-IL-4-transgenic (Tg) mouse model of atopic dermatitis (AD) have revealed
that angiogenic process parallels the inflammatory process. Since lymphangiogenesis tends to occur
in conjunction with angiogenesis, we aim at investigating the lymphangiogenic process in this AD
model, using skin samples obtained from Tg mice before disease onset (Tg-BO), Tg mice with skin
lesions of one week or less duration (Tg-EL), Tg mice with skin lesions of 3 weeks or longer dura-
tion (Tg-LL), and non-Tg littermates. Immunoflourescence microscopy (IF) and computer-assisted
photometric analysis were performed on cryosections immunolabeled with monoclonal antibod-
ies specific for mouse Lyve-1 (specific lymphatic marker), VEGFR-3 (receptor for VEGF-C and VEGF-
D), and podoplanin (specific for mature lymphatic endothelial cells). Reverse Transcription-PCR was
performed on RNAs extracted from these samples using primer pairs specific for Lyve-1, VEGFR-3,
podoplanin, VEGF-C, VEGF-D, and Ang-1. In addition, angiogenic microarray assays were performed
to analyze whether IL-4 regulate lymphangiogenic process via cultured human keratinocytes. Con-
sistent with the IF data, Lyve-1, VEGFR-3, and podoplanin mRNAs were detected in an increasing
trend as the Tg mice evolve from Tg-BO to Tg-EL and Tg-LL stages. In addition, VEGF-C mRNAs
showed a similar trend, where VEGF-D (a factor primarily present in lung tissues) showed no change.
Ang-1 mRNAs showed up-regulation only at Tg-LL stage. Microarray data showed over 2-fold up-
regulation of IL-4-induced keratinocyte mRNAs of pro-lymphaniogenic factors, namely angiopoi-
etin-like 4, collagen IV, CXCL1, CXCL6, insulin-like growth factor-1, neuropilin-1, and VEGFA. Taken
together, this IL-4-initiated inflammation event triggers a pro-lymphangiogenic process, which may
represent an attempt to control the chronic inflammation, as suggested by the data of a VEGFA-trans-
genic mouse model of psoriasis-like inflammation.
022
Transcriptomic analysis of psoriatic skin by RNA-seq
A Jabbari,1,2 M Suarez-Farinas,2 S Dewell3 and JG Krueger2 1 Ronald O. Perelman Department
of Dermatology, NYU School of Medicine, New York, NY, 2 Laboratory of Investigative
Dermatology, Rockefeller University, New York, NY and 3 Genomics Resource Center,
Rockefeller University, New York, NY
Psoriasis vulgaris is a chronic cutaneous disease that affects 1-3% of the population. In addition to
skin involvement, joint disease may variably be present, and recent evidence suggests associations
between psoriasis and both metabolic syndrome and atherosclerotic cardiovascular disease. Fur-
thermore, psoriasis has a significant negative impact on the quality of life of affected patients. The
molecular characterization of psoriatic clinical samples has lead to a greater understanding of the
pathogenesis of the disease and has been useful in identifying therapeutic targets. Much of our
knowledge of the molecular factors and inflammatory contributors of this disease has come from
data generated by microarray experiments. However, microarray studies to identify differentially
regulated genes are limited by many potential limitations including a high background, the need
for a template of those sequences to be examined, and a relatively limited dynamic range. RNA-
seq, also known as deep RNA sequencing, is a method that may be used to assess the transcrip-
tome of cells and tissues that does not suffer from the shortcomings described. In this study, we use
RNA-seq to assess the transcriptomic profile of psoriatic lesional skin as compared to nonlesional
skin from the same patient. We identified a substantial number of differentially regulated genes that
have not been previously described. As predicted, many of the differentially regulated genes newly
identified in this study are present at relatively lower concentrations that may be difficult to detect
by microarray analysis due to the higher background of this technique. The use of RNA-seq in the
examination of psoriatic skin, therefore, has the potential to increase our understanding of the patho-
genesis of this disease and may be helpful in identifying novel therapeutic targets.
023
Alopecia areata development may be associated with cardiac fibrosis
EH Wang,1 K Chong,1 D Granville,2 J Shapiro3 and KJ McElwee1 1 Dermatology and Skin
Science, University of British Columbia, Vancouver, BC, Canada, 2 The James Hogg iCAPTURE
Centre for Cardiovascular and Pulmonary Research St. Paul’s Hospital, University of British
Columbia, Vancouver, BC, Canada and 3 Dermatology and Skin Science, Vancouver General
Hospital, Vancouver, BC, Canada
Alopecia areata (AA), a non-scarring, inflammatory hair loss disease, is believed to involve an autoim-
mune mechanism. In other autoimmune skin conditions, such as psoriasis, there is evidence that
affected individuals have an increased risk of heart disease and heart failure. We investigated the
potential for a relationship between AA and heart disease. It was noted in passing that some of the
C3H/HeJ mice with AA had enlarged atria and ventricular hypertrophy compared to the normal
haired littermates. Quantitative PCR (qPCR) analysis showed a significant increase in the expres-
sion of IL18 (4.6 fold), IL18 receptor-1 (IL18r1, 2.8 fold) and IL18 binding protein (IL18bp, 5.2 fold)
in the AA heart tissue compared to controls. In a time course study, significant increase of mRNA
expression of IL18r1, IL18bp and Interleukin Converting Enzyme (ICE) were observed 10 weeks
post skin graft. However, the expression of IL18 showed an opposite trend possibly due to an unknown
negative feedback mechanism to restrict IL18 over-expression. Masson’s Trichrome Stain for colla-
gen deposition revealed a significantly higher amount of collagen around the blood vessels within
the heart of AA mice, an indication of fibrosis. In addition, the thickness of the endothelial layer of
these blood vessels was significantly thinner. Immunohistochemistry analysis showed a localiza-
tion of IL18 in the atria of AA mice that resembles phenotype of atrial fibrillation. IL18r1 and
IL18bp showed a more dispersed pattern covering the whole heart in both AA and controls. It has
been found by another group that serum IL18 level is significantly increased in human AA patients.
Based on our observations, the development of AA may result in an elevated IL18 activity that can
lead to fibrosis of heart tissues.
024
Comprehensive characterization of leukocyte subsets in the blood of psoriasis patients
G Obermoser,1,2 C Ryan,1,3 J Banchereau,1 V Pascual,1 D Chaussabel1 and A Menter1,3 1 Baylor
Institute of Immunology Research, Dallas, TX, 2 Department of Dermatology, University
Hospital Innsbruck, Innsbruck, Austria and 3 Department of Dermatology, Baylor Research
Institute, Dalals, TX
There is growing evidence that chronic plaque psoriasis (CPP) is a systemic disease with associated
comorbidities, including an increased risk of cardiovascular mortality and metabolic syndrome.
Little is known about the contribution of leukocyte subsets to systemic inflammation in psoriasis
patients. Over 100 leukocyte subsets were characterized in the whole blood of 21 psoriasis patients
and 40 healthy controls using 11 color/14 parameter flow cytometry. For analysis of CD4+T mem-
ory compartments, singlet CD45briCD3+CD8-CD4+ cells were gated on CD45RA and CCR7 expres-
sion. CD4+T cell subsets were gated on singlet CCX5-CD45RA-CD45briCD3+CD8-CD4+ cells
based on the expression of chemokine receptors CCR6 and CXCR3. B cell subsets were defined by
CD27 and surface IgD expression in CD45+CD19+ lymphocytes. Dendritic cell subsets were defined
by expression of BDCA-2, CD1c and BDCA-3 in Lin-HLA-DR+ cells. Data was acquired on a cus-
tom BD LSRII and analyzed in FlowJo 8.8.6. There was dysregulation of several inflammatory cell
subsets, including an increase in central memory CD4+ T cells (p=0.0033), and reductions in naïve
CD4+T cells (p=0.0128), CD127loCD25+ CD4+ T regulatory cells (p=0.0024), BDCA2+ plasma-
cytoid dendritic cells (p<0.0001) and CD19+ B cells (p=0.0046). An alteration in Th17 cells was
not demonstrated. The frequency and activation of plasmacytoid dendritic cells and regulatory T
cells have been shown to be increased in lesional psoriatic skin. The observed decrease of these
cell populations in the systemic circulation likely results from their recruitment to sites of cuta-
neous inflammation. This is the largest study to date to comprehensively characterize leukocyte sub-
sets in the blood of patients with CPP. The findings provide new insights into potential immune cel-
lular alterations in psoriasis and may help to identify clinically relevant blood biomarkers.
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Erlotinib-stimulated epidermal hyperplasia is mediated by IL-1
NL Ward,2 N Bhagavathula,1 CM Loyd,2 S Dawes,2 A Johnston,1 J Varani1 and JT Elder1 1 Univ of
Michigan, Ann Arbor, MI and 2 Case Western Univ, Cleveland, OH
Skin rash is a dose-limiting toxicity of EGFR tyrosine kinase inhibitors (RTKI). We reported (SID 2010)
that Erlotinib (Erl) treatment of K5tTA:TetOSTek/Tie2 bigenic mice (KC-Tie2 mice, 10 mg/kg IP daily
for 28d from postnatal day p10) markedly increased epidermal thickness that was not seen in lit-
termate controls. Similar Erl-induced increases in epidermal thickness were inhibited by the IL-1
receptor antagonist anakinra in human skin organ cultures (HSOC). In an effort to confirm this
result in mice, we treated KC-Tie2 mice and littermate controls with saline, Erl (10mg/kg IP), anakinra
(100mg/kg IP), or both, daily for 28 d from p10. Erl significantly increased epidermal thickness in
KC-Tie2 mice (53.8+/-3.2 vs 35.4 +/- 2.2 um vs. saline control, n = 11 - 13, p = 0.00014, mean +/-
SEM), which was abrogated by anakinra (36.2 +/- 5.6, n = 7, p = 0.0085), with no effect in con-
trols. Erl-mediated increases in epidermal thickness were accompanied by 1.9 and 1.4-fold increases
in CD4+ T-cells and F4/80+ macrophages (p=0.026 and 0.039, respectively). Whereas Erl dose-
dependently inhibited human KC monolayer proliferation (>95% at 120 nM), 8-day HSOC devel-
oped acanthosis in response to Erl (125 +/- 9 vs 79 +/- 4 um, mean +/- SEM, n = 27, p < 0.0001)
that was prevented by anakinra (89 +/- 6 um, n = 8, p = 0.048). Erl-induced elaboration of MMP-
1 by HSOC (37.6 +/- 4.1 vs. 18.3 +/- 2.6, p = 0.0002) was also abrogated by anakinra (10.6 +/- 2.5,
p < 0.00001 vs Erl). These results might be explained by influx and/or activation of inflammatory
cells by KC-derived cytokines, as EGFR-RTKI treatment induces CCL2 in cultured KC (AJP165:303).
By ELISA, we confirmed that Erl increases CCL2 in HSOC supernatants (9.8 +/- 2.0 vs 2.9 +/- 0.3
ng/ml, n = 13, p < 0.03), and this increase was also inhibited by anakinra (6.5 +/- 2.4 ng/ml, n = 9,
p < 0.05). Taken together, these results support an IL-1-mediated pro-inflammatory effect of EGFR-
RTKI in mouse and human skin, triggered at least in part by up-regulation of CCL2.
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IL-17C is overexpressed in psoriasis skin and contributes to cytokine-driven inflammation
CS Chen,1 PM Al-Attar,1 W Fu,2 CM Loyd,2 M Riblett,1 X Xing,1 JJ Voorhees,1 JT Elder,1 NL Ward,2
JE Gudjonsson1 and A Johnston1 1 Dermatology, University of Michigan, Ann Arbor, MI and 2
Dermatology, Case Western Reserve University, Cleveland, OH
Interleukin (IL)-17C is a novel IL-17 family member: it shares 26% homology with IL-17A but uti-
lizes a novel receptor (IL17RE) and is functionally distinct. Given the pro-inflammatory nature of
IL-17A, we evaluated IL-17 family expression in psoriasis skin by QRT-PCR. IL-17C was the most
strongly upregulated (30-fold, p<0.01) transcript in lesional psoriatic (PP) versus normal (NN) skin
with IL-17C >17A >17F >17E >17B >17D, and IL-17C was increased 5-fold (p<0.04) in PP skin
versus uninvolved (PN) skin by ELISA. Moreover, IL-17C was one of the first transcripts to be sig-
nificantly decreased during effective treatment of psoriasis with the anti-TNF-α agent etanercept
(n=8, p=0.0181). Using normal human KC (NHK) we determined that IL-17C is significantly induced
by IL-1α, IL-17A or TNF-α (14-, 160-, and 14-fold respectively, all p<0.02) and TNF-α-induced
expression of IL-17C was significantly abrogated by pharmacological inhibitors of NF-κB, PI3K, p38,
Src, and JNK. IL-17RE was expressed by human epidermis and NHK, and IL-17C dose-dependently
induced IL-20, IL-24, CCL20 and CXCL1 mRNA by NHK, which was sensitive to inhibition of MEK1/2,
p38 and JNK signaling. In addition to its expression by keratinocytes, IL-17C mRNA was also expressed
by activated blood monocytes, but not T cells. As IL-17C was overexpressed in lesional psoriasis
skin and is implicated in skin inflammation, we expressed murine IL-17C in the basal layer of mouse
epidermal keratinocytes using an inducible K5-tTA/Tetos-Il17c system. By three months of age,
bitransgenic mice showed dramatically elevated (10,000-fold) expression of Il17c mRNA, had ery-
thema and scaling at sites of injury and at the histological level, demonstrated acanthosis of non-
injured skin. Our results suggest that IL-17C may be part of a positive feedback loop involving TNF-
α, lymphocytes and KC and has an important role in maintaining inflammation in psoriatic lesions.
029
Primary ceramide deficiency in keratinocytes leads to gene alterations linked to dermatitis
K Nakajima,1 M Terao,2 H Azukizawa,2 I Katayama,2 J Takeda3 and S Sano1 1 Department of
Dermatology, Kochi Medical School, Kochi University, Kochi, Japan, 2 Department of
Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan and 3
Department of Social and Environmental Medicine, Osaka University Graduate School of
Medicine, Osaka, Japan
Impaired skin barrier is associated with inflammatory skin disorders including atopic dermatitis (AD)
and psoriasis. We have studied the role of epidermal ceramide by using keratinocytes-specific Sptlc
deficient mice (K5.SPT-KO), which lacked serine palmitoyltransferase (SPT), a rate-limiting enzyme
for ceramide biosynthesis. K5.SPT-KO mice exhibited barrier disruption from two weeks of age and
developed skin lesions with hyperkeratosis, epidermal hyperplasia, and dermal inflammation. To
examine whether ceramide deficiency itself affected gene expression within keratinocytes, we per-
formed an array analysis on primary cultured keratinocytes of newborn K5.SPT-KO mice. Tran-
scriptional profiling revealed that increased expression of thymic stromal lymphopoietin (TSLP,
ratio=4.2), amphiregulin (Areg, 3.2), and aquaporin 3 (Aqp3, 3.0). Interestingly, these three mole-
cules are associated with the pathogenesis of AD and psoriasis. Since no skin lesion except for skin
dehydration was found in newborn KO mice, the up-regulation of these genes in keratinocytes was
primary consequences of constitutive ceramide deficiency. AQP3 and AR were increased in the
lesional skin of K5.SPT KO mice. Langerhans cells (LCs) in the epidermis of K5.SPT-KO mice appeared
mature and increased numbers of langerin+ dendritic cells were found in the skin-draining lymph
nodes of K5.SPT-KO mice. This might be consistent with recent notion that local increase of TSLP
was directly associated with LC activation. Strikingly, acute barrier disruption by tape stripping led
to up-regulation of AQP3 and AR as well as activation of LCs in hairless mice. We suggested that
primary ceramide deficiency in keratinocytes and/or barrier disruption resulted in increased expres-
sion of AQP3, AR, and TSLP, which may contribute to development of dermatitis.
028
Oxazolone induced atopic dermatitis murine model may be useful to screen TSLP inhibitors
N Yoon,1,2 M Jung,1,2 D Kim,1,2 H Lee1,2 and E Choi1,2 1 Dermatology, Yonsei University Wonju
College of Medicine, Wonju, Republic of Korea and 2 Healthy Woods Skin Center, Yanggu,
Republic of Korea
Thymic stromal lymphopoietin(TSLP) is an epithelial cell-derived cytokine expressed in the skin,
gut, lung and thymus, and closely concerned with IL-7. TSLP plays an important role in shaping the
immune response, in a pathogenesis of asthma and atopic dermatitis(AD). TSLP is overexpressed in
the keratinocytes of AD skin lesions, which triggers a mechanism underlying the progression from
AD to asthma (so-called ‘allergic march’). In addition to early protection of the skin barrier defect
on AD, a selective inhibition of epidermal and systemic TSLP might be a key blocking progression
from AD to Asthma. So, an easy and useful in vivo model to screen novel TSLP inhibitors is needed.
Therefore, we evaluated TSLP and other epidermal permeability markers in the oxazolone induced
atopic dermatitis like model, which represents Th2 immunophenotype and abnormal keratinocyte
differentiation. TSLP in keratinocytes was remarkably overexpressed in oxazolone induced AD model,
compared with its control. After topical steroid application once a day for 10 days, epidermal TSLP
expression was markedly decreased, compared with vehicle application. AD like skin lesions and
basal TEWL increases in AD model were significantly improved by topical steroid, compared with
vehicle. Topical steroid also improved the stratum corneum hydration and the epidermal differen-
tiation markers; for example, filaggrin, loricrin and involucrin in the AD model. Also, the CRTH2
immunostaining that represents Th2 lymphocytes and the expression of antimicrobial peptide(AMP)
at both the mRNA and protein level decreased in the AD model. Our result shows that TSLP expres-
sion is proportional to skin barrier impairment in oxazolone induced AD murine model; this model
may be a good screening model to search the novel TSLP inhibitors in vivo.
026
Early tissue responses in psoriasis to the anti-TNF-α biologic etanercept suggest reduced IL-
17R expression and signaling
AM Guzman,1 A Johnston,1 X Xing,1 L Maier,1 F Wang,1 S Kang,2 G Fisher1 and JE Gudjonsson1 1
Dermatology, University of Michigan, Ann Arbor, MI and 2 Dermatology, Johns Hopkins
Medicine, Baltimore, MD
Anti-TNF-α therapy has made a significant impact on the treatment of psoriasis, arthritis and Crohn’s
disease. Despite being designed to neutralize TNF-α activity, the mechanism of action of these agents
in the resolution of psoriasis remains unclear. We hypothesized that the mechanism of action of
etanercept involves early tissue responses which precede changes in T-cell numbers, keratinocyte
differentiation and proliferation. To test our hypothesis, we analyzed mRNA expression by QRT-PCR
and tissue cytokine and phosphoprotein expression using multiplexed bead arrays using skin biop-
sies from chronic plaque psoriasis patients (n=8) receiving 50mg etanercept (Enbrel®) twice weekly.
Skin biopsies were obtained before treatment and on day1, day3 and day7 post-treatment and imme-
diately snap-frozen. We found that CXCL11, IL12A, IL12B mRNA were suppressed by 72%, 66%,
49% respectively, and tissue levels of the T-cell chemokine CCL27 was suppressed by 36% after 1
day of treatment. Strikingly, IL17A, IL22 and IFN-g mRNA and protein showed no significant changes
in the first week of treatment; however, there was a 2.5-fold down-regulation of IL17RC mRNA
(p<0.05) after day 1, although IL22RA and IL10RB were unchanged. Phospho-GSK3a/b and phos-
pho-ERK1/2 were reduced by 50% and 64% respectively on d1, however we detected no change
in the levels of phospho-STAT3. These results suggest that the early responses of psoriasis plaques
to etanercept may be due to decreased IL-17A activity, not from lowered Th17 cytokine expression,
as the lesions are still rich in IL-17A and IL-22, and activated STAT3, but from diminished tissue
responsiveness to IL-17A as a result of the decreased expression of IL17RC which encodes one sub-
unit of the IL-17A receptor, thus blunting responses to Th17 cytokines and breaking a potentially
self-sustaining cycle which contributes to the maintenance of psoriasis lesions.
030
Effect of norepinephrine (NE) on lipopolysaccaride (LPS) induction of cytokine/chemokine
expression by murine bone marrow (BM)-derived dendritic cells (DCs)
LL Stohl, M Manni, W Ding and RD Granstein Weill Cornell Medical College, New York, NY
DCs play important roles in immune responses and the transition between innate and acquired
immunity. DC maturation is initiated when signals bind to toll-like receptors (TLRs), triggering expres-
sion of costimulatory molecules and cytokines/chemokines. The symphathetic nervous system (SNS)
is involved in stress and immune modulation. SNS fibers innervate lymphoid organs, skin and vas-
culature, and alter immune cell functions via adrenergic receptors (ARs). Murine BMDCs express
ARs and NE, a SNS transmitter (also produced by keratinocytes and melanocytes), decreases pro-
duction of IL-12 and potentiates IL-10 production from stimulation with bacterial TLR agonists. NE
also inhibits IL-6 and TNFα production induced by TLR2 stimulation. We have now further delin-
eated the role of NE on LPS (a TLR4 agonist)-induced DC cytokine/chemokine production. BALB/c
BMDCs were purified from BM cultured for 9 d in granulocyte-macrophage colony-stimulating fac-
tor by magnetic sorting using CD11c beads. BMDCs were treated with NE (10-8M to 10-5M) +/- LPS
for 6 or 24 h, supernatants collected and protein content assessed by ELISA. NE dramatically inhib-
ited LPS induction of IL-6, TNFα, CCL3 and CCL5 production at both timepoints. The specific β2-
adrenergic agonist salbuterol also inhibited LPS-induced secretion of IL-6, TNFα and CCL3. BMDCs
were subsequently treated with NE and LPS in the presence or absence of α- and β-AR antagonists.
Propranolol (non-specific β1/β2 antagonist) and ICI 118,151 (β2-specific) significantly blocked the
NE effect while phentolamine (non-specific α) did not, indicating the NE effect is primarily medi-
ated by β2-ARs. A more complex pattern was observed for CCL5 inhibition and may involve more
than one receptor subtype. Real-time RT-PCR revealed mRNA levels of each gene were also inhib-
ited by NE, although with different kinetics, indicating that decreased levels of protein observed
were due in part to a decrease in transcription. NE released by the SNS may mediate immunologic
effects of stress through effects on DCs.
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Heterogeneity in the inflammatory network in chronic plaque psoriasis
WR Swindell,1 X Xing,2 C Chen,2 RP Nair,2 JJ Voorhees,2 JT Elder,2 A Johnston2 and JE Gudjonsson2
1 Department of Genetics, Harvard University, Boston, MA and 2 Department of
Dermatology, University of Michigan, Ann Arbor, MI
The clinical features of psoriasis, characterized by sharply demarcated scaly erythematous plaques,
are typically so distinctive that a diagnosis can easily be made on clinical grounds alone. However,
there can be great variability in the way that the disease responds to treatments, and this may reflect
heterogeneity of inflammatory network structure among individual patients. In this study, whole-
genome transcriptional profiling was used to characterize inflammatory network heterogeneity
among 62 patients with stable chronic plaque psoriasis, based upon expression signatures from
inflammatory subsets and keratinocyte-derived cytokine signatures. A consistent feature in all patients
was a heightened gene expression signature for keratinocytes (100% of subjects), with concomi-
tantly heightened signatures for CD4+ T cells (> 95%) and dendritic cells (> 90%). A prominent
macrophage signature was also observed in most patients (60%), along with a surprisingly strong
signature for gamma-delta T-cells (>80%). The significance of neutrophil and NK cell signatures
varied among individual patients (26% and 30%, respectively). The presence of these immune cell
subsets was confirmed by immunohistochemistry. Cytokine signatures common to all patients
included those of the IL-20 family of cytokines (IL-19, IL-20, IL-22 and IL-24), IL-1α and IFN-γ
(>98%), whereas 80% and 72% had significant TNF-α and IL-17A signatures, respectively. Inter-
estingly 30-40% of patients had significant IFN-α and IL-13 signatures, whereas the IL-4 response
was weak and only observed in fewer than 20% of patients. Taken together, our data delineate cen-
tral cellular and cytokine pathways shared among nearly all patients with chronic plaque psoriasis,
and define variable points of the inflammatory network structure, which could shape clinical course
and treatment response.
020
MHC class II restricted CD4+ T lymphocytes directed against melanocyte antigens: Tyrosi-
nase, Tyrosinase Related Protein 2 and MART-1 in Vitiligo
A Singh,1 P Sharma,2 HK Kar,2 MK Tembhre,3 S Gupta,3 VK Sharma,3 RS Gokhale4,1 and R Rani1 1
Immungenetics Lab, National Institute of Immunology, New Delhi, India, 2 Department of
Dermatology, Dr. Ram Manohar Lohia Hospital, New Delhi, India, 3 Department of
Dermatology, All India Institute of Medical Sciences, New Delhi, India and 4 Systems Biology
Group, Institute of Genomics and Integrative Biology, New Delhi, India
Vitiligo, a depigmenting disorder of the skin characterized by milky white lesions, is thought to result
from an autoimmune mediated destruction of melanocytes in the epidermis. HLA Class I restricted
CD8+ Cytotoxic T lymphocytes (CTL) specific for melanocyte differentiation antigens like gp100,
MART-1 and tyrosinase have been demonstrated in vitiligo patients supporting the concept of autoim-
mune destruction of melanocytes, however, there is a missing link. For the precursor CTLs to become
effector CTLs, help is required from HLA Class II restricted T helper cells, which play a crucial role
in orchestrating the cascade of immune responses. Presence of melanocyte specific CD4+ T helper
cells has not been demonstrated so far in vitiligo. We demonstrate for the first time melanocyte spe-
cific, HLA class-II restricted memory CD4+ T cells in peripheral circulation of vitiligo patients using
Enzyme-linked immonospot (ELISPOT) assay. T cell responses to nine peptides derived from five
melanocyte enzymes and differentiation antigens, tyrosinase, Tyrosinase related protein 2 (TRP2),
TRP-1, MART-1 and gp100 and recombinant human tyrosinase (rTyr) were tested in 37 vitiligo
patients with progressive disease using IFN-γ ELISPOT assay. 77% of patients showed MHC class-
II restricted positive IFN-γ response directed against at least one of the auto-antigenic peptides or
rTyr tested in vitro. Peptides TRP2 391-405 (p<0.001), MART-1 26-40 (p<0.04) and rTyr (p<0.04)
induced significantly higher number of IFN-γ producing CD4+ memory T cells in HLA class-II
restricted manner. Our results emphasize the role of CD4+ T cells as important players in the induc-
tion of autoimmune responses in vitiligo.
021
Lymphaniogenic process in the Keratin-14-IL-4-transgenic mouse model of atopic dermatitis
parallels the evolution of skin inflammation
VY Shi,1 L Bao,1 H Zhang,1 JR Tian,1 R Zhu1 and LS Chan1,2 1 Dermatology, University of Illinois,
Chicago, IL and 2 Jesse Brown VA Medical Center, Chicago, IL
The studies of keratin-14-IL-4-transgenic (Tg) mouse model of atopic dermatitis (AD) have revealed
that angiogenic process parallels the inflammatory process. Since lymphangiogenesis tends to occur
in conjunction with angiogenesis, we aim at investigating the lymphangiogenic process in this AD
model, using skin samples obtained from Tg mice before disease onset (Tg-BO), Tg mice with skin
lesions of one week or less duration (Tg-EL), Tg mice with skin lesions of 3 weeks or longer dura-
tion (Tg-LL), and non-Tg littermates. Immunoflourescence microscopy (IF) and computer-assisted
photometric analysis were performed on cryosections immunolabeled with monoclonal antibod-
ies specific for mouse Lyve-1 (specific lymphatic marker), VEGFR-3 (receptor for VEGF-C and VEGF-
D), and podoplanin (specific for mature lymphatic endothelial cells). Reverse Transcription-PCR was
performed on RNAs extracted from these samples using primer pairs specific for Lyve-1, VEGFR-3,
podoplanin, VEGF-C, VEGF-D, and Ang-1. In addition, angiogenic microarray assays were performed
to analyze whether IL-4 regulate lymphangiogenic process via cultured human keratinocytes. Con-
sistent with the IF data, Lyve-1, VEGFR-3, and podoplanin mRNAs were detected in an increasing
trend as the Tg mice evolve from Tg-BO to Tg-EL and Tg-LL stages. In addition, VEGF-C mRNAs
showed a similar trend, where VEGF-D (a factor primarily present in lung tissues) showed no change.
Ang-1 mRNAs showed up-regulation only at Tg-LL stage. Microarray data showed over 2-fold up-
regulation of IL-4-induced keratinocyte mRNAs of pro-lymphaniogenic factors, namely angiopoi-
etin-like 4, collagen IV, CXCL1, CXCL6, insulin-like growth factor-1, neuropilin-1, and VEGFA. Taken
together, this IL-4-initiated inflammation event triggers a pro-lymphangiogenic process, which may
represent an attempt to control the chronic inflammation, as suggested by the data of a VEGFA-trans-
genic mouse model of psoriasis-like inflammation.
022
Transcriptomic analysis of psoriatic skin by RNA-seq
A Jabbari,1,2 M Suarez-Farinas,2 S Dewell3 and JG Krueger2 1 Ronald O. Perelman Department
of Dermatology, NYU School of Medicine, New York, NY, 2 Laboratory of Investigative
Dermatology, Rockefeller University, New York, NY and 3 Genomics Resource Center,
Rockefeller University, New York, NY
Psoriasis vulgaris is a chronic cutaneous disease that affects 1-3% of the population. In addition to
skin involvement, joint disease may variably be present, and recent evidence suggests associations
between psoriasis and both metabolic syndrome and atherosclerotic cardiovascular disease. Fur-
thermore, psoriasis has a significant negative impact on the quality of life of affected patients. The
molecular characterization of psoriatic clinical samples has lead to a greater understanding of the
pathogenesis of the disease and has been useful in identifying therapeutic targets. Much of our
knowledge of the molecular factors and inflammatory contributors of this disease has come from
data generated by microarray experiments. However, microarray studies to identify differentially
regulated genes are limited by many potential limitations including a high background, the need
for a template of those sequences to be examined, and a relatively limited dynamic range. RNA-
seq, also known as deep RNA sequencing, is a method that may be used to assess the transcrip-
tome of cells and tissues that does not suffer from the shortcomings described. In this study, we use
RNA-seq to assess the transcriptomic profile of psoriatic lesional skin as compared to nonlesional
skin from the same patient. We identified a substantial number of differentially regulated genes that
have not been previously described. As predicted, many of the differentially regulated genes newly
identified in this study are present at relatively lower concentrations that may be difficult to detect
by microarray analysis due to the higher background of this technique. The use of RNA-seq in the
examination of psoriatic skin, therefore, has the potential to increase our understanding of the patho-
genesis of this disease and may be helpful in identifying novel therapeutic targets.
023
Alopecia areata development may be associated with cardiac fibrosis
EH Wang,1 K Chong,1 D Granville,2 J Shapiro3 and KJ McElwee1 1 Dermatology and Skin
Science, University of British Columbia, Vancouver, BC, Canada, 2 The James Hogg iCAPTURE
Centre for Cardiovascular and Pulmonary Research St. Paul’s Hospital, University of British
Columbia, Vancouver, BC, Canada and 3 Dermatology and Skin Science, Vancouver General
Hospital, Vancouver, BC, Canada
Alopecia areata (AA), a non-scarring, inflammatory hair loss disease, is believed to involve an autoim-
mune mechanism. In other autoimmune skin conditions, such as psoriasis, there is evidence that
affected individuals have an increased risk of heart disease and heart failure. We investigated the
potential for a relationship between AA and heart disease. It was noted in passing that some of the
C3H/HeJ mice with AA had enlarged atria and ventricular hypertrophy compared to the normal
haired littermates. Quantitative PCR (qPCR) analysis showed a significant increase in the expres-
sion of IL18 (4.6 fold), IL18 receptor-1 (IL18r1, 2.8 fold) and IL18 binding protein (IL18bp, 5.2 fold)
in the AA heart tissue compared to controls. In a time course study, significant increase of mRNA
expression of IL18r1, IL18bp and Interleukin Converting Enzyme (ICE) were observed 10 weeks
post skin graft. However, the expression of IL18 showed an opposite trend possibly due to an unknown
negative feedback mechanism to restrict IL18 over-expression. Masson’s Trichrome Stain for colla-
gen deposition revealed a significantly higher amount of collagen around the blood vessels within
the heart of AA mice, an indication of fibrosis. In addition, the thickness of the endothelial layer of
these blood vessels was significantly thinner. Immunohistochemistry analysis showed a localiza-
tion of IL18 in the atria of AA mice that resembles phenotype of atrial fibrillation. IL18r1 and
IL18bp showed a more dispersed pattern covering the whole heart in both AA and controls. It has
been found by another group that serum IL18 level is significantly increased in human AA patients.
Based on our observations, the development of AA may result in an elevated IL18 activity that can
lead to fibrosis of heart tissues.
024
Comprehensive characterization of leukocyte subsets in the blood of psoriasis patients
G Obermoser,1,2 C Ryan,1,3 J Banchereau,1 V Pascual,1 D Chaussabel1 and A Menter1,3 1 Baylor
Institute of Immunology Research, Dallas, TX, 2 Department of Dermatology, University
Hospital Innsbruck, Innsbruck, Austria and 3 Department of Dermatology, Baylor Research
Institute, Dalals, TX
There is growing evidence that chronic plaque psoriasis (CPP) is a systemic disease with associated
comorbidities, including an increased risk of cardiovascular mortality and metabolic syndrome.
Little is known about the contribution of leukocyte subsets to systemic inflammation in psoriasis
patients. Over 100 leukocyte subsets were characterized in the whole blood of 21 psoriasis patients
and 40 healthy controls using 11 color/14 parameter flow cytometry. For analysis of CD4+T mem-
ory compartments, singlet CD45briCD3+CD8-CD4+ cells were gated on CD45RA and CCR7 expres-
sion. CD4+T cell subsets were gated on singlet CCX5-CD45RA-CD45briCD3+CD8-CD4+ cells
based on the expression of chemokine receptors CCR6 and CXCR3. B cell subsets were defined by
CD27 and surface IgD expression in CD45+CD19+ lymphocytes. Dendritic cell subsets were defined
by expression of BDCA-2, CD1c and BDCA-3 in Lin-HLA-DR+ cells. Data was acquired on a cus-
tom BD LSRII and analyzed in FlowJo 8.8.6. There was dysregulation of several inflammatory cell
subsets, including an increase in central memory CD4+ T cells (p=0.0033), and reductions in naïve
CD4+T cells (p=0.0128), CD127loCD25+ CD4+ T regulatory cells (p=0.0024), BDCA2+ plasma-
cytoid dendritic cells (p<0.0001) and CD19+ B cells (p=0.0046). An alteration in Th17 cells was
not demonstrated. The frequency and activation of plasmacytoid dendritic cells and regulatory T
cells have been shown to be increased in lesional psoriatic skin. The observed decrease of these
cell populations in the systemic circulation likely results from their recruitment to sites of cuta-
neous inflammation. This is the largest study to date to comprehensively characterize leukocyte sub-
sets in the blood of patients with CPP. The findings provide new insights into potential immune cel-
lular alterations in psoriasis and may help to identify clinically relevant blood biomarkers.
S4 Journal of Investigative Dermatology (2011), Volume 131
SID11_Abstracts-5  2/28/11  9:27 AM  Page S4
ABSTRACTS
037
The role of Syndecan 1 and Syndecan 4 in the severity of murine contact hypersensitivity
J Bühligen,1 F Echtermeyer,2 M Götte,2 M Averbeck1 and JC Simon1 1 Dermatologie, Universität
Leipzig, Leipzig, Germany and 2 Department of Physiological Chemistry and
Pathobiochemistry, University Hospital Münster, Münster, Germany
The migration of Dendritic Cells (DC) towards the local lymph nodes and the presentation of anti-
gens towards the T-Cells play an important role in the induction of the immune-response and the
maintenance of immunological tolerance. The antigen-dependent activation and migration of DC
in peripheral tissues is closely associated with their interactions with the Extracellular Matrix (ECM).
Syndecans (SDC) are transmembrane proteoglycans with heparan sulfate side chains. They act as
integrin co-receptors and sequester extracellular signals like cytokines. We investigated SDC 1 and
SDC 4-knockout mice compared to wildtype mice in the murine contact hypersensitivity (CHS)
model. Wildtype-mice, SDC4-/- and SDC1-/- mice were sensitized by 7% trinitrochlorobenzene
(TNCB) painted on the shaved abdomen. 5 days later the mice were challenged with 1% TNCB and
the induced earswelling was measured by micrometer. The SDC1-/- mice showed an enhanced ear-
swelling while the SDC4-/- mice showed a similar ear-swelling after CHS response compared to
wildtype. In vivo DC migration was investigated by sensitization with fluorescence tetramethylrho-
damine (TRITC) and detection of CD11c+ TRITC+ in the draining Lymphnodes. While DC migra-
tion in SDC1-/- was increased, a decreased DC migration in SDC4-/- mice was observed. We con-
clude that the altered migratory capacity of DC in SDC 4-/- mice and SDC 1-/- mice might affect
the severity of contact hypersensitivity.
039
Type IV collagen binding-site within type VII collagen is a pathogenic epitope for EBA autoan-
tibodies
X Wang, R Gupta, A Garlapati, J Cogan, D Woodley and M Chen Dermatology, University of
Southern California, Los Angeles, CA
Type VII (anchoring fibril) collagen (C7) mediates epidermal-dermal adherence and is the target for
IgG autoantibodies in patients with epidermolysis bullosa acquisita (EBA). The amino-terminal
non-collagenous (NC1) domain of C7 harbors the antigenic epitopes for EBA autoantibodies and
contains 9 fibronectin type III-like homology repeats (FNIII). We previously demonstrated NC1 had
affinity for type IV collagen. Using a panel of recombinant NC1 deletion mutant proteins and a
solid-phase ligand, antigen-to-antigen affinity assay, in this study, we further refined the type IV col-
lagen-binding site to residues 202-360, a 158 amino acid stretch within one of the FNIII. Further,
EBA autoantibodies shown to bind to this subdomain by epitope mapping were capable of inhibit-
ing C7 affinity for type IV collagen while IgG from normal human serum did not. Using a FNIII sub-
domain affinity column, we affinity purified FNIII-specific antibodies from a high titer rabbit poly-
clonal antibody against NC1, and injected these antibodies into hairless, immunocompetent mice
(20-100 microgram/gm body weight) daily for 7 days. Skin bullae, erosions and nail loss developed
in the injected mice and biopsies of lesional skin revealed histological, ultrastructural and immuno-
logical features of human EBA including sub-epidermal bullae formation, a sub-lamina densa blis-
ter cleavage plane and rabbit IgG and murine C3 immunodeposits at the dermal-epidermal junc-
tion. The extent of skin disease correlated with the titer of anti-FNIII antibodies circulating in the
animal’s plasma. In contrast, no skin pathology was observed with the injection of normal rabbit
serum. We conclude that the type IV collagen binding site within one of the FNIII like sub-domains
of C7 likely plays an important role in epidermal-dermal adherence and that EBA autoantibodies
to this subdomain are highly pathogenic and responsible for the induced epidermal-dermal disad-
herence observed in EBA.
041
A novel mouse model to study immune regulatory pathways in the skin
M Rosenblum,1 I Gratz,2 J Paw1,2 and A Abbas2 1 Dermatology, University of California, San
Francisco, San Francisco, CA and 2 Pathology, University of California, San Francisco, San
Francisco, CA
Failure to establish immune tolerance results in the initiation of autoimmune disease. However,
once autoimmune reactions are incited, regulatory pathways act to attenuate the inflammatory
response in an attempt to limit tissue damage. Little is known about the regulatory mechanisms that
suppress antigen-specific inflammation in the skin. We have developed a novel mouse model to
study the mechanisms responsible for limiting and resolving cutaneous inflammation. Mice have
been engineered to have tetracycline-inducible expression of a neo-self antigen (Ovalbumin) in the
basal layer of the epidermis (under control of the K5 promoter). In K5/Ova mice, Ova expression is
tightly controlled, as adoptively transferred Ova-specific (DO11) CD4+ T cells proliferate in skin-
draining lymph nodes only after treatment with doxycycline. Expression of Ova in the thymus is
independent of doxycycline, as an increase in DO11 regulatory T cells (Tregs) is observed in
K5/Ova/DO11 mice (K5/Ova mice crossed onto the DO11 background). Despite a large percent-
age of DO11 Tregs, induction of Ova expression in K5/Ova/DO11 mice results in a pronounced
inflammatory dermatitis. Disease peaks at 14 days after antigen induction and is characterized by
erythema, scaling, alopecia and an inflammatory infiltrate composed of DO11 T cells and GR-
1+CD11b+ myeloid cells. Interestingly, skin inflammation spontaneously resolves. At approximately
40 days after antigen induction, mice show complete clinical and histological resolution of dis-
ease. Inflammation resolves despite persistent Ova expression in the skin and continuous thymic
output of Ova-specific T cells. Resolution of inflammation correlates with DO11 Tregs in the skin
that express high levels of the immunoregulatory receptor, PD-1. Expression of PD-L1 (the ligand
for PD-1) is increased in the skin upon antigen induction and remains high as inflammation resolves.
We propose that the PD-1/PD-L1 pathway may represent a novel mechanism of limiting antigen-
specific inflammation in the skin.
040
The mechanism by which cathepsin S triggers receptor activation to cause itch
VB Reddy, SB Elmariah, Y Sun and EA Lerner Dermatology/Cutaneous Biology Research
Center, Massachusetts General Hospital, Charlestown, MA
Non-histamine itch is mediated by protease-activated receptors, specifically PAR2. This receptor is
also critical in inflammation and nociception. It has been shown previously that cathepsin S, a cys-
teine protease implicated in inflammation, triggers this receptor and causes itch. The purpose of
this study was to determine the mechanism by which cathepsin S activates PAR2. The mechanism
by which serine proteases, such as trypsin or kallikreins, activate PAR2 has been characterized pre-
viously. Serine proteases cleave near the N-terminus of PAR2 to uncover a new N-terminus that
interacts with transmembrane domains leading to signal transduction. This activation can be mim-
icked by synthetic hexapeptides that correspond to the new N-terminus. Whether cysteine proteases
shared a similar mechanism of action was not known. To examine this possibility, the N-terminal
region of PAR2 was synthesized, exposed to cathepsin S, and subjected to amino acid sequencing
using mass spectrometry. Cathepsin S cleaved PAR2 after leucine and glycine as indicated by the
dashes: GTNRSSKGRSL—IG—KVDGTSHVTGKGVT. The corresponding hexapeptides IGKVDG and
KVDGTS were then synthesized. These hexapeptides were examined for their capacity to activate
PAR2 on HeLa cells transfected with PAR2 cDNA and loaded with the calcium responsive dye fura-
2. Ratiometric imaging revealed that both peptides activated PAR2 in a concentration dependent
manner. This result was confirmed by the capacity of the hexapeptides to phosphorylate protein
kinase C in transfected cells. The sequences of these hexapeptides differ from SLIGKV, the hexa-
peptide associated with PAR activation by serine proteases. In conclusion, these results demonstrate
that a cysteine protease activates PAR2 by cleavage at a site different from that of serine proteases
and that several hexapeptides can trigger intact PAR2.
038
Up-regulation of cathepsin S by IL-23 may contribute to itching in psoriasis
Y Sun, SB Elmariah, VB Reddy and EA Lerner Dermatology/Cutaneous Biology Research Center,
Massachusetts General Hospital, Charlestown, MA
Itching is a symptom associated with psoriasis and other inflammatory conditions but the media-
tors of itch are not clear. Cathepsin S is elevated in psoriatic skin and can mediate non-histamine
itch by triggering protease-activated receptor 2, a G-protein coupled receptor present in keratinocytes
and sensory nerves. But what regulates the expression of cathepsin S? We used real-time qPCR and
Western blots to examine the capacity of a panel of cytokines to affect the expression of cathepsin
S in NHEKs. IL-23 induced the expression of cathepsin s mRNA almost 150-fold with a correspon-
ding increase in protein levels whereas the partner cytokine, IL-12, had almost no effect in experi-
ments conducted in a concentration and time dependent manner. IFN-gamma and TNF-alpha pro-
vided positive controls but had less pronounced effects than IL-23. IL-31, recently implicated in
pruritus, was without effect. In conclusion, these data support the possibility that cathepsin S may
contribute to the itching associated with inflammatory conditions involving IL-23, IFN-gamma or
TNF-alpha and could serve as a therapeutic target.
042
Self-reported environmental triggers associated with onset of alopecia areata
K Fernandes,1 AM Christiano,2 M Hordinsky,3 V Price,4 D Norris,5 J Osei,1 C Amos1 and M Duvic1
1 University of Texas MD Anderson Cancer Center, Houston, TX, 2 Columbia Medical Center,
New York, NY, 3 University of Minnesota, Minneapolis, MN, 4 University of California, San
Francisco, CA and 5 University of Colorado, Denver, CO
The Alopecia Areata Registry (AAR) at website “alopeciaareataregistry.org,” funded by NIAMS in
2000, was created to further knowledge. There are 7821 individuals registered (5358 females/2463
males): 5225 are affected and 3027 have donated serum and DNA. A recently published, genome-
wide association study [Nature Vol 466, 1 Jul 2010] implicates genetic loci for AA; however, monozy-
gotic twins have a concordancy rate of only 42-55%, supporting an important role for environmental
factors. This study was to examine the incidence and nature of self-reported trigger factors in reg-
istry AA patients. One or more trigger factors were self-reported by 37% or 1908 of 5225 AA reg-
istrants, similar in incidence by sex. General term “stress” was reported by 806 AA (42%). “Stress”
was often related to relationships, family, or work related issues. Listed in order of frequency are
pregnancy/birth (5%), hair treatment (4%), surgery (3%), car accident (3%), moving (3%), diagno-
sis of other disease (3%), vaccination (2%), exposure (2%), allergic reaction or allergies (2%). “Infec-
tion” was reported by 18% (354) of AA versus 8% of controls. Infections were categorized as viral
40% (161) with 23 reporting mononucleosis and 17 chicken pox; bacteria 21%(75); staph (10) and
strep (20); fungal (11); or general 21% (74). These self-reported data suggest that 37% of AA patients
relate the onset of their AA to a stressful event and 18% to an infection. Further understanding of
the role of “stress” and “infection” on host immune response in AA is warranted.
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The intersection between tissue macrophages and host lipid metabolism in psoriasis
NM Gharavi,1 D Wharton,1 M Navab,2 S Lee,3 JA Berliner,3 AM Fogelman2 and RL Modlin1 1
Medicine/Dermatology, University of California, Los Angeles, Los Angeles, CA, 2 Cardiology,
University of California, Los Angeles, Los Angeles, CA and 3 Pathology and Laboratory
Medicine, University of California, Los Angeles, Los Angeles, CA
Increasing evidence suggests a link between psoriasis and atherosclerosis, based on epidemiologic
studies and clinical co-morbidity, as well as common inflammatory mediators, including macrophage
signaling and the presence of oxidized low-density lipoprotein (LDL) in psoriatic plaques. In these
studies, we have examined the role of lipid metabolism and tissue macrophages in psoriasis. Using
immunohistochemistry on tissue from psoriatic plaques, we identified a subpopulation of
CD209+/CD163+ dermal macrophages. We had previously reported that these macrophages have
phagocytic properties and are capable of engulfing oxidized lipids. Next, we examined the effect
of oxidized lipids on macrophage signaling using gene-expression arrays. Treatment of THP-1
macrophages for 4-hours with oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine
(OxPAPC), a component minimally oxidized LDL, significantly induced the expression of several
genes reported to play a role in psoriasis, including interleukins-1, -6, -15, -17, -23, cathelicidin
and vascular endothelial growth factor. Lastly, we examined the properties of high-density lipopro-
tein (HDL) in serum obtained from psoriatic patients. In healthy patients, HDL is capable of reverse
cholesterol transport and has potent anti-inflammatory properties. In the setting of systemic inflam-
matory disease, including atherosclerosis, rheumatoid arthritis, and lupus erythematosus, HDL loses
these properties and becomes dysfunctional. Using a well-established model of monocyte chemo-
taxis as a marker of inflammation, we demonstrated that HDL isolated from psoriatic patients was
dysfunctional and had pro-inflammatory properties, in comparison to healthy, age-matched con-
trols. Taken together, these data provide a common mechanism, involving tissue macrophages and
host lipid metabolism, in the co-morbidity of psoriasis and atherosclerosis.
032
Periodontal disease and risk of psoriasis among US women
S Nakib,1 J Han,2,3,4 T Li2 and A Qureshi2,3 1 Dept. of Dermatology and Internal Medicine,
University of Minnesota, Minneapolis, MN, 2 Channing Lab., Dept. of Medicine, Brigham and
Women’s Hospital, Harvard Medical School (BWH, HMS), Boston, MA, 3 Clinical Research
Prog., Dept. of Dermatology, BWH, HMS, Boston, MA and 4 Dept. of Epidemiology, Harvard
School of Public Health, Boston, MA
Periodontal disease (PD) has been associated with systemic inflammation and may be a risk factor
for autoimmune diseases. We evaluated the association between PD and incident psoriasis in a large
US-based cohort study of women. The exposure was self-reported history of periodontal bone loss
and the outcome was incident psoriasis among 65,822 women in the Nurses’ Health Study. Peri-
odontal bone loss was used as proxy for history of PD (asked in 1998 and 2000). Secondary analy-
ses examined associations between psoriasis risk and self-reported history of periodontal surgery in
the past 2 years, root canals (asked in 2000), tooth loss in the past 2 years, and number of natural
teeth (asked in 1992). Cox proportional hazards models were used to assess multivariate estimates,
simultaneously adjusting for age, smoking, body mass index, alcohol intake and physical activity.
Compared with no history of periodontal bone loss, higher multivariate risk of psoriasis was asso-
ciated with mild periodontal bone loss (RR 1.35, 95%CI 1.04, 1.77) and moderate to severe peri-
odontal bone loss (RR 1.52, 95%CI 1.10, 2.09). In addition, a significantly elevated multivariate
risk of psoriasis was associated with history of periodontal surgery in the past 2 years (RR 1.28,
95% CI 1.01-1.63) and history of 3 or more root canals (RR 1.24, 95% CI 1.04, 1.48). Those with
fewer number of natural teeth or tooth loss in the past 2 years were not at greater risk of psoriasis
in our study. In this US-based cohort study, we found evidence for an increased risk of psoriasis
among women with a history of periodontal bone loss, periodontal surgery, and 3 or more root
canals. Further work is needed to better understand the biologic basis of this association.
033
Complement activation in dermatomyositis and polymyositis: Complementing or challeng-
ing cell-mediated pathogenesis?
MJ Molnar,1 P Dupuy2 and M Basta3 1 Clinical and Research Center for Molecular Neurology,
Semmelweis University, Budapest, Hungary, 2 Orfagen, Toulouse, France and 3 BioVisions,
Inc, Potomac, MD
Dermatomyosits (DM), Polymyositis (PM) and inclusion body myositis (IBM) belong to the group of
immune-mediated inflammatory myopathies. The current consensus is that DM has a complement-
mediated pathogenesis with formation of membrane attack complexes (MAC) that induces muscle
fiber necrosis, whereas PM is a cell mediated disorder in which CD8+ cytotoxic T cells invade mus-
cle fibers expressing MHC class I antigens and cause fiber necrosis through release of pore-form-
ing protein perforin. The role of complement activation in PM has not been considered nor inves-
tigated. Here, we present immunohistochemical evidence that activated complement fragments
are deposited at the site of muscle inflammation in PM. Serial muscle sections from histologically
and clinically confirmed cases of DM (n=6), PM (n=6), IBM (n=2) and normal controls (n=2) were
subjected to staining with antibodies against perforin, C3b, iC3b and MAC. Perforin was strongly
expressed in 5/6 PM biopsies, but in only one of the DM biopsies and in none of the other controls.
As expected, MAC as well as C3b and iC3b complement fragments were expressed in 4/6 DM
biopsies. Strong staining for these markers was observed in the same proportion of PM patients.
This is the first report on possible involvement of complement in the pathogenesis of PM. Our find-
ings suggests that the pathophysiology of DM and PM are more related than previously thought and
that humoral immune mechanisms may contribute to T-cell effects in developing clinical manifes-
tations of the two disorders. Complement modulation may have a place in therapeutic interven-
tions for both DM and PM.
034
TRAF3IP2 couples IL-17 to the epidermal defense response
S Lambert, SW Stoll and JT Elder Dept of Dermatology, University of Michigan, Ann Arbor, MI
Genetic and functional evidence implicates sequential signaling through Interleukin (IL)-23 and IL-
17 in psoriasis and other autoimmune disorders. TRAF3IP2 encodes Act1, an adapter protein that
connects the IL-17 receptor to NFkB via TRAF6 and the IKK complex. Recent studies have impli-
cated TRAF3IP2 in susceptibility to psoriasis and psoriatic arthritis. This pathway also utilizes the
products of 4 other psoriasis susceptibility loci: TNFAIP3, TNIP1, NFKBIA, and REL. The gene expres-
sion profile of psoriasis lesions is remarkable for marked KC overexpression of genes involved in
antimicrobial responses (e.g., DEFB4/103, S100A7/A8/A9/A12, LCN2) as well as cytokine genes
involved in promoting innate immunity and inflammatory cell infiltration (e.g., CCL20, IL19, IL20,
IL24, and IL1F9), defining a polygenic “epidermal defense response”. IL-17 and TNF-a (TNF) syn-
ergistically induce these mRNAs in cultured KC monolayers, identifying KC as a promising system
for molecular dissection of TRAF3IP2 function. We thus investigated the effects of shRNA-mediated
knockdown or over-expression of TRAF3IP2 on IL-17+TNF-stimulated gene expression in KC. Using
either normal primary KC or telomerase-immortalized tetracycline-inducible NTERT-TR cells, by
QRT-PCR we found that TRAF3IP2 knockdown induces a marked and significant decrease in expres-
sion of DEFB103 (89% inhibition, p=0.02), DEFB4 (91%, p=0.01), S100A7 (60%, p=0.09), LCN2
(76%, p=0.006), CCL20 (85%, p=0.002), IL19 (92%, p=0.00001), IL20 (88%, p=0.007), IL24 (80%,
p=0.006), and IL1F9 (67%, p=0.02), in response to IL-17+TNF stimulation. Similarly, overexpres-
sion of TRAF3IP2 using a CMV promoter markedly increased expression of several of these genes
in the absence of exogenous IL-17 or TNF. Our results confirm that IL-17 and TNF can synergisti-
cally induce the epidermal defense response, and demonstrate that this response is Act1-depend-
ent. Additionally, they elucidate a plausible molecular mechanism by which TRAF3IP2 may exert
its genetic influence on psoriasis susceptibility, and provide a tractable experimental system for its
further molecular dissection.
035
Mast cell chymase plays a critical role in bullous pemphigoid in mice
L Lin,1 E Bankaitis,1 N Li,1 M Abrink,2 G Pejler,2 L Diaz,1 Z Werb3 and Z Liu1 1 University of North
Carolina, Chapel Hill, NC, 2 Swedish University of Agricultural Sciences, Uppsala, Sweden
and 3 University of California, San Francisco, CA
Bullous pemphigoid (BP) is an autoimmune inflammatory subepidermal blistering disease associ-
ated with autoantibodies against two major hemidesmosomal components, the BP230 and BP180.
The separation of the epidermis from the dermis occurs within the lamina lucida of the basement
membrane and is accompanied by an extensive inflammatory infiltrate and destruction of hemidesmo-
somal and extracellular matrix components. Several proteinases, including neutrophil elastase (NE),
MMP-9, and plasmin, released from infiltrating inflammatory cells have been detected in BP blis-
ter fluids and lesional/perilesional sites and implicated in BP. We have showed that subepidermal
blistering in C57BL/6J (B6) mice triggered by anti-mouse BP180 IgG (anti-mBP180) or BP180 human-
ized mice (hBP180 mice) triggered by anti-human BP180 autoantibodies depends on complement,
mast cells, and neutrophils. B6 mice lacking NE, MMP-9, or plasmin are resistant to BP. Here, we
show that BP blistering in mice requires the chymase mast cell proteinase-4 (mMCP-4). B6 mice
lacking mMCP-4 and hBP180 mice treated with mMCP-4 neutralizing antibody develop delayed
and reduced BP disease phenotype. Levels of active MMP-9 in the skin of mMCP-4-deficient mice
were significantly reduced as compared to the diseased wild-type mice. In vitro, human skin mast
cell chymase, when incubated with mouse skin, produces dermal-epidermal separation. Further-
more, human mast cell chymase cleaves epidermal BP180 and recombinant BP180. These data sug-
gest that this mast cell proteinase plays a dual role in BP- activation of MMP-9 and degradation of
BP180.
036
A mouse model of the cytokine storm: inhibiting IFN-γ or TNF-α blocks a lethal response
E Nelson,1 F Miyagawa,1 HA Young,2 D Reynolds,2 J Linton,1 J Gutermuth1 and SI Katz1 1
Dermatology, NCI, Bethesda, MD and 2 Cellular and Molecular Immunology, NCI, Bethesda,
MD
In 2006, six healthy volunteers suffered a life-threatening systemic inflammatory response during
phase I clinical trials of TGN1412, a super-antagonistic antibody anti-CD28. This type of reaction,
which was considered a cytokine storm, was unpredicted since preclinical studies in mice suggested
that the antibody was safe and effective. In order to better understand the mechanism(s) involved
in this type of severe adverse event and to identify potential interventions, we have developed a
mouse model of a cytokine storm. When OT-I homozygous mice that express transgenic T cell recep-
tors that recognize an ovalbumin peptide (SIINFEKL) in association with H-2Kb are given SIINFEKL
peptide ip, there is a massive increase in serum cytokine levels within 2 h of injection. Within 1
hour of SIINFEKL injection, mice exhibit a dose-dependent panoply of symptoms including shal-
low breathing, lethargy, hunched appearance, and, at doses of 100 μg of peptide, death at 8-16 h
after injection. Lower doses (10 and 50 μg) lead to signs of clinical disease but not always death.
Serum cytokine analyses show very high concentrations of IL-6, IL-10, TNF-α and IFN-γ (greater
than 5000 IU for each) as early as 2hrs after injection of SIINFEKL, with minimal increases in IL-2
and IL-4 and no increase in IL-17a. Blocking of TNF-α (with etanercept) and/or IFN-γ (with anti
IFN-γ ab) decreases the effective serum concentration of each of these cytokines and attenuates the
clinical disease in mice given SIINFEKL peptide in doses of 10 or 50 μg. FACS analysis of spleen at
24 hr after peptide injection showed that the percentage of CD25, and CD69 positive OT-I cells
was decreased when the mice were treated with etanercept and/or anti-IFN-γ Ab. This model sug-
gests that TNF-α and IFN-γ, and to a lesser extent, IL-6 and IL-10, may all be involved in the gen-
eration of this cytokine storm and that decreasing their serum concentration may provide immedi-
ate attenuation of this otherwise devastating response.
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The role of Syndecan 1 and Syndecan 4 in the severity of murine contact hypersensitivity
J Bühligen,1 F Echtermeyer,2 M Götte,2 M Averbeck1 and JC Simon1 1 Dermatologie, Universität
Leipzig, Leipzig, Germany and 2 Department of Physiological Chemistry and
Pathobiochemistry, University Hospital Münster, Münster, Germany
The migration of Dendritic Cells (DC) towards the local lymph nodes and the presentation of anti-
gens towards the T-Cells play an important role in the induction of the immune-response and the
maintenance of immunological tolerance. The antigen-dependent activation and migration of DC
in peripheral tissues is closely associated with their interactions with the Extracellular Matrix (ECM).
Syndecans (SDC) are transmembrane proteoglycans with heparan sulfate side chains. They act as
integrin co-receptors and sequester extracellular signals like cytokines. We investigated SDC 1 and
SDC 4-knockout mice compared to wildtype mice in the murine contact hypersensitivity (CHS)
model. Wildtype-mice, SDC4-/- and SDC1-/- mice were sensitized by 7% trinitrochlorobenzene
(TNCB) painted on the shaved abdomen. 5 days later the mice were challenged with 1% TNCB and
the induced earswelling was measured by micrometer. The SDC1-/- mice showed an enhanced ear-
swelling while the SDC4-/- mice showed a similar ear-swelling after CHS response compared to
wildtype. In vivo DC migration was investigated by sensitization with fluorescence tetramethylrho-
damine (TRITC) and detection of CD11c+ TRITC+ in the draining Lymphnodes. While DC migra-
tion in SDC1-/- was increased, a decreased DC migration in SDC4-/- mice was observed. We con-
clude that the altered migratory capacity of DC in SDC 4-/- mice and SDC 1-/- mice might affect
the severity of contact hypersensitivity.
039
Type IV collagen binding-site within type VII collagen is a pathogenic epitope for EBA autoan-
tibodies
X Wang, R Gupta, A Garlapati, J Cogan, D Woodley and M Chen Dermatology, University of
Southern California, Los Angeles, CA
Type VII (anchoring fibril) collagen (C7) mediates epidermal-dermal adherence and is the target for
IgG autoantibodies in patients with epidermolysis bullosa acquisita (EBA). The amino-terminal
non-collagenous (NC1) domain of C7 harbors the antigenic epitopes for EBA autoantibodies and
contains 9 fibronectin type III-like homology repeats (FNIII). We previously demonstrated NC1 had
affinity for type IV collagen. Using a panel of recombinant NC1 deletion mutant proteins and a
solid-phase ligand, antigen-to-antigen affinity assay, in this study, we further refined the type IV col-
lagen-binding site to residues 202-360, a 158 amino acid stretch within one of the FNIII. Further,
EBA autoantibodies shown to bind to this subdomain by epitope mapping were capable of inhibit-
ing C7 affinity for type IV collagen while IgG from normal human serum did not. Using a FNIII sub-
domain affinity column, we affinity purified FNIII-specific antibodies from a high titer rabbit poly-
clonal antibody against NC1, and injected these antibodies into hairless, immunocompetent mice
(20-100 microgram/gm body weight) daily for 7 days. Skin bullae, erosions and nail loss developed
in the injected mice and biopsies of lesional skin revealed histological, ultrastructural and immuno-
logical features of human EBA including sub-epidermal bullae formation, a sub-lamina densa blis-
ter cleavage plane and rabbit IgG and murine C3 immunodeposits at the dermal-epidermal junc-
tion. The extent of skin disease correlated with the titer of anti-FNIII antibodies circulating in the
animal’s plasma. In contrast, no skin pathology was observed with the injection of normal rabbit
serum. We conclude that the type IV collagen binding site within one of the FNIII like sub-domains
of C7 likely plays an important role in epidermal-dermal adherence and that EBA autoantibodies
to this subdomain are highly pathogenic and responsible for the induced epidermal-dermal disad-
herence observed in EBA.
041
A novel mouse model to study immune regulatory pathways in the skin
M Rosenblum,1 I Gratz,2 J Paw1,2 and A Abbas2 1 Dermatology, University of California, San
Francisco, San Francisco, CA and 2 Pathology, University of California, San Francisco, San
Francisco, CA
Failure to establish immune tolerance results in the initiation of autoimmune disease. However,
once autoimmune reactions are incited, regulatory pathways act to attenuate the inflammatory
response in an attempt to limit tissue damage. Little is known about the regulatory mechanisms that
suppress antigen-specific inflammation in the skin. We have developed a novel mouse model to
study the mechanisms responsible for limiting and resolving cutaneous inflammation. Mice have
been engineered to have tetracycline-inducible expression of a neo-self antigen (Ovalbumin) in the
basal layer of the epidermis (under control of the K5 promoter). In K5/Ova mice, Ova expression is
tightly controlled, as adoptively transferred Ova-specific (DO11) CD4+ T cells proliferate in skin-
draining lymph nodes only after treatment with doxycycline. Expression of Ova in the thymus is
independent of doxycycline, as an increase in DO11 regulatory T cells (Tregs) is observed in
K5/Ova/DO11 mice (K5/Ova mice crossed onto the DO11 background). Despite a large percent-
age of DO11 Tregs, induction of Ova expression in K5/Ova/DO11 mice results in a pronounced
inflammatory dermatitis. Disease peaks at 14 days after antigen induction and is characterized by
erythema, scaling, alopecia and an inflammatory infiltrate composed of DO11 T cells and GR-
1+CD11b+ myeloid cells. Interestingly, skin inflammation spontaneously resolves. At approximately
40 days after antigen induction, mice show complete clinical and histological resolution of dis-
ease. Inflammation resolves despite persistent Ova expression in the skin and continuous thymic
output of Ova-specific T cells. Resolution of inflammation correlates with DO11 Tregs in the skin
that express high levels of the immunoregulatory receptor, PD-1. Expression of PD-L1 (the ligand
for PD-1) is increased in the skin upon antigen induction and remains high as inflammation resolves.
We propose that the PD-1/PD-L1 pathway may represent a novel mechanism of limiting antigen-
specific inflammation in the skin.
040
The mechanism by which cathepsin S triggers receptor activation to cause itch
VB Reddy, SB Elmariah, Y Sun and EA Lerner Dermatology/Cutaneous Biology Research
Center, Massachusetts General Hospital, Charlestown, MA
Non-histamine itch is mediated by protease-activated receptors, specifically PAR2. This receptor is
also critical in inflammation and nociception. It has been shown previously that cathepsin S, a cys-
teine protease implicated in inflammation, triggers this receptor and causes itch. The purpose of
this study was to determine the mechanism by which cathepsin S activates PAR2. The mechanism
by which serine proteases, such as trypsin or kallikreins, activate PAR2 has been characterized pre-
viously. Serine proteases cleave near the N-terminus of PAR2 to uncover a new N-terminus that
interacts with transmembrane domains leading to signal transduction. This activation can be mim-
icked by synthetic hexapeptides that correspond to the new N-terminus. Whether cysteine proteases
shared a similar mechanism of action was not known. To examine this possibility, the N-terminal
region of PAR2 was synthesized, exposed to cathepsin S, and subjected to amino acid sequencing
using mass spectrometry. Cathepsin S cleaved PAR2 after leucine and glycine as indicated by the
dashes: GTNRSSKGRSL—IG—KVDGTSHVTGKGVT. The corresponding hexapeptides IGKVDG and
KVDGTS were then synthesized. These hexapeptides were examined for their capacity to activate
PAR2 on HeLa cells transfected with PAR2 cDNA and loaded with the calcium responsive dye fura-
2. Ratiometric imaging revealed that both peptides activated PAR2 in a concentration dependent
manner. This result was confirmed by the capacity of the hexapeptides to phosphorylate protein
kinase C in transfected cells. The sequences of these hexapeptides differ from SLIGKV, the hexa-
peptide associated with PAR activation by serine proteases. In conclusion, these results demonstrate
that a cysteine protease activates PAR2 by cleavage at a site different from that of serine proteases
and that several hexapeptides can trigger intact PAR2.
038
Up-regulation of cathepsin S by IL-23 may contribute to itching in psoriasis
Y Sun, SB Elmariah, VB Reddy and EA Lerner Dermatology/Cutaneous Biology Research Center,
Massachusetts General Hospital, Charlestown, MA
Itching is a symptom associated with psoriasis and other inflammatory conditions but the media-
tors of itch are not clear. Cathepsin S is elevated in psoriatic skin and can mediate non-histamine
itch by triggering protease-activated receptor 2, a G-protein coupled receptor present in keratinocytes
and sensory nerves. But what regulates the expression of cathepsin S? We used real-time qPCR and
Western blots to examine the capacity of a panel of cytokines to affect the expression of cathepsin
S in NHEKs. IL-23 induced the expression of cathepsin s mRNA almost 150-fold with a correspon-
ding increase in protein levels whereas the partner cytokine, IL-12, had almost no effect in experi-
ments conducted in a concentration and time dependent manner. IFN-gamma and TNF-alpha pro-
vided positive controls but had less pronounced effects than IL-23. IL-31, recently implicated in
pruritus, was without effect. In conclusion, these data support the possibility that cathepsin S may
contribute to the itching associated with inflammatory conditions involving IL-23, IFN-gamma or
TNF-alpha and could serve as a therapeutic target.
042
Self-reported environmental triggers associated with onset of alopecia areata
K Fernandes,1 AM Christiano,2 M Hordinsky,3 V Price,4 D Norris,5 J Osei,1 C Amos1 and M Duvic1
1 University of Texas MD Anderson Cancer Center, Houston, TX, 2 Columbia Medical Center,
New York, NY, 3 University of Minnesota, Minneapolis, MN, 4 University of California, San
Francisco, CA and 5 University of Colorado, Denver, CO
The Alopecia Areata Registry (AAR) at website “alopeciaareataregistry.org,” funded by NIAMS in
2000, was created to further knowledge. There are 7821 individuals registered (5358 females/2463
males): 5225 are affected and 3027 have donated serum and DNA. A recently published, genome-
wide association study [Nature Vol 466, 1 Jul 2010] implicates genetic loci for AA; however, monozy-
gotic twins have a concordancy rate of only 42-55%, supporting an important role for environmental
factors. This study was to examine the incidence and nature of self-reported trigger factors in reg-
istry AA patients. One or more trigger factors were self-reported by 37% or 1908 of 5225 AA reg-
istrants, similar in incidence by sex. General term “stress” was reported by 806 AA (42%). “Stress”
was often related to relationships, family, or work related issues. Listed in order of frequency are
pregnancy/birth (5%), hair treatment (4%), surgery (3%), car accident (3%), moving (3%), diagno-
sis of other disease (3%), vaccination (2%), exposure (2%), allergic reaction or allergies (2%). “Infec-
tion” was reported by 18% (354) of AA versus 8% of controls. Infections were categorized as viral
40% (161) with 23 reporting mononucleosis and 17 chicken pox; bacteria 21%(75); staph (10) and
strep (20); fungal (11); or general 21% (74). These self-reported data suggest that 37% of AA patients
relate the onset of their AA to a stressful event and 18% to an infection. Further understanding of
the role of “stress” and “infection” on host immune response in AA is warranted.
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The intersection between tissue macrophages and host lipid metabolism in psoriasis
NM Gharavi,1 D Wharton,1 M Navab,2 S Lee,3 JA Berliner,3 AM Fogelman2 and RL Modlin1 1
Medicine/Dermatology, University of California, Los Angeles, Los Angeles, CA, 2 Cardiology,
University of California, Los Angeles, Los Angeles, CA and 3 Pathology and Laboratory
Medicine, University of California, Los Angeles, Los Angeles, CA
Increasing evidence suggests a link between psoriasis and atherosclerosis, based on epidemiologic
studies and clinical co-morbidity, as well as common inflammatory mediators, including macrophage
signaling and the presence of oxidized low-density lipoprotein (LDL) in psoriatic plaques. In these
studies, we have examined the role of lipid metabolism and tissue macrophages in psoriasis. Using
immunohistochemistry on tissue from psoriatic plaques, we identified a subpopulation of
CD209+/CD163+ dermal macrophages. We had previously reported that these macrophages have
phagocytic properties and are capable of engulfing oxidized lipids. Next, we examined the effect
of oxidized lipids on macrophage signaling using gene-expression arrays. Treatment of THP-1
macrophages for 4-hours with oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine
(OxPAPC), a component minimally oxidized LDL, significantly induced the expression of several
genes reported to play a role in psoriasis, including interleukins-1, -6, -15, -17, -23, cathelicidin
and vascular endothelial growth factor. Lastly, we examined the properties of high-density lipopro-
tein (HDL) in serum obtained from psoriatic patients. In healthy patients, HDL is capable of reverse
cholesterol transport and has potent anti-inflammatory properties. In the setting of systemic inflam-
matory disease, including atherosclerosis, rheumatoid arthritis, and lupus erythematosus, HDL loses
these properties and becomes dysfunctional. Using a well-established model of monocyte chemo-
taxis as a marker of inflammation, we demonstrated that HDL isolated from psoriatic patients was
dysfunctional and had pro-inflammatory properties, in comparison to healthy, age-matched con-
trols. Taken together, these data provide a common mechanism, involving tissue macrophages and
host lipid metabolism, in the co-morbidity of psoriasis and atherosclerosis.
032
Periodontal disease and risk of psoriasis among US women
S Nakib,1 J Han,2,3,4 T Li2 and A Qureshi2,3 1 Dept. of Dermatology and Internal Medicine,
University of Minnesota, Minneapolis, MN, 2 Channing Lab., Dept. of Medicine, Brigham and
Women’s Hospital, Harvard Medical School (BWH, HMS), Boston, MA, 3 Clinical Research
Prog., Dept. of Dermatology, BWH, HMS, Boston, MA and 4 Dept. of Epidemiology, Harvard
School of Public Health, Boston, MA
Periodontal disease (PD) has been associated with systemic inflammation and may be a risk factor
for autoimmune diseases. We evaluated the association between PD and incident psoriasis in a large
US-based cohort study of women. The exposure was self-reported history of periodontal bone loss
and the outcome was incident psoriasis among 65,822 women in the Nurses’ Health Study. Peri-
odontal bone loss was used as proxy for history of PD (asked in 1998 and 2000). Secondary analy-
ses examined associations between psoriasis risk and self-reported history of periodontal surgery in
the past 2 years, root canals (asked in 2000), tooth loss in the past 2 years, and number of natural
teeth (asked in 1992). Cox proportional hazards models were used to assess multivariate estimates,
simultaneously adjusting for age, smoking, body mass index, alcohol intake and physical activity.
Compared with no history of periodontal bone loss, higher multivariate risk of psoriasis was asso-
ciated with mild periodontal bone loss (RR 1.35, 95%CI 1.04, 1.77) and moderate to severe peri-
odontal bone loss (RR 1.52, 95%CI 1.10, 2.09). In addition, a significantly elevated multivariate
risk of psoriasis was associated with history of periodontal surgery in the past 2 years (RR 1.28,
95% CI 1.01-1.63) and history of 3 or more root canals (RR 1.24, 95% CI 1.04, 1.48). Those with
fewer number of natural teeth or tooth loss in the past 2 years were not at greater risk of psoriasis
in our study. In this US-based cohort study, we found evidence for an increased risk of psoriasis
among women with a history of periodontal bone loss, periodontal surgery, and 3 or more root
canals. Further work is needed to better understand the biologic basis of this association.
033
Complement activation in dermatomyositis and polymyositis: Complementing or challeng-
ing cell-mediated pathogenesis?
MJ Molnar,1 P Dupuy2 and M Basta3 1 Clinical and Research Center for Molecular Neurology,
Semmelweis University, Budapest, Hungary, 2 Orfagen, Toulouse, France and 3 BioVisions,
Inc, Potomac, MD
Dermatomyosits (DM), Polymyositis (PM) and inclusion body myositis (IBM) belong to the group of
immune-mediated inflammatory myopathies. The current consensus is that DM has a complement-
mediated pathogenesis with formation of membrane attack complexes (MAC) that induces muscle
fiber necrosis, whereas PM is a cell mediated disorder in which CD8+ cytotoxic T cells invade mus-
cle fibers expressing MHC class I antigens and cause fiber necrosis through release of pore-form-
ing protein perforin. The role of complement activation in PM has not been considered nor inves-
tigated. Here, we present immunohistochemical evidence that activated complement fragments
are deposited at the site of muscle inflammation in PM. Serial muscle sections from histologically
and clinically confirmed cases of DM (n=6), PM (n=6), IBM (n=2) and normal controls (n=2) were
subjected to staining with antibodies against perforin, C3b, iC3b and MAC. Perforin was strongly
expressed in 5/6 PM biopsies, but in only one of the DM biopsies and in none of the other controls.
As expected, MAC as well as C3b and iC3b complement fragments were expressed in 4/6 DM
biopsies. Strong staining for these markers was observed in the same proportion of PM patients.
This is the first report on possible involvement of complement in the pathogenesis of PM. Our find-
ings suggests that the pathophysiology of DM and PM are more related than previously thought and
that humoral immune mechanisms may contribute to T-cell effects in developing clinical manifes-
tations of the two disorders. Complement modulation may have a place in therapeutic interven-
tions for both DM and PM.
034
TRAF3IP2 couples IL-17 to the epidermal defense response
S Lambert, SW Stoll and JT Elder Dept of Dermatology, University of Michigan, Ann Arbor, MI
Genetic and functional evidence implicates sequential signaling through Interleukin (IL)-23 and IL-
17 in psoriasis and other autoimmune disorders. TRAF3IP2 encodes Act1, an adapter protein that
connects the IL-17 receptor to NFkB via TRAF6 and the IKK complex. Recent studies have impli-
cated TRAF3IP2 in susceptibility to psoriasis and psoriatic arthritis. This pathway also utilizes the
products of 4 other psoriasis susceptibility loci: TNFAIP3, TNIP1, NFKBIA, and REL. The gene expres-
sion profile of psoriasis lesions is remarkable for marked KC overexpression of genes involved in
antimicrobial responses (e.g., DEFB4/103, S100A7/A8/A9/A12, LCN2) as well as cytokine genes
involved in promoting innate immunity and inflammatory cell infiltration (e.g., CCL20, IL19, IL20,
IL24, and IL1F9), defining a polygenic “epidermal defense response”. IL-17 and TNF-a (TNF) syn-
ergistically induce these mRNAs in cultured KC monolayers, identifying KC as a promising system
for molecular dissection of TRAF3IP2 function. We thus investigated the effects of shRNA-mediated
knockdown or over-expression of TRAF3IP2 on IL-17+TNF-stimulated gene expression in KC. Using
either normal primary KC or telomerase-immortalized tetracycline-inducible NTERT-TR cells, by
QRT-PCR we found that TRAF3IP2 knockdown induces a marked and significant decrease in expres-
sion of DEFB103 (89% inhibition, p=0.02), DEFB4 (91%, p=0.01), S100A7 (60%, p=0.09), LCN2
(76%, p=0.006), CCL20 (85%, p=0.002), IL19 (92%, p=0.00001), IL20 (88%, p=0.007), IL24 (80%,
p=0.006), and IL1F9 (67%, p=0.02), in response to IL-17+TNF stimulation. Similarly, overexpres-
sion of TRAF3IP2 using a CMV promoter markedly increased expression of several of these genes
in the absence of exogenous IL-17 or TNF. Our results confirm that IL-17 and TNF can synergisti-
cally induce the epidermal defense response, and demonstrate that this response is Act1-depend-
ent. Additionally, they elucidate a plausible molecular mechanism by which TRAF3IP2 may exert
its genetic influence on psoriasis susceptibility, and provide a tractable experimental system for its
further molecular dissection.
035
Mast cell chymase plays a critical role in bullous pemphigoid in mice
L Lin,1 E Bankaitis,1 N Li,1 M Abrink,2 G Pejler,2 L Diaz,1 Z Werb3 and Z Liu1 1 University of North
Carolina, Chapel Hill, NC, 2 Swedish University of Agricultural Sciences, Uppsala, Sweden
and 3 University of California, San Francisco, CA
Bullous pemphigoid (BP) is an autoimmune inflammatory subepidermal blistering disease associ-
ated with autoantibodies against two major hemidesmosomal components, the BP230 and BP180.
The separation of the epidermis from the dermis occurs within the lamina lucida of the basement
membrane and is accompanied by an extensive inflammatory infiltrate and destruction of hemidesmo-
somal and extracellular matrix components. Several proteinases, including neutrophil elastase (NE),
MMP-9, and plasmin, released from infiltrating inflammatory cells have been detected in BP blis-
ter fluids and lesional/perilesional sites and implicated in BP. We have showed that subepidermal
blistering in C57BL/6J (B6) mice triggered by anti-mouse BP180 IgG (anti-mBP180) or BP180 human-
ized mice (hBP180 mice) triggered by anti-human BP180 autoantibodies depends on complement,
mast cells, and neutrophils. B6 mice lacking NE, MMP-9, or plasmin are resistant to BP. Here, we
show that BP blistering in mice requires the chymase mast cell proteinase-4 (mMCP-4). B6 mice
lacking mMCP-4 and hBP180 mice treated with mMCP-4 neutralizing antibody develop delayed
and reduced BP disease phenotype. Levels of active MMP-9 in the skin of mMCP-4-deficient mice
were significantly reduced as compared to the diseased wild-type mice. In vitro, human skin mast
cell chymase, when incubated with mouse skin, produces dermal-epidermal separation. Further-
more, human mast cell chymase cleaves epidermal BP180 and recombinant BP180. These data sug-
gest that this mast cell proteinase plays a dual role in BP- activation of MMP-9 and degradation of
BP180.
036
A mouse model of the cytokine storm: inhibiting IFN-γ or TNF-α blocks a lethal response
E Nelson,1 F Miyagawa,1 HA Young,2 D Reynolds,2 J Linton,1 J Gutermuth1 and SI Katz1 1
Dermatology, NCI, Bethesda, MD and 2 Cellular and Molecular Immunology, NCI, Bethesda,
MD
In 2006, six healthy volunteers suffered a life-threatening systemic inflammatory response during
phase I clinical trials of TGN1412, a super-antagonistic antibody anti-CD28. This type of reaction,
which was considered a cytokine storm, was unpredicted since preclinical studies in mice suggested
that the antibody was safe and effective. In order to better understand the mechanism(s) involved
in this type of severe adverse event and to identify potential interventions, we have developed a
mouse model of a cytokine storm. When OT-I homozygous mice that express transgenic T cell recep-
tors that recognize an ovalbumin peptide (SIINFEKL) in association with H-2Kb are given SIINFEKL
peptide ip, there is a massive increase in serum cytokine levels within 2 h of injection. Within 1
hour of SIINFEKL injection, mice exhibit a dose-dependent panoply of symptoms including shal-
low breathing, lethargy, hunched appearance, and, at doses of 100 μg of peptide, death at 8-16 h
after injection. Lower doses (10 and 50 μg) lead to signs of clinical disease but not always death.
Serum cytokine analyses show very high concentrations of IL-6, IL-10, TNF-α and IFN-γ (greater
than 5000 IU for each) as early as 2hrs after injection of SIINFEKL, with minimal increases in IL-2
and IL-4 and no increase in IL-17a. Blocking of TNF-α (with etanercept) and/or IFN-γ (with anti
IFN-γ ab) decreases the effective serum concentration of each of these cytokines and attenuates the
clinical disease in mice given SIINFEKL peptide in doses of 10 or 50 μg. FACS analysis of spleen at
24 hr after peptide injection showed that the percentage of CD25, and CD69 positive OT-I cells
was decreased when the mice were treated with etanercept and/or anti-IFN-γ Ab. This model sug-
gests that TNF-α and IFN-γ, and to a lesser extent, IL-6 and IL-10, may all be involved in the gen-
eration of this cytokine storm and that decreasing their serum concentration may provide immedi-
ate attenuation of this otherwise devastating response.
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Live imaging and assessment of vascular permeability using two-photon microscopy
G Egawa, Y Miyachi and K Kabashima Dermatology, Kyoto University, Kyoto, Japan
Surface barrier at skin and intestinal mucosa are essential for the maintenance of homeostasis. On
the other hand, the barrier function of the blood vessels, known as “vascular permeability”, is impor-
tant for the regulation of immune functions. Therefore, to characterize vascular barrier is important
to understand the pathogenesis of skin inflammation such as interstitial swelling; however, it is yet
to be defined. Thus, we developed a new system to study this issue using two-photon microscopy.
A variety of sizes of FITC-conjugated dextran were injected via tail vein to visualize blood capil-
lary network of the skin, and the leakage of labeled dextran were tracked over time. We used 70-
kDa-dextran as a reference, because the size of albumin is about 70-kDa and it plays a critical role
to maintain plasma osmotic pressure. In the steady state, 70-kDa-dextran retained within the blood
vessels for a long time as expected. In contrast, the dextran smaller than 40-kDa were promptly
leaked from the vessels to the interstitial space, suggesting that the plasma proteins smaller than 40-
kDa can freely intercommunicate between blood vessels and peripheral interstitium. On the other
hand, when the skin inflammation was caused by PMA application, even 155-kDa-dextran was eas-
ily penetrated from the blood vessels to the interstitial space. We also demonstrated that FITC-con-
jugated IgG (about 150-kDa) retained within the blood vessels in non-inflamed skin but not in
inflamed skin. These novel findings may create a new paradigm for understanding the pathogene-
sis of humoral immunity-mediated autoimmune diseases such as pemphigus vulgaris; the plasma
proteins larger than 40-kDa, including immunoglobulins and complement, retain within the blood
circulatory system in the steady state, and translocate to peripheral tissues where inflammation are
elicited to increase the vascular permeability. Following this concept, it is suggested that the prompt
control of initial inflammation is important for preventing the exacerbation/establishment of autoim-
mune skin diseases.
051
Anti-inflammatory activity of NPS-1577, PAR-2 specific antagonist, on oxazolone-induced
chronic dermatitis animal model
S Jeong,1 D Lee,2 H Kim,3 J Jeon,1 J Bae,1 H Gwak,1 J Yun,2 H Lee,2 S Lee4 and S Lee4 1 Research
Division, NeoPharm Co., Ltd., Daejeon, Republic of Korea, 2 Research Division,
LegoChemBioScience Co., Ltd., Daejeon, Republic of Korea, 3 Department of
Dermatology/Atopy Clinic, Seoul Medical Center, Seoul, Republic of Korea and 4 Department
of Dermatology, Yonsei University College of Medicine, Seoul, Republic of Korea
Therapeutic application of PAR-2 specific antagonist has been repeatedly suggested for the inflam-
matory skin diseases including atopic dermatitis and psoriasis. However, due to the lack of potent
PAR-2 specific antagonist for topical use, direct evaluation of PAR-2 antagonist has not been reported
yet. In this study, the anti-inflammatory activity of newly developed PAR-2 antagonist, NPS-1557,
was evaluated. In order to assess the effect of PAR-2 antagonist on epidermal permeability barrier
function, NPS-1577 was topically applied on acutely barrier disrupted skin of hairless mouse. Top-
ical application of NPS-1577 significantly accelerated the permeability barrier recovery rate, which
was similar to the previous reports. In an epidermal hyperplasia model induced by repeated barrier
disruption, NPS-1577 significantly prevented the increase of epidermal thickness. In a TPA-induced
skin edema model, topical application of NPS-1577 significantly prevented the increase of ear weight
in ICR mice in a dose dependent manner. Finally, in an oxazolone-induced chronic dermatitis model,
topical application of NPS-1577 showed significant improvement in epidermal permeability bar-
rier function and skin hydration, respectively. Epidermal thickness and number of proliferating cell
nucleus antigen (PCNA)-positive keratinocyte in epidermis were also significantly reduced by NPS-
1577, in a dose dependent manner. Interestingly, increased PAR-2 expression in epidermis after oxa-
zolone challenge was abrogated in NPS-1577 treated site. These results suggest that topical PAR-2
antagonist has beneficial effects on skin barrier function and anti-inflammatory activity, and can be
a potential therapeutic agent for inflammatory skin diseases.
053
FcgammaRIV is crucial for neutrophil effector function in experimental epidermolysis bul-
losa acquisita
M Kasperkiewicz,1 S Wende,1 F Nimmerjahn,2 M Hirose,1 H Iwata,1 K Kalies,3 E Schmidt,1
J Westermann,3 J Köhl,4 D Zillikens1 and R Ludwig1 1 Department of Dermatology, University of
Lübeck, Lübeck, Germany, 2 University of Erlangen-Nuremberg, Erlangen, Germany, 3
Institute of Anatomy, University of Lübeck, Lübeck, Germany and 4 Institute for Systemic
Inflammation Research, University of Lübeck, Lübeck, Germany
Epidermolysis bullosa acquisita (EBA) is an autoimmune bullous disease mediated by autoantibod-
ies against type VII collagen, the major component of anchoring fibrils of the dermal-epidermal junc-
tion. When passively transferred into mice, rabbit IgG against type VII collagen induces Fc-depend-
ent activation of complement, the recruitment of leucocytes into the skin, and subepidermal blistering.
In this study, we determined the role of different Fc gamma receptors (FcgammaRs) and the patho-
genetically relevant FcgammaR-bearing cells in experimental EBA. Mice lacking the common gamma
chain of activating FcgammaRs were completely resistant to experimental EBA induction. Similarly,
mice deficient in FcgammaRIV were completely resistant to EBA, which has been confirmed by a
FcgammaRIV function blocking antibody. Mice lacking FcgammaRI or FcgammaRIII and those
deficient in both FcgammaRI and FcgammaRIII showed similar disease as compared to control mice.
In contrast, lack of the inhibitory FcgammaRIIB lead to an over 2-fold enhanced disease severity.
Importantly, EBA disease was restored in Fcgamma chain-deficient mice reconstituted with neu-
trophils from wild-type but not from Fcgamma chain-deficient mice. Our data provide direct evi-
dence that while FcgammaRIIB exhibits protective activity, FcgammaRIV plays an essential role in
neutrophil activation and subsequent blister formation in experimental EBA.
052
Human TLR7 and TLR8 expressing slan (6-sulfo LacNAc)dendritic cells as a novel proinflam-
matory cell type in Lupus erythematosus
A Hänsel,1 C Günther,2 T Döbel,1 W Baran3 and K Schäkel1 1 Dermatology, University Hospital
Heidelberg, Heidelberg, Germany, 2 Dermatology, University Hospital Dresden, Dresden,
Germany and 3 Dermatology, Venereology and Allergology, Medical University Wroclaw,
Wroclaw, Poland
Lupus erythematosus (LE) is a disorder of immune regulation characterized by autoimmune com-
plexes, hyperactive dendritic cells (DCs) as well as autoreactive T cells and B cells. Here we asked
whether slan(6-sulfo LacNAc) DCs may contribute to the immunopathology seen in LE. SlanDCs
are a population of Th1 and Th17 programming blood DCs. Recently, slanDCs were also identified
as dermal inflammatory DCs in psoriasis. Staining skin section from LE patients with an anti-slan
mAb (clone DD2) we identified increased numbers of slanDCs in skin lesions of systemic and cuta-
neous forms of LE. SlanDCs were found scattered within the dermis (SLE and SCLE) and to cluster
with T cells in lymph follicle-like structures and to locally expressed TNF-α (CDLE). A common
proinflammatory signalling pathway in SLE is induced by autoimmune complexes containing sin-
gle stranded RNA binding to toll-like receptors (TLR) 7 and 8. PCR analysis of slanDCs revealed the
expression of TLR7 and TLR8. This combined TLR7/8 expression is in contrast to CD1c+ DCs and
pDCs that either express TLR8 or TLR7. Accordingly, only slanDCs responded to highly selective
TLR7/8-ligands with a strong TNF-α- and IL-12-production. Interestingly, slanDCs did not produce
IFN-α. In conclusion, our data provide strong evidence for slanDCs as having molecular and func-
tional features of a novel proinflammatory effector cell type involved in the immunopathogenesis
of LE.
050
Development of peptide microarrays to investigate autoantibody epitope specificity in Pem-
phigus vulgaris
J Hazelton,1 M Patel,1 G Furstenberg,1 S Tyagi,1 BB Haab,2 WH Robinson,3 K Seiffert-Sinha1 and
AA Sinha1 1 Dermatology & Cutaneous Sciences, Michigan State University, East Lansing, MI,
2 Van Andel Research Institute, Grand Rapids, MI and 3 Rheumatology and Immunology,
Stanford University, Palo Alto, MI
A clear role of autoantibodies directed against the desmosomal glycoprotein desmoglein (Dsg)3
has been established in the pathogenesis of Pemphigus vulgaris (PV). T cells have been shown to
direct autoantibody production by B cells in PV, and a number of peptides in the intra- and extra-
cellular domain of anti- desmoglein (Dsg)3 have been shown to elicit T cell reactivity. However the
full spectrum of autoantibody responses to Dsg3-peptides in PV patients remains to be determined.
The purpose of this study was to develop a novel protein microarray platform to rapidly and accu-
rately identify Dsg3 peptides recognized by autoantibodies in PV patients and patient subgroups.
Eighteen overlapping peptide fragments, spanning the extracellular region of the Dsg3 protein were
printed on glass microarray slides and incubated with serum samples from active PV patients and
healthy controls. Slides were then incubated with biotinylated anti-human pan Ig followed by
streptavidin-phycoerythryn to detect the presence of autoantigen-specific reactivity. The absolute
fluorescence intensity was determined using a TECAN scanner and Genepix 5.0 software. Appli-
cation of the SAM algorithm identified five Dsg3 peptide fragments with significantly higher autore-
activities in active PV patients vs. healthy controls (SAM d-score >1.32; FDR: <0.20). We demon-
strate the feasibility of utilizing peptide array technology to investigate autoimmune skin responses.
Our data are relevant to understanding the fine specificity of self-directed reactivity in PV and pro-
vide insights into disease mechanisms. Defining comprehensive and detailed autoantibody profiles
in patients can be expected to facilitate the future development of precisely targeted therapeutic
approaches and ultimately more individualized and effective treatments.
054
Pentyl-Rhamnoside userfullness in inflammatory response associated with atopic dermatitis
pathology
M Aries, J Besse and N Castex-Rizzi Dermo Cosmetic Department, Pierre FABRE Research and
Development Center, Toulouse, France
Atopic dermatitis (AD) is a multifactorial inflammatory skin disease sustained by susceptibility genes
and environmental factors interactions and characterized by pruritic skin lesions, immunodysreg-
ulation, allergic inflammation, genetic barrier defects associated with filaggrin mutations. Depend-
ing on the cell infiltrate present in AD skin lesions, keratinocytes which are highly active immuno-
logical cells with major control over acute and chronic phases of inflammation by means of
cytokine/chemokine production and surface molecule expression, contribute to the disease process
and clinical phenotype development. The aim of the present study was to investigate gene expres-
sion of these inflammatory molecules in Normal Human Keratinocytes (NHK) and to evaluate the
anti-inflammatory activity of pentyl-rhamnoside on this keratinocyte response. As lymphokines
and cytokines released by T lymphocytes and other immune cells represent the most important stim-
uli that elicit keratinocyte inflammatory activation, NHK were stimulated by the association
polyI:C+IL4+IL13+TNFα for 3 or 24 hours : the transcriptional profile observed in this inflamma-
tory keratinocyte model correlated with the one of lesional atopic skin. The gene expression study
was performed by GeneAtlasTM Microarray System from Affymetrix and analyzed by Ingenuity Path-
ways Analysis (IPA). The Pentyl-rhamnoside inhibited gene expression of various cytokines,
chemokines and surface molecules including TNFα, TSLP, MIP-1α/CCL3, MIP-1β/CCL4,
CTACK/CCL27, Gro-α/CXCL1, GCP-2/CXCL6, IL8/CXCL8, ICAM-1, and induced filaggrin gene
expression. Our findings demonstrate the inhibitory activity of Pentyl-rhamnoside on cytokines,
chemokines and surface molecules genes expression in inflammatory keratinocytes exposed to AD
environment, and reveal the powerful interest of Pentyl-rhamnoside in AD inflammatory response.
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Eosinophils express the high affinity IgE receptor (FcεRI) in bullous pemphigoid
AS Frydman,1,3 KA Messingham1 and JA Fairley1,2 1 Dermatology, University of Iowa, Iowa City,
IA, 2 Veterans Administration Hospital, Iowa City, IA and 3 Mt. Sinai School of Medicine, New
York, NY
IgE class autoantibodies have recently been shown to play a pathogenic role in bullous pemphigoid
(BP). Most effects of IgE are mediated via its high affinity receptor, FcεRI, which is expressed on
mast cells, basophils, and, under some conditions, eosinophils. Since lesional and peripheral
eosinophils are hallmarks of early, untreated BP, we tested whether BP patients’ peripheral and tis-
sue eosinophils expressed FcεRI. Peripheral blood from 26 BP patients and 26 controls was obtained,
and the granulocytes were isolated by density centrifugation. These cells were incubated with CD49d-
PE and CD9-APC to identify the eosinophils, and with either anti-human FcεRI-FITC or its isotype,
to evaluate receptor expression by flow cytometry. Circulating IgE levels were measured for each
sample. Additionally, cryosections of lesional or perilesional biopsies from 3 BP patients and 2
control patients were double stained using monoclonal antibodies directed against major basic pro-
tein (MBP) and FcεRI. 6/26 BP patients expressed an upregulation in FcεRI, as opposed to 0/26 con-
trols. Treatment and disease remission led to a loss of FcεRI positivity in 3 patients for whom serial
samples were available. Clinically, 4/6 positive patients had generalized, active disease (scored as
a 4 on a 1-4 point scaling system for BP), as opposed to 4/20 patients with a negative flow result.
The mean IgE levels of those BP patients who expressed FcεRI upregulation was higher (1601.2 IU)
than that of the BP patients who did not (1025.2 IU). 3/3 BP biopsies showed co-localization of
FcεRI and MBP (10-50% of MBP positive cells), indicating the presence of eosinophils expressing
FcεRI, while the control tissue showed no co-localization. Expression of FcεRI by eosinophils in BP
may represent an important factor in the pathogenesis of BP and is under further study.
044
CD11c+ CD45RO+ cells colocalize with Extra Domain A fibronectin, not S100A8/A9 in
human psoriasis
ME Rodriguez, TS McCormick, AB Young and KD Cooper Dermatology, Case Western Reserve
University, Cleveland, OH
Macrophages are critical mediators of psoriasis pathogenesis. Several murine models demonstrate
elevated macrophages in psoriasis-like skin lesions and have been posited to play a key role in the
pathogenesis of psoriasiform skin inflammation. Previous human psoriasis histology has demon-
strated macrophages that occupy a unique dermal/epidermal junction (DEJ) niche, where they are
in direct apposition to basal keratinocyte stem cells. Although the presence of “lining macrophages”
has been confirmed by several independent investigators, including our laboratory, the mechanism
leading to macrophage recruitment and activation has not yet been clearly defined. S100 proteins
A7, A8 and A9 are highly upregulated in psoriasis patient tissue and serum and have been impli-
cated to be predictive of psoriasis severity as well as cardiovascular risk. In addition, macrophages
have also been postulated to produce and assemble cellular fibronectin (Fn) and the splice variant
prominent in psoriasis, Extra Domain A (EDA-Fn). Using laser capture microdissection (LCM) we
isolated dermal and DEJ macrophages as well as basal keratinocytes devoid of immunocytes. Inter-
stingly, we demonstrate that CD11c+ CD45RO+ cells predominantly produce EDA-Fn with 16.7 +
3.7 CD45RO+ EDA+ cells per 3.3mm DEJ, 14.3 + 2.6 CD11c+ EDA+ cells whereas involved basal
keratinocytes produce over 100-fold more S100A8 and A9 mRNA compared to either CD11c+ or
CD45RO+ cells. Classical macrophage markers including HAM56, CD68, MAC387 and CD163
were used to identify distinct macrophage populations in normal,lesional and non-lesional psori-
atic skin. Cells that co-localize with EDA-Fn were CD11c+ but not CD68+ or HAM56+ immuno-
cytes. This data indicates that dermal myeloid cells, but not macrophages, are likely the source of
DEJ EDA-Fn expression, while basal keratinocytes produce the vast majority of S100 proteins.
045
Dissecting the inflammatory skin lesions in NOMID and the resulting homeostatic tissue
responses in the context of IL-1 blocking therapy
P Aubert,1 M Suárez-Fariñas,2,3 H Mitsui,2 LM Johnson-Huang,2 K Pierson,2 JG Dolan,1
I Novitskaya,2 I Coats,2 JG Krueger,2 J Estes,4 E Cowen,5 N Plass,1 C Lee,1 H Sun,6 MA Lowes2 and
R Goldbach-Mansky1 1 Translational Autoinflammatory Disease Section, NIAMS/NIH,
Bethesda, MD, 2 Laboratory for Investigational Dermatology, The Rockefeller University, New
York, NY, 3 Center for Clinical and Translational Science, The Rockefeller University, New
York, NY, 4 SAIC, Frederick, MD, 5 Dermatology, NCI/NIH, Bethesda, MD and 6 NIAMS/NIH,
Bethesda, MD
Neonatal-onset multisystem inflammatory disease (NOMID) is the most severe phenotype of autoin-
flammatory disorders caused by mutations in CIAS1. Mutations lead to caspase-1 activation result-
ing in increased secretion of active IL-1β and systemic and organ-specific inflammation of the skin,
central nervous system and bony growth plates, which respond dramatically to treatment with IL-1
blocking agents. We compared the cellular infiltrates and transcriptome of skin biopsies from patients
with NOMID (n=14) before treatment [lesional (LS), non-lesional (pre-NL)] and after treatment (post-
NL) with the IL-1 receptor blocker anakinra, to normal skin (n=5). Abundant neutrophils distinguish
LS skin. CD11c+ dermal dendritic cells and CD163+ macrophages expressed activated caspase-1
and are the likely source of cutaneous IL-1 production. Treatment with the IL-1 receptor antagonist
led to disappearance of neutrophils, but CD3+ T cells, HLA-DR+ cells, and CD11c+ DCs remained
elevated. Gene expression profiling showed that transcripts for neutrophil defensins 1 and 3 were
only detected in LS samples, as were those for IL-17, TNF and IL-6. Surprisingly, over two thirds of
the differentially regulated genes were downregulated compared to normal tissue. Significantly dif-
ferentially regulated canonical pathways were suggestive of downregulation of IL-1R/TLR, type I
and II cytokine receptor signaling, epigenetic modification including microRNAs, and downregu-
lation of pathways associated with mitochondrial function. The down-regulated pathways/genes
might represent adaptive mechanisms to control inflammation and maintain tissue homeostasis.
046
Collagen XVII (BP180) functions in regulating the keratinocyte pro-inflammatory response
SL Eliason,1 F Van den Bergh,2,3 BT Burmeister1 and GJ Giudice1,4 1 Dermatology, Univ Iowa,
Iowa City, IA, 2 Pharmacology, Med Coll Wisconsin, Milwaukee, WI, 3 Cancer Center, Med
Coll Wisconsin, Milwaukee, WI and 4 Biochemistry, Univ Iowa, Iowa City, IA
Collagen XVII (COL17), also known as BP180, is a critical component of the dermal-epidermal
anchoring complex and is necessary for maintaining normal skin architecture. We previously reported
that, when compared with normal human keratinocytes (NHK; COL17-positive), non-Herlitz JEB
keratinocytes (JEBnH KC; COL17-deficient) exhibit an enhanced pro-inflammatory response after
treatment with various stimuli, including bacterial lipopolysaccharide (LPS). We have now extended
these findings to further define the role played by COL17 in the KC pro-inflammatory response,
using IL-8 expression as our primary readout. Induction of COL17 expression in JEBnH KC leads to
a normalization of the LPS-induced pro-inflammatory response in these cells. In a complementary
experiment, siRNA-mediated knockdown of COL17 expression in NHK results in an abnormally
high pro-inflammatory response to LPS treatment – similar to that observed in JEBnH KC. We iden-
tified by cDNA array analysis sets of genes with expression patterns that correlate with COL17-
dependent alterations in IL-8 expression, which include genes involved in NF-κB, JAK STAT and
Hedgehog pathways. The COL17 effects on LPS-induced IL-8 expression in KC were shown to be
unaffected by treatment with NF-κB inhibitors, Bay 11-7082 and SN50. Down-regulation of COL17
expression in NHK correlates with an up-regulation of α6β4 integrin, which is also involved in the
pro-inflammatory response. However, knockdown of α6β4 expression had no effect on COL17-
dependent alterations in the LPS-driven pro-inflammatory response. These findings support the
hypothesis that COL17 plays an important regulatory role in the KC pro-inflammatory response, and
does so via a mechanism independent of NF-κB and α6β4 integrin. We speculate that perturba-
tions in COL17 expression and/or function can lead to an enhanced pro-inflammatory response in
the skin.
047
IgG autoantibodies to human desmocollins 1-3 in paraneoplastic pemphigus without anti-
desmoglein autoantibodies
S Fukuda,1,2 N Ishii,1,2 T Kwesi,1,2 R Sogame,1,2 T Hamada,1,2 F Ono,1,2 T Ishikawa,1,2
S Sakaguchi,1,2 T Dainichi,1,2 T Karashima,1,2 D Tsuruta,1,2 T Nakama1,2 and T Hashimoto1,2 1
Department of Dermatology, Kurume University School of Medicine, Kurume, Fukuoka, Japan
and 2 Kurume University Institute of Cutaneous Cell Biology, Kurume, Fukuoka, Japan
Desmocollins (Dsc) 1-3 and desmogleins (Dsg) 1-4 are the cadherin-type transmembrane proteins,
and are critical components of the desmosomes in kerationocytes. Autoimmune blistering diseases
of pemphigus group show mainly IgG autoantibodies to Dsg1 and 3, while IgG antibodies to Dsc1-
3 were rarely detected. Paraneoplastic pemphigus (PNP) is almost always associated with lympho-
proliferative disorder, and is serologically diagnosed by identification of polyclonal IgG autoanti-
bodies against plakin proteins, as well as Dsg1 and 3 in most cases. However, the pathogenic
mechanism for skin lesions in PNP cases without IgG anti-Dsg autoantibodies is still unknown. In
this study, to investigate further the pathogenesis in PNP, we examined IgG reactivity with Dsc1-3
in PNP without anti-Dsg antibodies. We collected 20 patients out of totally 70 PNP patients who
showed no IgG anti-Dsg autoantibodies by both immunoblotting using normal human epidermal
extracts and Dsg ELISAs. We examined IgG reactivity with Dsc1-3 by cDNA transfection method,
in which eukaryotic vectors containing full length cDNAs of human Dsc1-3 were transfected into
COS-7 cells, and IgG reactivity to each Dsc expressed on cell surfaces was detected by live cell
immunofluorescence and by the IgG ELISAs for Dsc1-3. As a result, 2 out of the 20 PNP cases reacted
with only Dsc3, 1 case reacted with Dsc1-3 and 1 case reacted with Dsc2 and 3. These findings
indicate that Dsc1-3, particularly Dsc3, are autoantigens in PNP and are possibly pathogenic. In
addition, we detected IgG anti-Dsc autoantibodies in various patterns in as many as 20 of 70 PNP
cases with IgG anti-Dsg autoantibodies, further suggesting an important role of anti-Dsc antibod-
ies in PNP.
048
Changes in keratinocyte elasticity measured by atomic force microscopy are correlates of
autoimmune pathology in Pemphigus vulgaris
K Seiffert-Sinha,1 R Yang,2 CK Fung,2 AS Payne,3 N Xi2 and AA Sinha1 1 Dermatology &
Cutaneous Sciences, Michigan State University, East Lansing, MI, 2 Electrical and Computer
Engineering, Michigan State University, East Lansing, MI and 3 Dermatology, University of
Pennsylvania, Philadelphia, PA
The detailed mechanisms by which autoimmune damage is mediated in Pemphigus vulgaris (PV)
remain unclear. Atomic force microscopy (AFM) can be utilized as an effective tool to assess cel-
lular processes because of its ability to provide three-dimensional images of cell-associated struc-
tures and quantitative assessments of changes in cell stiffness/elasticity in physiologically stable envi-
ronments at the nano-scale. We have previously shown that the addition of pathogenic anti-Dsg3
antibodies leads to an initial decrease in cellular stiffness within 1 h, followed by a significant and
long-lasting increase in stiffness starting 2 h after antibody treatment as measured by AFM. In con-
trast, the addition of non-pathogenic antibodies leads only to the initial decrease in stiffness that
then returns to baseline levels after 2 h. We now show that this quantitative AFM force measure-
ment analysis of keratinocytes in culture can be correlated with biologic effects of antibody bind-
ing: The early decrease in cellular stiffness seen by AFM is associated with the dissolution of intra-
cellular adhesion structures, as shown by physical disruption of established keratinocyte adhesion
structures by nanosurgical methods and by calcium depletion in cell culture models. The later
increase in stiffness seen subsequent to pathogenic autoantibody binding appears to reflect the
induction of apoptotic processes based on the reversal of this finding upon the inclusion of apop-
totic inhibitors in culture. Our data demonstrate the utility of AFM technology as an efficient read-
out system to assess differences in autoantibody pathogenicity.
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Live imaging and assessment of vascular permeability using two-photon microscopy
G Egawa, Y Miyachi and K Kabashima Dermatology, Kyoto University, Kyoto, Japan
Surface barrier at skin and intestinal mucosa are essential for the maintenance of homeostasis. On
the other hand, the barrier function of the blood vessels, known as “vascular permeability”, is impor-
tant for the regulation of immune functions. Therefore, to characterize vascular barrier is important
to understand the pathogenesis of skin inflammation such as interstitial swelling; however, it is yet
to be defined. Thus, we developed a new system to study this issue using two-photon microscopy.
A variety of sizes of FITC-conjugated dextran were injected via tail vein to visualize blood capil-
lary network of the skin, and the leakage of labeled dextran were tracked over time. We used 70-
kDa-dextran as a reference, because the size of albumin is about 70-kDa and it plays a critical role
to maintain plasma osmotic pressure. In the steady state, 70-kDa-dextran retained within the blood
vessels for a long time as expected. In contrast, the dextran smaller than 40-kDa were promptly
leaked from the vessels to the interstitial space, suggesting that the plasma proteins smaller than 40-
kDa can freely intercommunicate between blood vessels and peripheral interstitium. On the other
hand, when the skin inflammation was caused by PMA application, even 155-kDa-dextran was eas-
ily penetrated from the blood vessels to the interstitial space. We also demonstrated that FITC-con-
jugated IgG (about 150-kDa) retained within the blood vessels in non-inflamed skin but not in
inflamed skin. These novel findings may create a new paradigm for understanding the pathogene-
sis of humoral immunity-mediated autoimmune diseases such as pemphigus vulgaris; the plasma
proteins larger than 40-kDa, including immunoglobulins and complement, retain within the blood
circulatory system in the steady state, and translocate to peripheral tissues where inflammation are
elicited to increase the vascular permeability. Following this concept, it is suggested that the prompt
control of initial inflammation is important for preventing the exacerbation/establishment of autoim-
mune skin diseases.
051
Anti-inflammatory activity of NPS-1577, PAR-2 specific antagonist, on oxazolone-induced
chronic dermatitis animal model
S Jeong,1 D Lee,2 H Kim,3 J Jeon,1 J Bae,1 H Gwak,1 J Yun,2 H Lee,2 S Lee4 and S Lee4 1 Research
Division, NeoPharm Co., Ltd., Daejeon, Republic of Korea, 2 Research Division,
LegoChemBioScience Co., Ltd., Daejeon, Republic of Korea, 3 Department of
Dermatology/Atopy Clinic, Seoul Medical Center, Seoul, Republic of Korea and 4 Department
of Dermatology, Yonsei University College of Medicine, Seoul, Republic of Korea
Therapeutic application of PAR-2 specific antagonist has been repeatedly suggested for the inflam-
matory skin diseases including atopic dermatitis and psoriasis. However, due to the lack of potent
PAR-2 specific antagonist for topical use, direct evaluation of PAR-2 antagonist has not been reported
yet. In this study, the anti-inflammatory activity of newly developed PAR-2 antagonist, NPS-1557,
was evaluated. In order to assess the effect of PAR-2 antagonist on epidermal permeability barrier
function, NPS-1577 was topically applied on acutely barrier disrupted skin of hairless mouse. Top-
ical application of NPS-1577 significantly accelerated the permeability barrier recovery rate, which
was similar to the previous reports. In an epidermal hyperplasia model induced by repeated barrier
disruption, NPS-1577 significantly prevented the increase of epidermal thickness. In a TPA-induced
skin edema model, topical application of NPS-1577 significantly prevented the increase of ear weight
in ICR mice in a dose dependent manner. Finally, in an oxazolone-induced chronic dermatitis model,
topical application of NPS-1577 showed significant improvement in epidermal permeability bar-
rier function and skin hydration, respectively. Epidermal thickness and number of proliferating cell
nucleus antigen (PCNA)-positive keratinocyte in epidermis were also significantly reduced by NPS-
1577, in a dose dependent manner. Interestingly, increased PAR-2 expression in epidermis after oxa-
zolone challenge was abrogated in NPS-1577 treated site. These results suggest that topical PAR-2
antagonist has beneficial effects on skin barrier function and anti-inflammatory activity, and can be
a potential therapeutic agent for inflammatory skin diseases.
053
FcgammaRIV is crucial for neutrophil effector function in experimental epidermolysis bul-
losa acquisita
M Kasperkiewicz,1 S Wende,1 F Nimmerjahn,2 M Hirose,1 H Iwata,1 K Kalies,3 E Schmidt,1
J Westermann,3 J Köhl,4 D Zillikens1 and R Ludwig1 1 Department of Dermatology, University of
Lübeck, Lübeck, Germany, 2 University of Erlangen-Nuremberg, Erlangen, Germany, 3
Institute of Anatomy, University of Lübeck, Lübeck, Germany and 4 Institute for Systemic
Inflammation Research, University of Lübeck, Lübeck, Germany
Epidermolysis bullosa acquisita (EBA) is an autoimmune bullous disease mediated by autoantibod-
ies against type VII collagen, the major component of anchoring fibrils of the dermal-epidermal junc-
tion. When passively transferred into mice, rabbit IgG against type VII collagen induces Fc-depend-
ent activation of complement, the recruitment of leucocytes into the skin, and subepidermal blistering.
In this study, we determined the role of different Fc gamma receptors (FcgammaRs) and the patho-
genetically relevant FcgammaR-bearing cells in experimental EBA. Mice lacking the common gamma
chain of activating FcgammaRs were completely resistant to experimental EBA induction. Similarly,
mice deficient in FcgammaRIV were completely resistant to EBA, which has been confirmed by a
FcgammaRIV function blocking antibody. Mice lacking FcgammaRI or FcgammaRIII and those
deficient in both FcgammaRI and FcgammaRIII showed similar disease as compared to control mice.
In contrast, lack of the inhibitory FcgammaRIIB lead to an over 2-fold enhanced disease severity.
Importantly, EBA disease was restored in Fcgamma chain-deficient mice reconstituted with neu-
trophils from wild-type but not from Fcgamma chain-deficient mice. Our data provide direct evi-
dence that while FcgammaRIIB exhibits protective activity, FcgammaRIV plays an essential role in
neutrophil activation and subsequent blister formation in experimental EBA.
052
Human TLR7 and TLR8 expressing slan (6-sulfo LacNAc)dendritic cells as a novel proinflam-
matory cell type in Lupus erythematosus
A Hänsel,1 C Günther,2 T Döbel,1 W Baran3 and K Schäkel1 1 Dermatology, University Hospital
Heidelberg, Heidelberg, Germany, 2 Dermatology, University Hospital Dresden, Dresden,
Germany and 3 Dermatology, Venereology and Allergology, Medical University Wroclaw,
Wroclaw, Poland
Lupus erythematosus (LE) is a disorder of immune regulation characterized by autoimmune com-
plexes, hyperactive dendritic cells (DCs) as well as autoreactive T cells and B cells. Here we asked
whether slan(6-sulfo LacNAc) DCs may contribute to the immunopathology seen in LE. SlanDCs
are a population of Th1 and Th17 programming blood DCs. Recently, slanDCs were also identified
as dermal inflammatory DCs in psoriasis. Staining skin section from LE patients with an anti-slan
mAb (clone DD2) we identified increased numbers of slanDCs in skin lesions of systemic and cuta-
neous forms of LE. SlanDCs were found scattered within the dermis (SLE and SCLE) and to cluster
with T cells in lymph follicle-like structures and to locally expressed TNF-α (CDLE). A common
proinflammatory signalling pathway in SLE is induced by autoimmune complexes containing sin-
gle stranded RNA binding to toll-like receptors (TLR) 7 and 8. PCR analysis of slanDCs revealed the
expression of TLR7 and TLR8. This combined TLR7/8 expression is in contrast to CD1c+ DCs and
pDCs that either express TLR8 or TLR7. Accordingly, only slanDCs responded to highly selective
TLR7/8-ligands with a strong TNF-α- and IL-12-production. Interestingly, slanDCs did not produce
IFN-α. In conclusion, our data provide strong evidence for slanDCs as having molecular and func-
tional features of a novel proinflammatory effector cell type involved in the immunopathogenesis
of LE.
050
Development of peptide microarrays to investigate autoantibody epitope specificity in Pem-
phigus vulgaris
J Hazelton,1 M Patel,1 G Furstenberg,1 S Tyagi,1 BB Haab,2 WH Robinson,3 K Seiffert-Sinha1 and
AA Sinha1 1 Dermatology & Cutaneous Sciences, Michigan State University, East Lansing, MI,
2 Van Andel Research Institute, Grand Rapids, MI and 3 Rheumatology and Immunology,
Stanford University, Palo Alto, MI
A clear role of autoantibodies directed against the desmosomal glycoprotein desmoglein (Dsg)3
has been established in the pathogenesis of Pemphigus vulgaris (PV). T cells have been shown to
direct autoantibody production by B cells in PV, and a number of peptides in the intra- and extra-
cellular domain of anti- desmoglein (Dsg)3 have been shown to elicit T cell reactivity. However the
full spectrum of autoantibody responses to Dsg3-peptides in PV patients remains to be determined.
The purpose of this study was to develop a novel protein microarray platform to rapidly and accu-
rately identify Dsg3 peptides recognized by autoantibodies in PV patients and patient subgroups.
Eighteen overlapping peptide fragments, spanning the extracellular region of the Dsg3 protein were
printed on glass microarray slides and incubated with serum samples from active PV patients and
healthy controls. Slides were then incubated with biotinylated anti-human pan Ig followed by
streptavidin-phycoerythryn to detect the presence of autoantigen-specific reactivity. The absolute
fluorescence intensity was determined using a TECAN scanner and Genepix 5.0 software. Appli-
cation of the SAM algorithm identified five Dsg3 peptide fragments with significantly higher autore-
activities in active PV patients vs. healthy controls (SAM d-score >1.32; FDR: <0.20). We demon-
strate the feasibility of utilizing peptide array technology to investigate autoimmune skin responses.
Our data are relevant to understanding the fine specificity of self-directed reactivity in PV and pro-
vide insights into disease mechanisms. Defining comprehensive and detailed autoantibody profiles
in patients can be expected to facilitate the future development of precisely targeted therapeutic
approaches and ultimately more individualized and effective treatments.
054
Pentyl-Rhamnoside userfullness in inflammatory response associated with atopic dermatitis
pathology
M Aries, J Besse and N Castex-Rizzi Dermo Cosmetic Department, Pierre FABRE Research and
Development Center, Toulouse, France
Atopic dermatitis (AD) is a multifactorial inflammatory skin disease sustained by susceptibility genes
and environmental factors interactions and characterized by pruritic skin lesions, immunodysreg-
ulation, allergic inflammation, genetic barrier defects associated with filaggrin mutations. Depend-
ing on the cell infiltrate present in AD skin lesions, keratinocytes which are highly active immuno-
logical cells with major control over acute and chronic phases of inflammation by means of
cytokine/chemokine production and surface molecule expression, contribute to the disease process
and clinical phenotype development. The aim of the present study was to investigate gene expres-
sion of these inflammatory molecules in Normal Human Keratinocytes (NHK) and to evaluate the
anti-inflammatory activity of pentyl-rhamnoside on this keratinocyte response. As lymphokines
and cytokines released by T lymphocytes and other immune cells represent the most important stim-
uli that elicit keratinocyte inflammatory activation, NHK were stimulated by the association
polyI:C+IL4+IL13+TNFα for 3 or 24 hours : the transcriptional profile observed in this inflamma-
tory keratinocyte model correlated with the one of lesional atopic skin. The gene expression study
was performed by GeneAtlasTM Microarray System from Affymetrix and analyzed by Ingenuity Path-
ways Analysis (IPA). The Pentyl-rhamnoside inhibited gene expression of various cytokines,
chemokines and surface molecules including TNFα, TSLP, MIP-1α/CCL3, MIP-1β/CCL4,
CTACK/CCL27, Gro-α/CXCL1, GCP-2/CXCL6, IL8/CXCL8, ICAM-1, and induced filaggrin gene
expression. Our findings demonstrate the inhibitory activity of Pentyl-rhamnoside on cytokines,
chemokines and surface molecules genes expression in inflammatory keratinocytes exposed to AD
environment, and reveal the powerful interest of Pentyl-rhamnoside in AD inflammatory response.
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Eosinophils express the high affinity IgE receptor (FcεRI) in bullous pemphigoid
AS Frydman,1,3 KA Messingham1 and JA Fairley1,2 1 Dermatology, University of Iowa, Iowa City,
IA, 2 Veterans Administration Hospital, Iowa City, IA and 3 Mt. Sinai School of Medicine, New
York, NY
IgE class autoantibodies have recently been shown to play a pathogenic role in bullous pemphigoid
(BP). Most effects of IgE are mediated via its high affinity receptor, FcεRI, which is expressed on
mast cells, basophils, and, under some conditions, eosinophils. Since lesional and peripheral
eosinophils are hallmarks of early, untreated BP, we tested whether BP patients’ peripheral and tis-
sue eosinophils expressed FcεRI. Peripheral blood from 26 BP patients and 26 controls was obtained,
and the granulocytes were isolated by density centrifugation. These cells were incubated with CD49d-
PE and CD9-APC to identify the eosinophils, and with either anti-human FcεRI-FITC or its isotype,
to evaluate receptor expression by flow cytometry. Circulating IgE levels were measured for each
sample. Additionally, cryosections of lesional or perilesional biopsies from 3 BP patients and 2
control patients were double stained using monoclonal antibodies directed against major basic pro-
tein (MBP) and FcεRI. 6/26 BP patients expressed an upregulation in FcεRI, as opposed to 0/26 con-
trols. Treatment and disease remission led to a loss of FcεRI positivity in 3 patients for whom serial
samples were available. Clinically, 4/6 positive patients had generalized, active disease (scored as
a 4 on a 1-4 point scaling system for BP), as opposed to 4/20 patients with a negative flow result.
The mean IgE levels of those BP patients who expressed FcεRI upregulation was higher (1601.2 IU)
than that of the BP patients who did not (1025.2 IU). 3/3 BP biopsies showed co-localization of
FcεRI and MBP (10-50% of MBP positive cells), indicating the presence of eosinophils expressing
FcεRI, while the control tissue showed no co-localization. Expression of FcεRI by eosinophils in BP
may represent an important factor in the pathogenesis of BP and is under further study.
044
CD11c+ CD45RO+ cells colocalize with Extra Domain A fibronectin, not S100A8/A9 in
human psoriasis
ME Rodriguez, TS McCormick, AB Young and KD Cooper Dermatology, Case Western Reserve
University, Cleveland, OH
Macrophages are critical mediators of psoriasis pathogenesis. Several murine models demonstrate
elevated macrophages in psoriasis-like skin lesions and have been posited to play a key role in the
pathogenesis of psoriasiform skin inflammation. Previous human psoriasis histology has demon-
strated macrophages that occupy a unique dermal/epidermal junction (DEJ) niche, where they are
in direct apposition to basal keratinocyte stem cells. Although the presence of “lining macrophages”
has been confirmed by several independent investigators, including our laboratory, the mechanism
leading to macrophage recruitment and activation has not yet been clearly defined. S100 proteins
A7, A8 and A9 are highly upregulated in psoriasis patient tissue and serum and have been impli-
cated to be predictive of psoriasis severity as well as cardiovascular risk. In addition, macrophages
have also been postulated to produce and assemble cellular fibronectin (Fn) and the splice variant
prominent in psoriasis, Extra Domain A (EDA-Fn). Using laser capture microdissection (LCM) we
isolated dermal and DEJ macrophages as well as basal keratinocytes devoid of immunocytes. Inter-
stingly, we demonstrate that CD11c+ CD45RO+ cells predominantly produce EDA-Fn with 16.7 +
3.7 CD45RO+ EDA+ cells per 3.3mm DEJ, 14.3 + 2.6 CD11c+ EDA+ cells whereas involved basal
keratinocytes produce over 100-fold more S100A8 and A9 mRNA compared to either CD11c+ or
CD45RO+ cells. Classical macrophage markers including HAM56, CD68, MAC387 and CD163
were used to identify distinct macrophage populations in normal,lesional and non-lesional psori-
atic skin. Cells that co-localize with EDA-Fn were CD11c+ but not CD68+ or HAM56+ immuno-
cytes. This data indicates that dermal myeloid cells, but not macrophages, are likely the source of
DEJ EDA-Fn expression, while basal keratinocytes produce the vast majority of S100 proteins.
045
Dissecting the inflammatory skin lesions in NOMID and the resulting homeostatic tissue
responses in the context of IL-1 blocking therapy
P Aubert,1 M Suárez-Fariñas,2,3 H Mitsui,2 LM Johnson-Huang,2 K Pierson,2 JG Dolan,1
I Novitskaya,2 I Coats,2 JG Krueger,2 J Estes,4 E Cowen,5 N Plass,1 C Lee,1 H Sun,6 MA Lowes2 and
R Goldbach-Mansky1 1 Translational Autoinflammatory Disease Section, NIAMS/NIH,
Bethesda, MD, 2 Laboratory for Investigational Dermatology, The Rockefeller University, New
York, NY, 3 Center for Clinical and Translational Science, The Rockefeller University, New
York, NY, 4 SAIC, Frederick, MD, 5 Dermatology, NCI/NIH, Bethesda, MD and 6 NIAMS/NIH,
Bethesda, MD
Neonatal-onset multisystem inflammatory disease (NOMID) is the most severe phenotype of autoin-
flammatory disorders caused by mutations in CIAS1. Mutations lead to caspase-1 activation result-
ing in increased secretion of active IL-1β and systemic and organ-specific inflammation of the skin,
central nervous system and bony growth plates, which respond dramatically to treatment with IL-1
blocking agents. We compared the cellular infiltrates and transcriptome of skin biopsies from patients
with NOMID (n=14) before treatment [lesional (LS), non-lesional (pre-NL)] and after treatment (post-
NL) with the IL-1 receptor blocker anakinra, to normal skin (n=5). Abundant neutrophils distinguish
LS skin. CD11c+ dermal dendritic cells and CD163+ macrophages expressed activated caspase-1
and are the likely source of cutaneous IL-1 production. Treatment with the IL-1 receptor antagonist
led to disappearance of neutrophils, but CD3+ T cells, HLA-DR+ cells, and CD11c+ DCs remained
elevated. Gene expression profiling showed that transcripts for neutrophil defensins 1 and 3 were
only detected in LS samples, as were those for IL-17, TNF and IL-6. Surprisingly, over two thirds of
the differentially regulated genes were downregulated compared to normal tissue. Significantly dif-
ferentially regulated canonical pathways were suggestive of downregulation of IL-1R/TLR, type I
and II cytokine receptor signaling, epigenetic modification including microRNAs, and downregu-
lation of pathways associated with mitochondrial function. The down-regulated pathways/genes
might represent adaptive mechanisms to control inflammation and maintain tissue homeostasis.
046
Collagen XVII (BP180) functions in regulating the keratinocyte pro-inflammatory response
SL Eliason,1 F Van den Bergh,2,3 BT Burmeister1 and GJ Giudice1,4 1 Dermatology, Univ Iowa,
Iowa City, IA, 2 Pharmacology, Med Coll Wisconsin, Milwaukee, WI, 3 Cancer Center, Med
Coll Wisconsin, Milwaukee, WI and 4 Biochemistry, Univ Iowa, Iowa City, IA
Collagen XVII (COL17), also known as BP180, is a critical component of the dermal-epidermal
anchoring complex and is necessary for maintaining normal skin architecture. We previously reported
that, when compared with normal human keratinocytes (NHK; COL17-positive), non-Herlitz JEB
keratinocytes (JEBnH KC; COL17-deficient) exhibit an enhanced pro-inflammatory response after
treatment with various stimuli, including bacterial lipopolysaccharide (LPS). We have now extended
these findings to further define the role played by COL17 in the KC pro-inflammatory response,
using IL-8 expression as our primary readout. Induction of COL17 expression in JEBnH KC leads to
a normalization of the LPS-induced pro-inflammatory response in these cells. In a complementary
experiment, siRNA-mediated knockdown of COL17 expression in NHK results in an abnormally
high pro-inflammatory response to LPS treatment – similar to that observed in JEBnH KC. We iden-
tified by cDNA array analysis sets of genes with expression patterns that correlate with COL17-
dependent alterations in IL-8 expression, which include genes involved in NF-κB, JAK STAT and
Hedgehog pathways. The COL17 effects on LPS-induced IL-8 expression in KC were shown to be
unaffected by treatment with NF-κB inhibitors, Bay 11-7082 and SN50. Down-regulation of COL17
expression in NHK correlates with an up-regulation of α6β4 integrin, which is also involved in the
pro-inflammatory response. However, knockdown of α6β4 expression had no effect on COL17-
dependent alterations in the LPS-driven pro-inflammatory response. These findings support the
hypothesis that COL17 plays an important regulatory role in the KC pro-inflammatory response, and
does so via a mechanism independent of NF-κB and α6β4 integrin. We speculate that perturba-
tions in COL17 expression and/or function can lead to an enhanced pro-inflammatory response in
the skin.
047
IgG autoantibodies to human desmocollins 1-3 in paraneoplastic pemphigus without anti-
desmoglein autoantibodies
S Fukuda,1,2 N Ishii,1,2 T Kwesi,1,2 R Sogame,1,2 T Hamada,1,2 F Ono,1,2 T Ishikawa,1,2
S Sakaguchi,1,2 T Dainichi,1,2 T Karashima,1,2 D Tsuruta,1,2 T Nakama1,2 and T Hashimoto1,2 1
Department of Dermatology, Kurume University School of Medicine, Kurume, Fukuoka, Japan
and 2 Kurume University Institute of Cutaneous Cell Biology, Kurume, Fukuoka, Japan
Desmocollins (Dsc) 1-3 and desmogleins (Dsg) 1-4 are the cadherin-type transmembrane proteins,
and are critical components of the desmosomes in kerationocytes. Autoimmune blistering diseases
of pemphigus group show mainly IgG autoantibodies to Dsg1 and 3, while IgG antibodies to Dsc1-
3 were rarely detected. Paraneoplastic pemphigus (PNP) is almost always associated with lympho-
proliferative disorder, and is serologically diagnosed by identification of polyclonal IgG autoanti-
bodies against plakin proteins, as well as Dsg1 and 3 in most cases. However, the pathogenic
mechanism for skin lesions in PNP cases without IgG anti-Dsg autoantibodies is still unknown. In
this study, to investigate further the pathogenesis in PNP, we examined IgG reactivity with Dsc1-3
in PNP without anti-Dsg antibodies. We collected 20 patients out of totally 70 PNP patients who
showed no IgG anti-Dsg autoantibodies by both immunoblotting using normal human epidermal
extracts and Dsg ELISAs. We examined IgG reactivity with Dsc1-3 by cDNA transfection method,
in which eukaryotic vectors containing full length cDNAs of human Dsc1-3 were transfected into
COS-7 cells, and IgG reactivity to each Dsc expressed on cell surfaces was detected by live cell
immunofluorescence and by the IgG ELISAs for Dsc1-3. As a result, 2 out of the 20 PNP cases reacted
with only Dsc3, 1 case reacted with Dsc1-3 and 1 case reacted with Dsc2 and 3. These findings
indicate that Dsc1-3, particularly Dsc3, are autoantigens in PNP and are possibly pathogenic. In
addition, we detected IgG anti-Dsc autoantibodies in various patterns in as many as 20 of 70 PNP
cases with IgG anti-Dsg autoantibodies, further suggesting an important role of anti-Dsc antibod-
ies in PNP.
048
Changes in keratinocyte elasticity measured by atomic force microscopy are correlates of
autoimmune pathology in Pemphigus vulgaris
K Seiffert-Sinha,1 R Yang,2 CK Fung,2 AS Payne,3 N Xi2 and AA Sinha1 1 Dermatology &
Cutaneous Sciences, Michigan State University, East Lansing, MI, 2 Electrical and Computer
Engineering, Michigan State University, East Lansing, MI and 3 Dermatology, University of
Pennsylvania, Philadelphia, PA
The detailed mechanisms by which autoimmune damage is mediated in Pemphigus vulgaris (PV)
remain unclear. Atomic force microscopy (AFM) can be utilized as an effective tool to assess cel-
lular processes because of its ability to provide three-dimensional images of cell-associated struc-
tures and quantitative assessments of changes in cell stiffness/elasticity in physiologically stable envi-
ronments at the nano-scale. We have previously shown that the addition of pathogenic anti-Dsg3
antibodies leads to an initial decrease in cellular stiffness within 1 h, followed by a significant and
long-lasting increase in stiffness starting 2 h after antibody treatment as measured by AFM. In con-
trast, the addition of non-pathogenic antibodies leads only to the initial decrease in stiffness that
then returns to baseline levels after 2 h. We now show that this quantitative AFM force measure-
ment analysis of keratinocytes in culture can be correlated with biologic effects of antibody bind-
ing: The early decrease in cellular stiffness seen by AFM is associated with the dissolution of intra-
cellular adhesion structures, as shown by physical disruption of established keratinocyte adhesion
structures by nanosurgical methods and by calcium depletion in cell culture models. The later
increase in stiffness seen subsequent to pathogenic autoantibody binding appears to reflect the
induction of apoptotic processes based on the reversal of this finding upon the inclusion of apop-
totic inhibitors in culture. Our data demonstrate the utility of AFM technology as an efficient read-
out system to assess differences in autoantibody pathogenicity.
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Interim analysis of the prevalence of the metabolic syndrome and cardiovascular risk factors
in children with moderate to severe psoriasis compared with an age matched population of
children with warts or acne vulgaris
S Au, E Volf, T Kerensky, N Dumont, D Levine, J Kuvin, A Goldminz, A Sekhon, K Hefferman,
E Patvardhan, D Loo and AB Gottlieb Dermatology, Tufts Medical Center, Boston, MA
Adult patients with psoriasis have an increased prevalence of the metabolic syndrome (MetS) and
cardiovascular disease (CVD) risk factors due to increased TNF and other inflammatory cytokine
levels, however, the prevalence of the MetS and risk factors for CVD in children with psoriasis is
unknown. We designed an assessor blinded study to determine if children with psoriasis have an
increased prevalence of MetS and surrogate factors for increased CVD risk in twenty children, ages
10-17 with moderate to severe psoriasis (present or history of ≥5% BSA) compared with twenty
age-matched children with warts or acne vulgaris. MetS was defined by the presence of three of the
following criteria: triglycerides ≥100 mg/dl, HDL-C <50 mg/dl for females or <45 mg/dl males, fast-
ing blood glucose ≥110 mg/dl, waist circumference >75th percentile for age and sex, systolic or
diastolic blood pressure >90th percentile for age, sex, and height. Serum lipid profiles were obtained
after 12-hour fast. Preliminary results of 24 enrolled children showed that children with psoriasis
had lower mean HDL-C levels, 41.7 mg/dl versus 53.8 mg/dl in the control group (p=0.048). Although
not statistically significant, 28% of pediatric psoriasis patients met criteria for MetS versus no chil-
dren in the control group (p=0.280).
063
Myeloid cells, and not T cells, are the main source of TNF-α in plaque-type psoriasis
PM Brunner, F Koszik, M Kalb, B Reininger, I Klein and G Stingl Department of Dermatology,
Medical University of Vienna, Vienna, Austria
The spectrum of tumor necrosis factor (TNF)-α-producing cells in psoriasis is not clearly defined.
The elucidation of this question should allow us to better understand the mode of action, efficacy
and, perhaps, also the risks of an anti-psoriatic therapy with TNF-α-antagonists. Using conven-
tional immunofluorescence methods, we were not able to detect TNF-α in sections of lesional pso-
riatic skin, but by the application of a tyramide amplification system we obtained reproducible and
firm stainings. TNF-α was exclusively found on dermal leukocytes co-expressing CD11c and HLA-
DR and, to a lesser extent, CD163. This marker profile is consistent with that of mDCs and
macrophages. Consistently, we found corresponding populations of TNF-α-producing mDCs and
monocytes in PBMCs of psoriatic patients but not of healthy individuals. TNF-α+ monocytes were
found to express CCR2 (“inflammatory monocyte”), whose ligands CCL2, CCL7 and CCL11 were
strongly upregulated in lesional psoriatic skin. TNF-α+ mDCs of the peripheral blood were of the
6sulfo LacNAc (slan)- rather than the BDCA-1-(CD1c)-subtype, and their number closely corre-
lated with disease activity. Isolated slanDCs produced high amounts of TNF-α upon stimulation with
self-RNA-LL37 complexes. These complexes are known to be a key inducer of skin inflammation
in psoriatic plaques via the activation of TLR-8. TNF-α-production of these slanDCs could be com-
pletely blocked by co-incubation with the IL-12/IL-23-antagonist ustekinumab. BDCA-1+ DCs did
not produce any TNF-α upon stimulation with self-RNA-LL37 complexes. Our data strongly sug-
gest that certain myeloid cells (slanDCs, monocytes/macrophages) are the main source of TNF-α in
chronic plaque-type psoriasis and serve as a key target not only of TNF-α-antagonists, but also of
antibody drugs interfering with Th-1 and Th-17 immunity.
065
Blockade of the IL-17R with AMG 827 leads to rapid reversal of gene expression and histopatho-
logic abnormalities in psoriatic skin, including substantial pathway-specific effects within one
week
CB Russell,1 K Kerkof,1 J Bigler,1 M Timour,1 AA Welcher,1 E Bautista,1 I Cueto,2 A Khatcherian,2
JG Krueger,2 H Rand1 and DA Martin1 1 Amgen, Inc., Seattle, WA and 2 Rockefeller Univ., New
York, NY
IL-17A, IL-17F and IL-17A/F are pro-inflammatory cytokines utilizing IL-17 Receptor A (IL-17RA)
and are implicated in the pathogenesis of several autoimmune diseases. They are upregulated in
psoriatic lesional skin, as are genes regulated by these cytokines. Using cytokine signaling scores
derived from stimulation of keratinocytes by individual cytokines, it is apparent that psoriasis lesional
skin gene expression reflects a high level of signaling by the IL-17 ligands as well as TNF and IFN.
AMG 827, a fully human antibody which blocks signaling through IL-17RA, was studied in a ran-
domized single-dose (350mg SC or 700mg IV) double-blind placebo-controlled trial in subjects with
plaque psoriasis. Post-dose biopsies showed rapid reversal of the inflammatory transcriptional pro-
file. Reduction in the IL-17 gene set score was observed within one week, concomitant with sig-
nificant decreases in KRT16 gene expression and Ki67 counts. This was followed by slower but
substantial reductions in TNF and IFN gene set scores, histopathologic parameters including epi-
dermal thickness and infiltrating leukocyte counts as well as improvements in clinical scores, with
PASI 75 and PGA of 0 or 1 (“clear” or “almost clear”) responses reached by 5/8 subjects for both
metrics in the 350 mg cohort and 7/8 or 8/8 subjects, respectively, in the 700 mg cohort, by week
6. The rapid reduction in KRT16 gene expression and Ki67 counts following blockade of IL-17RA
suggests a close link between IL-17 signaling and the mechanisms of keratinocyte hyperplasia. The
observed normalization of cellular and molecular markers following treatment with AMG 827 sup-
ports a broad central role for IL-17 family signaling in psoriasis, suggests that the combination of
IL-17A, IL-17F, and IL-17A/F inhibition disrupts an essential inflammatory cycle, and validates tar-
geting the IL-17R pathway in psoriasis.
064
Autoimmune component of Grover’s disease
C Phillips,1 V Gindi,1 S Marchenko,1 A Chernyavsky,1 V Galitovskiy,1 D Paslin2 and SA Grando1 1
University of California, Irvine, CA and 2 University of California, San Francisco, CA
Grover’s disease (transient acantholytic dermatosis) is a pruritic acantholytic skin disease of unknown
etiology. Earlier reports revealed the presence of autoantibodies in patients’ skin. The purpose of this
study was to elucidate contribution of autoimmune component to the pathogenesis of Grover’s dis-
ease. To determine if autoantibodies are directed against keratinocytes, the monolayers of normal
human adult keratinocytes were preincubated for 24 hrs with serum from 11 patients versus nor-
mal human serum, and stained with FITC-labeled anti-human IgA, IgE, IgG or IgM antibodies.
Three serum samples contained anti-keratinocyte IgG and two samples—IgA antibodies. To test a
hypothesis that autoantibodies cause acantholysis by altering cell shape, we performed a time-course
study of live keratinocytes exposed to patients’ sera, but observed no changes consistent with acan-
tholysis. Next, we hypothesized that autoantibodies lead to a loss of keratinocyte adhesion by alter-
ing the physiologic control of cell viability and/or adhesion. The exposed monolayers were stained
for BAD, PCNA, desmoglein (Dsg) 1 or Dsg 3 and protein expression was analyzed by semi-quan-
titative fluorescence. We found a decreased intensity of staining for PCNA, Dsg 1, and Dsg 3 in ker-
atinocytes preincubated with each of the three sera positive for IgG autoantibodies and one posi-
tive for IgA, compared to the staining of keratinocytes exposed to normal control serum. The difference
in staining was most notable when the monolayers were cultured at 2.5 mM calcium in the growth
medium, compared to 0.06 mM. Furthermore, preincubation with two of the sera positive for IgG
autoantibodies decreased intensity of BAD staining. Our results provide an insight into the mech-
anism of keratinocyte damage in the skin of patients with Grover’s disease and suggest that autoim-
munity plays a role in the pathogenesis. These findings may guide future studies toward develop-
ment of a more efficient treatment modality.
062
Pemphigus vulgaris (PV) antibodies target PERP and several other keratinocyte membrane and
mitochondrial proteins
M Kalantari-Dehaghi,1 GJ Anhalt,2 MJ Camilleri,3 KM Leiferman,4 S Marchenko,1 MR Pittelkow,3
JJ Zone4 and SA Grando1 1 University of California, Irvine, CA, 2 Johns Hopkins University,
Baltimore, MD, 3 Mayo Clinic, Rochester, MN and 4 University of Utah, Salt Lake City, UT
Current teaching of PV pathophysiology does not explain the mechanism of acantholysis in patients
lacking anti-desmoglein antibodies, urging a search for novel targets of pemphigus autoimmunity.
Several non-organ specific antibodies identified in PV patients by protein array technology have
been verified by other approaches, indicating reliability of proteomic technique in PV antibody dis-
covery. To characterize anti-keratinocyte antibodies in this study, we developed an array targeting
746 human keratinocyte genes amplified using Mammalian Gene Clone Collection with gene-spe-
cific primers containing 20-bp nucleotide extension complementary to ends of linear pXT7 vector.
The array included adhesion molecules, mitochondrial proteins and a large variety of cell-surface
receptors. Expressed proteins were printed onto nitrocellulose-coated glass slides, and protein expres-
sion was confirmed using monoclonal anti-polyhistidine and anti-hemagglutinin antibodies. We
tested 99 samples of PV sera positive for anti-keratinocyte (“intercellular”) antibodies and 42 nor-
mal human sera. The assay identified several PV antibodies differentially reacting with keratinocyte
proteins (p<0.05), including PERP, structurally related PMP22 protein, and a number of receptor
and mitochondrial proteins. The percentage of positive PV patient versus control sera was 41 vs 0,
respectively, for PERP, 60 vs 2 for PMP22, 45 vs 2 for parathyroid hormone 1 receptor, 42 vs 0 for
TGF-β receptor associated protein, 37 vs 2 for insulin-like growth factor 1 receptor, and 37 vs 0 for
the mitochondrial proline dehydrogenase 1. Whereas the roles of the majority of novel PV anti-
bodies in disease pathophysiology remain to be elucidated, the significance of antibodies targeting
proteins of PMP22 family stems from the critical role of PERP in desmosomal adhesion evidenced
by the PV phenocopy in mice lacking PERP.
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Immature slan (6-sulfo LacNAc) dendritic cells display a unique capacity of Fc gamma RIII-
mediated immune complex binding which is controlled by ADAM10 and ADAM17
T Döbel, A Hänsel and K Schäkel Dermatology, University Hospital Heidelberg, Heidelberg,
Germany
Recognition of immune complexes (ICs) by dendritic cells (DCs) is critical for the activation and
amplification of immune responses. It is not known so far, whether a specific subset of DCs is hard
wired to bind ICs. Slan (6-sulfo LacNAc) DCs stand out by their high level expression of the low
affinity Fc gamma receptor III (CD16). SlanDCs are highly proinflammatory, serve as a major and
early source of IL-12, IL-1 beta and TNF-alpha and can become inflammatory dermal DCs in pso-
riasis. Comparative binding studies of IgG ICs revealed a far higher capacity of slanDCs to bind ICs
compared to CD1c+ DCs, pDCs and monocytes. Blocking experiments revealed a strong CD16-
dependent binding of ICs by slanDCs. CD16 also proved critical for slanDCs to phagocytose IgG-
opsonized red blood cells. Furthermore, a higher proliferative response of antigen-specific T cells
was observed when antigen was targeted to CD16 on slanDCs. Maturation of slanDCs is accom-
panied by rapid downregulation of CD16 while maturation markers and MHC class II are upregu-
lated. We identified the metalloproteinases ADAM10 and ADAM17 as responsible for the release
of a soluble form of CD16 into the cell culture supernatant. Coculture with specific inhibitors for
ADAM10 and ADAM17 (GW280264x and GI254023x) led to the retention of CD16 on the surface
of slanDCs. Taken together the expression of CD16 equips immature slanDCs with a unique capac-
ity to capture ICs for the subsequent presentation of antigen to T cells and this capacity is controlled
by ADAM10 and ADAM17. As slanDCs can become inflammatory dermal DCs, the high capacity
to capture ICs adds an important function to these cells in terms of bridging innate and adaptive
immunity.
056
Low serum BAFF response and increased IgD– B cell recovery predict clinical flares in bul-
lous pemphigoid(BP)patients treated with rituximab
K Edhegard,1 A Ronaghy,1 RD Streilein,1 D Hannah,1 M Levesque2 and RP Hall1 1 Dermatology,
Duke Univ, Durham, NC and 2 Medicine, Univ Pittsburgh, Pittsburgh, PA
7 BP patients with persistent disease activity on 17.5 mg or more of prednisone per day for at least
8 weeks were treated with rituximab (1000 mg on day 0 and day 14). Patients were followed for 1
year and prednisone was tapered as dictated by clinical disease. B cell subsets were analyzed using
flow cytometry. IgG anti-BP180, anti- BP230, anti-VZV levels and serum BAFF levels were deter-
mined by ELISA. 5 females and 2 male were studied (mean age 59 years; mean disease duration
3.6 years; mean starting prednisone 31 mg/day). IgG anti-BP180 was present in 6/7 subjects
(64,35,198,112,40,3556 u/ml). IgG anti-BP230 was present in 4/7 subjects (14,59,61,47 u/ml). No
study drug related serious adverse events occurred. Patients achieved a dose of prednisone below
10 mg/day at a mean of 109 days (range 55 – 162)after the first infusion. At 12 months 5 patients
were off prednisone, 1 patient was on 5 mg/day and one patient on 30 mg/day. 2 patients experi-
enced a clinical disease flare at 6.6 and 12 months requiring increased prednisone. IgG anti BP
180 levels were 43% of baseline (range 11% to 86%) at month 6( p<0.020) and IgG anti BP-230
levels were 24 % of baseline at month 6. No change in IgG anti –VZV was seen. Serum BAFF lev-
els increased in all patients after rituximab therapy however BAFF levels were significantly lower
in patients who experienced a clinical flare (p < 0.01). Lower BAFF levels were apparent in patients
who flared beginning 2 weeks after infusion despite no difference in circulating B cell number. At
9 months no difference in the total B cell re- population was seen between patients however patients
with clinical flare had an increased proportion of IgD- B cells compared to pretreatment(p<.04).
These studies demonstrate that rituximab can be a successful treatment of severe BP and that treat-
ment failure is associated with an early blunted increase in serum BAFF levels and a preferential
recovery of IgD- memory B cells during B cell repopulation.
057
Preclinical anti-inflammatory activity and safety assessment of SIG990, a novel topical small
molecule for the treatment of rosacea
E Perez,1 MV Voronkov,1 JR Fernandez,1 X Feng,1 K Rouzard,1 M Stock,1 JS Gordon,1 JB Stock1,2
and B Shroot1 1 Argyle Therapeutics, Monmouth Junction, NJ and 2 Princeton University,
Princeton, NJ
Isoprenylcysteine (IPC) analogs are structural mimics of the lipidated C-termini of the Gγ subunit of
all heterotrimeric G-proteins and small G-proteins, which elicit many inflammatory responses such
as the release of pro-inflammatory mediators, and the migration and activation of inflammatory cells.
We have previously shown that a novel IPC small molecule, SIG990, could inhibit TPA-induced
erythema, edema, neutrophil infiltration and several cytokines (TNF-α, IL-6, IL-8) in vivo (SID 2010
poster # 118) as well as toll-like receptor-2 (TLR-2) inflammation in vitro (SID 2010 poster #761).
Patients with rosacea have enhanced TLR-2 expression which over-activates the cutaneous innate
immune response thus acting as a key element in the pathogenesis of rosacea. Furthermore, acti-
vation of G-protein coupled receptor, formyl peptide receptor-like 1 (FPRL1) and reactive oxygen
species (ROS) release have also been proposed to be involved in the pathogenesis of rosacea. Uti-
lizing human keratinocytes, endothelial cells and differentiated neutrophils we show SIG990 inhibits
both TLR2-induced cytokine production and FPR-induced ROS and cytokine release. SIG990 has
undergone a comprehensive preclinical safety evaluation (e.g. sensitization, dermal penetration,
mini-pig tolerability, Ames, CYPs, hERG, histopathology) and was found to have an excellent topi-
cal and systemic safety profile. Our results demonstrate SIG990 is a potential therapeutic candidate
possessing a novel specific multi-facetted anti-inflammatory activity towards TLR and GPCR sig-
naling. This new chemical entity will be subject of an Investigational New Drug application target-
ing rosacea.
058
Differences in epitopes of non-pathogenic autoantibodies to desmoglein1 in pemphigus foli-
aceus in comparison with those in pemphigus vulgaris and rheumatoid arthritis
Y Aoyama,1 K Kamiya,1 O Yamasaki,1 Y Shirafuji,1 T Hamada,1 S Morizane,1 K Fujii,1 A Kubo2 and
K Iwatsuki1 1 Dermatology, Okayama University, Okayama, Japan and 2 Dermatology, Keio
University, Tokyo, Japan
In pemphigus foliaceus (PF), antibodies (Abs) to Ca2+dependent conformational epitopes of
Desmoglein (Dsg) 1 have a pathogenic role. We previously reported that the patients with rheuma-
toid arthritis receiving the thiol compounds and pemphigus vulgaris (PV) in remission developed
Abs to non-conformational/EDTA-resistant epitopes of Dsgs, and that such Abs alone were inca-
pable of inducing acantholysis. The present study was designed to define the Ab-binding epitopes
of EDTA-treated Dsg1, and establish a method to distinguish pathogenic anti-Dsg1 Abs against the
conformational epitopes from nonpathogenic ones against non-conformational epitopes of Dsg1.
To characterize the extracellular domains (EC) of Dsg1 remain unchanged after EDTA-treatment,
we performed Dsg1 ELISA with/without EDTA or staphylococcal exfoliative toxin A (ET) treatment.
AntiDsg1 mAb (p23), which was developed against EC2-4, did not show reduction in the binding
activity to Dsg1 at all after EDTA or ET treatment. ET is known to cleave Dsg1 specifically between
EC3 and 4. These results suggest that p23 mAb binds exclusively to EC4, and EC4-5 is stable after
EDTA treatment. To assess the epitopes of autoAbs against Dsg1, which were detected in patients
with PF in their remission phase, we performed Dsg1-ELISA with/without EDTA or ET treatment.
Sera were obtained from five patients with PF in both active and remission phases, in which the
serum anti-Dsg1 antibody levels were higher than 100 index value. The mean reduction rates of
anti Dsg1 Abs in EDTA- or ET-treated ELISA compared to original index were 89.2% and 91.6% in
active phase, were 85.1% and 89.0% in inactive phase respectively. Unlike cases with rheumatoid
arthritis and PV, the epitopes of non-pathogenic anti-Dsg1 Abs detected in remission phase bound
to the conformational structure of Dsg1.This is of particular interest, leading to a speculation of a
different blistering mechanisms between PF and PV.
059
NF-κB blockade reduces hair follicle NKG2D ligand expression and susceptibility to lym-
phocyte attack revealing a novel therapeutic approach for alopecia areata
MS Hayden,1 T Dainichi,1 P Singh,2 Y Shimomura,2 R Clynes,3 AM Christiano2 and S Ghosh1 1
Microbiology and Immunology, Columbia University College of Physicians and Surgeons,
New York, NY, 2 Dermatology, Columbia University College of Physicians and Surgeons, New
York, NY and 3 Medicine, Columbia University College of Physicians and Surgeons, New York,
NY
Recent data from our genome wide association study in alopecia areata (AA) revealed a link between
the NKG2D ligands ULBP3 and ULBP6 and disease. Supporting a direct association with disease,
we showed that ULBPs were specifically upregulated in the hair follicle (HF) of AA skin. The abil-
ity of NKG2DL to provide a co-stimulatory signal for resident cytolytic NK and CD8+ T cells sug-
gested that upregulation of NKG2DL might contribute to HF damage in AA. Although NKG2DL are
upregulated by stress stimuli, their transcriptional regulation remains poorly defined. Here, we
describe a key role for the transcription factor NF-κB in regulation of ULBP expression. We found
that several pro-inflammatory stimuli that activate NF-κB induce upregulation of NKG2DL at the
HF. In addition, we identified potential NF-κB binding sites within the promoters of ULBP3 and 6,
and demonstrated that these sites contribute to ULBP promoter activity induced by TNF or LPS.
Using mice in which NF-κB p65was conditionally deleted in the epidermis, we demonstrate that
upregulation of HF NKG2DL by pro-inflammatory stimuli is dependent upon NF-κB. To assess the
contribution of NF-κB to transcriptional regulation of human NKG2DLs, we utilized a peptide
inhibitor of the NF-κB pathway. This inhibitor blocked ULBP upregulation ex vivo in human HF
organ cultures. Consistent with an important role for NF-κB as a regulator of ULBP expression and
ULBP expression as a potential trigger of HF attack by cytolytic lymphocytes, NF-κB inhibition pre-
vented lymphokine activated killer cell destruction of HF cells in vitro. Taken together, these data
provide mechanistic insight into the regulation of NKG2DL expression in skin, and suggest NF-κB
blockade as a novel therapeutic approach for the treatment of AA.
060
Murine alopecia areata immunopathogenesis is dominated by NKG2D positive CD8 T cells
and NKG2D blockade protects hair follicles from cytolytic attack
L Xing,1 P Singh,2 C Higgins,2 S Harel,2 AM Christiano2 and R Clynes1 1 Department of Medicine,
Columbia University College of Physicians and Surgeons, New York, NY and 2 Department of
Dermatology, Columbia University College of Physicians and Surgeons, New York, NY
Alopecia areata (AA) in both humans and mice results from autoimmune destruction of the hair fol-
licle by infiltrating T cells long characterized as a “swarm of bees” surrounding the hair follicle, yet
their molecular phenotype has remained largely undefined. Using immunoflourescence studies and
flow cytometric analysis, here we demonstrate that in C3H/HeJ alopecic skin, NKG2D+CD8+αβT
cells are intimately associated with the hair follicle. These NKG2D+ CD8+ T cells are massively
expanded in the cutaneous lymph nodes, comprising between 3-8% of total lymph node cells. In
the skin, CXCL9-11 chemokines were strikingly upregulated, implicating a dominant role for CXCR3
in the cutaneous recruitment of NKG2D+ CD8+ T cells. NKG2D+CD8+ T cells exhibit other
immunophenotypic signs of NK reprogramming most likely in response to locally produced IL-15,
including expression of the NK immunoreceptors NKG2A/C/E, CD49b and the expression of the
protein tyrosine kinase, Syk. Interestingly, cutaneous lymph nodes were also found to contain CD4
and CD8 T cells that produced interferon gamma, which could drive both the inflammatory response
and loss of immune privilege. To test this hypothesis, interferon gamma was shown to induce NKG2D
ligand (NKG2DL) expression in C3H/HeJ vibrissae follicles in organ culture, as well as C3H/HeJ
dermal sheath (DS) cells, thereby sensitizing these cells for cytolytic attack, which is rescued by
NKG2D blocking antibodies. We cultured human DS cells under similar conditions, and found
that interferon-sensitized DS cells were killed by activated cytolytic T cells in an NKG2D-depend-
ent manner. Taken together, these findings extend our recent identification of NKG2D+CD8+ T cells
in the immune infiltrate of human AA and define several potential immunotherapeutic targets that
could limit the activation, recruitment and cytolytic function of these cells.
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Interim analysis of the prevalence of the metabolic syndrome and cardiovascular risk factors
in children with moderate to severe psoriasis compared with an age matched population of
children with warts or acne vulgaris
S Au, E Volf, T Kerensky, N Dumont, D Levine, J Kuvin, A Goldminz, A Sekhon, K Hefferman,
E Patvardhan, D Loo and AB Gottlieb Dermatology, Tufts Medical Center, Boston, MA
Adult patients with psoriasis have an increased prevalence of the metabolic syndrome (MetS) and
cardiovascular disease (CVD) risk factors due to increased TNF and other inflammatory cytokine
levels, however, the prevalence of the MetS and risk factors for CVD in children with psoriasis is
unknown. We designed an assessor blinded study to determine if children with psoriasis have an
increased prevalence of MetS and surrogate factors for increased CVD risk in twenty children, ages
10-17 with moderate to severe psoriasis (present or history of ≥5% BSA) compared with twenty
age-matched children with warts or acne vulgaris. MetS was defined by the presence of three of the
following criteria: triglycerides ≥100 mg/dl, HDL-C <50 mg/dl for females or <45 mg/dl males, fast-
ing blood glucose ≥110 mg/dl, waist circumference >75th percentile for age and sex, systolic or
diastolic blood pressure >90th percentile for age, sex, and height. Serum lipid profiles were obtained
after 12-hour fast. Preliminary results of 24 enrolled children showed that children with psoriasis
had lower mean HDL-C levels, 41.7 mg/dl versus 53.8 mg/dl in the control group (p=0.048). Although
not statistically significant, 28% of pediatric psoriasis patients met criteria for MetS versus no chil-
dren in the control group (p=0.280).
063
Myeloid cells, and not T cells, are the main source of TNF-α in plaque-type psoriasis
PM Brunner, F Koszik, M Kalb, B Reininger, I Klein and G Stingl Department of Dermatology,
Medical University of Vienna, Vienna, Austria
The spectrum of tumor necrosis factor (TNF)-α-producing cells in psoriasis is not clearly defined.
The elucidation of this question should allow us to better understand the mode of action, efficacy
and, perhaps, also the risks of an anti-psoriatic therapy with TNF-α-antagonists. Using conven-
tional immunofluorescence methods, we were not able to detect TNF-α in sections of lesional pso-
riatic skin, but by the application of a tyramide amplification system we obtained reproducible and
firm stainings. TNF-α was exclusively found on dermal leukocytes co-expressing CD11c and HLA-
DR and, to a lesser extent, CD163. This marker profile is consistent with that of mDCs and
macrophages. Consistently, we found corresponding populations of TNF-α-producing mDCs and
monocytes in PBMCs of psoriatic patients but not of healthy individuals. TNF-α+ monocytes were
found to express CCR2 (“inflammatory monocyte”), whose ligands CCL2, CCL7 and CCL11 were
strongly upregulated in lesional psoriatic skin. TNF-α+ mDCs of the peripheral blood were of the
6sulfo LacNAc (slan)- rather than the BDCA-1-(CD1c)-subtype, and their number closely corre-
lated with disease activity. Isolated slanDCs produced high amounts of TNF-α upon stimulation with
self-RNA-LL37 complexes. These complexes are known to be a key inducer of skin inflammation
in psoriatic plaques via the activation of TLR-8. TNF-α-production of these slanDCs could be com-
pletely blocked by co-incubation with the IL-12/IL-23-antagonist ustekinumab. BDCA-1+ DCs did
not produce any TNF-α upon stimulation with self-RNA-LL37 complexes. Our data strongly sug-
gest that certain myeloid cells (slanDCs, monocytes/macrophages) are the main source of TNF-α in
chronic plaque-type psoriasis and serve as a key target not only of TNF-α-antagonists, but also of
antibody drugs interfering with Th-1 and Th-17 immunity.
065
Blockade of the IL-17R with AMG 827 leads to rapid reversal of gene expression and histopatho-
logic abnormalities in psoriatic skin, including substantial pathway-specific effects within one
week
CB Russell,1 K Kerkof,1 J Bigler,1 M Timour,1 AA Welcher,1 E Bautista,1 I Cueto,2 A Khatcherian,2
JG Krueger,2 H Rand1 and DA Martin1 1 Amgen, Inc., Seattle, WA and 2 Rockefeller Univ., New
York, NY
IL-17A, IL-17F and IL-17A/F are pro-inflammatory cytokines utilizing IL-17 Receptor A (IL-17RA)
and are implicated in the pathogenesis of several autoimmune diseases. They are upregulated in
psoriatic lesional skin, as are genes regulated by these cytokines. Using cytokine signaling scores
derived from stimulation of keratinocytes by individual cytokines, it is apparent that psoriasis lesional
skin gene expression reflects a high level of signaling by the IL-17 ligands as well as TNF and IFN.
AMG 827, a fully human antibody which blocks signaling through IL-17RA, was studied in a ran-
domized single-dose (350mg SC or 700mg IV) double-blind placebo-controlled trial in subjects with
plaque psoriasis. Post-dose biopsies showed rapid reversal of the inflammatory transcriptional pro-
file. Reduction in the IL-17 gene set score was observed within one week, concomitant with sig-
nificant decreases in KRT16 gene expression and Ki67 counts. This was followed by slower but
substantial reductions in TNF and IFN gene set scores, histopathologic parameters including epi-
dermal thickness and infiltrating leukocyte counts as well as improvements in clinical scores, with
PASI 75 and PGA of 0 or 1 (“clear” or “almost clear”) responses reached by 5/8 subjects for both
metrics in the 350 mg cohort and 7/8 or 8/8 subjects, respectively, in the 700 mg cohort, by week
6. The rapid reduction in KRT16 gene expression and Ki67 counts following blockade of IL-17RA
suggests a close link between IL-17 signaling and the mechanisms of keratinocyte hyperplasia. The
observed normalization of cellular and molecular markers following treatment with AMG 827 sup-
ports a broad central role for IL-17 family signaling in psoriasis, suggests that the combination of
IL-17A, IL-17F, and IL-17A/F inhibition disrupts an essential inflammatory cycle, and validates tar-
geting the IL-17R pathway in psoriasis.
064
Autoimmune component of Grover’s disease
C Phillips,1 V Gindi,1 S Marchenko,1 A Chernyavsky,1 V Galitovskiy,1 D Paslin2 and SA Grando1 1
University of California, Irvine, CA and 2 University of California, San Francisco, CA
Grover’s disease (transient acantholytic dermatosis) is a pruritic acantholytic skin disease of unknown
etiology. Earlier reports revealed the presence of autoantibodies in patients’ skin. The purpose of this
study was to elucidate contribution of autoimmune component to the pathogenesis of Grover’s dis-
ease. To determine if autoantibodies are directed against keratinocytes, the monolayers of normal
human adult keratinocytes were preincubated for 24 hrs with serum from 11 patients versus nor-
mal human serum, and stained with FITC-labeled anti-human IgA, IgE, IgG or IgM antibodies.
Three serum samples contained anti-keratinocyte IgG and two samples—IgA antibodies. To test a
hypothesis that autoantibodies cause acantholysis by altering cell shape, we performed a time-course
study of live keratinocytes exposed to patients’ sera, but observed no changes consistent with acan-
tholysis. Next, we hypothesized that autoantibodies lead to a loss of keratinocyte adhesion by alter-
ing the physiologic control of cell viability and/or adhesion. The exposed monolayers were stained
for BAD, PCNA, desmoglein (Dsg) 1 or Dsg 3 and protein expression was analyzed by semi-quan-
titative fluorescence. We found a decreased intensity of staining for PCNA, Dsg 1, and Dsg 3 in ker-
atinocytes preincubated with each of the three sera positive for IgG autoantibodies and one posi-
tive for IgA, compared to the staining of keratinocytes exposed to normal control serum. The difference
in staining was most notable when the monolayers were cultured at 2.5 mM calcium in the growth
medium, compared to 0.06 mM. Furthermore, preincubation with two of the sera positive for IgG
autoantibodies decreased intensity of BAD staining. Our results provide an insight into the mech-
anism of keratinocyte damage in the skin of patients with Grover’s disease and suggest that autoim-
munity plays a role in the pathogenesis. These findings may guide future studies toward develop-
ment of a more efficient treatment modality.
062
Pemphigus vulgaris (PV) antibodies target PERP and several other keratinocyte membrane and
mitochondrial proteins
M Kalantari-Dehaghi,1 GJ Anhalt,2 MJ Camilleri,3 KM Leiferman,4 S Marchenko,1 MR Pittelkow,3
JJ Zone4 and SA Grando1 1 University of California, Irvine, CA, 2 Johns Hopkins University,
Baltimore, MD, 3 Mayo Clinic, Rochester, MN and 4 University of Utah, Salt Lake City, UT
Current teaching of PV pathophysiology does not explain the mechanism of acantholysis in patients
lacking anti-desmoglein antibodies, urging a search for novel targets of pemphigus autoimmunity.
Several non-organ specific antibodies identified in PV patients by protein array technology have
been verified by other approaches, indicating reliability of proteomic technique in PV antibody dis-
covery. To characterize anti-keratinocyte antibodies in this study, we developed an array targeting
746 human keratinocyte genes amplified using Mammalian Gene Clone Collection with gene-spe-
cific primers containing 20-bp nucleotide extension complementary to ends of linear pXT7 vector.
The array included adhesion molecules, mitochondrial proteins and a large variety of cell-surface
receptors. Expressed proteins were printed onto nitrocellulose-coated glass slides, and protein expres-
sion was confirmed using monoclonal anti-polyhistidine and anti-hemagglutinin antibodies. We
tested 99 samples of PV sera positive for anti-keratinocyte (“intercellular”) antibodies and 42 nor-
mal human sera. The assay identified several PV antibodies differentially reacting with keratinocyte
proteins (p<0.05), including PERP, structurally related PMP22 protein, and a number of receptor
and mitochondrial proteins. The percentage of positive PV patient versus control sera was 41 vs 0,
respectively, for PERP, 60 vs 2 for PMP22, 45 vs 2 for parathyroid hormone 1 receptor, 42 vs 0 for
TGF-β receptor associated protein, 37 vs 2 for insulin-like growth factor 1 receptor, and 37 vs 0 for
the mitochondrial proline dehydrogenase 1. Whereas the roles of the majority of novel PV anti-
bodies in disease pathophysiology remain to be elucidated, the significance of antibodies targeting
proteins of PMP22 family stems from the critical role of PERP in desmosomal adhesion evidenced
by the PV phenocopy in mice lacking PERP.
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Immature slan (6-sulfo LacNAc) dendritic cells display a unique capacity of Fc gamma RIII-
mediated immune complex binding which is controlled by ADAM10 and ADAM17
T Döbel, A Hänsel and K Schäkel Dermatology, University Hospital Heidelberg, Heidelberg,
Germany
Recognition of immune complexes (ICs) by dendritic cells (DCs) is critical for the activation and
amplification of immune responses. It is not known so far, whether a specific subset of DCs is hard
wired to bind ICs. Slan (6-sulfo LacNAc) DCs stand out by their high level expression of the low
affinity Fc gamma receptor III (CD16). SlanDCs are highly proinflammatory, serve as a major and
early source of IL-12, IL-1 beta and TNF-alpha and can become inflammatory dermal DCs in pso-
riasis. Comparative binding studies of IgG ICs revealed a far higher capacity of slanDCs to bind ICs
compared to CD1c+ DCs, pDCs and monocytes. Blocking experiments revealed a strong CD16-
dependent binding of ICs by slanDCs. CD16 also proved critical for slanDCs to phagocytose IgG-
opsonized red blood cells. Furthermore, a higher proliferative response of antigen-specific T cells
was observed when antigen was targeted to CD16 on slanDCs. Maturation of slanDCs is accom-
panied by rapid downregulation of CD16 while maturation markers and MHC class II are upregu-
lated. We identified the metalloproteinases ADAM10 and ADAM17 as responsible for the release
of a soluble form of CD16 into the cell culture supernatant. Coculture with specific inhibitors for
ADAM10 and ADAM17 (GW280264x and GI254023x) led to the retention of CD16 on the surface
of slanDCs. Taken together the expression of CD16 equips immature slanDCs with a unique capac-
ity to capture ICs for the subsequent presentation of antigen to T cells and this capacity is controlled
by ADAM10 and ADAM17. As slanDCs can become inflammatory dermal DCs, the high capacity
to capture ICs adds an important function to these cells in terms of bridging innate and adaptive
immunity.
056
Low serum BAFF response and increased IgD– B cell recovery predict clinical flares in bul-
lous pemphigoid(BP)patients treated with rituximab
K Edhegard,1 A Ronaghy,1 RD Streilein,1 D Hannah,1 M Levesque2 and RP Hall1 1 Dermatology,
Duke Univ, Durham, NC and 2 Medicine, Univ Pittsburgh, Pittsburgh, PA
7 BP patients with persistent disease activity on 17.5 mg or more of prednisone per day for at least
8 weeks were treated with rituximab (1000 mg on day 0 and day 14). Patients were followed for 1
year and prednisone was tapered as dictated by clinical disease. B cell subsets were analyzed using
flow cytometry. IgG anti-BP180, anti- BP230, anti-VZV levels and serum BAFF levels were deter-
mined by ELISA. 5 females and 2 male were studied (mean age 59 years; mean disease duration
3.6 years; mean starting prednisone 31 mg/day). IgG anti-BP180 was present in 6/7 subjects
(64,35,198,112,40,3556 u/ml). IgG anti-BP230 was present in 4/7 subjects (14,59,61,47 u/ml). No
study drug related serious adverse events occurred. Patients achieved a dose of prednisone below
10 mg/day at a mean of 109 days (range 55 – 162)after the first infusion. At 12 months 5 patients
were off prednisone, 1 patient was on 5 mg/day and one patient on 30 mg/day. 2 patients experi-
enced a clinical disease flare at 6.6 and 12 months requiring increased prednisone. IgG anti BP
180 levels were 43% of baseline (range 11% to 86%) at month 6( p<0.020) and IgG anti BP-230
levels were 24 % of baseline at month 6. No change in IgG anti –VZV was seen. Serum BAFF lev-
els increased in all patients after rituximab therapy however BAFF levels were significantly lower
in patients who experienced a clinical flare (p < 0.01). Lower BAFF levels were apparent in patients
who flared beginning 2 weeks after infusion despite no difference in circulating B cell number. At
9 months no difference in the total B cell re- population was seen between patients however patients
with clinical flare had an increased proportion of IgD- B cells compared to pretreatment(p<.04).
These studies demonstrate that rituximab can be a successful treatment of severe BP and that treat-
ment failure is associated with an early blunted increase in serum BAFF levels and a preferential
recovery of IgD- memory B cells during B cell repopulation.
057
Preclinical anti-inflammatory activity and safety assessment of SIG990, a novel topical small
molecule for the treatment of rosacea
E Perez,1 MV Voronkov,1 JR Fernandez,1 X Feng,1 K Rouzard,1 M Stock,1 JS Gordon,1 JB Stock1,2
and B Shroot1 1 Argyle Therapeutics, Monmouth Junction, NJ and 2 Princeton University,
Princeton, NJ
Isoprenylcysteine (IPC) analogs are structural mimics of the lipidated C-termini of the Gγ subunit of
all heterotrimeric G-proteins and small G-proteins, which elicit many inflammatory responses such
as the release of pro-inflammatory mediators, and the migration and activation of inflammatory cells.
We have previously shown that a novel IPC small molecule, SIG990, could inhibit TPA-induced
erythema, edema, neutrophil infiltration and several cytokines (TNF-α, IL-6, IL-8) in vivo (SID 2010
poster # 118) as well as toll-like receptor-2 (TLR-2) inflammation in vitro (SID 2010 poster #761).
Patients with rosacea have enhanced TLR-2 expression which over-activates the cutaneous innate
immune response thus acting as a key element in the pathogenesis of rosacea. Furthermore, acti-
vation of G-protein coupled receptor, formyl peptide receptor-like 1 (FPRL1) and reactive oxygen
species (ROS) release have also been proposed to be involved in the pathogenesis of rosacea. Uti-
lizing human keratinocytes, endothelial cells and differentiated neutrophils we show SIG990 inhibits
both TLR2-induced cytokine production and FPR-induced ROS and cytokine release. SIG990 has
undergone a comprehensive preclinical safety evaluation (e.g. sensitization, dermal penetration,
mini-pig tolerability, Ames, CYPs, hERG, histopathology) and was found to have an excellent topi-
cal and systemic safety profile. Our results demonstrate SIG990 is a potential therapeutic candidate
possessing a novel specific multi-facetted anti-inflammatory activity towards TLR and GPCR sig-
naling. This new chemical entity will be subject of an Investigational New Drug application target-
ing rosacea.
058
Differences in epitopes of non-pathogenic autoantibodies to desmoglein1 in pemphigus foli-
aceus in comparison with those in pemphigus vulgaris and rheumatoid arthritis
Y Aoyama,1 K Kamiya,1 O Yamasaki,1 Y Shirafuji,1 T Hamada,1 S Morizane,1 K Fujii,1 A Kubo2 and
K Iwatsuki1 1 Dermatology, Okayama University, Okayama, Japan and 2 Dermatology, Keio
University, Tokyo, Japan
In pemphigus foliaceus (PF), antibodies (Abs) to Ca2+dependent conformational epitopes of
Desmoglein (Dsg) 1 have a pathogenic role. We previously reported that the patients with rheuma-
toid arthritis receiving the thiol compounds and pemphigus vulgaris (PV) in remission developed
Abs to non-conformational/EDTA-resistant epitopes of Dsgs, and that such Abs alone were inca-
pable of inducing acantholysis. The present study was designed to define the Ab-binding epitopes
of EDTA-treated Dsg1, and establish a method to distinguish pathogenic anti-Dsg1 Abs against the
conformational epitopes from nonpathogenic ones against non-conformational epitopes of Dsg1.
To characterize the extracellular domains (EC) of Dsg1 remain unchanged after EDTA-treatment,
we performed Dsg1 ELISA with/without EDTA or staphylococcal exfoliative toxin A (ET) treatment.
AntiDsg1 mAb (p23), which was developed against EC2-4, did not show reduction in the binding
activity to Dsg1 at all after EDTA or ET treatment. ET is known to cleave Dsg1 specifically between
EC3 and 4. These results suggest that p23 mAb binds exclusively to EC4, and EC4-5 is stable after
EDTA treatment. To assess the epitopes of autoAbs against Dsg1, which were detected in patients
with PF in their remission phase, we performed Dsg1-ELISA with/without EDTA or ET treatment.
Sera were obtained from five patients with PF in both active and remission phases, in which the
serum anti-Dsg1 antibody levels were higher than 100 index value. The mean reduction rates of
anti Dsg1 Abs in EDTA- or ET-treated ELISA compared to original index were 89.2% and 91.6% in
active phase, were 85.1% and 89.0% in inactive phase respectively. Unlike cases with rheumatoid
arthritis and PV, the epitopes of non-pathogenic anti-Dsg1 Abs detected in remission phase bound
to the conformational structure of Dsg1.This is of particular interest, leading to a speculation of a
different blistering mechanisms between PF and PV.
059
NF-κB blockade reduces hair follicle NKG2D ligand expression and susceptibility to lym-
phocyte attack revealing a novel therapeutic approach for alopecia areata
MS Hayden,1 T Dainichi,1 P Singh,2 Y Shimomura,2 R Clynes,3 AM Christiano2 and S Ghosh1 1
Microbiology and Immunology, Columbia University College of Physicians and Surgeons,
New York, NY, 2 Dermatology, Columbia University College of Physicians and Surgeons, New
York, NY and 3 Medicine, Columbia University College of Physicians and Surgeons, New York,
NY
Recent data from our genome wide association study in alopecia areata (AA) revealed a link between
the NKG2D ligands ULBP3 and ULBP6 and disease. Supporting a direct association with disease,
we showed that ULBPs were specifically upregulated in the hair follicle (HF) of AA skin. The abil-
ity of NKG2DL to provide a co-stimulatory signal for resident cytolytic NK and CD8+ T cells sug-
gested that upregulation of NKG2DL might contribute to HF damage in AA. Although NKG2DL are
upregulated by stress stimuli, their transcriptional regulation remains poorly defined. Here, we
describe a key role for the transcription factor NF-κB in regulation of ULBP expression. We found
that several pro-inflammatory stimuli that activate NF-κB induce upregulation of NKG2DL at the
HF. In addition, we identified potential NF-κB binding sites within the promoters of ULBP3 and 6,
and demonstrated that these sites contribute to ULBP promoter activity induced by TNF or LPS.
Using mice in which NF-κB p65was conditionally deleted in the epidermis, we demonstrate that
upregulation of HF NKG2DL by pro-inflammatory stimuli is dependent upon NF-κB. To assess the
contribution of NF-κB to transcriptional regulation of human NKG2DLs, we utilized a peptide
inhibitor of the NF-κB pathway. This inhibitor blocked ULBP upregulation ex vivo in human HF
organ cultures. Consistent with an important role for NF-κB as a regulator of ULBP expression and
ULBP expression as a potential trigger of HF attack by cytolytic lymphocytes, NF-κB inhibition pre-
vented lymphokine activated killer cell destruction of HF cells in vitro. Taken together, these data
provide mechanistic insight into the regulation of NKG2DL expression in skin, and suggest NF-κB
blockade as a novel therapeutic approach for the treatment of AA.
060
Murine alopecia areata immunopathogenesis is dominated by NKG2D positive CD8 T cells
and NKG2D blockade protects hair follicles from cytolytic attack
L Xing,1 P Singh,2 C Higgins,2 S Harel,2 AM Christiano2 and R Clynes1 1 Department of Medicine,
Columbia University College of Physicians and Surgeons, New York, NY and 2 Department of
Dermatology, Columbia University College of Physicians and Surgeons, New York, NY
Alopecia areata (AA) in both humans and mice results from autoimmune destruction of the hair fol-
licle by infiltrating T cells long characterized as a “swarm of bees” surrounding the hair follicle, yet
their molecular phenotype has remained largely undefined. Using immunoflourescence studies and
flow cytometric analysis, here we demonstrate that in C3H/HeJ alopecic skin, NKG2D+CD8+αβT
cells are intimately associated with the hair follicle. These NKG2D+ CD8+ T cells are massively
expanded in the cutaneous lymph nodes, comprising between 3-8% of total lymph node cells. In
the skin, CXCL9-11 chemokines were strikingly upregulated, implicating a dominant role for CXCR3
in the cutaneous recruitment of NKG2D+ CD8+ T cells. NKG2D+CD8+ T cells exhibit other
immunophenotypic signs of NK reprogramming most likely in response to locally produced IL-15,
including expression of the NK immunoreceptors NKG2A/C/E, CD49b and the expression of the
protein tyrosine kinase, Syk. Interestingly, cutaneous lymph nodes were also found to contain CD4
and CD8 T cells that produced interferon gamma, which could drive both the inflammatory response
and loss of immune privilege. To test this hypothesis, interferon gamma was shown to induce NKG2D
ligand (NKG2DL) expression in C3H/HeJ vibrissae follicles in organ culture, as well as C3H/HeJ
dermal sheath (DS) cells, thereby sensitizing these cells for cytolytic attack, which is rescued by
NKG2D blocking antibodies. We cultured human DS cells under similar conditions, and found
that interferon-sensitized DS cells were killed by activated cytolytic T cells in an NKG2D-depend-
ent manner. Taken together, these findings extend our recent identification of NKG2D+CD8+ T cells
in the immune infiltrate of human AA and define several potential immunotherapeutic targets that
could limit the activation, recruitment and cytolytic function of these cells.
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Absence of myeloid derived suppressor cells and activation of tumor blood vessels may under-
lie regression of keratoacanthomas
WJ Crisler, A Gehad, CD Schmults, MK Lichtman, JE Teague, R Watanabe, M Dowlatshahi,
TS Kupper and RA Clark Department of Dermatology, Brigham and Women’s Hospital, Boston,
MA
Keratoacanthomas (KA) are a clinical, histologically indistinguishable subset of cutaneous squa-
mous cell carcinomas (SCC) that grow rapidly but spontaneously regress. We found previously that
blood vessels in SCC lack expression of the T cell homing addressin E-selectin and fail to recruit
CLA+ skin homing T cells, the subset expected to contain tumor specific T cells. Topical treatment
with TLR7 agonist imiquimod up-regulates vascular E-selectin, induces influx of CLA+ T cells and
can induce tumor regression. We report here that KA differ from other SCC in that a significant
number of KA tumor vessels express E-selectin. 41% of blood vessels in KA expressed E-selectin,
compared with 6.7% in untreated SCC and 34% in imiquimod treated SCC undergoing immuno-
logic destruction. Correspondingly, >50% of T cells in KA expressed CLA, compared with 13% in
untreated SCC. TUNEL staining confirmed increased tumor cell death in KA. We recently reported
that untreated SCC are infiltrated by iNOS+ myeloid derived suppressor cells (MDSC) and that nitric
oxide (NO) produced by these cells likely suppresses vascular E-selectin expression. We observed
a striking absence of iNOS+ MDSC in KA. KA contained mean 3.1 iNOS+ MDSC per 200X field as
compared to 75 iNOS+ MDSC/200X field in untreated SCC. In summary, we find that KA lack NO-
producing MDSC, have up-regulation of vascular E-selectin expression, are infiltrated by CLA+ T
cells and show evidence of increased tumor cell death. In short, KA are remarkably similar to
imiquimod-treated SCC undergoing immunologic destruction. Our findings suggest regression of
KA may be immunologically mediated and that critical differences between KA and SCC are the
presence of NO-producing MDSC and endothelial activation of tumor vessels. Agents that block
MDSC recruitment to tumors, inhibit nitric oxide production and enhance vascular E-selectin expres-
sion may have efficacy in the treatment of cutaneous SCC.
075
The PPARγ paradox: Cellular mechanism regulating hyper-inflammatory macrophage gener-
ation
J Rosenjack,1 BW Doreian,1 M Cathcart,2 RL Silverstein,2 KD Cooper1 and KQ Lu1,2 1
Dermatology, Case Western Reserve University, Cleveland, OH and 2 Cell Biology, CCF,
Cleveland, OH
Our lab has generated a hyper-inflammatory macrophage through PPARγ activation in the absence
of IL-6 resulting in massive skin damage and delayed wound healing. These macrophages express
high levels of iNOS and TNF-α in skin and other organ models. We hypothesized that in our exper-
imental condition, PPARγ agonist induction of SOCS3 inhibits STAT3 activation, resulting in unreg-
ulated NFκB-mediated iNOS expression. We show that PPARγ agonist treatment of IL-6-/-
macrophages stimulated with LPS results in increased cytoplasmic SOCS3 protein at 15 minutes
and a subsequent decrease of nuclear STAT3 with concomitant increase in nuclear NFκB at 60
minutes (n=3). Under these treatment conditions, we observe a 45-fold increase of iNOS mRNA
expression (n=4, P<0.01). To evaluate the role of SOCS3 in our experimental condition, we trans-
fected IL-6-/- macrophages with a SOCS3 antisense oligonucleotide. SOCS3 antisense treatment
results in decreased cytoplasmic SOCS3 protein at 15 minutes with associated increase of nuclear
STAT3 protein at 60 minutes (n=3). Consistent with the hypothesis, inhibiting SOCS3 results in a
32% reduction of iNOS mRNA expression following LPS stimulation in PPARγ agonist treated
macrophages (n=1). Given these findings, we wanted to determine whether antagonizing STAT3
alone is sufficient to drive iNOS expression in the absence of a PPARγ agonist. IL-6-/- macrophages
were transfected with a STAT3 decoy, an oligonucleotide with the specific binding sequence for
STAT3. We observe that disruption of nuclear STAT3 accumulation results in a 49-fold increase of
iNOS mRNA expression following LPS stimulation independent of PPARγ activation (n=3, P<0.05).
Our data demonstrate that the key mechanism of PPARγagonist hyper-induction of iNOS in
macrophages is via SOCS3 mediated decrease of STAT3 transrepression of NFκB activity. There-
fore, precaution should be used clinically when administering PPARγ agonists as they may gener-
ate paradoxical inflammation by altering the balance of STAT3 and NFκB.
077
Non-calcemic natural vitamin D analogue, 20(OH)D3, protects mice from bleomycin induced
scleroderma
AE Postlethwaite,1,2 W Li,1 J Chen,1 DD Miller,1 W Gu,1 Y Jiao1 and A Slominski1 1 University of
Tennessee Health Science Center, Memphis, TN and 2 VA Medical Center, Memphis, TN
The purpose of the present study is to assess anti-fibrotic effects of a novel vitamin D analogue. 1α,
25-dihydroxyvitamin D3 [1,25(OH)2 D3] regulates calcium homeostasis and bone remodeling. It is
also known to inhibit collagen synthesis by some types of fibroblasts, has been shown to inhibit
interstitial fibrosis in a renal model and may improve bone marrow fibrosis in patients with myelofi-
brosis. Use of 1,25(OH)2 D3 as a therapeutic anti-fibrotic agent is limited by its inherent ability to
induce hypercalcemia. Recently our group identified a novel secosteroid, 20(OH)D3, that does not
induce calcemia. We found that 1,25(OH)2 D3 and 20(OH)D3 at 10
-10 and 10-9 M significantly inhib-
ited (from ≥ 90%) total collagen and hyaluronan synthesis by cultured human dermal fibroblasts
stimulated with TGF-β1 (5 ng/ml) with no cytotoxic. In the present study we administered 20(OH)D3
or sesame oil i.p. daily for 21 days at a dose of 3 μg/kg to C57BL/6 mice receiving subcutaneous
injection of bleomycin to induce localized dermal fibrosis, a standard murine model of scleroderma.
At day 22 mice were euthanized and skin obtained for histology and quantitation of total collagen
content using a Sicrcoll Collagen Assay. 20(OH)D3 treatment of mice led to marked significant
(p=0.019) reduction in total collagen content (ng/mg of tissue) of skin to compared to sesame oil
vehicle treated mice that approached collagen content of bleomycin vehicle control
(576±70=20(OH)D3 + Bleomycin; 1326±236=sesame oil + Bleomycin; 503±85=sesame oil + saline.
Furthermore, 20(OH)D3 inhibited type I collagen synthesis by scleroderma and normal donor skin
fibroblasts cultured with TGF-β1 as well as Col1A1 mRNA. In conclusion, these data suggest that
20(OH)D3 identified by us with no hypercalcemic property retains the anti-fibrotic properties of
1,25(OH)2 D3 in vivo in a scleroderma mouse model and in vitro in cultured scleroderma and nor-
mal fibroblasts.
076
Histone deacetylase activity is required for skin Langerhans cell homeostasis and function
R Qi,1,2,3 M Liu,1,2 X Gao,3 H Chen,3 L Zhou1,2 and Q Mi1,2 1 Immunology Program, Henry Ford
Health System, Detroit, MI, 2 Dept of Dermatology, Henry Ford Health System, Detroit, MI
and 3 Dept of Dermatology, No. 1 Hospital of China Medical University, Shengyang, China.,
Shenyang, China
Langerhans cells (LCs) are skin-resident DCs that express the C-type lectin Langerin and have a life
cycle distinct from many other types of DCs. Even though LCs were first described more than 100
years ago, their development and immunological functions still remain enigmatic. Histone acety-
lation plays key roles in modulating chromatin structure. Histone deacetylases (HDACs) induce the
hypoacetylation of histone and regulate gene transcription and epigenetic integrity. Recent studies
suggest that HDAC inhibitors suppress the bone marrow-derived dendritic cells differentiation,
maturation and functions, which may be involved in the anti-inflammatory effects mediated by
HDAC inhibitors. Here we tested if HDACs are involved in skin LC homeostasis and function. Epi-
dermal cell suspensions prepared from C57BL/6 mice were treated with different doses of HDAC
inhibitor trichostatin A (TSA) from 6.125nM to 200nM for 48 or 72 hours. We found that the per-
centage of epidermal LCs was dramatically reduced in TSA-treated epidermal cells in a time and
dose dependent manner. TSA significantly increased LC apoptosis. Furthermore, TSA-treated LCs
have defects on their maturation and antigen uptaking. Thus, our findings highly suggest that his-
tone deacetylase activity is required for skin Langerhans cell homeostasis and function.
074
Comparing the effects of 9-cis UAB30, a novel rexinoid, and bexarotene on the rates of pro-
liferation and apoptosis in human cutaneous T-cell lymphoma cell lines
Z Verney,1 V Attigada,2 C Elmets,1,5 D Muccio,2 C Grubbs3,5 and P Chang1,4,5 1 Dermatology,
UAB, Birmingham, AL, 2 Chemistry, UAB, Birmingham, AL, 3 Surgery, UAB, Birmingham, AL,
4 Nutrition Sciences, UAB, Birmingham, AL and 5 Comprehensive Cancer Center, UAB,
Birmingham, AL
Cutaneous T-cell lymphoma (CTCL) represent a heterogeneous group of malignancies, character-
ized by the infiltration and detection of transformed T-cell lymphocytes in the skin. Although there
is no cure for CTCL, a wide range of treatment options have been developed for use in the clinical
setting. Bexarotene, a retinoid X receptor (RXR) agonist or rexinoid, is a commonly used treatment
modality for CTCL. However, documented increases in the levels of triglycerides of CTCL patients,
resulting from treatment with bexarotene, point to concerns over the long-term use and efficacy of
this anti-cancer agent. We have recently synthesized a novel rexinoid, 9-cis UAB30, which does
not elevate triglycerides in vivo and have begun evaluating its use as a potential chemotherapeutic
agent for the treatment of CTCL. In this study, we compared the efficacy of 9-cis UAB30 to that of
bexarotene in reducing cell proliferation and inducing apoptosis, in the three human CTCL cell lines
HH, MJ, and Hut78. A standard XTT assay was used to determine the rate of cell proliferation of
CTCL cells. In all three lines, 9-cis UAB30 was equally and sometimes more effective than bexarotene
at suppressing cell proliferation. We next analyzed the rate of apoptosis in these human CTCL
lines, using an annexin V binding assay. Interestingly, the MJ cell line was found to be resistant to
apoptosis, when treated with either compound. The other two cell lines, however, displayed a greater
increase in their rate of apoptosis, when treated with 9-cis UAB30, as compared to bexarotene.
Collectively, these results indicate that 9-cis UAB30 appears to be equally if not more effective than
bexarotene at suppressing cell proliferation and/or enhancing apoptosis of human CTCL cells. There-
fore, 9-cis UAB30 may be a better alternative for the treatment of CTCL.
078
Automated detection and tracking of inflammatory acne lesions through digital imaging
GO Cula, PR Bargo and N Kollias Measurement Sciences, Johnson & Johnson Consumer
Companies, Skillman, NJ
It is known that effectiveness of acne treatment increases when the lesions are detected earlier, before
they progress into mature wound-like lesions, which lead to scarring and discoloration. However,
little is known about the evolution of acne from early signs until after the lesion heals. In this work
we computationally characterize the evolution of inflammatory acne lesions, based on analyzing
cross-polarized images that document acne-prone facial skin over time. Taking skin images over
time, and being able to follow skin features in these images present serious challenges, due to change
in the appearance of skin, difficulty in repositioning the subject, involuntary movement such as
breathing. A computational technique for automatic detection of lesions by separating the back-
ground normal skin from the acne lesions, based on fitting Gaussian distributions to the intensity
histograms, is presented. In order to track and quantify the evolution of lesions, in terms of the degree
of progress or regress, we designed a study to capture facial skin images from acne-prone young
individuals that were followed over time. Based on the behavior of the lesions between two con-
secutive time points, the automatically detected lesions are classified in four categories: new lesions,
resolved lesions (i.e. lesions that disappear completely), lesions that are progressing, and lesions
that are regressing (i.e. lesions in the process of healing). The classification our methods achieve
correlates well with visual inspection of a trained professional.
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6-Sulfo-LacNAc (Slan) dendritic cells in psoriasis lesions
KC Pierson, LM Johnson-Huang, T Lentini, J Fuentes-Duculan, I Novitskaya, JG Krueger and
MA Lowes Laboratory for Investigative Dermatology, Rockefeller University, New York, NY
Dendritic cells (DCs) are key antigen presenting cells that bridge innate and adaptive immunity. 6-
Sulfo-LacNAc (Slan), a novel carbohydrate modification of P selectin glycoprotein ligand-1 (PSGL-
1), identifies 0.5-1% of circulating white blood cells. Slan+ cells produce abundant TNF-α and IL-
12 on stimulation with LPS. Our group has described “inflammatory” DCs in psoriasis lesions, which
produce TNF and IL-23, and are phenotypically defined as CD11c+/CD1c-. The identification of
these SlanDC+ cells in the blood raised the intriguing possibility that these cells are precursors of
inflammatory DCs in skin lesions of psoriasis, and slanDC could be a positive marker of inflam-
matory DCs in situ. SlanDCs in the skin of psoriasis patients were characterized by immunohisto-
chemistry and immunofluorescence of frozen sections using the M-DC8/DD1 clone (Miltenyi).
SlanDC+ cells were increased in psoriasis lesions (p<0.05), and showed (non-significant) reduction
with both efalizumab (Raptiva, Genentech, anti-CD11a, n=7) and narrow-band ultraviolet radia-
tion B (NB-UVB, n=11) treatment. SlanDC+ cells were also increased in patients who experienced
a relapse on ceasing efalizumab (p<0.05). However, SlanDC+ cells were less than 10% of CD11c+
cells in psoriasis lesions, which is the classic interstitial pan-myeloid DC marker in humans. Although
circulating SlanDC+ cells expressed CD11c and HLA-DR by FACS, slanDC+ cells in situ demon-
strated minimal co-expression of CD11c, no HLA-DR co-localization, and only occasional cells
were positive for CD68 by two-color immunofluorescence. There was no co-expression of SlanDC
with other inflammatory DC markers in psoriasis lesions, including TNF, TRAIL and iNOS. Thus
while the commercially available SlanDC antibody identified a small number of cells in lesional
psoriasis skin that were increased compared to non-lesional skin, SlanDC+ cells in situ did not co-
express abundant classic or inflammatory DC markers.
068
Cytokine-specific gene expression signatures identify high signaling by IL-17, TNF and IFN in
lesional psoriatic skin and frequent underlying IL-17 signaling in non-lesional psoriatic skin
H Rand, K Kerkof, J Bigler, M Timour, A Welcher, Y Zhang, J Towne, DA Martin and CB Russell
Amgen, Inc., Seattle, WA
Many cytokine responsive genes are variably induced in psoriatic lesional (PLS) and non-lesional
(PNL) skin, and we chose to investigate this range of expression on the level of individual skin sam-
ples. Keratinocytes were stimulated in vitro with TNFα, IFNγ, or IL-17A, to generate initial sets con-
taining genes responsive to each cytokine with minimal effects from the others. Using expression
profiles from skin samples, these sets were further refined into signatures of 12 to 30 genes that pro-
vide a coherent summary measure resistant to experimental or minor biological noise. By charac-
terizing individual samples in terms of these components, we quantified important differences
between PLS (N=50), PNL (N=50), and healthy normal (HN, N=30) skin, as well as inter-person dif-
ferences. PLS skin had high scores for all three cytokines, with the IL-17 score consistently in a nar-
row range well separated from the low values seen in most HN skin. TNF and IFN scores were also
elevated in PLS samples compared to HN, but with less statistical separation than observed for the
IL-17 scores. Repeat PLS biopsies (N=5, 3 biopsies each over 2 to 6 weeks) maintained consistent
TNF and IFN scores for each subject within the broader distribution of scores in the PLS samples,
suggesting some individual stability in the level of signaling for these two cytokines. Remarkably,
approximately half the PNL skin samples had elevated IL-17 scores distributed across the range
between the HN and PLS values, while IFN and TNF scores remained in the HN range. IFN, IL-17,
and TNF scores were always elevated in untreated PLS skin and pathway specific decreases were
observed in individual lesional samples following therapeutic interventions. This analysis of HN,
PNL, and PLS skin on a sample-by-sample basis supports the existence of a stable positive-feed-
back loop involving IFN, TNF, and IL-17 in psoriatic lesions, and illustrates a unique role for IL-17
signaling in both lesional and non-lesional skin.
069
Mechanistic studies on novel anti-inflammatory molecule used in the treatment of facial red-
ness
S Sonti,1 R Mehta1 and R Holtz2 1 R&D, SkinMedica, Inc, Carlsbad, CA and 2 BioInnovations
Lab, Inc, Lakewood, CO
Facial redness is a common problem in both medical and surgical dermatology. 4-ethoxyben-
zaldehyde (4-EB, Calmplex TM), a novel anti-inflammatory molecule, has been shown to signifi-
cantly reduce redness in 3 separate clinical trials. Prostaglandin E2 (PGE2) signaling is essential in
producing keratinocyte mediated acute inflammation and vasodilation after UV exposure, a key fac-
tor in the pathophysiology of visible redness. The purpose of this study was to better understand the
role of 4-EB in the modulation of the arachidonic acid pathway and prostaglandin production. In
this in vitro study, human keratinoctyes were first irradiated with UVB to induce prostaglandin syn-
thesis and then treated with different concentrations (0.2μM-200μM) of 4-EB for 24 hours.
Indomethacin, a known anti-inflammatory agent and PGE2 inhibitor, was used a positive control
in all experiments. After the treatment period, the keratinocyte cell culture supernatant was assayed
for prostaglandin levels (PGI2, PGE2 and PGF2α) using ELISAs while changes in the number of
viable cells was determined using an MTT assay. The results demonstrate that 4-EB is a strong inhibitor
of UV-induced PGE2 and PGF2 and this inhibition was dose-dependent. Since the cyclooxygenase
(COX-1/COX-2) enzyme catalyzes the important initial conversion of arachidonic acid and begins
the process of prostaglandin synthesis, we also studied the effect of this test article on COX activ-
ity. The effect of 4-EB (0.2 μM-500μM) on COX activity was conducted using a purified enzyme
model. 4-EB showed no inhibition of either COX-1 or COX-2 enzyme at all concentrations tested.
These results suggest that the anti-inflammatory role of 4-EB is mediated by inhibition of PGE2
independent of COX activity. In conclusion, data from this study points to the PGE2 inhibitory
activity as a mechanism by which 4-EB treatment causes a significant reduction in facial redness.
This mechanism of action points to further applications in other PGE2 mediated conditions such as
post-inflammatory hyperpigmentation.
070
IgA and IgE anti-basement membrane antibodies together cause greater inflammation than
either alone in a SCID mouse passive transfer model of Linear IgA Bullous Dermatosis (LABD)
LJ Meyer,1,2 TB Taylor,1,2 LA Schmidt,1,2 CM Hull2 and JJ Zone2 1 VAHCS, Salt Lake City, UT and
2 Dermatology, University of Utah, Salt Lake City, UT
Many immune responses have multiple classes of antibodies. Although IgG is the predominant
antibody in bullous pemphigoid, IgE is realized to play a role in the urticarial phase and in eosinophil
infiltration. We sought to examine the effect of IgE alone and with IgA in a human skin xenograft
SCID mouse model of LABD. Monoclonal IgA antibody to LABD-97 was administered by the back-
pack technique. IgE was given as 2 mg per injection. When both antibodies were given together,
the first IgE injection was on day 9, 3 days prior to a visible tumor, with additional injections on
days 10, 11, 12 and 14. Biopsies were done on day 12 and the mice were sacrificed on day 16. Ten
mice received both IgA and IgE antibodies, and five were given each class separately. Overall, a
combination of the antibody classes caused more significant inflammation and resulted in more
uniform blister formation than either antibody alone. All human skin grafts demonstrated positive
immunofluorescence for the administered antibodies. However, IgE was present at day 12 but absent
at day 16 from 3 of 10 grafts given both antibodies, presumably due to inflammation. Blisters had
formed by day 12 in 4 of 10 IgA and IgE mice and in all 10 at day 16, but in only 3 of 5 IgE mice,
and 2 of 5 given IgA. Cellular infiltration was similar, with all 10 grafts given IgA and IgE showing
both neutrophil and eosinophil infiltration at both 12 and 16 days. IgE mice demonstrated neu-
trophils and eosinophils in 4 of 5 and 5 of 5 at days 12 and 16 respectively. IgA mice demonstrated
neutrophils in 2 of 5 and 3 of 5 at days 12 and 16, and eosinophils in 1 of 5 and 3 of 5 at days 12
and 16. Degranulated eosinophils were observed in all mice given IgE, and all blistered mice had
degranulated neutrophils. We conclude that there is synergy of IgE with IgA to increase inflamma-
tion and blistering in this model system. A search for presence of IgE in LABD and other immunob-
ullous diseases is warranted.
071
Prevention of post-inflammatory hyperpigmentation with a novel anti-inflammatory combi-
nation product
E Ho, R Mehta and S Sonti R&D, SkinMedica, Inc, Carlsbad, CA, CA
Chemical mediators released in the inflammatory process have considerable influence on melano-
genesis. Several pathways leading to post-inflammatory hyperpigmentation (PIH) have been iden-
tified including UV mediated increase in the levels of prostaglandin E2 (PGE2). 4-ethoxybenzalde-
hyde (4-EB, Calmplex TM), a novel anti-inflammatory agent that inhibits PGE2, was combined with
a melanosomes transfer inhibitor (niacinamide) to evaluate its effect on prevention of PIH after UV
mediated inflammation. An antioxidant combination product with Vitamin C, E and Ferulic acid
(CEF product) was used as a control. 17 healthy female subjects, aged 26-63 years with Fitzpatrick
Skin Types III-IV completed a single-center, double-blinded comparison study. At baseline, test areas
were marked onto the backs of the subjects and randomized as treatment or control sites. The min-
imal erythemal dose (MED) for each subject was determined using a solar simulator (UVB: 290-
320 nm, UVA: 320-400nm). 30μL of each test product were applied to the respective test sites by
the study staff, once daily, for 4 days. On Day 5, test sites were irradiated with 1.0, 1.5, 2.0, and
2.5 MEDs. Application of test products resumed on Day 6 through 19. Standardized digital photo-
graphs were taken of the test sites on Days 6 and 20 (end of study visit). The images were analyzed
using a computer-aided colorimetry algorithm, according to the CIE color standard, to determine
a* (degree of redness) and L* (brightness) at Days 6 and 20. At day 6, both 4-EB product and CEF
product showed a statistically significant change in a* (P=0.01) and L* (P<0.001) when compared
to untreated control, demonstrating prevention of initial UV mediated damage. At Day 20, 4-EB
product continued to show significantly higher L* (P<0.001) compared to untreated control. 4-EB
product also showed a 3-fold significantly greater L* than CEF product (P<0.0001). The results
demonstrated that a product containing PGE2 inhibitor provides significant protection against PIH
and should be further evaluated in clinical studies.
072
Perils of polypharmacy: Combination of statin and rosiglitazone generates paradoxical hyper-
inflammation and tissue destruction
BW Doreian, J Rosenjack, KD Cooper and KQ Lu Dermatology, Case Western Reserve
University, Cleveland, OH
Medications often have beneficial off-target effects that are exploited in clinical use. Our lab has
demonstrated that in contrast to the potential beneficial anti-inflammatory properties of the PPAR-
γ agonist rosiglitazone, its presence in the absence of IL-6 paradoxically drives macrophages to
express super-elevated levels of iNOS resulting in tissue destruction and delayed wound healing.
We were interested in investigating the interaction of statins with rosiglitazone, because statins have
been shown to reduce IL-6 and clinically, these medications are often co-prescribed in type II dia-
betics for cardiovascular disease prevention. We hypothesized that this combination would gener-
ate a paradoxical hyper-inflammatory response in vitro, and result in tissue destruction and delay
wound healing in vivo. Here we show that LPS stimulation of macrophages pre-treated with mev-
astatin and rosiglitazone results in a 18.3-fold increase in iNOS expression compared to LPS alone
(n=3, p=0.002). In vivo studies demonstrate that i.p. injection of mevastatin to mice prior to wound-
ing, followed by daily topical rosiglitazone administration, results in tissue destruction and a nine
day delay in wound healing (n=3). We hypothesized that the mechanism of increased iNOS fol-
lowing treatment is due to a decreased ability of STAT3 to transrepress NF-κB activity in the nucleus,
resulting in unregulated iNOS expression. LPS stimulation of statin and rosiglitazone pretreated
macrophages results in upregulation of SOCS3 in the cytoplasm followed by a decrease in STAT3
with a concomitant increase in NF-κB accumulation in the nucleus (n=2). In summary, we demon-
strate that the presence of two medications with known anti-inflammatory properties, rosiglitazone
and mevastatin, results in a paradoxical increase in inflammation and a tissue destructive pheno-
type. These findings have clinical implications due to the common combined use of these classes
of drugs and current controversies surrounding deleterious side affects in patients treated with
these medications.
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Absence of myeloid derived suppressor cells and activation of tumor blood vessels may under-
lie regression of keratoacanthomas
WJ Crisler, A Gehad, CD Schmults, MK Lichtman, JE Teague, R Watanabe, M Dowlatshahi,
TS Kupper and RA Clark Department of Dermatology, Brigham and Women’s Hospital, Boston,
MA
Keratoacanthomas (KA) are a clinical, histologically indistinguishable subset of cutaneous squa-
mous cell carcinomas (SCC) that grow rapidly but spontaneously regress. We found previously that
blood vessels in SCC lack expression of the T cell homing addressin E-selectin and fail to recruit
CLA+ skin homing T cells, the subset expected to contain tumor specific T cells. Topical treatment
with TLR7 agonist imiquimod up-regulates vascular E-selectin, induces influx of CLA+ T cells and
can induce tumor regression. We report here that KA differ from other SCC in that a significant
number of KA tumor vessels express E-selectin. 41% of blood vessels in KA expressed E-selectin,
compared with 6.7% in untreated SCC and 34% in imiquimod treated SCC undergoing immuno-
logic destruction. Correspondingly, >50% of T cells in KA expressed CLA, compared with 13% in
untreated SCC. TUNEL staining confirmed increased tumor cell death in KA. We recently reported
that untreated SCC are infiltrated by iNOS+ myeloid derived suppressor cells (MDSC) and that nitric
oxide (NO) produced by these cells likely suppresses vascular E-selectin expression. We observed
a striking absence of iNOS+ MDSC in KA. KA contained mean 3.1 iNOS+ MDSC per 200X field as
compared to 75 iNOS+ MDSC/200X field in untreated SCC. In summary, we find that KA lack NO-
producing MDSC, have up-regulation of vascular E-selectin expression, are infiltrated by CLA+ T
cells and show evidence of increased tumor cell death. In short, KA are remarkably similar to
imiquimod-treated SCC undergoing immunologic destruction. Our findings suggest regression of
KA may be immunologically mediated and that critical differences between KA and SCC are the
presence of NO-producing MDSC and endothelial activation of tumor vessels. Agents that block
MDSC recruitment to tumors, inhibit nitric oxide production and enhance vascular E-selectin expres-
sion may have efficacy in the treatment of cutaneous SCC.
075
The PPARγ paradox: Cellular mechanism regulating hyper-inflammatory macrophage gener-
ation
J Rosenjack,1 BW Doreian,1 M Cathcart,2 RL Silverstein,2 KD Cooper1 and KQ Lu1,2 1
Dermatology, Case Western Reserve University, Cleveland, OH and 2 Cell Biology, CCF,
Cleveland, OH
Our lab has generated a hyper-inflammatory macrophage through PPARγ activation in the absence
of IL-6 resulting in massive skin damage and delayed wound healing. These macrophages express
high levels of iNOS and TNF-α in skin and other organ models. We hypothesized that in our exper-
imental condition, PPARγ agonist induction of SOCS3 inhibits STAT3 activation, resulting in unreg-
ulated NFκB-mediated iNOS expression. We show that PPARγ agonist treatment of IL-6-/-
macrophages stimulated with LPS results in increased cytoplasmic SOCS3 protein at 15 minutes
and a subsequent decrease of nuclear STAT3 with concomitant increase in nuclear NFκB at 60
minutes (n=3). Under these treatment conditions, we observe a 45-fold increase of iNOS mRNA
expression (n=4, P<0.01). To evaluate the role of SOCS3 in our experimental condition, we trans-
fected IL-6-/- macrophages with a SOCS3 antisense oligonucleotide. SOCS3 antisense treatment
results in decreased cytoplasmic SOCS3 protein at 15 minutes with associated increase of nuclear
STAT3 protein at 60 minutes (n=3). Consistent with the hypothesis, inhibiting SOCS3 results in a
32% reduction of iNOS mRNA expression following LPS stimulation in PPARγ agonist treated
macrophages (n=1). Given these findings, we wanted to determine whether antagonizing STAT3
alone is sufficient to drive iNOS expression in the absence of a PPARγ agonist. IL-6-/- macrophages
were transfected with a STAT3 decoy, an oligonucleotide with the specific binding sequence for
STAT3. We observe that disruption of nuclear STAT3 accumulation results in a 49-fold increase of
iNOS mRNA expression following LPS stimulation independent of PPARγ activation (n=3, P<0.05).
Our data demonstrate that the key mechanism of PPARγagonist hyper-induction of iNOS in
macrophages is via SOCS3 mediated decrease of STAT3 transrepression of NFκB activity. There-
fore, precaution should be used clinically when administering PPARγ agonists as they may gener-
ate paradoxical inflammation by altering the balance of STAT3 and NFκB.
077
Non-calcemic natural vitamin D analogue, 20(OH)D3, protects mice from bleomycin induced
scleroderma
AE Postlethwaite,1,2 W Li,1 J Chen,1 DD Miller,1 W Gu,1 Y Jiao1 and A Slominski1 1 University of
Tennessee Health Science Center, Memphis, TN and 2 VA Medical Center, Memphis, TN
The purpose of the present study is to assess anti-fibrotic effects of a novel vitamin D analogue. 1α,
25-dihydroxyvitamin D3 [1,25(OH)2 D3] regulates calcium homeostasis and bone remodeling. It is
also known to inhibit collagen synthesis by some types of fibroblasts, has been shown to inhibit
interstitial fibrosis in a renal model and may improve bone marrow fibrosis in patients with myelofi-
brosis. Use of 1,25(OH)2 D3 as a therapeutic anti-fibrotic agent is limited by its inherent ability to
induce hypercalcemia. Recently our group identified a novel secosteroid, 20(OH)D3, that does not
induce calcemia. We found that 1,25(OH)2 D3 and 20(OH)D3 at 10
-10 and 10-9 M significantly inhib-
ited (from ≥ 90%) total collagen and hyaluronan synthesis by cultured human dermal fibroblasts
stimulated with TGF-β1 (5 ng/ml) with no cytotoxic. In the present study we administered 20(OH)D3
or sesame oil i.p. daily for 21 days at a dose of 3 μg/kg to C57BL/6 mice receiving subcutaneous
injection of bleomycin to induce localized dermal fibrosis, a standard murine model of scleroderma.
At day 22 mice were euthanized and skin obtained for histology and quantitation of total collagen
content using a Sicrcoll Collagen Assay. 20(OH)D3 treatment of mice led to marked significant
(p=0.019) reduction in total collagen content (ng/mg of tissue) of skin to compared to sesame oil
vehicle treated mice that approached collagen content of bleomycin vehicle control
(576±70=20(OH)D3 + Bleomycin; 1326±236=sesame oil + Bleomycin; 503±85=sesame oil + saline.
Furthermore, 20(OH)D3 inhibited type I collagen synthesis by scleroderma and normal donor skin
fibroblasts cultured with TGF-β1 as well as Col1A1 mRNA. In conclusion, these data suggest that
20(OH)D3 identified by us with no hypercalcemic property retains the anti-fibrotic properties of
1,25(OH)2 D3 in vivo in a scleroderma mouse model and in vitro in cultured scleroderma and nor-
mal fibroblasts.
076
Histone deacetylase activity is required for skin Langerhans cell homeostasis and function
R Qi,1,2,3 M Liu,1,2 X Gao,3 H Chen,3 L Zhou1,2 and Q Mi1,2 1 Immunology Program, Henry Ford
Health System, Detroit, MI, 2 Dept of Dermatology, Henry Ford Health System, Detroit, MI
and 3 Dept of Dermatology, No. 1 Hospital of China Medical University, Shengyang, China.,
Shenyang, China
Langerhans cells (LCs) are skin-resident DCs that express the C-type lectin Langerin and have a life
cycle distinct from many other types of DCs. Even though LCs were first described more than 100
years ago, their development and immunological functions still remain enigmatic. Histone acety-
lation plays key roles in modulating chromatin structure. Histone deacetylases (HDACs) induce the
hypoacetylation of histone and regulate gene transcription and epigenetic integrity. Recent studies
suggest that HDAC inhibitors suppress the bone marrow-derived dendritic cells differentiation,
maturation and functions, which may be involved in the anti-inflammatory effects mediated by
HDAC inhibitors. Here we tested if HDACs are involved in skin LC homeostasis and function. Epi-
dermal cell suspensions prepared from C57BL/6 mice were treated with different doses of HDAC
inhibitor trichostatin A (TSA) from 6.125nM to 200nM for 48 or 72 hours. We found that the per-
centage of epidermal LCs was dramatically reduced in TSA-treated epidermal cells in a time and
dose dependent manner. TSA significantly increased LC apoptosis. Furthermore, TSA-treated LCs
have defects on their maturation and antigen uptaking. Thus, our findings highly suggest that his-
tone deacetylase activity is required for skin Langerhans cell homeostasis and function.
074
Comparing the effects of 9-cis UAB30, a novel rexinoid, and bexarotene on the rates of pro-
liferation and apoptosis in human cutaneous T-cell lymphoma cell lines
Z Verney,1 V Attigada,2 C Elmets,1,5 D Muccio,2 C Grubbs3,5 and P Chang1,4,5 1 Dermatology,
UAB, Birmingham, AL, 2 Chemistry, UAB, Birmingham, AL, 3 Surgery, UAB, Birmingham, AL,
4 Nutrition Sciences, UAB, Birmingham, AL and 5 Comprehensive Cancer Center, UAB,
Birmingham, AL
Cutaneous T-cell lymphoma (CTCL) represent a heterogeneous group of malignancies, character-
ized by the infiltration and detection of transformed T-cell lymphocytes in the skin. Although there
is no cure for CTCL, a wide range of treatment options have been developed for use in the clinical
setting. Bexarotene, a retinoid X receptor (RXR) agonist or rexinoid, is a commonly used treatment
modality for CTCL. However, documented increases in the levels of triglycerides of CTCL patients,
resulting from treatment with bexarotene, point to concerns over the long-term use and efficacy of
this anti-cancer agent. We have recently synthesized a novel rexinoid, 9-cis UAB30, which does
not elevate triglycerides in vivo and have begun evaluating its use as a potential chemotherapeutic
agent for the treatment of CTCL. In this study, we compared the efficacy of 9-cis UAB30 to that of
bexarotene in reducing cell proliferation and inducing apoptosis, in the three human CTCL cell lines
HH, MJ, and Hut78. A standard XTT assay was used to determine the rate of cell proliferation of
CTCL cells. In all three lines, 9-cis UAB30 was equally and sometimes more effective than bexarotene
at suppressing cell proliferation. We next analyzed the rate of apoptosis in these human CTCL
lines, using an annexin V binding assay. Interestingly, the MJ cell line was found to be resistant to
apoptosis, when treated with either compound. The other two cell lines, however, displayed a greater
increase in their rate of apoptosis, when treated with 9-cis UAB30, as compared to bexarotene.
Collectively, these results indicate that 9-cis UAB30 appears to be equally if not more effective than
bexarotene at suppressing cell proliferation and/or enhancing apoptosis of human CTCL cells. There-
fore, 9-cis UAB30 may be a better alternative for the treatment of CTCL.
078
Automated detection and tracking of inflammatory acne lesions through digital imaging
GO Cula, PR Bargo and N Kollias Measurement Sciences, Johnson & Johnson Consumer
Companies, Skillman, NJ
It is known that effectiveness of acne treatment increases when the lesions are detected earlier, before
they progress into mature wound-like lesions, which lead to scarring and discoloration. However,
little is known about the evolution of acne from early signs until after the lesion heals. In this work
we computationally characterize the evolution of inflammatory acne lesions, based on analyzing
cross-polarized images that document acne-prone facial skin over time. Taking skin images over
time, and being able to follow skin features in these images present serious challenges, due to change
in the appearance of skin, difficulty in repositioning the subject, involuntary movement such as
breathing. A computational technique for automatic detection of lesions by separating the back-
ground normal skin from the acne lesions, based on fitting Gaussian distributions to the intensity
histograms, is presented. In order to track and quantify the evolution of lesions, in terms of the degree
of progress or regress, we designed a study to capture facial skin images from acne-prone young
individuals that were followed over time. Based on the behavior of the lesions between two con-
secutive time points, the automatically detected lesions are classified in four categories: new lesions,
resolved lesions (i.e. lesions that disappear completely), lesions that are progressing, and lesions
that are regressing (i.e. lesions in the process of healing). The classification our methods achieve
correlates well with visual inspection of a trained professional.
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6-Sulfo-LacNAc (Slan) dendritic cells in psoriasis lesions
KC Pierson, LM Johnson-Huang, T Lentini, J Fuentes-Duculan, I Novitskaya, JG Krueger and
MA Lowes Laboratory for Investigative Dermatology, Rockefeller University, New York, NY
Dendritic cells (DCs) are key antigen presenting cells that bridge innate and adaptive immunity. 6-
Sulfo-LacNAc (Slan), a novel carbohydrate modification of P selectin glycoprotein ligand-1 (PSGL-
1), identifies 0.5-1% of circulating white blood cells. Slan+ cells produce abundant TNF-α and IL-
12 on stimulation with LPS. Our group has described “inflammatory” DCs in psoriasis lesions, which
produce TNF and IL-23, and are phenotypically defined as CD11c+/CD1c-. The identification of
these SlanDC+ cells in the blood raised the intriguing possibility that these cells are precursors of
inflammatory DCs in skin lesions of psoriasis, and slanDC could be a positive marker of inflam-
matory DCs in situ. SlanDCs in the skin of psoriasis patients were characterized by immunohisto-
chemistry and immunofluorescence of frozen sections using the M-DC8/DD1 clone (Miltenyi).
SlanDC+ cells were increased in psoriasis lesions (p<0.05), and showed (non-significant) reduction
with both efalizumab (Raptiva, Genentech, anti-CD11a, n=7) and narrow-band ultraviolet radia-
tion B (NB-UVB, n=11) treatment. SlanDC+ cells were also increased in patients who experienced
a relapse on ceasing efalizumab (p<0.05). However, SlanDC+ cells were less than 10% of CD11c+
cells in psoriasis lesions, which is the classic interstitial pan-myeloid DC marker in humans. Although
circulating SlanDC+ cells expressed CD11c and HLA-DR by FACS, slanDC+ cells in situ demon-
strated minimal co-expression of CD11c, no HLA-DR co-localization, and only occasional cells
were positive for CD68 by two-color immunofluorescence. There was no co-expression of SlanDC
with other inflammatory DC markers in psoriasis lesions, including TNF, TRAIL and iNOS. Thus
while the commercially available SlanDC antibody identified a small number of cells in lesional
psoriasis skin that were increased compared to non-lesional skin, SlanDC+ cells in situ did not co-
express abundant classic or inflammatory DC markers.
068
Cytokine-specific gene expression signatures identify high signaling by IL-17, TNF and IFN in
lesional psoriatic skin and frequent underlying IL-17 signaling in non-lesional psoriatic skin
H Rand, K Kerkof, J Bigler, M Timour, A Welcher, Y Zhang, J Towne, DA Martin and CB Russell
Amgen, Inc., Seattle, WA
Many cytokine responsive genes are variably induced in psoriatic lesional (PLS) and non-lesional
(PNL) skin, and we chose to investigate this range of expression on the level of individual skin sam-
ples. Keratinocytes were stimulated in vitro with TNFα, IFNγ, or IL-17A, to generate initial sets con-
taining genes responsive to each cytokine with minimal effects from the others. Using expression
profiles from skin samples, these sets were further refined into signatures of 12 to 30 genes that pro-
vide a coherent summary measure resistant to experimental or minor biological noise. By charac-
terizing individual samples in terms of these components, we quantified important differences
between PLS (N=50), PNL (N=50), and healthy normal (HN, N=30) skin, as well as inter-person dif-
ferences. PLS skin had high scores for all three cytokines, with the IL-17 score consistently in a nar-
row range well separated from the low values seen in most HN skin. TNF and IFN scores were also
elevated in PLS samples compared to HN, but with less statistical separation than observed for the
IL-17 scores. Repeat PLS biopsies (N=5, 3 biopsies each over 2 to 6 weeks) maintained consistent
TNF and IFN scores for each subject within the broader distribution of scores in the PLS samples,
suggesting some individual stability in the level of signaling for these two cytokines. Remarkably,
approximately half the PNL skin samples had elevated IL-17 scores distributed across the range
between the HN and PLS values, while IFN and TNF scores remained in the HN range. IFN, IL-17,
and TNF scores were always elevated in untreated PLS skin and pathway specific decreases were
observed in individual lesional samples following therapeutic interventions. This analysis of HN,
PNL, and PLS skin on a sample-by-sample basis supports the existence of a stable positive-feed-
back loop involving IFN, TNF, and IL-17 in psoriatic lesions, and illustrates a unique role for IL-17
signaling in both lesional and non-lesional skin.
069
Mechanistic studies on novel anti-inflammatory molecule used in the treatment of facial red-
ness
S Sonti,1 R Mehta1 and R Holtz2 1 R&D, SkinMedica, Inc, Carlsbad, CA and 2 BioInnovations
Lab, Inc, Lakewood, CO
Facial redness is a common problem in both medical and surgical dermatology. 4-ethoxyben-
zaldehyde (4-EB, Calmplex TM), a novel anti-inflammatory molecule, has been shown to signifi-
cantly reduce redness in 3 separate clinical trials. Prostaglandin E2 (PGE2) signaling is essential in
producing keratinocyte mediated acute inflammation and vasodilation after UV exposure, a key fac-
tor in the pathophysiology of visible redness. The purpose of this study was to better understand the
role of 4-EB in the modulation of the arachidonic acid pathway and prostaglandin production. In
this in vitro study, human keratinoctyes were first irradiated with UVB to induce prostaglandin syn-
thesis and then treated with different concentrations (0.2μM-200μM) of 4-EB for 24 hours.
Indomethacin, a known anti-inflammatory agent and PGE2 inhibitor, was used a positive control
in all experiments. After the treatment period, the keratinocyte cell culture supernatant was assayed
for prostaglandin levels (PGI2, PGE2 and PGF2α) using ELISAs while changes in the number of
viable cells was determined using an MTT assay. The results demonstrate that 4-EB is a strong inhibitor
of UV-induced PGE2 and PGF2 and this inhibition was dose-dependent. Since the cyclooxygenase
(COX-1/COX-2) enzyme catalyzes the important initial conversion of arachidonic acid and begins
the process of prostaglandin synthesis, we also studied the effect of this test article on COX activ-
ity. The effect of 4-EB (0.2 μM-500μM) on COX activity was conducted using a purified enzyme
model. 4-EB showed no inhibition of either COX-1 or COX-2 enzyme at all concentrations tested.
These results suggest that the anti-inflammatory role of 4-EB is mediated by inhibition of PGE2
independent of COX activity. In conclusion, data from this study points to the PGE2 inhibitory
activity as a mechanism by which 4-EB treatment causes a significant reduction in facial redness.
This mechanism of action points to further applications in other PGE2 mediated conditions such as
post-inflammatory hyperpigmentation.
070
IgA and IgE anti-basement membrane antibodies together cause greater inflammation than
either alone in a SCID mouse passive transfer model of Linear IgA Bullous Dermatosis (LABD)
LJ Meyer,1,2 TB Taylor,1,2 LA Schmidt,1,2 CM Hull2 and JJ Zone2 1 VAHCS, Salt Lake City, UT and
2 Dermatology, University of Utah, Salt Lake City, UT
Many immune responses have multiple classes of antibodies. Although IgG is the predominant
antibody in bullous pemphigoid, IgE is realized to play a role in the urticarial phase and in eosinophil
infiltration. We sought to examine the effect of IgE alone and with IgA in a human skin xenograft
SCID mouse model of LABD. Monoclonal IgA antibody to LABD-97 was administered by the back-
pack technique. IgE was given as 2 mg per injection. When both antibodies were given together,
the first IgE injection was on day 9, 3 days prior to a visible tumor, with additional injections on
days 10, 11, 12 and 14. Biopsies were done on day 12 and the mice were sacrificed on day 16. Ten
mice received both IgA and IgE antibodies, and five were given each class separately. Overall, a
combination of the antibody classes caused more significant inflammation and resulted in more
uniform blister formation than either antibody alone. All human skin grafts demonstrated positive
immunofluorescence for the administered antibodies. However, IgE was present at day 12 but absent
at day 16 from 3 of 10 grafts given both antibodies, presumably due to inflammation. Blisters had
formed by day 12 in 4 of 10 IgA and IgE mice and in all 10 at day 16, but in only 3 of 5 IgE mice,
and 2 of 5 given IgA. Cellular infiltration was similar, with all 10 grafts given IgA and IgE showing
both neutrophil and eosinophil infiltration at both 12 and 16 days. IgE mice demonstrated neu-
trophils and eosinophils in 4 of 5 and 5 of 5 at days 12 and 16 respectively. IgA mice demonstrated
neutrophils in 2 of 5 and 3 of 5 at days 12 and 16, and eosinophils in 1 of 5 and 3 of 5 at days 12
and 16. Degranulated eosinophils were observed in all mice given IgE, and all blistered mice had
degranulated neutrophils. We conclude that there is synergy of IgE with IgA to increase inflamma-
tion and blistering in this model system. A search for presence of IgE in LABD and other immunob-
ullous diseases is warranted.
071
Prevention of post-inflammatory hyperpigmentation with a novel anti-inflammatory combi-
nation product
E Ho, R Mehta and S Sonti R&D, SkinMedica, Inc, Carlsbad, CA, CA
Chemical mediators released in the inflammatory process have considerable influence on melano-
genesis. Several pathways leading to post-inflammatory hyperpigmentation (PIH) have been iden-
tified including UV mediated increase in the levels of prostaglandin E2 (PGE2). 4-ethoxybenzalde-
hyde (4-EB, Calmplex TM), a novel anti-inflammatory agent that inhibits PGE2, was combined with
a melanosomes transfer inhibitor (niacinamide) to evaluate its effect on prevention of PIH after UV
mediated inflammation. An antioxidant combination product with Vitamin C, E and Ferulic acid
(CEF product) was used as a control. 17 healthy female subjects, aged 26-63 years with Fitzpatrick
Skin Types III-IV completed a single-center, double-blinded comparison study. At baseline, test areas
were marked onto the backs of the subjects and randomized as treatment or control sites. The min-
imal erythemal dose (MED) for each subject was determined using a solar simulator (UVB: 290-
320 nm, UVA: 320-400nm). 30μL of each test product were applied to the respective test sites by
the study staff, once daily, for 4 days. On Day 5, test sites were irradiated with 1.0, 1.5, 2.0, and
2.5 MEDs. Application of test products resumed on Day 6 through 19. Standardized digital photo-
graphs were taken of the test sites on Days 6 and 20 (end of study visit). The images were analyzed
using a computer-aided colorimetry algorithm, according to the CIE color standard, to determine
a* (degree of redness) and L* (brightness) at Days 6 and 20. At day 6, both 4-EB product and CEF
product showed a statistically significant change in a* (P=0.01) and L* (P<0.001) when compared
to untreated control, demonstrating prevention of initial UV mediated damage. At Day 20, 4-EB
product continued to show significantly higher L* (P<0.001) compared to untreated control. 4-EB
product also showed a 3-fold significantly greater L* than CEF product (P<0.0001). The results
demonstrated that a product containing PGE2 inhibitor provides significant protection against PIH
and should be further evaluated in clinical studies.
072
Perils of polypharmacy: Combination of statin and rosiglitazone generates paradoxical hyper-
inflammation and tissue destruction
BW Doreian, J Rosenjack, KD Cooper and KQ Lu Dermatology, Case Western Reserve
University, Cleveland, OH
Medications often have beneficial off-target effects that are exploited in clinical use. Our lab has
demonstrated that in contrast to the potential beneficial anti-inflammatory properties of the PPAR-
γ agonist rosiglitazone, its presence in the absence of IL-6 paradoxically drives macrophages to
express super-elevated levels of iNOS resulting in tissue destruction and delayed wound healing.
We were interested in investigating the interaction of statins with rosiglitazone, because statins have
been shown to reduce IL-6 and clinically, these medications are often co-prescribed in type II dia-
betics for cardiovascular disease prevention. We hypothesized that this combination would gener-
ate a paradoxical hyper-inflammatory response in vitro, and result in tissue destruction and delay
wound healing in vivo. Here we show that LPS stimulation of macrophages pre-treated with mev-
astatin and rosiglitazone results in a 18.3-fold increase in iNOS expression compared to LPS alone
(n=3, p=0.002). In vivo studies demonstrate that i.p. injection of mevastatin to mice prior to wound-
ing, followed by daily topical rosiglitazone administration, results in tissue destruction and a nine
day delay in wound healing (n=3). We hypothesized that the mechanism of increased iNOS fol-
lowing treatment is due to a decreased ability of STAT3 to transrepress NF-κB activity in the nucleus,
resulting in unregulated iNOS expression. LPS stimulation of statin and rosiglitazone pretreated
macrophages results in upregulation of SOCS3 in the cytoplasm followed by a decrease in STAT3
with a concomitant increase in NF-κB accumulation in the nucleus (n=2). In summary, we demon-
strate that the presence of two medications with known anti-inflammatory properties, rosiglitazone
and mevastatin, results in a paradoxical increase in inflammation and a tissue destructive pheno-
type. These findings have clinical implications due to the common combined use of these classes
of drugs and current controversies surrounding deleterious side affects in patients treated with
these medications.
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The role of KLF4 in UVB-induced murine skin tumor development and its correlation with
cyclin D1, p53, and p21Waf1/Cip1 in epithelial tumors of the human skin
K Kim, S Youn and H Kim Dermatology, Hallym University Sacred Heart Hospital, Anyang,
Republic of Korea
The zinc finger-type transcriptional factor KLF4 is expressed in a variety of tissues including skin.
KLF4 can function as either a tumor suppressor or an oncogene, depending on the type of tissue in
which it is expressed, by modulating the expression of various factors. To understand the role of
KLF4 in human skin cancer and also to evaluate the expression of cyclin D1, p53, and p21Waf1/Cip1
in relation to the expression of KLF4, we evaluated the pattern of KLF4 expression during UVB-
induced skin tumor development in SKH-1 hairless mice and in human skin cancer. We also deter-
mined whether there are correlations between the expression of KLF4, cyclin D1, p53, and p21
and non-melanoma skin tumors. KLF4 expression was found in the basal layer of non-irradiated
control murine skin. Chronic UVB irradiation caused a progressive decrease in KLF4 expression,
which was substantially decreased in UVB-induced murine skin tumors. In human precancerous
lesions, KLF4 expression was maintained in 64.3% of Bowen’s disease samples and 90.0% of AK
samples. In contrast, KLF4 expression was significantly reduced in human cancer lesions (p=0.004).
A positive correlation was found between the expression of KLF4 and p21Waf1/Cip1 in AK, whereas
there was a negative correlation between the expression of cyclin D1 and p21Waf1/Cip1 in Bowen’s
disease. Thus, our results suggest that KLF4 may function as a tumor suppressor in the skin and that
the deregulated expression of KLF4 in the context of p21Waf1/Cip1 and cyclin D1 expression may
be involved in skin tumorigenesis.
087
Egln/PHD proteins and their role in control of hypoxia pathway in epidermal keratinocytes
L Weir, D Robertson, IM Leigh and AA Panteleyev Medical Sciences, University of Dundee,
Dundee, United Kingdom
HIF-dependent pathway is a pivotal component of hypoxia response and its deregulation is linked
to pathogenesis of skin cancer, psoriasis and chronic wounds. HIF activity is tightly regulated by
complex and still ill-characterised mechanisms among which prolyl hydroxylases (PHD) are possi-
bly the key players. Little is known about the regulation of HIF pathway in the epidermis. Using pri-
mary mouse and human N-TERT keratinocytes cultured in normoxic (ambient O2 level) and hypoxic
(1% O2) conditions we assessed expression of different PHDs coded by Egln genes and determined
their role in maintenance of HIF activity in the epidermis. Egln1 mRNA (coding for Phd2) was neg-
ligible at normoxia and showed moderate increase after 18h of exposure only. Phd2 protein level
was also low and not responsive to hypoxia. Egln2 mRNA (coding for PHD1) was always at the
limit of detection showing no response to low O2. Western blotting failed to detect positive signal
for PHD1 suggesting that it is not translated in epidermal keratinocytes. Neither Phd1 nor Phd2 were
detected in human N-TERT keratinocytes. Egln3 mRNA (coding for Phd3) was also very low under
normoxia but, in contrast to Egln1/2, was steadily and significantly (>30 fold) upregulated by hypoxia
reaching the levels comparable to B2M. Surprisingly, and again in contrast to Phd1/Phd2, the level
of Phd3 was high under hypoxia and under normoxia possibly due to the absence of Siah2 (a key
factor of Egln3 proteasomal degradation) in hypoxic and normoxic human keratinocytes. Thus, in
contrast to previous reports, we have found no inhibition of PHDs during acute stage of hypoxia.
This discrepancy may be accounted for by prevalence of Egln3 and lack of Siah2 in epidermal ker-
atinocytes as compared to other cell types. Our results identify Egln3/Phd3 as a key factor of HIF1/2α
stability in keratinocytes and highlight its specific role in downregulation of HIF activity in chronic
hypoxia. At the same time, high level of Phd3 in normoxic cells suggests as yet unknown hypoxia-
independent function for this protein in the epidermis.
089
Cell cycle mediates global DNA methylation in normal human keratinocytes
J Wille1 and JY Park2 1 Bioderm Technologies, Inc., Chesterfield, NJ and 2 Moffitt Cancer
Center, Tampa, FL
The 5-methylcytosine (5-MC) DNA content of murine embryonic fibroblasts arrested in G1 by four
growth conditions (Gc, Gn, Gd, and Gs) were hypermethylated relative to rapidly growing (RG)
fibroblasts. Normal human keratinocytes (NHK) arrested in G1 by suspension were hypermethy-
lated relative to RG cultures. Four RG cultures of epidermoid carcinoma cells (ECC) were hypomethy-
lated relative to RG NHK cultures, and two cultures (SCC25 and A431) were further hypomethy-
lated by SUS- induced arrest. Linear regression analyses established a positive linear correlation
between growth rate and 5-MC content for three murine fibroblasts lines, and a negative correla-
tion for both NHK and ECC lines.
088
Canonical polarity protein PKC iota/lambda regulates Shh signaling during hair follicle and
basal cell carcinoma growth
SX Atwood, M Li and AE Oro Program in Epithelial Biology, Stanford University School of
Medicine, Stanford, CA
Basal cell carcinoma (BCC) initiation and expansion requires high levels of Sonic hedgehog (Shh)
signaling. While smoothened inhibitors are effective, early tumor resistance illustrates the need for
additional downstream targets for therapy. Previously, we found that Missing-in-Metastasis (MIM),
a multi-domain scaffold protein that links membrane dynamics with the actin cytoskeleton, pro-
motes de novo hair follicle formation by regulating primary cilia formation and Shh responsiveness
at the basal body. How MIM mediates its effects remains poorly understood. Here we identify Pro-
tein Kinase C iota/lambda (aPKC) as a novel MIM effector. aPKC and its partners Par3, Par-6, and
Cdc42 colocalize at the basal body and form a complex with MIM in purified centrosomes. Genetic
knockdown using shRNA against MIM or aPKC, or pharmacological inhibition of aPKC, inhibits
proliferation and Shh signaling of the murine BCC cell line ASZ001. As aPKC functions to maintain
cellular polarity in epithelia and may indirectly influence primary cilia and Shh signaling, we used
nonpolar primary murine dermal cells to interrogate aPKC’s cilia-specific function. Surprisingly,
pharmacological inhibition of aPKC in dermal cells promotes cilia elongation and Shh signaling, a
phenotype reminiscent of actin-specific proteins. Accordingly, shRNA knockdown of downstream
aPKC effectors such as WASp mimic the aPKC phenotype. In addition, activation of aPKC inhibits
cilia and suppresses Shh signaling suggesting aPKC plays multiple tissue-specific roles. Consistent
with its role in regulating hedgehog signaling, application of topical aPKC inhibitors lengthens
murine anagen in vivo whereas activation of aPKC delays onset of anagen. These results demon-
strate polarity signaling is critical for Shh-mediated processes and suggest aPKC may be a new ther-
apeutic target for the treatment of BCCs.
086
The deacetylase SIRT1 regulates global genome nucleotide excision repair
M Ming,1 CR Shea,1 X Guo,2 X Li,2 K Soltani,1 W Han1 and Y He1 1 University of Chicago,
Chicago, IL and 2 NIEHS, Research Triangle Park, NC
Disruption of the nucleotide excision repair (NER) pathway by mutations can cause xeroderma pig-
mentosum, a syndrome predisposing affected individuals to development of skin cancer. The xero-
derma pigmentosum C (XPC) protein is essential for initiating global genome NER by recognizing
the DNA lesion and recruiting downstream factors. Here we show that inhibition of the deacety-
lase and longevity factor SIRT1 impairs global genome NER through suppressing the transcription
of XPC in a SIRT1 deacetylase-dependent manner. SIRT1 enhances XPC expression by reducing
AKT-dependent nuclear localization of the transcription repressor of XPC. Finally, we demonstrate
that SIRT1 levels are significantly reduced in human skin tumors from Caucasian patients, a popu-
lation at highest risk. These results suggest that SIRT1 acts as a tumor suppressor through its role in
DNA repair.
090
Differentially-expressed genes identified from patients with Langerhans Cell Histiocytosis
JL Selway,1 PM Seldon,2 P Harikumar,1 K Langlands1 and AC Chu1 1 The Clore Laboratory,
University of Buckingham, Buckingham, United Kingdom and 2 Imperial College London,
London, United Kingdom
Although Langerhans Cell Histiocytosis (LCH) is considered to be a malignant expansion of den-
dritic cells, both its aetiology and specific pathogenic mechanisms remain obscure. Using a com-
bination of suppressive subtraction hybridisation (SSH) and next-generation RNA sequencing tech-
nologies (RNAseq), we sought to profile gene expression patterns characteristic of single- and multi-site
disease. Transcriptional profiling was performed on RNA prepared from CD1a-enriched cells iso-
lated from a range of lesional biopsies (gum, dermis, abscess and scalp) and compared to a control
population of pooled normal cutaneous LCs. A number of genes were identified that show consis-
tent differential expression patterns in a range of LCH lesions, including ASS1, OLR1, OPN3 and
PLAP in addition to a range of as-yet unannotated transcripts. For example, ASS1 is an ATP-depend-
ent enzyme whose over-expression could lead to excess nitric oxide production and the initiation
of the inflammatory cytokine cascade characteristic of LCH. PLAP is a glycosylated membrane-
bound enzyme involved in inflammatory process, previously identified as a tumour marker. The
presence of PLAP in LCH cells could provide further evidence for the malignant nature of LCH. Dif-
ferential expression of candidate genes was confirmed using real-time PCR and colocalisation of
target genes with LC markers (including CD1a, CD207 and S100) in lesional biopsies by immuno-
fluorescence and confocal microscopy. The relative rarity and heterologous nature of LCH has made
molecular analysis difficult, but the increasing power of transcriptional profiling techniques prom-
ises to yield profound insights into disease processes. Our improved understanding of the mecha-
nisms of LCH development will facilitate improved diagnosis and management of this rare but dev-
astating disease.
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Sterol intermediates of cholesterol biosynthesis trigger an innate immune response in hair
follicle cells and in cicatricial alopecia
T Ganguly,1 SP Panicker,1 MC Consolo,1 AA Lattif,1 K Honda1,2 and P Karnik1,2 1 Dermatology,
Case Western Reserve Univ, Cleveland, OH and 2 Univ Hosp Case Med Ctr, Cleveland, OH
The signals that incite an inflammatory attack on hair follicles in primary cicatricial alopecia (PCA)
are currently unknown. The affected follicles in PCA fail to re-grow because of destructive inflam-
matory changes in the permanent portion of the hair follicle. It is not clear whether this inflamma-
tion is triggered by changes within the hair follicle (self-antigens) or by exogenous factors. Gene
expression profiling of lymphocytic and neutrophilic PCA revealed that the cholesterol biosynthe-
sis pathway is significantly decreased in PCA and is an early event in disease pathogenesis. Genes
that encode DHCR7 and EBP, post-squalene cholesterol biosynthesis enzymes, are significantly
decreased in all PCA samples. To understand the effects of decreased cholesterol biosynthesis, we
treated human hair follicle outer root sheath (HFORS) cells with the cholesterol biosynthesis inhibitor
BM15766 that targets DHCR7 and EBP enzymes. The inhibition of these enzymes in HFORS cells
caused the accumulation of cholesterol biosynthesis intermediates lathosterol and 7 - dehydroc-
holesterol (7-DHC). Treatment of HFORS cells with BM15766 or with 7-DHC triggered an inflam-
matory response with increased expression of innate immunity genes - TLRs, IFNα and NFkB. To
determine the in vivo effects of sterol intermediates on the hair follicle, we painted mouse skin with
BM15766 or with 7-DHC. Our data showed that mice treated with BM15766 or 7-DHC had hair
follicles that were arrested in telogen and failed to re-grow. Intriguingly, H&E staining of BM15766
or 7-DHC painted mice revealed an inflammatory cell infiltrate consisting of tissue macrophages
around the hair follicles. These data suggest that sterol intermediates generated within hair follicle
cells trigger the production of pro-inflammatory cytokines and thereby incite an inflammatory attack.
Our data provides the first direct evidence that PCA development involves autoimmune targeting
of hair follicle-generated lipid self-antigens.
080
The antidesmosomal autoantibody profile in fogo selvagem supports epitope spreading in dis-
ease pathogenesis 
G Flores,1 DA Culton,1 B Qaqish,2 M Maldonado,1 P Prisayanh,1 K James,1 V Aoki,3 G Hans,4
E Rivitti3 and LA Diaz1 1 Dermatology, University of North Carolina at Chapel Hill, Chapel Hill,
NC, 2 Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, 3 University
of Sao Paulo, Sao Paulo, Brazil and 4 University of Mato Grosso do Sul, Campo Grande, Brazil
In an effort to evaluate the Dsg1 restriction of the IgG response in Fogo Selvagem (FS) to desmoso-
mal antigens we tested sera from 3 cohorts: 101 FS patients from Limao Verde (LV), a highly endemic
population of FS, 106 normal individuals living in LV, and 106 normal individuals living in the US.
The recombinant ectodomains of desmoglein (Dsg) 1, Dsg2, Dsg3, Dsg4, desmocollin (Dsc) 1, Dsc2,
Dsc3 and E-cadherin (E-cadh) were expressed in the baculovirus, purified and tested for IgG reac-
tivity with the sera of the 3 cohorts by ELISA. The results were expressed as index value units and
ROC curves were determined for each antigen/antibody system to establish cutpoints. The cut-
points were set to give a specificity of 95% and low sensitivities. Sperman’s correlations were also
computed among the systems. Less than 5% of the US control group possess autoantibody reactiv-
ity against the 8 desmosomal antigens tested. Over 97% of the FS group recognized Dsg1, 38%
Dsg2, 41% Dsg3, 21% Dsg4, 43% Dsc1, 30% Dsc2, 16% Dsc3 and 50% recognized E-cadh. The
LV control group showed anti-Dsg1 autoantibodies in 42%, Dsg2 in 19%, Dsg3 in 14%, Dsg4 in
27%, Dsc1 in 31%, Dsc2 in 42%, Dsc3 in 13% and E-cadh in 57% respectively. Significant differ-
ences in antibody levels exist between the LV controls and US controls (p < 0.02) except for Dsc1.
Overall, the highest Sperman correlations among the 8 antigen/antibody systems are in LV normal
controls, followed by FS cases, and lowest in US controls. These findings suggest the existence of
chronic antigenic stimulation among normal controls living in endemic areas and raise the intrigu-
ing possibility that the initial cross-reactive epidermal antigen may be one other than Dsg1. The
autoimmune response may then undergo epitope spreading to involve Dsg1, leading to FS.
081
Soluble adenylyl cyclase is necessary for IL-22-dependent keratinocyte proliferation
A Vishwanath, L Levin, J Buck and J Zippin Weill Cornell Medical College, New York, NY
The pathogenesis of psoriasis has been a hotly debated topic for decades. Initial research focused
on a keratinocyte role in the disease; in fact, until the early 1980s, psoriasis was treated as a dis-
ease primarily of keratinocytes. Early work also suggested that second messenger signaling path-
ways, namely cAMP, were important, but a clear source or role for cAMP was never firmly estab-
lished. We study a distinct source of cAMP in mammalian cells called soluble adenylyl cyclase
(sAC). Unlike transmembrane adenylyl cyclases (tmACs), sAC is not responsive to G proteins, and
instead is regulated by calcium, bicarbonate ions, and ATP. In addition, sAC is present in the nucleus,
mitochondria, and cytoplasm. We previously published that sAC is normally present throughout
the cytoplasm in keratinocytes, but in psoriatic lesions, sAC is present in the nucleus and is associ-
ated with activated CREB protein. This suggested that sAC may be involved in psoriasis pathogen-
esis. We examined the role of sAC in keratinocyte proliferation downstream of the cytokine IL-22.
We measured cAMP production in human keratinocytes downstream of IL-22 in the presence and
absence of sAC inhibitors. To explore the role of sAC in vivo, we injected IL-22 into mouse ears and
measured acanthosis in the presence or absence of sAC inhibitor. In a human keratinocyte cell line,
IL-22 increased the cellular cAMP level in a dose-dependent manner, and this effect was completely
inhibited by KH7 (a specific inhibitor of sAC). Injection of IL-22 induces both acanthosis and parak-
eratosis in mouse ear skin, and KH7 after either co-injection or topical application blocked these
effects entirely. These data suggest that sAC activity is essential for IL-22-dependent cAMP produc-
tion and psoriasis-like pathogenesis in mouse skin.
082
Involvement of the EGFR in pemphigus vulgaris – an in vitro internalization study
MM Nordling-David,1 M Frušic-Zlotkin,1 B Michel2 and Y Milner1 1 Myers Skin Laboratory,
Department of Biological Chemistry, The Hebrew University of Jerusalem, Jerusalem, Israel
and 2 Beno Michel Inc., Cleveland, OH
Binding of pemphigus vulgaris immunoglobulins (PV-IgG) to the cell membrane antigens mobilizes
a number of membranal receptors, including EGFR followed by its downstream signaling effectors.
Since the activation of the EGFR is canonically associated with cell proliferation and survival, we
undertook to further investigate the role and fate of the EGFR in the overall process of cellular
“damage signaling” in PV. Activation of EGFR initiates a complex signaling cascade leading to its
rapid internalization. The internalized receptor can then either recycle back to the membrane or
undergo lysosomal degradation leading to both “positive and negative” effects on the signaling net-
work. Using fluorescence microscopy, we show that PV-IgG are able to induce internalization of
the receptor in A431 cells as soon as 40 min after treatment. Not all of the internalized EGFR is
found to be co-localized with early endosomes, suggesting that there are additional pathways for
PV-IgG-induced EGFR internalization. The observed internalization is followed by the reduction in
the amount of EGFR in cell membranes in adjacent cells, and by its complete disappearance from
the cell-cell separation points at the beginning of the lesion formation. These results are corrobo-
rated by immunoblotting experiments showing that PV-IgG treatment in skin in organ culture caused
an almost total degradation of the receptor by 24 hrs. However, in fluorescent studies, EGFR is seen
back in the cell membrane at longer time points. This recycling, observed in A431 cells, which
over-express EGFR, may be a cellular response to overcome a PV-IgG assault. In conclusion, our
data indicate that the aberrant survival signaling of EGFR, due to its internalization and degrada-
tion from the cell plasma membrane, is involved in the apoptotic/ acantholytic signaling pathway
in keratinocytes in response to PV-IgG binding to cell membrane antigens.
083
Spontaneous resolution of a unilesional primary cutaneous CD8+ CD30+ lymphoprolifera-
tive disorder
SW Carlson,1 CM Magro,2 P Porcu3 and HK Wong1 1 Dermatology, The Ohio State University
Medical Center, Columbus, OH, 2 Pathology and Laboratory Medicine, Weill Cornell Medical
College, New York, NY and 3 Hematology/Oncology, The Ohio State University Medical
Center, Columbus, OH
We present a rare case of a CD8+ CD30+ atypical lymphocytic infiltrate manifesting clinically as
a cutaneous ulcerated nodule which underwent spontaneous regression. A 78-year-old Caucasian
male presented with an ulcerated nodule on the anterior aspect of his left 4th digit, which he noticed
5-6 weeks prior to presentation. Over the initial 1-2 weeks, the nodule became larger and painful,
and subsequently ulcerated. He reported a similar but larger lesion on his right lip one year prior
which was treated with antibiotics and healed over 3-4 months. The patient denied any arthropod
assault, and denied contact with any farm animals. A skin biopsy revealed an atypical T-cell infil-
trate within the dermis with angiocentric accentuation. The cells were large histiocytoid-like appear-
ing cells with a vesicular nucleus, prominent macroeosinophilic nucleolation, and fairly abundant
cytoplasms, and stained with antibodies to CD2, CD3, CD5, CD8, CD30, and HLA-DR. There was
a diminution of CD7 staining, as well as CD4 loss. Approximately 1 month after presentation (2
months after initial symptoms), the ulcerated nodule resolved spontaneously without therapy. A vari-
ety of benign and malignant cutaneous conditions can express CD30. The diffuse infiltrate of malig-
nant-appearing cells and lack of viral cytopathic changes defied categorization as a reactive process,
and the patient was diagnosed with a primary cutaneous CD30+ lymphoproliferative disorder.
Although extremely rare, CD8+ primary cutaneous anaplastic large cell lymphoma (PCALCL) was
favored; given the possible recurrent nature of the lesions (considering the previous lesion described),
Type C lymphomatoid papulosis of the CD8 variant was also considered. A predilection for the fin-
gers may be common among CD8+ PCALCL.
084
Milk phospholipid’s protective effects against UV damage in skin equivalent models
Z Achay, C Dargitz, M Bingham, E Keeling and L Laiho California Polytechnic State University,
San Luis Obispo, CA
Exposure of skin tissue to UV radiation causes DNA photodamage, which may eventually lead to
mutations that induce skin carcinogenesis. In order to prevent replication of damaged DNA, the
protein p21 is overexpressed, thereby halting the cell cycle and allowing the cell to repair the dam-
age or undergo apoptosis. Preliminary work involving confocal reflectance and fluorescence
microscopy suggests that milk phospholipids may possess protective properties against UV dam-
age. This study aims to verify the protective effects of milk phospholipids by studying changes in
cell morphology, p21 expression, and apoptosis in tissue engineered epidermis after incubation with
milk phospholipids and subsequent UV-exposure. Tissues were divided into four treatment groups
consisting of: a control group with no UV and no milk phospholipid treatment, a group exposed to
UV alone, a group treated with milk phospholipids and UV, and a group incubated with milk phos-
pholipids alone. All groups were incubated for 24 hours after treatment. Tissues were then fixed,
processed, and embedded in paraffin. Histological sections were obtained and stained with hema-
toxylin and eosin. Additional tissue samples were used for double immunofluorescence staining
using Hoechst and p21 antibodies. Lastly, western blot was performed on whole tissue lysates. An
increase in p21 protein levels was inhibited in tissues treated with milk phospholipids prior to UV
exposure compared to the group treated with UV alone. Further observations with confocal
microscopy revealed hallmarks of apoptosis such as half-moon nuclei and apoptotic bodies (nuclear
fragmentation), which were predominantly seen in the groups exposed to UV alone, and which
diminished in tissues treated with milk phospholipids and UV. Upon initial inspection, we noted a
decrease in p21 levels in tissues treated with milk phospholipids and UV compared to tissues exposed
to UV alone. The number of cells showing markers of apoptosis also decreased with milk phos-
pholipid treatment.
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The role of KLF4 in UVB-induced murine skin tumor development and its correlation with
cyclin D1, p53, and p21Waf1/Cip1 in epithelial tumors of the human skin
K Kim, S Youn and H Kim Dermatology, Hallym University Sacred Heart Hospital, Anyang,
Republic of Korea
The zinc finger-type transcriptional factor KLF4 is expressed in a variety of tissues including skin.
KLF4 can function as either a tumor suppressor or an oncogene, depending on the type of tissue in
which it is expressed, by modulating the expression of various factors. To understand the role of
KLF4 in human skin cancer and also to evaluate the expression of cyclin D1, p53, and p21Waf1/Cip1
in relation to the expression of KLF4, we evaluated the pattern of KLF4 expression during UVB-
induced skin tumor development in SKH-1 hairless mice and in human skin cancer. We also deter-
mined whether there are correlations between the expression of KLF4, cyclin D1, p53, and p21
and non-melanoma skin tumors. KLF4 expression was found in the basal layer of non-irradiated
control murine skin. Chronic UVB irradiation caused a progressive decrease in KLF4 expression,
which was substantially decreased in UVB-induced murine skin tumors. In human precancerous
lesions, KLF4 expression was maintained in 64.3% of Bowen’s disease samples and 90.0% of AK
samples. In contrast, KLF4 expression was significantly reduced in human cancer lesions (p=0.004).
A positive correlation was found between the expression of KLF4 and p21Waf1/Cip1 in AK, whereas
there was a negative correlation between the expression of cyclin D1 and p21Waf1/Cip1 in Bowen’s
disease. Thus, our results suggest that KLF4 may function as a tumor suppressor in the skin and that
the deregulated expression of KLF4 in the context of p21Waf1/Cip1 and cyclin D1 expression may
be involved in skin tumorigenesis.
087
Egln/PHD proteins and their role in control of hypoxia pathway in epidermal keratinocytes
L Weir, D Robertson, IM Leigh and AA Panteleyev Medical Sciences, University of Dundee,
Dundee, United Kingdom
HIF-dependent pathway is a pivotal component of hypoxia response and its deregulation is linked
to pathogenesis of skin cancer, psoriasis and chronic wounds. HIF activity is tightly regulated by
complex and still ill-characterised mechanisms among which prolyl hydroxylases (PHD) are possi-
bly the key players. Little is known about the regulation of HIF pathway in the epidermis. Using pri-
mary mouse and human N-TERT keratinocytes cultured in normoxic (ambient O2 level) and hypoxic
(1% O2) conditions we assessed expression of different PHDs coded by Egln genes and determined
their role in maintenance of HIF activity in the epidermis. Egln1 mRNA (coding for Phd2) was neg-
ligible at normoxia and showed moderate increase after 18h of exposure only. Phd2 protein level
was also low and not responsive to hypoxia. Egln2 mRNA (coding for PHD1) was always at the
limit of detection showing no response to low O2. Western blotting failed to detect positive signal
for PHD1 suggesting that it is not translated in epidermal keratinocytes. Neither Phd1 nor Phd2 were
detected in human N-TERT keratinocytes. Egln3 mRNA (coding for Phd3) was also very low under
normoxia but, in contrast to Egln1/2, was steadily and significantly (>30 fold) upregulated by hypoxia
reaching the levels comparable to B2M. Surprisingly, and again in contrast to Phd1/Phd2, the level
of Phd3 was high under hypoxia and under normoxia possibly due to the absence of Siah2 (a key
factor of Egln3 proteasomal degradation) in hypoxic and normoxic human keratinocytes. Thus, in
contrast to previous reports, we have found no inhibition of PHDs during acute stage of hypoxia.
This discrepancy may be accounted for by prevalence of Egln3 and lack of Siah2 in epidermal ker-
atinocytes as compared to other cell types. Our results identify Egln3/Phd3 as a key factor of HIF1/2α
stability in keratinocytes and highlight its specific role in downregulation of HIF activity in chronic
hypoxia. At the same time, high level of Phd3 in normoxic cells suggests as yet unknown hypoxia-
independent function for this protein in the epidermis.
089
Cell cycle mediates global DNA methylation in normal human keratinocytes
J Wille1 and JY Park2 1 Bioderm Technologies, Inc., Chesterfield, NJ and 2 Moffitt Cancer
Center, Tampa, FL
The 5-methylcytosine (5-MC) DNA content of murine embryonic fibroblasts arrested in G1 by four
growth conditions (Gc, Gn, Gd, and Gs) were hypermethylated relative to rapidly growing (RG)
fibroblasts. Normal human keratinocytes (NHK) arrested in G1 by suspension were hypermethy-
lated relative to RG cultures. Four RG cultures of epidermoid carcinoma cells (ECC) were hypomethy-
lated relative to RG NHK cultures, and two cultures (SCC25 and A431) were further hypomethy-
lated by SUS- induced arrest. Linear regression analyses established a positive linear correlation
between growth rate and 5-MC content for three murine fibroblasts lines, and a negative correla-
tion for both NHK and ECC lines.
088
Canonical polarity protein PKC iota/lambda regulates Shh signaling during hair follicle and
basal cell carcinoma growth
SX Atwood, M Li and AE Oro Program in Epithelial Biology, Stanford University School of
Medicine, Stanford, CA
Basal cell carcinoma (BCC) initiation and expansion requires high levels of Sonic hedgehog (Shh)
signaling. While smoothened inhibitors are effective, early tumor resistance illustrates the need for
additional downstream targets for therapy. Previously, we found that Missing-in-Metastasis (MIM),
a multi-domain scaffold protein that links membrane dynamics with the actin cytoskeleton, pro-
motes de novo hair follicle formation by regulating primary cilia formation and Shh responsiveness
at the basal body. How MIM mediates its effects remains poorly understood. Here we identify Pro-
tein Kinase C iota/lambda (aPKC) as a novel MIM effector. aPKC and its partners Par3, Par-6, and
Cdc42 colocalize at the basal body and form a complex with MIM in purified centrosomes. Genetic
knockdown using shRNA against MIM or aPKC, or pharmacological inhibition of aPKC, inhibits
proliferation and Shh signaling of the murine BCC cell line ASZ001. As aPKC functions to maintain
cellular polarity in epithelia and may indirectly influence primary cilia and Shh signaling, we used
nonpolar primary murine dermal cells to interrogate aPKC’s cilia-specific function. Surprisingly,
pharmacological inhibition of aPKC in dermal cells promotes cilia elongation and Shh signaling, a
phenotype reminiscent of actin-specific proteins. Accordingly, shRNA knockdown of downstream
aPKC effectors such as WASp mimic the aPKC phenotype. In addition, activation of aPKC inhibits
cilia and suppresses Shh signaling suggesting aPKC plays multiple tissue-specific roles. Consistent
with its role in regulating hedgehog signaling, application of topical aPKC inhibitors lengthens
murine anagen in vivo whereas activation of aPKC delays onset of anagen. These results demon-
strate polarity signaling is critical for Shh-mediated processes and suggest aPKC may be a new ther-
apeutic target for the treatment of BCCs.
086
The deacetylase SIRT1 regulates global genome nucleotide excision repair
M Ming,1 CR Shea,1 X Guo,2 X Li,2 K Soltani,1 W Han1 and Y He1 1 University of Chicago,
Chicago, IL and 2 NIEHS, Research Triangle Park, NC
Disruption of the nucleotide excision repair (NER) pathway by mutations can cause xeroderma pig-
mentosum, a syndrome predisposing affected individuals to development of skin cancer. The xero-
derma pigmentosum C (XPC) protein is essential for initiating global genome NER by recognizing
the DNA lesion and recruiting downstream factors. Here we show that inhibition of the deacety-
lase and longevity factor SIRT1 impairs global genome NER through suppressing the transcription
of XPC in a SIRT1 deacetylase-dependent manner. SIRT1 enhances XPC expression by reducing
AKT-dependent nuclear localization of the transcription repressor of XPC. Finally, we demonstrate
that SIRT1 levels are significantly reduced in human skin tumors from Caucasian patients, a popu-
lation at highest risk. These results suggest that SIRT1 acts as a tumor suppressor through its role in
DNA repair.
090
Differentially-expressed genes identified from patients with Langerhans Cell Histiocytosis
JL Selway,1 PM Seldon,2 P Harikumar,1 K Langlands1 and AC Chu1 1 The Clore Laboratory,
University of Buckingham, Buckingham, United Kingdom and 2 Imperial College London,
London, United Kingdom
Although Langerhans Cell Histiocytosis (LCH) is considered to be a malignant expansion of den-
dritic cells, both its aetiology and specific pathogenic mechanisms remain obscure. Using a com-
bination of suppressive subtraction hybridisation (SSH) and next-generation RNA sequencing tech-
nologies (RNAseq), we sought to profile gene expression patterns characteristic of single- and multi-site
disease. Transcriptional profiling was performed on RNA prepared from CD1a-enriched cells iso-
lated from a range of lesional biopsies (gum, dermis, abscess and scalp) and compared to a control
population of pooled normal cutaneous LCs. A number of genes were identified that show consis-
tent differential expression patterns in a range of LCH lesions, including ASS1, OLR1, OPN3 and
PLAP in addition to a range of as-yet unannotated transcripts. For example, ASS1 is an ATP-depend-
ent enzyme whose over-expression could lead to excess nitric oxide production and the initiation
of the inflammatory cytokine cascade characteristic of LCH. PLAP is a glycosylated membrane-
bound enzyme involved in inflammatory process, previously identified as a tumour marker. The
presence of PLAP in LCH cells could provide further evidence for the malignant nature of LCH. Dif-
ferential expression of candidate genes was confirmed using real-time PCR and colocalisation of
target genes with LC markers (including CD1a, CD207 and S100) in lesional biopsies by immuno-
fluorescence and confocal microscopy. The relative rarity and heterologous nature of LCH has made
molecular analysis difficult, but the increasing power of transcriptional profiling techniques prom-
ises to yield profound insights into disease processes. Our improved understanding of the mecha-
nisms of LCH development will facilitate improved diagnosis and management of this rare but dev-
astating disease.
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Sterol intermediates of cholesterol biosynthesis trigger an innate immune response in hair
follicle cells and in cicatricial alopecia
T Ganguly,1 SP Panicker,1 MC Consolo,1 AA Lattif,1 K Honda1,2 and P Karnik1,2 1 Dermatology,
Case Western Reserve Univ, Cleveland, OH and 2 Univ Hosp Case Med Ctr, Cleveland, OH
The signals that incite an inflammatory attack on hair follicles in primary cicatricial alopecia (PCA)
are currently unknown. The affected follicles in PCA fail to re-grow because of destructive inflam-
matory changes in the permanent portion of the hair follicle. It is not clear whether this inflamma-
tion is triggered by changes within the hair follicle (self-antigens) or by exogenous factors. Gene
expression profiling of lymphocytic and neutrophilic PCA revealed that the cholesterol biosynthe-
sis pathway is significantly decreased in PCA and is an early event in disease pathogenesis. Genes
that encode DHCR7 and EBP, post-squalene cholesterol biosynthesis enzymes, are significantly
decreased in all PCA samples. To understand the effects of decreased cholesterol biosynthesis, we
treated human hair follicle outer root sheath (HFORS) cells with the cholesterol biosynthesis inhibitor
BM15766 that targets DHCR7 and EBP enzymes. The inhibition of these enzymes in HFORS cells
caused the accumulation of cholesterol biosynthesis intermediates lathosterol and 7 - dehydroc-
holesterol (7-DHC). Treatment of HFORS cells with BM15766 or with 7-DHC triggered an inflam-
matory response with increased expression of innate immunity genes - TLRs, IFNα and NFkB. To
determine the in vivo effects of sterol intermediates on the hair follicle, we painted mouse skin with
BM15766 or with 7-DHC. Our data showed that mice treated with BM15766 or 7-DHC had hair
follicles that were arrested in telogen and failed to re-grow. Intriguingly, H&E staining of BM15766
or 7-DHC painted mice revealed an inflammatory cell infiltrate consisting of tissue macrophages
around the hair follicles. These data suggest that sterol intermediates generated within hair follicle
cells trigger the production of pro-inflammatory cytokines and thereby incite an inflammatory attack.
Our data provides the first direct evidence that PCA development involves autoimmune targeting
of hair follicle-generated lipid self-antigens.
080
The antidesmosomal autoantibody profile in fogo selvagem supports epitope spreading in dis-
ease pathogenesis 
G Flores,1 DA Culton,1 B Qaqish,2 M Maldonado,1 P Prisayanh,1 K James,1 V Aoki,3 G Hans,4
E Rivitti3 and LA Diaz1 1 Dermatology, University of North Carolina at Chapel Hill, Chapel Hill,
NC, 2 Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, 3 University
of Sao Paulo, Sao Paulo, Brazil and 4 University of Mato Grosso do Sul, Campo Grande, Brazil
In an effort to evaluate the Dsg1 restriction of the IgG response in Fogo Selvagem (FS) to desmoso-
mal antigens we tested sera from 3 cohorts: 101 FS patients from Limao Verde (LV), a highly endemic
population of FS, 106 normal individuals living in LV, and 106 normal individuals living in the US.
The recombinant ectodomains of desmoglein (Dsg) 1, Dsg2, Dsg3, Dsg4, desmocollin (Dsc) 1, Dsc2,
Dsc3 and E-cadherin (E-cadh) were expressed in the baculovirus, purified and tested for IgG reac-
tivity with the sera of the 3 cohorts by ELISA. The results were expressed as index value units and
ROC curves were determined for each antigen/antibody system to establish cutpoints. The cut-
points were set to give a specificity of 95% and low sensitivities. Sperman’s correlations were also
computed among the systems. Less than 5% of the US control group possess autoantibody reactiv-
ity against the 8 desmosomal antigens tested. Over 97% of the FS group recognized Dsg1, 38%
Dsg2, 41% Dsg3, 21% Dsg4, 43% Dsc1, 30% Dsc2, 16% Dsc3 and 50% recognized E-cadh. The
LV control group showed anti-Dsg1 autoantibodies in 42%, Dsg2 in 19%, Dsg3 in 14%, Dsg4 in
27%, Dsc1 in 31%, Dsc2 in 42%, Dsc3 in 13% and E-cadh in 57% respectively. Significant differ-
ences in antibody levels exist between the LV controls and US controls (p < 0.02) except for Dsc1.
Overall, the highest Sperman correlations among the 8 antigen/antibody systems are in LV normal
controls, followed by FS cases, and lowest in US controls. These findings suggest the existence of
chronic antigenic stimulation among normal controls living in endemic areas and raise the intrigu-
ing possibility that the initial cross-reactive epidermal antigen may be one other than Dsg1. The
autoimmune response may then undergo epitope spreading to involve Dsg1, leading to FS.
081
Soluble adenylyl cyclase is necessary for IL-22-dependent keratinocyte proliferation
A Vishwanath, L Levin, J Buck and J Zippin Weill Cornell Medical College, New York, NY
The pathogenesis of psoriasis has been a hotly debated topic for decades. Initial research focused
on a keratinocyte role in the disease; in fact, until the early 1980s, psoriasis was treated as a dis-
ease primarily of keratinocytes. Early work also suggested that second messenger signaling path-
ways, namely cAMP, were important, but a clear source or role for cAMP was never firmly estab-
lished. We study a distinct source of cAMP in mammalian cells called soluble adenylyl cyclase
(sAC). Unlike transmembrane adenylyl cyclases (tmACs), sAC is not responsive to G proteins, and
instead is regulated by calcium, bicarbonate ions, and ATP. In addition, sAC is present in the nucleus,
mitochondria, and cytoplasm. We previously published that sAC is normally present throughout
the cytoplasm in keratinocytes, but in psoriatic lesions, sAC is present in the nucleus and is associ-
ated with activated CREB protein. This suggested that sAC may be involved in psoriasis pathogen-
esis. We examined the role of sAC in keratinocyte proliferation downstream of the cytokine IL-22.
We measured cAMP production in human keratinocytes downstream of IL-22 in the presence and
absence of sAC inhibitors. To explore the role of sAC in vivo, we injected IL-22 into mouse ears and
measured acanthosis in the presence or absence of sAC inhibitor. In a human keratinocyte cell line,
IL-22 increased the cellular cAMP level in a dose-dependent manner, and this effect was completely
inhibited by KH7 (a specific inhibitor of sAC). Injection of IL-22 induces both acanthosis and parak-
eratosis in mouse ear skin, and KH7 after either co-injection or topical application blocked these
effects entirely. These data suggest that sAC activity is essential for IL-22-dependent cAMP produc-
tion and psoriasis-like pathogenesis in mouse skin.
082
Involvement of the EGFR in pemphigus vulgaris – an in vitro internalization study
MM Nordling-David,1 M Frušic-Zlotkin,1 B Michel2 and Y Milner1 1 Myers Skin Laboratory,
Department of Biological Chemistry, The Hebrew University of Jerusalem, Jerusalem, Israel
and 2 Beno Michel Inc., Cleveland, OH
Binding of pemphigus vulgaris immunoglobulins (PV-IgG) to the cell membrane antigens mobilizes
a number of membranal receptors, including EGFR followed by its downstream signaling effectors.
Since the activation of the EGFR is canonically associated with cell proliferation and survival, we
undertook to further investigate the role and fate of the EGFR in the overall process of cellular
“damage signaling” in PV. Activation of EGFR initiates a complex signaling cascade leading to its
rapid internalization. The internalized receptor can then either recycle back to the membrane or
undergo lysosomal degradation leading to both “positive and negative” effects on the signaling net-
work. Using fluorescence microscopy, we show that PV-IgG are able to induce internalization of
the receptor in A431 cells as soon as 40 min after treatment. Not all of the internalized EGFR is
found to be co-localized with early endosomes, suggesting that there are additional pathways for
PV-IgG-induced EGFR internalization. The observed internalization is followed by the reduction in
the amount of EGFR in cell membranes in adjacent cells, and by its complete disappearance from
the cell-cell separation points at the beginning of the lesion formation. These results are corrobo-
rated by immunoblotting experiments showing that PV-IgG treatment in skin in organ culture caused
an almost total degradation of the receptor by 24 hrs. However, in fluorescent studies, EGFR is seen
back in the cell membrane at longer time points. This recycling, observed in A431 cells, which
over-express EGFR, may be a cellular response to overcome a PV-IgG assault. In conclusion, our
data indicate that the aberrant survival signaling of EGFR, due to its internalization and degrada-
tion from the cell plasma membrane, is involved in the apoptotic/ acantholytic signaling pathway
in keratinocytes in response to PV-IgG binding to cell membrane antigens.
083
Spontaneous resolution of a unilesional primary cutaneous CD8+ CD30+ lymphoprolifera-
tive disorder
SW Carlson,1 CM Magro,2 P Porcu3 and HK Wong1 1 Dermatology, The Ohio State University
Medical Center, Columbus, OH, 2 Pathology and Laboratory Medicine, Weill Cornell Medical
College, New York, NY and 3 Hematology/Oncology, The Ohio State University Medical
Center, Columbus, OH
We present a rare case of a CD8+ CD30+ atypical lymphocytic infiltrate manifesting clinically as
a cutaneous ulcerated nodule which underwent spontaneous regression. A 78-year-old Caucasian
male presented with an ulcerated nodule on the anterior aspect of his left 4th digit, which he noticed
5-6 weeks prior to presentation. Over the initial 1-2 weeks, the nodule became larger and painful,
and subsequently ulcerated. He reported a similar but larger lesion on his right lip one year prior
which was treated with antibiotics and healed over 3-4 months. The patient denied any arthropod
assault, and denied contact with any farm animals. A skin biopsy revealed an atypical T-cell infil-
trate within the dermis with angiocentric accentuation. The cells were large histiocytoid-like appear-
ing cells with a vesicular nucleus, prominent macroeosinophilic nucleolation, and fairly abundant
cytoplasms, and stained with antibodies to CD2, CD3, CD5, CD8, CD30, and HLA-DR. There was
a diminution of CD7 staining, as well as CD4 loss. Approximately 1 month after presentation (2
months after initial symptoms), the ulcerated nodule resolved spontaneously without therapy. A vari-
ety of benign and malignant cutaneous conditions can express CD30. The diffuse infiltrate of malig-
nant-appearing cells and lack of viral cytopathic changes defied categorization as a reactive process,
and the patient was diagnosed with a primary cutaneous CD30+ lymphoproliferative disorder.
Although extremely rare, CD8+ primary cutaneous anaplastic large cell lymphoma (PCALCL) was
favored; given the possible recurrent nature of the lesions (considering the previous lesion described),
Type C lymphomatoid papulosis of the CD8 variant was also considered. A predilection for the fin-
gers may be common among CD8+ PCALCL.
084
Milk phospholipid’s protective effects against UV damage in skin equivalent models
Z Achay, C Dargitz, M Bingham, E Keeling and L Laiho California Polytechnic State University,
San Luis Obispo, CA
Exposure of skin tissue to UV radiation causes DNA photodamage, which may eventually lead to
mutations that induce skin carcinogenesis. In order to prevent replication of damaged DNA, the
protein p21 is overexpressed, thereby halting the cell cycle and allowing the cell to repair the dam-
age or undergo apoptosis. Preliminary work involving confocal reflectance and fluorescence
microscopy suggests that milk phospholipids may possess protective properties against UV dam-
age. This study aims to verify the protective effects of milk phospholipids by studying changes in
cell morphology, p21 expression, and apoptosis in tissue engineered epidermis after incubation with
milk phospholipids and subsequent UV-exposure. Tissues were divided into four treatment groups
consisting of: a control group with no UV and no milk phospholipid treatment, a group exposed to
UV alone, a group treated with milk phospholipids and UV, and a group incubated with milk phos-
pholipids alone. All groups were incubated for 24 hours after treatment. Tissues were then fixed,
processed, and embedded in paraffin. Histological sections were obtained and stained with hema-
toxylin and eosin. Additional tissue samples were used for double immunofluorescence staining
using Hoechst and p21 antibodies. Lastly, western blot was performed on whole tissue lysates. An
increase in p21 protein levels was inhibited in tissues treated with milk phospholipids prior to UV
exposure compared to the group treated with UV alone. Further observations with confocal
microscopy revealed hallmarks of apoptosis such as half-moon nuclei and apoptotic bodies (nuclear
fragmentation), which were predominantly seen in the groups exposed to UV alone, and which
diminished in tissues treated with milk phospholipids and UV. Upon initial inspection, we noted a
decrease in p21 levels in tissues treated with milk phospholipids and UV compared to tissues exposed
to UV alone. The number of cells showing markers of apoptosis also decreased with milk phos-
pholipid treatment.
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Initiation with DMBA metabolite bypasses requirement for Langerhans cell in two-stage chem-
ical carcinogenesis
B Modi,1 J Lewis,1 R Filler,1 P Fu,2 L Cai,3 A Hayday4 and M Girardi1 1 Yale Univ., New Haven,
CT, 2 NCTR/FDA, Jefferson, AR, 3 Biotranex, Monmouth, NJ and 4 GKT, London, United
Kingdom
Polyaromatic hydrocarbons (PAH) are potent mutagens, and dimethyl-benza[a]anthracine (DMBA)
is a model PAH used to study carcinogenesis. DMBA metabolism yields intermediates such as DMBA
trans-3,4-diol (Dt34d) which, via epoxide hydrolase, cause the signature codon 61 mutation in Hras
gene. We previously demonstrated that mice deficient in Langerhans cells (LC) are resistant to two-
stage chemical carcinogenesis (DMBA/TPA). To assess LC’s ability to metabolize DMBA and exter-
nalize metabolite, we exposed LC line XS106 to DMBA and analyzed the media by liquid chro-
matography/tandem mass spectrometry. Dt34d was readily identified and quantified at a mean
concentration of 29.2nM in 32μM-DMBA-treated XS106 cell samples and 42.4nM in 64μM-DMBA-
treated samples. To investigate whether LC metabolism of DMBA is necessary for the tumor resist-
ance observed in LC-deficient (LC-def) mice, synthesized metabolite Dt34d was applied at either
high (hd) or low (ld) dose for use as the initiator in two-stage carcinogenesis of LC-def and LC-intact
mice. In contrast to the markedly reduced tumorigenesis observed in DMBA-treated LC-def skin
relative to LC-intact skin (hd: 2.8 ± 0.59 vs 22.2 ± 0.59, p<0.001; ld: 0.08 ± 0.08 vs 17.1 ± 2.93,
p<0.001), initiation with Dt34d produced comparable tumor development in the two groups (hd:
2.92 ± 0.53 vs 4.64 ± 0.95, NS; ld: 1.00 ± 0.41 vs 1.15 ± 0.32, NS). The facts that LC have the
capacity to metabolize DMBA to Dt34d, and initiation with Dt34d restores carcinogenesis in LC-
def skin, indicate that LC make substantial contributions to carcinogenesis through the processing
of DMBA, potentially also enhancing the local bioavailability of mutagens to the target basal ker-
atinocytes. These findings describe a novel role of LC in the early stages of PAH-induced tumor ini-
tiation and may have implications more generally for epithelial tumors that develop in the presence
of tissue-associated DC.
099
Topical tacrolimus treatment does not facilitate UV-induced carcinogenesis in a mouse model
T Shiga, M Yokogawa, M Tarutani and S Sano Dermatology, Kochi University, Nankoku, Japan
Tacrolimus, a calcineurin inhibitor, is an immunosuppressive drug mainly through down-regula-
tion of T cell activation. Topical application of tacrolimus is therapeutically effective on chronic
inflammatory skin diseases such as atopic dermatitis. However, there has been a concern about
increased risk of UV exposure-induced skin cancer facilitated by topical tacrolimus, because of its
potential suppression of anti-tumor immunity. The aim of this study was to examine whether topi-
cal tacrolimus treatment facilitated UV-induced carcinogenesis using K5.Stat3C mice. K5.Stat3C
mice expressed constitutively activated Stat3 in epidermis and therefore were prone to skin cancers,
induced by carcinogenesis regimen with UVB irradiation or the two-stage protocol of chemicals.
To verify immunosuppressive potential of tacrolimus, an experiment of contact hypersensitivy (CH)
by dinitrofluorobenzene (DNFB) was conducted. Four days after sensitization of DNFB in the back
skins of K5.Stat3C mice, DNFB was challenged onto the ear skins twice weekly, with or without
topical tacrolimus treatment. Tacrolimus significantly attenuated ear swelling and dermatitis devel-
opment induced by repeated DNFB application, indicating that tacrolimus ameliorated CH response
as expected. Also, tacrolimus treatment showed a marked reduction of ear swelling by high-dose
UVB irradiation, indicative of anti-inflammatory effect. Finally, K5.Stat3C mice were subjected to
UVB carcinogenesis regimen (three times weekly irradiation), which induced epidermal atypia
after 12 weeks and squamous cell carcinoma after 16 weeks. Immediately after every irradiation,
we topically treated them with tacrolimus or vehicle onto the right ears and left ears, respectively.
Histopathological examination revealed that there was no difference between the two groups in
the latent period of onset of epidermal atypia, cancer development or histological appearance. Taken
collectively, topical tacrolimus did not facilitate UVB-induced carcinogenesis, although it suppressed
CH response to hapten and acute skin inflammation by UVB irradiation.
101
MicroRNA profiles in cutaneous squamous cell carcinomas: A personalized medicine approach
KA Gordon, O Stojadinovic, S Choudhary, E Lebrun, S Jackson, K Nouri and M Tomic-Canic
Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of
Medicine, Miami, FL
Cutaneous squamous cell carcinoma (cSCC) is a malignant proliferation of keratinocytes with an
unknown molecular basis that causes significant morbidity. MicroRNAs (miRNAs) are small RNA
molecules of approximately 22 nucleotides (nt) that regulate gene expression through post-tran-
scriptional gene silencing. miRNAs are critical to various biological processes and hold great prom-
ise in the treatment of dermatologic diseases including skin cancer pathology. To determine if miR-
NAs play a role in pathogenesis of cSCC and further if specific miRNA molecules direct the
invasiveness of SCC, we collected patients’ specimens from in-situ SCC and invasive cSCC. In addi-
tion, we utilized adjacent, tumor- free control skin for each tumor. We examined miRNAs expres-
sion levels using quantitative PCR. We examined miRNA 21, miRNA 103a, miRNA 200b, miRNA
203, and miRNA 205 expressions because each of these miRNAs has shown promise in skin and
cancer pathology. miRNA levels were first compared to adjacent, tumor-free control skin of the same
patient and subsequently to healthy skin derived from reduction surgery as an additional control.
Then, we clustered expression profiles of each miRNA examined by the type of the tumor. Overall,
we found deregulation of miRNA expression in both in-situ and invasive cutaneous SCC. The major-
ity of miRNAs expressions demonstrated individual tumor specificity and profile. Interestingly, we
found that miRNA 21 was consistently upregulated in patients’ cSCC specimens, followed by an
upregulation of miRNA 205. We concluded that miRNA 21 and miRNA 205 may have diagnostic
value in determining the invasiveness of cSCCs. Furthermore, our data suggest that each individual
cSCC has unique miRNA profile underscoring the personalized medicine approach in developing
treatment modalities using specific anti-miRNAs (anatagomirs) and/or mimics.
100
Hyperstimulation of mitogen signal pathways is responsible for dysregulated Laminin-332
expression in premalignant keratinocytes and squamous cell carcinoma
M Degen, P Barron, H Widlund and JG Rheinwald Dermatology, Brigham and Women’s
Hospital, Boston, MA
The basement membrane beneath normal, unwounded epithelia is very stable. Consequently, nor-
mal basal keratinocytes do not express immunohistologically detectable amounts of the α3, β3, and
γ2 subunits of the trimeric basement membrane protein Laminin-332. In contrast, oral and epider-
mal squamous cell carcinomas (SCC) and many preinvasive epithelial dysplasias abnormally express
high levels of Laminin γ2. We have been able to investigate the mechanisms underlying this dys-
regulation in cell culture. Normal primary or TERT-immortalized human keratinocytes displayed
density-dependent repression of γ2 synthesis, whereas premalignant keratinocyte and SCC cell lines
continued to synthesize high levels of γ2 at confluence, resulting in secretion of the abnormal Laminin
β3γ2 dimer and γ2 monomer. Six SCC cell lines we examined expressed elevated levels of the EGF
receptor (EGFR), and EGFR kinase inhibitors blocked their high density γ2 expression. We next
sought to determine the effects of activating specific signaling proteins downstream of EGFR. When
the TERT-immortalized epidermal keratinocyte line N/TERT-1 was stably transduced to express con-
stitutively active, mutant forms of either H-ras, c-raf1, or MEK1, the cells lost the ability to repress
γ2 at confluence. Interestingly, normal keratinocytes engineered to express HPV16 E6 and E7 also
lost γ2 control. These cells proved to share with SCC cells, and with N/TERT-1/ras, /raf, and /MEK
transductants, EGFR downstream signaling abnormalities which included elevated levels of phos-
pho-S6. Thus, EGFR-MAPK signal pathway hyperstimulation is necessary and sufficient to dysregu-
late γ2 synthesis. These results identify γ2 dysregulation and mitogen signal pathway hyperactivity
as causally related, preinvasive events during neoplastic progression, providing the basis for find-
ing better diagnostic and prognostic markers to stage epithelial dysplasias and plan their treatment.
098
HGF transactivates keratinocyte EGFR signaling, potentiates the tumorigenic phenotype of
oncogenic ras-transduced keratinocytes in vitro and enhances skin carcinogenesis in vivo
F Liu,1,2 C Cataisson,1 R Zaidi,1 G Merlino1 and SH Yuspa1 1 Laboratory of Cancer Biology and
Genetics, National Cancer Institute, Bethesda, MD and 2 HHMI-NIH Research Scholar,
Howard Hughes Medical Institute, Chevy Chase, MD
To elucidate the role of keratinocyte-derived inflammation on skin cancers, a double transgenic
mouse model (HGF-PKCα or DT) was used. K5-PKCα mice – which overexpress PKCα in basal ker-
atinocytes and develop a strong neutrophilic cutaneous inflammatory response upon topical TPA
(12-tetradecanoylphorbol-13-acetate) application – were crossed with melanoma-prone MT1-
HGF mice – which overexpress HGF under a metallothionein promoter – to create HGF-PKCαmice
and their respective controls. While we previously reported the contribution of HGF and PKCα
driven epidermal inflammation on melanomagenesis in DT mice, we observed that DT animals
were very sensitive to squamous carcinogenesis. The low dose tumor promotion protocol used
yielded an average of 6 tumors per mouse in the DT group; single transgenic K5-PKCα or MT-HGF
mice developed an average of 1 tumor while WT developed none at this TPA dose. We hypothe-
size that in DT mice, keratinocyte-derived HGF synergizes with PKCα to drive tumor promotion
and increase tumor growth. Primary keratinocytes derived from HGF or DT mice display a pheno-
type reminiscent of EGFR activated cells: increased expression of pro-inflammatory factors, upreg-
ulation of Keratin 8 (K8) and downregulation of K1 and K10 mRNAs. Indeed western blot analysis
shows that EGFR is transactivated in HGF and DT keratinocytes but not PKCα or WT keratinocytes.
The release of CXCL1 is augmented in ras-keratinocyte cell culture supernatants with DT ras-ker-
atinocytes producing the most. Together these results suggest that the sensitivity of DT transgenic
skin to squamous tumor induction is associated with the ability of HGF to transactivate EGFR sig-
naling likely leading to enhanced growth of neoplastic clones.
102
Immunohistochemical Demonstration of Z-DNA in the Epidermal Cells of Human Melanoma
Tissue
K Beheshti,1 CE Gagna1,2,3 and W Lambert2,3 1 Life Sciences, New York Institute of Technology,
Old Westbury, NY, 2 Dermatology, New Jersey Medical School, Newark, NJ and 3 Pathology
& Laboratory Medicine, New Jersey Medical School, Newark, NJ
Several types of skin cancer exist and melanoma is the most serious type. In the United States each
year, more than 50,000 people are diagnosed with melanoma. Additionally, the occurrence of
melanoma has continued to increase over the past few decades. Genomics and proteomics must
be employed to find new target sites, and develop new classes of drugs that can be used to treat
and/or cure melanoma. Left-handed double-stranded (ds-) Z-DNA is an alternative form of the
more common right-handed ds-B-DNA. Z-DNA plays a role in gene expression, viz., RNA editing,
and transcriptional enhancement. We have immunohistochemically (i.e., anti-Z-DNA antibodies)
stained human melanoma tissue fixed in either Carnoy’s solution, or 10% neutral buffered forma-
lin (NBF) to identify the presence and distribution of Z-DNA. We have observed elevated amounts
of Z-DNA within the cells of the epidermis of human tissue with melanoma. Therefore, we believe
that Z-DNA exists within mutated genes (i.e., melanoma) and plays a role in the molecular biology
of this disease. Tissue fixed in 10% NBF required antigen retrieval for the demonstration of Z-DNA
immunohistochemistry. Microwave-based histotechnological processing has been used to reduce
damage to ds-DNA, for more accurate data. The ability to target Z-DNA in epidermal genes will
allow for new classes of medicines. This project was supported in part by a NYIT ISRC grant.
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Voriconazole treatment plus UVB irradiation causes malignant transformation of human
HaCaT keratinocyes
RL Berrios,1 A Martin-Garrido,2 MY Bonner,1 BP Pollack1,3 and JL Arbiser1,3 1 Dermatology,
Emory University School of Medicine, Atlanta, GA, 2 Cardiology, Emory University School of
Medicine, Atlanta, GA and 3 Dermatology, Atlanta Veterans Affairs Medical Center, Decatur,
GA
A rise in the incidence of squamous cell carcinoma and melanoma has been described in patients
exposed to the triazole antifungal agent voriconazole. We sought to explore the mutagenic effects
of voriconazole in combination with ultraviolet (UV) light irradiation on HaCaT cells, an immor-
talized keratinocyte line that is normally not tumorigenic in mice. HaCaT cells were grown for one
month in either native media or media containing 10 micromolar voriconazole. On days 14 and
28, cells were irradiated with UVB light (290-320 nm) for a total dose of 80 mJ cm-2. Following
repopulation, one million cells of each type were injected subcutaneously into nude mice. On day
105 post-injection, tumors were noted in three of four mice injected with voriconazole-treated
HaCaT cells while none were observed in the four control mice. Western blot analysis revealed a
surprising downregulation of phospho-Akt but upregulation in phospho-SGK-3 and FoxM1 levels,
suggesting that voriconazole may be inducing turmorigenesis not in an Akt-dependent fashion but
in a phosphoinositol-3 kinase-dependent pathway. Further investigation is necessary in order to bet-
ter determine the mechanisms of voriconazole-induced tumorigenesis, but these data paired with
previous reports suggest that patients exposed to voriconazole require careful surveillance and
possible chemopreventive strategies.
092
Tumor derived nitric oxide suppresses the expression of CXCL10 and leads to the poor out-
come of Stage ΙΙΙ melanoma
K Tanese,1,2 E Grimm1 and S Ekmekcioglu1 1 Melanoma Medical Oncology, University of Texas
MD Anderson Cancer Center, Houston, TX and 2 Dermatology, Keio University School of
Medicine, Tokyo, Japan
Accumulating evidence suggests that melanoma is heterogeneous disease, based on findings in
molecular biology, etiology, and epidemiology. As one of subpopulation, we previously reported
expression of inducible nitric-oxide synthase (iNOS) in melanoma tumor cells, which strongly cor-
relate with poor patient survival. We hypothesize that nitric oxide (NO) produced by iNOS is a key
molecule in melanoma inflammatory tumor microenvironment of poor patient outcome. To gain
further insight into the role of NO and iNOS in the melanoma tumor microenvironment, we per-
formed PCR array related to inflammatory and autoimmunity gene on a series of Stage ΙΙΙmelanoma
lymph node metastases samples. As a result, expression of CXC Chemokine ligand 10 (CXCL10)
was significantly upregulated in iNOS negative patient group. Immunohistochemical analysis was
performed and strong CXCL10 staining group showed the favorable prognosis. In the in vitro analy-
sis, treating iNOS negative and CXCL10 positive melanoma cell line with NO donor, S-nitroso-N-
acetyl-l,l-penicillamine suppressed the expression of CXCL10. Furthermore, quenching NO from
iNOS positive cell line treated with NO scavenger, 2-(4-Carboxyphenyl)-4,4,5,5-tetramethylimida-
zoline-1-oxyl-3-oxide (c-PTIO) showed the significant difference in the chemokine expression sta-
tus including expression of CXCL10. Culture media of c-PTIO treated melanoma cells promoted
the migration of plasmacytoid dendritic cells, which was diminished when treated with CXCL10
neutralizing antibody. CXCL10 is reported to play a major role in the recruitment of CD8+ T cells,
and NK cells into the tumor microenvironment as well as antagonizing the activities of angiogenic
factors. Our study suggests that production of NO by iNOS inhibits the expression of CXCL10 in
melanoma and comprises the pro-tumorigenic tumor microenvironment. Inhibition of NO may ren-
der the tumor microenvironment to anti-tumorigenic status and iNOS will be a good target in the
treatment of melanoma.
093
Reprogramming genes for induced pluripotent stem cells (iPSCs) reversed changes associated
with epithelial-to-mesenchymal transition of skin cancer cells
M Takaishi,1 M Yokogawa,1 J Takeda2 and S Sano1 1 Dermatology, Kochi University, Nankoku,
Japan and 2 Social and Environmental Medicine, Osaka University, Suita, Japan
The epithelial-to-mesenchymal transition (EMT) plays a key role in morphogenesis and cancer
invasion. We have established a skin cancer cell line derived from UVB-induced squamous cell car-
cinoma (SCC) in K5.Stat3C mice, which constitutively expressed activated Stat3 in keratinocytes
and were highly sensitive to carcinogenesis regimens. One of their SCC lines, named SS3, showed
fibrosarcoma-like morphology along with altered mesenchymal properties, which included decreased
expression of keratins and E-cadherin but increased vimentin and fibronectin. This suggested that
they underwent EMT. Recent studies have demonstrated that the conversion of fibroblasts to iPSCs
by reprogramming genes is accompanied by morphological changes reminiscent of mesenchymal-
to -epithelial transition (MET), a reverse process of EMT. This prompted us to examine whether
introduction of these genes into SS3 cells led to biological changes similar to MET. To this end, SS3
cells were transfected with five factor genes including OCT3/4, Sox2, Klf4, c-Myc, and Lin28 by an
efficient piggyBac transposon-based approach. Successful transfection was confirmed by expres-
sions of the signature genes after puromycin selection. Strikingly, the transfected cells were polyg-
onal, although the parental SS3 cells were spindle-shaped in culture. Cell proliferation and cell inva-
sion activity were reduced in the transfected cells compared to parental SS3 cells. Taken collectively,
these results suggested that a malignant process of the EMT conversion was reversed by introduc-
tion of genes required for reprogramming of somatic cells into iPSCs. This finding provides an idea
for future therapeutic use to reverse malignant nature of metastatic cancer.
094
Cross talk of melanoma cells and peritumoral fibroblasts influences melanoma proliferation:
Regulation of hyaluronan synthesis in fibroblasts
U Anderegg, A Willenberg, A Saalbach and JC Simon Dermatology, University of Leipzig,
Leipzig, Germany
Hyaluronan (HA), an ECM component, plays a pivotal role in tumor progression. Stroma-derived
HA may support tumor cell proliferation and migration. Previously we have shown that soluble
mediators from tumor cells of the Malignant Melanoma elevate the synthesis of HA in stromal fibrob-
lasts through the induction of HA-Synthetases (HAS) 1 and 2. Based on these findings we aimed to
identify the functional impact for the tumor cells and the signaling pathways that are involved in
this paracrine tumor-stroma interaction. Using co-culture experiments we could demonstrate that
melanoma cell lines Bro and HT144 show increased cell proliferation when grown on a layer of
HA-secreting fibroblasts. Blocking of HA-synthesis in fibroblasts with 4-Methyl-umbelliferone or
with transduction of HAS2 specific shRNA vectors abrogated this effect. In media transfer experi-
ments we analysed melanoma-derived mediators that induce HAS1 and HAS2 mRNA in fibroblasts
treated with melanoma cell conditioned medium (MMCM). Stimulation experiments with candi-
date factors, siRNA transfections and function blocking antibodies were used to identify the MM-
derived mediators and their respective receptors on fibroblasts. We show that soluble mediator
proteins in MMCM elevate HAS1- and HAS2 mRNA expression in fibroblasts resulting in a signifi-
cantly increased HA synthesis. This induction is highly sensitive to inhibitors of PI3- and MAP-kinase
signaling pathways. The growth factors PDGF-AA and PDGF-CC induce HAS2 expression in fibrob-
lasts. Furthermore, silencing PDGF-A and PDGF-C mRNA in melanoma cells or blocking of PDGFR-
α on fibroblasts could reduce the observed stimulation of HA synthesis by MMCM. Additionally,
we show that TGF-β1 is the stimulating mediator for HAS1 and silencing of TGFβ1 in Bro cells
abrogated this induction. Taken together, melanoma-derived mediators like TGFβ1, PDGF-AA and
PDGF-CC stimulate HA-synthesis in stromal fibroblasts thus enhancing tumor cell proliferation of
malignant melanoma.
095
Definition of an “invasion signature gene set” at the leading edge of cutaneous squamous
cell carcinoma (SCC) generated by laser capture microdissection (LCM)
H Mitsui,1 M Suárez-Fariñas,1,2 KR Shah,1 M Kennedy,1 E Billick,1 I Coats,1 JA Carucci3 and
JG Krueger1 1 Investigative Dermatology, The Rockefeller University, New York, NY, 2 Center
for Clinical and Translational Science, The Rockefeller University, New York, NY and 3
Dermatology, New York University Langone Medical Center, New York, NY
The precise mechanisms governing invasion at the leading edge of SCC and its subsequent metas-
tasis are not fully understood. LCM greatly improves the sensitivity to detect differentially expressed
genes (DEGs) within a given region when it is combined with global gene expression profiling, thus
allowing analysis of precisely defined zones within the tumor microenvironment. We studied dif-
ferences between the leading edge of invasive SCC vs. bulk tumor using this method. Malignant ker-
atinocytes (KCs) from dysplastic epidermis/actinic keratosis, SCC in situ, and SCC invasive nests in
the dermis, were microdissected. Relative gene expression profiles for each region were compared
to microdissected normal epidermis from non-diseased skin. We generated a “SCC invasion signa-
ture gene set”, including >500 genes specifically expressed only in SCC invasive nests, but not in
other cell types. We found key proteases including MMP3, MMP7, MMP13, and PLAU were sig-
nificantly up-regulated in SCC invasive nests. All components of laminin332 were also part of this
signature. Co-expression of laminin332 and MMP7 in invasive nests is of particular interest, as it
has been reported that the cleavage of lamin332 by MMP7 increased the migratory capacity of colon
carcinoma cells. Down-regulation of melanocyte (MC) related genes (TYRP1, DCT, KIT, and MLANA)
is also a feature of SCC invasion, suggesting dissociation of MC and KC interaction during migra-
tion of malignant KCs from epidermis to deep dermis. This study is the first to identify regional dif-
ferences in gene expression at the leading edge of an epithelial carcinoma compared with the bulk
tumor that is not actively invading tissue. Further elucidation of mechanisms of invasion may sup-
port the development of new treatments for aggressive SCC.
096
Role of PKCδ in maintenance of cancer stem cells
Y Lee, K Sohn, D Choi, M Im, Y Seo and J Lee Dermatology, Chungnam National University,
Daejeon, Republic of Korea
Cancer stem cells, also called tumor initiating cells, are characterized by their stem-like properties
in diverse human cancers. In concordant with a concept of stem cells in normal epithelial cells,
squamous cell carcinoma (SCC) cell lines are reported to contain distinct sub-populations with dif-
ferent growth and tumorigenic potential. To investigate the potential role of PKCδ in SCC, we first
examined the expression of PKCδ in human SCC tissues. As compared with normal skins, PKCδ
expression was generally decreased in SCC tissues. This result suggests that PKCδ may have anti-
tumorigenic effect in the development of SCC. To investigate the possible role of PKCδ in SCC, we
overexpressed PKCδ in SCC13 cells by recombinant adenovirus. After adenoviral overexpression of
PKCδ, cell growth of SCC13 was markedly reduced, determined by [3H]thymidine incorporation
assay. We hypothesized that PKCδ may affect the cancer stemness of SCC13 cells, then determined
the change of stem cell population by flow cytometry. Cells were double-stained by integrinα6 and
CD71, then α6bri/CD71dim population was regarded as stem cells. As expected, overexpression
of PKCδ led to the reduction of α6bri/CD71dim population, suggesting that PKCδ is a negative reg-
ulator for maintenance of cancer stem cells. Consistent with this notion, colony forming acitivity
was markedly decreased by PKCδ. Furthermore, overexpression of PKCδ led to remarkable decrease
of p63 level in SCC13 cells, suggesting that PKCδ regulates cancer stem cells negatively through
the modulation of p63.
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Initiation with DMBA metabolite bypasses requirement for Langerhans cell in two-stage chem-
ical carcinogenesis
B Modi,1 J Lewis,1 R Filler,1 P Fu,2 L Cai,3 A Hayday4 and M Girardi1 1 Yale Univ., New Haven,
CT, 2 NCTR/FDA, Jefferson, AR, 3 Biotranex, Monmouth, NJ and 4 GKT, London, United
Kingdom
Polyaromatic hydrocarbons (PAH) are potent mutagens, and dimethyl-benza[a]anthracine (DMBA)
is a model PAH used to study carcinogenesis. DMBA metabolism yields intermediates such as DMBA
trans-3,4-diol (Dt34d) which, via epoxide hydrolase, cause the signature codon 61 mutation in Hras
gene. We previously demonstrated that mice deficient in Langerhans cells (LC) are resistant to two-
stage chemical carcinogenesis (DMBA/TPA). To assess LC’s ability to metabolize DMBA and exter-
nalize metabolite, we exposed LC line XS106 to DMBA and analyzed the media by liquid chro-
matography/tandem mass spectrometry. Dt34d was readily identified and quantified at a mean
concentration of 29.2nM in 32μM-DMBA-treated XS106 cell samples and 42.4nM in 64μM-DMBA-
treated samples. To investigate whether LC metabolism of DMBA is necessary for the tumor resist-
ance observed in LC-deficient (LC-def) mice, synthesized metabolite Dt34d was applied at either
high (hd) or low (ld) dose for use as the initiator in two-stage carcinogenesis of LC-def and LC-intact
mice. In contrast to the markedly reduced tumorigenesis observed in DMBA-treated LC-def skin
relative to LC-intact skin (hd: 2.8 ± 0.59 vs 22.2 ± 0.59, p<0.001; ld: 0.08 ± 0.08 vs 17.1 ± 2.93,
p<0.001), initiation with Dt34d produced comparable tumor development in the two groups (hd:
2.92 ± 0.53 vs 4.64 ± 0.95, NS; ld: 1.00 ± 0.41 vs 1.15 ± 0.32, NS). The facts that LC have the
capacity to metabolize DMBA to Dt34d, and initiation with Dt34d restores carcinogenesis in LC-
def skin, indicate that LC make substantial contributions to carcinogenesis through the processing
of DMBA, potentially also enhancing the local bioavailability of mutagens to the target basal ker-
atinocytes. These findings describe a novel role of LC in the early stages of PAH-induced tumor ini-
tiation and may have implications more generally for epithelial tumors that develop in the presence
of tissue-associated DC.
099
Topical tacrolimus treatment does not facilitate UV-induced carcinogenesis in a mouse model
T Shiga, M Yokogawa, M Tarutani and S Sano Dermatology, Kochi University, Nankoku, Japan
Tacrolimus, a calcineurin inhibitor, is an immunosuppressive drug mainly through down-regula-
tion of T cell activation. Topical application of tacrolimus is therapeutically effective on chronic
inflammatory skin diseases such as atopic dermatitis. However, there has been a concern about
increased risk of UV exposure-induced skin cancer facilitated by topical tacrolimus, because of its
potential suppression of anti-tumor immunity. The aim of this study was to examine whether topi-
cal tacrolimus treatment facilitated UV-induced carcinogenesis using K5.Stat3C mice. K5.Stat3C
mice expressed constitutively activated Stat3 in epidermis and therefore were prone to skin cancers,
induced by carcinogenesis regimen with UVB irradiation or the two-stage protocol of chemicals.
To verify immunosuppressive potential of tacrolimus, an experiment of contact hypersensitivy (CH)
by dinitrofluorobenzene (DNFB) was conducted. Four days after sensitization of DNFB in the back
skins of K5.Stat3C mice, DNFB was challenged onto the ear skins twice weekly, with or without
topical tacrolimus treatment. Tacrolimus significantly attenuated ear swelling and dermatitis devel-
opment induced by repeated DNFB application, indicating that tacrolimus ameliorated CH response
as expected. Also, tacrolimus treatment showed a marked reduction of ear swelling by high-dose
UVB irradiation, indicative of anti-inflammatory effect. Finally, K5.Stat3C mice were subjected to
UVB carcinogenesis regimen (three times weekly irradiation), which induced epidermal atypia
after 12 weeks and squamous cell carcinoma after 16 weeks. Immediately after every irradiation,
we topically treated them with tacrolimus or vehicle onto the right ears and left ears, respectively.
Histopathological examination revealed that there was no difference between the two groups in
the latent period of onset of epidermal atypia, cancer development or histological appearance. Taken
collectively, topical tacrolimus did not facilitate UVB-induced carcinogenesis, although it suppressed
CH response to hapten and acute skin inflammation by UVB irradiation.
101
MicroRNA profiles in cutaneous squamous cell carcinomas: A personalized medicine approach
KA Gordon, O Stojadinovic, S Choudhary, E Lebrun, S Jackson, K Nouri and M Tomic-Canic
Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of
Medicine, Miami, FL
Cutaneous squamous cell carcinoma (cSCC) is a malignant proliferation of keratinocytes with an
unknown molecular basis that causes significant morbidity. MicroRNAs (miRNAs) are small RNA
molecules of approximately 22 nucleotides (nt) that regulate gene expression through post-tran-
scriptional gene silencing. miRNAs are critical to various biological processes and hold great prom-
ise in the treatment of dermatologic diseases including skin cancer pathology. To determine if miR-
NAs play a role in pathogenesis of cSCC and further if specific miRNA molecules direct the
invasiveness of SCC, we collected patients’ specimens from in-situ SCC and invasive cSCC. In addi-
tion, we utilized adjacent, tumor- free control skin for each tumor. We examined miRNAs expres-
sion levels using quantitative PCR. We examined miRNA 21, miRNA 103a, miRNA 200b, miRNA
203, and miRNA 205 expressions because each of these miRNAs has shown promise in skin and
cancer pathology. miRNA levels were first compared to adjacent, tumor-free control skin of the same
patient and subsequently to healthy skin derived from reduction surgery as an additional control.
Then, we clustered expression profiles of each miRNA examined by the type of the tumor. Overall,
we found deregulation of miRNA expression in both in-situ and invasive cutaneous SCC. The major-
ity of miRNAs expressions demonstrated individual tumor specificity and profile. Interestingly, we
found that miRNA 21 was consistently upregulated in patients’ cSCC specimens, followed by an
upregulation of miRNA 205. We concluded that miRNA 21 and miRNA 205 may have diagnostic
value in determining the invasiveness of cSCCs. Furthermore, our data suggest that each individual
cSCC has unique miRNA profile underscoring the personalized medicine approach in developing
treatment modalities using specific anti-miRNAs (anatagomirs) and/or mimics.
100
Hyperstimulation of mitogen signal pathways is responsible for dysregulated Laminin-332
expression in premalignant keratinocytes and squamous cell carcinoma
M Degen, P Barron, H Widlund and JG Rheinwald Dermatology, Brigham and Women’s
Hospital, Boston, MA
The basement membrane beneath normal, unwounded epithelia is very stable. Consequently, nor-
mal basal keratinocytes do not express immunohistologically detectable amounts of the α3, β3, and
γ2 subunits of the trimeric basement membrane protein Laminin-332. In contrast, oral and epider-
mal squamous cell carcinomas (SCC) and many preinvasive epithelial dysplasias abnormally express
high levels of Laminin γ2. We have been able to investigate the mechanisms underlying this dys-
regulation in cell culture. Normal primary or TERT-immortalized human keratinocytes displayed
density-dependent repression of γ2 synthesis, whereas premalignant keratinocyte and SCC cell lines
continued to synthesize high levels of γ2 at confluence, resulting in secretion of the abnormal Laminin
β3γ2 dimer and γ2 monomer. Six SCC cell lines we examined expressed elevated levels of the EGF
receptor (EGFR), and EGFR kinase inhibitors blocked their high density γ2 expression. We next
sought to determine the effects of activating specific signaling proteins downstream of EGFR. When
the TERT-immortalized epidermal keratinocyte line N/TERT-1 was stably transduced to express con-
stitutively active, mutant forms of either H-ras, c-raf1, or MEK1, the cells lost the ability to repress
γ2 at confluence. Interestingly, normal keratinocytes engineered to express HPV16 E6 and E7 also
lost γ2 control. These cells proved to share with SCC cells, and with N/TERT-1/ras, /raf, and /MEK
transductants, EGFR downstream signaling abnormalities which included elevated levels of phos-
pho-S6. Thus, EGFR-MAPK signal pathway hyperstimulation is necessary and sufficient to dysregu-
late γ2 synthesis. These results identify γ2 dysregulation and mitogen signal pathway hyperactivity
as causally related, preinvasive events during neoplastic progression, providing the basis for find-
ing better diagnostic and prognostic markers to stage epithelial dysplasias and plan their treatment.
098
HGF transactivates keratinocyte EGFR signaling, potentiates the tumorigenic phenotype of
oncogenic ras-transduced keratinocytes in vitro and enhances skin carcinogenesis in vivo
F Liu,1,2 C Cataisson,1 R Zaidi,1 G Merlino1 and SH Yuspa1 1 Laboratory of Cancer Biology and
Genetics, National Cancer Institute, Bethesda, MD and 2 HHMI-NIH Research Scholar,
Howard Hughes Medical Institute, Chevy Chase, MD
To elucidate the role of keratinocyte-derived inflammation on skin cancers, a double transgenic
mouse model (HGF-PKCα or DT) was used. K5-PKCα mice – which overexpress PKCα in basal ker-
atinocytes and develop a strong neutrophilic cutaneous inflammatory response upon topical TPA
(12-tetradecanoylphorbol-13-acetate) application – were crossed with melanoma-prone MT1-
HGF mice – which overexpress HGF under a metallothionein promoter – to create HGF-PKCαmice
and their respective controls. While we previously reported the contribution of HGF and PKCα
driven epidermal inflammation on melanomagenesis in DT mice, we observed that DT animals
were very sensitive to squamous carcinogenesis. The low dose tumor promotion protocol used
yielded an average of 6 tumors per mouse in the DT group; single transgenic K5-PKCα or MT-HGF
mice developed an average of 1 tumor while WT developed none at this TPA dose. We hypothe-
size that in DT mice, keratinocyte-derived HGF synergizes with PKCα to drive tumor promotion
and increase tumor growth. Primary keratinocytes derived from HGF or DT mice display a pheno-
type reminiscent of EGFR activated cells: increased expression of pro-inflammatory factors, upreg-
ulation of Keratin 8 (K8) and downregulation of K1 and K10 mRNAs. Indeed western blot analysis
shows that EGFR is transactivated in HGF and DT keratinocytes but not PKCα or WT keratinocytes.
The release of CXCL1 is augmented in ras-keratinocyte cell culture supernatants with DT ras-ker-
atinocytes producing the most. Together these results suggest that the sensitivity of DT transgenic
skin to squamous tumor induction is associated with the ability of HGF to transactivate EGFR sig-
naling likely leading to enhanced growth of neoplastic clones.
102
Immunohistochemical Demonstration of Z-DNA in the Epidermal Cells of Human Melanoma
Tissue
K Beheshti,1 CE Gagna1,2,3 and W Lambert2,3 1 Life Sciences, New York Institute of Technology,
Old Westbury, NY, 2 Dermatology, New Jersey Medical School, Newark, NJ and 3 Pathology
& Laboratory Medicine, New Jersey Medical School, Newark, NJ
Several types of skin cancer exist and melanoma is the most serious type. In the United States each
year, more than 50,000 people are diagnosed with melanoma. Additionally, the occurrence of
melanoma has continued to increase over the past few decades. Genomics and proteomics must
be employed to find new target sites, and develop new classes of drugs that can be used to treat
and/or cure melanoma. Left-handed double-stranded (ds-) Z-DNA is an alternative form of the
more common right-handed ds-B-DNA. Z-DNA plays a role in gene expression, viz., RNA editing,
and transcriptional enhancement. We have immunohistochemically (i.e., anti-Z-DNA antibodies)
stained human melanoma tissue fixed in either Carnoy’s solution, or 10% neutral buffered forma-
lin (NBF) to identify the presence and distribution of Z-DNA. We have observed elevated amounts
of Z-DNA within the cells of the epidermis of human tissue with melanoma. Therefore, we believe
that Z-DNA exists within mutated genes (i.e., melanoma) and plays a role in the molecular biology
of this disease. Tissue fixed in 10% NBF required antigen retrieval for the demonstration of Z-DNA
immunohistochemistry. Microwave-based histotechnological processing has been used to reduce
damage to ds-DNA, for more accurate data. The ability to target Z-DNA in epidermal genes will
allow for new classes of medicines. This project was supported in part by a NYIT ISRC grant.
www.jidonline.org   S17
SID11_Abstracts-5  2/28/11  9:27 AM  Page S17
ABSTRACTS
091
Voriconazole treatment plus UVB irradiation causes malignant transformation of human
HaCaT keratinocyes
RL Berrios,1 A Martin-Garrido,2 MY Bonner,1 BP Pollack1,3 and JL Arbiser1,3 1 Dermatology,
Emory University School of Medicine, Atlanta, GA, 2 Cardiology, Emory University School of
Medicine, Atlanta, GA and 3 Dermatology, Atlanta Veterans Affairs Medical Center, Decatur,
GA
A rise in the incidence of squamous cell carcinoma and melanoma has been described in patients
exposed to the triazole antifungal agent voriconazole. We sought to explore the mutagenic effects
of voriconazole in combination with ultraviolet (UV) light irradiation on HaCaT cells, an immor-
talized keratinocyte line that is normally not tumorigenic in mice. HaCaT cells were grown for one
month in either native media or media containing 10 micromolar voriconazole. On days 14 and
28, cells were irradiated with UVB light (290-320 nm) for a total dose of 80 mJ cm-2. Following
repopulation, one million cells of each type were injected subcutaneously into nude mice. On day
105 post-injection, tumors were noted in three of four mice injected with voriconazole-treated
HaCaT cells while none were observed in the four control mice. Western blot analysis revealed a
surprising downregulation of phospho-Akt but upregulation in phospho-SGK-3 and FoxM1 levels,
suggesting that voriconazole may be inducing turmorigenesis not in an Akt-dependent fashion but
in a phosphoinositol-3 kinase-dependent pathway. Further investigation is necessary in order to bet-
ter determine the mechanisms of voriconazole-induced tumorigenesis, but these data paired with
previous reports suggest that patients exposed to voriconazole require careful surveillance and
possible chemopreventive strategies.
092
Tumor derived nitric oxide suppresses the expression of CXCL10 and leads to the poor out-
come of Stage ΙΙΙ melanoma
K Tanese,1,2 E Grimm1 and S Ekmekcioglu1 1 Melanoma Medical Oncology, University of Texas
MD Anderson Cancer Center, Houston, TX and 2 Dermatology, Keio University School of
Medicine, Tokyo, Japan
Accumulating evidence suggests that melanoma is heterogeneous disease, based on findings in
molecular biology, etiology, and epidemiology. As one of subpopulation, we previously reported
expression of inducible nitric-oxide synthase (iNOS) in melanoma tumor cells, which strongly cor-
relate with poor patient survival. We hypothesize that nitric oxide (NO) produced by iNOS is a key
molecule in melanoma inflammatory tumor microenvironment of poor patient outcome. To gain
further insight into the role of NO and iNOS in the melanoma tumor microenvironment, we per-
formed PCR array related to inflammatory and autoimmunity gene on a series of Stage ΙΙΙmelanoma
lymph node metastases samples. As a result, expression of CXC Chemokine ligand 10 (CXCL10)
was significantly upregulated in iNOS negative patient group. Immunohistochemical analysis was
performed and strong CXCL10 staining group showed the favorable prognosis. In the in vitro analy-
sis, treating iNOS negative and CXCL10 positive melanoma cell line with NO donor, S-nitroso-N-
acetyl-l,l-penicillamine suppressed the expression of CXCL10. Furthermore, quenching NO from
iNOS positive cell line treated with NO scavenger, 2-(4-Carboxyphenyl)-4,4,5,5-tetramethylimida-
zoline-1-oxyl-3-oxide (c-PTIO) showed the significant difference in the chemokine expression sta-
tus including expression of CXCL10. Culture media of c-PTIO treated melanoma cells promoted
the migration of plasmacytoid dendritic cells, which was diminished when treated with CXCL10
neutralizing antibody. CXCL10 is reported to play a major role in the recruitment of CD8+ T cells,
and NK cells into the tumor microenvironment as well as antagonizing the activities of angiogenic
factors. Our study suggests that production of NO by iNOS inhibits the expression of CXCL10 in
melanoma and comprises the pro-tumorigenic tumor microenvironment. Inhibition of NO may ren-
der the tumor microenvironment to anti-tumorigenic status and iNOS will be a good target in the
treatment of melanoma.
093
Reprogramming genes for induced pluripotent stem cells (iPSCs) reversed changes associated
with epithelial-to-mesenchymal transition of skin cancer cells
M Takaishi,1 M Yokogawa,1 J Takeda2 and S Sano1 1 Dermatology, Kochi University, Nankoku,
Japan and 2 Social and Environmental Medicine, Osaka University, Suita, Japan
The epithelial-to-mesenchymal transition (EMT) plays a key role in morphogenesis and cancer
invasion. We have established a skin cancer cell line derived from UVB-induced squamous cell car-
cinoma (SCC) in K5.Stat3C mice, which constitutively expressed activated Stat3 in keratinocytes
and were highly sensitive to carcinogenesis regimens. One of their SCC lines, named SS3, showed
fibrosarcoma-like morphology along with altered mesenchymal properties, which included decreased
expression of keratins and E-cadherin but increased vimentin and fibronectin. This suggested that
they underwent EMT. Recent studies have demonstrated that the conversion of fibroblasts to iPSCs
by reprogramming genes is accompanied by morphological changes reminiscent of mesenchymal-
to -epithelial transition (MET), a reverse process of EMT. This prompted us to examine whether
introduction of these genes into SS3 cells led to biological changes similar to MET. To this end, SS3
cells were transfected with five factor genes including OCT3/4, Sox2, Klf4, c-Myc, and Lin28 by an
efficient piggyBac transposon-based approach. Successful transfection was confirmed by expres-
sions of the signature genes after puromycin selection. Strikingly, the transfected cells were polyg-
onal, although the parental SS3 cells were spindle-shaped in culture. Cell proliferation and cell inva-
sion activity were reduced in the transfected cells compared to parental SS3 cells. Taken collectively,
these results suggested that a malignant process of the EMT conversion was reversed by introduc-
tion of genes required for reprogramming of somatic cells into iPSCs. This finding provides an idea
for future therapeutic use to reverse malignant nature of metastatic cancer.
094
Cross talk of melanoma cells and peritumoral fibroblasts influences melanoma proliferation:
Regulation of hyaluronan synthesis in fibroblasts
U Anderegg, A Willenberg, A Saalbach and JC Simon Dermatology, University of Leipzig,
Leipzig, Germany
Hyaluronan (HA), an ECM component, plays a pivotal role in tumor progression. Stroma-derived
HA may support tumor cell proliferation and migration. Previously we have shown that soluble
mediators from tumor cells of the Malignant Melanoma elevate the synthesis of HA in stromal fibrob-
lasts through the induction of HA-Synthetases (HAS) 1 and 2. Based on these findings we aimed to
identify the functional impact for the tumor cells and the signaling pathways that are involved in
this paracrine tumor-stroma interaction. Using co-culture experiments we could demonstrate that
melanoma cell lines Bro and HT144 show increased cell proliferation when grown on a layer of
HA-secreting fibroblasts. Blocking of HA-synthesis in fibroblasts with 4-Methyl-umbelliferone or
with transduction of HAS2 specific shRNA vectors abrogated this effect. In media transfer experi-
ments we analysed melanoma-derived mediators that induce HAS1 and HAS2 mRNA in fibroblasts
treated with melanoma cell conditioned medium (MMCM). Stimulation experiments with candi-
date factors, siRNA transfections and function blocking antibodies were used to identify the MM-
derived mediators and their respective receptors on fibroblasts. We show that soluble mediator
proteins in MMCM elevate HAS1- and HAS2 mRNA expression in fibroblasts resulting in a signifi-
cantly increased HA synthesis. This induction is highly sensitive to inhibitors of PI3- and MAP-kinase
signaling pathways. The growth factors PDGF-AA and PDGF-CC induce HAS2 expression in fibrob-
lasts. Furthermore, silencing PDGF-A and PDGF-C mRNA in melanoma cells or blocking of PDGFR-
α on fibroblasts could reduce the observed stimulation of HA synthesis by MMCM. Additionally,
we show that TGF-β1 is the stimulating mediator for HAS1 and silencing of TGFβ1 in Bro cells
abrogated this induction. Taken together, melanoma-derived mediators like TGFβ1, PDGF-AA and
PDGF-CC stimulate HA-synthesis in stromal fibroblasts thus enhancing tumor cell proliferation of
malignant melanoma.
095
Definition of an “invasion signature gene set” at the leading edge of cutaneous squamous
cell carcinoma (SCC) generated by laser capture microdissection (LCM)
H Mitsui,1 M Suárez-Fariñas,1,2 KR Shah,1 M Kennedy,1 E Billick,1 I Coats,1 JA Carucci3 and
JG Krueger1 1 Investigative Dermatology, The Rockefeller University, New York, NY, 2 Center
for Clinical and Translational Science, The Rockefeller University, New York, NY and 3
Dermatology, New York University Langone Medical Center, New York, NY
The precise mechanisms governing invasion at the leading edge of SCC and its subsequent metas-
tasis are not fully understood. LCM greatly improves the sensitivity to detect differentially expressed
genes (DEGs) within a given region when it is combined with global gene expression profiling, thus
allowing analysis of precisely defined zones within the tumor microenvironment. We studied dif-
ferences between the leading edge of invasive SCC vs. bulk tumor using this method. Malignant ker-
atinocytes (KCs) from dysplastic epidermis/actinic keratosis, SCC in situ, and SCC invasive nests in
the dermis, were microdissected. Relative gene expression profiles for each region were compared
to microdissected normal epidermis from non-diseased skin. We generated a “SCC invasion signa-
ture gene set”, including >500 genes specifically expressed only in SCC invasive nests, but not in
other cell types. We found key proteases including MMP3, MMP7, MMP13, and PLAU were sig-
nificantly up-regulated in SCC invasive nests. All components of laminin332 were also part of this
signature. Co-expression of laminin332 and MMP7 in invasive nests is of particular interest, as it
has been reported that the cleavage of lamin332 by MMP7 increased the migratory capacity of colon
carcinoma cells. Down-regulation of melanocyte (MC) related genes (TYRP1, DCT, KIT, and MLANA)
is also a feature of SCC invasion, suggesting dissociation of MC and KC interaction during migra-
tion of malignant KCs from epidermis to deep dermis. This study is the first to identify regional dif-
ferences in gene expression at the leading edge of an epithelial carcinoma compared with the bulk
tumor that is not actively invading tissue. Further elucidation of mechanisms of invasion may sup-
port the development of new treatments for aggressive SCC.
096
Role of PKCδ in maintenance of cancer stem cells
Y Lee, K Sohn, D Choi, M Im, Y Seo and J Lee Dermatology, Chungnam National University,
Daejeon, Republic of Korea
Cancer stem cells, also called tumor initiating cells, are characterized by their stem-like properties
in diverse human cancers. In concordant with a concept of stem cells in normal epithelial cells,
squamous cell carcinoma (SCC) cell lines are reported to contain distinct sub-populations with dif-
ferent growth and tumorigenic potential. To investigate the potential role of PKCδ in SCC, we first
examined the expression of PKCδ in human SCC tissues. As compared with normal skins, PKCδ
expression was generally decreased in SCC tissues. This result suggests that PKCδ may have anti-
tumorigenic effect in the development of SCC. To investigate the possible role of PKCδ in SCC, we
overexpressed PKCδ in SCC13 cells by recombinant adenovirus. After adenoviral overexpression of
PKCδ, cell growth of SCC13 was markedly reduced, determined by [3H]thymidine incorporation
assay. We hypothesized that PKCδ may affect the cancer stemness of SCC13 cells, then determined
the change of stem cell population by flow cytometry. Cells were double-stained by integrinα6 and
CD71, then α6bri/CD71dim population was regarded as stem cells. As expected, overexpression
of PKCδ led to the reduction of α6bri/CD71dim population, suggesting that PKCδ is a negative reg-
ulator for maintenance of cancer stem cells. Consistent with this notion, colony forming acitivity
was markedly decreased by PKCδ. Furthermore, overexpression of PKCδ led to remarkable decrease
of p63 level in SCC13 cells, suggesting that PKCδ regulates cancer stem cells negatively through
the modulation of p63.
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Induction of chemokine receptor CXCR4 expression by transforming growth factor-β1 in
human basal cell carcinoma cells
S Jee,1 C Chu,1 S Cha,2,3 Y Hu,1 H Chiu1 and M Kuo2,3 1 Department of Dermatology, College
of Medicine, National Taiwan University, Taipei, Taiwan, 2 Graduate Institute of Toxicology,
College of Medicine, National Taiwan University, Taipei, Taiwan and 3 Angiogenesis Research
Center, National Taiwan University, Taipei, Taiwan
Basal cell carcinoma (BCC) is one of the most common skin neoplasm in humans and is charac-
terized by local aggressiveness with little metastatic potential. Recently, CXCR4 expression was
shown in previous studies to enhance invasiveness and angiogenesis of BCC cells. In our previous
study, we also found invasive types (morphea or infiltrative type) of BCCs had higher expression of
CXCR4 protein as compared to those of non-invasive types. In this study, we investigated mecha-
nism involved in the regulation of CXCR4 expression in invasive type BCCs. We found that inva-
sive type BCC specimens had higher expression of transforming growth factor-β1 (TGF-β1) and con-
nective tissue growth factor (CTGF) mRNAs than non-invasive type BCCs. In addition,
immunohistochemical studies revealed intensely staining of TGF-β1 and CTGF in the surrounding
fibroblasts of invasive type BCCs which were positively correlated with the CXCR4 expression on
BCC tumour nest cells. Non-contact co-culture of Hs68 fibroblast cell line cells with human BCC
cells also increased the expression of CXCR4 in human BCC cells. Treatment with recombinant
human TGF-β1, but not CTGF, enhanced the CXCR4 mRNA, protein and surface expression of
BCC cells in time- and does-dependent manners. The transcriptional regulation of CXCR4 by TGF-
β1 was mediated by phosphorylation of extracellular signal-related kinase 1/2 (ERK1/2) pathway. In
summary, this study indicated TGF-β1 mediated invasion of BCC via ERK1/2/CXCR4 signal cascade
in context of interaction between cancer associated fibroblasts and BCC.
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Glycolipid O-acetylation drives human squamous cell carcinoma proliferation and survival
via EGFR/Ras-independent activation of PKCα and Akt signaling
X Wang, A Aurora, H Iordanov, N Gatla, D Bach, E Angulo and AS Paller Dermatology,
Northwestern Univ., Chicago, IL
PKCα activation has recently been shown to correlate with more aggressive squamous carcinoma
cell (SCC) behavior, but the upstream triggers of PKCα activation are unknown. Ganglioside 9-O-
acetylGD3 (9AcGD3) is strongly expressed in SCCs, but not in normal epidermis or cultured ker-
atinocytes, suggesting a role for 9AcGD3 in SCCs. Indeed, a marked increase in proliferation was
noted when 9AcGD3 was ectopically expressed in SCC12 cells. Furthermore, in SCID mice, explants
of “9-O” cells, which stably overexpress 9-O-acetylGD3 synthase (O-AcGD3S; MFG-E8), had an
8-fold greater tumor volume than the tumors generated from mock-transfected SCC12 cells. The pro-
liferation of 9-O cells was not suppressed by the EGFR inhibitor AG1478, but was reduced to con-
trol levels by inhibition of PKCα. 9AcGD3 overexpression led to activation of PKCα, Akt, PI3K and
ERK, while an antibody directed against 9AcGD3 reversed the increase in PKCα activation. Increased
expression of cyclin E and Bcl-2, markers of cell cycling and survival, respectively, were observed
in “9-O” cells. Such increases correlate with a poor prognosis in patients with SCCs. While sup-
pression of either PKCα or Akt markedly inhibited expression of cyclin E and Bcl-2 in 9-O cells,
inhibition of PI3K, ERK or the combination of PKCα and Akt totally eliminated cyclin E and Bcl-2
expression. Raf inhibition, but not EGFR or Ras, suppressed the stimulatory effect of O-AcGD3S on
cell growth and survival, further supporting the role of PKCα activation in O-AcGD3S-driven pro-
liferation and survival. Furthermore, inhibition of PKCα or Akt suppressed ERK, but not PI3K acti-
vation, suggesting that ERK is downstream, while PI3K is required for either PKCα or Akt activation
in 9-O cells. These results suggest that overexpression of O-AcGD3S, leading to 9AcGD3 expres-
sion, drives the activation of PI3K, PKCα and Akt in SCCs and raises the possibility of targeting O-
AcGD3S or 9AcGD3 as a therapy.
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Akt inhibits autophagy through Beclin 1 phosphorylation and formation of a Beclin 1/keratin
intermediate filament Complex
RC Wang,1 Y Wei2 and B Levine2,3 1 Dermatology, UT Southwestern, Dallas, TX, 2 Internal
Medicine, UT Southwestern, Dallas, TX and 3 Howard Hughes Medical Institute, Dallas, TX
While the catabolic processes of autophagy are essential during stressors like starvation, its activ-
ity is carefully restricted during cell growth. Although mTOR contributes to the inhibition of autophagy
through its phosphorylation of ULK, the possible role of other growth signaling pathways is incom-
pletely understood. We present evidence for a novel model of autophagy regulation in which growth
signals inhibit autophagy upstream of mTOR through Akt. Active Akt1 binds and phosphorylates
Beclin 1 in vitro and in vivo. The modification of Beclin 1 by Akt1 generates a phosphomotif, which
allows 14-3-3 binding proteins to bind in a regulated manner. These 14-3-3 proteins in turn medi-
ate Beclin 1’s interaction with phosphorylated Type I keratin intermediate filaments. Importantly, a
non-phosphorylatable mutant of Beclin 1 can bind neither 14-3-3 nor keratins. Moreover, a mutant
of keratin that cannot bind 14-3-3 also fails to interact with Beclin 1. The disruption of the complex
either through the expression of nonphosphorylatable Beclin 1 mutants or through the depletion of
keratins results in the induction of autophagy. The expression of the nonphosphorylatable Beclin 1
mutant also has effects on tumorigenesis in vitro. Thus, active Akt keeps Beclin 1 in an inactive
complex with 14-3-3 and keratins, suggesting a novel mechanism for the regulation of autophagy
by the PI3K-Akt signaling pathway.
112
In-situ expression of fas apoptotic pathway proteins in archival samples of cutaneous t-cell
lymphoma (ctcl), cutaneous anaplastic large cell lymphoma (alcl) and lymphomatoid papu-
losis (lyp)
N Stutz,1 RD Johnson1 and GS Wood1,2 1 University of Wisconsin, Madison, WI and 2 VAMC,
Madison, WI
Our published studies of in-situ FAS expression in frozen sections showed that many CTCL skin
lesions did not strongly express FAS, suggesting apoptotic resistance (AR). To explore this concept
more comprehensively, we performed immunoperoxidase studies of death receptor FAS, its ligand
(FASL) and inhibitor cFLIP in paraffin sections of lesional skin biopsies. We studied CTCL, ALCL
and LyP in order to compare and contrast cutaneous T-cell lymphoproliferative disorders that typi-
cally do not regress spontaneously (CTCL, ALCL) with one that does (LyP). AR by means of FAS defi-
ciency or FAS/cFLIP co-expression has been documented by us and others for CTCL lines and cases
of leukemic CTCL as well as for 4 ALCL cell lines. Consistent with these findings 32/33 CTCL lesions
were FASL-low while 30/33 were either FAS-low or co-expressed both FAS and cFLIP (a FAS path-
way inhibitor). Similarly 3/3 of ALCL indicated AR by either high Fas/ high cFLIP or low Fas/low
cFLIP combinations. While ALCL and CTCL represent a progressing tumor disease, LYP is charac-
terized by recurrent crops of spontaneously regressing cutaneous papules containing large atypical
lymphoid cells. Regression is preceded by ulceration. We compared the FAS/FASL/cFLIP expres-
sion of CTCL/ALCL to that of 22 LyP biopsies. Of 17 non-ulcerated lesions, most (15/17) had large
atypical cells that were FASL-low, suggesting AR. High expression of FAS (11) or cFLIP (9) was more
mixed. However, most of the FAS-high lesions (7/11) were also cFLIP-high, again suggesting AR. In
contrast, among 5 ulcerated spontaneously regressing lesions, the phenotype of the large atypical
cells was suggestive of sensitivity to apoptosis. Most (4/5) were FASL-high and most (4/5) were FAS-
high/cFLIP-low. These findings document our ability to detect a variety of FAS pathway expression
patterns in-situ in paraffin sections and provide a strong correlation between apoptosis-resistant
and apoptosis-sensitive phenotypes and clinical evidence of T-cell death.
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Inhibition of vascular endothelial growth factor receptor 3 ligands inhibits tumor develop-
ment in a model of multistep skin carcinogenesis
AK Alitalo, D Aebischer, N Schneider, R Huggenberger and M Detmar Institute of
Pharmaceutical Sciences, Swiss Federal Institue of Technology Zurich, Zurich, Switzerland
In this study, we address the functional blockage of the vascular endothelial growth factor (VEGF)-
C/D - VEGF receptor-3 (VEGFR-3) pathway as a potential method to inhibit the growth and metas-
tasis of squamous cell carcinomas in a mouse chemical skin carcinogenesis model. Previous stud-
ies have shown that inhibition of the VEGF-A - VEGFR-2 signalling inhibits tumor growth in mouse
xenograft and transgenic tumor models. Besides VEGF-A, VEGF-C is also elevated in human squa-
mous cell carcinomas (SCCs) and there is evidence that it plays an important role in tumor pro-
gression. Thus, we induced squamous cell carcinomas of the skin in transgenic mice in which VEGF-
C/-D signalling is blocked by expression of a soluble form of the VEGFR-3 (VEGFR3-Ig) in skin
keratinocytes. Compared to wild-type controls, the VEGFR3-Ig transgenic mice developed signifi-
cantly fewer papillomas per mouse and also fewer SCCs. Analysis of blood vessel density in the
carcinogen-treated skin and in tumors indicated an attenuated angiogenic response in the trans-
genic mice, whereas lymphangiogenesis was completely blocked. Interestingly, the transgenic mice
showed signs a of decreased inflammatory response during the carcinogenesis treatment. The trans-
genic mice had less inflammatory cells in the skin and less macrophages in carcinogen-treated skin
and in carcinomas, as analyzed with antibodies against the leukocyte common antigen CD45 and
the macrophage marker CD11b. In conclusion, our results indicate that the functional blockage of
VEGF-C/-D - VEGFR-3 signalling inhibits the development of squamous cell papillomas, an effect
potentially mediated by inflammatory and vascular mechanisms.
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Relation between DNA damage accumulation, reactive oxygen species, and metabolism alter-
ation during carcinogenesis
HR Rezvani,1,2,3 A Kim,2 HD Verneuil,1 A Taieb,1,3 D Bickers2 and F Mazurier1,3 1 Inserm U1035,
Univ Victor Segalen Bordeaux 2, Bordeaux, France, 2 Dermatology, Columbia University, New
York, NY and 3 National Reference Centre for Rare Skin Disorders, Bordeaux, France
DNA damage is a well-known initiator of tumorigenesis. Studies have shown that most cancer cells
rely on aerobic glycolysis for their bioenergetics. We sought to identify a molecular link between
genomic mutations and metabolic alterations in neoplastic transformation. We took advantage of
the intrinsic genomic instability arising in xeroderma pigmentosum C (XPC). The XPC protein plays
a key role in recognizing DNA damage in nucleotide excision repair, and patients with XPC defi-
ciency have increased incidence of skin cancer and other malignancies. In cultured human ker-
atinocytes, we showed that lentivirus-mediated knockdown of XPC reduced mitochondrial oxida-
tive phosphorylation and increased glycolysis, recapitulating cancer cell metabolism. Decreases in
the NADH dehydrogenase subunit 1 and cytochrome c oxidase subunit III; and increases in pro-
teins involved in glucose uptake and lactate generation were associated with the modified metab-
olism. We found that accumulation of unrepaired DNA following XPC silencing increased DNA-
dependent protein kinase activity, which subsequently activated AKT1 and NADPH oxidase-1
(NOX1), resulting in ROS production and accumulation of specific deletions in mitochondrial
DNA (mtDNA) over time. Subcutaneous injection of XPC-deficient keratinocytes into immunode-
ficient mice led to squamous cell carcinoma (SCCs) formation, demonstrating the tumorigenic poten-
tial of transduced cells. While enforcing antioxidant defenses by overexpressing catalase, CuZn-
SOD, or MnSOD could not block the metabolism remodeling, conversely, simultaneous knockdown
of either NOX1 or AKT1 blocked the metabolism alteration and the neoplastic transformation induced
by XPC silencing. As we further observed NOX-1 activation in human SCCs, the blockade of NOX-
1 could be a target for the prevention and the treatment of skin cancers.
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Lysate from cultured fetal fibroblast for skin rejuvenation: Composition and in vitro activities
J Eberle,2 F Dreher1 and E Stockfleth2 1 Neocutis Inc., San Francisco, CA and 2 Charité -
Universitätsmedizin Berlin, Berlin, Germany
A cell lysate (Processed Skin Cell Proteins, PSP®) obtained after freeze-thawing of fetal fibroblasts
originating from a characterized cell bank has been shown to reduce skin wrinkles. This study aimed
to characterize the lysate with respect to growth factor and cytokine composition as well as to assess
its effects on proliferation and apoptosis in cultured normal human epidermal keratinocytes and
dermal fibroblasts. Since the lysate comprises a series of proliferative cytokines, its effects were fur-
ther tested in cutaneous squameous cell carcinoma (SCC) cells, and interference with death ligand-
mediated apoptosis was investigated in vitro. As shown with a cytokine antibody array, which allows
simultaneous, semi-quantitative detection of 120 cytokines, a large number of growth factors such
as epidermal growth factor, fibroblast growth factors, transforming growth factor-β, vascular endothe-
lial growth factor as well as anti- and pro-inflammatory interleukins were detected. The lysate pro-
moted proliferation of cultured keratinocytes and fibroblasts in a dose-dependent manner at non-
cytotoxic concentrations of up to 0.25%, as shown by real-time cell analysis and [3H]-thymidine
incorporation, respectively. Importantly, the lysate did not significantly stimulate proliferation of four
SCC lines (SCL-I, SCL-II, SCC-12, SCC-13) but reproducibly decreased their proliferation at higher
concentrations (1%). In some SCC cell lines, 1% of the lysate also slightly increased apoptosis, as
assessed by cell cycle analysis after propidium iodine nuclear staining (sub-G1) and DNA frag-
mentation analysis (ELISA). The lysate was further shown to enhance death ligand-induced apop-
tosis in SCC cell lines either of agonistic CD95 antibody (CH-11) or of TNF-related apoptosis-
inducing ligand (TRAIL), which was cell line specific. Concluding, this study indicates that the growth
factor containing lysate PSP promotes proliferation of normal skin cells without significantly pro-
moting SCC cell growth or interfering with death ligand-mediated apoptosis in vitro.
104
ADAMTS-12: A biomarker for nonmelanoma skin cancer disease progression
LS Peng and S Regan Medicine/Dermatology, University of Arizona, Tucson, AZ
The ADAMs (A Disintegrin and Metalloproteinase) and ADAMTSs (ADAM with thrombospondin-
like motifs) comprise a family of multidomain transmembrane and secreted proteins involved in
cytokine and growth factor release, proteolysis and cell adhesion. Multiple family members have
been shown to play a role in cancer formation and disease progression. Increased ADAMTS-12
expression has been found in the stroma during colon cancer progression. It has been suggested
that ADAMTS-12 may play a role in the host response to tumor progression via the Ras-dependent
ERK signaling pathway. Substantially more than 1 million cases of non-melanoma skin cancer (NMSC)
occur annually in the United States according to the American Cancer Society. Basal cell carcinoma
(BCC) and squamous cell carcinoma (SCC) are the two major types of NMSC and most are related
to chronic sun exposure. We have demonstrated by microarray analysis that ADAMTS-12 expres-
sion is increased in human keratinocytes chronically irradiated with a solar-simulated light source.
Using a human SCC skin carcinogenesis model, we have demonstrated that ADAMTS-12 expres-
sion correlates with disease progression. We believe that ADAMTS-12 may be important in the host
response to SCC progression and may serve as a biomarker of human skin SCC disease. This may
be important for earlier detection and for the possible development of targeted therapy that may
serve as an alternative to potentially disfiguring surgical treatment.
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The role of transcription factor RBP-J-mediated signaling in basal cell carcinoma growth
M Yu,1 D Zloty,1 RH Bell,2 A Haegert,2 N Carr,3 J Shapiro,1 B Cowan,1 L Warshawski1 and
KJ McElwee1 1 Dermatology Department, Vancouver Coastal Health Research Institute,
Vancouver, BC, Canada, 2 Surgery Department, Prostate Centre, Vancouver, BC, Canada and
3 Surgery Department, Plastic Surgery Division, Vancouver, BC, Canada
Hair follicles (HF) and basal cell carcinomas (BCCs) can be regarded as ordered and disordered
skin appendages respectively. Multiple reports suggest that a significant subset of basal cell carci-
nomas (BCCs) are directly HF-derived. They may utilize similar molecular mechanisms of growth.
We examined the similarities and differences in gene expression by microarrays between nodular
BCCs and HFs including the bulge region which has been identified as a potential primary source
of BCCs. Microarray data was validated using quantitative PCR, immunohistochemistry and in vitro
studies. Two differentially expressed gene sets were identified by significance analysis of microar-
ray (SAM) in BCC and HF versus skin epithelium respectively. Subsequently, multiple signaling path-
way analyses were conducted. The results indicated specific molecular mechanisms involved in
the process of self renewal, such as Notch and Hedgehog pathways, were active in the growth of
both HF and BCCs. However, Notch signaling, including tumor suppressor genes NOTCH1,
NOTCH2, ligands JAG1, JAG2, signaling inhibitor NUMB, and downstream Notch pathway genes
DTX1, DTX2, RBP-J, LFNG, HR, and HES7, all showed significant differential expression in BCCs
compared to HF. The data suggests downstream gene expression in the Notch signaling pathway
components that code for HF may be suppressed in BCCs. We tested the effect of transcription fac-
tor RBP-J and found transcription factor RBP-J-mediated signaling suppresses BCC cell growth and
induces cell apoptosis in vitro. Jag1- induced notch signaling pathway activation can increase HF
keratinocyte proliferation and differentiation via a RBP-J -dependent pathway in vitro. Our data
suggest that RBP-J, which is important for appropriately regulated HF formation, serves as a tumor
suppressor in BCC. Modulation of the Notch pathway may be a focus for the development of BCC
treatments.
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A genetic appraisal of the frequency of functional RET G691S polymorphism in the pure ver-
sus the mixed variants of desmoplastic melanoma
S Yang,1 A Emley,2 A Deng,3 MP Hoang4 and M Mahalingam2 1 Department of Pathology,
Boston University School of Medicine, Boston, MA, 2 Dermatopathology Section, Department
of Dermatology, Boston University School of Medicine, Boston, MA, 3 Department of
Pathology, UMASS Medical School, Worcester, MA and 4 Department of Pathology,
Massachusetts General Hospital, Boston, MA
The higher incidence of lymph node involvement in desmoplastic melanoma (DM) with an admixed
component of epithelioid cells supports the clinical usefulness of classifying DM into histologic sub-
types of pure (PDM) and mixed (MDM). The RET proto-oncogene (RETp) is a receptor tyrosine kinase
whose ligand is glial cell line-derived neurotropic factor (GDNF) and polymorphism at codon G691S
juxtamembrane region (RETp) is a germline polymorphism. Activation of RET induces signaling
through the RAS-BRAF-ERK pathways, known to be involved in carcinogenesis of conventional
melanoma, albeit not in DM. Since DM is highly neurotropic, we hypothesize that RETp may play
a role in enhancing the more aggressive clinical course associated with MDM. Genomic DNA was
isolated from 41 cases (24 PDM and 17 MDM) to assess the frequency of RETp G691s polymor-
phism. Analysis of BRAFV600E was also undertaken. We identified RETp G691S polymorphism in
12/41 (29%) cases of DM; four MDM (24%) and 8 PDM (33%). The only case with a BRAFV600E
mutation did not exhibit G691S polymorphisms in RETp. The lack of statistically significant differ-
ences between frequencies of RETp G691S polymorphism in MDM and PDM argues against the
relevance of RETp in the enhanced propensity for lymph node involvement by the former. The
increased frequency of RETp G691S polymorphism in DMs however suggests that it may be of sig-
nificance in the increased incidence of neurotropism observed in this variant of melanoma.
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CXCR3/ligand signaling is important for the development of non-melanoma skin cancer ker-
atinocytes
BK Lo,1 N Tai,1 L Chen,1 Y Zhou,1,2 D Zloty,2 B Cowan,2 J Shapiro2 and KJ McElwee1 1
Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada and 2
Dermatology and Skin Science, Vancouver General Hospital, Vancouver, BC, Canada
Cutaneous squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) are the most common
non-melanoma skin cancers (NMSC). Previously we showed that chemokine receptor CXCR3 sig-
naling was an essential mediator for primary human BCC-derived cell growth in vitro. However,
the effects of CXCR3 on SCC and its pre-cancerous forms have yet to be established. We hypothe-
sized that CXCR3 signaling may be involved in the growth of NMSC including SCC. We evaluated
gene expressions of 18 chemokines/receptors in 10 SCC, 5 BCC, 10 seborrheic keratosis, 6 actinic
keratosis, and 5 Bowen’s disease biopsies by real-time RT-PCR as compared to 13 normal skin epithe-
lium samples. We conducted dual immunohistochemistry (IHC) of keratin 13 (K13) and CXCR3 in
SCC biopsies. We applied CXCR3 neutralizing antibody with or without its CXCL11 ligand to a
human immortalized keratinocyte cell line, HaCaT cells and evaluated cell growth. Also, we assayed
the migration and invasion response of HaCaT cells towards recombinant CXCL11. The mRNA for
CXCR3 and its ligands were upregulated at the highest levels in SCC. Dual IHC revealed colocal-
ization of CXCR3 and K13, a SCC keratinocyte marker, in SCC biopsies. Neutralization of CXCR3
bioactivity in HaCaT cells led to substantially reduced cell growth rates and enhanced apoptosis.
Treatment of anti-CXCR3 plus CXCL11 peptide on HaCaT cells led to similar results as compared
to the cells treated with CXCL11 only. CXCL11-treated HaCaT cells partially recovered when CXCR3
neutralization was removed. The migration and invasion of HaCaT cells increased significantly
towards CXCL11 peptide in a dose dependent manner. Taken together, CXCR3/ligand signaling
may be important for cell growth and survival as well as invasive characteristics in cancerous ker-
atinocytes, especially in SCC. Targeting CXCR3/ligands may be effective in treating non-melanoma
skin lesions.
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Expression of epidermal growth factor receptor (EGFR) and detection of mutant EGFR
(EGFRvIII) in human cutaneous squamous cell carcinoma
M DeMara,1 N Duncan,1 S Wong,2 M Neuburg,1 Z Lazarova1 and EB Olasz1 1 Dermatology,
Medical College of Wisconsin, Milwaukee, WI and 2 Oncology, Medical College of Wisconsin,
Milwaukee, WI
Epidermal growth factor receptor (EGFR) is overexpressed in large percentage of cutaneous squa-
mous cell carcinomas (SCC). Therapeutic trials using EGFR blockade to treat high-risk or metasta-
tic squamous cell carcinoma are ongoing. The most common form of mutant EGFR (EGFRvIII) has
been described in several cancers, including head and neck cancer. It has been shown that EGFRvIII
contributes to enhanced growth of SCC and resistance in targeting wild-type EGFR. To date expres-
sion of EGFRvIII has not been evaluated in human SCC. Our goal was to assess expression of wild-
type EGFR and EGFRvIII in SCC and correlate it with tumor biology. SCC specimens (n=50) from
patients undergoing Mohs micrographic surgery were collected consecutively. Tumor specimens
were embedded in paraffin and assessed for EGFR expression by immunohistochemistry while
EGFRvIII expression was determined by RT-PCR. A representative SCC cell line stably transfected
with an EGFRvIII expression construct served as a positive control. Ten (20%) in situ, 16 (32%) well-
differentiated, 8 (16%) moderately-well differentiated and 8 (16%) poorly differentiated tumor
were included in the study, 8 (16%) was excluded due to insufficient tumor volume. Eight of the
tumors (16%) were collected from solid organ transplant patients. All tumors (100%) were positive
for EGFR, with variation in intensity and proportion of labeled cells. EGFR expression, however, was
not correlated with tumor differentiation, anatomic location or transplant status. Surprisingly, none
of the tumors (0%) expressed EGFRvIII mRNA. Evaluation of metastatic SCC for the mutant EGFR
is currently underway. The lack of mutant EGFRvIII expression may have implications on the design
of future clinical trials using EGFR inhibitors for treatment of high risk cutaneous SCC.
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Induction of chemokine receptor CXCR4 expression by transforming growth factor-β1 in
human basal cell carcinoma cells
S Jee,1 C Chu,1 S Cha,2,3 Y Hu,1 H Chiu1 and M Kuo2,3 1 Department of Dermatology, College
of Medicine, National Taiwan University, Taipei, Taiwan, 2 Graduate Institute of Toxicology,
College of Medicine, National Taiwan University, Taipei, Taiwan and 3 Angiogenesis Research
Center, National Taiwan University, Taipei, Taiwan
Basal cell carcinoma (BCC) is one of the most common skin neoplasm in humans and is charac-
terized by local aggressiveness with little metastatic potential. Recently, CXCR4 expression was
shown in previous studies to enhance invasiveness and angiogenesis of BCC cells. In our previous
study, we also found invasive types (morphea or infiltrative type) of BCCs had higher expression of
CXCR4 protein as compared to those of non-invasive types. In this study, we investigated mecha-
nism involved in the regulation of CXCR4 expression in invasive type BCCs. We found that inva-
sive type BCC specimens had higher expression of transforming growth factor-β1 (TGF-β1) and con-
nective tissue growth factor (CTGF) mRNAs than non-invasive type BCCs. In addition,
immunohistochemical studies revealed intensely staining of TGF-β1 and CTGF in the surrounding
fibroblasts of invasive type BCCs which were positively correlated with the CXCR4 expression on
BCC tumour nest cells. Non-contact co-culture of Hs68 fibroblast cell line cells with human BCC
cells also increased the expression of CXCR4 in human BCC cells. Treatment with recombinant
human TGF-β1, but not CTGF, enhanced the CXCR4 mRNA, protein and surface expression of
BCC cells in time- and does-dependent manners. The transcriptional regulation of CXCR4 by TGF-
β1 was mediated by phosphorylation of extracellular signal-related kinase 1/2 (ERK1/2) pathway. In
summary, this study indicated TGF-β1 mediated invasion of BCC via ERK1/2/CXCR4 signal cascade
in context of interaction between cancer associated fibroblasts and BCC.
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Glycolipid O-acetylation drives human squamous cell carcinoma proliferation and survival
via EGFR/Ras-independent activation of PKCα and Akt signaling
X Wang, A Aurora, H Iordanov, N Gatla, D Bach, E Angulo and AS Paller Dermatology,
Northwestern Univ., Chicago, IL
PKCα activation has recently been shown to correlate with more aggressive squamous carcinoma
cell (SCC) behavior, but the upstream triggers of PKCα activation are unknown. Ganglioside 9-O-
acetylGD3 (9AcGD3) is strongly expressed in SCCs, but not in normal epidermis or cultured ker-
atinocytes, suggesting a role for 9AcGD3 in SCCs. Indeed, a marked increase in proliferation was
noted when 9AcGD3 was ectopically expressed in SCC12 cells. Furthermore, in SCID mice, explants
of “9-O” cells, which stably overexpress 9-O-acetylGD3 synthase (O-AcGD3S; MFG-E8), had an
8-fold greater tumor volume than the tumors generated from mock-transfected SCC12 cells. The pro-
liferation of 9-O cells was not suppressed by the EGFR inhibitor AG1478, but was reduced to con-
trol levels by inhibition of PKCα. 9AcGD3 overexpression led to activation of PKCα, Akt, PI3K and
ERK, while an antibody directed against 9AcGD3 reversed the increase in PKCα activation. Increased
expression of cyclin E and Bcl-2, markers of cell cycling and survival, respectively, were observed
in “9-O” cells. Such increases correlate with a poor prognosis in patients with SCCs. While sup-
pression of either PKCα or Akt markedly inhibited expression of cyclin E and Bcl-2 in 9-O cells,
inhibition of PI3K, ERK or the combination of PKCα and Akt totally eliminated cyclin E and Bcl-2
expression. Raf inhibition, but not EGFR or Ras, suppressed the stimulatory effect of O-AcGD3S on
cell growth and survival, further supporting the role of PKCα activation in O-AcGD3S-driven pro-
liferation and survival. Furthermore, inhibition of PKCα or Akt suppressed ERK, but not PI3K acti-
vation, suggesting that ERK is downstream, while PI3K is required for either PKCα or Akt activation
in 9-O cells. These results suggest that overexpression of O-AcGD3S, leading to 9AcGD3 expres-
sion, drives the activation of PI3K, PKCα and Akt in SCCs and raises the possibility of targeting O-
AcGD3S or 9AcGD3 as a therapy.
113
Akt inhibits autophagy through Beclin 1 phosphorylation and formation of a Beclin 1/keratin
intermediate filament Complex
RC Wang,1 Y Wei2 and B Levine2,3 1 Dermatology, UT Southwestern, Dallas, TX, 2 Internal
Medicine, UT Southwestern, Dallas, TX and 3 Howard Hughes Medical Institute, Dallas, TX
While the catabolic processes of autophagy are essential during stressors like starvation, its activ-
ity is carefully restricted during cell growth. Although mTOR contributes to the inhibition of autophagy
through its phosphorylation of ULK, the possible role of other growth signaling pathways is incom-
pletely understood. We present evidence for a novel model of autophagy regulation in which growth
signals inhibit autophagy upstream of mTOR through Akt. Active Akt1 binds and phosphorylates
Beclin 1 in vitro and in vivo. The modification of Beclin 1 by Akt1 generates a phosphomotif, which
allows 14-3-3 binding proteins to bind in a regulated manner. These 14-3-3 proteins in turn medi-
ate Beclin 1’s interaction with phosphorylated Type I keratin intermediate filaments. Importantly, a
non-phosphorylatable mutant of Beclin 1 can bind neither 14-3-3 nor keratins. Moreover, a mutant
of keratin that cannot bind 14-3-3 also fails to interact with Beclin 1. The disruption of the complex
either through the expression of nonphosphorylatable Beclin 1 mutants or through the depletion of
keratins results in the induction of autophagy. The expression of the nonphosphorylatable Beclin 1
mutant also has effects on tumorigenesis in vitro. Thus, active Akt keeps Beclin 1 in an inactive
complex with 14-3-3 and keratins, suggesting a novel mechanism for the regulation of autophagy
by the PI3K-Akt signaling pathway.
112
In-situ expression of fas apoptotic pathway proteins in archival samples of cutaneous t-cell
lymphoma (ctcl), cutaneous anaplastic large cell lymphoma (alcl) and lymphomatoid papu-
losis (lyp)
N Stutz,1 RD Johnson1 and GS Wood1,2 1 University of Wisconsin, Madison, WI and 2 VAMC,
Madison, WI
Our published studies of in-situ FAS expression in frozen sections showed that many CTCL skin
lesions did not strongly express FAS, suggesting apoptotic resistance (AR). To explore this concept
more comprehensively, we performed immunoperoxidase studies of death receptor FAS, its ligand
(FASL) and inhibitor cFLIP in paraffin sections of lesional skin biopsies. We studied CTCL, ALCL
and LyP in order to compare and contrast cutaneous T-cell lymphoproliferative disorders that typi-
cally do not regress spontaneously (CTCL, ALCL) with one that does (LyP). AR by means of FAS defi-
ciency or FAS/cFLIP co-expression has been documented by us and others for CTCL lines and cases
of leukemic CTCL as well as for 4 ALCL cell lines. Consistent with these findings 32/33 CTCL lesions
were FASL-low while 30/33 were either FAS-low or co-expressed both FAS and cFLIP (a FAS path-
way inhibitor). Similarly 3/3 of ALCL indicated AR by either high Fas/ high cFLIP or low Fas/low
cFLIP combinations. While ALCL and CTCL represent a progressing tumor disease, LYP is charac-
terized by recurrent crops of spontaneously regressing cutaneous papules containing large atypical
lymphoid cells. Regression is preceded by ulceration. We compared the FAS/FASL/cFLIP expres-
sion of CTCL/ALCL to that of 22 LyP biopsies. Of 17 non-ulcerated lesions, most (15/17) had large
atypical cells that were FASL-low, suggesting AR. High expression of FAS (11) or cFLIP (9) was more
mixed. However, most of the FAS-high lesions (7/11) were also cFLIP-high, again suggesting AR. In
contrast, among 5 ulcerated spontaneously regressing lesions, the phenotype of the large atypical
cells was suggestive of sensitivity to apoptosis. Most (4/5) were FASL-high and most (4/5) were FAS-
high/cFLIP-low. These findings document our ability to detect a variety of FAS pathway expression
patterns in-situ in paraffin sections and provide a strong correlation between apoptosis-resistant
and apoptosis-sensitive phenotypes and clinical evidence of T-cell death.
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Inhibition of vascular endothelial growth factor receptor 3 ligands inhibits tumor develop-
ment in a model of multistep skin carcinogenesis
AK Alitalo, D Aebischer, N Schneider, R Huggenberger and M Detmar Institute of
Pharmaceutical Sciences, Swiss Federal Institue of Technology Zurich, Zurich, Switzerland
In this study, we address the functional blockage of the vascular endothelial growth factor (VEGF)-
C/D - VEGF receptor-3 (VEGFR-3) pathway as a potential method to inhibit the growth and metas-
tasis of squamous cell carcinomas in a mouse chemical skin carcinogenesis model. Previous stud-
ies have shown that inhibition of the VEGF-A - VEGFR-2 signalling inhibits tumor growth in mouse
xenograft and transgenic tumor models. Besides VEGF-A, VEGF-C is also elevated in human squa-
mous cell carcinomas (SCCs) and there is evidence that it plays an important role in tumor pro-
gression. Thus, we induced squamous cell carcinomas of the skin in transgenic mice in which VEGF-
C/-D signalling is blocked by expression of a soluble form of the VEGFR-3 (VEGFR3-Ig) in skin
keratinocytes. Compared to wild-type controls, the VEGFR3-Ig transgenic mice developed signifi-
cantly fewer papillomas per mouse and also fewer SCCs. Analysis of blood vessel density in the
carcinogen-treated skin and in tumors indicated an attenuated angiogenic response in the trans-
genic mice, whereas lymphangiogenesis was completely blocked. Interestingly, the transgenic mice
showed signs a of decreased inflammatory response during the carcinogenesis treatment. The trans-
genic mice had less inflammatory cells in the skin and less macrophages in carcinogen-treated skin
and in carcinomas, as analyzed with antibodies against the leukocyte common antigen CD45 and
the macrophage marker CD11b. In conclusion, our results indicate that the functional blockage of
VEGF-C/-D - VEGFR-3 signalling inhibits the development of squamous cell papillomas, an effect
potentially mediated by inflammatory and vascular mechanisms.
114
Relation between DNA damage accumulation, reactive oxygen species, and metabolism alter-
ation during carcinogenesis
HR Rezvani,1,2,3 A Kim,2 HD Verneuil,1 A Taieb,1,3 D Bickers2 and F Mazurier1,3 1 Inserm U1035,
Univ Victor Segalen Bordeaux 2, Bordeaux, France, 2 Dermatology, Columbia University, New
York, NY and 3 National Reference Centre for Rare Skin Disorders, Bordeaux, France
DNA damage is a well-known initiator of tumorigenesis. Studies have shown that most cancer cells
rely on aerobic glycolysis for their bioenergetics. We sought to identify a molecular link between
genomic mutations and metabolic alterations in neoplastic transformation. We took advantage of
the intrinsic genomic instability arising in xeroderma pigmentosum C (XPC). The XPC protein plays
a key role in recognizing DNA damage in nucleotide excision repair, and patients with XPC defi-
ciency have increased incidence of skin cancer and other malignancies. In cultured human ker-
atinocytes, we showed that lentivirus-mediated knockdown of XPC reduced mitochondrial oxida-
tive phosphorylation and increased glycolysis, recapitulating cancer cell metabolism. Decreases in
the NADH dehydrogenase subunit 1 and cytochrome c oxidase subunit III; and increases in pro-
teins involved in glucose uptake and lactate generation were associated with the modified metab-
olism. We found that accumulation of unrepaired DNA following XPC silencing increased DNA-
dependent protein kinase activity, which subsequently activated AKT1 and NADPH oxidase-1
(NOX1), resulting in ROS production and accumulation of specific deletions in mitochondrial
DNA (mtDNA) over time. Subcutaneous injection of XPC-deficient keratinocytes into immunode-
ficient mice led to squamous cell carcinoma (SCCs) formation, demonstrating the tumorigenic poten-
tial of transduced cells. While enforcing antioxidant defenses by overexpressing catalase, CuZn-
SOD, or MnSOD could not block the metabolism remodeling, conversely, simultaneous knockdown
of either NOX1 or AKT1 blocked the metabolism alteration and the neoplastic transformation induced
by XPC silencing. As we further observed NOX-1 activation in human SCCs, the blockade of NOX-
1 could be a target for the prevention and the treatment of skin cancers.
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Lysate from cultured fetal fibroblast for skin rejuvenation: Composition and in vitro activities
J Eberle,2 F Dreher1 and E Stockfleth2 1 Neocutis Inc., San Francisco, CA and 2 Charité -
Universitätsmedizin Berlin, Berlin, Germany
A cell lysate (Processed Skin Cell Proteins, PSP®) obtained after freeze-thawing of fetal fibroblasts
originating from a characterized cell bank has been shown to reduce skin wrinkles. This study aimed
to characterize the lysate with respect to growth factor and cytokine composition as well as to assess
its effects on proliferation and apoptosis in cultured normal human epidermal keratinocytes and
dermal fibroblasts. Since the lysate comprises a series of proliferative cytokines, its effects were fur-
ther tested in cutaneous squameous cell carcinoma (SCC) cells, and interference with death ligand-
mediated apoptosis was investigated in vitro. As shown with a cytokine antibody array, which allows
simultaneous, semi-quantitative detection of 120 cytokines, a large number of growth factors such
as epidermal growth factor, fibroblast growth factors, transforming growth factor-β, vascular endothe-
lial growth factor as well as anti- and pro-inflammatory interleukins were detected. The lysate pro-
moted proliferation of cultured keratinocytes and fibroblasts in a dose-dependent manner at non-
cytotoxic concentrations of up to 0.25%, as shown by real-time cell analysis and [3H]-thymidine
incorporation, respectively. Importantly, the lysate did not significantly stimulate proliferation of four
SCC lines (SCL-I, SCL-II, SCC-12, SCC-13) but reproducibly decreased their proliferation at higher
concentrations (1%). In some SCC cell lines, 1% of the lysate also slightly increased apoptosis, as
assessed by cell cycle analysis after propidium iodine nuclear staining (sub-G1) and DNA frag-
mentation analysis (ELISA). The lysate was further shown to enhance death ligand-induced apop-
tosis in SCC cell lines either of agonistic CD95 antibody (CH-11) or of TNF-related apoptosis-
inducing ligand (TRAIL), which was cell line specific. Concluding, this study indicates that the growth
factor containing lysate PSP promotes proliferation of normal skin cells without significantly pro-
moting SCC cell growth or interfering with death ligand-mediated apoptosis in vitro.
104
ADAMTS-12: A biomarker for nonmelanoma skin cancer disease progression
LS Peng and S Regan Medicine/Dermatology, University of Arizona, Tucson, AZ
The ADAMs (A Disintegrin and Metalloproteinase) and ADAMTSs (ADAM with thrombospondin-
like motifs) comprise a family of multidomain transmembrane and secreted proteins involved in
cytokine and growth factor release, proteolysis and cell adhesion. Multiple family members have
been shown to play a role in cancer formation and disease progression. Increased ADAMTS-12
expression has been found in the stroma during colon cancer progression. It has been suggested
that ADAMTS-12 may play a role in the host response to tumor progression via the Ras-dependent
ERK signaling pathway. Substantially more than 1 million cases of non-melanoma skin cancer (NMSC)
occur annually in the United States according to the American Cancer Society. Basal cell carcinoma
(BCC) and squamous cell carcinoma (SCC) are the two major types of NMSC and most are related
to chronic sun exposure. We have demonstrated by microarray analysis that ADAMTS-12 expres-
sion is increased in human keratinocytes chronically irradiated with a solar-simulated light source.
Using a human SCC skin carcinogenesis model, we have demonstrated that ADAMTS-12 expres-
sion correlates with disease progression. We believe that ADAMTS-12 may be important in the host
response to SCC progression and may serve as a biomarker of human skin SCC disease. This may
be important for earlier detection and for the possible development of targeted therapy that may
serve as an alternative to potentially disfiguring surgical treatment.
105
The role of transcription factor RBP-J-mediated signaling in basal cell carcinoma growth
M Yu,1 D Zloty,1 RH Bell,2 A Haegert,2 N Carr,3 J Shapiro,1 B Cowan,1 L Warshawski1 and
KJ McElwee1 1 Dermatology Department, Vancouver Coastal Health Research Institute,
Vancouver, BC, Canada, 2 Surgery Department, Prostate Centre, Vancouver, BC, Canada and
3 Surgery Department, Plastic Surgery Division, Vancouver, BC, Canada
Hair follicles (HF) and basal cell carcinomas (BCCs) can be regarded as ordered and disordered
skin appendages respectively. Multiple reports suggest that a significant subset of basal cell carci-
nomas (BCCs) are directly HF-derived. They may utilize similar molecular mechanisms of growth.
We examined the similarities and differences in gene expression by microarrays between nodular
BCCs and HFs including the bulge region which has been identified as a potential primary source
of BCCs. Microarray data was validated using quantitative PCR, immunohistochemistry and in vitro
studies. Two differentially expressed gene sets were identified by significance analysis of microar-
ray (SAM) in BCC and HF versus skin epithelium respectively. Subsequently, multiple signaling path-
way analyses were conducted. The results indicated specific molecular mechanisms involved in
the process of self renewal, such as Notch and Hedgehog pathways, were active in the growth of
both HF and BCCs. However, Notch signaling, including tumor suppressor genes NOTCH1,
NOTCH2, ligands JAG1, JAG2, signaling inhibitor NUMB, and downstream Notch pathway genes
DTX1, DTX2, RBP-J, LFNG, HR, and HES7, all showed significant differential expression in BCCs
compared to HF. The data suggests downstream gene expression in the Notch signaling pathway
components that code for HF may be suppressed in BCCs. We tested the effect of transcription fac-
tor RBP-J and found transcription factor RBP-J-mediated signaling suppresses BCC cell growth and
induces cell apoptosis in vitro. Jag1- induced notch signaling pathway activation can increase HF
keratinocyte proliferation and differentiation via a RBP-J -dependent pathway in vitro. Our data
suggest that RBP-J, which is important for appropriately regulated HF formation, serves as a tumor
suppressor in BCC. Modulation of the Notch pathway may be a focus for the development of BCC
treatments.
106
A genetic appraisal of the frequency of functional RET G691S polymorphism in the pure ver-
sus the mixed variants of desmoplastic melanoma
S Yang,1 A Emley,2 A Deng,3 MP Hoang4 and M Mahalingam2 1 Department of Pathology,
Boston University School of Medicine, Boston, MA, 2 Dermatopathology Section, Department
of Dermatology, Boston University School of Medicine, Boston, MA, 3 Department of
Pathology, UMASS Medical School, Worcester, MA and 4 Department of Pathology,
Massachusetts General Hospital, Boston, MA
The higher incidence of lymph node involvement in desmoplastic melanoma (DM) with an admixed
component of epithelioid cells supports the clinical usefulness of classifying DM into histologic sub-
types of pure (PDM) and mixed (MDM). The RET proto-oncogene (RETp) is a receptor tyrosine kinase
whose ligand is glial cell line-derived neurotropic factor (GDNF) and polymorphism at codon G691S
juxtamembrane region (RETp) is a germline polymorphism. Activation of RET induces signaling
through the RAS-BRAF-ERK pathways, known to be involved in carcinogenesis of conventional
melanoma, albeit not in DM. Since DM is highly neurotropic, we hypothesize that RETp may play
a role in enhancing the more aggressive clinical course associated with MDM. Genomic DNA was
isolated from 41 cases (24 PDM and 17 MDM) to assess the frequency of RETp G691s polymor-
phism. Analysis of BRAFV600E was also undertaken. We identified RETp G691S polymorphism in
12/41 (29%) cases of DM; four MDM (24%) and 8 PDM (33%). The only case with a BRAFV600E
mutation did not exhibit G691S polymorphisms in RETp. The lack of statistically significant differ-
ences between frequencies of RETp G691S polymorphism in MDM and PDM argues against the
relevance of RETp in the enhanced propensity for lymph node involvement by the former. The
increased frequency of RETp G691S polymorphism in DMs however suggests that it may be of sig-
nificance in the increased incidence of neurotropism observed in this variant of melanoma.
107
CXCR3/ligand signaling is important for the development of non-melanoma skin cancer ker-
atinocytes
BK Lo,1 N Tai,1 L Chen,1 Y Zhou,1,2 D Zloty,2 B Cowan,2 J Shapiro2 and KJ McElwee1 1
Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada and 2
Dermatology and Skin Science, Vancouver General Hospital, Vancouver, BC, Canada
Cutaneous squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) are the most common
non-melanoma skin cancers (NMSC). Previously we showed that chemokine receptor CXCR3 sig-
naling was an essential mediator for primary human BCC-derived cell growth in vitro. However,
the effects of CXCR3 on SCC and its pre-cancerous forms have yet to be established. We hypothe-
sized that CXCR3 signaling may be involved in the growth of NMSC including SCC. We evaluated
gene expressions of 18 chemokines/receptors in 10 SCC, 5 BCC, 10 seborrheic keratosis, 6 actinic
keratosis, and 5 Bowen’s disease biopsies by real-time RT-PCR as compared to 13 normal skin epithe-
lium samples. We conducted dual immunohistochemistry (IHC) of keratin 13 (K13) and CXCR3 in
SCC biopsies. We applied CXCR3 neutralizing antibody with or without its CXCL11 ligand to a
human immortalized keratinocyte cell line, HaCaT cells and evaluated cell growth. Also, we assayed
the migration and invasion response of HaCaT cells towards recombinant CXCL11. The mRNA for
CXCR3 and its ligands were upregulated at the highest levels in SCC. Dual IHC revealed colocal-
ization of CXCR3 and K13, a SCC keratinocyte marker, in SCC biopsies. Neutralization of CXCR3
bioactivity in HaCaT cells led to substantially reduced cell growth rates and enhanced apoptosis.
Treatment of anti-CXCR3 plus CXCL11 peptide on HaCaT cells led to similar results as compared
to the cells treated with CXCL11 only. CXCL11-treated HaCaT cells partially recovered when CXCR3
neutralization was removed. The migration and invasion of HaCaT cells increased significantly
towards CXCL11 peptide in a dose dependent manner. Taken together, CXCR3/ligand signaling
may be important for cell growth and survival as well as invasive characteristics in cancerous ker-
atinocytes, especially in SCC. Targeting CXCR3/ligands may be effective in treating non-melanoma
skin lesions.
108
Expression of epidermal growth factor receptor (EGFR) and detection of mutant EGFR
(EGFRvIII) in human cutaneous squamous cell carcinoma
M DeMara,1 N Duncan,1 S Wong,2 M Neuburg,1 Z Lazarova1 and EB Olasz1 1 Dermatology,
Medical College of Wisconsin, Milwaukee, WI and 2 Oncology, Medical College of Wisconsin,
Milwaukee, WI
Epidermal growth factor receptor (EGFR) is overexpressed in large percentage of cutaneous squa-
mous cell carcinomas (SCC). Therapeutic trials using EGFR blockade to treat high-risk or metasta-
tic squamous cell carcinoma are ongoing. The most common form of mutant EGFR (EGFRvIII) has
been described in several cancers, including head and neck cancer. It has been shown that EGFRvIII
contributes to enhanced growth of SCC and resistance in targeting wild-type EGFR. To date expres-
sion of EGFRvIII has not been evaluated in human SCC. Our goal was to assess expression of wild-
type EGFR and EGFRvIII in SCC and correlate it with tumor biology. SCC specimens (n=50) from
patients undergoing Mohs micrographic surgery were collected consecutively. Tumor specimens
were embedded in paraffin and assessed for EGFR expression by immunohistochemistry while
EGFRvIII expression was determined by RT-PCR. A representative SCC cell line stably transfected
with an EGFRvIII expression construct served as a positive control. Ten (20%) in situ, 16 (32%) well-
differentiated, 8 (16%) moderately-well differentiated and 8 (16%) poorly differentiated tumor
were included in the study, 8 (16%) was excluded due to insufficient tumor volume. Eight of the
tumors (16%) were collected from solid organ transplant patients. All tumors (100%) were positive
for EGFR, with variation in intensity and proportion of labeled cells. EGFR expression, however, was
not correlated with tumor differentiation, anatomic location or transplant status. Surprisingly, none
of the tumors (0%) expressed EGFRvIII mRNA. Evaluation of metastatic SCC for the mutant EGFR
is currently underway. The lack of mutant EGFRvIII expression may have implications on the design
of future clinical trials using EGFR inhibitors for treatment of high risk cutaneous SCC.
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Platelet derived growth factor (PDGF) directly binds to integrins and this interaction plays a
role in PDGF signaling
P Davari,1,2 TJ Dickerson,1,2 YK Takada1,2 and Y Takada1,2 1 Dermatology, University of California
Davis School of Medicine, Sacramento, CA and 2 Biochemistry and Molecular Medicine,
University of California Davis School of Medicine, Sacramento, CA
It has been well established that integrins play a role in growth factor signaling (integrin-growth fac-
tor crosstalk). Recently, we demonstrated that direct binding of integrins to IGF-1, FGF-1, and neureg-
ulin-1 is critical for growth factor/receptor signaling, and these growth factors induce a ternary com-
plex formation (integrin-growth factor-growth factor receptor). Notably, excess mutants suppress the
signaling induced by wild-type growth factors (dominant-negative effect). This suggests that growth
factor-integrin interaction may be a possible mechanism of the crosstalk. PDGF plays a role in wound
healing, fibrosis, and cancer progression and it would be a novel therapeutic target. It has been
reported that PDGFRβ co-precipitates integrin αvβ3. We tested the possibility that PDGF-BB may
bind to integrins and mediate PDGFR-integrin association. Here we discovered that PDGF-BB specif-
ically bound to integrins. We generated a PDGF-B mutant that was defective in integrin binding.
We found that the mutant was defective in inducing cell proliferation and inducing PDGFR phos-
phorylation and AKT and ERK1/2 activation in NIH 3T3 fibroblasts, while it still bound to PDGFR.
Interestingly, excess mutant suppressed proliferation and intracellular cell signaling induced by wild-
type PDGF in NIH 3T3 cells (a dominant negative effect). These results suggest that direct binging
of integrin to PDGF is a potential mechanism for PDGF-integrin cross-talk and may play a remark-
able role in PDGF signaling through ternary complex formation (integrin-PDGF-PDGFR). Addi-
tionally, the novel PDGF mutant may have potential as a therapeutic agent.
123
The p38 mitogen-activated protein kinase isoforms p38β and p38δ are essential in vivo reg-
ulators of mouse skin carcinogenesis
AC Koppel,1 C Lin,1 C Burns,1 E Gribben,1 J Anders,2 C Cataisson,2 SH Yuspa,2 GE Kissling,3
M Blumenberg,4 JC Arthur5 and T Efimova1 1 Dermatology, Washington University School of
Medicine, St. Louis, MO, 2 Laboratory of Cancer Biology and Genetics, NCI, NIH, Bethesda,
MD, 3 Biostatistics, NIEHS, Research Triangle Park, NC, 4 Dermatology, NYU School of
Medicine, New York, NY and 5 MRC Protein Phosphorylation Unit, Faculty of Life Sciences,
University of Dundee, Dundee, United Kingdom
The p38 family includes α, β, γ and δ isoforms. Much remains to be learned about the contribution
of each isoform to skin carcinogenesis. p38α and p38δ are highly expressed in normal epidermal
keratinocytes, while p38β expression is low, and p38γ is undetectable. Our previous studies showed
that p38δ-null mice have significantly reduced susceptibility to chemical skin carcinogenesis com-
pared with wild-type (wt) mice, due to aberrant proliferation during tumor promotion. Using ortho-
topic skin grafting of v-rasHa-transduced wt and p38δ-null keratinocytes onto nude mice, we now
report that malignant conversion rate was reduced in p38δ-null tumors, suggesting that endoge-
nous keratinocyte p38δ functions together with oncogenic Ras to promote malignant conversion.
Expression profiling analysis revealed multiple genes differentially regulated in p38δ-null keratinocytes
upon transformation with v-rasHa or TPA exposure. p38β and p38γ expression is increased in chem-
ically-induced mouse skin tumors, suggesting a potential role for p38β and p38γ in skin tumorige-
nesis. Using chemical carcinogenesis protocol, we report that p38β-null mice displayed extended
tumor latency and fewer tumors relative to wt mice, but showed enhanced malignant conversion
to squamous cell carcinomas. Simultaneous genetic ablation of p38γ in the context of p38δ defi-
ciency did not impart additional protection against skin tumorigenesis, indicating that p38γ is dis-
pensable for skin carcinogenesis in this model. Altogether, our findings suggest that p38β and p38δ
are essential in vivo regulators of skin carcinogenesis.
125
Intact p53 functionality in murine basal cell carcinomas in ionizing radiation-treated Ptch1+/-
mice
GY Wang, L Wang, J Wang, E Libove and EH Epstein Children’s Hospital Oakland Research
Institute, Oakland, CA
Human basal cell carcinomas (BCCs), the most common human cancer, typically arise in sun-dam-
aged skin containing epidermal clones of p53 mutant cells, implying that p53 is a crucial BCC tumor
suppressor. In line with this notion, we found that deletion of p53 specifically in K14-expressing
keratinocytes dramatically accelerates BCC carcinogenesis in ionizing radiation (IR)-treated Patched
1 (Ptch1)+/- mice. In IR-treated Ptch1+/- mice without p53 deletion, visible BCCs can also arise
from but with longer tumor latency (9m vs. 5m) and a lower tumor incidence and multiplicity. How-
ever it is not known whether loss of p53 signaling activity is required for the development of visi-
ble BCCs in p53+/+ mice. To address this question, we compared p53 signaling activity in IR-induced
BCCs in Ptch1+/- p53+/+ mice vs. in BCCs in Ptch1+/- p53-/- mice after a second, DNA-damaging
dose of IR. Using immunohistochemistry, we found the expected minimal IR-induced expression
of p53, Puma, and Noxa as well as TUNEL-detected apoptosis in BCCs of p53-deleted mice. By
contrast, IR induced robust expression of p53, Noxa, Puma, and apoptosis in BCCs from Ptch1+/-
p53-intact mice. Without IR exposure, BCCs in p53+/+ mice had scattered p53+ cells and low
level of expression of Puma and Noxa but no TUNEL+ cells. Our data thus suggest that IR-induced
BCCs generated in Ptch1+/- p53+/+ mice retain their functional p53 signaling capacity and that
these tumors are able to evade an intact DNA damage response.
124
An inflammatory response in the ΔNp63 transgenic mice reveals a pro-tumorigenic role for
ΔNp63
R Romano and S Sinha Biochemistry, SUNY at Buffalo, Buffalo, NY
While it is clear that the p63 family of transcription factors play an indispensible role in skin epithe-
lial development, differentiation, and homeostasis, their contribution to tumor development is quite
complex. This stems primarily from the dual and opposite functions of the ΔNp63 and TAp63 iso-
forms. Indeed, studies support the view that TAp63, like p53, exhibit tumor-suppressive properties,
while upregulation of the ΔNp63 isoforms is a common and distinctive feature of tumorigenesis in
a variety of human tumors of squamous cell origin. The ΔNp63 isoforms are prominently expressed
in keratinocytes, where they sustain pro-survival and pro-proliferative signals and regulate a cohort
of genes involved in various cellular programs. It is therefore plausible that the dysregulated expres-
sion of this transcriptional regulator is important for various facets of the tumorigenic process,
although direct experimental support for such a role is lacking. To explore this possibility, we have
generated inducible transgenic animals with targeted expression of ΔNp63 to the basal layer of the
epidermis. Interestingly, sustained induction of ΔNp63 in adult mice led to severe epidermal hyper-
plasia, aberrant cellular differentiation, and improper wound healing. Furthermore, the ΔNp63 trans-
genic skin exhibited a chronic and reactive inflammatory microenvironment marked by widespread
neutrophil, macrophage, and lymphocyte infiltration. Remarkably overexpression of ΔNp63 in the
epidermal keratinocytes of the transgenic animals triggered the ectopic expression of various mark-
ers associated with EMT, a feature that is intimately associated with tumor progression. Finally, global
transcriptome analysis and comparison of transgenic skin to control skin revealed widespread changes
in the chemokine/cytokine profile, with predominant activation of the IL-6/Stat3 signaling pathway
as a critical component of the molecular phenotype. Together, our data suggests that elevated lev-
els of ΔNp63 function in a pro-tumorigenic fashion by sustaining a hyperproliferative and inflam-
matory niche that might facilitate tumor development.
122
Regulation of FAS expression in cutaneous T-Cell lymphoma
J Wu1,2 and GS Wood1,2 1 Dermatology, University of Wisconsin Madison, Madison, WI and 2
Dermatology, VAMC, Madison, WI
The FAS pathway is a major mediator of T-cell apoptosis. In CTCL, there is a direct relationship
among the level of FAS protein, FAS transcript and sensitivity to FAS mediated apoptosis. There is
an inverse correlation between these three features and FAS promoter methylation. Demethylation
of the FAS promoter restores FAS expression and enhances apoptotic sensitivity. We observed that
methotrexate (MTX) functions as a demethylator probably by depleting SAM, the principal methyl
donor for DNA methyltransferases. MTX reduces FAS promoter methylation and increases FAS expres-
sion by FAS-low HH, SZ4 and CTCL blood cells. Interferon-alfa (IFNa) increases FAS expression by
a different mechanism. STAT1 induced by IFNa binds to a non-methylated FAS promoter element
involving nt -671 that can be either A (wildtype) or G (SNP). Among Caucasians, the prevalence of
the homozygous GG SNP is 20% while among Caucasians with CTCL, the prevalence is 30%
(p<0.03). Oligos bearing the G SNP bind less STAT1 compared to wildtype. Luciferase reporters
show lower basal and IFNa-induced FAS promoter activity for the G SNP construct compared to
wildtype. CTCL cells with the -671 GG genotype fail to up-regulate FAS in response to IFNa whereas
those with the homozygous (AA) or hemizygous (A) genotype do up-regulate FAS. Loss of FAS alle-
les occurs in FAS-hemizygous HH and FAS-null SeAx, suggesting deletion as a means for somatic
conversion of the germline -671 AG genotype to hemizygous -671 G and acquisition of IFNa resist-
ance. These results demonstrate that MTX and IFNa can augment FAS expression via two distinct
promoter mechanisms, one involving epigenetic methylation and the other involving a germline
SNP. They may help explain the previously reported high response rate of advanced CTCL to MTX/IFNa
therapy. Regarding upstream regulation of FAS, FAS-high MyLa had low promoter methylation,
DNMT-1, activated STAT3 and activated c-Jun. The opposite was true for FAS-low HH. These rela-
tionships are consistent with the known induction of DNMT-1 by STAT3, and the known inhibition
of FAS transcription by combined STAT3/c-Jun.
126
Fusion of the melanoma gene, p14arf on 9p, to a translocation hotspot in a gap in 22q in a
patient with melanoma, deafness and DNA repair deficiency, is a negative regulator of p14arf
and TBX1
X Tan,1 SL Anzick,2 SG Khan,1 T Ueda,3 G Stone,2 JJ DiGiovanna,1 D Tamura,1 D Wattendorf,6
C Brewer,4 C Zalewski,4 R Walker,2 A Griffith,4 J Butman,5 P Meltzer,2 P Bergstresser7 and
KH Kraemer1 1 Derm Br, NCI, Bethesda, MA, 2 Genetics Br, NCI, Bethesda, MA, 3 Pharm/ Med
Dev, Tokyo, Japan, 4 Otolaryn Br, NIDCD, Bethesda, MD, 5 Radiology Dept, CC, Bethesda,
MD, 6 DARPA, Washington, DC and 7 Derm, Univ of Texas SW Med Ctr, Dallas, TX
The role of CDKN2A suppressor gene p14ARF in melanoma is unclear. We studied a 12 y/o boy
(DD129BE) with melanoma, DNA repair deficiency, congenital deafness due to failure of develop-
ment of the inner ear, and features of DiGeorge Syndrome with a novel chromosome translocation
t(9;22)(p21;q11.2). A comprehensive analysis was performed by fluorescent in situ hybridization,
array comparative genome hybridization on flow-sorted derivative chromosomes, and by expres-
sion and function analysis. There was under-expression of p14arf and TBX1 mRNA and protein
despite the presence of the normal chromosomes 9 and 22. The 9p21 breakpoint was located in
p14ARF intron 1. The DNA repair deficiency in DD129BE fibroblasts was improved by transfection
with p14ARF. Laser capture microdissection of a melanoma revealed two heterozygous UV–type
missense mutations in CDKN2A exon1β in addition to the 9,22 translocation. The 22q11.2 break-
point was located in a palindrome AT rich repeat (PATRR) translocation hotspot in an unclonable
gap near a predicted gene (loc653203) but 800kb from TBX1. A chimeric p14arf-loc653203 tran-
script was detected. Targeted inhibition of the chimeric transcript by siRNA resulted in increased
expression of p14ARF and TBX1 mRNA and protein. We propose a model in which the chimeric
transcript resulted in reduced expression of p14arf and TBX1. The melanoma is caused by disrup-
tion of one allele of p14arf by the translocation and disruption of the other allele by mutations. The
down-regulation of TBX1 contributed to the deafness and other developmental features of the patient.
The chimeric transcript could provide a unique target for skin cancer prevention in this patient.
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The developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcino-
mas
G Spallone,1 E Botti,1 F Moretti,1 B Marinari,1 V Pinetti,1 S Chimenti,1 M Fanciulli,2 G Blandino,2
L Guerrini3 and A Costanzo1 1 Dermatology, University of Rome Tor Vergata, Roma, Italy, 2
Oncogenomic Centre, Regina Elena Cancer Centre, Roma, Italy and 3 Cell Biology, University
of Milan, Milano, Italy
The transcription factor IRF6 regulates craniofacial development and epidermal proliferation. We
have recently demonstrated that IRF6 is a component of a regulatory feedback loop that controls
the proliferative potential of epidermal cells, being transcriptionally activated by ΔNp63 and induc-
ing its proteasome-mediated downregulation, thereby limiting keratinocyte proliferative potential.
We have hypothesized that IRF6 could be also involved in skin carcinogenesis. Therefore, we ana-
lyzed IRF6 expression in a large series of SquamoCellular Carcinomas finding strong downregula-
tion of IRF6 that correlated with their invasive and differentiation status. IRF6 downregulation in
SCC cell lines and primary tumors correlates with methylation on a CpG island located in its pro-
moter region. To identify the molecular mechanisms regulating IRF6 potential tumor suppressive
activity, we performed genome wide analysis by combining ChIP-seq for IRF6 binding sites and
gene expression profiling in primary human keratinocytes after siRNA-mediated IRF6 depletion. We
observed disregulation of cell cycle related genes and of genes involved in differentiation, cell adhe-
sion and cell-cell contact. Many of these genes were direct targets of the IRF6 transcription factor.
We also performed in vitro invasion assays demonstrating that IRF6 downregulation promotes tumor
cell invasivity and increases SCC side population. Reintroduction of IRF6 in SCC cells strongly
inhibits their growth as shown by colony forming assays. Our data highlights a novel function for
the developmental regulator IRF6 that exhibits tumor suppressor activity within carcinogenesis of
stratified epithelia.
116
Senescence in human basal cell carcinoma
MS Pirzado,1 MM Rahman,1 J Elliott,1 R Cerio,2 GW Neill1 and MP Philpott1 1 Center for
Cutaneous Research, Bilzard Institute of Cell and Molecular Sciences,, London, United
Kingdom and 2 BICMS Pathology Group, Blizard Institute of Cell and Molecular Science,
London, United Kingdom
Oncogene-induced senescence (OIS) has an important role in tumour biology as it represents a
physiological response that restricts the progression of benign tumours into their malignant coun-
terparts. Full malignancy is associated with the loss of important tumour suppressor genes includ-
ing RETINOBLASTOMA and/or TP53. Basal cell carcinoma (BCC) of the skin is the most common
skin tumour form and is associated with mutational inactivation of the PTCH1 tumour suppressor
gene (and less frequently oncogenic activation of SMOOTHENED). Although BCC does not appear
to stem from precursor lesions and is relatively stable at the genomic level, we sought to determine
if these unique tumours display any characteristics of OIS. Human BCCs were positive for Senes-
cence-associated β-galactosidase (SA-β-gal) activity (pH 6.0). Interestingly, SA-β-gal activity was
observed in stromal cells surrounding the tumour islands but only weakly in the tumour epithe-
lium; this may be due to UV irradiation which is known to induce senescence in cultured fibrob-
lasts and may also account for why BCCs are difficult to culture in vitro. Explant cultures of fibrob-
lasts from BCC expressed higher levels of senescence markers than dermal fibroblasts. Both tumour
epithelium and stroma also expressed known markers of senescence including DCR2, SHARP2
(DEC1) as well as the cell cycle inhibitors p15, p16 and p21. To determine if OIS is associated with
Hedgehog signalling in BCC, we employed a novel in vitro model of BCC created through PTCH1
suppression in human immortalised NEB1 keratinocytes. NEB1-shPTCH1 cells are viable and pro-
liferative (albeit more slowly than control NEB1-shCON cells) and do not display SA-β-gal activity
but they express higher levels of DCR2. Whether this is dependent upon p53 and/or the oncopro-
tein GLI1 which are also increased in NEB1-shPTCH1 cells is currently under investigation.
117
Aberrant regulation of keratinocyte migration by intracellular protein O-glycosylation in the
A431 squamous cell carcinoma cell line
M Bektas1 and D Rubenstein1,2,3 1 Dermatology, UNC-CH, Chapel Hill, NC, 2 Pharmacology,
UNC-CH, Chapel Hill, NC and 3 Lineberger Comprehensive Cancer Center, UNC-CH, Chapel
Hill, NC
O-glycosylation of serine and threonine residues is a common regulatory post-translational modi-
fication analogous to protein phosphorylation. Two intracellular enzymes, OGT and OGA, medi-
ate addition and removal, respectively, of N-acetylglucosamine (GlcNAc) from intracellular protein
substrates. Previous data from our group demonstrated that increased O-glycosylation stabilizes
cell-cell adhesion in part by increasing the post-translational stability of desmosome components
including plakoglobin. To investigate the ability of intracellular protein O-glycosylation to regulate
keratinocyte migration in HaCaT control and the A431 squamous cell carcinoma cell lines, phar-
macologic and genetic approaches were used to manipulate intracellular protein O-GlcNAc mod-
ification and the effects on cell migration determined using Boyden chamber assays. Intracellular
protein O-glycosylation levels were enhanced by treating cells with either the OGA inhibitor PUGNAc
or by transduction with lentivirus carrying OGA specific shRNA. Alternatively, viral transduction of
OGT specific shRNA were used to decrease protein O-glycosylation. In HaCaT control keratinocytes,
pretreatment with 50 uM PUGNAc inhibited migration towards serum. Similarly, HaCaT cells
transduced with shOGT showed more migration, while migration of shOGA transduced cells was
comparable to GFP shRNA and to non-transduced controls. In contrast, A431 cells treated with 50
uM PUGNAc for 24hr showed increased migration towards serum. Additionally, A431 cells trans-
duced with shOGT and shOGA migrated significantly more towards serum than GFP control shRNA
transduced cells. Thus, enhancing intracellular protein O-glycosylation inhibited cell migration in
control, but not malignant, keratinocytes. These observations suggest that normal processes regu-
lating cell migration by O-GlcNAc protein modification are dysregulated in squamous cell carci-
noma cell lines.
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An animal explant model for the study of human cutaneous squamous cell carcinoma (SCC)
DA Belkin,1 J Chen,1 JL Mo,1 DP Poppas,1 JG Krueger,2 D Felsen1 and JA Carucci3 1 Weill Cornell
Medical College, New York, NY, 2 Laboratory for Investigative Dermatology, Rockefeller
University, New York, NY and 3 New York University School of Medicine, New York, NY
Animal model systems are needed to study human SCC and to develop therapeutics. Models of
SCC include chemical carcinogens and the inoculation of SCID mice with human SCC cells. The
goal of this study was to develop a model that more closely resembles naturally-occurring human
SCC. Tumor bearing skin from 8 patients obtained at surgery was grafted onto nude rats (n=8) as
previously described by our group (Petratos et al., PRS 111:1988, 2003). After four weeks, tumors
were extracted. Gross examination during extraction revealed the presence of tumor nodules in all
rats (average size decrease approximately 40%). Staining was done on a portion of each tumor
retained prior to grafting and a sample from the same tumor post extraction. They were compared
for morphology, cell proliferation, cell death, and immune infiltrate. Morphology characteristic of
SCC remained after four weeks, as determined by H&E staining. These areas were identified as
human by HLA Class I staining, and SCC was confirmed by cytokeratin 5/6 staining. PCNA stain-
ing showed continued proliferation in some areas, whereas TUNEL staining for apoptotic cells was
less apparent. Human immune cells such as T cells (CD3+ and CD8+), regulatory T cells (foxP3+),
and dendritic cells (CD11c+) were present but scarce after four weeks. Human blood vessel endothe-
lial cells (PAL-E+) were virtually absent. Human SCC tumors implanted in the nude rat survive at
four weeks and retain characteristics of SCC including morphology and CK5/6+ staining. Although
proliferation was found in SCC tissue, there was shrinkage of tumor, which may reflect initial con-
traction due to poor blood supply before vessel in-growth presumably occurs. By including the
whole tumor and tumor bed, this model recapitulates the architecture and microenvironment of
human SCC more accurately than previous animal models and may serve as a useful system to study
and develop novel therapeutics.
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Immunosuppressive surface protein CD200 is up-regulated in the dermal microenvironment
of cutaneous squamous cell carcinoma (SCC)
DA Belkin,1 H Mitsui,2 M Suàrez-Fariñas,2 CQ Wang,2 KR Shah,2 I Coats,2 JG Krueger2 and
JA Carucci3 1 Department of Dermatology, Weill Cornell Medical College, New York, NY, 2
Laboratory for Investigative Dermatology, Rockefeller University, New York, NY and 3 Ronald
O. Perelman Department of Dermatology, NYU School of Medicine, New York, NY
SCC is the second most common human cancer, and aggressive cases are responsible for the approx-
imately 10,000 non-melanoma skin cancer deaths each year in the United States. Our group has
shown that the invasive capacity of SCC may be due to characteristics of its immune microenvi-
ronment. For example, dendritic cells in the SCC microenvironment are poor stimulators of T cell
proliferation compared to those in normal skin. In this study, we sought to further characterize the
immune microenvironment of SCC. Infiltrating cells surrounding SCC tumor nests and correspon-
ding dermal regions of normal skin biopsies were obtained by laser capture microdissection. This
was followed by cDNA microarray analysis with determination of the relative gene expression pro-
file in the tumor microenvironment compared with normal dermis. We found a 4.9 fold up-regu-
lation in surface glycoprotein CD200 in the SCC microenvironment. Protein level expression of
CD200 was confirmed with immunohistochemistry, which showed a significantly higher number
of CD200+ cells in the SCC microenvironment compared with normal dermis (180.8 per mm2 der-
mis vs 24.6, p=0.0071). Interestingly, immunofluorescence staining revealed CD200 was predom-
inantly expressed on PAL-E+ and CD31+ blood vessel endothelial cells in the SCC microenviron-
ment, but did not appear to be expressed on blood vessels in healthy skin. The surface glycoprotein
CD200 is known to be an immunosuppressive ligand and thought to maintain homeostasis in var-
ious tissues by inactivating CD200-receptor bearing immune cells, mainly myeloid lineage cells.
Our findings demonstrate blood vessels associated with the SCC microenvironment express CD200
and thus may explain in part the inactivation of immune cells associated with this cancer.
120
Catalase potentiates a sex discrepancy in myeloid-derived suppressor cell expansion in a
mouse model of ultraviolet light-induced skin cancer
NJ Sullivan,1 KL Tober,1 E Burns,1 J Schick,1 J Riggenbach,1 M Bill,2 G Young,3 TM Oberyszyn1 and
GB Lesinski2 1 Pathology, The Ohio State University, Columbus, OH, 2 Internal Medicine, The
Ohio State University, Columbus, OH and 3 Biostatistics, The Ohio State University,
Columbus, OH
Men are at higher risk of developing non-melanoma skin cancer, the most common type of human
cancer. UVB, a predominant risk factor, elicits immune suppression. One contributing factor to
inflammation-induced immune suppression and carcinogenesis is a heterogeneous population of
myeloid cells, known as myeloid-derived suppressor cells (MDSC). MDSC proliferation and differ-
entiation can be affected ex vivo by catalase, an endogenous antioxidant enzyme that detoxifies
hydrogen peroxide. The current study utilized the outbred, immune competent Skh-1 hairless mouse
model of UVB-induced non-melanoma skin cancer to further define mechanisms underlying sex
discrepancies in UVB-induced skin carcinogenesis. We detected MDSC in UVB-induced skin tumors
and demonstrated that male tumor-bearing mice exhibited more splenic MDSC compared to female
skin tumor-bearing mice, after adjusting for tumor burden. Acute UVB exposure increased splenic
MDSC levels and inhibited splenic T-cell proliferation. Baseline endogenous skin catalase activity
was lower in male compared to female mice. Diclofenac, a clinical NSAID, repressed acute UVB-
induced splenic MDSC expansion and enhanced skin catalase activity in male but not female
mice. Diclofenac inhibited male and female UVB-induced skin tumorigenesis, which indicates
that diclofenac may modulate distinct pathways in males and females. Catalase treatment inhibited
acute UVB-induced splenic and skin MDSC infiltration. Moreover, catalase inhibited UVB-induced
skin tumorigenesis. Collectively, these results strongly suggest that relatively lower male skin cata-
lase activity may increase male susceptibility to UVB-induced MDSC expansion and subsequent
skin carcinogenesis.
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Platelet derived growth factor (PDGF) directly binds to integrins and this interaction plays a
role in PDGF signaling
P Davari,1,2 TJ Dickerson,1,2 YK Takada1,2 and Y Takada1,2 1 Dermatology, University of California
Davis School of Medicine, Sacramento, CA and 2 Biochemistry and Molecular Medicine,
University of California Davis School of Medicine, Sacramento, CA
It has been well established that integrins play a role in growth factor signaling (integrin-growth fac-
tor crosstalk). Recently, we demonstrated that direct binding of integrins to IGF-1, FGF-1, and neureg-
ulin-1 is critical for growth factor/receptor signaling, and these growth factors induce a ternary com-
plex formation (integrin-growth factor-growth factor receptor). Notably, excess mutants suppress the
signaling induced by wild-type growth factors (dominant-negative effect). This suggests that growth
factor-integrin interaction may be a possible mechanism of the crosstalk. PDGF plays a role in wound
healing, fibrosis, and cancer progression and it would be a novel therapeutic target. It has been
reported that PDGFRβ co-precipitates integrin αvβ3. We tested the possibility that PDGF-BB may
bind to integrins and mediate PDGFR-integrin association. Here we discovered that PDGF-BB specif-
ically bound to integrins. We generated a PDGF-B mutant that was defective in integrin binding.
We found that the mutant was defective in inducing cell proliferation and inducing PDGFR phos-
phorylation and AKT and ERK1/2 activation in NIH 3T3 fibroblasts, while it still bound to PDGFR.
Interestingly, excess mutant suppressed proliferation and intracellular cell signaling induced by wild-
type PDGF in NIH 3T3 cells (a dominant negative effect). These results suggest that direct binging
of integrin to PDGF is a potential mechanism for PDGF-integrin cross-talk and may play a remark-
able role in PDGF signaling through ternary complex formation (integrin-PDGF-PDGFR). Addi-
tionally, the novel PDGF mutant may have potential as a therapeutic agent.
123
The p38 mitogen-activated protein kinase isoforms p38β and p38δ are essential in vivo reg-
ulators of mouse skin carcinogenesis
AC Koppel,1 C Lin,1 C Burns,1 E Gribben,1 J Anders,2 C Cataisson,2 SH Yuspa,2 GE Kissling,3
M Blumenberg,4 JC Arthur5 and T Efimova1 1 Dermatology, Washington University School of
Medicine, St. Louis, MO, 2 Laboratory of Cancer Biology and Genetics, NCI, NIH, Bethesda,
MD, 3 Biostatistics, NIEHS, Research Triangle Park, NC, 4 Dermatology, NYU School of
Medicine, New York, NY and 5 MRC Protein Phosphorylation Unit, Faculty of Life Sciences,
University of Dundee, Dundee, United Kingdom
The p38 family includes α, β, γ and δ isoforms. Much remains to be learned about the contribution
of each isoform to skin carcinogenesis. p38α and p38δ are highly expressed in normal epidermal
keratinocytes, while p38β expression is low, and p38γ is undetectable. Our previous studies showed
that p38δ-null mice have significantly reduced susceptibility to chemical skin carcinogenesis com-
pared with wild-type (wt) mice, due to aberrant proliferation during tumor promotion. Using ortho-
topic skin grafting of v-rasHa-transduced wt and p38δ-null keratinocytes onto nude mice, we now
report that malignant conversion rate was reduced in p38δ-null tumors, suggesting that endoge-
nous keratinocyte p38δ functions together with oncogenic Ras to promote malignant conversion.
Expression profiling analysis revealed multiple genes differentially regulated in p38δ-null keratinocytes
upon transformation with v-rasHa or TPA exposure. p38β and p38γ expression is increased in chem-
ically-induced mouse skin tumors, suggesting a potential role for p38β and p38γ in skin tumorige-
nesis. Using chemical carcinogenesis protocol, we report that p38β-null mice displayed extended
tumor latency and fewer tumors relative to wt mice, but showed enhanced malignant conversion
to squamous cell carcinomas. Simultaneous genetic ablation of p38γ in the context of p38δ defi-
ciency did not impart additional protection against skin tumorigenesis, indicating that p38γ is dis-
pensable for skin carcinogenesis in this model. Altogether, our findings suggest that p38β and p38δ
are essential in vivo regulators of skin carcinogenesis.
125
Intact p53 functionality in murine basal cell carcinomas in ionizing radiation-treated Ptch1+/-
mice
GY Wang, L Wang, J Wang, E Libove and EH Epstein Children’s Hospital Oakland Research
Institute, Oakland, CA
Human basal cell carcinomas (BCCs), the most common human cancer, typically arise in sun-dam-
aged skin containing epidermal clones of p53 mutant cells, implying that p53 is a crucial BCC tumor
suppressor. In line with this notion, we found that deletion of p53 specifically in K14-expressing
keratinocytes dramatically accelerates BCC carcinogenesis in ionizing radiation (IR)-treated Patched
1 (Ptch1)+/- mice. In IR-treated Ptch1+/- mice without p53 deletion, visible BCCs can also arise
from but with longer tumor latency (9m vs. 5m) and a lower tumor incidence and multiplicity. How-
ever it is not known whether loss of p53 signaling activity is required for the development of visi-
ble BCCs in p53+/+ mice. To address this question, we compared p53 signaling activity in IR-induced
BCCs in Ptch1+/- p53+/+ mice vs. in BCCs in Ptch1+/- p53-/- mice after a second, DNA-damaging
dose of IR. Using immunohistochemistry, we found the expected minimal IR-induced expression
of p53, Puma, and Noxa as well as TUNEL-detected apoptosis in BCCs of p53-deleted mice. By
contrast, IR induced robust expression of p53, Noxa, Puma, and apoptosis in BCCs from Ptch1+/-
p53-intact mice. Without IR exposure, BCCs in p53+/+ mice had scattered p53+ cells and low
level of expression of Puma and Noxa but no TUNEL+ cells. Our data thus suggest that IR-induced
BCCs generated in Ptch1+/- p53+/+ mice retain their functional p53 signaling capacity and that
these tumors are able to evade an intact DNA damage response.
124
An inflammatory response in the ΔNp63 transgenic mice reveals a pro-tumorigenic role for
ΔNp63
R Romano and S Sinha Biochemistry, SUNY at Buffalo, Buffalo, NY
While it is clear that the p63 family of transcription factors play an indispensible role in skin epithe-
lial development, differentiation, and homeostasis, their contribution to tumor development is quite
complex. This stems primarily from the dual and opposite functions of the ΔNp63 and TAp63 iso-
forms. Indeed, studies support the view that TAp63, like p53, exhibit tumor-suppressive properties,
while upregulation of the ΔNp63 isoforms is a common and distinctive feature of tumorigenesis in
a variety of human tumors of squamous cell origin. The ΔNp63 isoforms are prominently expressed
in keratinocytes, where they sustain pro-survival and pro-proliferative signals and regulate a cohort
of genes involved in various cellular programs. It is therefore plausible that the dysregulated expres-
sion of this transcriptional regulator is important for various facets of the tumorigenic process,
although direct experimental support for such a role is lacking. To explore this possibility, we have
generated inducible transgenic animals with targeted expression of ΔNp63 to the basal layer of the
epidermis. Interestingly, sustained induction of ΔNp63 in adult mice led to severe epidermal hyper-
plasia, aberrant cellular differentiation, and improper wound healing. Furthermore, the ΔNp63 trans-
genic skin exhibited a chronic and reactive inflammatory microenvironment marked by widespread
neutrophil, macrophage, and lymphocyte infiltration. Remarkably overexpression of ΔNp63 in the
epidermal keratinocytes of the transgenic animals triggered the ectopic expression of various mark-
ers associated with EMT, a feature that is intimately associated with tumor progression. Finally, global
transcriptome analysis and comparison of transgenic skin to control skin revealed widespread changes
in the chemokine/cytokine profile, with predominant activation of the IL-6/Stat3 signaling pathway
as a critical component of the molecular phenotype. Together, our data suggests that elevated lev-
els of ΔNp63 function in a pro-tumorigenic fashion by sustaining a hyperproliferative and inflam-
matory niche that might facilitate tumor development.
122
Regulation of FAS expression in cutaneous T-Cell lymphoma
J Wu1,2 and GS Wood1,2 1 Dermatology, University of Wisconsin Madison, Madison, WI and 2
Dermatology, VAMC, Madison, WI
The FAS pathway is a major mediator of T-cell apoptosis. In CTCL, there is a direct relationship
among the level of FAS protein, FAS transcript and sensitivity to FAS mediated apoptosis. There is
an inverse correlation between these three features and FAS promoter methylation. Demethylation
of the FAS promoter restores FAS expression and enhances apoptotic sensitivity. We observed that
methotrexate (MTX) functions as a demethylator probably by depleting SAM, the principal methyl
donor for DNA methyltransferases. MTX reduces FAS promoter methylation and increases FAS expres-
sion by FAS-low HH, SZ4 and CTCL blood cells. Interferon-alfa (IFNa) increases FAS expression by
a different mechanism. STAT1 induced by IFNa binds to a non-methylated FAS promoter element
involving nt -671 that can be either A (wildtype) or G (SNP). Among Caucasians, the prevalence of
the homozygous GG SNP is 20% while among Caucasians with CTCL, the prevalence is 30%
(p<0.03). Oligos bearing the G SNP bind less STAT1 compared to wildtype. Luciferase reporters
show lower basal and IFNa-induced FAS promoter activity for the G SNP construct compared to
wildtype. CTCL cells with the -671 GG genotype fail to up-regulate FAS in response to IFNa whereas
those with the homozygous (AA) or hemizygous (A) genotype do up-regulate FAS. Loss of FAS alle-
les occurs in FAS-hemizygous HH and FAS-null SeAx, suggesting deletion as a means for somatic
conversion of the germline -671 AG genotype to hemizygous -671 G and acquisition of IFNa resist-
ance. These results demonstrate that MTX and IFNa can augment FAS expression via two distinct
promoter mechanisms, one involving epigenetic methylation and the other involving a germline
SNP. They may help explain the previously reported high response rate of advanced CTCL to MTX/IFNa
therapy. Regarding upstream regulation of FAS, FAS-high MyLa had low promoter methylation,
DNMT-1, activated STAT3 and activated c-Jun. The opposite was true for FAS-low HH. These rela-
tionships are consistent with the known induction of DNMT-1 by STAT3, and the known inhibition
of FAS transcription by combined STAT3/c-Jun.
126
Fusion of the melanoma gene, p14arf on 9p, to a translocation hotspot in a gap in 22q in a
patient with melanoma, deafness and DNA repair deficiency, is a negative regulator of p14arf
and TBX1
X Tan,1 SL Anzick,2 SG Khan,1 T Ueda,3 G Stone,2 JJ DiGiovanna,1 D Tamura,1 D Wattendorf,6
C Brewer,4 C Zalewski,4 R Walker,2 A Griffith,4 J Butman,5 P Meltzer,2 P Bergstresser7 and
KH Kraemer1 1 Derm Br, NCI, Bethesda, MA, 2 Genetics Br, NCI, Bethesda, MA, 3 Pharm/ Med
Dev, Tokyo, Japan, 4 Otolaryn Br, NIDCD, Bethesda, MD, 5 Radiology Dept, CC, Bethesda,
MD, 6 DARPA, Washington, DC and 7 Derm, Univ of Texas SW Med Ctr, Dallas, TX
The role of CDKN2A suppressor gene p14ARF in melanoma is unclear. We studied a 12 y/o boy
(DD129BE) with melanoma, DNA repair deficiency, congenital deafness due to failure of develop-
ment of the inner ear, and features of DiGeorge Syndrome with a novel chromosome translocation
t(9;22)(p21;q11.2). A comprehensive analysis was performed by fluorescent in situ hybridization,
array comparative genome hybridization on flow-sorted derivative chromosomes, and by expres-
sion and function analysis. There was under-expression of p14arf and TBX1 mRNA and protein
despite the presence of the normal chromosomes 9 and 22. The 9p21 breakpoint was located in
p14ARF intron 1. The DNA repair deficiency in DD129BE fibroblasts was improved by transfection
with p14ARF. Laser capture microdissection of a melanoma revealed two heterozygous UV–type
missense mutations in CDKN2A exon1β in addition to the 9,22 translocation. The 22q11.2 break-
point was located in a palindrome AT rich repeat (PATRR) translocation hotspot in an unclonable
gap near a predicted gene (loc653203) but 800kb from TBX1. A chimeric p14arf-loc653203 tran-
script was detected. Targeted inhibition of the chimeric transcript by siRNA resulted in increased
expression of p14ARF and TBX1 mRNA and protein. We propose a model in which the chimeric
transcript resulted in reduced expression of p14arf and TBX1. The melanoma is caused by disrup-
tion of one allele of p14arf by the translocation and disruption of the other allele by mutations. The
down-regulation of TBX1 contributed to the deafness and other developmental features of the patient.
The chimeric transcript could provide a unique target for skin cancer prevention in this patient.
www.jidonline.org   S21
SID11_Abstracts-5  2/28/11  9:27 AM  Page S21
ABSTRACTS
115
The developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcino-
mas
G Spallone,1 E Botti,1 F Moretti,1 B Marinari,1 V Pinetti,1 S Chimenti,1 M Fanciulli,2 G Blandino,2
L Guerrini3 and A Costanzo1 1 Dermatology, University of Rome Tor Vergata, Roma, Italy, 2
Oncogenomic Centre, Regina Elena Cancer Centre, Roma, Italy and 3 Cell Biology, University
of Milan, Milano, Italy
The transcription factor IRF6 regulates craniofacial development and epidermal proliferation. We
have recently demonstrated that IRF6 is a component of a regulatory feedback loop that controls
the proliferative potential of epidermal cells, being transcriptionally activated by ΔNp63 and induc-
ing its proteasome-mediated downregulation, thereby limiting keratinocyte proliferative potential.
We have hypothesized that IRF6 could be also involved in skin carcinogenesis. Therefore, we ana-
lyzed IRF6 expression in a large series of SquamoCellular Carcinomas finding strong downregula-
tion of IRF6 that correlated with their invasive and differentiation status. IRF6 downregulation in
SCC cell lines and primary tumors correlates with methylation on a CpG island located in its pro-
moter region. To identify the molecular mechanisms regulating IRF6 potential tumor suppressive
activity, we performed genome wide analysis by combining ChIP-seq for IRF6 binding sites and
gene expression profiling in primary human keratinocytes after siRNA-mediated IRF6 depletion. We
observed disregulation of cell cycle related genes and of genes involved in differentiation, cell adhe-
sion and cell-cell contact. Many of these genes were direct targets of the IRF6 transcription factor.
We also performed in vitro invasion assays demonstrating that IRF6 downregulation promotes tumor
cell invasivity and increases SCC side population. Reintroduction of IRF6 in SCC cells strongly
inhibits their growth as shown by colony forming assays. Our data highlights a novel function for
the developmental regulator IRF6 that exhibits tumor suppressor activity within carcinogenesis of
stratified epithelia.
116
Senescence in human basal cell carcinoma
MS Pirzado,1 MM Rahman,1 J Elliott,1 R Cerio,2 GW Neill1 and MP Philpott1 1 Center for
Cutaneous Research, Bilzard Institute of Cell and Molecular Sciences,, London, United
Kingdom and 2 BICMS Pathology Group, Blizard Institute of Cell and Molecular Science,
London, United Kingdom
Oncogene-induced senescence (OIS) has an important role in tumour biology as it represents a
physiological response that restricts the progression of benign tumours into their malignant coun-
terparts. Full malignancy is associated with the loss of important tumour suppressor genes includ-
ing RETINOBLASTOMA and/or TP53. Basal cell carcinoma (BCC) of the skin is the most common
skin tumour form and is associated with mutational inactivation of the PTCH1 tumour suppressor
gene (and less frequently oncogenic activation of SMOOTHENED). Although BCC does not appear
to stem from precursor lesions and is relatively stable at the genomic level, we sought to determine
if these unique tumours display any characteristics of OIS. Human BCCs were positive for Senes-
cence-associated β-galactosidase (SA-β-gal) activity (pH 6.0). Interestingly, SA-β-gal activity was
observed in stromal cells surrounding the tumour islands but only weakly in the tumour epithe-
lium; this may be due to UV irradiation which is known to induce senescence in cultured fibrob-
lasts and may also account for why BCCs are difficult to culture in vitro. Explant cultures of fibrob-
lasts from BCC expressed higher levels of senescence markers than dermal fibroblasts. Both tumour
epithelium and stroma also expressed known markers of senescence including DCR2, SHARP2
(DEC1) as well as the cell cycle inhibitors p15, p16 and p21. To determine if OIS is associated with
Hedgehog signalling in BCC, we employed a novel in vitro model of BCC created through PTCH1
suppression in human immortalised NEB1 keratinocytes. NEB1-shPTCH1 cells are viable and pro-
liferative (albeit more slowly than control NEB1-shCON cells) and do not display SA-β-gal activity
but they express higher levels of DCR2. Whether this is dependent upon p53 and/or the oncopro-
tein GLI1 which are also increased in NEB1-shPTCH1 cells is currently under investigation.
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Aberrant regulation of keratinocyte migration by intracellular protein O-glycosylation in the
A431 squamous cell carcinoma cell line
M Bektas1 and D Rubenstein1,2,3 1 Dermatology, UNC-CH, Chapel Hill, NC, 2 Pharmacology,
UNC-CH, Chapel Hill, NC and 3 Lineberger Comprehensive Cancer Center, UNC-CH, Chapel
Hill, NC
O-glycosylation of serine and threonine residues is a common regulatory post-translational modi-
fication analogous to protein phosphorylation. Two intracellular enzymes, OGT and OGA, medi-
ate addition and removal, respectively, of N-acetylglucosamine (GlcNAc) from intracellular protein
substrates. Previous data from our group demonstrated that increased O-glycosylation stabilizes
cell-cell adhesion in part by increasing the post-translational stability of desmosome components
including plakoglobin. To investigate the ability of intracellular protein O-glycosylation to regulate
keratinocyte migration in HaCaT control and the A431 squamous cell carcinoma cell lines, phar-
macologic and genetic approaches were used to manipulate intracellular protein O-GlcNAc mod-
ification and the effects on cell migration determined using Boyden chamber assays. Intracellular
protein O-glycosylation levels were enhanced by treating cells with either the OGA inhibitor PUGNAc
or by transduction with lentivirus carrying OGA specific shRNA. Alternatively, viral transduction of
OGT specific shRNA were used to decrease protein O-glycosylation. In HaCaT control keratinocytes,
pretreatment with 50 uM PUGNAc inhibited migration towards serum. Similarly, HaCaT cells
transduced with shOGT showed more migration, while migration of shOGA transduced cells was
comparable to GFP shRNA and to non-transduced controls. In contrast, A431 cells treated with 50
uM PUGNAc for 24hr showed increased migration towards serum. Additionally, A431 cells trans-
duced with shOGT and shOGA migrated significantly more towards serum than GFP control shRNA
transduced cells. Thus, enhancing intracellular protein O-glycosylation inhibited cell migration in
control, but not malignant, keratinocytes. These observations suggest that normal processes regu-
lating cell migration by O-GlcNAc protein modification are dysregulated in squamous cell carci-
noma cell lines.
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An animal explant model for the study of human cutaneous squamous cell carcinoma (SCC)
DA Belkin,1 J Chen,1 JL Mo,1 DP Poppas,1 JG Krueger,2 D Felsen1 and JA Carucci3 1 Weill Cornell
Medical College, New York, NY, 2 Laboratory for Investigative Dermatology, Rockefeller
University, New York, NY and 3 New York University School of Medicine, New York, NY
Animal model systems are needed to study human SCC and to develop therapeutics. Models of
SCC include chemical carcinogens and the inoculation of SCID mice with human SCC cells. The
goal of this study was to develop a model that more closely resembles naturally-occurring human
SCC. Tumor bearing skin from 8 patients obtained at surgery was grafted onto nude rats (n=8) as
previously described by our group (Petratos et al., PRS 111:1988, 2003). After four weeks, tumors
were extracted. Gross examination during extraction revealed the presence of tumor nodules in all
rats (average size decrease approximately 40%). Staining was done on a portion of each tumor
retained prior to grafting and a sample from the same tumor post extraction. They were compared
for morphology, cell proliferation, cell death, and immune infiltrate. Morphology characteristic of
SCC remained after four weeks, as determined by H&E staining. These areas were identified as
human by HLA Class I staining, and SCC was confirmed by cytokeratin 5/6 staining. PCNA stain-
ing showed continued proliferation in some areas, whereas TUNEL staining for apoptotic cells was
less apparent. Human immune cells such as T cells (CD3+ and CD8+), regulatory T cells (foxP3+),
and dendritic cells (CD11c+) were present but scarce after four weeks. Human blood vessel endothe-
lial cells (PAL-E+) were virtually absent. Human SCC tumors implanted in the nude rat survive at
four weeks and retain characteristics of SCC including morphology and CK5/6+ staining. Although
proliferation was found in SCC tissue, there was shrinkage of tumor, which may reflect initial con-
traction due to poor blood supply before vessel in-growth presumably occurs. By including the
whole tumor and tumor bed, this model recapitulates the architecture and microenvironment of
human SCC more accurately than previous animal models and may serve as a useful system to study
and develop novel therapeutics.
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Immunosuppressive surface protein CD200 is up-regulated in the dermal microenvironment
of cutaneous squamous cell carcinoma (SCC)
DA Belkin,1 H Mitsui,2 M Suàrez-Fariñas,2 CQ Wang,2 KR Shah,2 I Coats,2 JG Krueger2 and
JA Carucci3 1 Department of Dermatology, Weill Cornell Medical College, New York, NY, 2
Laboratory for Investigative Dermatology, Rockefeller University, New York, NY and 3 Ronald
O. Perelman Department of Dermatology, NYU School of Medicine, New York, NY
SCC is the second most common human cancer, and aggressive cases are responsible for the approx-
imately 10,000 non-melanoma skin cancer deaths each year in the United States. Our group has
shown that the invasive capacity of SCC may be due to characteristics of its immune microenvi-
ronment. For example, dendritic cells in the SCC microenvironment are poor stimulators of T cell
proliferation compared to those in normal skin. In this study, we sought to further characterize the
immune microenvironment of SCC. Infiltrating cells surrounding SCC tumor nests and correspon-
ding dermal regions of normal skin biopsies were obtained by laser capture microdissection. This
was followed by cDNA microarray analysis with determination of the relative gene expression pro-
file in the tumor microenvironment compared with normal dermis. We found a 4.9 fold up-regu-
lation in surface glycoprotein CD200 in the SCC microenvironment. Protein level expression of
CD200 was confirmed with immunohistochemistry, which showed a significantly higher number
of CD200+ cells in the SCC microenvironment compared with normal dermis (180.8 per mm2 der-
mis vs 24.6, p=0.0071). Interestingly, immunofluorescence staining revealed CD200 was predom-
inantly expressed on PAL-E+ and CD31+ blood vessel endothelial cells in the SCC microenviron-
ment, but did not appear to be expressed on blood vessels in healthy skin. The surface glycoprotein
CD200 is known to be an immunosuppressive ligand and thought to maintain homeostasis in var-
ious tissues by inactivating CD200-receptor bearing immune cells, mainly myeloid lineage cells.
Our findings demonstrate blood vessels associated with the SCC microenvironment express CD200
and thus may explain in part the inactivation of immune cells associated with this cancer.
120
Catalase potentiates a sex discrepancy in myeloid-derived suppressor cell expansion in a
mouse model of ultraviolet light-induced skin cancer
NJ Sullivan,1 KL Tober,1 E Burns,1 J Schick,1 J Riggenbach,1 M Bill,2 G Young,3 TM Oberyszyn1 and
GB Lesinski2 1 Pathology, The Ohio State University, Columbus, OH, 2 Internal Medicine, The
Ohio State University, Columbus, OH and 3 Biostatistics, The Ohio State University,
Columbus, OH
Men are at higher risk of developing non-melanoma skin cancer, the most common type of human
cancer. UVB, a predominant risk factor, elicits immune suppression. One contributing factor to
inflammation-induced immune suppression and carcinogenesis is a heterogeneous population of
myeloid cells, known as myeloid-derived suppressor cells (MDSC). MDSC proliferation and differ-
entiation can be affected ex vivo by catalase, an endogenous antioxidant enzyme that detoxifies
hydrogen peroxide. The current study utilized the outbred, immune competent Skh-1 hairless mouse
model of UVB-induced non-melanoma skin cancer to further define mechanisms underlying sex
discrepancies in UVB-induced skin carcinogenesis. We detected MDSC in UVB-induced skin tumors
and demonstrated that male tumor-bearing mice exhibited more splenic MDSC compared to female
skin tumor-bearing mice, after adjusting for tumor burden. Acute UVB exposure increased splenic
MDSC levels and inhibited splenic T-cell proliferation. Baseline endogenous skin catalase activity
was lower in male compared to female mice. Diclofenac, a clinical NSAID, repressed acute UVB-
induced splenic MDSC expansion and enhanced skin catalase activity in male but not female
mice. Diclofenac inhibited male and female UVB-induced skin tumorigenesis, which indicates
that diclofenac may modulate distinct pathways in males and females. Catalase treatment inhibited
acute UVB-induced splenic and skin MDSC infiltration. Moreover, catalase inhibited UVB-induced
skin tumorigenesis. Collectively, these results strongly suggest that relatively lower male skin cata-
lase activity may increase male susceptibility to UVB-induced MDSC expansion and subsequent
skin carcinogenesis.
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Shh and Akt1 signaling pathways converge through mammalian target of rapamycin (mTOR)
signaling to drive the growth of BCCs
J Back,1 Y Zhu,1 X Tang,1 M Athar,2 AL Kim1 and DR Bickers1 1 Dermatology, Columbia
University Medical Center, New York, NY and 2 University of Alabama at Birmingham,
Birmingham, AL
Aberrant sonic hedgehog (Shh) signaling is the primary driver of BCC pathogenesis, although pre-
clinical studies show that additional pathway(s) may be involved. Akt1/PKB serine/threonine pro-
tein kinase regulates cell proliferation and is dysregulated in many human cancers. Akt1 is also
activated in both UVB-induced murine and human BCCs. However, the role of Akt1 signaling in
the growth of BCCs is unclear. Here, we show that combined treatment of murine BCC (ASZ001)
cells with LY294002, a PI3K inhibitor, and cyclopamine, a Shh inhibitor, synergistically decreased
cell proliferation as shown by reduction of BrdU incorporation and abrogation of cyclin D1 expres-
sion. Combined administration of these agents to Ptch+/-/SKH-1 mice, synergistically decreased
the growth of UVB-induced BCCs. Interestingly, residual tumors in the combined treatment group
showed downregulation of total mTOR proteins. Furthermore we found that the promoter region of
mTOR harbors three Sry-related HMG box 9 (SOX9) binding motifs. SOX9 is a known transcription
factor, that is induced in human BCCs and its expression is regulated by Gli-1. Cyclopamine treat-
ment reduced SOX9 expression in ASZ001 cells. Both endogenous and recombinant SOX9 pro-
teins were shown to directly bind to the mTOR promoter as assessed by electrophoretic mobility
gel shift assays and shRNA-mediated downregulation of SOX9 reduced this binding. Importantly,
genetic ablation of SOX9 reduced the expression of mTOR and the phosphorylation of known down-
stream mTOR signaling proteins (p-p7056K and p-4E-BP1) and cyclin D1. Furthermore, itracona-
zole, an imidazole anti-fungal agent, known to inhibit Shh signaling, reduced expression of SOX9
as efficiently as did cyclopamine, blocked mTOR signaling, and reduced the growth of UVB-induced
BCCs in Ptch1+/-/SKH-1 mice. Our data provide strong evidence for a link between the SOX9, mTOR
and Shh signaling pathways that together are likely to contribute to the pathogenesis of BCCs.
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Mode of T cell administration determines homing sites of tumor-associated-antigen (TAA)-
specific Th1 cells to the tumor site and treatment success
CM Griessinger,1 A Schmid,1 D Bukala,1 K Fuchs,2 H Braumüller,2 S Kaesler,2 T Biedermann,2
BJ Pichler,1 M Röcken2 and M Kneilling2 1 Department of Preclinical Imaging and
Radiopharmacy, Tuebingen, Germany and 2 Department of Dermatology, Tuebingen,
Germany
Treatment with intra-peritoneal (i.p.) administered Tag2-Th1 cells arrest multistage carcinogenesis
and prolonged life of pancreatic cancer bearing RIP1-Tag2 mice two-fold. Aims of our study were
to analyze differences in treatment success and homing due to intra-venous (i.v.) or i.p. adminis-
tration of TAA-Th1 cells. CD4+ T cells were isolated from Tag2 TCR-tg mice or ovalbumin (OVA)-
TCR-tg mice and specifically cultured to generate a Th1 phenotype. We i.p. or i.v. injected Tag2-
Th1 cells into RIP1-Tag2 mice starting at 6 weeks of age once weekly and monitored mice by magnetic
resonance imaging (MRI) and detection of blood glucose levels (BGL). At 17 weeks of age we i.v.
or i.p. injected Cy5 fluorescence labeled Tag2-Th1 cells and sacrificed mice five days later. Addi-
tionally, we i.v. or i.p. injected Cy5 fluorescence labeled OVA-Th1 cells into B16- and OVA-B16-
melanoma bearing mice, and scarified mice four days later. Tag2 or OVA specific Th1 cell migra-
tion and biodistribution were investigated in vivo and ex vivo by optical imaging (OI) and
FACS-analysis. At 14 weeks of age average tumor volume was 88mm3 in sham treated RIP1-Tag2
mice, 7.4 mm3 in i.p. treated mice, while no tumors were detectable by MRI in i.v. treated mice.
BGL in i.p. treated RIP1-Tag2 mice was 69 (± 18) mg/dl, at norm values in i.v. treated (129 (± 4)
mg/dl), and < 30 mg/dl in sham treated mice. H&E staining of pancreatic tissue from 17 weeks old
RIP1-Tag2 mice showed large pancreatic tumors in i.p. treated but only small tumors in i.v. treated
mice. Surprisingly we could not detect Cy5-Tag2-Th1 cells at the tumor site after i.v. but a strong
accumulation after i.p. administration in both carcinoma models. Our data clearly indicate that i.v.
administration of Tag2-Th1 cells in RIP1-Tag2 mice is a much more efficient than i.p. administra-
tion even though Tag2-Th1 don’t reach the tumor site.
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Sirt1 histone deacetylase (HDAC) is increased in cutaneous t-cell lymphoma (CTCL) and its
inhibition induces apoptosis
M Nihal,1 N Ahmad1 and GS Wood1,2 1 University of Wisconsin, Madison, WI and 2 Wm. S.
Middleton VAMC, Madison, WI
CTCL is a cutaneous T-cell lymphoproliferative disorder in which we and others have documented
resistance to apoptosis related in part to silencing of tumor suppressor genes such as those involved
in FAS pathway apoptosis. One mechanism of gene silencing involves histone deacetylation. 30-
40% of CTCL patients exhibit a significant clinical response to HDAC inhibitors (at least 50% regres-
sion of lesions), suggesting that histone deacetylases play an important role in CTCL tumor biology.
Therefore, we were interested in the potential role of the histone deacetylase, Sirt1, in CTCL. Sirt1
is the most well studied member of the Sirtuin (Sir2) family enzymes, which are nicotinamide ade-
nine dinucleotide dependent class III histone deacetylases, and have been shown to deacetylate
lysine residues on various proteins. Sirt1 has been shown to be involved in a number of cellular
processes including gene silencing, DNA repair, recombination, and stress response. Sirt1 also reg-
ulates the tumor suppressor p53. This study was designed to test the hypothesis that Sirt1 is differ-
entially expressed in CTCL and could be used as a target for designing novel approaches for the
management of this neoplasm. Western blotting, flow cytometry and cytospin immunostaining
demonstrated high Sirt1 expression among CTCL lines HH, Hut 78, MyLa, SeAx and SZ4 in com-
parison to normal blood lymphocytes. Sirt1 knockdown using shRNA resulted in increased expres-
sion of acetylated p53 and PARP cleavage products, consistent with induction of apoptosis. No sig-
nificant alteration of cell cycle distribution was found with Sirt1 knockdown. There is cooperation
between DNA methylation and protein deacetylation in gene silencing. We have shown that
methotrexate can act as a demethylating agent by depleting cellular S-adenosyl methionine, the
major methyl donor for DNA methyltransferases. Therefore, further studies are in progress to deter-
mine the effects on CTCL of combination therapy with histone deacetylase inhibitors and methotrex-
ate.
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Identification of mediators of immune evasion in a modular mouse model of squamous cell
carcinoma
DW Dwyer,2 ML Leung,2 TB Thompson2 and KY Tsai1,2 1 Dermatology, University of Texas MD
Anderson Cancer Center, Houston, TX and 2 Immunology, University of Texas MD Anderson
Cancer Center, Houston, TX
The roles of the immune system in promoting and controlling cancer development and progression
are now well established experimentally. Individuals who are immunocompromised are exquis-
itely susceptible to non-melanoma skin cancers, notably squamous cell carcinoma (SCC). We pres-
ent here a modular model of SCC in mice that enables the independent manipulation of both tumor
cells as well as immune background. By examining and comparing tumor growth in differing back-
grounds of immunodeficiency, we have established a system through which tumor intrinsic adap-
tations to immune pressure may be identified and validated. Models that utilize chemical carcino-
genesis protocols or genetically engineered mice effectively model spontaneous tumor development,
but they do not permit the real-time manipulation of tumor cells and mechanistic exploration of
tumor-immune cell interactions. Our model is based upon the PDV transplantable SCC model in
C57BL/6 mice. Tumors arise with greatly increased frequency and dramatically shortened latency
on immunodeficient backgrounds, including strains lacking Rag recombinases and IL2-receptor
common gamma chain. We have utilized this difference as a basis for identifying tumor intrinsic
differences in gene expression that are related to background immune status. Through a series of
gene expression array analysis and serial passaging experiments, we have identified initial candi-
dates as well as transcription factor pathways necessary for immune evasion in immunocompetent
hosts. We believe this has important implications for an understanding of tumor-immune cell inter-
actions even beyond SCC.
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Modeling the consequences of EGFR ablation therapy in squamous cancer by gene expres-
sion profiling of oncogenically transformed mouse keratinocytes
LN Wright, Y Riss, A Ryscavage and SH Yuspa Laboratory of Cancer Biology and Genetics,
National Cancer Institute, Bethesda, MD
EGFR targeted therapy is in clinical use to treat squamous cell carcinoma of the head and neck.
Activating ras mutations is a negative prognostic factor for response to EGFR ablation therapy in
multiple epithelial cancer types. Furthermore, the major adverse consequence of this therapy is an
acneiform papulopustular eruption on normal skin. We performed gene expression profiling on
oncogenic ras transformed and wildtype keratinocytes with EGFR ablated either genetically in the
germ line or pharmacologically by acute drug treatment to better understand the ras-EGFR ablation
interaction and the pathways altered by EGFR ablation in normal keratinocytes. We were able to
identify a 25 gene signature specific to the ras-EGFR ablation interaction and a distinct 19 gene
EGFR ablation signature on normal keratinocytes. The study also yielded secondary information on
differences in ontologies between chronic genetic EGFR ablation during development and acute
pharmacological ablation, both with and without ras activation. In the absence of EGFR, ras acti-
vation enriches the ontologies for ion channels and membrane transporters. In the absence of ras
activation, EGFR ablation reduces ontologies favoring cell cycle control and transcription. Pathway
analysis indicates that activation of p38α is a response to both acute and chronic abrogation of EGFR
signaling under conditions of ras activation. This was confirmed in oncogenic ras transduced human
keratinocytes and by immunohistochemistry of tumor orthografts of EGFR ablated mouse keratinocytes
transformed by oncogenic ras. Pathway analysis of EGFR ablation in the absence of oncogenic ras
displayed a node emanating from Erk signaling. Both of these findings could influence the thera-
peutic response to EGFR ablation therapy.
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The desmosomal cadherin desmoglein 1 regulates differentiation of head and neck squa-
mous cell carcinoma cells
BV Desai, V Todorovic, J Chen, DM Sweeney, CA Franzen, DB Solt, JE Koblinski, JC Pelling and
KJ Green Department of Pathology, Northwestern University, Chicago, IL
It is well-established that the loss of intercellular adhesions is an important aspect of tumor pro-
gression. However, the importance of the desmosomal cadherin sub-class of cadherins in cancer is
not well understood. Desmoglein 1 (Dsg1) is one of four desmogleins which are spatially arrayed
in distinct patterns in complex epithelia, and is first expressed as cells emerge from the basal layer.
We recently demonstrated that this cadherin is required to promote a program of differentiation of
normal human epidermal keratinocytes (NHEK). Additionally, two independent studies using tissue
microarrays have demonstrated a positive correlation between Dsg1 expression, differentiation sta-
tus and patient outcome, respectively, in head and neck squamous cell carcinomas (HNSCC). Using
immunohistochemical analysis on human sections we observed reduced expression of Dsg1 in
advanced dysplasia suggesting its early loss during tumor progression. Based on these observations
we hypothesized that Dsg1 determines the differentiation status and aggressiveness of HNSCC. Of
a panel of cell lines derived from tumors of varying stage and malignancy, 1483 cells retained the
ability to express Dsg1 under conditions promoting differentiation in vitro. Additionally, using an
orthotopic mouse model system we demonstrated that xenografted 1483 cells form Dsg1 and K10
expressing differentiated tumors. Silencing Dsg1 in vitro inhibited the induction of differentiation
markers K1, K10 and Dsc1. To further delineate Dsg1’s role in tumor progression, we determined
the ability of Dsg1 KD cells to support anchorage independent growth in soft agar and to invade
through 3D matrix. In preliminary studies, Dsg1-silenced cells formed more colonies and exhib-
ited increased invadopodia extensions and matrix degradation compared to the control. Together,
these data raise the possibility that loss of Dsg1 in tumors shifts the balance away from a differen-
tiated phenotype while promoting tumor growth and invasion.
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Expression of p53, smooth muscle actin and c-kit in dermatofibrosarcoma protuberans and
evaluation of correlation with clinical features
M Kim,1 K Cho,1 J Lee,2 M Chang3,4 and S Cho1,2 1 Dermatology, Seoul National University
College of Medicine, Seoul, Republic of Korea, 2 Dermatology, Seoul National University
Boramae Hospital, Seoul, Republic of Korea, 3 Pathology, Seoul National University College
of Medicine, Seoul, Republic of Korea and 4 Pathology, Seoul National University Boramae
Hospital, Seoul, Republic of Korea
Dermatofibrosarcoma protuberans (DFSP) is a rare cutaneous tumor with intermediate malignancy.
The purpose of this study is to evaluate the utility of p53, smooth muscle actin and c-kit as immuno-
histochemical markers which could correlate to the clinical outcome. We conducted a retrospec-
tive review of patients diagnosed with primary or recurrent DFSP between 2000 and 2009 at Seoul
National University Hospital and Boramae Hospital. Clinical data were retrieved by chart review,
and pathologic slides were reviewed in available cases and classified into subtypes. Immunohisto-
chemical study was performed with antibodies of p53, c-kit and smooth muscle actin. We ana-
lyzed data for 32 lesions from 31 patients. On review of pathologic slide, conventional subtypes
(17 cases) were observed most commonly, followed by myoid (5 cases), myxoid (4 cases), Bednar
(3 cases), and ones with fibrosarcomatous(FS) change (2 cases). DFSP-FS showed high immunore-
activity for SMA compared with other subtypes (P=.026). No difference in p53 immunoreactivity
was observed between subtypes. There was no correlation between SMA and p53 immunoreactiv-
ity and other clinical factors. c-kit staining for mast cell count showed a negative correlation with
mitosis and tumor size (P<0.05). Immunoreactivities for p53, SMA and c-kit are not useful markers
to predict the clinical outcome of DFSP. The negative correlation of the mast cell number with malig-
nancy grade shown in this study implies a secondary role of mast cells as host immune response
unlike primary role of mast cells in tumor angiogenesis in other tumors. Further studies are required
to define the exact role of mast cells.
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The squamous cell carcinoma transcriptome defined by high-throughput sequencing (RNA-
seq)
L Luan and T Andl Vanderbilt University, Nashville, TN
Cancer is a genetic disease that is characterized by massive changes in gene expression. These
changes are not limited to mere expression level alterations but can involve events such as alter-
native splicing, alternative promoter, 5’untranslated region (UTR) and 3’UTR usage. Advances in
high-throughput sequencing technologies of transcriptomes (RNA-seq) will allow for a much more
refined view of all these process and their contribution to carcinogenesis on the single-nucleotide
level. Application of RNA-seq to the analysis of cancer transcriptomes will lead to novel insights
into the abundance and quality of alterations at an unprecedented depth. Here, we present our
data of the comparison of a squamous cell carcinoma and a normal skin sample by RNA-seq.
Using the Illumina GAII sequencer we obtained 10883041 and 13213834 short sequence reads for
normal and tumor mRNA, respectively. We have identified 4113 genes statistically verified as dif-
ferentially expressed. Grouping based on GO terms of the 300 most highly overexpressed and
reduced genes revealed significant changes in genes associated with the immune response, prolif-
eration, extracellular-matrix receptor interactions, focal adhesion, the actin cytoskeleton organiza-
tion, glycerophospholipid metabolism, TGF-beta signaling, leukocyte transendothelial migration
and the MAPK signaling pathway. Furthermore, analysis of alternative splicing events have identi-
fied a large number of mRNA isoform differentially represented in tumor and normal skin. How-
ever, the challenges and pitfalls of whole transcriptome sequencing are evident from our analysis
and range from inadequate analysis algorithms to difficulties in the interpretation of for example
alternative polyadenylation site usage probably due to biases introduced during the multiple steps
of enzymatic processing of RNA and DNA. Nevertheless, the data from this experiment will be a
starting point for the validation of tumor-specific isoforms of proteins involved in key signaling path-
ways that could be used as the basis for new drug and treatment targets.
129
High throughput RNA sequencing of Sezary syndrome and cutaneous squamous cell carci-
noma
C Lee, K Qu, D Webster, M Kretz, A Mah, A Ungewickell, R Armstrong, W Weng, Y Kim, H Chang
and P Khavari Veterans Affairs Palo Alto Healthcare System and Stanford University, Palo Alto,
CA
To characterize genetic alterations in epithelial and non-epithelial malignancies affecting human
skin, we performed high throughput whole transcriptome sequencing of cutaneous squamous cell
carcinoma (SCC) and Sezary Syndrome (SS). The Illumina paired-end HiSeq platform with read
length of 101 nucleotides was used, at >100 million reads per experimental sample. 3 SCC sam-
ples as well as patient-matched, normal adjacent skin control were sequenced and then analyzed
for novel gene fusions, missense somatic mutations, noncoding RNAs, gene expression differences,
novel viral sequences, and transcript variants resulting from alternative splicing events. The tran-
scriptomes of 3 SS patients were also sequenced after sorting peripheral blood for CD4+ Sezary cells
identified by specific clonal T-cell receptor (TCR) V beta epitope as well as patient-matched, CD4+
normal lymphocytes. >70% of sample reads successfully mapped back to the human genome
using the read-mapping algorithm TopHat. SeqGene open-source software was used to identify
novel, disease-specific missense mutations and indels as well as quantify gene expression differ-
ences between malignant cells and their normal counterparts. Alternative splicing events were iden-
tified using Cufflinks and fusion transcripts were detected using FusionSeq. We are currently screen-
ing a large cohort of patients to identify the prevalence of novel mutations and chimeric transcripts
in SCC and SS as well as normal, disease-free individuals. These efforts characterize alterations in
genomic transcriptional sequences in malignancies arising from distinct cellular lineages present
in human skin.
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Chemokine receptor CXCR4 is a novel marker for the progression of skin cancer
S Toyozawa,1 Y Yamamoto,1 C Kaminaka,1 T Kishi,1 Y Nakamura2 and F Furukawa1 1
Dermatology, Wakayama Medical University, Wakayama, Japan and 2 Clinical Laboratory
Medicine, Wakayama Medical University, Wakayama, Japan
Functional chemokine receptors are expressed in many malignant tumors. The CXCR4/CXCL12 path-
way has been recently involved in stimulating the metastatic process of many different neoplasms,
where CXCR4 is able to activate various phenomena such as chemotaxis, invasion, angiogenesis
and proliferation. The purpose of this study are to analyze a possible association between the expres-
sion of chemokine receptors CXCR4, CCR6, CCR7 and the clinical features of skin cancers, and to
assess the usefulness of these chemokine receptors for diagnosis and prognosis. The immunohisto-
chemical expression of CXCR4, CCR6 and CCR7 was investigated on primary tissues of 8 der-
matofibrosarcoma protuberance (DFSP), 6 malignant fibrous histiocytoma, 18 malignant melanoma,
5 angiosarcoma and 16 premalignant skin tumor such as actinic keratosis and Bowen’s disease.
Associations between patient features and immunoreactivity were analyzed statistically. The signif-
icant higher expression of CXCR4 was observed in these skin malignant tumors including prema-
lignant skin tumor which had no effect with the nonsurgical treatment as compared with benign
control. CXCR4 staining was observed in cytoplasm of tumor cells. Interestingly, CXCR4 expression
was significantly higher in relapsed DFSP as compared with non-relapsed DFSP, and CXCR4 was
more useful marker than CD34. In malignant melanoma tissues, CXCR4 expression was significantly
correlated with Breslow’s tumor thickness and nodular melanoma. CCR6 and CCR7 expression
was observed in some cases of all kinds of tumors; however, no significant associations were detected
between patient features and immunoreactivity. These data suggest that the assessment of CXCR4
immunoreactivity is a novel and useful tool for expressing local tumor aggressiveness of skin tumors.
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MicroRNA-21 is an important downstream component of BMP signaling in skin epithelial
cells
MI Ahmed,1 AN Mardaryev,1 AA Sharov2 and NV Botchkareva1 1 Centre for Skin Sciences,
University of Bradford, Bradford, United Kingdom and 2 Department of Dermatology, Boston
University, Boston, MA
Bone morphogenetic proteins (BMPs) play essential roles during skin development, postnatal tissue
remodeling and tumorigenesis. To explore whether some of these inhibitory effects of the BMP sig-
nalling are mediated by microRNAs, miRNAs were isolated from the primary mouse epidermal ker-
atinocytes, treated with BMP4 and processed for evaluation of global miRNA expression patterns
using the microarray profiling. Microarray and real-time PCR analyses revealed substantial BMP4-
dependent changes in the expression of distinct miRNAs including miR-21, which expression was
strongly decreased in the keratinocytes after BMP4 treatment. However, miR-21 expression was sub-
stantially higher in the skin of transgenic mice overexpressing BMP antagonist Noggin under con-
trol of the K14 promoter. In normal mouse skin, miR-21 expression was observed in the epidermis
and hair follicle epithelium. In K14-Noggin skin, prominent miR-21 expression was seen in the epi-
dermis, while in the HF-derived trichofolliculoma-like tumours miR-21 was expressed predomi-
nantly in their peripheral portion that contain proliferating and low-differentiated cells. Furthermore,
by transfecting the keratinocytes with miR-21 mimic we identified the existence of two groups of
the BMP target genes, which are differentially regulated by miR-21. BMP-dependent tumor-sup-
pressor genes such as Pten, Pdcd4, Timp3, and Tpm1, are negatively regulated by miR-21, while
Id1, Id2, Id3 and Msx2 that predominantly mediate the effects of BMPs on cell differentiation and
apoptosis are miR-21 independent. Thus, our study establishes a novel mechanism involved in the
realization of the BMP effects in the skin and suggests miRNAs as important regulators modulating
the effects of growth factor signaling pathways on skin development and tumorigenesis.
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Interferon-γ/STAT1-signaling determines whether T cells promote or arrest carcinogenesis
S Fischer, T Wieder, H Braumüller, E Brenner, W Kempf and M Röcken Dermatology, University
Medical Center Tuebingen, Tuebingen, Germany
Th1 cells have recently been shown to be effective in treating malignant melanoma. The mode of
action remains unclear. To unravel the underlying mechanisms, we studied oncogenic T antigen
(Tag) driven cancers that first lead to adenomas and, subsequently, cancer in RIP1-Tag2 transgenic
mice. Treatment of mice with interferon-γ (IFN-γ)-producing Th1 cells specific for a Tag peptide
strongly inhibited tumor growth in the absence of cytotoxic T cells and without inducing cancer-
cell apoptosis. Inversely, blocking the in vivo action of IFN-γ with mAb abolishes the therapeutic
effect of Tag-Th1 cells, and even enhances cancer angiogenesis and cancer growth. Here, we stud-
ied the effects of IFN-γ on proliferation, apoptosis, cell cycle regulation and senescence in isolated
RIP1-Tag2 cancer cells in vitro and in vivo. Proliferation was assessed by 24h BrdU labeling (ELISA),
and apoptosis by TUNEL assay and sub-G1 analysis. The cell cycle analysis was performed by 7-
AAD/BrdU double staining and flow cytometry, and senescence was analyzed by senescence-asso-
ciated-beta-galactosidase-assay (SA-β-gal-assay) and immunofluorescence of pHP1-γ-staining. To
specifically study the role of IFN-γ/STAT1 signaling, we compared the effects of IFN-γ on RIP1-Tag2
cancers with that on STAT1-deficient RIP1-Tag2 cancers. IFN-γ directly inhibits RIP1-Tag2 cancer
proliferation by arresting the cells in the G1/G0 phase of the cell cycle. Cell cycle arrest occurred
in the absence of apoptosis but with induction of SA-β-gal-positive cancer cells and formation of
heterochromatin foci, both characterizing a senescent phenotype. Importantly, IFN-γ dependent
therapy with Th1 cells in vivo established permanent growth arrest of cancer cells, the most strin-
gent criterion characterizing cancer cell senescence. IFN-γ-induced senescence was completely
blunted in STAT1-deficient RIP1-Tag2 cancers. Thus, tumor-specific Th1 cells can arrest malignant
growth of oncogen-driven cancers by inducing a permanent, IFN-γ-dependent cell cycle arrest.
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Shh and Akt1 signaling pathways converge through mammalian target of rapamycin (mTOR)
signaling to drive the growth of BCCs
J Back,1 Y Zhu,1 X Tang,1 M Athar,2 AL Kim1 and DR Bickers1 1 Dermatology, Columbia
University Medical Center, New York, NY and 2 University of Alabama at Birmingham,
Birmingham, AL
Aberrant sonic hedgehog (Shh) signaling is the primary driver of BCC pathogenesis, although pre-
clinical studies show that additional pathway(s) may be involved. Akt1/PKB serine/threonine pro-
tein kinase regulates cell proliferation and is dysregulated in many human cancers. Akt1 is also
activated in both UVB-induced murine and human BCCs. However, the role of Akt1 signaling in
the growth of BCCs is unclear. Here, we show that combined treatment of murine BCC (ASZ001)
cells with LY294002, a PI3K inhibitor, and cyclopamine, a Shh inhibitor, synergistically decreased
cell proliferation as shown by reduction of BrdU incorporation and abrogation of cyclin D1 expres-
sion. Combined administration of these agents to Ptch+/-/SKH-1 mice, synergistically decreased
the growth of UVB-induced BCCs. Interestingly, residual tumors in the combined treatment group
showed downregulation of total mTOR proteins. Furthermore we found that the promoter region of
mTOR harbors three Sry-related HMG box 9 (SOX9) binding motifs. SOX9 is a known transcription
factor, that is induced in human BCCs and its expression is regulated by Gli-1. Cyclopamine treat-
ment reduced SOX9 expression in ASZ001 cells. Both endogenous and recombinant SOX9 pro-
teins were shown to directly bind to the mTOR promoter as assessed by electrophoretic mobility
gel shift assays and shRNA-mediated downregulation of SOX9 reduced this binding. Importantly,
genetic ablation of SOX9 reduced the expression of mTOR and the phosphorylation of known down-
stream mTOR signaling proteins (p-p7056K and p-4E-BP1) and cyclin D1. Furthermore, itracona-
zole, an imidazole anti-fungal agent, known to inhibit Shh signaling, reduced expression of SOX9
as efficiently as did cyclopamine, blocked mTOR signaling, and reduced the growth of UVB-induced
BCCs in Ptch1+/-/SKH-1 mice. Our data provide strong evidence for a link between the SOX9, mTOR
and Shh signaling pathways that together are likely to contribute to the pathogenesis of BCCs.
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Mode of T cell administration determines homing sites of tumor-associated-antigen (TAA)-
specific Th1 cells to the tumor site and treatment success
CM Griessinger,1 A Schmid,1 D Bukala,1 K Fuchs,2 H Braumüller,2 S Kaesler,2 T Biedermann,2
BJ Pichler,1 M Röcken2 and M Kneilling2 1 Department of Preclinical Imaging and
Radiopharmacy, Tuebingen, Germany and 2 Department of Dermatology, Tuebingen,
Germany
Treatment with intra-peritoneal (i.p.) administered Tag2-Th1 cells arrest multistage carcinogenesis
and prolonged life of pancreatic cancer bearing RIP1-Tag2 mice two-fold. Aims of our study were
to analyze differences in treatment success and homing due to intra-venous (i.v.) or i.p. adminis-
tration of TAA-Th1 cells. CD4+ T cells were isolated from Tag2 TCR-tg mice or ovalbumin (OVA)-
TCR-tg mice and specifically cultured to generate a Th1 phenotype. We i.p. or i.v. injected Tag2-
Th1 cells into RIP1-Tag2 mice starting at 6 weeks of age once weekly and monitored mice by magnetic
resonance imaging (MRI) and detection of blood glucose levels (BGL). At 17 weeks of age we i.v.
or i.p. injected Cy5 fluorescence labeled Tag2-Th1 cells and sacrificed mice five days later. Addi-
tionally, we i.v. or i.p. injected Cy5 fluorescence labeled OVA-Th1 cells into B16- and OVA-B16-
melanoma bearing mice, and scarified mice four days later. Tag2 or OVA specific Th1 cell migra-
tion and biodistribution were investigated in vivo and ex vivo by optical imaging (OI) and
FACS-analysis. At 14 weeks of age average tumor volume was 88mm3 in sham treated RIP1-Tag2
mice, 7.4 mm3 in i.p. treated mice, while no tumors were detectable by MRI in i.v. treated mice.
BGL in i.p. treated RIP1-Tag2 mice was 69 (± 18) mg/dl, at norm values in i.v. treated (129 (± 4)
mg/dl), and < 30 mg/dl in sham treated mice. H&E staining of pancreatic tissue from 17 weeks old
RIP1-Tag2 mice showed large pancreatic tumors in i.p. treated but only small tumors in i.v. treated
mice. Surprisingly we could not detect Cy5-Tag2-Th1 cells at the tumor site after i.v. but a strong
accumulation after i.p. administration in both carcinoma models. Our data clearly indicate that i.v.
administration of Tag2-Th1 cells in RIP1-Tag2 mice is a much more efficient than i.p. administra-
tion even though Tag2-Th1 don’t reach the tumor site.
137
Sirt1 histone deacetylase (HDAC) is increased in cutaneous t-cell lymphoma (CTCL) and its
inhibition induces apoptosis
M Nihal,1 N Ahmad1 and GS Wood1,2 1 University of Wisconsin, Madison, WI and 2 Wm. S.
Middleton VAMC, Madison, WI
CTCL is a cutaneous T-cell lymphoproliferative disorder in which we and others have documented
resistance to apoptosis related in part to silencing of tumor suppressor genes such as those involved
in FAS pathway apoptosis. One mechanism of gene silencing involves histone deacetylation. 30-
40% of CTCL patients exhibit a significant clinical response to HDAC inhibitors (at least 50% regres-
sion of lesions), suggesting that histone deacetylases play an important role in CTCL tumor biology.
Therefore, we were interested in the potential role of the histone deacetylase, Sirt1, in CTCL. Sirt1
is the most well studied member of the Sirtuin (Sir2) family enzymes, which are nicotinamide ade-
nine dinucleotide dependent class III histone deacetylases, and have been shown to deacetylate
lysine residues on various proteins. Sirt1 has been shown to be involved in a number of cellular
processes including gene silencing, DNA repair, recombination, and stress response. Sirt1 also reg-
ulates the tumor suppressor p53. This study was designed to test the hypothesis that Sirt1 is differ-
entially expressed in CTCL and could be used as a target for designing novel approaches for the
management of this neoplasm. Western blotting, flow cytometry and cytospin immunostaining
demonstrated high Sirt1 expression among CTCL lines HH, Hut 78, MyLa, SeAx and SZ4 in com-
parison to normal blood lymphocytes. Sirt1 knockdown using shRNA resulted in increased expres-
sion of acetylated p53 and PARP cleavage products, consistent with induction of apoptosis. No sig-
nificant alteration of cell cycle distribution was found with Sirt1 knockdown. There is cooperation
between DNA methylation and protein deacetylation in gene silencing. We have shown that
methotrexate can act as a demethylating agent by depleting cellular S-adenosyl methionine, the
major methyl donor for DNA methyltransferases. Therefore, further studies are in progress to deter-
mine the effects on CTCL of combination therapy with histone deacetylase inhibitors and methotrex-
ate.
136
Identification of mediators of immune evasion in a modular mouse model of squamous cell
carcinoma
DW Dwyer,2 ML Leung,2 TB Thompson2 and KY Tsai1,2 1 Dermatology, University of Texas MD
Anderson Cancer Center, Houston, TX and 2 Immunology, University of Texas MD Anderson
Cancer Center, Houston, TX
The roles of the immune system in promoting and controlling cancer development and progression
are now well established experimentally. Individuals who are immunocompromised are exquis-
itely susceptible to non-melanoma skin cancers, notably squamous cell carcinoma (SCC). We pres-
ent here a modular model of SCC in mice that enables the independent manipulation of both tumor
cells as well as immune background. By examining and comparing tumor growth in differing back-
grounds of immunodeficiency, we have established a system through which tumor intrinsic adap-
tations to immune pressure may be identified and validated. Models that utilize chemical carcino-
genesis protocols or genetically engineered mice effectively model spontaneous tumor development,
but they do not permit the real-time manipulation of tumor cells and mechanistic exploration of
tumor-immune cell interactions. Our model is based upon the PDV transplantable SCC model in
C57BL/6 mice. Tumors arise with greatly increased frequency and dramatically shortened latency
on immunodeficient backgrounds, including strains lacking Rag recombinases and IL2-receptor
common gamma chain. We have utilized this difference as a basis for identifying tumor intrinsic
differences in gene expression that are related to background immune status. Through a series of
gene expression array analysis and serial passaging experiments, we have identified initial candi-
dates as well as transcription factor pathways necessary for immune evasion in immunocompetent
hosts. We believe this has important implications for an understanding of tumor-immune cell inter-
actions even beyond SCC.
134
Modeling the consequences of EGFR ablation therapy in squamous cancer by gene expres-
sion profiling of oncogenically transformed mouse keratinocytes
LN Wright, Y Riss, A Ryscavage and SH Yuspa Laboratory of Cancer Biology and Genetics,
National Cancer Institute, Bethesda, MD
EGFR targeted therapy is in clinical use to treat squamous cell carcinoma of the head and neck.
Activating ras mutations is a negative prognostic factor for response to EGFR ablation therapy in
multiple epithelial cancer types. Furthermore, the major adverse consequence of this therapy is an
acneiform papulopustular eruption on normal skin. We performed gene expression profiling on
oncogenic ras transformed and wildtype keratinocytes with EGFR ablated either genetically in the
germ line or pharmacologically by acute drug treatment to better understand the ras-EGFR ablation
interaction and the pathways altered by EGFR ablation in normal keratinocytes. We were able to
identify a 25 gene signature specific to the ras-EGFR ablation interaction and a distinct 19 gene
EGFR ablation signature on normal keratinocytes. The study also yielded secondary information on
differences in ontologies between chronic genetic EGFR ablation during development and acute
pharmacological ablation, both with and without ras activation. In the absence of EGFR, ras acti-
vation enriches the ontologies for ion channels and membrane transporters. In the absence of ras
activation, EGFR ablation reduces ontologies favoring cell cycle control and transcription. Pathway
analysis indicates that activation of p38α is a response to both acute and chronic abrogation of EGFR
signaling under conditions of ras activation. This was confirmed in oncogenic ras transduced human
keratinocytes and by immunohistochemistry of tumor orthografts of EGFR ablated mouse keratinocytes
transformed by oncogenic ras. Pathway analysis of EGFR ablation in the absence of oncogenic ras
displayed a node emanating from Erk signaling. Both of these findings could influence the thera-
peutic response to EGFR ablation therapy.
138
The desmosomal cadherin desmoglein 1 regulates differentiation of head and neck squa-
mous cell carcinoma cells
BV Desai, V Todorovic, J Chen, DM Sweeney, CA Franzen, DB Solt, JE Koblinski, JC Pelling and
KJ Green Department of Pathology, Northwestern University, Chicago, IL
It is well-established that the loss of intercellular adhesions is an important aspect of tumor pro-
gression. However, the importance of the desmosomal cadherin sub-class of cadherins in cancer is
not well understood. Desmoglein 1 (Dsg1) is one of four desmogleins which are spatially arrayed
in distinct patterns in complex epithelia, and is first expressed as cells emerge from the basal layer.
We recently demonstrated that this cadherin is required to promote a program of differentiation of
normal human epidermal keratinocytes (NHEK). Additionally, two independent studies using tissue
microarrays have demonstrated a positive correlation between Dsg1 expression, differentiation sta-
tus and patient outcome, respectively, in head and neck squamous cell carcinomas (HNSCC). Using
immunohistochemical analysis on human sections we observed reduced expression of Dsg1 in
advanced dysplasia suggesting its early loss during tumor progression. Based on these observations
we hypothesized that Dsg1 determines the differentiation status and aggressiveness of HNSCC. Of
a panel of cell lines derived from tumors of varying stage and malignancy, 1483 cells retained the
ability to express Dsg1 under conditions promoting differentiation in vitro. Additionally, using an
orthotopic mouse model system we demonstrated that xenografted 1483 cells form Dsg1 and K10
expressing differentiated tumors. Silencing Dsg1 in vitro inhibited the induction of differentiation
markers K1, K10 and Dsc1. To further delineate Dsg1’s role in tumor progression, we determined
the ability of Dsg1 KD cells to support anchorage independent growth in soft agar and to invade
through 3D matrix. In preliminary studies, Dsg1-silenced cells formed more colonies and exhib-
ited increased invadopodia extensions and matrix degradation compared to the control. Together,
these data raise the possibility that loss of Dsg1 in tumors shifts the balance away from a differen-
tiated phenotype while promoting tumor growth and invasion.
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Expression of p53, smooth muscle actin and c-kit in dermatofibrosarcoma protuberans and
evaluation of correlation with clinical features
M Kim,1 K Cho,1 J Lee,2 M Chang3,4 and S Cho1,2 1 Dermatology, Seoul National University
College of Medicine, Seoul, Republic of Korea, 2 Dermatology, Seoul National University
Boramae Hospital, Seoul, Republic of Korea, 3 Pathology, Seoul National University College
of Medicine, Seoul, Republic of Korea and 4 Pathology, Seoul National University Boramae
Hospital, Seoul, Republic of Korea
Dermatofibrosarcoma protuberans (DFSP) is a rare cutaneous tumor with intermediate malignancy.
The purpose of this study is to evaluate the utility of p53, smooth muscle actin and c-kit as immuno-
histochemical markers which could correlate to the clinical outcome. We conducted a retrospec-
tive review of patients diagnosed with primary or recurrent DFSP between 2000 and 2009 at Seoul
National University Hospital and Boramae Hospital. Clinical data were retrieved by chart review,
and pathologic slides were reviewed in available cases and classified into subtypes. Immunohisto-
chemical study was performed with antibodies of p53, c-kit and smooth muscle actin. We ana-
lyzed data for 32 lesions from 31 patients. On review of pathologic slide, conventional subtypes
(17 cases) were observed most commonly, followed by myoid (5 cases), myxoid (4 cases), Bednar
(3 cases), and ones with fibrosarcomatous(FS) change (2 cases). DFSP-FS showed high immunore-
activity for SMA compared with other subtypes (P=.026). No difference in p53 immunoreactivity
was observed between subtypes. There was no correlation between SMA and p53 immunoreactiv-
ity and other clinical factors. c-kit staining for mast cell count showed a negative correlation with
mitosis and tumor size (P<0.05). Immunoreactivities for p53, SMA and c-kit are not useful markers
to predict the clinical outcome of DFSP. The negative correlation of the mast cell number with malig-
nancy grade shown in this study implies a secondary role of mast cells as host immune response
unlike primary role of mast cells in tumor angiogenesis in other tumors. Further studies are required
to define the exact role of mast cells.
128
The squamous cell carcinoma transcriptome defined by high-throughput sequencing (RNA-
seq)
L Luan and T Andl Vanderbilt University, Nashville, TN
Cancer is a genetic disease that is characterized by massive changes in gene expression. These
changes are not limited to mere expression level alterations but can involve events such as alter-
native splicing, alternative promoter, 5’untranslated region (UTR) and 3’UTR usage. Advances in
high-throughput sequencing technologies of transcriptomes (RNA-seq) will allow for a much more
refined view of all these process and their contribution to carcinogenesis on the single-nucleotide
level. Application of RNA-seq to the analysis of cancer transcriptomes will lead to novel insights
into the abundance and quality of alterations at an unprecedented depth. Here, we present our
data of the comparison of a squamous cell carcinoma and a normal skin sample by RNA-seq.
Using the Illumina GAII sequencer we obtained 10883041 and 13213834 short sequence reads for
normal and tumor mRNA, respectively. We have identified 4113 genes statistically verified as dif-
ferentially expressed. Grouping based on GO terms of the 300 most highly overexpressed and
reduced genes revealed significant changes in genes associated with the immune response, prolif-
eration, extracellular-matrix receptor interactions, focal adhesion, the actin cytoskeleton organiza-
tion, glycerophospholipid metabolism, TGF-beta signaling, leukocyte transendothelial migration
and the MAPK signaling pathway. Furthermore, analysis of alternative splicing events have identi-
fied a large number of mRNA isoform differentially represented in tumor and normal skin. How-
ever, the challenges and pitfalls of whole transcriptome sequencing are evident from our analysis
and range from inadequate analysis algorithms to difficulties in the interpretation of for example
alternative polyadenylation site usage probably due to biases introduced during the multiple steps
of enzymatic processing of RNA and DNA. Nevertheless, the data from this experiment will be a
starting point for the validation of tumor-specific isoforms of proteins involved in key signaling path-
ways that could be used as the basis for new drug and treatment targets.
129
High throughput RNA sequencing of Sezary syndrome and cutaneous squamous cell carci-
noma
C Lee, K Qu, D Webster, M Kretz, A Mah, A Ungewickell, R Armstrong, W Weng, Y Kim, H Chang
and P Khavari Veterans Affairs Palo Alto Healthcare System and Stanford University, Palo Alto,
CA
To characterize genetic alterations in epithelial and non-epithelial malignancies affecting human
skin, we performed high throughput whole transcriptome sequencing of cutaneous squamous cell
carcinoma (SCC) and Sezary Syndrome (SS). The Illumina paired-end HiSeq platform with read
length of 101 nucleotides was used, at >100 million reads per experimental sample. 3 SCC sam-
ples as well as patient-matched, normal adjacent skin control were sequenced and then analyzed
for novel gene fusions, missense somatic mutations, noncoding RNAs, gene expression differences,
novel viral sequences, and transcript variants resulting from alternative splicing events. The tran-
scriptomes of 3 SS patients were also sequenced after sorting peripheral blood for CD4+ Sezary cells
identified by specific clonal T-cell receptor (TCR) V beta epitope as well as patient-matched, CD4+
normal lymphocytes. >70% of sample reads successfully mapped back to the human genome
using the read-mapping algorithm TopHat. SeqGene open-source software was used to identify
novel, disease-specific missense mutations and indels as well as quantify gene expression differ-
ences between malignant cells and their normal counterparts. Alternative splicing events were iden-
tified using Cufflinks and fusion transcripts were detected using FusionSeq. We are currently screen-
ing a large cohort of patients to identify the prevalence of novel mutations and chimeric transcripts
in SCC and SS as well as normal, disease-free individuals. These efforts characterize alterations in
genomic transcriptional sequences in malignancies arising from distinct cellular lineages present
in human skin.
130
Chemokine receptor CXCR4 is a novel marker for the progression of skin cancer
S Toyozawa,1 Y Yamamoto,1 C Kaminaka,1 T Kishi,1 Y Nakamura2 and F Furukawa1 1
Dermatology, Wakayama Medical University, Wakayama, Japan and 2 Clinical Laboratory
Medicine, Wakayama Medical University, Wakayama, Japan
Functional chemokine receptors are expressed in many malignant tumors. The CXCR4/CXCL12 path-
way has been recently involved in stimulating the metastatic process of many different neoplasms,
where CXCR4 is able to activate various phenomena such as chemotaxis, invasion, angiogenesis
and proliferation. The purpose of this study are to analyze a possible association between the expres-
sion of chemokine receptors CXCR4, CCR6, CCR7 and the clinical features of skin cancers, and to
assess the usefulness of these chemokine receptors for diagnosis and prognosis. The immunohisto-
chemical expression of CXCR4, CCR6 and CCR7 was investigated on primary tissues of 8 der-
matofibrosarcoma protuberance (DFSP), 6 malignant fibrous histiocytoma, 18 malignant melanoma,
5 angiosarcoma and 16 premalignant skin tumor such as actinic keratosis and Bowen’s disease.
Associations between patient features and immunoreactivity were analyzed statistically. The signif-
icant higher expression of CXCR4 was observed in these skin malignant tumors including prema-
lignant skin tumor which had no effect with the nonsurgical treatment as compared with benign
control. CXCR4 staining was observed in cytoplasm of tumor cells. Interestingly, CXCR4 expression
was significantly higher in relapsed DFSP as compared with non-relapsed DFSP, and CXCR4 was
more useful marker than CD34. In malignant melanoma tissues, CXCR4 expression was significantly
correlated with Breslow’s tumor thickness and nodular melanoma. CCR6 and CCR7 expression
was observed in some cases of all kinds of tumors; however, no significant associations were detected
between patient features and immunoreactivity. These data suggest that the assessment of CXCR4
immunoreactivity is a novel and useful tool for expressing local tumor aggressiveness of skin tumors.
131
MicroRNA-21 is an important downstream component of BMP signaling in skin epithelial
cells
MI Ahmed,1 AN Mardaryev,1 AA Sharov2 and NV Botchkareva1 1 Centre for Skin Sciences,
University of Bradford, Bradford, United Kingdom and 2 Department of Dermatology, Boston
University, Boston, MA
Bone morphogenetic proteins (BMPs) play essential roles during skin development, postnatal tissue
remodeling and tumorigenesis. To explore whether some of these inhibitory effects of the BMP sig-
nalling are mediated by microRNAs, miRNAs were isolated from the primary mouse epidermal ker-
atinocytes, treated with BMP4 and processed for evaluation of global miRNA expression patterns
using the microarray profiling. Microarray and real-time PCR analyses revealed substantial BMP4-
dependent changes in the expression of distinct miRNAs including miR-21, which expression was
strongly decreased in the keratinocytes after BMP4 treatment. However, miR-21 expression was sub-
stantially higher in the skin of transgenic mice overexpressing BMP antagonist Noggin under con-
trol of the K14 promoter. In normal mouse skin, miR-21 expression was observed in the epidermis
and hair follicle epithelium. In K14-Noggin skin, prominent miR-21 expression was seen in the epi-
dermis, while in the HF-derived trichofolliculoma-like tumours miR-21 was expressed predomi-
nantly in their peripheral portion that contain proliferating and low-differentiated cells. Furthermore,
by transfecting the keratinocytes with miR-21 mimic we identified the existence of two groups of
the BMP target genes, which are differentially regulated by miR-21. BMP-dependent tumor-sup-
pressor genes such as Pten, Pdcd4, Timp3, and Tpm1, are negatively regulated by miR-21, while
Id1, Id2, Id3 and Msx2 that predominantly mediate the effects of BMPs on cell differentiation and
apoptosis are miR-21 independent. Thus, our study establishes a novel mechanism involved in the
realization of the BMP effects in the skin and suggests miRNAs as important regulators modulating
the effects of growth factor signaling pathways on skin development and tumorigenesis.
132
Interferon-γ/STAT1-signaling determines whether T cells promote or arrest carcinogenesis
S Fischer, T Wieder, H Braumüller, E Brenner, W Kempf and M Röcken Dermatology, University
Medical Center Tuebingen, Tuebingen, Germany
Th1 cells have recently been shown to be effective in treating malignant melanoma. The mode of
action remains unclear. To unravel the underlying mechanisms, we studied oncogenic T antigen
(Tag) driven cancers that first lead to adenomas and, subsequently, cancer in RIP1-Tag2 transgenic
mice. Treatment of mice with interferon-γ (IFN-γ)-producing Th1 cells specific for a Tag peptide
strongly inhibited tumor growth in the absence of cytotoxic T cells and without inducing cancer-
cell apoptosis. Inversely, blocking the in vivo action of IFN-γ with mAb abolishes the therapeutic
effect of Tag-Th1 cells, and even enhances cancer angiogenesis and cancer growth. Here, we stud-
ied the effects of IFN-γ on proliferation, apoptosis, cell cycle regulation and senescence in isolated
RIP1-Tag2 cancer cells in vitro and in vivo. Proliferation was assessed by 24h BrdU labeling (ELISA),
and apoptosis by TUNEL assay and sub-G1 analysis. The cell cycle analysis was performed by 7-
AAD/BrdU double staining and flow cytometry, and senescence was analyzed by senescence-asso-
ciated-beta-galactosidase-assay (SA-β-gal-assay) and immunofluorescence of pHP1-γ-staining. To
specifically study the role of IFN-γ/STAT1 signaling, we compared the effects of IFN-γ on RIP1-Tag2
cancers with that on STAT1-deficient RIP1-Tag2 cancers. IFN-γ directly inhibits RIP1-Tag2 cancer
proliferation by arresting the cells in the G1/G0 phase of the cell cycle. Cell cycle arrest occurred
in the absence of apoptosis but with induction of SA-β-gal-positive cancer cells and formation of
heterochromatin foci, both characterizing a senescent phenotype. Importantly, IFN-γ dependent
therapy with Th1 cells in vivo established permanent growth arrest of cancer cells, the most strin-
gent criterion characterizing cancer cell senescence. IFN-γ-induced senescence was completely
blunted in STAT1-deficient RIP1-Tag2 cancers. Thus, tumor-specific Th1 cells can arrest malignant
growth of oncogen-driven cancers by inducing a permanent, IFN-γ-dependent cell cycle arrest.
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The anti-motility signaling mechanism by transforming growth factor-β (TGFβ) in human
dermal fibroblasts during wound healing
A Han, B Bandyopadhay, J Fan, M Chen, D Woodley and W Li Dermatology and Norris
Comprehensive Cancer Center, University of Southern California, Los Angeles, CA
The transforming growth factor-beta (TGFβ) family cytokines play critical roles in skin homeostasis
and skin diseases, most noticeably cell growth control, cell differentiation, tissue inflammation,
fibrosis and skin cancer progression. Anti-proliferation and anti-migration are the primary effects of
TGFβ on human skin cells. These “negative” effects are often nullified in skin cancers. We have pre-
viously shown that these two signals from TGFβ3 play critical roles in the regulation of the orderly
events of normal skin wound healing. In this current study, we carried out a step-by-step investiga-
tion of the anti-migration versus anti-proliferation signaling of TGFβ in primary human dermal fibrob-
lasts (DFs). We demonstrate that the transduction of these two signals across the cell membrane is
distinguished first at the type II TGFβ receptor (TβRII) level. Higher levels of TβRII in DFs transmit
both signals, whereas lower levels of TβRII in epidermal cells only allow the anti-proliferation sig-
nal and prevent the anti-migration signal. In DFs, TβRII then transmits the full scale of anti-migra-
tion and anti-proliferation to the type I TGFβ receptor (TβRI/Alk5), because down-regulation of
TβRI eliminated both signals and a constitutively activated TβRI (TβRI-TD) replaced the signals of
TGFβ3 to block both DNA synthesis and migration. Similarly, down-regulation of Smad2 and Smad3
abolished transduction of both signals. However, down-regulation of Smad4 only partially blocked
the anti-migration signal. Instead, we have identified CREB (cAMP response element binding pro-
tein) as a critical downstream factor that mediates the anti-motility signal of TGFβ3. This is the first
study of TGFβ’s anti-motility mechanism and has unveiled a previously unrecognized anti-migra-
tion pathway of TGFβ: high TβRII level > TβRI >Smad2/3 > CREB > inhibition of growth factor-acti-
vated DF migration.
147
Analysis of gene copy number variation and expression in cutaneous T-cell lymphoma cell
lines
W Lin, B Modi, J Lewis, R Filler and M Girardi Dermatology, Yale University, New Haven, CT
In the genomic era, characterizing the cancer genomes of the malignant cells purified from patients
with cutaneous T-cell lymphoma has enabled the identification of novel oncogenes and tumor sup-
pressors and advanced our understanding of the biologic pathways involved in this malignancy.
Translating these discoveries of critical gene alterations – particularly those with available targeted
therapeutics – to pre-clinical testing, however, has been encumbered by the lack of a genomically
annotated model system. Towards that goal, we generated high-resolution microarray DNA copy
number and mRNA expression data from 7 existing CTCL cell lines (Myla, Sez4, SeAx, HH, Pno,
HUT78-A, HUT78-B). Gene copy number alterations in these 7 cell lines were compared to that
profiled from 24 CTCL patient samples at our institution, as well as to a meta-analysis of CTCL copy
number alterations. In addition, we performed quantitative genomic PCR (ABI Taqman Copy Num-
ber Assays) to examine copy number variations in select genes in both cell lines and patient sam-
ples. These analyses provide a framework with which to interpret the degree to which available
CTCL cell lines adequately reflect the alterations observed in affected patients, and identify specific
differences that may provide an opportunity to logically investigate in vitro potential targeted ther-
apies for CTCL.
149
Engineered dendritic cell (DC)- or DNA-based vaccines raise immune responses to a car-
cinogen-induced point mutation of the H-ras oncogene that protects against tumor develop-
ment.
K Rudemiller,1 T Nasti,1 G Twitty,1 H Kim,1 A Rivera,2 J Roth,2 A Holzer,1 Y Tsruta,1 N Yusuf,1
M Athar,1 C Elmets1 and L Timares1,2 1 Dermatology, University of Alabama at Birmingham,
School of Medicine, Birmingham, AL and 2 Human Gene Therapy, University of Alabama at
Birmingham, School of Medicine, Birmingham, AL
We have found that development of a T cell-mediated immune response senstized by polyaromatic
hydrocarbons (PAHs) is associated with resistance to tumorigenesis by those agents. The carcino-
genic PAH 7,12-dimethylbenzanthracene (DMBA) results in a characteristic point mutation, Q61L,
in the H-ras oncogene (H*ras). We tested the hypothesis that a vaccine designed to focus T cell spe-
cific immunity to H*ras would eliminate cells with DMBA-induced mutations and protect against
carcinogenesis. We first observed that mutant, but not wild type (WT) H-ras peptide induced DTH
responses when challenged with mutant but not WT peptide in A/J and C3H/HeN mice. Hapten-
specific DTH responses are mediated by CD8 T cells but suppressed by CD4 T cells; A ubiquitin
(Ub) tagged chimeric gene encoding H*ras or WT H-ras epitope/EGFP fusion protein was engineered
to favor MHC class I loading. H*ras-specific DTH and CTL responses were detected in mice vac-
cinated with plasmid DNA or engineered DC encoding Ub/H*ras/EGFP, but not control Ub/WT H-
ras/EGFP. Engineered DC lines similarly induced H*ras-specific DTH responses and generated
increased numbers of IFN producing CD8 T cells. Detectable DTH responses were elicited by DMBA
in Ub/H*ras/EGFP vaccinated mice, indicating that DMBA-induced H*ras expressing cells were rec-
ognized. Cohorts of mice (n=20) were subjected to a two-step DMBA/TPA chemical carcinogene-
sis protocol for 24 weeks. Ub/H*ras/EGFP vaccinated mice developed 55% fewer (p=0.004) and
75% smaller (p=0.02) tumors compared to tumors in control cohorts. The studies indicate that vac-
cination strategies engineered to focus effector T cell responses to mutant oncogenes can be employed
for the immunoprevention of chemically induced skin tumors.
148
Human basal cell carcinoma demonstrate both outer and inner root sheath differentiation
A Beneketh, I Siciliano, PE Bowden, C Colmont and GK Patel Dermatology and Wound Healing,
Cardiff University, Cardiff, United Kingdom
Basal cell carcinoma (BCC) is believed to be derived from the human hair follicle outer root sheath.
While the hair follicle elegantly demonstrates both inward and upward differentiation patterns, the
pattern BCC differentiation and its regulation remains unclear. To test this hypothesis we have taken
20 human BCC samples, to study the architectural patterns of differentiation within the tumor and
their regulatory control. During this study we used normal hair bearing skin as both positive and
negative control. In addition we developed an in vitro assay, to test the hypothesis that extracellu-
lar signals may influence differentiation. All BCC samples expressed the outer root sheath (ORS) ker-
atins, K6 and K17, consistent with over expression the sonic hedgehog signalling pathway and
nuclear translocation of the transcriptional regulator Gli1. Similarly, all BCC samples demonstrated
K19 expression, which maintained its’ relative incongruent relationship with cell proliferation. In
seven samples tested, there was also expression of the ORS and ORS companion layer keratins K16
and K75 respectively, in a sub-population of cells within the tumour mass; coinciding with nuclear
translocation of NFIL-6 (CEBP-beta). Those BCC samples expressing K16 and K75, also expressed
the inner root sheath keratin K26 but not K28 in a small sub-population of tumour cells. In contrast,
none of the BCC samples demonstrated expression of the early hair shaft keratins K31, K32 and
K81 nor the transcriptional regulator GAD-153. Ongoing experiments using an in vitro colony form-
ing assay, which we have developed to explore the role of mesenchymal signals, may highlight
mesenchymal regulation of BCC tumor differentiation. In conclusion, BCC exhibit multiple hair fol-
licle differentiation patterns, demonstrating a hierarchical organisation of the hair follicle root sheath.
These findings are consistent with the cancer stem cell model of tumour growth and support the
potential existence of tumor initiating cells (cancer stem cells) within BCC.
146
MAGE proteins direct KAP-1 mediated gene suppression and mediate KRAB Zinc Finger
Transcription Factor (KZFTF) binding and ubiquitination
TZ Xiao,1 N Bhatia,1 R Urrutia,2 GA Lomberk,2 A Simpson3 and J Longley1 1 Department of
Dermatology, University of Wisconsin School of Medicine and Public Health, Madison, WI, 2
Department of Molecular Neuroscience, Mayo Clinic, Rochester, MN and 3 Ludwig Institute
for Cancer Research, New York, NY
Class I human Melanoma Associated AntiGens (MAGE) are normally expressed only in developing
germ cells but are aberrantly expressed in melanoma and many other cancers where they promote
survival, aggressive growth, and chemoresistance. KRAB domain zinc finger transcription factors
(KZNFs) are the largest group of vertebrate transcription factors and target tumor suppressors and
regulate proliferation, apoptosis, and neoplastic transformation. KZNFs bind to the RBCC region of
the KAP-1 protein and direct KAP-1 to specific DNA sequences where it suppresses gene expres-
sion by inducing localized heterochromatin characterized by histone 3 serine 9 trimethylation
(H3me3K9). Discovery that MAGE proteins also bind to the KAP1 RBCC region prompted us to
investigate whether MAGE can affect KZNF and KAP-1 mediated gene regulation. We performed a
genome wide survey of KAP-1 binding sites, in the presence and absence of MAGE, by chromatin
immunoprecipitation and high-throughput DNA sequencing (ChIP-seq). KAP-1 bound to 6033
sites without MAGE whereas ectopic expression of MAGE caused a major shift with detection of
KAP-1 binding to10253 new sites. KAP-1 binding was enriched within transcribed regions of tar-
get genes. ChIP with anti-KAP-1 and anti-H3me3K9 Abs, and reverse transcription RT-PCR validated
ChIP-seq results for selected genes including the ID1 tumor suppressor gene, a target of KZNF382.
Reporter construct studies showed that MAGE decreases KAP-1 binding with ZNF382, and that
MAGE increases ubiquitination and degradation of KZNF382. Since KZNFs are required to direct
KAP-1 to specific genes, these results suggest that MAGE proteins can affect the majority of KZNF
targets and establish MAGE proteins as master regulators of the complex KZNF family.
150
SerpinA1: A novel biomarker for progression of cutaneous squamous cell carcinoma
M Farshchian,1 A Kivisaari,1 R Ala-aho,1 P Riihilä,1 M Kallajoki,1 R Grénman,1 J Peltonen,1
T Pihlajaniemi,2 R Heljasvaara2 and V Kähäri1 1 University of Turku, Turku, Finland and 2
University of Oulu, Oulu, Finland
The incidence of keratinocyte-derived nonmelanoma skin cancers is increasing globally due to
cumulative recreational exposure to sunlight. At present, no specific molecular markers are avail-
able for assessing progression of premalignant actinic keratoses to invasive cutaneous squamous
cell carcinoma (SCC). Here, we have examined the role of serine proteinase inhibitor (Serpin) fam-
ily in SCC of skin. Expression profiling of cutaneous SCC cell lines (n=8) revealed up-regulation of
SerpinA1 compared to normal human epidermal keratinocytes established from healthy individu-
als (n=5). Analysis with quantitative RT-PCR showed that SerpinA1 mRNA was markedly up-regu-
lated in cutaneous (n=8) and head and neck (n=38) SCC cell lines, and in head and neck SCC tumors
(n=51), as compared to corresponding normal cells and tissues. SerpinA1 production by skin SCC
cells was dependent on p38 MAPK activity and was upregulated by EGF, TNF-α, IFN-γ, and IL-1β.
Immunostaining of tissue arrays containing altogether 148 human tissue samples revealed tumor
cell-specific expression of SerpinA1 in 19 of 36 actinic keratoses, 22 of 29 Bowen’s disease sam-
ples, 67 of 71 sporadic SCCs and in all 12 recessive dystrophic epidermolysis bullosa-associated
SCCs. Moreover, tumor cell-specific SerpinA1 staining was detected in all chemically induced mouse
skin SCCs (n=17) studied. These results identify SerpinA1 as a novel tumor cell specific biomarker
for progression of cutaneous SCC, and suggest it as a potential therapeutic target in unresectable
and metastatic SCCs of the skin.
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Inhibition of PI3K/AKT/mTOR pathway in human melanoma cells with induction of autophagy
and decreased tumor growth both in vitro and in vivo by a dietary flavonoid fisetin
DN Syed, VM Adhami, J Chamcheu and H Mukhtar Department of Dermatology, University of
Wisconsin, Madison, Madison, WI
Flavonoids, natural components of our diet, known to possess anti-inflammatory activity are increas-
ingly being investigated for their therapeutic properties. We have recently shown that the dietary
flavonoid fisetin decreases MITF levels in human melanoma cells through interference with Wnt/β-
catenin signaling (Syed et al., JID 2011; in press). The PI3K/AKT/mTOR pathway, constitutively acti-
vated in melanoma, is an attractive therapeutic target as it serves as a convergence point for growth
stimuli that contribute to the initiation and maintenance of tumor growth. In addition, both AKT
and mTOR are components of pathways that are involved in apoptosis and autophagy resistance of
cancer cells. Here, we determined the effect of fisetin on the PI3K/AKT/mTOR pathway and its down-
stream targets, in cell culture and mouse melanoma model. Fisetin treatment (40-80μM) of highly
aggressive 451Lu human melanoma cells resulted in cell cycle arrest in the G1 phase within 24 h.
At 48 h, fisetin treatment induced autophagy, as assessed by increased levels of LC3-II and beclin.
Fisetin mediated activation of AMP-activated kinase was associated with negative regulatory effects
on the mTOR signaling cascade and activation of tumor suppressor TSC2. Using human skin equiv-
alent melanoma model we show that fisetin treatment led to synergistic suppression of AKT and
ribosomal S6 protein phosphorylation with downregulation of the mTORC complex. Xenograft stud-
ies in mice implanted with 451Lu cells further demonstrated that fisetin significantly reduced tumor
growth and increased the median survival time, associated with decreased expression of AKT/mTOR
signaling molecules. Our study shows that fisetin can be developed as a potential anti-melanoma
agent capable of targeting signaling pathways mechanistically linked to melanoma carcinogenesis.
We suggest that fisetin alone or in combination may be used for the treatment of melanoma.
140
Srcasm induces regression of pre-existing squamous cell carcinomas in K14-Fyn Y528F mice
X Yang, H Nishida, L Zhao, C Marshall, T Dentchev and J Seykora Dermatology, Univ. of
Pennsylvania, Philadelphia, PA
Cutaneous squamous cell carcinoma (cSCC) is the second most common human cancer and is asso-
ciated with cumulative UV exposure which leads to frequent mutations in RAS and p53. Most human
cSCCs demonstrate increased activity of Src tyrosine kinases which promotes RAS-dependent sig-
naling and downregulates p53. Human sSCCs also have decreased levels of Srcasm, a negative reg-
ulator of Src kinases. These features of human cSCCs have been modeled in vivo using K14-Fyn
Y528F mice which spontaneously develop cSCCs in 5-8 weeks; the development of cSCCs is inhib-
ited by raising Srcasm levels with a K14-Srcasm transgene. Although elevating Srcasm levels with
a K14-Srcasm transgene can inhibit the formation of cSCCs in K14-Fyn Y528F mice, it is unknown
if inducing Srcasm levels can promote regression of pre-existing cSCCs. To address this question,
we first derived K14-Fyn Y528F/CMV-rtTA/TRE-Srcasm triple transgenic mice. Experimental cohorts
of these triple transgenic mice manifesting 32 and 31 cSCCs were exposed to doxycycline or no
treatment, and tumors were followed and analyzed over time. The doxycycline treated cohort demon-
strated a rapid and robust induction of Srcasm in the epidermis and dermis that was approximately
5-fold higher than controls by western blot analysis. The doxycycline-treated cohort showed regres-
sion of 26/32 in four weeks. The control cohort showed no regression of 31 cSCCs over the same
period. Inducing Srcasm was associated with cSCC regression, p < 0.01. Withdrawal of doxycy-
cline after four weeks resulted in recurrence of one tumor. Sequential biopsies of regressing tumors
demonstrated that increased Srcasm levels promoted regression without tumor cell necrosis; mild
inflammation and dermal fibrosis were noted at sites of regression. In regressing tumors, levels of
pErk 1/2, pPDK-1, pSTAT-3 and p-Src kinases normalized with increasing Srcasm. Levels of p53
also were restored. The data presented suggest that enhancing Srcasm function or targeting Src
kinases may be useful for treating cSCCs.
141
IL-17 receptor A deficient mice are resistant to chemical carcinogen induced cutaneous tumors
D He, H Li, N Yusuf, CA Elmets, M Athar, S Katiyar, J Li, J Mountz and H Xu University of Alabama
at Birmingham, Birmingham, AL
Inflammation associated tumor development is a central issue for tumor biology and immunology.
It remains largely to be defined why and how immune responses, which act to prevent tumor
development, can promote tumors in forms of inflammation. Although IL-17 producing cells and
IL-17 responses are detected in cancer patients and tumor bearing mice, studies in the role of IL-
17 in tumor development reveal conflicting results. In the current studies using an inflammation
associated tumor model, we showed that IL-17 receptor-A gene deficient mice (IL-17R-/-) were resist-
ant to chemical carcinogen induced tumors in the skin. Moreover, the defect in IL-17R reversed the
increased susceptibility of IL-12p35 deficient mice to tumor development. Analysis showed that
angiogenesis and infiltration of myeloid cells were inhibited whereas the infiltration of CD8 T cells
was increased in the inflamed skin of IL-17R-/- mice. The development of myeloid derived sup-
pressor cells, Inflammation induced Cox-2 activity and S100A8/A9 proteins, and inflammation asso-
ciated epidermal hyperplasia were suppressed in IL-17R-/- mice. Furthermore, the production of
tumor promoting inflammatory cytokines IL-1β and TNF-α were reduced. These findings demon-
strate that IL-17 signals are required for the induction of tumor promoting inflammation and a defi-
ciency in IL-17 responses inhibits inflammation associated tumor development. The study provides
insights into a novel mechanism by which IL-17 mediates tumor promoting inflammation and induces
tumor escape from immune surveillance. It has major implications for targeting IL-17 in prevention
and treatment of tumors.
142
Bioinformatics characterization of Z-DNA in the genes of human epidermis with melanoma
K Beheshti,1 CE Gagna,1,2,3 N Agostino,4 NA Bhagat,1 R Leston,1 A Hicks,1 R Joy,1 S Hde Tene1 and
W Lambert2,3 1 Life Sciences, New York Institute of Technology, Old Westbury, NY, 2
Dermatology, New Jersey Medical School, Newark, NJ, 3 Pathology & Laboratory Medicine,
New Jersey Medical School, Newark, NJ and 4 School of Natural Sciences, Fairleigh Dickinson
University, Teaneck, NJ
Melanoma is the most lethal skin cancer. It accounts for 4% of all cases of skin cancers, but results
in 79% of skin cancer deaths. In 2002, the American Cancer Society approximated that there were
54,000 new cases of this disease in America and about 7,400 deaths. The majority of DNA in human
genes is made of right-handed double-stranded (ds-) B-DNA. Left-handed ds-Z-DNA is an alterna-
tive type of ds-DNA, and plays a role as a transcriptional enhancer in RNA editing and recombi-
nation. Our group has employed bioinformatics to identify the presence of Z-DNA in normal and
diseased epidermal genes. We used the Z-Hunt computer software to find genes that have poten-
tial Z-DNA-forming sequences in them. Our results showed that some mutated epidermal genes
contain potential Z-DNA-forming sequences, while others do not. Some of these genes containing
potential Z-DNA sequences had higher Z-scores than others (i.e., ease at which B-DNA can tran-
sition to Z-DNA). New classes of drugs need to be produced that can be used to treat and/or cure
this disease (e.g., bind to specific structures of DNA, such as Z-DNA, and “turn off” gene expres-
sion). These types of studies will help shed light on the genetics of melanoma. This kind of bioin-
formatic data has the potential to help in the diagnosis of the disease. Being able to locate Z-DNA
in mutated epidermal genes will allow for additional target sites to produce new classes of drugs,
viz., based on B-DNA to Z-DNA transitions. This research project was supported in part by a NYIT
ISRC grant.
143
Oncogene addiction to Merkel cell polyomavirus large T antigen in Merkel cell carcinoma
ME Verhaegen,1 CK Bichakjian,1 M Voutsalath,1 J Weick,1 P Baciu,1 E Quintana,3 TD Stromer,1
J Pero,1 KT Nash,1 AE Ayar,1 TM Johnson1 and AA Dlugosz1,2 1 Dermatology, University of
Michigan, Ann Arbor, MI, 2 Cell and Developmental Biology, University of Michigan, Ann
Arbor, MI and 3 Life Sciences, University of Michigan, Ann Arbor, MI
Merkel cell carcinoma (MCC) is a rare but potentially lethal neuroendocrine carcinoma of the skin,
with no current effective treatment options for patients with advanced disease. Recent studies have
indicated that a high proportion of MCCs contain DNA sequences from Merkel cell polyomavirus
(MCV), harboring a T antigen (TAg) oncoprotein locus. Although the MCV large (L) TAg is predicted
to modulate tumor suppressor and cell cycle regulatory proteins, its role in MCC pathogenesis
remains uncertain, due largely to a paucity of in vitro and in vivo experimental models. To begin
rigorously testing the functional role of the MCV LTAg in MCC, we have established 8 robust MCC
cell lines, derived either directly from patient tumors or from tumors first grown as xenografts in
immunocompromised mice. All 8 MCC cell lines grow in suspension as tight spheres or loose aggre-
gates and express the neuroendocrine marker chromogranin A, with a subset also expressing ker-
atin 20. Additionally, 7 out of 8 MCC lines have been passaged over 17 times in culture. Four MCC
lines express the MCV LTAg at both the RNA and protein level. To directly address the role of LTAg
in MCC, we evaluated the effect of MCV LTAg inactivation by short hairpin-driven RNA (shRNA)
interference. Three distinct lentiviral shRNA constructs inducing more than a 55-95% reduction in
LTAg (as determined by immunoblotting and Q-RT-PCR) resulted in decreased cellular proliferation,
based on cell numbers and a reduction in the mitosis marker phosho-histone H3, as well as increased
cell death determined by Trypan Blue assay. Our data indicate that the MCV LTAg is required for
MCC maintenance by regulating cell proliferation and survival, and suggest that the LTAg, or its
endogenous cellular targets, may represent a point of vulnerability in MCC that can potentially be
exploited for future treatment approaches.
144
Whole genome (exome) sequencing of xeroderma pigmentosum patients reveals a finite and
distinct pattern of mutations in pathophysiologically relevant genes
P Bauer,1 Y Kamenisch,2 C Bauer,1 M Röcken,2 O Riess1 and M Berneburg2 1 Department of
Genetics, Eberhard Karls University, Tuebingen, Germany and 2 Department of Dermatology,
Eberhard Karls University, Tuebingen, Germany
Xeroderma pigmentosum (XP) is a rare autosomal recessive disease clinically characterized by
photosensitivity, xerosis cutis, poikiloderma, telangiectasia and a 1000-fold increased risk to develop
skin cancer. Patients with XP are defective in nucleotide excision repair (NER) a mechanism respon-
sible for removal of bulky helix-distorting DNA damage mainly induced by ultraviolet (UV) radia-
tion. When UV-induced DNA damage is not removed from the genome, the remaining photoproducts
will give rise to UV-signature mutations such as C to T and CC to TT transitions. While in XP patients
it has been shown that isolated genes such as p53 harbor such mutations, thus far it was technically
impossible to comprehensively investigate the exome of the whole human genome. In this study,
we identified somatic mutations in DNA from two patients suffering from XP complementation group
C. Skin samples of sun-exposed and non-exposed skin were compared to the respective germline
genomes derived from blood of the patient. Exome-Sequencing was performed using sequence cap-
ture (NimbleGen EZ1) followed by next-generation sequencing. Exome sequencing in PBCs enabled
us to subtract the germline genome, leaving the somatic changes in XP. Although analysis are still
under way, preliminary data demonstrate an over-representation of C>T and CC>TT transitions in
skin cells (less than 500 in total). This study indicates that even in DNA repair deficient tissues with
a presumed mutator phenotype, only a finite number of somatic mutations is present in skin sam-
ples exposed to the relevant genotoxic stress. These findings could shed new light on the relations
of DNA mutations and cancer susceptibility.
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The anti-motility signaling mechanism by transforming growth factor-β (TGFβ) in human
dermal fibroblasts during wound healing
A Han, B Bandyopadhay, J Fan, M Chen, D Woodley and W Li Dermatology and Norris
Comprehensive Cancer Center, University of Southern California, Los Angeles, CA
The transforming growth factor-beta (TGFβ) family cytokines play critical roles in skin homeostasis
and skin diseases, most noticeably cell growth control, cell differentiation, tissue inflammation,
fibrosis and skin cancer progression. Anti-proliferation and anti-migration are the primary effects of
TGFβ on human skin cells. These “negative” effects are often nullified in skin cancers. We have pre-
viously shown that these two signals from TGFβ3 play critical roles in the regulation of the orderly
events of normal skin wound healing. In this current study, we carried out a step-by-step investiga-
tion of the anti-migration versus anti-proliferation signaling of TGFβ in primary human dermal fibrob-
lasts (DFs). We demonstrate that the transduction of these two signals across the cell membrane is
distinguished first at the type II TGFβ receptor (TβRII) level. Higher levels of TβRII in DFs transmit
both signals, whereas lower levels of TβRII in epidermal cells only allow the anti-proliferation sig-
nal and prevent the anti-migration signal. In DFs, TβRII then transmits the full scale of anti-migra-
tion and anti-proliferation to the type I TGFβ receptor (TβRI/Alk5), because down-regulation of
TβRI eliminated both signals and a constitutively activated TβRI (TβRI-TD) replaced the signals of
TGFβ3 to block both DNA synthesis and migration. Similarly, down-regulation of Smad2 and Smad3
abolished transduction of both signals. However, down-regulation of Smad4 only partially blocked
the anti-migration signal. Instead, we have identified CREB (cAMP response element binding pro-
tein) as a critical downstream factor that mediates the anti-motility signal of TGFβ3. This is the first
study of TGFβ’s anti-motility mechanism and has unveiled a previously unrecognized anti-migra-
tion pathway of TGFβ: high TβRII level > TβRI >Smad2/3 > CREB > inhibition of growth factor-acti-
vated DF migration.
147
Analysis of gene copy number variation and expression in cutaneous T-cell lymphoma cell
lines
W Lin, B Modi, J Lewis, R Filler and M Girardi Dermatology, Yale University, New Haven, CT
In the genomic era, characterizing the cancer genomes of the malignant cells purified from patients
with cutaneous T-cell lymphoma has enabled the identification of novel oncogenes and tumor sup-
pressors and advanced our understanding of the biologic pathways involved in this malignancy.
Translating these discoveries of critical gene alterations – particularly those with available targeted
therapeutics – to pre-clinical testing, however, has been encumbered by the lack of a genomically
annotated model system. Towards that goal, we generated high-resolution microarray DNA copy
number and mRNA expression data from 7 existing CTCL cell lines (Myla, Sez4, SeAx, HH, Pno,
HUT78-A, HUT78-B). Gene copy number alterations in these 7 cell lines were compared to that
profiled from 24 CTCL patient samples at our institution, as well as to a meta-analysis of CTCL copy
number alterations. In addition, we performed quantitative genomic PCR (ABI Taqman Copy Num-
ber Assays) to examine copy number variations in select genes in both cell lines and patient sam-
ples. These analyses provide a framework with which to interpret the degree to which available
CTCL cell lines adequately reflect the alterations observed in affected patients, and identify specific
differences that may provide an opportunity to logically investigate in vitro potential targeted ther-
apies for CTCL.
149
Engineered dendritic cell (DC)- or DNA-based vaccines raise immune responses to a car-
cinogen-induced point mutation of the H-ras oncogene that protects against tumor develop-
ment.
K Rudemiller,1 T Nasti,1 G Twitty,1 H Kim,1 A Rivera,2 J Roth,2 A Holzer,1 Y Tsruta,1 N Yusuf,1
M Athar,1 C Elmets1 and L Timares1,2 1 Dermatology, University of Alabama at Birmingham,
School of Medicine, Birmingham, AL and 2 Human Gene Therapy, University of Alabama at
Birmingham, School of Medicine, Birmingham, AL
We have found that development of a T cell-mediated immune response senstized by polyaromatic
hydrocarbons (PAHs) is associated with resistance to tumorigenesis by those agents. The carcino-
genic PAH 7,12-dimethylbenzanthracene (DMBA) results in a characteristic point mutation, Q61L,
in the H-ras oncogene (H*ras). We tested the hypothesis that a vaccine designed to focus T cell spe-
cific immunity to H*ras would eliminate cells with DMBA-induced mutations and protect against
carcinogenesis. We first observed that mutant, but not wild type (WT) H-ras peptide induced DTH
responses when challenged with mutant but not WT peptide in A/J and C3H/HeN mice. Hapten-
specific DTH responses are mediated by CD8 T cells but suppressed by CD4 T cells; A ubiquitin
(Ub) tagged chimeric gene encoding H*ras or WT H-ras epitope/EGFP fusion protein was engineered
to favor MHC class I loading. H*ras-specific DTH and CTL responses were detected in mice vac-
cinated with plasmid DNA or engineered DC encoding Ub/H*ras/EGFP, but not control Ub/WT H-
ras/EGFP. Engineered DC lines similarly induced H*ras-specific DTH responses and generated
increased numbers of IFN producing CD8 T cells. Detectable DTH responses were elicited by DMBA
in Ub/H*ras/EGFP vaccinated mice, indicating that DMBA-induced H*ras expressing cells were rec-
ognized. Cohorts of mice (n=20) were subjected to a two-step DMBA/TPA chemical carcinogene-
sis protocol for 24 weeks. Ub/H*ras/EGFP vaccinated mice developed 55% fewer (p=0.004) and
75% smaller (p=0.02) tumors compared to tumors in control cohorts. The studies indicate that vac-
cination strategies engineered to focus effector T cell responses to mutant oncogenes can be employed
for the immunoprevention of chemically induced skin tumors.
148
Human basal cell carcinoma demonstrate both outer and inner root sheath differentiation
A Beneketh, I Siciliano, PE Bowden, C Colmont and GK Patel Dermatology and Wound Healing,
Cardiff University, Cardiff, United Kingdom
Basal cell carcinoma (BCC) is believed to be derived from the human hair follicle outer root sheath.
While the hair follicle elegantly demonstrates both inward and upward differentiation patterns, the
pattern BCC differentiation and its regulation remains unclear. To test this hypothesis we have taken
20 human BCC samples, to study the architectural patterns of differentiation within the tumor and
their regulatory control. During this study we used normal hair bearing skin as both positive and
negative control. In addition we developed an in vitro assay, to test the hypothesis that extracellu-
lar signals may influence differentiation. All BCC samples expressed the outer root sheath (ORS) ker-
atins, K6 and K17, consistent with over expression the sonic hedgehog signalling pathway and
nuclear translocation of the transcriptional regulator Gli1. Similarly, all BCC samples demonstrated
K19 expression, which maintained its’ relative incongruent relationship with cell proliferation. In
seven samples tested, there was also expression of the ORS and ORS companion layer keratins K16
and K75 respectively, in a sub-population of cells within the tumour mass; coinciding with nuclear
translocation of NFIL-6 (CEBP-beta). Those BCC samples expressing K16 and K75, also expressed
the inner root sheath keratin K26 but not K28 in a small sub-population of tumour cells. In contrast,
none of the BCC samples demonstrated expression of the early hair shaft keratins K31, K32 and
K81 nor the transcriptional regulator GAD-153. Ongoing experiments using an in vitro colony form-
ing assay, which we have developed to explore the role of mesenchymal signals, may highlight
mesenchymal regulation of BCC tumor differentiation. In conclusion, BCC exhibit multiple hair fol-
licle differentiation patterns, demonstrating a hierarchical organisation of the hair follicle root sheath.
These findings are consistent with the cancer stem cell model of tumour growth and support the
potential existence of tumor initiating cells (cancer stem cells) within BCC.
146
MAGE proteins direct KAP-1 mediated gene suppression and mediate KRAB Zinc Finger
Transcription Factor (KZFTF) binding and ubiquitination
TZ Xiao,1 N Bhatia,1 R Urrutia,2 GA Lomberk,2 A Simpson3 and J Longley1 1 Department of
Dermatology, University of Wisconsin School of Medicine and Public Health, Madison, WI, 2
Department of Molecular Neuroscience, Mayo Clinic, Rochester, MN and 3 Ludwig Institute
for Cancer Research, New York, NY
Class I human Melanoma Associated AntiGens (MAGE) are normally expressed only in developing
germ cells but are aberrantly expressed in melanoma and many other cancers where they promote
survival, aggressive growth, and chemoresistance. KRAB domain zinc finger transcription factors
(KZNFs) are the largest group of vertebrate transcription factors and target tumor suppressors and
regulate proliferation, apoptosis, and neoplastic transformation. KZNFs bind to the RBCC region of
the KAP-1 protein and direct KAP-1 to specific DNA sequences where it suppresses gene expres-
sion by inducing localized heterochromatin characterized by histone 3 serine 9 trimethylation
(H3me3K9). Discovery that MAGE proteins also bind to the KAP1 RBCC region prompted us to
investigate whether MAGE can affect KZNF and KAP-1 mediated gene regulation. We performed a
genome wide survey of KAP-1 binding sites, in the presence and absence of MAGE, by chromatin
immunoprecipitation and high-throughput DNA sequencing (ChIP-seq). KAP-1 bound to 6033
sites without MAGE whereas ectopic expression of MAGE caused a major shift with detection of
KAP-1 binding to10253 new sites. KAP-1 binding was enriched within transcribed regions of tar-
get genes. ChIP with anti-KAP-1 and anti-H3me3K9 Abs, and reverse transcription RT-PCR validated
ChIP-seq results for selected genes including the ID1 tumor suppressor gene, a target of KZNF382.
Reporter construct studies showed that MAGE decreases KAP-1 binding with ZNF382, and that
MAGE increases ubiquitination and degradation of KZNF382. Since KZNFs are required to direct
KAP-1 to specific genes, these results suggest that MAGE proteins can affect the majority of KZNF
targets and establish MAGE proteins as master regulators of the complex KZNF family.
150
SerpinA1: A novel biomarker for progression of cutaneous squamous cell carcinoma
M Farshchian,1 A Kivisaari,1 R Ala-aho,1 P Riihilä,1 M Kallajoki,1 R Grénman,1 J Peltonen,1
T Pihlajaniemi,2 R Heljasvaara2 and V Kähäri1 1 University of Turku, Turku, Finland and 2
University of Oulu, Oulu, Finland
The incidence of keratinocyte-derived nonmelanoma skin cancers is increasing globally due to
cumulative recreational exposure to sunlight. At present, no specific molecular markers are avail-
able for assessing progression of premalignant actinic keratoses to invasive cutaneous squamous
cell carcinoma (SCC). Here, we have examined the role of serine proteinase inhibitor (Serpin) fam-
ily in SCC of skin. Expression profiling of cutaneous SCC cell lines (n=8) revealed up-regulation of
SerpinA1 compared to normal human epidermal keratinocytes established from healthy individu-
als (n=5). Analysis with quantitative RT-PCR showed that SerpinA1 mRNA was markedly up-regu-
lated in cutaneous (n=8) and head and neck (n=38) SCC cell lines, and in head and neck SCC tumors
(n=51), as compared to corresponding normal cells and tissues. SerpinA1 production by skin SCC
cells was dependent on p38 MAPK activity and was upregulated by EGF, TNF-α, IFN-γ, and IL-1β.
Immunostaining of tissue arrays containing altogether 148 human tissue samples revealed tumor
cell-specific expression of SerpinA1 in 19 of 36 actinic keratoses, 22 of 29 Bowen’s disease sam-
ples, 67 of 71 sporadic SCCs and in all 12 recessive dystrophic epidermolysis bullosa-associated
SCCs. Moreover, tumor cell-specific SerpinA1 staining was detected in all chemically induced mouse
skin SCCs (n=17) studied. These results identify SerpinA1 as a novel tumor cell specific biomarker
for progression of cutaneous SCC, and suggest it as a potential therapeutic target in unresectable
and metastatic SCCs of the skin.
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Inhibition of PI3K/AKT/mTOR pathway in human melanoma cells with induction of autophagy
and decreased tumor growth both in vitro and in vivo by a dietary flavonoid fisetin
DN Syed, VM Adhami, J Chamcheu and H Mukhtar Department of Dermatology, University of
Wisconsin, Madison, Madison, WI
Flavonoids, natural components of our diet, known to possess anti-inflammatory activity are increas-
ingly being investigated for their therapeutic properties. We have recently shown that the dietary
flavonoid fisetin decreases MITF levels in human melanoma cells through interference with Wnt/β-
catenin signaling (Syed et al., JID 2011; in press). The PI3K/AKT/mTOR pathway, constitutively acti-
vated in melanoma, is an attractive therapeutic target as it serves as a convergence point for growth
stimuli that contribute to the initiation and maintenance of tumor growth. In addition, both AKT
and mTOR are components of pathways that are involved in apoptosis and autophagy resistance of
cancer cells. Here, we determined the effect of fisetin on the PI3K/AKT/mTOR pathway and its down-
stream targets, in cell culture and mouse melanoma model. Fisetin treatment (40-80μM) of highly
aggressive 451Lu human melanoma cells resulted in cell cycle arrest in the G1 phase within 24 h.
At 48 h, fisetin treatment induced autophagy, as assessed by increased levels of LC3-II and beclin.
Fisetin mediated activation of AMP-activated kinase was associated with negative regulatory effects
on the mTOR signaling cascade and activation of tumor suppressor TSC2. Using human skin equiv-
alent melanoma model we show that fisetin treatment led to synergistic suppression of AKT and
ribosomal S6 protein phosphorylation with downregulation of the mTORC complex. Xenograft stud-
ies in mice implanted with 451Lu cells further demonstrated that fisetin significantly reduced tumor
growth and increased the median survival time, associated with decreased expression of AKT/mTOR
signaling molecules. Our study shows that fisetin can be developed as a potential anti-melanoma
agent capable of targeting signaling pathways mechanistically linked to melanoma carcinogenesis.
We suggest that fisetin alone or in combination may be used for the treatment of melanoma.
140
Srcasm induces regression of pre-existing squamous cell carcinomas in K14-Fyn Y528F mice
X Yang, H Nishida, L Zhao, C Marshall, T Dentchev and J Seykora Dermatology, Univ. of
Pennsylvania, Philadelphia, PA
Cutaneous squamous cell carcinoma (cSCC) is the second most common human cancer and is asso-
ciated with cumulative UV exposure which leads to frequent mutations in RAS and p53. Most human
cSCCs demonstrate increased activity of Src tyrosine kinases which promotes RAS-dependent sig-
naling and downregulates p53. Human sSCCs also have decreased levels of Srcasm, a negative reg-
ulator of Src kinases. These features of human cSCCs have been modeled in vivo using K14-Fyn
Y528F mice which spontaneously develop cSCCs in 5-8 weeks; the development of cSCCs is inhib-
ited by raising Srcasm levels with a K14-Srcasm transgene. Although elevating Srcasm levels with
a K14-Srcasm transgene can inhibit the formation of cSCCs in K14-Fyn Y528F mice, it is unknown
if inducing Srcasm levels can promote regression of pre-existing cSCCs. To address this question,
we first derived K14-Fyn Y528F/CMV-rtTA/TRE-Srcasm triple transgenic mice. Experimental cohorts
of these triple transgenic mice manifesting 32 and 31 cSCCs were exposed to doxycycline or no
treatment, and tumors were followed and analyzed over time. The doxycycline treated cohort demon-
strated a rapid and robust induction of Srcasm in the epidermis and dermis that was approximately
5-fold higher than controls by western blot analysis. The doxycycline-treated cohort showed regres-
sion of 26/32 in four weeks. The control cohort showed no regression of 31 cSCCs over the same
period. Inducing Srcasm was associated with cSCC regression, p < 0.01. Withdrawal of doxycy-
cline after four weeks resulted in recurrence of one tumor. Sequential biopsies of regressing tumors
demonstrated that increased Srcasm levels promoted regression without tumor cell necrosis; mild
inflammation and dermal fibrosis were noted at sites of regression. In regressing tumors, levels of
pErk 1/2, pPDK-1, pSTAT-3 and p-Src kinases normalized with increasing Srcasm. Levels of p53
also were restored. The data presented suggest that enhancing Srcasm function or targeting Src
kinases may be useful for treating cSCCs.
141
IL-17 receptor A deficient mice are resistant to chemical carcinogen induced cutaneous tumors
D He, H Li, N Yusuf, CA Elmets, M Athar, S Katiyar, J Li, J Mountz and H Xu University of Alabama
at Birmingham, Birmingham, AL
Inflammation associated tumor development is a central issue for tumor biology and immunology.
It remains largely to be defined why and how immune responses, which act to prevent tumor
development, can promote tumors in forms of inflammation. Although IL-17 producing cells and
IL-17 responses are detected in cancer patients and tumor bearing mice, studies in the role of IL-
17 in tumor development reveal conflicting results. In the current studies using an inflammation
associated tumor model, we showed that IL-17 receptor-A gene deficient mice (IL-17R-/-) were resist-
ant to chemical carcinogen induced tumors in the skin. Moreover, the defect in IL-17R reversed the
increased susceptibility of IL-12p35 deficient mice to tumor development. Analysis showed that
angiogenesis and infiltration of myeloid cells were inhibited whereas the infiltration of CD8 T cells
was increased in the inflamed skin of IL-17R-/- mice. The development of myeloid derived sup-
pressor cells, Inflammation induced Cox-2 activity and S100A8/A9 proteins, and inflammation asso-
ciated epidermal hyperplasia were suppressed in IL-17R-/- mice. Furthermore, the production of
tumor promoting inflammatory cytokines IL-1β and TNF-α were reduced. These findings demon-
strate that IL-17 signals are required for the induction of tumor promoting inflammation and a defi-
ciency in IL-17 responses inhibits inflammation associated tumor development. The study provides
insights into a novel mechanism by which IL-17 mediates tumor promoting inflammation and induces
tumor escape from immune surveillance. It has major implications for targeting IL-17 in prevention
and treatment of tumors.
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Bioinformatics characterization of Z-DNA in the genes of human epidermis with melanoma
K Beheshti,1 CE Gagna,1,2,3 N Agostino,4 NA Bhagat,1 R Leston,1 A Hicks,1 R Joy,1 S Hde Tene1 and
W Lambert2,3 1 Life Sciences, New York Institute of Technology, Old Westbury, NY, 2
Dermatology, New Jersey Medical School, Newark, NJ, 3 Pathology & Laboratory Medicine,
New Jersey Medical School, Newark, NJ and 4 School of Natural Sciences, Fairleigh Dickinson
University, Teaneck, NJ
Melanoma is the most lethal skin cancer. It accounts for 4% of all cases of skin cancers, but results
in 79% of skin cancer deaths. In 2002, the American Cancer Society approximated that there were
54,000 new cases of this disease in America and about 7,400 deaths. The majority of DNA in human
genes is made of right-handed double-stranded (ds-) B-DNA. Left-handed ds-Z-DNA is an alterna-
tive type of ds-DNA, and plays a role as a transcriptional enhancer in RNA editing and recombi-
nation. Our group has employed bioinformatics to identify the presence of Z-DNA in normal and
diseased epidermal genes. We used the Z-Hunt computer software to find genes that have poten-
tial Z-DNA-forming sequences in them. Our results showed that some mutated epidermal genes
contain potential Z-DNA-forming sequences, while others do not. Some of these genes containing
potential Z-DNA sequences had higher Z-scores than others (i.e., ease at which B-DNA can tran-
sition to Z-DNA). New classes of drugs need to be produced that can be used to treat and/or cure
this disease (e.g., bind to specific structures of DNA, such as Z-DNA, and “turn off” gene expres-
sion). These types of studies will help shed light on the genetics of melanoma. This kind of bioin-
formatic data has the potential to help in the diagnosis of the disease. Being able to locate Z-DNA
in mutated epidermal genes will allow for additional target sites to produce new classes of drugs,
viz., based on B-DNA to Z-DNA transitions. This research project was supported in part by a NYIT
ISRC grant.
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Oncogene addiction to Merkel cell polyomavirus large T antigen in Merkel cell carcinoma
ME Verhaegen,1 CK Bichakjian,1 M Voutsalath,1 J Weick,1 P Baciu,1 E Quintana,3 TD Stromer,1
J Pero,1 KT Nash,1 AE Ayar,1 TM Johnson1 and AA Dlugosz1,2 1 Dermatology, University of
Michigan, Ann Arbor, MI, 2 Cell and Developmental Biology, University of Michigan, Ann
Arbor, MI and 3 Life Sciences, University of Michigan, Ann Arbor, MI
Merkel cell carcinoma (MCC) is a rare but potentially lethal neuroendocrine carcinoma of the skin,
with no current effective treatment options for patients with advanced disease. Recent studies have
indicated that a high proportion of MCCs contain DNA sequences from Merkel cell polyomavirus
(MCV), harboring a T antigen (TAg) oncoprotein locus. Although the MCV large (L) TAg is predicted
to modulate tumor suppressor and cell cycle regulatory proteins, its role in MCC pathogenesis
remains uncertain, due largely to a paucity of in vitro and in vivo experimental models. To begin
rigorously testing the functional role of the MCV LTAg in MCC, we have established 8 robust MCC
cell lines, derived either directly from patient tumors or from tumors first grown as xenografts in
immunocompromised mice. All 8 MCC cell lines grow in suspension as tight spheres or loose aggre-
gates and express the neuroendocrine marker chromogranin A, with a subset also expressing ker-
atin 20. Additionally, 7 out of 8 MCC lines have been passaged over 17 times in culture. Four MCC
lines express the MCV LTAg at both the RNA and protein level. To directly address the role of LTAg
in MCC, we evaluated the effect of MCV LTAg inactivation by short hairpin-driven RNA (shRNA)
interference. Three distinct lentiviral shRNA constructs inducing more than a 55-95% reduction in
LTAg (as determined by immunoblotting and Q-RT-PCR) resulted in decreased cellular proliferation,
based on cell numbers and a reduction in the mitosis marker phosho-histone H3, as well as increased
cell death determined by Trypan Blue assay. Our data indicate that the MCV LTAg is required for
MCC maintenance by regulating cell proliferation and survival, and suggest that the LTAg, or its
endogenous cellular targets, may represent a point of vulnerability in MCC that can potentially be
exploited for future treatment approaches.
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Whole genome (exome) sequencing of xeroderma pigmentosum patients reveals a finite and
distinct pattern of mutations in pathophysiologically relevant genes
P Bauer,1 Y Kamenisch,2 C Bauer,1 M Röcken,2 O Riess1 and M Berneburg2 1 Department of
Genetics, Eberhard Karls University, Tuebingen, Germany and 2 Department of Dermatology,
Eberhard Karls University, Tuebingen, Germany
Xeroderma pigmentosum (XP) is a rare autosomal recessive disease clinically characterized by
photosensitivity, xerosis cutis, poikiloderma, telangiectasia and a 1000-fold increased risk to develop
skin cancer. Patients with XP are defective in nucleotide excision repair (NER) a mechanism respon-
sible for removal of bulky helix-distorting DNA damage mainly induced by ultraviolet (UV) radia-
tion. When UV-induced DNA damage is not removed from the genome, the remaining photoproducts
will give rise to UV-signature mutations such as C to T and CC to TT transitions. While in XP patients
it has been shown that isolated genes such as p53 harbor such mutations, thus far it was technically
impossible to comprehensively investigate the exome of the whole human genome. In this study,
we identified somatic mutations in DNA from two patients suffering from XP complementation group
C. Skin samples of sun-exposed and non-exposed skin were compared to the respective germline
genomes derived from blood of the patient. Exome-Sequencing was performed using sequence cap-
ture (NimbleGen EZ1) followed by next-generation sequencing. Exome sequencing in PBCs enabled
us to subtract the germline genome, leaving the somatic changes in XP. Although analysis are still
under way, preliminary data demonstrate an over-representation of C>T and CC>TT transitions in
skin cells (less than 500 in total). This study indicates that even in DNA repair deficient tissues with
a presumed mutator phenotype, only a finite number of somatic mutations is present in skin sam-
ples exposed to the relevant genotoxic stress. These findings could shed new light on the relations
of DNA mutations and cancer susceptibility.
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Amphiregulin precursor controls cell-cycle regulatory gene expression in human keratinocytes
SW Stoll,1 L Rittié,1 S Lambert,1 M Prasad,1 JE Gudjonsson,1 B Li,2 Y Wei,2 G Abecasis,2 PE Stuart,1
RP Nair1 and JT Elder1 1 Dermatology, University of Michigan, Ann Arbor, MI and 2
Biostatistics, University of Michigan, Ann Arbor, MI
Amphiregulin (AREG) has been implicated as an autocrine growth factor in multiple benign and
malignant epithelial neoplasias and we have shown that AREG is particularly important in the con-
text of autocrine keratinocyte (KC) proliferation (JID 130:295). Although binding of proteolytically-
processed soluble AREG to the EGFR has traditionally been thought to mediate its growth factor-
specific functions, we recently identified an EGFR-independent, previously unrecognized role of
the AREG precursor (proAREG) cytoplasmic domain in the regulation of KC cell-cycle progression
and cytokinesis (JID 130:2031). To explore the mechanisms by which proAREG regulates KC biol-
ogy, we analyzed the effect of AREG knockdown on the global transcriptome using high through-
put RNA sequencing (RNASeq). N-TERT KC (MCB 20:1436) engineered to conditionally express
AREG specific shRNA were incubated with or without TET induction for 60 h +/- 20 ng/ml EGF fol-
lowed by cDNA isolation, poly(A)+ mRNA library preparation and RNASeq analysis. AREG knock-
down decreased expression of 1013 genes (> 2-fold, p<2.2x10-7), 67.8% of which were unaffected
by subsequent addition of EGF (< 1.5-fold). Consistent with the appearance of bi- and multinucle-
ated cells in AREG knockdown KC, Gene Ontology analysis revealed that many of the down-regu-
lated genes are involved in mitosis. Notably, these included the transcription factor FOXM1 as well
as many of its target genes, whose products function in the regulation of G2/M transition and mito-
sis. QRT-PCR confirmed strongly decreased expression of FOXM1 (13.8% of control with TET; 13.8%
with TET/EGF) and its gene cluster in AREG knockdown cells including KIF20A (12.9%; 5.2%), NEK2
(18.4%; 16.8%) and CENPA (12.8%; 14.2%), n=4 with p<0.02 for all tests. In sum, our data indi-
cate that proAREG controls cell-cycle regulatory gene expression in KC via activation of a FOXM1-
dependent transcriptional program whose function regulates G2/M progression and cytokinesis.
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Investigating the immunomodulatory properties of cutaneous squamous cell carcinoma stem
cells
BJ Kubick1,2,3 and DR Roop2,3,1 1 Cell Biology, Stem Cells, and Development, University of
Colorado Denver Anschutz Medical Campus, Aurora, CO, 2 Dermatology, University of
Colorado Denver Anschutz Medical Campus, Aurora, CO and 3 The Charles C. Gates Center
for Regenerative Medicine and Stem Cell Biology, University of Colorado Denver Anschutz
Medical Campus, Aurora, CO
Amongst the cellular heterogeneity found within a cancer, only a subset of cells, often referred to
as cancer stem cells, maintains the ability to initiate and maintain the cancer. In recent years,
efforts to measure the relative abundance of these cancer initiating cells (CICs) from xenografted,
human tumors have produced conflicting results and many of these studies have been criticized for
neglecting to recapitulate important components of the human stromal microenvironment. The
absence of a functional immune system in xenografting experiments is of particular concern since
immune surveillance has been shown to restrict tumor formation in a variety of tumor types. Thus,
the relative number of CICs is likely overestimated in these studies. Since immune effector cells are
so abundant throughout the skin, immune function is particularly relevant to cutaneous malignan-
cies and their derivative stem cells. To circumvent the problems of xenografting, we have devel-
oped a syngeneic mouse model that enables the characterization of mouse squamous cell carci-
noma CICs in the context of an intact immune system. This model, paired with a transplant technique
that mimics the natural tumor microenvironment, is to our knowledge the most accurate simula-
tion of tumorigenesis allowed by current technology for the measurement of CICs from a solid tumor.
Using this system, we observe that rare side population cells, distinguished by their relative ability
to efflux Hoechst dye, have the ability to propagate squamous cell carcinoma. Preliminary studies
of these cells suggest that immune evasion mechanisms include reduced antigen presentation and
disruption of immune effector cell homing.
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Interplay between the epidermal differentiation transcription factor Grhl3/Get1 and microRNA
miR-21
A Bhandari,1,2 D Dizon,1 W Gordon,1,2 A Soto Hopkin1,2 and B Andersen1,2 1 Medicine,
University of California Irvine, Irvine, CA and 2 Biological Chemistry, University of California
Irvine, Irvine, CA
The epidermal stratification process, crucial for barrier formation, is regulated by a complex inter-
play of several transcription factors, including the evolutionarily conserved Grainyhead-like 3
(Grhl3/Get1). Grhl3-deleted mice exhibit barrier function defects associated with impaired differ-
entiation of the epidermis and decreased expression of genes involved in lipid metabolism and
cell-cell adhesion. Intriguingly, many of these genes lack Grhl3 binding sites in their proximal pro-
moters leading us to hypothesize that Grhl3 might be involved in their regulation indirectly by con-
trolling the expression of specific microRNAs (miRs). Through miR profiling, we identified 11 miRs
that are differentially regulated in Grhl3-/- skin, one of which is miR-21, previously shown to be
upregulated in diseased skin, including in psoriasis and squamous cell skin cancer. We found that
miR-21 is normally expressed in the post-mitotic suprabasal layers of the epidermis in an overlap-
ping manner with that of Grhl3. Grhl3 binds to the miR-21 promoter region and represses its activ-
ity suggesting these two factors may be involved in a regulatory loop maintaining homeostasis in
the epidermis. miR-21 overexpression in normal keratinocytes results in reduced cell proliferation
due to a G1-S block. Consistent with this finding, mRNA profiling in keratinocytes treated with either
miR-21 or anti-miR-21 identified several cell cycle associated genes as miR-21 targets that could
account for this effect. Interestingly, when activated Ras is introduced into keratinocytes, we observe
a much more dramatic downregulation of pro-tumorigenic targets of miR-21 such as PDCD4,
NFIB, and MSH2, suggesting that transformed keratinocytes are more sensitive to miR-21’s effects
than normal keratinocytes. These findings are consistent with a role for miR-21 in diseased ker-
atinocytes, suggesting the possibility that decreased Grhl3 expression leads to upregulation of miR-
21 under pathological conditions.
160
Novel glucocorticoid receptor modulator Compound A inhibits skin inflammation and hyper-
plasia
A Klopot, G Baida and I Budunova Dermatology, Northwestern University, Chicago, IL
Glucocorticoids that act via glucocorticoid receptor (GR) are important regulators of skin develop-
ment, maintenance and tumorigenesis. GR regulates gene expression by (i) transactivation that
requires GR binding to gene promoters and (ii transrepression through negative GR interaction with
other transcription factors. It was shown that therapeutic anti-inflammatory effects of glucocorti-
coids are mediated by GR transrepression. At the same time, GR transactivation underlies many
metabolic side effects of glucocororticoids. We and others showed that GR/glucocorticoids exert
strong tumor suppressor effect in skin, and that gene transrepression plays a leading role in GR anti-
cancer effects. This ties anti-cancer and anti-inflammatory effects of glucocorticoids. Thus, “disso-
ciated” ligands that preferentially shift GR activity towards transrepression hold a great promise for
the treatment of inflammatory skin diseases as well as for skin cancer prevention and treatment.
Compound A (CpdA), a plant-derived phenyl aziridine precursor, was recently characterized by us
and others as novel non-steroidal ligand acting mostly via GR transrepression. Here we report that
CpdA acted as GR dissociated ligand in mouse keratinocytes in vitro and in vivo. CpdA did not acti-
vate GR-dependent genes but mimicked inhibitory effect of glucocorticoids on expression of inflam-
matory cytokines and matrix metalloproteinases. When applied topically to skin, CpdA inhibited
skin hyperplasia and inflammation induced by tumor promoter TPA. In contrast to glucocorticoids,
CpdA in single treatment did not induce skin hypoplasia which is considered one of the important
adverse effects of glucocorticoids. These results suggest that CpdA and its derivatives represent a
novel promising class of anti-inflammatory and anti-cancer compounds for the treatment of der-
matological patients. We are currently searching for novel dissociated GR ligands by docking analy-
sis of chemical libraries using CpdA as a prototype. This work was supported by NIH grant R01
CA118890 (IB).
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Inhibitor specificity of MAPK, JAK3/STAT and mTOR signaling pathways in KitV560G and KitD816V
mutations found in mastocytosis
I Chan and MD Tharp Dermatology, Rush University Medical Center, Chicago, IL
Autoactivating kit mutations (KitV560G and KitD816V) are important in the development of mastocyto-
sis. Our previous studies have shown that KitV560G and KitD816V have different intracellular signaling
pathways controlling mast cell growth. KITV560G signaling appears to depend on the JAK3/STAT path-
way whereas the KITD816V seems to rely on mTOR. Treatment with the MAPK pathway specific
inhibitor (U0126), decreases the growth of mast cells expressing either KitV560G or KitV560G+D816V by
50%, when compared to controls. The JAK3 inhibitor (Whi-P131) is more effective in inhibiting the
growth of mast cells expressing KitV560G(>82%) than cells expressing KitD816V (52%). In contrast, the
mTOR inhibitor (rapamycin) is more effective in limiting the growth of cells expressing KitD816V (73%)
than KitV560G (47%). In order to further define critical signaling pathways in mastocytosis mast cells,
we investigated the pathway specificity of each inhibitor (U0126, Whi-P131 and rapamycin) using
Western blot hybridization. Treatment of mast cells with U0126 selectively inhibited the phospho-
rylation of the MAPK signaling molecules, ERK1/2 and MSK1/2, but not MEK1/2. Whi-P131 treat-
ment effectively inhibited the phosphorylation of JAK3 and STAT3 in mast cells expressing KitV560G
significantly more than cells expressing KitD816V. Rapamycin treatment inhibited the phosphoryla-
tion of mTOR at Serine2481 in mast cells expressing KitD816V. The results of this study indicate that
U0126 inhibits the MAPK pathway by directly blocking the catalytic sites of activated MEK1/2 in
mast cells expressing either KitV560G or KitD816V. JAK3/STAT3 appears to be the predominant signal-
ing pathway for mastocytosis mast cells expressing mutated KitV560G. Finally inhibition of mTOR by
rapamycin in cells expressing KitD816V suggests that this pathway is also important in mastocytosis
mast cell growth and may be a possible therapeutic tool for mastocytosis patients with this muta-
tion.
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Genotoxicity testing of topically applied skin care and dermatology products using the nor-
mal human cell based skin model EpiDermTM
Y Kaluzhny, P Hayden, V Karetsky, J DeLuca, S Ayehunie and M Klausner MatTek Corporation,
Ashland, MA
Safety assessment of topically applied products for human use requires genotoxicity testing to ensure
their non-carcinogenicity. Current in vitro assays have low specificity resulting in a high rate of false
positives. To determine the biological relevance of in vitro genotoxicity results, in vivo assays are
conducted. However, in 2009, in vivo genotoxicity testing was banned in Europe by the 7th Amend-
ment to the Cosmetics Directive. To address this need, reconstructed skin micronucleus (RSMN) and
comet assays (CA) utilizing MatTek’s highly differentiated EpiDerm™ skin model, have been devel-
oped. EpiDerm is a highly reproducible, organotypic model of human epidermis that contains a
skin-like barrier, possesses biotransformation capabilities, and allows for topical exposure. In the
RSMN assay, test materials were topically applied over a 2-day period in a similar fashion to actual
human contact. Acetone (vehicle control) exposed tissues resulted in a reproducible population of
binucleated cells (49.2+/-9.5%) with a low background of micronucleated cells (MNC) (0.1+/-
0.11%). The well-studied genotoxin, mitomycin-C (positive control), induced a statistically signifi-
cant increase in MNC (1.67+/-0.99%). In addition, 10 direct genotoxins and 7 genotoxins that require
metabolic activation resulted in dose-related, statistically significant increases in MNC while no
increases for 10 non-genotoxins were observed. In the CA, 2 model genotoxins, methyl methane
sulfonate and 4-nintroquinoline-1-oxide, induced statistically significant increases in % tail DNA
after 3 hours of topical exposure. Hence, the RSMN and Comet assays appear to be useful for pre-
dicting dermal genotoxicity following real life exposure. Together, the RSMN and Comet assays will
identify a wide spectrum of dermal genotoxic hazards, increase confidence in vitro test results, and
potentially replace animal studies in the genotoxicity evaluation of many materials, especially skin
care cosmetics and dermally applied pharmaceuticals.
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Real-time cell cycle imaging: Melanomas are composed of differentially cycling tumor cells
in a subcompartment-specific distribution
NK Haass,1,2 A Anfosso,1 I Kinjyo,1 O Kanagawa3 and W Weninger1,2 1 Centenary Institute,
Sydney, NSW, Australia, 2 Discipline of Dermatology, The University of Sydney, Sydney, NSW,
Australia and 3 Research Center for Allergy and Immunology, RIKEN, Yokohama City, Japan
While it is well appreciated that unrestricted proliferation is a cancer hallmark, the geometry and
dynamics of cell cycle progression of individual tumor cells are not known. We have made use of
the fluorescence ubiquitination cell cycle indicator (FUCCI) system to assess the cell cycle dynam-
ics in melanoma in real-time. In this system, cells transition from red (G1) to yellow (S) and green
(S/G2/M), followed by a short period of fluorescence negativity during cytokinesis. We character-
ized the cell cycle behavior of melanoma cells during proliferation, migration, and in response to
targeted therapy in vitro. This allowed us to measure the precise duration of G1, S and S/G2/M phases
and to correlate cell cycle phases with migration. In our 3D-spheroid model composed of FUCCI-
tagged melanoma cells, initially, the ratio of red:green melanoma cells was roughly equal, and
their distribution was random. Within hours cycling green cells sequestered in a ring-like pattern at
the periphery of the spheroid, while cells in the center remained in G1 (red). Treatment with the
MEK1/2 inhibitor U0126 induced G1 arrest in melanoma over the course of 24h (indicated by the
homogeneous red fluorescence). Importantly, U0126 did not block invasion. To investigate the micro-
anatomical distribution of cycling melanoma cells in vivo, FUCCI-tagged melanoma cells were
xenografted into NOD/SCID mice. Tumors were allowed to grow until they were palpable and
were then analyzed by confocal microscopy. Early tumors showed a similar pattern as the sphe-
roids, whereas in large tumors we found clusters of differentially cycling subpopulations that were
located next to each other, often with a sharp demarcation between the clusters. Together, our data
suggest that melanomas are composed of differentially cycling tumor cells in a subcompartment-
specific distribution, which has implications for the evaluation of targeted therapies.
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Rapamycin augments the chemopreventive effects of sulindac and suppresses UVB-induced
cutaneous photocarcinogenesis in Ptch+/- hairless mice
SC Chaudhary,1 D Kurundkar,1 T Singh,1 Z Weng,1 CA Elmets,1 L Kopelovich2 and M Athar1 1
Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL and 2
Division of Cancer Prevention, National Cancer Institute, Bethesda, MD
Sulindac, an NSAID, is widely used to reduce inflammation. It also possesses chemopreventive activ-
ity against a variety of epithelial cancers both in humans and in experimental animals. In this study,
we show that rapamycin (rapa), a well-known mTOR inhibitor, augments the cancer chemopre-
ventive activity of sulindac against UVB-induced photocarcinogenesis in the skin of Ptch+/-/SKH-
1 hairless mice. Treatment with sulindac or rapa reduced both UVB-induced basal cell carcinoma
(BCCs) and squamous cell carcinoma (SCCs). However, when both agents were tested in combi-
nation, the reduction in both tumor types was significantly greater than with either agent alone. The
growth of BCCs was reduced by 90% as compared to UVB controls. However, SCCs decreased by
only 67%. Similarly, tumor size was also decreased significantly. Sulindac and rapa in combination
were more effective in inducing apoptosis in these lesions than single agents. In addition, the com-
bined treatment attenuated the levels of UVB-disrupted cell cycle regulatory proteins. These treat-
ments also induced pro-apoptotic proteins with a concomitant reduction in anti-apoptotic pro-
teins. However, treatment with rapa+sulindac decreased UVB-induced phosphorylation of
extracellular signal-regulated kinase1/2 and p38 MAP kinases in addition to pro-inflammatory pro-
teins, COX-2, iNOS and NFkβp65. UVB induces expression of mesenchymal markers such as N-
cadherin and fibronectin in epidermis which promote epithelial-mesenchymal transition. How-
ever, we observed a substantial reduction in the levels of these proteins in the combinatorial group.
Rapa+sulindac together inhibited Shh and mTOR signaling pathways in the tumor adjacent skin
more effectively than the single treatments. Our data in preclinical murine models suggest that sulin-
dac may be highly effective in reducing skin cancer in organ transplant patients receiving rapamycin.
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Merkel cell polyomavirus large T antigen impairs DNA repair and cell cycle arrest following
DNA damage
SK Demetriou,1,2 EM Sullivan,1,2 TK Dong1,2 and DH Oh1,2 1 Department of Dermatology,
University of California, San Francisco, CA and 2 Dermatology Research Service, VA Medical
Center, San Francisco, CA
Merkel cell carcinoma (MCC) is an unusually lethal skin cancer that typically occurs on sun-exposed
skin. Recently, MCCs have been strongly associated with a new virus, Merkel cell polyomavirus
(MCV), but the pathways by which MCV promotes cancer remain undefined. MCV expresses a
homolog of the SV40 large T antigen (LTAg) which is known to impair the DNA damage response
by disrupting functions of retinoblastoma and p53 proteins. We tested the hypothesis that MCV act-
ing through LTAg impairs normal global genomic repair (GGR) and other cellular responses to
ultraviolet radiation (UVR)-induced DNA lesions. In contrast to a virus-negative MCC cell line (UISO),
a virus-infected cell line (MKL-1) exhibited UVR hypersensitivity and drastically impaired GGR of
UVR-induced photoproducts. In addition, in contrast to UISO cells, virus-infected MKL-1 cells were
characterized by loss of the G1 cell cycle checkpoint following UVR, allowing cells to replicate
despite DNA damage. To ensure that observed differences were not specific to these cell lines,
LTAg from a different MCC tumor was expressed in UISO cells and, relative to empty vector con-
trols, also resulted in loss of GGR and in persistent DNA replication following UVR. Furthermore,
LTAg expression in normal human fibroblasts similarly inhibited GGR, indicating that the actions
of LTAg extend to normal, non-transformed cells. Finally, shRNA-mediated knockdown of p53 in
UISO cells was sufficient to model the LTAg-induced impairment of GGR and the G1 cell cycle
checkpoint, suggesting that LTAg may inhibit p53. While no significant changes in p53 levels were
observed after expression of LTAg, GGR defects were associated with reduced levels of the DNA
damage recognition protein, XPC, whose expression can be induced by p53. These results indicate
that LTAg expression inhibits key responses to UVR-induced DNA damage and suggest that MCV-
induced genomic instability may underlie Merkel cell carcinogenesis.
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Oncogenic activity of dysregulated ΔNp63α in squamous carcinogenesis
L Ha,1 KE King,1 RM Ponnamperuma,1 S Jay,2 S Ricci1 and WC Weinberg1 1 CDER/FDA,
Bethesda, MD and 2 SAIC-Frederick, Inc., Frederick, MD
Expression of ΔNp63α is associated with proliferation in normal epithelium and is elevated in
squamous cell carcinomas, but the contribution of dysregulated p63 to cancer pathogenesis remains
unclear. We developed lentiviral vectors to assess the phenotypic consequences of sustained ele-
vated ΔNp63α expression in an in vivo mouse skin model of cancer and in vitro correlates. As
observed previously with transient adenovirus-mediated ΔNp63α overexpression, lentivirus-driven
ΔNp63α expression in primary mouse epidermal keratinocytes blocks in vitro induction of bio-
chemical markers of differentiation and associated growth arrest. Cultured keratinocytes express-
ing lenti-GFP, but not lenti-ΔNp63α, undergo both spontaneous replicative senescence and onco-
genic v-rasHa-induced senescence, as evidenced by the expression of SA-β-gal or the presence of
nuclear foci of heterochromatin protein 1γ (HP1γ). Both replicative and oncogene-induced senes-
cence are accompanied by an upregulation of p16 and p19, which is delayed and attenuated in
lenti-ΔNp63α-expressing cells. Keratinocytes expressing lenti-GFP- or lenti-ΔNp63α alone consis-
tently form normal skin following grafting to nude mice. Lenti-GFP/v-rasHa keratinocytes form well-
differentiated papillomas, while lenti-ΔNp63α/v-rasHa keratinocytes form undifferentiated carcino-
mas. The average volume of tumors arising from grafted lenti-ΔNp63α/v-rasHa keratinocytes was
higher than those in the lenti-GFP/v-rasHa group, consistent with increased BrdU incorporation
detected by immunohistochemistry. p19 null keratinocytes expressing lenti-GFP and v-rasHa yielded
undifferentiated carcinomas in a graft site, similar to those seen with ΔNp63α overexpression. How-
ever, p19 null tumors did not grow as rapidly, suggesting that mechanisms in addition to p19 gene
regulation are involved in ΔNp63α-mediated tumor growth. This model will be a valuable tool to
dissect the contribution of interacting pathways in ΔNp63α-mediated carcinogenesis.
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Endothelin-3 and bFGF jointly induce the proliferation of normal human melanocytes in
defined media and increase synthesis of chemokines that are linked to melanoma progres-
sion
CQ Wang,1 H Mitsui,1 M Suarez-Farinas,1 N Gulati,1 J Gonzalez,2 E Billick1 and JG Krueger1 1
Laboratory for Investigative Dermatology, Rockefeller University, New York, NY and 2 Center
for Clinical and Translational Science, Rockefeller University, New York, NY
bFGF, stem cell factor (SCF), and endothelin-3 (ET-3) are all mitogens that are essential for melanocyte
development during embryogenesis as well as support the survival and growth of melanocytes. How-
ever, it is unclear as to which one of these growth factors, or which combinations of them, are able
to induce the proliferation of normal melanocytes in fully-defined serum free conditions. In this
study, we demonstrate in time-lapse imaging that the combination of ET-3 and bFGF is sufficient to
induce the proliferation of melanocytes over 4 days. However, in media conditioned with single
growth factors ET-3, bFGF or SCF, enhanced survival but no cell division was observed. Further-
more, melanocytes cultured in ET-3 and bFGF together have the highest percentage (31%) of Ki67-
positive cells, when compared to cells grown in media conditioned with single growth factors or
combinations of bFGF+SCF and ET-3+SCF (9-13%). Other cell proliferation markers that were ele-
vated at the mRNA level included cyclins D1, B1, A1 and Cdc2. These observations were sup-
ported by FACS-based cell cycle analysis, which showed melanocytes cultured in ET-3+bFGF media
contain the lowest G1 population (37%). Additionally, we examined the expression of cytokines
that are associated with melanoma progression. Using real-time PCR, we detected elevated mRNA
levels of IL-24, CXCL-2 and Neuregulin in melanocytes cultured in ET-3+bFGF. We conclude that
some cytokines (singly) can promote melanocyte survival, but at least two are required to induce
proliferation in chemically defined media. Since prior work suggests that ET-3+bFGF overexpres-
sion in human skin grafts on SCID mice can regulate melanoma formation, we propose that growth
factor responses of normal melanocytes may reflect essential pathways of melanomagenesis and
thus be of therapeutic importance.
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Liver kinase B1 in the pathogenesis of UVB-induced murine basal cell carcinoma
YA Byekova, JL Herrmann, J Xu, CA Elmets and M Athar Department of Dermatology and Skin
Disease Research Center, University of Alabama at Birmingham, Birmingham, AL
Liver kinase B1 (LKB1), a known tumor suppressor, is mutated in Peutz-Jeghers Syndrome. It is respon-
sible for the enhanced cancer risk in this population. Its dysregulation is also known in various
epithelial cancers. Recently, LKB1 expression was shown to be altered by UVB in skin keratinocytes.
However, its role in the pathogenesis of skin cancer remains elusive. We investigated the expres-
sion of LKB1 in UVB-induced basal cell carcinoma (BCC) derived from Patched+/- (Ptch+/-) mice.
Our data show that LKB1 expression is significantly enhanced in BCCs. LKB1-dependent AMP-
kinase (AMPK) and acetyl Co-A carboxylase (ACC), two downstream targets of LKB1 are also enhanced
in this neoplasm as compared to normal age-matched skin. To further probe the role of increased
LKB1 in BCC development, we investigated Wnt/β-catenin, mTOR, and MAPK signaling. We observed
an enhanced expression of phosphorylated p-Akt, a kinase known to inactivate GSK3β through its
phosphorylation, in UVB-induced BCCs. Consistently, we observed an accumulation of inactivated
p-GSK3β and an increase in activated nuclear β-catenin in BCCs. As GSK3β is a negative regulator
of Wnt/β-catenin signaling, our data suggest that LKB1 potentiates Wnt signaling in BCCs via inhi-
bition of GSK3β. However, mTOR signaling, which is also downstream of LKB1 and is inhibited by
LKB1 overexpression, remains upregulated in BCCs. This is evidence by the increased expression
of p-4E binding protein 1, p-p70 ribosomal S6 kinase, and p-S6-proteins. Interestingly, we observed
a marked decrease in the expression of sestrins, which function as potent negative regulators of
mTOR signaling. Thus, our data show that the LKB1/AMPK axis fails to regulate mTOR pathway,
and a complex regulatory mechanism exists for the persistent mTOR activation in BCCs derived
from irradiated Ptch+/- mice.
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Amphiregulin precursor controls cell-cycle regulatory gene expression in human keratinocytes
SW Stoll,1 L Rittié,1 S Lambert,1 M Prasad,1 JE Gudjonsson,1 B Li,2 Y Wei,2 G Abecasis,2 PE Stuart,1
RP Nair1 and JT Elder1 1 Dermatology, University of Michigan, Ann Arbor, MI and 2
Biostatistics, University of Michigan, Ann Arbor, MI
Amphiregulin (AREG) has been implicated as an autocrine growth factor in multiple benign and
malignant epithelial neoplasias and we have shown that AREG is particularly important in the con-
text of autocrine keratinocyte (KC) proliferation (JID 130:295). Although binding of proteolytically-
processed soluble AREG to the EGFR has traditionally been thought to mediate its growth factor-
specific functions, we recently identified an EGFR-independent, previously unrecognized role of
the AREG precursor (proAREG) cytoplasmic domain in the regulation of KC cell-cycle progression
and cytokinesis (JID 130:2031). To explore the mechanisms by which proAREG regulates KC biol-
ogy, we analyzed the effect of AREG knockdown on the global transcriptome using high through-
put RNA sequencing (RNASeq). N-TERT KC (MCB 20:1436) engineered to conditionally express
AREG specific shRNA were incubated with or without TET induction for 60 h +/- 20 ng/ml EGF fol-
lowed by cDNA isolation, poly(A)+ mRNA library preparation and RNASeq analysis. AREG knock-
down decreased expression of 1013 genes (> 2-fold, p<2.2x10-7), 67.8% of which were unaffected
by subsequent addition of EGF (< 1.5-fold). Consistent with the appearance of bi- and multinucle-
ated cells in AREG knockdown KC, Gene Ontology analysis revealed that many of the down-regu-
lated genes are involved in mitosis. Notably, these included the transcription factor FOXM1 as well
as many of its target genes, whose products function in the regulation of G2/M transition and mito-
sis. QRT-PCR confirmed strongly decreased expression of FOXM1 (13.8% of control with TET; 13.8%
with TET/EGF) and its gene cluster in AREG knockdown cells including KIF20A (12.9%; 5.2%), NEK2
(18.4%; 16.8%) and CENPA (12.8%; 14.2%), n=4 with p<0.02 for all tests. In sum, our data indi-
cate that proAREG controls cell-cycle regulatory gene expression in KC via activation of a FOXM1-
dependent transcriptional program whose function regulates G2/M progression and cytokinesis.
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Investigating the immunomodulatory properties of cutaneous squamous cell carcinoma stem
cells
BJ Kubick1,2,3 and DR Roop2,3,1 1 Cell Biology, Stem Cells, and Development, University of
Colorado Denver Anschutz Medical Campus, Aurora, CO, 2 Dermatology, University of
Colorado Denver Anschutz Medical Campus, Aurora, CO and 3 The Charles C. Gates Center
for Regenerative Medicine and Stem Cell Biology, University of Colorado Denver Anschutz
Medical Campus, Aurora, CO
Amongst the cellular heterogeneity found within a cancer, only a subset of cells, often referred to
as cancer stem cells, maintains the ability to initiate and maintain the cancer. In recent years,
efforts to measure the relative abundance of these cancer initiating cells (CICs) from xenografted,
human tumors have produced conflicting results and many of these studies have been criticized for
neglecting to recapitulate important components of the human stromal microenvironment. The
absence of a functional immune system in xenografting experiments is of particular concern since
immune surveillance has been shown to restrict tumor formation in a variety of tumor types. Thus,
the relative number of CICs is likely overestimated in these studies. Since immune effector cells are
so abundant throughout the skin, immune function is particularly relevant to cutaneous malignan-
cies and their derivative stem cells. To circumvent the problems of xenografting, we have devel-
oped a syngeneic mouse model that enables the characterization of mouse squamous cell carci-
noma CICs in the context of an intact immune system. This model, paired with a transplant technique
that mimics the natural tumor microenvironment, is to our knowledge the most accurate simula-
tion of tumorigenesis allowed by current technology for the measurement of CICs from a solid tumor.
Using this system, we observe that rare side population cells, distinguished by their relative ability
to efflux Hoechst dye, have the ability to propagate squamous cell carcinoma. Preliminary studies
of these cells suggest that immune evasion mechanisms include reduced antigen presentation and
disruption of immune effector cell homing.
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Interplay between the epidermal differentiation transcription factor Grhl3/Get1 and microRNA
miR-21
A Bhandari,1,2 D Dizon,1 W Gordon,1,2 A Soto Hopkin1,2 and B Andersen1,2 1 Medicine,
University of California Irvine, Irvine, CA and 2 Biological Chemistry, University of California
Irvine, Irvine, CA
The epidermal stratification process, crucial for barrier formation, is regulated by a complex inter-
play of several transcription factors, including the evolutionarily conserved Grainyhead-like 3
(Grhl3/Get1). Grhl3-deleted mice exhibit barrier function defects associated with impaired differ-
entiation of the epidermis and decreased expression of genes involved in lipid metabolism and
cell-cell adhesion. Intriguingly, many of these genes lack Grhl3 binding sites in their proximal pro-
moters leading us to hypothesize that Grhl3 might be involved in their regulation indirectly by con-
trolling the expression of specific microRNAs (miRs). Through miR profiling, we identified 11 miRs
that are differentially regulated in Grhl3-/- skin, one of which is miR-21, previously shown to be
upregulated in diseased skin, including in psoriasis and squamous cell skin cancer. We found that
miR-21 is normally expressed in the post-mitotic suprabasal layers of the epidermis in an overlap-
ping manner with that of Grhl3. Grhl3 binds to the miR-21 promoter region and represses its activ-
ity suggesting these two factors may be involved in a regulatory loop maintaining homeostasis in
the epidermis. miR-21 overexpression in normal keratinocytes results in reduced cell proliferation
due to a G1-S block. Consistent with this finding, mRNA profiling in keratinocytes treated with either
miR-21 or anti-miR-21 identified several cell cycle associated genes as miR-21 targets that could
account for this effect. Interestingly, when activated Ras is introduced into keratinocytes, we observe
a much more dramatic downregulation of pro-tumorigenic targets of miR-21 such as PDCD4,
NFIB, and MSH2, suggesting that transformed keratinocytes are more sensitive to miR-21’s effects
than normal keratinocytes. These findings are consistent with a role for miR-21 in diseased ker-
atinocytes, suggesting the possibility that decreased Grhl3 expression leads to upregulation of miR-
21 under pathological conditions.
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Novel glucocorticoid receptor modulator Compound A inhibits skin inflammation and hyper-
plasia
A Klopot, G Baida and I Budunova Dermatology, Northwestern University, Chicago, IL
Glucocorticoids that act via glucocorticoid receptor (GR) are important regulators of skin develop-
ment, maintenance and tumorigenesis. GR regulates gene expression by (i) transactivation that
requires GR binding to gene promoters and (ii transrepression through negative GR interaction with
other transcription factors. It was shown that therapeutic anti-inflammatory effects of glucocorti-
coids are mediated by GR transrepression. At the same time, GR transactivation underlies many
metabolic side effects of glucocororticoids. We and others showed that GR/glucocorticoids exert
strong tumor suppressor effect in skin, and that gene transrepression plays a leading role in GR anti-
cancer effects. This ties anti-cancer and anti-inflammatory effects of glucocorticoids. Thus, “disso-
ciated” ligands that preferentially shift GR activity towards transrepression hold a great promise for
the treatment of inflammatory skin diseases as well as for skin cancer prevention and treatment.
Compound A (CpdA), a plant-derived phenyl aziridine precursor, was recently characterized by us
and others as novel non-steroidal ligand acting mostly via GR transrepression. Here we report that
CpdA acted as GR dissociated ligand in mouse keratinocytes in vitro and in vivo. CpdA did not acti-
vate GR-dependent genes but mimicked inhibitory effect of glucocorticoids on expression of inflam-
matory cytokines and matrix metalloproteinases. When applied topically to skin, CpdA inhibited
skin hyperplasia and inflammation induced by tumor promoter TPA. In contrast to glucocorticoids,
CpdA in single treatment did not induce skin hypoplasia which is considered one of the important
adverse effects of glucocorticoids. These results suggest that CpdA and its derivatives represent a
novel promising class of anti-inflammatory and anti-cancer compounds for the treatment of der-
matological patients. We are currently searching for novel dissociated GR ligands by docking analy-
sis of chemical libraries using CpdA as a prototype. This work was supported by NIH grant R01
CA118890 (IB).
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Inhibitor specificity of MAPK, JAK3/STAT and mTOR signaling pathways in KitV560G and KitD816V
mutations found in mastocytosis
I Chan and MD Tharp Dermatology, Rush University Medical Center, Chicago, IL
Autoactivating kit mutations (KitV560G and KitD816V) are important in the development of mastocyto-
sis. Our previous studies have shown that KitV560G and KitD816V have different intracellular signaling
pathways controlling mast cell growth. KITV560G signaling appears to depend on the JAK3/STAT path-
way whereas the KITD816V seems to rely on mTOR. Treatment with the MAPK pathway specific
inhibitor (U0126), decreases the growth of mast cells expressing either KitV560G or KitV560G+D816V by
50%, when compared to controls. The JAK3 inhibitor (Whi-P131) is more effective in inhibiting the
growth of mast cells expressing KitV560G(>82%) than cells expressing KitD816V (52%). In contrast, the
mTOR inhibitor (rapamycin) is more effective in limiting the growth of cells expressing KitD816V (73%)
than KitV560G (47%). In order to further define critical signaling pathways in mastocytosis mast cells,
we investigated the pathway specificity of each inhibitor (U0126, Whi-P131 and rapamycin) using
Western blot hybridization. Treatment of mast cells with U0126 selectively inhibited the phospho-
rylation of the MAPK signaling molecules, ERK1/2 and MSK1/2, but not MEK1/2. Whi-P131 treat-
ment effectively inhibited the phosphorylation of JAK3 and STAT3 in mast cells expressing KitV560G
significantly more than cells expressing KitD816V. Rapamycin treatment inhibited the phosphoryla-
tion of mTOR at Serine2481 in mast cells expressing KitD816V. The results of this study indicate that
U0126 inhibits the MAPK pathway by directly blocking the catalytic sites of activated MEK1/2 in
mast cells expressing either KitV560G or KitD816V. JAK3/STAT3 appears to be the predominant signal-
ing pathway for mastocytosis mast cells expressing mutated KitV560G. Finally inhibition of mTOR by
rapamycin in cells expressing KitD816V suggests that this pathway is also important in mastocytosis
mast cell growth and may be a possible therapeutic tool for mastocytosis patients with this muta-
tion.
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Genotoxicity testing of topically applied skin care and dermatology products using the nor-
mal human cell based skin model EpiDermTM
Y Kaluzhny, P Hayden, V Karetsky, J DeLuca, S Ayehunie and M Klausner MatTek Corporation,
Ashland, MA
Safety assessment of topically applied products for human use requires genotoxicity testing to ensure
their non-carcinogenicity. Current in vitro assays have low specificity resulting in a high rate of false
positives. To determine the biological relevance of in vitro genotoxicity results, in vivo assays are
conducted. However, in 2009, in vivo genotoxicity testing was banned in Europe by the 7th Amend-
ment to the Cosmetics Directive. To address this need, reconstructed skin micronucleus (RSMN) and
comet assays (CA) utilizing MatTek’s highly differentiated EpiDerm™ skin model, have been devel-
oped. EpiDerm is a highly reproducible, organotypic model of human epidermis that contains a
skin-like barrier, possesses biotransformation capabilities, and allows for topical exposure. In the
RSMN assay, test materials were topically applied over a 2-day period in a similar fashion to actual
human contact. Acetone (vehicle control) exposed tissues resulted in a reproducible population of
binucleated cells (49.2+/-9.5%) with a low background of micronucleated cells (MNC) (0.1+/-
0.11%). The well-studied genotoxin, mitomycin-C (positive control), induced a statistically signifi-
cant increase in MNC (1.67+/-0.99%). In addition, 10 direct genotoxins and 7 genotoxins that require
metabolic activation resulted in dose-related, statistically significant increases in MNC while no
increases for 10 non-genotoxins were observed. In the CA, 2 model genotoxins, methyl methane
sulfonate and 4-nintroquinoline-1-oxide, induced statistically significant increases in % tail DNA
after 3 hours of topical exposure. Hence, the RSMN and Comet assays appear to be useful for pre-
dicting dermal genotoxicity following real life exposure. Together, the RSMN and Comet assays will
identify a wide spectrum of dermal genotoxic hazards, increase confidence in vitro test results, and
potentially replace animal studies in the genotoxicity evaluation of many materials, especially skin
care cosmetics and dermally applied pharmaceuticals.
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Real-time cell cycle imaging: Melanomas are composed of differentially cycling tumor cells
in a subcompartment-specific distribution
NK Haass,1,2 A Anfosso,1 I Kinjyo,1 O Kanagawa3 and W Weninger1,2 1 Centenary Institute,
Sydney, NSW, Australia, 2 Discipline of Dermatology, The University of Sydney, Sydney, NSW,
Australia and 3 Research Center for Allergy and Immunology, RIKEN, Yokohama City, Japan
While it is well appreciated that unrestricted proliferation is a cancer hallmark, the geometry and
dynamics of cell cycle progression of individual tumor cells are not known. We have made use of
the fluorescence ubiquitination cell cycle indicator (FUCCI) system to assess the cell cycle dynam-
ics in melanoma in real-time. In this system, cells transition from red (G1) to yellow (S) and green
(S/G2/M), followed by a short period of fluorescence negativity during cytokinesis. We character-
ized the cell cycle behavior of melanoma cells during proliferation, migration, and in response to
targeted therapy in vitro. This allowed us to measure the precise duration of G1, S and S/G2/M phases
and to correlate cell cycle phases with migration. In our 3D-spheroid model composed of FUCCI-
tagged melanoma cells, initially, the ratio of red:green melanoma cells was roughly equal, and
their distribution was random. Within hours cycling green cells sequestered in a ring-like pattern at
the periphery of the spheroid, while cells in the center remained in G1 (red). Treatment with the
MEK1/2 inhibitor U0126 induced G1 arrest in melanoma over the course of 24h (indicated by the
homogeneous red fluorescence). Importantly, U0126 did not block invasion. To investigate the micro-
anatomical distribution of cycling melanoma cells in vivo, FUCCI-tagged melanoma cells were
xenografted into NOD/SCID mice. Tumors were allowed to grow until they were palpable and
were then analyzed by confocal microscopy. Early tumors showed a similar pattern as the sphe-
roids, whereas in large tumors we found clusters of differentially cycling subpopulations that were
located next to each other, often with a sharp demarcation between the clusters. Together, our data
suggest that melanomas are composed of differentially cycling tumor cells in a subcompartment-
specific distribution, which has implications for the evaluation of targeted therapies.
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Rapamycin augments the chemopreventive effects of sulindac and suppresses UVB-induced
cutaneous photocarcinogenesis in Ptch+/- hairless mice
SC Chaudhary,1 D Kurundkar,1 T Singh,1 Z Weng,1 CA Elmets,1 L Kopelovich2 and M Athar1 1
Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL and 2
Division of Cancer Prevention, National Cancer Institute, Bethesda, MD
Sulindac, an NSAID, is widely used to reduce inflammation. It also possesses chemopreventive activ-
ity against a variety of epithelial cancers both in humans and in experimental animals. In this study,
we show that rapamycin (rapa), a well-known mTOR inhibitor, augments the cancer chemopre-
ventive activity of sulindac against UVB-induced photocarcinogenesis in the skin of Ptch+/-/SKH-
1 hairless mice. Treatment with sulindac or rapa reduced both UVB-induced basal cell carcinoma
(BCCs) and squamous cell carcinoma (SCCs). However, when both agents were tested in combi-
nation, the reduction in both tumor types was significantly greater than with either agent alone. The
growth of BCCs was reduced by 90% as compared to UVB controls. However, SCCs decreased by
only 67%. Similarly, tumor size was also decreased significantly. Sulindac and rapa in combination
were more effective in inducing apoptosis in these lesions than single agents. In addition, the com-
bined treatment attenuated the levels of UVB-disrupted cell cycle regulatory proteins. These treat-
ments also induced pro-apoptotic proteins with a concomitant reduction in anti-apoptotic pro-
teins. However, treatment with rapa+sulindac decreased UVB-induced phosphorylation of
extracellular signal-regulated kinase1/2 and p38 MAP kinases in addition to pro-inflammatory pro-
teins, COX-2, iNOS and NFkβp65. UVB induces expression of mesenchymal markers such as N-
cadherin and fibronectin in epidermis which promote epithelial-mesenchymal transition. How-
ever, we observed a substantial reduction in the levels of these proteins in the combinatorial group.
Rapa+sulindac together inhibited Shh and mTOR signaling pathways in the tumor adjacent skin
more effectively than the single treatments. Our data in preclinical murine models suggest that sulin-
dac may be highly effective in reducing skin cancer in organ transplant patients receiving rapamycin.
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Merkel cell polyomavirus large T antigen impairs DNA repair and cell cycle arrest following
DNA damage
SK Demetriou,1,2 EM Sullivan,1,2 TK Dong1,2 and DH Oh1,2 1 Department of Dermatology,
University of California, San Francisco, CA and 2 Dermatology Research Service, VA Medical
Center, San Francisco, CA
Merkel cell carcinoma (MCC) is an unusually lethal skin cancer that typically occurs on sun-exposed
skin. Recently, MCCs have been strongly associated with a new virus, Merkel cell polyomavirus
(MCV), but the pathways by which MCV promotes cancer remain undefined. MCV expresses a
homolog of the SV40 large T antigen (LTAg) which is known to impair the DNA damage response
by disrupting functions of retinoblastoma and p53 proteins. We tested the hypothesis that MCV act-
ing through LTAg impairs normal global genomic repair (GGR) and other cellular responses to
ultraviolet radiation (UVR)-induced DNA lesions. In contrast to a virus-negative MCC cell line (UISO),
a virus-infected cell line (MKL-1) exhibited UVR hypersensitivity and drastically impaired GGR of
UVR-induced photoproducts. In addition, in contrast to UISO cells, virus-infected MKL-1 cells were
characterized by loss of the G1 cell cycle checkpoint following UVR, allowing cells to replicate
despite DNA damage. To ensure that observed differences were not specific to these cell lines,
LTAg from a different MCC tumor was expressed in UISO cells and, relative to empty vector con-
trols, also resulted in loss of GGR and in persistent DNA replication following UVR. Furthermore,
LTAg expression in normal human fibroblasts similarly inhibited GGR, indicating that the actions
of LTAg extend to normal, non-transformed cells. Finally, shRNA-mediated knockdown of p53 in
UISO cells was sufficient to model the LTAg-induced impairment of GGR and the G1 cell cycle
checkpoint, suggesting that LTAg may inhibit p53. While no significant changes in p53 levels were
observed after expression of LTAg, GGR defects were associated with reduced levels of the DNA
damage recognition protein, XPC, whose expression can be induced by p53. These results indicate
that LTAg expression inhibits key responses to UVR-induced DNA damage and suggest that MCV-
induced genomic instability may underlie Merkel cell carcinogenesis.
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Oncogenic activity of dysregulated ΔNp63α in squamous carcinogenesis
L Ha,1 KE King,1 RM Ponnamperuma,1 S Jay,2 S Ricci1 and WC Weinberg1 1 CDER/FDA,
Bethesda, MD and 2 SAIC-Frederick, Inc., Frederick, MD
Expression of ΔNp63α is associated with proliferation in normal epithelium and is elevated in
squamous cell carcinomas, but the contribution of dysregulated p63 to cancer pathogenesis remains
unclear. We developed lentiviral vectors to assess the phenotypic consequences of sustained ele-
vated ΔNp63α expression in an in vivo mouse skin model of cancer and in vitro correlates. As
observed previously with transient adenovirus-mediated ΔNp63α overexpression, lentivirus-driven
ΔNp63α expression in primary mouse epidermal keratinocytes blocks in vitro induction of bio-
chemical markers of differentiation and associated growth arrest. Cultured keratinocytes express-
ing lenti-GFP, but not lenti-ΔNp63α, undergo both spontaneous replicative senescence and onco-
genic v-rasHa-induced senescence, as evidenced by the expression of SA-β-gal or the presence of
nuclear foci of heterochromatin protein 1γ (HP1γ). Both replicative and oncogene-induced senes-
cence are accompanied by an upregulation of p16 and p19, which is delayed and attenuated in
lenti-ΔNp63α-expressing cells. Keratinocytes expressing lenti-GFP- or lenti-ΔNp63α alone consis-
tently form normal skin following grafting to nude mice. Lenti-GFP/v-rasHa keratinocytes form well-
differentiated papillomas, while lenti-ΔNp63α/v-rasHa keratinocytes form undifferentiated carcino-
mas. The average volume of tumors arising from grafted lenti-ΔNp63α/v-rasHa keratinocytes was
higher than those in the lenti-GFP/v-rasHa group, consistent with increased BrdU incorporation
detected by immunohistochemistry. p19 null keratinocytes expressing lenti-GFP and v-rasHa yielded
undifferentiated carcinomas in a graft site, similar to those seen with ΔNp63α overexpression. How-
ever, p19 null tumors did not grow as rapidly, suggesting that mechanisms in addition to p19 gene
regulation are involved in ΔNp63α-mediated tumor growth. This model will be a valuable tool to
dissect the contribution of interacting pathways in ΔNp63α-mediated carcinogenesis.
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Endothelin-3 and bFGF jointly induce the proliferation of normal human melanocytes in
defined media and increase synthesis of chemokines that are linked to melanoma progres-
sion
CQ Wang,1 H Mitsui,1 M Suarez-Farinas,1 N Gulati,1 J Gonzalez,2 E Billick1 and JG Krueger1 1
Laboratory for Investigative Dermatology, Rockefeller University, New York, NY and 2 Center
for Clinical and Translational Science, Rockefeller University, New York, NY
bFGF, stem cell factor (SCF), and endothelin-3 (ET-3) are all mitogens that are essential for melanocyte
development during embryogenesis as well as support the survival and growth of melanocytes. How-
ever, it is unclear as to which one of these growth factors, or which combinations of them, are able
to induce the proliferation of normal melanocytes in fully-defined serum free conditions. In this
study, we demonstrate in time-lapse imaging that the combination of ET-3 and bFGF is sufficient to
induce the proliferation of melanocytes over 4 days. However, in media conditioned with single
growth factors ET-3, bFGF or SCF, enhanced survival but no cell division was observed. Further-
more, melanocytes cultured in ET-3 and bFGF together have the highest percentage (31%) of Ki67-
positive cells, when compared to cells grown in media conditioned with single growth factors or
combinations of bFGF+SCF and ET-3+SCF (9-13%). Other cell proliferation markers that were ele-
vated at the mRNA level included cyclins D1, B1, A1 and Cdc2. These observations were sup-
ported by FACS-based cell cycle analysis, which showed melanocytes cultured in ET-3+bFGF media
contain the lowest G1 population (37%). Additionally, we examined the expression of cytokines
that are associated with melanoma progression. Using real-time PCR, we detected elevated mRNA
levels of IL-24, CXCL-2 and Neuregulin in melanocytes cultured in ET-3+bFGF. We conclude that
some cytokines (singly) can promote melanocyte survival, but at least two are required to induce
proliferation in chemically defined media. Since prior work suggests that ET-3+bFGF overexpres-
sion in human skin grafts on SCID mice can regulate melanoma formation, we propose that growth
factor responses of normal melanocytes may reflect essential pathways of melanomagenesis and
thus be of therapeutic importance.
156
Liver kinase B1 in the pathogenesis of UVB-induced murine basal cell carcinoma
YA Byekova, JL Herrmann, J Xu, CA Elmets and M Athar Department of Dermatology and Skin
Disease Research Center, University of Alabama at Birmingham, Birmingham, AL
Liver kinase B1 (LKB1), a known tumor suppressor, is mutated in Peutz-Jeghers Syndrome. It is respon-
sible for the enhanced cancer risk in this population. Its dysregulation is also known in various
epithelial cancers. Recently, LKB1 expression was shown to be altered by UVB in skin keratinocytes.
However, its role in the pathogenesis of skin cancer remains elusive. We investigated the expres-
sion of LKB1 in UVB-induced basal cell carcinoma (BCC) derived from Patched+/- (Ptch+/-) mice.
Our data show that LKB1 expression is significantly enhanced in BCCs. LKB1-dependent AMP-
kinase (AMPK) and acetyl Co-A carboxylase (ACC), two downstream targets of LKB1 are also enhanced
in this neoplasm as compared to normal age-matched skin. To further probe the role of increased
LKB1 in BCC development, we investigated Wnt/β-catenin, mTOR, and MAPK signaling. We observed
an enhanced expression of phosphorylated p-Akt, a kinase known to inactivate GSK3β through its
phosphorylation, in UVB-induced BCCs. Consistently, we observed an accumulation of inactivated
p-GSK3β and an increase in activated nuclear β-catenin in BCCs. As GSK3β is a negative regulator
of Wnt/β-catenin signaling, our data suggest that LKB1 potentiates Wnt signaling in BCCs via inhi-
bition of GSK3β. However, mTOR signaling, which is also downstream of LKB1 and is inhibited by
LKB1 overexpression, remains upregulated in BCCs. This is evidence by the increased expression
of p-4E binding protein 1, p-p70 ribosomal S6 kinase, and p-S6-proteins. Interestingly, we observed
a marked decrease in the expression of sestrins, which function as potent negative regulators of
mTOR signaling. Thus, our data show that the LKB1/AMPK axis fails to regulate mTOR pathway,
and a complex regulatory mechanism exists for the persistent mTOR activation in BCCs derived
from irradiated Ptch+/- mice.
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Basal cell carcinoma tumor subtype is defined by its cell of origin
M Grachtchouk,1 J Pero,1 AN Ermilov,1 LE Michael,1 D Wilbert,1 S Lim1 and AA Dlugosz1,2 1
Dermatology, University of Michigan, Ann Arbor, MI and 2 Cell & Developmental Biology,
University of Michigan, Ann Arbor, MI
Constitutive Hedgehog (Hh) signaling drives the development of basal cell carcinoma (BCC), the
most common cancer in humans, but the cell of origin for BCC is unclear. While Hh pathway dys-
regulation is common to essentially all BCCs there exist several histological subtypes, including
superficial and nodular variants, raising the possibility that morphologically distinct BCCs may
arise from different cellular compartments in skin. We used multiple mouse models to control the
timing and level of oncogenic Hh signaling activity, and most importantly, the particular cell pop-
ulations where Hh signaling was altered. We show that induction of the Hh pathway effector GLI2*,
selectively in stem cells of resting hair follicles, induces nodular BCC development from a small
subset of cells in the lower bulge and secondary hair germ compartments. Acute induction of
GLI2* activates proliferation in quiescent stem cells of the upper bulge as well, but cells in this
compartment activate a cell death program and are resistant to neoplastic transformation. Tumori-
genesis is markedly accelerated in growing hair follicles, and nodular BCC-like tumors can arise
directly from the follicle outer root when GLI2* is activated in mature follicles. In contrast, focal
activation of GLI2* in epidermis leads to the formation of superficial BCCs. Expression of GLI2* at
reduced levels yields tumors resembling basaloid follicular hamartomas, which have previously
been linked to low-level Hh signaling both in mice and humans. Our data show that the cell of ori-
gin, tissue context (quiescent versus growing hair follicles), and level of oncogenic signaling deter-
mine the phenotype of Hh/Gli-driven skin tumors, with high-level signaling required for develop-
ment of superficial BCC-like tumors from interfollicular epidermis and nodular BCC-like tumors
from hair follicle stem cells and their progeny.
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MtDNA mutations alter intracellular ROS levels in fibroblasts resulting in cellular hyperpro-
liferation
J Jandova,1,2,3 J Janda1,2,3 and JE Sligh1,2,3 1 Southern Arizona VA Healthcare System, Tucson, AZ,
2 Arizona Cancer Center, Tucson, AZ and 3 University of Arizona, Tucson, AZ
We modeled mitochondrial dysfunction in fibroblasts by creating identical murine fibroblast (mtB6
and mtBALB) cybrid lines that differ only in their mtDNA haplotype. The mtBALB cybrids have sig-
nificantly increased proliferation over the mtB6 cybrids when grown in galactose, a result that mir-
rors what is seen in glucose medium. We theorized that the hyperproliferative activity of the mtBALB
cybrids compared to the mtB6 could be explained by an increased level of reactive oxygen species
(ROS). The hyperproliferative mtBALB cells revealed significantly higher levels of ROS compared to
B6 cybrids. We treated the cybrid cells with the antioxidant compounds N-acetyl-L-cysteine (NAC)
or vitamin E (vit E) to determine if scavenging ROS would diminish their proliferative capabilities.
The addition of NAC selectively reduced the proliferative capacity of the mtBALB cybrids while hav-
ing no significant antiproliferative effect on the mtB6 cybrids. Vit E caused a greater reduction in
proliferation of the cybrids than did NAC, and the effect was not selective as was seen with NAC as
the reduction in proliferation was significant for both mtBALB and mtB6 cybrids compared to their
untreated controls. We explored whether a 7 d pre-treatment with NAC in medium with either glu-
cose or galactose has the same or even more profound effect on growing ability of cybrids. We
observed that NAC did selectively slow down the growth of the mtBALB cybrids but had no signif-
icant antiproliferative effect on the mtB6 cybrids when growing in glucose or galactose. The ability
of NAC to selectively inhibit the proliferation of mtBALB over mtB6 cybrids (an effect not seen by
vit E) may reflect the differences in oxygen scavenging activity of the two compounds for specific
radicals. Obtained data support a role of ROS as specific second messengers in signaling cascades
involved in cell proliferation and differentiation.
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Phosphatidylinositol 3-kinase enhancer is required for the proliferative action of epidermal
growth factor in squamous cell carcinoma cells
Z Xie,1 Y Jiang,2 E Liao,2 Y Chen3 and S Pennypacker1 1 Endocrine Unit, Veterans Affairs Medical
Center, Northern California Institute for Research and Education and University of California,
San Francisco, CA, 2 The Second Xiang-Ya Hospital, Central South University, Changsha,
China and 3 Institute of Chinese Materia Medica, China Academy of Chinese Medical
Sciences, Beijing, China
One of the key drivers for squamous cell carcinoma (SCC) proliferation is activation of the epider-
mal growth factor receptor (EGFR). However, the mechanism by which activated-EGFR mediates
SCC proliferation remains unclear. Our previous studies indicate that epidermal growth factor (EGF)-
induced SCC cell proliferation requires the SH3 domain of phospholipase C-γ1 (PLC-γ1) but not
PLC-γ1 catalytic activity. In the present study, we found that phosphatidylinositol 3-kinase enhancer
(PIKE), a key downstream effector of the SH3 domain of PLC-γ1, is highly expressed in human SCC
cell lines (SCC4 and SCC12B2) but at a very low level in normal human keratinocytes. Immuno-
histochemical analysis showed strong nuclear staining of PIKE in human skin and tongue SCC
specimens but little staining in the adjacent normal squamous epithelium. Treatment of SCC4 and
SCC12B2 cells with EGF induced binding of PIKE to PLC-γ1 and PI3K in the nucleus. Knockdown
of PIKE blocked EGF-induced activation of phosphatidylinositol 3-kinase (PI3K) and protein kinase
C-ζ (PKC-ζ)and phosphorylation of nucleolin in the nucleus as well as SCC cell proliferation. Knock-
down of PLC-γ1 had the same effect as PIKE knockdown. However, inhibition of the catalytic activ-
ity of PLC-γ1 had little effect on EGF-induced activation of PI3K and PKC-ζ and phosphorylation of
nucleolin in the nucleus and proliferation of SCC4 cells. These data suggest that EGF-induced SCC
cell proliferation is mediated through a PLC-γ1/PIKE dependent pathway.
172
Disruption of lipid rafts induces EGFR signaling in hair follicle cells and in cicatricial alope-
cia
AA Lattif,1 SP Panicker,1 T Ganguly,1 MC Consolo1 and P Karnik1,2 1 Dermatology, Case Western
Reserve University, Cleveland, OH and 2 Univ Hosp Case Med Ctr, Cleveland, OH
Primary Cicatricial Alopecia (PCA) is a group of poorly understood inflammatory hair diseases that
cause scarring and permanent hair loss. Gene expression profiling of lymphocytic and neutrophilic
PCA showed that post-squalene cholesterol biosynthesis is significantly decreased. One of the con-
sequences of decreased cholesterol biosynthesis in PCA could be the disruption of cell membrane
lipid rafts. Lipid rafts are cholesterol rich signaling platforms on cell membranes that regulate the
activity of membrane receptors. In the current study, we investigated the role of lipid rafts in mouse
hair follicles and in PCA. The cholesterol biosynthesis inhibitor BM15766 inhibits the enzymes
DHCR7 and EBP and causes the accumulation of sterol intermediates lathosterol, desmosterol and
7-dehydrocholesterol (7-DHC). To investigate the in vivo effects of sterol intermediates on the hair
follicle, we treated mouse skin with BM15766 or with 7-DHC. Staining of mouse skin with the cho-
lesterol-binding fluorescent dye, Filipin, showed intense staining in regions with high cholesterol
content in the plasma membrane. In stark contrast, mouse skin treated with BM15766 or with 7-
DHC showed loss of lipid raft staining. Intriguingly, hair follicles of BM15766 or 7-DHC treated
mice were arrested in telogen and failed to re-grow. This suggests that disruption of lipid rafts caused
by inhibition of cholesterol biosynthesis alters the activity of membrane proteins that affect hair
growth. Ingenuity Pathways Analysis revealed that Epidermal Growth Factor Receptor (EGFR), a lipid
raft protein, is consistently up-regulated in PCA. EGFR over-expression is reported to cause hair loss
and epidermal thickening. Real-time PCR analysis demonstrated that the expression of EGFR is sig-
nificantly up-regulated in mouse skin painted with sterol intermediates of cholesterol biosynthesis.
Our data suggests that lipid rafts and their associated signaling pathways play an important role in
hair follicle growth and in the pathogenesis of PCA.
170
Blockade of mTOR-dependent phosphorylation of Sirtuin 1 prevents escape from premature
senescence
AL Kim, J Back, Y Zhu and DR Bickers Dermatology, Columbia University Medical Center, New
York, NY
Induction of premature senescence is a recognized strategy for permanent cellular growth-arrest.
Cancer cells become senescent following exposure to sub-lethal doses of DNA-damaging chemother-
apeutic drugs, thus providing a potentially novel approach for controlling tumor growth. Paradox-
ically, it is known that prematurely senescent cancer cells may be resistant to chemotherapeutic
agents thereby permitting tumor recurrence. Furthermore, since prematurely senescent tumor cells
can escape growth arrest and re-enter the cell cycle, it is essential to identify the mechanisms that
sustain cell survival under these conditions. Here, we show that treatment of A431 human squa-
mous cell carcinoma (SCC) cells with either the plant polyphenol resveratrol (RES) or the anthra-
cycline antibiotic doxorubicin (DOX) induced DNA-damage-dependent, p53-independent prema-
ture senescence which involved the nuclear translocation of mTOR Complex 1 (mTORC1), followed
by the mTOR-dependent inhibitory phosphorylation of Sirtuin 1 (SIRT1) at S47. This led to upregu-
lation of the anti-apoptotic factor Bfl-1/A1 via increased acetylation of the p65RelA subunit of NF-
κB. The physical interaction between the mTORC1 and a TOR signaling (TOS) motif in the SIRT1
protein was absolutely essential for SIRT1 S47 inhibitory phosphorylation. Creation of a mutant
SIRT1 containing a single amino acid substitution in the TOS motif (F474A) rendered it incapable
of forming a complex with mTOR, thereby preventing S47 phosphorylation, as determined by in
vitro mTOR-dependent kinase assay. Furthermore, overexpression of either F474A SIRT1 or S47A
SIRT1 mutant proteins in SCC cells blocked RES/DOX-induced Bfl-1/A1 expression, and sensitized
cells for apoptosis. RES/DOX-induced premature senescent SCC cells eventually escaped growth
arrest. Inhibition of mTOR by treatment with rapamycin blocked regrowth of senescent SCC cells.
Our results indicate that mTOR directly regulates SIRT1’s activity and that targeting mTOR/SIRT1
signaling might be an effective treatment to prevent regrowth/escape from premature senescence.
174
MAGE-C2 promotes tumor growth, DNA damage repair, and phosphorylation of KAP-1
N Bhatia, S Thiyagarajan, TZ Xiao, MR Albertini and JB Longley University of Wisconsin,
Madison, WI
Melanoma associated antigens (MAGE)/cancer testes antigens (CT antigens) are a rational thera-
peutic target because they are expressed in melanoma and other cancers but not in normal somatic
cells. Clinical, in vitro, and in vivo studies associate MAGE expression with aggressive tumor growth,
poor clinical outcome and resistance to chemotherapy but neither a causal link nor a mechanism
for these associations is fully established. To investigate these relationships, we transduced MAGE-
C2 (+) A375 cells and low passage primary melanoma cell lines with lentiviral encoded inducible
shRNA targeting MAGE-C2. Down-regulation of MAGE-C2 reduced cell growth and induced apop-
tosis, and reduced growth of melanoma cells xenografted into nude mice, compared to the same
cells induced to express scrambled shRNA. MAGE-C2 knockdown also increased tumor cell death
caused by doxorubicin, a DNA damaging agent. We have previously shown that MAGE-C2 binds
to KAP-1, a multifunctional scaffolding protein central to maintenance of chromatin structure and
gene suppression. Phosphorylation of KAP-1 on ser824 by ATM kinase is necessary for the cellular
response to DNA damage, and we found that down-regulation of MAGE-C2 reduced, and over-
expression of MAGE-C2 increased, KAP-1 ser824 phosphorylation by ATM kinase. Furthermore,
KAP-1 expression increased repair of specific DNA double strand breaks in a DNA damage repair
assay. Our results suggest MAGE-C2 expression contributes to tumor cell survival by promoting
repair of damaged DNA and that suppression of MAGE in MAGE (+) tumors may increase the effect
of DNA damaging agents, providing a novel treatment approach for melanomas and other MAGE
(+) tumors.
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Biophotometric analysis reveals that self-perpetuating focal areas of hyperemia invariably
precede cutaneous neoplasia and are suppressed by topical celecoxib treatment
RL Konger,1 RP Sahu,1 Z Xu2 and YL Kim2 1 Pathology, Indiana University School of Medicine,
Indianapolis, IN and 2 Biomedical Engineering, Purdue University, West Lafayette, IN
Biophotometric imaging combined with spectroscopic analysis and back-directional gating has been
utilized to show that hyperemia is a feature of not only neoplastic lesions but is also present in oth-
erwise normal epithelium in the surrounding tissue field. We utilized this methodology in mouse
models of chemical and photocarcinogenesis to show that hyperemia invariably precedes the appear-
ance of grossly visible tumors. While all tumors developed in areas of high Hgb content, not all
hyperemic areas developed tumors: The probability for future tumor occurrence was 80-90% in
both models using a cutoff for Hgb content > 1.7-1.75 mg/ml. In the UVB studies, mice were irra-
diated for 10 weeks with 2240 J/m2 UVB 3 times/week and treated topically with either vehicle (ace-
tone) or celecoxib (500 mcg/0.2 ml) after each UV treatment. UVB treatments were discontinued
at 10 weeks, but the mice continued to receive topical treatments for 30 weeks. Interestingly, focal
areas of high Hgb content continued to increase in size after cessation of the UVB treatments sug-
gesting a self-perpetuating mechanism. Celecoxib treatment reduced tumor occurrence and also
markedly suppressed the formation of areas of high Hgb content (59% suppression of the skin area
with Hgb content > 1.75 mg/ml). At 30 weeks, areas of high and low Hgb content without visible
tumors were assessed histologically. High Hgb content was associated with marked epidermal hyper-
plasia/dermal inflammation and some small low grade papillomas. Areas of low Hgb content showed
modest hyperplasia, no neoplastic lesions and limited inflammatory infiltrates. Celecoxib treatment
had no significant effect on the histology of areas of high Hgb content. Our data suggests that this
imaging approach can be used to identify areas of subclinical or pre-neoplastic disease, to assess
the efficacy of chemopreventive strategies and to identify focal areas resistant to chemopreventive
approaches.
164
Combined inhibition of sonic hedgehog (shh) and nuclear factor κB (NFκB) signaling path-
ways in the prevention of basal cell carcinomas (BCCs)
A Arumugam,1 Z Weng,1 L Kopelovich2 and M Athar1 1 Dermatology, University of Alabama at
Birmingham, Birmingham, AL and 2 Division of Cancer Prevention, NCI, Bethesda, MD
BCCs are the most common form of human cancer, affecting 750,000 Americans annually. Solar
ultraviolet B (UVB) is the major etiologic factor for this neoplasm. Aberrant activation of Shh path-
way is involved in the pathogenesis of both sporadic BCCs, and BCCs developed in patients with
the nevoid basal cell carcinoma syndrome. In this study, we tested whether crosstalk between Shh
signaling and NFkB is involved in the pathogenesis of BCCs. For this, we employed cyclopamine
(CP), a plant-derived steroidal alkaloid Shh inhibitor, and sulfasalazine (SZ), an anti-inflammatory
agent known to block NFkB activation. Ptch+/-/SKH-1 mice irradiated with UVB (180 mJ/cm2, twice
a week) were administered sulfasalazine (500 ppm in drinking water, ad libitum) and cyclopamine
(50 mg/kg body weight, twice a week, i.p) alone or in combination for 40 weeks. At this stage mice
receiving SZ, CP, and CP + SZ developed respectively 16%, 67%, and 92% fewer tumors as com-
pared to the UVB (alone) irradiated animals. In addition, microscopic BCCs were reduced by 19%,
82%, and 86%, respectively, by these treatments. RT-PCR and western blot analysis showed that
these treatments diminished the expression of Shh pathway related genes (Gli1, Gli2, Gli3, Ptch1,
and Ptch2) as well as those involved in the cell cycle regulation (cyclin D1, cyclin D2, cyclin D3
and cyclin E) both in residual BCCs and tumor-adjacent skin. In addition, expression of p-p65
NFkB was reduced. Comparison of these treatment groups revealed that the combination of CP +
SZ was the most effective in this regard. Our data show that combinatorial inhibition of Shh and
NFkB signaling pathway is more effective in reducing BCCs than the individual treatments in a pre-
clinical murine model.
165
Digital transcriptome subtraction for pathogen sequence detection and gene expression pro-
filing in CTCL
ED Mirvish,1,2 H Feng,2 RG Pomerantz,1 LD Falo,1 Y Chang,2 PS Moore2 and LJ Geskin1 1
Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, PA and 2 Cancer
Virology Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA
Mycosis fungoides (MF) and Sezary syndrome (SS) are the most common forms of cutaneous T-cell
lymphoma (CTCL), a malignancy of skin-homing CD4+ T lymphocytes. Molecular and epidemio-
logic features of CTCL are suggestive of an infectious etiology, but studies to date have failed to yield
consistent results. We analyzed MF and SS tumors using Digital Transcriptome Subtraction (DTS),
an unbiased method for detection of novel and differentially expressed genes. Total RNA was extracted
from the tumors of three MF patients and three SS patients, as well as the CD4+ lymphocytes of
three healthy blood donors. MF, SS, and non-diseased CD4+ cDNA libraries were next constructed
using barcoded oligo(dT) primers, which enabled differentiation of specimen-specific transcripts
after samples were pooled for 454 Titanium platform pyrosequencing. Sequencing yielded approx-
imately 5x10^5 reads for each library. For DTS, reads were quality filtered using the LUCY algo-
rithm, and the resultant high-fidelity dataset was subtracted in silico from human RefSeq sequences.
After completion of DTS, non-subtracted, putatively “non-human” sequences were aligned against
viral genetic databases. In the preliminary analysis, candidate sequences did not align with high
specificity against putative human pathogens. We demonstrate a lack of exogenous transcript using
DTS, provinding providing strong quantitative evidence against the presence of a directly oncogenic
virus in CTCL. In addition, sequenced tumor and control libraries were compared for the purposes
of gene expression profiling, revealing multiple transcripts that are differentially expressed in tumors
versus lymphocyte controls, including zinc finger protein 217 (ZNF217), T-Plastin (PLS3), and
aquaporin 3 (AQP3). Taken together, these results yield novel insights into the pathogenesis and
molecular biology of CTCL.
166
Quantitative immunohistochemistry of cutaneous metastatic breast carcinoma
M Elgart,3 C Welsh2 and EV Badiavas1 1 Dermatology, University of Miami, Miami, FL, 2
Hematology-Oncology, University of Miami, Miami, FL and 3 Gulliver School, Miami, FL
Breast carcinoma is the most common primary tumor to metastasize to skin. In this series of ten
cases we identified patterns among metastatic lesions comparing expression of estrogen receptor,
cyclin D1, and Ki-67 by quantitative immunohistochemistry. Routine immunohistochemical stain-
ing studies are limited by the interpretation of presence of absence of staining and non-quantitative
measures. Employment of computer assisted quantitative evaluation of expression as in this study,
allows for numerical interpretation of staining intensity, color, and saturation. Clear association of
the two measures of cell proliferation (cyclin d1 AND Ki-67) was seen in that the expression of the
two markers was generally seen in tandem. However, both markers were inversely present in com-
parison to estrogen receptor staining. These findings suggest that quantitative immunohistochem-
istry reflects consistent measure of breast cancer outcome in the metastatic setting in skin biopsy
samples.
167
Somatic alterations in mtDNA trigger changes in CCL20 expression promoting tumorigenic
phenotypes
J Jandova,1,2,3 J Janda1,2,3 and JE Sligh1,2,3 1 Southern Arizona VA Healthcare System, Tucson, AZ,
2 Arizona Cancer Center, Tucson, AZ and 3 University of Arizona, Tucson, AZ
Somatic mitochondrial mutations are common in human cancers and can by used as a tool for
early detection of cancer. We modeled the effects of somatic variation at mt-Tr by harvesting mito-
chondria from brain synaptosomes of B6 and BALB mice and transferring them to a mouse fibrob-
last ρ0 cell line that lacked its own mitochondria. The resulting cybrid cell lines contain the same
nuclear genotype and differ in their mtDNA. Microarray analysis was conducted in order to eluci-
date the expression differences between the two cybrid lines. Agilent 44K mouse whole genome
chip revealed more than 1,000 differentially expressed genes between the two cybrid lines. From
the potential targets we focused on CCL20 which has been reported to promote cancer cell prolif-
eration and migration in vitro. Real-time PCR confirmed up-regulation of CCL20 in mtBALB cybrids
compared to mtB6 cybrids. Based on previously reported role of CCL20 in tumor progression we
examined whether the mtBALB haplotype is associated with higher level of cellular growth, migra-
tion and invasiveness compared to mtB6 haplotype. Our results indicate that the mtBALB cybrids
demonstrate significantly increased proliferation, migration and invasion abilities. Additionally, the
treatment of both cybrid hapltotypes with recombinant mouse CCL20 protein (rmCCL20) resulted
in enhanced proliferation of mtB6 cybrids but had no effect on mtBALB cybrid cells. In migration
transwell assays, mtB6 cybrids were either pretreated with rmCCL20 or rmCCL20 was added to the
bottom well as a chemo-attractant. The results showed that mtB6 cybrid cells pretreated with rmCCL20
have a statistically significant increase in migration compared to untreated mtB6 controls. In addi-
tion, when rmCCL20 was added as a chemoattractant there was even more profound effect on migra-
tion of mtB6 cybrids almost to the level of mtBALB cybrids. These studies reveal a role for CCL20
in potential tumorigenic behavior of mtBALB cybrids associated with their ability to hyperprolifer-
ate, migrate and invade.
168
Disease stage-related decreases in distinct superantigen-related T cell receptor-Vβs in cuta-
neous T-cell lymphoma
RG Pomerantz, ED Mirvish, TJ Patton, LD Falo and LJ Geskin Department of Dermatology,
University of Pittsburgh School of Medicine, Pittsburgh, PA
The objective of this study was to evaluate the T cell receptor-Vβ (TCR-Vβ; Vβ) repertoire in patients
with Mycosis Fungoides (MF) and Sezary Syndrome (SS) variants of cutaneous T cell lymphoma
(CTCL) across all stages, in order to identify relationships between Vβ expression levels and disease
stage. Blood was drawn from MF/SS patients (n=31), the percentage of CD4+ T cells expressing each
Vβ was determined by multiparameter flow cytometery, and the change in expression levels with
progressive disease stage was calculated with Spearman’s rank correlation coefficients. In agree-
ment with prior reports, we found that individual TCR-Vβ families were expanded in some patients
with advanced MF/SS. Surprisingly, when we scrutinized TCR-Vβ families by individual stages, our
statistical analysis revealed significant decreases in the proportions of five distinct TCR-Vβs with
progressive stages of disease, while the proportion of all other tested TCR-Vβ families did not change
with disease stage. These data show disease stage-related changes in the expression of certain TCR-
Vβs known to be activated by viral superantigens. In particular, there was a highly significant decrease
in expression of TCR-Vβ13, which has been found to be activated by an EBV-associated superanti-
gen, in advanced CTCL. Based on these findings, we theorize that in early stages of CTCL, viral
infection may play a role in the expansion of specific superantigen-associated T-cells; while in later
stages, these same T-cells become eliminated by a yet unknown mechanism.
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Basal cell carcinoma tumor subtype is defined by its cell of origin
M Grachtchouk,1 J Pero,1 AN Ermilov,1 LE Michael,1 D Wilbert,1 S Lim1 and AA Dlugosz1,2 1
Dermatology, University of Michigan, Ann Arbor, MI and 2 Cell & Developmental Biology,
University of Michigan, Ann Arbor, MI
Constitutive Hedgehog (Hh) signaling drives the development of basal cell carcinoma (BCC), the
most common cancer in humans, but the cell of origin for BCC is unclear. While Hh pathway dys-
regulation is common to essentially all BCCs there exist several histological subtypes, including
superficial and nodular variants, raising the possibility that morphologically distinct BCCs may
arise from different cellular compartments in skin. We used multiple mouse models to control the
timing and level of oncogenic Hh signaling activity, and most importantly, the particular cell pop-
ulations where Hh signaling was altered. We show that induction of the Hh pathway effector GLI2*,
selectively in stem cells of resting hair follicles, induces nodular BCC development from a small
subset of cells in the lower bulge and secondary hair germ compartments. Acute induction of
GLI2* activates proliferation in quiescent stem cells of the upper bulge as well, but cells in this
compartment activate a cell death program and are resistant to neoplastic transformation. Tumori-
genesis is markedly accelerated in growing hair follicles, and nodular BCC-like tumors can arise
directly from the follicle outer root when GLI2* is activated in mature follicles. In contrast, focal
activation of GLI2* in epidermis leads to the formation of superficial BCCs. Expression of GLI2* at
reduced levels yields tumors resembling basaloid follicular hamartomas, which have previously
been linked to low-level Hh signaling both in mice and humans. Our data show that the cell of ori-
gin, tissue context (quiescent versus growing hair follicles), and level of oncogenic signaling deter-
mine the phenotype of Hh/Gli-driven skin tumors, with high-level signaling required for develop-
ment of superficial BCC-like tumors from interfollicular epidermis and nodular BCC-like tumors
from hair follicle stem cells and their progeny.
171
MtDNA mutations alter intracellular ROS levels in fibroblasts resulting in cellular hyperpro-
liferation
J Jandova,1,2,3 J Janda1,2,3 and JE Sligh1,2,3 1 Southern Arizona VA Healthcare System, Tucson, AZ,
2 Arizona Cancer Center, Tucson, AZ and 3 University of Arizona, Tucson, AZ
We modeled mitochondrial dysfunction in fibroblasts by creating identical murine fibroblast (mtB6
and mtBALB) cybrid lines that differ only in their mtDNA haplotype. The mtBALB cybrids have sig-
nificantly increased proliferation over the mtB6 cybrids when grown in galactose, a result that mir-
rors what is seen in glucose medium. We theorized that the hyperproliferative activity of the mtBALB
cybrids compared to the mtB6 could be explained by an increased level of reactive oxygen species
(ROS). The hyperproliferative mtBALB cells revealed significantly higher levels of ROS compared to
B6 cybrids. We treated the cybrid cells with the antioxidant compounds N-acetyl-L-cysteine (NAC)
or vitamin E (vit E) to determine if scavenging ROS would diminish their proliferative capabilities.
The addition of NAC selectively reduced the proliferative capacity of the mtBALB cybrids while hav-
ing no significant antiproliferative effect on the mtB6 cybrids. Vit E caused a greater reduction in
proliferation of the cybrids than did NAC, and the effect was not selective as was seen with NAC as
the reduction in proliferation was significant for both mtBALB and mtB6 cybrids compared to their
untreated controls. We explored whether a 7 d pre-treatment with NAC in medium with either glu-
cose or galactose has the same or even more profound effect on growing ability of cybrids. We
observed that NAC did selectively slow down the growth of the mtBALB cybrids but had no signif-
icant antiproliferative effect on the mtB6 cybrids when growing in glucose or galactose. The ability
of NAC to selectively inhibit the proliferation of mtBALB over mtB6 cybrids (an effect not seen by
vit E) may reflect the differences in oxygen scavenging activity of the two compounds for specific
radicals. Obtained data support a role of ROS as specific second messengers in signaling cascades
involved in cell proliferation and differentiation.
173
Phosphatidylinositol 3-kinase enhancer is required for the proliferative action of epidermal
growth factor in squamous cell carcinoma cells
Z Xie,1 Y Jiang,2 E Liao,2 Y Chen3 and S Pennypacker1 1 Endocrine Unit, Veterans Affairs Medical
Center, Northern California Institute for Research and Education and University of California,
San Francisco, CA, 2 The Second Xiang-Ya Hospital, Central South University, Changsha,
China and 3 Institute of Chinese Materia Medica, China Academy of Chinese Medical
Sciences, Beijing, China
One of the key drivers for squamous cell carcinoma (SCC) proliferation is activation of the epider-
mal growth factor receptor (EGFR). However, the mechanism by which activated-EGFR mediates
SCC proliferation remains unclear. Our previous studies indicate that epidermal growth factor (EGF)-
induced SCC cell proliferation requires the SH3 domain of phospholipase C-γ1 (PLC-γ1) but not
PLC-γ1 catalytic activity. In the present study, we found that phosphatidylinositol 3-kinase enhancer
(PIKE), a key downstream effector of the SH3 domain of PLC-γ1, is highly expressed in human SCC
cell lines (SCC4 and SCC12B2) but at a very low level in normal human keratinocytes. Immuno-
histochemical analysis showed strong nuclear staining of PIKE in human skin and tongue SCC
specimens but little staining in the adjacent normal squamous epithelium. Treatment of SCC4 and
SCC12B2 cells with EGF induced binding of PIKE to PLC-γ1 and PI3K in the nucleus. Knockdown
of PIKE blocked EGF-induced activation of phosphatidylinositol 3-kinase (PI3K) and protein kinase
C-ζ (PKC-ζ)and phosphorylation of nucleolin in the nucleus as well as SCC cell proliferation. Knock-
down of PLC-γ1 had the same effect as PIKE knockdown. However, inhibition of the catalytic activ-
ity of PLC-γ1 had little effect on EGF-induced activation of PI3K and PKC-ζ and phosphorylation of
nucleolin in the nucleus and proliferation of SCC4 cells. These data suggest that EGF-induced SCC
cell proliferation is mediated through a PLC-γ1/PIKE dependent pathway.
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Disruption of lipid rafts induces EGFR signaling in hair follicle cells and in cicatricial alope-
cia
AA Lattif,1 SP Panicker,1 T Ganguly,1 MC Consolo1 and P Karnik1,2 1 Dermatology, Case Western
Reserve University, Cleveland, OH and 2 Univ Hosp Case Med Ctr, Cleveland, OH
Primary Cicatricial Alopecia (PCA) is a group of poorly understood inflammatory hair diseases that
cause scarring and permanent hair loss. Gene expression profiling of lymphocytic and neutrophilic
PCA showed that post-squalene cholesterol biosynthesis is significantly decreased. One of the con-
sequences of decreased cholesterol biosynthesis in PCA could be the disruption of cell membrane
lipid rafts. Lipid rafts are cholesterol rich signaling platforms on cell membranes that regulate the
activity of membrane receptors. In the current study, we investigated the role of lipid rafts in mouse
hair follicles and in PCA. The cholesterol biosynthesis inhibitor BM15766 inhibits the enzymes
DHCR7 and EBP and causes the accumulation of sterol intermediates lathosterol, desmosterol and
7-dehydrocholesterol (7-DHC). To investigate the in vivo effects of sterol intermediates on the hair
follicle, we treated mouse skin with BM15766 or with 7-DHC. Staining of mouse skin with the cho-
lesterol-binding fluorescent dye, Filipin, showed intense staining in regions with high cholesterol
content in the plasma membrane. In stark contrast, mouse skin treated with BM15766 or with 7-
DHC showed loss of lipid raft staining. Intriguingly, hair follicles of BM15766 or 7-DHC treated
mice were arrested in telogen and failed to re-grow. This suggests that disruption of lipid rafts caused
by inhibition of cholesterol biosynthesis alters the activity of membrane proteins that affect hair
growth. Ingenuity Pathways Analysis revealed that Epidermal Growth Factor Receptor (EGFR), a lipid
raft protein, is consistently up-regulated in PCA. EGFR over-expression is reported to cause hair loss
and epidermal thickening. Real-time PCR analysis demonstrated that the expression of EGFR is sig-
nificantly up-regulated in mouse skin painted with sterol intermediates of cholesterol biosynthesis.
Our data suggests that lipid rafts and their associated signaling pathways play an important role in
hair follicle growth and in the pathogenesis of PCA.
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Blockade of mTOR-dependent phosphorylation of Sirtuin 1 prevents escape from premature
senescence
AL Kim, J Back, Y Zhu and DR Bickers Dermatology, Columbia University Medical Center, New
York, NY
Induction of premature senescence is a recognized strategy for permanent cellular growth-arrest.
Cancer cells become senescent following exposure to sub-lethal doses of DNA-damaging chemother-
apeutic drugs, thus providing a potentially novel approach for controlling tumor growth. Paradox-
ically, it is known that prematurely senescent cancer cells may be resistant to chemotherapeutic
agents thereby permitting tumor recurrence. Furthermore, since prematurely senescent tumor cells
can escape growth arrest and re-enter the cell cycle, it is essential to identify the mechanisms that
sustain cell survival under these conditions. Here, we show that treatment of A431 human squa-
mous cell carcinoma (SCC) cells with either the plant polyphenol resveratrol (RES) or the anthra-
cycline antibiotic doxorubicin (DOX) induced DNA-damage-dependent, p53-independent prema-
ture senescence which involved the nuclear translocation of mTOR Complex 1 (mTORC1), followed
by the mTOR-dependent inhibitory phosphorylation of Sirtuin 1 (SIRT1) at S47. This led to upregu-
lation of the anti-apoptotic factor Bfl-1/A1 via increased acetylation of the p65RelA subunit of NF-
κB. The physical interaction between the mTORC1 and a TOR signaling (TOS) motif in the SIRT1
protein was absolutely essential for SIRT1 S47 inhibitory phosphorylation. Creation of a mutant
SIRT1 containing a single amino acid substitution in the TOS motif (F474A) rendered it incapable
of forming a complex with mTOR, thereby preventing S47 phosphorylation, as determined by in
vitro mTOR-dependent kinase assay. Furthermore, overexpression of either F474A SIRT1 or S47A
SIRT1 mutant proteins in SCC cells blocked RES/DOX-induced Bfl-1/A1 expression, and sensitized
cells for apoptosis. RES/DOX-induced premature senescent SCC cells eventually escaped growth
arrest. Inhibition of mTOR by treatment with rapamycin blocked regrowth of senescent SCC cells.
Our results indicate that mTOR directly regulates SIRT1’s activity and that targeting mTOR/SIRT1
signaling might be an effective treatment to prevent regrowth/escape from premature senescence.
174
MAGE-C2 promotes tumor growth, DNA damage repair, and phosphorylation of KAP-1
N Bhatia, S Thiyagarajan, TZ Xiao, MR Albertini and JB Longley University of Wisconsin,
Madison, WI
Melanoma associated antigens (MAGE)/cancer testes antigens (CT antigens) are a rational thera-
peutic target because they are expressed in melanoma and other cancers but not in normal somatic
cells. Clinical, in vitro, and in vivo studies associate MAGE expression with aggressive tumor growth,
poor clinical outcome and resistance to chemotherapy but neither a causal link nor a mechanism
for these associations is fully established. To investigate these relationships, we transduced MAGE-
C2 (+) A375 cells and low passage primary melanoma cell lines with lentiviral encoded inducible
shRNA targeting MAGE-C2. Down-regulation of MAGE-C2 reduced cell growth and induced apop-
tosis, and reduced growth of melanoma cells xenografted into nude mice, compared to the same
cells induced to express scrambled shRNA. MAGE-C2 knockdown also increased tumor cell death
caused by doxorubicin, a DNA damaging agent. We have previously shown that MAGE-C2 binds
to KAP-1, a multifunctional scaffolding protein central to maintenance of chromatin structure and
gene suppression. Phosphorylation of KAP-1 on ser824 by ATM kinase is necessary for the cellular
response to DNA damage, and we found that down-regulation of MAGE-C2 reduced, and over-
expression of MAGE-C2 increased, KAP-1 ser824 phosphorylation by ATM kinase. Furthermore,
KAP-1 expression increased repair of specific DNA double strand breaks in a DNA damage repair
assay. Our results suggest MAGE-C2 expression contributes to tumor cell survival by promoting
repair of damaged DNA and that suppression of MAGE in MAGE (+) tumors may increase the effect
of DNA damaging agents, providing a novel treatment approach for melanomas and other MAGE
(+) tumors.
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Biophotometric analysis reveals that self-perpetuating focal areas of hyperemia invariably
precede cutaneous neoplasia and are suppressed by topical celecoxib treatment
RL Konger,1 RP Sahu,1 Z Xu2 and YL Kim2 1 Pathology, Indiana University School of Medicine,
Indianapolis, IN and 2 Biomedical Engineering, Purdue University, West Lafayette, IN
Biophotometric imaging combined with spectroscopic analysis and back-directional gating has been
utilized to show that hyperemia is a feature of not only neoplastic lesions but is also present in oth-
erwise normal epithelium in the surrounding tissue field. We utilized this methodology in mouse
models of chemical and photocarcinogenesis to show that hyperemia invariably precedes the appear-
ance of grossly visible tumors. While all tumors developed in areas of high Hgb content, not all
hyperemic areas developed tumors: The probability for future tumor occurrence was 80-90% in
both models using a cutoff for Hgb content > 1.7-1.75 mg/ml. In the UVB studies, mice were irra-
diated for 10 weeks with 2240 J/m2 UVB 3 times/week and treated topically with either vehicle (ace-
tone) or celecoxib (500 mcg/0.2 ml) after each UV treatment. UVB treatments were discontinued
at 10 weeks, but the mice continued to receive topical treatments for 30 weeks. Interestingly, focal
areas of high Hgb content continued to increase in size after cessation of the UVB treatments sug-
gesting a self-perpetuating mechanism. Celecoxib treatment reduced tumor occurrence and also
markedly suppressed the formation of areas of high Hgb content (59% suppression of the skin area
with Hgb content > 1.75 mg/ml). At 30 weeks, areas of high and low Hgb content without visible
tumors were assessed histologically. High Hgb content was associated with marked epidermal hyper-
plasia/dermal inflammation and some small low grade papillomas. Areas of low Hgb content showed
modest hyperplasia, no neoplastic lesions and limited inflammatory infiltrates. Celecoxib treatment
had no significant effect on the histology of areas of high Hgb content. Our data suggests that this
imaging approach can be used to identify areas of subclinical or pre-neoplastic disease, to assess
the efficacy of chemopreventive strategies and to identify focal areas resistant to chemopreventive
approaches.
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Combined inhibition of sonic hedgehog (shh) and nuclear factor κB (NFκB) signaling path-
ways in the prevention of basal cell carcinomas (BCCs)
A Arumugam,1 Z Weng,1 L Kopelovich2 and M Athar1 1 Dermatology, University of Alabama at
Birmingham, Birmingham, AL and 2 Division of Cancer Prevention, NCI, Bethesda, MD
BCCs are the most common form of human cancer, affecting 750,000 Americans annually. Solar
ultraviolet B (UVB) is the major etiologic factor for this neoplasm. Aberrant activation of Shh path-
way is involved in the pathogenesis of both sporadic BCCs, and BCCs developed in patients with
the nevoid basal cell carcinoma syndrome. In this study, we tested whether crosstalk between Shh
signaling and NFkB is involved in the pathogenesis of BCCs. For this, we employed cyclopamine
(CP), a plant-derived steroidal alkaloid Shh inhibitor, and sulfasalazine (SZ), an anti-inflammatory
agent known to block NFkB activation. Ptch+/-/SKH-1 mice irradiated with UVB (180 mJ/cm2, twice
a week) were administered sulfasalazine (500 ppm in drinking water, ad libitum) and cyclopamine
(50 mg/kg body weight, twice a week, i.p) alone or in combination for 40 weeks. At this stage mice
receiving SZ, CP, and CP + SZ developed respectively 16%, 67%, and 92% fewer tumors as com-
pared to the UVB (alone) irradiated animals. In addition, microscopic BCCs were reduced by 19%,
82%, and 86%, respectively, by these treatments. RT-PCR and western blot analysis showed that
these treatments diminished the expression of Shh pathway related genes (Gli1, Gli2, Gli3, Ptch1,
and Ptch2) as well as those involved in the cell cycle regulation (cyclin D1, cyclin D2, cyclin D3
and cyclin E) both in residual BCCs and tumor-adjacent skin. In addition, expression of p-p65
NFkB was reduced. Comparison of these treatment groups revealed that the combination of CP +
SZ was the most effective in this regard. Our data show that combinatorial inhibition of Shh and
NFkB signaling pathway is more effective in reducing BCCs than the individual treatments in a pre-
clinical murine model.
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Digital transcriptome subtraction for pathogen sequence detection and gene expression pro-
filing in CTCL
ED Mirvish,1,2 H Feng,2 RG Pomerantz,1 LD Falo,1 Y Chang,2 PS Moore2 and LJ Geskin1 1
Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, PA and 2 Cancer
Virology Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA
Mycosis fungoides (MF) and Sezary syndrome (SS) are the most common forms of cutaneous T-cell
lymphoma (CTCL), a malignancy of skin-homing CD4+ T lymphocytes. Molecular and epidemio-
logic features of CTCL are suggestive of an infectious etiology, but studies to date have failed to yield
consistent results. We analyzed MF and SS tumors using Digital Transcriptome Subtraction (DTS),
an unbiased method for detection of novel and differentially expressed genes. Total RNA was extracted
from the tumors of three MF patients and three SS patients, as well as the CD4+ lymphocytes of
three healthy blood donors. MF, SS, and non-diseased CD4+ cDNA libraries were next constructed
using barcoded oligo(dT) primers, which enabled differentiation of specimen-specific transcripts
after samples were pooled for 454 Titanium platform pyrosequencing. Sequencing yielded approx-
imately 5x10^5 reads for each library. For DTS, reads were quality filtered using the LUCY algo-
rithm, and the resultant high-fidelity dataset was subtracted in silico from human RefSeq sequences.
After completion of DTS, non-subtracted, putatively “non-human” sequences were aligned against
viral genetic databases. In the preliminary analysis, candidate sequences did not align with high
specificity against putative human pathogens. We demonstrate a lack of exogenous transcript using
DTS, provinding providing strong quantitative evidence against the presence of a directly oncogenic
virus in CTCL. In addition, sequenced tumor and control libraries were compared for the purposes
of gene expression profiling, revealing multiple transcripts that are differentially expressed in tumors
versus lymphocyte controls, including zinc finger protein 217 (ZNF217), T-Plastin (PLS3), and
aquaporin 3 (AQP3). Taken together, these results yield novel insights into the pathogenesis and
molecular biology of CTCL.
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Quantitative immunohistochemistry of cutaneous metastatic breast carcinoma
M Elgart,3 C Welsh2 and EV Badiavas1 1 Dermatology, University of Miami, Miami, FL, 2
Hematology-Oncology, University of Miami, Miami, FL and 3 Gulliver School, Miami, FL
Breast carcinoma is the most common primary tumor to metastasize to skin. In this series of ten
cases we identified patterns among metastatic lesions comparing expression of estrogen receptor,
cyclin D1, and Ki-67 by quantitative immunohistochemistry. Routine immunohistochemical stain-
ing studies are limited by the interpretation of presence of absence of staining and non-quantitative
measures. Employment of computer assisted quantitative evaluation of expression as in this study,
allows for numerical interpretation of staining intensity, color, and saturation. Clear association of
the two measures of cell proliferation (cyclin d1 AND Ki-67) was seen in that the expression of the
two markers was generally seen in tandem. However, both markers were inversely present in com-
parison to estrogen receptor staining. These findings suggest that quantitative immunohistochem-
istry reflects consistent measure of breast cancer outcome in the metastatic setting in skin biopsy
samples.
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Somatic alterations in mtDNA trigger changes in CCL20 expression promoting tumorigenic
phenotypes
J Jandova,1,2,3 J Janda1,2,3 and JE Sligh1,2,3 1 Southern Arizona VA Healthcare System, Tucson, AZ,
2 Arizona Cancer Center, Tucson, AZ and 3 University of Arizona, Tucson, AZ
Somatic mitochondrial mutations are common in human cancers and can by used as a tool for
early detection of cancer. We modeled the effects of somatic variation at mt-Tr by harvesting mito-
chondria from brain synaptosomes of B6 and BALB mice and transferring them to a mouse fibrob-
last ρ0 cell line that lacked its own mitochondria. The resulting cybrid cell lines contain the same
nuclear genotype and differ in their mtDNA. Microarray analysis was conducted in order to eluci-
date the expression differences between the two cybrid lines. Agilent 44K mouse whole genome
chip revealed more than 1,000 differentially expressed genes between the two cybrid lines. From
the potential targets we focused on CCL20 which has been reported to promote cancer cell prolif-
eration and migration in vitro. Real-time PCR confirmed up-regulation of CCL20 in mtBALB cybrids
compared to mtB6 cybrids. Based on previously reported role of CCL20 in tumor progression we
examined whether the mtBALB haplotype is associated with higher level of cellular growth, migra-
tion and invasiveness compared to mtB6 haplotype. Our results indicate that the mtBALB cybrids
demonstrate significantly increased proliferation, migration and invasion abilities. Additionally, the
treatment of both cybrid hapltotypes with recombinant mouse CCL20 protein (rmCCL20) resulted
in enhanced proliferation of mtB6 cybrids but had no effect on mtBALB cybrid cells. In migration
transwell assays, mtB6 cybrids were either pretreated with rmCCL20 or rmCCL20 was added to the
bottom well as a chemo-attractant. The results showed that mtB6 cybrid cells pretreated with rmCCL20
have a statistically significant increase in migration compared to untreated mtB6 controls. In addi-
tion, when rmCCL20 was added as a chemoattractant there was even more profound effect on migra-
tion of mtB6 cybrids almost to the level of mtBALB cybrids. These studies reveal a role for CCL20
in potential tumorigenic behavior of mtBALB cybrids associated with their ability to hyperprolifer-
ate, migrate and invade.
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Disease stage-related decreases in distinct superantigen-related T cell receptor-Vβs in cuta-
neous T-cell lymphoma
RG Pomerantz, ED Mirvish, TJ Patton, LD Falo and LJ Geskin Department of Dermatology,
University of Pittsburgh School of Medicine, Pittsburgh, PA
The objective of this study was to evaluate the T cell receptor-Vβ (TCR-Vβ; Vβ) repertoire in patients
with Mycosis Fungoides (MF) and Sezary Syndrome (SS) variants of cutaneous T cell lymphoma
(CTCL) across all stages, in order to identify relationships between Vβ expression levels and disease
stage. Blood was drawn from MF/SS patients (n=31), the percentage of CD4+ T cells expressing each
Vβ was determined by multiparameter flow cytometery, and the change in expression levels with
progressive disease stage was calculated with Spearman’s rank correlation coefficients. In agree-
ment with prior reports, we found that individual TCR-Vβ families were expanded in some patients
with advanced MF/SS. Surprisingly, when we scrutinized TCR-Vβ families by individual stages, our
statistical analysis revealed significant decreases in the proportions of five distinct TCR-Vβs with
progressive stages of disease, while the proportion of all other tested TCR-Vβ families did not change
with disease stage. These data show disease stage-related changes in the expression of certain TCR-
Vβs known to be activated by viral superantigens. In particular, there was a highly significant decrease
in expression of TCR-Vβ13, which has been found to be activated by an EBV-associated superanti-
gen, in advanced CTCL. Based on these findings, we theorize that in early stages of CTCL, viral
infection may play a role in the expansion of specific superantigen-associated T-cells; while in later
stages, these same T-cells become eliminated by a yet unknown mechanism.
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Ectodomain shedding of LYVE-1 in psoriasis: VEGF-A induces the biochemical cleavage in
lymphatic vessels
S Hirakawa,1 H Nishida-Fukuda,2 R Araki,3 X Dai,3 Y Hanakawa,3 K Sayama,3 Y Shirakata,3
M Tohyama,3 M Detmar,4 K Hashimoto,3 S Higashiyama2 and Y Tokura1 1 Dermatology,
Hamamatsu University School of Medicine, Hamamatsu, Japan, 2 Cell Growth and Tumor
Regulation, Ehime Proteo-Medicine Research Center, Ehime University, Toon, Japan, 3
Dermatology, Ehime University Graduate School of Medicine, Toon, Japan and 4 Institute of
Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland
Psoriasis is a chronic inflammatory skin disease with pronounced angiogenesis and lymphangio-
genesis. We have previously shown that targeted overexpression of VEGF-A in mice results in chronic
skin alterations resembling psoriasis. Furthermore, VEGF-A transgenic mice revealed pronounced
lymphangiogenesis in the skin, indicating that VEGF-A might induce lymphangiogenesis as well as
angiogenesis. However, it remains unclear whether VEGF-A modulates the expression and kinetics
of lymphatic vessel-specific molecules such as lymphatic vessel endothelial hyaluronan receptor
(LYVE)-1. In the present study, we identified that VEGF-A induces the ectodomain shedding of
LYVE-1 in cultured human lymphatic endothelial cells (LECs). LECs were subjected to an analysis
of ectopic expression of wild-type or a mutated form of LYVE-1 in the extracellular domain using
an adenoviral system. Wild-type, but not the mutated form, of LYVE-1 underwent proteolytic cleav-
age in the presence of VEGF-A. Furthermore, Western blot analyses showed that LYVE-1 shedding
is mediated through the activation of VEGFR-2 and ERK in cultured LECs. Moreover, siRNA tech-
nique identified ADAM17 as a responsible MMP for the LYVE-1 shedding in lymphatic endothe-
lium. Importantly, double immunofluorescence stains for the N- and C-terminus of LYVE-1 in pso-
riatic lesions showed distinct patterns of localization in lymphatic vessels even though these stains
are completely merged in normal lymphatic vessels. Together, these results indicate, for the first
time, that LYVE-1 undergoes ectodomain shedding in vivo and in vitro, and suggest that the bio-
chemical product of LYVE-1 may contribute to the pathogenesis of psoriasis.
183
Characterizing the collagenolytic activity of rHuCathepsin L and rHuMMP1 for the devel-
opment of potential treatments of fibrotic skin conditions
RD Paladini, G Wei, A Kundu, Q Zhao, P Selvam, H Shepard, GI Frost and GA Keller Halozyme
Therapeutics Inc., San Diego, CA
Fibroblast/myofibroblast activation and proliferation result in the disordered and exaggerated extra-
cellular matrix deposition of collagen that can lead to a host of diseases with high unmet clinical
need such as Dupuytren’s contracture, Peyronie’s disease, localized scleroderma, keloids and hyper-
trophic scarring. Fibrotic tissue consists of predominantly type III collagen in the early stages and
type I collagen as the disease progresses. In an effort to develop an anti-fibrotic therapy that directly
targets extracellular matrix collagen deposition, we have characterized the collagenolytic ability of
two recombinant human proteins, Cathepsin L (rHuCat L) and matrix metalloproteinase 1 (MMP1),
in various in vitro and in vivo assays. rHuCat L is a 26 kDa glycosylated cysteine protease that is
active at acidic but not physiological pH. MMP1 is, upon activation, a 43 kDa zinc dependent
endopeptidase that is active at physiological pH. Both rHuCat L at acidic pH, and MMP1 at phys-
iological pH, were able to digest soluble rat collagen I in vitro. When injected intradermally in
Zucker rat ventral skin, rHuCat L and MMP1 degraded interstitial collagen and disrupted the nor-
mal skin architecture as determined by histological analysis. In addition, Western blot analysis
revealed degraded collagen I in perfusates from the treated skin. Collagenolytic activity was not lim-
ited to the rat since collagen I from human cadaver thigh skin and biopsied keloids was degraded
when treated with rHuCat L and MMP1 as determined by histological analysis. Taken together, these
data suggest that the use of rHuCat L and/or rHuMMP1 may be an effective therapy for the treat-
ment of fibrotic skin conditions characterized by excessive collagen deposition.
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Implication of dermatopontin and decorin in dermal fibers organization and preservation
from UV stress
L Mur,1 C Plaza,1 G Menon,2 J Botto,1 C Dal Farra1 and N Domloge1 1 Global Skin Research
Center, ISP Vincience, Sophia Antipolis, France and 2 Corporate Research Center, ISP, Wayne,
NJ
The dermal extracellular matrix (ECM) sustains the skin histoarchitecture, providing fibroblasts with
a substratum for adhesion and migration and allowing biological information exchange. Dermato-
pontin (or Tyrosine-Rich Acidic extracellular Matrix Protein, TRAMP) is a 22 kDa sulfated protein
which plays an important role in matrix assembly and cell-matrix interactions, mediating cell adhe-
sion via surface integrin binding. Dermatopontin accelerates and organizes dermal collagen fibril-
logenesis, and together with Decorin, a leucin-rich proteoglycan, contributes to the fibril stability
and interfibril interactions, particularly of collagen I, and interacts with extracellular adhesive mol-
ecules such as fibronectin. In this study, we investigated the role of dermatopontin in the develop-
ment of collagen fibers in the human dermis, using IV09.002, a compound designed to regulate
dermatopontin and associated proteins expression. We evaluated the effect of IV09.002 on fiber
organization and biosynthesis level of several ECM proteins (dermatopontin, decorin, pro-colla-
gen, collagen I, fibronectin…) by immunofluorescence, both in ex vivo skin and in cultured fibrob-
lasts. We also investigated protein tyrosine-sulfation profile. In order to assess the preservation of
elastic and collagen fibers organization when skin was submitted to UV irradiation, we performed
Elastica Van Gieson and of Masson’s Trichrome stains. This study revealed a beneficial effect of
IV09.002 on these fibers against UV damage. These observations were confirmed by ultrastructural
electron microscopy studies. In conclusion, the modulation of the expression of Dermatopontin and
associated proteins could exert a beneficial role on the expression and maturation/organization of
dermal fibers, which could in turn preserve the natural skin elasticity.
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Bacterial challenge on percutaneous implants
G Zhao,1 M Usui,1 R Underwood,1 M Andrew,2 J Olerud1 and P Fleckman1 1 Dept. of
Medicine/Div. of Dermatology, University of Washington, Seattle, WA and 2 Healionics,
Seattle, WA
Percutaneous devices are critical for medical care, but are associated with significant risk of infec-
tions costing over 1 billion dollars annually. In current animal models subcutaneous biomaterials
are inoculated with bacteria either before implantation or through peri-implant dermal injection.
In this study, we describe an animal model that more closely mimics the route of clinical infection
by inoculating the percutaneous biomaterial at the biomaterial/skin interface, the natural clinical
portal for infection. Cylindrical rods made of solid silicone, porous silicone, solid poly(2-hydrox-
yethyl methacrylate) (polyHEMA), or porous polyHEMA, were implanted percutaneously on the
back of C57BL/6 mice. Immediately after rod insertion, the skin surrounding the implantation site
was directly challenged with 107cfu Staphylococcus aureus as biofilm grown on polycarbonate fil-
ters. Implants were examined at 2, 7 and 28 days. Results showed that a human clinical S. aureus
strain resulted in greater severity of infection than a mouse S. aureus strain. S. aureus challenge
resulted in erythema, an elevated inflammatory response, skin erosion and occasional abscess for-
mation around the implants. Quantification assays showed the amount of S. aureus on the skin grad-
ually decreased over time (approximately 107, 106 and 105cfu at 2, 7 and 28 days respectively),
while the amount of bacteria around the implant at insertion sites remained at 107. Bacterial inva-
sion proceeded quickly. The middle region of the implants showed 104-105 bacteria throughout all
time points. The results confirmed that bacterial challenge at the implantation site leads to infec-
tion, which validates the clinical rationale for stringently eliminating skin flora before catheter inser-
tion to significantly reduce infection. This bacterial challenge mouse model can be used to evalu-
ate the cutaneous response to bacterial challenge of percutaneous biomaterial implantation.
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Desmosomal cadherins utilize distinct mechanism for assembly into desmosomes
O Nekrasova,1 E Amargo1 and KJ Green1,2 1 Department of Pathology, Northwestern University
Feinberg School of Medicine, Chicago, IL and 2 Department of Dermathology, Northwestern
University Feinberg School of Medicine, Chicago, IL
Desmosomes are intercellular junctions that provide strong adhesion between cells, mediated by
two types of cadherin: desmogleins, Dsg and desmocollins, Dsc . While the importance of desmo-
somal cadherins for maintaining the structural and functional integrity of epidermis has been well
established, the molecular machinery responsible for their trafficking from a vesicular compart-
ment to intercellular junctions remains poorly understood. Using live cell imaging we show that
both types of desmosomal cadherins exhibit long range microtubule-dependent trafficking in epithe-
lial cells. As kinesin-1 antibody co-localized with Dsg2-containing vesicles, si/shRNA constructs
were used to knock-down the kinesin-1 heavy chain (KHC) in keratinocytes, followed by exami-
nation of Dsg2 dynamics. Fluorescence intensity measurements revealed that Dsg2 at cell-cell inter-
faces of KHC-deficient cells was less then 50% reduced compared to control cells. Further, Dsg2
vesicle movement was largely blocked in cells expressing the shRNA of kinesin-1 without affecting
the movement of Dsc2. On the other hand, the inhibition of kinesin-2 function, using a dominant
negative construct against KIF3A (one of the motor domains of kinesin-2) or siRNA knock-down of
KAP3 (intermediate chain of kinesin-2) completely blocked intracellular movement of Dsc2 and
decreased its expression on the plasma membrane without affecting Dsg2 trafficking. Thus, the
temporal and spatial coordination of Dsg2 and Dsc2 assembly into intercellular junctions is con-
trolled by distinct mechanisms involving independent kinesin motors. These data suggest a mech-
anism by which differential regulation of desmosomal cadherin transport could alter Dsg:Dsc sto-
ichiometry and adhesion during tissue homeostasis and remodeling, and contribute broadly to
pathogenesis of desmosome-related diseases of the epidermis.
186
Differential effects of glucocorticoid treatment on inflammatory changes of cutaneous lym-
phatic and blood vessels
R Huggenberger, K Messmer, SS Siddiqui, MM Schulz and M Detmar Institute of Pharmaceutical
Sciences, Swiss Federal Institute of Technology, ETH Zurich, Zurich, Switzerland
Psoriasis is characterized by extensive remodeling of blood and lymphatic vessels. Although the
blood vasculature normalizes after resolution of inflammation, the extent of reversibility of lym-
phatic vessel changes in cutaneous inflammation is unclear. Lymphatic vessels contribute to the reg-
ulation of immune responses through their role in antigen transport and leukocyte migration to drain-
ing lymph nodes, and they drain edematous tissue fluid, inflammatory cells, and cytokines from
inflamed skin. We investigated the effects of betamethasone treatment on lymphatic endothelial cell
(LEC) proliferation, migration, and sprouting in vitro and on the vasculature in the oxazolone-induced
hemizygous K14-VEGF-A Tg mouse model of chronic skin inflammation in vivo. Our results indi-
cate that LECs express the glucocorticoid receptor, and that the incubation of LECs with betametha-
sone results in a dose-dependent increase in proliferation and migration but potently inhibits sprout
formation in vitro. Topical application of betamethasone, initiated at the chronic phase of oxazolone-
induced skin inflammation in hemizygous K14-VEGF-A Tg mice, reversed lymphatic but not blood
vessel remodeling after 7 days of treatment, despite complete resolution of edema and inflamma-
tion. Interestingly, the expression of the lymphangiogenic growth factor VEGF-C and its lymphatic-
specific receptor VEGFR-3 were significantly increased upon betamethasone treatment in mice.
Unexpectedly, lymphatic vessel enlargement persisted in human psoriasis after 4-weeks of treat-
ment, whereas the blood vasculature normalized, and inflammation resolved. These findings indi-
cate that the potent anti-inflammatory glucocorticoids might directly modulate the lymphatic endothe-
lium. Thus, specific effects of glucocorticoids on lymphatics might help resolving skin inflammation.
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Disease-specific spectrum of mutations in TGFBR1 causing multiple self-healing squamous
epithelioma (Ferguson-Smith disease)
D Goudie,1 M D’Alessandro,2 B Merriman,3 H Lee,3 I Szeverenyi,4 S Avery,4 B O’Connor,3
S Nelson,3 S Coats,1 A Stewart,1 L Christie,1 G Pichert,5 J Friedel,6 I Hayes,7 N Burrows,8
S Whittaker,9 A Gerdes,10,11 S Broesby-Olsen,11 MA Ferguson-Smith,12 C Verma,13 DP Lunny,4
B Reversade4 and B Lane1,4 1 College of Medicine, Dentistry & Nursing, University of Dundee,
Dundee, United Kingdom, 2 College of Life Sciences, University of Dundee, Dundee, United
Kingdom, 3 Dept of Human Genetics, David Geffen School of Medicine at UCLA, Los
Angeles, CA, 4 Institute of Medical Biology, Singapore, Singapore, 5 Clinical Genetics, Guy’s
& St Thomas’ NHS Trust, London, United Kingdom, 6 CH William-Morey, Chalon-sur-Saône,
France, 7 Auckland City Hospital, Auckland, New Zealand, 8 Dept of Dermatology,
Addenbrookes Hospital, Cambridge, United Kingdom, 9 St. John’s Institute of Dermatology,
Guys and St Thomas NHS Foundation Trust, London, United Kingdom, 10 Dept of Clinical
Genetics, Rigshospitalet, Copenhagen, Denmark, 11 Odense University Hospital, Odense,
Denmark, 12 Resource Centre for Comparative Genomics, Cambridge University, Cambridge,
United Kingdom and 13 Bioinformatics Institute, Singapore, Singapore
We have ascertained that the elusive genetic defect causing the rare skin cancer condition, multi-
ple self-healing squamous epithelioma (MSSE, or Ferguson-Smith disease (FSD)), is attributable to
defects in the TGFβ-R1 receptor. MSSE/FSD is an autosomal dominant genetic disorder that pres-
ents as multiple locally invasive tumours that grow for a few weeks and then regress spontaneously.
Independent TGFBR1 mutations were initially found in 3 unrelated families by high-throughput
genomic sequencing using exon array capture over a 24.2 Mb region on chromosome 9, extend-
ing beyond the disease locus predicted by linkage analysis. Sanger sequencing then identified 11
distinct TGFBR1 mutations in 18 MSSE/FSD families, confirming TGFBR1 as the causative gene for
MSSE/FSD. These mutations include the first-reported mutations in the TGFβR1 extracellular TGFβ-
ligand-binding domain plus truncating mutations in its kinase domain. The nature of the mutations
points specifically to loss of function of TGFBR1 in MSSE/FSD. This distinguishes it from Marfan
syndrome-related disorders, in which missense mutations in the same gene lead to widespread vas-
cular defects, but no increased cancer incidence.
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The DSPII splice variant is critical for desmosome-mediated HaCaT keratinocyte adhesion
RM Cabral,1 D Tattersall,1 V Patel,1 E Hatzimasoura,1 DJ Abrams,2 AP South3 and DP Kelsell1 1
Centre for Cutaneous Research, Blizard Institute of Cell and Molecular Science, Barts & The
London School of Medicine and Dentistry, Queen Mary University of London, London, United
Kingdom, 2 Cardiology Research Department, Barts and The London NHS Trust, St
Bartholomew’s Hospital, Queen Mary, University of London, London, United Kingdom and 3
Centre for Oncology & Molecular Medicine, University of Dundee, Ninewells Hospital &
Medical School, Dundee, United Kingdom
Desmosomes are intercellular junctions specialised for strong adhesion, prominent in the epider-
mis and heart. Defective desmosomes due to inherited mutations in the constitutive desmosomal
gene desmoplakin (DSP) cause skin or heart disorders and in some instances both. Different muta-
tions have different disease-causing molecular mechanisms as evidenced by the varying phenotypes
resulting from mutations affecting different domains of DSP, however the majority of these mecha-
nisms remain to be determined. We studied two DSP mutations which lead to different dosages of
the two major isoforms, DSPI and DSPII, and compared their molecular mechanisms. One of the
mutations results in total DSP haploinsufficiency and is associated with autosomal dominant stri-
ate palmoplantar keratoderma (PPK). The other leads to complete absence of DSPI and the minor
isoform DSPIa but normal levels of DSPII, and is associated with recessive PPK, woolly hair and
severe cardiomyopathy. Using siRNA and two adhesion assays we found striking differences between
DSP isoforms with respect to HaCaT keratinocyte adhesion upon cellular stress with DSPII being
the key component in intermediate filament stability and desmosomal adhesion. In addition, reduc-
tion in DSP expression reduced the amount of plakophilin 1, desmocollin (DSC) 2 and DSC3 with
DSPI having a greater influence than DSPII on the expression levels of DSC3. These results suggest
that the two major DSP splice variants are not completely redundant in function and that DSPII
dosage is particularly important for desmosomal adhesion in the skin.
177
Regulation of PDGF receptor β signaling in pericytes by MFG-E8
S Motegi,1 S Garfield2 and MC Udey1 1 Dermatology Branch, Center for Cancer Research,
National Cancer Institute, NIH, Bethesda, MD and 2 Laboratory of Experimental
Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD
PDGF:PDGF receptor β (PDGFRβ) signaling regulates pericyte function during neoangiogenesis.
We have determined that pericytes are important sources of MFG-E8 (lactadherin, SED1) in vivo,
and that this αvβ3 ligand enhances pathologic angiogenesis in tumors and oxygen-induced retinopa-
thy in mice. We hypothesized that pericyte-derived MFG-E8 might influence pericytes as well as
endothelial cells. Prior studies demonstrated that inhibition of MFG-E8 production by pericyte-like
10T1/2 cells using siRNAs and shRNAs, or some anti-MFG-E8 Ab, attenuated PDGF induced peri-
cyte migration in vitro. We are now exploring mechanisms by which MFG-E8 might modulate
PDGF:PDGFRβ signaling in pericytes. Depletion of MFG-E8 from 10T1/2 cells using siRNAs enhanced
PDGF-dependent degradation of PDGFRβ and attenuated PDGFR signaling as manifested by
decreased PDGFRβ tyrosine phosphorylation. Co-immunoprecipitation experiments revealed tran-
sient association of MFG-E8 with PDGFRβ in PDGF-treated 10T1/2 cells. Laser scanning confocal
immunoflorescence microscopy demonstrated that MFG-E8-Ig fusion proteins bound to 10T1/2 cells
via the RGD motif in the E2 domain in the presence or absence of exogenous PDGF, while co-
localization of endogenous MFG-E8 with PDGFRβwas ligand-dependent, and confirmed that PDGF-
induced degradation of PDGFRβ in MFG-E8 siRNA treated cells was enhanced compared with that
in control cells. Ubiquitination of PDGFRβ in MFG-E8 siRNA transfected cells was also significantly
increased, consistent with enhanced degradation. These results suggest that MFG-E8 promotes the
association of αv integrins and PDGFRβ after PDGF treatment, prolongs expression of PDGFRβ on
cell surfaces and delays degradation of PDGFRβ, thus potentiating downstream signaling and enhanc-
ing pericyte function. We conclude that pericyte-derived MFG-E8 promotes pathologic angiogen-
esis, at least in part, via cell autonomous actions on pericytes that result from modulation of
PDGF:PDGF receptor β signaling.
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Matrix metalloproteinase-8 is involved in dermal nerve growth: Implications for possible appli-
cation to pruritus from in vitro models
M Tominaga1,2 and K Takamori1,2 1 Institute for Environmental and Gender Specific Medicine,
Juntendo University Graduate School of Medicine, Urayasu, Japan and 2 Department of
Dermatology, Juntendo University Urayasu Hospital, Urayasu, Japan
Cutaneous nerve density is related to abnormal itch perception in dermatoses, such as atopic der-
matitis and xerosis. However, the elongation mechanisms of dermal nerve fibers within interstitial
collagen matrix are poorly understood. Here, a culture system of rat dorsal root ganglion neurons
consisting of type I collagen and a Boyden chamber containing a nerve growth factor (NGF) con-
centration gradient was used. Nerve fibers penetrating into type I collagen gel were observed in the
presence of the NGF concentration gradient. Transcripts for matrix metalloproteinase-8 (MMP-8)
were significantly increased in the cultured neurons, and the nerve fiber penetration was dose-
dependently inhibited by MMP-8 blockers. Moreover, MMP-8 immunoreactivity was partially local-
ized at growth cones in NGF-responsive nerve fibers. Semaphorin 3A stimulation also showed the
opposite effects on these NGF-dependent events. Intriguingly, MMP-8 expression was upregulated
by type I and III collagens, which are substrates for this enzyme. These results suggested that MMP-
8 is involved in sensory nerve growth within interstitial collagen matrix through modulation by
axonal guidance molecules and/or extracellular matrix components. This finding may provide insight
to understand the development of pruritus involving skin nerve density.
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Establishment of the Matrigel plug assay in domestic pig skin to investigate intra-dermal angio-
genesis
JG Meingassner, M Pillinger, H Fahrngruber, E Kowalsky and A Stuetz Novartis Institutes for
BioMedical Research, Vienna, Austria
Angiogenesis is a pathologic feature in chronic skin inflammation, such as psoriasis. An experi-
mental method to study proliferation of small vessels is the investigation of neovascularisation of a
subcutaneously injected semi-solid matrix (Matrigel) in mice. A limitation of this assay is the poor
correlation between mouse and human skin, particularly regarding skin penetration properties upon
topical treatment. Here we report on the establishment of the Matrigel plug assay in the dermis of
domestic pigs, the skin of which closely resembles the human situation. Furthermore, the anti-angio-
genic properties of the novel VEGF receptor tyrosine kinase inhibitor NVP-BFH772 in this model
are reported. Intradermal injection of 100μl Matrigel was performed in the lateral thorax/abdomen
of domestic pigs. Animals were sacrificed after three days and 8mm biopsies with the Matrigel plug
in the center were obtained from the injection sites. Biopsies were embedded for subsequent IHC
analysis or dissected to remove the Matrigel plug. Obtained gels were dissolved by incubation in
dispase and resulting cell suspensions were analyzed by flow cytometry for infiltrating cells. Endothe-
lial cells were indentified by CD31 surface expression. Matrigel plugs alone contained infiltrating
cells, of which approximately 50% were identified as endothelial cells. VEGF addition to Matrigel
prior to injection led to a two-fold increase of infiltrating cells with two-thirds being endothelial
cells. Microscopic examination revealed that infiltrating endothelial cells were assembled in regu-
lar vessel structures. Topical application of 0.5% solution of NVP-BFH772 in EtOH/propylene gly-
col (3:7) reduced VEGF stimulated endothelial cell content in Matrigel plugs by 50% after 3 days
of treatment. In conclusion, the Matrigel plug assay in pig dermis may serve as a valuable model to
study intradermal angiogenesis and the therapeutic potential of topically applied anti-angiogenic
compounds.
180
Calcium-induced cell-cell adhesion and differentiation in human epidermal keratinocytes
require Rho-GEF Trio and filamin A
C Tu,1,2 M You1 and DD Bikle1,2 1 Endocrine Unit, VA Medical Center, San Francisco, CA and 2
University of California, San Francisco, CA
The E-cadherin-mediated signaling plays a critical role in promoting cell survival and differentia-
tion in epidermal keratinocytes. Our previous studies indicate that extracellular Ca2+ (Ca2+o)-induced
E-cadherin-mediated cell-cell adhesion and keratinocyte differentiation are regulated by the cal-
cium-sensing receptor (CaR) via Rho A-mediated signaling and these processes require the involve-
ment of filamin A, a cytoskeletal actin-binding scaffolding protein capable of binding to Rho-gua-
nine nucleotide exchange factors (GEF) and Rho-like small GTPases. Trio is a multifunctional
filamin-interacting protein which contains two GEF domains specifically targeting Rac 1 and Rho
A. To investigate the role of Trio and filamin A in keratinocyte cell-cell adhesion and differentiation,
we examined the impact of knockdown of filamin A and Trio on endogenous Rho activity. Raising
Ca2+o concentration from 0.03 to 2 mM rapidly induced association of Rho A to adherens junctions
and increased endogenous Rho activity. Suppressing endogenous filamin A or Trio expression by
small interfering RNA (siRNA)-mediated gene silencing blocked these processes. Knockdown of fil-
amin A and Trio also inhibited the Ca2+o-induced membrane localization and formation of the pro-
tein complex of E-cadherin, β-, γ-, and p120-catenin. Furthermore, pull-down assays using anti-
bodies against CaR and Rho A demonstrated that CaR, Trio, Rho A and E-cadherin form a signaling
complex via filamin A at the cell membrane in response to elevated Ca2+o, suggesting that CaR acti-
vates Rho signaling through direct protein interaction. Finally, filamin A and Trio silencing decreased
the Ca2+o-stimulated protein expression of terminal differentiation markers keratin 1, transglutami-
nase 1, involucrin, loricrin and filaggrin, whereas the expression of basal cell marker keratin 14
was not changed. These results signify an important role for Trio and filamin A in the regulation of
Ca2+o-induced E-cadherin mediated cell-cell adhesion and keratinocyte differentiation.
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Ectodomain shedding of LYVE-1 in psoriasis: VEGF-A induces the biochemical cleavage in
lymphatic vessels
S Hirakawa,1 H Nishida-Fukuda,2 R Araki,3 X Dai,3 Y Hanakawa,3 K Sayama,3 Y Shirakata,3
M Tohyama,3 M Detmar,4 K Hashimoto,3 S Higashiyama2 and Y Tokura1 1 Dermatology,
Hamamatsu University School of Medicine, Hamamatsu, Japan, 2 Cell Growth and Tumor
Regulation, Ehime Proteo-Medicine Research Center, Ehime University, Toon, Japan, 3
Dermatology, Ehime University Graduate School of Medicine, Toon, Japan and 4 Institute of
Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland
Psoriasis is a chronic inflammatory skin disease with pronounced angiogenesis and lymphangio-
genesis. We have previously shown that targeted overexpression of VEGF-A in mice results in chronic
skin alterations resembling psoriasis. Furthermore, VEGF-A transgenic mice revealed pronounced
lymphangiogenesis in the skin, indicating that VEGF-A might induce lymphangiogenesis as well as
angiogenesis. However, it remains unclear whether VEGF-A modulates the expression and kinetics
of lymphatic vessel-specific molecules such as lymphatic vessel endothelial hyaluronan receptor
(LYVE)-1. In the present study, we identified that VEGF-A induces the ectodomain shedding of
LYVE-1 in cultured human lymphatic endothelial cells (LECs). LECs were subjected to an analysis
of ectopic expression of wild-type or a mutated form of LYVE-1 in the extracellular domain using
an adenoviral system. Wild-type, but not the mutated form, of LYVE-1 underwent proteolytic cleav-
age in the presence of VEGF-A. Furthermore, Western blot analyses showed that LYVE-1 shedding
is mediated through the activation of VEGFR-2 and ERK in cultured LECs. Moreover, siRNA tech-
nique identified ADAM17 as a responsible MMP for the LYVE-1 shedding in lymphatic endothe-
lium. Importantly, double immunofluorescence stains for the N- and C-terminus of LYVE-1 in pso-
riatic lesions showed distinct patterns of localization in lymphatic vessels even though these stains
are completely merged in normal lymphatic vessels. Together, these results indicate, for the first
time, that LYVE-1 undergoes ectodomain shedding in vivo and in vitro, and suggest that the bio-
chemical product of LYVE-1 may contribute to the pathogenesis of psoriasis.
183
Characterizing the collagenolytic activity of rHuCathepsin L and rHuMMP1 for the devel-
opment of potential treatments of fibrotic skin conditions
RD Paladini, G Wei, A Kundu, Q Zhao, P Selvam, H Shepard, GI Frost and GA Keller Halozyme
Therapeutics Inc., San Diego, CA
Fibroblast/myofibroblast activation and proliferation result in the disordered and exaggerated extra-
cellular matrix deposition of collagen that can lead to a host of diseases with high unmet clinical
need such as Dupuytren’s contracture, Peyronie’s disease, localized scleroderma, keloids and hyper-
trophic scarring. Fibrotic tissue consists of predominantly type III collagen in the early stages and
type I collagen as the disease progresses. In an effort to develop an anti-fibrotic therapy that directly
targets extracellular matrix collagen deposition, we have characterized the collagenolytic ability of
two recombinant human proteins, Cathepsin L (rHuCat L) and matrix metalloproteinase 1 (MMP1),
in various in vitro and in vivo assays. rHuCat L is a 26 kDa glycosylated cysteine protease that is
active at acidic but not physiological pH. MMP1 is, upon activation, a 43 kDa zinc dependent
endopeptidase that is active at physiological pH. Both rHuCat L at acidic pH, and MMP1 at phys-
iological pH, were able to digest soluble rat collagen I in vitro. When injected intradermally in
Zucker rat ventral skin, rHuCat L and MMP1 degraded interstitial collagen and disrupted the nor-
mal skin architecture as determined by histological analysis. In addition, Western blot analysis
revealed degraded collagen I in perfusates from the treated skin. Collagenolytic activity was not lim-
ited to the rat since collagen I from human cadaver thigh skin and biopsied keloids was degraded
when treated with rHuCat L and MMP1 as determined by histological analysis. Taken together, these
data suggest that the use of rHuCat L and/or rHuMMP1 may be an effective therapy for the treat-
ment of fibrotic skin conditions characterized by excessive collagen deposition.
185
Implication of dermatopontin and decorin in dermal fibers organization and preservation
from UV stress
L Mur,1 C Plaza,1 G Menon,2 J Botto,1 C Dal Farra1 and N Domloge1 1 Global Skin Research
Center, ISP Vincience, Sophia Antipolis, France and 2 Corporate Research Center, ISP, Wayne,
NJ
The dermal extracellular matrix (ECM) sustains the skin histoarchitecture, providing fibroblasts with
a substratum for adhesion and migration and allowing biological information exchange. Dermato-
pontin (or Tyrosine-Rich Acidic extracellular Matrix Protein, TRAMP) is a 22 kDa sulfated protein
which plays an important role in matrix assembly and cell-matrix interactions, mediating cell adhe-
sion via surface integrin binding. Dermatopontin accelerates and organizes dermal collagen fibril-
logenesis, and together with Decorin, a leucin-rich proteoglycan, contributes to the fibril stability
and interfibril interactions, particularly of collagen I, and interacts with extracellular adhesive mol-
ecules such as fibronectin. In this study, we investigated the role of dermatopontin in the develop-
ment of collagen fibers in the human dermis, using IV09.002, a compound designed to regulate
dermatopontin and associated proteins expression. We evaluated the effect of IV09.002 on fiber
organization and biosynthesis level of several ECM proteins (dermatopontin, decorin, pro-colla-
gen, collagen I, fibronectin…) by immunofluorescence, both in ex vivo skin and in cultured fibrob-
lasts. We also investigated protein tyrosine-sulfation profile. In order to assess the preservation of
elastic and collagen fibers organization when skin was submitted to UV irradiation, we performed
Elastica Van Gieson and of Masson’s Trichrome stains. This study revealed a beneficial effect of
IV09.002 on these fibers against UV damage. These observations were confirmed by ultrastructural
electron microscopy studies. In conclusion, the modulation of the expression of Dermatopontin and
associated proteins could exert a beneficial role on the expression and maturation/organization of
dermal fibers, which could in turn preserve the natural skin elasticity.
184
Bacterial challenge on percutaneous implants
G Zhao,1 M Usui,1 R Underwood,1 M Andrew,2 J Olerud1 and P Fleckman1 1 Dept. of
Medicine/Div. of Dermatology, University of Washington, Seattle, WA and 2 Healionics,
Seattle, WA
Percutaneous devices are critical for medical care, but are associated with significant risk of infec-
tions costing over 1 billion dollars annually. In current animal models subcutaneous biomaterials
are inoculated with bacteria either before implantation or through peri-implant dermal injection.
In this study, we describe an animal model that more closely mimics the route of clinical infection
by inoculating the percutaneous biomaterial at the biomaterial/skin interface, the natural clinical
portal for infection. Cylindrical rods made of solid silicone, porous silicone, solid poly(2-hydrox-
yethyl methacrylate) (polyHEMA), or porous polyHEMA, were implanted percutaneously on the
back of C57BL/6 mice. Immediately after rod insertion, the skin surrounding the implantation site
was directly challenged with 107cfu Staphylococcus aureus as biofilm grown on polycarbonate fil-
ters. Implants were examined at 2, 7 and 28 days. Results showed that a human clinical S. aureus
strain resulted in greater severity of infection than a mouse S. aureus strain. S. aureus challenge
resulted in erythema, an elevated inflammatory response, skin erosion and occasional abscess for-
mation around the implants. Quantification assays showed the amount of S. aureus on the skin grad-
ually decreased over time (approximately 107, 106 and 105cfu at 2, 7 and 28 days respectively),
while the amount of bacteria around the implant at insertion sites remained at 107. Bacterial inva-
sion proceeded quickly. The middle region of the implants showed 104-105 bacteria throughout all
time points. The results confirmed that bacterial challenge at the implantation site leads to infec-
tion, which validates the clinical rationale for stringently eliminating skin flora before catheter inser-
tion to significantly reduce infection. This bacterial challenge mouse model can be used to evalu-
ate the cutaneous response to bacterial challenge of percutaneous biomaterial implantation.
182
Desmosomal cadherins utilize distinct mechanism for assembly into desmosomes
O Nekrasova,1 E Amargo1 and KJ Green1,2 1 Department of Pathology, Northwestern University
Feinberg School of Medicine, Chicago, IL and 2 Department of Dermathology, Northwestern
University Feinberg School of Medicine, Chicago, IL
Desmosomes are intercellular junctions that provide strong adhesion between cells, mediated by
two types of cadherin: desmogleins, Dsg and desmocollins, Dsc . While the importance of desmo-
somal cadherins for maintaining the structural and functional integrity of epidermis has been well
established, the molecular machinery responsible for their trafficking from a vesicular compart-
ment to intercellular junctions remains poorly understood. Using live cell imaging we show that
both types of desmosomal cadherins exhibit long range microtubule-dependent trafficking in epithe-
lial cells. As kinesin-1 antibody co-localized with Dsg2-containing vesicles, si/shRNA constructs
were used to knock-down the kinesin-1 heavy chain (KHC) in keratinocytes, followed by exami-
nation of Dsg2 dynamics. Fluorescence intensity measurements revealed that Dsg2 at cell-cell inter-
faces of KHC-deficient cells was less then 50% reduced compared to control cells. Further, Dsg2
vesicle movement was largely blocked in cells expressing the shRNA of kinesin-1 without affecting
the movement of Dsc2. On the other hand, the inhibition of kinesin-2 function, using a dominant
negative construct against KIF3A (one of the motor domains of kinesin-2) or siRNA knock-down of
KAP3 (intermediate chain of kinesin-2) completely blocked intracellular movement of Dsc2 and
decreased its expression on the plasma membrane without affecting Dsg2 trafficking. Thus, the
temporal and spatial coordination of Dsg2 and Dsc2 assembly into intercellular junctions is con-
trolled by distinct mechanisms involving independent kinesin motors. These data suggest a mech-
anism by which differential regulation of desmosomal cadherin transport could alter Dsg:Dsc sto-
ichiometry and adhesion during tissue homeostasis and remodeling, and contribute broadly to
pathogenesis of desmosome-related diseases of the epidermis.
186
Differential effects of glucocorticoid treatment on inflammatory changes of cutaneous lym-
phatic and blood vessels
R Huggenberger, K Messmer, SS Siddiqui, MM Schulz and M Detmar Institute of Pharmaceutical
Sciences, Swiss Federal Institute of Technology, ETH Zurich, Zurich, Switzerland
Psoriasis is characterized by extensive remodeling of blood and lymphatic vessels. Although the
blood vasculature normalizes after resolution of inflammation, the extent of reversibility of lym-
phatic vessel changes in cutaneous inflammation is unclear. Lymphatic vessels contribute to the reg-
ulation of immune responses through their role in antigen transport and leukocyte migration to drain-
ing lymph nodes, and they drain edematous tissue fluid, inflammatory cells, and cytokines from
inflamed skin. We investigated the effects of betamethasone treatment on lymphatic endothelial cell
(LEC) proliferation, migration, and sprouting in vitro and on the vasculature in the oxazolone-induced
hemizygous K14-VEGF-A Tg mouse model of chronic skin inflammation in vivo. Our results indi-
cate that LECs express the glucocorticoid receptor, and that the incubation of LECs with betametha-
sone results in a dose-dependent increase in proliferation and migration but potently inhibits sprout
formation in vitro. Topical application of betamethasone, initiated at the chronic phase of oxazolone-
induced skin inflammation in hemizygous K14-VEGF-A Tg mice, reversed lymphatic but not blood
vessel remodeling after 7 days of treatment, despite complete resolution of edema and inflamma-
tion. Interestingly, the expression of the lymphangiogenic growth factor VEGF-C and its lymphatic-
specific receptor VEGFR-3 were significantly increased upon betamethasone treatment in mice.
Unexpectedly, lymphatic vessel enlargement persisted in human psoriasis after 4-weeks of treat-
ment, whereas the blood vasculature normalized, and inflammation resolved. These findings indi-
cate that the potent anti-inflammatory glucocorticoids might directly modulate the lymphatic endothe-
lium. Thus, specific effects of glucocorticoids on lymphatics might help resolving skin inflammation.
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Disease-specific spectrum of mutations in TGFBR1 causing multiple self-healing squamous
epithelioma (Ferguson-Smith disease)
D Goudie,1 M D’Alessandro,2 B Merriman,3 H Lee,3 I Szeverenyi,4 S Avery,4 B O’Connor,3
S Nelson,3 S Coats,1 A Stewart,1 L Christie,1 G Pichert,5 J Friedel,6 I Hayes,7 N Burrows,8
S Whittaker,9 A Gerdes,10,11 S Broesby-Olsen,11 MA Ferguson-Smith,12 C Verma,13 DP Lunny,4
B Reversade4 and B Lane1,4 1 College of Medicine, Dentistry & Nursing, University of Dundee,
Dundee, United Kingdom, 2 College of Life Sciences, University of Dundee, Dundee, United
Kingdom, 3 Dept of Human Genetics, David Geffen School of Medicine at UCLA, Los
Angeles, CA, 4 Institute of Medical Biology, Singapore, Singapore, 5 Clinical Genetics, Guy’s
& St Thomas’ NHS Trust, London, United Kingdom, 6 CH William-Morey, Chalon-sur-Saône,
France, 7 Auckland City Hospital, Auckland, New Zealand, 8 Dept of Dermatology,
Addenbrookes Hospital, Cambridge, United Kingdom, 9 St. John’s Institute of Dermatology,
Guys and St Thomas NHS Foundation Trust, London, United Kingdom, 10 Dept of Clinical
Genetics, Rigshospitalet, Copenhagen, Denmark, 11 Odense University Hospital, Odense,
Denmark, 12 Resource Centre for Comparative Genomics, Cambridge University, Cambridge,
United Kingdom and 13 Bioinformatics Institute, Singapore, Singapore
We have ascertained that the elusive genetic defect causing the rare skin cancer condition, multi-
ple self-healing squamous epithelioma (MSSE, or Ferguson-Smith disease (FSD)), is attributable to
defects in the TGFβ-R1 receptor. MSSE/FSD is an autosomal dominant genetic disorder that pres-
ents as multiple locally invasive tumours that grow for a few weeks and then regress spontaneously.
Independent TGFBR1 mutations were initially found in 3 unrelated families by high-throughput
genomic sequencing using exon array capture over a 24.2 Mb region on chromosome 9, extend-
ing beyond the disease locus predicted by linkage analysis. Sanger sequencing then identified 11
distinct TGFBR1 mutations in 18 MSSE/FSD families, confirming TGFBR1 as the causative gene for
MSSE/FSD. These mutations include the first-reported mutations in the TGFβR1 extracellular TGFβ-
ligand-binding domain plus truncating mutations in its kinase domain. The nature of the mutations
points specifically to loss of function of TGFBR1 in MSSE/FSD. This distinguishes it from Marfan
syndrome-related disorders, in which missense mutations in the same gene lead to widespread vas-
cular defects, but no increased cancer incidence.
176
The DSPII splice variant is critical for desmosome-mediated HaCaT keratinocyte adhesion
RM Cabral,1 D Tattersall,1 V Patel,1 E Hatzimasoura,1 DJ Abrams,2 AP South3 and DP Kelsell1 1
Centre for Cutaneous Research, Blizard Institute of Cell and Molecular Science, Barts & The
London School of Medicine and Dentistry, Queen Mary University of London, London, United
Kingdom, 2 Cardiology Research Department, Barts and The London NHS Trust, St
Bartholomew’s Hospital, Queen Mary, University of London, London, United Kingdom and 3
Centre for Oncology & Molecular Medicine, University of Dundee, Ninewells Hospital &
Medical School, Dundee, United Kingdom
Desmosomes are intercellular junctions specialised for strong adhesion, prominent in the epider-
mis and heart. Defective desmosomes due to inherited mutations in the constitutive desmosomal
gene desmoplakin (DSP) cause skin or heart disorders and in some instances both. Different muta-
tions have different disease-causing molecular mechanisms as evidenced by the varying phenotypes
resulting from mutations affecting different domains of DSP, however the majority of these mecha-
nisms remain to be determined. We studied two DSP mutations which lead to different dosages of
the two major isoforms, DSPI and DSPII, and compared their molecular mechanisms. One of the
mutations results in total DSP haploinsufficiency and is associated with autosomal dominant stri-
ate palmoplantar keratoderma (PPK). The other leads to complete absence of DSPI and the minor
isoform DSPIa but normal levels of DSPII, and is associated with recessive PPK, woolly hair and
severe cardiomyopathy. Using siRNA and two adhesion assays we found striking differences between
DSP isoforms with respect to HaCaT keratinocyte adhesion upon cellular stress with DSPII being
the key component in intermediate filament stability and desmosomal adhesion. In addition, reduc-
tion in DSP expression reduced the amount of plakophilin 1, desmocollin (DSC) 2 and DSC3 with
DSPI having a greater influence than DSPII on the expression levels of DSC3. These results suggest
that the two major DSP splice variants are not completely redundant in function and that DSPII
dosage is particularly important for desmosomal adhesion in the skin.
177
Regulation of PDGF receptor β signaling in pericytes by MFG-E8
S Motegi,1 S Garfield2 and MC Udey1 1 Dermatology Branch, Center for Cancer Research,
National Cancer Institute, NIH, Bethesda, MD and 2 Laboratory of Experimental
Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD
PDGF:PDGF receptor β (PDGFRβ) signaling regulates pericyte function during neoangiogenesis.
We have determined that pericytes are important sources of MFG-E8 (lactadherin, SED1) in vivo,
and that this αvβ3 ligand enhances pathologic angiogenesis in tumors and oxygen-induced retinopa-
thy in mice. We hypothesized that pericyte-derived MFG-E8 might influence pericytes as well as
endothelial cells. Prior studies demonstrated that inhibition of MFG-E8 production by pericyte-like
10T1/2 cells using siRNAs and shRNAs, or some anti-MFG-E8 Ab, attenuated PDGF induced peri-
cyte migration in vitro. We are now exploring mechanisms by which MFG-E8 might modulate
PDGF:PDGFRβ signaling in pericytes. Depletion of MFG-E8 from 10T1/2 cells using siRNAs enhanced
PDGF-dependent degradation of PDGFRβ and attenuated PDGFR signaling as manifested by
decreased PDGFRβ tyrosine phosphorylation. Co-immunoprecipitation experiments revealed tran-
sient association of MFG-E8 with PDGFRβ in PDGF-treated 10T1/2 cells. Laser scanning confocal
immunoflorescence microscopy demonstrated that MFG-E8-Ig fusion proteins bound to 10T1/2 cells
via the RGD motif in the E2 domain in the presence or absence of exogenous PDGF, while co-
localization of endogenous MFG-E8 with PDGFRβwas ligand-dependent, and confirmed that PDGF-
induced degradation of PDGFRβ in MFG-E8 siRNA treated cells was enhanced compared with that
in control cells. Ubiquitination of PDGFRβ in MFG-E8 siRNA transfected cells was also significantly
increased, consistent with enhanced degradation. These results suggest that MFG-E8 promotes the
association of αv integrins and PDGFRβ after PDGF treatment, prolongs expression of PDGFRβ on
cell surfaces and delays degradation of PDGFRβ, thus potentiating downstream signaling and enhanc-
ing pericyte function. We conclude that pericyte-derived MFG-E8 promotes pathologic angiogen-
esis, at least in part, via cell autonomous actions on pericytes that result from modulation of
PDGF:PDGF receptor β signaling.
178
Matrix metalloproteinase-8 is involved in dermal nerve growth: Implications for possible appli-
cation to pruritus from in vitro models
M Tominaga1,2 and K Takamori1,2 1 Institute for Environmental and Gender Specific Medicine,
Juntendo University Graduate School of Medicine, Urayasu, Japan and 2 Department of
Dermatology, Juntendo University Urayasu Hospital, Urayasu, Japan
Cutaneous nerve density is related to abnormal itch perception in dermatoses, such as atopic der-
matitis and xerosis. However, the elongation mechanisms of dermal nerve fibers within interstitial
collagen matrix are poorly understood. Here, a culture system of rat dorsal root ganglion neurons
consisting of type I collagen and a Boyden chamber containing a nerve growth factor (NGF) con-
centration gradient was used. Nerve fibers penetrating into type I collagen gel were observed in the
presence of the NGF concentration gradient. Transcripts for matrix metalloproteinase-8 (MMP-8)
were significantly increased in the cultured neurons, and the nerve fiber penetration was dose-
dependently inhibited by MMP-8 blockers. Moreover, MMP-8 immunoreactivity was partially local-
ized at growth cones in NGF-responsive nerve fibers. Semaphorin 3A stimulation also showed the
opposite effects on these NGF-dependent events. Intriguingly, MMP-8 expression was upregulated
by type I and III collagens, which are substrates for this enzyme. These results suggested that MMP-
8 is involved in sensory nerve growth within interstitial collagen matrix through modulation by
axonal guidance molecules and/or extracellular matrix components. This finding may provide insight
to understand the development of pruritus involving skin nerve density.
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Establishment of the Matrigel plug assay in domestic pig skin to investigate intra-dermal angio-
genesis
JG Meingassner, M Pillinger, H Fahrngruber, E Kowalsky and A Stuetz Novartis Institutes for
BioMedical Research, Vienna, Austria
Angiogenesis is a pathologic feature in chronic skin inflammation, such as psoriasis. An experi-
mental method to study proliferation of small vessels is the investigation of neovascularisation of a
subcutaneously injected semi-solid matrix (Matrigel) in mice. A limitation of this assay is the poor
correlation between mouse and human skin, particularly regarding skin penetration properties upon
topical treatment. Here we report on the establishment of the Matrigel plug assay in the dermis of
domestic pigs, the skin of which closely resembles the human situation. Furthermore, the anti-angio-
genic properties of the novel VEGF receptor tyrosine kinase inhibitor NVP-BFH772 in this model
are reported. Intradermal injection of 100μl Matrigel was performed in the lateral thorax/abdomen
of domestic pigs. Animals were sacrificed after three days and 8mm biopsies with the Matrigel plug
in the center were obtained from the injection sites. Biopsies were embedded for subsequent IHC
analysis or dissected to remove the Matrigel plug. Obtained gels were dissolved by incubation in
dispase and resulting cell suspensions were analyzed by flow cytometry for infiltrating cells. Endothe-
lial cells were indentified by CD31 surface expression. Matrigel plugs alone contained infiltrating
cells, of which approximately 50% were identified as endothelial cells. VEGF addition to Matrigel
prior to injection led to a two-fold increase of infiltrating cells with two-thirds being endothelial
cells. Microscopic examination revealed that infiltrating endothelial cells were assembled in regu-
lar vessel structures. Topical application of 0.5% solution of NVP-BFH772 in EtOH/propylene gly-
col (3:7) reduced VEGF stimulated endothelial cell content in Matrigel plugs by 50% after 3 days
of treatment. In conclusion, the Matrigel plug assay in pig dermis may serve as a valuable model to
study intradermal angiogenesis and the therapeutic potential of topically applied anti-angiogenic
compounds.
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Calcium-induced cell-cell adhesion and differentiation in human epidermal keratinocytes
require Rho-GEF Trio and filamin A
C Tu,1,2 M You1 and DD Bikle1,2 1 Endocrine Unit, VA Medical Center, San Francisco, CA and 2
University of California, San Francisco, CA
The E-cadherin-mediated signaling plays a critical role in promoting cell survival and differentia-
tion in epidermal keratinocytes. Our previous studies indicate that extracellular Ca2+ (Ca2+o)-induced
E-cadherin-mediated cell-cell adhesion and keratinocyte differentiation are regulated by the cal-
cium-sensing receptor (CaR) via Rho A-mediated signaling and these processes require the involve-
ment of filamin A, a cytoskeletal actin-binding scaffolding protein capable of binding to Rho-gua-
nine nucleotide exchange factors (GEF) and Rho-like small GTPases. Trio is a multifunctional
filamin-interacting protein which contains two GEF domains specifically targeting Rac 1 and Rho
A. To investigate the role of Trio and filamin A in keratinocyte cell-cell adhesion and differentiation,
we examined the impact of knockdown of filamin A and Trio on endogenous Rho activity. Raising
Ca2+o concentration from 0.03 to 2 mM rapidly induced association of Rho A to adherens junctions
and increased endogenous Rho activity. Suppressing endogenous filamin A or Trio expression by
small interfering RNA (siRNA)-mediated gene silencing blocked these processes. Knockdown of fil-
amin A and Trio also inhibited the Ca2+o-induced membrane localization and formation of the pro-
tein complex of E-cadherin, β-, γ-, and p120-catenin. Furthermore, pull-down assays using anti-
bodies against CaR and Rho A demonstrated that CaR, Trio, Rho A and E-cadherin form a signaling
complex via filamin A at the cell membrane in response to elevated Ca2+o, suggesting that CaR acti-
vates Rho signaling through direct protein interaction. Finally, filamin A and Trio silencing decreased
the Ca2+o-stimulated protein expression of terminal differentiation markers keratin 1, transglutami-
nase 1, involucrin, loricrin and filaggrin, whereas the expression of basal cell marker keratin 14
was not changed. These results signify an important role for Trio and filamin A in the regulation of
Ca2+o-induced E-cadherin mediated cell-cell adhesion and keratinocyte differentiation.
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MMP2-null mice are less susceptible to pemphigus foliaceus induction
N Li,1 Z Liu,1 L Heinbach,1 M Park,1 R Senior2 and LA Diaz1 1 Dept. of Dermatology, University
of North Carolina at Chapel Hill, Chapel Hill, NC and 2 Dept. of Internal Medicine,,
Washington University at St. Louis, St. Louis, MO
Pemphigus foliaceus (PF) is an autoimmune skin blistering disease characterized by autoantibodies
to desmoglein-1 and subcorneal cell detachment (acantholysis). PF autoantibodies are pathogenic
when passively transferred to neonatal mice, which recapitulate the human disease. The mecha-
nism of how these autoantibodies induce acantholysis remains under intense investigation in dif-
ferent laboratories. We have shown that matrix metalloproteinases (MMP) inhibitors selective for
MMP2/MMP9 and MMP2, but not MMP9, blocked PF IgG-induced skin blisters in mice (JID 129,
Sup 1, S38, Abs# 227, 2009), raising the possibility that MMP2 may play a role in PF acantholysis.
In the present study we evaluated whether genetic deletion of MMP2 would provide protection
against PF autoantibody-induced acantholysis and skin blisters. Pathogenic PF IgG was injected into
MMP2-null mice (n=12) and wild-type (WT) control mice (n=8). After 20 hours injection, the extent
of skin disease was examined and scored in a range of 0 to 3+ (0, no blistering; 0.5+, <10%; 1+,
10-25%; 2+, 25-50%; 3+, >50%). Mice were then sacrificed and skin specimens were obtained for
histological evaluation. Of the 12 MMP2-null mice tested, 9 showed no disease and 3 developed
very limited skin blisters (score 0.5+). In contrast, all the WT mice demonstrated extensive disease.
The difference of the mean disease scores between the MMP2-null (0.12 + 0.07) and WT mice (2.63
+ 0.13) is statistically significant (p < 0.0001, Student’s t test). Histological analysis of the skin spec-
imens of the MMP2-null mice revealed no or limited acantholysis. These MMP2 genetic ablation
results are consistent with our previous pharmacological inhibition study, suggesting that this met-
alloproteinase is critically involved in PF acantholysis and skin blistering.
195
The role of desmocollin 3 in skin tumor development and progression
J Chen,1,3 C O’Shea,1,3 JE Fitzpatrick,1 MI Koster1,3 and PJ Koch1,2,3 1 Dermatology, University of
Colorado Denver, Aurora, CO, 2 Department of Cell & Developmental Biology, University of
Colorado Denver, Aurora, CO and 3 Center for Regenerative Medicine and Stem Cell Biology,
University of Colorado Denver, Aurora, CO
Using a mouse model, we have previously demonstrated that desmocollin 3 (DSC3), a desmoso-
mal cadherin, is essential for maintaining cell adhesion in the epidermis. Dsc3 gene ablation in the
epidermis leads to intra-epidermal blistering with a histopathology identical to that observed in
skin blisters of pemphigus vulgaris patients. Previously, loss or down-regulation of DSC3 has also
been observed in cancers of the breast and the oral cavity. The present study addressed the ques-
tion of whether DSC3 plays a role in skin tumor development or progression. We generated a tri-
genic mouse model that allows for the tissue-specific and inducible ablation of Dsc3 with simulta-
neous activation of an oncogenic K-Ras allele (mutant mice). As controls, we utilized mice in
which Dsc3 expression was maintained in the presence of K-Ras activation. Mutant mice showed
a statistically significant increase in the tumor incidence. Tumor progression, however, was not
affected by the Dsc3 null mutation. Our results indicate that loss of Dsc3 synergizes with K-Ras in
inducing skin tumors. We hypothesize that skin blistering-induced epithelial hyperplasia is respon-
sible for the increased tumor development in mutant mice. These findings are relevant for the under-
standing of Acantholytic Squamous Cell Carcinomas, a subgroup of human tumors that shows acan-
tholysis in the tumor epithelium. Surprisingly, we also found that control tumors spontaneously lost
DSC3 expression during later stages of tumorigenesis, providing a possible explanation for the com-
parable rates of tumor progression in mutant and control mice. Future experiments will address
whether loss of Dsc3 is essential for skin tumor progression. We found that DSC3 expression is also
lost during the progression of human skin tumors, suggesting that our animal model will be a use-
ful tool for investigating skin tumor progression.
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Expression of catalytically active Matrix Metalloproteinase-1 in dermal fibroblasts induces
morphological and functional alterations that mimic aged human skin
W Xia, C Hammerberg, Y Li, JJ Voorhees and GJ Fisher Dermatology, University of Michigan,
Ann Arbor, MI
Increased fragmentation of the dermal collagenous extracellular matrix is a prominent feature of
aged human skin. This fragmentation is initiated by matrix metalloproteinase-1 (MMP-1), which is
elevated in aged human skin. MMP-1 is synthesized as an inactive proenzyme, which contains an
inhibitory N-terminal domain. We have established a model to investigate the impact of activated
MMP-1 on dermal fibroblast function, in aged human skin. A series of inhibitory domain MMP-1
mutants were constructed, and their enzymatic activities analyzed. Only MMP-1 V94G mutant
(MMP-1/V94G) efficiently degraded collagen lattices. Protease inhibitor, kinetics, and temperature
dependence studies revealed that MMP-1/V94G cleaved its own inhibitory domain, resulting in
auto-activation. Expression of MMP-1/V94G in fibroblasts cultured in three-dimensional collagen
lattices increased collagen fragmentation 2.1 fold (n=3, p<0.01). Fibroblasts in MMP-1/V94G-frag-
mented collagen lattices had reduced cytoplasmic area, and a collapsed appearance, similar to
fibroblasts in aged human skin in vivo. Reduction of MMP-1/V94G activity by siRNA-mediated
knockdown, or MMP inhibitor MMI270 markedly reduced collagen lattice fragmentation. Further-
more, fibroblasts cultured in MMP-1/V94G-fragmented collagen lattices displayed reduced expres-
sion of collagen (40%, n=3, p<0.01), and regulators of collagen production, including TGFβR-II
(reduced 30%), CTGF (reduced 80%), and CYR61 (reduced 83%) (all n=3, p<0.01). Importantly,
these alterations mimic those observed in fibroblasts in aged human skin, and thereby support the
concept that MMP-1-mediated fragmentation of dermal collagen impairs the structure and function
of dermal fibroblasts. These data provide the foundation for understanding specific mechanisms that
link collagen fragmentation to decline of fibroblast function, and development of novel approaches
to improving skin health in the aged.
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Loss of type VII collagen in squamous cell carcinoma leads to increased invasion and TGF-
beta signalling in vivo
V Martins,1 K Moore,2 M Chen,3 J Marshall2 and EA O’Toole1 1 Centre for Cutaneous Research,
Barts and the London School of Medicine and Dentistry, London, United Kingdom, 2 Institute
of Cancer, Barts and the London School of Medicine and Dentistry, London, United Kingdom
and 3 Dermatology, University of Southern California, Los Angeles, CA
Mutations in the type VII collagen (ColVII) gene cause the blistering disorder, recessive dystrophic
epidermolysis bullosa (RDEB), associated with increased risk of metastatic squamous cell carcinoma
(SCC). We have previously shown that transient knock-down of ColVII increased SCC migration/inva-
sion with increased epithelial-mesenchymal transition (EMT). In this study, we explored the role of
TGF-beta in tumorigenesis of SCC cells with absent ColVII. Stable knock-down of ColVII was estab-
lished in human cutaneous SCC cell lines using lentiviral shRNA with > 95% knock-down. Live
cell imaging suggested that ColVII-knock-down cells (shCOL7) have increased migration, as well
as changes in tail retraction and membrane protrusions, when compared to shControl cells. Expres-
sion of the Rho GTPases RhoA and Cdc42 was increased in shCOL7 cells, a possible explanation
for the membrane changes observed. Results from 3-D organotypic cultures demonstrated that
shCOL7 cells have increased expression of active TGF-beta as well as the TGF-beta-pathway tar-
gets CTGF, CLIC4 and p-ERK1/2. Interestingly, addition of a TGF-beta type I receptor inhibitor, SD-
208, reduced cell migration as well as components of the TGF-beta pathway in shCOL7 cell 3-D
cultures. Grafting of composites of cells and collagen gels onto immunodeficient nude mice for 6
weeks demonstrated that shCOL7 cells are more invasive than control with reduced differentiation.
Increased expression of the TGF-beta signalling pathway components, pSmad2/3, was also observed
in invading cells in vivo. Our results suggest that the TGF-beta pathway may play a critical role in
migration of SCC cells with absent ColVII. Furthermore, we provide in vivo evidence for the first
time that SCC cells with loss of ColVII are more invasive contributing to a better understanding of
the accelerated metastasis of RDEB SCC.
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Elucidation of the molecular mechanisms underlying inversa type of recessive dystrophic
epidermolysis bullosa using site-directed mutagenesis
Y Hou, J Cogan, E Cua, S Lee, D Woodley and M Chen Dermatology, University of Southern
California, Los Angeles, CA
Type VII collagen (C7), composed of a central triple helical domain (TH) flanked by non-helical
domains, NC1 and NC2, is the major component of anchoring fibrils. Mutations in the type VII col-
lagen gene (COL7A1) cause dystrophic epidermolysis bullosa (DEB). Inversa recessive DEB (RDEB-
I), a rare form of DEB, is associated with missense mutations involving arginine or glycine within
the TH. Because the lesions in RDEB-I are mainly restricted to body sites with higher skin temper-
ature, it has been hypothesized that the pathophysiology of RDEB-I is temperature dependent. How-
ever, the biological consequences of specific COL7A1 mutations leading to the unique RDEB-I phe-
notypes have not been extensively elucidated. In this study, we generated 18 substitution mutations
associated with RDEB-I and purified the recombinant mutant proteins. Biochemical, structural and
functional characterization of the purified mutant C7s and comparisons of them with wild type C7
under different temperatures demonstrated: (1) All mutations except G1907E synthesized and secreted
a 290 kDa mutant C7 at levels similar to the wild type C7. (2) Most RDEB-I mutations produced
mutant C7s with the reduced thermal stability, as demonstrated by increased sensitivity to protease
digestion and reduced ability to form trimers at higher temperature. (3) Many RDEB-I mutations gen-
erated mutated C7s with significantly reduced ability to promote keratinocyte migration and sup-
port cell adhesion at higher temperatures. Nevertheless, under lower temperature, these RDEB-I
mutant C7s were as effective as wild type C7 in supporting keratinocyte adhesion and migration.
(4) The R2622W and R2628W RDEB-I mutations next to NC2 reduced C7’s ability to form antipar-
allel dimers. We conclude that effects of RDEB-I mutations on C7 functions such as folding, molec-
ular stability, cell attachment, or cell motility are highly temperature dependent and are concor-
dant with the observed clinical phenotype.
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Elevated Cysteine-rich protein 61 (CYR61/CCN1) mediates down-regulation of collagen expres-
sion in senescent human dermal fibroblasts.
T Quan, Z Qin, T He, JJ Voorhees and GJ Fisher Dermatology, University of Michigan, Ann
Arbor, MI
Chronologically aged human skin is thin and fragile, largely as a consequence of reduced dermal
connective tissue collagen. Type I collagen fibrils are the major constituent of the dermal extracel-
lular matrix, which confers mechanical strength. Age-related loss of connective tissue collagen results
from reduced synthesis and increased degradation of collagen by dermal fibroblasts, the primary
cells responsible for collagen homeostasis in skin. Cysteine-rich protein 61 (CCN1), a member of
CCN family proteins, is elevated in aged human skin in vivo. CCN1 is a secreted matricellular pro-
tein that regulates collagen metabolism in dermal fibroblasts. We utilized replicative senescent pri-
mary adult human dermal fibroblasts as an in vitro aging model to investigate the role of elevated
CCN1 in age-related alterations of collagen homeostasis. Replicative senescent dermal fibroblasts
expressed significantly lower collagen mRNA and protein (n=3, p<0.01) and significantly elevated
collagen-degrading matrix metalloproteinase-1 mRNA and protein (n=3, p<0.05), compared to non-
senescent fibroblasts. These alterations in collagen metabolism mimic those observed in aged human
skin in vivo. Importantly, CCN1 was increased 3-fold in senescent fibroblasts, compared to non-
senescent fibroblasts (n=3, p<0.05), similar to the elevation of CCN1 that is observed in aged human
skin in vivo. siRNA-mediated knock-down of elevated CCN1 in senescent dermal fibroblasts par-
tially normalized collagen homeostasis by increasing type I collagen expression (3-fold, n=3, p<0.01)
and reducing MMP-1 expression (2-fold, n=3, p<0.05). Given the ability of CCN1 to regulate both
synthesis and degradation of type I collagen in human dermal fibroblasts, it is likely that elevated-
CCN1 functions as an important mediator of collagen deficiency that occurs in aged human skin.
CCN1 is a novel therapeutic target to lessen skin fragility in the aged.
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Vascularization of human acellular dermis on chick chorioallantoic membrane
P Blasi,1 M Andreassi,2 L Barberini,3 A Schoubben,1 P Alberti,4 M Ricci,1 C Anselmi,2 C Cirotto,3
C Rossi1 and L Andreassi5 1 Department of Pharmaceutical Technology, University of Perugia,
Perugia, Italy, 2 Department of Pharmaceutical Technology, University of Siena, Siena, Italy, 3
Department of Environmental and Cellular Biology, University of Perugia, Perugia, Italy, 4
Department of Internal Medicine, University of Perugia, Perugia, Italy and 5 Department of
Dermatology, University of Siena, Siena, Italy
The EU has adopted a ban on animal testing for cosmetic ingredients or finished products. These
regulations have promoted the research on alternative reliable systems, some of which have already
been approved. In order to develop models of engineered skin, a vascularised de-epidermised der-
mis(DED) was developed on chicken embryo chorioallantoic membrane (CAM) as alive support.
DED was obtained using skin fragments from discarded surgical skin treated by repeated freeze-
thawing cycles in liquid nitrogen and irradiated by 3.5 Gy from a cobalt source. Fertilized eggs were
incubated in a vertical position and windowed 3 days after incubation for alive embryo selection.
At day 6, DED was deposited on the CAM with the basal lamina contiguous to the latter. DED was
added, alternatively, with foetal calf serum, epidermal growth factor, and keratinocyte culture medium.
An untreated group was used as control. Embryos were photographed every day and scarified at
day 12. DED together with the CAM were fixed and processed for histological examination. Stereo-
scopic examination during the experiments showed an easily invasion of the implanted DED by
chicken erythrocytes. Due to the DED thickness, methaemoglobin was sometimes observed. At day
12, the non supplemented DED shrunk with an evident size reduction. Histological examination
showed the colonization of the de-cellularised matrix and the formation of a rudimental vascular
structure. These preliminary results look very promising for the production of vascularised systems,
a basis for the engineered skin construction.
188
Ephrins promote the EphA2-EphA1 transition to regulate epidermal differentiation
SY Lin, K Gordon, H Blatt, N Kaplan, RM Lavker and S Getsios Dermatology, Northwestern
University, Chicago, IL
EphA1 and EphA2 are highly related receptor tyrosine kinases (RTKs) that mediate cell-cell com-
munication when engaged by ephrin ligands residing on adjacent cells. Although EphA1 and EphA2
are both expressed by normal human epidermal keratinocytes (NHEKs), EphA2 becomes down-
regulated whereas EphA1 levels remain high in more differentiated organotypic raft cultures and
intact human epidermis. Both receptors compete for the same ephrin-A1 ligand, which we recently
showed was capable of promoting keratinocyte differentiation via an increase in the desmosome
adhesion molecule, desmoglein 1. Accordingly, ligand-mediated differentiation was also accom-
panied by the loss of EphA2 and maintenance of EphA1. These observations led us to hypothesize
that ephrin ligands remove EphA2 from the cell surface in order to allow EphA1 to promote ker-
atinocyte differentiation. In support of this possibility, EphA2 was rapidly (15 min) recruited to sites
of cell-cell contact in NHEKs switched into high Ca2+ while EphA1 was only stabilized at mature
junctions after 24 h. Overexpression of EphA1 to enhance its signaling during the initial stages of
keratinocyte differentiation resulted in the early recruitment of EphA1 at cell-cell junctions and
accelerated keratinocyte differentiation. In contrast, gene silencing of EphA1 impaired epidermal
differentiation and morphogenesis in organotypic raft cultures and led to the re-expression of EphA2.
Similarly, sustaining high levels of EphA2 by ectopic overexpression in raft cultures reduced nor-
mal EphA1 levels and limited differentiation. Collectively, these studies provide compelling evi-
dence that epidermal homeostasis is maintained by a tightly regulated balance between EphA1 and
EphA2, which is likely controlled by ephrin ligands. Targeting ephrins to restore the proper EphA2-
EphA1 equilibrium may represent a novel therapeutic approach to diseases of altered keratiniza-
tion.
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Possible role of a multi-domain adaptor protein, ArgBP2, in the tight junction maintenance
of epithelial cells
K Murase,1 H Ito,2 K Sudo,2 I Iwamoto,2 R Morishita,2 H Kanoh,1 M Seishima1 and K Nagata2 1
Dermatology, Gifu University Graduate School of Medicine, Gifu, Japan and 2 Molecular
Neurobiology, Institute for Developmental Research, Aichi Human Service Center, Kasugai,
Japan
Arg-binding protein 2 (ArgBP2) is a member of the SoHo (Sorbin Homology) family of multi-domain
adaptor proteins composed of ArgBP2, vinexin and CAP/Ponsin. They share three SH3 domains
and a SoHo domain at the C- and N-terminals, respectively. Accumulating evidence suggests that
SoHo family proteins are involved in cell migration, spreading and adhesion through the cytoskele-
ton-related signal transduction, although the molecular basis of its function is almost unknown. On
the other hand, vinexin was reported to be localized at cell-cell junctoins in some epithelial cells,
raising the possibility that ArgBP2 also functions at cell-cell junctions. Immunofluorescence analy-
ses revealed that ArgBP2 was enriched at tight junctions (TJs) in epithelial NMuMG cells while
vinexin showed cytoplasmic distribution in the cell. Interestingly, ArgBP2 was recruited from cytosol
to TJs as the cell became polarized, and the second SH3 domain was essential for the TJ-localiza-
tion. Meanwhile, we identified ArgBP2δ, a novel short isoform consisting of three SH3 domains
and lacking SoHo domain. We compared biochemical and cell biological characters of ArgBP2δ
to those of vinexinβ with structural similarity to ArgBP2δ. Like vinexinβ, ArgBP2δ, directly bound
with actin-polymerizing factor, N-WASP. Also, ArgBP2δ as well as vinexinβ activated extracellular
signal-regulated kinase (ERK) in an anchorage-independent manner. On the other hand, while vinex-
inβ interacted with mSos, an activating factor for small GTPase Ras and Rac, ArgBP2δ did not.
Taken together, our findings suggest that ArgBP2 has distinct functions from vinexin, and is involved
in the maintenance of TJs possibly through actin-cytoskeletal organizaton and cell signaling in
NMuMG cells.
190
Action of skincare active ingredients on actin and matrix contraction in dermal and epider-
mal structures ex vivo
E Lati,1 F Arnold,2 C Merle,1 L Peno-Mazzarino,1 P Gasser1 and M Mercier3 1 Laboratoire Bio-EC,
Centre de Recherches Biologiques et d’Expérimentations Cutanées, Longjumeau, France, 2
MMP Sarl, Issy les Moulineaux, France and 3 MMP, Inc., South Plainfield, NJ
Actin is a protein involved in the cell-cell communication through the formation of gap junctions
and in the cellular shape, stimulating the cellular functional capacity. It exists under monomer
granular forms and under polymerized filamentous forms. Its role in tissue repair (epithelialization
and fibroblasts contraction) has been described in cells culture and in in vitro tests. Actin stress fibers
also play an important role in force and mechanical transmission and transmit focal adhesions to
the extracellular matrix and create matrix contraction. The aim of this study is to evaluate ex vivo
the presence and configuration of actin in human skin explants maintained in survival. A prelimi-
nary step evaluated actin expression as a function of age in young human skin sections and mature
human skin sections. Living skin explants of the selected age were then treated topically by skin-
care ingredients active on collagen gel contraction in vitro. After treatment, the following parame-
ters were monitored: general morphology of the epidermal and dermal structures, expression of
actin after specific immunostaining and contact between fibroblasts and the extracellular matrix.
In this experimental model, the treatment with ingredients which are active on matrix contraction
in vitro shows that these materials interfere with the actin expression and can modulate force trans-
mission in the skin ex vivo.
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Novel properties of a well-known molecule: Urea stimulates collagen production by human
dermal fibroblasts
S Grether-Beck,1 F Ingo,1 H Brenden,1 A Marini,1 T Jaenicke,1 C Trullas,2 PM Elias,3 M Rodriguez-
Martin4 and J Krutmann1 1 IUF-Leibniz Research Institute for Environmental Medicine,
Duesseldorf, Germany, 2 ISDIN, Barcelona, Spain, 3 VA Medical Center, San Francisco, CA
and 4 Hospital Universitario de Canarias, San Francisco, Spain
Urea has been used for decades in dermatology to treat dry skin conditions. In previous studies we
have shown that urea has unrecognized gene regulatory properties to enhance keratinocyte differ-
entiation in vitro and in vivo and to upregulate the expression of antimicrobial peptides within the
epidermis. Now we show for the first time that urea also acts on cultured primary human dermal
fibroblasts (HDF) by induction of expression of the main dermal collagens COL1A1 and COL1A2
on mRNA and protein level. These effects were of in-vivo relevance because in a placebo-controlled,
double-blinded study with 21 healthy human volunteers, a 4-week application of a 10 % and even
more a 20% urea containing topical preparation significantly increased the expression of COL1A1
by a factor of 6.1 and 7.3, and COL1A2 by a factor of 5.6 and 6.7 as compared to the untreated
control. Expression of collagen was significantly higher in the urea treated skin areas as compared
to the placebo control and could be corroborated on the protein level by immunohistochemistry.
At a mechanistical level, urea induced collagen gene expression in HDF was not due to a urea
induced shift in osmolarity, but mediated by specific urea transporters. HDF expressed the human
urea transporters hUTA2 and hUTA1, and the competitive urea transport inhibitor thiourea decreased
14C labelled urea uptake in HDF by 60% and most importantly, also blocked urea induced upreg-
ulation of collagens. These studies show for the first time that urea possesses gene regulatory prop-
erties which can be used to stimulate collagen synthesis in HDFs. This unexpected property of urea
indicates that this well known compound may be used for the treatment of (photo)-aged skin.
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Antagonizing the effects of pemphigus IgG by manipulating intracellular protein O-glycosy-
lation
P Berkowitz1 and D Rubenstein1,2,3 1 Dermatology, UNC-CH, Chapel Hill, NC, 2
Pharmacology, UNC-CH, Chapel Hill, NC and 3 Lineberger Comprehensive Cancer Center,
UNC-CH, Chapel Hill, NC
In pemphigus vulgaris (PV), pathogenic IgG against desmosomal cadherins induce loss of keratinocyte
cell-cell adhesion resulting in clinical blisters. Previous work by our group and others suggests that
pathogenic PV IgG activate intracellular events that contribute to loss of cell-cell adhesion. Two
key events in PV acantholysis appear to be activation of p38MAPK and endocytosis of dsg3. We
have previously shown that inhibition of p38MAPK blocks dsg3 endocytosis and blistering in both
in vitro and in vivo models of PV and PF. This observation suggests that stabilization of the desmo-
some represents a potential approach to treating pemphigus. Regulation of the desmosome is likely
to be multifaceted. Analagous to phosphorylation, O-glycosylation of serine and threonine residues
of intracellular proteins is a common regulatory post-translational modification. Two intracellular
enzymes, OGT and OGA, mediate addition and removal, respectively, of N-acetylglucosamine (Glc-
NAc) from intracellular protein substrates. Previous data from our group demonstrated that O-gly-
cosylation stabilizes cell-cell adhesion in part by increasing the post-translational stability of desmo-
some components including plakoglobin. This observation suggests that increasing intracellular
protein O-glycosylation could stabilize the desmosome and make cells resistant to PV IgG. To test
this hypothesis, human keratinocytes were treated with the OGA inhibitor PUGNAc. In cells treated
with PUGNAc, we observed (i) increased intracellular protein O-glycosylation, (ii) increased amounts
of desmosome proteins, (iii) and increased resistance to the biological effects of PV IgG including
resistance of PUGNAc treated keratinocytes to PV IgG induced dsg3 endocytosis. These observa-
tions suggest that pharmacologic stabilization of desmosomal proteins by manipulation of O-Glc-
NAc protein modification could represent an additional therapeutic approach to pemphigus.
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MMP2-null mice are less susceptible to pemphigus foliaceus induction
N Li,1 Z Liu,1 L Heinbach,1 M Park,1 R Senior2 and LA Diaz1 1 Dept. of Dermatology, University
of North Carolina at Chapel Hill, Chapel Hill, NC and 2 Dept. of Internal Medicine,,
Washington University at St. Louis, St. Louis, MO
Pemphigus foliaceus (PF) is an autoimmune skin blistering disease characterized by autoantibodies
to desmoglein-1 and subcorneal cell detachment (acantholysis). PF autoantibodies are pathogenic
when passively transferred to neonatal mice, which recapitulate the human disease. The mecha-
nism of how these autoantibodies induce acantholysis remains under intense investigation in dif-
ferent laboratories. We have shown that matrix metalloproteinases (MMP) inhibitors selective for
MMP2/MMP9 and MMP2, but not MMP9, blocked PF IgG-induced skin blisters in mice (JID 129,
Sup 1, S38, Abs# 227, 2009), raising the possibility that MMP2 may play a role in PF acantholysis.
In the present study we evaluated whether genetic deletion of MMP2 would provide protection
against PF autoantibody-induced acantholysis and skin blisters. Pathogenic PF IgG was injected into
MMP2-null mice (n=12) and wild-type (WT) control mice (n=8). After 20 hours injection, the extent
of skin disease was examined and scored in a range of 0 to 3+ (0, no blistering; 0.5+, <10%; 1+,
10-25%; 2+, 25-50%; 3+, >50%). Mice were then sacrificed and skin specimens were obtained for
histological evaluation. Of the 12 MMP2-null mice tested, 9 showed no disease and 3 developed
very limited skin blisters (score 0.5+). In contrast, all the WT mice demonstrated extensive disease.
The difference of the mean disease scores between the MMP2-null (0.12 + 0.07) and WT mice (2.63
+ 0.13) is statistically significant (p < 0.0001, Student’s t test). Histological analysis of the skin spec-
imens of the MMP2-null mice revealed no or limited acantholysis. These MMP2 genetic ablation
results are consistent with our previous pharmacological inhibition study, suggesting that this met-
alloproteinase is critically involved in PF acantholysis and skin blistering.
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The role of desmocollin 3 in skin tumor development and progression
J Chen,1,3 C O’Shea,1,3 JE Fitzpatrick,1 MI Koster1,3 and PJ Koch1,2,3 1 Dermatology, University of
Colorado Denver, Aurora, CO, 2 Department of Cell & Developmental Biology, University of
Colorado Denver, Aurora, CO and 3 Center for Regenerative Medicine and Stem Cell Biology,
University of Colorado Denver, Aurora, CO
Using a mouse model, we have previously demonstrated that desmocollin 3 (DSC3), a desmoso-
mal cadherin, is essential for maintaining cell adhesion in the epidermis. Dsc3 gene ablation in the
epidermis leads to intra-epidermal blistering with a histopathology identical to that observed in
skin blisters of pemphigus vulgaris patients. Previously, loss or down-regulation of DSC3 has also
been observed in cancers of the breast and the oral cavity. The present study addressed the ques-
tion of whether DSC3 plays a role in skin tumor development or progression. We generated a tri-
genic mouse model that allows for the tissue-specific and inducible ablation of Dsc3 with simulta-
neous activation of an oncogenic K-Ras allele (mutant mice). As controls, we utilized mice in
which Dsc3 expression was maintained in the presence of K-Ras activation. Mutant mice showed
a statistically significant increase in the tumor incidence. Tumor progression, however, was not
affected by the Dsc3 null mutation. Our results indicate that loss of Dsc3 synergizes with K-Ras in
inducing skin tumors. We hypothesize that skin blistering-induced epithelial hyperplasia is respon-
sible for the increased tumor development in mutant mice. These findings are relevant for the under-
standing of Acantholytic Squamous Cell Carcinomas, a subgroup of human tumors that shows acan-
tholysis in the tumor epithelium. Surprisingly, we also found that control tumors spontaneously lost
DSC3 expression during later stages of tumorigenesis, providing a possible explanation for the com-
parable rates of tumor progression in mutant and control mice. Future experiments will address
whether loss of Dsc3 is essential for skin tumor progression. We found that DSC3 expression is also
lost during the progression of human skin tumors, suggesting that our animal model will be a use-
ful tool for investigating skin tumor progression.
197
Expression of catalytically active Matrix Metalloproteinase-1 in dermal fibroblasts induces
morphological and functional alterations that mimic aged human skin
W Xia, C Hammerberg, Y Li, JJ Voorhees and GJ Fisher Dermatology, University of Michigan,
Ann Arbor, MI
Increased fragmentation of the dermal collagenous extracellular matrix is a prominent feature of
aged human skin. This fragmentation is initiated by matrix metalloproteinase-1 (MMP-1), which is
elevated in aged human skin. MMP-1 is synthesized as an inactive proenzyme, which contains an
inhibitory N-terminal domain. We have established a model to investigate the impact of activated
MMP-1 on dermal fibroblast function, in aged human skin. A series of inhibitory domain MMP-1
mutants were constructed, and their enzymatic activities analyzed. Only MMP-1 V94G mutant
(MMP-1/V94G) efficiently degraded collagen lattices. Protease inhibitor, kinetics, and temperature
dependence studies revealed that MMP-1/V94G cleaved its own inhibitory domain, resulting in
auto-activation. Expression of MMP-1/V94G in fibroblasts cultured in three-dimensional collagen
lattices increased collagen fragmentation 2.1 fold (n=3, p<0.01). Fibroblasts in MMP-1/V94G-frag-
mented collagen lattices had reduced cytoplasmic area, and a collapsed appearance, similar to
fibroblasts in aged human skin in vivo. Reduction of MMP-1/V94G activity by siRNA-mediated
knockdown, or MMP inhibitor MMI270 markedly reduced collagen lattice fragmentation. Further-
more, fibroblasts cultured in MMP-1/V94G-fragmented collagen lattices displayed reduced expres-
sion of collagen (40%, n=3, p<0.01), and regulators of collagen production, including TGFβR-II
(reduced 30%), CTGF (reduced 80%), and CYR61 (reduced 83%) (all n=3, p<0.01). Importantly,
these alterations mimic those observed in fibroblasts in aged human skin, and thereby support the
concept that MMP-1-mediated fragmentation of dermal collagen impairs the structure and function
of dermal fibroblasts. These data provide the foundation for understanding specific mechanisms that
link collagen fragmentation to decline of fibroblast function, and development of novel approaches
to improving skin health in the aged.
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Loss of type VII collagen in squamous cell carcinoma leads to increased invasion and TGF-
beta signalling in vivo
V Martins,1 K Moore,2 M Chen,3 J Marshall2 and EA O’Toole1 1 Centre for Cutaneous Research,
Barts and the London School of Medicine and Dentistry, London, United Kingdom, 2 Institute
of Cancer, Barts and the London School of Medicine and Dentistry, London, United Kingdom
and 3 Dermatology, University of Southern California, Los Angeles, CA
Mutations in the type VII collagen (ColVII) gene cause the blistering disorder, recessive dystrophic
epidermolysis bullosa (RDEB), associated with increased risk of metastatic squamous cell carcinoma
(SCC). We have previously shown that transient knock-down of ColVII increased SCC migration/inva-
sion with increased epithelial-mesenchymal transition (EMT). In this study, we explored the role of
TGF-beta in tumorigenesis of SCC cells with absent ColVII. Stable knock-down of ColVII was estab-
lished in human cutaneous SCC cell lines using lentiviral shRNA with > 95% knock-down. Live
cell imaging suggested that ColVII-knock-down cells (shCOL7) have increased migration, as well
as changes in tail retraction and membrane protrusions, when compared to shControl cells. Expres-
sion of the Rho GTPases RhoA and Cdc42 was increased in shCOL7 cells, a possible explanation
for the membrane changes observed. Results from 3-D organotypic cultures demonstrated that
shCOL7 cells have increased expression of active TGF-beta as well as the TGF-beta-pathway tar-
gets CTGF, CLIC4 and p-ERK1/2. Interestingly, addition of a TGF-beta type I receptor inhibitor, SD-
208, reduced cell migration as well as components of the TGF-beta pathway in shCOL7 cell 3-D
cultures. Grafting of composites of cells and collagen gels onto immunodeficient nude mice for 6
weeks demonstrated that shCOL7 cells are more invasive than control with reduced differentiation.
Increased expression of the TGF-beta signalling pathway components, pSmad2/3, was also observed
in invading cells in vivo. Our results suggest that the TGF-beta pathway may play a critical role in
migration of SCC cells with absent ColVII. Furthermore, we provide in vivo evidence for the first
time that SCC cells with loss of ColVII are more invasive contributing to a better understanding of
the accelerated metastasis of RDEB SCC.
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Elucidation of the molecular mechanisms underlying inversa type of recessive dystrophic
epidermolysis bullosa using site-directed mutagenesis
Y Hou, J Cogan, E Cua, S Lee, D Woodley and M Chen Dermatology, University of Southern
California, Los Angeles, CA
Type VII collagen (C7), composed of a central triple helical domain (TH) flanked by non-helical
domains, NC1 and NC2, is the major component of anchoring fibrils. Mutations in the type VII col-
lagen gene (COL7A1) cause dystrophic epidermolysis bullosa (DEB). Inversa recessive DEB (RDEB-
I), a rare form of DEB, is associated with missense mutations involving arginine or glycine within
the TH. Because the lesions in RDEB-I are mainly restricted to body sites with higher skin temper-
ature, it has been hypothesized that the pathophysiology of RDEB-I is temperature dependent. How-
ever, the biological consequences of specific COL7A1 mutations leading to the unique RDEB-I phe-
notypes have not been extensively elucidated. In this study, we generated 18 substitution mutations
associated with RDEB-I and purified the recombinant mutant proteins. Biochemical, structural and
functional characterization of the purified mutant C7s and comparisons of them with wild type C7
under different temperatures demonstrated: (1) All mutations except G1907E synthesized and secreted
a 290 kDa mutant C7 at levels similar to the wild type C7. (2) Most RDEB-I mutations produced
mutant C7s with the reduced thermal stability, as demonstrated by increased sensitivity to protease
digestion and reduced ability to form trimers at higher temperature. (3) Many RDEB-I mutations gen-
erated mutated C7s with significantly reduced ability to promote keratinocyte migration and sup-
port cell adhesion at higher temperatures. Nevertheless, under lower temperature, these RDEB-I
mutant C7s were as effective as wild type C7 in supporting keratinocyte adhesion and migration.
(4) The R2622W and R2628W RDEB-I mutations next to NC2 reduced C7’s ability to form antipar-
allel dimers. We conclude that effects of RDEB-I mutations on C7 functions such as folding, molec-
ular stability, cell attachment, or cell motility are highly temperature dependent and are concor-
dant with the observed clinical phenotype.
198
Elevated Cysteine-rich protein 61 (CYR61/CCN1) mediates down-regulation of collagen expres-
sion in senescent human dermal fibroblasts.
T Quan, Z Qin, T He, JJ Voorhees and GJ Fisher Dermatology, University of Michigan, Ann
Arbor, MI
Chronologically aged human skin is thin and fragile, largely as a consequence of reduced dermal
connective tissue collagen. Type I collagen fibrils are the major constituent of the dermal extracel-
lular matrix, which confers mechanical strength. Age-related loss of connective tissue collagen results
from reduced synthesis and increased degradation of collagen by dermal fibroblasts, the primary
cells responsible for collagen homeostasis in skin. Cysteine-rich protein 61 (CCN1), a member of
CCN family proteins, is elevated in aged human skin in vivo. CCN1 is a secreted matricellular pro-
tein that regulates collagen metabolism in dermal fibroblasts. We utilized replicative senescent pri-
mary adult human dermal fibroblasts as an in vitro aging model to investigate the role of elevated
CCN1 in age-related alterations of collagen homeostasis. Replicative senescent dermal fibroblasts
expressed significantly lower collagen mRNA and protein (n=3, p<0.01) and significantly elevated
collagen-degrading matrix metalloproteinase-1 mRNA and protein (n=3, p<0.05), compared to non-
senescent fibroblasts. These alterations in collagen metabolism mimic those observed in aged human
skin in vivo. Importantly, CCN1 was increased 3-fold in senescent fibroblasts, compared to non-
senescent fibroblasts (n=3, p<0.05), similar to the elevation of CCN1 that is observed in aged human
skin in vivo. siRNA-mediated knock-down of elevated CCN1 in senescent dermal fibroblasts par-
tially normalized collagen homeostasis by increasing type I collagen expression (3-fold, n=3, p<0.01)
and reducing MMP-1 expression (2-fold, n=3, p<0.05). Given the ability of CCN1 to regulate both
synthesis and degradation of type I collagen in human dermal fibroblasts, it is likely that elevated-
CCN1 functions as an important mediator of collagen deficiency that occurs in aged human skin.
CCN1 is a novel therapeutic target to lessen skin fragility in the aged.
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Vascularization of human acellular dermis on chick chorioallantoic membrane
P Blasi,1 M Andreassi,2 L Barberini,3 A Schoubben,1 P Alberti,4 M Ricci,1 C Anselmi,2 C Cirotto,3
C Rossi1 and L Andreassi5 1 Department of Pharmaceutical Technology, University of Perugia,
Perugia, Italy, 2 Department of Pharmaceutical Technology, University of Siena, Siena, Italy, 3
Department of Environmental and Cellular Biology, University of Perugia, Perugia, Italy, 4
Department of Internal Medicine, University of Perugia, Perugia, Italy and 5 Department of
Dermatology, University of Siena, Siena, Italy
The EU has adopted a ban on animal testing for cosmetic ingredients or finished products. These
regulations have promoted the research on alternative reliable systems, some of which have already
been approved. In order to develop models of engineered skin, a vascularised de-epidermised der-
mis(DED) was developed on chicken embryo chorioallantoic membrane (CAM) as alive support.
DED was obtained using skin fragments from discarded surgical skin treated by repeated freeze-
thawing cycles in liquid nitrogen and irradiated by 3.5 Gy from a cobalt source. Fertilized eggs were
incubated in a vertical position and windowed 3 days after incubation for alive embryo selection.
At day 6, DED was deposited on the CAM with the basal lamina contiguous to the latter. DED was
added, alternatively, with foetal calf serum, epidermal growth factor, and keratinocyte culture medium.
An untreated group was used as control. Embryos were photographed every day and scarified at
day 12. DED together with the CAM were fixed and processed for histological examination. Stereo-
scopic examination during the experiments showed an easily invasion of the implanted DED by
chicken erythrocytes. Due to the DED thickness, methaemoglobin was sometimes observed. At day
12, the non supplemented DED shrunk with an evident size reduction. Histological examination
showed the colonization of the de-cellularised matrix and the formation of a rudimental vascular
structure. These preliminary results look very promising for the production of vascularised systems,
a basis for the engineered skin construction.
188
Ephrins promote the EphA2-EphA1 transition to regulate epidermal differentiation
SY Lin, K Gordon, H Blatt, N Kaplan, RM Lavker and S Getsios Dermatology, Northwestern
University, Chicago, IL
EphA1 and EphA2 are highly related receptor tyrosine kinases (RTKs) that mediate cell-cell com-
munication when engaged by ephrin ligands residing on adjacent cells. Although EphA1 and EphA2
are both expressed by normal human epidermal keratinocytes (NHEKs), EphA2 becomes down-
regulated whereas EphA1 levels remain high in more differentiated organotypic raft cultures and
intact human epidermis. Both receptors compete for the same ephrin-A1 ligand, which we recently
showed was capable of promoting keratinocyte differentiation via an increase in the desmosome
adhesion molecule, desmoglein 1. Accordingly, ligand-mediated differentiation was also accom-
panied by the loss of EphA2 and maintenance of EphA1. These observations led us to hypothesize
that ephrin ligands remove EphA2 from the cell surface in order to allow EphA1 to promote ker-
atinocyte differentiation. In support of this possibility, EphA2 was rapidly (15 min) recruited to sites
of cell-cell contact in NHEKs switched into high Ca2+ while EphA1 was only stabilized at mature
junctions after 24 h. Overexpression of EphA1 to enhance its signaling during the initial stages of
keratinocyte differentiation resulted in the early recruitment of EphA1 at cell-cell junctions and
accelerated keratinocyte differentiation. In contrast, gene silencing of EphA1 impaired epidermal
differentiation and morphogenesis in organotypic raft cultures and led to the re-expression of EphA2.
Similarly, sustaining high levels of EphA2 by ectopic overexpression in raft cultures reduced nor-
mal EphA1 levels and limited differentiation. Collectively, these studies provide compelling evi-
dence that epidermal homeostasis is maintained by a tightly regulated balance between EphA1 and
EphA2, which is likely controlled by ephrin ligands. Targeting ephrins to restore the proper EphA2-
EphA1 equilibrium may represent a novel therapeutic approach to diseases of altered keratiniza-
tion.
189
Possible role of a multi-domain adaptor protein, ArgBP2, in the tight junction maintenance
of epithelial cells
K Murase,1 H Ito,2 K Sudo,2 I Iwamoto,2 R Morishita,2 H Kanoh,1 M Seishima1 and K Nagata2 1
Dermatology, Gifu University Graduate School of Medicine, Gifu, Japan and 2 Molecular
Neurobiology, Institute for Developmental Research, Aichi Human Service Center, Kasugai,
Japan
Arg-binding protein 2 (ArgBP2) is a member of the SoHo (Sorbin Homology) family of multi-domain
adaptor proteins composed of ArgBP2, vinexin and CAP/Ponsin. They share three SH3 domains
and a SoHo domain at the C- and N-terminals, respectively. Accumulating evidence suggests that
SoHo family proteins are involved in cell migration, spreading and adhesion through the cytoskele-
ton-related signal transduction, although the molecular basis of its function is almost unknown. On
the other hand, vinexin was reported to be localized at cell-cell junctoins in some epithelial cells,
raising the possibility that ArgBP2 also functions at cell-cell junctions. Immunofluorescence analy-
ses revealed that ArgBP2 was enriched at tight junctions (TJs) in epithelial NMuMG cells while
vinexin showed cytoplasmic distribution in the cell. Interestingly, ArgBP2 was recruited from cytosol
to TJs as the cell became polarized, and the second SH3 domain was essential for the TJ-localiza-
tion. Meanwhile, we identified ArgBP2δ, a novel short isoform consisting of three SH3 domains
and lacking SoHo domain. We compared biochemical and cell biological characters of ArgBP2δ
to those of vinexinβ with structural similarity to ArgBP2δ. Like vinexinβ, ArgBP2δ, directly bound
with actin-polymerizing factor, N-WASP. Also, ArgBP2δ as well as vinexinβ activated extracellular
signal-regulated kinase (ERK) in an anchorage-independent manner. On the other hand, while vinex-
inβ interacted with mSos, an activating factor for small GTPase Ras and Rac, ArgBP2δ did not.
Taken together, our findings suggest that ArgBP2 has distinct functions from vinexin, and is involved
in the maintenance of TJs possibly through actin-cytoskeletal organizaton and cell signaling in
NMuMG cells.
190
Action of skincare active ingredients on actin and matrix contraction in dermal and epider-
mal structures ex vivo
E Lati,1 F Arnold,2 C Merle,1 L Peno-Mazzarino,1 P Gasser1 and M Mercier3 1 Laboratoire Bio-EC,
Centre de Recherches Biologiques et d’Expérimentations Cutanées, Longjumeau, France, 2
MMP Sarl, Issy les Moulineaux, France and 3 MMP, Inc., South Plainfield, NJ
Actin is a protein involved in the cell-cell communication through the formation of gap junctions
and in the cellular shape, stimulating the cellular functional capacity. It exists under monomer
granular forms and under polymerized filamentous forms. Its role in tissue repair (epithelialization
and fibroblasts contraction) has been described in cells culture and in in vitro tests. Actin stress fibers
also play an important role in force and mechanical transmission and transmit focal adhesions to
the extracellular matrix and create matrix contraction. The aim of this study is to evaluate ex vivo
the presence and configuration of actin in human skin explants maintained in survival. A prelimi-
nary step evaluated actin expression as a function of age in young human skin sections and mature
human skin sections. Living skin explants of the selected age were then treated topically by skin-
care ingredients active on collagen gel contraction in vitro. After treatment, the following parame-
ters were monitored: general morphology of the epidermal and dermal structures, expression of
actin after specific immunostaining and contact between fibroblasts and the extracellular matrix.
In this experimental model, the treatment with ingredients which are active on matrix contraction
in vitro shows that these materials interfere with the actin expression and can modulate force trans-
mission in the skin ex vivo.
191
Novel properties of a well-known molecule: Urea stimulates collagen production by human
dermal fibroblasts
S Grether-Beck,1 F Ingo,1 H Brenden,1 A Marini,1 T Jaenicke,1 C Trullas,2 PM Elias,3 M Rodriguez-
Martin4 and J Krutmann1 1 IUF-Leibniz Research Institute for Environmental Medicine,
Duesseldorf, Germany, 2 ISDIN, Barcelona, Spain, 3 VA Medical Center, San Francisco, CA
and 4 Hospital Universitario de Canarias, San Francisco, Spain
Urea has been used for decades in dermatology to treat dry skin conditions. In previous studies we
have shown that urea has unrecognized gene regulatory properties to enhance keratinocyte differ-
entiation in vitro and in vivo and to upregulate the expression of antimicrobial peptides within the
epidermis. Now we show for the first time that urea also acts on cultured primary human dermal
fibroblasts (HDF) by induction of expression of the main dermal collagens COL1A1 and COL1A2
on mRNA and protein level. These effects were of in-vivo relevance because in a placebo-controlled,
double-blinded study with 21 healthy human volunteers, a 4-week application of a 10 % and even
more a 20% urea containing topical preparation significantly increased the expression of COL1A1
by a factor of 6.1 and 7.3, and COL1A2 by a factor of 5.6 and 6.7 as compared to the untreated
control. Expression of collagen was significantly higher in the urea treated skin areas as compared
to the placebo control and could be corroborated on the protein level by immunohistochemistry.
At a mechanistical level, urea induced collagen gene expression in HDF was not due to a urea
induced shift in osmolarity, but mediated by specific urea transporters. HDF expressed the human
urea transporters hUTA2 and hUTA1, and the competitive urea transport inhibitor thiourea decreased
14C labelled urea uptake in HDF by 60% and most importantly, also blocked urea induced upreg-
ulation of collagens. These studies show for the first time that urea possesses gene regulatory prop-
erties which can be used to stimulate collagen synthesis in HDFs. This unexpected property of urea
indicates that this well known compound may be used for the treatment of (photo)-aged skin.
192
Antagonizing the effects of pemphigus IgG by manipulating intracellular protein O-glycosy-
lation
P Berkowitz1 and D Rubenstein1,2,3 1 Dermatology, UNC-CH, Chapel Hill, NC, 2
Pharmacology, UNC-CH, Chapel Hill, NC and 3 Lineberger Comprehensive Cancer Center,
UNC-CH, Chapel Hill, NC
In pemphigus vulgaris (PV), pathogenic IgG against desmosomal cadherins induce loss of keratinocyte
cell-cell adhesion resulting in clinical blisters. Previous work by our group and others suggests that
pathogenic PV IgG activate intracellular events that contribute to loss of cell-cell adhesion. Two
key events in PV acantholysis appear to be activation of p38MAPK and endocytosis of dsg3. We
have previously shown that inhibition of p38MAPK blocks dsg3 endocytosis and blistering in both
in vitro and in vivo models of PV and PF. This observation suggests that stabilization of the desmo-
some represents a potential approach to treating pemphigus. Regulation of the desmosome is likely
to be multifaceted. Analagous to phosphorylation, O-glycosylation of serine and threonine residues
of intracellular proteins is a common regulatory post-translational modification. Two intracellular
enzymes, OGT and OGA, mediate addition and removal, respectively, of N-acetylglucosamine (Glc-
NAc) from intracellular protein substrates. Previous data from our group demonstrated that O-gly-
cosylation stabilizes cell-cell adhesion in part by increasing the post-translational stability of desmo-
some components including plakoglobin. This observation suggests that increasing intracellular
protein O-glycosylation could stabilize the desmosome and make cells resistant to PV IgG. To test
this hypothesis, human keratinocytes were treated with the OGA inhibitor PUGNAc. In cells treated
with PUGNAc, we observed (i) increased intracellular protein O-glycosylation, (ii) increased amounts
of desmosome proteins, (iii) and increased resistance to the biological effects of PV IgG including
resistance of PUGNAc treated keratinocytes to PV IgG induced dsg3 endocytosis. These observa-
tions suggest that pharmacologic stabilization of desmosomal proteins by manipulation of O-Glc-
NAc protein modification could represent an additional therapeutic approach to pemphigus.
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Oral prednisone use and risk of keratinocyte carcinoma: The VA topical tretinoin chemopre-
vention trial
AT Baibergenova1 and MA Weinstock2,3,4 1 Dermatology Division, University of Toronto,
Toronto, ON, Canada, 2 Dermatoepidemiology Unit, VA Medical Center, Providence, RI, 3
Department of Dermatology, RI Hospital, Providence, RI and 4 Department of Dermatology,
Brown University, Providence, RI
Some retrospective studies have reported increased risk of basal cell carcinoma (BCC) and squa-
mous cell carcinoma (SCC) associated with glucocorticosteroid use. We sought to assess the effect
of oral glucocorticosteroid use on the risk of BCC and SCC using prospective data. A cohort study
was conducted in the Veterans Affairs Topical Tretinoin Chemoprevention trial. Eligible veterans
had 2 or more keratinocyte carcinomas in the 5 years prior to enrollment; none were organ-trans-
plant recipients. Two primary outcomes were: time to first diagnosis of BCC and time to first diag-
nosis of SCC. Exposure to prednisone was ascertained from the VA pharmacy records and defined
as any use prednisone during study period and as use of prednisone for 30 days or more. Prednisone
was the only glucocorticosteroid used by study participants. Cox proportional hazards models
were used to estimate hazard ratios (HRs) after adjustment for multiple potential confounders. The
1051 study participants were followed for median of 3.4 years. Forty four percent of participants
developed at least one BCC and 29% at least one SCC during study. One forty eight (14.1%) patients
had a prednisone prescription filled during study period, and 63 (6.0%) patients had used it for a
month or more. Among any time prednisone users, the adjusted HR was 1.07 (95% CI, 0.84-1.37)
for BCC, and 1.05 (95% CI, 0.76-1.44) for SCC. Among those who used oral prednisone for 30 or
more days, the adjusted HR was 1.26 (95% CI, 0.90-1.78) for BCC, and 1.03 (95% CI, 0.66-1.61)
for SCC. Our study does not support the existence of an association between use of oral prednisone
and risk of BCC or SCC.
207
Dermatologist preferences for first-line therapy of moderate-to-severe psoriasis in healthy
adults
J Wan,1 K Abuabara,1 AB Troxel,1 DB Shin,1 AS Van Voorhees,1,2 BF Bebo,2 GG Krueger,3 K Callis
Duffin3 and JM Gelfand1 1 University of Pennsylvania, Philadelphia, PA, 2 National Psoriasis
Foundation, Portland, OR and 3 University of Utah, Salt Lake City, UT
Despite increasing therapies for moderate-to-severe psoriasis, dermatologists’ treatment preferences
are unknown and must be assessed to understand the determinants of treatment selection and to
inform future comparative effectiveness trials. Thus 1000 US dermatologists (500 National Psoria-
sis Foundation and 500 American Academy of Dermatology members who treat psoriasis; response
rate 39%) were surveyed about their preferences for first-line treatment of moderate-to-severe pso-
riasis in healthy adults of childbearing age. Preferred therapies for males and females were: UVB
(40% and 56%, respectively), etanercept (15%, 19%), methotrexate (16%, 4%), and adalimumab
(12%, 10%). Sixty-six percent of respondents had phototherapy units in their practice. After adjust-
ing for provider characteristics, those preferring first-line UVB for males or females were more
likely to have phototherapy in their practice (OR 3.4, 95% CI 1.8-6.6 and OR 2.8, 95% CI 1.5-5.3,
respectively) and to have used UVB in more than 10 patients in the last 3 months (OR 8.0, 95% CI
3.9-16.4; OR 9.6, 95% CI 4.3-21.6). Heavy etanercept or methotrexate use in recent months was
also associated with first-line preference for those therapies. Physicians in the Midwest were sig-
nificantly more likely than those in the Northeast to prefer adalimumab first-line for male and females
(OR 26.4, 95% CI 2.9-241.1 and OR 19.5, 95% CI 2.9-133.6, respectively). In this first U.S.-wide
study of dermatologists’ treatment preferences for psoriasis, we observe low phototherapy avail-
ability relative to its selection for first-line use even in a sample of dermatologists interested in pso-
riasis. Despite UVB being commonly preferred first-line for moderate-to-severe psoriasis in healthy
adults, preferences vary based on region, phototherapy availability, and prior treatment experi-
ence, suggesting wide variation in preference unrelated to the patient’s indication for treatment.
209
Menopausal hormones and skin cancer risk in postmenopausal women: The women’s health
initiative hormone therapy trials.
KM Spaunhurst,1,2 JY Tang,1 E Keiser,1 ML Anderson,5 RT Chlebowski,3 JC Larson,6 J Ockene,4
F Thomas,8 J Wactawski-Wende,7 N Zeitouni7 and ML Stefanick1 1 Department of Dermatology,
Stanford University School of Medicine, Stanford, CA, 2 University of Southern California
Keck School of Medicine, Los Angeles, CA, 3 Departments of Medicine, Surgery, and
Obstetrics and Gynecology, UCLA School of Medicine, Harbor-UCLA Medical Center, Los
Angeles, CA, 4 University of Massachusetts, Worcester, MA, 5 Baylor College of Medicine,
Houston, TX, 6 WHI Clinical Coordinating Center, Fred Hutchinson Cancer Research Center,
Seattle, WA, 7 University of Buffalo, Buffalo, NY and 8 University of Tennessee Health Science
Center, Memphis, TN
Case-control studies have reported a higher risk of skin cancer with exogenous estrogen use. The
associations of menopausal hormone therapy (HT) with nonmelanoma skin cancer (NMSC) and
melanoma were evaluated in randomized controlled trials of combined estrogen plus progestin
(E+P) and estrogen only (E-alone) HT. Postmenopausal women aged 50-79 years were randomly
assigned to conjugated equine estrogen (CEE, 0.625 mg/d) plus medroxyprogesterone acetate (2.5
mg/d) or placebo if they had an intact uterus (N=16,608) or to the CEE alone or placebo if they had
a prior hysterectomy (N=10,739) for a mean follow-up of 5.6 years and 7.1 years, respectively.
NMSC (N= 980 in E+P trial, N = 820 in E-alone trial; total N=1800) and melanoma (N=57, N=38,
respectively; total N=95) skin cancers were ascertained by annual self-report; melanoma reports
underwent physician adjudication. Incident NMSC and melanoma rates were similar between active
hormone and placebo groups (NMSC hazard ratio, HR: 0.98; 95% confidence interval, CI: 0.89,
1.07 and melanoma HR: 0.92; 95% CI 0.61, 1.37, respectively). Results were similar for the E+P
and E-alone trials, when analyzed individually. HT did not affect NMSC or melanoma outcomes
within any of six pre-specified subgroups, e.g. age, BMI, UV exposure, history of cancer, smoking
or NSAID use as determined at enrollment. Our results show that HT does not affect risk of NMSC
or melanoma in postmenopausal women.
208
Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin
cancer.
T Fu,1 JY Tang,1 E LeBlanc,2 JE Manson,3 D Feldman,1 J Larson,4 E Linos,1 MZ Vitolins,5
NC Zeitouni6 and ML Stefanick1 1 Dermatology, Stanford School of Medicine, Redwood City,
CA, 2 Northwest Kaiser Center for Health Research, Portland, OR, 3 Division of Preventive
Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 4 WHI
Clinical Coordinating Center, Fred Hutchinson Cancer Research Center, Seattle, WA, 5 Roswell
Park Cancer Institute and University at Buffalo, NY, Buffalo, NY and 6 Department of Health
Sciences, Wake Forest University, Winston-Salem, NC
Vitamin D intake and serum 25-hydroxyvitamin D levels have been inversely associated with risk
of nonmelanoma skin cancer (NMSC) and melanoma in several observational studies. These rela-
tionships were evaluated within a randomized clinical trial. Postmenopausal women aged 50-79
years (N=36,282) were randomly assigned to 1000 mg of elemental calcium plus 400 IU of vita-
min D3 daily or placebo in the Women’s Health Initiative calcium plus vitamin D (CaD) clinical
trial with a mean follow-up of 7.0 years. NMSC and melanoma were ascertained by annual self-
report; melanoma cases underwent physician adjudication. Incident NMSC and melanoma rates
were similar between treatment and placebo groups (HR: 1.02; 95% CI 0.95, 1.09 and HR: 0.86;
95% CI 0.64, 1.16, respectively). In a pre-specified 16-subgroup analysis, CaD supplementation
decreased risk of melanoma in women with prior history of NMSC (HR 0.43, 95% CI 0.21, 0.90,
p-interaction=0.038) but not in women without history of NMSC (HR 1.02, 95% CI 0.73, 1.41). In
a separate analysis, women with serum 25(OH)D levels < 20 ng/mL were at increased risk for
melanoma compared to women with levels > 30 ng/mL (OR 5.04, 95% CI 1.66, 15.25, p=0.004.)
Overall, CaD supplementation did not reduce overall incidence of NMSC or melanoma. However,
supplementation reduced risk of melanoma in women with prior history of NMSC, and low serum
25(OH)D levels were associated with higher risk for melanoma. These findings suggest a possible
role for calcium, vitamin D, or both in reducing melanoma risk in women at high risk for melanoma
due to history of NMSC.
206
Patients with psoriasis are at an increased risk of diabetes - a population based study
NM Seminara,1 RS Azfar,1,2 DB Shin,1,2 AB Troxel,2 DJ Margolis1,2 and JM Gelfand1,2 1
Dermatology, Univ. of Pennsylvania, Philadelphia, PA and 2 Center for Clinical Epidemiology
and Biostatistics, Univ. of Pennsylvania, Philadelphia, PA
Studies have shown that psoriasis, especially if severe, is associated with obesity, insulin resistance,
and type II diabetes mellitus (T2DM); however no studies have analyzed if diabetics with psoriasis
are at risk for more severe diabetes requiring control with insulin or oral hypoglycemics. Our aim
was to perform the largest longitudinal, population-based cohort study to assess the risk and sever-
ity of incident T2DM in psoriasis. A cohort of patients was identified in The Health Improvement
Network (THIN), a medical records database representative of 5% of the UK population. The exposed
psoriasis cohort consisted of patients 18-90 yrs who received a previously validated psoriasis diag-
nostic code. A diagnosis of T2DM required 2+ diagnostic T2DM codes or one code and a treatment
or lab. To study incident T2DM we excluded any patient with a diabetes code prior to or within one
year of their start date. Psoriasis patients were classified as mild or severe based on psoriasis treat-
ment patterns, and each was matched with up to four unexposed controls from the same practice
who were seen in a similar timeframe. 139,959 patients met criteria for our exposed psoriasis cohort
and 6,229 of them were classified as severe psoriasis. Cox proportional hazard models adjusted for
age, sex, BMI, HTN, and hyperlipidemia revealed a hazard ratio for incident T2DM of 1.45 (95CI:
1.27-1.65) in the severe group, and 1.11 (95CI; 1.07-1.16) in the mild group. Furthermore a nested
cohort study of all patients with incident T2DM revealed the adjusted odds ratio of receiving an
oral or insulin diabetes treatment was 1.55 (95CI: 1.15-2.10) in the severe psoriasis group and 1.01
(95CI: 0.93-1.10) in the mild group. This study suggests that psoriasis, especially if severe, is an inde-
pendent risk factor for T2DM and that patients with severe psoriasis and T2DM are more likely to
require oral or insulin treatment compared to diabetics who do not have psoriasis.
210
Validation of the AJCC staging system for cutaneous squamous cell carcinoma and a proposed
refinement to improve prognostic discrimination
A Jambusaria,1 P Kanetsky,5 W Hwang,5 J Gelfand,1,5 F Whalen,4 R Elenitsas,1 G Xu3 and
C Schmults2 1 Dept of Dermatology, Hospital of the Univ. of Penn., Philadelphia, PA, 2 Dept
of Dermatology, Dana Farber Cancer Center, Jamaica Plain, MA, 3 Dept of Pathology, Hospital
of the Univ. of Penn., Philadelphia, PA, 4 Dept of Dermatology, Geisinger Medical System,
Danville, PA and 5 Center for Clinical Epidemiology and Biostatistics, Univ. of Penn. School of
Medicine, Philadelphia, PA
Identify predictive factors of nodal metastasis (NM) and validate the 2010 AJCC staging system for
high risk cutaneous squamous cell carcinoma (HRCSCC). Retrospective cohort study. Medical records
of a randomly selected proportion of patients with HRCSCC were reviewed for clinical and patho-
logic high-risk factors and disease recurrence. The primary endpoint was NM with secondary end-
points including local recurrence (LR) and disease-specific death. Logistic Regression modeling was
used to determine independent risk factors for endpoints of interest. The data was classified based
on the 2010 AJCC T staging system and compared to a refined staging system developed using data
from this study. Medical records of 292 HRCSCC cases were reviewed. During a median follow-up
period of 44 months, 28 patients developed LR, 43 patients developed NM, and 21 patients died
from disease. On multivariate analysis, prognostic factors for NM included poorly differentiated his-
tology (OR 7.3; 95%CI 3.1-17.3), diameter ≥2cm (OR 3.7; 95%CI 1.5-8.8), and tumor depth beyond
the fat (OR; 95%CI 1.9-13.2). In the refined staging system developed, there was improved dis-
crimination between T subgroups with a higher number of events with increasing T stage. Poorly
differentiated histology, size ≥2 cm, and tumor depth beyond the fat are independently associated
with NM. The alternative staging system proposed in this study may have improved prognostic dis-
crimination over the current AJCC staging system. Optimal management of HRCSCC awaits the
development of an accurate prognostic model and a validated tumor staging system with excellent
discrimination.
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Fibronectin is a negative regulator of keratinocyte migration
KJ Hamill, SB Hopkinson, P Hoover, V Todorovic, KJ Green and JC Jones Northwestern
University, Chicago, IL
Epidermal cell migration is essential in skin wound repair. To dissect the mechanisms underlying
keratinocyte migration, we assay the movement of single cells viewed in real time by phase con-
trast microscopy. Strikingly, in this assay, mouse epidermal keratinocytes (MEKs) displayed dramat-
ically slower migration rates than their human counterparts (HEKs). Moreover, plating HEKs onto
the extracellular matrix elaborated by MEKs led to a dramatic reduction in their migration rate rel-
ative to the motility of HEKs on HEK derived matrix. This result suggests that differences in matrix
composition may contribute to the differential migratory behaviors. In the skin, two major ECM
proteins, laminin 332 (LM332) and fibronectin (FN) are upregulated during wound healing and both
have been reported to support cell motility. We therefore analyzed the expression of LM332 and
FN in primary and immortalized MEKs and HEKs. While LM332 levels were similar across species,
the mouse-derived cells expressed significantly more FN than human cells. Interestingly, as pri-
mary HEK passage number increased their migration rates were enhanced while concomitantly, FN
expression levels decreased. These data raise the possibility that the presence of FN in the matrix
of MEKs contributes to their slower migration. To test this possibility, we used siRNA to reduce MEK
FN expression. MEKs exhibiting FN knockdown displayed increased migration rates compared to
control siRNA treated MEKs. Moreover, HEKs plated onto matrix elaborated by FN deficient MEKs
migrated significantly faster than following plating onto a control MEK matrix. Taken together, our
results indicate a fundamental difference in matrix composition of cultured MEKs and HEKs, which
influences their motile behaviors. Furthermore, our data uncover a previously unappreciated func-
tion for FN in retarding the migration of keratinocytes.
200
The desmosomal protein plakophilin 2 is required for proper extracellular matrix attachment
and keratinocyte differentiation
EV Amargo,1 JL Koetsier,1 JL Johnson,1 V Todorovic,1 KJ Green1,2 and LM Godsel1,2 1 Pathology,
Northwestern University, Chicago, IL and 2 Dermatology, Northwestern University, Chicago,
IL
Members of the plakophilin (PKP) subfamily of armadillo proteins are components of desmosomes,
intercellular junctions essential for maintaining tissue integrity. Mutations in PKP family members
have been linked to skin and heart diseases, illustrating their importance in tissue function. PKP2
associates with the intermediate filament anchoring protein desmoplakin (DP) in cytoplasmic junc-
tion precursors and PKP2 knock down (KD) results in aberrant DP junction assembly. We recently
showed that PKP2 regulates DP dynamics following cadherin ligation in part through proper local-
ization of activated RhoA GTPase and cortical actin remodeling. This was accompanied by global
elevation of RhoA activity and an increase in stress fibers and other indicators of contractile sig-
naling. Based on these findings, we hypothesized that PKP2 may also regulate extracellular matrix
(ECM) attachment and focal adhesion formation and dynamics, well known RhoA signaling targets.
Results showed that after 15min, ~30% more PKP2KD cells attached to collagen I coated surfaces
than control cells. However, 5hrs after attachment PKP2KD cell areas were ~50% of the size of the
well-spread control cells. Activated forms of the focal adhesion proteins FAK and paxillin, normally
observed at leading edges during contact formation, were decreased upon PKP2KD. Cell-substrate
adhesion and RhoA activity have been proposed as regulators of terminal differentiation. As PKP2
is predominantly expressed in the basal layer of skin this protein may spatially control actin dynam-
ics to allow for cell-cell contacts, while maintaining proper basement membrane attachments. Pre-
liminary findings show that PKP2-silenced organotypic skin cultures exhibited morphologic abnor-
malities such as parakeratosis. The data support a model whereby PKP2 regulates RhoA signaling,
affecting cytoskeletal organization, ECM attachments and keratinocyte differentiation.
201
Increasing insulin resistance correlates with progressive skin damage in murine models of
obesity and diabetes
A Al-Habian, MS Zaibi, CJ Stocker, MA Kepczynska, ET Wargent, MA Cawthorne and K Langlands
The Clore Laboratory, University of Buckingham, Buckingham, United Kingdom
Dermatological complications are extremely common in type II diabetes mellitus, although little is
known of their molecular basis. Murine models of obesity-associated insulin resistance are useful
in elucidating mechanisms of, for example, impaired wound healing, but they may also provide
insight into other pathophysiological processes in the skin. We investigated dorsal skin integrity in
a series of mildly insulin-resistant (dietary-induced obesity), insulin-resistant ob/ob and frankly dia-
betic db/db mice. Subcutaneous adipose expansion was accompanied by a reduction in dermal
depth, ranging from a 26% reduction in dietary-induced obesity through to a decrease of 71% in
the most obese animals, relative to lean controls. Papillary dermis was retained in all groups, although
cross-polar imaging of picro-sirius stained sections showed a loss of normal “basket-weave” organ-
isation. Profiling subcutaneous adipokine release from obese animals did not reveal an increase in
proinflammatory cytokines, and no histological evidence of chronic inflammation was detected
with either giemsa or CD68 staining. Notably, skin damage preceded the onset of hyperglycaemia,
and neither periodic acid-Schiff nor RAGE staining identified increased glycation in any model, sug-
gesting an intrinsic role for impaired insulin signalling in dermal pathology. Patterns of K14, involu-
crin and profilaggrin immunoreactivity indicated that epidermal development was unaffected except
in the most insulin-resistant animals, which displayed abnormal terminal differentiation. Dermal
fibroblasts isolated from 3 month old ob/ob mice showed a loss of fibroblast morphology, reduced
proliferation, increased senescence and a 27% reduction in collagen production compared to
wild-type controls, providing an in vitro model to investigate the molecular basis of dermal pathol-
ogy. These studies will facilitate understanding of the mechanisms of peripheral damage in meta-
bolic disease, and may lead to new approaches to the management of diabetic skin lesions.
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The MAPKAP kinase MK2 regulates desmoglein 3 endocytosis by pemphigus vulgaris autoan-
tibodies
X Mao and AS Payne Dermatology, University of Pennsylvania, Philadelphia, PA
Pemphigus vulgaris (PV) is a potentially fatal blistering disease characterized by autoantibodies
(autoAbs) against the cell adhesion protein desmoglein (Dsg) 3. The current model for disease patho-
physiology is that pathogenic autoAbs bind the intercellular adhesion domain of Dsg3, leading to
its endocytosis and depletion from the desmosome, whereas nonpathogenic autoAbs bind non-
adhesive domains and do not affect Dsg3 function. Therapy for pemphigus relies on general immune
suppression to decrease serum antibodies, which risks fatal infection and secondary cancers. A novel
and potentially safer approach to therapy could instead target the end-organ pathologic response,
i.e. Dsg3 endocytosis. Prior studies have shown that the mitogen activated protein kinase (MAPK)
p38 regulates Dsg3 endocytosis in response to PV autoAbs. However, p38 has 4 isoforms and at
least 17 downstream targets, contributing to lack of specificity and systemic toxicity with current
clinical p38 inhibitors. We therefore sought to identify downstream effectors of p38 that regulate
Dsg3 endocytosis. In primary human keratinocytes, pathogenic but not nonpathogenic PV autoAbs
activate the p38 MAPK-activated protein (MAPKAP) kinase MK2 in a dose-dependent manner. Small
molecule inhibition of MK2 prevents pathogenic PV autoAb-induced Dsg3 internalization by
immunofluorescence and loss of desmosomal Dsg3 by subcellular fractionation. MK2 inhibition or
RNAi silencing of MK2 expression causes a calcium-independent increase of cell surface Dsg3 in
primary human keratinocytes, suggesting that MK2 inhibition prevents endocytosis of Dsg3 from
the cell surface rather than inhibiting the translocation of Dsg3 to the cell surface after biosynthe-
sis. Taken together, these data suggest that MK2 is a key downstream effector of p38 that regulates
Dsg3 endocytosis. A better understanding of the role of MK2 in modulating desmosomal cell adhe-
sion may lead to novel adjunctive therapies for pemphigus.
203
MtDNA changes alter murine fibroblasts migration and invasiveness by inducing the expres-
sion of the matrix metalloproteinase 9 (MMP-9), an effect mediated by NF-κB
J Janda,1,2,3 J Jandova1,2,3 and JE Sligh1,2,3 1 Southern Arizona VA Healthcare System, Tucson, AZ,
2 Arizona Cancer Center, Tucson, AZ and 3 University of Arizona, Tucson, AZ
MtDNA mutations are frequently found in human malignancies and are thought to contribute to
neoplasia. We exploited the homogeneous nature of the mouse mitochondrial genome to investi-
gate the role of mtDNA mutations in skin cancer by generating the murine fibroblast cybrid cell
lines that have identical nuclear genomes and differ in their mtDNA. Microarray analysis revealed
that the specific mtDNA changes result in up-regulation of matrix matalloproteinases (MMPs) MMP-
9 and MMP-2 and down-regulation of collagen in mtBALB cybrids compared to mtB6 cybrids. Based
on the reported role of MMPs in tumor cell invasion and migration we examined whether the mtBALB
haplotype is associated with higher level of cell migration and invasiveness compared to mtB6
haplotype. We conducted transwell migration assays through uncoated inserts and invasion assays
through matrigel coated transwells. The mtBALB cybrids demonstrate significantly increased migra-
tion (3-fold) and invasion (2.5-fold) ability compared to mtB6 cybrids. The broad range MMP inhibitor
GM6001 significantly inhibited migratory and invasion abilities of mtBALB cybrids what confirms
a critical role for MMPs in cellular motility. Nuclear factor-κB (NF-κB) is a key transcription factor
for production of MMPs. An inhibitor of NF-κB activation, Bay11-7082, was used to inhibit the
expression of MMP-9 in cybrids. Transwell assays were performed in order to see whether decreased
expression of MMP-9 caused by Bay11-7082 would diminish migratory abilities of cybrids. Our
results showed a significant decrease in migration and invasion of mtBALB cybrids in the presence
of NF-κB inhibitor. These studies confirm a role of NF-κB in the regulation of MMP-9 expression
and through this regulation modulates the migration and invasion capabilities of mtBALB cybrids.
Enhanced migration and invasion capabilities caused by up-regulated MMP-9 may contribute to the
tumorigenic phenotypic characteristics of mtBALB cybrids.
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Hemoglobin a1c predicts healing rate in diabetic wounds
AL Christman,1 E Selvin,1 GS Lazarus2,3 and LA Garza2,3 1 Epidemiology, Johns Hopkins
University Bloomberg School of Public Health, Baltimore, MD, 2 Dermatology, Johns Hopkins
University School of Medicine, Baltimore, MD and 3 Johns Hopkins Wound Center, Johns
Hopkins University Bayview Medical Center, Baltimore, MD
Lower-extremity wounds and amputations are a major complication of diabetes mellitus. The iden-
tification of clinical factors that can be modified to promote healing will improve patient health.
Hemoglobin A1c (HbA1c) is the standard measure for glycemic control over the past 2-3 months,
but results from previous studies have not shown a consistent association of HbA1c with wound
healing in persons with diabetes. We hypothesized that elevated HbA1c values would be the strongest
predictor of poor healing among commonly ordered laboratory studies. To test our hypothesis we
constructed a retrospective cohort of 183 diabetic individuals treated at the Johns Hopkins Wound
Center. Our primary outcome was wound-area healing rate (cm2/day). Calibrated tracings of digi-
tal images were used to measure wound area. We estimated coefficients for healing rate using a
multiple linear regression model controlling for clustering of wounds within individuals and other
common clinic variables. The study population was 45% female and 41% black with a mean age
of 61 years. The mean HbA1c was 8.0% and there were 2.3 wounds per individual (310 wounds
total). Of all laboratory measures assessed, only HbA1c was significantly independently associated
with wound-area-healing rate. Specifically, for each 1% increase in HbA1c, the daily wound-area-
healing rate decreased by 0.03 cm2 (95% CI: 0.01, 0.06, p = 0.02). The association remained sig-
nificant when the analysis was restricted to neuropathic foot wounds (p = 0.033) but the associa-
tion was not significant when restricted to all other wounds (p = 0.306). In conclusion, our results
suggest that optimizing glycemia will speed wound healing in diabetic patients.
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Oral prednisone use and risk of keratinocyte carcinoma: The VA topical tretinoin chemopre-
vention trial
AT Baibergenova1 and MA Weinstock2,3,4 1 Dermatology Division, University of Toronto,
Toronto, ON, Canada, 2 Dermatoepidemiology Unit, VA Medical Center, Providence, RI, 3
Department of Dermatology, RI Hospital, Providence, RI and 4 Department of Dermatology,
Brown University, Providence, RI
Some retrospective studies have reported increased risk of basal cell carcinoma (BCC) and squa-
mous cell carcinoma (SCC) associated with glucocorticosteroid use. We sought to assess the effect
of oral glucocorticosteroid use on the risk of BCC and SCC using prospective data. A cohort study
was conducted in the Veterans Affairs Topical Tretinoin Chemoprevention trial. Eligible veterans
had 2 or more keratinocyte carcinomas in the 5 years prior to enrollment; none were organ-trans-
plant recipients. Two primary outcomes were: time to first diagnosis of BCC and time to first diag-
nosis of SCC. Exposure to prednisone was ascertained from the VA pharmacy records and defined
as any use prednisone during study period and as use of prednisone for 30 days or more. Prednisone
was the only glucocorticosteroid used by study participants. Cox proportional hazards models
were used to estimate hazard ratios (HRs) after adjustment for multiple potential confounders. The
1051 study participants were followed for median of 3.4 years. Forty four percent of participants
developed at least one BCC and 29% at least one SCC during study. One forty eight (14.1%) patients
had a prednisone prescription filled during study period, and 63 (6.0%) patients had used it for a
month or more. Among any time prednisone users, the adjusted HR was 1.07 (95% CI, 0.84-1.37)
for BCC, and 1.05 (95% CI, 0.76-1.44) for SCC. Among those who used oral prednisone for 30 or
more days, the adjusted HR was 1.26 (95% CI, 0.90-1.78) for BCC, and 1.03 (95% CI, 0.66-1.61)
for SCC. Our study does not support the existence of an association between use of oral prednisone
and risk of BCC or SCC.
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Dermatologist preferences for first-line therapy of moderate-to-severe psoriasis in healthy
adults
J Wan,1 K Abuabara,1 AB Troxel,1 DB Shin,1 AS Van Voorhees,1,2 BF Bebo,2 GG Krueger,3 K Callis
Duffin3 and JM Gelfand1 1 University of Pennsylvania, Philadelphia, PA, 2 National Psoriasis
Foundation, Portland, OR and 3 University of Utah, Salt Lake City, UT
Despite increasing therapies for moderate-to-severe psoriasis, dermatologists’ treatment preferences
are unknown and must be assessed to understand the determinants of treatment selection and to
inform future comparative effectiveness trials. Thus 1000 US dermatologists (500 National Psoria-
sis Foundation and 500 American Academy of Dermatology members who treat psoriasis; response
rate 39%) were surveyed about their preferences for first-line treatment of moderate-to-severe pso-
riasis in healthy adults of childbearing age. Preferred therapies for males and females were: UVB
(40% and 56%, respectively), etanercept (15%, 19%), methotrexate (16%, 4%), and adalimumab
(12%, 10%). Sixty-six percent of respondents had phototherapy units in their practice. After adjust-
ing for provider characteristics, those preferring first-line UVB for males or females were more
likely to have phototherapy in their practice (OR 3.4, 95% CI 1.8-6.6 and OR 2.8, 95% CI 1.5-5.3,
respectively) and to have used UVB in more than 10 patients in the last 3 months (OR 8.0, 95% CI
3.9-16.4; OR 9.6, 95% CI 4.3-21.6). Heavy etanercept or methotrexate use in recent months was
also associated with first-line preference for those therapies. Physicians in the Midwest were sig-
nificantly more likely than those in the Northeast to prefer adalimumab first-line for male and females
(OR 26.4, 95% CI 2.9-241.1 and OR 19.5, 95% CI 2.9-133.6, respectively). In this first U.S.-wide
study of dermatologists’ treatment preferences for psoriasis, we observe low phototherapy avail-
ability relative to its selection for first-line use even in a sample of dermatologists interested in pso-
riasis. Despite UVB being commonly preferred first-line for moderate-to-severe psoriasis in healthy
adults, preferences vary based on region, phototherapy availability, and prior treatment experi-
ence, suggesting wide variation in preference unrelated to the patient’s indication for treatment.
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Menopausal hormones and skin cancer risk in postmenopausal women: The women’s health
initiative hormone therapy trials.
KM Spaunhurst,1,2 JY Tang,1 E Keiser,1 ML Anderson,5 RT Chlebowski,3 JC Larson,6 J Ockene,4
F Thomas,8 J Wactawski-Wende,7 N Zeitouni7 and ML Stefanick1 1 Department of Dermatology,
Stanford University School of Medicine, Stanford, CA, 2 University of Southern California
Keck School of Medicine, Los Angeles, CA, 3 Departments of Medicine, Surgery, and
Obstetrics and Gynecology, UCLA School of Medicine, Harbor-UCLA Medical Center, Los
Angeles, CA, 4 University of Massachusetts, Worcester, MA, 5 Baylor College of Medicine,
Houston, TX, 6 WHI Clinical Coordinating Center, Fred Hutchinson Cancer Research Center,
Seattle, WA, 7 University of Buffalo, Buffalo, NY and 8 University of Tennessee Health Science
Center, Memphis, TN
Case-control studies have reported a higher risk of skin cancer with exogenous estrogen use. The
associations of menopausal hormone therapy (HT) with nonmelanoma skin cancer (NMSC) and
melanoma were evaluated in randomized controlled trials of combined estrogen plus progestin
(E+P) and estrogen only (E-alone) HT. Postmenopausal women aged 50-79 years were randomly
assigned to conjugated equine estrogen (CEE, 0.625 mg/d) plus medroxyprogesterone acetate (2.5
mg/d) or placebo if they had an intact uterus (N=16,608) or to the CEE alone or placebo if they had
a prior hysterectomy (N=10,739) for a mean follow-up of 5.6 years and 7.1 years, respectively.
NMSC (N= 980 in E+P trial, N = 820 in E-alone trial; total N=1800) and melanoma (N=57, N=38,
respectively; total N=95) skin cancers were ascertained by annual self-report; melanoma reports
underwent physician adjudication. Incident NMSC and melanoma rates were similar between active
hormone and placebo groups (NMSC hazard ratio, HR: 0.98; 95% confidence interval, CI: 0.89,
1.07 and melanoma HR: 0.92; 95% CI 0.61, 1.37, respectively). Results were similar for the E+P
and E-alone trials, when analyzed individually. HT did not affect NMSC or melanoma outcomes
within any of six pre-specified subgroups, e.g. age, BMI, UV exposure, history of cancer, smoking
or NSAID use as determined at enrollment. Our results show that HT does not affect risk of NMSC
or melanoma in postmenopausal women.
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Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin
cancer.
T Fu,1 JY Tang,1 E LeBlanc,2 JE Manson,3 D Feldman,1 J Larson,4 E Linos,1 MZ Vitolins,5
NC Zeitouni6 and ML Stefanick1 1 Dermatology, Stanford School of Medicine, Redwood City,
CA, 2 Northwest Kaiser Center for Health Research, Portland, OR, 3 Division of Preventive
Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 4 WHI
Clinical Coordinating Center, Fred Hutchinson Cancer Research Center, Seattle, WA, 5 Roswell
Park Cancer Institute and University at Buffalo, NY, Buffalo, NY and 6 Department of Health
Sciences, Wake Forest University, Winston-Salem, NC
Vitamin D intake and serum 25-hydroxyvitamin D levels have been inversely associated with risk
of nonmelanoma skin cancer (NMSC) and melanoma in several observational studies. These rela-
tionships were evaluated within a randomized clinical trial. Postmenopausal women aged 50-79
years (N=36,282) were randomly assigned to 1000 mg of elemental calcium plus 400 IU of vita-
min D3 daily or placebo in the Women’s Health Initiative calcium plus vitamin D (CaD) clinical
trial with a mean follow-up of 7.0 years. NMSC and melanoma were ascertained by annual self-
report; melanoma cases underwent physician adjudication. Incident NMSC and melanoma rates
were similar between treatment and placebo groups (HR: 1.02; 95% CI 0.95, 1.09 and HR: 0.86;
95% CI 0.64, 1.16, respectively). In a pre-specified 16-subgroup analysis, CaD supplementation
decreased risk of melanoma in women with prior history of NMSC (HR 0.43, 95% CI 0.21, 0.90,
p-interaction=0.038) but not in women without history of NMSC (HR 1.02, 95% CI 0.73, 1.41). In
a separate analysis, women with serum 25(OH)D levels < 20 ng/mL were at increased risk for
melanoma compared to women with levels > 30 ng/mL (OR 5.04, 95% CI 1.66, 15.25, p=0.004.)
Overall, CaD supplementation did not reduce overall incidence of NMSC or melanoma. However,
supplementation reduced risk of melanoma in women with prior history of NMSC, and low serum
25(OH)D levels were associated with higher risk for melanoma. These findings suggest a possible
role for calcium, vitamin D, or both in reducing melanoma risk in women at high risk for melanoma
due to history of NMSC.
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Patients with psoriasis are at an increased risk of diabetes - a population based study
NM Seminara,1 RS Azfar,1,2 DB Shin,1,2 AB Troxel,2 DJ Margolis1,2 and JM Gelfand1,2 1
Dermatology, Univ. of Pennsylvania, Philadelphia, PA and 2 Center for Clinical Epidemiology
and Biostatistics, Univ. of Pennsylvania, Philadelphia, PA
Studies have shown that psoriasis, especially if severe, is associated with obesity, insulin resistance,
and type II diabetes mellitus (T2DM); however no studies have analyzed if diabetics with psoriasis
are at risk for more severe diabetes requiring control with insulin or oral hypoglycemics. Our aim
was to perform the largest longitudinal, population-based cohort study to assess the risk and sever-
ity of incident T2DM in psoriasis. A cohort of patients was identified in The Health Improvement
Network (THIN), a medical records database representative of 5% of the UK population. The exposed
psoriasis cohort consisted of patients 18-90 yrs who received a previously validated psoriasis diag-
nostic code. A diagnosis of T2DM required 2+ diagnostic T2DM codes or one code and a treatment
or lab. To study incident T2DM we excluded any patient with a diabetes code prior to or within one
year of their start date. Psoriasis patients were classified as mild or severe based on psoriasis treat-
ment patterns, and each was matched with up to four unexposed controls from the same practice
who were seen in a similar timeframe. 139,959 patients met criteria for our exposed psoriasis cohort
and 6,229 of them were classified as severe psoriasis. Cox proportional hazard models adjusted for
age, sex, BMI, HTN, and hyperlipidemia revealed a hazard ratio for incident T2DM of 1.45 (95CI:
1.27-1.65) in the severe group, and 1.11 (95CI; 1.07-1.16) in the mild group. Furthermore a nested
cohort study of all patients with incident T2DM revealed the adjusted odds ratio of receiving an
oral or insulin diabetes treatment was 1.55 (95CI: 1.15-2.10) in the severe psoriasis group and 1.01
(95CI: 0.93-1.10) in the mild group. This study suggests that psoriasis, especially if severe, is an inde-
pendent risk factor for T2DM and that patients with severe psoriasis and T2DM are more likely to
require oral or insulin treatment compared to diabetics who do not have psoriasis.
210
Validation of the AJCC staging system for cutaneous squamous cell carcinoma and a proposed
refinement to improve prognostic discrimination
A Jambusaria,1 P Kanetsky,5 W Hwang,5 J Gelfand,1,5 F Whalen,4 R Elenitsas,1 G Xu3 and
C Schmults2 1 Dept of Dermatology, Hospital of the Univ. of Penn., Philadelphia, PA, 2 Dept
of Dermatology, Dana Farber Cancer Center, Jamaica Plain, MA, 3 Dept of Pathology, Hospital
of the Univ. of Penn., Philadelphia, PA, 4 Dept of Dermatology, Geisinger Medical System,
Danville, PA and 5 Center for Clinical Epidemiology and Biostatistics, Univ. of Penn. School of
Medicine, Philadelphia, PA
Identify predictive factors of nodal metastasis (NM) and validate the 2010 AJCC staging system for
high risk cutaneous squamous cell carcinoma (HRCSCC). Retrospective cohort study. Medical records
of a randomly selected proportion of patients with HRCSCC were reviewed for clinical and patho-
logic high-risk factors and disease recurrence. The primary endpoint was NM with secondary end-
points including local recurrence (LR) and disease-specific death. Logistic Regression modeling was
used to determine independent risk factors for endpoints of interest. The data was classified based
on the 2010 AJCC T staging system and compared to a refined staging system developed using data
from this study. Medical records of 292 HRCSCC cases were reviewed. During a median follow-up
period of 44 months, 28 patients developed LR, 43 patients developed NM, and 21 patients died
from disease. On multivariate analysis, prognostic factors for NM included poorly differentiated his-
tology (OR 7.3; 95%CI 3.1-17.3), diameter ≥2cm (OR 3.7; 95%CI 1.5-8.8), and tumor depth beyond
the fat (OR; 95%CI 1.9-13.2). In the refined staging system developed, there was improved dis-
crimination between T subgroups with a higher number of events with increasing T stage. Poorly
differentiated histology, size ≥2 cm, and tumor depth beyond the fat are independently associated
with NM. The alternative staging system proposed in this study may have improved prognostic dis-
crimination over the current AJCC staging system. Optimal management of HRCSCC awaits the
development of an accurate prognostic model and a validated tumor staging system with excellent
discrimination.
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Fibronectin is a negative regulator of keratinocyte migration
KJ Hamill, SB Hopkinson, P Hoover, V Todorovic, KJ Green and JC Jones Northwestern
University, Chicago, IL
Epidermal cell migration is essential in skin wound repair. To dissect the mechanisms underlying
keratinocyte migration, we assay the movement of single cells viewed in real time by phase con-
trast microscopy. Strikingly, in this assay, mouse epidermal keratinocytes (MEKs) displayed dramat-
ically slower migration rates than their human counterparts (HEKs). Moreover, plating HEKs onto
the extracellular matrix elaborated by MEKs led to a dramatic reduction in their migration rate rel-
ative to the motility of HEKs on HEK derived matrix. This result suggests that differences in matrix
composition may contribute to the differential migratory behaviors. In the skin, two major ECM
proteins, laminin 332 (LM332) and fibronectin (FN) are upregulated during wound healing and both
have been reported to support cell motility. We therefore analyzed the expression of LM332 and
FN in primary and immortalized MEKs and HEKs. While LM332 levels were similar across species,
the mouse-derived cells expressed significantly more FN than human cells. Interestingly, as pri-
mary HEK passage number increased their migration rates were enhanced while concomitantly, FN
expression levels decreased. These data raise the possibility that the presence of FN in the matrix
of MEKs contributes to their slower migration. To test this possibility, we used siRNA to reduce MEK
FN expression. MEKs exhibiting FN knockdown displayed increased migration rates compared to
control siRNA treated MEKs. Moreover, HEKs plated onto matrix elaborated by FN deficient MEKs
migrated significantly faster than following plating onto a control MEK matrix. Taken together, our
results indicate a fundamental difference in matrix composition of cultured MEKs and HEKs, which
influences their motile behaviors. Furthermore, our data uncover a previously unappreciated func-
tion for FN in retarding the migration of keratinocytes.
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The desmosomal protein plakophilin 2 is required for proper extracellular matrix attachment
and keratinocyte differentiation
EV Amargo,1 JL Koetsier,1 JL Johnson,1 V Todorovic,1 KJ Green1,2 and LM Godsel1,2 1 Pathology,
Northwestern University, Chicago, IL and 2 Dermatology, Northwestern University, Chicago,
IL
Members of the plakophilin (PKP) subfamily of armadillo proteins are components of desmosomes,
intercellular junctions essential for maintaining tissue integrity. Mutations in PKP family members
have been linked to skin and heart diseases, illustrating their importance in tissue function. PKP2
associates with the intermediate filament anchoring protein desmoplakin (DP) in cytoplasmic junc-
tion precursors and PKP2 knock down (KD) results in aberrant DP junction assembly. We recently
showed that PKP2 regulates DP dynamics following cadherin ligation in part through proper local-
ization of activated RhoA GTPase and cortical actin remodeling. This was accompanied by global
elevation of RhoA activity and an increase in stress fibers and other indicators of contractile sig-
naling. Based on these findings, we hypothesized that PKP2 may also regulate extracellular matrix
(ECM) attachment and focal adhesion formation and dynamics, well known RhoA signaling targets.
Results showed that after 15min, ~30% more PKP2KD cells attached to collagen I coated surfaces
than control cells. However, 5hrs after attachment PKP2KD cell areas were ~50% of the size of the
well-spread control cells. Activated forms of the focal adhesion proteins FAK and paxillin, normally
observed at leading edges during contact formation, were decreased upon PKP2KD. Cell-substrate
adhesion and RhoA activity have been proposed as regulators of terminal differentiation. As PKP2
is predominantly expressed in the basal layer of skin this protein may spatially control actin dynam-
ics to allow for cell-cell contacts, while maintaining proper basement membrane attachments. Pre-
liminary findings show that PKP2-silenced organotypic skin cultures exhibited morphologic abnor-
malities such as parakeratosis. The data support a model whereby PKP2 regulates RhoA signaling,
affecting cytoskeletal organization, ECM attachments and keratinocyte differentiation.
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Increasing insulin resistance correlates with progressive skin damage in murine models of
obesity and diabetes
A Al-Habian, MS Zaibi, CJ Stocker, MA Kepczynska, ET Wargent, MA Cawthorne and K Langlands
The Clore Laboratory, University of Buckingham, Buckingham, United Kingdom
Dermatological complications are extremely common in type II diabetes mellitus, although little is
known of their molecular basis. Murine models of obesity-associated insulin resistance are useful
in elucidating mechanisms of, for example, impaired wound healing, but they may also provide
insight into other pathophysiological processes in the skin. We investigated dorsal skin integrity in
a series of mildly insulin-resistant (dietary-induced obesity), insulin-resistant ob/ob and frankly dia-
betic db/db mice. Subcutaneous adipose expansion was accompanied by a reduction in dermal
depth, ranging from a 26% reduction in dietary-induced obesity through to a decrease of 71% in
the most obese animals, relative to lean controls. Papillary dermis was retained in all groups, although
cross-polar imaging of picro-sirius stained sections showed a loss of normal “basket-weave” organ-
isation. Profiling subcutaneous adipokine release from obese animals did not reveal an increase in
proinflammatory cytokines, and no histological evidence of chronic inflammation was detected
with either giemsa or CD68 staining. Notably, skin damage preceded the onset of hyperglycaemia,
and neither periodic acid-Schiff nor RAGE staining identified increased glycation in any model, sug-
gesting an intrinsic role for impaired insulin signalling in dermal pathology. Patterns of K14, involu-
crin and profilaggrin immunoreactivity indicated that epidermal development was unaffected except
in the most insulin-resistant animals, which displayed abnormal terminal differentiation. Dermal
fibroblasts isolated from 3 month old ob/ob mice showed a loss of fibroblast morphology, reduced
proliferation, increased senescence and a 27% reduction in collagen production compared to
wild-type controls, providing an in vitro model to investigate the molecular basis of dermal pathol-
ogy. These studies will facilitate understanding of the mechanisms of peripheral damage in meta-
bolic disease, and may lead to new approaches to the management of diabetic skin lesions.
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The MAPKAP kinase MK2 regulates desmoglein 3 endocytosis by pemphigus vulgaris autoan-
tibodies
X Mao and AS Payne Dermatology, University of Pennsylvania, Philadelphia, PA
Pemphigus vulgaris (PV) is a potentially fatal blistering disease characterized by autoantibodies
(autoAbs) against the cell adhesion protein desmoglein (Dsg) 3. The current model for disease patho-
physiology is that pathogenic autoAbs bind the intercellular adhesion domain of Dsg3, leading to
its endocytosis and depletion from the desmosome, whereas nonpathogenic autoAbs bind non-
adhesive domains and do not affect Dsg3 function. Therapy for pemphigus relies on general immune
suppression to decrease serum antibodies, which risks fatal infection and secondary cancers. A novel
and potentially safer approach to therapy could instead target the end-organ pathologic response,
i.e. Dsg3 endocytosis. Prior studies have shown that the mitogen activated protein kinase (MAPK)
p38 regulates Dsg3 endocytosis in response to PV autoAbs. However, p38 has 4 isoforms and at
least 17 downstream targets, contributing to lack of specificity and systemic toxicity with current
clinical p38 inhibitors. We therefore sought to identify downstream effectors of p38 that regulate
Dsg3 endocytosis. In primary human keratinocytes, pathogenic but not nonpathogenic PV autoAbs
activate the p38 MAPK-activated protein (MAPKAP) kinase MK2 in a dose-dependent manner. Small
molecule inhibition of MK2 prevents pathogenic PV autoAb-induced Dsg3 internalization by
immunofluorescence and loss of desmosomal Dsg3 by subcellular fractionation. MK2 inhibition or
RNAi silencing of MK2 expression causes a calcium-independent increase of cell surface Dsg3 in
primary human keratinocytes, suggesting that MK2 inhibition prevents endocytosis of Dsg3 from
the cell surface rather than inhibiting the translocation of Dsg3 to the cell surface after biosynthe-
sis. Taken together, these data suggest that MK2 is a key downstream effector of p38 that regulates
Dsg3 endocytosis. A better understanding of the role of MK2 in modulating desmosomal cell adhe-
sion may lead to novel adjunctive therapies for pemphigus.
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MtDNA changes alter murine fibroblasts migration and invasiveness by inducing the expres-
sion of the matrix metalloproteinase 9 (MMP-9), an effect mediated by NF-κB
J Janda,1,2,3 J Jandova1,2,3 and JE Sligh1,2,3 1 Southern Arizona VA Healthcare System, Tucson, AZ,
2 Arizona Cancer Center, Tucson, AZ and 3 University of Arizona, Tucson, AZ
MtDNA mutations are frequently found in human malignancies and are thought to contribute to
neoplasia. We exploited the homogeneous nature of the mouse mitochondrial genome to investi-
gate the role of mtDNA mutations in skin cancer by generating the murine fibroblast cybrid cell
lines that have identical nuclear genomes and differ in their mtDNA. Microarray analysis revealed
that the specific mtDNA changes result in up-regulation of matrix matalloproteinases (MMPs) MMP-
9 and MMP-2 and down-regulation of collagen in mtBALB cybrids compared to mtB6 cybrids. Based
on the reported role of MMPs in tumor cell invasion and migration we examined whether the mtBALB
haplotype is associated with higher level of cell migration and invasiveness compared to mtB6
haplotype. We conducted transwell migration assays through uncoated inserts and invasion assays
through matrigel coated transwells. The mtBALB cybrids demonstrate significantly increased migra-
tion (3-fold) and invasion (2.5-fold) ability compared to mtB6 cybrids. The broad range MMP inhibitor
GM6001 significantly inhibited migratory and invasion abilities of mtBALB cybrids what confirms
a critical role for MMPs in cellular motility. Nuclear factor-κB (NF-κB) is a key transcription factor
for production of MMPs. An inhibitor of NF-κB activation, Bay11-7082, was used to inhibit the
expression of MMP-9 in cybrids. Transwell assays were performed in order to see whether decreased
expression of MMP-9 caused by Bay11-7082 would diminish migratory abilities of cybrids. Our
results showed a significant decrease in migration and invasion of mtBALB cybrids in the presence
of NF-κB inhibitor. These studies confirm a role of NF-κB in the regulation of MMP-9 expression
and through this regulation modulates the migration and invasion capabilities of mtBALB cybrids.
Enhanced migration and invasion capabilities caused by up-regulated MMP-9 may contribute to the
tumorigenic phenotypic characteristics of mtBALB cybrids.
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Hemoglobin a1c predicts healing rate in diabetic wounds
AL Christman,1 E Selvin,1 GS Lazarus2,3 and LA Garza2,3 1 Epidemiology, Johns Hopkins
University Bloomberg School of Public Health, Baltimore, MD, 2 Dermatology, Johns Hopkins
University School of Medicine, Baltimore, MD and 3 Johns Hopkins Wound Center, Johns
Hopkins University Bayview Medical Center, Baltimore, MD
Lower-extremity wounds and amputations are a major complication of diabetes mellitus. The iden-
tification of clinical factors that can be modified to promote healing will improve patient health.
Hemoglobin A1c (HbA1c) is the standard measure for glycemic control over the past 2-3 months,
but results from previous studies have not shown a consistent association of HbA1c with wound
healing in persons with diabetes. We hypothesized that elevated HbA1c values would be the strongest
predictor of poor healing among commonly ordered laboratory studies. To test our hypothesis we
constructed a retrospective cohort of 183 diabetic individuals treated at the Johns Hopkins Wound
Center. Our primary outcome was wound-area healing rate (cm2/day). Calibrated tracings of digi-
tal images were used to measure wound area. We estimated coefficients for healing rate using a
multiple linear regression model controlling for clustering of wounds within individuals and other
common clinic variables. The study population was 45% female and 41% black with a mean age
of 61 years. The mean HbA1c was 8.0% and there were 2.3 wounds per individual (310 wounds
total). Of all laboratory measures assessed, only HbA1c was significantly independently associated
with wound-area-healing rate. Specifically, for each 1% increase in HbA1c, the daily wound-area-
healing rate decreased by 0.03 cm2 (95% CI: 0.01, 0.06, p = 0.02). The association remained sig-
nificant when the analysis was restricted to neuropathic foot wounds (p = 0.033) but the associa-
tion was not significant when restricted to all other wounds (p = 0.306). In conclusion, our results
suggest that optimizing glycemia will speed wound healing in diabetic patients.
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Contribution of nodular subtype to overall melanoma mortality
WR Shaikh,1,2 M Xiong1,2 and MA Weinstock1,2 1 Dermatoepidemiology Unit, VA Medical Ctr.,
Providence, RI and 2 Dermatology, Brown University, Providence, RI
Traditional public health efforts have focused on the ABCD warning signs for melanoma. These signs,
however, are best at detecting superficial spreading melanoma (SSM) rather than nodular melanoma
(NM). Since NM is less common than SSM, and the primary goal is to reduce overall melanoma
mortality, we sought to determine the population-based contribution of NM vs. SSM to melanoma
deaths. Our primary analysis used the original 9 Surveillance, Epidemiology, and End Results
(SEER) registries established in the 1970’s, which include 10% of the US population. We examined
the incidence of melanomas that were ultimately fatal according to death certificates. Since over-
all relative survival stabilizes after 9 years, we limited our analysis to 1973-97 with follow-up through
2007 when evaluating ultimately fatal melanomas. When restricting focus to melanomas of speci-
fied subtypes, SSM and NM represent 66% and 14% of incident melanomas, respectively. How-
ever, SSM and NM represent 46% and 36% of ultimately fatal incident melanomas (proportions
that varied little from the 1970’s to 1997), with no other subtype accounting for more than 6%. A
large proportion of invasive melanomas (43%) was not classified by subtype (NOS). The proportion
of melanomas that were NOS correlated most closely with the proportion of SSM among melanomas
of specified subtypes (r= -0.77). However, the proportion of melanoma NOS also strongly posi-
tively correlated with the proportion of NM (r=+0.58). We compared the relative survival of patients
with each subtype of melanoma diagnosed in 1978-87 to those diagnosed in 1988-97. Relative
survival for NM and acral lentiginous melanoma differed little between the two periods, but sub-
stantial improvements were noted in relative survival for SSM, lentigo maligna melanoma and
melanoma NOS. We see links between SSM and melanoma NOS but cannot make firm inferences.
Our data do strongly suggest that NM makes a substantial contribution to melanoma mortality in
the US, and that public health messages should include a focus on NM for maximum reduction of
mortality.
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Increased dermatologist density associated with reduction in melanoma mortality
S Aneja,1,2 S Aneja3 and JS Bordeaux1,2 1 Dept of Dermatology, University Hospitals Case
Medical Center, Cleveland, OH, 2 Case Western Reserve University School of Medicine,
Cleveland, OH and 3 Yale University School of Medicine, New Haven, CT
We sought to determine the association between dermatologist density and melanoma mortality in
US counties. We also examined the effect of age, race, education, income, unemployment rate,
health insurance rate, density of primary care physicians, melanoma incidence, county demographics
(metropolitan vs. non metropolitan), access to hospitals with oncologic services and health profes-
sional shortage area classification on melanoma mortality. Data were collected from the Area
Resource File, US Centers for Disease Control, and National Cancer Institute’s Surveillance, Epi-
demiology, and End Results and National Program for Cancer Registries. Multivariate analysis demon-
strated that the presence of >0 to 1 dermatologist per 100,000 people was associated with a 35%
reduction in melanoma mortality (95% CI 13.4% to 56.6%) when compared to counties with no
dermatologist. The presence of >1 to 2 dermatologists per 100,000 people was associated with a
53% reduction in melanoma mortality (95% CI 30.6% to 75.4%). Having more than 2 dermatolo-
gists per 100,000 people did not further decrease melanoma mortality. Melanoma mortality was
also decreased in metropolitan counties (30.3%, 95% CI 17.3% to 43.3%) and in counties where
there are hospitals with oncology departments (1.9%, 95% CI 0.6% to 3.1%). Melanoma mortality
rates were increased in counties with higher incidence of melanoma (2.3%, 95% CI 1.6% to 3.1%),
greater Caucasian population (1.5%, 95% CI 1.1% to 1.9%), and greater health insured populations
(1.5%, 95% CI 0.2% to 2.8%). Age, education, income, primary care provider density, health pro-
fessional shortage area classification, and unemployment rate were not associated with melanoma
mortality. In conclusion, we found that a greater dermatologist density is associated with a signifi-
cant reduction in melanoma mortality when compared to counties that lacked a dermatologist.
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An age estimation study using spatial frequency analysis on digital images of Japanese women’s
faces
A Tada,1 S Inoue Torii,2 M Hayashi,1 M Ohata1 and K Yamazaki1 1 POLA Chemical Industries,
Inc., Yokohama, Japan and 2 Konan Women’s University, Kobe, Japan
The face provides important information about age and helps build personal relationships and dis-
tinguish an individual. Current technology allows us to estimate age based on wrinkles or slack in
the face, as well as changes in the shape of the eyes, nose, or mouth. The objective of this study
was to examine a methodology designed to estimate age based on the whole face image, rather than
a specific part of the face, using spatial frequency analysis technology. Subjects comprised 140
healthy Japanese women (mean age, 49 years; range, 19-82 years). Photographs of the whole face
were taken using a single lens reflex digital camera. Digital images of photographs were edited to
remove hair, convert the image into a 1024 x 1024 pixel gray digital image, fix the pupils of the
right and left eyes at a constant position, and standardize the size and position of the face. Spatial
frequency was analyzed with MATLAB software. All statistical analyses were performed using SPSS
software. Correlation values were determined between power values of the spatial frequency analy-
sis and each subject’s age. High spatial frequency domains that increased the positive correlation
with age and low spatial frequency domains that showed a negative correlation with age were rec-
ognized. We carried out cluster analysis of power values of the spatial frequency analysis to clas-
sify the characteristic frequency; this frequency was a power value that was classified into four
domains. We used linear regression analysis and then multiple regression analysis. The dependent
variable was the subject’s age, and the independent variable was the power value from the spatial
frequency analysis. The multiple correlation coefficient was R=0.869, which indicates high preci-
sion. We classified frequency of facial characteristics into four frequency domains by analyzing a
complete facial image of women using spatial frequency. Using the power value of each domain,
we established a method that could estimate the age of a Japanese woman based on facial appear-
ance.
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Psoriasis and risk of hypertension in US women
AW Armstrong,1 J Han,2,3,4 T Li,3 JP Forman3 and AA Qureshi2,3 1 Dermatology, University of
California Davis, Sacramento, CA, 2 Dermatology, Brigham and Women’s Hospital, Harvard
Medical School, Boston, MA, 3 Channing Laboratory, Brigham and Women’s Hospital,
Harvard Medical School, Boston, MA and 4 Epidemiology, Harvard School of Public Health,
Boston, MA
Previous epidemiologic studies have suggested an association between psoriasis and hypertension.
We evaluated the association between psoriasis and risk of incident hypertension in two large US
cohorts of women: Nurses’ Health Study (NHS) from 1998 to 2006 and Nurses’ Health Study (NHS
II) from 1991 to 2007. A total of 130,102 women (39,089 from NHS and 91,013 from NHSII) were
included in this study with complete information on psoriasis, hypertension and covariates of inter-
est. During the combined 1,543,529 person-years of follow-up, 4,981 women reported psoriasis.
Of these, 1,930 had baseline psoriasis in 1991 (NHSII) and 1998 (NHS) respectively, and 3,051
women developed psoriasis during follow-up. A total of 36,527 cases of incident hypertension
occurred during the follow-up. The age-adjusted relative risk (RR) for hypertension among women
with psoriasis was 1.18 (95%CI 1.10-1.27). After simultaneous adjustment for age, body mass index,
smoking, alcohol intake, and physical activity, RR for hypertension was 1.09 (95% CI, 1.01-1.17).
In a subset of women with confirmed psoriasis from NHS II, the age-adjusted RR of hypertension
was 1.20 (95% CI 1.06-1.35) and multivariate RR was 1.07 (95%CI 0.94-1.20). We also evaluated
the effect of age on the association between psoriasis and hypertension; multivariate RR of hyper-
tension for women <50 years age at the end of follow-up in NHS II was 1.15 (95%CI 1.03-1.27)
and 0.97 (95%CI 0.82-1.16) for women ≥50 years. In this study, psoriasis was associated with a sig-
nificantly increased risk of hypertension.
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Negative psychological impact of striae gravidarum
K Korgavkar, Y Helfrich, H Chubb, JJ Voorhees, GJ Fisher and F Wang Department of
Dermatology, University of Michigan, Ann Arbor, MI
Striae gravidarum (SG), or stretch marks during pregnancy, may occur in as many as 90% of women.
We evaluated the psychological impact of SG with respect to sociodemographic factors and sever-
ity of lesions by surveying pregnant women with or without SG. To examine correlation between
variables, Pearson product-moment correlation coefficients were generated. Of the responders
(N=84), 81% were ages 25-35, 69% were Caucasian, 64% were primigravidas, and 89% were in
the third trimester. Eighty percent (80%) noted permanency of SG as the main concern. When SG
were present (N=64), lesion severity ranged from “barely visible” (N=20) to “moderate” (N=31) to
“very prominent” (N=13), while embarrassment from SG was reported as “not at all” (N=21), “a lit-
tle” (N=19), “moderate” (N=15) or “a lot” (N=9). In order of decreasing correlation, increased sever-
ity of SG was correlated with increased impact on embarrassment/self-consciousness (R=0.55,
P<0.0001), self-esteem (R=0.48, P<0.0001), anxiety or depression (R=0.45, P=0.0002), choice of
attire (R=0.40, P=0.001), and quality of life (QOL) (R=0.39, P=0.002). Of note, increased degree
of embarrassment due to SG was correlated with increased impact on self-esteem (R=0.70, P<0.0001),
social activities (R=0.56, P<0.0001), QOL (R=0.55, P<0.0001) and anxiety or depression (R=0.47,
P=0.0001). Younger age was also correlated with increased impact of SG on self-esteem (R=-0.35,
P=0.005) and interpersonal problems (R=-0.26, P=0.04). Interestingly, women with lower incomes
reported more embarrassment from SG (R=-0.33, P=0.008), as well as a greater effect of SG on QOL
(R=-0.28, P=0.02) and self-esteem (R=-0.28, P=0.03). These data show that decreased psychologi-
cal wellness due to SG may be influenced by a number of factors, including younger age, per-
ceived permanency, apprehension of social consequences, and low income. Importantly, the effects
of SG on QOL and psychological wellness highlight the significance of this disorder to women, indi-
cating a need for further epidemiological, biochemical and translational research.
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Not so positive: Optimism and public self-consciousness were not associated with the placebo
response in a rosacea trial.
M Kardos,1 G Kim,2 AS Chang2 and AB Kimball1 1 Dermatology, Massachusetts General
Hospital, Boston, MA and 2 Dermatology, Stanford University School of Medicine, Redwood
City, CA
Although not well understood, dermatologic diseases studied in clinical trials often demonstrate
substantial response to placebo. For example, randomized controlled trials in acne, psoriasis and
rosacea have shown placebo response rates ranging from 6% to 33%. The purpose of this pilot
study was to determine if optimism and public-self consciousness influenced response to treatment
or placebo and to help determine sample sizes for future study design. We mailed questionnaires
to subjects previously enrolled in a multi-center rosacea study who had been randomized to either
a treatment or placebo gel. The 29-item questionnaire included the Revised Life Orientation Test
(LOT-R) to measure optimism, and the Public Self-Consciousness Scale to measure public-self con-
sciousness. In both measures, the greater the score, the more optimistic or self-conscious the indi-
vidual is, respectively. Responder was defined as those in the top 50% percent of those who improved
while non-responder was defined as the bottom 50% of those who worsened. 44 subjects out of 83
(53%) responded to the questionnaire. 22 (50%) were randomized to placebo, while 22 (50%)
were randomized to treatment. There was no statistically significant difference in the LOT-R score
in those who responded to placebo vs. those who did not respond (17.7 vs. 18.2, p = 0.81) or in
those who responded to active treatment vs. those who did not respond (16.3 vs. 17.1, p = 0.61).
There was no difference in public-self consciousness among placebo responders vs. non-respon-
ders (12.4 vs. 10.6, p =0.49) or among active treatment responders vs. non-responders (14.2 vs.
13.4, p = 0.76). Although this pilot study is small, there was no meaningful difference in levels of
optimism or public self-consciousness among those who responded to placebo, suggesting other
factors may be responsible for this effect.
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Psoriasis is associated with an increased prevalence of metabolic syndrome that varies directly
with objectively measured severity
S Langan, N Seminara, D Shin, A Troxel, S Kimmel, N Mehta, D Margolis and J Gelfand University
of Pennsylvania, Philadelphia, PA
Increasing epidemiological evidence suggests that psoriasis is associated with cardiovascular and
metabolic disease independent of traditional risk factors for these conditions. Our hypothesis was
that the prevalence of metabolic syndrome and its components is increased in psoriasis and that
this relates to psoriasis severity. This cross-sectional study used computerized medical records from
The Health Improvement Network, a large population-based UK general practice database. Study
population included individuals aged 45-65 years with psoriasis and practice-matched controls.
Psoriasis diagnosis and extent were determined using physician questionnaires. The prevalence of
metabolic syndrome was defined using National Cholesterol Education Program Adult Treatment
Panel III diagnostic criteria. 44,715 individuals were included in the study: 4065 with psoriasis and
40,650 controls. 2044 participants had mild psoriasis (≤2% body surface area (BSA)), 1377 had
moderate disease (3-10% BSA), while 475 had severe psoriasis (>10% BSA). Psoriasis was signifi-
cantly associated with the metabolic syndrome, odds ratio (OR) 1.41 (95% CI 1.31-1.51). Psoria-
sis extent determined the degree of association, ranging from mild (OR 1.22 95% CI 1.11-1.35) to
severe psoriasis (OR 1.98 95% CI 1.62-2.43). Obesity was a component of metabolic syndrome
significantly associated with psoriasis (OR 1.25 95% CI 1.16-1.34); however, strong independent
associations were also detected with raised triglycerides (OR 1.20 95% CI 1.10-1.31) and raised
glucose (OR 1.16 95% CI 1.06-1.27). Psoriasis is associated with the metabolic syndrome and the
prevalence of metabolic syndrome and its components increase with increasing severity of skin
disease. This novel population-based study used objective measures of psoriasis severity, direct meas-
urement of metabolic syndrome components and standard diagnostic criteria for metabolic syn-
drome and suggests that individuals with psoriasis should be candidates for enhanced screening for
metabolic disease.
212
Patient-centered online model for follow-up management of psoriasis: A randomized con-
trolled trial
CJ Chambers, K Parsi, C Schupp and AW Armstrong University of California Davis, Sacramento,
CA
Outcomes-based comparative effectiveness studies evaluating traditional face-to-face care with tech-
nology-enabled asynchronous healthcare delivery are scarce. Health services research utilizing val-
idated outcomes measures is necessary for adoption of novel healthcare models. To compare the
clinical equivalence of a novel, patient-centered online healthcare delivery model with standard
in-office care for follow-up management of psoriasis patients. Sixty-four participants with psoriasis
were randomized in to receive follow-up care either in-office or online over a 24-week period.
Patients randomized to the online group underwent standardized training on how to capture high-
quality digital images of their psoriatic skin and how to transmit these images and clinical history
to a dermatologist securely. From the transmitted clinical data, the dermatologist performed asyn-
chronous, online evaluation and provided recommendations directly to patients. We used clinically
validated disease severity and quality of life measures, including the Psoriasis Area Severity Index
(PASI), Investigator Global Assessment (IGA), and Dermatology Life Quality Index (DLQI) to assess
effectiveness of these two healthcare delivery modalities at all study visits. Both in-office and online
groups showed improvement in psoriasis disease severity as measured by mean improvement in
PASI after 24 weeks (online group: μ = -3.2, p <0.0001, in-office: μ = -2.6, p= 0.0015). No signif-
icant differences existed in the mean change in PASI between the two groups (Mean difference in
PASI change 0.6, 95% CI: -2.2 to 2.3, a priori delta=2.5). IGA and DLQI scores also improved dur-
ing the study period, and no significant differences existed between the in-office and online groups.
Compared to traditional in-office care, the patient-centered online healthcare delivery model resulted
in similar improvements in psoriasis disease severity and quality of life. Patient-centered online
model may be effective for follow-up management of psoriasis.
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Early UV exposure and risk of multiple non-melanoma skin cancers in U.S. men and women
EX Wei,1 J Han,2,3,4 T Li2 and AA Qureshi2,3 1 Harvard Medical School, Boston, MA, 2
Dermatology, Brigham & Women’s Hospital & Harvard Medical School, Boston, MA, 3
Channing Laboratory, Brigham & Women’s Hospital & Harvard Medical School, Boston, MA
and 4 Epidemiology, Harvard School of Public Health, Boston, MA
Given the rising incidence of Non-melanoma skin cancers (NMSCs) and the aging American pop-
ulation, increasing number of individuals are at risk for developing multiple primary tumors. The
effect of early ambient UV exposure on the subsequent development of multiple NMSCs was eval-
uated among 80,275 American men and women from Nurses’ Health Study and Health Profes-
sionals Follow-up Study. Outcome was self-reported lifetime multiple NMSCs treated surgically.
Exposure was UV index of residence at birth, age 15, and 30. Individuals with one primary NMSC
were the reference group. During the 1.5 million person-year follow-up, 21% of individuals were
diagnosed with ≥2 primary NMSC. The age-adjusted relative risk (RR) of developing ≥11 primary
NMSCs in individuals living in high UV index zones at birth was 1.54; 95% confidence interval
[CI] 1.17–2.02, at age 15 was 1.48; 95% CI 1.13–1.95, and at age 30 was 1.25; 95% CI 0.95–1.65.
After simultaneously adjusting for age, gender, hair color, number of sunburns, ability-to-tan, fam-
ily history of melanoma, and nevus count, the multivariate RRs of developing of ≥11 tumors in indi-
viduals residing in medium or high UV index zone at all three time points were 1.41 (95% CI
1.07–1.86) and 1.33 (95% CI 0.93-1.91), respectively. After simultaneously adjusting for sun behav-
ior (i.e. time spent outdoors at age 25, 36, and 60), the RRs for developing ≥11 NMSCs were 1.41
(95% CI 1.07–1.87) for medium UV index zones, and 1.30 (95% CI 0.91–1.86) for high UV index
zone. In this study, we found that early ambient UV exposure is an independent risk factor for devel-
oping multiple NMSCs regardless of inherent phenotypic predisposition or behavior later in life.
214
Chickenpox in childhood suppresses atopy and production of Immunoglobulin E
JI Silverberg,1,2,4 E Kleiman,2 NB Silverberg,1 HG Durkin,2 R Joks2 and T Smith-Norowitz3 1
Dermatology, St. Luke’s-Roosevelt Hospital and Beth Israel Medical Centers, New York, NY, 2
Medicine, State University of New York Downstate Medical Center, Brooklyn, NY, 3 Pediatrics,
State University of New York Downstate Medical Center, Brooklyn, NY and 4 School of Public
Health, State University of New York Downstate Medical Center, Brooklyn, NY
Chickenpox in childhood has been shown to protect against atopic dermatitis and asthma. To
determine whether chickenpox in childhood protects against atopy. Retrospective, practice-based,
cohort study that randomly sampled 100 children with chickenpox up to 8 years of age and 323
children who received varicella vaccine. Chickenpox infection up to 8 years of age is associated
with decreased atopy (logistic regression, OR = 0.11, 95% CI = 0.03 – 0.38, P = 0.0004), as well
as decreased total serum IgE levels (mixed linear model, least-squares means [95% CI]: 129.09
[33.22 – 501.63] vs. 334.21 [102.38 – 1091.04] IU/ml; P = 0.02) that persists for > 10 years (P =
0.003 – 0.03). Chickenpox is also associated with persistent (>10 years) decreases in numbers of
peripheral blood lymphocytes (2.65 [2.17 – 3.23] vs. 3.37 [2.80 – 4.06] x 103/mm3; P < 0.0001),
monocytes (0.36 [0.25 – 0.51] vs. 0.50 [0.36 – 0.69] x 103/mm3; P = 0.002) and basophils (P <
0.03). Chickenpox up to 8 years of age results in persistent suppression of atopy and IgE produc-
tion, and changes of leukocyte distributions.
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The severity of pediatric psoriasis correlates with risk of obesity: An international multi-cen-
ter controlled assessment
A Mahoney,1 L Benjamin,1 C Heath,1 S Callahan,1 C Robinson,1 A Menter,2 KM Cordoro,4
G Girolomoni,5 W Tom,6 S Choon,3 S Patel,1 M Kwasny,1 A Rademaker1 and AS Paller1 1
Northwestern University, Chicago, IL, 2 Baylor Research Institute, Dallas, TX, 3 Hospital
Sultanah Aminah, Johor Bahru, Malaysia, 4 University of California, San Francisco, San
Francisco, CA, 5 University of Verona, Verona, Italy and 6 University of California, San Diego,
San Diego, CA
The association between psoriasis and obesity is well established in adults, but few studies have
explored the relationship in pediatric patients. None has evaluated the relative risk of obesity in
mild vs. severe psoriatic (MP, SP) disease, or have compared having psoriasis (P) to atopic dermati-
tis (AD) or non-inflammatory skin disease (NI). This international study assessed demographics, clin-
ical characteristics, measurement of blood pressure and waist circumference, and calculated body
mass index (BMI) in 318 children (n=157 MP; n=161 SP) with P vs. 338 controls (moderate to severe
AD, n=180; and NI, n=158). Age-adjusted BMI percentile was higher in children with P than con-
trols (p=.004). Height percentile was significantly lower for children with either P or AD in com-
parison with NI (p=.012). The percentage of psoriasis patients at “healthy weight” (5-<85%ile) was
50.3% (MP) to 54.7% (SP), in contrast to 72.2% (NI) to 68.9% (AD); overall 40.9% of children with
P were overweight (85-95%ile) or obese (>95%ile). Overweight SP children were more likely to be
obese (68.9%) than MP children (42.0%) (p=.003). Blood pressure, birth weight, and family history
of cardiovascular disease risk factors were not different among children with P and controls. Age of
onset, history of antecedent streptococcal disease or guttate P, and associated psoriatic arthritis did
not correlate with P severity, but more children with SP than MP had a family history of psoriatic
arthritis. These data further suggest a co-occurrence of childhood P and obesity, and correlate
severity of disease with BMI in the subset of overweight children with psoriasis.
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A prospective study of physical activity and risk of incident psoriasis in women
HC Frankel,1,2 J Han,1,2,3 T Li2 and AA Qureshi1,2 1 Dermatology, Brigham and Women’s
Hospital, Harvard Medical School, Boston, MA, 2 Medicine, Channing Laboratory, Brigham
and Women’s Hospital, Harvard Medical School, Boston, MA and 3 Epidemiology, Harvard
School of Public Health, Boston, MA
Psoriasis is an immune-mediated condition characterized by chronic skin plaques and systemic
inflammation. An increased risk of psoriasis has been associated with higher body mass index, weight
gain, and alcohol consumption, but the association with physical activity has not been investi-
gated. We prospectively evaluated the association between physical activity and the incidence of
self-reported physician-diagnosed psoriasis among female registered nurses aged 27 to 44 in 1991,
followed up to 2005. A total of 86,665 women reported their amount and type of physical activity
in biennial questionnaires. 1026 cases of incident psoriasis diagnosed after 1991 were included in
our analysis. We found an inverse association between the amount of overall physical activity and
the risk of incident psoriasis. The most physically active quintile of women had a significantly lower
multivariate relative risk (RR) of psoriasis of 0.72 (95% confidence interval [CI], 0.59-0.89) com-
pared with the least active quintile. We then evaluated the association between the intensity of phys-
ical activity and the risk of incident psoriasis. Vigorous physical activity (≥6 metabolic-equivalents)
was also associated with a significantly reduced risk of psoriasis (multivariate RR for highest quin-
tile of vigorous physical activity, 0.66; 95% CI, 0.54-0.81), whereas walking was not associated with
a risk reduction. This association remained significant after adjusting for BMI (RR, 0.73; 95% CI,
0.60-0.90). In a sensitivity analysis using a subset of 550 confirmed psoriasis cases, we observed a
similarly reduced risk of psoriasis associated with vigorous physical activity (multivariate RR for
highest quintile of vigorous physical activity, 0.64; 95% CI, 0.48-0.86). In this study of US women,
we found that vigorous physical activity was independently associated with a reduced risk of inci-
dent psoriasis.
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Contribution of nodular subtype to overall melanoma mortality
WR Shaikh,1,2 M Xiong1,2 and MA Weinstock1,2 1 Dermatoepidemiology Unit, VA Medical Ctr.,
Providence, RI and 2 Dermatology, Brown University, Providence, RI
Traditional public health efforts have focused on the ABCD warning signs for melanoma. These signs,
however, are best at detecting superficial spreading melanoma (SSM) rather than nodular melanoma
(NM). Since NM is less common than SSM, and the primary goal is to reduce overall melanoma
mortality, we sought to determine the population-based contribution of NM vs. SSM to melanoma
deaths. Our primary analysis used the original 9 Surveillance, Epidemiology, and End Results
(SEER) registries established in the 1970’s, which include 10% of the US population. We examined
the incidence of melanomas that were ultimately fatal according to death certificates. Since over-
all relative survival stabilizes after 9 years, we limited our analysis to 1973-97 with follow-up through
2007 when evaluating ultimately fatal melanomas. When restricting focus to melanomas of speci-
fied subtypes, SSM and NM represent 66% and 14% of incident melanomas, respectively. How-
ever, SSM and NM represent 46% and 36% of ultimately fatal incident melanomas (proportions
that varied little from the 1970’s to 1997), with no other subtype accounting for more than 6%. A
large proportion of invasive melanomas (43%) was not classified by subtype (NOS). The proportion
of melanomas that were NOS correlated most closely with the proportion of SSM among melanomas
of specified subtypes (r= -0.77). However, the proportion of melanoma NOS also strongly posi-
tively correlated with the proportion of NM (r=+0.58). We compared the relative survival of patients
with each subtype of melanoma diagnosed in 1978-87 to those diagnosed in 1988-97. Relative
survival for NM and acral lentiginous melanoma differed little between the two periods, but sub-
stantial improvements were noted in relative survival for SSM, lentigo maligna melanoma and
melanoma NOS. We see links between SSM and melanoma NOS but cannot make firm inferences.
Our data do strongly suggest that NM makes a substantial contribution to melanoma mortality in
the US, and that public health messages should include a focus on NM for maximum reduction of
mortality.
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Increased dermatologist density associated with reduction in melanoma mortality
S Aneja,1,2 S Aneja3 and JS Bordeaux1,2 1 Dept of Dermatology, University Hospitals Case
Medical Center, Cleveland, OH, 2 Case Western Reserve University School of Medicine,
Cleveland, OH and 3 Yale University School of Medicine, New Haven, CT
We sought to determine the association between dermatologist density and melanoma mortality in
US counties. We also examined the effect of age, race, education, income, unemployment rate,
health insurance rate, density of primary care physicians, melanoma incidence, county demographics
(metropolitan vs. non metropolitan), access to hospitals with oncologic services and health profes-
sional shortage area classification on melanoma mortality. Data were collected from the Area
Resource File, US Centers for Disease Control, and National Cancer Institute’s Surveillance, Epi-
demiology, and End Results and National Program for Cancer Registries. Multivariate analysis demon-
strated that the presence of >0 to 1 dermatologist per 100,000 people was associated with a 35%
reduction in melanoma mortality (95% CI 13.4% to 56.6%) when compared to counties with no
dermatologist. The presence of >1 to 2 dermatologists per 100,000 people was associated with a
53% reduction in melanoma mortality (95% CI 30.6% to 75.4%). Having more than 2 dermatolo-
gists per 100,000 people did not further decrease melanoma mortality. Melanoma mortality was
also decreased in metropolitan counties (30.3%, 95% CI 17.3% to 43.3%) and in counties where
there are hospitals with oncology departments (1.9%, 95% CI 0.6% to 3.1%). Melanoma mortality
rates were increased in counties with higher incidence of melanoma (2.3%, 95% CI 1.6% to 3.1%),
greater Caucasian population (1.5%, 95% CI 1.1% to 1.9%), and greater health insured populations
(1.5%, 95% CI 0.2% to 2.8%). Age, education, income, primary care provider density, health pro-
fessional shortage area classification, and unemployment rate were not associated with melanoma
mortality. In conclusion, we found that a greater dermatologist density is associated with a signifi-
cant reduction in melanoma mortality when compared to counties that lacked a dermatologist.
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An age estimation study using spatial frequency analysis on digital images of Japanese women’s
faces
A Tada,1 S Inoue Torii,2 M Hayashi,1 M Ohata1 and K Yamazaki1 1 POLA Chemical Industries,
Inc., Yokohama, Japan and 2 Konan Women’s University, Kobe, Japan
The face provides important information about age and helps build personal relationships and dis-
tinguish an individual. Current technology allows us to estimate age based on wrinkles or slack in
the face, as well as changes in the shape of the eyes, nose, or mouth. The objective of this study
was to examine a methodology designed to estimate age based on the whole face image, rather than
a specific part of the face, using spatial frequency analysis technology. Subjects comprised 140
healthy Japanese women (mean age, 49 years; range, 19-82 years). Photographs of the whole face
were taken using a single lens reflex digital camera. Digital images of photographs were edited to
remove hair, convert the image into a 1024 x 1024 pixel gray digital image, fix the pupils of the
right and left eyes at a constant position, and standardize the size and position of the face. Spatial
frequency was analyzed with MATLAB software. All statistical analyses were performed using SPSS
software. Correlation values were determined between power values of the spatial frequency analy-
sis and each subject’s age. High spatial frequency domains that increased the positive correlation
with age and low spatial frequency domains that showed a negative correlation with age were rec-
ognized. We carried out cluster analysis of power values of the spatial frequency analysis to clas-
sify the characteristic frequency; this frequency was a power value that was classified into four
domains. We used linear regression analysis and then multiple regression analysis. The dependent
variable was the subject’s age, and the independent variable was the power value from the spatial
frequency analysis. The multiple correlation coefficient was R=0.869, which indicates high preci-
sion. We classified frequency of facial characteristics into four frequency domains by analyzing a
complete facial image of women using spatial frequency. Using the power value of each domain,
we established a method that could estimate the age of a Japanese woman based on facial appear-
ance.
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Psoriasis and risk of hypertension in US women
AW Armstrong,1 J Han,2,3,4 T Li,3 JP Forman3 and AA Qureshi2,3 1 Dermatology, University of
California Davis, Sacramento, CA, 2 Dermatology, Brigham and Women’s Hospital, Harvard
Medical School, Boston, MA, 3 Channing Laboratory, Brigham and Women’s Hospital,
Harvard Medical School, Boston, MA and 4 Epidemiology, Harvard School of Public Health,
Boston, MA
Previous epidemiologic studies have suggested an association between psoriasis and hypertension.
We evaluated the association between psoriasis and risk of incident hypertension in two large US
cohorts of women: Nurses’ Health Study (NHS) from 1998 to 2006 and Nurses’ Health Study (NHS
II) from 1991 to 2007. A total of 130,102 women (39,089 from NHS and 91,013 from NHSII) were
included in this study with complete information on psoriasis, hypertension and covariates of inter-
est. During the combined 1,543,529 person-years of follow-up, 4,981 women reported psoriasis.
Of these, 1,930 had baseline psoriasis in 1991 (NHSII) and 1998 (NHS) respectively, and 3,051
women developed psoriasis during follow-up. A total of 36,527 cases of incident hypertension
occurred during the follow-up. The age-adjusted relative risk (RR) for hypertension among women
with psoriasis was 1.18 (95%CI 1.10-1.27). After simultaneous adjustment for age, body mass index,
smoking, alcohol intake, and physical activity, RR for hypertension was 1.09 (95% CI, 1.01-1.17).
In a subset of women with confirmed psoriasis from NHS II, the age-adjusted RR of hypertension
was 1.20 (95% CI 1.06-1.35) and multivariate RR was 1.07 (95%CI 0.94-1.20). We also evaluated
the effect of age on the association between psoriasis and hypertension; multivariate RR of hyper-
tension for women <50 years age at the end of follow-up in NHS II was 1.15 (95%CI 1.03-1.27)
and 0.97 (95%CI 0.82-1.16) for women ≥50 years. In this study, psoriasis was associated with a sig-
nificantly increased risk of hypertension.
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Negative psychological impact of striae gravidarum
K Korgavkar, Y Helfrich, H Chubb, JJ Voorhees, GJ Fisher and F Wang Department of
Dermatology, University of Michigan, Ann Arbor, MI
Striae gravidarum (SG), or stretch marks during pregnancy, may occur in as many as 90% of women.
We evaluated the psychological impact of SG with respect to sociodemographic factors and sever-
ity of lesions by surveying pregnant women with or without SG. To examine correlation between
variables, Pearson product-moment correlation coefficients were generated. Of the responders
(N=84), 81% were ages 25-35, 69% were Caucasian, 64% were primigravidas, and 89% were in
the third trimester. Eighty percent (80%) noted permanency of SG as the main concern. When SG
were present (N=64), lesion severity ranged from “barely visible” (N=20) to “moderate” (N=31) to
“very prominent” (N=13), while embarrassment from SG was reported as “not at all” (N=21), “a lit-
tle” (N=19), “moderate” (N=15) or “a lot” (N=9). In order of decreasing correlation, increased sever-
ity of SG was correlated with increased impact on embarrassment/self-consciousness (R=0.55,
P<0.0001), self-esteem (R=0.48, P<0.0001), anxiety or depression (R=0.45, P=0.0002), choice of
attire (R=0.40, P=0.001), and quality of life (QOL) (R=0.39, P=0.002). Of note, increased degree
of embarrassment due to SG was correlated with increased impact on self-esteem (R=0.70, P<0.0001),
social activities (R=0.56, P<0.0001), QOL (R=0.55, P<0.0001) and anxiety or depression (R=0.47,
P=0.0001). Younger age was also correlated with increased impact of SG on self-esteem (R=-0.35,
P=0.005) and interpersonal problems (R=-0.26, P=0.04). Interestingly, women with lower incomes
reported more embarrassment from SG (R=-0.33, P=0.008), as well as a greater effect of SG on QOL
(R=-0.28, P=0.02) and self-esteem (R=-0.28, P=0.03). These data show that decreased psychologi-
cal wellness due to SG may be influenced by a number of factors, including younger age, per-
ceived permanency, apprehension of social consequences, and low income. Importantly, the effects
of SG on QOL and psychological wellness highlight the significance of this disorder to women, indi-
cating a need for further epidemiological, biochemical and translational research.
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Not so positive: Optimism and public self-consciousness were not associated with the placebo
response in a rosacea trial.
M Kardos,1 G Kim,2 AS Chang2 and AB Kimball1 1 Dermatology, Massachusetts General
Hospital, Boston, MA and 2 Dermatology, Stanford University School of Medicine, Redwood
City, CA
Although not well understood, dermatologic diseases studied in clinical trials often demonstrate
substantial response to placebo. For example, randomized controlled trials in acne, psoriasis and
rosacea have shown placebo response rates ranging from 6% to 33%. The purpose of this pilot
study was to determine if optimism and public-self consciousness influenced response to treatment
or placebo and to help determine sample sizes for future study design. We mailed questionnaires
to subjects previously enrolled in a multi-center rosacea study who had been randomized to either
a treatment or placebo gel. The 29-item questionnaire included the Revised Life Orientation Test
(LOT-R) to measure optimism, and the Public Self-Consciousness Scale to measure public-self con-
sciousness. In both measures, the greater the score, the more optimistic or self-conscious the indi-
vidual is, respectively. Responder was defined as those in the top 50% percent of those who improved
while non-responder was defined as the bottom 50% of those who worsened. 44 subjects out of 83
(53%) responded to the questionnaire. 22 (50%) were randomized to placebo, while 22 (50%)
were randomized to treatment. There was no statistically significant difference in the LOT-R score
in those who responded to placebo vs. those who did not respond (17.7 vs. 18.2, p = 0.81) or in
those who responded to active treatment vs. those who did not respond (16.3 vs. 17.1, p = 0.61).
There was no difference in public-self consciousness among placebo responders vs. non-respon-
ders (12.4 vs. 10.6, p =0.49) or among active treatment responders vs. non-responders (14.2 vs.
13.4, p = 0.76). Although this pilot study is small, there was no meaningful difference in levels of
optimism or public self-consciousness among those who responded to placebo, suggesting other
factors may be responsible for this effect.
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Psoriasis is associated with an increased prevalence of metabolic syndrome that varies directly
with objectively measured severity
S Langan, N Seminara, D Shin, A Troxel, S Kimmel, N Mehta, D Margolis and J Gelfand University
of Pennsylvania, Philadelphia, PA
Increasing epidemiological evidence suggests that psoriasis is associated with cardiovascular and
metabolic disease independent of traditional risk factors for these conditions. Our hypothesis was
that the prevalence of metabolic syndrome and its components is increased in psoriasis and that
this relates to psoriasis severity. This cross-sectional study used computerized medical records from
The Health Improvement Network, a large population-based UK general practice database. Study
population included individuals aged 45-65 years with psoriasis and practice-matched controls.
Psoriasis diagnosis and extent were determined using physician questionnaires. The prevalence of
metabolic syndrome was defined using National Cholesterol Education Program Adult Treatment
Panel III diagnostic criteria. 44,715 individuals were included in the study: 4065 with psoriasis and
40,650 controls. 2044 participants had mild psoriasis (≤2% body surface area (BSA)), 1377 had
moderate disease (3-10% BSA), while 475 had severe psoriasis (>10% BSA). Psoriasis was signifi-
cantly associated with the metabolic syndrome, odds ratio (OR) 1.41 (95% CI 1.31-1.51). Psoria-
sis extent determined the degree of association, ranging from mild (OR 1.22 95% CI 1.11-1.35) to
severe psoriasis (OR 1.98 95% CI 1.62-2.43). Obesity was a component of metabolic syndrome
significantly associated with psoriasis (OR 1.25 95% CI 1.16-1.34); however, strong independent
associations were also detected with raised triglycerides (OR 1.20 95% CI 1.10-1.31) and raised
glucose (OR 1.16 95% CI 1.06-1.27). Psoriasis is associated with the metabolic syndrome and the
prevalence of metabolic syndrome and its components increase with increasing severity of skin
disease. This novel population-based study used objective measures of psoriasis severity, direct meas-
urement of metabolic syndrome components and standard diagnostic criteria for metabolic syn-
drome and suggests that individuals with psoriasis should be candidates for enhanced screening for
metabolic disease.
212
Patient-centered online model for follow-up management of psoriasis: A randomized con-
trolled trial
CJ Chambers, K Parsi, C Schupp and AW Armstrong University of California Davis, Sacramento,
CA
Outcomes-based comparative effectiveness studies evaluating traditional face-to-face care with tech-
nology-enabled asynchronous healthcare delivery are scarce. Health services research utilizing val-
idated outcomes measures is necessary for adoption of novel healthcare models. To compare the
clinical equivalence of a novel, patient-centered online healthcare delivery model with standard
in-office care for follow-up management of psoriasis patients. Sixty-four participants with psoriasis
were randomized in to receive follow-up care either in-office or online over a 24-week period.
Patients randomized to the online group underwent standardized training on how to capture high-
quality digital images of their psoriatic skin and how to transmit these images and clinical history
to a dermatologist securely. From the transmitted clinical data, the dermatologist performed asyn-
chronous, online evaluation and provided recommendations directly to patients. We used clinically
validated disease severity and quality of life measures, including the Psoriasis Area Severity Index
(PASI), Investigator Global Assessment (IGA), and Dermatology Life Quality Index (DLQI) to assess
effectiveness of these two healthcare delivery modalities at all study visits. Both in-office and online
groups showed improvement in psoriasis disease severity as measured by mean improvement in
PASI after 24 weeks (online group: μ = -3.2, p <0.0001, in-office: μ = -2.6, p= 0.0015). No signif-
icant differences existed in the mean change in PASI between the two groups (Mean difference in
PASI change 0.6, 95% CI: -2.2 to 2.3, a priori delta=2.5). IGA and DLQI scores also improved dur-
ing the study period, and no significant differences existed between the in-office and online groups.
Compared to traditional in-office care, the patient-centered online healthcare delivery model resulted
in similar improvements in psoriasis disease severity and quality of life. Patient-centered online
model may be effective for follow-up management of psoriasis.
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Early UV exposure and risk of multiple non-melanoma skin cancers in U.S. men and women
EX Wei,1 J Han,2,3,4 T Li2 and AA Qureshi2,3 1 Harvard Medical School, Boston, MA, 2
Dermatology, Brigham & Women’s Hospital & Harvard Medical School, Boston, MA, 3
Channing Laboratory, Brigham & Women’s Hospital & Harvard Medical School, Boston, MA
and 4 Epidemiology, Harvard School of Public Health, Boston, MA
Given the rising incidence of Non-melanoma skin cancers (NMSCs) and the aging American pop-
ulation, increasing number of individuals are at risk for developing multiple primary tumors. The
effect of early ambient UV exposure on the subsequent development of multiple NMSCs was eval-
uated among 80,275 American men and women from Nurses’ Health Study and Health Profes-
sionals Follow-up Study. Outcome was self-reported lifetime multiple NMSCs treated surgically.
Exposure was UV index of residence at birth, age 15, and 30. Individuals with one primary NMSC
were the reference group. During the 1.5 million person-year follow-up, 21% of individuals were
diagnosed with ≥2 primary NMSC. The age-adjusted relative risk (RR) of developing ≥11 primary
NMSCs in individuals living in high UV index zones at birth was 1.54; 95% confidence interval
[CI] 1.17–2.02, at age 15 was 1.48; 95% CI 1.13–1.95, and at age 30 was 1.25; 95% CI 0.95–1.65.
After simultaneously adjusting for age, gender, hair color, number of sunburns, ability-to-tan, fam-
ily history of melanoma, and nevus count, the multivariate RRs of developing of ≥11 tumors in indi-
viduals residing in medium or high UV index zone at all three time points were 1.41 (95% CI
1.07–1.86) and 1.33 (95% CI 0.93-1.91), respectively. After simultaneously adjusting for sun behav-
ior (i.e. time spent outdoors at age 25, 36, and 60), the RRs for developing ≥11 NMSCs were 1.41
(95% CI 1.07–1.87) for medium UV index zones, and 1.30 (95% CI 0.91–1.86) for high UV index
zone. In this study, we found that early ambient UV exposure is an independent risk factor for devel-
oping multiple NMSCs regardless of inherent phenotypic predisposition or behavior later in life.
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Chickenpox in childhood suppresses atopy and production of Immunoglobulin E
JI Silverberg,1,2,4 E Kleiman,2 NB Silverberg,1 HG Durkin,2 R Joks2 and T Smith-Norowitz3 1
Dermatology, St. Luke’s-Roosevelt Hospital and Beth Israel Medical Centers, New York, NY, 2
Medicine, State University of New York Downstate Medical Center, Brooklyn, NY, 3 Pediatrics,
State University of New York Downstate Medical Center, Brooklyn, NY and 4 School of Public
Health, State University of New York Downstate Medical Center, Brooklyn, NY
Chickenpox in childhood has been shown to protect against atopic dermatitis and asthma. To
determine whether chickenpox in childhood protects against atopy. Retrospective, practice-based,
cohort study that randomly sampled 100 children with chickenpox up to 8 years of age and 323
children who received varicella vaccine. Chickenpox infection up to 8 years of age is associated
with decreased atopy (logistic regression, OR = 0.11, 95% CI = 0.03 – 0.38, P = 0.0004), as well
as decreased total serum IgE levels (mixed linear model, least-squares means [95% CI]: 129.09
[33.22 – 501.63] vs. 334.21 [102.38 – 1091.04] IU/ml; P = 0.02) that persists for > 10 years (P =
0.003 – 0.03). Chickenpox is also associated with persistent (>10 years) decreases in numbers of
peripheral blood lymphocytes (2.65 [2.17 – 3.23] vs. 3.37 [2.80 – 4.06] x 103/mm3; P < 0.0001),
monocytes (0.36 [0.25 – 0.51] vs. 0.50 [0.36 – 0.69] x 103/mm3; P = 0.002) and basophils (P <
0.03). Chickenpox up to 8 years of age results in persistent suppression of atopy and IgE produc-
tion, and changes of leukocyte distributions.
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The severity of pediatric psoriasis correlates with risk of obesity: An international multi-cen-
ter controlled assessment
A Mahoney,1 L Benjamin,1 C Heath,1 S Callahan,1 C Robinson,1 A Menter,2 KM Cordoro,4
G Girolomoni,5 W Tom,6 S Choon,3 S Patel,1 M Kwasny,1 A Rademaker1 and AS Paller1 1
Northwestern University, Chicago, IL, 2 Baylor Research Institute, Dallas, TX, 3 Hospital
Sultanah Aminah, Johor Bahru, Malaysia, 4 University of California, San Francisco, San
Francisco, CA, 5 University of Verona, Verona, Italy and 6 University of California, San Diego,
San Diego, CA
The association between psoriasis and obesity is well established in adults, but few studies have
explored the relationship in pediatric patients. None has evaluated the relative risk of obesity in
mild vs. severe psoriatic (MP, SP) disease, or have compared having psoriasis (P) to atopic dermati-
tis (AD) or non-inflammatory skin disease (NI). This international study assessed demographics, clin-
ical characteristics, measurement of blood pressure and waist circumference, and calculated body
mass index (BMI) in 318 children (n=157 MP; n=161 SP) with P vs. 338 controls (moderate to severe
AD, n=180; and NI, n=158). Age-adjusted BMI percentile was higher in children with P than con-
trols (p=.004). Height percentile was significantly lower for children with either P or AD in com-
parison with NI (p=.012). The percentage of psoriasis patients at “healthy weight” (5-<85%ile) was
50.3% (MP) to 54.7% (SP), in contrast to 72.2% (NI) to 68.9% (AD); overall 40.9% of children with
P were overweight (85-95%ile) or obese (>95%ile). Overweight SP children were more likely to be
obese (68.9%) than MP children (42.0%) (p=.003). Blood pressure, birth weight, and family history
of cardiovascular disease risk factors were not different among children with P and controls. Age of
onset, history of antecedent streptococcal disease or guttate P, and associated psoriatic arthritis did
not correlate with P severity, but more children with SP than MP had a family history of psoriatic
arthritis. These data further suggest a co-occurrence of childhood P and obesity, and correlate
severity of disease with BMI in the subset of overweight children with psoriasis.
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A prospective study of physical activity and risk of incident psoriasis in women
HC Frankel,1,2 J Han,1,2,3 T Li2 and AA Qureshi1,2 1 Dermatology, Brigham and Women’s
Hospital, Harvard Medical School, Boston, MA, 2 Medicine, Channing Laboratory, Brigham
and Women’s Hospital, Harvard Medical School, Boston, MA and 3 Epidemiology, Harvard
School of Public Health, Boston, MA
Psoriasis is an immune-mediated condition characterized by chronic skin plaques and systemic
inflammation. An increased risk of psoriasis has been associated with higher body mass index, weight
gain, and alcohol consumption, but the association with physical activity has not been investi-
gated. We prospectively evaluated the association between physical activity and the incidence of
self-reported physician-diagnosed psoriasis among female registered nurses aged 27 to 44 in 1991,
followed up to 2005. A total of 86,665 women reported their amount and type of physical activity
in biennial questionnaires. 1026 cases of incident psoriasis diagnosed after 1991 were included in
our analysis. We found an inverse association between the amount of overall physical activity and
the risk of incident psoriasis. The most physically active quintile of women had a significantly lower
multivariate relative risk (RR) of psoriasis of 0.72 (95% confidence interval [CI], 0.59-0.89) com-
pared with the least active quintile. We then evaluated the association between the intensity of phys-
ical activity and the risk of incident psoriasis. Vigorous physical activity (≥6 metabolic-equivalents)
was also associated with a significantly reduced risk of psoriasis (multivariate RR for highest quin-
tile of vigorous physical activity, 0.66; 95% CI, 0.54-0.81), whereas walking was not associated with
a risk reduction. This association remained significant after adjusting for BMI (RR, 0.73; 95% CI,
0.60-0.90). In a sensitivity analysis using a subset of 550 confirmed psoriasis cases, we observed a
similarly reduced risk of psoriasis associated with vigorous physical activity (multivariate RR for
highest quintile of vigorous physical activity, 0.64; 95% CI, 0.48-0.86). In this study of US women,
we found that vigorous physical activity was independently associated with a reduced risk of inci-
dent psoriasis.
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Skin aging as a mirror of lung damage
A Vierkoetter,1 T Schikowski,2 D Sugiri,1 M Matsui,3 J Krutmann1 and U Kraemer1 1 IUF-Leibniz
Research Institute for Environmental Medicine, Düsseldorf, Germany, 2 Swiss Tropical and
Public Health Institute, Basel, Switzerland and 3 Estee Lauder Inc., Melville, NY
Skin and lung are considered to be model organs for aging. As interface organs between the body
and the environment, both are exposed to environmental noxae and are thus prone to extrinsic
aging. We have recently shown that exposure to traffic related particulate matter, known to dam-
age lung tissue and cause chronic obstructive pulmonary disease (COPD), is strongly associated
with extrinsic skin aging. During aging both organs undergo tissue remodelling, i.e. a process
mediated at least in part by matrix metalloproteinases (MMPs). We speculate that specific skin aging
parameters may predict lung damage. To test this hypothesis we assessed airflow obstruction by
spirometry in the SALIA study cohort composed of N=590 women who were investigated in the
1980s (55 years old at that time) and a second time between 2007 and 2009. Skin aging symptoms
were evaluated at follow-up by a validated system, ‘SCINEXA’, and compared to spirometry data
from both time points. We also assessed the presence of a single nucleotide polymorphism (SNP)
G/Del-1607GG in the promoter of the MMP1 gene. Wrinkle scores were significantly correlated
with airflow obstruction at both baseline and at follow-up (p<0.01). Laxity scores were also signif-
icantly associated with airflow obstruction at follow-up (p=0.012), however, not significantly with
airflow obstruction at baseline (p=0.272). The Del/G and GG genotypes of the MMP1 gene were
associated with airflow obstruction and with higher wrinkle scores in comparison to the Del/Del
genotype. Furthermore, only in women with the Del/G or GG genotype there was a significant asso-
ciation between wrinkles and airflow obstruction. These results strongly indicate that signs of skin
aging mirror lung damage. However, this association was independent of exposure to extrinsic fac-
tors such as pollution and smoking. The correlation between skin aging and lung function was instead
due to intrinsic genetically based factors such as SNPs.
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Epidemiologic study on the prevalence, disease severity and risk factors of atopic dermatitis
in 19-year-old Korean males.
I Kwon,1 K Kim,2 S Kim,2 C Won,3 S Seo,4 C Park1 and J Kim5 1 Department of Dermatology,
College of Medicine, Hallym University, Chuncheon, Republic of Korea, 2 Department of
Dermatology, College of Medicine, Seoul National University, Seoul, Republic of Korea, 3
Department of Dermatology, College of Medicine, University of Ulsan, Ulsan, Republic of
Korea, 4 Department of Dermatology, College of Medicine, Chung Ang University, Seoul,
Republic of Korea and 5 Department of Dermatology, College of Medicine, The Catholic
University of Korea, Seoul, Republic of Korea
The natural course of atopic dermatitis(AD) is not yet completely known. Moreover, very few stud-
ies have been performed on its prevalence and epidemiologic characteristics in adulthood. All 19-
year-old Korean males must undergo the medical examination for conscription. During this physi-
cal check up, AD was diagnosed by experienced dermatologists on the basis of the Hanifin and
Rajka criteria at five provinces in Korea. Accordingly, we precisely evaluated the prevalence rate.
The disease severity was assessed by SCORAD index. In order to investigate the risk factors of AD,
each subject belonging to case or control group filled in the questionnaire concerning their parental
atopic history, the geographical characteristics of their past habitation, the past economic status of
their family, the number of their siblings, their parental occupation, etc. The prevalence rate of each
province in Korea ranged from 1.15 to 1.44%. The low economic status at the age of 5 or younger
and their parental atopic history increased the risk for the prevalence of AD in 19-year-old
males(p<0.05). The earlier onset of AD, their parental atopic history and the history of habitation
on the region of lower population were significantly correlated with high SCORAD index(p<0.05).
The results about the prevalence in 19-year-old males could help us to presume the natural course
of AD and to estimate the socioeconomic cost caused by AD in adulthood. It is suggested that their
treatment activity in infancy and childhood could affect the prevalence and disease severity of AD
in adulthood.
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Internet social networking sites and the future of dermatology journals: Promises and perils
AA Hay,1 LS Huff2 and RP Dellavalle3,4,5 1 School of Medicine, Loma Linda University, Loma
Linda, CA, 2 School of Medicine, University of Colorado, Denver, CO, 3 Dermatology,
University of Colorado, Denver, CO, 4 Dermatology, Department of Veterans Affairs Medical
Center, Denver, CO and 5 Epidemiology, Colorado School of Public Health, Aurora, CO
Five hundred million, 83 million and 48 million people respectively used Facebook, Twitter, and
YouTube in 2010. Minimal research exists regarding dermatology information and participation by
peer-reviewed journals on these Internet sites. In October 2010 we evaluated Twitter accounts con-
taining “derm” or “dermatology” (n=103), Facebook accounts containing “dermatology” (n= ~1,700),
“psoriasis” (n=204), “acne” (n= ~1,100), and “melanoma” (n=196) and YouTube’s three most viewed
videos for acne (top video 2,103,808 views), psoriasis (top video 721,692 views), warts (top video
6,212,999 views), and melanoma (top video 69,827 views). Private practices and health organiza-
tions comprised the majority of the search results (75% of YouTube videos). Twitter, YouTube, and
Facebook were also searched for all 94 dermatology category journals on SCImago’s journal rank
list. Results showed 2 journals on Twitter, 13 on Facebook, and 1 on YouTube. The Internet may
include inaccurate information however the vast majority of free, highly accessible, dermatology
information appears reliable. Advertisement revenue is shifting from print to online media and rates
will reflect web views. Dermatology journals need to aggressively pursue novel information dis-
semination channels to better ensure sustainable business models as the Internet continues to dis-
rupt and revolutionize academic publishing.
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High correlation between the SPASI and PASI supports the use of the SPASI as a simple alter-
native to the PASI
J Walsh, J Woodcock, G Stoddard, G Krueger, DO Clegg and KC Duffin University of Utah, Salt
Lake City, UT
It was previously demonstrated that a simplified version of the Psoriasis Area and Severity Index
(PASI) called the SPASI correlated well with the PASI in a computer simulated model (R=0.90). Our
study compares the performances of the PASI to 6 simplifed instruments derived from the SPASI in
real patients. The simplified instruments differ from the PASI in that the body surface area (BSA),
erythema (E), induration (I), and desquamation (D) are estimated once for the total body, whereas
the PASI requires evaluators to estimate these variables 4 times for 4 body regions. An example of
a simplified instrument formula is SPASI-4 = A*∑(E + I + D), where A is the area score with 0 for no
involvement, 1 for up to 5% BSA, 2 for 5-9%, 3 for 10-19%, 4 for 20-29%, 5 for 30-39%, 6 for 40-
49%, 7 for 50-59%, 8 for 60-69%, 9 for 70-79%, 10 for ≥80%. The other simplifed instruments are
similar, except for unique area scores. Pearson correlation coefficients and Wald scores were used
to compare the PASI and patient-derived measures of quality of life (QOL) and patient global (PG)
assessment with the 6 simplified instruments from 528 patient visits. The ability of the instruments
to capture change was evaluated in 268 patients with a modified standard response to the mean
[mSRM = absolute value of the mean change/ the standard deviation of the absolute value of the
mean change]. All 6 simplified instruments had excellent correlations with the PASI (R = 0.90-0.94)
and moderate correlations with QOL (R = 0.39-0.48) and PG (R = 0.49-0.63). There were no sta-
tistical differences among the simplified instruments’ correlations to the PASI. The correlations of
the SPASI-4 to the QOL and PG were statistically superior or equal to those of the other instru-
ments. The SPASI-4 was the most responsive to change (mSRM = 0.80) and was more responsive
than the PASI (mSRM =0.73). The SPASI-4 was the best-performing simplified instrument and should
be considered as an alternative to the PASI, since it closely approximates the PASI and is more con-
ducive to routine use in clinical care.
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Characteristics of hair-graying in a dark-haired population
S Jo,1 S Paik,1 J Lee,2 S Cho,2 K Kim1 and O Kwon1 1 Dematology, Seoul National University
Hospital, Seoul, Republic of Korea and 2 Dermatology, SNU Boramae Medical Center, Seoul,
Republic of Korea
Hair-graying is one of the conspicuous signs of aging. However, little is known about the clinical
characteristics of gray hair especially in black-haired subjects, although gray hair leads to greater
cosmetic problem in them as it is more noticeable against dark hair. To evaluate the prevalence and
characteristics of gray hair in a black-haired population, we collected clinical data from question-
naires and investigators’ examination, respectively. From January to October 2010, a total 1002 sub-
jects without pigment disorder or hair disease except patterned hair loss were included. Subjects
were all with black hair and surveyed using questionnaires. Investigators’ examination using 6-point
gray hair scale on their status of hair graying was also performed. According to the questionnaires,
64.8% of whole subjects answered that they had gray hair, while most of the people over 50 years
had gray hair. The involvement of temporal and occipital area seemed to be more common in men
than in women. The average onset-age was 41.6 ± 13.1 years. Hair graying usually started at tem-
poral area in men while frontal area was the most common in women. We defined early-onset group
as the population in whom gray hair firstly appeared before the age of 40 years. More subjects in
early-onset group firstly showed gray hair in parietal and occipital area than in late-onset group.
Using multivariate logistic linear regression analysis, we found that smoking was correlated with
the presence of gray hair. In summary, this study shows the clinical characteristics of gray hair in a
black-haired population. We suggest that our results can be used as basic data for further studies
on hair graying.
234
Differences in itch characteristics among psoriasis and atopic dermatitis patients: Results of
a web-based questionnaire
JL O’Neill,1 Y Chan,2 SR Rapp1 and G Yosipovitch1 1 Wake Forest University School of
Medicine, Winston Salem, NC and 2 Yong Loo Lin School of Medicine, National University
Health System, Singapore, Singapore
Differences in itch characteristics between different inflammatory dermatoses are not well described.
We aimed to assess differences in itch characteristics among sufferers of psoriasis and atopic der-
matitis (AD) using a previously validated web-based questionnaire which was made available through
the National Psoriasis Foundation and National Eczema Association for Science and Education web-
sites. Participants rated frequency and intensity of itch, associated symptoms, itch descriptors, and
effect of scratching. A total of 524 atopic dermatitis subjects and 195 psoriasis subjects completed
the survey. AD responders suffered from more frequent and more intense itch. Associated sweating
and heat sensation were also more common in AD. Scratching was considered pleasurable in both
AD and psoriasis; pleasurability weakly correlated with itch intensity in AD. Psoriasis respondents
reported higher embarrassment associated with itch. Itch sensation is experienced differently among
patients with AD and psoriasis. Future therapeutic interventions may be developed to target these
differences.
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Pathway analysis for genome-wide association study of basal cell carcinoma
M Zhang,1 L Liang,2 AA Qureshi1,3 and J Han1,2,3 1 Department of Dermatology, Brigham and
Women’s Hospital, Harvard Medical School, Boston, MA, 2 Department of Epidemiology and
Biostatistics, Harvard School of Public Health, Boston, MA and 3 Channing Laboratory,
Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston,
MA
Genome-wide association studies (GWASs) have successfully identified susceptibility genes for sev-
eral complex disorders, and some of the susceptibility genes for a certain disease have suggested
related functions. A pathway-based approach, which evaluated the cumulative contribution of the
functionally related genes, may improve the power of utilizing the GWAS data. In this study, we
conducted a pathway analysis for the GWAS of basal cell carcinoma (BCC). We first conducted the
GWAS of BCC among 1,797 BCC cases and 5,197 controls in Caucasians with 740,760 genotyped
SNPs and assigned them into gene transcripts within 20kb in distance. Then, all the genes were
grouped into 174 Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways and 205 BioCarta
pathways for the pathway analysis by using the Kolmogorov-Smirnov test. 1,000 permutations were
conducted to assess the significance by shuffling the case-control status and recalculating the sta-
tistical value. We also included three positive control pathways (the pigmentation pathway, BCC
risk pathway and the two combined). As a result, although no single SNP reached genome-wide
significance, all of the three positive control pathways reached a pathway p value < 0.05, and other
four pathways were significantly associated with BCC risk with a p value < 0.05 and false discov-
ery rate (FDR) < 0.5. They were the heparin sulfate biosynthesis pathway (p = 0.007, FDR = 0.35),
the mCalpain pathway (p = 0.002, FDR = 0.12), the Rho cell motility signaling pathway (p = 0.011,
FDR = 0.30), and the nitric oxide pathway (p = 0.022, FDR = 0.42). Our data suggest new insights
in the etiology of BCC upon further validation, and the pathway analysis for the GWAS data may
help identify biological pathways underlying other disease, which may be missed in traditional
GWAS approach focusing on marginal effects of individual markers.
224
An analysis of the characteristics of initial and second primary melanomas using data from
the Surveillance, Epidemiology, and End Results (SEER) Program
ME Ming and DB Shin Univ of Pennsylvania, Philadelphia, PA
Although risk factors for second primary melanoma have been identified, little is known about
whether the clinical and microscopic characteristics of initial and second primary melanomas in
the same patient are more similar than would be expected by chance. We have previously presented
initial analyses of this subject using our own patient data but were hampered by sample size issues.
To understand this question more fully, we used data from the Surveillance, Epidemiology, and End
Results (SEER) Program from 1988–2007. Multinomial statistics using a matched-pair design, includ-
ing tests for symmetry and marginal homogeneity, were performed. 1194 patients with at least two
microscopically confirmed melanomas were identified. The mean age at first diagnosis was 58.8
years (95% CI: 57.9, 59.7), with a mean of 37.1 months (95% CI: 34.6, 39.6) between the first and
second melanoma diagnosis. Controlling for sex and age, the odds of having a second melanoma
of the same histologic subtype as the initial melanoma were significantly increased for all 4 major
subtypes (superficial spreading melanoma: OR=2.49, 95% CI: 1.90, 3.27; nodular melanoma:
OR=3.98; 95% CI: 2.24, 7.07; lentigo maligna melanoma: OR=3.60; 95% CI: 2.60, 4.99; acral
lentiginous melanoma: OR=101.9; 95% CI: 21.85, 475.3). The same relationship was also found
for different anatomic regions, with the odds of having a second melanoma in the same region as
the initial melanoma (again controlling for sex and age) being significantly increased for the head
and neck (OR=5.59, 95% CI: 4.16, 7.52), trunk (OR=2.04, 95% CI: 1.56, 2.67), upper extremities
(OR=1.87, 95% CI: 1.39, 2.53), and lower extremities (OR=3.59, 95% CI: 2.45, 5.26). This study
is the first demonstration of this association for all four major histologic subtypes and all four of
these anatomic regions. Second melanomas do not appear to be randomly distributed, but instead
seem to share characteristics with the initial melanomas on the same patient, which may have impli-
cations for strategies for early detection and prevention.
225
Treating patients with psychocutaneous disease in the outpatient dermatology setting. The
results of a survey 
SN Gee,1 L Zakhary,2 D Kroshinsky1 and AB Kimball1 1 Dermatology, Massachusetts General
Hospital, Boston, MA and 2 Psychiatry, Massachusetts General Hospital, Boston, MA
Psychocutaneous medicine is a developing field whose diagnostic methods and approaches to treat-
ment are largely based on small case series and anecdotal evidence. Collaboration with psychiatric
colleagues is often needed for additional therapeutic guidance but is frequently met with patient
resistance. To better assess how patients with psychocutaneous diseases are managed by outpatient
dermatologists a survey was emailed to board certified attending dermatologists and dermatology
residents at Massachusetts General Hospital to capture demographic information, level of comfort
with diagnosis and treatment of psychocutaneous disease, and feelings of treatment success. Of 49
surveys emailed, 41 (84%) were completed (19 current residents, 22 board certified attendings). Of
the attending responses, 0% felt extremely successful treating each of the following psychocuta-
neous conditions: delusions of parasitosis, compulsive skin picking, cutaneous sensory disorders,
factitious disorders, trichotillomania, and body dysmorphic disorder. Of these, they felt least suc-
cessful treating cutaneous sensory disorders and delusions of parasitosis. 83% reported feeling
uncomfortable starting antidepressants, 94% antipsychotics, 100% mood stabilizers, and 88%
anxiolytics. Of attendings board certified in 2000-2010, 33% felt comfortable starting antidepres-
sants, 10% antipsychotics, and 26% anxiolytics. Of attendings board certified prior to 1999, 0%
felt comfortable starting the aforementioned classes of medications. Dermatology attendings in our
outpatient setting feel unsuccessful treating patients with psychocutaneous disease and are uncom-
fortable with starting many psychotropics.
226
Indoor tanning is associated with increased utilization of skin cancer screening by patients
otherwise at low risk for skin cancer
A Secrest, R Andrulonis, T Patton, L Grandinetti and LK Ferris University of Pittsburgh, Pittsburgh,
PA
As with most malignancies, the incidence of skin cancer increases with age. Thus, skin cancer screen-
ing has been shown to be cost effective when it begins at age 50. However, younger patients often
seek skin cancer screening from dermatologists. Recently, there has been increasing evidence that
the use of indoor tanning facilities is associated with an increased risk of melanoma. To determine
if the utilization of skin cancer screening by younger, lower-risk patients is associated with their use
of indoor tanning facilities, we conducted a survey of 482 patients seeking skin cancer screening
to determine their indoor tanning use and beliefs about the role of skin cancer screening in people
who tan indoors. Overall, 48% of all patients seeking skin cancer screening were under age 50.
38% of all patients reported a history of indoor tanning (53.8% of patients under age 50 vs. 24.4%
of patients 50 or older, p<0.001). Indoor tanners were more likely to be otherwise at low risk for
skin cancer (defined as under age 50 with no personal history of skin cancer), (57% of tanners vs.
29% of non-tanners, p<0.001). 25% of tanners reported that their use of indoor tanning contributed
at least in part to their decision to seek skin cancer screening. Tanners were also more likely than
non-tanners to believe that skin cancer screening has been show to help prevent skin cancer caused
by indoor tanning (46.7% of tanners vs. 32.7% of non-tanners, p=0.003) and to reduce the risk of
death from skin cancer caused by indoor tanning (58.4% of tanners vs. 44.9% of non-tanners,
p=0.007). Indoor tanning may increase utilization of the limited resource of dermatologist screen-
ing by otherwise low-risk patients and is associated with unrealistic expectations from skin cancer
screening.
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Smoking in psoriasis patients may lessen risk of psoriatic arthritis development and delay age
of onset
D Zaghi,1 TR Nandi,2 B Sauer,1 G Stoddard,1 B Feng,1 J Walsh,1 B Wong,3 J Woodcock,1
GG Krueger1 and KC Duffin1 1 School of Medicine, University of Utah, Salt Lake City, UT, 2
Dermatology, Case Western University, Cleveland, OH and 3 Nursing, University of Utah, Salt
Lake City, UT
Previously we have reported that tobacco use before or after onset of psoriasis influences the time
to developing psoriatic arthritis (PsA). To further explore the influence of smoking on PsA, we have
performed additional analyses on our psoriasis cohort known as the Utah Psoriasis Initiative (UPI).
We conducted a retrospective cohort study of 1155 participants with dermatologist-diagnosed pso-
riasis enrolled in the UPI from December 2002 to July 2010 (49.9% women, 50.0% men). We used
a Cox proportional hazards model to determine the hazard ratio (HR) of PsA development across
smoking exposures. Smoking exposure was analyzed through pack years and smoking status (non-
smoker, past, current). We next performed a nested linear regression to study the relationship between
pack years smoked and age of onset of PsA. We controlled for psoriatic nail disease, worst-ever body
surface area involvement and koebnerization. Patients were considered to have PsA if they reported
their diagnosis was rheumatologist-confirmed. We observed a lowered hazard ratio for PsA among
those who smoked more than 20 pack years (HR 0.60, P = 0.042) and among current smokers (HR
0.67, P = 0.039). We observed a delayed age of onset of PsA with a greater than 20 pack year smok-
ing history, even after controlling for age of enrollment (+12 years delay, P < 0.01). This study sug-
gests that heavy smoking and current smoking status may protect against PsA development. Addi-
tionally, patients with more than 20 pack years of smoking exposure exhibited a delayed age of
onset of PsA. It is unclear how the effects of smoking combine with the inflammatory milieu of pso-
riasis to influence PsA. Additional studies are needed to confirm and explore PsA severity across
smoking exposures. Given the known harmful effects of smoking, it would be wise to continue to
discourage smoking in psoriasis patients.
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Familial risk of psoriasis and lymphoma in the Utah Population Database
KC Duffin,1 C Schaefer,2 K Rowe,3 GG Krueger,1 G Mineau2 and DE Goldgar1 1 Dermatology,
University of Utah, Salt Lake City, UT, 2 Huntsman Cancer Institute, University of Utah, Salt
Lake City, UT and 3 Oncology Clinical Program, Intermountain Healthcare, Salt Lake City, UT
Psoriasis patients are at risk of developing Hodgkin’s (HL), non-Hodgkin’s (NHL), and cutaneous T-
cell lymphoma (CTCL). Both psoriasis and lymphoma have a familial component. Our objective
was to examine familial clustering of psoriasis and lymphoma using the Utah Population Database
(UPDB). 9007 patients with psoriasis and 1332 patients with psoriatic arthritis (PsA) were identi-
fied from the Utah Psoriasis Initiative, University of Utah and Intermountain Healthcare records.
These had been linked to the UPDB, a resource that includes genealogy, demographic, medical,
and cancer records of > 6 million individuals. For each case, 5-10 controls matched on birth year,
gender, and state of birth were selected from the UPDB. Familial relative risk estimates for psoria-
sis, PsA, HL, NHL, and CTCL were calculated using Kinship Analysis Tools. There was a significant
relative risk (RR) of psoriasis in 1st (6.56, CI 5.78-7.44), 2nd (RR 3.2, CI 2.76-3.72), and 3rd degree
relatives (RR 2.0, CI 1.68-2.38) that remained when UPI and U of U patients were excluded (1st
degree RR 4.8, CI 3.69-6.23, 2nd degree RR 2.6 CI 1.9-3.47, cousins RR 1.6, CI 1.16-2.13). The RR
of PsA in 1st degree relatives of PsA patients was 18.14 (CI 10.35-31.8) and in 2nd degree relatives
was 3.53 (CI 1.58-7.85). Of the patients with psoriasis, 81 had a diagnosis of lymphoma. The RR of
NHL in the psoriasis probands was 1.52 (CI 1.14-2.04) and for CTCL was 11.65 (CI 4.82-28.17) but
the RR for NHL and CTCL was not significant in 1st degree relatives. There was no evidence of
association of psoriasis with HL. This study supports a strong familial component to PsA. The results
also indicate that a psoriasis proband has an increased risk for NHL, but not HL, over matched con-
trols. There is an increased risk for CTCL in probands, but the CI is wide due to the small number
of patients. First degree relatives of patients with psoriasis do not appear to have increased risk of
lymphoma.
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Skin aging as a mirror of lung damage
A Vierkoetter,1 T Schikowski,2 D Sugiri,1 M Matsui,3 J Krutmann1 and U Kraemer1 1 IUF-Leibniz
Research Institute for Environmental Medicine, Düsseldorf, Germany, 2 Swiss Tropical and
Public Health Institute, Basel, Switzerland and 3 Estee Lauder Inc., Melville, NY
Skin and lung are considered to be model organs for aging. As interface organs between the body
and the environment, both are exposed to environmental noxae and are thus prone to extrinsic
aging. We have recently shown that exposure to traffic related particulate matter, known to dam-
age lung tissue and cause chronic obstructive pulmonary disease (COPD), is strongly associated
with extrinsic skin aging. During aging both organs undergo tissue remodelling, i.e. a process
mediated at least in part by matrix metalloproteinases (MMPs). We speculate that specific skin aging
parameters may predict lung damage. To test this hypothesis we assessed airflow obstruction by
spirometry in the SALIA study cohort composed of N=590 women who were investigated in the
1980s (55 years old at that time) and a second time between 2007 and 2009. Skin aging symptoms
were evaluated at follow-up by a validated system, ‘SCINEXA’, and compared to spirometry data
from both time points. We also assessed the presence of a single nucleotide polymorphism (SNP)
G/Del-1607GG in the promoter of the MMP1 gene. Wrinkle scores were significantly correlated
with airflow obstruction at both baseline and at follow-up (p<0.01). Laxity scores were also signif-
icantly associated with airflow obstruction at follow-up (p=0.012), however, not significantly with
airflow obstruction at baseline (p=0.272). The Del/G and GG genotypes of the MMP1 gene were
associated with airflow obstruction and with higher wrinkle scores in comparison to the Del/Del
genotype. Furthermore, only in women with the Del/G or GG genotype there was a significant asso-
ciation between wrinkles and airflow obstruction. These results strongly indicate that signs of skin
aging mirror lung damage. However, this association was independent of exposure to extrinsic fac-
tors such as pollution and smoking. The correlation between skin aging and lung function was instead
due to intrinsic genetically based factors such as SNPs.
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Epidemiologic study on the prevalence, disease severity and risk factors of atopic dermatitis
in 19-year-old Korean males.
I Kwon,1 K Kim,2 S Kim,2 C Won,3 S Seo,4 C Park1 and J Kim5 1 Department of Dermatology,
College of Medicine, Hallym University, Chuncheon, Republic of Korea, 2 Department of
Dermatology, College of Medicine, Seoul National University, Seoul, Republic of Korea, 3
Department of Dermatology, College of Medicine, University of Ulsan, Ulsan, Republic of
Korea, 4 Department of Dermatology, College of Medicine, Chung Ang University, Seoul,
Republic of Korea and 5 Department of Dermatology, College of Medicine, The Catholic
University of Korea, Seoul, Republic of Korea
The natural course of atopic dermatitis(AD) is not yet completely known. Moreover, very few stud-
ies have been performed on its prevalence and epidemiologic characteristics in adulthood. All 19-
year-old Korean males must undergo the medical examination for conscription. During this physi-
cal check up, AD was diagnosed by experienced dermatologists on the basis of the Hanifin and
Rajka criteria at five provinces in Korea. Accordingly, we precisely evaluated the prevalence rate.
The disease severity was assessed by SCORAD index. In order to investigate the risk factors of AD,
each subject belonging to case or control group filled in the questionnaire concerning their parental
atopic history, the geographical characteristics of their past habitation, the past economic status of
their family, the number of their siblings, their parental occupation, etc. The prevalence rate of each
province in Korea ranged from 1.15 to 1.44%. The low economic status at the age of 5 or younger
and their parental atopic history increased the risk for the prevalence of AD in 19-year-old
males(p<0.05). The earlier onset of AD, their parental atopic history and the history of habitation
on the region of lower population were significantly correlated with high SCORAD index(p<0.05).
The results about the prevalence in 19-year-old males could help us to presume the natural course
of AD and to estimate the socioeconomic cost caused by AD in adulthood. It is suggested that their
treatment activity in infancy and childhood could affect the prevalence and disease severity of AD
in adulthood.
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Internet social networking sites and the future of dermatology journals: Promises and perils
AA Hay,1 LS Huff2 and RP Dellavalle3,4,5 1 School of Medicine, Loma Linda University, Loma
Linda, CA, 2 School of Medicine, University of Colorado, Denver, CO, 3 Dermatology,
University of Colorado, Denver, CO, 4 Dermatology, Department of Veterans Affairs Medical
Center, Denver, CO and 5 Epidemiology, Colorado School of Public Health, Aurora, CO
Five hundred million, 83 million and 48 million people respectively used Facebook, Twitter, and
YouTube in 2010. Minimal research exists regarding dermatology information and participation by
peer-reviewed journals on these Internet sites. In October 2010 we evaluated Twitter accounts con-
taining “derm” or “dermatology” (n=103), Facebook accounts containing “dermatology” (n= ~1,700),
“psoriasis” (n=204), “acne” (n= ~1,100), and “melanoma” (n=196) and YouTube’s three most viewed
videos for acne (top video 2,103,808 views), psoriasis (top video 721,692 views), warts (top video
6,212,999 views), and melanoma (top video 69,827 views). Private practices and health organiza-
tions comprised the majority of the search results (75% of YouTube videos). Twitter, YouTube, and
Facebook were also searched for all 94 dermatology category journals on SCImago’s journal rank
list. Results showed 2 journals on Twitter, 13 on Facebook, and 1 on YouTube. The Internet may
include inaccurate information however the vast majority of free, highly accessible, dermatology
information appears reliable. Advertisement revenue is shifting from print to online media and rates
will reflect web views. Dermatology journals need to aggressively pursue novel information dis-
semination channels to better ensure sustainable business models as the Internet continues to dis-
rupt and revolutionize academic publishing.
232
High correlation between the SPASI and PASI supports the use of the SPASI as a simple alter-
native to the PASI
J Walsh, J Woodcock, G Stoddard, G Krueger, DO Clegg and KC Duffin University of Utah, Salt
Lake City, UT
It was previously demonstrated that a simplified version of the Psoriasis Area and Severity Index
(PASI) called the SPASI correlated well with the PASI in a computer simulated model (R=0.90). Our
study compares the performances of the PASI to 6 simplifed instruments derived from the SPASI in
real patients. The simplified instruments differ from the PASI in that the body surface area (BSA),
erythema (E), induration (I), and desquamation (D) are estimated once for the total body, whereas
the PASI requires evaluators to estimate these variables 4 times for 4 body regions. An example of
a simplified instrument formula is SPASI-4 = A*∑(E + I + D), where A is the area score with 0 for no
involvement, 1 for up to 5% BSA, 2 for 5-9%, 3 for 10-19%, 4 for 20-29%, 5 for 30-39%, 6 for 40-
49%, 7 for 50-59%, 8 for 60-69%, 9 for 70-79%, 10 for ≥80%. The other simplifed instruments are
similar, except for unique area scores. Pearson correlation coefficients and Wald scores were used
to compare the PASI and patient-derived measures of quality of life (QOL) and patient global (PG)
assessment with the 6 simplified instruments from 528 patient visits. The ability of the instruments
to capture change was evaluated in 268 patients with a modified standard response to the mean
[mSRM = absolute value of the mean change/ the standard deviation of the absolute value of the
mean change]. All 6 simplified instruments had excellent correlations with the PASI (R = 0.90-0.94)
and moderate correlations with QOL (R = 0.39-0.48) and PG (R = 0.49-0.63). There were no sta-
tistical differences among the simplified instruments’ correlations to the PASI. The correlations of
the SPASI-4 to the QOL and PG were statistically superior or equal to those of the other instru-
ments. The SPASI-4 was the most responsive to change (mSRM = 0.80) and was more responsive
than the PASI (mSRM =0.73). The SPASI-4 was the best-performing simplified instrument and should
be considered as an alternative to the PASI, since it closely approximates the PASI and is more con-
ducive to routine use in clinical care.
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Characteristics of hair-graying in a dark-haired population
S Jo,1 S Paik,1 J Lee,2 S Cho,2 K Kim1 and O Kwon1 1 Dematology, Seoul National University
Hospital, Seoul, Republic of Korea and 2 Dermatology, SNU Boramae Medical Center, Seoul,
Republic of Korea
Hair-graying is one of the conspicuous signs of aging. However, little is known about the clinical
characteristics of gray hair especially in black-haired subjects, although gray hair leads to greater
cosmetic problem in them as it is more noticeable against dark hair. To evaluate the prevalence and
characteristics of gray hair in a black-haired population, we collected clinical data from question-
naires and investigators’ examination, respectively. From January to October 2010, a total 1002 sub-
jects without pigment disorder or hair disease except patterned hair loss were included. Subjects
were all with black hair and surveyed using questionnaires. Investigators’ examination using 6-point
gray hair scale on their status of hair graying was also performed. According to the questionnaires,
64.8% of whole subjects answered that they had gray hair, while most of the people over 50 years
had gray hair. The involvement of temporal and occipital area seemed to be more common in men
than in women. The average onset-age was 41.6 ± 13.1 years. Hair graying usually started at tem-
poral area in men while frontal area was the most common in women. We defined early-onset group
as the population in whom gray hair firstly appeared before the age of 40 years. More subjects in
early-onset group firstly showed gray hair in parietal and occipital area than in late-onset group.
Using multivariate logistic linear regression analysis, we found that smoking was correlated with
the presence of gray hair. In summary, this study shows the clinical characteristics of gray hair in a
black-haired population. We suggest that our results can be used as basic data for further studies
on hair graying.
234
Differences in itch characteristics among psoriasis and atopic dermatitis patients: Results of
a web-based questionnaire
JL O’Neill,1 Y Chan,2 SR Rapp1 and G Yosipovitch1 1 Wake Forest University School of
Medicine, Winston Salem, NC and 2 Yong Loo Lin School of Medicine, National University
Health System, Singapore, Singapore
Differences in itch characteristics between different inflammatory dermatoses are not well described.
We aimed to assess differences in itch characteristics among sufferers of psoriasis and atopic der-
matitis (AD) using a previously validated web-based questionnaire which was made available through
the National Psoriasis Foundation and National Eczema Association for Science and Education web-
sites. Participants rated frequency and intensity of itch, associated symptoms, itch descriptors, and
effect of scratching. A total of 524 atopic dermatitis subjects and 195 psoriasis subjects completed
the survey. AD responders suffered from more frequent and more intense itch. Associated sweating
and heat sensation were also more common in AD. Scratching was considered pleasurable in both
AD and psoriasis; pleasurability weakly correlated with itch intensity in AD. Psoriasis respondents
reported higher embarrassment associated with itch. Itch sensation is experienced differently among
patients with AD and psoriasis. Future therapeutic interventions may be developed to target these
differences.
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Pathway analysis for genome-wide association study of basal cell carcinoma
M Zhang,1 L Liang,2 AA Qureshi1,3 and J Han1,2,3 1 Department of Dermatology, Brigham and
Women’s Hospital, Harvard Medical School, Boston, MA, 2 Department of Epidemiology and
Biostatistics, Harvard School of Public Health, Boston, MA and 3 Channing Laboratory,
Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston,
MA
Genome-wide association studies (GWASs) have successfully identified susceptibility genes for sev-
eral complex disorders, and some of the susceptibility genes for a certain disease have suggested
related functions. A pathway-based approach, which evaluated the cumulative contribution of the
functionally related genes, may improve the power of utilizing the GWAS data. In this study, we
conducted a pathway analysis for the GWAS of basal cell carcinoma (BCC). We first conducted the
GWAS of BCC among 1,797 BCC cases and 5,197 controls in Caucasians with 740,760 genotyped
SNPs and assigned them into gene transcripts within 20kb in distance. Then, all the genes were
grouped into 174 Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways and 205 BioCarta
pathways for the pathway analysis by using the Kolmogorov-Smirnov test. 1,000 permutations were
conducted to assess the significance by shuffling the case-control status and recalculating the sta-
tistical value. We also included three positive control pathways (the pigmentation pathway, BCC
risk pathway and the two combined). As a result, although no single SNP reached genome-wide
significance, all of the three positive control pathways reached a pathway p value < 0.05, and other
four pathways were significantly associated with BCC risk with a p value < 0.05 and false discov-
ery rate (FDR) < 0.5. They were the heparin sulfate biosynthesis pathway (p = 0.007, FDR = 0.35),
the mCalpain pathway (p = 0.002, FDR = 0.12), the Rho cell motility signaling pathway (p = 0.011,
FDR = 0.30), and the nitric oxide pathway (p = 0.022, FDR = 0.42). Our data suggest new insights
in the etiology of BCC upon further validation, and the pathway analysis for the GWAS data may
help identify biological pathways underlying other disease, which may be missed in traditional
GWAS approach focusing on marginal effects of individual markers.
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An analysis of the characteristics of initial and second primary melanomas using data from
the Surveillance, Epidemiology, and End Results (SEER) Program
ME Ming and DB Shin Univ of Pennsylvania, Philadelphia, PA
Although risk factors for second primary melanoma have been identified, little is known about
whether the clinical and microscopic characteristics of initial and second primary melanomas in
the same patient are more similar than would be expected by chance. We have previously presented
initial analyses of this subject using our own patient data but were hampered by sample size issues.
To understand this question more fully, we used data from the Surveillance, Epidemiology, and End
Results (SEER) Program from 1988–2007. Multinomial statistics using a matched-pair design, includ-
ing tests for symmetry and marginal homogeneity, were performed. 1194 patients with at least two
microscopically confirmed melanomas were identified. The mean age at first diagnosis was 58.8
years (95% CI: 57.9, 59.7), with a mean of 37.1 months (95% CI: 34.6, 39.6) between the first and
second melanoma diagnosis. Controlling for sex and age, the odds of having a second melanoma
of the same histologic subtype as the initial melanoma were significantly increased for all 4 major
subtypes (superficial spreading melanoma: OR=2.49, 95% CI: 1.90, 3.27; nodular melanoma:
OR=3.98; 95% CI: 2.24, 7.07; lentigo maligna melanoma: OR=3.60; 95% CI: 2.60, 4.99; acral
lentiginous melanoma: OR=101.9; 95% CI: 21.85, 475.3). The same relationship was also found
for different anatomic regions, with the odds of having a second melanoma in the same region as
the initial melanoma (again controlling for sex and age) being significantly increased for the head
and neck (OR=5.59, 95% CI: 4.16, 7.52), trunk (OR=2.04, 95% CI: 1.56, 2.67), upper extremities
(OR=1.87, 95% CI: 1.39, 2.53), and lower extremities (OR=3.59, 95% CI: 2.45, 5.26). This study
is the first demonstration of this association for all four major histologic subtypes and all four of
these anatomic regions. Second melanomas do not appear to be randomly distributed, but instead
seem to share characteristics with the initial melanomas on the same patient, which may have impli-
cations for strategies for early detection and prevention.
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Treating patients with psychocutaneous disease in the outpatient dermatology setting. The
results of a survey 
SN Gee,1 L Zakhary,2 D Kroshinsky1 and AB Kimball1 1 Dermatology, Massachusetts General
Hospital, Boston, MA and 2 Psychiatry, Massachusetts General Hospital, Boston, MA
Psychocutaneous medicine is a developing field whose diagnostic methods and approaches to treat-
ment are largely based on small case series and anecdotal evidence. Collaboration with psychiatric
colleagues is often needed for additional therapeutic guidance but is frequently met with patient
resistance. To better assess how patients with psychocutaneous diseases are managed by outpatient
dermatologists a survey was emailed to board certified attending dermatologists and dermatology
residents at Massachusetts General Hospital to capture demographic information, level of comfort
with diagnosis and treatment of psychocutaneous disease, and feelings of treatment success. Of 49
surveys emailed, 41 (84%) were completed (19 current residents, 22 board certified attendings). Of
the attending responses, 0% felt extremely successful treating each of the following psychocuta-
neous conditions: delusions of parasitosis, compulsive skin picking, cutaneous sensory disorders,
factitious disorders, trichotillomania, and body dysmorphic disorder. Of these, they felt least suc-
cessful treating cutaneous sensory disorders and delusions of parasitosis. 83% reported feeling
uncomfortable starting antidepressants, 94% antipsychotics, 100% mood stabilizers, and 88%
anxiolytics. Of attendings board certified in 2000-2010, 33% felt comfortable starting antidepres-
sants, 10% antipsychotics, and 26% anxiolytics. Of attendings board certified prior to 1999, 0%
felt comfortable starting the aforementioned classes of medications. Dermatology attendings in our
outpatient setting feel unsuccessful treating patients with psychocutaneous disease and are uncom-
fortable with starting many psychotropics.
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Indoor tanning is associated with increased utilization of skin cancer screening by patients
otherwise at low risk for skin cancer
A Secrest, R Andrulonis, T Patton, L Grandinetti and LK Ferris University of Pittsburgh, Pittsburgh,
PA
As with most malignancies, the incidence of skin cancer increases with age. Thus, skin cancer screen-
ing has been shown to be cost effective when it begins at age 50. However, younger patients often
seek skin cancer screening from dermatologists. Recently, there has been increasing evidence that
the use of indoor tanning facilities is associated with an increased risk of melanoma. To determine
if the utilization of skin cancer screening by younger, lower-risk patients is associated with their use
of indoor tanning facilities, we conducted a survey of 482 patients seeking skin cancer screening
to determine their indoor tanning use and beliefs about the role of skin cancer screening in people
who tan indoors. Overall, 48% of all patients seeking skin cancer screening were under age 50.
38% of all patients reported a history of indoor tanning (53.8% of patients under age 50 vs. 24.4%
of patients 50 or older, p<0.001). Indoor tanners were more likely to be otherwise at low risk for
skin cancer (defined as under age 50 with no personal history of skin cancer), (57% of tanners vs.
29% of non-tanners, p<0.001). 25% of tanners reported that their use of indoor tanning contributed
at least in part to their decision to seek skin cancer screening. Tanners were also more likely than
non-tanners to believe that skin cancer screening has been show to help prevent skin cancer caused
by indoor tanning (46.7% of tanners vs. 32.7% of non-tanners, p=0.003) and to reduce the risk of
death from skin cancer caused by indoor tanning (58.4% of tanners vs. 44.9% of non-tanners,
p=0.007). Indoor tanning may increase utilization of the limited resource of dermatologist screen-
ing by otherwise low-risk patients and is associated with unrealistic expectations from skin cancer
screening.
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Smoking in psoriasis patients may lessen risk of psoriatic arthritis development and delay age
of onset
D Zaghi,1 TR Nandi,2 B Sauer,1 G Stoddard,1 B Feng,1 J Walsh,1 B Wong,3 J Woodcock,1
GG Krueger1 and KC Duffin1 1 School of Medicine, University of Utah, Salt Lake City, UT, 2
Dermatology, Case Western University, Cleveland, OH and 3 Nursing, University of Utah, Salt
Lake City, UT
Previously we have reported that tobacco use before or after onset of psoriasis influences the time
to developing psoriatic arthritis (PsA). To further explore the influence of smoking on PsA, we have
performed additional analyses on our psoriasis cohort known as the Utah Psoriasis Initiative (UPI).
We conducted a retrospective cohort study of 1155 participants with dermatologist-diagnosed pso-
riasis enrolled in the UPI from December 2002 to July 2010 (49.9% women, 50.0% men). We used
a Cox proportional hazards model to determine the hazard ratio (HR) of PsA development across
smoking exposures. Smoking exposure was analyzed through pack years and smoking status (non-
smoker, past, current). We next performed a nested linear regression to study the relationship between
pack years smoked and age of onset of PsA. We controlled for psoriatic nail disease, worst-ever body
surface area involvement and koebnerization. Patients were considered to have PsA if they reported
their diagnosis was rheumatologist-confirmed. We observed a lowered hazard ratio for PsA among
those who smoked more than 20 pack years (HR 0.60, P = 0.042) and among current smokers (HR
0.67, P = 0.039). We observed a delayed age of onset of PsA with a greater than 20 pack year smok-
ing history, even after controlling for age of enrollment (+12 years delay, P < 0.01). This study sug-
gests that heavy smoking and current smoking status may protect against PsA development. Addi-
tionally, patients with more than 20 pack years of smoking exposure exhibited a delayed age of
onset of PsA. It is unclear how the effects of smoking combine with the inflammatory milieu of pso-
riasis to influence PsA. Additional studies are needed to confirm and explore PsA severity across
smoking exposures. Given the known harmful effects of smoking, it would be wise to continue to
discourage smoking in psoriasis patients.
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Familial risk of psoriasis and lymphoma in the Utah Population Database
KC Duffin,1 C Schaefer,2 K Rowe,3 GG Krueger,1 G Mineau2 and DE Goldgar1 1 Dermatology,
University of Utah, Salt Lake City, UT, 2 Huntsman Cancer Institute, University of Utah, Salt
Lake City, UT and 3 Oncology Clinical Program, Intermountain Healthcare, Salt Lake City, UT
Psoriasis patients are at risk of developing Hodgkin’s (HL), non-Hodgkin’s (NHL), and cutaneous T-
cell lymphoma (CTCL). Both psoriasis and lymphoma have a familial component. Our objective
was to examine familial clustering of psoriasis and lymphoma using the Utah Population Database
(UPDB). 9007 patients with psoriasis and 1332 patients with psoriatic arthritis (PsA) were identi-
fied from the Utah Psoriasis Initiative, University of Utah and Intermountain Healthcare records.
These had been linked to the UPDB, a resource that includes genealogy, demographic, medical,
and cancer records of > 6 million individuals. For each case, 5-10 controls matched on birth year,
gender, and state of birth were selected from the UPDB. Familial relative risk estimates for psoria-
sis, PsA, HL, NHL, and CTCL were calculated using Kinship Analysis Tools. There was a significant
relative risk (RR) of psoriasis in 1st (6.56, CI 5.78-7.44), 2nd (RR 3.2, CI 2.76-3.72), and 3rd degree
relatives (RR 2.0, CI 1.68-2.38) that remained when UPI and U of U patients were excluded (1st
degree RR 4.8, CI 3.69-6.23, 2nd degree RR 2.6 CI 1.9-3.47, cousins RR 1.6, CI 1.16-2.13). The RR
of PsA in 1st degree relatives of PsA patients was 18.14 (CI 10.35-31.8) and in 2nd degree relatives
was 3.53 (CI 1.58-7.85). Of the patients with psoriasis, 81 had a diagnosis of lymphoma. The RR of
NHL in the psoriasis probands was 1.52 (CI 1.14-2.04) and for CTCL was 11.65 (CI 4.82-28.17) but
the RR for NHL and CTCL was not significant in 1st degree relatives. There was no evidence of
association of psoriasis with HL. This study supports a strong familial component to PsA. The results
also indicate that a psoriasis proband has an increased risk for NHL, but not HL, over matched con-
trols. There is an increased risk for CTCL in probands, but the CI is wide due to the small number
of patients. First degree relatives of patients with psoriasis do not appear to have increased risk of
lymphoma.
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Spitz nevi – a pediatric dermatology perspective
BE Tlougan, SJ Orlow and JV Schaffer Department of Dermatology, New York University School
of Medicine, New York, NY
As melanocytic lesions that tend to grow rapidly and with atypical lesions sometimes having his-
tology that overlaps melanoma, there remains controversy among dermatologists with regard to
strategies for diagnosis and management of Spitz nevi. The purpose of our study was to gather data
on the opinions, management behaviors, and experiences of pediatric dermatologists with regard
to Spitz nevi in children and adolescents. With >75% of Spitz nevi occurring in the 1st two decades
of life and pediatric dermatologists having the greatest collective experience in Spitz nevi, we per-
formed an anonymous survey-based study via surveymonkey.com of pediatric dermatologists from
around the world. The response rate for our study was 51.2% [175/342]. 84% of respondents had
>50% of their practices composed of pediatric patients and 64% had practices with >75% pedi-
atric patients. Altogether our respondents had >2500 collective years in practice and saw approx-
imately 1500 Spitz nevi per year (total ~3,756,000 Spitz nevi seen by respondents over their careers).
We observed that academic pediatric dermatologists tended to classify Spitz nevi as benign [p=0.005]
and academicians were more likely to follow lesions clinically vs. private practitioners [p=0.04].
100% of academicians seeing >75% pediatric patients daily classified Spitz nevi as benign. Pre-
dictors to follow Spitz nevi clinically included: never seeing an unambiguous melanoma in a child
[p=0.009], believing that Spitz nevi are not precursors to melanoma [p=0.02], and always having
a dermatopathologist with expertise in melanocytic lesions available to review biopsies [p=0.006].
72% of respondents believed nothing is gained from a SLNB in patients with atypical Spitz nevi.
Many clinicians witnessed involution and evolution of both pigmented and typical Spitz nevi to
more banal nevus subtypes, which is further evidence of benignity. No academicians observed dis-
ease-related death from atypical Spitz nevi in their careers, and overall death due to disease was
extremely rare as reported by private practitioners in only 2 out of 3,756,000 lesions (0.00005%).
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Psoriasis and risk of type 2 diabetes among women and men in the United States
W Li,1 J Han,1,2 F Hu,2 G Curhan2 and A Qureshi1,2 1 Brigham and Women’s Hospital, Harvard
Medical School, Boston, MA and 2 Harvard School of Public Health, Boston, MA
Although previous studies have shown that type 2 diabetes (T2D) shares some common risk factors
with psoriasis, evidence regarding the association between psoriasis and risk of incident T2D from
cohort study is limited. To evaluate the association among women and men in the United States in
a cohort study, 184,395 eligible participants were included, of which 63,927 were from an older
cohort of women (the Nurses’ Health Study, NHS) (1996-2008), 95,779 from a younger cohort of
women (NHS II) (1991-2007) and 24,689 from an older cohort of men (Health Professionals’ Fol-
low-Up Study, HPFS) (1986-2006).Lifetime history of physician-diagnosed psoriasis was obtained
by self-reported questionnaire and confirmed for NHS II participants. Incidence of T2D was obtained
by self-reported biennial questionnaires and confirmed by a supplementary questionnaire. During
2,700,958 person-years of follow-up, 9,938 incident T2D cases were confirmed. We found a sig-
nificantly increased risk of T2D associated with psoriasis only among younger women (NHS II); mul-
tivariate-adjusted relative risk (RR) was 1.25 (95% confidence interval (CI): 1.05-1.49). When only
including those younger than 60 years during follow-up in the older cohorts (NHS and HPFS), we
observed a non-significant trend toward increased risk for T2D. In a meta-analysis of the three cohorts,
individuals with psoriasis younger than 60 years were at a higher risk of T2D; multivariate-adjusted
RR 1.26 (95% CI: 1.08-1.48) for women, and 1.26 (95% CI: 1.08-1.46) for all. Further, the risk of
T2D was much higher for those developing psoriasis at an early age. In addition, the association
remained consistent in a sensitivity analysis using confirmed psoriasis cases (NHS II). In conclu-
sion, psoriasis may be an independent predictor for T2D among individuals younger than 60 years.
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Association between atopic dermatitis and serum vitamin D in children
Y Gilaberte,1 R Sanmartin,2 R Alijarde,2 J Puzo,3 E Ubalde4 and C Pardos2 1 Dermatology,
Hospital San Jorge, Huesca, Spain, 2 Pediatric, Perpetuo Socorro P.C. Center, Huesca, Spain,
3 Biochemistry, Hospital San Jorge, Huesca, Spain and 4 Pediatric, Hospital San Jorge,
Huesca, Spain
The pathogenesis of atopic dermatitis (AD)involves dysfunction of both the epidermal barrier and
immunological system. Vitamin D has been shown to suppress inflammatory responses,enhance
antimicrobial peptide activity and promote the integrity of the epidermal barrier. The aim of our
study was to assess the relationship of vitamin D (25OHD)with AD in children. We conducted a
cross-sectional study of patients aged up to 14 years-old with AD living in Huesca(Spain)(54,000
inhabitans). Patients were consecutively enrolled in pediatric primary care centers, outpatient der-
matology and pediatric allergy clinics of the city Hospital S.Jorge, between September 1,2009 and
August 31,2010. Primary outcome was serum 25OHD.Patients were classified according to the
severity of eczema quantified by SCORAD,and to the clinical phase (infantile 0-2, childhood 3-12
and youth 13 or more years-old). The ANOVA test was used for statistical evaluation.78 children,
53.3% males and 46.7% females, with a mean age of 5±3.95 years-old (range 3 months to 14
years)were included. According to the SCORAD, 17.18% were classified as mild, 65.62% as mod-
erate and 17.18% as severe AD. Mean levels of serum 25OHD were inversely correlated to the
severity of the eczema (29.36±9.6 ng/ml, 28.07±10.75 ng/ml and 21.74±9 ng/ml, respectively
(p=0.154)). Most of the patients were enrolled during winter (59.42%), followed by autumn and
spring (14.50% each) and 11.60% in summer. Nevertheless,serum 25OHD levels were satisfactory
only in summer (34.54±11.95 ng/ml).We observed a statistically significant progressive reduction
of 25OHD levels with age (infantile 32.55±11.14ng/ml; 24.90±9.00 childhood and youth
20.74±9.55,p=0.005).Our data support an inverse relationship between AD and serum 25OHD:
1)in summer,the least outbreaks were associated with highest serum levels; 2)lower serum levels
correlate with increased severity of eczema;and 3)serum 25OHD decreases with age,being lowest
in the more chronic clinical phase of AD.
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Obesity, waist circumference, weight change, and the risk of psoriatic arthritis in US women
S Kumar, J Han and A Qureshi Dermatology, Brigham & Women’s Hospital, Boston, MA
Psoriatic arthritis (PsA) is an inflammatory arthritis seen with psoriasis. Although an association
between obesity and psoriasis has been reported, there is paucity of literature on obesity and PsA.
In this study, we evaluated the risk of PsA with obesity in two large cohorts of US women nurses,
the Nurses’ Health Study (NHS) and NHS II. The exposure was body mass index (BMI) at baseline
(1996 for NHS, 1991 for NHS II), updated biennially, waist and hip circumference, and weight
change updated biennially since the age of 18 years. The outcome was self-reported PsA over a 12-
yr period (1996-2008) in NHS and confirmed PsA over a 14-year period (1991-2005) in NHS II. In
Cox proportional hazards models, we simultaneously adjusted for age, smoking, physical activity
and alcohol intake. The mean age at baseline was 59.5 (NHS) and 36.3 years (NHS II). A total of
156,305 women for a combined follow-up time of 2,074,278 person-years were studied with a
report of 236 incident cases of PsA (95 in NHS and 141 in NHS II). There was a graded positive
association between baseline/updated BMI and the risk of PsA; the younger cohort showing much
stronger association. In NHS, in comparison to reference group of updated BMI of 18.5-24.9, the
multivariate relative risk of incident PsA was 1.22 (95% CI, 0.73-2.04) for a BMI of 25.0-29.9, 1.85
(95% CI, 1.02-3.38) for a BMI of 30.0-34.9, and 3.09 (95% CI, 1.60-5.97) for a BMI of >35.0 (P for
1 unit increment in BMI, 0.0035). The NHS II results were 1.85 (95% CI, 1.17-2.93), 3.56 (95% CI,
2.21-5.76), and 6.00 (95% CI, 3.75-9.62) respectively (P for 1 unit increment, <0.0001). Higher
waist circumference and hip circumference were all associated with a higher risk of PsA (P for trend,
<0.0001 in NHS II), but lost significance when adjusted for BMI. Weight change from the age of 18
years showed multivariate RR with 10 lbs increment as 1.10 (1.03-1.18) (P for trend, 0.0052) in NHS
and 1.20 (1.15-1.25) (P for trend, <0.0001) in NHS II. This large prospective study indicates that
increased adiposity and weight gain are stronger risk factors for PsA in younger women.
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Cutaneous and systemic lupus from dermatology and rheumatology clinics: Quality of life
differences
K Foering,1,2 S Rao,3,2 R Goreshi,1,2 S Kolasinski,3 J Okawa1,2 and VP Werth1,2 1 Dermatology, U
Penn, Phila, PA, 2 Dermatology, VAMC, Phila, PA and 3 Rheumatology, U Penn, Phila, PA
This study examined activity and QoL across cutaneous lupus erythematosus (CLE) and SLE popu-
lations. This cross-sectional, observational cohort study was conducted at the U Penn dermatology
and rheumatology clinics. Subjects with CLE, SLE, and both SLE and CLE (SLE/CLE) participated.
Cutaneous and systemic activity were assessed with the CLASI and SLEDAI. Subjects completed the
SF-36 and Skindex. Grouping variables included diagnosis (SLE, CLE, and SLE/CLE) and specialty
(Derm, Rheum). Of the 227 subjects, 177 were from derm and 50 were from rheum. 105 subjects
had CLE, 29 had SLE (6 had lupus nonspecific skin manifestations, 23 had no skin findings), and
93 had both CLE and SLE (27 from rheum, 66 from derm). The Rheum SLE/CLE group experienced
more arthritis (p=0.003) and nephritis (p=0.006) than the Derm SLE/CLE group. SLE (SLE/CLE and
SLE groups) scored worse than CLE alone on the physical component summary of the SF-36
(p=0.0001). CLE and SLE groups did not differ significantly in their mental health summary of the
SF-36 (p=0.108). CLE (CLE and SLE/CLE groups) scored worse on all subscales of the Skindex com-
pared to SLE alone (p<0.05). The Derm SLE/CLE group scored worse on all Skindex subscales com-
pared to the Rheum SLE/CLE group (p<0.003). CLASI activity positively correlated with all Skindex
subscales within the CLE and SLE/CLE groups (range of r values: 0.33-0.49). CLASI activity and
SLEDAI did not correlate in any group. In conclusion, SLE/CLE patients score worst on both general
health and skin-specific QoL surveys. The SF-36 captures physical QoL impairments related to SLE
but does a poor job of distinguishing the mental health impairments between SLE and CLE. The
Skindex captures both mental and physical impairments in CLE (both CLE and SLE/CLE). Skindex
subscales correlate well with CLE activity. Finally, CLASI and SLEDAI did not correlate in any
group, providing further evidence that skin manifestations are not a reliable indicator of systemic
lupus activity.
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Psychiatric comorbidity in pediatric eczema
P Yaghmaie,1 CW Koudelka2 and EL Simpson1 1 Dermatology, Oregon Health & Science
University, Portland, OR and 2 Biostatitistics Shared Resouce, Oregon Health & Science
University, Portland, OR
There is a growing interest in understanding the comorbidities associated with inflammatory skin
diseases. Well-known comorbidities in children with eczema (atopic dermatitis) include food allergy,
asthma, allergic rhinitis, and a predisposition to skin infections. Psychiatric comorbidities are emerg-
ing as a newly recognized risk associated with eczema development. We examined the risk of devel-
oping various psychiatric disorders in children with eczema using cross-sectional data from the 2007
National Survey of Children’s Health, a survey of over 90,000 children in the United States. We
found a significant increased risk of attention deficit hyperactivity disorder (ADHD) in children
with provider-diagnosed eczema (OR 1.62, 95% CI 1.35-1.93, P<0.0001). There was a striking
increase in ADHD prevalence in those children with more severe eczema. A diagnosis of ADHD
was found in 10.7%, 13.2%, and 27.7% in those children with mild, moderate, and severe eczema,
respectively (P<0.0001). The relationship between ADHD and eczema was confirmed even when
confounding factors were controlled for including sleep loss and socioeconomic factors (OR 1.77,
95% CI 1.40-2.23, P<0.0001). Significant associations were also found between eczema and other
psychiatric conditions including depression (OR 2.00, 95% CI 1.49-2.69, P<0.0001), oppositional
defiant disorder (OR 2.03, 95% CI 1.63-2.52, P<0.0001), anxiety (OR 1.81, 95% CI 1.43-2.29,
P<0.0001), and autism (OR 2.73, 95% CI 1.94-3.84). These data confirm recent reports from Ger-
many of an increased risk of ADHD in children with eczema and identify other mental health con-
ditions that are associated with this population. These data add evidence towards establishing a
causal relationship between eczema and a child’s mental health status. Strategies that establish early
control or prevent the disease may help improve the long-term mental health of children. Further
work is needed to better understand the mechanisms involved in these associations.
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Confidence and skill in managing skin disorders in African-Americans
K Buster,1,3 L Yang2 and C Elmets1,3 1 Dermatology, University of Alabama at Birmingham,
Birmingham, AL, 2 Preventive Medicine, University of Alabama at Birmingham, Birmingham,
AL and 3 Skin Disease Research Center, University of Alabama at Birmingham, Birmingham,
AL
Little evidence exists regarding the access and utilization of dermatologic services by ethnic minori-
ties or adequacy of training of dermatologists to care for ethnic minorities. Given the projected
increase in people of color in the U.S. over the next 40 years, we conducted a web-based survey
of U.S. dermatologists (n=182) and dermatology residents (n=80) to evaluate access to and quality
of care for African-American (AA) patients. Most respondents (62.97%) practice in metropolitan
areas, work in academic (47.33%) or private practice (36.26%), and identified themselves as white,
non-Hispanic (77.86%). Among significant results, we found that confidence in diagnosis and
treatment of common skin disorders in AA patients positively correlated with the number of AA
patients seen per week in both medical school (p ≤ 0.0476) and residency (p ≤0.0132). Those who
perceived both their medical school and residency training as sufficient in the diagnosis and treat-
ment of skin disease in AA patients had significantly higher confidence (p≤0.0104) compared to
those who perceived either as insufficient. Confidence in treating AA patients was highest for those
with the more years of clinical experience. Respondents were most confident in diagnosing and
treating acne, and least confident managing alopecia in AA patients. Confidence did not always
positively correlate with diagnostic and therapeutic skill as assess by image identification and mul-
tiple choice treatment options. These results support the need for adequate exposure to dermato-
logic diseases in AA patients during and beyond training to ensure dermatologists are prepared for
the anticipated increase in ethnic minorities in the U.S. population.
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Statin use is not protective for incident psoriasis
HB Naik,1 J Han,1,2,3 T Li1,2 and AA Qureshi1,2 1 Harvard Medical School, Boston, MA, 2
Brigham and Women’s Hospital, Boston, MA and 3 Harvard School of Public Health, Boston,
MA
Preliminary evidence suggests that statins may be associated with improvement in plaque psoria-
sis, presumably via their anti-inflammatory effects. The aim of this study was to further investigate
this relationship by prospectively evaluating the association between statin use and risk of incident
psoriasis in two large national cohorts of men(Health Professionals Follow-up Study (HPFS)) and
women (Nurses’ Health Study (NHS)). Data on self-reported statin use and physician-diagnosis of
psoriasis were collected beginning in 1994. Cox proportional hazards regression analyses were used
to calculate multivariate relative risks (RRs), simultaneously adjusting for age, gender, smoking sta-
tus, alcohol intake, body mass index and physical activity. RRs were calculated with 95% confi-
dence intervals (CIs), and all tests were 2-sided. In the HPFS and NHS cohorts, 469 and 827 par-
ticipants developed psoriasis over the follow-up period, respectively. Comparing participants who
had ever used statins to those who had never used statins, RR of incident psoriasis was 0.95 (95%
CI, 0.72-1.27) and 0.92 (0.76-1.11), in men and women respectively. In current users versus never
users, RR was 1.00 (0.75-1.33) and 0.91 (0.75- 1.10), for men and women respectively. The RR of
incident psoriasis given statin duration was calculated: <2 years (men 0.97 (0.65-1.43), women 0.87
(0.67-1.13)), 3-5 years (men 0.76 (0.47-1.24), women 1.10 (0.82-1.48)), and 6+ years (men 1.06
(0.72-1.57), women 0.98 (0.75-1.29)). In hypercholesterolemics, RR was calculated for previous
users (men 0.76 (0.52-1.10), women 0.85 (0.68-1.07)) and current users (men 0.81 (0.55-1.17),
women 0.81 (0.65-1.02)). In hypercholesterolemics, RR given statin duration was also calculated:
<2 years (men, 0.68 (0.40-1.18), women 0.74 (0.53-1.04)), 3-5 years (men 0.80 (0.45-1.42), women
1.07 (0.77-1.50)), and 6+ years (men 0.71 (0.43-1.18), women 0.89 (0.66-1.21)). In this study we
found that previous or current statin use, or duration of statin use, was not protective for new onset
psoriasis in men and women.
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Patterns of use of non-UV alternatives to indoor tanning among female college students
VA Russo,1 MM Van Acker,1 JS Vander Wal,2 QL Erickson2 and AA Sinha1 1 Division of
Dermatology and Cutaneous Sciences, Michigan State University, East Lansing, MI and 2
Department of Dermatology, Saint Louis University, Saint Louis, MO
Indoor tanning contributes appreciably to the overall risk for melanoma, the second leading cause
of cancer in women 15-29 years of age. The use of non-UV alternatives to indoor tanning is largely
unexplored. The purpose of this study was to determine the use of and attitudes toward non-UV
alternatives to indoor tanning held by college women who have previously tanned indoors. An
online survey was used to collect data from 393 students at two Midwestern universities. 85% of
respondents have gone indoor tanning in the past year, with event tanners (72%) and regular tan-
ners (6.4%) representing the largest and smallest clusters, respectively, of indoor tanning behavioral
types. The majority (87%) of respondents have used a non-UV sunless tanning product in the past
year, most frequently bronzing powders (79%), followed by sunless tanning lotions (45.5%), and
spray tans (14%). A commonly endorsed motive for sunless tanning product use included the per-
ception that sunless tanners enhance appearance; conversely, concerns of having skin with a streaked
or orange appearance were frequency cited reasons for non-use. Those who used sunless tanning
products agreed more strongly than non-users that sunless tanning lotions and spray tans (p<.021)
as well as bronzing powders (p<.001) are safer than tanning beds. Although sunless tanning prod-
uct use did not differ according to indoor tanning behavioral type, regular tanners were more likely
than event tanners to believe that sunless tanning lotions and spray tans (p<.014) and bronzing pow-
ders (p<.005) are protective against harmful effects of the sun. Results from our study provide insights
into tanning attitudes and behaviors and may inform tailored interventions to deliver to women at
risk. Future studies are needed to examine the effects of non-UV tanning alternatives on indoor tan-
ning behaviors, especially in event tanners who may be most amenable to change.
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Cohort findings in genome-wide association study era
J Han1,2 and A Qureshi1,2 1 Dermatology, Brigham and Women’s Hospital, Boston, MA and 2
Channing Lab, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
Genome-wide SNP data available in cohorts open opportunities to conduct the genome-wide asso-
ciation studies (GWAS) on multiple outcomes and phenotypes. We used the existing 10,000 GWAS
samples with 2.5 million HapMap SNPs to conduct analysis on pigmentary phenotypes (natural hair
color, eye color, and tanning ability), mole counts, and skin cancers. Novel loci for these traits were
revealed after multiple stages of replications. These novel loci pinpoint new pathways or biomark-
ers in the etiology of skin cancers. For example, new pathways involved in human nevogenesis,
pigmentation, and melanoma and basal cell carcinoma were identified and confirmed in inde-
pendent samples. In addition, the cohorts provide unique opportunities to follow up the GWAS find-
ings. For instance, a GWAS on skin cancers identified a SNP near human telomerase gene to have
an opposing effect on the risk of melanoma from other cancer sites. Using the pre-diagnostically
collected blood samples in cohorts, we demonstrated that the shorter telomere lengths in periph-
eral blood leukocytes were associated with a decreased risk of melanoma.
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Risk of squamous and basal cell carcinomas in patients with inflammatory bowel disorders
exposed to thiopurines: the CESAME national cohort study
K Khosrotehrani,1 L Perrin-Biroulet,2 F Carrat,3 A Bouvier,4 J Chevaux,2 F Carbonnel,6 J Colombel,6
J Dupas,6 P Godeberge,6 J Hugot,6 M Lemann,6 S Nahon,6 J Sabate,6 G Tucat6 and L Beaugerie5 1
Centre for Clinical Research, The University of Queensland, Brisbane, QLD, Australia, 2
Gastroenterology, CHU NANCY, Nancy, France, 3 Clinical investigation, APHP-Hopital Saint-
Antoine, Paris, France, 4 INSERM, Dijon, France, 5 Gastroenterology, APHP-Hopital Saint-
Antoine, Paris, France and 6 CESAME study group, Paris, France
The potential responsibility of thiopurines in promoting skin carcinomas remains controversial among
patients with inflammatory disorders as opposed to solid organ recipients. Our aim was to assess
this matter in a prospective cohort of patients with inflammatory bowel disorders (IBD). 19,486
patients with IBD were enrolled in a nationwide French cohort. Details of immunosuppressive
therapy and cases of cancer were reported. Median follow-up was 35 months. The risk of skin car-
cinomas was assessed according to thiopurine exposure. At baseline, 5,867 (30.1%) patients were
receiving, 2,809 (14.4%) had discontinued, and 10,810 had never received thiopurines. Thirty two
cases of skin carcinomas were recorded (20 BCC and 12 SCC). The incidence of skin carcinomas
among patients receiving thiopurine therapy was 0.59[0.25-1.16] per 10 000 patient year before
the age of 50 as compared to 0 in patients never exposed to thiopurines. Previous interrupted expo-
sure also resulted in an increased incidence of skin carcinomas (0,50 [0,14-1,29]). A similar trend
was observed in patients between 50-65 and over 65 years of age. The multivariate-adjusted haz-
ard ratio of skin carcinomas between patients with current or past exposure to thiopurines and those
who had never received the drug was 7.3 [2.7–19.8] (p=0.0001) and 5.7 [1.7-15.3] (p=0.004) respec-
tively. Similar results were obtained when considering SCC and BCCs separately. In conclusions,
present or past exposure to thiopurines significantly increases the risk of skin carcinomas in patients
with IBD. This evidence strongly supports sun protection and dermatological screening.
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Severity of sun damage in full-face ultraviolet photographs of 12 year-old children relates to
phenotypic skin cancer risk factors
RG Gamble,1 J Aalborg,2 NL Asdigian,2 V Gonzalez,1 LS Huff,1 NF Box,1 LA Crane2 and
RP Dellavalle1,3,4 1 Dermatology, University of Colorado Denver, Aurora, CO, 2 Community
and Behavioral Health, Colorado School of Public Health, Aurora, CO, 3 Denver Veteran
Affairs Medical Center, Denver, CO and 4 Epidemiology, Colorado School of Public Health,
Aurora, CO
Ultraviolet (UV) photography is an important component of some of the most successful sun pro-
tection interventions, but the relationship between the severity of sun damage shown in UV pho-
tographs and skin cancer risk factors has never been assessed. We recorded full-face UV photo-
graphs and phenotypic characteristics for N=585 12 year-old children. The photographs were captured
with a Canfield VISIA™ digital imaging booth. UV spots were defined as areas of skin meeting a
threshold level of color contrast to adjacent skin. A score quantifying the percent area of the face
comprised of UV spots was produced using VISIA™ 5.2 software. We found measurable sun dam-
age in 12 year-old children, with an average UV score of 1.48% and a range of 0.00-13.8%. Chil-
dren with phenotypic risk factors for skin cancer, such as white non-Hispanic race/ethnicity, red
hair color, blue eye color, increased facial freckling, light base skin color, and a larger number of
nevi had significantly higher UV scores than children without these risk factors (all P’s < 0.0001).
Children with blonde/brown hair had lower scores than those with red hair, and children with
black hair had the lowest scores (both P’s < 0.0001). Not all phenotypic subgroups had signifi-
cantly different scores. The scores for white-Hispanic, Black and Asian children were not different
from each other (all P’s > 0.10). Although men have higher rates of skin cancer than women, the
scores for boys and girls were not different (P > 0.25). Overall, the close relationship between the
severity of sun damage shown in UV photographs and children’s phenotypic skin cancer risk fac-
tors adds validity to the use of UV photography in sun protection interventions and suggests that
the photographs could be used to target children at high skin cancer risk.
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Spitz nevi – a pediatric dermatology perspective
BE Tlougan, SJ Orlow and JV Schaffer Department of Dermatology, New York University School
of Medicine, New York, NY
As melanocytic lesions that tend to grow rapidly and with atypical lesions sometimes having his-
tology that overlaps melanoma, there remains controversy among dermatologists with regard to
strategies for diagnosis and management of Spitz nevi. The purpose of our study was to gather data
on the opinions, management behaviors, and experiences of pediatric dermatologists with regard
to Spitz nevi in children and adolescents. With >75% of Spitz nevi occurring in the 1st two decades
of life and pediatric dermatologists having the greatest collective experience in Spitz nevi, we per-
formed an anonymous survey-based study via surveymonkey.com of pediatric dermatologists from
around the world. The response rate for our study was 51.2% [175/342]. 84% of respondents had
>50% of their practices composed of pediatric patients and 64% had practices with >75% pedi-
atric patients. Altogether our respondents had >2500 collective years in practice and saw approx-
imately 1500 Spitz nevi per year (total ~3,756,000 Spitz nevi seen by respondents over their careers).
We observed that academic pediatric dermatologists tended to classify Spitz nevi as benign [p=0.005]
and academicians were more likely to follow lesions clinically vs. private practitioners [p=0.04].
100% of academicians seeing >75% pediatric patients daily classified Spitz nevi as benign. Pre-
dictors to follow Spitz nevi clinically included: never seeing an unambiguous melanoma in a child
[p=0.009], believing that Spitz nevi are not precursors to melanoma [p=0.02], and always having
a dermatopathologist with expertise in melanocytic lesions available to review biopsies [p=0.006].
72% of respondents believed nothing is gained from a SLNB in patients with atypical Spitz nevi.
Many clinicians witnessed involution and evolution of both pigmented and typical Spitz nevi to
more banal nevus subtypes, which is further evidence of benignity. No academicians observed dis-
ease-related death from atypical Spitz nevi in their careers, and overall death due to disease was
extremely rare as reported by private practitioners in only 2 out of 3,756,000 lesions (0.00005%).
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Psoriasis and risk of type 2 diabetes among women and men in the United States
W Li,1 J Han,1,2 F Hu,2 G Curhan2 and A Qureshi1,2 1 Brigham and Women’s Hospital, Harvard
Medical School, Boston, MA and 2 Harvard School of Public Health, Boston, MA
Although previous studies have shown that type 2 diabetes (T2D) shares some common risk factors
with psoriasis, evidence regarding the association between psoriasis and risk of incident T2D from
cohort study is limited. To evaluate the association among women and men in the United States in
a cohort study, 184,395 eligible participants were included, of which 63,927 were from an older
cohort of women (the Nurses’ Health Study, NHS) (1996-2008), 95,779 from a younger cohort of
women (NHS II) (1991-2007) and 24,689 from an older cohort of men (Health Professionals’ Fol-
low-Up Study, HPFS) (1986-2006).Lifetime history of physician-diagnosed psoriasis was obtained
by self-reported questionnaire and confirmed for NHS II participants. Incidence of T2D was obtained
by self-reported biennial questionnaires and confirmed by a supplementary questionnaire. During
2,700,958 person-years of follow-up, 9,938 incident T2D cases were confirmed. We found a sig-
nificantly increased risk of T2D associated with psoriasis only among younger women (NHS II); mul-
tivariate-adjusted relative risk (RR) was 1.25 (95% confidence interval (CI): 1.05-1.49). When only
including those younger than 60 years during follow-up in the older cohorts (NHS and HPFS), we
observed a non-significant trend toward increased risk for T2D. In a meta-analysis of the three cohorts,
individuals with psoriasis younger than 60 years were at a higher risk of T2D; multivariate-adjusted
RR 1.26 (95% CI: 1.08-1.48) for women, and 1.26 (95% CI: 1.08-1.46) for all. Further, the risk of
T2D was much higher for those developing psoriasis at an early age. In addition, the association
remained consistent in a sensitivity analysis using confirmed psoriasis cases (NHS II). In conclu-
sion, psoriasis may be an independent predictor for T2D among individuals younger than 60 years.
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Association between atopic dermatitis and serum vitamin D in children
Y Gilaberte,1 R Sanmartin,2 R Alijarde,2 J Puzo,3 E Ubalde4 and C Pardos2 1 Dermatology,
Hospital San Jorge, Huesca, Spain, 2 Pediatric, Perpetuo Socorro P.C. Center, Huesca, Spain,
3 Biochemistry, Hospital San Jorge, Huesca, Spain and 4 Pediatric, Hospital San Jorge,
Huesca, Spain
The pathogenesis of atopic dermatitis (AD)involves dysfunction of both the epidermal barrier and
immunological system. Vitamin D has been shown to suppress inflammatory responses,enhance
antimicrobial peptide activity and promote the integrity of the epidermal barrier. The aim of our
study was to assess the relationship of vitamin D (25OHD)with AD in children. We conducted a
cross-sectional study of patients aged up to 14 years-old with AD living in Huesca(Spain)(54,000
inhabitans). Patients were consecutively enrolled in pediatric primary care centers, outpatient der-
matology and pediatric allergy clinics of the city Hospital S.Jorge, between September 1,2009 and
August 31,2010. Primary outcome was serum 25OHD.Patients were classified according to the
severity of eczema quantified by SCORAD,and to the clinical phase (infantile 0-2, childhood 3-12
and youth 13 or more years-old). The ANOVA test was used for statistical evaluation.78 children,
53.3% males and 46.7% females, with a mean age of 5±3.95 years-old (range 3 months to 14
years)were included. According to the SCORAD, 17.18% were classified as mild, 65.62% as mod-
erate and 17.18% as severe AD. Mean levels of serum 25OHD were inversely correlated to the
severity of the eczema (29.36±9.6 ng/ml, 28.07±10.75 ng/ml and 21.74±9 ng/ml, respectively
(p=0.154)). Most of the patients were enrolled during winter (59.42%), followed by autumn and
spring (14.50% each) and 11.60% in summer. Nevertheless,serum 25OHD levels were satisfactory
only in summer (34.54±11.95 ng/ml).We observed a statistically significant progressive reduction
of 25OHD levels with age (infantile 32.55±11.14ng/ml; 24.90±9.00 childhood and youth
20.74±9.55,p=0.005).Our data support an inverse relationship between AD and serum 25OHD:
1)in summer,the least outbreaks were associated with highest serum levels; 2)lower serum levels
correlate with increased severity of eczema;and 3)serum 25OHD decreases with age,being lowest
in the more chronic clinical phase of AD.
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Obesity, waist circumference, weight change, and the risk of psoriatic arthritis in US women
S Kumar, J Han and A Qureshi Dermatology, Brigham & Women’s Hospital, Boston, MA
Psoriatic arthritis (PsA) is an inflammatory arthritis seen with psoriasis. Although an association
between obesity and psoriasis has been reported, there is paucity of literature on obesity and PsA.
In this study, we evaluated the risk of PsA with obesity in two large cohorts of US women nurses,
the Nurses’ Health Study (NHS) and NHS II. The exposure was body mass index (BMI) at baseline
(1996 for NHS, 1991 for NHS II), updated biennially, waist and hip circumference, and weight
change updated biennially since the age of 18 years. The outcome was self-reported PsA over a 12-
yr period (1996-2008) in NHS and confirmed PsA over a 14-year period (1991-2005) in NHS II. In
Cox proportional hazards models, we simultaneously adjusted for age, smoking, physical activity
and alcohol intake. The mean age at baseline was 59.5 (NHS) and 36.3 years (NHS II). A total of
156,305 women for a combined follow-up time of 2,074,278 person-years were studied with a
report of 236 incident cases of PsA (95 in NHS and 141 in NHS II). There was a graded positive
association between baseline/updated BMI and the risk of PsA; the younger cohort showing much
stronger association. In NHS, in comparison to reference group of updated BMI of 18.5-24.9, the
multivariate relative risk of incident PsA was 1.22 (95% CI, 0.73-2.04) for a BMI of 25.0-29.9, 1.85
(95% CI, 1.02-3.38) for a BMI of 30.0-34.9, and 3.09 (95% CI, 1.60-5.97) for a BMI of >35.0 (P for
1 unit increment in BMI, 0.0035). The NHS II results were 1.85 (95% CI, 1.17-2.93), 3.56 (95% CI,
2.21-5.76), and 6.00 (95% CI, 3.75-9.62) respectively (P for 1 unit increment, <0.0001). Higher
waist circumference and hip circumference were all associated with a higher risk of PsA (P for trend,
<0.0001 in NHS II), but lost significance when adjusted for BMI. Weight change from the age of 18
years showed multivariate RR with 10 lbs increment as 1.10 (1.03-1.18) (P for trend, 0.0052) in NHS
and 1.20 (1.15-1.25) (P for trend, <0.0001) in NHS II. This large prospective study indicates that
increased adiposity and weight gain are stronger risk factors for PsA in younger women.
242
Cutaneous and systemic lupus from dermatology and rheumatology clinics: Quality of life
differences
K Foering,1,2 S Rao,3,2 R Goreshi,1,2 S Kolasinski,3 J Okawa1,2 and VP Werth1,2 1 Dermatology, U
Penn, Phila, PA, 2 Dermatology, VAMC, Phila, PA and 3 Rheumatology, U Penn, Phila, PA
This study examined activity and QoL across cutaneous lupus erythematosus (CLE) and SLE popu-
lations. This cross-sectional, observational cohort study was conducted at the U Penn dermatology
and rheumatology clinics. Subjects with CLE, SLE, and both SLE and CLE (SLE/CLE) participated.
Cutaneous and systemic activity were assessed with the CLASI and SLEDAI. Subjects completed the
SF-36 and Skindex. Grouping variables included diagnosis (SLE, CLE, and SLE/CLE) and specialty
(Derm, Rheum). Of the 227 subjects, 177 were from derm and 50 were from rheum. 105 subjects
had CLE, 29 had SLE (6 had lupus nonspecific skin manifestations, 23 had no skin findings), and
93 had both CLE and SLE (27 from rheum, 66 from derm). The Rheum SLE/CLE group experienced
more arthritis (p=0.003) and nephritis (p=0.006) than the Derm SLE/CLE group. SLE (SLE/CLE and
SLE groups) scored worse than CLE alone on the physical component summary of the SF-36
(p=0.0001). CLE and SLE groups did not differ significantly in their mental health summary of the
SF-36 (p=0.108). CLE (CLE and SLE/CLE groups) scored worse on all subscales of the Skindex com-
pared to SLE alone (p<0.05). The Derm SLE/CLE group scored worse on all Skindex subscales com-
pared to the Rheum SLE/CLE group (p<0.003). CLASI activity positively correlated with all Skindex
subscales within the CLE and SLE/CLE groups (range of r values: 0.33-0.49). CLASI activity and
SLEDAI did not correlate in any group. In conclusion, SLE/CLE patients score worst on both general
health and skin-specific QoL surveys. The SF-36 captures physical QoL impairments related to SLE
but does a poor job of distinguishing the mental health impairments between SLE and CLE. The
Skindex captures both mental and physical impairments in CLE (both CLE and SLE/CLE). Skindex
subscales correlate well with CLE activity. Finally, CLASI and SLEDAI did not correlate in any
group, providing further evidence that skin manifestations are not a reliable indicator of systemic
lupus activity.
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Psychiatric comorbidity in pediatric eczema
P Yaghmaie,1 CW Koudelka2 and EL Simpson1 1 Dermatology, Oregon Health & Science
University, Portland, OR and 2 Biostatitistics Shared Resouce, Oregon Health & Science
University, Portland, OR
There is a growing interest in understanding the comorbidities associated with inflammatory skin
diseases. Well-known comorbidities in children with eczema (atopic dermatitis) include food allergy,
asthma, allergic rhinitis, and a predisposition to skin infections. Psychiatric comorbidities are emerg-
ing as a newly recognized risk associated with eczema development. We examined the risk of devel-
oping various psychiatric disorders in children with eczema using cross-sectional data from the 2007
National Survey of Children’s Health, a survey of over 90,000 children in the United States. We
found a significant increased risk of attention deficit hyperactivity disorder (ADHD) in children
with provider-diagnosed eczema (OR 1.62, 95% CI 1.35-1.93, P<0.0001). There was a striking
increase in ADHD prevalence in those children with more severe eczema. A diagnosis of ADHD
was found in 10.7%, 13.2%, and 27.7% in those children with mild, moderate, and severe eczema,
respectively (P<0.0001). The relationship between ADHD and eczema was confirmed even when
confounding factors were controlled for including sleep loss and socioeconomic factors (OR 1.77,
95% CI 1.40-2.23, P<0.0001). Significant associations were also found between eczema and other
psychiatric conditions including depression (OR 2.00, 95% CI 1.49-2.69, P<0.0001), oppositional
defiant disorder (OR 2.03, 95% CI 1.63-2.52, P<0.0001), anxiety (OR 1.81, 95% CI 1.43-2.29,
P<0.0001), and autism (OR 2.73, 95% CI 1.94-3.84). These data confirm recent reports from Ger-
many of an increased risk of ADHD in children with eczema and identify other mental health con-
ditions that are associated with this population. These data add evidence towards establishing a
causal relationship between eczema and a child’s mental health status. Strategies that establish early
control or prevent the disease may help improve the long-term mental health of children. Further
work is needed to better understand the mechanisms involved in these associations.
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Confidence and skill in managing skin disorders in African-Americans
K Buster,1,3 L Yang2 and C Elmets1,3 1 Dermatology, University of Alabama at Birmingham,
Birmingham, AL, 2 Preventive Medicine, University of Alabama at Birmingham, Birmingham,
AL and 3 Skin Disease Research Center, University of Alabama at Birmingham, Birmingham,
AL
Little evidence exists regarding the access and utilization of dermatologic services by ethnic minori-
ties or adequacy of training of dermatologists to care for ethnic minorities. Given the projected
increase in people of color in the U.S. over the next 40 years, we conducted a web-based survey
of U.S. dermatologists (n=182) and dermatology residents (n=80) to evaluate access to and quality
of care for African-American (AA) patients. Most respondents (62.97%) practice in metropolitan
areas, work in academic (47.33%) or private practice (36.26%), and identified themselves as white,
non-Hispanic (77.86%). Among significant results, we found that confidence in diagnosis and
treatment of common skin disorders in AA patients positively correlated with the number of AA
patients seen per week in both medical school (p ≤ 0.0476) and residency (p ≤0.0132). Those who
perceived both their medical school and residency training as sufficient in the diagnosis and treat-
ment of skin disease in AA patients had significantly higher confidence (p≤0.0104) compared to
those who perceived either as insufficient. Confidence in treating AA patients was highest for those
with the more years of clinical experience. Respondents were most confident in diagnosing and
treating acne, and least confident managing alopecia in AA patients. Confidence did not always
positively correlate with diagnostic and therapeutic skill as assess by image identification and mul-
tiple choice treatment options. These results support the need for adequate exposure to dermato-
logic diseases in AA patients during and beyond training to ensure dermatologists are prepared for
the anticipated increase in ethnic minorities in the U.S. population.
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Statin use is not protective for incident psoriasis
HB Naik,1 J Han,1,2,3 T Li1,2 and AA Qureshi1,2 1 Harvard Medical School, Boston, MA, 2
Brigham and Women’s Hospital, Boston, MA and 3 Harvard School of Public Health, Boston,
MA
Preliminary evidence suggests that statins may be associated with improvement in plaque psoria-
sis, presumably via their anti-inflammatory effects. The aim of this study was to further investigate
this relationship by prospectively evaluating the association between statin use and risk of incident
psoriasis in two large national cohorts of men(Health Professionals Follow-up Study (HPFS)) and
women (Nurses’ Health Study (NHS)). Data on self-reported statin use and physician-diagnosis of
psoriasis were collected beginning in 1994. Cox proportional hazards regression analyses were used
to calculate multivariate relative risks (RRs), simultaneously adjusting for age, gender, smoking sta-
tus, alcohol intake, body mass index and physical activity. RRs were calculated with 95% confi-
dence intervals (CIs), and all tests were 2-sided. In the HPFS and NHS cohorts, 469 and 827 par-
ticipants developed psoriasis over the follow-up period, respectively. Comparing participants who
had ever used statins to those who had never used statins, RR of incident psoriasis was 0.95 (95%
CI, 0.72-1.27) and 0.92 (0.76-1.11), in men and women respectively. In current users versus never
users, RR was 1.00 (0.75-1.33) and 0.91 (0.75- 1.10), for men and women respectively. The RR of
incident psoriasis given statin duration was calculated: <2 years (men 0.97 (0.65-1.43), women 0.87
(0.67-1.13)), 3-5 years (men 0.76 (0.47-1.24), women 1.10 (0.82-1.48)), and 6+ years (men 1.06
(0.72-1.57), women 0.98 (0.75-1.29)). In hypercholesterolemics, RR was calculated for previous
users (men 0.76 (0.52-1.10), women 0.85 (0.68-1.07)) and current users (men 0.81 (0.55-1.17),
women 0.81 (0.65-1.02)). In hypercholesterolemics, RR given statin duration was also calculated:
<2 years (men, 0.68 (0.40-1.18), women 0.74 (0.53-1.04)), 3-5 years (men 0.80 (0.45-1.42), women
1.07 (0.77-1.50)), and 6+ years (men 0.71 (0.43-1.18), women 0.89 (0.66-1.21)). In this study we
found that previous or current statin use, or duration of statin use, was not protective for new onset
psoriasis in men and women.
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Patterns of use of non-UV alternatives to indoor tanning among female college students
VA Russo,1 MM Van Acker,1 JS Vander Wal,2 QL Erickson2 and AA Sinha1 1 Division of
Dermatology and Cutaneous Sciences, Michigan State University, East Lansing, MI and 2
Department of Dermatology, Saint Louis University, Saint Louis, MO
Indoor tanning contributes appreciably to the overall risk for melanoma, the second leading cause
of cancer in women 15-29 years of age. The use of non-UV alternatives to indoor tanning is largely
unexplored. The purpose of this study was to determine the use of and attitudes toward non-UV
alternatives to indoor tanning held by college women who have previously tanned indoors. An
online survey was used to collect data from 393 students at two Midwestern universities. 85% of
respondents have gone indoor tanning in the past year, with event tanners (72%) and regular tan-
ners (6.4%) representing the largest and smallest clusters, respectively, of indoor tanning behavioral
types. The majority (87%) of respondents have used a non-UV sunless tanning product in the past
year, most frequently bronzing powders (79%), followed by sunless tanning lotions (45.5%), and
spray tans (14%). A commonly endorsed motive for sunless tanning product use included the per-
ception that sunless tanners enhance appearance; conversely, concerns of having skin with a streaked
or orange appearance were frequency cited reasons for non-use. Those who used sunless tanning
products agreed more strongly than non-users that sunless tanning lotions and spray tans (p<.021)
as well as bronzing powders (p<.001) are safer than tanning beds. Although sunless tanning prod-
uct use did not differ according to indoor tanning behavioral type, regular tanners were more likely
than event tanners to believe that sunless tanning lotions and spray tans (p<.014) and bronzing pow-
ders (p<.005) are protective against harmful effects of the sun. Results from our study provide insights
into tanning attitudes and behaviors and may inform tailored interventions to deliver to women at
risk. Future studies are needed to examine the effects of non-UV tanning alternatives on indoor tan-
ning behaviors, especially in event tanners who may be most amenable to change.
238
Cohort findings in genome-wide association study era
J Han1,2 and A Qureshi1,2 1 Dermatology, Brigham and Women’s Hospital, Boston, MA and 2
Channing Lab, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
Genome-wide SNP data available in cohorts open opportunities to conduct the genome-wide asso-
ciation studies (GWAS) on multiple outcomes and phenotypes. We used the existing 10,000 GWAS
samples with 2.5 million HapMap SNPs to conduct analysis on pigmentary phenotypes (natural hair
color, eye color, and tanning ability), mole counts, and skin cancers. Novel loci for these traits were
revealed after multiple stages of replications. These novel loci pinpoint new pathways or biomark-
ers in the etiology of skin cancers. For example, new pathways involved in human nevogenesis,
pigmentation, and melanoma and basal cell carcinoma were identified and confirmed in inde-
pendent samples. In addition, the cohorts provide unique opportunities to follow up the GWAS find-
ings. For instance, a GWAS on skin cancers identified a SNP near human telomerase gene to have
an opposing effect on the risk of melanoma from other cancer sites. Using the pre-diagnostically
collected blood samples in cohorts, we demonstrated that the shorter telomere lengths in periph-
eral blood leukocytes were associated with a decreased risk of melanoma.
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Risk of squamous and basal cell carcinomas in patients with inflammatory bowel disorders
exposed to thiopurines: the CESAME national cohort study
K Khosrotehrani,1 L Perrin-Biroulet,2 F Carrat,3 A Bouvier,4 J Chevaux,2 F Carbonnel,6 J Colombel,6
J Dupas,6 P Godeberge,6 J Hugot,6 M Lemann,6 S Nahon,6 J Sabate,6 G Tucat6 and L Beaugerie5 1
Centre for Clinical Research, The University of Queensland, Brisbane, QLD, Australia, 2
Gastroenterology, CHU NANCY, Nancy, France, 3 Clinical investigation, APHP-Hopital Saint-
Antoine, Paris, France, 4 INSERM, Dijon, France, 5 Gastroenterology, APHP-Hopital Saint-
Antoine, Paris, France and 6 CESAME study group, Paris, France
The potential responsibility of thiopurines in promoting skin carcinomas remains controversial among
patients with inflammatory disorders as opposed to solid organ recipients. Our aim was to assess
this matter in a prospective cohort of patients with inflammatory bowel disorders (IBD). 19,486
patients with IBD were enrolled in a nationwide French cohort. Details of immunosuppressive
therapy and cases of cancer were reported. Median follow-up was 35 months. The risk of skin car-
cinomas was assessed according to thiopurine exposure. At baseline, 5,867 (30.1%) patients were
receiving, 2,809 (14.4%) had discontinued, and 10,810 had never received thiopurines. Thirty two
cases of skin carcinomas were recorded (20 BCC and 12 SCC). The incidence of skin carcinomas
among patients receiving thiopurine therapy was 0.59[0.25-1.16] per 10 000 patient year before
the age of 50 as compared to 0 in patients never exposed to thiopurines. Previous interrupted expo-
sure also resulted in an increased incidence of skin carcinomas (0,50 [0,14-1,29]). A similar trend
was observed in patients between 50-65 and over 65 years of age. The multivariate-adjusted haz-
ard ratio of skin carcinomas between patients with current or past exposure to thiopurines and those
who had never received the drug was 7.3 [2.7–19.8] (p=0.0001) and 5.7 [1.7-15.3] (p=0.004) respec-
tively. Similar results were obtained when considering SCC and BCCs separately. In conclusions,
present or past exposure to thiopurines significantly increases the risk of skin carcinomas in patients
with IBD. This evidence strongly supports sun protection and dermatological screening.
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Severity of sun damage in full-face ultraviolet photographs of 12 year-old children relates to
phenotypic skin cancer risk factors
RG Gamble,1 J Aalborg,2 NL Asdigian,2 V Gonzalez,1 LS Huff,1 NF Box,1 LA Crane2 and
RP Dellavalle1,3,4 1 Dermatology, University of Colorado Denver, Aurora, CO, 2 Community
and Behavioral Health, Colorado School of Public Health, Aurora, CO, 3 Denver Veteran
Affairs Medical Center, Denver, CO and 4 Epidemiology, Colorado School of Public Health,
Aurora, CO
Ultraviolet (UV) photography is an important component of some of the most successful sun pro-
tection interventions, but the relationship between the severity of sun damage shown in UV pho-
tographs and skin cancer risk factors has never been assessed. We recorded full-face UV photo-
graphs and phenotypic characteristics for N=585 12 year-old children. The photographs were captured
with a Canfield VISIA™ digital imaging booth. UV spots were defined as areas of skin meeting a
threshold level of color contrast to adjacent skin. A score quantifying the percent area of the face
comprised of UV spots was produced using VISIA™ 5.2 software. We found measurable sun dam-
age in 12 year-old children, with an average UV score of 1.48% and a range of 0.00-13.8%. Chil-
dren with phenotypic risk factors for skin cancer, such as white non-Hispanic race/ethnicity, red
hair color, blue eye color, increased facial freckling, light base skin color, and a larger number of
nevi had significantly higher UV scores than children without these risk factors (all P’s < 0.0001).
Children with blonde/brown hair had lower scores than those with red hair, and children with
black hair had the lowest scores (both P’s < 0.0001). Not all phenotypic subgroups had signifi-
cantly different scores. The scores for white-Hispanic, Black and Asian children were not different
from each other (all P’s > 0.10). Although men have higher rates of skin cancer than women, the
scores for boys and girls were not different (P > 0.25). Overall, the close relationship between the
severity of sun damage shown in UV photographs and children’s phenotypic skin cancer risk fac-
tors adds validity to the use of UV photography in sun protection interventions and suggests that
the photographs could be used to target children at high skin cancer risk.
S40 Journal of Investigative Dermatology (2011), Volume 131
SID11_Abstracts-5  2/28/11  9:27 AM  Page S40
ABSTRACTS
253
High prevalence of psoriatic arthritis (PsA) with a significant impact on quality of life (QOL)
in psoriasis (PsO) patients evaluated at a multidisciplinary center for complex psoriatic dis-
ease<b/>
AA Deodhar,1 B Truong,2 A Samrao,2 BL Ehst,2 T Devere,2 JM Gelfand3 and A Blauvelt2 1
Rheumatology, Oregon Health & Sci. Univ., Portland, OR, 2 Dermatology, Oregon Health &
Sci. Univ., Portland, OR and 3 Dermatology, Univ. of Penn., Philadelphia, PA
The Center of Excellence for Psoriasis and Psoriatic Arthritis (CEPPA) is a multidisciplinary clinic at
our institution. The purpose of the study reported here was to assess the prevalence of PsA as well
as demographic characteristics of PsA patients in CEPPA. Between Nov. 1, 2006 and Aug. 31,
2010, 529 PsO patients were seen in CEPPA and considered evaluable for analysis. The mean age
was 48.9 years, 19.7% were active smokers, the mean body surface area (BSA) affected by psoria-
sis was 14.4%, and the mean body mass index (BMI) was 30.4. On an initial questionnaire, 30.5%
of patients reported a history of PsA, 30.7% reported no history of PsA, and 38.8% of patients were
unsure about PsA. A subset of 173 patients was evaluated by rheumatology to confirm or rule out
PsA. All patients who self-reported as having PsA had PsA, all patients who self-reported as not hav-
ing PsA did not have PsA, and 27.6% of patients who self-reported that they were unsure about PsA
had PsA as diagnosed by a rheumatologist, leading to an estimated PsA prevalence of 41.2%. BSA
positively correlated with BMI, but BMI was not associated with PsA (p<0.15). PsA was also not
associated with smoking (p<0.14) or alcohol use (p<0.18). Compared to patients with PsO alone,
PsA patients had significantly worse QOL scores (p<0.001 for both SF-12 and PQOL-12) and were
significantly more adversely affected at work (p<0.001). In summary, a high estimated prevalence
of PsA (41.2%) was observed in a large cohort of PsO patients evaluated in a multidisciplinary clinic
designed for patients with complex psoriatic disease, most likely due to referral bias. Over 60% of
patients correctly self-identified themselves as having PsA, whereas at least 10% of patients pre-
sented with previously undiagnosed PsA. PsA was associated with significantly worse QOL com-
pared to patients with PsO alone.
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Physician survey of dermatology quality reporting initiatives in Colorado.
BT Alvarez,1 CA Dunnick2,3 and RP Dellavalle2,3,4 1 Colorado School of Public Health, UC
Denver, Aurora, CO, 2 Dermatology, UC Denver, Aurora, CO, 3 School of Medicine, UC
Denver, Aurora, CO and 4 Dermatology, Department of Veterans Affairs Medical Center,
Denver, CO
In 2006, the Centers for Medicare and Medicaid Services (CMS) established Physician Quality Report-
ing Initiatives (PQRI) as part of a voluntary incentive payment process to improve healthcare and
support preventive practices. As of 2010, there were 375 measures but only three were applicable
to dermatology practices, specifically the management of melanoma patients: follow-up, continu-
ity of care and coordination of care. To assess how the current PQRI measures are currently used
in Colorado dermatology practices, an 18-question survey was distributed to dermatologists at the
2010 Colorado Dermatological Society Annual Meeting in Denver, Colorado. Of the 107 attendees,
32 completed the survey yielding a response rate of 30%. Only half used the PQRIs in their CMS
claims, (14:14:3 [yes:no:don’t know]) but almost all provided counseling to patients at high risk for
melanoma. Less than half (14:18 [yes:no]) used an electronic medical record (EMR) system, and
the majority did not use an E-Prescribing program (11:21 [yes:no]). More physicians (11:5:16
[yes:no:don’t know]) felt that the measures were worth the time and effort than those who believed
that the monetary reimbursements were adequate (4:8:20 [yes:no:don’t know]). Since CMS will
begin penalizing practices that do not report these measures, it is important to assess the current
system. CMS is pushing to only accept PQRIs from the EMR, thus causing a potential problem for
those who still operate using only paper charts. Because there is little in the literature regarding this
topic, this survey is an attempt to gauge utilization and opinions of the current PQRI system among
Colorado dermatologists.
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Atopic dermatitis prevalence and co-morbidities in the Growing Up Today Study II
HC Frankel,1,2 L Frazier,2,3 CA Camargo,2,4 J Han,1,2,4 T Li2 and AA Qureshi1,2 1 Dermatology,
Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 2 Medicine, Channing
Laboratory, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 3 Pediatric
Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA and 4
Epidemiology, Harvard School of Public Health, Boston, MA
Atopic dermatitis (AD) is a highly prevalent chronic inflammatory skin disease that affects adults
and children in the United States. The incidence of AD and other atopic disorders, such as asthma,
allergic rhinitis, and food allergy, is increasing in developed countries, particularly in urban areas.
Environmental factors may influence the development of AD and explain both the increasing inci-
dence and also variations in AD prevalence seen within the United States. In this study, we char-
acterized the prevalence of AD and co-morbid conditions in the Growing Up Today Study II (GUT-
SII) cohort. GUTSII participants are children of women in the Nurses’ Health Study II cohort and
were aged 9-14 years in 2004 upon initiation of the study. On biennial questionnaires, participants
reported health and diet information including physician-diagnosed AD, asthma, allergic rhinitis,
and food allergy. Among 10,314 study participants, 963 (9.3%) reported a physician-diagnosis of
AD. 515 (53%) were female and 448 (47%) were male. In 2004, the mean age was 13 years (range,
10-16) and 908 (94%) were Caucasian. Participants with AD did not differ significantly from those
without AD in age or sex. Of the individuals with AD, 866 (90%) had an asthma diagnosis, 163
(17%) had an allergic rhinitis diagnosis, and 163 (25%) had a food allergy diagnosis. Thirty (3.1%)
participants had been diagnosed with all four conditions (AD, asthma, allergic rhinitis, and food
allergy). Further characterization of the GUTSII participants with atopic disorders and epidemio-
logical analyses of risk factors leading to the development of these disorders may give us a better
understanding of the environmental factors affecting AD expression.
256
Treatment for nonmelanoma skin cancer among patients with limited life expectancies
M Chren,1,2 E Linos,3 R Parvataneni,1 J Torres,2 S Stuart,2 WJ Boscardin1 and CS Landefeld1,2 1 Univ
of California at San Francisco, San Francisco, CA, 2 San Francisco Veterans Affairs Medical
Center, San Francisco, CA and 3 Stanford University, Stanford, CA
Because nonmelanoma skin cancers (NMSCs) do not typically affect survival or short-term quality
of life, the care of NMSC in patients with limited life expectancy may not be straightforward. To
learn about NMSC care in patients with poor prognoses, we followed 1472 patients with 1910
NMSCs for 10 years after diagnosis in 1999-2000 in 2 medical centers. We focused on 3 groups:
patients who were old-old (> 85 years at the time of biopsy), patients with multi-morbidity (Charl-
son comorbidity score of > 3), and patients who ultimately died within two years of therapy. Over-
all, 25% of tumors were treated with destruction, 35% with excision, 36% with Mohs surgery, 1%
with less common treatments, and for 3% no treatment was performed. Median survival was shorter
in the 126 patients who were old-old (4.0 years vs. 9.7 years in younger patients who died; P<0.001)
and in the 244 patients with multi-morbidity (7.6 years vs. 9.9 years in other patients who died;
P<0.001). 124 patients died within 2 years of therapy. The frequencies of treatment with destruc-
tion, excision, and Mohs surgery did not differ significantly (P>0.3) among groups at higher risk of
death. For example, Mohs surgery was performed in 36% of old-old and 36% of younger patients,
in 34% with multi-morbidity and 38% without multi-morbidity; and in 32% and 36% of those who
survived < 2 years and >2 years, respectively. Even for smaller tumors or those not in the H-zone
of the face, the frequency of treatments did not differ among patients who were old-old, had multi-
morbidity, or died within 2 years. In multivariable models that adjusted for tumor severity, neither
old-old age, multi-morbidity, nor subsequent death within two years affected the likelihood of
treatment with Mohs surgery. We conclude that NMSCs were often treated aggressively in patients
with limited life expectancy, and treatment choices were not affected by conventional measures of
worse prognosis.
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Sun safety video contest: promoting skin cancer prevention through online media
AL Dawson,1 AA Hay,2 LS Huff,1 RG Gamble,1 W Howe,3 I Kane4 and RP Dellavalle1 1
Dermatology, University of Colorado Denver School of Medicine, Aurora, CO, 2 Loma Linda
University School of Medicine, Loma Linda, CA, 3 Hill Center for Dermatology, Golden, CO
and 4 Klein Buendel, Inc., Golden, CO
Approximately 179 million American adults – 69% of the adult population – accessed health infor-
mation on the internet in 2010. More than 44% of these individuals obtained health information
via social media websites such as YouTube. Given this broad usage, YouTube and similar websites
represent a primary means by which to distribute preventive health messages. This project aimed
to identify and publicize exemplary online skin cancer prevention videos via an annual contest as
well as to determine whether the contest led to increased viewing of winning videos. In 2008 The
Sulzberger Institute funded a YouTube contest to promote sun safety public health messaging though
a $5000 grant to William Howe, MD. In 2010 and 2011 we solicited video submissions and searched
existing YouTube videos. Contest committees selected 3 video finalists based on content and pres-
entation. Finalists were then ranked into first, second, and third places by a panel of judges com-
prised of dermatologists, scientists, and patients. Finalists were announced at the 2010 and 2011
American Academy of Dermatology (AAD) Annual Meetings and via a contest website. After pub-
licizing the winning videos, YouTube view counts were observed for 3 months to identify changes
in viewing frequency. In 2010, review of video view counts revealed no apparent change in view-
ing frequency after the AAD announcement with the rate-of-increase of view count number remain-
ing constant over the subsequent 3 month time period. The impact of the 2011 contest announce-
ment on view count will be determined in February through April 2011. This contest successfully
identified and rewarded excellent sun safety videos, but increased video views have yet to be seen.
Future directions include improving efforts to publicize the contest as well as to measure the impact
of videos on influencing consumers to modify sun-safety behaviors.
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Predictors of patient satisfaction in Mohs surgery: Analysis of pre-, intra- and post-operative
factors in a large prospective cohort
MM Asgari,1,2 E Warton,1 R Neugebauer1 and M Chren2 1 Division of Research, Kaiser
Permanente Northern California, Oakland, CA and 2 Dermatology, University of California
San Francisco, San Francisco, CA
Factors that influence satisfaction in patients undergoing Mohs surgery have not been systematically
studied. Using data from a large prospective cohort, we sought to identify pre-, intra-, and post-
operative variables that impact short and long-term patient satisfaction in 339 consecutive patients
treated with Mohs surgery. Graphical causal modeling was used to determine appropriate con-
founding adjustment in standard logistic regression models. Poor skin-related quality of life (mea-
sured with Skindex) was the most salient variable in predicting worse short- and long-term satis-
faction (OR satisfied= 0.43, 95% CI:0.19-0.99 and 0.19, 95% CI:0.06-0.60 respectively comparing
Skindex < median vs. > median). High short-term satisfaction was associated with 3 or more Mohs
stages (OR = 7.06, 95% CI:2.02-24.67), fewer post-operative complications and more perceived
involvement in decision making. Higher long-term satisfaction was associated with being married
(OR = 2.36, 95% CI:1.10-5.09) and with 3 or more Mohs stages (OR = 5.30, 95% CI: 1.24-22.64).
We conclude that short-term patient satisfaction after Mohs surgery is predicted by better pre-oper-
ative skin-related quality of life, intra-operative number of stages (3 or more), and post-operative
factors, such as bleeding and perceived greater involvement in decision making. With time, the post-
operative variables no longer appear to significantly impact patient satisfaction. Higher long-term
satisfaction was influenced by pre-operative variables (better skin-related quality of life, less worry,
and being married) and intra-operative number of Mohs stages. These results may help identify
patients at high risk for being unsatisfied with Mohs surgery, such that additional measures can be
taken to improve their experience with Mohs treatment and their resulting satisfaction.
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Sun protection counseling of non-white ethnoracial groups: The physician’s perspective
C Pourciau,1 M Eide,1,2 M Mahan2 and H Lim1 1 Dermatology, Henry Ford Hospital, Detroit,
MI and 2 Biostatistics and Research Epidemiology, Henry Ford Hospital, Detroit, MI
The morbidity of skin cancer in non-white, ethno-racial populations is well-established, yet no defin-
itive guidelines exist addressing the manner in which this population should be counseled regard-
ing sun exposure. Additionally, no studies have been performed to evaluate the frequency of pho-
toprotection counseling of non-white patients by physicians. We developed a 20-item web-based
questionnaire to describe the behavior of dermatologists when providing photoprotection recom-
mendations to non-white, ethno-racial patients as well as assess the perceived relevance of coun-
seling for this population. Physician members of the Photomedicine Society, the Skin of Color Soci-
ety and the National Medical Association were asked to participate. Descriptive statistics are
presented. Forty physicians completed the survey with a response rate of 20%. Sixty-six percent of
respondents were women, 79% self-identified as ethno-racial minorities, and more than 50% had
been in practice for greater than 10 years with the majority working as general clinicians. Approx-
imately 30% of participants indicated they do not counsel patients with Fitzpatrick Skin Type VI on
sun protection. Personal or family histories of skin cancer were the primary factors used to identify
patients for counseling. This study provides a better understanding of physicians’ attitudes towards
photoprotection for non-white, ethno-racial patients. The majority of polled dermatologists felt that
recommendations on sun protection for this population would be beneficial. Based on these data,
guidelines on photoprotection counseling for non-white, ethno-racial groups may be indicated.
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DNA in the mail
DJ Margolis,1 A Apter,1 N Mitra,1 I McLean2 and T Rebbeck1 1 University of Pennsylvania,
Philadelphia, PA and 2 University of Dundee, Dundee, United Kingdom
Many Food and Drug Administration mandated post-marketing studies are currently being con-
ducted. Linking phenotypic data from these studies to biologic materials could provide valuable
information about the natural history of many illnesses. Our goal was to describe a method for and
demonstrate the feasibility of obtaining in the mail DNA from a large national community-based
mandated study of children who have atopic dermatitis (AD). At the time of this report, 3,281 with
AD were enrolled in the study. With this cohort, we tested the usefulness of a pre-notification let-
ter, the ability to obtain DNA from those who did not respond to the pre-notification letter, and the
use of varying incentives ($1, $2, or $5). All subjects received a pre-notification letter, followed by
a sample transport kit with a randomly assigned monetary incentive. 732 of 3,281 (22.4%) provided
samples for DNA extraction. A willingness to participate note was received after a pre-notification
letter from 674 (20.5%). 402 (402/674 or 59.6%) of these individuals provided a sample. 330 who
had not responded to our initial participation mailings (330/2590 or 12.7%) provided a sample. On
average 30 μg of buccal DNA (SD 28 μg) was obtained. Individuals who responded to a pre-noti-
fication letter were 4.7 (4.2, 5.3) more likely to provide a sample. Individuals sent a $5 incentive
were slightly more likely to participate (1.26 [1.03, 1.51]). Overall those with asthma (1.26 [1.07,
1.50]), between 6 and 9 years of age at enrollment (1.57 [1.19, 2.08]), with a family income of
between $75,000 and $99,999 (2.33[1.70, 3.18]), and from the New England states were most likely
to provide a sample. African Americans were less likely to participate (0.72 [0.61, 0.85]). Similar
effect estimates were noted for these covariates whether they responded and did not respond to the
pre-notification letter. In conclusion, it is possible to obtain DNA from a cohort of children previ-
ously enrolled in a mandated post-marketing study that was not designed to request or obtain a
biosample. The use of a pre-notification letter is very helpful.
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Disparities in skin cancer screening exams conducted in the primary care setting
KJ Martires,1 GJ Minwell1 and JS Bordeaux2 1 Case Western Reserve University School of
Medicine, Cleveland, OH and 2 Dermatology, University Hospitals Case Medical Center,
Cleveland, OH
The incidence of melanoma continues to rise. Early detection and treatment may reduce its mor-
tality. Skin exams are not routinely performed in primary care, as it is not recommended by the U.S.
Preventive Services Task Force. To assess the rate of skin exams over time and compare to other
screening exams, data was extracted from the National Ambulatory Medical Care Survey for the
years 1997-2006. Only “non-illness” or “preventive care” visits among adults in internal medicine,
general practice, or family practices were included. The rate of skin exams in 2006 was not signif-
icantly higher than the rate in 1997 (25.7% vs 16.8%, p=0.116). There was a marginally higher skin
exam rate for white patients during the years 2005-2006, compared with 1997-2000 (26.3% vs.
18.7%, p=0.054). This trend was not seen in non-whites (19.8% vs. 23.8%, p=0.537). Rates of
other exams, breast (34.4% vs 29.7%, p=0.349) and pelvic (34.1% and 31.3% p=0.539), did not
change over this time. Patients with BMI<25 were 1.5 times as likely as those with BMI>25 to receive
a skin exam in 2005-2006 (95% CI: 1.1, 2.1). In 1997-2000, patients paying privately (insurance
or out of pocket) were 1.7 times as likely as those with public sources of payment (Medicare or Med-
icaid) to receive a skin exam (CI: 1.2, 2.4) with a similar result found in 2005-2006 (1.4, CI: 1.0,
2.4). Patients seeing a physician were 6.2 times as likely as those seeing a non-physician (nurse or
physician’s assistant) to receive a skin exam in 1997-2000 (CI: 2.2, 17.3) but that effect was not
apparent in 2005-2006 (1.6, CI: 0.6, 4.0). In a multivariable model, patients with a private source
of payment (vs. public) (OR= 1.61, p=0.001) and a visit with a physician (vs. non-physician) (OR=
3.03, p<0.001) were more likely to receive a skin exam. The rate of skin exams is low and not increas-
ing appreciably over time. Patients with private sources of payment, lower BMI, and visits with a
physician are more likely to receive skin exams.
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Celiac disease associated antibodies are present in 9% of alopecia areata sera
L Petukhova,1,2 C Arguelles-Grande,3 B Lebwohl,3 M Duvic,5 M Hordinsky,6 D Norris,7 V Price,8
R Clynes,3 PH Green3 and AM Christiano1,4 1 Dermatology, Columbia University, NY, NY, 2
Epidemiology, Columbia University, NY, NY, 3 Medicine, Columbia University, NY, NY, 4
Genetics & Development, Columbia University, NY, NY, 5 Dermatology, MD Anderson,
Houston, TX, 6 Dermatology, Univ of Minnesota, Minneapolis, MN, 7 Dermatology, Univ of
Colorado, Denver, CO and 8 Dermatology, UCSF, San Francisco, CA
Alopecia areata (AA) is diagnosed by clinical and histopathological findings, both of which are non-
quantitative and lack sufficient resolution to identify molecular subtypes of disease. Serum bio-
markers provide an efficient way to screen and assess disease activity and could additionally pro-
vide information to classify AA patients by molecular characteristics. Our recent GWAS identified
genes that strongly align AA with other autoimmune diseases, in support of the ‘Common Cause
Hypothesis’. We therefore sought to determine if there is analogous evidence in the sera of AA
patients by screening for circulating antibodies frequently found in CeD patients, in part motivated
by previous reports of the co-occurrence of CeD and AA, some of which included correlated pos-
itive serum testing. Using a combined ELISA detection assay, AA serum (n=100) obtained from the
National Alopocia Areata Registry across the phenotypic spectrum of AA: transient (AAT); patchy
(AAP); no scalp hair (AT) and no body hair (AU), was screened for antibodies against tissue transg-
lutaminase (α-tTG) and deamidated gliadin peptides (α-DGP). Combined tTG/DGP-IgA/IgG anti-
body titers were increased in AU (n=3), AT (n=4), and AAP (n=2), but not in AAT patients. This study
shows a higher prevalence of CeD associated antibodies among AA patients (9%) than in the gen-
eral population (~1%), thereby extending evidence for the Common Cause Hypothesis from genet-
ics to serology and corroborating reports that certain AA patients regrow their hair on a gluten-free
diet (GFD). These findings further suggest that CeD biomarkers may be used for endophenotyping
AA patients and CeD-seropositive AA patients may represent a subgroup in which GFD may be help-
ful in disease management.
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Quantifying and characterizing adverse events in dermatologic surgery
J O’Neill,1 DJ Pearce,1 Y Lee,1 JA Solomon,3 P Williford,1 DN Robins2 and SR Feldman1 1 Wake
Forest University School of Medicine, Winston-Salem, NC, 2 University of Central Florida
College of Medicine, Lake Nona, FL and 3 Advanced Dermatology and Cosmetic Surgery,
Jacksonville, FL
In spite of increasing public awareness of patient safety, little is documented about how adverse
events (AEs) can or should be monitored in dermatologic surgery. Prospective data was collected
on adverse events occurring after dermatologic surgery procedures. A web-based data collection
interface was created with the input of four dermatologic surgeons. Patient demographic and oper-
ative data are collected at the time of a dermatologic surgery procedure. Adverse events occurring
at any time post-operatively are logged, as well as subsequent follow-up visits relating to the AE.
Data collection occurred at two sites: Wake Forest University Dermatologic Surgery and Advanced
Dermatology & Cosmetic Surgery (Ormond Beach and Jacksonville offices), Florida. Data were
collected on 1800 subjects from 2/1/2010 through 12/14/2010. The mean age was 67, and 59% of
participants were male. There were 28 AEs, most frequently: suspicion of infection (57%), post-op
hemorrhage (25%), and wound dehiscence (14%). There were 11 confirmed infections out of 13
cultured. There were no serious AEs and no deaths. By site, the head/neck (not facial) area was the
most common location for AEs. The AE rate after outpatient dermatologic surgery is very low:
1.55% with no serious AE’s in this prospective study. The study relied upon voluntary reporting and
recall of AEs, therefore future data tracking systems may refine the means by which AE reporting is
triggered.
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Widespread functional impact of chronic pruritus in children
RE Sahn,1 ML Spratt,1 LP Lawley,1,2 MK Spraker1,2 and SC Chen1,2 1 Department of Dermatology,
Emory University, Atlanta, GA and 2 Division of Dermatology, Atlanta Veterans Affairs Medical
Center, Atlanta, GA
Chronic pruritus affects one’s health-related quality of life (HRQOL). The emotional, symptomatic,
and functional impairment of chronic pruritus has been investigated in adults, but few studies have
examined these issues in children. As part of a larger study, we consecutively recruited patients
ages 4-18 from the pediatric dermatology clinics at Emory University and conducted open-ended
interviews to learn how chronic pruritus affects children’s HRQOL. Of 31 patients and their parents
approached, 27 chose to participate, and 1 was excluded because of inability to focus on the inter-
view. Of 26 participants included in the study, 15 (58%) were female, and 11 (42%) were less than
8 years of age. Most (73%) carried a diagnosis of atopic dermatitis, and 2 (8%) had psoriasis. The
most frequently reported emotions were sadness (38%), anger (27%), and frustration (15%). The
most commonly reported symptoms were pain (hurting or stinging) (27%), bleeding (15%), and scar-
ring (4%). The most often reported functional impairments were inability to play outside or partic-
ipate in sports (77%), difficulty sleeping or poor sleep quality (50%), and difficulty concentrating
on schoolwork or homework (46%). Children with chronic pruritus may experience greater func-
tional impairment and less emotional and symptomatic impairment of HRQOL than their adult
counterparts. Further research is needed to determine if our findings are reproducible in larger
sample populations.
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High prevalence of psoriatic arthritis (PsA) with a significant impact on quality of life (QOL)
in psoriasis (PsO) patients evaluated at a multidisciplinary center for complex psoriatic dis-
ease<b/>
AA Deodhar,1 B Truong,2 A Samrao,2 BL Ehst,2 T Devere,2 JM Gelfand3 and A Blauvelt2 1
Rheumatology, Oregon Health & Sci. Univ., Portland, OR, 2 Dermatology, Oregon Health &
Sci. Univ., Portland, OR and 3 Dermatology, Univ. of Penn., Philadelphia, PA
The Center of Excellence for Psoriasis and Psoriatic Arthritis (CEPPA) is a multidisciplinary clinic at
our institution. The purpose of the study reported here was to assess the prevalence of PsA as well
as demographic characteristics of PsA patients in CEPPA. Between Nov. 1, 2006 and Aug. 31,
2010, 529 PsO patients were seen in CEPPA and considered evaluable for analysis. The mean age
was 48.9 years, 19.7% were active smokers, the mean body surface area (BSA) affected by psoria-
sis was 14.4%, and the mean body mass index (BMI) was 30.4. On an initial questionnaire, 30.5%
of patients reported a history of PsA, 30.7% reported no history of PsA, and 38.8% of patients were
unsure about PsA. A subset of 173 patients was evaluated by rheumatology to confirm or rule out
PsA. All patients who self-reported as having PsA had PsA, all patients who self-reported as not hav-
ing PsA did not have PsA, and 27.6% of patients who self-reported that they were unsure about PsA
had PsA as diagnosed by a rheumatologist, leading to an estimated PsA prevalence of 41.2%. BSA
positively correlated with BMI, but BMI was not associated with PsA (p<0.15). PsA was also not
associated with smoking (p<0.14) or alcohol use (p<0.18). Compared to patients with PsO alone,
PsA patients had significantly worse QOL scores (p<0.001 for both SF-12 and PQOL-12) and were
significantly more adversely affected at work (p<0.001). In summary, a high estimated prevalence
of PsA (41.2%) was observed in a large cohort of PsO patients evaluated in a multidisciplinary clinic
designed for patients with complex psoriatic disease, most likely due to referral bias. Over 60% of
patients correctly self-identified themselves as having PsA, whereas at least 10% of patients pre-
sented with previously undiagnosed PsA. PsA was associated with significantly worse QOL com-
pared to patients with PsO alone.
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Physician survey of dermatology quality reporting initiatives in Colorado.
BT Alvarez,1 CA Dunnick2,3 and RP Dellavalle2,3,4 1 Colorado School of Public Health, UC
Denver, Aurora, CO, 2 Dermatology, UC Denver, Aurora, CO, 3 School of Medicine, UC
Denver, Aurora, CO and 4 Dermatology, Department of Veterans Affairs Medical Center,
Denver, CO
In 2006, the Centers for Medicare and Medicaid Services (CMS) established Physician Quality Report-
ing Initiatives (PQRI) as part of a voluntary incentive payment process to improve healthcare and
support preventive practices. As of 2010, there were 375 measures but only three were applicable
to dermatology practices, specifically the management of melanoma patients: follow-up, continu-
ity of care and coordination of care. To assess how the current PQRI measures are currently used
in Colorado dermatology practices, an 18-question survey was distributed to dermatologists at the
2010 Colorado Dermatological Society Annual Meeting in Denver, Colorado. Of the 107 attendees,
32 completed the survey yielding a response rate of 30%. Only half used the PQRIs in their CMS
claims, (14:14:3 [yes:no:don’t know]) but almost all provided counseling to patients at high risk for
melanoma. Less than half (14:18 [yes:no]) used an electronic medical record (EMR) system, and
the majority did not use an E-Prescribing program (11:21 [yes:no]). More physicians (11:5:16
[yes:no:don’t know]) felt that the measures were worth the time and effort than those who believed
that the monetary reimbursements were adequate (4:8:20 [yes:no:don’t know]). Since CMS will
begin penalizing practices that do not report these measures, it is important to assess the current
system. CMS is pushing to only accept PQRIs from the EMR, thus causing a potential problem for
those who still operate using only paper charts. Because there is little in the literature regarding this
topic, this survey is an attempt to gauge utilization and opinions of the current PQRI system among
Colorado dermatologists.
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Atopic dermatitis prevalence and co-morbidities in the Growing Up Today Study II
HC Frankel,1,2 L Frazier,2,3 CA Camargo,2,4 J Han,1,2,4 T Li2 and AA Qureshi1,2 1 Dermatology,
Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 2 Medicine, Channing
Laboratory, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 3 Pediatric
Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA and 4
Epidemiology, Harvard School of Public Health, Boston, MA
Atopic dermatitis (AD) is a highly prevalent chronic inflammatory skin disease that affects adults
and children in the United States. The incidence of AD and other atopic disorders, such as asthma,
allergic rhinitis, and food allergy, is increasing in developed countries, particularly in urban areas.
Environmental factors may influence the development of AD and explain both the increasing inci-
dence and also variations in AD prevalence seen within the United States. In this study, we char-
acterized the prevalence of AD and co-morbid conditions in the Growing Up Today Study II (GUT-
SII) cohort. GUTSII participants are children of women in the Nurses’ Health Study II cohort and
were aged 9-14 years in 2004 upon initiation of the study. On biennial questionnaires, participants
reported health and diet information including physician-diagnosed AD, asthma, allergic rhinitis,
and food allergy. Among 10,314 study participants, 963 (9.3%) reported a physician-diagnosis of
AD. 515 (53%) were female and 448 (47%) were male. In 2004, the mean age was 13 years (range,
10-16) and 908 (94%) were Caucasian. Participants with AD did not differ significantly from those
without AD in age or sex. Of the individuals with AD, 866 (90%) had an asthma diagnosis, 163
(17%) had an allergic rhinitis diagnosis, and 163 (25%) had a food allergy diagnosis. Thirty (3.1%)
participants had been diagnosed with all four conditions (AD, asthma, allergic rhinitis, and food
allergy). Further characterization of the GUTSII participants with atopic disorders and epidemio-
logical analyses of risk factors leading to the development of these disorders may give us a better
understanding of the environmental factors affecting AD expression.
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Treatment for nonmelanoma skin cancer among patients with limited life expectancies
M Chren,1,2 E Linos,3 R Parvataneni,1 J Torres,2 S Stuart,2 WJ Boscardin1 and CS Landefeld1,2 1 Univ
of California at San Francisco, San Francisco, CA, 2 San Francisco Veterans Affairs Medical
Center, San Francisco, CA and 3 Stanford University, Stanford, CA
Because nonmelanoma skin cancers (NMSCs) do not typically affect survival or short-term quality
of life, the care of NMSC in patients with limited life expectancy may not be straightforward. To
learn about NMSC care in patients with poor prognoses, we followed 1472 patients with 1910
NMSCs for 10 years after diagnosis in 1999-2000 in 2 medical centers. We focused on 3 groups:
patients who were old-old (> 85 years at the time of biopsy), patients with multi-morbidity (Charl-
son comorbidity score of > 3), and patients who ultimately died within two years of therapy. Over-
all, 25% of tumors were treated with destruction, 35% with excision, 36% with Mohs surgery, 1%
with less common treatments, and for 3% no treatment was performed. Median survival was shorter
in the 126 patients who were old-old (4.0 years vs. 9.7 years in younger patients who died; P<0.001)
and in the 244 patients with multi-morbidity (7.6 years vs. 9.9 years in other patients who died;
P<0.001). 124 patients died within 2 years of therapy. The frequencies of treatment with destruc-
tion, excision, and Mohs surgery did not differ significantly (P>0.3) among groups at higher risk of
death. For example, Mohs surgery was performed in 36% of old-old and 36% of younger patients,
in 34% with multi-morbidity and 38% without multi-morbidity; and in 32% and 36% of those who
survived < 2 years and >2 years, respectively. Even for smaller tumors or those not in the H-zone
of the face, the frequency of treatments did not differ among patients who were old-old, had multi-
morbidity, or died within 2 years. In multivariable models that adjusted for tumor severity, neither
old-old age, multi-morbidity, nor subsequent death within two years affected the likelihood of
treatment with Mohs surgery. We conclude that NMSCs were often treated aggressively in patients
with limited life expectancy, and treatment choices were not affected by conventional measures of
worse prognosis.
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Sun safety video contest: promoting skin cancer prevention through online media
AL Dawson,1 AA Hay,2 LS Huff,1 RG Gamble,1 W Howe,3 I Kane4 and RP Dellavalle1 1
Dermatology, University of Colorado Denver School of Medicine, Aurora, CO, 2 Loma Linda
University School of Medicine, Loma Linda, CA, 3 Hill Center for Dermatology, Golden, CO
and 4 Klein Buendel, Inc., Golden, CO
Approximately 179 million American adults – 69% of the adult population – accessed health infor-
mation on the internet in 2010. More than 44% of these individuals obtained health information
via social media websites such as YouTube. Given this broad usage, YouTube and similar websites
represent a primary means by which to distribute preventive health messages. This project aimed
to identify and publicize exemplary online skin cancer prevention videos via an annual contest as
well as to determine whether the contest led to increased viewing of winning videos. In 2008 The
Sulzberger Institute funded a YouTube contest to promote sun safety public health messaging though
a $5000 grant to William Howe, MD. In 2010 and 2011 we solicited video submissions and searched
existing YouTube videos. Contest committees selected 3 video finalists based on content and pres-
entation. Finalists were then ranked into first, second, and third places by a panel of judges com-
prised of dermatologists, scientists, and patients. Finalists were announced at the 2010 and 2011
American Academy of Dermatology (AAD) Annual Meetings and via a contest website. After pub-
licizing the winning videos, YouTube view counts were observed for 3 months to identify changes
in viewing frequency. In 2010, review of video view counts revealed no apparent change in view-
ing frequency after the AAD announcement with the rate-of-increase of view count number remain-
ing constant over the subsequent 3 month time period. The impact of the 2011 contest announce-
ment on view count will be determined in February through April 2011. This contest successfully
identified and rewarded excellent sun safety videos, but increased video views have yet to be seen.
Future directions include improving efforts to publicize the contest as well as to measure the impact
of videos on influencing consumers to modify sun-safety behaviors.
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Predictors of patient satisfaction in Mohs surgery: Analysis of pre-, intra- and post-operative
factors in a large prospective cohort
MM Asgari,1,2 E Warton,1 R Neugebauer1 and M Chren2 1 Division of Research, Kaiser
Permanente Northern California, Oakland, CA and 2 Dermatology, University of California
San Francisco, San Francisco, CA
Factors that influence satisfaction in patients undergoing Mohs surgery have not been systematically
studied. Using data from a large prospective cohort, we sought to identify pre-, intra-, and post-
operative variables that impact short and long-term patient satisfaction in 339 consecutive patients
treated with Mohs surgery. Graphical causal modeling was used to determine appropriate con-
founding adjustment in standard logistic regression models. Poor skin-related quality of life (mea-
sured with Skindex) was the most salient variable in predicting worse short- and long-term satis-
faction (OR satisfied= 0.43, 95% CI:0.19-0.99 and 0.19, 95% CI:0.06-0.60 respectively comparing
Skindex < median vs. > median). High short-term satisfaction was associated with 3 or more Mohs
stages (OR = 7.06, 95% CI:2.02-24.67), fewer post-operative complications and more perceived
involvement in decision making. Higher long-term satisfaction was associated with being married
(OR = 2.36, 95% CI:1.10-5.09) and with 3 or more Mohs stages (OR = 5.30, 95% CI: 1.24-22.64).
We conclude that short-term patient satisfaction after Mohs surgery is predicted by better pre-oper-
ative skin-related quality of life, intra-operative number of stages (3 or more), and post-operative
factors, such as bleeding and perceived greater involvement in decision making. With time, the post-
operative variables no longer appear to significantly impact patient satisfaction. Higher long-term
satisfaction was influenced by pre-operative variables (better skin-related quality of life, less worry,
and being married) and intra-operative number of Mohs stages. These results may help identify
patients at high risk for being unsatisfied with Mohs surgery, such that additional measures can be
taken to improve their experience with Mohs treatment and their resulting satisfaction.
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Sun protection counseling of non-white ethnoracial groups: The physician’s perspective
C Pourciau,1 M Eide,1,2 M Mahan2 and H Lim1 1 Dermatology, Henry Ford Hospital, Detroit,
MI and 2 Biostatistics and Research Epidemiology, Henry Ford Hospital, Detroit, MI
The morbidity of skin cancer in non-white, ethno-racial populations is well-established, yet no defin-
itive guidelines exist addressing the manner in which this population should be counseled regard-
ing sun exposure. Additionally, no studies have been performed to evaluate the frequency of pho-
toprotection counseling of non-white patients by physicians. We developed a 20-item web-based
questionnaire to describe the behavior of dermatologists when providing photoprotection recom-
mendations to non-white, ethno-racial patients as well as assess the perceived relevance of coun-
seling for this population. Physician members of the Photomedicine Society, the Skin of Color Soci-
ety and the National Medical Association were asked to participate. Descriptive statistics are
presented. Forty physicians completed the survey with a response rate of 20%. Sixty-six percent of
respondents were women, 79% self-identified as ethno-racial minorities, and more than 50% had
been in practice for greater than 10 years with the majority working as general clinicians. Approx-
imately 30% of participants indicated they do not counsel patients with Fitzpatrick Skin Type VI on
sun protection. Personal or family histories of skin cancer were the primary factors used to identify
patients for counseling. This study provides a better understanding of physicians’ attitudes towards
photoprotection for non-white, ethno-racial patients. The majority of polled dermatologists felt that
recommendations on sun protection for this population would be beneficial. Based on these data,
guidelines on photoprotection counseling for non-white, ethno-racial groups may be indicated.
248
DNA in the mail
DJ Margolis,1 A Apter,1 N Mitra,1 I McLean2 and T Rebbeck1 1 University of Pennsylvania,
Philadelphia, PA and 2 University of Dundee, Dundee, United Kingdom
Many Food and Drug Administration mandated post-marketing studies are currently being con-
ducted. Linking phenotypic data from these studies to biologic materials could provide valuable
information about the natural history of many illnesses. Our goal was to describe a method for and
demonstrate the feasibility of obtaining in the mail DNA from a large national community-based
mandated study of children who have atopic dermatitis (AD). At the time of this report, 3,281 with
AD were enrolled in the study. With this cohort, we tested the usefulness of a pre-notification let-
ter, the ability to obtain DNA from those who did not respond to the pre-notification letter, and the
use of varying incentives ($1, $2, or $5). All subjects received a pre-notification letter, followed by
a sample transport kit with a randomly assigned monetary incentive. 732 of 3,281 (22.4%) provided
samples for DNA extraction. A willingness to participate note was received after a pre-notification
letter from 674 (20.5%). 402 (402/674 or 59.6%) of these individuals provided a sample. 330 who
had not responded to our initial participation mailings (330/2590 or 12.7%) provided a sample. On
average 30 μg of buccal DNA (SD 28 μg) was obtained. Individuals who responded to a pre-noti-
fication letter were 4.7 (4.2, 5.3) more likely to provide a sample. Individuals sent a $5 incentive
were slightly more likely to participate (1.26 [1.03, 1.51]). Overall those with asthma (1.26 [1.07,
1.50]), between 6 and 9 years of age at enrollment (1.57 [1.19, 2.08]), with a family income of
between $75,000 and $99,999 (2.33[1.70, 3.18]), and from the New England states were most likely
to provide a sample. African Americans were less likely to participate (0.72 [0.61, 0.85]). Similar
effect estimates were noted for these covariates whether they responded and did not respond to the
pre-notification letter. In conclusion, it is possible to obtain DNA from a cohort of children previ-
ously enrolled in a mandated post-marketing study that was not designed to request or obtain a
biosample. The use of a pre-notification letter is very helpful.
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Disparities in skin cancer screening exams conducted in the primary care setting
KJ Martires,1 GJ Minwell1 and JS Bordeaux2 1 Case Western Reserve University School of
Medicine, Cleveland, OH and 2 Dermatology, University Hospitals Case Medical Center,
Cleveland, OH
The incidence of melanoma continues to rise. Early detection and treatment may reduce its mor-
tality. Skin exams are not routinely performed in primary care, as it is not recommended by the U.S.
Preventive Services Task Force. To assess the rate of skin exams over time and compare to other
screening exams, data was extracted from the National Ambulatory Medical Care Survey for the
years 1997-2006. Only “non-illness” or “preventive care” visits among adults in internal medicine,
general practice, or family practices were included. The rate of skin exams in 2006 was not signif-
icantly higher than the rate in 1997 (25.7% vs 16.8%, p=0.116). There was a marginally higher skin
exam rate for white patients during the years 2005-2006, compared with 1997-2000 (26.3% vs.
18.7%, p=0.054). This trend was not seen in non-whites (19.8% vs. 23.8%, p=0.537). Rates of
other exams, breast (34.4% vs 29.7%, p=0.349) and pelvic (34.1% and 31.3% p=0.539), did not
change over this time. Patients with BMI<25 were 1.5 times as likely as those with BMI>25 to receive
a skin exam in 2005-2006 (95% CI: 1.1, 2.1). In 1997-2000, patients paying privately (insurance
or out of pocket) were 1.7 times as likely as those with public sources of payment (Medicare or Med-
icaid) to receive a skin exam (CI: 1.2, 2.4) with a similar result found in 2005-2006 (1.4, CI: 1.0,
2.4). Patients seeing a physician were 6.2 times as likely as those seeing a non-physician (nurse or
physician’s assistant) to receive a skin exam in 1997-2000 (CI: 2.2, 17.3) but that effect was not
apparent in 2005-2006 (1.6, CI: 0.6, 4.0). In a multivariable model, patients with a private source
of payment (vs. public) (OR= 1.61, p=0.001) and a visit with a physician (vs. non-physician) (OR=
3.03, p<0.001) were more likely to receive a skin exam. The rate of skin exams is low and not increas-
ing appreciably over time. Patients with private sources of payment, lower BMI, and visits with a
physician are more likely to receive skin exams.
250
Celiac disease associated antibodies are present in 9% of alopecia areata sera
L Petukhova,1,2 C Arguelles-Grande,3 B Lebwohl,3 M Duvic,5 M Hordinsky,6 D Norris,7 V Price,8
R Clynes,3 PH Green3 and AM Christiano1,4 1 Dermatology, Columbia University, NY, NY, 2
Epidemiology, Columbia University, NY, NY, 3 Medicine, Columbia University, NY, NY, 4
Genetics & Development, Columbia University, NY, NY, 5 Dermatology, MD Anderson,
Houston, TX, 6 Dermatology, Univ of Minnesota, Minneapolis, MN, 7 Dermatology, Univ of
Colorado, Denver, CO and 8 Dermatology, UCSF, San Francisco, CA
Alopecia areata (AA) is diagnosed by clinical and histopathological findings, both of which are non-
quantitative and lack sufficient resolution to identify molecular subtypes of disease. Serum bio-
markers provide an efficient way to screen and assess disease activity and could additionally pro-
vide information to classify AA patients by molecular characteristics. Our recent GWAS identified
genes that strongly align AA with other autoimmune diseases, in support of the ‘Common Cause
Hypothesis’. We therefore sought to determine if there is analogous evidence in the sera of AA
patients by screening for circulating antibodies frequently found in CeD patients, in part motivated
by previous reports of the co-occurrence of CeD and AA, some of which included correlated pos-
itive serum testing. Using a combined ELISA detection assay, AA serum (n=100) obtained from the
National Alopocia Areata Registry across the phenotypic spectrum of AA: transient (AAT); patchy
(AAP); no scalp hair (AT) and no body hair (AU), was screened for antibodies against tissue transg-
lutaminase (α-tTG) and deamidated gliadin peptides (α-DGP). Combined tTG/DGP-IgA/IgG anti-
body titers were increased in AU (n=3), AT (n=4), and AAP (n=2), but not in AAT patients. This study
shows a higher prevalence of CeD associated antibodies among AA patients (9%) than in the gen-
eral population (~1%), thereby extending evidence for the Common Cause Hypothesis from genet-
ics to serology and corroborating reports that certain AA patients regrow their hair on a gluten-free
diet (GFD). These findings further suggest that CeD biomarkers may be used for endophenotyping
AA patients and CeD-seropositive AA patients may represent a subgroup in which GFD may be help-
ful in disease management.
251
Quantifying and characterizing adverse events in dermatologic surgery
J O’Neill,1 DJ Pearce,1 Y Lee,1 JA Solomon,3 P Williford,1 DN Robins2 and SR Feldman1 1 Wake
Forest University School of Medicine, Winston-Salem, NC, 2 University of Central Florida
College of Medicine, Lake Nona, FL and 3 Advanced Dermatology and Cosmetic Surgery,
Jacksonville, FL
In spite of increasing public awareness of patient safety, little is documented about how adverse
events (AEs) can or should be monitored in dermatologic surgery. Prospective data was collected
on adverse events occurring after dermatologic surgery procedures. A web-based data collection
interface was created with the input of four dermatologic surgeons. Patient demographic and oper-
ative data are collected at the time of a dermatologic surgery procedure. Adverse events occurring
at any time post-operatively are logged, as well as subsequent follow-up visits relating to the AE.
Data collection occurred at two sites: Wake Forest University Dermatologic Surgery and Advanced
Dermatology & Cosmetic Surgery (Ormond Beach and Jacksonville offices), Florida. Data were
collected on 1800 subjects from 2/1/2010 through 12/14/2010. The mean age was 67, and 59% of
participants were male. There were 28 AEs, most frequently: suspicion of infection (57%), post-op
hemorrhage (25%), and wound dehiscence (14%). There were 11 confirmed infections out of 13
cultured. There were no serious AEs and no deaths. By site, the head/neck (not facial) area was the
most common location for AEs. The AE rate after outpatient dermatologic surgery is very low:
1.55% with no serious AE’s in this prospective study. The study relied upon voluntary reporting and
recall of AEs, therefore future data tracking systems may refine the means by which AE reporting is
triggered.
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Widespread functional impact of chronic pruritus in children
RE Sahn,1 ML Spratt,1 LP Lawley,1,2 MK Spraker1,2 and SC Chen1,2 1 Department of Dermatology,
Emory University, Atlanta, GA and 2 Division of Dermatology, Atlanta Veterans Affairs Medical
Center, Atlanta, GA
Chronic pruritus affects one’s health-related quality of life (HRQOL). The emotional, symptomatic,
and functional impairment of chronic pruritus has been investigated in adults, but few studies have
examined these issues in children. As part of a larger study, we consecutively recruited patients
ages 4-18 from the pediatric dermatology clinics at Emory University and conducted open-ended
interviews to learn how chronic pruritus affects children’s HRQOL. Of 31 patients and their parents
approached, 27 chose to participate, and 1 was excluded because of inability to focus on the inter-
view. Of 26 participants included in the study, 15 (58%) were female, and 11 (42%) were less than
8 years of age. Most (73%) carried a diagnosis of atopic dermatitis, and 2 (8%) had psoriasis. The
most frequently reported emotions were sadness (38%), anger (27%), and frustration (15%). The
most commonly reported symptoms were pain (hurting or stinging) (27%), bleeding (15%), and scar-
ring (4%). The most often reported functional impairments were inability to play outside or partic-
ipate in sports (77%), difficulty sleeping or poor sleep quality (50%), and difficulty concentrating
on schoolwork or homework (46%). Children with chronic pruritus may experience greater func-
tional impairment and less emotional and symptomatic impairment of HRQOL than their adult
counterparts. Further research is needed to determine if our findings are reproducible in larger
sample populations.
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The Presence of Nε-(Carboxymethyl) lysine in the human epidermis
K Kawabata,1 H Yoshikawa,2 K Saruwatari,1 Y Akazawa,1 T Inoue,1 T Kuze,2 T Sayo,1 N Uchida2
and Y Sugiyama1 1 Innovative Beauty Science Laboratory, Kanebo Cosmetics Inc., Odawara,
Japan and 2 Quality Management Group, Kanebo Cosmetics Inc., Odawara, Japan
It is well known that advanced glycation end products (AGEs) are formed in long-lived dermal pro-
teins such as collagen, and that their formation is related to skin aging. To examine the distribution
of Nε-(Carboxymethyl) lysine (CML), an AGE structure, in skin tissues, we performed immunofluo-
rescence studies on the human skin using an anti-CML antibody. Interestingly, CML signals were
observed not only in the dermis but also in the epidermis. The objectives of this study were to con-
firm the presence of CML in the human epidermis and to characterize the CML-modified proteins.
The presence of CML in the stratum corneum (SC) was examined using liquid chromatography-elec-
trospray ionization time-of-flight mass spectrometry. Concordance between the retention times of
a compound in the SC hydrolysate and authentic CML, as well as with the specific mass transition
of CML, was detected. This result showed that CML is present in the epidermis. In order to charac-
terize the CML-modified proteins in the epidermis, protein samples extracted from the SC were ana-
lyzed using two-dimensional electrophoresis followed by an amino acid sequence analysis. The
clarified peptide sequences covered approximately 27% of the amino acid sequences of cytoker-
atin10 (K10). In the immunoblotting experiment following the two-dimensional electrophoresis,
where protein samples extracted from whole epidermis were used, the position of the major CML-
positive spots corresponded to those of K10. Taken together these results showed that CML is pres-
ent in the human epidermis, and suggest that K10 is one of the target molecules for CML modifi-
cation in the epidermis.
267
Callus formation is associated with hyperproliferation, incomplete differentiation of ker-
atinocytes, and increased expression of adhesion molecules
H Choi,1 S Kim,1 G Choi,1 K Sohn,2 Y Lee,2 C Kim,2 T Yoon,3 J Lee2 and Y Lee1 1 Department of
Anatomy, School of Medicine, Chungnam National University, Daejeon, Republic of Korea, 2
Department of Dermatology, School of Medicine, Chungnam National University, Daejeon,
Republic of Korea and 3 Department of Dermatology, School of Medicine, Gyeongsang
National University, Jinju, Republic of Korea
A callus is a local thickening of skin, characterised by accelerated keratinisation and a reduced rate
of desquamation. However, the mechanism of callus formation is not fully understood. The aim of
this study was to evaluate the expression patterns, in callused skin, of genes that are implicated in
keratinisation and adhesion/desquamation. Samples of skin from the dorsum of the foot (DF), cen-
tre of the plantar arch (CP), and anterior aspect of the heel (AH) were obtained from fresh cadav-
ers, and protein and gene expression were determined by immunohistochemistry and RT-PCR,
respectively. The stratum corneum in the DF showed a splitting phenotype by conventional H&E
staining, while the stratum corneum was normal in the AH. Cells of the stratum corneum in the AH
were non-squamous. Expression of cornification-related molecules including involucrin, filaggrin,
caspase 14, and calcium-sensing receptor (CaSR) was higher in the AH. Similarly, expression of
adhesive proteins, such as corneodesmosin (CDSN), desmoglein 1 (DSG1), and desmocollin 1
(DSC1), was increased in the AH. However, protease-activated receptor 2 (PAR2) expression was
reduced in the stratum granulosum in the AH. The number of proliferating cells in the stratum basale
was significantly increased in the AH, compared with the DF and CP. Our data suggest that calluses
form as a result of hyperproliferation and incomplete differentiation of epidermal keratinocytes,
and increased expression of adhesion molecules.
269
Impaired stratum corneum barrier and enhanced percutaneous immune responses in filag-
grin knockout mice
H Kawasaki,1 K Nagao,1 A Kubo,1 T Hata,1,3 H Mizuno,4 T Yamada2 and M Amagai1 1
Dermatology, Keio University School of Medicine, Tokyo, Japan, 2 Pathology, Keio University
School of Medicine, Tokyo, Japan, 3 KOSÉ Corporation, Tokyo, Japan and 4 RIKEN Brain
Science Institute, Wako, Japan
Research in atopic dermatitis (AD) has gained huge momentum after the finding that mutations in
filaggrin gene are major predisposing factors. Filaggrin is a structural protein of stratum corneum
(SC) and its breakdown products form natural moisturizing factor (NMF). Accumulating reports
suggest that filaggrin contributes skin barrier formation, but the precise mechanisms remain unclear.
Flaky tail (ft/ma) mice, which have a point mutation in filaggrin gene have been used as a filaggrin
deficient model, however these mice were not null for mature filaggrin, and have another putative
gene mutation, matted. Therefore, we generated filaggrin knockout (KO) mice to evaluate the impact
of pure filaggrin deficiency on skin barrier function. Filaggrin KO mice exhibited dry and scaly
skin, but did not develop any spontaneous dermatitis. Despite of prominent decrease in NMF,
water content and transepidermal water loss (TEWL) in SC of filaggrin KO mice was unaffected,
suggesting that loss of NMF nor ‘dry skin’ phenotype correlated directly with dehydration of SC.
The fact that younger ft/ma mice showed normal TEWL, which progressively increased as they devel-
oped dermatitis, indicated that filaggrin-loss is not necessarily linked to TEWL elevation. Perme-
ability assay using calcein-encapsulating liposomes demonstrated that filaggrin-deficiency allows
its penetration through SC. This impairment in SC barrier appears to be a consequence of increased
fragility and premature detachment of cornified layers, as suggested by carefully controlled and
quantified tape stripping experiments. Barrier defect in filaggrin KO mice led to enhanced hapten-
induced contact hypersensitivity responses and humoral responses to topically immunized protein
antigens. Our filaggrin KO mice represent pure filaggrin deficiency, and should provide a valuable
tool to dissect the function of SC, especially in the context of AD.
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A purified feverfew extract increases skin’s antioxidant and cellular detoxification defenses
by activating the Nrf2 — antioxidant response element (ARE) pathway
S Kaur, K Rodriguez, F Liebel and MD Southall Johnson and Johnson Skin Research Center,
Johnson & Johnson, Skillman, NJ
Environmental factors such as solar UV radiation, coupled with recent increases in atmospheric pol-
lutants and other external aggressors, provide an oxidative challenge that is very detrimental to skin
health. Endogenous antioxidants protect skin from the effects of oxidative stress. However, the lev-
els of antioxidants in the skin decrease with age, thus resulting in less protection and a greater poten-
tial for skin damage. NF-E2-related factor-2 (Nrf2) is a transcription factor which induces expres-
sion of antioxidant and detoxification genes through activation of the antioxidant response element
(ARE). The genes regulated by the Nrf2-ARE pathway increase resistance to oxidative stress and can
help restore oxidative homeostatis of the skin. A purified Feverfew extract (Tanacetum parthenium)
was found to enhance ARE activity, resulting in over two-fold induction of the ARE promoter. Ker-
atinocytes treated with Feverfew also showed an increase in Nrf2 translocation. Enhanced expres-
sion of antioxidant and detoxification genes, such as Glutathione Peroxidase and Lactoperoxidase
was confirmed using a PCR array of Feverfew-treated human skin equivalents in vitro. A panel of
kinase inhibitors was evaluated to understand the signaling pathway(s) involved in activation of
ARE by Feverfew. Pre-treatment with the selective pharmacological inhibitor of PI3K pathway,
LY294002 suppressed Feverfew mediated induction of ARE promoter. Feverfew was also found to
reduce the UV induced reactive oxygen species production from human skin equivalents, and clin-
ically was found to decrease free radicals measured on the forehead of human subjects using chemi-
luminescence detection of skin. Through the ability to scavenge free radicals and increase endoge-
nous antioxidant levels by activation of the Nrf2-ARE pathway, a purified Feverfew extract may
protect the skin from numerous external aggressions encountered daily by skin and reduce the dam-
age to oxidatively challenged skin.
266
Increased endogenous retinoic acid by the absence of Cyp26b1 impairs peridermal devel-
opment and skin barrier formation during development
J Okano,1 U Lichti,2 M Aronova,3 G Zhang,3 SH Yuspa,2 Y Sakai4 and MI Morasso1 1
Developmental Skin Biology Section, NIAMS, NIH, Bethesda, MD, 2 Laboratory of Cancer
Biology and Genetics, NCI, NIH, Bethesda, MD, 3 Laboratory of Bioengineering and Physical
Science, NIBIB, NIH, Bethesda, MD and 4 Department of Plastic and Reconstructive Surgery,
Osaka University, Osaka, Japan
Retinoic acid (RA), a metabolite of vitamin A, plays a key role in a variety of biological processes
and is essential for normal embryonic development. While excess exogenous retinoic acid (RA) is
known to have teratogenic effects on the developing fetus, little is known about the consequences
of elevated endogenous retinoids during skin development. Using a mouse model with deletion of
Cyp26b1, a RA-degrading enzyme, we show that specific RA levels are requisite for peridermal
desquamation and the development of stratified epidermis. We found upregulation of not only Ker-
atin 19, a known target of RA, but also genes linked to peridermal development such as Keratin 6a
and the Keratin Associated Proteins (KAP)-complex genes in Cyp26b1-/- epidermis. Administration
of exogenous RA to wild-type embryos induced acute morphological peridermal-specific changes
and marked upregulation of Krtap13, demonstrating that peridermal gene expression responds
directly to RA. Grafting Cyp26b1-/- skin disc on mice with normal RA metabolism rescued the abnor-
mal skin differentiation phenotype with associated down-regulation of peridermal phenotype. These
data reveal a complex RA-dependent interplay between periderm differentiation and development
of the underlying stratified epidermis during embryogenesis.
270
The p75 neurotrophin receptor acts as a “switch on-off” protein in keratinocyte differentia-
tion
E Palazzo, F Truzzi, A Marconi, R Lotti, K Dallaglio, T Petrachi and C Pincelli Dermatology,
University of Modena and Reggio Emilia, Modena, Italy
p75 neurotrophin receptor (p75NTR) mediates neurotrophin (NT) signals alone or in combination
with the high affinity receptor Trk, also in cell settings outside the nervous system. In the present
work, we studied the role of p75NTR during keratinocyte differentiation. p75NTR protein was up-
regulated after serum treatment in both confluent and post-confluent keratinocytes, together with
the expression of cytokeratin 10 (CK10) and involucrin. Moreover, calcium treatment of subcon-
fluent keratinocytes induced the expression of involucrin, CK10, and the up-regulation of p75NTR,
both at the mRNA and at the protein level. Western blotting and confocal analysis showed that
p75NTR positive (+) keratinocytes isolated by magnetic cell sorting, expressed less CK10 and
CK15, as compared to p75NTR negative (-) cells. p75NTR+ keratinocytes formed a lower number
of colonies and proliferated to a lesser extent, as compared to p75NTR- cells. p75NTR is only
expressed in the basal keratinocyte layer and is confined to a MIB-1 negative transit amplifying (TA)
cell population. p75NTR+ keratinocytes, isolated from TA cells, expressed more survivin and CK15,
while displayed less CK10 than p75NTR- TA. Colony forming efficiency was higher in p75NTR+ TA
than in p75NTR- TA cells. Moreover, long term proliferation analysis revealed that p75NTR+ TA
yielded a higher number of cells than p75NTR- TA. p75NTR retroviral infection of stem cells induced
a more differentiated phenotype, with the same features of TA cells. On the other hand, when p75NTR
was silenced, calcium treatment failed to induce differentiation in subconfluent keratinocytes, as
shown by the absence of involucrin expression. These results suggest that p75NTR+ keratinocytes
represent a subpopulation of TA cells, directly derived from stem cells that just started the differen-
tiation process. p75NTR may act as a “switch on-off” protein in stem-TA transition initiating ker-
atinocyte differentiation.
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OCA2 and MC1R interact with UV exposure to determine nevus counts and freckle scores
in children
N Box,1 V Gonzalez,1 N Asdigian,2 J Aalborg,2 T Terzian,1 A Baron,3 R Stiegmann,1 E Torchia,1
R Dellavalle,1 S Mokrohisky,1 J Morelli1 and L Crane2 1 Dermatology, UC Denver, Aurora, CO,
2 Preventive Medicine, UC Denver, Aurora, CO and 3 Biostatistics, UC Denver, Aurora, CO
Melanoma is an important public health problem, where efforts at prevention are key. Risk of
melanoma is determined largely by the interaction of childhood and adolescent UV exposure with
melanoma risk genes. A deeper understanding of how risk genes interact with childhood UV expo-
sure to determine phenotypic risk indicators such as nevus counts and freckle scores has important
public health implications. The Melanocortin 1 Receptor (MC1R) is a key melanoma risk gene that
when mutated causes the red hair color phenotype, including poor tanning and susceptibility to
sunburns and melanoma. MC1R interacts with the Oculocutaneous Albinism Type II (OCA2) gene
to determine pigmentation phenotypes. We utilized the Colorado Kids Sun Care Program (CKSP) to
study how MC1R and OCA2 interact with different UV exposure profiles to influence sun-sensitiv-
ity phenotypes. The CKSP includes a cohort of over 900 children who have been followed from
ages 6 to 10 with annual skin exams and data collection on nevus counts, sun exposure, pheno-
type and behavioral variables. The genotyping of MC1R and OCA2 and correlation studies with phe-
notypic measures show association between the major blue/brown eye color OCA2/HERC2
rs12913832 SNP, UV exposure and nevus counts. The data suggest that individuals who are homozy-
gous for this SNP are particularly sensitive to modification of nevus counts by UV exposure. Fur-
thermore, this modification is preferred in individuals with intermittent vs. chronic UV exposure
behaviors. We have similarly examined the interactions of these variables with MC1R variants to
illustrate how different genes interact with different UV exposure profiles to give maximal nevus
counts in children. The data generated by this study highlights the importance of preventive and per-
sonalized medicine and will be crucial for the selection of individuals with nevus and melanoma
susceptibility genotypes who may be targeted for primary prevention.
260
Endothelin-converting enzyme-1 modulates endothelin-1-induced pruritus by inhibiting
endothelin receptor recycling and prolonging ERK1/2 signaling in murine sensory neurons
M Kido,1,2 J Buddenkotte,1 C Kempkes,3 S Seeliger,4 F Cevikbas,3 M Furue2 and M Steinhoff1,3 1
Dermatology, University of Münster, Ludwig Bolzmann Institute for Cell and Immunobiology
of the Skin, Münster, Germany, 2 Dermatology, Graduate School of Medical Sciences, Kyushu
University, Fukuoka, Japan, 3 Dermatology and Surgery, University of California, San
Francisco, San Francisco, CA and 4 Pediatrics, University of Göttingen, Göttingen, Germany
Although of importance, the molecular and cellular mechanisms regulating pruritus are still poorly
understood. Endothelin-1 (ET1) evokes a pruritic sensation in humans and rodents mediated by acti-
vation of the G protein coupled receptor (GPCR), Endothelin A receptor (ETAR). We previously
demonstrated that ECE1 degrades neuropeptides in early endosomes thereby controlling receptor
recycling of GPCRs and cell signaling. Accordingly, we hypothesized that ECE1 contributes to ET1-
induced pruritus and neuronal signaling in mice. We detected co-expression of ETAR and ECE1 in
small- to medium-sized murine DRG neurons and cutaneous sensory nerves. Moreover, ET1 induced
marked scratching behavior which was significantly augmented by pretreatment with a specific ECE1
inhibitor in vivo. To reveal the mechanism, we cultured murine DRG neurons and investigated the
influence of ECE1 on receptor recycling and cell signaling. ET1 induced internalization of ETAR
and ECE1 into early endosomes. Of note, while ETAR recycling was accelerated by ECE1 inhibi-
tion, the ET1-induced phosphorylation of ERK1/2 was prolonged by inhibition of ECE1 in DRG
neurons. By HPLC, we confirmed that ET1 can be degraded by ECE1 in endosomes. In conclusion,
ET1 induces pruritus in mice in vivo, probably by ETAR activation and internalization. ECE1 mod-
ulates ET1 induced pruritus by prolonging ERK1/2 signaling in DRG neurons. Our results for the
first time dissect the signal transduction pathway for ET1-induced itch and provide evidence for a
specific molecular marker that is integral to the intracellular signal transduction in DRG neurons
during pruritus.
261
The role of adenomatous polyposis coli (APC) in epidermal development and hair follicle mor-
phogenesis
K Cook,1,2 X Wu,1 N Stokes1 and E Fuchs1,2 1 Rockefeller University, New York, NY and 2 The
Howard Hughes Medical Institute, Chevy Chase, MD
The role of the tumor suppressor and negative regulator of Wnt signaling, APC, in the skin and epi-
dermal appendages is poorly understood. The development of a mouse model, the APC conditional
KO (cKO), circumvents homozygotic lethality by the localization of Cre recombinase to remove
the floxed APC allele via linkage with a tissue specific promoter, Keratin 14. cKO embryos displayed
a distinct phenotype beginning at E15.5, characterized by silvery plaques covering the skin. Embryos
exhibited fused digits and open eyelids, indicative of aberrations in epidermal development. Although
epidermal differentiation occurred in APC cKO animals, the architecture of the epidermis was highly
irregular. The epidermis showed an expansion of basal-like cells and precocious presence of a stra-
tum corneum-like structure. However, a dye exclusion assay revealed an impaired epidermal bar-
rier at E17.5 when compared with control littermates, indicating that the stratum corneum was not
functional. Hair follicle (HF) morphogenesis was significantly impaired in the cKO. HF placodes or
pegs were not visible in sagittal sections of E15.5-E17.5 backskins, and immunofluorescence stain-
ing for early HF markers was absent in the cKO embryos. Moreover, backskin from E17.5 cKO
embryos failed to generate HFs when grafted onto Nude mice, in comparison to WT littermates.
Interestingly, the dermis underlying the cKO epidermis was diffusely positive for dermal papillae
(DP) marker alkaline phosphatase, suggesting that the early mesenchymal-epithelial crosstalk impor-
tant for initiating the dermal condensate and forming the epidermal placode was compromised.
Taken together, loss of APC in the epidermis in vivo results in impaired epidermal differentiation as
well as impaired HF morphogenesis; however, the entire epidermis does not adopt a HF fate as
seen in constitutively active β-catenin embryonic mutants, suggesting that APC may have a role in
epidermal development that is independent of its role as a negative regulator of Wnt signaling and
β-catenin stabilization.
262
ARNT-dependent expression of amphiregulin and consequent activation of EGFR/Erk path-
way is essential for normal epidermal differentiation
D Robertson, L Weir, IM Leigh and AA Panteleyev Medical Sciences, University of Dundee,
Dundee, United Kingdom
EGFR activation by specific ligands is involved in the control of growth and differentiation in nor-
mal and cancerous epidermal keratinocytes. Previously we showed a role for the aryl hydrocarbon
receptor nuclear translocator (ARNT), a key factor in hypoxia and toxic responses, in control of
EGFR ligands and keratinocyte differentiation in mouse epidermis. To assess the functions of ARNT
in human keratinocytes we used stable shRNA lentiviral suppression of ARNT in N-TERT cells. 3D
epidermal equivalent developed using these cells showed defective morphology and significantly
increased expression of key differentiation markers such as filaggrin, loricrin, involucrin, and K10
while basal markers (K5/14) remained unchanged. Amphiregulin (AREG) was found to be the most
abundant EGFR ligand in N-TERT cells which was significantly downregulated at both mRNA and
protein levels in ARNT-depleted monolayer culture and 3D model. Correspondingly, AREG was
upregulated in ARNT-overexpressing cells. Lack of ARNT also resulted in decline of EGFR and Erk1/2
phosphorylation in both ARNT-deficient models. Downregulation of AREG in Arnt-depleted cells
was abolished by TSA treatment suggesting a role for HDACs in this effect. Prominent increase of
total HDAC activity in ARNT-depleted cells and its corresponding decrease in ARNT-overexpress-
ing keratinocytes further support implication of epigenetic mechanisms in control of AREG by ARNT.
Expression and localization of HDACs 1/3 (the most abundant deacetylases in normal N-TERT
cells) was strictly dependent on the level of ARNT in both monolayer and 3D models. Finally gel-
danamycin, a potent inhibitor of ARNT dimerization partners, blocks AREG expression in normal
N-TERTs and, importantly, abolishes AREG induction in ARNT-overexpressing cells. These results
suggest that ARNT controls AREG expression and the downstream EGFR/Erk pathway through mod-
ulation of HDAC1/3 activity. This novel regulatory pathway targeting epidermal differentiation may
have important implications for skin pathology.
263
Differential regulation of HIF-α splice variants by hypoxia in epidermal keratinocytes
L Weir,1 D Robertson,1 IM Leigh,1 JK Vass2 and AA Panteleyev1 1 Medical Sciences, University
of Dundee, Dundee, United Kingdom and 2 Translational Medicine Research Collaboration,
University of Dundee, Dundee, United Kingdom
The activity of hypoxia-regulated HIF pathway is a key factor of tumour microenvironment affect-
ing its aggressiveness and susceptibility to therapy. It is also linked to wound healing and patho-
genesis of such skin diseases as psoriasis. Nevertheless, the mechanisms controlling HIF activity in
the epidermis are still obscure. Our studies of primary mouse epidermal keratinocytes cultured at
different O2 levels showed that they express a unique array of protein-coding splice variants of Hif1α
and 3α which are differentially regulated by hypoxia (1%O2) while Hif2α (mRNA and protein) was
virtually absent irrespective of O2 level. Hif1α-001 splice variant was highly expressed in normoxic
cells (at B2M level) and showed strong two-step decline at 1-2h and after 5h of hypoxia suggesting
different mechanisms of regulation under acute and chronic exposure. Hif1α-003 showed similar
patterns of expression but at much lower level. In contrast, Hif1α-002 (a truncated isoform lacking
the oxygen degradation domain - ODDD) was positively regulated by hypoxia. Correspondingly,
Western blotting showed substitution of two Hif1α-specific bands in normoxic cells with just one
band of different size under hypoxia. Hif3α-001 splice variant was barely detectable in both types
of cells. Hif3α-002/NEPAS, while being low, showed significant induction by hypoxia. On the con-
trary, Hif3α-003/IPAS splice variant was found to be expressed at B2M level in normoxic cells and
significantly suppressed by hypoxia. Thus, in mouse epidermal keratinocytes Hif1α-001 and ODDD-
lacking Hif3α-003/IPAS isoforms are responsible for yet uncharacterized hypoxia-independent HIF-
α function and for control of HIF pathway during acute phase of hypoxia. During chronic phase of
exposure, pro-angiogenic signalling is HIF-independent or maintained by Hif1α-002 splice vari-
ant. These findings suggest differential regulation of keratinocyte response to acute and chronic
hypoxia and highlight the complexity of HIF machinery control in the epidermis.
264
Expression human β-defensins 2,3 of epidermis by heat damage
J Lee,1 H Jeong,1 J Lee,1 H Kim,1 S Lee,1 T Sohn,1 C Yoon1 and I Kim2 1 Research Center, Bestian
Hospital, Daejeon, Republic of Korea and 2 Eulji Hospital, Daejeon, Republic of Korea
Defensins are anti-microbial peptides of the innate host defense system. β-defensins are variably
expressed in the skin and organs. Burns is severe damage by heat, chemicals, electricity, sunlight
or radiation. They also can lead to infections because that damage skin’s protective barrier. Anti-
microbial peptide in skin can prevent or treat from serious infections. β-Defensins are especially
widely distributed by leukocytes and epithelial cells in humans. Also they were found in the human
skin during inflammatory conditions like psoriasis and during wound healing. To investigate whether
β-defensins can protect to host defense in burns, we examined expression of β-defensin 2,3 in ani-
mal and human keratinocytes of in vitro burn model. The expression of β-defensin 2,3 was exchanged
during healing stage at burn tissues. The expression of β-defensin 2 was returned at short time and
β-defensin 3 was transient up-regulated at human keratinocytes by heat. We proposed that β-defensins
may have the potential roles therefore it will be a therapeutic agent for treat burns infection.
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The Presence of Nε-(Carboxymethyl) lysine in the human epidermis
K Kawabata,1 H Yoshikawa,2 K Saruwatari,1 Y Akazawa,1 T Inoue,1 T Kuze,2 T Sayo,1 N Uchida2
and Y Sugiyama1 1 Innovative Beauty Science Laboratory, Kanebo Cosmetics Inc., Odawara,
Japan and 2 Quality Management Group, Kanebo Cosmetics Inc., Odawara, Japan
It is well known that advanced glycation end products (AGEs) are formed in long-lived dermal pro-
teins such as collagen, and that their formation is related to skin aging. To examine the distribution
of Nε-(Carboxymethyl) lysine (CML), an AGE structure, in skin tissues, we performed immunofluo-
rescence studies on the human skin using an anti-CML antibody. Interestingly, CML signals were
observed not only in the dermis but also in the epidermis. The objectives of this study were to con-
firm the presence of CML in the human epidermis and to characterize the CML-modified proteins.
The presence of CML in the stratum corneum (SC) was examined using liquid chromatography-elec-
trospray ionization time-of-flight mass spectrometry. Concordance between the retention times of
a compound in the SC hydrolysate and authentic CML, as well as with the specific mass transition
of CML, was detected. This result showed that CML is present in the epidermis. In order to charac-
terize the CML-modified proteins in the epidermis, protein samples extracted from the SC were ana-
lyzed using two-dimensional electrophoresis followed by an amino acid sequence analysis. The
clarified peptide sequences covered approximately 27% of the amino acid sequences of cytoker-
atin10 (K10). In the immunoblotting experiment following the two-dimensional electrophoresis,
where protein samples extracted from whole epidermis were used, the position of the major CML-
positive spots corresponded to those of K10. Taken together these results showed that CML is pres-
ent in the human epidermis, and suggest that K10 is one of the target molecules for CML modifi-
cation in the epidermis.
267
Callus formation is associated with hyperproliferation, incomplete differentiation of ker-
atinocytes, and increased expression of adhesion molecules
H Choi,1 S Kim,1 G Choi,1 K Sohn,2 Y Lee,2 C Kim,2 T Yoon,3 J Lee2 and Y Lee1 1 Department of
Anatomy, School of Medicine, Chungnam National University, Daejeon, Republic of Korea, 2
Department of Dermatology, School of Medicine, Chungnam National University, Daejeon,
Republic of Korea and 3 Department of Dermatology, School of Medicine, Gyeongsang
National University, Jinju, Republic of Korea
A callus is a local thickening of skin, characterised by accelerated keratinisation and a reduced rate
of desquamation. However, the mechanism of callus formation is not fully understood. The aim of
this study was to evaluate the expression patterns, in callused skin, of genes that are implicated in
keratinisation and adhesion/desquamation. Samples of skin from the dorsum of the foot (DF), cen-
tre of the plantar arch (CP), and anterior aspect of the heel (AH) were obtained from fresh cadav-
ers, and protein and gene expression were determined by immunohistochemistry and RT-PCR,
respectively. The stratum corneum in the DF showed a splitting phenotype by conventional H&E
staining, while the stratum corneum was normal in the AH. Cells of the stratum corneum in the AH
were non-squamous. Expression of cornification-related molecules including involucrin, filaggrin,
caspase 14, and calcium-sensing receptor (CaSR) was higher in the AH. Similarly, expression of
adhesive proteins, such as corneodesmosin (CDSN), desmoglein 1 (DSG1), and desmocollin 1
(DSC1), was increased in the AH. However, protease-activated receptor 2 (PAR2) expression was
reduced in the stratum granulosum in the AH. The number of proliferating cells in the stratum basale
was significantly increased in the AH, compared with the DF and CP. Our data suggest that calluses
form as a result of hyperproliferation and incomplete differentiation of epidermal keratinocytes,
and increased expression of adhesion molecules.
269
Impaired stratum corneum barrier and enhanced percutaneous immune responses in filag-
grin knockout mice
H Kawasaki,1 K Nagao,1 A Kubo,1 T Hata,1,3 H Mizuno,4 T Yamada2 and M Amagai1 1
Dermatology, Keio University School of Medicine, Tokyo, Japan, 2 Pathology, Keio University
School of Medicine, Tokyo, Japan, 3 KOSÉ Corporation, Tokyo, Japan and 4 RIKEN Brain
Science Institute, Wako, Japan
Research in atopic dermatitis (AD) has gained huge momentum after the finding that mutations in
filaggrin gene are major predisposing factors. Filaggrin is a structural protein of stratum corneum
(SC) and its breakdown products form natural moisturizing factor (NMF). Accumulating reports
suggest that filaggrin contributes skin barrier formation, but the precise mechanisms remain unclear.
Flaky tail (ft/ma) mice, which have a point mutation in filaggrin gene have been used as a filaggrin
deficient model, however these mice were not null for mature filaggrin, and have another putative
gene mutation, matted. Therefore, we generated filaggrin knockout (KO) mice to evaluate the impact
of pure filaggrin deficiency on skin barrier function. Filaggrin KO mice exhibited dry and scaly
skin, but did not develop any spontaneous dermatitis. Despite of prominent decrease in NMF,
water content and transepidermal water loss (TEWL) in SC of filaggrin KO mice was unaffected,
suggesting that loss of NMF nor ‘dry skin’ phenotype correlated directly with dehydration of SC.
The fact that younger ft/ma mice showed normal TEWL, which progressively increased as they devel-
oped dermatitis, indicated that filaggrin-loss is not necessarily linked to TEWL elevation. Perme-
ability assay using calcein-encapsulating liposomes demonstrated that filaggrin-deficiency allows
its penetration through SC. This impairment in SC barrier appears to be a consequence of increased
fragility and premature detachment of cornified layers, as suggested by carefully controlled and
quantified tape stripping experiments. Barrier defect in filaggrin KO mice led to enhanced hapten-
induced contact hypersensitivity responses and humoral responses to topically immunized protein
antigens. Our filaggrin KO mice represent pure filaggrin deficiency, and should provide a valuable
tool to dissect the function of SC, especially in the context of AD.
268
A purified feverfew extract increases skin’s antioxidant and cellular detoxification defenses
by activating the Nrf2 — antioxidant response element (ARE) pathway
S Kaur, K Rodriguez, F Liebel and MD Southall Johnson and Johnson Skin Research Center,
Johnson & Johnson, Skillman, NJ
Environmental factors such as solar UV radiation, coupled with recent increases in atmospheric pol-
lutants and other external aggressors, provide an oxidative challenge that is very detrimental to skin
health. Endogenous antioxidants protect skin from the effects of oxidative stress. However, the lev-
els of antioxidants in the skin decrease with age, thus resulting in less protection and a greater poten-
tial for skin damage. NF-E2-related factor-2 (Nrf2) is a transcription factor which induces expres-
sion of antioxidant and detoxification genes through activation of the antioxidant response element
(ARE). The genes regulated by the Nrf2-ARE pathway increase resistance to oxidative stress and can
help restore oxidative homeostatis of the skin. A purified Feverfew extract (Tanacetum parthenium)
was found to enhance ARE activity, resulting in over two-fold induction of the ARE promoter. Ker-
atinocytes treated with Feverfew also showed an increase in Nrf2 translocation. Enhanced expres-
sion of antioxidant and detoxification genes, such as Glutathione Peroxidase and Lactoperoxidase
was confirmed using a PCR array of Feverfew-treated human skin equivalents in vitro. A panel of
kinase inhibitors was evaluated to understand the signaling pathway(s) involved in activation of
ARE by Feverfew. Pre-treatment with the selective pharmacological inhibitor of PI3K pathway,
LY294002 suppressed Feverfew mediated induction of ARE promoter. Feverfew was also found to
reduce the UV induced reactive oxygen species production from human skin equivalents, and clin-
ically was found to decrease free radicals measured on the forehead of human subjects using chemi-
luminescence detection of skin. Through the ability to scavenge free radicals and increase endoge-
nous antioxidant levels by activation of the Nrf2-ARE pathway, a purified Feverfew extract may
protect the skin from numerous external aggressions encountered daily by skin and reduce the dam-
age to oxidatively challenged skin.
266
Increased endogenous retinoic acid by the absence of Cyp26b1 impairs peridermal devel-
opment and skin barrier formation during development
J Okano,1 U Lichti,2 M Aronova,3 G Zhang,3 SH Yuspa,2 Y Sakai4 and MI Morasso1 1
Developmental Skin Biology Section, NIAMS, NIH, Bethesda, MD, 2 Laboratory of Cancer
Biology and Genetics, NCI, NIH, Bethesda, MD, 3 Laboratory of Bioengineering and Physical
Science, NIBIB, NIH, Bethesda, MD and 4 Department of Plastic and Reconstructive Surgery,
Osaka University, Osaka, Japan
Retinoic acid (RA), a metabolite of vitamin A, plays a key role in a variety of biological processes
and is essential for normal embryonic development. While excess exogenous retinoic acid (RA) is
known to have teratogenic effects on the developing fetus, little is known about the consequences
of elevated endogenous retinoids during skin development. Using a mouse model with deletion of
Cyp26b1, a RA-degrading enzyme, we show that specific RA levels are requisite for peridermal
desquamation and the development of stratified epidermis. We found upregulation of not only Ker-
atin 19, a known target of RA, but also genes linked to peridermal development such as Keratin 6a
and the Keratin Associated Proteins (KAP)-complex genes in Cyp26b1-/- epidermis. Administration
of exogenous RA to wild-type embryos induced acute morphological peridermal-specific changes
and marked upregulation of Krtap13, demonstrating that peridermal gene expression responds
directly to RA. Grafting Cyp26b1-/- skin disc on mice with normal RA metabolism rescued the abnor-
mal skin differentiation phenotype with associated down-regulation of peridermal phenotype. These
data reveal a complex RA-dependent interplay between periderm differentiation and development
of the underlying stratified epidermis during embryogenesis.
270
The p75 neurotrophin receptor acts as a “switch on-off” protein in keratinocyte differentia-
tion
E Palazzo, F Truzzi, A Marconi, R Lotti, K Dallaglio, T Petrachi and C Pincelli Dermatology,
University of Modena and Reggio Emilia, Modena, Italy
p75 neurotrophin receptor (p75NTR) mediates neurotrophin (NT) signals alone or in combination
with the high affinity receptor Trk, also in cell settings outside the nervous system. In the present
work, we studied the role of p75NTR during keratinocyte differentiation. p75NTR protein was up-
regulated after serum treatment in both confluent and post-confluent keratinocytes, together with
the expression of cytokeratin 10 (CK10) and involucrin. Moreover, calcium treatment of subcon-
fluent keratinocytes induced the expression of involucrin, CK10, and the up-regulation of p75NTR,
both at the mRNA and at the protein level. Western blotting and confocal analysis showed that
p75NTR positive (+) keratinocytes isolated by magnetic cell sorting, expressed less CK10 and
CK15, as compared to p75NTR negative (-) cells. p75NTR+ keratinocytes formed a lower number
of colonies and proliferated to a lesser extent, as compared to p75NTR- cells. p75NTR is only
expressed in the basal keratinocyte layer and is confined to a MIB-1 negative transit amplifying (TA)
cell population. p75NTR+ keratinocytes, isolated from TA cells, expressed more survivin and CK15,
while displayed less CK10 than p75NTR- TA. Colony forming efficiency was higher in p75NTR+ TA
than in p75NTR- TA cells. Moreover, long term proliferation analysis revealed that p75NTR+ TA
yielded a higher number of cells than p75NTR- TA. p75NTR retroviral infection of stem cells induced
a more differentiated phenotype, with the same features of TA cells. On the other hand, when p75NTR
was silenced, calcium treatment failed to induce differentiation in subconfluent keratinocytes, as
shown by the absence of involucrin expression. These results suggest that p75NTR+ keratinocytes
represent a subpopulation of TA cells, directly derived from stem cells that just started the differen-
tiation process. p75NTR may act as a “switch on-off” protein in stem-TA transition initiating ker-
atinocyte differentiation.
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OCA2 and MC1R interact with UV exposure to determine nevus counts and freckle scores
in children
N Box,1 V Gonzalez,1 N Asdigian,2 J Aalborg,2 T Terzian,1 A Baron,3 R Stiegmann,1 E Torchia,1
R Dellavalle,1 S Mokrohisky,1 J Morelli1 and L Crane2 1 Dermatology, UC Denver, Aurora, CO,
2 Preventive Medicine, UC Denver, Aurora, CO and 3 Biostatistics, UC Denver, Aurora, CO
Melanoma is an important public health problem, where efforts at prevention are key. Risk of
melanoma is determined largely by the interaction of childhood and adolescent UV exposure with
melanoma risk genes. A deeper understanding of how risk genes interact with childhood UV expo-
sure to determine phenotypic risk indicators such as nevus counts and freckle scores has important
public health implications. The Melanocortin 1 Receptor (MC1R) is a key melanoma risk gene that
when mutated causes the red hair color phenotype, including poor tanning and susceptibility to
sunburns and melanoma. MC1R interacts with the Oculocutaneous Albinism Type II (OCA2) gene
to determine pigmentation phenotypes. We utilized the Colorado Kids Sun Care Program (CKSP) to
study how MC1R and OCA2 interact with different UV exposure profiles to influence sun-sensitiv-
ity phenotypes. The CKSP includes a cohort of over 900 children who have been followed from
ages 6 to 10 with annual skin exams and data collection on nevus counts, sun exposure, pheno-
type and behavioral variables. The genotyping of MC1R and OCA2 and correlation studies with phe-
notypic measures show association between the major blue/brown eye color OCA2/HERC2
rs12913832 SNP, UV exposure and nevus counts. The data suggest that individuals who are homozy-
gous for this SNP are particularly sensitive to modification of nevus counts by UV exposure. Fur-
thermore, this modification is preferred in individuals with intermittent vs. chronic UV exposure
behaviors. We have similarly examined the interactions of these variables with MC1R variants to
illustrate how different genes interact with different UV exposure profiles to give maximal nevus
counts in children. The data generated by this study highlights the importance of preventive and per-
sonalized medicine and will be crucial for the selection of individuals with nevus and melanoma
susceptibility genotypes who may be targeted for primary prevention.
260
Endothelin-converting enzyme-1 modulates endothelin-1-induced pruritus by inhibiting
endothelin receptor recycling and prolonging ERK1/2 signaling in murine sensory neurons
M Kido,1,2 J Buddenkotte,1 C Kempkes,3 S Seeliger,4 F Cevikbas,3 M Furue2 and M Steinhoff1,3 1
Dermatology, University of Münster, Ludwig Bolzmann Institute for Cell and Immunobiology
of the Skin, Münster, Germany, 2 Dermatology, Graduate School of Medical Sciences, Kyushu
University, Fukuoka, Japan, 3 Dermatology and Surgery, University of California, San
Francisco, San Francisco, CA and 4 Pediatrics, University of Göttingen, Göttingen, Germany
Although of importance, the molecular and cellular mechanisms regulating pruritus are still poorly
understood. Endothelin-1 (ET1) evokes a pruritic sensation in humans and rodents mediated by acti-
vation of the G protein coupled receptor (GPCR), Endothelin A receptor (ETAR). We previously
demonstrated that ECE1 degrades neuropeptides in early endosomes thereby controlling receptor
recycling of GPCRs and cell signaling. Accordingly, we hypothesized that ECE1 contributes to ET1-
induced pruritus and neuronal signaling in mice. We detected co-expression of ETAR and ECE1 in
small- to medium-sized murine DRG neurons and cutaneous sensory nerves. Moreover, ET1 induced
marked scratching behavior which was significantly augmented by pretreatment with a specific ECE1
inhibitor in vivo. To reveal the mechanism, we cultured murine DRG neurons and investigated the
influence of ECE1 on receptor recycling and cell signaling. ET1 induced internalization of ETAR
and ECE1 into early endosomes. Of note, while ETAR recycling was accelerated by ECE1 inhibi-
tion, the ET1-induced phosphorylation of ERK1/2 was prolonged by inhibition of ECE1 in DRG
neurons. By HPLC, we confirmed that ET1 can be degraded by ECE1 in endosomes. In conclusion,
ET1 induces pruritus in mice in vivo, probably by ETAR activation and internalization. ECE1 mod-
ulates ET1 induced pruritus by prolonging ERK1/2 signaling in DRG neurons. Our results for the
first time dissect the signal transduction pathway for ET1-induced itch and provide evidence for a
specific molecular marker that is integral to the intracellular signal transduction in DRG neurons
during pruritus.
261
The role of adenomatous polyposis coli (APC) in epidermal development and hair follicle mor-
phogenesis
K Cook,1,2 X Wu,1 N Stokes1 and E Fuchs1,2 1 Rockefeller University, New York, NY and 2 The
Howard Hughes Medical Institute, Chevy Chase, MD
The role of the tumor suppressor and negative regulator of Wnt signaling, APC, in the skin and epi-
dermal appendages is poorly understood. The development of a mouse model, the APC conditional
KO (cKO), circumvents homozygotic lethality by the localization of Cre recombinase to remove
the floxed APC allele via linkage with a tissue specific promoter, Keratin 14. cKO embryos displayed
a distinct phenotype beginning at E15.5, characterized by silvery plaques covering the skin. Embryos
exhibited fused digits and open eyelids, indicative of aberrations in epidermal development. Although
epidermal differentiation occurred in APC cKO animals, the architecture of the epidermis was highly
irregular. The epidermis showed an expansion of basal-like cells and precocious presence of a stra-
tum corneum-like structure. However, a dye exclusion assay revealed an impaired epidermal bar-
rier at E17.5 when compared with control littermates, indicating that the stratum corneum was not
functional. Hair follicle (HF) morphogenesis was significantly impaired in the cKO. HF placodes or
pegs were not visible in sagittal sections of E15.5-E17.5 backskins, and immunofluorescence stain-
ing for early HF markers was absent in the cKO embryos. Moreover, backskin from E17.5 cKO
embryos failed to generate HFs when grafted onto Nude mice, in comparison to WT littermates.
Interestingly, the dermis underlying the cKO epidermis was diffusely positive for dermal papillae
(DP) marker alkaline phosphatase, suggesting that the early mesenchymal-epithelial crosstalk impor-
tant for initiating the dermal condensate and forming the epidermal placode was compromised.
Taken together, loss of APC in the epidermis in vivo results in impaired epidermal differentiation as
well as impaired HF morphogenesis; however, the entire epidermis does not adopt a HF fate as
seen in constitutively active β-catenin embryonic mutants, suggesting that APC may have a role in
epidermal development that is independent of its role as a negative regulator of Wnt signaling and
β-catenin stabilization.
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ARNT-dependent expression of amphiregulin and consequent activation of EGFR/Erk path-
way is essential for normal epidermal differentiation
D Robertson, L Weir, IM Leigh and AA Panteleyev Medical Sciences, University of Dundee,
Dundee, United Kingdom
EGFR activation by specific ligands is involved in the control of growth and differentiation in nor-
mal and cancerous epidermal keratinocytes. Previously we showed a role for the aryl hydrocarbon
receptor nuclear translocator (ARNT), a key factor in hypoxia and toxic responses, in control of
EGFR ligands and keratinocyte differentiation in mouse epidermis. To assess the functions of ARNT
in human keratinocytes we used stable shRNA lentiviral suppression of ARNT in N-TERT cells. 3D
epidermal equivalent developed using these cells showed defective morphology and significantly
increased expression of key differentiation markers such as filaggrin, loricrin, involucrin, and K10
while basal markers (K5/14) remained unchanged. Amphiregulin (AREG) was found to be the most
abundant EGFR ligand in N-TERT cells which was significantly downregulated at both mRNA and
protein levels in ARNT-depleted monolayer culture and 3D model. Correspondingly, AREG was
upregulated in ARNT-overexpressing cells. Lack of ARNT also resulted in decline of EGFR and Erk1/2
phosphorylation in both ARNT-deficient models. Downregulation of AREG in Arnt-depleted cells
was abolished by TSA treatment suggesting a role for HDACs in this effect. Prominent increase of
total HDAC activity in ARNT-depleted cells and its corresponding decrease in ARNT-overexpress-
ing keratinocytes further support implication of epigenetic mechanisms in control of AREG by ARNT.
Expression and localization of HDACs 1/3 (the most abundant deacetylases in normal N-TERT
cells) was strictly dependent on the level of ARNT in both monolayer and 3D models. Finally gel-
danamycin, a potent inhibitor of ARNT dimerization partners, blocks AREG expression in normal
N-TERTs and, importantly, abolishes AREG induction in ARNT-overexpressing cells. These results
suggest that ARNT controls AREG expression and the downstream EGFR/Erk pathway through mod-
ulation of HDAC1/3 activity. This novel regulatory pathway targeting epidermal differentiation may
have important implications for skin pathology.
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Differential regulation of HIF-α splice variants by hypoxia in epidermal keratinocytes
L Weir,1 D Robertson,1 IM Leigh,1 JK Vass2 and AA Panteleyev1 1 Medical Sciences, University
of Dundee, Dundee, United Kingdom and 2 Translational Medicine Research Collaboration,
University of Dundee, Dundee, United Kingdom
The activity of hypoxia-regulated HIF pathway is a key factor of tumour microenvironment affect-
ing its aggressiveness and susceptibility to therapy. It is also linked to wound healing and patho-
genesis of such skin diseases as psoriasis. Nevertheless, the mechanisms controlling HIF activity in
the epidermis are still obscure. Our studies of primary mouse epidermal keratinocytes cultured at
different O2 levels showed that they express a unique array of protein-coding splice variants of Hif1α
and 3α which are differentially regulated by hypoxia (1%O2) while Hif2α (mRNA and protein) was
virtually absent irrespective of O2 level. Hif1α-001 splice variant was highly expressed in normoxic
cells (at B2M level) and showed strong two-step decline at 1-2h and after 5h of hypoxia suggesting
different mechanisms of regulation under acute and chronic exposure. Hif1α-003 showed similar
patterns of expression but at much lower level. In contrast, Hif1α-002 (a truncated isoform lacking
the oxygen degradation domain - ODDD) was positively regulated by hypoxia. Correspondingly,
Western blotting showed substitution of two Hif1α-specific bands in normoxic cells with just one
band of different size under hypoxia. Hif3α-001 splice variant was barely detectable in both types
of cells. Hif3α-002/NEPAS, while being low, showed significant induction by hypoxia. On the con-
trary, Hif3α-003/IPAS splice variant was found to be expressed at B2M level in normoxic cells and
significantly suppressed by hypoxia. Thus, in mouse epidermal keratinocytes Hif1α-001 and ODDD-
lacking Hif3α-003/IPAS isoforms are responsible for yet uncharacterized hypoxia-independent HIF-
α function and for control of HIF pathway during acute phase of hypoxia. During chronic phase of
exposure, pro-angiogenic signalling is HIF-independent or maintained by Hif1α-002 splice vari-
ant. These findings suggest differential regulation of keratinocyte response to acute and chronic
hypoxia and highlight the complexity of HIF machinery control in the epidermis.
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Expression human β-defensins 2,3 of epidermis by heat damage
J Lee,1 H Jeong,1 J Lee,1 H Kim,1 S Lee,1 T Sohn,1 C Yoon1 and I Kim2 1 Research Center, Bestian
Hospital, Daejeon, Republic of Korea and 2 Eulji Hospital, Daejeon, Republic of Korea
Defensins are anti-microbial peptides of the innate host defense system. β-defensins are variably
expressed in the skin and organs. Burns is severe damage by heat, chemicals, electricity, sunlight
or radiation. They also can lead to infections because that damage skin’s protective barrier. Anti-
microbial peptide in skin can prevent or treat from serious infections. β-Defensins are especially
widely distributed by leukocytes and epithelial cells in humans. Also they were found in the human
skin during inflammatory conditions like psoriasis and during wound healing. To investigate whether
β-defensins can protect to host defense in burns, we examined expression of β-defensin 2,3 in ani-
mal and human keratinocytes of in vitro burn model. The expression of β-defensin 2,3 was exchanged
during healing stage at burn tissues. The expression of β-defensin 2 was returned at short time and
β-defensin 3 was transient up-regulated at human keratinocytes by heat. We proposed that β-defensins
may have the potential roles therefore it will be a therapeutic agent for treat burns infection.
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Human epidermal tight junctions are functional and allow penetration of activated Langer-
hans cell dendrites
K Yoshida,1 A Kubo,1,2 M Yokouchi,1 K Ishii,1,3 H Kawasaki,1 T Ebihara,1 M Ohyama,1 K Nagao1
and M Amagai1 1 Dermatology, Keio University, Tokyo, Japan, 2 Kanrinmaru Project, Keio
University, Tokyo, Japan and 3 Teikyo University Chiba Medical Center, Chiba, Japan
Mammalian skin consists of two sets of epidermal barriers: stratum corneum and tight junctions
(TJ). We previously demonstrated in mice that epidermal Langerhans cells (LC) penetrated TJ upon
activation and uptake antigens from extra-TJ environments. Although TJ has a pivotal role in the
epidermal barriers, little is known about the structure and function of TJ barrier in human epider-
mis. In this study, we first visualized the 3D structure of human epidermal TJ. In contrast to single-
layered ZO-1-staining in mice, several layers of intercellular honeycomb staining of occludin and
ZO-1 were observed in human skin. However, biotin permeation assay revealed that functional TJ
barrier was limited to one layer of cells, which are the second layer cells of stratum granulosum,
similar to mice. We further showed that effects of intradermally-injected exfoliative toxin or a sin-
gle chain variable fragment of immunoglobulin against desmoglein 1 were constantly limited below
TJ, suggesting that epidermal TJ act as a diffusion barrier against soluble proteins. Next, we visual-
ized TJ and LC of healthy human epidermis in 3D. While most LC projected their dendrites upward
to the skin surface but stopped short of TJ, some dendrites of activated LC penetrated TJ with accu-
mulation of langerin to the dendrite tips. To investigate whether TJ penetration of LC is affected by
skin conditions, we compared healthy skin, lesional and nonlesional skin of atopic dermatitis (AD).
The number of LC in lesional and nonlesional AD skin was significantly reduced than that in healthy
skin. In contrast, the number of TJ-docked LC dendrites was dramatically increased in lesional AD
skin when compared with healthy skin or nonlesional AD skin. These findings suggested that the
surveillance of extra-TJ environment by activated LC is conserved within mammals, which will pro-
vide new insights of human epidermal barrier and barrier disrupted skin diseases.
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Role of centrosomal proteins and cortical microtubules in epidermal barrier formation
K Sumigray and T Lechler Cell Biology, Duke University Medical Center, Durham, NC
The essential barrier function of the epidermis is dependent on both proper cell adhesion and
cytoskeletal organization. However, we have an incomplete view of how different adhesion and
cytoskeletal complexes are coordinated during differentiation to form a barrier. Here we present
evidence that desmosome-dependent microtubule reorganization plays an integral role in this
process. Upon differentiation, epidermal cells reorganize their microtubule cytoskeleton from a cen-
trosomal array into a cortical array. The formation of these cortical microtubules requires desmo-
plakin, a core component of the desmosome. Desmoplakin functions to recruit a group of centro-
somal proteins, all of which have been implicated in microtubule organization, to the desmosome.
We have genetically ablated the gene encoding for one of these proteins, Lis1, specifically in the
epidermis. Lis1-deficient epidermis lacks cortical microtubule, displays desmosome defects and
results in fully-penetrant lethality associated with loss of barrier activity. This reveals novel desmo-
some-associated proteins that are essential for epidermal function. In addition, we have used cul-
tured keratinocytes to demonstrate that cortical microtubules promote increased epithelial sheet
integrity by acting to stabilize adherens junctions and tight junctions. These data demonstrate a coor-
dination between the three major cell-cell adhesion systems in the epidermis that is provided by
cortical microtubules.
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LEDGF plays a crucial role in pathogenesis of psoriasis vulgaris via activation of the
p38MAPK/MK2/IL-6/STAT3 pathway
T Takeichi, K Sugiura, Y Muro, Y Ogawa and M Akiyama Dermatology, Nagoya University
Graduate School of Medicine, Nagoya, Japan
Lens epithelium-derived growth factor (LEDGF)/dense fine speckles 70 kDa protein (DFS70) is an
activator of Cdc7/ASK, a major S-phase cell cycle kinase, and is overexpressed in various cancers.
LEDGF acts in the nucleus of proliferating cells. We have demonstrated that in normal epidermis
LEDGF/DFS70 localizes to the nucleus of keratinocytes (KCs) in the basal layer, and to the cyto-
plasm of cells in the upper layers (Sugiura et al., J Invest Dermatol 2007). In a recent study, we
detected strong nuclear staining of LEDGF/DFS70 in the spinous layers as well as the basal layer of
the epidermis of psoriatic skin, suggesting that ectopic expression of LEDGF in KCs could be involved
in the pathology of psoriasis vulgaris (Takeichi et al., J Invest Dermatol 2010). In this study, in order
to investigate the roles of LEDGF/DFS70 in the epidermis of psoriatic skin, we generated HaCaT
cells that constitutively express enhanced green fluorescence protein-tagged LEDGF (EGFP-LEDGF-
HaCaT) or EGFP alone (EGFP-HaCaT) as a control. EGFP-LEDGF-HaCaT exhibited increased expres-
sion of interleukin-6 (IL-6) and activated STAT3, which was attenuated by LEDGF-specific RNA inter-
ference and p38-specific inhibitors. Moreover, MAPK-activated protein kinase 2 (MK2), which is
involved in the IL-6/STAT3 pathway, was also activated in EGFP-LEDGF-HaCaT. In addition, EGFP-
LEDGF-HaCaT showed increased expression of TNF-α, IFN-β1, IL-8, CCL5, S100A7 and S100A9,
and decreased expression of K1, K10 and filaggrin. These findings clearly indicate that ectopic
expression of LEDGF/DFS70 in KCs of the upper epidermis is involved in formation of psoriatic
skin lesions via activation of the p38MAPK/MK2/IL-6/STAT3 pathway. These results suggest that inhi-
bition of LEDGF activity might be a novel therapeutic strategy for psoriasis vulgaris.
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Filaggrin-induced stratum corneum pH modulation following external and internal stressors
T Roelandt,1 C Giddelo,1 T Hillary,1 C Baudouin,2 P Msika,2 D Roseeuw,1 J Fluhr3 and J Hachem1
1 Department of Dermatology, Vrije Universiteit Brussel, Brussels, Belgium, 2 Laboratoires
Expanscience, Epernon, France and 3 Department of Dermatology, Charité -
Universitätsmedizin, Berlin, Germany
Stratum corneum (SC) pH regulates epidermal permeability barrier and SC integrity and cohesion.
We investigated the implication of the filaggrin (flg) pathway in modulating SC pH and epidermal
structure/function responses to either external (SC alkalization) or internal (psychological stress, PS)
stressors in hairless, flaky tail (characterized by the absence of filaggrin expression) and wildtype
littermate mice. We show first that SC pH was decreased in hairless mice subject to 3 days PS com-
pared to control animals. Furthermore, PS decreases epidermal differentiation markers assessed by
western immunoblotting (i.e. cytokeratin 1, 10, loricrin and involucrin) and alters epidermal pro-
liferation/differentiation (i.e. decreases cyclin D1, PCNA and caspase 14). To assess the mechanisms
leading to decreased SC pH we addressed filaggrin processing in both PS mouse models and flaky
tail mice. We found that PS leads to filaggrin processing (i.e. decrease in pro-flg and increase in low
MW flg following PS) and subsequent urocanic acid formation, which accounts for the decreased
pH. Contrariwise, and despite a lower basal level of SC pH, we found a significant loss in SC
buffering capacity in flaky tail mice following superbase-induced SC alkalization. Our data suggest
that filaggrin processing is implicated in epidermal acidification and epidermal response to PS.
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STRA6 modulates retinol uptake and cell proliferation in epidermal keratinocytes
C Skazik,1 R Heise,1 Y Marquardt,1 K Czaja,1 HF Merk,1 DR Bickers2 and JM Baron1 1 Department
of Dermatology, University Hospital RWTH, Aachen, Germany and 2 Department of
Dermatology, Columbia University, New York, NY
Retinoids play a key role in cell proliferation and differentiation. Recently STRA6, a multitrans-
membrane domain protein, was identified as a specific membrane receptor for retinol bound to
retinol-binding protein in bovine retinal epithelium cells. To determine whether similar transport
processes take place in human skin cells, we analyzed expression of human STRA6 in normal human
epidermal keratinocytes (NHEK), HaCaT keratinocytes and human dermal fibroblasts. Quantitative
RT-PCR analysis revealed a constitutive expression of STRA6 in these skin cells. STRA6 mRNA and
protein expression was significantly upregulated by ligands of the nuclear retinoic acid receptor
(RAR) e.g. 9-cis-RA or all-trans-RA as well as retinol itself, but expression was not affected by lig-
ands of other class II nuclear receptors. To investigate the influence of STRA6 knockdown on the
physiological function and morphological structure of human skin we established an organotypic
3D skin model employing HaCaT cells with stable knockdown of STRA6 using shRNAs from lentivi-
ral vectors. Cells transduced with lentivirus non-target vector served as controls. Within 7 days the
epidermis in the STRA6 knockdown 3D model showed increased proliferation and significantly
enhanced expression of keratin 16 compared to the control. After 14 days of cell culture the knock-
down 3D model displayed a 3-fold thicker epidermis compared to organotypic models derived from
HaCaT cells transfected with the control vector. HaCaT cells with STRA6 knockdown also revealed
a significantly increased proliferation in monolayer culture experiments. In conclusion, our results
indicate that STRA6 is constitutively expressed in human skin cells and mediates active uptake of
RBP-bound retinol into these cells. This transporter mediated uptake may play an important role in
retinoid signaling in human skin.
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Integration of Langerhans-like cells into a three-dimensional full-thickness skin model
V Laubach,1 N Zöller,1 M Rossberg,1 K Görg,1 S Kippenberger,1 J Bereiter-Hahn,2 R Kaufmann1
and A Bernd1 1 Dermatology, Venerology and Allergology, J.W. Goethe-University,
Frankfurt/Main, Germany and 2 Kinematic Cell Research Group, J.W. Goethe-University,
Frankfurt/Main, Germany
Langerhans cells (LCs) are immature dendritic cells residing suprabasally within the epidermis. Stud-
ies regarding these cells are somehow hampered by the difficult cultivation in vitro. Here we show
that MUTZ-3 cells, derived from a CD34+ human acute myeloid leukemia, can be differentiated
into Langerhans-like cells in the presence of a cytokine cocktail including GM-CSF, TGF-β1 and
TNF-α. As differentiation markers served the expression of langerin, CD1a, CCR6 and the intracel-
lular presence of Birbeck granules. The aim of this study was to integrate differentiated MUTZ-3 cells
(MUTZ-3-LCs) into a three-dimensional full thickness skin model consisting of primary human ker-
atinocytes and fibroblasts. On top of fibroblast-containing collagen matrix (Henkel AG & Co. KGaA,
Düsseldorf) a mixture of keratinocytes and MUTZ-3-LCs were seeded and cultured for 24 hours.
Subsequently, the models were lifted up to the air liquid interface. Histological evaluation featured
a fully stratified epidermis with all characteristic epidermal strata. Langerin-positive cells were
detected suprabasally within the epidermis indicating that keratinocytes and/or fibroblasts provide
environmental conditions for long-time maintenance of MUTZ-3-LCs. These skin models provide a
relevant research tool to study LC biology in vitro. Particularly, the interactions between LCs and
other skin cells and their contribution in cutaneous immune responses can be investigated.
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IL17 modulates barrier gene expression in human keratinocytes: a new role in psoriasis?
A De Benedetto,1 B Jones,2 M Behrendt,1 I Kuo,1,3 T Yoshida,1 A Ivanov,4 M Elloso2 and LA Beck1
1 Department of Dermatology, University of Rochester Medical Center, Rochester, NY, 2
Centocor R&D, Inc, Malvern, PA, 3 Department of Pathology and Laboratory Medicine,
University of Rochester Medical Center, Rochester, NY and 4 Department of Medicine,
University of Rochester Medical Center, Rochester, NY
Psoriasis is a Th1 and Th17-polarized skin disorder characterized by abnormal keratinocyte differ-
entiation. We evaluated the effect of IL17 on the expression of epidermal barrier proteins important
for the integrity of the stratum corneum (SC) and tight junctions (TJ). Primary human foreskin ker-
atinocytes (PHK) were terminally differentiated in high Ca+2(1.8 mM), serum-free media (DMEM)
for 5 days in the presence of IL17 (10-1000ng/ml). Expression of differentiation markers (filaggrin/FLG,
Loricrin/LOR, and keratin 10/KRT10) as well as TJ proteins (claudin/CLDN1, 4, 23, ZO-1 and
occludin/OCL) were analyzed using a custom made Taqman Low Density Array Card. Data were
expressed as fold change over unstimulated PHK; a 2-wayANOVA test was used for statistical analy-
sis. We evaluated the immunoreactivity of several genes dysregulated by IL17 in lesional and non-
lesional biopsies from subjects with psoriasis (n=5). IL17 significantly inhibited PHK terminal dif-
ferentiation (FLG<0.2 fold over control, P<0.001; KRT10<0.4 fold, P<0.001 and LOR<0.2 fold,
P<0.001) in a dose-dependent fashion. IL17 also down-regulated CLDN1 expression (0.5 fold
[1000ng/ml], P<0.001) while OCL expression was modestly enhanced (1.5 fold [10ng/ml], P<0.05).
The expression of other TJ or adherens junction (E-cadherin and Nectin1) components was unaf-
fected by IL17 treatment. The inhibitory effect of IL17 on PHK was confirmed at the protein level
by Western blot. Reduced immunoreactivity for KRT10, FLG and CLDN1 was observed in psoria-
sis lesions compared to nonlesional samples from the same subjects. In summary, IL17 significantly
inhibited the expression of keratinocyte differentiation markers as well as CLDN1. This data sug-
gests that IL17 might play a direct role in the dedifferentiation characteristic of lesional psoriatic
epithelium.
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Psoriasis-like skin lesion induced by Raf-MAPK signaling requires Stat3 activation
M Tarutani, K Miyoshi, M Takaishi and S Sano Dematology, Kochi Medical School, Kochi
University, Nankoku, Japan
Raf is one of the downstream effectors of Ras GTPases, and plays a key role in cell proliferation and
differentiation through activation of MAPK. We have previously demonstrated that temporal induc-
tion of Raf in the epidermis of K14-Raf:ER transgenic mice results in development of psoriasis-like
phenotype, including epidermal hyperplasia, lymphocyte and neutrophil infiltrates. It has been
demonstrated that epidermal Stat3 activation was required for psoriasis development, since ker-
atinocytes-specific Stat3 activation in a mouse model demonstrated psoriasis-like phenotype, and
inhibition of Stat3 signaling ameliorated psoriatic lesions. Here, we investigated whether Stat3 sig-
naling was involved in Raf-MAPK-dependent psoriasis-like lesions. Epidermal hyperplasia of K14-
Raf:ER mice following topical tamoxifen application showed Stat3 activation in keratinocytes. We
mated them with epidermis-specific Stat3 null mice (K5-Cre.Stat3f/f). Surprisingly, over-expression
of Raf by tamoxifen treatment in Stat3 deficient background (K14-Raf:ER;K5-Cre.Stat3f/f) demon-
strated greatly attenuated epidermal hyperplasia or dermal cell infitrates, compared to K14-Raf:ER;K5-
Cre.Stat3f/wt mice. Also, up-regulation of psoriasis-associated cytokine profiles, including VEGF,
was not detected in the skin from K14-Raf:ER;K5-Cre.Stat3f/f upon tamoxifen treatment. This result
clearly indicated that Raf-MAPK-dependent psoriatic-skin development required Stat3 signaling in
keratinocytes. Finally, topical treatment of K14-Raf:ER transgenic mice skin with a small Stat3 inhibitor
STA-21 resulted in attenuation of epidermal hyperplasia upon tamoxifen induction. Further analy-
sis of the mechanistic crosstalk of these two important signalings in developing psoriasis is cur-
rently being undertaken.
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IFNγ inhibits TNFα-induced CTACK/CCL27 production from keratinocytes through EGF recep-
tor signaling pathway in a differentiation dependent manner and CTACK/CCL27 production
in the centrals of psoriatic lesion
M Karakawa,1,2 M Komine,1,2 H Tsuda,1 K Tamaki,2 S Sato2 and M Ohtsuki1 1 Dermatology, Jichi
Medical University, Shimotsuke, Japan and 2 Dermatology, University of Tokyo, Tokyo, Japan
Cutaneous T cell attracting chemokine (CTACK)/CCL27 is a chemokine indispensable in skin inflam-
mation. Its expression is exclusively limited in epidermal keratinocytes, which characterizes the skin
inflammation. CTACK/CCL27 production is induced by TNFα. IFNγ synergistically enhance the
TNFα-induced production of various chemokines. We investigated the effect of IFNγ on TNFα-
induced production of CTACK/CCL27 from keratinocytes and its signaling pathway using cultured
human keratinocytes in vitro. We stimulated keratinocytes by TNFα with or without IFNγ. TNFα
induced, but IFNγ suppressed CTACK/CCL27 production at both mRNA and protein levels. Then
we investigated whether the effect of IFNγ is dependent on the differentiation of keratinocytes.
High confluent culture condition suppressed the inhibitory effect of IFNγ. EGF receptor(EGFR) sig-
naling pathway is usually up-regulated in inflammatory skin diseases such as psoriasis, and its acti-
vation is dependent of the differentiation of keratinocytes. EGFR tyrosine kinase inhibitor completely
reversed the inhibitory effect of IFNγ. IFNγ induced several EGFR ligands in keratinocytes. These
results suggest that IFNγ induces EGFR ligand production and that the EGFR ligands suppress
CTACK/CCL27 production through EGFR. Then we investigated CTACK/CCL27 production in biopsy
specimen from psoriatic lesion using immunohistochemistry. CTACK/CCL27 production is stronger
in the peripheral than in the central of psoriatic lesion. This study indicates that, CTACK/CCL27
play important role in the formation of skin inflammation, and when the inflammation is developed
into maintenance phase. And it is also suggested that inflammation is formed actively at peripheral
of the lesion and maintained stably at the central of the lesion in psoriasis.
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Is the functional skin adaptation complete and competent in infancy?
JW Fluhr,1 R Darlenski,2 J Hachem,3 P Msika,4 C de Belilovsky,5 C Baudouin4 and E Berardesca6
1 Dermatology Department, Charité University Clinic, Berlin, Germany, 2 Department of
Dermatology and Venereology, Medical Faculty, Sofia, Bulgaria, 3 Dermatology Research,
Vrije Universiteit, Brussels, Belgium, 4 Innovation R&D Direction, Laboratoires Expanscience,
Epernon, France, 5 Dermatology Department, Institut Alfred Fournier, Paris, France and 6
Dermatology Department, San Gallicano Dermatological Institute, Rome, Italy
Over the last decade, knowledge on newborn skin physiology has evolved with obvious data but
also controversies. We elucidate the main cutaneous physiological functions in neonate infants.
Skin ‘acid mantle’ is necessary to maintain bacteriological, chemical and mechanical resistance.
After birth, skin surface pH of both full-term and preterm neonates is higher than in adults, and
decreases within the first weeks postpartum. Trans-Epidermal Water Loss (TEWL) is below 10g/m2/h
in term neonates similarly to that of healthy adults, indicating a complete barrier function devel-
opment at birth. Although Stratum Corneum (SC) hydration of term neonates in the first days is low
compared to adults, it increases with time to be similar or even higher (3-48 months). Gestational
age, anatomical site and environment condition influence pH, barrier function and hydration. Preterm
newborns have higher TEWL than term neonates, but complete barrier maturation is generally ful-
filled within 2 to 4 weeks after birth. In the diapers’area, high TEWL and pH were measured asso-
ciated with low SC hydration. Skin blood vessels respond to external stimuli shortly after birth in
term neonates but the blood flow control still matures until 14-17 weeks. This vasculature adapta-
tion can take longer in immature infants. The newborns’ skin is quickly adjusting to the challeng-
ing postpartum environmental conditions. However, some functions continue to develop even
beyond the neonatal period. Based on functional infant skin knowledge and on clinical expertise,
recommendations for skin care of newborns and infants are displayed.
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Aryl hydrocarbon receptor dependent c-kit expression is required for dendritic epidermal T
cell homeostasis in murine skin
S Kadow, B Wingerath, B Jux, S Chmill, J Krutmann, H Weighardt and C Esser IUF-Leibniz
Research Institute for Environmental Medicine, Düsseldorf, Germany
The aryl hydrocarbon receptor (AhR) is a ligand-dependent transcription factor which is critically
involved in tissue development and homeostasis. Recently we had shown in AhR deficient (-/-) mice
that AhR-dependent GMCSF is necessary for normal Langerhans cell (LC) maturation and function.
Here, we analyzed dendritic epidermal T cells (DETC), which are a major source of GMCSF in
murine epidermis. DETC express an invariant γδT cell receptor, which recognizes keratinocyte stress
proteins. They are important for wound healing and participate in barrier function. Using immuno-
histochemistry and flow cytometry, we found that DETC were absent in the epidermis of AhR-/-
mice. DETC were generated at normal frequencies in fetal thymi from AhR-/- mice, and migrated
to the epidermis. However, in contrast to wild-type (WT) DETC, they proliferated less after birth,
and quickly decreased to levels of about 0.5% of epidermal cells by three weeks of age, decreas-
ing further in ageing mice. The few remaining DETC did not develop dendrites, and expressed lower
levels of γδ and CD3. Cross-over depletion and supplementation of DETC in epidermal cultures
from AhR-/- and WT mice showed that DETC-produced GMCSF was important for LC maturation.
In the skin of keratinocyte-specific (K5Cre)-conditional AhR deficient mice, DETC abundance was
normal, indicating that growth factors provided from surrounding keratinocytes are not affected by
AhR-deficiency. However, DETC from AhR-/- mice failed to express c-kit. This tyrosine kinase is a
growth factor for gut γδ T cells, and has putative AhR-responsive promoter elements (ARE). The c-
kit promoter drove a luciferase reporter gene upon AhR-activation. Activity was abrogated after muta-
tion of the ARE elements. We propose that AhR-dependent c-kit expression controls DETC home-
ostasis. To our knowledge this is the first report of a mouse model where DETC, but not peripheral
γδ T cells, are lacking.
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Sunflower oleodistillate: A topical PPAR-alpha (peroxisome proliferator-activated receptors)
agonist developed for atopic dermatitis
C de Belilovsky,1 C Baudouin,2 S Brédif,2 B Chadoutaud3 and P Msika2 1 Dermatology
Department, Institut Alfred Fournier, Paris, France, 2 Innovation R&D Direction, Laboratoires
Expanscience, Epernon, France and 3 Clinreal Online, Toulouse, France
Sunflower Oleodistillate (SO) has proven a triple action on epidermal lipid barrier, cutaneous inflam-
mation and immunological Th2 response, which demonstrates a specific indication in Atopic Der-
matitis (AD) (1). In our experimental studies, SO activates PPARs-alpha in cell model. On human
skin explants, 2% SO formulation induces the synthesis of ceramides x 3 and cholesterol x 2. 2%
SO cream limits the release of inflammatory mediators (TSLP, TARC and RANTES) and enhances
barrier markers expression (filaggrin, kallikrein and betaglucocerebrosidase) on a skin model mim-
icking AD Th2 context. 2% SO formulation reduces TPA-induced inflammation on animal model,
a single application of 2% S0 cream provides significant hydration (capacitance: + 50% H1, +64%
H3, +34% H24), It also significantly decreases TEWL (-18% H4, -21% H8). A Clinical trials open
study on 227 children with mild to moderate AD (30 days) showed a significant decrease of dry-
ness, flaking, itching and redness (-80 to -88%). First randomised comparative study demonstrated
steroid-sparing effect and positive effect on quality-of-life. 86 children (4-48 months) with AD have
been attributed to 5 groups with desonide 0.05% + 2% SO cream (21 days). Similar and significant
improvement of SCORAD (p<0.01) in all groups were demonstrated: 63% to 75% (2). Second ran-
domised comparative study has demonstrated comparable therapeutic properties to a Topical Steroid
among 40 children (mean age 2.3 years), with moderate AD: Significant and similar SCORAD
decrease D7 and D21 (-70%, –75%) (3). The central role of deficient PPARs-alpha has been recently
discovered in the physiopathology of AD. PPAR-alpha agonist properties of 2% SO cream might
explain its short term clinical impact comparable to a topical steroid.
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Human epidermal tight junctions are functional and allow penetration of activated Langer-
hans cell dendrites
K Yoshida,1 A Kubo,1,2 M Yokouchi,1 K Ishii,1,3 H Kawasaki,1 T Ebihara,1 M Ohyama,1 K Nagao1
and M Amagai1 1 Dermatology, Keio University, Tokyo, Japan, 2 Kanrinmaru Project, Keio
University, Tokyo, Japan and 3 Teikyo University Chiba Medical Center, Chiba, Japan
Mammalian skin consists of two sets of epidermal barriers: stratum corneum and tight junctions
(TJ). We previously demonstrated in mice that epidermal Langerhans cells (LC) penetrated TJ upon
activation and uptake antigens from extra-TJ environments. Although TJ has a pivotal role in the
epidermal barriers, little is known about the structure and function of TJ barrier in human epider-
mis. In this study, we first visualized the 3D structure of human epidermal TJ. In contrast to single-
layered ZO-1-staining in mice, several layers of intercellular honeycomb staining of occludin and
ZO-1 were observed in human skin. However, biotin permeation assay revealed that functional TJ
barrier was limited to one layer of cells, which are the second layer cells of stratum granulosum,
similar to mice. We further showed that effects of intradermally-injected exfoliative toxin or a sin-
gle chain variable fragment of immunoglobulin against desmoglein 1 were constantly limited below
TJ, suggesting that epidermal TJ act as a diffusion barrier against soluble proteins. Next, we visual-
ized TJ and LC of healthy human epidermis in 3D. While most LC projected their dendrites upward
to the skin surface but stopped short of TJ, some dendrites of activated LC penetrated TJ with accu-
mulation of langerin to the dendrite tips. To investigate whether TJ penetration of LC is affected by
skin conditions, we compared healthy skin, lesional and nonlesional skin of atopic dermatitis (AD).
The number of LC in lesional and nonlesional AD skin was significantly reduced than that in healthy
skin. In contrast, the number of TJ-docked LC dendrites was dramatically increased in lesional AD
skin when compared with healthy skin or nonlesional AD skin. These findings suggested that the
surveillance of extra-TJ environment by activated LC is conserved within mammals, which will pro-
vide new insights of human epidermal barrier and barrier disrupted skin diseases.
279
Role of centrosomal proteins and cortical microtubules in epidermal barrier formation
K Sumigray and T Lechler Cell Biology, Duke University Medical Center, Durham, NC
The essential barrier function of the epidermis is dependent on both proper cell adhesion and
cytoskeletal organization. However, we have an incomplete view of how different adhesion and
cytoskeletal complexes are coordinated during differentiation to form a barrier. Here we present
evidence that desmosome-dependent microtubule reorganization plays an integral role in this
process. Upon differentiation, epidermal cells reorganize their microtubule cytoskeleton from a cen-
trosomal array into a cortical array. The formation of these cortical microtubules requires desmo-
plakin, a core component of the desmosome. Desmoplakin functions to recruit a group of centro-
somal proteins, all of which have been implicated in microtubule organization, to the desmosome.
We have genetically ablated the gene encoding for one of these proteins, Lis1, specifically in the
epidermis. Lis1-deficient epidermis lacks cortical microtubule, displays desmosome defects and
results in fully-penetrant lethality associated with loss of barrier activity. This reveals novel desmo-
some-associated proteins that are essential for epidermal function. In addition, we have used cul-
tured keratinocytes to demonstrate that cortical microtubules promote increased epithelial sheet
integrity by acting to stabilize adherens junctions and tight junctions. These data demonstrate a coor-
dination between the three major cell-cell adhesion systems in the epidermis that is provided by
cortical microtubules.
281
LEDGF plays a crucial role in pathogenesis of psoriasis vulgaris via activation of the
p38MAPK/MK2/IL-6/STAT3 pathway
T Takeichi, K Sugiura, Y Muro, Y Ogawa and M Akiyama Dermatology, Nagoya University
Graduate School of Medicine, Nagoya, Japan
Lens epithelium-derived growth factor (LEDGF)/dense fine speckles 70 kDa protein (DFS70) is an
activator of Cdc7/ASK, a major S-phase cell cycle kinase, and is overexpressed in various cancers.
LEDGF acts in the nucleus of proliferating cells. We have demonstrated that in normal epidermis
LEDGF/DFS70 localizes to the nucleus of keratinocytes (KCs) in the basal layer, and to the cyto-
plasm of cells in the upper layers (Sugiura et al., J Invest Dermatol 2007). In a recent study, we
detected strong nuclear staining of LEDGF/DFS70 in the spinous layers as well as the basal layer of
the epidermis of psoriatic skin, suggesting that ectopic expression of LEDGF in KCs could be involved
in the pathology of psoriasis vulgaris (Takeichi et al., J Invest Dermatol 2010). In this study, in order
to investigate the roles of LEDGF/DFS70 in the epidermis of psoriatic skin, we generated HaCaT
cells that constitutively express enhanced green fluorescence protein-tagged LEDGF (EGFP-LEDGF-
HaCaT) or EGFP alone (EGFP-HaCaT) as a control. EGFP-LEDGF-HaCaT exhibited increased expres-
sion of interleukin-6 (IL-6) and activated STAT3, which was attenuated by LEDGF-specific RNA inter-
ference and p38-specific inhibitors. Moreover, MAPK-activated protein kinase 2 (MK2), which is
involved in the IL-6/STAT3 pathway, was also activated in EGFP-LEDGF-HaCaT. In addition, EGFP-
LEDGF-HaCaT showed increased expression of TNF-α, IFN-β1, IL-8, CCL5, S100A7 and S100A9,
and decreased expression of K1, K10 and filaggrin. These findings clearly indicate that ectopic
expression of LEDGF/DFS70 in KCs of the upper epidermis is involved in formation of psoriatic
skin lesions via activation of the p38MAPK/MK2/IL-6/STAT3 pathway. These results suggest that inhi-
bition of LEDGF activity might be a novel therapeutic strategy for psoriasis vulgaris.
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Filaggrin-induced stratum corneum pH modulation following external and internal stressors
T Roelandt,1 C Giddelo,1 T Hillary,1 C Baudouin,2 P Msika,2 D Roseeuw,1 J Fluhr3 and J Hachem1
1 Department of Dermatology, Vrije Universiteit Brussel, Brussels, Belgium, 2 Laboratoires
Expanscience, Epernon, France and 3 Department of Dermatology, Charité -
Universitätsmedizin, Berlin, Germany
Stratum corneum (SC) pH regulates epidermal permeability barrier and SC integrity and cohesion.
We investigated the implication of the filaggrin (flg) pathway in modulating SC pH and epidermal
structure/function responses to either external (SC alkalization) or internal (psychological stress, PS)
stressors in hairless, flaky tail (characterized by the absence of filaggrin expression) and wildtype
littermate mice. We show first that SC pH was decreased in hairless mice subject to 3 days PS com-
pared to control animals. Furthermore, PS decreases epidermal differentiation markers assessed by
western immunoblotting (i.e. cytokeratin 1, 10, loricrin and involucrin) and alters epidermal pro-
liferation/differentiation (i.e. decreases cyclin D1, PCNA and caspase 14). To assess the mechanisms
leading to decreased SC pH we addressed filaggrin processing in both PS mouse models and flaky
tail mice. We found that PS leads to filaggrin processing (i.e. decrease in pro-flg and increase in low
MW flg following PS) and subsequent urocanic acid formation, which accounts for the decreased
pH. Contrariwise, and despite a lower basal level of SC pH, we found a significant loss in SC
buffering capacity in flaky tail mice following superbase-induced SC alkalization. Our data suggest
that filaggrin processing is implicated in epidermal acidification and epidermal response to PS.
278
STRA6 modulates retinol uptake and cell proliferation in epidermal keratinocytes
C Skazik,1 R Heise,1 Y Marquardt,1 K Czaja,1 HF Merk,1 DR Bickers2 and JM Baron1 1 Department
of Dermatology, University Hospital RWTH, Aachen, Germany and 2 Department of
Dermatology, Columbia University, New York, NY
Retinoids play a key role in cell proliferation and differentiation. Recently STRA6, a multitrans-
membrane domain protein, was identified as a specific membrane receptor for retinol bound to
retinol-binding protein in bovine retinal epithelium cells. To determine whether similar transport
processes take place in human skin cells, we analyzed expression of human STRA6 in normal human
epidermal keratinocytes (NHEK), HaCaT keratinocytes and human dermal fibroblasts. Quantitative
RT-PCR analysis revealed a constitutive expression of STRA6 in these skin cells. STRA6 mRNA and
protein expression was significantly upregulated by ligands of the nuclear retinoic acid receptor
(RAR) e.g. 9-cis-RA or all-trans-RA as well as retinol itself, but expression was not affected by lig-
ands of other class II nuclear receptors. To investigate the influence of STRA6 knockdown on the
physiological function and morphological structure of human skin we established an organotypic
3D skin model employing HaCaT cells with stable knockdown of STRA6 using shRNAs from lentivi-
ral vectors. Cells transduced with lentivirus non-target vector served as controls. Within 7 days the
epidermis in the STRA6 knockdown 3D model showed increased proliferation and significantly
enhanced expression of keratin 16 compared to the control. After 14 days of cell culture the knock-
down 3D model displayed a 3-fold thicker epidermis compared to organotypic models derived from
HaCaT cells transfected with the control vector. HaCaT cells with STRA6 knockdown also revealed
a significantly increased proliferation in monolayer culture experiments. In conclusion, our results
indicate that STRA6 is constitutively expressed in human skin cells and mediates active uptake of
RBP-bound retinol into these cells. This transporter mediated uptake may play an important role in
retinoid signaling in human skin.
282
Integration of Langerhans-like cells into a three-dimensional full-thickness skin model
V Laubach,1 N Zöller,1 M Rossberg,1 K Görg,1 S Kippenberger,1 J Bereiter-Hahn,2 R Kaufmann1
and A Bernd1 1 Dermatology, Venerology and Allergology, J.W. Goethe-University,
Frankfurt/Main, Germany and 2 Kinematic Cell Research Group, J.W. Goethe-University,
Frankfurt/Main, Germany
Langerhans cells (LCs) are immature dendritic cells residing suprabasally within the epidermis. Stud-
ies regarding these cells are somehow hampered by the difficult cultivation in vitro. Here we show
that MUTZ-3 cells, derived from a CD34+ human acute myeloid leukemia, can be differentiated
into Langerhans-like cells in the presence of a cytokine cocktail including GM-CSF, TGF-β1 and
TNF-α. As differentiation markers served the expression of langerin, CD1a, CCR6 and the intracel-
lular presence of Birbeck granules. The aim of this study was to integrate differentiated MUTZ-3 cells
(MUTZ-3-LCs) into a three-dimensional full thickness skin model consisting of primary human ker-
atinocytes and fibroblasts. On top of fibroblast-containing collagen matrix (Henkel AG & Co. KGaA,
Düsseldorf) a mixture of keratinocytes and MUTZ-3-LCs were seeded and cultured for 24 hours.
Subsequently, the models were lifted up to the air liquid interface. Histological evaluation featured
a fully stratified epidermis with all characteristic epidermal strata. Langerin-positive cells were
detected suprabasally within the epidermis indicating that keratinocytes and/or fibroblasts provide
environmental conditions for long-time maintenance of MUTZ-3-LCs. These skin models provide a
relevant research tool to study LC biology in vitro. Particularly, the interactions between LCs and
other skin cells and their contribution in cutaneous immune responses can be investigated.
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IL17 modulates barrier gene expression in human keratinocytes: a new role in psoriasis?
A De Benedetto,1 B Jones,2 M Behrendt,1 I Kuo,1,3 T Yoshida,1 A Ivanov,4 M Elloso2 and LA Beck1
1 Department of Dermatology, University of Rochester Medical Center, Rochester, NY, 2
Centocor R&D, Inc, Malvern, PA, 3 Department of Pathology and Laboratory Medicine,
University of Rochester Medical Center, Rochester, NY and 4 Department of Medicine,
University of Rochester Medical Center, Rochester, NY
Psoriasis is a Th1 and Th17-polarized skin disorder characterized by abnormal keratinocyte differ-
entiation. We evaluated the effect of IL17 on the expression of epidermal barrier proteins important
for the integrity of the stratum corneum (SC) and tight junctions (TJ). Primary human foreskin ker-
atinocytes (PHK) were terminally differentiated in high Ca+2(1.8 mM), serum-free media (DMEM)
for 5 days in the presence of IL17 (10-1000ng/ml). Expression of differentiation markers (filaggrin/FLG,
Loricrin/LOR, and keratin 10/KRT10) as well as TJ proteins (claudin/CLDN1, 4, 23, ZO-1 and
occludin/OCL) were analyzed using a custom made Taqman Low Density Array Card. Data were
expressed as fold change over unstimulated PHK; a 2-wayANOVA test was used for statistical analy-
sis. We evaluated the immunoreactivity of several genes dysregulated by IL17 in lesional and non-
lesional biopsies from subjects with psoriasis (n=5). IL17 significantly inhibited PHK terminal dif-
ferentiation (FLG<0.2 fold over control, P<0.001; KRT10<0.4 fold, P<0.001 and LOR<0.2 fold,
P<0.001) in a dose-dependent fashion. IL17 also down-regulated CLDN1 expression (0.5 fold
[1000ng/ml], P<0.001) while OCL expression was modestly enhanced (1.5 fold [10ng/ml], P<0.05).
The expression of other TJ or adherens junction (E-cadherin and Nectin1) components was unaf-
fected by IL17 treatment. The inhibitory effect of IL17 on PHK was confirmed at the protein level
by Western blot. Reduced immunoreactivity for KRT10, FLG and CLDN1 was observed in psoria-
sis lesions compared to nonlesional samples from the same subjects. In summary, IL17 significantly
inhibited the expression of keratinocyte differentiation markers as well as CLDN1. This data sug-
gests that IL17 might play a direct role in the dedifferentiation characteristic of lesional psoriatic
epithelium.
272
Psoriasis-like skin lesion induced by Raf-MAPK signaling requires Stat3 activation
M Tarutani, K Miyoshi, M Takaishi and S Sano Dematology, Kochi Medical School, Kochi
University, Nankoku, Japan
Raf is one of the downstream effectors of Ras GTPases, and plays a key role in cell proliferation and
differentiation through activation of MAPK. We have previously demonstrated that temporal induc-
tion of Raf in the epidermis of K14-Raf:ER transgenic mice results in development of psoriasis-like
phenotype, including epidermal hyperplasia, lymphocyte and neutrophil infiltrates. It has been
demonstrated that epidermal Stat3 activation was required for psoriasis development, since ker-
atinocytes-specific Stat3 activation in a mouse model demonstrated psoriasis-like phenotype, and
inhibition of Stat3 signaling ameliorated psoriatic lesions. Here, we investigated whether Stat3 sig-
naling was involved in Raf-MAPK-dependent psoriasis-like lesions. Epidermal hyperplasia of K14-
Raf:ER mice following topical tamoxifen application showed Stat3 activation in keratinocytes. We
mated them with epidermis-specific Stat3 null mice (K5-Cre.Stat3f/f). Surprisingly, over-expression
of Raf by tamoxifen treatment in Stat3 deficient background (K14-Raf:ER;K5-Cre.Stat3f/f) demon-
strated greatly attenuated epidermal hyperplasia or dermal cell infitrates, compared to K14-Raf:ER;K5-
Cre.Stat3f/wt mice. Also, up-regulation of psoriasis-associated cytokine profiles, including VEGF,
was not detected in the skin from K14-Raf:ER;K5-Cre.Stat3f/f upon tamoxifen treatment. This result
clearly indicated that Raf-MAPK-dependent psoriatic-skin development required Stat3 signaling in
keratinocytes. Finally, topical treatment of K14-Raf:ER transgenic mice skin with a small Stat3 inhibitor
STA-21 resulted in attenuation of epidermal hyperplasia upon tamoxifen induction. Further analy-
sis of the mechanistic crosstalk of these two important signalings in developing psoriasis is cur-
rently being undertaken.
273
IFNγ inhibits TNFα-induced CTACK/CCL27 production from keratinocytes through EGF recep-
tor signaling pathway in a differentiation dependent manner and CTACK/CCL27 production
in the centrals of psoriatic lesion
M Karakawa,1,2 M Komine,1,2 H Tsuda,1 K Tamaki,2 S Sato2 and M Ohtsuki1 1 Dermatology, Jichi
Medical University, Shimotsuke, Japan and 2 Dermatology, University of Tokyo, Tokyo, Japan
Cutaneous T cell attracting chemokine (CTACK)/CCL27 is a chemokine indispensable in skin inflam-
mation. Its expression is exclusively limited in epidermal keratinocytes, which characterizes the skin
inflammation. CTACK/CCL27 production is induced by TNFα. IFNγ synergistically enhance the
TNFα-induced production of various chemokines. We investigated the effect of IFNγ on TNFα-
induced production of CTACK/CCL27 from keratinocytes and its signaling pathway using cultured
human keratinocytes in vitro. We stimulated keratinocytes by TNFα with or without IFNγ. TNFα
induced, but IFNγ suppressed CTACK/CCL27 production at both mRNA and protein levels. Then
we investigated whether the effect of IFNγ is dependent on the differentiation of keratinocytes.
High confluent culture condition suppressed the inhibitory effect of IFNγ. EGF receptor(EGFR) sig-
naling pathway is usually up-regulated in inflammatory skin diseases such as psoriasis, and its acti-
vation is dependent of the differentiation of keratinocytes. EGFR tyrosine kinase inhibitor completely
reversed the inhibitory effect of IFNγ. IFNγ induced several EGFR ligands in keratinocytes. These
results suggest that IFNγ induces EGFR ligand production and that the EGFR ligands suppress
CTACK/CCL27 production through EGFR. Then we investigated CTACK/CCL27 production in biopsy
specimen from psoriatic lesion using immunohistochemistry. CTACK/CCL27 production is stronger
in the peripheral than in the central of psoriatic lesion. This study indicates that, CTACK/CCL27
play important role in the formation of skin inflammation, and when the inflammation is developed
into maintenance phase. And it is also suggested that inflammation is formed actively at peripheral
of the lesion and maintained stably at the central of the lesion in psoriasis.
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Is the functional skin adaptation complete and competent in infancy?
JW Fluhr,1 R Darlenski,2 J Hachem,3 P Msika,4 C de Belilovsky,5 C Baudouin4 and E Berardesca6
1 Dermatology Department, Charité University Clinic, Berlin, Germany, 2 Department of
Dermatology and Venereology, Medical Faculty, Sofia, Bulgaria, 3 Dermatology Research,
Vrije Universiteit, Brussels, Belgium, 4 Innovation R&D Direction, Laboratoires Expanscience,
Epernon, France, 5 Dermatology Department, Institut Alfred Fournier, Paris, France and 6
Dermatology Department, San Gallicano Dermatological Institute, Rome, Italy
Over the last decade, knowledge on newborn skin physiology has evolved with obvious data but
also controversies. We elucidate the main cutaneous physiological functions in neonate infants.
Skin ‘acid mantle’ is necessary to maintain bacteriological, chemical and mechanical resistance.
After birth, skin surface pH of both full-term and preterm neonates is higher than in adults, and
decreases within the first weeks postpartum. Trans-Epidermal Water Loss (TEWL) is below 10g/m2/h
in term neonates similarly to that of healthy adults, indicating a complete barrier function devel-
opment at birth. Although Stratum Corneum (SC) hydration of term neonates in the first days is low
compared to adults, it increases with time to be similar or even higher (3-48 months). Gestational
age, anatomical site and environment condition influence pH, barrier function and hydration. Preterm
newborns have higher TEWL than term neonates, but complete barrier maturation is generally ful-
filled within 2 to 4 weeks after birth. In the diapers’area, high TEWL and pH were measured asso-
ciated with low SC hydration. Skin blood vessels respond to external stimuli shortly after birth in
term neonates but the blood flow control still matures until 14-17 weeks. This vasculature adapta-
tion can take longer in immature infants. The newborns’ skin is quickly adjusting to the challeng-
ing postpartum environmental conditions. However, some functions continue to develop even
beyond the neonatal period. Based on functional infant skin knowledge and on clinical expertise,
recommendations for skin care of newborns and infants are displayed.
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Aryl hydrocarbon receptor dependent c-kit expression is required for dendritic epidermal T
cell homeostasis in murine skin
S Kadow, B Wingerath, B Jux, S Chmill, J Krutmann, H Weighardt and C Esser IUF-Leibniz
Research Institute for Environmental Medicine, Düsseldorf, Germany
The aryl hydrocarbon receptor (AhR) is a ligand-dependent transcription factor which is critically
involved in tissue development and homeostasis. Recently we had shown in AhR deficient (-/-) mice
that AhR-dependent GMCSF is necessary for normal Langerhans cell (LC) maturation and function.
Here, we analyzed dendritic epidermal T cells (DETC), which are a major source of GMCSF in
murine epidermis. DETC express an invariant γδT cell receptor, which recognizes keratinocyte stress
proteins. They are important for wound healing and participate in barrier function. Using immuno-
histochemistry and flow cytometry, we found that DETC were absent in the epidermis of AhR-/-
mice. DETC were generated at normal frequencies in fetal thymi from AhR-/- mice, and migrated
to the epidermis. However, in contrast to wild-type (WT) DETC, they proliferated less after birth,
and quickly decreased to levels of about 0.5% of epidermal cells by three weeks of age, decreas-
ing further in ageing mice. The few remaining DETC did not develop dendrites, and expressed lower
levels of γδ and CD3. Cross-over depletion and supplementation of DETC in epidermal cultures
from AhR-/- and WT mice showed that DETC-produced GMCSF was important for LC maturation.
In the skin of keratinocyte-specific (K5Cre)-conditional AhR deficient mice, DETC abundance was
normal, indicating that growth factors provided from surrounding keratinocytes are not affected by
AhR-deficiency. However, DETC from AhR-/- mice failed to express c-kit. This tyrosine kinase is a
growth factor for gut γδ T cells, and has putative AhR-responsive promoter elements (ARE). The c-
kit promoter drove a luciferase reporter gene upon AhR-activation. Activity was abrogated after muta-
tion of the ARE elements. We propose that AhR-dependent c-kit expression controls DETC home-
ostasis. To our knowledge this is the first report of a mouse model where DETC, but not peripheral
γδ T cells, are lacking.
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Sunflower oleodistillate: A topical PPAR-alpha (peroxisome proliferator-activated receptors)
agonist developed for atopic dermatitis
C de Belilovsky,1 C Baudouin,2 S Brédif,2 B Chadoutaud3 and P Msika2 1 Dermatology
Department, Institut Alfred Fournier, Paris, France, 2 Innovation R&D Direction, Laboratoires
Expanscience, Epernon, France and 3 Clinreal Online, Toulouse, France
Sunflower Oleodistillate (SO) has proven a triple action on epidermal lipid barrier, cutaneous inflam-
mation and immunological Th2 response, which demonstrates a specific indication in Atopic Der-
matitis (AD) (1). In our experimental studies, SO activates PPARs-alpha in cell model. On human
skin explants, 2% SO formulation induces the synthesis of ceramides x 3 and cholesterol x 2. 2%
SO cream limits the release of inflammatory mediators (TSLP, TARC and RANTES) and enhances
barrier markers expression (filaggrin, kallikrein and betaglucocerebrosidase) on a skin model mim-
icking AD Th2 context. 2% SO formulation reduces TPA-induced inflammation on animal model,
a single application of 2% S0 cream provides significant hydration (capacitance: + 50% H1, +64%
H3, +34% H24), It also significantly decreases TEWL (-18% H4, -21% H8). A Clinical trials open
study on 227 children with mild to moderate AD (30 days) showed a significant decrease of dry-
ness, flaking, itching and redness (-80 to -88%). First randomised comparative study demonstrated
steroid-sparing effect and positive effect on quality-of-life. 86 children (4-48 months) with AD have
been attributed to 5 groups with desonide 0.05% + 2% SO cream (21 days). Similar and significant
improvement of SCORAD (p<0.01) in all groups were demonstrated: 63% to 75% (2). Second ran-
domised comparative study has demonstrated comparable therapeutic properties to a Topical Steroid
among 40 children (mean age 2.3 years), with moderate AD: Significant and similar SCORAD
decrease D7 and D21 (-70%, –75%) (3). The central role of deficient PPARs-alpha has been recently
discovered in the physiopathology of AD. PPAR-alpha agonist properties of 2% SO cream might
explain its short term clinical impact comparable to a topical steroid.
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Expression of the major epidermal antimicrobial peptide, cathelicidin, is regulated by sphin-
gosine-1-phosphate signaling in response to ER stress in keratinocyte
K Park, PM Elias, T Mauro, WM Holleran and Y Uchida Dermatology, Univ. of California, San
Francisco, San Francisco, CA
Although expression of the major epidermal antimicrobial peptide, LL-37/hCAP18, is transcrip-
tionally regulated by the vitamin D receptor (VDR) in a variety of cell types including keratinocytes
(KC), we recently discovered that endoplasmic reticulum (ER) stress upregulates hCAP18 expres-
sion via a previously-unidentified NF-κB-C/EBPα pathway, likely independent from the VDR. Our
recent studies also showed that UV irradiation causes ER stress in KC in parallel with increased pro-
duction of ceramide (Cer) and its metabolites, i.e., sphingosine (SO), and sphingosine-1-phosphate
(S1P), both of which are signaling lipids that regulate cellular proliferation/differentiation/apopto-
sis. Thus, we hypothesize that ER stress stimulates Cer/S1P production, which in turn, regulates
hCAP18 generation. Both cellular Cer, SO, and S1P levels increased under ER stress in KC, while
both exogenous cell permeable C2Cer (N-acetylsphingosine, 7.5 μM) and S1P (1 μM) increased
hCAP18 mRNA/protein expression in KC. Blockade of either CerÇSO or SOÇS1P metabolic con-
version using specific inhibitors of ceramidase (N-oleoylethanolamine [NOE]) or sphingosine kinase
(dimethylsphigosine [DMS]), respectively, attenuates the increase in hCAP18 expression in KC
exposed to thapsigargin (Tg), an ER stressor, as well as to exogenous C2Cer or S1P. Similar to Tg,
exogenous S1P also increased NF-κB transactivity. Moreover, phosphorylation at both Ser21 and
Thr222/226 of the transcriptional factor C/EBPα increased after Tg as well as C2Cer, while NOE
inhibited phosphorylation of both sites. Interestingly, DMS only attenuated Tg- or C2Cer-induced
phosphorylation at Thr sites, suggesting that the Thr222/226 phosphorylation induced by S1P (not
by SO) is required for ER stress-mediated upregulation of hCAP18 expression via S1P-NF-κB in KC.
These studies demonstrate an important novel role for S1P signaling in epidermal innate immune
function in response to external stressors.
291
Cold-induced expression of epidermal differentiation markers
Q Zhou, N Kan, A Karapetyan, M Araya, V Blas, DR Coles and EL Rugg University of California
Irvine, Irvine, CA
The temperature of human skin varies widely depending on body site but rarely reaches 37°C.
Despite the fact that keratinocytes have to survive and function at temperatures below 37°C, little
is known about the effects of cold temperatures on keratinocyte growth and differentiation. The
purpose of this investigation was to determine the effects of low temperature on keratinocyte gene
expression. Human keratinocytes were grown at 37°C (normal culture conditions) or 26°C (the aver-
age temperature of plantar skin) and gene expression was measured using the Affymetrix® GeneChip®
Human Gene 1.0 ST array. Statistically significant differentially expressed genes were identified by
Cyber-T analysis. Keratinocytes grown at 26°C were viable and able to proliferate, albeit at a reduced
rate compared to cells at 37°C. Five hundred and thirty transcripts were increased by at least 2-fold
in cells grown at 26°C, while 600 genes showed a 2-fold or greater decrease in expression. Onto-
logical analysis identified genes involved in epidermal cell differentiation, particularly keratiniza-
tion, as being significantly over-represented among the upregulated transcripts. Genes which showed
increased expression included CDSN, CNFN, SBSN, late cornified envelope proteins (LCE3D and
3E) and several small proline-rich repeat proteins (SPRR1A, 2A, 2B, 2D, 2E, 2G and SPRR3). Expres-
sion of a number of transcription factors involved in the regulation of epidermal development and
differentiation also increased at 26°C (e.g. GATA-3, GRHL3, and OVOL1). Little is known about the
mechanism underlying cold-induced gene expression in mammals but it appears to involve RNA
binding proteins that alter translation and stability of transcripts. The two most characterized cold-
inducible genes are CIRB1 and RBM3; both of these transcripts were increased in the 26°C cul-
tures. These results suggest that genes involved in keratinization are activated by cold temperatures
and raises the possibility that temperature may play a regulatory role in the formation and mainte-
nance of the skin barrier.
293
Normal epidermal barrier function and recovery is controlled by nicotinic acetylcholine recep-
tor activation 
S Droho,1 BJ Curtis1 and KA Radek1,2 1 Burn and Shock Trauma Institute, Loyola University
Medical Center, Maywood, IL and 2 Department of Surgery, Loyola University Medical Center,
Maywood, IL
We examined the effects of activated epidermal nicotinic acetylcholine receptors (nAChRs) on bar-
rier function. Recent evidence suggests psychological stress results in deleterious effects to the antimi-
crobial barrier via activation of nAChRs. These effects include reduced antimicrobial peptide expres-
sion and concomitant increased bacterial susceptibility. Since the antimicrobial and physical skin
barriers are co-dependent, we sought to assess physical cutaneous barrier function following nAChR
activation during stress. Measurements of transepidermal water loss (TEWL) were taken on the dor-
sum of mice that underwent 3 days of psychological stress and received topical treatment with the
specific nAChR antagonist, α-bungarotoxin or vehicle. Experimental mice were compared to
unstressed mice or mice that received topical treatment of nicotine. In addition, we assessed the
ability of mice from each treatment group to recover from a physical disruption of the barrier via
tape stripping. Via HPLC analysis, we found stress increased the levels of endogenous acetyl-
choline (ACh) in skin. Stress and topical treatment of either nicotine or α-bungarotoxin in the absence
of stress causes disruption of the epidermal inside-out barrier. Stress reduces the ability of skin to
maintain barrier homeostasis post-disruption. Although stressed mice receiving the α7 selective
nAChR antagonist α-bungarotoxin show similarly elevated levels of skin ACh, barrier function was
significantly improved, suggesting that α7 nAChR activation maintains normal cutaneous barrier
homeostasis. Defects in barrier seen with direct application of nicotine alone could not be rescued
with α-bungarotoxin, indicating that other nAChR subtypes are critical to barrier maintenance.
Psychological stress, acting at least in part through nAChR signaling, causes deleterious effects on
cutaneous barrier function, suggesting a new mechanism linking barrier function and skin disease.
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Enhancing CoQ10 in the skin for anti aging effect. In vivo study
Y Guerif-Ferreira,1 G Oberto,1 C Pouzet,1 A Berghi,1 C Coquet-Morel,1 K Cucumel,1 C Dal Farra2
and N Domloge1 1 Vincience, ISP Global Skin Research Center, ISP Vincience, Sophia antipo-
lis, France and 2 ISP Corporate Research Center, ISP, Wayne, NJ
Our skin is constantly aggressed by various oxidative stresses: external such as UV radiation and
internal by molecules generated during cell metabolism. Consequently oxidative stresses are rec-
ognized as key factors in skin aging. As CoQ10 is known as a powerful mitochondrial anti-oxidant
and can play an essential role in mitochondrial energy synthesis, we designed a new anti-oxidant
(IV08.004) that acts through CoQ10 induction. Indeed in vitro evaluation of the IV08.004 on human
keratinocytes showed that 1 % of treatment with IV08.004 can enhance CoQ10 in the cells. More-
over formulated IV08.004 was clinically tested to determine its in vivo effects. A 28-day in vivo
double blind study was conducted with IV08.004 compound versus placebo on 10 volunteers. They
applied the inducer-containing cream and placebo cream, twice a day on the crow’s feet (eye
area). In this study, the micro relief of a negative replica was assayed with Quantiline® software.
We calculated all the classical parameters of roughness and we demonstrated a great benefit of the
formulae. When we compared to D28 in the IV08.004-treated side, all the parameters of roughness
decreased compared to placebo, and all these measurements are significant Wilcoxon test. More-
over the benefit of the formulae was visibly on pictures of the crow’s feet. Furthermore, 60% of
users perceived an improvement in disappearance of wrinkles, the glow, firmness and tone. In con-
clusion, these studies confirm the interest in enhancing skin CoQ10 for its anti aging effect.
290
ER stress stimulates keratinocyte cathelicidin expression via a novel NF-κB C/EBPα depend-
ent pathway
K Park,1 PM Elias,1 Y Oda,2 T Mauro,1 WM Holleran1 and Y Uchida1 1 Dermatology, Univ. of
California, San Francisco, San Francisco, CA and 2 Medicine & Endocrinology, Univ. of
California, San Francisco, San Francisco, CA
LL-37, the carboxyterminal fragment of human cathelicidin protein (hCAP18), is a major epidermal
antimicrobial peptide. LL-37/hCAP18 expression increases in keratinocytes (KC) in response to exter-
nal perturbants that potentially compromise antimicrobial defense. We hypothesized that endo-
plasmic reticulum (ER) stress is a consequence of these external perturbations, and demonstrated
that ER stress upregulates hCAP18 production, but not due to the well-established vitamin D recep-
tor (VDR) dependent mechanism in KC. Here, we characterized the transcriptional mechanisms for
hCAP18 expression in KC following ER stress. Again hCAP18 mRNA/protein expression increased
in both cultured primary normal human and HaCaT KC treated with two specific, structurally and
mechanistically distinct ER stressors, thapsigargin (Tg) and tunicamycin (Tm). Increased transactiv-
ity of NF-κB (that has been shown to regulate multiple cellular responses, including ER stress) was
evident in KC exposed to ER stressors in parallel with elevated hCAP18 expression. Conversely,
blockade of NF-κB activity using specific inhibitors (quinazoline and BAY11-7082 [BAY]) attenu-
ated the expected ER stress-induced increase in hCAP18 mRNA/protein expression. In addition,
siRNA suppression of the transcriptional factor C/EBPα (but not C/EBPε) attenuated the ER stress-
induced increase in hCAP18 expression. Moreover, Tg increased phosphorylation at both Ser21 and
Thr222/226 of C/EBPα, while blockade of NF-κB activity by BAY or MAP kinase activation (by
U0126/SB201290) diminished both Tg-induced phosphorylation of C/EBPα and hCAP18 expres-
sion. Finally, topical Tg increased the production of the murine homologue of hCAP18 in mouse
epidermis. These results indicate that ER stress increases hCAP18 expression via NF-κB-C/EBPα acti-
vation, independent of VDR, and illuminate a role for ER stress in regulating epidermal innate immune
function in response to external stressors.
294
Comparison between keratinocytes monolayer culture and keratinocytes/fibroblasts co-cul-
ture, after exposure to chemicals treatment
I Garcia, M Arcioni, C Pouzet, M Brulas, E Bauza and N Domloge Global Skin Research Center,
ISP Vincience, Sophia antipolis, France
New EU directives on animal testing pushed cosmetic manufacturers to invest in research and devel-
opment of in vitro methods for the safety assessment of their new molecules. Great efforts have been
made, and many tests have been validated by ECVAM. However, all the models approved for skin
irritation testing, are built with only one cell type. Skin irritation is a complex mechanism implying
several cytokines released by many cell types. Then, it was of great interest to compare the per-
formances of a simple HaCaT cell culture model versus HaCaT and fibroblasts cells co-culture. To
that purpose, we first co-cultured HaCaT cells and fibroblasts in the presence of different culture
media. The stress induced by reference chemicals (irritants, sensitizers, long term toxics) on the two
models, was evaluated by MTT cell viability assay of each cell population, followed by IL-1alpha
quantification in the extracellular medium. In untreated conditions, no difference in viability was
observed between HaCaT cultured alone and co-cultured. ELISA assay revealed that co-cultured
HaCaT cells released less IL-1alpha compared to HaCaT cell cultured alone. Moreover, this decrease
of released IL-1 alpha in the co-culture model was also observed after treatment with chemical sub-
stances, known to induce irritation. Furthermore, after 24h of these chemicals application, co-cul-
tured HaCaT cells viability seems slightly higher than HaCaT cells cultured alone, which suggests
an epithelial-mesenchymal cell interaction between HaCaT cells and fibroblast that could make
the former cell line less vulnerable. This also indicates that HaCaT and Fibroblasts co-culture model
is not enough sensitive to be used as skin irritancy assay.
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A dietary anthocyanidin delphinidin promotes epidermal differentiation and activation of cas-
pase-14 in human epidermal keratinocytes and reconstituted skin
F Afaq,1 DN Syed,2 N Khan2 and H Mukhtar2 1 Dermatology, University of Alabama,
Birmingham, AL and 2 Dermatology, University of Wisconsin, Madison, WI
Agents that lead to differentiation of epidermal keratinocytes may have therapeutic effects against
many hyperproliferative skin disorders including psoriasis. Thus, identifying naturally occurring anti-
inflammatory agents which possess the ability to induce epidermal differentiation, activate cas-
pase-14 processing and inhibit hyperproliferation could possess therapeutic efficay for psoriasis.
One such agent, delphinidin, an anthocyanidin abundantly present in pigmented fruits and veg-
etables, possesses anti-inflammatory and anti-proliferative activities. Delphinidin treatment (10-40
μM; 24-48 h) of normal human epidermal keratinocytes (NHEK) induced keratinocyte differentia-
tion. Immunoblot and RT-PCR analyses demonstrated that the treatment of NHEK with delphinidin
resulted in increased protein and mRNA expression of (i) caspase-14, (ii) involucrin, and (iii) trans-
glutaminase-1. Furthermore, delphinidin treatment of NHEK increased the protein expression of AP-
1 subunits, NF-κB/p50 and RelB. Importantly, delphinidin under identical treatment conditions did
not induce apoptosis as evident by lack of effects on: (i) activation of caspases-3,-8, and -9, (ii) cleav-
age of PARP, (iii) protein expression of Bcl-2 family, and (iv) cytochrome c release. Delphinidin treat-
ment of human reconstituted skin (10-20 μM) enforced the program of terminal differentiation result-
ing in (i) more rapid formation of cornified envelopes, (ii) fewer intermediate cell layers, (iii) earlier
development of cornified layers, and (iv) increased processing of caspase-14 into catalytically active
subunits p10 and p20. Overall, our study show that delphinidin promotes epidermal differentia-
tion, formation of cornified envelopes and activation of caspase-14 that is critical for skin regener-
ation and maintenance of normal barrier function. Delphinidin could be a promising agent for the
treatment of psoriasis and other hyperproliferative skin disorders.
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Age-related NADH oxidase catalyzed oxidation and cross-linking of skin proteins
C Meadows,2 DG Kern,1 ZD Draelos,3 HE Knaggs,1 DM Morré2 and DJ Morré2 1 Nu SKin
Enterprises, Inc., Provo, UT, 2 NOX Technologies, Inc., West Lafayette, IN and 3 Dermatology
Consulting Services, High Point, NC
Age-related NADH Oxidase (arNOX), a hydroquinone oxidase of the cell surface and capable of
superoxide generation, appears around 30 years of age and increases with age thereafter. Its
ectodomain is shed into body fluids including sera, saliva and those permeating the extracellular
supporting matrices important to skin health and appearance. Superoxide formation is measured
spectrophotometrically from the reduction of ferricytochrome c. A role of arNOX in skin health is
indicated as well from measurements of autofluorescence of advanced glycation endproducts that
correlate with epidermal arNOX activity. To demonstrate protein cross-linking a fluorescence-labeled
analog of tyrosine, tyramine, that reacts with proteins carrying arNOX-generated tyrosyl radicals,
was used to demonstrate arNOX-catalyzed protein cross-linking. The assay demonstrated arNOX-
induced dityrosine formation with human collagen and elastin and with intact human embryo fibrob-
lasts and frozen sections from epidermal punch biopsies. The oxidative damage was partially inhib-
ited by superoxide dismutase and arNOX-specific peptide antibodies and inhibitors. Remaining
oxidative damage may be due to direct oxidation by arNOX not involving superoxide. The findings
support a role for arNOX as a major source of damage leading to oxidation and cross-linking of
skin proteins.
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Impact of Gantrez S97 BF on ex vivo skin barrier quality
M Bonnans,1 G Bressier,1 N Esselin,1 A Lushen,2 H Fares,2 N Garcia,1 C Dal Farra2 and
N Domloge1 1 Vincience, ISP Global Skin Research Center, ISP Vincience, Sophia Antipolis,
France and 2 ISP corporate Research Center, ISP, Wayne, NJ
Facial chemical peeling is among most used skin rejuvenation tools. However, peeling chemicals
are known to induce, in addition to epidermal desquamation, irritation and barrier damage. Hence,
we were interested in investigating a special new superficial chemical peel: Gantrez S97 BF. From
this perspective, we evaluated the effects of 1% and 5% product solutions on ex vivo skin mor-
phology and cutaneous barrier quality. We first examined the morphology of the skin, by Hema-
toxylin and Eosin staining, after 3-hours treatment with Gantrez S97 BF solutions, and after 6 days
of recovery. We noticed no morphological alteration after treatments but better renewal after 6-
days culture in Gantrez S97 BF-treated skin compared to placebo-treated skin. We then checked
epidermal barrier proteins and lipids after Gantrez S97 BF treatments, by lipid staining and corni-
fied envelope proteins immunostainings such as involucrin, claudin-1 and kallikrein-7. Lipid Nile
red staining and involucrin immunostaining appeared unchanged after Gantrez S97 BF treatments.
However, the claudin-1 tight junction protein immunostaining exhibited less intensity after 1% and
5% Gantrez S97 BF treatments compared to placebo. In the same way, kallikrein-7, a chymotrypsin-
like enzyme responsible for the desquamation, appeared to be enhanced by the product treatments.
Hence, Gantrez S97 BF treatments, in contrary to current peelings which alter and damage super-
ficial layers of the epidermis, seem to selectively stimulate upper epidermal junctions degradation,
thus inducing gentle desquamation with consequent better epidermis regeneration. Thereby, Gantrez
S97 BF is of interest in superficial peelings.
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siRNA-induced survivin deficiency promotes mitotic catastrophe events in human keratinocyte
stem cells
F Labarrade,1 J Botto,1 C Dal Farra2 and N Domloge1 1 ISP Global Skin Research Center, ISP
VINCIENCE, Sophia Antipolis, France and 2 ISP Corporate Research Center, ISP, Wayne, NJ
The constant renewal of cutaneous epidermis is supported by cellular proliferation and differentia-
tion of specialized somatic stem cells located in the basal epidermal layer. In this process, the con-
trol of the mitosis is critical. Catastrophic mitoses occur when a combination of DNA damage,
deranged spindle assembly and deficient cell-cycle checkpoints, triggers an attempt of premature
or aberrant chromosome segregation. This combination of events prevents to arrest the cell cycle
before mitosis, impeding any possibility of repairing catastrophic events. Mitotic catastrophe (MC)
lead to abnormal configurations and chromosomes arrangements. Survivin, a member of the Chro-
mosomal Passenger Complex, is an important regulator of cell division and controls several mitotic
events including microtubule organization, spindle assembly checkpoint and cytokinesis. Deregu-
lation of survivin level is associated with severe mitotic defects, including hyperduplication of cen-
trosomes and aberrant spindle assembly. In this study, we artificially triggered an increase in cata-
strophic mitoses by applying a survivin-specific siRNA on cultured human keratinocytes (NHK) or
on cellular fraction enriched in keratinocytes stem cells (KSCs). Although the basal occurrence of
MC-like events was low, survivin-specific siRNA increased MC phenotype in cells, with chromo-
somal segregation defects and polylobed nuclei. In both NHK and KSCs, the effect of the survivin-
specific siRNA could be reversed by pre-treatment of the cells with IV08.009, a compound devel-
oped to regulate survivin expression. In conclusion, the limitation of catastrophic mitoses could
preserve the skin KSC pool which sustains the epidermal renewal, and in addition support differ-
entiating keratinocytes which express less survivin than the KSCs.
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CoQ10-Binding Protein and PDSS1 play an essential role in epidermal anti-oxidant defences
L Bergeron,1 L Mur,1 A Lebleu,1 C Serre,1 C Plaza,1 A Fuet,1 J Botto,1 C Dal Farra2 and N Domloge1
1 ISP Global Skin Research Center, ISP VIncience, Sophia Antipolis, France and 2 ISP
Corporate Research center, ISP, Wayne, NJ
The Mitochondrial Respiratory Chain (MRC) consisting of four multisubunit complexes, collects
metabolites mainly from the Krebs cycle, from pyruvate oxidation, amino-acid and fatty acid catab-
olism, to finally synthesize ATP. During this process, toxic Reactive Oxygen Species (ROS) are pro-
duced and contributes to aging side-effects. The coenzyme Q10 (Q10 ubiquinone) plays an essen-
tial role in the MRC as an electron carrier and is the main endogenous lipid-soluble antioxidant with
a strong implication in preventing oxidation of proteins, lipids and DNA. Humans possess a
decaprenyl diphosphate synthase composed of PDSS1 and PDSS2, which produces Q10 ubiquinone,
and the protein COQ10B serves as a chaperone in this process. In order to study the role of Q10
ubiquinone, COQ10B and PDSS1 in the antioxidant protection of skin, we investigated the effect
of IV08.004, a newly developed biofunctional for this purpose. Immunofluorescent detection of
CoQ10B in primary human keratinocytes and in ex vivo human skin showed an increase in CoQ10B
expression after IV08.004 treatment. Moreover, CoQ10B expression was also restored in human
skin after H2O2 oxidative stress, highlighting a possible role of CoQ10B in preserving the skin from
oxidative stress. Finally, we studied the expression of PDSS1 in human keratinocytes and fibroblasts
by western-blotting. IV08.004 treatment enhanced PDSS1 expression, suggesting a role in stimu-
lating key enzymes involved in coenzyme Q10 synthesis in skin. In conclusion, PDSS1, Q10
ubiquinone and CoQ10B seem to act together for protecting the skin from oxidative damage, and
that an efficient modulation of their expression may help the natural antioxidant potential of the
skin.
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Cathelicidin and β-defensin 1 antimicrobial peptides expression in keratinocytes and in human
skin
L Mur,1 C Plaza,1 G Menon,2 J Botto,1 C Dal Farra2 and N Domloge1 1 ISP Global Skin Reseach
Center, ISP Vincience, Sophia Antipolis, France and 2 ISP Corporate Research Center, ISP,
Wayne, NJ
The skin comes into direct contact with external environment and is exposed to numerous micro-
bial pathogens. To protect the organism against bacteria, fungi and viral pathogens). Keratinocytes
are capable of constitutively expressing a wide variety of gene-encoded Antimicrobial Peptides
(AMPs) such as human epithelial β-Defensins (DEFBs) and Cathelicidin (LL-37) which are broad-
spectrum cationic mediators of the nonspecific innate immune system, with distinct and overlap-
ping anti-microbial activity. Only DEFB1, DEFB2 and DEFB3 are expressed in the skin; the latter
two being possibly upregulated in response to inflammation. Besides DEFBs, the human Catheli-
cidin Antimicrobial Protein hCAP18 has the capacity to kill a wide variety of microbes through its
carboxy-terminal peptidic fragment LL-37 and moreover modulates the immune response. Here
we present, the effect of IV10.004, a compound targeting AMPs production, on the expression of
DEFB1 and LL-37 in cultured human keratinocytes and in ex vivo skin. Immunofluorescence detec-
tion showed an increase in DEFB1 and LL-37 expression in NHK either treated with vitamin D3,
known to induce AMPs expression, or with IV10.004. In ex vivo skin, LL-37 was found expressed
only in the stratum corneum whereas DEFB1 was localized into supra-basal layers with a concen-
tration gradient. IV10.004 treatment increased both hBD1 and LL-37 expression in ex vivo skin,
which reflect enhanced antimicrobial properties of the human epidermis. In conclusion, the mod-
ulation of the expression of Antimicrobial Peptides such as DEFBs and LL-37 could strengthen the
natural ability of the skin to regulate the microbial flora. Moreover, such specific modulation could
be of interest in atopic dermatitis, in which cathelicidin is suppressed; or in rosacea where cathe-
licidin peptides are abnormally processed.
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Expression of the major epidermal antimicrobial peptide, cathelicidin, is regulated by sphin-
gosine-1-phosphate signaling in response to ER stress in keratinocyte
K Park, PM Elias, T Mauro, WM Holleran and Y Uchida Dermatology, Univ. of California, San
Francisco, San Francisco, CA
Although expression of the major epidermal antimicrobial peptide, LL-37/hCAP18, is transcrip-
tionally regulated by the vitamin D receptor (VDR) in a variety of cell types including keratinocytes
(KC), we recently discovered that endoplasmic reticulum (ER) stress upregulates hCAP18 expres-
sion via a previously-unidentified NF-κB-C/EBPα pathway, likely independent from the VDR. Our
recent studies also showed that UV irradiation causes ER stress in KC in parallel with increased pro-
duction of ceramide (Cer) and its metabolites, i.e., sphingosine (SO), and sphingosine-1-phosphate
(S1P), both of which are signaling lipids that regulate cellular proliferation/differentiation/apopto-
sis. Thus, we hypothesize that ER stress stimulates Cer/S1P production, which in turn, regulates
hCAP18 generation. Both cellular Cer, SO, and S1P levels increased under ER stress in KC, while
both exogenous cell permeable C2Cer (N-acetylsphingosine, 7.5 μM) and S1P (1 μM) increased
hCAP18 mRNA/protein expression in KC. Blockade of either CerÇSO or SOÇS1P metabolic con-
version using specific inhibitors of ceramidase (N-oleoylethanolamine [NOE]) or sphingosine kinase
(dimethylsphigosine [DMS]), respectively, attenuates the increase in hCAP18 expression in KC
exposed to thapsigargin (Tg), an ER stressor, as well as to exogenous C2Cer or S1P. Similar to Tg,
exogenous S1P also increased NF-κB transactivity. Moreover, phosphorylation at both Ser21 and
Thr222/226 of the transcriptional factor C/EBPα increased after Tg as well as C2Cer, while NOE
inhibited phosphorylation of both sites. Interestingly, DMS only attenuated Tg- or C2Cer-induced
phosphorylation at Thr sites, suggesting that the Thr222/226 phosphorylation induced by S1P (not
by SO) is required for ER stress-mediated upregulation of hCAP18 expression via S1P-NF-κB in KC.
These studies demonstrate an important novel role for S1P signaling in epidermal innate immune
function in response to external stressors.
291
Cold-induced expression of epidermal differentiation markers
Q Zhou, N Kan, A Karapetyan, M Araya, V Blas, DR Coles and EL Rugg University of California
Irvine, Irvine, CA
The temperature of human skin varies widely depending on body site but rarely reaches 37°C.
Despite the fact that keratinocytes have to survive and function at temperatures below 37°C, little
is known about the effects of cold temperatures on keratinocyte growth and differentiation. The
purpose of this investigation was to determine the effects of low temperature on keratinocyte gene
expression. Human keratinocytes were grown at 37°C (normal culture conditions) or 26°C (the aver-
age temperature of plantar skin) and gene expression was measured using the Affymetrix® GeneChip®
Human Gene 1.0 ST array. Statistically significant differentially expressed genes were identified by
Cyber-T analysis. Keratinocytes grown at 26°C were viable and able to proliferate, albeit at a reduced
rate compared to cells at 37°C. Five hundred and thirty transcripts were increased by at least 2-fold
in cells grown at 26°C, while 600 genes showed a 2-fold or greater decrease in expression. Onto-
logical analysis identified genes involved in epidermal cell differentiation, particularly keratiniza-
tion, as being significantly over-represented among the upregulated transcripts. Genes which showed
increased expression included CDSN, CNFN, SBSN, late cornified envelope proteins (LCE3D and
3E) and several small proline-rich repeat proteins (SPRR1A, 2A, 2B, 2D, 2E, 2G and SPRR3). Expres-
sion of a number of transcription factors involved in the regulation of epidermal development and
differentiation also increased at 26°C (e.g. GATA-3, GRHL3, and OVOL1). Little is known about the
mechanism underlying cold-induced gene expression in mammals but it appears to involve RNA
binding proteins that alter translation and stability of transcripts. The two most characterized cold-
inducible genes are CIRB1 and RBM3; both of these transcripts were increased in the 26°C cul-
tures. These results suggest that genes involved in keratinization are activated by cold temperatures
and raises the possibility that temperature may play a regulatory role in the formation and mainte-
nance of the skin barrier.
293
Normal epidermal barrier function and recovery is controlled by nicotinic acetylcholine recep-
tor activation 
S Droho,1 BJ Curtis1 and KA Radek1,2 1 Burn and Shock Trauma Institute, Loyola University
Medical Center, Maywood, IL and 2 Department of Surgery, Loyola University Medical Center,
Maywood, IL
We examined the effects of activated epidermal nicotinic acetylcholine receptors (nAChRs) on bar-
rier function. Recent evidence suggests psychological stress results in deleterious effects to the antimi-
crobial barrier via activation of nAChRs. These effects include reduced antimicrobial peptide expres-
sion and concomitant increased bacterial susceptibility. Since the antimicrobial and physical skin
barriers are co-dependent, we sought to assess physical cutaneous barrier function following nAChR
activation during stress. Measurements of transepidermal water loss (TEWL) were taken on the dor-
sum of mice that underwent 3 days of psychological stress and received topical treatment with the
specific nAChR antagonist, α-bungarotoxin or vehicle. Experimental mice were compared to
unstressed mice or mice that received topical treatment of nicotine. In addition, we assessed the
ability of mice from each treatment group to recover from a physical disruption of the barrier via
tape stripping. Via HPLC analysis, we found stress increased the levels of endogenous acetyl-
choline (ACh) in skin. Stress and topical treatment of either nicotine or α-bungarotoxin in the absence
of stress causes disruption of the epidermal inside-out barrier. Stress reduces the ability of skin to
maintain barrier homeostasis post-disruption. Although stressed mice receiving the α7 selective
nAChR antagonist α-bungarotoxin show similarly elevated levels of skin ACh, barrier function was
significantly improved, suggesting that α7 nAChR activation maintains normal cutaneous barrier
homeostasis. Defects in barrier seen with direct application of nicotine alone could not be rescued
with α-bungarotoxin, indicating that other nAChR subtypes are critical to barrier maintenance.
Psychological stress, acting at least in part through nAChR signaling, causes deleterious effects on
cutaneous barrier function, suggesting a new mechanism linking barrier function and skin disease.
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Enhancing CoQ10 in the skin for anti aging effect. In vivo study
Y Guerif-Ferreira,1 G Oberto,1 C Pouzet,1 A Berghi,1 C Coquet-Morel,1 K Cucumel,1 C Dal Farra2
and N Domloge1 1 Vincience, ISP Global Skin Research Center, ISP Vincience, Sophia antipo-
lis, France and 2 ISP Corporate Research Center, ISP, Wayne, NJ
Our skin is constantly aggressed by various oxidative stresses: external such as UV radiation and
internal by molecules generated during cell metabolism. Consequently oxidative stresses are rec-
ognized as key factors in skin aging. As CoQ10 is known as a powerful mitochondrial anti-oxidant
and can play an essential role in mitochondrial energy synthesis, we designed a new anti-oxidant
(IV08.004) that acts through CoQ10 induction. Indeed in vitro evaluation of the IV08.004 on human
keratinocytes showed that 1 % of treatment with IV08.004 can enhance CoQ10 in the cells. More-
over formulated IV08.004 was clinically tested to determine its in vivo effects. A 28-day in vivo
double blind study was conducted with IV08.004 compound versus placebo on 10 volunteers. They
applied the inducer-containing cream and placebo cream, twice a day on the crow’s feet (eye
area). In this study, the micro relief of a negative replica was assayed with Quantiline® software.
We calculated all the classical parameters of roughness and we demonstrated a great benefit of the
formulae. When we compared to D28 in the IV08.004-treated side, all the parameters of roughness
decreased compared to placebo, and all these measurements are significant Wilcoxon test. More-
over the benefit of the formulae was visibly on pictures of the crow’s feet. Furthermore, 60% of
users perceived an improvement in disappearance of wrinkles, the glow, firmness and tone. In con-
clusion, these studies confirm the interest in enhancing skin CoQ10 for its anti aging effect.
290
ER stress stimulates keratinocyte cathelicidin expression via a novel NF-κB C/EBPα depend-
ent pathway
K Park,1 PM Elias,1 Y Oda,2 T Mauro,1 WM Holleran1 and Y Uchida1 1 Dermatology, Univ. of
California, San Francisco, San Francisco, CA and 2 Medicine & Endocrinology, Univ. of
California, San Francisco, San Francisco, CA
LL-37, the carboxyterminal fragment of human cathelicidin protein (hCAP18), is a major epidermal
antimicrobial peptide. LL-37/hCAP18 expression increases in keratinocytes (KC) in response to exter-
nal perturbants that potentially compromise antimicrobial defense. We hypothesized that endo-
plasmic reticulum (ER) stress is a consequence of these external perturbations, and demonstrated
that ER stress upregulates hCAP18 production, but not due to the well-established vitamin D recep-
tor (VDR) dependent mechanism in KC. Here, we characterized the transcriptional mechanisms for
hCAP18 expression in KC following ER stress. Again hCAP18 mRNA/protein expression increased
in both cultured primary normal human and HaCaT KC treated with two specific, structurally and
mechanistically distinct ER stressors, thapsigargin (Tg) and tunicamycin (Tm). Increased transactiv-
ity of NF-κB (that has been shown to regulate multiple cellular responses, including ER stress) was
evident in KC exposed to ER stressors in parallel with elevated hCAP18 expression. Conversely,
blockade of NF-κB activity using specific inhibitors (quinazoline and BAY11-7082 [BAY]) attenu-
ated the expected ER stress-induced increase in hCAP18 mRNA/protein expression. In addition,
siRNA suppression of the transcriptional factor C/EBPα (but not C/EBPε) attenuated the ER stress-
induced increase in hCAP18 expression. Moreover, Tg increased phosphorylation at both Ser21 and
Thr222/226 of C/EBPα, while blockade of NF-κB activity by BAY or MAP kinase activation (by
U0126/SB201290) diminished both Tg-induced phosphorylation of C/EBPα and hCAP18 expres-
sion. Finally, topical Tg increased the production of the murine homologue of hCAP18 in mouse
epidermis. These results indicate that ER stress increases hCAP18 expression via NF-κB-C/EBPα acti-
vation, independent of VDR, and illuminate a role for ER stress in regulating epidermal innate immune
function in response to external stressors.
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Comparison between keratinocytes monolayer culture and keratinocytes/fibroblasts co-cul-
ture, after exposure to chemicals treatment
I Garcia, M Arcioni, C Pouzet, M Brulas, E Bauza and N Domloge Global Skin Research Center,
ISP Vincience, Sophia antipolis, France
New EU directives on animal testing pushed cosmetic manufacturers to invest in research and devel-
opment of in vitro methods for the safety assessment of their new molecules. Great efforts have been
made, and many tests have been validated by ECVAM. However, all the models approved for skin
irritation testing, are built with only one cell type. Skin irritation is a complex mechanism implying
several cytokines released by many cell types. Then, it was of great interest to compare the per-
formances of a simple HaCaT cell culture model versus HaCaT and fibroblasts cells co-culture. To
that purpose, we first co-cultured HaCaT cells and fibroblasts in the presence of different culture
media. The stress induced by reference chemicals (irritants, sensitizers, long term toxics) on the two
models, was evaluated by MTT cell viability assay of each cell population, followed by IL-1alpha
quantification in the extracellular medium. In untreated conditions, no difference in viability was
observed between HaCaT cultured alone and co-cultured. ELISA assay revealed that co-cultured
HaCaT cells released less IL-1alpha compared to HaCaT cell cultured alone. Moreover, this decrease
of released IL-1 alpha in the co-culture model was also observed after treatment with chemical sub-
stances, known to induce irritation. Furthermore, after 24h of these chemicals application, co-cul-
tured HaCaT cells viability seems slightly higher than HaCaT cells cultured alone, which suggests
an epithelial-mesenchymal cell interaction between HaCaT cells and fibroblast that could make
the former cell line less vulnerable. This also indicates that HaCaT and Fibroblasts co-culture model
is not enough sensitive to be used as skin irritancy assay.
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SID11_Abstracts-5  2/28/11  9:27 AM  Page S49
ABSTRACTS
283
A dietary anthocyanidin delphinidin promotes epidermal differentiation and activation of cas-
pase-14 in human epidermal keratinocytes and reconstituted skin
F Afaq,1 DN Syed,2 N Khan2 and H Mukhtar2 1 Dermatology, University of Alabama,
Birmingham, AL and 2 Dermatology, University of Wisconsin, Madison, WI
Agents that lead to differentiation of epidermal keratinocytes may have therapeutic effects against
many hyperproliferative skin disorders including psoriasis. Thus, identifying naturally occurring anti-
inflammatory agents which possess the ability to induce epidermal differentiation, activate cas-
pase-14 processing and inhibit hyperproliferation could possess therapeutic efficay for psoriasis.
One such agent, delphinidin, an anthocyanidin abundantly present in pigmented fruits and veg-
etables, possesses anti-inflammatory and anti-proliferative activities. Delphinidin treatment (10-40
μM; 24-48 h) of normal human epidermal keratinocytes (NHEK) induced keratinocyte differentia-
tion. Immunoblot and RT-PCR analyses demonstrated that the treatment of NHEK with delphinidin
resulted in increased protein and mRNA expression of (i) caspase-14, (ii) involucrin, and (iii) trans-
glutaminase-1. Furthermore, delphinidin treatment of NHEK increased the protein expression of AP-
1 subunits, NF-κB/p50 and RelB. Importantly, delphinidin under identical treatment conditions did
not induce apoptosis as evident by lack of effects on: (i) activation of caspases-3,-8, and -9, (ii) cleav-
age of PARP, (iii) protein expression of Bcl-2 family, and (iv) cytochrome c release. Delphinidin treat-
ment of human reconstituted skin (10-20 μM) enforced the program of terminal differentiation result-
ing in (i) more rapid formation of cornified envelopes, (ii) fewer intermediate cell layers, (iii) earlier
development of cornified layers, and (iv) increased processing of caspase-14 into catalytically active
subunits p10 and p20. Overall, our study show that delphinidin promotes epidermal differentia-
tion, formation of cornified envelopes and activation of caspase-14 that is critical for skin regener-
ation and maintenance of normal barrier function. Delphinidin could be a promising agent for the
treatment of psoriasis and other hyperproliferative skin disorders.
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Age-related NADH oxidase catalyzed oxidation and cross-linking of skin proteins
C Meadows,2 DG Kern,1 ZD Draelos,3 HE Knaggs,1 DM Morré2 and DJ Morré2 1 Nu SKin
Enterprises, Inc., Provo, UT, 2 NOX Technologies, Inc., West Lafayette, IN and 3 Dermatology
Consulting Services, High Point, NC
Age-related NADH Oxidase (arNOX), a hydroquinone oxidase of the cell surface and capable of
superoxide generation, appears around 30 years of age and increases with age thereafter. Its
ectodomain is shed into body fluids including sera, saliva and those permeating the extracellular
supporting matrices important to skin health and appearance. Superoxide formation is measured
spectrophotometrically from the reduction of ferricytochrome c. A role of arNOX in skin health is
indicated as well from measurements of autofluorescence of advanced glycation endproducts that
correlate with epidermal arNOX activity. To demonstrate protein cross-linking a fluorescence-labeled
analog of tyrosine, tyramine, that reacts with proteins carrying arNOX-generated tyrosyl radicals,
was used to demonstrate arNOX-catalyzed protein cross-linking. The assay demonstrated arNOX-
induced dityrosine formation with human collagen and elastin and with intact human embryo fibrob-
lasts and frozen sections from epidermal punch biopsies. The oxidative damage was partially inhib-
ited by superoxide dismutase and arNOX-specific peptide antibodies and inhibitors. Remaining
oxidative damage may be due to direct oxidation by arNOX not involving superoxide. The findings
support a role for arNOX as a major source of damage leading to oxidation and cross-linking of
skin proteins.
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Impact of Gantrez S97 BF on ex vivo skin barrier quality
M Bonnans,1 G Bressier,1 N Esselin,1 A Lushen,2 H Fares,2 N Garcia,1 C Dal Farra2 and
N Domloge1 1 Vincience, ISP Global Skin Research Center, ISP Vincience, Sophia Antipolis,
France and 2 ISP corporate Research Center, ISP, Wayne, NJ
Facial chemical peeling is among most used skin rejuvenation tools. However, peeling chemicals
are known to induce, in addition to epidermal desquamation, irritation and barrier damage. Hence,
we were interested in investigating a special new superficial chemical peel: Gantrez S97 BF. From
this perspective, we evaluated the effects of 1% and 5% product solutions on ex vivo skin mor-
phology and cutaneous barrier quality. We first examined the morphology of the skin, by Hema-
toxylin and Eosin staining, after 3-hours treatment with Gantrez S97 BF solutions, and after 6 days
of recovery. We noticed no morphological alteration after treatments but better renewal after 6-
days culture in Gantrez S97 BF-treated skin compared to placebo-treated skin. We then checked
epidermal barrier proteins and lipids after Gantrez S97 BF treatments, by lipid staining and corni-
fied envelope proteins immunostainings such as involucrin, claudin-1 and kallikrein-7. Lipid Nile
red staining and involucrin immunostaining appeared unchanged after Gantrez S97 BF treatments.
However, the claudin-1 tight junction protein immunostaining exhibited less intensity after 1% and
5% Gantrez S97 BF treatments compared to placebo. In the same way, kallikrein-7, a chymotrypsin-
like enzyme responsible for the desquamation, appeared to be enhanced by the product treatments.
Hence, Gantrez S97 BF treatments, in contrary to current peelings which alter and damage super-
ficial layers of the epidermis, seem to selectively stimulate upper epidermal junctions degradation,
thus inducing gentle desquamation with consequent better epidermis regeneration. Thereby, Gantrez
S97 BF is of interest in superficial peelings.
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siRNA-induced survivin deficiency promotes mitotic catastrophe events in human keratinocyte
stem cells
F Labarrade,1 J Botto,1 C Dal Farra2 and N Domloge1 1 ISP Global Skin Research Center, ISP
VINCIENCE, Sophia Antipolis, France and 2 ISP Corporate Research Center, ISP, Wayne, NJ
The constant renewal of cutaneous epidermis is supported by cellular proliferation and differentia-
tion of specialized somatic stem cells located in the basal epidermal layer. In this process, the con-
trol of the mitosis is critical. Catastrophic mitoses occur when a combination of DNA damage,
deranged spindle assembly and deficient cell-cycle checkpoints, triggers an attempt of premature
or aberrant chromosome segregation. This combination of events prevents to arrest the cell cycle
before mitosis, impeding any possibility of repairing catastrophic events. Mitotic catastrophe (MC)
lead to abnormal configurations and chromosomes arrangements. Survivin, a member of the Chro-
mosomal Passenger Complex, is an important regulator of cell division and controls several mitotic
events including microtubule organization, spindle assembly checkpoint and cytokinesis. Deregu-
lation of survivin level is associated with severe mitotic defects, including hyperduplication of cen-
trosomes and aberrant spindle assembly. In this study, we artificially triggered an increase in cata-
strophic mitoses by applying a survivin-specific siRNA on cultured human keratinocytes (NHK) or
on cellular fraction enriched in keratinocytes stem cells (KSCs). Although the basal occurrence of
MC-like events was low, survivin-specific siRNA increased MC phenotype in cells, with chromo-
somal segregation defects and polylobed nuclei. In both NHK and KSCs, the effect of the survivin-
specific siRNA could be reversed by pre-treatment of the cells with IV08.009, a compound devel-
oped to regulate survivin expression. In conclusion, the limitation of catastrophic mitoses could
preserve the skin KSC pool which sustains the epidermal renewal, and in addition support differ-
entiating keratinocytes which express less survivin than the KSCs.
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CoQ10-Binding Protein and PDSS1 play an essential role in epidermal anti-oxidant defences
L Bergeron,1 L Mur,1 A Lebleu,1 C Serre,1 C Plaza,1 A Fuet,1 J Botto,1 C Dal Farra2 and N Domloge1
1 ISP Global Skin Research Center, ISP VIncience, Sophia Antipolis, France and 2 ISP
Corporate Research center, ISP, Wayne, NJ
The Mitochondrial Respiratory Chain (MRC) consisting of four multisubunit complexes, collects
metabolites mainly from the Krebs cycle, from pyruvate oxidation, amino-acid and fatty acid catab-
olism, to finally synthesize ATP. During this process, toxic Reactive Oxygen Species (ROS) are pro-
duced and contributes to aging side-effects. The coenzyme Q10 (Q10 ubiquinone) plays an essen-
tial role in the MRC as an electron carrier and is the main endogenous lipid-soluble antioxidant with
a strong implication in preventing oxidation of proteins, lipids and DNA. Humans possess a
decaprenyl diphosphate synthase composed of PDSS1 and PDSS2, which produces Q10 ubiquinone,
and the protein COQ10B serves as a chaperone in this process. In order to study the role of Q10
ubiquinone, COQ10B and PDSS1 in the antioxidant protection of skin, we investigated the effect
of IV08.004, a newly developed biofunctional for this purpose. Immunofluorescent detection of
CoQ10B in primary human keratinocytes and in ex vivo human skin showed an increase in CoQ10B
expression after IV08.004 treatment. Moreover, CoQ10B expression was also restored in human
skin after H2O2 oxidative stress, highlighting a possible role of CoQ10B in preserving the skin from
oxidative stress. Finally, we studied the expression of PDSS1 in human keratinocytes and fibroblasts
by western-blotting. IV08.004 treatment enhanced PDSS1 expression, suggesting a role in stimu-
lating key enzymes involved in coenzyme Q10 synthesis in skin. In conclusion, PDSS1, Q10
ubiquinone and CoQ10B seem to act together for protecting the skin from oxidative damage, and
that an efficient modulation of their expression may help the natural antioxidant potential of the
skin.
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Cathelicidin and β-defensin 1 antimicrobial peptides expression in keratinocytes and in human
skin
L Mur,1 C Plaza,1 G Menon,2 J Botto,1 C Dal Farra2 and N Domloge1 1 ISP Global Skin Reseach
Center, ISP Vincience, Sophia Antipolis, France and 2 ISP Corporate Research Center, ISP,
Wayne, NJ
The skin comes into direct contact with external environment and is exposed to numerous micro-
bial pathogens. To protect the organism against bacteria, fungi and viral pathogens). Keratinocytes
are capable of constitutively expressing a wide variety of gene-encoded Antimicrobial Peptides
(AMPs) such as human epithelial β-Defensins (DEFBs) and Cathelicidin (LL-37) which are broad-
spectrum cationic mediators of the nonspecific innate immune system, with distinct and overlap-
ping anti-microbial activity. Only DEFB1, DEFB2 and DEFB3 are expressed in the skin; the latter
two being possibly upregulated in response to inflammation. Besides DEFBs, the human Catheli-
cidin Antimicrobial Protein hCAP18 has the capacity to kill a wide variety of microbes through its
carboxy-terminal peptidic fragment LL-37 and moreover modulates the immune response. Here
we present, the effect of IV10.004, a compound targeting AMPs production, on the expression of
DEFB1 and LL-37 in cultured human keratinocytes and in ex vivo skin. Immunofluorescence detec-
tion showed an increase in DEFB1 and LL-37 expression in NHK either treated with vitamin D3,
known to induce AMPs expression, or with IV10.004. In ex vivo skin, LL-37 was found expressed
only in the stratum corneum whereas DEFB1 was localized into supra-basal layers with a concen-
tration gradient. IV10.004 treatment increased both hBD1 and LL-37 expression in ex vivo skin,
which reflect enhanced antimicrobial properties of the human epidermis. In conclusion, the mod-
ulation of the expression of Antimicrobial Peptides such as DEFBs and LL-37 could strengthen the
natural ability of the skin to regulate the microbial flora. Moreover, such specific modulation could
be of interest in atopic dermatitis, in which cathelicidin is suppressed; or in rosacea where cathe-
licidin peptides are abnormally processed.
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Defining gene expression in normal human epidermal keratinocytes and melanocytes
E Billick,2,1 M Kennedy Crispin,1 M Suárez-Fariñas,1 H Mitsui,1 H Fujita1 and J Krueger1 1
Investigative Dermatology, Rockefeller University, New York, NY and 2 Tri-Institutional
MD/PhD Program, Cornell/Rockefeller/Sloan-Kettering, New York, NY
For the past four decades the predominant study of skin, aside from animal models, has been con-
ducted in vitro, with media supplemented by serum: a variety of undefined growth factors and hor-
mones that affect gene expression. Terminally differentiated cells of the epidermis, keratinocytes and
melanocytes, have been grown in culture and assumed to be “normal”, though, these cell types are
largely non-proliferative in vivo. It has long been acknowledged that keratinocytes in culture often
resemble pathogenic stages, expressing wound healing and psoriatic markers. A new gold standard
is needed. We employed flow cytometry (FACS) and laser capture microdissection (LCM) that derived
cells ex vivo from normal human skin, as compared to commercially available primary cell lines (n
= 10) from PromoCell of keratinocytes and melanocytes. We collected epidermis (n=10) by LCM
as stained by a simplified Hematoxoylin & Eosin method to examine keratinocytes in situ. It is cur-
rently not possible to identify melanocytes by microscopy without a specific stain that would dam-
age the RNA needed for analysis. We therefore compared the gene expression of in vitro melanocytes
to those isolated by FACS based on their expression of CD177 (c-kit.) Gene expression analysis was
conducted by isolating mRNA that was double-amplified, labeled with biotinolated ribonucleotides,
fragmented and hybridized to Affymetrix 2.0 plus HU133 arrays. Cells in vitro were less differenti-
ated in general with a pattern of deregulation of cell cycle accompanied by up-regulation of proto-
oncogenes. In addition to the creation of a more accurate genomic definition for both keratinocytes
and melanocytes, a prerequisite for the study of hyperplasia and neoplasia, our study defined the
artifacts created by tissue culture and categorized changes in gene expression precisely so that results
from experiments conducted with this model system can be examined with appropriate stipulations.
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Loss of epidermal hypoxia-inducible factor-1alpha accelerates epidermal aging and affects
reepithelization in human and mouse
N Ali, HR Rezvani, A Taieb, H de Verneuil and FR Mazurier Univ Victor Segalen Bordeaux 2,
Inserm U1035, bordeaux, France
In mouse and human skin, HIF-1α is constitutively expressed in the epidermis, mainly in the basal
layer. Critical systemic effects have been demonstrated: regulation of kidney erythroproietin pro-
duction in the mouse with constitutive HIF-1α epidermal deletion and hypervascularity following
epidermal HIF-1α overexpression. However, its local role in the keratinocyte physiology has not
been clearly defined. To address the function of HIF-1α specifically in the epidermis, we used the
mouse model of HIF-1α knockout targeted to keratinocytes (K14-Cre/HIF-1αflox/flox). These mice
presented a delayed skin phenotype characterized by skin atrophy and pruritic inflammation, partly
mediated via basement membrane disturbances involving laminin-332 (Ln-332) and integrins. Mice
have also a dramatic decrease in wound healing. We further investigated the relevance of mouse
findings in human skin using reconstructed epidermis and showed that upon HIF-1α knockdown
(HIF-1αKD) human keratinocytes cannot reconstruct a viable epidermis. A diminution of keratinocyte
growth potential, following HIF-1α silencing, was associated with a decreased expression of Ln-
322 and α6 and β1 integrins. Finally, the blunt knockdown of HIF-1α in the epidermis, cause by
tamoxifen treatment of K14-Cre-ERT2/HIF-1αflox/flox mice, induces lethality with massive epider-
mal changes in aged mice. Overall, these results indicate a role of HIF-1α in skin homeostasis
especially during skin aging.
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Role oft the Arylhydrocarbon Receptor (AhR) in extrinsic aging of human skin
J Tigges,1 U Huebenthal,1 HF Merk,2 J Krutmann1 and E Fritsche2,1 1 IUF - Leibniz Research
Institute for Environmental Medicine, Duesseldorf, Germany and 2 Dermatology, University
Hospital, RWTH, Aachen, Germany
In addition to ultraviolet (UV) radiation, exposure to traffic related airborne particles (soot) was
shown to be correlated with extrinsic aging of human skin including coarse wrinkle formation. The
mechanism for this is currently unknown. Soot consists of carbon particles, covered by polyaro-
matic hydrocarbons (PAHs). PAHs such as benzo(a)pyrene (BaP) are activators of the AhR pathway,
which was shown by us to be functional in UVB-induced signaling in human keratinocytes. We now
report that activation of the AhR in human skin by UVB radiation, and also by PAHs, most likely
contributes to extrinsic skin aging by increasing matrix-metalloproteinase-1 (MMP-1) activity, which
causes wrinkle formation via collagen degradation. Stimulation of primary human adult keratinocytes
with either BaP or UVB light significantly induced MMP-1 mRNA and protein expression, and
these responses were inhibited if cells were pretreated with the AhR inhibitor 3’-methoxy-4’-
nitroflavone (MNF). In addition, exposure to BaP or UVB significantly induced MMP-13 (functional
murine homologue of MMP-1) mRNA expression in wildtype, but not in AhR deficient SKH-1
mice. Upon activation by UVB, AhR signaling is mediated via 2 different limbs: the AhR dissociates
from a cytoplasmic protein complex and (i) is translocated into the nucleus where it binds to the
promoter region of genes involved in xenobiotic metabolism, whereas (ii) a src-kinase from this
complex translocates to the cell membrane and induces epidermal growth factor receptor (EGFR)
and downstream MEK signaling. In this study, both BaP and UVB induced MMP-1 activation were
found to be mediated via the 2nd limb of the AhR pathway, because they could be blocked by src-
kinase, EGFR and MEK inhibitors, respectively. These results indicate that activation of the AhR is
involved in extrinsic skin aging. They also provide a mechanistic rational for soot-induced wrinkle
formation in human skin and indicate that AhR inhibtion may be used to reduce pollution-induced
extrinsic skin aging.
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Proteomics analysis of changes in the epidermal proteome after inactivation of an essential
regulator of autophagy
M Stichenwirth,1 H Rossiter1 and E Tschachler1,2 1 Department of Dermatology, Medical
University Vienna, Vienna, Austria and 2 Centre d Investigations Epidermiques et Sensorielles
(CE. R. I. E.S.), Neuilly, France
Autophagy is a cellular self digestion process which has recently been found to have critical func-
tions in many tissues. To investigate the role of autophagy in epidermal differentiation and home-
ostasis, we have established a mouse model in which ATG7, an essential regulator of autophagy, is
deleted in the epidermis by use of the cre/LoxP system (ATG7Δep). In the present study a differen-
tial in-gel electrophoresis (DIGE) proteomics approach is used to screen the entire proteome of
autophagy deficient epidermis for specific changes in expression, processing and breakdown of pro-
teins that depend, either directly or indirectly, on autophagy. Differences in proteomic profile of
autophagy deficient epidermis were qualitatively and quantitatively determined using the DeCyder
7 software. Differentially expressed proteins were identified by ESI-MS/MS analysis. As a result, we
found 28 candidate spots which were up-regulated and 19 candidate spots which were down-reg-
ulated in autophagy deficient epidermis compared to control epidermis. The results will expand
our understanding of the role of autophagy in epidermal keratinocyte biology and may provide
new insights into the molecular mechanisms of skin barrier formation.
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Skin barrier homeostasis is impaired in type 2 diabetes mellitus animal models such as db/db
and ob/ob mice
J Kim,1,2 H Park,1,2 M Jung1,2 and E Choi1,2 1 Dermatology, Yonsei University Wonju College of
Medicine, Wonju, Republic of Korea and 2 Korea and Healthy Woods Skin Center, Yanggu,
Republic of Korea
Although type 2 diabetes mellitus (DM) is a prevalent disease that induces many skin problems, lit-
tle is known about the skin barrier state of type 2 DM patients which dysfunction could be a major
cause of skin problems. Recently, we used OLETF rats as an animal model for chronic mild type 2
DM and found that the chronic DM impairs skin barrier in proportion to the duration of hyper-
glycemia. In this study, we used more popular type 2 DM animal models such as db/db and ob/ob
mice to confirm whether the hyperglycemic condition such as type 2 DM impairs skin barrier home-
ostasis. Metabolic and functional studies were performed at the 8th and 14th weeks of age. Both
db/db and ob/ob mice showed faster and greater weight gain and had significantly higher hemo-
globin A1c levels. In addition, both db/db and ob/ob mice exhibited a significantly higher fasting
blood glucose level compared with control mice. Neither db/db nor ob/ob mice showed any remark-
able changes in the basal skin barrier state including basal TEWL, SC hydration and SC integrity.
However, both db/db and ob/ob mice had significantly delayed barrier recovery compared with
control. Collectively, these results confirm that uncontrolled hyperglycemia could impair skin bar-
rier homeostasis.
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Notch protein expression changes in human skin during ageing, keratinocyte differentiation
and UVB-exposure
A Marconi, E Palazzo, K Dallaglio, F Truzzi, R Lotti, T Petrachi and C Pincelli Department of
Dermatology, University of Modena and Reggio Emilia, Modena, Italy
Notch proteins (Notch-1, -2, -3, -4) comprise a family of surface receptors which are implicated in
maintaining epidermal homeostasis. We first collected skin samples from different age donors: young
(Y-under 20 years), adult (A-between 20 and 50 years) and old (O-over 50 years). In the epidermis,
CK15 and CK10 expression doesn’t change with age, while there is a reduction in Ki67-positive
cells and an increased involucrin expression. In culture, keratinocytes display reduced proliferation
and a lower colony forming efficiency, as a function of age. Transit amplifying (TA) cells appear to
more affected than stem keratinocytes by ageing. In epidermal sections, Notch-1 expression shows
a reduction with age, while Notch-2 is located in the upper layers in Y, in all layers in A and pre-
dominantly in the basal layer in O. In cultures, Notch-1 decreases with age, while Notch-2 seems
to be more expressed in Y cells than A and O cells, as shown by western blotting. By confocal
microscopy, Notch-1 and Notch-2 are mainly expressed in the cytoplasm of TA cells, Notch-1
being present also in the nucleus. Moreover, both proteins are activated by calcium, as shown by
the appearance of the cleaved band in western blotting. Notch-1 activation decreases in confluent
and more differentiated keratinocytes in all age groups, while its expression decreases in subcon-
fluent cells and increases in confluent cells, as a function of age. Notch-2 is mostly expressed and
activated at cell confluence in all age groups. Furthermore, Notch-1 is strongly activated upon UVB
irradiation (75 mJ/cm2) in Y keratinocytes. In addition, Notch-1 is re-activated in O keratinocytes
after UVB (5 mJ/cm2), and it is not expressed in more aged keratinocytes after UVB (75 mJ/cm2).
Notch-2 is mainly expressed after UVB irradiation with 5 mJ/cm2. Taken together, these data con-
firm the role of Notch proteins within epidermal niche and their possible involvement in the mech-
anisms of photoaging.
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Lipid metabolism in the epidermis is regulated by dsRNA
AW Borkowski,1 Y Uchida,2 K Park2 and RL Gallo1 1 Division of Dermatology, School of
Medicine, University of California, San Diego, San Diego, CA and 2 Department of
Dermatology, School of Medicine, University of California, San Francisco, San Francisco, CA
The processes contributing to epidermal barrier homeostasis following injury are poorly understood.
We hypothesized that pattern recognition receptors (PRRs) play a role by serving to recognize
injury and trigger barrier repair. To test this, normal human epidermal keratinocytes (NHEK) or HaCaT
cells were cultured with toll-like receptor (TLR) ligands and expression of genes involved in differ-
entiation was measured. Both NHEK and HaCaT cells showed no significant changes if treated with
ligands to TLR1/6, 2/6, 4, 5, 7/8 or 9, but Poly (I:C), a dsRNA and TLR3 ligand, leads to significant
increases in ATP-binding cassette, sub-family A, member 12 (ABCA12) mRNA (16.5 fold at 24 hours,
P < 0.001) and β-Glucocerebrosidase (GBA) mRNA (5.3 fold at 24 hours, P < 0.005), genes involved
in lipid trafficking and processing, respectively. This treatment was also accompanied by significant
increases of keratinocyte lipid production as observed in NHEKs by Oil Red O staining at 24 hrs
(24.8% increase, P < 0.001) and increases of glucosylceramide (2.99 fold), sphingomyelin (6.39
fold), and cholesterol (2.56 fold) observed by HPTLC. Surprisingly, blocking signaling by TLR3 had
no effect on the Poly (I:C) induced expression of ABCA12 and GBA, suggesting alternate signaling
mechanisms that control lipid metabolism in keratinocytes following exposure to dsRNA. We con-
clude that dsRNA, a normal product released in abundance from damaged cells, induces the expres-
sion of ABCA12 and GBA in keratinocytes and subsequently increases epidermal lipids. This find-
ing may represent a key system to maintain barrier homeostasis.
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FOXO3a transcription factor is implicated in fibroblast and skin senescence
A Lebleu,1 A Fuet,1 G Menon,2 J Botto,1 C Dal Farra2 and N Domloge1 1 Global Skin Research
Center, ISP Vincience, Sophia Antipolis, France and 2 Corporate Research Center, ISP, Wayne,
NJ
FOXO3a (Forkhead Box O3a) is a member of the “O” subclass of the Forkhead family of transcrip-
tion factors, characterized by an evolutionarily conserved DNA-binding domain: the Forkhead box
or FOX. FOXO3a transcription factor is mainly regulated by the insulin/insulin-like growth factor-
1/phosphatidylinositol-3 kinase/Akt signaling pathway, which has been conserved throughout evo-
lution and which is involved in the aging and lifespan control of many organisms and mammals.
FOXO3a regulates genes implicated in cell cycle arrest, apoptosis and response to cellular stress.
In normal human skin, FOXO3a could play an important role in the control of cell aging. In the
present work, we studied the involvement of FOXO3a in skin aging. First, we investigated the
implication of FOXO3a in the regulation of cellular senescence in human dermal fibroblasts. We
used a FOXO3a-specific siRNA in order to down-regulate FOXO3a expression and the effects were
followed by the detection of the senescence-associated β-galactosidase (SA-β-Gal) and immuno-
histological approaches. To help us in our investigations, we developed and studied a biofunctional
(IV10.005) for its ability to modulate FOXO3a induced-senescence. We investigated the action of
IV10.005 on the expression of Extra Cellular Matrix (ECM) components that are known to be altered
by aging (collagen I, hyaluronic acid…), using immunoblotting and immunofluorescence approaches.
In conclusion, these studies confirmed the role of FOXO3a in skin aging, and hence could repre-
sent a reliable marker for aging studies as well as studies on anti-aging components.
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Basal epidermal niche components are important in the preservation of keratinocyte stem
cells and epidermis self-renewal
J Botto,1 F Labarrade,1 Y Guerif-Ferreira,1 L Mur,1 G Oberto,1 A Berghi,1 K Cucumel,1 C Dal Farra2
and N Domloge2 1 Global Skin Research Center, ISP Vincience, Sophia Antipolis, France and
2 ISP Corporate Research Center, ISP, Wayne, NJ
The skin is exposed to external aggressions and undergoes constant renewal. In the epidermis, cell
replacement comes from progenitor cells called “keratinocyte stem cells” (KSCs), constituting 2–10%
of the proliferative population and located in the epidermal basal layer. Skin KSCs are cells express-
ing high level of Survivin, a key protein involved in mitosis regulation and control of physiological
apoptosis processes. KSCs are immersed in a particular environment called the “niche”, which allows
the maintenance of their stemness features: basal epidermal localization, anchorage to the base-
ment membrane, great proliferative potential for epidermal self-renewal. During aging, the niche
grows poorer as lower levels of basal layer/basement membrane proteins are expressed. The skin
tends to become thinner with morphological changes in the dermo-epidermal junction and epi-
dermal pegs retraction; the epidermis renewal is slower conducing to diminished protective barrier
function. In the present work, we studied the effects of IV08.009, a compound designed to modu-
late the expression of KSCs environmental components of the niche, on the expression of integrins,
laminins and collagens in ex vivo skin. In order to study the maintenance of rete pegs, we evalu-
ated by confocal microscopy (VivaScope® 1500) in a double blinded in vivo study, the number of
active dermal papillae, after formulated IV08.009 application for 28 days. Whereas the number of
functional papillae either in the placebo or the untreated side remained unchanged, it had increased
by 5 times with the IV08.009-treated formula, after 28 days. These findings suggest that favoring the
correct composition of KSCs niche environment, which is critical for the maintenance of a func-
tional stem cell population, could be of great interest in anti-aging approaches.
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Tight junctions, what’s your function? Changes in tight junction properties during epidermal
development
Y Zhai, A Celli, J Jiang, D Crumrine, P Elias, K Feingold and T Mauro Dermatology, UCSF-VAMC,
San Francisco, CA
Mammalian epidermis serves several important protective functions, regulating passage of water,
ions, antigens, toxins and micro-organisms. The term “epidermal permeability barrier” has been
used to describe each of these functions, leading to confusion, especially when used to describe
tight junctions’ (TJ) role in the epidermis. Using morphologic and voltage-clamp assays, we now
show that TJ can block ion permeation, but only early and transiently during epidermal develop-
ment, in both a prenatal rat model and in organotypic human keratinocyte cultures. TJ’s lose their
ability to block ion movement after formation of the lipid-based extracellular barrier but retain their
ability to block larger molecules such as biotin. The TJ protein, claudin 1, is increased early in epi-
dermal development but also increases postnatally, suggesting that this protein may subserve dif-
ferent functions in undifferentiated vs. differentiated epidermis. These data suggest that the roles of
TJ and lipid-based barrier vary, according to the stage of epidermal development. We propose that
the term “epidermal permeability barrier” be restricted to the well-established ability of the lipid-
based barrier to restrict paracellular water and ion flux. We propose the term “isotonic barrier” to
describe the ability of TJ to restrict paracellular ion and water movement in prenatal or undifferen-
tiated epidermis.
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Epidermal and dermal innervation density in keloids
B Maddison,1 E Tey,2 E Hui Wang,3 Y Ishiju,3 A McMichael,3 M Marks,3 P Wilford,3 D Maruziva,1
D Ferdinando,1 J Dicks1 and G Yosipovitch3 1 Colworth Discover, Unilever R&D, Sharnbrook,
United Kingdom, 2 National Skin Centre, Singapore, Singapore and 3 Departments of
Pathology and Dermatology, Wake Forest University School of Medicine, Winston Salem, NC
Itch occurring in keloids is a common complaint. We have previously found that itch occurs more
frequently at the periphery of keloids, whereas pain tends to occur in the center. Abnormalities of
sensory testing of symptomatic keloids suggest the presence of small nerve fiber neuropathy in the
condition. Peripheral and central biopsies of keloids from 7 patients and 9 age- and body-site-
matched healthy controls were obtained. PGP 9.5, a pan-neuronal marker, was used to immuno-
localize nerve fibers in the specimens. Confocal microscopy and a bespoke image analysis algo-
rithm were subsequently used to analyze the images. No differences in nerve fiber density and
distribution were found in the epidermis. In the dermis, however, there is a trend towards reduced
nerve fiber density in central keloid specimens (p=0.12). This result suggests that a reduction in
innervation density may occur in keloids and this may possibly be related to the occurrence of pain
and itch in keloids.
300
Mechanisms of epidermal barrier impairment in FLG-deficient human epidermis
R Gruber,1 PM Elias,2 D Crumrine,2 T Lin,2 JM Brandner,3 J Hachem,4 RB Presland,5,6 P Fleckman,5
A Sandilands,7 I McLean,7 M Mildner,8 E Tschachler8 and M Schmuth1 1 Department of
Dermatology, Innsbruck Medical University, Innsbruck, Austria, 2 Veterans Affairs Medical
Center, University of California, San Francisco, CA, 3 Department of Dermatology, University
Hospital Hamburg-Eppendorf, Hamburg, Germany, 4 Department of Dermatology, Free
University of Brussels, Brussels, Belgium, 5 Division of Dermatology, Department of Medicine,
University of Washington, Seattle, WA, 6 Department of Oral Biology, School of Dentistry,
University of Washington, Seattle, WA, 7 Epithelial Genetics Group, Colleges of Life Sciences
and Medicine, University of Dundee, Dundee, United Kingdom and 8 Department of
Dermatology, University of Vienna Medical School, Vienna, Austria
It is widely suggested that FLG deficiency provides a permeability barrier abnormality, however
direct evidence is lacking and the cellular basis for this hypothesis is poorly known. For assessing
the specific relationship between FLG mutations and epidermal alterations, a total of 19 patients
with IV and 20 controls were characterized at a molecular, functional and morphological level. Our
results demonstrate that FLG mutations lead to a dose-dependent decrease in FLG expression, an
increase in SC cell layers and impaired structural integrity of CEs. Furthermore, we observed increased
basal TEWL, delayed recovery kinetics of TEWL after barrier disruption, and extracellular lanthanum
nitrate tracer permeation, indicating an extracellular barrier abnormality. This correlated with alter-
ations in keratin filament organization (perinuclear retraction), delayed processing and abnormal
organization of extracellular lipids, and impaired lamellar body secretion. In addition, cor-
neodesmosome density and tight junction protein expression was reduced. Finally, despite a lack
of visible inflammation, double-allele patients displayed a sparse, mast cell-enriched inflammatory
infiltrate. FLG-deficient SC displayed an increased pH, a likely mechanism for the described abnor-
malities. Taken together, we report here that the presence of FLG mutations predicts extracellular
alterations in epidermal permeability barrier function.
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Defining gene expression in normal human epidermal keratinocytes and melanocytes
E Billick,2,1 M Kennedy Crispin,1 M Suárez-Fariñas,1 H Mitsui,1 H Fujita1 and J Krueger1 1
Investigative Dermatology, Rockefeller University, New York, NY and 2 Tri-Institutional
MD/PhD Program, Cornell/Rockefeller/Sloan-Kettering, New York, NY
For the past four decades the predominant study of skin, aside from animal models, has been con-
ducted in vitro, with media supplemented by serum: a variety of undefined growth factors and hor-
mones that affect gene expression. Terminally differentiated cells of the epidermis, keratinocytes and
melanocytes, have been grown in culture and assumed to be “normal”, though, these cell types are
largely non-proliferative in vivo. It has long been acknowledged that keratinocytes in culture often
resemble pathogenic stages, expressing wound healing and psoriatic markers. A new gold standard
is needed. We employed flow cytometry (FACS) and laser capture microdissection (LCM) that derived
cells ex vivo from normal human skin, as compared to commercially available primary cell lines (n
= 10) from PromoCell of keratinocytes and melanocytes. We collected epidermis (n=10) by LCM
as stained by a simplified Hematoxoylin & Eosin method to examine keratinocytes in situ. It is cur-
rently not possible to identify melanocytes by microscopy without a specific stain that would dam-
age the RNA needed for analysis. We therefore compared the gene expression of in vitro melanocytes
to those isolated by FACS based on their expression of CD177 (c-kit.) Gene expression analysis was
conducted by isolating mRNA that was double-amplified, labeled with biotinolated ribonucleotides,
fragmented and hybridized to Affymetrix 2.0 plus HU133 arrays. Cells in vitro were less differenti-
ated in general with a pattern of deregulation of cell cycle accompanied by up-regulation of proto-
oncogenes. In addition to the creation of a more accurate genomic definition for both keratinocytes
and melanocytes, a prerequisite for the study of hyperplasia and neoplasia, our study defined the
artifacts created by tissue culture and categorized changes in gene expression precisely so that results
from experiments conducted with this model system can be examined with appropriate stipulations.
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Loss of epidermal hypoxia-inducible factor-1alpha accelerates epidermal aging and affects
reepithelization in human and mouse
N Ali, HR Rezvani, A Taieb, H de Verneuil and FR Mazurier Univ Victor Segalen Bordeaux 2,
Inserm U1035, bordeaux, France
In mouse and human skin, HIF-1α is constitutively expressed in the epidermis, mainly in the basal
layer. Critical systemic effects have been demonstrated: regulation of kidney erythroproietin pro-
duction in the mouse with constitutive HIF-1α epidermal deletion and hypervascularity following
epidermal HIF-1α overexpression. However, its local role in the keratinocyte physiology has not
been clearly defined. To address the function of HIF-1α specifically in the epidermis, we used the
mouse model of HIF-1α knockout targeted to keratinocytes (K14-Cre/HIF-1αflox/flox). These mice
presented a delayed skin phenotype characterized by skin atrophy and pruritic inflammation, partly
mediated via basement membrane disturbances involving laminin-332 (Ln-332) and integrins. Mice
have also a dramatic decrease in wound healing. We further investigated the relevance of mouse
findings in human skin using reconstructed epidermis and showed that upon HIF-1α knockdown
(HIF-1αKD) human keratinocytes cannot reconstruct a viable epidermis. A diminution of keratinocyte
growth potential, following HIF-1α silencing, was associated with a decreased expression of Ln-
322 and α6 and β1 integrins. Finally, the blunt knockdown of HIF-1α in the epidermis, cause by
tamoxifen treatment of K14-Cre-ERT2/HIF-1αflox/flox mice, induces lethality with massive epider-
mal changes in aged mice. Overall, these results indicate a role of HIF-1α in skin homeostasis
especially during skin aging.
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Role oft the Arylhydrocarbon Receptor (AhR) in extrinsic aging of human skin
J Tigges,1 U Huebenthal,1 HF Merk,2 J Krutmann1 and E Fritsche2,1 1 IUF - Leibniz Research
Institute for Environmental Medicine, Duesseldorf, Germany and 2 Dermatology, University
Hospital, RWTH, Aachen, Germany
In addition to ultraviolet (UV) radiation, exposure to traffic related airborne particles (soot) was
shown to be correlated with extrinsic aging of human skin including coarse wrinkle formation. The
mechanism for this is currently unknown. Soot consists of carbon particles, covered by polyaro-
matic hydrocarbons (PAHs). PAHs such as benzo(a)pyrene (BaP) are activators of the AhR pathway,
which was shown by us to be functional in UVB-induced signaling in human keratinocytes. We now
report that activation of the AhR in human skin by UVB radiation, and also by PAHs, most likely
contributes to extrinsic skin aging by increasing matrix-metalloproteinase-1 (MMP-1) activity, which
causes wrinkle formation via collagen degradation. Stimulation of primary human adult keratinocytes
with either BaP or UVB light significantly induced MMP-1 mRNA and protein expression, and
these responses were inhibited if cells were pretreated with the AhR inhibitor 3’-methoxy-4’-
nitroflavone (MNF). In addition, exposure to BaP or UVB significantly induced MMP-13 (functional
murine homologue of MMP-1) mRNA expression in wildtype, but not in AhR deficient SKH-1
mice. Upon activation by UVB, AhR signaling is mediated via 2 different limbs: the AhR dissociates
from a cytoplasmic protein complex and (i) is translocated into the nucleus where it binds to the
promoter region of genes involved in xenobiotic metabolism, whereas (ii) a src-kinase from this
complex translocates to the cell membrane and induces epidermal growth factor receptor (EGFR)
and downstream MEK signaling. In this study, both BaP and UVB induced MMP-1 activation were
found to be mediated via the 2nd limb of the AhR pathway, because they could be blocked by src-
kinase, EGFR and MEK inhibitors, respectively. These results indicate that activation of the AhR is
involved in extrinsic skin aging. They also provide a mechanistic rational for soot-induced wrinkle
formation in human skin and indicate that AhR inhibtion may be used to reduce pollution-induced
extrinsic skin aging.
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Proteomics analysis of changes in the epidermal proteome after inactivation of an essential
regulator of autophagy
M Stichenwirth,1 H Rossiter1 and E Tschachler1,2 1 Department of Dermatology, Medical
University Vienna, Vienna, Austria and 2 Centre d Investigations Epidermiques et Sensorielles
(CE. R. I. E.S.), Neuilly, France
Autophagy is a cellular self digestion process which has recently been found to have critical func-
tions in many tissues. To investigate the role of autophagy in epidermal differentiation and home-
ostasis, we have established a mouse model in which ATG7, an essential regulator of autophagy, is
deleted in the epidermis by use of the cre/LoxP system (ATG7Δep). In the present study a differen-
tial in-gel electrophoresis (DIGE) proteomics approach is used to screen the entire proteome of
autophagy deficient epidermis for specific changes in expression, processing and breakdown of pro-
teins that depend, either directly or indirectly, on autophagy. Differences in proteomic profile of
autophagy deficient epidermis were qualitatively and quantitatively determined using the DeCyder
7 software. Differentially expressed proteins were identified by ESI-MS/MS analysis. As a result, we
found 28 candidate spots which were up-regulated and 19 candidate spots which were down-reg-
ulated in autophagy deficient epidermis compared to control epidermis. The results will expand
our understanding of the role of autophagy in epidermal keratinocyte biology and may provide
new insights into the molecular mechanisms of skin barrier formation.
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Skin barrier homeostasis is impaired in type 2 diabetes mellitus animal models such as db/db
and ob/ob mice
J Kim,1,2 H Park,1,2 M Jung1,2 and E Choi1,2 1 Dermatology, Yonsei University Wonju College of
Medicine, Wonju, Republic of Korea and 2 Korea and Healthy Woods Skin Center, Yanggu,
Republic of Korea
Although type 2 diabetes mellitus (DM) is a prevalent disease that induces many skin problems, lit-
tle is known about the skin barrier state of type 2 DM patients which dysfunction could be a major
cause of skin problems. Recently, we used OLETF rats as an animal model for chronic mild type 2
DM and found that the chronic DM impairs skin barrier in proportion to the duration of hyper-
glycemia. In this study, we used more popular type 2 DM animal models such as db/db and ob/ob
mice to confirm whether the hyperglycemic condition such as type 2 DM impairs skin barrier home-
ostasis. Metabolic and functional studies were performed at the 8th and 14th weeks of age. Both
db/db and ob/ob mice showed faster and greater weight gain and had significantly higher hemo-
globin A1c levels. In addition, both db/db and ob/ob mice exhibited a significantly higher fasting
blood glucose level compared with control mice. Neither db/db nor ob/ob mice showed any remark-
able changes in the basal skin barrier state including basal TEWL, SC hydration and SC integrity.
However, both db/db and ob/ob mice had significantly delayed barrier recovery compared with
control. Collectively, these results confirm that uncontrolled hyperglycemia could impair skin bar-
rier homeostasis.
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Notch protein expression changes in human skin during ageing, keratinocyte differentiation
and UVB-exposure
A Marconi, E Palazzo, K Dallaglio, F Truzzi, R Lotti, T Petrachi and C Pincelli Department of
Dermatology, University of Modena and Reggio Emilia, Modena, Italy
Notch proteins (Notch-1, -2, -3, -4) comprise a family of surface receptors which are implicated in
maintaining epidermal homeostasis. We first collected skin samples from different age donors: young
(Y-under 20 years), adult (A-between 20 and 50 years) and old (O-over 50 years). In the epidermis,
CK15 and CK10 expression doesn’t change with age, while there is a reduction in Ki67-positive
cells and an increased involucrin expression. In culture, keratinocytes display reduced proliferation
and a lower colony forming efficiency, as a function of age. Transit amplifying (TA) cells appear to
more affected than stem keratinocytes by ageing. In epidermal sections, Notch-1 expression shows
a reduction with age, while Notch-2 is located in the upper layers in Y, in all layers in A and pre-
dominantly in the basal layer in O. In cultures, Notch-1 decreases with age, while Notch-2 seems
to be more expressed in Y cells than A and O cells, as shown by western blotting. By confocal
microscopy, Notch-1 and Notch-2 are mainly expressed in the cytoplasm of TA cells, Notch-1
being present also in the nucleus. Moreover, both proteins are activated by calcium, as shown by
the appearance of the cleaved band in western blotting. Notch-1 activation decreases in confluent
and more differentiated keratinocytes in all age groups, while its expression decreases in subcon-
fluent cells and increases in confluent cells, as a function of age. Notch-2 is mostly expressed and
activated at cell confluence in all age groups. Furthermore, Notch-1 is strongly activated upon UVB
irradiation (75 mJ/cm2) in Y keratinocytes. In addition, Notch-1 is re-activated in O keratinocytes
after UVB (5 mJ/cm2), and it is not expressed in more aged keratinocytes after UVB (75 mJ/cm2).
Notch-2 is mainly expressed after UVB irradiation with 5 mJ/cm2. Taken together, these data con-
firm the role of Notch proteins within epidermal niche and their possible involvement in the mech-
anisms of photoaging.
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Lipid metabolism in the epidermis is regulated by dsRNA
AW Borkowski,1 Y Uchida,2 K Park2 and RL Gallo1 1 Division of Dermatology, School of
Medicine, University of California, San Diego, San Diego, CA and 2 Department of
Dermatology, School of Medicine, University of California, San Francisco, San Francisco, CA
The processes contributing to epidermal barrier homeostasis following injury are poorly understood.
We hypothesized that pattern recognition receptors (PRRs) play a role by serving to recognize
injury and trigger barrier repair. To test this, normal human epidermal keratinocytes (NHEK) or HaCaT
cells were cultured with toll-like receptor (TLR) ligands and expression of genes involved in differ-
entiation was measured. Both NHEK and HaCaT cells showed no significant changes if treated with
ligands to TLR1/6, 2/6, 4, 5, 7/8 or 9, but Poly (I:C), a dsRNA and TLR3 ligand, leads to significant
increases in ATP-binding cassette, sub-family A, member 12 (ABCA12) mRNA (16.5 fold at 24 hours,
P < 0.001) and β-Glucocerebrosidase (GBA) mRNA (5.3 fold at 24 hours, P < 0.005), genes involved
in lipid trafficking and processing, respectively. This treatment was also accompanied by significant
increases of keratinocyte lipid production as observed in NHEKs by Oil Red O staining at 24 hrs
(24.8% increase, P < 0.001) and increases of glucosylceramide (2.99 fold), sphingomyelin (6.39
fold), and cholesterol (2.56 fold) observed by HPTLC. Surprisingly, blocking signaling by TLR3 had
no effect on the Poly (I:C) induced expression of ABCA12 and GBA, suggesting alternate signaling
mechanisms that control lipid metabolism in keratinocytes following exposure to dsRNA. We con-
clude that dsRNA, a normal product released in abundance from damaged cells, induces the expres-
sion of ABCA12 and GBA in keratinocytes and subsequently increases epidermal lipids. This find-
ing may represent a key system to maintain barrier homeostasis.
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FOXO3a transcription factor is implicated in fibroblast and skin senescence
A Lebleu,1 A Fuet,1 G Menon,2 J Botto,1 C Dal Farra2 and N Domloge1 1 Global Skin Research
Center, ISP Vincience, Sophia Antipolis, France and 2 Corporate Research Center, ISP, Wayne,
NJ
FOXO3a (Forkhead Box O3a) is a member of the “O” subclass of the Forkhead family of transcrip-
tion factors, characterized by an evolutionarily conserved DNA-binding domain: the Forkhead box
or FOX. FOXO3a transcription factor is mainly regulated by the insulin/insulin-like growth factor-
1/phosphatidylinositol-3 kinase/Akt signaling pathway, which has been conserved throughout evo-
lution and which is involved in the aging and lifespan control of many organisms and mammals.
FOXO3a regulates genes implicated in cell cycle arrest, apoptosis and response to cellular stress.
In normal human skin, FOXO3a could play an important role in the control of cell aging. In the
present work, we studied the involvement of FOXO3a in skin aging. First, we investigated the
implication of FOXO3a in the regulation of cellular senescence in human dermal fibroblasts. We
used a FOXO3a-specific siRNA in order to down-regulate FOXO3a expression and the effects were
followed by the detection of the senescence-associated β-galactosidase (SA-β-Gal) and immuno-
histological approaches. To help us in our investigations, we developed and studied a biofunctional
(IV10.005) for its ability to modulate FOXO3a induced-senescence. We investigated the action of
IV10.005 on the expression of Extra Cellular Matrix (ECM) components that are known to be altered
by aging (collagen I, hyaluronic acid…), using immunoblotting and immunofluorescence approaches.
In conclusion, these studies confirmed the role of FOXO3a in skin aging, and hence could repre-
sent a reliable marker for aging studies as well as studies on anti-aging components.
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Basal epidermal niche components are important in the preservation of keratinocyte stem
cells and epidermis self-renewal
J Botto,1 F Labarrade,1 Y Guerif-Ferreira,1 L Mur,1 G Oberto,1 A Berghi,1 K Cucumel,1 C Dal Farra2
and N Domloge2 1 Global Skin Research Center, ISP Vincience, Sophia Antipolis, France and
2 ISP Corporate Research Center, ISP, Wayne, NJ
The skin is exposed to external aggressions and undergoes constant renewal. In the epidermis, cell
replacement comes from progenitor cells called “keratinocyte stem cells” (KSCs), constituting 2–10%
of the proliferative population and located in the epidermal basal layer. Skin KSCs are cells express-
ing high level of Survivin, a key protein involved in mitosis regulation and control of physiological
apoptosis processes. KSCs are immersed in a particular environment called the “niche”, which allows
the maintenance of their stemness features: basal epidermal localization, anchorage to the base-
ment membrane, great proliferative potential for epidermal self-renewal. During aging, the niche
grows poorer as lower levels of basal layer/basement membrane proteins are expressed. The skin
tends to become thinner with morphological changes in the dermo-epidermal junction and epi-
dermal pegs retraction; the epidermis renewal is slower conducing to diminished protective barrier
function. In the present work, we studied the effects of IV08.009, a compound designed to modu-
late the expression of KSCs environmental components of the niche, on the expression of integrins,
laminins and collagens in ex vivo skin. In order to study the maintenance of rete pegs, we evalu-
ated by confocal microscopy (VivaScope® 1500) in a double blinded in vivo study, the number of
active dermal papillae, after formulated IV08.009 application for 28 days. Whereas the number of
functional papillae either in the placebo or the untreated side remained unchanged, it had increased
by 5 times with the IV08.009-treated formula, after 28 days. These findings suggest that favoring the
correct composition of KSCs niche environment, which is critical for the maintenance of a func-
tional stem cell population, could be of great interest in anti-aging approaches.
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Tight junctions, what’s your function? Changes in tight junction properties during epidermal
development
Y Zhai, A Celli, J Jiang, D Crumrine, P Elias, K Feingold and T Mauro Dermatology, UCSF-VAMC,
San Francisco, CA
Mammalian epidermis serves several important protective functions, regulating passage of water,
ions, antigens, toxins and micro-organisms. The term “epidermal permeability barrier” has been
used to describe each of these functions, leading to confusion, especially when used to describe
tight junctions’ (TJ) role in the epidermis. Using morphologic and voltage-clamp assays, we now
show that TJ can block ion permeation, but only early and transiently during epidermal develop-
ment, in both a prenatal rat model and in organotypic human keratinocyte cultures. TJ’s lose their
ability to block ion movement after formation of the lipid-based extracellular barrier but retain their
ability to block larger molecules such as biotin. The TJ protein, claudin 1, is increased early in epi-
dermal development but also increases postnatally, suggesting that this protein may subserve dif-
ferent functions in undifferentiated vs. differentiated epidermis. These data suggest that the roles of
TJ and lipid-based barrier vary, according to the stage of epidermal development. We propose that
the term “epidermal permeability barrier” be restricted to the well-established ability of the lipid-
based barrier to restrict paracellular water and ion flux. We propose the term “isotonic barrier” to
describe the ability of TJ to restrict paracellular ion and water movement in prenatal or undifferen-
tiated epidermis.
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Epidermal and dermal innervation density in keloids
B Maddison,1 E Tey,2 E Hui Wang,3 Y Ishiju,3 A McMichael,3 M Marks,3 P Wilford,3 D Maruziva,1
D Ferdinando,1 J Dicks1 and G Yosipovitch3 1 Colworth Discover, Unilever R&D, Sharnbrook,
United Kingdom, 2 National Skin Centre, Singapore, Singapore and 3 Departments of
Pathology and Dermatology, Wake Forest University School of Medicine, Winston Salem, NC
Itch occurring in keloids is a common complaint. We have previously found that itch occurs more
frequently at the periphery of keloids, whereas pain tends to occur in the center. Abnormalities of
sensory testing of symptomatic keloids suggest the presence of small nerve fiber neuropathy in the
condition. Peripheral and central biopsies of keloids from 7 patients and 9 age- and body-site-
matched healthy controls were obtained. PGP 9.5, a pan-neuronal marker, was used to immuno-
localize nerve fibers in the specimens. Confocal microscopy and a bespoke image analysis algo-
rithm were subsequently used to analyze the images. No differences in nerve fiber density and
distribution were found in the epidermis. In the dermis, however, there is a trend towards reduced
nerve fiber density in central keloid specimens (p=0.12). This result suggests that a reduction in
innervation density may occur in keloids and this may possibly be related to the occurrence of pain
and itch in keloids.
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Mechanisms of epidermal barrier impairment in FLG-deficient human epidermis
R Gruber,1 PM Elias,2 D Crumrine,2 T Lin,2 JM Brandner,3 J Hachem,4 RB Presland,5,6 P Fleckman,5
A Sandilands,7 I McLean,7 M Mildner,8 E Tschachler8 and M Schmuth1 1 Department of
Dermatology, Innsbruck Medical University, Innsbruck, Austria, 2 Veterans Affairs Medical
Center, University of California, San Francisco, CA, 3 Department of Dermatology, University
Hospital Hamburg-Eppendorf, Hamburg, Germany, 4 Department of Dermatology, Free
University of Brussels, Brussels, Belgium, 5 Division of Dermatology, Department of Medicine,
University of Washington, Seattle, WA, 6 Department of Oral Biology, School of Dentistry,
University of Washington, Seattle, WA, 7 Epithelial Genetics Group, Colleges of Life Sciences
and Medicine, University of Dundee, Dundee, United Kingdom and 8 Department of
Dermatology, University of Vienna Medical School, Vienna, Austria
It is widely suggested that FLG deficiency provides a permeability barrier abnormality, however
direct evidence is lacking and the cellular basis for this hypothesis is poorly known. For assessing
the specific relationship between FLG mutations and epidermal alterations, a total of 19 patients
with IV and 20 controls were characterized at a molecular, functional and morphological level. Our
results demonstrate that FLG mutations lead to a dose-dependent decrease in FLG expression, an
increase in SC cell layers and impaired structural integrity of CEs. Furthermore, we observed increased
basal TEWL, delayed recovery kinetics of TEWL after barrier disruption, and extracellular lanthanum
nitrate tracer permeation, indicating an extracellular barrier abnormality. This correlated with alter-
ations in keratin filament organization (perinuclear retraction), delayed processing and abnormal
organization of extracellular lipids, and impaired lamellar body secretion. In addition, cor-
neodesmosome density and tight junction protein expression was reduced. Finally, despite a lack
of visible inflammation, double-allele patients displayed a sparse, mast cell-enriched inflammatory
infiltrate. FLG-deficient SC displayed an increased pH, a likely mechanism for the described abnor-
malities. Taken together, we report here that the presence of FLG mutations predicts extracellular
alterations in epidermal permeability barrier function.
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The role of mitochondrial sirtuins in keratinocyte biology
AS Bause,1 M Matsui2 and MC Haigis1 1 Department of Pathology and Cell Biology, Harvard
Medical School, Boston, MA and 2 Estee Lauder Companies, Melville, NY
Sirtuins are a family of conserved NAD-dependent protein deacetylases that have been shown to
play a role in many cellular processes that impact organismal aging. Three sirtuins, SIRT3, SIRT4
and SIRT5, are located in the mitochondria where they modulate the activity of enzymes that are
involved in the regulation of metabolic pathways and mitochondrial function. During human aging,
epidermal keratinocytes exhibit a decline in mitochondrial function, and decreased mitochondrial
metabolism is believed to result in impaired skin function. The aim of this study was to examine the
role of mitochondrial sirtuins in keratinocyte biology. To accomplish this, we used N/TERT ker-
atinocytes as a model and observed dynamically regulated expression of mitochondrial sirtuins dur-
ing differentiation. We also examined the impact of modifying mitochondrial sirtuin activity by over-
expression on keratinocyte differentiation markers, such as loricrin and filaggrin. These studies will
elucidate how mitochondrial sirtuins may regulate skin barrier function.
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Pathogenesis(pathway)-based therapy and genetic basis for lateralization in CHILD syndrome
A Paller,1 M Rodriguez-Martin,2 M van Steensel,3 J Sorrell,1 C Heath,1 D Crumrine,4 M van Geel3
and P Elias4 1 Dermatology/Pediatrics, Northwestern Univ, Chicago, IL, 2 Dermatology, Hosp
Univ/Canarias, La Laguna, Spain, 3 Dermatology, Maastricht Univ Med Ctr, Maastricht,
Netherlands and 4 Dermatology, VA Med Ctr/UCSF, San Francisco, CA
Identification of the underlying genetic, cellular, and biochemical basis of lipid metabolic disor-
ders has begun to delineate the pathogenesis of their cutaneous phenotypes. These insights provide
a potential opportunity to deploy mechanism-targeted, corrective topical therapy. We assessed this
therapeutic approach in two patients with Congenital Hemidysplasia with Ichthyosiform Erythro-
derma and Limb Defects (CHILD) syndrome, an X-linked dominant disorder of distal cholesterol
metabolism. Based upon ultrastructural evidence of cytotoxicity that does not occur with choles-
terol deficiency alone, we hypothesized that the CHILD syndrome reflects a dual process of toxic
sterol metabolite accumulation, superimposed upon cholesterol deficiency. Accordingly, topical
cholesterol alone did not improve the ichthyosiform lesions. However, topical treatment with lovas-
tatin plus cholesterol virtually cleared skin lesions in both patients by 3 months, accompanied by
histologic and ultrastructural evidence of normalization of epidermal structure and lipid secretion.
Finally, gene activation studies in cells derived from affected and unaffected skin, that unique lat-
eralization of abnormalities in CHILD syndrome reflects selective clearance of keratinocytes and
fibroblasts bearing the mutant allele from the unaffected side. Together, these findings validate patho-
genesis (pathway)-based therapy that provides both the deficient end-product (cholesterol) in par-
allel with a proximal inhibitor of sterol synthesis to prevent the accumulation of toxic sterol metabo-
lites in CHILD syndrome. An analogous approach could be deployed to treat other inherited disorders
of cholesterol synthesis.
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A bi-mineral complex induces activation of the antioxidant response element via production
of H2O2
KJ Rodriguez, Y Sun and MD Southall Johnson and Johnson Skin Research Center, Skillman, NJ
Pollution and sunlight are some of the environmental factors that threaten the human skin daily.
Over exposure to these factors induces oxidative stress, a major cause of premature aging. Antiox-
idant and detoxification gene expression in skin are induced through activation of the antioxidant
response element (ARE). The genes regulated by activation of the ARE promoter increase resistance
to oxidative stress and can help restore oxidative homeostasis of the skin. A proprietary bi-mineral
complex consisting of elemental zinc and copper, able to induce biomimetic signals, has demon-
strated anti-inflammatory activity and upregulation of matrix proteins. This study investigates the
capacity of this bi-mineral complex to induce an antioxidant response. Epidermoid cells (ECs) trans-
fected with the ARE- dual luciferase promoter were treated overnight with the bi-mineral complex.
The bi-mineral complex significantly increased ARE promoter activity in a dose dependent manner,
when compared to untreated cells. To elucidate the mechanism by which this bi-mineral complex
activates ARE, cells were pre-treated with LY 294002, a selective pharmacological inhibitor of the
PI3K pathway. PI3K inhibition had a significant reduction of the basal ARE activity; however, LY
294002 had no effect on the ARE levels induced by the bi-mineral complex suggesting that ARE
activation is independent of PI3K pathway. Previous findings have shown that increased levels of
hydrogen peroxide (H2O2) can activate ARE. Herein, the bi-mineral complex was found to produce
elevated concentrations of H2O2 in the μM range when compared to zinc only, in an oxygen and
time dependent manner. Overnight treatment with supernatants from a bi-mineral complex solu-
tion resulted in increased levels of ARE when compared to cells treated with supernatants from a
placebo. Thus, suggesting that H2O2 produced by the bi-mineral complex induces ARE. These find-
ings suggest that the bi-mineral complex can provide protection to skin by stimulating endogenous
antioxidant response.
316
Ets1 regulates the skin differentiation program by interfering with Notch activity
S Chin,1 P Nagarajan,1 D Wang,2 S Liu,2 L Garrett-Sinha1 and S Sinha1 1 Biochemistry, State
University of New York at Buffalo, Buffalo, NY and 2 Biostatistics, Roswell Park Cancer
Institute, Buffalo, NY
Prior studies have shown that the transcription factor Ets1 is over-expressed in many squamous cell
carcinomas of the skin and oral cavity. To clarify how Ets1 might promote tumorigenesis, we gen-
erated transgenic mice carrying a Tet-inducible Ets1 transgene. Crossing these mice to mice carry-
ing specific Tet driver transgenes allows us to generate bi-transgenic mice (BT) in which we can tar-
get Ets1 expression to various layers of the interfollicular epidermis (IFE) in an inducible fashion.
Here we utilize the K5-Tet driver to inducibly target Ets1 expression to the basal layer of the IFE.
Upon induction post-natal BT mice exhibit a range of skin phenotypes with severely affected ani-
mals being runted and suffering from progressive hair loss, epidermal hyperplasia and non-healing
wounds. Over-expression of Ets1 derails the stepwise expression of differentiation markers in the
IFE, such that expression of basal markers (ΔNp63, K5, K14) is expanded and expression of spin-
ous markers is severely diminished. Suprabasal keratinocytes co-express basal and granular layer
markers, suggesting that Ets1 triggers the progression of keratinocytes from a basal-like state directly
to a granular fate, largely skipping the intermediate spinous fate. We examined prenatal BT epi-
dermis to identify early, immediate effects of Ets1 expression. Induction of Ets1 prenatally causes
an apparent duplication of the basal layer, while the spinous layer is decreased, a phenotype simi-
lar to what we observed in adult BT mice. Microarray analysis demonstrates changes in the expres-
sion pattern of a variety of key regulators of IFE differentiation, including components of the Notch
pathway. Notch signaling is important in the transition of basal keratinocytes to spinous keratinoc-
tyes and Notch signaling appears to be inhibited in BT skin. Altogether, these results are consistent
with a process in which Ets1 promotes the basal cell fate at the expense of the spinous layer fate by
regulating Notch activity.
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Activation of transient receptor potential vanilloid channel TRPV6 accelerates keratinocyte
differentiation
V Lehen’kyi,1 M Vandenberghe,1 F Belaubre,2 S Julié,2 N Castex Rizzi,2 R Skryma1 and
N Prevarskaya1 1 Inserm, U-800, Villeneuve d’Ascq, France and 2 Laboratoire de
Pharmacologie Cellulaire, Pierre Fabre Dermocosmétique, Toulouse, France
Numerous studies have demonstrated the beneficial effect of Avène thermal spring water (ATSW)
in dermatological diseases but the molecular mechanisms remain unknown. The objective of the
present study was to evaluate the effect of ATSW on the morphological and molecular features related
to the more advanced status of differentiation of human keratinocytes. Normal Human Epidermal
Keratinocytes (NHEK) were differentiated in medium powder reconstituted with ATSW and assessed
by RT-PCR and immunohistochemistry. Calcium entry was measured by a Fura-2 AM probe. TRPV6
channel were detected by immunohistochemistry, RT-PCR and western blot. Treatment of NHEK
with ATSW led to an enhanced constitutive calcium entry that resulted in the increased expression
of involucrin and cytokeratins 1 and 10. This enhanced constitutive calcium entry in ATSW-treated
keratinocytes was mediated by the TRPV6 calcium channel. Moreover, ATSW-mediated calcium
entry was due to the increase in TRPV6 expression as well as the channel abundance at the cell
membrane. Another mechanism of action of ATSW is described. ATSW treatment induced an
enhanced constitutive calcium entry mediated by TRPV6 channel leading to the acceleration of
human keratinocytes differentiation.
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Not all camellias are created equal: The effect of Camellia japonica extracts on barrier func-
tion and protection from environmental insult
P Bhatt,1 A D’Arcangelis,1 A Leo,1 Y Maestro2 and C Lasserre1 1 Chanel, Inc., Piscataway, NJ and
2 Chanel PB, Mougins, France
A properly formed epidermal barrier is crucial to maintaining hydration in the skin and to protect-
ing the body from external stress such as UV irradiation and damage from radical species. Ker-
atinocytes undergo a highly complex differentiation process and transform into corneocytes which
are the “bricks” of the impenetrable stratum corneum. Keratinocytes also synthesize and secrete a
variety of lipids through the formation of lamellar bodies (LB), which act as the “mortar” for the
“bricks”. As skin chronologically ages and is repeatedly exposed to environmental stress, the lev-
els of some biological molecules responsible for barrier maintenance and protection are depleted
or at inappropriate levels. The aim of our study was to compare extracts of several Camellia japon-
ica varieties and identify the extract with the best activity profile against biological targets involved
in epidermal barrier maintenance and protection. Neonatal keratinocytes were cultured and incu-
bated with the extracts or controls. The effect of the camellia extracts was then assessed by West-
ern blot, ELISA, and Q-PCR. We find that all camellia extracts tested are able to stimulate expres-
sion of the epidermal differentiation target HSP27, and only Camellia japonica alba plena extract
is able to stimulate PPARβ/δ expression. The PPARβ/δ receptor, when activated, has been shown to
be a master regulator of barrier maintenance as it can modulate the expression of key barrier form-
ing proteins loricrin and filaggrin, stimulate cornified envelope formation, as well as lipid synthe-
sis. Some, but not all, of the Camellia extracts stimulate the protective target HSP32 (HO-1). The
Camellia japonica alba plena extract is also a highly effective antioxidant with its ability to inhibit
the formation of several radical and oxidative species. These results suggest that not all varieties of
Camellia japonica flowers exhibit the same efficacy in modulating targets involved in barrier main-
tenance and protection.
www.jidonline.org   S53
SID11_Abstracts-5  2/28/11  9:27 AM  Page S53
ABSTRACTS
307
The in vitro sebum suppressive benefits of tridecylcarboxyethylate
J Bajor, B Harirchian, S Mukherjee and C Bosko BioScience, Unilever, Trumbull, CT
Sebaceous glands secrete a unique lipid mixture to the skin surface referred to as sebum. Although
the biological function of human sebum is unclear, overproduction results in the appearance of
oily/greasy skin that can be cosmetically undesirable and has been associated with the skin disease
acne. Aside from the retinoids, few compounds have been identified which significantly reduce
sebaceous gland secretions. Monolayer culture of human sebocytes provides a useful model for the
rapid screening for potential sebum suppressive compounds. Through the use of this model, it was
discovered that tridecyl propionic acid or more simply, tridecylcarboxyethylate, prepared by the
carboxyethylation of tridecyl alcohol, significantly decreased sebocyte lipogenesis as measured by
reduced incorporation of a radiolabeled lipogenic substrate. Dose response effects were evident
generating an IC50 of 5 microMolar. Visual inspection of the sebocytes indicated no cellular toxi-
city at these concentrations and analysis for lactate dehydrogenase levels in the medium as a marker
of cellular crisis remained at baseline levels. Additionally, there were no adverse effects on prolif-
eration at the concentrations required to inhibit lipogenesis. This confirms that the effect of the actives
on the sebocytes was due to inhibition of lipogenesis and not necrosis. These results collectively
demonstrate the in vitro sebum suppressive activity of tridecylcarboxyethylate and suggest that top-
ical applications may reduce sebaceous gland secretions in vivo.
308
Characterization of phase I and II enzymes in human skin, skin equivalents and cultured ker-
atinocytes: Human skin is a conjugating and detoxifying rather than activating metabolic
organ
C Goetz,1 K Ruwiedel,1 R Pfeiffer,1 J Tigges,1 U Hübenthal,1 M Majora,1 R Edwards,2 P Aeby,3
C Goebel,3 C Pease,4 H Merk,5 J Krutmann1 and E Fritsche1,5 1 IUF- Leibniz Research Institute,
Duesseldorf, Germany, 2 Imperial College, London, United Kingdom, 3 Procter and Gamble,
Marly, Switzerland, 4 Unilever, Bedford, United Kingdom and 5 University Clinic RWTH,
Aachen, Germany
Due to its nature as a borderline organ human skin represents a large contact site for all kinds of
potentially harmful substances. As a consequence testing of chemicals in order to exclude or pre-
vent skin irritation, sensitization and toxicity in cosmetics is mandatory. However, the use of ani-
mals for that purpose is de facto prohibited in the European Union and also poorly accepted in the
public. Therefore cosmetic testing will depend on reliable and efficient alternative testing methods.
Such methods would have to display a similar detoxifying potential like living human skin. There-
fore, the aim of this study was to characterize the enzymatic activities of human skin and to com-
pare it with keratinocytes and an epidermal model with special emphasis on the activity of relevant
Phase I (“activation”) and Phase II (“conjugation”) xenobiotic-metabolizing enzymes. Regarding
Phase I we have found that CYPs are poorly detectable at the activity level unless they are induced
e.g by AhR ligands. COX activity measured by PGE2 production was present in all systems, though
we could show that immortalized cell lines are not suitable to predict COX activity in vitro. In con-
trast to Phase I, skin is well equipped with Phase II enzyme activity. The detoxifying enzymes inves-
tigated in this work were GST, UGT and NAT, which all displayed specific substrate turnover in the
nmol min-1 mg-1 range. This means considerable contribution of human skin to xenobiotic detox-
ification. Our results demonstrate for the 1st time that human skin is a conjugating and detoxifying
rather than an activating site. It is well equipped with Phase II enzyme activities, while Phase I is
less prominent. This situation is better mimicked by the 3-D epidermal model EPI-200 than by ker-
atinocyte monolayers. This work was funded by COLIPA.
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Abnormalities in ultrastructure of epidermal lamellar bodies and corneocyte lipid envelope
in Refsum’s disease
GK Menon,1 E Orso,2 G Schmitz,2 D Crumrine3 and PM Elias3 1 Global R & D, ISP Corporation,
Wayne, NJ, 2 Inst for Clinical Chemistry & Laboratory Medicine, University of Regensburg,
Regensburg, Germany and 3 Dermatology, University of California San Francisco, San
Francisco, CA
Classic Refsum’s disease (RD) is a rare, autosomal recessively-inherited disorder of peroxisome
metabolism due to a defect in the initial step in the alpha oxidation of phytanic acid, which accu-
mulates in plasma and lipid enriched tissues (Wills et al. QJ Med 2001, 94: 403-406). It has been
proposed that the disease complex in RD is in part due to the high affinity of phytanic acid for RXRs
and PPARs. Structurally, Epidermal hyperplasia, increased numbers of cornified cell layers, pres-
ence of cells with lipid droplets in SB and reduction of granular layer to a single layer have been
reported by Blanchet-Bardon et al (1978). However, Lamellar body (LB) density and secretion were
reportedly normal. We recently examined biopsies from 3 unrelated patients, using both OSO4
and RUO4 post-fixation to evaluate the barrier lipid structural organization. Although lamellar body
density appeared normal, individual organelles often had distorted shape, or had non-lamellar
domains interspersed with lamellar structures. Some of the organelles seemed to lack lamellar con-
tents altogether, showing a uniformly electron dense content. In addition, we observed mitochon-
drial abnormalities as well in the nucleated epidermis. SG-SC junctions also showed co-existence
of non-lamellar domains within the lamellar lipids, indicative of lipid phase separation. Also, par-
tial detachment or complete absence of cornified lipid envelopes were see in SC. Abnormal LB mor-
phology and lipid contents correlate with the defects in the cornified cell lipid envelopes leading
to impaired barrier functions and desquamation.
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Formation and function of the corneocyte lipid envelope
Y Zheng,1 D Beier,2 A Brash,1 P Elias3 and D Crumrine3 1 Pharmacology, Vanderbilt Univ School
of Medicine, Nashville, TN, 2 Genetics, Harvard Medical School, Boston, MA and 3
Dermatology, VA Med Ctr/UCSF, San Francisco, CA
Corneocytes are surrounded by a unique structure, the corneocyte lipid envelope (CLE), whose func-
tion is unclear, though roles in intercellular cohesion, permeability barrier function, and corneo-
cyte hydration have all been proposed. This monolayer is enriched in covalently-bound ω-hydrox-
yceramides (ωOHCer), which are thought to be generated from a pool of acylceramides (acylCer)
bearing the essential fatty acid linoleate as the ω-esterified acid. Studies of dietary essential fatty
acids indicate that specifically linoleate has to be esterified in acylCer, otherwise ichthyosiform
symptoms appear. Linoleate is a potential substrate for oxygenation by lipoxygenase enzymes (LOX),
and pertinently, patients with autosomal recessive, loss-of-function mutations in either 12R-LOX or
epidermal LOX-3 (eLOX3) display a prominent, congenital ichthyosis with a putative barrier abnor-
mality. Here we investigated the potential LOX metabolism of the linoleate in acylCer, and the con-
sequences for subsequent processing to form the CLE. In normal pig and mouse epidermis, we iden-
tified oxidized forms of acylCer produced via the sequential activity of 12R-LOX and eLOX-3. Using
12RLOX null mice, which die within hours after birth due to a severe barrier abnormality, we found
(i) a complete absence of these specific LOX products in the epidermis, (ii) only 1% of the wild-
type level of ωOHCer bound to protein, and (iii) an absence of the CLE on electron microscopy. We
conclude that the activity of the LOX enzymes renders acylCer susceptible to hydrolysis of the (oxi-
dized) linoleate, freeing the ωOHCer and allowing its subsequent esterification to the external face
of the corneocyte envelope, thus forming the CLE. Together, these studies illuminate the metabolic
steps that generate the CLE, and point to the key role of this structure in maintaining permeability
barrier homeostasis.
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Expression of epidermal CAMP changes in parallel with permeability barrier status
M Rodriguez-Martin,1 G Martin-Ezquerra,2 M Man,3 M Hupe,3 J Youm,3 D Mackenzie,3 S Cho,4
C Trullas,5 W Holleran,3 K Radek6 and P Elias3 1 Derm, Hosp Univ/Canarias, La Laguna, Spain,
2 Derm, Hosp del Mar-IMIM, Barcelona, Spain, 3 Derm, VA Med Ctr/UCSF, San Francisco,
CA, 4 Derm, Boramae Hospital, Seoul, Democratic People’s Republic of Korea, 5 ISDIN,
Barcelona, Spain and 6 Burn/Shock/Trauma, Loyola Med Ctr, Maywood, IL
Two critical defensive functions of mammalian epidermis, the permeability barrier and antimicro-
bial defense in the outer epidermis, share certain structural and biochemical features. Three antimi-
crobial peptides (AMP); i.e., mouse beta-defensin, mBD3 (murine homologue of human beta-defensin
2), mouse cathelicidin protein (CAMP) (murine homologue of LL-37), and the neuroendocrine pep-
tide, catestatin (Cst), all localize to the outer epidermis. CAMP/LL-37 and mBD3/hBD2 are co-
secreted from epidermal lamellar bodies along with other organelle contents that subserve the per-
meability barrier. All three of these AMP up-regulate specifically in response to acute permeability
barrier disruption; and finally, CAMP/LL-37 is required for normal permeability barrier homeosta-
sis. To determine further whether these two functions are co-regulated, we investigated changes in
levels of these 3 AMP under a variety of unrelated, experimental conditions that either compromise
or enhance permeability barrier function in normal mouse skin (compromised function: psycho-
logical stress, testosterone repletion [male vs. female gender], erythemogenic UV-B irradiation,
and chronologic [intrinsic] aging; improved function: topical applications of calcipotriol, imiquimod,
optimal-molar physiologic lipids, urea, and PPAR/LXR activators). Either compromised or enhanced
permeability barrier function correlated with reduced or enhanced immunohistochemical expres-
sion of CAMP, but to a lesser extent with changes in mBD3, and often conversely with Cst expres-
sion. Together, these studies show that changes in cathelicidin expression parallel changes in per-
meability barrier status, but a less clear relationship exists between changes in barrier function and
mBD3 expression. The inverse changes in Cst expression likely are explicable by its role as an
endogenous inhibitor of cathelicidin expression.
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Impaired keratinocyte homeostasis in obesity and metabolic disease
KR Taylor, AE Costanzo and JM Jameson Immunology and Microbial Sciences, The Scripps
Research Institute, La Jolla, CA
Chronic skin complications and non-healing wounds are common complications in obesity, meta-
bolic disease and type 2 diabetes. Within the epidermis a resident intraepithelial lymphocyte pop-
ulation, γδ T cells, provide growth factors for keratinocytes, protect against pathogens and play a
role in inflammation and tissue repair after wounding. We have recently found that γδ T cells in
obese mice are unable to maintain homeostatic numbers, have diminished production of growth
factors and are hyporesponsive to injury. This led us to ask what impact γδ T cells in the obese envi-
ronment have on keratinocyte homeostasis. Since re-creating obesity and metabolic disease in vitro
is difficult, we have instead investigated epithelial cell function either in vivo or directly ex vivo
using two separate mouse models of obesity. We have determined that keratinocytes are unable to
maintain homeostatic numbers in obese C57BLKS/J db/db and C57BL/6J high-fat diet fed mice. Ker-
atinocytes in obese mice exhibit diminished proliferation as determined by in vivo BrdU experi-
ments and immunofluorescence. Furthermore, obese mice have a dysregulated epidermis in which
basal keratinocytes have diminished expression of the proliferation marker keratin 5 and increased
expression of the early differentiation marker keratin 1. Additionally, keratinocytes in the obese envi-
ronment have altered expression of E-cadherin, the prototypic cadherin in epithelial adherens
junctions. Finally, we have correlated that keratinocyte numbers are directly proportional to the
number of closely neighboring γδ T cells. In a normal mouse, fewer keratinocytes are present in
regions lacking γδ T cells. We have found that in obese mice, although γδ T cells may be present,
these keratinocyte regions resemble areas that are devoid of γδT cells in wild-type mice. This demon-
strates that dysfunctional γδ T cells in the epidermis of obese mice may contribute to impaired ker-
atinocyte homeostasis through altered growth factor production or lack of proper cell-cell contact.
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The role of mitochondrial sirtuins in keratinocyte biology
AS Bause,1 M Matsui2 and MC Haigis1 1 Department of Pathology and Cell Biology, Harvard
Medical School, Boston, MA and 2 Estee Lauder Companies, Melville, NY
Sirtuins are a family of conserved NAD-dependent protein deacetylases that have been shown to
play a role in many cellular processes that impact organismal aging. Three sirtuins, SIRT3, SIRT4
and SIRT5, are located in the mitochondria where they modulate the activity of enzymes that are
involved in the regulation of metabolic pathways and mitochondrial function. During human aging,
epidermal keratinocytes exhibit a decline in mitochondrial function, and decreased mitochondrial
metabolism is believed to result in impaired skin function. The aim of this study was to examine the
role of mitochondrial sirtuins in keratinocyte biology. To accomplish this, we used N/TERT ker-
atinocytes as a model and observed dynamically regulated expression of mitochondrial sirtuins dur-
ing differentiation. We also examined the impact of modifying mitochondrial sirtuin activity by over-
expression on keratinocyte differentiation markers, such as loricrin and filaggrin. These studies will
elucidate how mitochondrial sirtuins may regulate skin barrier function.
315
Pathogenesis(pathway)-based therapy and genetic basis for lateralization in CHILD syndrome
A Paller,1 M Rodriguez-Martin,2 M van Steensel,3 J Sorrell,1 C Heath,1 D Crumrine,4 M van Geel3
and P Elias4 1 Dermatology/Pediatrics, Northwestern Univ, Chicago, IL, 2 Dermatology, Hosp
Univ/Canarias, La Laguna, Spain, 3 Dermatology, Maastricht Univ Med Ctr, Maastricht,
Netherlands and 4 Dermatology, VA Med Ctr/UCSF, San Francisco, CA
Identification of the underlying genetic, cellular, and biochemical basis of lipid metabolic disor-
ders has begun to delineate the pathogenesis of their cutaneous phenotypes. These insights provide
a potential opportunity to deploy mechanism-targeted, corrective topical therapy. We assessed this
therapeutic approach in two patients with Congenital Hemidysplasia with Ichthyosiform Erythro-
derma and Limb Defects (CHILD) syndrome, an X-linked dominant disorder of distal cholesterol
metabolism. Based upon ultrastructural evidence of cytotoxicity that does not occur with choles-
terol deficiency alone, we hypothesized that the CHILD syndrome reflects a dual process of toxic
sterol metabolite accumulation, superimposed upon cholesterol deficiency. Accordingly, topical
cholesterol alone did not improve the ichthyosiform lesions. However, topical treatment with lovas-
tatin plus cholesterol virtually cleared skin lesions in both patients by 3 months, accompanied by
histologic and ultrastructural evidence of normalization of epidermal structure and lipid secretion.
Finally, gene activation studies in cells derived from affected and unaffected skin, that unique lat-
eralization of abnormalities in CHILD syndrome reflects selective clearance of keratinocytes and
fibroblasts bearing the mutant allele from the unaffected side. Together, these findings validate patho-
genesis (pathway)-based therapy that provides both the deficient end-product (cholesterol) in par-
allel with a proximal inhibitor of sterol synthesis to prevent the accumulation of toxic sterol metabo-
lites in CHILD syndrome. An analogous approach could be deployed to treat other inherited disorders
of cholesterol synthesis.
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A bi-mineral complex induces activation of the antioxidant response element via production
of H2O2
KJ Rodriguez, Y Sun and MD Southall Johnson and Johnson Skin Research Center, Skillman, NJ
Pollution and sunlight are some of the environmental factors that threaten the human skin daily.
Over exposure to these factors induces oxidative stress, a major cause of premature aging. Antiox-
idant and detoxification gene expression in skin are induced through activation of the antioxidant
response element (ARE). The genes regulated by activation of the ARE promoter increase resistance
to oxidative stress and can help restore oxidative homeostasis of the skin. A proprietary bi-mineral
complex consisting of elemental zinc and copper, able to induce biomimetic signals, has demon-
strated anti-inflammatory activity and upregulation of matrix proteins. This study investigates the
capacity of this bi-mineral complex to induce an antioxidant response. Epidermoid cells (ECs) trans-
fected with the ARE- dual luciferase promoter were treated overnight with the bi-mineral complex.
The bi-mineral complex significantly increased ARE promoter activity in a dose dependent manner,
when compared to untreated cells. To elucidate the mechanism by which this bi-mineral complex
activates ARE, cells were pre-treated with LY 294002, a selective pharmacological inhibitor of the
PI3K pathway. PI3K inhibition had a significant reduction of the basal ARE activity; however, LY
294002 had no effect on the ARE levels induced by the bi-mineral complex suggesting that ARE
activation is independent of PI3K pathway. Previous findings have shown that increased levels of
hydrogen peroxide (H2O2) can activate ARE. Herein, the bi-mineral complex was found to produce
elevated concentrations of H2O2 in the μM range when compared to zinc only, in an oxygen and
time dependent manner. Overnight treatment with supernatants from a bi-mineral complex solu-
tion resulted in increased levels of ARE when compared to cells treated with supernatants from a
placebo. Thus, suggesting that H2O2 produced by the bi-mineral complex induces ARE. These find-
ings suggest that the bi-mineral complex can provide protection to skin by stimulating endogenous
antioxidant response.
316
Ets1 regulates the skin differentiation program by interfering with Notch activity
S Chin,1 P Nagarajan,1 D Wang,2 S Liu,2 L Garrett-Sinha1 and S Sinha1 1 Biochemistry, State
University of New York at Buffalo, Buffalo, NY and 2 Biostatistics, Roswell Park Cancer
Institute, Buffalo, NY
Prior studies have shown that the transcription factor Ets1 is over-expressed in many squamous cell
carcinomas of the skin and oral cavity. To clarify how Ets1 might promote tumorigenesis, we gen-
erated transgenic mice carrying a Tet-inducible Ets1 transgene. Crossing these mice to mice carry-
ing specific Tet driver transgenes allows us to generate bi-transgenic mice (BT) in which we can tar-
get Ets1 expression to various layers of the interfollicular epidermis (IFE) in an inducible fashion.
Here we utilize the K5-Tet driver to inducibly target Ets1 expression to the basal layer of the IFE.
Upon induction post-natal BT mice exhibit a range of skin phenotypes with severely affected ani-
mals being runted and suffering from progressive hair loss, epidermal hyperplasia and non-healing
wounds. Over-expression of Ets1 derails the stepwise expression of differentiation markers in the
IFE, such that expression of basal markers (ΔNp63, K5, K14) is expanded and expression of spin-
ous markers is severely diminished. Suprabasal keratinocytes co-express basal and granular layer
markers, suggesting that Ets1 triggers the progression of keratinocytes from a basal-like state directly
to a granular fate, largely skipping the intermediate spinous fate. We examined prenatal BT epi-
dermis to identify early, immediate effects of Ets1 expression. Induction of Ets1 prenatally causes
an apparent duplication of the basal layer, while the spinous layer is decreased, a phenotype simi-
lar to what we observed in adult BT mice. Microarray analysis demonstrates changes in the expres-
sion pattern of a variety of key regulators of IFE differentiation, including components of the Notch
pathway. Notch signaling is important in the transition of basal keratinocytes to spinous keratinoc-
tyes and Notch signaling appears to be inhibited in BT skin. Altogether, these results are consistent
with a process in which Ets1 promotes the basal cell fate at the expense of the spinous layer fate by
regulating Notch activity.
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Activation of transient receptor potential vanilloid channel TRPV6 accelerates keratinocyte
differentiation
V Lehen’kyi,1 M Vandenberghe,1 F Belaubre,2 S Julié,2 N Castex Rizzi,2 R Skryma1 and
N Prevarskaya1 1 Inserm, U-800, Villeneuve d’Ascq, France and 2 Laboratoire de
Pharmacologie Cellulaire, Pierre Fabre Dermocosmétique, Toulouse, France
Numerous studies have demonstrated the beneficial effect of Avène thermal spring water (ATSW)
in dermatological diseases but the molecular mechanisms remain unknown. The objective of the
present study was to evaluate the effect of ATSW on the morphological and molecular features related
to the more advanced status of differentiation of human keratinocytes. Normal Human Epidermal
Keratinocytes (NHEK) were differentiated in medium powder reconstituted with ATSW and assessed
by RT-PCR and immunohistochemistry. Calcium entry was measured by a Fura-2 AM probe. TRPV6
channel were detected by immunohistochemistry, RT-PCR and western blot. Treatment of NHEK
with ATSW led to an enhanced constitutive calcium entry that resulted in the increased expression
of involucrin and cytokeratins 1 and 10. This enhanced constitutive calcium entry in ATSW-treated
keratinocytes was mediated by the TRPV6 calcium channel. Moreover, ATSW-mediated calcium
entry was due to the increase in TRPV6 expression as well as the channel abundance at the cell
membrane. Another mechanism of action of ATSW is described. ATSW treatment induced an
enhanced constitutive calcium entry mediated by TRPV6 channel leading to the acceleration of
human keratinocytes differentiation.
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Not all camellias are created equal: The effect of Camellia japonica extracts on barrier func-
tion and protection from environmental insult
P Bhatt,1 A D’Arcangelis,1 A Leo,1 Y Maestro2 and C Lasserre1 1 Chanel, Inc., Piscataway, NJ and
2 Chanel PB, Mougins, France
A properly formed epidermal barrier is crucial to maintaining hydration in the skin and to protect-
ing the body from external stress such as UV irradiation and damage from radical species. Ker-
atinocytes undergo a highly complex differentiation process and transform into corneocytes which
are the “bricks” of the impenetrable stratum corneum. Keratinocytes also synthesize and secrete a
variety of lipids through the formation of lamellar bodies (LB), which act as the “mortar” for the
“bricks”. As skin chronologically ages and is repeatedly exposed to environmental stress, the lev-
els of some biological molecules responsible for barrier maintenance and protection are depleted
or at inappropriate levels. The aim of our study was to compare extracts of several Camellia japon-
ica varieties and identify the extract with the best activity profile against biological targets involved
in epidermal barrier maintenance and protection. Neonatal keratinocytes were cultured and incu-
bated with the extracts or controls. The effect of the camellia extracts was then assessed by West-
ern blot, ELISA, and Q-PCR. We find that all camellia extracts tested are able to stimulate expres-
sion of the epidermal differentiation target HSP27, and only Camellia japonica alba plena extract
is able to stimulate PPARβ/δ expression. The PPARβ/δ receptor, when activated, has been shown to
be a master regulator of barrier maintenance as it can modulate the expression of key barrier form-
ing proteins loricrin and filaggrin, stimulate cornified envelope formation, as well as lipid synthe-
sis. Some, but not all, of the Camellia extracts stimulate the protective target HSP32 (HO-1). The
Camellia japonica alba plena extract is also a highly effective antioxidant with its ability to inhibit
the formation of several radical and oxidative species. These results suggest that not all varieties of
Camellia japonica flowers exhibit the same efficacy in modulating targets involved in barrier main-
tenance and protection.
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The in vitro sebum suppressive benefits of tridecylcarboxyethylate
J Bajor, B Harirchian, S Mukherjee and C Bosko BioScience, Unilever, Trumbull, CT
Sebaceous glands secrete a unique lipid mixture to the skin surface referred to as sebum. Although
the biological function of human sebum is unclear, overproduction results in the appearance of
oily/greasy skin that can be cosmetically undesirable and has been associated with the skin disease
acne. Aside from the retinoids, few compounds have been identified which significantly reduce
sebaceous gland secretions. Monolayer culture of human sebocytes provides a useful model for the
rapid screening for potential sebum suppressive compounds. Through the use of this model, it was
discovered that tridecyl propionic acid or more simply, tridecylcarboxyethylate, prepared by the
carboxyethylation of tridecyl alcohol, significantly decreased sebocyte lipogenesis as measured by
reduced incorporation of a radiolabeled lipogenic substrate. Dose response effects were evident
generating an IC50 of 5 microMolar. Visual inspection of the sebocytes indicated no cellular toxi-
city at these concentrations and analysis for lactate dehydrogenase levels in the medium as a marker
of cellular crisis remained at baseline levels. Additionally, there were no adverse effects on prolif-
eration at the concentrations required to inhibit lipogenesis. This confirms that the effect of the actives
on the sebocytes was due to inhibition of lipogenesis and not necrosis. These results collectively
demonstrate the in vitro sebum suppressive activity of tridecylcarboxyethylate and suggest that top-
ical applications may reduce sebaceous gland secretions in vivo.
308
Characterization of phase I and II enzymes in human skin, skin equivalents and cultured ker-
atinocytes: Human skin is a conjugating and detoxifying rather than activating metabolic
organ
C Goetz,1 K Ruwiedel,1 R Pfeiffer,1 J Tigges,1 U Hübenthal,1 M Majora,1 R Edwards,2 P Aeby,3
C Goebel,3 C Pease,4 H Merk,5 J Krutmann1 and E Fritsche1,5 1 IUF- Leibniz Research Institute,
Duesseldorf, Germany, 2 Imperial College, London, United Kingdom, 3 Procter and Gamble,
Marly, Switzerland, 4 Unilever, Bedford, United Kingdom and 5 University Clinic RWTH,
Aachen, Germany
Due to its nature as a borderline organ human skin represents a large contact site for all kinds of
potentially harmful substances. As a consequence testing of chemicals in order to exclude or pre-
vent skin irritation, sensitization and toxicity in cosmetics is mandatory. However, the use of ani-
mals for that purpose is de facto prohibited in the European Union and also poorly accepted in the
public. Therefore cosmetic testing will depend on reliable and efficient alternative testing methods.
Such methods would have to display a similar detoxifying potential like living human skin. There-
fore, the aim of this study was to characterize the enzymatic activities of human skin and to com-
pare it with keratinocytes and an epidermal model with special emphasis on the activity of relevant
Phase I (“activation”) and Phase II (“conjugation”) xenobiotic-metabolizing enzymes. Regarding
Phase I we have found that CYPs are poorly detectable at the activity level unless they are induced
e.g by AhR ligands. COX activity measured by PGE2 production was present in all systems, though
we could show that immortalized cell lines are not suitable to predict COX activity in vitro. In con-
trast to Phase I, skin is well equipped with Phase II enzyme activity. The detoxifying enzymes inves-
tigated in this work were GST, UGT and NAT, which all displayed specific substrate turnover in the
nmol min-1 mg-1 range. This means considerable contribution of human skin to xenobiotic detox-
ification. Our results demonstrate for the 1st time that human skin is a conjugating and detoxifying
rather than an activating site. It is well equipped with Phase II enzyme activities, while Phase I is
less prominent. This situation is better mimicked by the 3-D epidermal model EPI-200 than by ker-
atinocyte monolayers. This work was funded by COLIPA.
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Abnormalities in ultrastructure of epidermal lamellar bodies and corneocyte lipid envelope
in Refsum’s disease
GK Menon,1 E Orso,2 G Schmitz,2 D Crumrine3 and PM Elias3 1 Global R & D, ISP Corporation,
Wayne, NJ, 2 Inst for Clinical Chemistry & Laboratory Medicine, University of Regensburg,
Regensburg, Germany and 3 Dermatology, University of California San Francisco, San
Francisco, CA
Classic Refsum’s disease (RD) is a rare, autosomal recessively-inherited disorder of peroxisome
metabolism due to a defect in the initial step in the alpha oxidation of phytanic acid, which accu-
mulates in plasma and lipid enriched tissues (Wills et al. QJ Med 2001, 94: 403-406). It has been
proposed that the disease complex in RD is in part due to the high affinity of phytanic acid for RXRs
and PPARs. Structurally, Epidermal hyperplasia, increased numbers of cornified cell layers, pres-
ence of cells with lipid droplets in SB and reduction of granular layer to a single layer have been
reported by Blanchet-Bardon et al (1978). However, Lamellar body (LB) density and secretion were
reportedly normal. We recently examined biopsies from 3 unrelated patients, using both OSO4
and RUO4 post-fixation to evaluate the barrier lipid structural organization. Although lamellar body
density appeared normal, individual organelles often had distorted shape, or had non-lamellar
domains interspersed with lamellar structures. Some of the organelles seemed to lack lamellar con-
tents altogether, showing a uniformly electron dense content. In addition, we observed mitochon-
drial abnormalities as well in the nucleated epidermis. SG-SC junctions also showed co-existence
of non-lamellar domains within the lamellar lipids, indicative of lipid phase separation. Also, par-
tial detachment or complete absence of cornified lipid envelopes were see in SC. Abnormal LB mor-
phology and lipid contents correlate with the defects in the cornified cell lipid envelopes leading
to impaired barrier functions and desquamation.
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Formation and function of the corneocyte lipid envelope
Y Zheng,1 D Beier,2 A Brash,1 P Elias3 and D Crumrine3 1 Pharmacology, Vanderbilt Univ School
of Medicine, Nashville, TN, 2 Genetics, Harvard Medical School, Boston, MA and 3
Dermatology, VA Med Ctr/UCSF, San Francisco, CA
Corneocytes are surrounded by a unique structure, the corneocyte lipid envelope (CLE), whose func-
tion is unclear, though roles in intercellular cohesion, permeability barrier function, and corneo-
cyte hydration have all been proposed. This monolayer is enriched in covalently-bound ω-hydrox-
yceramides (ωOHCer), which are thought to be generated from a pool of acylceramides (acylCer)
bearing the essential fatty acid linoleate as the ω-esterified acid. Studies of dietary essential fatty
acids indicate that specifically linoleate has to be esterified in acylCer, otherwise ichthyosiform
symptoms appear. Linoleate is a potential substrate for oxygenation by lipoxygenase enzymes (LOX),
and pertinently, patients with autosomal recessive, loss-of-function mutations in either 12R-LOX or
epidermal LOX-3 (eLOX3) display a prominent, congenital ichthyosis with a putative barrier abnor-
mality. Here we investigated the potential LOX metabolism of the linoleate in acylCer, and the con-
sequences for subsequent processing to form the CLE. In normal pig and mouse epidermis, we iden-
tified oxidized forms of acylCer produced via the sequential activity of 12R-LOX and eLOX-3. Using
12RLOX null mice, which die within hours after birth due to a severe barrier abnormality, we found
(i) a complete absence of these specific LOX products in the epidermis, (ii) only 1% of the wild-
type level of ωOHCer bound to protein, and (iii) an absence of the CLE on electron microscopy. We
conclude that the activity of the LOX enzymes renders acylCer susceptible to hydrolysis of the (oxi-
dized) linoleate, freeing the ωOHCer and allowing its subsequent esterification to the external face
of the corneocyte envelope, thus forming the CLE. Together, these studies illuminate the metabolic
steps that generate the CLE, and point to the key role of this structure in maintaining permeability
barrier homeostasis.
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Expression of epidermal CAMP changes in parallel with permeability barrier status
M Rodriguez-Martin,1 G Martin-Ezquerra,2 M Man,3 M Hupe,3 J Youm,3 D Mackenzie,3 S Cho,4
C Trullas,5 W Holleran,3 K Radek6 and P Elias3 1 Derm, Hosp Univ/Canarias, La Laguna, Spain,
2 Derm, Hosp del Mar-IMIM, Barcelona, Spain, 3 Derm, VA Med Ctr/UCSF, San Francisco,
CA, 4 Derm, Boramae Hospital, Seoul, Democratic People’s Republic of Korea, 5 ISDIN,
Barcelona, Spain and 6 Burn/Shock/Trauma, Loyola Med Ctr, Maywood, IL
Two critical defensive functions of mammalian epidermis, the permeability barrier and antimicro-
bial defense in the outer epidermis, share certain structural and biochemical features. Three antimi-
crobial peptides (AMP); i.e., mouse beta-defensin, mBD3 (murine homologue of human beta-defensin
2), mouse cathelicidin protein (CAMP) (murine homologue of LL-37), and the neuroendocrine pep-
tide, catestatin (Cst), all localize to the outer epidermis. CAMP/LL-37 and mBD3/hBD2 are co-
secreted from epidermal lamellar bodies along with other organelle contents that subserve the per-
meability barrier. All three of these AMP up-regulate specifically in response to acute permeability
barrier disruption; and finally, CAMP/LL-37 is required for normal permeability barrier homeosta-
sis. To determine further whether these two functions are co-regulated, we investigated changes in
levels of these 3 AMP under a variety of unrelated, experimental conditions that either compromise
or enhance permeability barrier function in normal mouse skin (compromised function: psycho-
logical stress, testosterone repletion [male vs. female gender], erythemogenic UV-B irradiation,
and chronologic [intrinsic] aging; improved function: topical applications of calcipotriol, imiquimod,
optimal-molar physiologic lipids, urea, and PPAR/LXR activators). Either compromised or enhanced
permeability barrier function correlated with reduced or enhanced immunohistochemical expres-
sion of CAMP, but to a lesser extent with changes in mBD3, and often conversely with Cst expres-
sion. Together, these studies show that changes in cathelicidin expression parallel changes in per-
meability barrier status, but a less clear relationship exists between changes in barrier function and
mBD3 expression. The inverse changes in Cst expression likely are explicable by its role as an
endogenous inhibitor of cathelicidin expression.
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Impaired keratinocyte homeostasis in obesity and metabolic disease
KR Taylor, AE Costanzo and JM Jameson Immunology and Microbial Sciences, The Scripps
Research Institute, La Jolla, CA
Chronic skin complications and non-healing wounds are common complications in obesity, meta-
bolic disease and type 2 diabetes. Within the epidermis a resident intraepithelial lymphocyte pop-
ulation, γδ T cells, provide growth factors for keratinocytes, protect against pathogens and play a
role in inflammation and tissue repair after wounding. We have recently found that γδ T cells in
obese mice are unable to maintain homeostatic numbers, have diminished production of growth
factors and are hyporesponsive to injury. This led us to ask what impact γδ T cells in the obese envi-
ronment have on keratinocyte homeostasis. Since re-creating obesity and metabolic disease in vitro
is difficult, we have instead investigated epithelial cell function either in vivo or directly ex vivo
using two separate mouse models of obesity. We have determined that keratinocytes are unable to
maintain homeostatic numbers in obese C57BLKS/J db/db and C57BL/6J high-fat diet fed mice. Ker-
atinocytes in obese mice exhibit diminished proliferation as determined by in vivo BrdU experi-
ments and immunofluorescence. Furthermore, obese mice have a dysregulated epidermis in which
basal keratinocytes have diminished expression of the proliferation marker keratin 5 and increased
expression of the early differentiation marker keratin 1. Additionally, keratinocytes in the obese envi-
ronment have altered expression of E-cadherin, the prototypic cadherin in epithelial adherens
junctions. Finally, we have correlated that keratinocyte numbers are directly proportional to the
number of closely neighboring γδ T cells. In a normal mouse, fewer keratinocytes are present in
regions lacking γδ T cells. We have found that in obese mice, although γδ T cells may be present,
these keratinocyte regions resemble areas that are devoid of γδT cells in wild-type mice. This demon-
strates that dysfunctional γδ T cells in the epidermis of obese mice may contribute to impaired ker-
atinocyte homeostasis through altered growth factor production or lack of proper cell-cell contact.
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Involvement of multiple pathways in keratinocyte DNA degradation
M Yamamoto,1,2 T Makino,3 A Motoyama,1 R Tsuboi2 and T Hibino1 1 Shiseido Research Center,
Yokohama, Japan, 2 Department of Dermatology, Tokyo Medical University, Tokyo, Japan and
3 Department of Dermatology, University of Toyama, Toyama, Japan
Loss of the nucleus is a critical step for keratinocyte terminal differentiation. However, the mecha-
nism of denucleation is still not fully understood. Previously we reported that caspase-14 (Casp14)
may contribute to DNA degradation by means of degrading an inhibitor of caspase-activated DNase
(ICAD). On the other hand, it has also been suggested that terminal differentiation is triggered by
the translocation of the filaggrin N-terminal fragment (FLG-N) into the nucleus. Our purpose in the
present study was to determine what types of enzyme are recruited for FLG-N processing. Using
LC-MS/MS analysis, we were able to demonstrate a possible interaction of Casp14 with both FLG-
N and mesotrypsin. We measured the molecular mass of FLG-N in a nuclear fraction of cultured
keratinocytes and found an approximately 55 kDa fragment of FLG-N translocated into the nucleus.
We constructed involucrin-driven vectors inserted with active forms of Casp14, mesotrypsin, kallikrein
5 (KLK5) and kallikrein 7 (KLK7), which are expressed in the human epidermis. After introduction
of these vectors, only active mesotrypsin liberated FLG-N with a similar mass in a prolonged cul-
ture condition. Interestingly, a marked increase of FLG-N was observed when the cells were co-
transfected with Casp14 and mesotrypsin. Only these transfected cells became TUNEL positive after
confluency. Immunohistochemical analysis demonstrated that both mesotrypsin and active Casp14
were hardly detectable in the parakeratotic area of psoriatic skin, although KLK5 and KLK7 remained
unchanged, or partly up-regulated, in the same area. We confirmed that active Casp14 showed
limited proteolysis on ICAD, liberating three fragments with 32 kDa, 27 kDa and 11 kDa. Similar
fragments were also detected in human cornified cell extracts. These results indicate that multiple
pathways are likely to be involved in keratinocyte DNA degradation and the maintenance of the
terminal differentiation process.
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Effects of 11β-hydroxysteroid dehydrogenase type 1 on lipogenesis in SZ95 sebocytes
J Kim,1,2 S Lee,2,3 S Jeong,4 CC Zouboulis5 and S Lee1,2,3 1 Brain Korea 21 Project for Medical
Science, Yonsei University, Seoul, Republic of Korea, 2 Human Barrier Research Institute,
Seoul, Republic of Korea, 3 Dermatology, Yonsei University College of Medicine, Seoul,
Republic of Korea, 4 Neopharm Co., Ltd, Daejeon, Republic of Korea and 5 Dermatology,
Venereology, Allergology and Immunology, Dessau Medical Center, Dessau, Germany
Emotional stress is suggested to be one of the aggravating factors for acne vulgaris. It has been known
that alpha-melanocyte stimulating hormone increases sebaceous lipogenesis. However, the rela-
tionship between stress and acne pathogenesis is still incompletely understood. Cortisol is released
under stress. 11β-hydroxysteroid dehydrogenase type 1 (11βHSD-1), which reduces cortisone to
the active hormone cortisol in peripheral tissues such as liver, adipose tissue, and the central nerv-
ous system has been demonstrated to be expressed in the skin. However, a role of 11βHSD-1 in
acne pathogenesis has not been reported yet. In this study, we detected 11βHSD-1 mRNA and pro-
tein levels in SZ95 sebocytes using real time quantitative PCR and western blotting. Treatment of
SZ95 sebocytes with 1 μM dexamethasone for 24 hours led to increased lipid content, as detected
by nile red lipid staining, with a high polar/neutral ratio with a parallel increase of 11βHSD-1 expres-
sion. Pre-treatment with a glucocorticoid receptor antagonist inhibited the dexamethasone-induced
up-regulation of lipid contents in SZ95 sebocytes. These findings suggest that 11βHSD-1 plays an
important role in sebaceous lipogenesis by up-regulation of cortisol synthesis in SZ95 sebocytes.
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Expression of protease-activated receptor-2 in SZ95 sebocytes and its role in sebaceous lipid
synthesis and inflammation
S Lee,1 S Jeong,2 J Jun,2 J Kim,1 CC Zouboulis3 and S Lee1 1 Dermatology, Yonsei University
College of Medicine, Seoul, Republic of Korea, 2 Research Division Neopharm Co., Ltd.,
Daejeon, Republic of Korea and 3 Dermatology, Venereology, Allergology and Immunology,
Dessau Medical Center, Dessau, Germany
We previously demonstrated that protease-activated receptor-2 (PAR-2) and protease activity were
increased in the epithelium of patients with acne, suggesting the role of PAR-2 in acne pathogene-
sis. PAR-2 is a sensor for endogenous as well as exogenous proteases and mediates numerous phys-
iological and pathophysiological responses in the skin. PAR-2 is expressed by keratinocytes and hair
follicles, however, the presence of PAR-2 in sebocytes remains controversial. In this study, we exam-
ined the presence of functional PAR-2 in the immortalized human sebaceous gland cell line SZ95
by analyzing PAR-2 gene expression and PAR-2-mediated intracellular Ca2+ ([Ca2+]i) signaling
using real-time PCR and a fluorometric imaging plate reader (FLIPR) calcium assay kit. We also
wanted to investigate the effects of PAR-2 activation on lipid synthesis in SZ95 sebocytes. Real-time
PCR studies showed that SZ95 sebocytes exhibit detectable PAR-2 mRNA levels. Stimulation with
a PAR-2 agonist peptide led to increased [Ca2+]i in SZ95 sebocytes in a dose-dependent manner
and this increase was significantly inhibited by a PAR-2 antagonist, indicating that PAR-2 expres-
sion in SZ95 sebocytes was functional. PAR-2 agonist peptide (5 μΜ, 10 μΜ) increased the intra-
cellular lipid droplets in SZ95 sebocytes in a dose-dependent manner. Stimulation with the PAR-2
agonist peptide upregulated mRNA expression of interleukin -1, -8, tumor necrosis factor-α, matrix
metalloproteinases 1, 3, and 9 in SZ95 sebocytes. Taken together, these data indicate that func-
tional PAR-2 is expressed in SZ95 sebocytes and mediates lipogenesis and inflammation in response
to various proteases via PAR-2-mediated signaling.
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Aryl hydrocarbon receptor modulates keratinocyte differentiation by SIRT1 expression
G Tsuji,1 M Takahara,1 H Uchi,1,2 S Takeuchi,1 F Yasukawa,1,2 Y Moroi1 and M Furue1,2 1
Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan and
2 Clinical and Research Center for Yusho and Dioxin, Kyushu University Hospital, Fukuoka,
Japan
Silent mating type information regulation 2 homolog 1 (SIRT1) is a NAD(+)-dependent histone
deacetylase that catalyses to remove acetylation of target genes. SIRT1 has been reported to play
an important role in mediating diverse biological functions including longevity, cell cycle and cel-
lular differentiation in many cells, however, the role in keratinocyte is still largely unknown. Con-
sidering that keratinocyte differentiation is controlled by proliferation and cell cycle, we hypothe-
sized that SIRT1 may mediate keratinocyte differentiation. In addition, since SIRT1 expression has
been shown to be induced strongly by resveratrol (RES) which is a ligand of aryl hydrocarbon
receptor (AhR), we hypothesized that AhR may be a key regulator of SIRT1 expression. To elucidate
that, we examined AhR and SIRT1 expression in cultured human keratinocyte (NHEKs) and con-
firmed that AhR and SIRT1 expression were upregulated in parallel with keratinocyte differentiation
by western blotting analysis. Further, to examine whether AhR modulates SIRT1 expression, we
treated NHEKs with AhR activators such as RES, ketoconazole (KCZ), and benzo(a)pyrene (BaP), a
dioxin contained in cigarette smoking. In real-time PCR and western blotting analysis, RES and
KCZ upregulated SIRT1 expression, while BaP downregulated SIRT1 expression, which were can-
celled by AhR knockdown via siRNA transfection, indicating that a strongly association of AhR
with SIRT1 expression in NHEKs. Moreover, involucrin expression, which is a marker of keratinocyte
differentiation, was upregulated by RES or KCZ, but was downregulated by BaP, indicating that SIRT1
expression by AhR activator modulates keratinocyte differentiation. These data suggest that AhR is
an important regulator of the keratinocyte differentiation.
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Characterization of diffusion and duration of action of a new botulinum toxin type A formu-
lation
H Stone, Z Zhu, T Thach and CL Ruegg Revance Therapeutics, Inc., Newark, CA
RT002, an injectable form of botulinum neurotoxin type A (BoNTA), comprised of a purified 150
kDa neurotoxin formulated in a novel formulation, is designed to limit the extent of diffusion and
permit safe administration of longer acting doses. The aim of this study was to evaluate the degree
of diffusion of RT002 in comparison to a commercially available BoNTA product, Botox® Cos-
metic (Allergan, Inc., USA), and establish the relative duration of effect for diffusion-matched doses
of the two BoNTA formulations using quantitative measurements in mice. Measurement of muscle
paralysis by muscle force generation (MFG) in mice at the injected muscles indicated that RT002
and Botox are equipotent. Measurements of MFG inhibition in an adjacent muscle indicated sig-
nificantly less diffusion for RT002 as compared to Botox. When RT002 and Botox were dosed using
the established diffusion matched doses, RT002 treatment resulted in an extended duration of drug
effect as compared to Botox by 58–100% as assessed by either partial or complete recovery end-
points. Use of a daily voluntary running activity model provided confirmation that the two BoNTA
formulations are equipotent by daily running distance and further confirmed the diffusion matched
dose ratio assessed by degree of drug effect on body weight gain. Using these diffusion matched
doses, RT002 treatment resulted in an extended duration of drug effect as compared to Botox
(100–126% increase in duration) as assessed by either partial or complete recovery endpoints. Use
of this model provides further evidence that the RT002 formulation limits diffusion with equipo-
tency and thereby may permit safe administration of higher and more efficacious doses. In sum-
mary, data from two murine models suggest that RT002 may represent a next generation of BoNTA
drug formulation offering superior degree and duration of effect at the intended target while con-
trolling the unwanted diffusion and accompanying adverse effects of BoNTA at neighboring mus-
cles and distal systemic targets.
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Pathogenetic roles of Wnt ligand and Notch signaling in psoriasis
J Kim, S Chang, S Bang, C Won, M Lee and J Choi Department of Dermatology, Asan Medical
Center, University of Ulsan Medical College, Seoul, Republic of Korea
Psoriasis is characterized by uncontrolled hyperproliferation, aberrant differentiation as well as
dermal infiltration of immune cells, T cells of Th17 subset. In our previous study, we demonstrated
that Notch1, a determinant of keratinocyte terminal differentiation was markedly decreased in pso-
riasis. The expression and distribution of Wnt5a and its receptors are known in adult human skin
and some recent papers showed increase of Wnt5a signaling in psoriasis by gene chip study. The
purpose of this study was to investigate the expression and interaction of Wnt5a and Notch signal-
ing in psoriasis in relation to T cell mediated epidermal hyperproliferation. For this study, we used
psoriatic skin biopsy, primary normal human keratinocytes (NHK), HaCaT cells and they were treated
with recombinant Wnt5a (rWnt5a) or Wnt5a conditioned media. In results, we detected increased
expression of Wnt5a and decreased Notch1 signaling in psoriasis compared to non-lesional skin of
psoriasis and normal skin. Treatment of rWnt5a increased proliferation of NHK but did not affect
migration of keratinocytes. Functionally, in NHK with mixture of cytokines (IL-1α, TNF-α, TGF-α
and IFN-γ), Notch1 and HES1, downstream of Notch1 were downmodulated while Wnt5a was
increased. In NHK treated with rWnt5a, increase of IL-23, IL-12 and TNF-α were detected in the
cell pellet and media. Finally, overexpression of Wnt5a downmodulated Notch1 and HES1 in HaCaT
cells. Based on these results, our data strengthen the notion that Wnt5a and Notch signaling have
counteracting roles to each other and are related to central pathomechanism of psoriasis. Increased
Wnt5a signaling and decreased Notch1 signaling may be associated with defect of terminal differ-
entiation and enhanced proliferation of keratinocytes in the pathogenesis of psoriasis. Furthermore,
increase of Wnt5a may be a pathogenetic link between dermal infiltration of immune cells and
abnormality of keratinocytes in psoriasis.
www.jidonline.org   S55
SID11_Abstracts-5  2/28/11  9:27 AM  Page S55
ABSTRACTS
319
Epidermal melanocytes regulate epidermal barrier function and antimicrobial peptide expres-
sion
M Man,1 T Lin,1 J Sundberg,2 M Hupe,1 K Silva,2 A Celli,1 T Mauro,1 K Feingold3 and P Elias1 1
Dermatology, VA Med Ctr/UCSF, San Francisco, CA, 2 Exp Derm/Genl Mouse Path, The
Jackson Lab, Bar Harbor, ME and 3 Medical Serv/Metabolism, VA Med Ctr/UCSF, San
Francisco, CA
Our recent studies have shown that humans with darkly-pigmented skin (Fitzpatrick Type IV/V),
independent of race or ethnicity, display permeability barrier function and stratum corneum (SC)
integrity/cohesion that is superior to the same functions in lightly-pigmented (Type I/II) humans.
Moreover, we could attribute these differences to the lower pH (≈½ pH unit) of SC in darker skin,
while conversely lowering the pH of SC in lightly-pigmented individuals resets these functions to
levels comparable to dark-skinned subjects. To address potential concerns about inter-individual
variations in function, we next assessed barrier function and surface pH in stable (non-inflamed)
vitiligo vs. contralateral or adjacent non-vitiliginous skin in a Chinese population (n=45, with a
uniform [Type III] pigment phenotype). Permeability barrier homeostasis, assessed as rates of return
of TEWL levels towards normal, was delayed in vitiliginous vs. pigmented skin sites, further evi-
dence that melanocytes influence epidermal structure and function. To further address this issue,
without the possibility of inflammation as a confounding factor, we next compared function in
Skh1 (hairless albino) vs. Skh2 (hairless pigmented) mice. While Skh1 mice display residual (non-
melanized) melanocytes, restricted to hair follicles, melanocytes instead are strictly restricted to the
interfollicular epidermis in Skh2 mice (no melanocytes in follicles). Permeability barrier homeostasis
is enhanced in Skh2 vs. Skh1 mice, and superior barrier function correlated further with a reduc-
tion in pH in the extracellular spaces of the lower SC, in parallel with accelerated lipid processing
(increased activity of ceramide-generating enzymes, such as β-glucocerebrosidase). Together, these
studies demonstrate that epidermal melanocytes exert positive effects on epidermal permeability
barrier function by acidifying extracellular spaces in the lower SC.
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Paradoxical benefits of psychological stress on barrier function and cutaneous inflammation
in mouse models of inflammatory dermatoses
J Sanchez-Mateos,1 T Lin,1 M Man,1 M Hupe,1 J Youm,1 K Feingold2 and P Elias1 1 Dermatology,
VA Med Ctr/UCSF, San Francisco, CA and 2 Medical Serv/Metabolism, VA Med Ctr/UCSF, San
Francisco, CA
Psychological stress (PS) negatively impacts a host of epidermal functions in normal skin, includ-
ing permeability barrier homeostasis, stratum corneum (SC) integrity, wound healing, and epider-
mal antimicrobial defense. Our studies show further that the negative consequences of PS in nor-
mal skin can be largely attributed to increased endogenous glucocorticoids (GC); and accordingly,
exogenous GC replicate all of the above, PS-provoked alterations. PS also is widely assumed to
exacerbate disease in a host of inflammatory dermatoses. Since excessive PS, accompanied by
increased endogenous GC, is an inevitable accompaniment of chronic disease, we hypothesized
here, that PS could have beneficial effects in inflammatory dermatoses, which would explain con-
servation of this component of the stress response during evolution. In 3 different mouse models of
cutaneous inflammation (single-hapten challenge producing acute allergic contact dermatitis [AACD],
repeated hapten challenges producing an atopic dermatitis [AD]-like dermatosis and a phorbol ester-
induced, irritant contact dermatitis [ICD] model), we show that PS: i) induced an increase in endoge-
nous GC; ii) normalized serum IgE levels; iii) improved basal transepidermal water loss; iv) decreased
epidermal cell turnover kinetics; and v) decreased cutaneous inflammation. These paradoxical
benefits of PS were reversed by systemic co-administration of the GC receptor antagonist, mife-
prostone (Ru486), indicating that they were mediated by increased GC. Thus, in contrast to current
dogma, PS appears to benefit, rather than aggravate cutaneous inflammatory dermatoses, appar-
ently due to the anti-inflammatory benefits of increased endogenous GC. Yet, these important ben-
efits of PS/GC are likely to be short-lived, because as inflammation recedes, the negative conse-
quences of PS/GC on epidermal function should rapidly emerge.
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Basis for desquamation of corneocytes in normal humans
T Lin,1 D Crumrine,1 R Sun,1 R Rice2 and P Elias1 1 Dermatology, VA Med Ctr/UCSF, San
Francisco, CA and 2 Environmental Toxicology, UC Davis, Davis, CA
Although the basis for the invisible desquamation of corneocytes from the skin surface is unknown,
three (3) mechanisms have been proposed to be responsible, either alone or together: 1) progres-
sive proteolytic degradation of corneodesmosomes (CD); ii) break-up or loss of extracellular lamel-
lar bilayers; and 3) the ‘swell-shrinkage-slough’ (SSS) that theoretically accompanies regular bathing.
We addressed all 3 mechanisms here, D-Squame strips exposed to ruthenium- and osmium-tetrox-
ide-based vapor fixation, followed by immediate immersion in an epoxy embedding medium, a
novel essentially artefact-free, tissue-processing protocol. We compared lamellar bilayer structure,
CD structure and content (DSG1, DSC1 and desmoplakin levels by immunofluorescence, Western
blotting, and proteomics), and changes in corneocyte/CD structure before and after bathing, utiliz-
ing sequential D-Squame strippings (comparison of #1 [outer SC] vs. #5 [mid-SC] stripping) from
the forearms of normal adult humans (n = 7). In mid-SC, both lamellar bilayers and CD appear intact,
confirmed by punctuate immunostaining for DSG1 and DSC1, as well as the presence of largely
undegraded protein in Western blots. Movement to the outer SC is accompanied by both loss of
lamellar bilayer architecture and degradation of CD. Hydration during SSS does not affect corneo-
cyte volume, but instead it expands the extracellular matrix, separating adjacent lamellar bilayers.
Together, these results show that CD degradation and splitting of lamellar bilayers during SSS account
for single cell desquamation from normal SC. This new protocol, coupled with these structural end-
points, could also be applied in numerous, clinical and therapeutic settings.
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miR705 is involved in skin and hair follicle morphogenesis
C Cela,1,2 M Tavazoie,2 K Fantauzzo,2 C Jahoda3 and A Christiano1,2 1 Dermatology, Columbia
University, New York, NY, 2 Genetics and Development, Columbia University, New York, NY
and 3 School of Biological and Biomedical Sciences, Durham University, Durham, United
Kingdom
MicroRNAs (miRNAs) are small 21-23 nucleotide non-coding RNA molecules that regulate expres-
sion of target genes though repression of mRNA translation and mRNA degradation. Several recent
studies have shown the importance of miRNA regulation during skin and hair follicle development
and their expression during mouse skin tissue. To define miRNA expression during skin morpho-
genesis and hair follicle development, we profiled miRNA expression in mouse back-skin epider-
mis and dermis microdissected at 24 hours intervals during the peak of epidermal and dermal spec-
ification and hair follicle development, corresponding to days E12.5 to E16.5. We identified 36
miRNAs that are highly expressed in the skin during this time period, suggesting that they may play
a role in skin and hair follicle morphogenesis. We defined the temporal pattern of miR-203 and miR-
205 (two miRNAs with known function in skin), which demonstrate that our approach is robust.
We found miRNAs that were expressed in epidermis alone, dermis alone, or both dermis and epi-
dermis. We validated the expression of these miRNAs by performing qPCR and whole mount in situ
hybridization, in order to analyze their expression patterns. Interestingly, miR-705 is highly expressed
in the epidermis at E13.5 (3.8 fold greater than miR-203) and strongly expressed at the hair placodes
at E15.5, but is not expressed in the dermis. This expression pattern suggests that miR-705 has a
crucial role for epidermal fate specification and hair follicle formation. FGF7 (also known as KGF)
is a predicted target gene of miR-705, whose expression is progressively decreased in the epider-
mis (27% at E14.5 vs. 99% at E15.5) at the precisely the time miR-705 is elevated. We postulate
that hair follicle initiation in placodes requires downregulation of FGF7 signaling, perhaps medi-
ated by miR-705.
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Ovol2 converges with p63 to regulate epidermal morphogenesis
B Lee and X Dai Biological Chemistry, University of California, Irvine, Irvine, CA
The Ovo gene family encodes evolutionary conserved zinc-finger transcription factors that reside
downstream of key developmental signaling pathways such as Wg/Wnt and BMP/TGF-β. Ovol1 is
predominantly expressed in suprabasal epidermal cells and has been shown to regulate cell cycle
exit of developmental epidermal progenitor cells, whereas in vitro studies suggest a role for Ovol2
in suppressing transient amplification and terminal differentiation but promoting long-term prolif-
eration of culture keratinocytes. Ovol2 is normally expressed at low levels in the basal layer of devel-
oping epidermis. Overexpression of Ovol2 in mouse epidermis results in thin, blistered skin with
defective terminal differentiation in neonatal mice, a phenotype that exhibits some similar charac-
teristics to that of AP-2α/γ double knockout mice and p63 knockout mice. Microarray analysis
revealed an altered gene expression program in Ovol2 overexpressing skin, with a subset of the
aberrantly expressed genes also affected (in opposite directions) by Ovol2 knockdown in cultured
human keratinocytes, suggesting a likely role for Ovol2 in controlling the expression of these genes
during epidermal development. Additionally, 20% of the Ovol2-responsive genes in the develop-
ing epidermis are previously shown to be regulated by p63, supporting a partial molecular con-
vergence between the Ovol2 and p63 regulatory pathways. Potential converging targets include
K14, K15, and AP-2γ. Interestingly, both p63 and AP-2γ promoters contain putative Ovol2 binding
sites within 2kb upstream of their transcription start sites. These data suggest a model whether Ovol2
functions to repress p63 and AP-2γ to balance proliferation and differentiation in the developing
skin. Further analysis is currently ongoing to test this hypothesis.
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Regulatory roles of clock gene (BMAL1) in the skin
K Ito,1 T Hamada,1 Y Kobayashi,2 S Shimba2 and A Iddamalgoda1 1 Research & Development
Dept., Ichimaru Pharcos Co., Ltd., Motosu, Japan and 2 Dept. of Hygienic Chemistry, College
of Pharmacy, Nihon University, Chiba, Japan
Circadian rhythm is observed in the skin as well as other organs. The regulatory system is com-
posed of several-clock genes (Bmal1, Clock, Per1 etc.). Suprachiasmatic nucleus of hypothalamaus
is master pacemaker of Circadian rhythm, which is stimulated by light /dark cycles and synchro-
nizes the phase of multiple peripheral clocks located in different peripheral tissues. Skin clock is
found in keratinocytes and dermal fibroblasts, and contributes the epidermal proliferation. How-
ever the function of clock genes in the skin have not been enough clarified yet. In this study, we
investigated the effect of skin clock in different light period. Clock-related genes (Rev-erbα, Dbp)
expression in mice skin was changed in constant lighting condition, compare with those in 12-
hour light/dark cycles. Recent studies have shown that UVB modulates clock gene expression in
human cultured keratinocytes. Next the effect of UVB on circadian rhythm of skin clock was inves-
tigated. The mRNA expression of Bmal1 and Clock were suppressed in the chronic UVB-irradiated
skin of hairless mice. Since there were reports that circadian changes of skin surface pH, tempera-
ture and barrier recovery, we examined the transepidermal water loss (TEWL) in Bmal1 knockout
(KO) mice. Epidermal barrier recovery after tape-stripping was significantly delayed in KO mice,
compared with those of wild-type mice. Increase of epidermal thickness was also observed in KO
mice. Although further study needs to be conducted, our study shows that skin clock is affected
with environmental lights, such as visible light and UV. It is well known fact that environmental
stresses such as UVB is involved in skin aging process. The clock genes in the skin may contribute
to the barrier formation by regulation of epidermal proliferation or differentiation.
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Involvement of multiple pathways in keratinocyte DNA degradation
M Yamamoto,1,2 T Makino,3 A Motoyama,1 R Tsuboi2 and T Hibino1 1 Shiseido Research Center,
Yokohama, Japan, 2 Department of Dermatology, Tokyo Medical University, Tokyo, Japan and
3 Department of Dermatology, University of Toyama, Toyama, Japan
Loss of the nucleus is a critical step for keratinocyte terminal differentiation. However, the mecha-
nism of denucleation is still not fully understood. Previously we reported that caspase-14 (Casp14)
may contribute to DNA degradation by means of degrading an inhibitor of caspase-activated DNase
(ICAD). On the other hand, it has also been suggested that terminal differentiation is triggered by
the translocation of the filaggrin N-terminal fragment (FLG-N) into the nucleus. Our purpose in the
present study was to determine what types of enzyme are recruited for FLG-N processing. Using
LC-MS/MS analysis, we were able to demonstrate a possible interaction of Casp14 with both FLG-
N and mesotrypsin. We measured the molecular mass of FLG-N in a nuclear fraction of cultured
keratinocytes and found an approximately 55 kDa fragment of FLG-N translocated into the nucleus.
We constructed involucrin-driven vectors inserted with active forms of Casp14, mesotrypsin, kallikrein
5 (KLK5) and kallikrein 7 (KLK7), which are expressed in the human epidermis. After introduction
of these vectors, only active mesotrypsin liberated FLG-N with a similar mass in a prolonged cul-
ture condition. Interestingly, a marked increase of FLG-N was observed when the cells were co-
transfected with Casp14 and mesotrypsin. Only these transfected cells became TUNEL positive after
confluency. Immunohistochemical analysis demonstrated that both mesotrypsin and active Casp14
were hardly detectable in the parakeratotic area of psoriatic skin, although KLK5 and KLK7 remained
unchanged, or partly up-regulated, in the same area. We confirmed that active Casp14 showed
limited proteolysis on ICAD, liberating three fragments with 32 kDa, 27 kDa and 11 kDa. Similar
fragments were also detected in human cornified cell extracts. These results indicate that multiple
pathways are likely to be involved in keratinocyte DNA degradation and the maintenance of the
terminal differentiation process.
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Effects of 11β-hydroxysteroid dehydrogenase type 1 on lipogenesis in SZ95 sebocytes
J Kim,1,2 S Lee,2,3 S Jeong,4 CC Zouboulis5 and S Lee1,2,3 1 Brain Korea 21 Project for Medical
Science, Yonsei University, Seoul, Republic of Korea, 2 Human Barrier Research Institute,
Seoul, Republic of Korea, 3 Dermatology, Yonsei University College of Medicine, Seoul,
Republic of Korea, 4 Neopharm Co., Ltd, Daejeon, Republic of Korea and 5 Dermatology,
Venereology, Allergology and Immunology, Dessau Medical Center, Dessau, Germany
Emotional stress is suggested to be one of the aggravating factors for acne vulgaris. It has been known
that alpha-melanocyte stimulating hormone increases sebaceous lipogenesis. However, the rela-
tionship between stress and acne pathogenesis is still incompletely understood. Cortisol is released
under stress. 11β-hydroxysteroid dehydrogenase type 1 (11βHSD-1), which reduces cortisone to
the active hormone cortisol in peripheral tissues such as liver, adipose tissue, and the central nerv-
ous system has been demonstrated to be expressed in the skin. However, a role of 11βHSD-1 in
acne pathogenesis has not been reported yet. In this study, we detected 11βHSD-1 mRNA and pro-
tein levels in SZ95 sebocytes using real time quantitative PCR and western blotting. Treatment of
SZ95 sebocytes with 1 μM dexamethasone for 24 hours led to increased lipid content, as detected
by nile red lipid staining, with a high polar/neutral ratio with a parallel increase of 11βHSD-1 expres-
sion. Pre-treatment with a glucocorticoid receptor antagonist inhibited the dexamethasone-induced
up-regulation of lipid contents in SZ95 sebocytes. These findings suggest that 11βHSD-1 plays an
important role in sebaceous lipogenesis by up-regulation of cortisol synthesis in SZ95 sebocytes.
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Expression of protease-activated receptor-2 in SZ95 sebocytes and its role in sebaceous lipid
synthesis and inflammation
S Lee,1 S Jeong,2 J Jun,2 J Kim,1 CC Zouboulis3 and S Lee1 1 Dermatology, Yonsei University
College of Medicine, Seoul, Republic of Korea, 2 Research Division Neopharm Co., Ltd.,
Daejeon, Republic of Korea and 3 Dermatology, Venereology, Allergology and Immunology,
Dessau Medical Center, Dessau, Germany
We previously demonstrated that protease-activated receptor-2 (PAR-2) and protease activity were
increased in the epithelium of patients with acne, suggesting the role of PAR-2 in acne pathogene-
sis. PAR-2 is a sensor for endogenous as well as exogenous proteases and mediates numerous phys-
iological and pathophysiological responses in the skin. PAR-2 is expressed by keratinocytes and hair
follicles, however, the presence of PAR-2 in sebocytes remains controversial. In this study, we exam-
ined the presence of functional PAR-2 in the immortalized human sebaceous gland cell line SZ95
by analyzing PAR-2 gene expression and PAR-2-mediated intracellular Ca2+ ([Ca2+]i) signaling
using real-time PCR and a fluorometric imaging plate reader (FLIPR) calcium assay kit. We also
wanted to investigate the effects of PAR-2 activation on lipid synthesis in SZ95 sebocytes. Real-time
PCR studies showed that SZ95 sebocytes exhibit detectable PAR-2 mRNA levels. Stimulation with
a PAR-2 agonist peptide led to increased [Ca2+]i in SZ95 sebocytes in a dose-dependent manner
and this increase was significantly inhibited by a PAR-2 antagonist, indicating that PAR-2 expres-
sion in SZ95 sebocytes was functional. PAR-2 agonist peptide (5 μΜ, 10 μΜ) increased the intra-
cellular lipid droplets in SZ95 sebocytes in a dose-dependent manner. Stimulation with the PAR-2
agonist peptide upregulated mRNA expression of interleukin -1, -8, tumor necrosis factor-α, matrix
metalloproteinases 1, 3, and 9 in SZ95 sebocytes. Taken together, these data indicate that func-
tional PAR-2 is expressed in SZ95 sebocytes and mediates lipogenesis and inflammation in response
to various proteases via PAR-2-mediated signaling.
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Aryl hydrocarbon receptor modulates keratinocyte differentiation by SIRT1 expression
G Tsuji,1 M Takahara,1 H Uchi,1,2 S Takeuchi,1 F Yasukawa,1,2 Y Moroi1 and M Furue1,2 1
Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan and
2 Clinical and Research Center for Yusho and Dioxin, Kyushu University Hospital, Fukuoka,
Japan
Silent mating type information regulation 2 homolog 1 (SIRT1) is a NAD(+)-dependent histone
deacetylase that catalyses to remove acetylation of target genes. SIRT1 has been reported to play
an important role in mediating diverse biological functions including longevity, cell cycle and cel-
lular differentiation in many cells, however, the role in keratinocyte is still largely unknown. Con-
sidering that keratinocyte differentiation is controlled by proliferation and cell cycle, we hypothe-
sized that SIRT1 may mediate keratinocyte differentiation. In addition, since SIRT1 expression has
been shown to be induced strongly by resveratrol (RES) which is a ligand of aryl hydrocarbon
receptor (AhR), we hypothesized that AhR may be a key regulator of SIRT1 expression. To elucidate
that, we examined AhR and SIRT1 expression in cultured human keratinocyte (NHEKs) and con-
firmed that AhR and SIRT1 expression were upregulated in parallel with keratinocyte differentiation
by western blotting analysis. Further, to examine whether AhR modulates SIRT1 expression, we
treated NHEKs with AhR activators such as RES, ketoconazole (KCZ), and benzo(a)pyrene (BaP), a
dioxin contained in cigarette smoking. In real-time PCR and western blotting analysis, RES and
KCZ upregulated SIRT1 expression, while BaP downregulated SIRT1 expression, which were can-
celled by AhR knockdown via siRNA transfection, indicating that a strongly association of AhR
with SIRT1 expression in NHEKs. Moreover, involucrin expression, which is a marker of keratinocyte
differentiation, was upregulated by RES or KCZ, but was downregulated by BaP, indicating that SIRT1
expression by AhR activator modulates keratinocyte differentiation. These data suggest that AhR is
an important regulator of the keratinocyte differentiation.
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Characterization of diffusion and duration of action of a new botulinum toxin type A formu-
lation
H Stone, Z Zhu, T Thach and CL Ruegg Revance Therapeutics, Inc., Newark, CA
RT002, an injectable form of botulinum neurotoxin type A (BoNTA), comprised of a purified 150
kDa neurotoxin formulated in a novel formulation, is designed to limit the extent of diffusion and
permit safe administration of longer acting doses. The aim of this study was to evaluate the degree
of diffusion of RT002 in comparison to a commercially available BoNTA product, Botox® Cos-
metic (Allergan, Inc., USA), and establish the relative duration of effect for diffusion-matched doses
of the two BoNTA formulations using quantitative measurements in mice. Measurement of muscle
paralysis by muscle force generation (MFG) in mice at the injected muscles indicated that RT002
and Botox are equipotent. Measurements of MFG inhibition in an adjacent muscle indicated sig-
nificantly less diffusion for RT002 as compared to Botox. When RT002 and Botox were dosed using
the established diffusion matched doses, RT002 treatment resulted in an extended duration of drug
effect as compared to Botox by 58–100% as assessed by either partial or complete recovery end-
points. Use of a daily voluntary running activity model provided confirmation that the two BoNTA
formulations are equipotent by daily running distance and further confirmed the diffusion matched
dose ratio assessed by degree of drug effect on body weight gain. Using these diffusion matched
doses, RT002 treatment resulted in an extended duration of drug effect as compared to Botox
(100–126% increase in duration) as assessed by either partial or complete recovery endpoints. Use
of this model provides further evidence that the RT002 formulation limits diffusion with equipo-
tency and thereby may permit safe administration of higher and more efficacious doses. In sum-
mary, data from two murine models suggest that RT002 may represent a next generation of BoNTA
drug formulation offering superior degree and duration of effect at the intended target while con-
trolling the unwanted diffusion and accompanying adverse effects of BoNTA at neighboring mus-
cles and distal systemic targets.
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Pathogenetic roles of Wnt ligand and Notch signaling in psoriasis
J Kim, S Chang, S Bang, C Won, M Lee and J Choi Department of Dermatology, Asan Medical
Center, University of Ulsan Medical College, Seoul, Republic of Korea
Psoriasis is characterized by uncontrolled hyperproliferation, aberrant differentiation as well as
dermal infiltration of immune cells, T cells of Th17 subset. In our previous study, we demonstrated
that Notch1, a determinant of keratinocyte terminal differentiation was markedly decreased in pso-
riasis. The expression and distribution of Wnt5a and its receptors are known in adult human skin
and some recent papers showed increase of Wnt5a signaling in psoriasis by gene chip study. The
purpose of this study was to investigate the expression and interaction of Wnt5a and Notch signal-
ing in psoriasis in relation to T cell mediated epidermal hyperproliferation. For this study, we used
psoriatic skin biopsy, primary normal human keratinocytes (NHK), HaCaT cells and they were treated
with recombinant Wnt5a (rWnt5a) or Wnt5a conditioned media. In results, we detected increased
expression of Wnt5a and decreased Notch1 signaling in psoriasis compared to non-lesional skin of
psoriasis and normal skin. Treatment of rWnt5a increased proliferation of NHK but did not affect
migration of keratinocytes. Functionally, in NHK with mixture of cytokines (IL-1α, TNF-α, TGF-α
and IFN-γ), Notch1 and HES1, downstream of Notch1 were downmodulated while Wnt5a was
increased. In NHK treated with rWnt5a, increase of IL-23, IL-12 and TNF-α were detected in the
cell pellet and media. Finally, overexpression of Wnt5a downmodulated Notch1 and HES1 in HaCaT
cells. Based on these results, our data strengthen the notion that Wnt5a and Notch signaling have
counteracting roles to each other and are related to central pathomechanism of psoriasis. Increased
Wnt5a signaling and decreased Notch1 signaling may be associated with defect of terminal differ-
entiation and enhanced proliferation of keratinocytes in the pathogenesis of psoriasis. Furthermore,
increase of Wnt5a may be a pathogenetic link between dermal infiltration of immune cells and
abnormality of keratinocytes in psoriasis.
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Epidermal melanocytes regulate epidermal barrier function and antimicrobial peptide expres-
sion
M Man,1 T Lin,1 J Sundberg,2 M Hupe,1 K Silva,2 A Celli,1 T Mauro,1 K Feingold3 and P Elias1 1
Dermatology, VA Med Ctr/UCSF, San Francisco, CA, 2 Exp Derm/Genl Mouse Path, The
Jackson Lab, Bar Harbor, ME and 3 Medical Serv/Metabolism, VA Med Ctr/UCSF, San
Francisco, CA
Our recent studies have shown that humans with darkly-pigmented skin (Fitzpatrick Type IV/V),
independent of race or ethnicity, display permeability barrier function and stratum corneum (SC)
integrity/cohesion that is superior to the same functions in lightly-pigmented (Type I/II) humans.
Moreover, we could attribute these differences to the lower pH (≈½ pH unit) of SC in darker skin,
while conversely lowering the pH of SC in lightly-pigmented individuals resets these functions to
levels comparable to dark-skinned subjects. To address potential concerns about inter-individual
variations in function, we next assessed barrier function and surface pH in stable (non-inflamed)
vitiligo vs. contralateral or adjacent non-vitiliginous skin in a Chinese population (n=45, with a
uniform [Type III] pigment phenotype). Permeability barrier homeostasis, assessed as rates of return
of TEWL levels towards normal, was delayed in vitiliginous vs. pigmented skin sites, further evi-
dence that melanocytes influence epidermal structure and function. To further address this issue,
without the possibility of inflammation as a confounding factor, we next compared function in
Skh1 (hairless albino) vs. Skh2 (hairless pigmented) mice. While Skh1 mice display residual (non-
melanized) melanocytes, restricted to hair follicles, melanocytes instead are strictly restricted to the
interfollicular epidermis in Skh2 mice (no melanocytes in follicles). Permeability barrier homeostasis
is enhanced in Skh2 vs. Skh1 mice, and superior barrier function correlated further with a reduc-
tion in pH in the extracellular spaces of the lower SC, in parallel with accelerated lipid processing
(increased activity of ceramide-generating enzymes, such as β-glucocerebrosidase). Together, these
studies demonstrate that epidermal melanocytes exert positive effects on epidermal permeability
barrier function by acidifying extracellular spaces in the lower SC.
320
Paradoxical benefits of psychological stress on barrier function and cutaneous inflammation
in mouse models of inflammatory dermatoses
J Sanchez-Mateos,1 T Lin,1 M Man,1 M Hupe,1 J Youm,1 K Feingold2 and P Elias1 1 Dermatology,
VA Med Ctr/UCSF, San Francisco, CA and 2 Medical Serv/Metabolism, VA Med Ctr/UCSF, San
Francisco, CA
Psychological stress (PS) negatively impacts a host of epidermal functions in normal skin, includ-
ing permeability barrier homeostasis, stratum corneum (SC) integrity, wound healing, and epider-
mal antimicrobial defense. Our studies show further that the negative consequences of PS in nor-
mal skin can be largely attributed to increased endogenous glucocorticoids (GC); and accordingly,
exogenous GC replicate all of the above, PS-provoked alterations. PS also is widely assumed to
exacerbate disease in a host of inflammatory dermatoses. Since excessive PS, accompanied by
increased endogenous GC, is an inevitable accompaniment of chronic disease, we hypothesized
here, that PS could have beneficial effects in inflammatory dermatoses, which would explain con-
servation of this component of the stress response during evolution. In 3 different mouse models of
cutaneous inflammation (single-hapten challenge producing acute allergic contact dermatitis [AACD],
repeated hapten challenges producing an atopic dermatitis [AD]-like dermatosis and a phorbol ester-
induced, irritant contact dermatitis [ICD] model), we show that PS: i) induced an increase in endoge-
nous GC; ii) normalized serum IgE levels; iii) improved basal transepidermal water loss; iv) decreased
epidermal cell turnover kinetics; and v) decreased cutaneous inflammation. These paradoxical
benefits of PS were reversed by systemic co-administration of the GC receptor antagonist, mife-
prostone (Ru486), indicating that they were mediated by increased GC. Thus, in contrast to current
dogma, PS appears to benefit, rather than aggravate cutaneous inflammatory dermatoses, appar-
ently due to the anti-inflammatory benefits of increased endogenous GC. Yet, these important ben-
efits of PS/GC are likely to be short-lived, because as inflammation recedes, the negative conse-
quences of PS/GC on epidermal function should rapidly emerge.
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Basis for desquamation of corneocytes in normal humans
T Lin,1 D Crumrine,1 R Sun,1 R Rice2 and P Elias1 1 Dermatology, VA Med Ctr/UCSF, San
Francisco, CA and 2 Environmental Toxicology, UC Davis, Davis, CA
Although the basis for the invisible desquamation of corneocytes from the skin surface is unknown,
three (3) mechanisms have been proposed to be responsible, either alone or together: 1) progres-
sive proteolytic degradation of corneodesmosomes (CD); ii) break-up or loss of extracellular lamel-
lar bilayers; and 3) the ‘swell-shrinkage-slough’ (SSS) that theoretically accompanies regular bathing.
We addressed all 3 mechanisms here, D-Squame strips exposed to ruthenium- and osmium-tetrox-
ide-based vapor fixation, followed by immediate immersion in an epoxy embedding medium, a
novel essentially artefact-free, tissue-processing protocol. We compared lamellar bilayer structure,
CD structure and content (DSG1, DSC1 and desmoplakin levels by immunofluorescence, Western
blotting, and proteomics), and changes in corneocyte/CD structure before and after bathing, utiliz-
ing sequential D-Squame strippings (comparison of #1 [outer SC] vs. #5 [mid-SC] stripping) from
the forearms of normal adult humans (n = 7). In mid-SC, both lamellar bilayers and CD appear intact,
confirmed by punctuate immunostaining for DSG1 and DSC1, as well as the presence of largely
undegraded protein in Western blots. Movement to the outer SC is accompanied by both loss of
lamellar bilayer architecture and degradation of CD. Hydration during SSS does not affect corneo-
cyte volume, but instead it expands the extracellular matrix, separating adjacent lamellar bilayers.
Together, these results show that CD degradation and splitting of lamellar bilayers during SSS account
for single cell desquamation from normal SC. This new protocol, coupled with these structural end-
points, could also be applied in numerous, clinical and therapeutic settings.
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miR705 is involved in skin and hair follicle morphogenesis
C Cela,1,2 M Tavazoie,2 K Fantauzzo,2 C Jahoda3 and A Christiano1,2 1 Dermatology, Columbia
University, New York, NY, 2 Genetics and Development, Columbia University, New York, NY
and 3 School of Biological and Biomedical Sciences, Durham University, Durham, United
Kingdom
MicroRNAs (miRNAs) are small 21-23 nucleotide non-coding RNA molecules that regulate expres-
sion of target genes though repression of mRNA translation and mRNA degradation. Several recent
studies have shown the importance of miRNA regulation during skin and hair follicle development
and their expression during mouse skin tissue. To define miRNA expression during skin morpho-
genesis and hair follicle development, we profiled miRNA expression in mouse back-skin epider-
mis and dermis microdissected at 24 hours intervals during the peak of epidermal and dermal spec-
ification and hair follicle development, corresponding to days E12.5 to E16.5. We identified 36
miRNAs that are highly expressed in the skin during this time period, suggesting that they may play
a role in skin and hair follicle morphogenesis. We defined the temporal pattern of miR-203 and miR-
205 (two miRNAs with known function in skin), which demonstrate that our approach is robust.
We found miRNAs that were expressed in epidermis alone, dermis alone, or both dermis and epi-
dermis. We validated the expression of these miRNAs by performing qPCR and whole mount in situ
hybridization, in order to analyze their expression patterns. Interestingly, miR-705 is highly expressed
in the epidermis at E13.5 (3.8 fold greater than miR-203) and strongly expressed at the hair placodes
at E15.5, but is not expressed in the dermis. This expression pattern suggests that miR-705 has a
crucial role for epidermal fate specification and hair follicle formation. FGF7 (also known as KGF)
is a predicted target gene of miR-705, whose expression is progressively decreased in the epider-
mis (27% at E14.5 vs. 99% at E15.5) at the precisely the time miR-705 is elevated. We postulate
that hair follicle initiation in placodes requires downregulation of FGF7 signaling, perhaps medi-
ated by miR-705.
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Ovol2 converges with p63 to regulate epidermal morphogenesis
B Lee and X Dai Biological Chemistry, University of California, Irvine, Irvine, CA
The Ovo gene family encodes evolutionary conserved zinc-finger transcription factors that reside
downstream of key developmental signaling pathways such as Wg/Wnt and BMP/TGF-β. Ovol1 is
predominantly expressed in suprabasal epidermal cells and has been shown to regulate cell cycle
exit of developmental epidermal progenitor cells, whereas in vitro studies suggest a role for Ovol2
in suppressing transient amplification and terminal differentiation but promoting long-term prolif-
eration of culture keratinocytes. Ovol2 is normally expressed at low levels in the basal layer of devel-
oping epidermis. Overexpression of Ovol2 in mouse epidermis results in thin, blistered skin with
defective terminal differentiation in neonatal mice, a phenotype that exhibits some similar charac-
teristics to that of AP-2α/γ double knockout mice and p63 knockout mice. Microarray analysis
revealed an altered gene expression program in Ovol2 overexpressing skin, with a subset of the
aberrantly expressed genes also affected (in opposite directions) by Ovol2 knockdown in cultured
human keratinocytes, suggesting a likely role for Ovol2 in controlling the expression of these genes
during epidermal development. Additionally, 20% of the Ovol2-responsive genes in the develop-
ing epidermis are previously shown to be regulated by p63, supporting a partial molecular con-
vergence between the Ovol2 and p63 regulatory pathways. Potential converging targets include
K14, K15, and AP-2γ. Interestingly, both p63 and AP-2γ promoters contain putative Ovol2 binding
sites within 2kb upstream of their transcription start sites. These data suggest a model whether Ovol2
functions to repress p63 and AP-2γ to balance proliferation and differentiation in the developing
skin. Further analysis is currently ongoing to test this hypothesis.
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Regulatory roles of clock gene (BMAL1) in the skin
K Ito,1 T Hamada,1 Y Kobayashi,2 S Shimba2 and A Iddamalgoda1 1 Research & Development
Dept., Ichimaru Pharcos Co., Ltd., Motosu, Japan and 2 Dept. of Hygienic Chemistry, College
of Pharmacy, Nihon University, Chiba, Japan
Circadian rhythm is observed in the skin as well as other organs. The regulatory system is com-
posed of several-clock genes (Bmal1, Clock, Per1 etc.). Suprachiasmatic nucleus of hypothalamaus
is master pacemaker of Circadian rhythm, which is stimulated by light /dark cycles and synchro-
nizes the phase of multiple peripheral clocks located in different peripheral tissues. Skin clock is
found in keratinocytes and dermal fibroblasts, and contributes the epidermal proliferation. How-
ever the function of clock genes in the skin have not been enough clarified yet. In this study, we
investigated the effect of skin clock in different light period. Clock-related genes (Rev-erbα, Dbp)
expression in mice skin was changed in constant lighting condition, compare with those in 12-
hour light/dark cycles. Recent studies have shown that UVB modulates clock gene expression in
human cultured keratinocytes. Next the effect of UVB on circadian rhythm of skin clock was inves-
tigated. The mRNA expression of Bmal1 and Clock were suppressed in the chronic UVB-irradiated
skin of hairless mice. Since there were reports that circadian changes of skin surface pH, tempera-
ture and barrier recovery, we examined the transepidermal water loss (TEWL) in Bmal1 knockout
(KO) mice. Epidermal barrier recovery after tape-stripping was significantly delayed in KO mice,
compared with those of wild-type mice. Increase of epidermal thickness was also observed in KO
mice. Although further study needs to be conducted, our study shows that skin clock is affected
with environmental lights, such as visible light and UV. It is well known fact that environmental
stresses such as UVB is involved in skin aging process. The clock genes in the skin may contribute
to the barrier formation by regulation of epidermal proliferation or differentiation.
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Association of the chromosome 11q13.5 polymorphism with atopic eczema in Austrian patients
EK Greisenegger,1 F Zimprich,2 A Zimprich,2 A Gleiss3 and T Kopp1 1 Department of
Dermatology, DIAID, Medical University of Vienna, Vienna, Austria, 2 Department of
Neurology, Medical University of Vienna, Vienna, Austria and 3 Core Unit for Medical
Statistics and Informatics, Section of Clinical Biometrics, Medical University of Vienna, Vienna,
Austria
Recently, the two single nucleotide polymorphisms rs7927894 on chromosome 11q13.5 and
rs877776 within the region of the hornerin gene were identified as novel susceptibility variants for
atopic eczema in the first genome wide association study in atopic eczema. The aim of our study
was to evaluate the influence of these two genetic variants on atopic eczema and disease-related
phenotypes in the Austrian population. 275 atopic eczema patients and 243 controls were geno-
typed for the two variants rs7927894 and rs877776 by using Taqman based allelic discrimination
assays. When comparing patients with controls we found a significant association of the rs7927894
variant on chromosome 11q13.5 with atopic eczema (p= 0.010; OR: 1.71; CI 1.14-2.59). Sub-
group analysis revealed no significant association of rs7927894 with age of onset, concomitant
asthma and allergic rhinoconjunctivitis, total serum IgE levels and family history of atopy. The analy-
sis of the rs877776 variant showed neither a relevant difference in the allelic distribution between
patients and controls nor a statistical significant association with any of the analyzed atopic eczema
phenotypes. In summary our data show a statistical significant association of the rs7927894 vari-
ant on chromosome 11q13.5 with atopic eczema but not with other disease-related phenotypes.
Therefore, we assume that the rs7927894 single nucleotide polymorphism selectively influences
eczema development. More investigations in distinct study populations are needed to assess the
role of this interesting polymorphism in atopic eczema.
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Insulin/IGF-1 signaling controls epidermal morphogenesis by regulating asymmetric divisions
H Stachelscheid,1,2 C Guenschmann,1,2 A Schmitz,1 JC Bruening2,3 and CM Niessen1,3 1
Department of Dermatology, University of Cologne, Cologne, Germany, 2 Institute for
Genetics, University of Cologne, Cologne, Germany and 3 Cologne Cluster on Cellular Stress
Responses in Aging associated diseases (CECAD), University of Cologne, Cologne, Germany
The skin epidermal barrier protects the organism from external challenges and dehydration. Recently,
we identified insulin/IGF-1 signaling as key determinants of epidermal morphogenesis and prolif-
erative potential. We observed a progressive decrease in the number of suprabasal layers in insulin
receptor (IR), IGF-1 receptor (IGF-1R) or IR/IGF-1R (dko) knockout mice, first obvious at E16.5. Here
we examined how IR/IGF-1R signalling regulate epidermal morphogenesis. At E16.5 a reduced num-
ber of anaphase spindles and an increased number of metaphase spindles were found in dko mice
compared to control, and in vitro in cultured keratinocytes. This indicated an arrest in the spindle
checkpoint of the cell cycle in the absence of IR/IGF-1R. This was associated with disturbed spin-
dle formation in IGF-1R-/- metaphase cells and reduced expression of AuroraB, a key regulator of
mitosis, as well as other cell cycle regulators, such as p53 and stratifin (14-3-3σ). Interestingly, the
reduction in cell divisions upon loss of IR/IGF-R was predominantly on the expense of asymmetric
divisions and correlated with reduced p63 expression, previously implicated in this process. Since
asymmetric cell divisions have been implicated in regulating epidermal stratification, the results
indicate that epidermal Insulin/IGF1 signaling couples cell cycle progression to asymmetric divi-
sions thereby regulating the number of suprabasal layers in the IFE during morphogenesis.
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A multifactorial gene expression approach to understanding skin aging
HE Knaggs,1 DG Kern,1 M Bartlett,1 SM Wood,1 A Mastaloudis,1 SB Ferguson1 and A Langerveld2
1 Center for Anti-Aging Research, Nu Skin Enterprises, Inc., Provo, UT and 2 Genemarkers
LLC, Portage, MI
The advent of genomic research has opened up new ways of investigating skin aging as well as
overall aging. From the present and continuing into the foreseeable future, vast amounts of gene
expression data will need to be evaluated to produce meaningful interpretations and conclusions.
Among the most promising routes are methodologies that seek to understand the interactions of
multiple genes during aging. Aging is the result of complex multifactorial influences occurring over
time between lifestyle choices, environment and genome, necessitating the study of multiple genes
and expression patterns in multiple tissues. Additionally, tissues age at different rates and their capac-
ity to repair varies. By scanning the entire genome of multiple key tissues using microarrays we
have identified multiple genetic expression patterns that occur with aging. Further, comparing
these genetic expression changes across many individuals has enabled the identification of changes
that are common and have a strong correlation with aging or youthfulness. This permits the desig-
nation of a key set of genetic markers that can be used to screen for active ingredients affecting these
genetic markers. Using data from muscle and skin, we describe our approach to discover multiple
markers of skin aging, their use in screening for candidate aging response modulators and demon-
strate the efficacy in modulating the gene expression of what we call skin youth gene clusters.
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The disintegrin/metalloproteinase ADAM10 controls epidermal Notch signaling and skin
homeostasis
S Weber,1 MT Niessen,2 J Prox,1 R Lüllmann-Rauch,3 R Schwanbeck,1 CP Blobel,4 E Jorissen,5,6
B de Strooper,5,6 CM Niessen2 and P Saftig1 1 Institut für Biochemie, University of Kiel, Kiel,
Germany, 2 Department of Dermatology, University of Cologne, Cologne, Germany, 3 Institute
for Anatomy, University of Kiel, Kiel, Germany, 4 Departments of Medicine and of Physiology,
Weill Medical College of Cornell University, New York, NY, 5 Center for Human Genetics,
University of Leuven, Leuven, Belgium and 6 Department for Developmental and Molecular
Genetics, VIB, Leuven, Belgium
The disintegrin and metalloproteinase ADAM10 has been implicated in the regulation of several key
signalling pathways that determine skin morphogenesis and homeostasis. To address the in vivo rel-
evance of ADAM10 in the epidermis and in key signaling pathways we have selectively disrupted
ADAM10 in the developing epidermis. This results in perinatal lethality of the mice associated with
barrier impairment and absence of sebaceous glands. Loss of ADAM10 triggers a premature differ-
entiation of spinous keratinocytes as reflected in reduced numbers of spinous layers. Postnatal
deletion of ADAM10 resulted in loss of hair, misformed vibrissae, epidermal hyperproliferation and
cyst formation, thymic atrophy and upregulation of the cytokine thymic stromal lymphopoetin (TSLP),
thus indicating disturbed skin homeostasis leading to systemic disease, likely due to a compromised
barrier. Previous studies implicated ADAM10 in Nocth signalling as well as cadherin shedding. Both
Notch processing and E-cadherin shedding is strongly reduced. This results in decreased levels of
signaling-competent Notch intracellular domain fragment and functional Notch signaling. The data
identify ADAM10 as a key regulator of cadherin and Notch function in the epidermis in vivo, and
thus as a central regulator of skin development and maintenance.
338
Enhancement of the desmoplakin-keratin association promotes keratinocyte intercellular
hyperadhesion
RP Hobbs1 and KJ Green1,2 1 Pathology, Northwestern University, Chicago, IL and 2
Dermatology, Northwestern University, Chicago, IL
Desmosomes play a crucial role in providing the epidermis with structural integrity and resistance
to mechanical stress by anchoring the tension-bearing keratin intermediate filament (IF) cytoskele-
ton to the desmosomal plaque protein desmoplakin (DP) at sites of cell-cell contact. Within tissues
it has been proposed that desmosomes establish a state of robust intercellular adhesion termed
hyperadhesion that contrasts with the calcium-sensitive state of newly formed desmosomes in dynam-
ically remodeling epithelia of developing embryos and healing wounds. We hypothesized that
enhancement of IF association with desmosomes may promote the acquisition of hyperadhesion in
epithelial sheets. Previously, we determined that expression of a point mutant that abrogates a PKC
consensus sequence within the IF-binding domain of DP (DPS2849G) enhanced the DP-IF associa-
tion, induced sequestration of DP on IF, and impaired desmosome assembly. Using a tet-inducible
system, we have determined that epithelial sheets expressing DPS2849G-GFP acquire hyperadhesive
desmosomes at a faster rate (2 days) than wild-type DP-GFP expressing sheets (6 days). Addition-
ally, it was previously established that PKC stimulation reverted hyperadhesive desmosomes to a
state of weaker adhesion. In our study, epithelial sheets expressing DPS2849G-GFP failed to revert to
weakly adherent sheets following pharmacologic PKC stimulation, suggesting that PKC-mediated
DPS2849 modification may be crucial for acquiring hyperadhesive desmosomes. Thus, phosphoryla-
tion of DPS2849 may serve as a dual-regulatory inside-out switch to control both desmosome assem-
bly and acquisition of hyperadhesion. DPS2849G behavior is mimicked by endogenous DP in ker-
atinocytes from patients with Darier’s disease, which harbor mutations in the SERCA2 intracellular
calcium pump and exhibit altered PKC signaling. Altogether these results suggest that PKC-depend-
ent modulation of DP-IF association is a common target impacting epidermal morphogenesis, tis-
sue remodeling and disease pathogenesis.
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Localization of the novel hair shaft protein VSIG8 in the hair follicle, nail unit, and oral cav-
ity
RH Rice,1 MA Phillips1 and JP Sundberg2 1 Environmental Toxicology, University of California,
Davis, CA and 2 Research & Development, The Jackson Laboratory, Bar Harbor, ME
The molecular bases of diseases of the epidermal appendages are gradually being elucidated as
genes encoding their constituents and regulation are defined. Identification of prominent constituents
will speed recognition of genes whose defects contribute to aberrant structure directly, or in some
cases indirectly, by exacerbating effects of deficiencies in other genes. Present work helps charac-
terize the novel component V-set and immunoglobulin domain containing 8 (VSIG8) in hair shaft
and nail plate to assist understanding its possible relation to disease states. Using a specific anti-
peptide rabbit antiserum raised to a highly conserved unique peptide segment of the predicted pro-
tein, we found expression in the hair follicle that is limited to the late anagen and early catagen
stages of the hair cycle. Cuticle and cortex layers of the hair shaft were immunoreactive, notably in
projections of the cortex into medullary cells. Immunoreactivity also was found in the superficial
layers of the nail matrix. In extracts of mouse and rat tissues, dorsal tongue, buccal, and esophageal
epithelia were clearly immunoreactive, yielding a single band of ≈45 kDa, matching the mobility
of the translated coding region in transfected cultures. These findings emphasize the possibility that
VSIG8 has an important role in proper epithelial differentiation and function in the upper alimen-
tary tract as well as epidermis. To elucidate possible roles of VSIG8 in normal function and disease,
particularly in the integument, hundreds of mouse models for specific human diseases provide
invaluable tools for future work.
www.jidonline.org   S57
SID11_Abstracts-5  2/28/11  9:27 AM  Page S57
ABSTRACTS
331
The role of a novel PPARγ agonist (GMG-43AC) in the control of sebogenesis: prospective for
an innovating treatment of acne
M Ottaviani,1 A Mastrofrancesco,1 D Kovacs,1 M Ludovici,1 CC Zouboulis,2 G Giuliani,3
E Camera1 and M Picardo1 1 Cutaneous Physiopathology Laboratory, San Gallicano
Dermatology Institute, Rome, Italy, 2 Depts. of Dermatology, Venereology, Allergology and
Immunology, Dessau Medical Center, Dessau, Germany and 3 R&D, Giuliani SpA, Milan, Italy
Increased sebum production and inflammation are accounted amongst the major factors involved
in the pathogenesis of acne. A growing body of evidence indicates that peroxisome proliferators-
activated receptor gamma (PPARγ), one of the three PPARs isoforms, offers a promising target for
the treatment of acne. PPARγ controls lipogenesis in sebaceous gland cells and exerts anti-inflam-
matory activities in various cell types by inhibiting the expression of pro-inflammatory mediators,
such as cytokines. Anyway, PPARγ agonists have been shown significant side effects that may be
linked to their mechanism of action. Recently, a novel class of PPARγ agonists has been designed
to increase specificity of the ligand-receptor interaction associated with a low cytotoxicity. We inves-
tigated the capacity of GMG-43AC to exert sebum regulating effects on SZ95 sebocytes. The mod-
ulation of lipid synthesis by GMG-43AC was evaluated in SZ95 stimulated with the combination
linoleic acid/testosterone. In SZ95 the increased PPARγ mRNA expression by 1 mM GMG-43AC
was associated with a significant reduction of the sebaceous lipids synthesis, as demonstrated with
the assay of Nile Red incorporated into neutral lipids and by gas chromatography-mass spectrom-
etry analysis. These results highlighted the ability of GMG-43AC to counteract the increased sebo-
genesis making it a potential new drug in the therapy of acne.
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iASPP/p63 auto-regulatory feedback loop is essential for epithelial integrity and autophagy
A Chikh and D Bergamaschi Centre for Cutaneous Research, Queen Mary University of
London, London, United Kingdom
iASPP, an inhibitory member of the ASPP family (apoptosis stimulating protein of p53) is an evolu-
tionarily conserved inhibitor of p53, which is frequently upregulated in human cancers. Here, we
investigate the function of iASPP under physiological conditions and hypothesise that it is involved
in epithelium integrity and autophagy. Immunohistochemical staining revealed that iASPP is detected
in human and mouse skin, specifically in the basal layer of the epidermis. Silencing of iASPP in ker-
atinocytes affected proteins related to epidermal adhesion, growth, differentiation and apoptosis.
We demonstrate a novel auto-regulatory feedback loop which controls crucial physiological activ-
ities by linking iASPP to p63, via two previously unreported micro-RNA. By investigating its func-
tion in stratified epithelia, we show that iASPP participates in the epithelial integrity program con-
ducted by p63; its silencing affects cellular adhesion, proliferation and differentiation. To assess the
role of iASPP in the skin, 3D organotypic skin models were established using keratinocytes depleted
for iASPP. Results showed that silencing of iASPP promotes differentiation whilst simultaneously
inhibiting the proliferation process in the stratified epidermal compartment of the skin. Our data
highlights that the integrity of the cell junctional complex in the epidermis rely on iASPP expres-
sion thus strengthening our model of an auto-regulatory feedback loop with p63. Our data also
suggest that iASPP is a potent inhibitor of autophagy because of its involvement in the metabolic
process of cell survival under stress conditions. Our results demonstrate a novel molecular mech-
anism driven by iASPP occurring in basal keratinocytes and confirm that iASPP is a key regulator
of epithelial integrity and metabolism. Together these findings provide a molecular basis for human
skin diseases, orchestrated by iASPP. Furthermore the function of iASPP in normal skin could have
significant implications for understanding the molecular mechanisms that underlie skin cancers.
333
Aldo-keto Reductase 1C3 (AKR1C3) is expressed in differentiated human epidermis and is
required for calcium-induced keratin 10 expression
A Mantel, A Mendini, J VanBuskirk and AP Pentland Dermatology, University of Rochester,
Rochester, NY
Sex hormones and prostaglandins (PG) have been shown to play a role in skin functions such as
keratinocyte proliferation, androgenic alopecia and skin cancer. The Aldo-Ketoreductase superfamily
consists of monomeric oxidoreductases that utilize NAD(P)(H) to reduce aldehydes and ketone
groups of substrates to their corresponding alcohols. AKR1C3 synthesizes PGF and activates sex
hormones. This suggests it has a role in ligand availability for signaling via estrogen, androgen and
PGF receptors. We sought to understand this enzyme’s role in epidermal function. Immunofluores-
cence revealed AKR1C3 colocalizes with differentiation marker keratin 10, but not keratin 5. West-
ern blot and RT-PCR revealed strong upregulation of both AKR1C3 protein and mRNA in calcium
induced differentiation. Utilizing siRNA and pharmacological approaches, we tested the role of
AKR1C3 in keratinocyte differentiation. AKR1C3 specific siRNA reduced AKR1C3 cDNA 46.5 fold
over control. Reduction was highly specific, with an 8.15 fold preference over related AKR1C fam-
ily member. By western blot, >85% knockdown of AKR1C3 occurred. PGD2 reduction to
9α,11β−PGF2 is a specific enzymatic reaction of AKR1C3. Using 9α,11β−PGF2 ELISA, we assessed
AKR1C3 activity in siRNA transfected cells and cells treated with 2’-hydroxyflavanone. AKR1C3
siRNA treatment reduced 9α,11β−PGF2 synthesis 93% at 30 min while 5μM 2’-hydroxyflavanone
inhibited AKR1C3 activity 84%. We then evaluated AKR1C3 action in keratinocyte differentiation.
Cells were treated with AKR1C3 siRNA or with 2’-hydroxyflavanone, induced to differentiate, and
the expression keratin 10 and loricrin was assessed. Keratin 10 expression was severely impaired
in siRNA or drug treated cells at all time points. In contrast, loricrin appeared to be induced. This
work demonstrates AKR1C3 activity participates in the differentiation associated protein regula-
tion.
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Dynamics of three-dimensional organization of the nucleus during terminal differentiation
of the epidermal keratinocytes
M Gdula,1 K Poterlowicz,1 A Mardaryev,1 A Sharov,2 M Fessing1 and V Botchkarev1,2 1 Centre for
Skin Sciences, University of Bradford, Bradford, United Kingdom and 2 Dermatology, Boston
University, Boston, MA
During terminal differentiation of the epidermal keratinocytes, nucleus undergoes programmed
transformation from highly active state associated with realization of the genetic program of epi-
dermal barrier formation to fully inactive condition and becomes a part of the keratinized cells of
the cornified epidermal layer. Here, we describe changes in three-dimensional organization of the
nucleus in the differentiating keratinocytes of the mouse epidermis in situ. By 3D-FISH and confo-
cal microscopy, we show that transition of the keratinocytes from basal epidermal layer to the spin-
ous layer is accompanied by increase of the transcription activity (as determined by immunostain-
ing for phospho-Serine-2 RNA Polymerase II) and expression of the tri-methylated H3K4 as a marker
of “active” chromatin, as well as by significant decrease in number of nucleoli and by increase of
their volume, possibly due to their fusion. However, number of the alpha-satellite chromatin domains
and expression of tri-methylated H3K9 as the markers of heterochromatin also increased in cells of
the spinous layer versus basal keratinocytes. Transition of the keratinocytes from the spinous to gran-
ular epidermal layer was accompanied by marked decrease of phospho-Serine-2 Pol II and trimethyl-
H3K4 expression, further decrease in a number of nucleoli, and by changes in the radial positions
of alpha-satellite chromatin clusters expressing tri-methyl-H3K9. This suggests that cessation of the
transcriptional activity in terminally differentiated cells is accompanied by re-arrangement of the
heterochromatin resulting in its more central positioning in the nucleus. In summary, we demon-
strated a specific remodeling of the nuclear architecture and global spatial chromatin re-arrange-
ment during epidermal keratinocyte differentiation in situ. Further studies of mechanisms control-
ling this remodeling will help to deeper understand a biology of cell differentiation process in healthy
and diseased epidermis.
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A plant extract boosts lysyl oxidase expression in keratinocytes and improves terminal dif-
ferentiation in a skin equivalent model
V Cenizo,1 G Le Provost,2 V André-Frei1 and P Sommer2 1 BASF Beauty Care Solutions France,
Lyon, France and 2 Institute for Biology and Chemistry of Proteins, Lyon, France
Skin aging is characterized by an epidermal thinning, due to a reduction of cell renewal and a dis-
organization of the differentiated keratinocyte layers. Lysyl oxidase (LOX) is an extracellular enzyme
that cross-links elastin and fibrillar collagens in connective tissues that is also found in epithelia
where its role remains unclear. In the epidermis, LOX protein is only expressed in differentiated
suprabasal layers which decrease with aging. Previous results showed that inhibiting LOX activity
or silencing its gene using a short hairpin RNA (shRNA) delayed the appearance of early differen-
tiation markers and impaired terminal differentiation in tridimensional culture models made of nor-
mal or immortalized human keratinocytes. These data designated LOX as an important target to
restore epidermal terminal differentiation in aging skin. Therefore, we screened a compound library
and selected a plant extract as a potent inducer of LOX gene expression. On confluent keratinocyte
monolayers this induction was followed by an increase of some early differentiation markers such
as K10, involucrin and transglutaminase. In a skin equivalent model made of normal human fibrob-
lasts and keratinocytes, the plant extract applied throughout the culture increased the same early
markers as well as late differentiation markers such as filaggrin and loricrin. This up-regulation was
accompanied by an increase in the number of spinous and granulous layers leading to a thicker
epidermis. Taken together, these in vitro results suggest that a subtle regulation of LOX improves
epidermal homeostasis. Moreover, in our reconstructed skin model, the plant extract appeared to
increase epidermal thickness without impairing the normal terminal differentiation process. On the
contrary, it increased components of the cornified envelope which are crucial players for barrier
function formation.
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mRNA profiling of circumscribed palmoplantar hypokeratosis and the identification of ITGBL1
associated with the palmoplantar type-keratinization
M Yasuda,1,2 D Utsumi,4 Y Miyachi,3 H Uezato,4 O Ishikawa,2 DR Roop1 and K Takahashi4 1
Department of Dermatology, Charles C. Gates Center for Regenerative Medicine and Stem
Cell Biology, University of Colorado Denver, Aurora, CO, 2 Gunma University Graduate
School of Medicine, Maebashi, Japan, 3 Kyoto University Graduate School of Medicine,
Kyoto, Japan and 4 University of the Ryukyus Graduate School of Medicine, Naha, Japan
Circumscribed palmoplantar hypokeratosis (CPH) is a recently described keratoderma character-
ized by well-circumscribed, depressed macules on palmoplantar skin. Histological examination
showed a sudden disappearance of the thick stratum corneum at the depressed lesion. We found
that the expression of palmoplantar specific keratin K9 disappears in the hypokeratotic lesional epi-
dermis at the transition depending on the stage of progression, in contrast, these keratinocytes showed
K16 or K10 expression. Based on these observations, we proposed that the hypokeratotic epider-
mis of CPH might develop as a result of the clonal expansion of keratinocytes incapable of differ-
entiating into hyperkeratotic palmoplantar-type keratinocytes. Consequently, we performed mRNA
profile analysis in order to reveal the pathogenesis of CPH and the mechanism of palmoplantar type-
keratinization. RNAs captured from both hypokeratotic lesional and no-lesional adjacent skin by in
situ laser micro-dissection were used for microarray analysis after amplification. Among many mRNAs
altered in CPH, we focused on integrin β-like 1 (ITGBL1), which diminished in hypokeratotic lesional
skin. ITGBL1 was selectively and abundantly expressed at palmoplantar type keratinocytes com-
pared with those of trunk skin in both mRNA and protein levels. Immunohistochemically, ITGBL1
was abundantly localized at the cell membrane of suprabasal layer in the palmoplantar epidermis,
whereas keratinocytes at the trunk skin did not show obvious expression. Our results implicate the
loss of ITGBL1 in causing CPH, and further studies will be required to determine how the loss of
ITGBL1 can induce the pathology associated with CPH.
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Association of the chromosome 11q13.5 polymorphism with atopic eczema in Austrian patients
EK Greisenegger,1 F Zimprich,2 A Zimprich,2 A Gleiss3 and T Kopp1 1 Department of
Dermatology, DIAID, Medical University of Vienna, Vienna, Austria, 2 Department of
Neurology, Medical University of Vienna, Vienna, Austria and 3 Core Unit for Medical
Statistics and Informatics, Section of Clinical Biometrics, Medical University of Vienna, Vienna,
Austria
Recently, the two single nucleotide polymorphisms rs7927894 on chromosome 11q13.5 and
rs877776 within the region of the hornerin gene were identified as novel susceptibility variants for
atopic eczema in the first genome wide association study in atopic eczema. The aim of our study
was to evaluate the influence of these two genetic variants on atopic eczema and disease-related
phenotypes in the Austrian population. 275 atopic eczema patients and 243 controls were geno-
typed for the two variants rs7927894 and rs877776 by using Taqman based allelic discrimination
assays. When comparing patients with controls we found a significant association of the rs7927894
variant on chromosome 11q13.5 with atopic eczema (p= 0.010; OR: 1.71; CI 1.14-2.59). Sub-
group analysis revealed no significant association of rs7927894 with age of onset, concomitant
asthma and allergic rhinoconjunctivitis, total serum IgE levels and family history of atopy. The analy-
sis of the rs877776 variant showed neither a relevant difference in the allelic distribution between
patients and controls nor a statistical significant association with any of the analyzed atopic eczema
phenotypes. In summary our data show a statistical significant association of the rs7927894 vari-
ant on chromosome 11q13.5 with atopic eczema but not with other disease-related phenotypes.
Therefore, we assume that the rs7927894 single nucleotide polymorphism selectively influences
eczema development. More investigations in distinct study populations are needed to assess the
role of this interesting polymorphism in atopic eczema.
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Insulin/IGF-1 signaling controls epidermal morphogenesis by regulating asymmetric divisions
H Stachelscheid,1,2 C Guenschmann,1,2 A Schmitz,1 JC Bruening2,3 and CM Niessen1,3 1
Department of Dermatology, University of Cologne, Cologne, Germany, 2 Institute for
Genetics, University of Cologne, Cologne, Germany and 3 Cologne Cluster on Cellular Stress
Responses in Aging associated diseases (CECAD), University of Cologne, Cologne, Germany
The skin epidermal barrier protects the organism from external challenges and dehydration. Recently,
we identified insulin/IGF-1 signaling as key determinants of epidermal morphogenesis and prolif-
erative potential. We observed a progressive decrease in the number of suprabasal layers in insulin
receptor (IR), IGF-1 receptor (IGF-1R) or IR/IGF-1R (dko) knockout mice, first obvious at E16.5. Here
we examined how IR/IGF-1R signalling regulate epidermal morphogenesis. At E16.5 a reduced num-
ber of anaphase spindles and an increased number of metaphase spindles were found in dko mice
compared to control, and in vitro in cultured keratinocytes. This indicated an arrest in the spindle
checkpoint of the cell cycle in the absence of IR/IGF-1R. This was associated with disturbed spin-
dle formation in IGF-1R-/- metaphase cells and reduced expression of AuroraB, a key regulator of
mitosis, as well as other cell cycle regulators, such as p53 and stratifin (14-3-3σ). Interestingly, the
reduction in cell divisions upon loss of IR/IGF-R was predominantly on the expense of asymmetric
divisions and correlated with reduced p63 expression, previously implicated in this process. Since
asymmetric cell divisions have been implicated in regulating epidermal stratification, the results
indicate that epidermal Insulin/IGF1 signaling couples cell cycle progression to asymmetric divi-
sions thereby regulating the number of suprabasal layers in the IFE during morphogenesis.
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A multifactorial gene expression approach to understanding skin aging
HE Knaggs,1 DG Kern,1 M Bartlett,1 SM Wood,1 A Mastaloudis,1 SB Ferguson1 and A Langerveld2
1 Center for Anti-Aging Research, Nu Skin Enterprises, Inc., Provo, UT and 2 Genemarkers
LLC, Portage, MI
The advent of genomic research has opened up new ways of investigating skin aging as well as
overall aging. From the present and continuing into the foreseeable future, vast amounts of gene
expression data will need to be evaluated to produce meaningful interpretations and conclusions.
Among the most promising routes are methodologies that seek to understand the interactions of
multiple genes during aging. Aging is the result of complex multifactorial influences occurring over
time between lifestyle choices, environment and genome, necessitating the study of multiple genes
and expression patterns in multiple tissues. Additionally, tissues age at different rates and their capac-
ity to repair varies. By scanning the entire genome of multiple key tissues using microarrays we
have identified multiple genetic expression patterns that occur with aging. Further, comparing
these genetic expression changes across many individuals has enabled the identification of changes
that are common and have a strong correlation with aging or youthfulness. This permits the desig-
nation of a key set of genetic markers that can be used to screen for active ingredients affecting these
genetic markers. Using data from muscle and skin, we describe our approach to discover multiple
markers of skin aging, their use in screening for candidate aging response modulators and demon-
strate the efficacy in modulating the gene expression of what we call skin youth gene clusters.
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The disintegrin/metalloproteinase ADAM10 controls epidermal Notch signaling and skin
homeostasis
S Weber,1 MT Niessen,2 J Prox,1 R Lüllmann-Rauch,3 R Schwanbeck,1 CP Blobel,4 E Jorissen,5,6
B de Strooper,5,6 CM Niessen2 and P Saftig1 1 Institut für Biochemie, University of Kiel, Kiel,
Germany, 2 Department of Dermatology, University of Cologne, Cologne, Germany, 3 Institute
for Anatomy, University of Kiel, Kiel, Germany, 4 Departments of Medicine and of Physiology,
Weill Medical College of Cornell University, New York, NY, 5 Center for Human Genetics,
University of Leuven, Leuven, Belgium and 6 Department for Developmental and Molecular
Genetics, VIB, Leuven, Belgium
The disintegrin and metalloproteinase ADAM10 has been implicated in the regulation of several key
signalling pathways that determine skin morphogenesis and homeostasis. To address the in vivo rel-
evance of ADAM10 in the epidermis and in key signaling pathways we have selectively disrupted
ADAM10 in the developing epidermis. This results in perinatal lethality of the mice associated with
barrier impairment and absence of sebaceous glands. Loss of ADAM10 triggers a premature differ-
entiation of spinous keratinocytes as reflected in reduced numbers of spinous layers. Postnatal
deletion of ADAM10 resulted in loss of hair, misformed vibrissae, epidermal hyperproliferation and
cyst formation, thymic atrophy and upregulation of the cytokine thymic stromal lymphopoetin (TSLP),
thus indicating disturbed skin homeostasis leading to systemic disease, likely due to a compromised
barrier. Previous studies implicated ADAM10 in Nocth signalling as well as cadherin shedding. Both
Notch processing and E-cadherin shedding is strongly reduced. This results in decreased levels of
signaling-competent Notch intracellular domain fragment and functional Notch signaling. The data
identify ADAM10 as a key regulator of cadherin and Notch function in the epidermis in vivo, and
thus as a central regulator of skin development and maintenance.
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Enhancement of the desmoplakin-keratin association promotes keratinocyte intercellular
hyperadhesion
RP Hobbs1 and KJ Green1,2 1 Pathology, Northwestern University, Chicago, IL and 2
Dermatology, Northwestern University, Chicago, IL
Desmosomes play a crucial role in providing the epidermis with structural integrity and resistance
to mechanical stress by anchoring the tension-bearing keratin intermediate filament (IF) cytoskele-
ton to the desmosomal plaque protein desmoplakin (DP) at sites of cell-cell contact. Within tissues
it has been proposed that desmosomes establish a state of robust intercellular adhesion termed
hyperadhesion that contrasts with the calcium-sensitive state of newly formed desmosomes in dynam-
ically remodeling epithelia of developing embryos and healing wounds. We hypothesized that
enhancement of IF association with desmosomes may promote the acquisition of hyperadhesion in
epithelial sheets. Previously, we determined that expression of a point mutant that abrogates a PKC
consensus sequence within the IF-binding domain of DP (DPS2849G) enhanced the DP-IF associa-
tion, induced sequestration of DP on IF, and impaired desmosome assembly. Using a tet-inducible
system, we have determined that epithelial sheets expressing DPS2849G-GFP acquire hyperadhesive
desmosomes at a faster rate (2 days) than wild-type DP-GFP expressing sheets (6 days). Addition-
ally, it was previously established that PKC stimulation reverted hyperadhesive desmosomes to a
state of weaker adhesion. In our study, epithelial sheets expressing DPS2849G-GFP failed to revert to
weakly adherent sheets following pharmacologic PKC stimulation, suggesting that PKC-mediated
DPS2849 modification may be crucial for acquiring hyperadhesive desmosomes. Thus, phosphoryla-
tion of DPS2849 may serve as a dual-regulatory inside-out switch to control both desmosome assem-
bly and acquisition of hyperadhesion. DPS2849G behavior is mimicked by endogenous DP in ker-
atinocytes from patients with Darier’s disease, which harbor mutations in the SERCA2 intracellular
calcium pump and exhibit altered PKC signaling. Altogether these results suggest that PKC-depend-
ent modulation of DP-IF association is a common target impacting epidermal morphogenesis, tis-
sue remodeling and disease pathogenesis.
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Localization of the novel hair shaft protein VSIG8 in the hair follicle, nail unit, and oral cav-
ity
RH Rice,1 MA Phillips1 and JP Sundberg2 1 Environmental Toxicology, University of California,
Davis, CA and 2 Research & Development, The Jackson Laboratory, Bar Harbor, ME
The molecular bases of diseases of the epidermal appendages are gradually being elucidated as
genes encoding their constituents and regulation are defined. Identification of prominent constituents
will speed recognition of genes whose defects contribute to aberrant structure directly, or in some
cases indirectly, by exacerbating effects of deficiencies in other genes. Present work helps charac-
terize the novel component V-set and immunoglobulin domain containing 8 (VSIG8) in hair shaft
and nail plate to assist understanding its possible relation to disease states. Using a specific anti-
peptide rabbit antiserum raised to a highly conserved unique peptide segment of the predicted pro-
tein, we found expression in the hair follicle that is limited to the late anagen and early catagen
stages of the hair cycle. Cuticle and cortex layers of the hair shaft were immunoreactive, notably in
projections of the cortex into medullary cells. Immunoreactivity also was found in the superficial
layers of the nail matrix. In extracts of mouse and rat tissues, dorsal tongue, buccal, and esophageal
epithelia were clearly immunoreactive, yielding a single band of ≈45 kDa, matching the mobility
of the translated coding region in transfected cultures. These findings emphasize the possibility that
VSIG8 has an important role in proper epithelial differentiation and function in the upper alimen-
tary tract as well as epidermis. To elucidate possible roles of VSIG8 in normal function and disease,
particularly in the integument, hundreds of mouse models for specific human diseases provide
invaluable tools for future work.
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The role of a novel PPARγ agonist (GMG-43AC) in the control of sebogenesis: prospective for
an innovating treatment of acne
M Ottaviani,1 A Mastrofrancesco,1 D Kovacs,1 M Ludovici,1 CC Zouboulis,2 G Giuliani,3
E Camera1 and M Picardo1 1 Cutaneous Physiopathology Laboratory, San Gallicano
Dermatology Institute, Rome, Italy, 2 Depts. of Dermatology, Venereology, Allergology and
Immunology, Dessau Medical Center, Dessau, Germany and 3 R&D, Giuliani SpA, Milan, Italy
Increased sebum production and inflammation are accounted amongst the major factors involved
in the pathogenesis of acne. A growing body of evidence indicates that peroxisome proliferators-
activated receptor gamma (PPARγ), one of the three PPARs isoforms, offers a promising target for
the treatment of acne. PPARγ controls lipogenesis in sebaceous gland cells and exerts anti-inflam-
matory activities in various cell types by inhibiting the expression of pro-inflammatory mediators,
such as cytokines. Anyway, PPARγ agonists have been shown significant side effects that may be
linked to their mechanism of action. Recently, a novel class of PPARγ agonists has been designed
to increase specificity of the ligand-receptor interaction associated with a low cytotoxicity. We inves-
tigated the capacity of GMG-43AC to exert sebum regulating effects on SZ95 sebocytes. The mod-
ulation of lipid synthesis by GMG-43AC was evaluated in SZ95 stimulated with the combination
linoleic acid/testosterone. In SZ95 the increased PPARγ mRNA expression by 1 mM GMG-43AC
was associated with a significant reduction of the sebaceous lipids synthesis, as demonstrated with
the assay of Nile Red incorporated into neutral lipids and by gas chromatography-mass spectrom-
etry analysis. These results highlighted the ability of GMG-43AC to counteract the increased sebo-
genesis making it a potential new drug in the therapy of acne.
332
iASPP/p63 auto-regulatory feedback loop is essential for epithelial integrity and autophagy
A Chikh and D Bergamaschi Centre for Cutaneous Research, Queen Mary University of
London, London, United Kingdom
iASPP, an inhibitory member of the ASPP family (apoptosis stimulating protein of p53) is an evolu-
tionarily conserved inhibitor of p53, which is frequently upregulated in human cancers. Here, we
investigate the function of iASPP under physiological conditions and hypothesise that it is involved
in epithelium integrity and autophagy. Immunohistochemical staining revealed that iASPP is detected
in human and mouse skin, specifically in the basal layer of the epidermis. Silencing of iASPP in ker-
atinocytes affected proteins related to epidermal adhesion, growth, differentiation and apoptosis.
We demonstrate a novel auto-regulatory feedback loop which controls crucial physiological activ-
ities by linking iASPP to p63, via two previously unreported micro-RNA. By investigating its func-
tion in stratified epithelia, we show that iASPP participates in the epithelial integrity program con-
ducted by p63; its silencing affects cellular adhesion, proliferation and differentiation. To assess the
role of iASPP in the skin, 3D organotypic skin models were established using keratinocytes depleted
for iASPP. Results showed that silencing of iASPP promotes differentiation whilst simultaneously
inhibiting the proliferation process in the stratified epidermal compartment of the skin. Our data
highlights that the integrity of the cell junctional complex in the epidermis rely on iASPP expres-
sion thus strengthening our model of an auto-regulatory feedback loop with p63. Our data also
suggest that iASPP is a potent inhibitor of autophagy because of its involvement in the metabolic
process of cell survival under stress conditions. Our results demonstrate a novel molecular mech-
anism driven by iASPP occurring in basal keratinocytes and confirm that iASPP is a key regulator
of epithelial integrity and metabolism. Together these findings provide a molecular basis for human
skin diseases, orchestrated by iASPP. Furthermore the function of iASPP in normal skin could have
significant implications for understanding the molecular mechanisms that underlie skin cancers.
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Aldo-keto Reductase 1C3 (AKR1C3) is expressed in differentiated human epidermis and is
required for calcium-induced keratin 10 expression
A Mantel, A Mendini, J VanBuskirk and AP Pentland Dermatology, University of Rochester,
Rochester, NY
Sex hormones and prostaglandins (PG) have been shown to play a role in skin functions such as
keratinocyte proliferation, androgenic alopecia and skin cancer. The Aldo-Ketoreductase superfamily
consists of monomeric oxidoreductases that utilize NAD(P)(H) to reduce aldehydes and ketone
groups of substrates to their corresponding alcohols. AKR1C3 synthesizes PGF and activates sex
hormones. This suggests it has a role in ligand availability for signaling via estrogen, androgen and
PGF receptors. We sought to understand this enzyme’s role in epidermal function. Immunofluores-
cence revealed AKR1C3 colocalizes with differentiation marker keratin 10, but not keratin 5. West-
ern blot and RT-PCR revealed strong upregulation of both AKR1C3 protein and mRNA in calcium
induced differentiation. Utilizing siRNA and pharmacological approaches, we tested the role of
AKR1C3 in keratinocyte differentiation. AKR1C3 specific siRNA reduced AKR1C3 cDNA 46.5 fold
over control. Reduction was highly specific, with an 8.15 fold preference over related AKR1C fam-
ily member. By western blot, >85% knockdown of AKR1C3 occurred. PGD2 reduction to
9α,11β−PGF2 is a specific enzymatic reaction of AKR1C3. Using 9α,11β−PGF2 ELISA, we assessed
AKR1C3 activity in siRNA transfected cells and cells treated with 2’-hydroxyflavanone. AKR1C3
siRNA treatment reduced 9α,11β−PGF2 synthesis 93% at 30 min while 5μM 2’-hydroxyflavanone
inhibited AKR1C3 activity 84%. We then evaluated AKR1C3 action in keratinocyte differentiation.
Cells were treated with AKR1C3 siRNA or with 2’-hydroxyflavanone, induced to differentiate, and
the expression keratin 10 and loricrin was assessed. Keratin 10 expression was severely impaired
in siRNA or drug treated cells at all time points. In contrast, loricrin appeared to be induced. This
work demonstrates AKR1C3 activity participates in the differentiation associated protein regula-
tion.
334
Dynamics of three-dimensional organization of the nucleus during terminal differentiation
of the epidermal keratinocytes
M Gdula,1 K Poterlowicz,1 A Mardaryev,1 A Sharov,2 M Fessing1 and V Botchkarev1,2 1 Centre for
Skin Sciences, University of Bradford, Bradford, United Kingdom and 2 Dermatology, Boston
University, Boston, MA
During terminal differentiation of the epidermal keratinocytes, nucleus undergoes programmed
transformation from highly active state associated with realization of the genetic program of epi-
dermal barrier formation to fully inactive condition and becomes a part of the keratinized cells of
the cornified epidermal layer. Here, we describe changes in three-dimensional organization of the
nucleus in the differentiating keratinocytes of the mouse epidermis in situ. By 3D-FISH and confo-
cal microscopy, we show that transition of the keratinocytes from basal epidermal layer to the spin-
ous layer is accompanied by increase of the transcription activity (as determined by immunostain-
ing for phospho-Serine-2 RNA Polymerase II) and expression of the tri-methylated H3K4 as a marker
of “active” chromatin, as well as by significant decrease in number of nucleoli and by increase of
their volume, possibly due to their fusion. However, number of the alpha-satellite chromatin domains
and expression of tri-methylated H3K9 as the markers of heterochromatin also increased in cells of
the spinous layer versus basal keratinocytes. Transition of the keratinocytes from the spinous to gran-
ular epidermal layer was accompanied by marked decrease of phospho-Serine-2 Pol II and trimethyl-
H3K4 expression, further decrease in a number of nucleoli, and by changes in the radial positions
of alpha-satellite chromatin clusters expressing tri-methyl-H3K9. This suggests that cessation of the
transcriptional activity in terminally differentiated cells is accompanied by re-arrangement of the
heterochromatin resulting in its more central positioning in the nucleus. In summary, we demon-
strated a specific remodeling of the nuclear architecture and global spatial chromatin re-arrange-
ment during epidermal keratinocyte differentiation in situ. Further studies of mechanisms control-
ling this remodeling will help to deeper understand a biology of cell differentiation process in healthy
and diseased epidermis.
335
A plant extract boosts lysyl oxidase expression in keratinocytes and improves terminal dif-
ferentiation in a skin equivalent model
V Cenizo,1 G Le Provost,2 V André-Frei1 and P Sommer2 1 BASF Beauty Care Solutions France,
Lyon, France and 2 Institute for Biology and Chemistry of Proteins, Lyon, France
Skin aging is characterized by an epidermal thinning, due to a reduction of cell renewal and a dis-
organization of the differentiated keratinocyte layers. Lysyl oxidase (LOX) is an extracellular enzyme
that cross-links elastin and fibrillar collagens in connective tissues that is also found in epithelia
where its role remains unclear. In the epidermis, LOX protein is only expressed in differentiated
suprabasal layers which decrease with aging. Previous results showed that inhibiting LOX activity
or silencing its gene using a short hairpin RNA (shRNA) delayed the appearance of early differen-
tiation markers and impaired terminal differentiation in tridimensional culture models made of nor-
mal or immortalized human keratinocytes. These data designated LOX as an important target to
restore epidermal terminal differentiation in aging skin. Therefore, we screened a compound library
and selected a plant extract as a potent inducer of LOX gene expression. On confluent keratinocyte
monolayers this induction was followed by an increase of some early differentiation markers such
as K10, involucrin and transglutaminase. In a skin equivalent model made of normal human fibrob-
lasts and keratinocytes, the plant extract applied throughout the culture increased the same early
markers as well as late differentiation markers such as filaggrin and loricrin. This up-regulation was
accompanied by an increase in the number of spinous and granulous layers leading to a thicker
epidermis. Taken together, these in vitro results suggest that a subtle regulation of LOX improves
epidermal homeostasis. Moreover, in our reconstructed skin model, the plant extract appeared to
increase epidermal thickness without impairing the normal terminal differentiation process. On the
contrary, it increased components of the cornified envelope which are crucial players for barrier
function formation.
336
mRNA profiling of circumscribed palmoplantar hypokeratosis and the identification of ITGBL1
associated with the palmoplantar type-keratinization
M Yasuda,1,2 D Utsumi,4 Y Miyachi,3 H Uezato,4 O Ishikawa,2 DR Roop1 and K Takahashi4 1
Department of Dermatology, Charles C. Gates Center for Regenerative Medicine and Stem
Cell Biology, University of Colorado Denver, Aurora, CO, 2 Gunma University Graduate
School of Medicine, Maebashi, Japan, 3 Kyoto University Graduate School of Medicine,
Kyoto, Japan and 4 University of the Ryukyus Graduate School of Medicine, Naha, Japan
Circumscribed palmoplantar hypokeratosis (CPH) is a recently described keratoderma character-
ized by well-circumscribed, depressed macules on palmoplantar skin. Histological examination
showed a sudden disappearance of the thick stratum corneum at the depressed lesion. We found
that the expression of palmoplantar specific keratin K9 disappears in the hypokeratotic lesional epi-
dermis at the transition depending on the stage of progression, in contrast, these keratinocytes showed
K16 or K10 expression. Based on these observations, we proposed that the hypokeratotic epider-
mis of CPH might develop as a result of the clonal expansion of keratinocytes incapable of differ-
entiating into hyperkeratotic palmoplantar-type keratinocytes. Consequently, we performed mRNA
profile analysis in order to reveal the pathogenesis of CPH and the mechanism of palmoplantar type-
keratinization. RNAs captured from both hypokeratotic lesional and no-lesional adjacent skin by in
situ laser micro-dissection were used for microarray analysis after amplification. Among many mRNAs
altered in CPH, we focused on integrin β-like 1 (ITGBL1), which diminished in hypokeratotic lesional
skin. ITGBL1 was selectively and abundantly expressed at palmoplantar type keratinocytes com-
pared with those of trunk skin in both mRNA and protein levels. Immunohistochemically, ITGBL1
was abundantly localized at the cell membrane of suprabasal layer in the palmoplantar epidermis,
whereas keratinocytes at the trunk skin did not show obvious expression. Our results implicate the
loss of ITGBL1 in causing CPH, and further studies will be required to determine how the loss of
ITGBL1 can induce the pathology associated with CPH.
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Microarray analysis of a marine extract as a potential inhibitor of cigarette smoke-induced
skin aging
RS Carver, K Tian, N Sinha and J Litchauer Department of Cell Biology, Beauty Care Solutions,
Stony Brook, NY
Cigarette smoking causes alterations in the structure and composition of the dermis and epidermis,
and has been shown to be a stronger predictor of skin aging than UV exposure. Molecular mecha-
nisms responsible for these effects are only beginning to be elucidated. The purpose of this study is
to investigate the potential of a proprietary marine-based extract to positively affect biological path-
ways involved in the tobacco-related skin aging process. Cultured monolayers of primary human
keratinocytes or dermal fibroblasts were exposed for 24hrs to aqueous cigarette smoke extract
(CSE) alone, or in the presence of a proprietary, marine-based extract. The extract was added simul-
taneously, or 24hrs prior to exposure to CSE. By microarray analysis, we then explored the poten-
tial for this extract to block or reverse the cellular responses to tobacco exposure at the gene expres-
sion level. In cultured fibroblasts, a total of 938 genes were regulated using a minimum cutoff of
85% induction or 46% suppression. Of those genes, 33 were counter-regulated to a significant
degree by inclusion of the marine extract before or during exposure to the CSE. These include: SOD1,
glutathione peroxidase, glutaredoxin 2, MMP3, endothelin 1, cytochrome p450, plus others. In
keratinocytes, a total of 887 genes were induced or suppressed by CSE with 30 genes significantly
counter regulated by the marine extract. These include: MMPs 1, 3, and 15, an oxidative stress
marker (OXSR1), IL13 receptor, IGF2 receptor, plus others. In conclusion, this proprietary marine
extract counter-regulated important genes involved in smoking related aging pathways. This cos-
metic ingredient could represent a potential treatment or preventative regimen for improving the
appearance of human skin affected by premature wrinkling, discoloration and structural changes
related to tobacco use.
351
Understanding transcriptional regulation of the epidermal differentiation complex (EDC)
locus by sequence motif discovery
D Albea and C de Guzman Strong Division of Dermatology, Department of Internal Medicine,
Washington University, St. Louis, MO
The epidermal differentiation complex (EDC) locus is comprised of FLG-like, LCE, SPRR, and S100
gene families that encode proteins required for the essential skin barrier. Both atopic dermatitis and
psoriasis, two common inflammatory skin diseases, share genetic linkage to the EDC. To date, lit-
tle is known about the coordinate regulation of the EDC during skin development. We previously
reported enhancer and repressor activities in a set of conserved noncoding elements within the EDC
in proliferating and differentiating keratinocytes suggesting dynamic cis-regulation. Using compu-
tational approaches, we further investigate the hypothesis that specific transcription factors are
responsible for the regulatory activities. Transcription factor database and Gibbs Sampler bioinfor-
matic inquiries identified common known and novel sequence motifs as potential transcription fac-
tor binding sites unique to each enhancer and repressor datasets. These motifs correlate to digital
DNaseI hypersensitivity suggesting a discrete and functional role for the transcription factors that
bind to these sequences in EDC regulation. Elucidation of these transcription factors will greatly
enhance our understanding of the molecular mechanism underlying epidermal differentiation and
inform skin disease studies.
353
Induced of permeation pathway and nanoparticles penetration by ultrasound contrast agent
with ultrasound in hairless mouse skin
K Choi,1 D Park,,2 S Lee,3 H Kweon,1 J Seo,2 B Lee4 and S Lee2 1 Division of Electron Microscopic
Research, Korea Basic Science Institute, Daejeon, Republic of Korea, 2 Department of
Biomedical Engineering, Yonsei University, Wonju, Republic of Korea, 3 Department of
Dermatology, Yonsei University College of Medicine, Seoul, Republic of Korea and 4
Nanopharm Corporation, Seoul, Republic of Korea
Sonophoresis uses ultrasound to increase the percutaneous absorption of drugs. Even though the
mechanisms of action are incompletely defined, the cavitation effect is believed to be responsible
for the ultrasonic permeabilization of cells and tissues such as skin. The cavitation effect is one of
the important mechanisms of skin permeation by Ultrasound. Theoretically, cavitation is demon-
strated to occur because of the presence of oxygen and nitrogen dissolved in the stratum corneum
and the existence of lacunae between corneocytes and can be a route of drug delivery. A more effi-
cient way to ensure cavitation could be to adopt a method where ultrasound contrast agent(UCA)
with ultrasound was used at its resonance frequency. UCAs are engineered microsized bubbles such
that they can be stably sustained within the fluid. Albumin, lipid, and polymers have all been used
as shell materials to provide a balance force against Laplace pressure due to the curvature of the
bubbles. In this study, we examined the ultrastructural changes of stratum corneum and the pene-
tration of nanoparticles(NPs) with electron microscopy after treatment UCA with ultrasound. In
results indicated that the observed penetration of NPs and lacunar dilatation in SC after sonophore-
sis with UCA increases than after sonophoresis with UCA. We suggest that these ultrastructural
changes of SC may provide a new approach to explain the mechanism of action the efficacy of
sonophoresis treatment. And the use of a UCA appeared to increase cavitation, demonstrating that
the use of a UCA can be effective in transdermal drug delivery.
352
EGFR is activated in pemphigus vulgaris and contributes to anti-desmoglein 3 antibody-medi-
ated loss of cohesion in cultured mouse keratinocytes
B Sayar, C Luyet, K Schulze, MM Suter, EJ Mueller and A Galichet Molecular Dermatology,
University of Bern, Bern, Switzerland
Activation of EGFR and its contribution to loss of cell-cell adhesion in the autoimmune disease pem-
phigus vulgaris (PV) have been controversially discussed. To further address the implication of EGFR
in PV, here we firstly investigated EGFR activation in cultured mouse keratinocytes and adult mice
injected with the desmoglein (Dsg) 3 function-disrupting antibody AK23. Secondly, AK23-challenged
mouse keratinocytes were treated with EGFR inhibitors to assess the consequences on Dsg3 anti-
body-induced cellular changes. Our results confirm EGFR activation within the first 2 hours after
AK23 treatment by means of EGFR tyrosine phosphorylation as well as phosphorylation of EGFR
on Tyr845 and Tyr1173, both in vitro and in vivo. Treatment of cultured mouse keratinocytes with
the EGFR/ErbB2 inhibitor 4557W increased basal levels of EGFR and reduced phosphorylation by
90% in presence of AK23, demonstrating that EGFR inhibition was effective in these cells. The
inhibitor also reverted the AK23-induced loss of Dsg3 from desmosomes and prevented the previ-
ously reported upregulation of c-Myc and cyclin D2. Upregulation of c-Myc is pathogenic as has
been demonstrated pharmacologically in neonatal mice injected with PV IgG or AK23 and ectopic
c-Myc expression was sufficient to induce loss of adhesion in a dispase-based dissociation assay.
Consistent with these finding, the 4557W-mediated reduction in EGFR phosphorylation and c-Myc
steady state protein restored adhesion in presence of AK23. Interestingly, while two other EGFR/ErbB2
inhibitors also prevented the AK23-induced loss of cohesion, the EGFR inhibitor GW2974, which
mainly targets mutated EGFR in cancer cells, had no effect. Together these results demonstrate that
EGFR is activated in response to Dsg3 function-disrupting antibodies and suggest that this activa-
tion might contribute to PV pathogenesis. Furthermore, discrepancies in results on the involvement
of EGFR in PV may depend on the time point analyzed and the EGFR inhibitor used.
350
Ichthyosis prematurity syndrome: Lipid metabolic abnormalities lead to an epidermal bar-
rier defect and predispose to atopy
D Khnykin,1,2 D Crumrine,2 Y Uchida,2 M Lin,3 J Miner,3 F Jahnsen1 and P Elias2 1 LIIPAT, Institute
of Pathology, Oslo University Hospital, Oslo, Norway, 2 Department of Dermatology, UCSF,
San Francisco, CA and 3 Department of Cell Biology and Physiology, Washington University
School of Medicine, St. Louis, MO
Ichthyosis prematurity syndrome (IPS) (OMIM #608649) is a rare autosomal recessive, congenital
skin disorder which is well characterized in the Norwegian population. IPS patients have a persist-
ent pruritic, non-scaly ichthyosis and most patients have high eosinophilia and serum IgE levels.
Identifying mechanisms responsible for IPS pathology could have impact on our understanding for
how atopy develops. Our data indicate that increased IgE and high numbers of eosinophils are
caused by a primary defect in the skin that establishes a proallergic environment in fetal life, which
may lead to atopic manifestations later in life. Mutations in the gene encoding fatty acid transport
protein 4 (FATP4) have been reported to be causative for IPS. This protein has an acyl-CoA synthetase
domain and it also have been proposed to mediate uptake of free fatty acids (FFA) from extracellu-
lar milieu to the cells by the mechanism of vectorial acylation. Lipid analyses of FATP4 deficient
human and mouse stratum corneum show excess of FFA in the extracellular lipid membranes. Our
results from EM studies indicate that the accumulation of FFAs in cytosol of keratinocytes may account
for formation of pathognomonic membrane aggregations observed in IPS. Interestingly, we have
found the specific ultrastructural changes in ER-outer nuclear membranes in stratum granulosum
cells of FATP4-deficient skin, which may indicate that stability of ER is affected, perhaps by the deter-
gent activity of FFA or accumulation of other FFA metabolites. We are hypothesizing that lack of
FATP4 activity will lead to accumulation of free, unesterified fatty acids which may affect integrity
of intracellular organelles and/or may serve as ligands for signaling pathways that compromise skin
barrier function, leading to downstream activation of proinflammatory and proallergic responses.
354
Suction blister technique to evaluate skin fragility in children with recessive dystrophic epi-
dermolysis bullosa (RDEB) treated with immunomyeloablative chemotherapy and allogeneic
stem-cell transplantation
A Junqueira Bertin,1 J Tolar,2 M Osborn,2 R Farah,1 MK Hordinsky1 and JE Wagner2 1 Department
of Dermatology, University of Minnesota, Minneapolis, MN and 2 Blood and Marrow
Transplant Program, Department of Pediatrics, University of Minnesota, Minneapolis, MN
Collagen, elastic fibers, and glycosaminoglycans make up the viscoelastic properties of skin. RDEB
is caused by mutations in COL7A1, the gene encoding type VII collagen (C7) and is an incurable,
often fatal disease. Recently we described that after allogeneic hematopoietic transplantation
increased C7 deposition and a sustained presence of donor cells were found in the skin of children
with RDEB. In this study, we assessed cutaneous biomechanical properties in the children pre and
post-transplantation, their parents, and healthy donor siblings using a suction blister device (Elec-
tronic Diversities). We hypothesized that blister induction time would increase after transplantation
as a result of more C7 present in the skin and that the parents as obligatory C7 heterozygotes would
have reduced blister time formation when compared to the wild type. We evaluated 6 children (3F,
2M; ages 1.5 – 14) their parents and donor siblings. The suction blister device with three 3-mm sites
was applied approximately 1 mm from recent skin erosions on the upper or lower extremities, or
to normal appearing skin of the parents or donor siblings. The skin was exposed to constant nega-
tive pressure of 12 inches of mercury. Blister initiation and completion times were recorded in min-
utes and averaged. Results were as follows: Patients: Baseline/9.75 – 10, Day 30/ 6.55 – 11.5, Day
60/9.8 - 15.9, Day 100/8.5 - 18.4, Day 180/15.42 - 26.67, Day 450/13.76- 31 and 29.24 minutes
at 1000 days, Mothers: 30.5 – 51.03 minutes, Fathers: 24.4 – 42.09 minutes, Donor Siblings: 52 –
66.55 minutes. In conclusion, we were able to demonstrate improved cutaneous biomechanical
properties in the patient population and lower values in the parents as compared to the normal
donors. The patient findings could be related to the increased presence of C7 in the skin.
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Abca12-mediated lipid transport and Snap29-dependent trafficking of lamellar granules are
critical for epidermal morphogenesis
Q Li,1 M Frank,1 M Akiyama,2,3 H Shimizu,2 E Sprecher4 and J Uitto1 1 Jefferson Medical College,
Philadelphia, PA, 2 Hokkaido University Graduate School of Medicine, Sapporo, Japan, 3
Nagoya University Graduate School of Medicine, Nagoya, Japan and 4 Tel Aviv Medical
Center, Tel Aviv, Israel
Zebrafish (Danio rerio), a freshwater vertebrate with well characterized genome, can serve as a
model for heritable skin diseases. The skin is rapidly developed during the first 5-6 days of embry-
onic growth, accompanied by expression of skin specific genes. Transmission electron microscopy
(TEM) at day 5 reveals two-cell layer epidermis separated from the underlying collagenous stroma
by a basement membrane with fully developed hemidesmosomes. Scanning electron microscopy
reveals ordered surface contour of keratinocytes with discrete microridges. To gain insight into epi-
dermal morphogenesis, we have employed morpholino-mediated knockdown of abca12 and snap29
genes, critical secretion and intracellular trafficking of lipids by lamellar granules. Morpholinos,
when placed on exon-intron junctions, were >95% effective in preventing the corresponding gene
expression when injected into 1-4 cell stage embryos. As early as day 3, TEM of abca12 morphants
showed accumulation of lipid-containing electron-dense lamellar granules while snap29 morphants
showed presence of apparently empty vesicles in the epidermis. Evaluation of epidermal morpho-
genesis by SEM revealed perturbations in the microridge architecture and development of spicule-
like protrusions on the surface of keratinocytes. These morphologic findings are akin to epidermis
changes in harlequin ichthyosis and CEDNIK syndrome, autosomal recessive keratinization disor-
ders due to mutations in the ABCA12 and SNAP29 genes, respectively. The results indicate that inter-
ference of independent pathways involving lipid metabolism and trafficking in the epidermis can
result in phenotypically similar perturbations in epidermal morphogenesis, and that these fish mutants
can serve as a model to study the pathomechanisms of these keratinization disorders.
344
Histone deacetylases inhibitor Trichostatin A regulates microRNA gene expressions in human
keratinocytes
L Qu,1,2,3 R Qi,1,2,3 C He,3 X Gao,3 H Chen,3 Q Mi1,2 and L Zhou1,2 1 Immunology Program,
Henry Ford Health System, Detroit, MI, 2 Dept of Dermatology, Henry Ford Health System,
Detroit, MI and 3 Dept of Dermatology, No. 1 Hospital of China Medical University,
Shenyang, China
Histone deacetylases (HDACs) control gene expression by regulating both chromatin structure and
transcriptional factors deacetyled. Trichostatin A (TSA), one of HDACs inhibitors, can indirectly
perform its function through targeting class I and II HDACs. Recent study indicated that HDAC1/2
played an important role in hair follicle specification, epidermal proliferation and stratification.
HDACs inhibitors were also reported as potential anti-skin cancer new drugs, but the precise mech-
anism was not clear. MicroRNAs (miRNAs), a class of 21-25 nucleotides single-stranded non-cod-
ing small RNAs, are increasingly being recognized as important regulators of gene expression dur-
ing skin development. It’s unclear if the miRNA regulation pathway is involved in HDAC
inhibition-induced keratinocyte growth arrest. To test this, we have analyzed miRNA gene expres-
sion profiles in HaCat cells treated with or without TSA using TaqMan miRNA arrays. We have found
that 23 miRNAs were down-regulated and 37 miRNAs were up-regulated (-DCt value≥2). The miRNA
miR-449a, functioning as a cell cycle negative regulator through targeting E2F1 and cyclinD1, was
significantly up-regulated in TSA-treated keratinocytes. Furthermore, overexpression of miR-449a
in HaCat cells promotes a cell-arrested phenotype. Thus, our results highly suggest that miRNAs
may be key factors involved in HDAC inhibitor TSA-mediated the growth arrest in keratinocytes.
345
Tandem repeated irritation in aged skin induces distinct barrier perturbation and cytokine
expression patterns in vivo
I Angelova-Fischer,1 V Becker,1 W Wigger-Alberti,2 TW Fischer,1 S Kezic3 and D Zillikens1 1
Department of Dermatology, University of Lübeck, Lübeck, Germany, 2 Bioskin, Hamburg,
Germany and 3 Coronel Institute of Occupational Health, Amsterdam, Netherlands
The barrier perturbation and in vivo cytokine expression pattern upon tandem repeated irritation to
aged skin have not been studied so far. We investigated the permeability barrier function and cytokine
response to controlled application of irritant tandems with synergic effects in aged versus young
skin in vivo. Four fields on the volar forearms of healthy aged and young volunteers (mean age 64
and 32 years, respectively) were sequentially exposed to 0.5% sodium lauryl sulphate (SLS) and
undiluted toluene in standardized tandem repeated irritation test over 96 hours. An adjacent untreated
field served as control. The permeability barrier function was monitored by repeated measurements
of transepidermal water loss (TEWL), capacitance and erythema every 24 hours up to 96 hours. The
cytokine samples were harvested by tape stripping of the test fields and analysed by multiplex bead
array and enzyme-linked immunosorbent assay. The tandem application of SLS/SLS, SLS/toluene and
toluene/SLS resulted in significant TEWL increase in both age groups while no such changes for
toluene/toluene were observed. The aged group displayed distinct barrier perturbation kinetics upon
exposure to SLS/toluene and toluene/SLS, characterized by delayed increase in TEWL and chro-
mametry a*-value as well as significantly lower ΔTEWL at the end of the study (in the aged and
young group, respectively 12.71±2.82 and 30.88±5.97 g/m2/h; p<0.01). Furthermore, the aged
skin group was characterized by significantly lower interleukin-1 receptor antagonist (IL-1Ra)/inter-
leukin-1α (IL-1α) ratio upon exposure to SLS/toluene (p<0.01), toluene/SLS (p<0.05) and
toluene/toluene (p<0.01) compared to the young, attributable to both higher IL-1α and lower IL-
1Ra levels. Our results show distinct barrier perturbation and cytokine expression patterns upon
tandem repeated exposure to irritants in aged compared to young skin.
346
In vivo assessment of skin barrier after mechanical removal of stratum corneum shows evi-
dence of a dual repair mechanism
PR Bargo,1 S Walston,1,2 M Chu,1 I Seo,1 E Ruvolo1 and N Kollias1 1 Measurement Sciences,
Johnson & Johnson Consumer Companies, Skillman, NJ and 2 University of Southern
California, Los Angeles, CA
The stratum corneum (SC) primary function is to serve as skin barrier vital to the existence of ter-
restrial life. Disruption of the SC stimulates a repair response in the underlying viable epidermis
shown to be regulated by ions (i.e. Calcium), cytokines, proteinase-activated receptor 2 (PAR2) and
nitric oxide (NO). Signaling pathways for SC formation and the composition of the lipid-enriched
lamellar bodies and membranes that compose the SC have been extensively studied but few stud-
ies have been performed on evaluating human SC repair in vivo, non-invasively. In the present
work tape striping was used as a model of mechanical injury to the SC and the injuries were fol-
lowed for 10 days. Seven healthy volunteers were recruited for the study following informed con-
sent. Tape stripping was performed on the arms and legs of the volunteers until all the SC was
removed. The injured site and a control adjacent site were measured before, immediately after, 3
hours, 1, 2, 3, 7 and 10 days after the injury. Transepidermal water loss (TEWL), tryptophan fluo-
rescence and reflectance confocal microscopy were used to determine permeability of the skin
barrier, cell turnover and epidermal morphology, respectively. The results show an exponential rate
of recovery for the skin permeability (TEWL) which contrasted with a linear increase in the thick-
ness of the SC of 2 microns per day up to twice the original thickness as determined by confocal
microscopy. Cell turnover increased rapidly immediately after the injury to 2.5 times the levels of
the control site, attaining a maximum of 3.5-4 times greater levels after three days and slowly returned
to baseline levels after the ten days. Cell turnover as well as viable epidermis thickness showed
similar biphasic functions which may suggest a dual repair mechanism of the barrier.
347
Evidence of the active transport of water into human skin: A potential contributor to wound
healing
V Ionita Manzatu, M Ingrassia, J Lombardi and T Mammone Estee Lauder Co., Melville, NY
It has been shown in different epithelial systems (e.g. amphibian, cavies, human) that trans-epithe-
lial electric potential (TEEP) is involved in wound healing. We have observed that organotypic tis-
sue has a TEEP and hypothesized that this potential helps to pump and retain water in the skin. This
hypothesis is supported by the use of two controls, a positive and negative that has been shown in
other systems to affect TEEP and water transport. The effects of the Na+ channel-blocking diuretic
agent amiloride and Na+ channel-opening agent aldosterone were assessed in the high-resistance
(epithelium) skin models MatTech EFT-300. Amiloride caused a rapid and dose-dependent decrease
in TEEP accompanied by a decrease of water content of the skin when applied from the apical side
in concentrations of 0.1μM, 1 μM and 10 μM. Aldosterone which upregulates epithelial sodium
channels (ENaC), thereby increasing apical membrane permeability for Na+, caused a rapid and
dose-dependent increase in TEEP accompanied by an increase in water uptake in the skin, when
applied from apical side using similar concentrations as above. In addition to the well published
fact that TEEP is involved in wound healing of epithelial tissue, we observed an increase in water
content with increasing TEEP and the two phenomena may not be mutually exclusive.
348
Effects of ozone in normal human epidermal keratinocytes
J McCarthy, E Pelle, K Brahmbhatt, D Yarosh and N Pernodet Estee Lauder Research
Laboratories, Melville, NY
Overall increases in air pollution coupled with Ultraviolet B (UVB, 295 – 320 nm) exposures have
led to worldwide increases in ground-level, tropospheric ozone. Since ozone has an oxidation poten-
tial of 2.07, protecting the skin against ozone-related oxidative stress has become an important
objective. Previously, we examined ozone-induced lipid peroxidation in liposomal model systems,
as well as cytochrome P450 increases via aryl hydrocarbon receptor signaling in normal human
epidermal keratinocytes (NHEK). In this study we measured the generation of reactive oxygen species
(ROS) in NHEK that were exposed to environmentally relevant levels of ozone (0.3 – 0.4 ppm) for
30 minutes. After exposure, the cells were incubated with 10 uM dichlorodihydrofluorescein diac-
etate and their fluorescence measured after 6 hours. We observed a 29.6% (+/- 6.2% SD) increase
in fluorescence demonstrating the induction of ROS in epidermal cells. Further, in the presence of
the polyphenolic antioxidant, resveratrol, these increases were inhibited.
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Microarray analysis of a marine extract as a potential inhibitor of cigarette smoke-induced
skin aging
RS Carver, K Tian, N Sinha and J Litchauer Department of Cell Biology, Beauty Care Solutions,
Stony Brook, NY
Cigarette smoking causes alterations in the structure and composition of the dermis and epidermis,
and has been shown to be a stronger predictor of skin aging than UV exposure. Molecular mecha-
nisms responsible for these effects are only beginning to be elucidated. The purpose of this study is
to investigate the potential of a proprietary marine-based extract to positively affect biological path-
ways involved in the tobacco-related skin aging process. Cultured monolayers of primary human
keratinocytes or dermal fibroblasts were exposed for 24hrs to aqueous cigarette smoke extract
(CSE) alone, or in the presence of a proprietary, marine-based extract. The extract was added simul-
taneously, or 24hrs prior to exposure to CSE. By microarray analysis, we then explored the poten-
tial for this extract to block or reverse the cellular responses to tobacco exposure at the gene expres-
sion level. In cultured fibroblasts, a total of 938 genes were regulated using a minimum cutoff of
85% induction or 46% suppression. Of those genes, 33 were counter-regulated to a significant
degree by inclusion of the marine extract before or during exposure to the CSE. These include: SOD1,
glutathione peroxidase, glutaredoxin 2, MMP3, endothelin 1, cytochrome p450, plus others. In
keratinocytes, a total of 887 genes were induced or suppressed by CSE with 30 genes significantly
counter regulated by the marine extract. These include: MMPs 1, 3, and 15, an oxidative stress
marker (OXSR1), IL13 receptor, IGF2 receptor, plus others. In conclusion, this proprietary marine
extract counter-regulated important genes involved in smoking related aging pathways. This cos-
metic ingredient could represent a potential treatment or preventative regimen for improving the
appearance of human skin affected by premature wrinkling, discoloration and structural changes
related to tobacco use.
351
Understanding transcriptional regulation of the epidermal differentiation complex (EDC)
locus by sequence motif discovery
D Albea and C de Guzman Strong Division of Dermatology, Department of Internal Medicine,
Washington University, St. Louis, MO
The epidermal differentiation complex (EDC) locus is comprised of FLG-like, LCE, SPRR, and S100
gene families that encode proteins required for the essential skin barrier. Both atopic dermatitis and
psoriasis, two common inflammatory skin diseases, share genetic linkage to the EDC. To date, lit-
tle is known about the coordinate regulation of the EDC during skin development. We previously
reported enhancer and repressor activities in a set of conserved noncoding elements within the EDC
in proliferating and differentiating keratinocytes suggesting dynamic cis-regulation. Using compu-
tational approaches, we further investigate the hypothesis that specific transcription factors are
responsible for the regulatory activities. Transcription factor database and Gibbs Sampler bioinfor-
matic inquiries identified common known and novel sequence motifs as potential transcription fac-
tor binding sites unique to each enhancer and repressor datasets. These motifs correlate to digital
DNaseI hypersensitivity suggesting a discrete and functional role for the transcription factors that
bind to these sequences in EDC regulation. Elucidation of these transcription factors will greatly
enhance our understanding of the molecular mechanism underlying epidermal differentiation and
inform skin disease studies.
353
Induced of permeation pathway and nanoparticles penetration by ultrasound contrast agent
with ultrasound in hairless mouse skin
K Choi,1 D Park,,2 S Lee,3 H Kweon,1 J Seo,2 B Lee4 and S Lee2 1 Division of Electron Microscopic
Research, Korea Basic Science Institute, Daejeon, Republic of Korea, 2 Department of
Biomedical Engineering, Yonsei University, Wonju, Republic of Korea, 3 Department of
Dermatology, Yonsei University College of Medicine, Seoul, Republic of Korea and 4
Nanopharm Corporation, Seoul, Republic of Korea
Sonophoresis uses ultrasound to increase the percutaneous absorption of drugs. Even though the
mechanisms of action are incompletely defined, the cavitation effect is believed to be responsible
for the ultrasonic permeabilization of cells and tissues such as skin. The cavitation effect is one of
the important mechanisms of skin permeation by Ultrasound. Theoretically, cavitation is demon-
strated to occur because of the presence of oxygen and nitrogen dissolved in the stratum corneum
and the existence of lacunae between corneocytes and can be a route of drug delivery. A more effi-
cient way to ensure cavitation could be to adopt a method where ultrasound contrast agent(UCA)
with ultrasound was used at its resonance frequency. UCAs are engineered microsized bubbles such
that they can be stably sustained within the fluid. Albumin, lipid, and polymers have all been used
as shell materials to provide a balance force against Laplace pressure due to the curvature of the
bubbles. In this study, we examined the ultrastructural changes of stratum corneum and the pene-
tration of nanoparticles(NPs) with electron microscopy after treatment UCA with ultrasound. In
results indicated that the observed penetration of NPs and lacunar dilatation in SC after sonophore-
sis with UCA increases than after sonophoresis with UCA. We suggest that these ultrastructural
changes of SC may provide a new approach to explain the mechanism of action the efficacy of
sonophoresis treatment. And the use of a UCA appeared to increase cavitation, demonstrating that
the use of a UCA can be effective in transdermal drug delivery.
352
EGFR is activated in pemphigus vulgaris and contributes to anti-desmoglein 3 antibody-medi-
ated loss of cohesion in cultured mouse keratinocytes
B Sayar, C Luyet, K Schulze, MM Suter, EJ Mueller and A Galichet Molecular Dermatology,
University of Bern, Bern, Switzerland
Activation of EGFR and its contribution to loss of cell-cell adhesion in the autoimmune disease pem-
phigus vulgaris (PV) have been controversially discussed. To further address the implication of EGFR
in PV, here we firstly investigated EGFR activation in cultured mouse keratinocytes and adult mice
injected with the desmoglein (Dsg) 3 function-disrupting antibody AK23. Secondly, AK23-challenged
mouse keratinocytes were treated with EGFR inhibitors to assess the consequences on Dsg3 anti-
body-induced cellular changes. Our results confirm EGFR activation within the first 2 hours after
AK23 treatment by means of EGFR tyrosine phosphorylation as well as phosphorylation of EGFR
on Tyr845 and Tyr1173, both in vitro and in vivo. Treatment of cultured mouse keratinocytes with
the EGFR/ErbB2 inhibitor 4557W increased basal levels of EGFR and reduced phosphorylation by
90% in presence of AK23, demonstrating that EGFR inhibition was effective in these cells. The
inhibitor also reverted the AK23-induced loss of Dsg3 from desmosomes and prevented the previ-
ously reported upregulation of c-Myc and cyclin D2. Upregulation of c-Myc is pathogenic as has
been demonstrated pharmacologically in neonatal mice injected with PV IgG or AK23 and ectopic
c-Myc expression was sufficient to induce loss of adhesion in a dispase-based dissociation assay.
Consistent with these finding, the 4557W-mediated reduction in EGFR phosphorylation and c-Myc
steady state protein restored adhesion in presence of AK23. Interestingly, while two other EGFR/ErbB2
inhibitors also prevented the AK23-induced loss of cohesion, the EGFR inhibitor GW2974, which
mainly targets mutated EGFR in cancer cells, had no effect. Together these results demonstrate that
EGFR is activated in response to Dsg3 function-disrupting antibodies and suggest that this activa-
tion might contribute to PV pathogenesis. Furthermore, discrepancies in results on the involvement
of EGFR in PV may depend on the time point analyzed and the EGFR inhibitor used.
350
Ichthyosis prematurity syndrome: Lipid metabolic abnormalities lead to an epidermal bar-
rier defect and predispose to atopy
D Khnykin,1,2 D Crumrine,2 Y Uchida,2 M Lin,3 J Miner,3 F Jahnsen1 and P Elias2 1 LIIPAT, Institute
of Pathology, Oslo University Hospital, Oslo, Norway, 2 Department of Dermatology, UCSF,
San Francisco, CA and 3 Department of Cell Biology and Physiology, Washington University
School of Medicine, St. Louis, MO
Ichthyosis prematurity syndrome (IPS) (OMIM #608649) is a rare autosomal recessive, congenital
skin disorder which is well characterized in the Norwegian population. IPS patients have a persist-
ent pruritic, non-scaly ichthyosis and most patients have high eosinophilia and serum IgE levels.
Identifying mechanisms responsible for IPS pathology could have impact on our understanding for
how atopy develops. Our data indicate that increased IgE and high numbers of eosinophils are
caused by a primary defect in the skin that establishes a proallergic environment in fetal life, which
may lead to atopic manifestations later in life. Mutations in the gene encoding fatty acid transport
protein 4 (FATP4) have been reported to be causative for IPS. This protein has an acyl-CoA synthetase
domain and it also have been proposed to mediate uptake of free fatty acids (FFA) from extracellu-
lar milieu to the cells by the mechanism of vectorial acylation. Lipid analyses of FATP4 deficient
human and mouse stratum corneum show excess of FFA in the extracellular lipid membranes. Our
results from EM studies indicate that the accumulation of FFAs in cytosol of keratinocytes may account
for formation of pathognomonic membrane aggregations observed in IPS. Interestingly, we have
found the specific ultrastructural changes in ER-outer nuclear membranes in stratum granulosum
cells of FATP4-deficient skin, which may indicate that stability of ER is affected, perhaps by the deter-
gent activity of FFA or accumulation of other FFA metabolites. We are hypothesizing that lack of
FATP4 activity will lead to accumulation of free, unesterified fatty acids which may affect integrity
of intracellular organelles and/or may serve as ligands for signaling pathways that compromise skin
barrier function, leading to downstream activation of proinflammatory and proallergic responses.
354
Suction blister technique to evaluate skin fragility in children with recessive dystrophic epi-
dermolysis bullosa (RDEB) treated with immunomyeloablative chemotherapy and allogeneic
stem-cell transplantation
A Junqueira Bertin,1 J Tolar,2 M Osborn,2 R Farah,1 MK Hordinsky1 and JE Wagner2 1 Department
of Dermatology, University of Minnesota, Minneapolis, MN and 2 Blood and Marrow
Transplant Program, Department of Pediatrics, University of Minnesota, Minneapolis, MN
Collagen, elastic fibers, and glycosaminoglycans make up the viscoelastic properties of skin. RDEB
is caused by mutations in COL7A1, the gene encoding type VII collagen (C7) and is an incurable,
often fatal disease. Recently we described that after allogeneic hematopoietic transplantation
increased C7 deposition and a sustained presence of donor cells were found in the skin of children
with RDEB. In this study, we assessed cutaneous biomechanical properties in the children pre and
post-transplantation, their parents, and healthy donor siblings using a suction blister device (Elec-
tronic Diversities). We hypothesized that blister induction time would increase after transplantation
as a result of more C7 present in the skin and that the parents as obligatory C7 heterozygotes would
have reduced blister time formation when compared to the wild type. We evaluated 6 children (3F,
2M; ages 1.5 – 14) their parents and donor siblings. The suction blister device with three 3-mm sites
was applied approximately 1 mm from recent skin erosions on the upper or lower extremities, or
to normal appearing skin of the parents or donor siblings. The skin was exposed to constant nega-
tive pressure of 12 inches of mercury. Blister initiation and completion times were recorded in min-
utes and averaged. Results were as follows: Patients: Baseline/9.75 – 10, Day 30/ 6.55 – 11.5, Day
60/9.8 - 15.9, Day 100/8.5 - 18.4, Day 180/15.42 - 26.67, Day 450/13.76- 31 and 29.24 minutes
at 1000 days, Mothers: 30.5 – 51.03 minutes, Fathers: 24.4 – 42.09 minutes, Donor Siblings: 52 –
66.55 minutes. In conclusion, we were able to demonstrate improved cutaneous biomechanical
properties in the patient population and lower values in the parents as compared to the normal
donors. The patient findings could be related to the increased presence of C7 in the skin.
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Abca12-mediated lipid transport and Snap29-dependent trafficking of lamellar granules are
critical for epidermal morphogenesis
Q Li,1 M Frank,1 M Akiyama,2,3 H Shimizu,2 E Sprecher4 and J Uitto1 1 Jefferson Medical College,
Philadelphia, PA, 2 Hokkaido University Graduate School of Medicine, Sapporo, Japan, 3
Nagoya University Graduate School of Medicine, Nagoya, Japan and 4 Tel Aviv Medical
Center, Tel Aviv, Israel
Zebrafish (Danio rerio), a freshwater vertebrate with well characterized genome, can serve as a
model for heritable skin diseases. The skin is rapidly developed during the first 5-6 days of embry-
onic growth, accompanied by expression of skin specific genes. Transmission electron microscopy
(TEM) at day 5 reveals two-cell layer epidermis separated from the underlying collagenous stroma
by a basement membrane with fully developed hemidesmosomes. Scanning electron microscopy
reveals ordered surface contour of keratinocytes with discrete microridges. To gain insight into epi-
dermal morphogenesis, we have employed morpholino-mediated knockdown of abca12 and snap29
genes, critical secretion and intracellular trafficking of lipids by lamellar granules. Morpholinos,
when placed on exon-intron junctions, were >95% effective in preventing the corresponding gene
expression when injected into 1-4 cell stage embryos. As early as day 3, TEM of abca12 morphants
showed accumulation of lipid-containing electron-dense lamellar granules while snap29 morphants
showed presence of apparently empty vesicles in the epidermis. Evaluation of epidermal morpho-
genesis by SEM revealed perturbations in the microridge architecture and development of spicule-
like protrusions on the surface of keratinocytes. These morphologic findings are akin to epidermis
changes in harlequin ichthyosis and CEDNIK syndrome, autosomal recessive keratinization disor-
ders due to mutations in the ABCA12 and SNAP29 genes, respectively. The results indicate that inter-
ference of independent pathways involving lipid metabolism and trafficking in the epidermis can
result in phenotypically similar perturbations in epidermal morphogenesis, and that these fish mutants
can serve as a model to study the pathomechanisms of these keratinization disorders.
344
Histone deacetylases inhibitor Trichostatin A regulates microRNA gene expressions in human
keratinocytes
L Qu,1,2,3 R Qi,1,2,3 C He,3 X Gao,3 H Chen,3 Q Mi1,2 and L Zhou1,2 1 Immunology Program,
Henry Ford Health System, Detroit, MI, 2 Dept of Dermatology, Henry Ford Health System,
Detroit, MI and 3 Dept of Dermatology, No. 1 Hospital of China Medical University,
Shenyang, China
Histone deacetylases (HDACs) control gene expression by regulating both chromatin structure and
transcriptional factors deacetyled. Trichostatin A (TSA), one of HDACs inhibitors, can indirectly
perform its function through targeting class I and II HDACs. Recent study indicated that HDAC1/2
played an important role in hair follicle specification, epidermal proliferation and stratification.
HDACs inhibitors were also reported as potential anti-skin cancer new drugs, but the precise mech-
anism was not clear. MicroRNAs (miRNAs), a class of 21-25 nucleotides single-stranded non-cod-
ing small RNAs, are increasingly being recognized as important regulators of gene expression dur-
ing skin development. It’s unclear if the miRNA regulation pathway is involved in HDAC
inhibition-induced keratinocyte growth arrest. To test this, we have analyzed miRNA gene expres-
sion profiles in HaCat cells treated with or without TSA using TaqMan miRNA arrays. We have found
that 23 miRNAs were down-regulated and 37 miRNAs were up-regulated (-DCt value≥2). The miRNA
miR-449a, functioning as a cell cycle negative regulator through targeting E2F1 and cyclinD1, was
significantly up-regulated in TSA-treated keratinocytes. Furthermore, overexpression of miR-449a
in HaCat cells promotes a cell-arrested phenotype. Thus, our results highly suggest that miRNAs
may be key factors involved in HDAC inhibitor TSA-mediated the growth arrest in keratinocytes.
345
Tandem repeated irritation in aged skin induces distinct barrier perturbation and cytokine
expression patterns in vivo
I Angelova-Fischer,1 V Becker,1 W Wigger-Alberti,2 TW Fischer,1 S Kezic3 and D Zillikens1 1
Department of Dermatology, University of Lübeck, Lübeck, Germany, 2 Bioskin, Hamburg,
Germany and 3 Coronel Institute of Occupational Health, Amsterdam, Netherlands
The barrier perturbation and in vivo cytokine expression pattern upon tandem repeated irritation to
aged skin have not been studied so far. We investigated the permeability barrier function and cytokine
response to controlled application of irritant tandems with synergic effects in aged versus young
skin in vivo. Four fields on the volar forearms of healthy aged and young volunteers (mean age 64
and 32 years, respectively) were sequentially exposed to 0.5% sodium lauryl sulphate (SLS) and
undiluted toluene in standardized tandem repeated irritation test over 96 hours. An adjacent untreated
field served as control. The permeability barrier function was monitored by repeated measurements
of transepidermal water loss (TEWL), capacitance and erythema every 24 hours up to 96 hours. The
cytokine samples were harvested by tape stripping of the test fields and analysed by multiplex bead
array and enzyme-linked immunosorbent assay. The tandem application of SLS/SLS, SLS/toluene and
toluene/SLS resulted in significant TEWL increase in both age groups while no such changes for
toluene/toluene were observed. The aged group displayed distinct barrier perturbation kinetics upon
exposure to SLS/toluene and toluene/SLS, characterized by delayed increase in TEWL and chro-
mametry a*-value as well as significantly lower ΔTEWL at the end of the study (in the aged and
young group, respectively 12.71±2.82 and 30.88±5.97 g/m2/h; p<0.01). Furthermore, the aged
skin group was characterized by significantly lower interleukin-1 receptor antagonist (IL-1Ra)/inter-
leukin-1α (IL-1α) ratio upon exposure to SLS/toluene (p<0.01), toluene/SLS (p<0.05) and
toluene/toluene (p<0.01) compared to the young, attributable to both higher IL-1α and lower IL-
1Ra levels. Our results show distinct barrier perturbation and cytokine expression patterns upon
tandem repeated exposure to irritants in aged compared to young skin.
346
In vivo assessment of skin barrier after mechanical removal of stratum corneum shows evi-
dence of a dual repair mechanism
PR Bargo,1 S Walston,1,2 M Chu,1 I Seo,1 E Ruvolo1 and N Kollias1 1 Measurement Sciences,
Johnson & Johnson Consumer Companies, Skillman, NJ and 2 University of Southern
California, Los Angeles, CA
The stratum corneum (SC) primary function is to serve as skin barrier vital to the existence of ter-
restrial life. Disruption of the SC stimulates a repair response in the underlying viable epidermis
shown to be regulated by ions (i.e. Calcium), cytokines, proteinase-activated receptor 2 (PAR2) and
nitric oxide (NO). Signaling pathways for SC formation and the composition of the lipid-enriched
lamellar bodies and membranes that compose the SC have been extensively studied but few stud-
ies have been performed on evaluating human SC repair in vivo, non-invasively. In the present
work tape striping was used as a model of mechanical injury to the SC and the injuries were fol-
lowed for 10 days. Seven healthy volunteers were recruited for the study following informed con-
sent. Tape stripping was performed on the arms and legs of the volunteers until all the SC was
removed. The injured site and a control adjacent site were measured before, immediately after, 3
hours, 1, 2, 3, 7 and 10 days after the injury. Transepidermal water loss (TEWL), tryptophan fluo-
rescence and reflectance confocal microscopy were used to determine permeability of the skin
barrier, cell turnover and epidermal morphology, respectively. The results show an exponential rate
of recovery for the skin permeability (TEWL) which contrasted with a linear increase in the thick-
ness of the SC of 2 microns per day up to twice the original thickness as determined by confocal
microscopy. Cell turnover increased rapidly immediately after the injury to 2.5 times the levels of
the control site, attaining a maximum of 3.5-4 times greater levels after three days and slowly returned
to baseline levels after the ten days. Cell turnover as well as viable epidermis thickness showed
similar biphasic functions which may suggest a dual repair mechanism of the barrier.
347
Evidence of the active transport of water into human skin: A potential contributor to wound
healing
V Ionita Manzatu, M Ingrassia, J Lombardi and T Mammone Estee Lauder Co., Melville, NY
It has been shown in different epithelial systems (e.g. amphibian, cavies, human) that trans-epithe-
lial electric potential (TEEP) is involved in wound healing. We have observed that organotypic tis-
sue has a TEEP and hypothesized that this potential helps to pump and retain water in the skin. This
hypothesis is supported by the use of two controls, a positive and negative that has been shown in
other systems to affect TEEP and water transport. The effects of the Na+ channel-blocking diuretic
agent amiloride and Na+ channel-opening agent aldosterone were assessed in the high-resistance
(epithelium) skin models MatTech EFT-300. Amiloride caused a rapid and dose-dependent decrease
in TEEP accompanied by a decrease of water content of the skin when applied from the apical side
in concentrations of 0.1μM, 1 μM and 10 μM. Aldosterone which upregulates epithelial sodium
channels (ENaC), thereby increasing apical membrane permeability for Na+, caused a rapid and
dose-dependent increase in TEEP accompanied by an increase in water uptake in the skin, when
applied from apical side using similar concentrations as above. In addition to the well published
fact that TEEP is involved in wound healing of epithelial tissue, we observed an increase in water
content with increasing TEEP and the two phenomena may not be mutually exclusive.
348
Effects of ozone in normal human epidermal keratinocytes
J McCarthy, E Pelle, K Brahmbhatt, D Yarosh and N Pernodet Estee Lauder Research
Laboratories, Melville, NY
Overall increases in air pollution coupled with Ultraviolet B (UVB, 295 – 320 nm) exposures have
led to worldwide increases in ground-level, tropospheric ozone. Since ozone has an oxidation poten-
tial of 2.07, protecting the skin against ozone-related oxidative stress has become an important
objective. Previously, we examined ozone-induced lipid peroxidation in liposomal model systems,
as well as cytochrome P450 increases via aryl hydrocarbon receptor signaling in normal human
epidermal keratinocytes (NHEK). In this study we measured the generation of reactive oxygen species
(ROS) in NHEK that were exposed to environmentally relevant levels of ozone (0.3 – 0.4 ppm) for
30 minutes. After exposure, the cells were incubated with 10 uM dichlorodihydrofluorescein diac-
etate and their fluorescence measured after 6 hours. We observed a 29.6% (+/- 6.2% SD) increase
in fluorescence demonstrating the induction of ROS in epidermal cells. Further, in the presence of
the polyphenolic antioxidant, resveratrol, these increases were inhibited.
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The TIG3 tumor suppressor interacts at the centrosome to alter microtubule function to halt
keratinocyte cell proliferation
H Jiang,1 T Scharadin1 and RL Eckert1,2,3 1 Biochemistry and Molecular Biology, University of
Maryland School of Medicine, Baltimore, MD, 2 Dermatology, University of Maryland School
of Medicine, Baltimore, MD and 3 Reproductive Sciences, University of Maryland School of
Medicine, Baltimore, MD
Tazarotene inducible gene 3 (TIG3) is a retinoid regulated tumor suppressor that is present at reduced
levels in skin cancer and other hyperproliferation-associated skin diseases. TIG3 is present in the
mature layers in normal epidermis and is known to induce differentiation. Moreover, TIG3 expres-
sion reduces cultured skin cancer cell survival. Although TIG3 is an important pro-differentiation
and anti-cancer regulator, the mechanism of action is not well understood. In the present study, we
describe a remarkable impact of TIG3 on microtubules. Appropriate microtubule function is required
for keratinocyte proliferation, differentiation, motility, stability and survival. We show that TIG3 local-
izes at the centrosome to alter interphase and mitotic phase microtubule dynamics. The microtubules
in TIG3-negative interphase cells radiate from the centrosome to the cell periphery and display
continuous dynamic plus-end anterograde (e.g., from centrosome to the cell periphery) growth. In
contrast, microtubule anterograde extension is suppressed and microtubule stability is increased in
interphase cells in the presence of TIG3. This grossly alters the microtubule distribution so that thin
microtubule threads radiate out from the centrosome to the cell periphery and stabilized micro-
tubules accumulate at the cell periphery. TIG3 also act in early prophase of mitosis to inhibit micro-
tubule-dependent daughter centrosome separation. These findings suggest that TIG3 is an impor-
tant controller of cell survival that promotes keratinocyte terminal differentiation and cessation of
proliferation by a centrosome-directed microtubule-dependent mechanism.
363
Mammalian aquaporin-3 and phospholipase D2 interact in Sf9 cells
H Qin and WB Bollag Department of Physiology, Medical College of Georgia/Georgia Health
Sciences University, Augusta, GA
Studies characterizing aquaporin-3 (AQP3) knockout mice suggest that this aquaglyceroporin is
required for normal skin wound healing, barrier recovery, hydration and elasticity. However, the
skin phenotype appears to arise not as a result of reduced water flux due to the lack of AQP3, but
of decreased epidermal glycerol content. Indeed, treatment with glycerol, but not other humectants,
can correct the epidermal defects. Our previous data indicate a colocalization between AQP3 and
phospholipase D2 (PLD2) in caveolin-rich membrane microdomains, and we have proposed that
these two proteins interact functionally to form the lipid signal phosphatidylglycerol. Indeed, AQP3
and PLD2 can be co-immunoprecipitated from keratinocyte microdomains; however, it is not clear
whether the interaction of these two proteins is direct or through a scaffolding or adaptor protein.
We investigated the ability of these proteins to interact directly using a rabbit reticulocyte tran-
scription/translation system. However, although our preliminary results demonstrated that in vitro
transcribed/translated PLD2 and AQP3 could be co-immunoprecipitated, we found that co-immuno-
precipitation was observed even in control reactions in which only one construct (AQP3 or PLD2)
was included in the mixture. Examination of the literature indicated that AQP3 is expressed in
reticulocytes. SInce PLD2 was also expressed, if an adaptor or scaffolding protein exists, it may be
present in these cells that express both AQP3 and PLD2. To address possible AQP3 and PLD2 inter-
action further, we expressed His-tagged PLD2 and GST-tagged AQP3 in an Sf9 insect cell expres-
sion system. When both bacmids were co-expressed in Sf9 cells, we observed co-immunoprecipi-
tation of PLD2 following immunoprecipitation of AQP3 with an anti-GST antibody, as well as
co-immunoprecipitation of AQP3 following immunoprecipitation of PLD2. In vitro co-immuno-
precipitation experiments to definitively demonstrate interaction, as well as deletion studies of PLD2
to determine the region responsible for this interaction, are in progress.
365
A splice site mutation in a skin-specific isoform of SMARCAD1 causes hereditary adermato-
glyphia
J Nousbeck,1 B Burger,2 D Fuchs-Telem,1 M Pavlovsky,1 S Fenig,1 O Sarig,1 P Itin2 and E Sprecher1
1 Department of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel and 2
Department of Dermatology, University Hospital Basel, Basel, Switzerland
Single-gene disorders offer unique opportunities to shed light upon human physiology. We investi-
gated a large Swiss kindred presenting with autosomal dominant hereditary adermatoglyphia (ADG;
absence of fingerprints), also known as the “Immigration delay disease” (Burger et al, JAAD, 2010).
Using the Infinium II HumanLinkage-12 panel, we identified a heterozygous haplotype shared by
all patients on 4q22. Haplotype analysis refined the disease locus to a 5.1 Mb interval between
markers D4S423 and D4S1560. All 11 genes contained within this region were sequenced. One of
these genes is SMARCAD1, a member of the SNF subfamily of the helicase protein superfamily,
which is thought to be involved in transcriptional regulation. Bioinformatic and RT-PCR analysis
revealed the existence of two SMARCAD1 isoforms, differing both in lengths and sites of transcrip-
tion initiation. The short SMARCAD1 isoform was found to contain a unique non-translated exon.
A heterozygous G>T transversion, predicted to abolish the acceptor splice site adjacent to the 3’-
end of this exon was found to segregate with the disease phenotype throughout the entire family.
The mutation (c.378+1G>T) is predicted to result in aberrant splicing out of the short SMARCAD1
isoform and to result in the generation of an alternative start codon, transcription control shift or
RNA instability. We excluded the mutation from a panel of 100 healthy individuals of Swiss extrac-
tion. Using RT-PCR, we showed that the long SMARCAD1 isoform is expressed ubiquitously. In con-
trast, the short SMARCAD1 isoform was found to be expressed almost exclusively in skin fibrob-
lasts and keratinocytes, which may underlie the extremely limited phenotype displayed by our
patients. In summary, through the deciphering of the genetic basis of a rare genodermatosis, our
results implicate a skin-specific isoform of an helicase family member in dermatoglyph develop-
ment.
364
The effect of aging, UV exposure, and oxidative stress on the expression of sirtuin genes in
human skin cells
Y Chen, J Lyga and R Wyborski Global R&D Center, Avon Products, Inc., Suffern, NY
Sirtuins are NAD-dependent histone dacetylases that are involved in various cellular processes,
including DNA repair, genome stability, energy production and metabolism, stress resistance and
cell survival. Sirtuin activity is closely modulated by post-translational regulations. Sumoylation of
Sirt1 protein regulates its activity and affects keratinocytes differentiation. In mammals, there are
three SUMO proteins and UBE21 is the E2 conjugation enzyme that regulates the sumoylation
process. We were interested in evaluating the effect of aging, UV exposure, and oxidative stress on
the expression of Sirtuin family genes, as well as the sumoylation pathway genes, specifically in the
human skin cells. Human epidermal keratinocytes and human dermal fibroblasts from different age
donors were obtained and maintained in culture. UV treatment was carried out with single wave-
length UVB or UVA lamps and irradiation intensity was measured using radiometer with corre-
sponding filters. Specifically, keratinocytes were irradiated with UVB and fibroblasts were irradi-
ated with UVA. Cells were recovered for 24 hours before RNA extraction. Oxidative stress was
achieved through H2O2 treatment. Gene expression analysis was performed using Taqman primer
and probes. We discovered that Sirtuins and SUMO gene expressions are significantly affected by
aging, UV exposure and oxidative stress. Furthermore, the responses are cell type specific. During
the course of skin aging, both intrinsic aging and photoaging play important roles. Sirtuin expres-
sions are significantly lower in the older age group as well as after UV exposure. We postulate that
by stimulating Sirtuin gene expression, it may be possible to slow down skin aging by boosting
energy production and stress resistance.
362
Combined biological and computational approaches to understand the role of Get1/Grhl3
in epidermal differentiation
RP Herndon,1 A Bhandari,1 D Dizon,1 R Chadwick,3 J Biesinger,2 X Xie2 and B Andersen1 1
Medicine and Biological Chemistry, University of California, Irvine, Irvine, CA, 2 Computer
Science, University of California, Irvine, Irvine, CA and 3 UCI Genomic High-Throughput
Facility, University of California, Irvine, Irvine, CA
Grainyhead-like 3 (Get1/Grhl3), a transcription factor expressed in numerous epithelial tissues, is
a key regulator of epidermal terminal differentiation and barrier formation, a function that is evo-
lutionarily conserved from flies to mammals. Get1-/- mice die at birth, with numerous epidermal
abnormalities including altered expression of adhesion proteins and changes in lipid composition,
resulting in increased barrier permeability. Gene expression profiling of Get1-/- mouse embryonic
skin revealed over 200 genes aberrantly regulated in the absence of Get1, including many genes
localized to the Epidermal Differentiation Complex (EDC), a chromosome region containing mul-
tiple genes involved in barrier formation. Get1 knockdown in primary human keratinocytes, a
commonly used model to study epidermal differentiation, also caused significant defects in differ-
entiation. Despite the significant role of Get1 in epidermal terminal differentiation and barrier for-
mation, its only known direct gene target in the epidermis is Transglutaminase 1, a gene encoding
an enzyme responsible for crosslinking of proteins in the cornified envelope. We performed ChIP-
Seq with an antibody to Get1 in both undifferentiated and differentiated epidermal keratinocytes,
and combined the data with gene expression profiling in both cell states. With these data, we defined
and validated a complement of genes directly regulated by Get1 during epidermal terminal differ-
entiation in primary human keratinocytes. These data indicate that Get1 is a key regulator of epi-
dermal differentiation, acting through a number of different regulatory mechanisms to coordinate
gene expression during this process.
366
Environmental influences on a model of atopic dermatitis
CM Fahy,1 WH McLean,2 AD Irvine1 and PG Fallon1 1 Inflammation and Immunity, School of
Medicine, Institute of Molecular Medicine, Trinity College Dublin, Dublin, Ireland and 2
Epithelial Genetics Group, University of Dundee, Dundee, United Kingdom
This study examines the effects of differing environments on an established mouse model of a defec-
tive skin barrier in filaggrin deficiency. Eczema (atopic dermatitis) is a common inflammatory skin
disease with a complex aetiology. It is part of the spectrum of atopy, the frequency of which has
increased in recent decades. Environmental factors feature as triggers of disease in paediatric patients
with eczema. Filaggrin is a vital, structural skin barrier protein. Loss-of-function mutations in the
filaggrin gene cause the skin disorder ichthyosis vulgaris and convey strong genetic risk for eczema.
This laboratory previously demonstrated how the flaky tail (maflgft/maflgft) mouse is a model of filag-
grin deficiency. Populations of maflgft/maflgft mice were bred in 2 specific-pathogen-free locations;
individually ventilated sealed cages, (IVC) and open-air cages, (OPEN). Sealed caging in IVC was
the only difference in husbandry of the subjects. Phenotype development was noted at weeks 1, 4,
8, 20 and 32. Serum IgE was measured by ELISA. Skin inflammation was assessed by H+E staining
of skin biopsies. Clinical phenotypical development varied between the units: clinical dermatitis
scoring, (p<0.02) and tail auto-amputation, (p<0.0001). More cutaneous inflammatory infiltrates
were found in the OPEN maflgft/maflgft mice compared to IVC subjects, (wk 1 p=0.0413, wk 4
p<0.01, wk 8, wk 20 p<0.05 and wk 32 ns). Total IgE was higher in the OPEN facility from wk 8
and significantly so from wk 20, (p<0.0006). This study examined the effects of differing environ-
ments on an established murine model of a defective skin barrier due to filaggrin deficiency. The
results indicate that phenotypical differences in disease between the comparative groups of
maflgft/maflgft mice may be dependent on housing/environmental conditions. This suggests that envi-
ronmental priming, in the context of filaggrin deficiency, can influence the development and sever-
ity of cutaneous inflammation and atopy.
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Raman profiles of the stratum corneum and filaggrin genotypes of French individuals with or
without a history of mild to moderate atopic dermatitis
V Mlitz,1 J Latreille,2 S Gardinier,2 L Eckhart,1 C Guinot2,3 and E Tschachler1,2 1 Department of
Dermatology, Medical University of Vienna, Vienna, Austria, 2 CE.R.I.E.S., Neuilly sur Seine,
France and 3 Computer Science Laboratory, University François Rabelais, Tours, France
Atopic dermatitis (AD) is associated with mutations in the filaggrin (FLG) gene. FLG encodes filag-
grin, a putative regulator of the epidermal barrier function and precursor of the natural moisturiz-
ing factor (NMF) of the stratum corneum (SC). In this study, 196 French adults, including 97 with a
history of mild to moderate AD, were genotyped by a novel hybridization probe-based method for
the three major European FLG mutations, R501X, 2282del4 and R2447X, and components of the
NMF, lipids and water content in the SC were determined by Raman spectroscopy. Deleterious muta-
tions of FLG were detected in 4% of controls and 10% of AD patients. The SC concentrations of
total NMF, water, ornithine and urocanic acid (UCA) were significantly smaller in AD patients than
in healthy controls. FLG mutations were associated with reduced concentrations of NMF compo-
nents and increased disease severity. To determine the specificity of associations between individ-
ual NMF components and FLG mutations, cutoff values equivalent to the maximum concentration
observed among carriers of FLG mutations were defined for each NMF component. The concomit-
tant presence of low concentrations of each histidine, alanine, and either glycine or pyrrolidone-5-
carboxylic acid (PCA) in the SC was associated with FLG mutations with more than 90% speci-
ficity. In summary, this study suggests that the prevalence of FLG mutations in patients with mild to
moderate AD is lower than that reported for moderate to severe AD. Our findings support an impor-
tant role of filaggrin in building the NMF of the SC. The combined measurement of several filaggrin
breakdown products in the SC may be useful to predict the presence of FLG null mutations.
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Human keratinocytes display a restricted unfolded protein response by ER stressors
D Franco1,3 and C Reardon1,2,3 1 Dermatology, Phoenix VA Health Care System, Phoenix, AZ,
2 Medicine, University of Arizona College of Medicine, Phoenix, AZ and 3 Molecular & Cell
Biology, Arizona State University, Tempe, AZ
The accumulation of misfolded proteins in the endoplasmic reticulum (ER) leads to cell stress. In
response to ER stress, the coordination of sensing and chaperoning aberrant proteins, as well as
inducing increased gene expression of specialized ER proteins are mediated through activation of
transduction pathways via a group of ER effectors that make up the unfolded protein response (UPR).
As a UPR sensor for misfolded proteins, Inositol Requiring Enzyme 1 alpha (IRE-1α) activates XBP-
1 that enhances transcription of additional UPR genes. When ER stress overwhelms the UPR, this
protective homeostatic response alters to transmit early apoptotic signals, such as the expression of
C/EBP homologous protein (CHOP). Human transformed epithelial cell lines show a vigorous UPR
response with a 9-fold enhancement of IRE-1α gene expression and a well over 300-fold increase
in CHOP expression when treated with the ER stress-inducing agent, Thapsigargin (TG) for 6 hours.
In contrast to the transformed cells, human foreskin-derived keratinocytes treated with TG elicited
only a modest UPR with only a 2-fold increase in IRE-1α message and a 7-fold increase in CHOP
expression. Because of the likely high level of existing misfolded ER proteins, the transformed cells
would be expected to decompensate when exposed to an exogenous ER stressor and develop a
large UPR, as reflected by the increases in IRE-1α and CHOP expression. However, compared to
transformed cells, keratinocytes possess a restricted ER stress-responsive UPR perhaps as a protec-
tive mechanism so that the many possible exogenous stressors which they may encounter do not
easily promote the UPR and potentially lead to apoptosis induction.
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p38δ signaling - multiple regulatory interactions drive differentiation in keratinocytes
SR Kanade1 and RL Eckert1,2,3 1 Biochemistry and Molecular Biology, University of Maryland
School of Medicine, Baltimore, MD, 2 Dermatology, University of Maryland School of
Medicine, Baltimore, MD and 3 Reproductive Sciences, University of Maryland School of
Medicine, Baltimore, MD
Recent studies indicate that mitogen-activated protein kinases (MAPK) are key controllers of ker-
atinocyte fate. In particular, p38δ MAPK has a central role in regulating differentiation, as siRNA
knockdown of p38δ eliminates a range of differentiation-associated responses. This signaling is com-
plex and how p38δ achieves this impact is not well understood. Our finding that p38δ interacts with
ERK implies that protein-protein interaction has a key role and suggests potential interaction with
other regulatory proteins. Identifying such partners is an essential step in understanding this regu-
lation and so we now show that p38δ interacts with selected kinases that are part of the PKCδ/MAPK
differentiation control cascade, including PKCα, PKCδ, MEKK1, MEK3, MEK6, PP2A and ERK1 and
ERK2. These interactions are specific, as p38δ does not interact with PKCε or MEK7. These com-
plexes vary in molecular mass from 75 to 1850 kDa, implying that p38δ partners in multiple inter-
active ways. These interactions are dynamic and are influenced by differentiating agents. p38δ inter-
action with ERK1 and ERK2 is an interesting example. ERK1 and ERK2 both interact with p38δ, but
ERK1 interaction is preferred and this interaction requires the unique ERK1 amino terminus. Dif-
ferentiation stimuli and presence of interacting partners influences these complexes. For example,
knockdown of PKCδ has no effect on integrity of the p38δ-ERK complex, but PKCδ knockdown
reduces p38δ interaction with MEK3. Moreover, phorbol ester increases p38δ/ERK interaction, while
OA or H2O2 treatment reduces p38δ level but increases p38δ-phosphorylation. These studies indi-
cate that p38δ regulation of keratinocyte differentiation involves the dynamic formation and disso-
ciation of multiple regulatory complexes and suggest that understanding these dynamics will be
necessary to understand differentiation
358
Protein arginine methyltransferase 5 (PRMT5) is a novel negative regulator of keratinocyte
differentiation
SR Kanade1 and RL Eckert1,2,3 1 Biochemistry and Molecular Biology, University of Maryland
School of Medicine, Baltimore, MD, 2 Dermatology, University of Maryland School of
Medicine, Baltimore, MD and 3 Reproductive Sciences, University of Maryland School of
Medicine, Baltimore, MD
Protein kinase c (PKC) kinases comprise a family of enzymes that play a key role in regulating cell
growth and differentiation. PKCδ stimulates keratinocyte differentiation via activation of p38δ
mitogen-activated protein kinase signaling. An important evolving concept is that p38δ exists in a
complex of interacting regulatory partners. A major goal is identifying these proteins. Using protein
purification and mass spectrometry, we identify protein arginine methyltransferase 5 (PRMT5) as
such a partner. PRMT5 is an important arginine methyltransferase that dimethylates arginine residues
in proteins. Protein arginine dimethylation is a major covalent regulatory modification that influ-
ences target protein function. We show that PRMT5 is a partner in the p38δ signaling complex that
modifies proteins in this complex to suppress keratinocyte differentiation as evidenced by reduced
involucrin expression and promoter activity. Moreover, PRMT5 function is controlled by PKCδ.
Knockdown of PKCδ increases PRMT5 mRNA/protein level and increases PRMT5 activity. Con-
versely, PKCδ activation reduces PRMT5 expression and activity. Thus, PKCδ and PRMT5 are oppos-
ing regulators of differentiation. This is the first evidence of a role for arginine modification signal-
ing in keratinocytes. These novel findings suggest that PRMT5 and MAPK signaling are intertwined
in a common differentiation-control signaling cascade, PKCδ activity drives differentiation, in part
by inhibiting PRMT5 activity, and differentiation depends upon the balance between PKCδ and
PRMT5 activity.
359
The effects of artemisia abrotanum (Southernwood) on multiple levels of the skin
M Russell, M Anthonavage and S Tucker-Samaras Johnson and Johnson, Skillman, NJ
Skin aging is a complex process integrating time and environmental exposure which involves more
than just the surface of the skin. In the epidermis, altered keratinocyte biology contributes to a thin-
ning epidermis giving the skin a fragile transparent look and weak barrier properties. In the dermis,
inappropriate protease activity along with a reduction in matrix production reduces skin’s strength
and elasticity. Even the subcutaneous fat layer, which provides insulation and padding, thins over
time, creating sags and wrinkles. Taken together, aging is a multifactor process that occurs at many
levels in the skin. Therefore, a successful antiaging product should be able to address these weak-
nesses by correcting and restoring balance in multiple layers in the skin. Southernwood (Artemisia
abrotanum) is an attractive bushy shrub that is grown in many cottage gardens as a decorative
plant. Gene chip data derived from epidermal keratinocytes treated with an aqueous extract of south-
ernwood, show positive effects on genes that enhance differentiation, epidermal cohesion, desqua-
mation and ceramide synthesis, data that is coroborated by in vivo analysis. The natural combina-
tion of polyphenols found in this extract deliver antioxidants and an anti-inflammatory component
to the skin as well demonstrated by ORAC testing and skin equivalent testing respectively. In the
dermis, the extract works by strengthening the collagen and elastin network through the prevention
of proteases. Finally, representing the deepest layer of the skin, adipocytes treated with an aqueous
extract of southernwood accumulate more triglycerides than their placebo treated counterparts.
Overall, an aqueous extract of Artemisia abrotanum provides numerous benefits to all layers of the
skin as demonstrated by in-vitro testing models designed to mimic the pathways of aging and skin
imbalance. Taken together, these data support the use of an aqueous extract of southernwood in
topical skin care products for the restoration of balance particularly caused by the progress of time
and environmental exposure.
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PKCδ suppresses keratinocyte proliferation by increasing p21Cip1 level via a KLF4-dependent
mechanism
YC Chew,1 G Adhikary1 and RL Eckert1,2,3 1 Biochemistry and Molecular Biology, University of
Maryland School of Medicine, Baltimore, MD, 2 Dermatology, University of Maryland School
of Medicine, Baltimore, MD and 3 Reproductive Sciences, University of Maryland School of
Medicine, Baltimore, MD
Keratinocyte differentiation is associated with cessation of proliferation. It has long been suspected
that these processes may be regulated by common signaling pathway. PKCδ, since it regulates dif-
ferentiation and proliferation, is such a candidate regulator. PKCδ regulation of differentiation has
been studied; however, how PKCδ suppresses proliferation is not well understood. We show that
PKCδ regulates p21Cip1 expression. PKCδ increases p21Cip1 mRNA and protein level and promoter
activity, and that dominant-negative PKCδ, PKCδ-siRNA or rottlerin inhibit these events. p21Cip1 pro-
moter activation is mediated by three DNA response elements. A series of GC-rich DNA elements
near the p21Cip1 promoter transcription start site are particularly important and mutation of these
sites results in a loss of response. KLF4 is an important member of the Kruppel-like transcription
factor family. PKCδ expression increases KLF4 mRNA and protein, and this is associated with increased
KLF4 binding to the GC-rich elements in the p21Cip1 promoter. These PKCδ-dependent changes can
be replicated by overexpression of KLF4 and reversed by KLF4 siRNA. PKCδ also stimulates p21Cip1
translocation to the nucleus, which is required for p21Cip1 activity. These findings suggest that PKCδ
signaling coordinately regulates keratinocyte differentiation and proliferation. It is of particular inter-
est that PKCδ signaling increases keratinocyte differentiation by activating AP1 and Sp1 transcrip-
tion factors, but utilizes KLF4 to suppress transcription. The present studies suggest a new function
for KLF4 in epidermis as an activator of a key suppressor of cell division.
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The TIG3 tumor suppressor interacts at the centrosome to alter microtubule function to halt
keratinocyte cell proliferation
H Jiang,1 T Scharadin1 and RL Eckert1,2,3 1 Biochemistry and Molecular Biology, University of
Maryland School of Medicine, Baltimore, MD, 2 Dermatology, University of Maryland School
of Medicine, Baltimore, MD and 3 Reproductive Sciences, University of Maryland School of
Medicine, Baltimore, MD
Tazarotene inducible gene 3 (TIG3) is a retinoid regulated tumor suppressor that is present at reduced
levels in skin cancer and other hyperproliferation-associated skin diseases. TIG3 is present in the
mature layers in normal epidermis and is known to induce differentiation. Moreover, TIG3 expres-
sion reduces cultured skin cancer cell survival. Although TIG3 is an important pro-differentiation
and anti-cancer regulator, the mechanism of action is not well understood. In the present study, we
describe a remarkable impact of TIG3 on microtubules. Appropriate microtubule function is required
for keratinocyte proliferation, differentiation, motility, stability and survival. We show that TIG3 local-
izes at the centrosome to alter interphase and mitotic phase microtubule dynamics. The microtubules
in TIG3-negative interphase cells radiate from the centrosome to the cell periphery and display
continuous dynamic plus-end anterograde (e.g., from centrosome to the cell periphery) growth. In
contrast, microtubule anterograde extension is suppressed and microtubule stability is increased in
interphase cells in the presence of TIG3. This grossly alters the microtubule distribution so that thin
microtubule threads radiate out from the centrosome to the cell periphery and stabilized micro-
tubules accumulate at the cell periphery. TIG3 also act in early prophase of mitosis to inhibit micro-
tubule-dependent daughter centrosome separation. These findings suggest that TIG3 is an impor-
tant controller of cell survival that promotes keratinocyte terminal differentiation and cessation of
proliferation by a centrosome-directed microtubule-dependent mechanism.
363
Mammalian aquaporin-3 and phospholipase D2 interact in Sf9 cells
H Qin and WB Bollag Department of Physiology, Medical College of Georgia/Georgia Health
Sciences University, Augusta, GA
Studies characterizing aquaporin-3 (AQP3) knockout mice suggest that this aquaglyceroporin is
required for normal skin wound healing, barrier recovery, hydration and elasticity. However, the
skin phenotype appears to arise not as a result of reduced water flux due to the lack of AQP3, but
of decreased epidermal glycerol content. Indeed, treatment with glycerol, but not other humectants,
can correct the epidermal defects. Our previous data indicate a colocalization between AQP3 and
phospholipase D2 (PLD2) in caveolin-rich membrane microdomains, and we have proposed that
these two proteins interact functionally to form the lipid signal phosphatidylglycerol. Indeed, AQP3
and PLD2 can be co-immunoprecipitated from keratinocyte microdomains; however, it is not clear
whether the interaction of these two proteins is direct or through a scaffolding or adaptor protein.
We investigated the ability of these proteins to interact directly using a rabbit reticulocyte tran-
scription/translation system. However, although our preliminary results demonstrated that in vitro
transcribed/translated PLD2 and AQP3 could be co-immunoprecipitated, we found that co-immuno-
precipitation was observed even in control reactions in which only one construct (AQP3 or PLD2)
was included in the mixture. Examination of the literature indicated that AQP3 is expressed in
reticulocytes. SInce PLD2 was also expressed, if an adaptor or scaffolding protein exists, it may be
present in these cells that express both AQP3 and PLD2. To address possible AQP3 and PLD2 inter-
action further, we expressed His-tagged PLD2 and GST-tagged AQP3 in an Sf9 insect cell expres-
sion system. When both bacmids were co-expressed in Sf9 cells, we observed co-immunoprecipi-
tation of PLD2 following immunoprecipitation of AQP3 with an anti-GST antibody, as well as
co-immunoprecipitation of AQP3 following immunoprecipitation of PLD2. In vitro co-immuno-
precipitation experiments to definitively demonstrate interaction, as well as deletion studies of PLD2
to determine the region responsible for this interaction, are in progress.
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A splice site mutation in a skin-specific isoform of SMARCAD1 causes hereditary adermato-
glyphia
J Nousbeck,1 B Burger,2 D Fuchs-Telem,1 M Pavlovsky,1 S Fenig,1 O Sarig,1 P Itin2 and E Sprecher1
1 Department of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel and 2
Department of Dermatology, University Hospital Basel, Basel, Switzerland
Single-gene disorders offer unique opportunities to shed light upon human physiology. We investi-
gated a large Swiss kindred presenting with autosomal dominant hereditary adermatoglyphia (ADG;
absence of fingerprints), also known as the “Immigration delay disease” (Burger et al, JAAD, 2010).
Using the Infinium II HumanLinkage-12 panel, we identified a heterozygous haplotype shared by
all patients on 4q22. Haplotype analysis refined the disease locus to a 5.1 Mb interval between
markers D4S423 and D4S1560. All 11 genes contained within this region were sequenced. One of
these genes is SMARCAD1, a member of the SNF subfamily of the helicase protein superfamily,
which is thought to be involved in transcriptional regulation. Bioinformatic and RT-PCR analysis
revealed the existence of two SMARCAD1 isoforms, differing both in lengths and sites of transcrip-
tion initiation. The short SMARCAD1 isoform was found to contain a unique non-translated exon.
A heterozygous G>T transversion, predicted to abolish the acceptor splice site adjacent to the 3’-
end of this exon was found to segregate with the disease phenotype throughout the entire family.
The mutation (c.378+1G>T) is predicted to result in aberrant splicing out of the short SMARCAD1
isoform and to result in the generation of an alternative start codon, transcription control shift or
RNA instability. We excluded the mutation from a panel of 100 healthy individuals of Swiss extrac-
tion. Using RT-PCR, we showed that the long SMARCAD1 isoform is expressed ubiquitously. In con-
trast, the short SMARCAD1 isoform was found to be expressed almost exclusively in skin fibrob-
lasts and keratinocytes, which may underlie the extremely limited phenotype displayed by our
patients. In summary, through the deciphering of the genetic basis of a rare genodermatosis, our
results implicate a skin-specific isoform of an helicase family member in dermatoglyph develop-
ment.
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The effect of aging, UV exposure, and oxidative stress on the expression of sirtuin genes in
human skin cells
Y Chen, J Lyga and R Wyborski Global R&D Center, Avon Products, Inc., Suffern, NY
Sirtuins are NAD-dependent histone dacetylases that are involved in various cellular processes,
including DNA repair, genome stability, energy production and metabolism, stress resistance and
cell survival. Sirtuin activity is closely modulated by post-translational regulations. Sumoylation of
Sirt1 protein regulates its activity and affects keratinocytes differentiation. In mammals, there are
three SUMO proteins and UBE21 is the E2 conjugation enzyme that regulates the sumoylation
process. We were interested in evaluating the effect of aging, UV exposure, and oxidative stress on
the expression of Sirtuin family genes, as well as the sumoylation pathway genes, specifically in the
human skin cells. Human epidermal keratinocytes and human dermal fibroblasts from different age
donors were obtained and maintained in culture. UV treatment was carried out with single wave-
length UVB or UVA lamps and irradiation intensity was measured using radiometer with corre-
sponding filters. Specifically, keratinocytes were irradiated with UVB and fibroblasts were irradi-
ated with UVA. Cells were recovered for 24 hours before RNA extraction. Oxidative stress was
achieved through H2O2 treatment. Gene expression analysis was performed using Taqman primer
and probes. We discovered that Sirtuins and SUMO gene expressions are significantly affected by
aging, UV exposure and oxidative stress. Furthermore, the responses are cell type specific. During
the course of skin aging, both intrinsic aging and photoaging play important roles. Sirtuin expres-
sions are significantly lower in the older age group as well as after UV exposure. We postulate that
by stimulating Sirtuin gene expression, it may be possible to slow down skin aging by boosting
energy production and stress resistance.
362
Combined biological and computational approaches to understand the role of Get1/Grhl3
in epidermal differentiation
RP Herndon,1 A Bhandari,1 D Dizon,1 R Chadwick,3 J Biesinger,2 X Xie2 and B Andersen1 1
Medicine and Biological Chemistry, University of California, Irvine, Irvine, CA, 2 Computer
Science, University of California, Irvine, Irvine, CA and 3 UCI Genomic High-Throughput
Facility, University of California, Irvine, Irvine, CA
Grainyhead-like 3 (Get1/Grhl3), a transcription factor expressed in numerous epithelial tissues, is
a key regulator of epidermal terminal differentiation and barrier formation, a function that is evo-
lutionarily conserved from flies to mammals. Get1-/- mice die at birth, with numerous epidermal
abnormalities including altered expression of adhesion proteins and changes in lipid composition,
resulting in increased barrier permeability. Gene expression profiling of Get1-/- mouse embryonic
skin revealed over 200 genes aberrantly regulated in the absence of Get1, including many genes
localized to the Epidermal Differentiation Complex (EDC), a chromosome region containing mul-
tiple genes involved in barrier formation. Get1 knockdown in primary human keratinocytes, a
commonly used model to study epidermal differentiation, also caused significant defects in differ-
entiation. Despite the significant role of Get1 in epidermal terminal differentiation and barrier for-
mation, its only known direct gene target in the epidermis is Transglutaminase 1, a gene encoding
an enzyme responsible for crosslinking of proteins in the cornified envelope. We performed ChIP-
Seq with an antibody to Get1 in both undifferentiated and differentiated epidermal keratinocytes,
and combined the data with gene expression profiling in both cell states. With these data, we defined
and validated a complement of genes directly regulated by Get1 during epidermal terminal differ-
entiation in primary human keratinocytes. These data indicate that Get1 is a key regulator of epi-
dermal differentiation, acting through a number of different regulatory mechanisms to coordinate
gene expression during this process.
366
Environmental influences on a model of atopic dermatitis
CM Fahy,1 WH McLean,2 AD Irvine1 and PG Fallon1 1 Inflammation and Immunity, School of
Medicine, Institute of Molecular Medicine, Trinity College Dublin, Dublin, Ireland and 2
Epithelial Genetics Group, University of Dundee, Dundee, United Kingdom
This study examines the effects of differing environments on an established mouse model of a defec-
tive skin barrier in filaggrin deficiency. Eczema (atopic dermatitis) is a common inflammatory skin
disease with a complex aetiology. It is part of the spectrum of atopy, the frequency of which has
increased in recent decades. Environmental factors feature as triggers of disease in paediatric patients
with eczema. Filaggrin is a vital, structural skin barrier protein. Loss-of-function mutations in the
filaggrin gene cause the skin disorder ichthyosis vulgaris and convey strong genetic risk for eczema.
This laboratory previously demonstrated how the flaky tail (maflgft/maflgft) mouse is a model of filag-
grin deficiency. Populations of maflgft/maflgft mice were bred in 2 specific-pathogen-free locations;
individually ventilated sealed cages, (IVC) and open-air cages, (OPEN). Sealed caging in IVC was
the only difference in husbandry of the subjects. Phenotype development was noted at weeks 1, 4,
8, 20 and 32. Serum IgE was measured by ELISA. Skin inflammation was assessed by H+E staining
of skin biopsies. Clinical phenotypical development varied between the units: clinical dermatitis
scoring, (p<0.02) and tail auto-amputation, (p<0.0001). More cutaneous inflammatory infiltrates
were found in the OPEN maflgft/maflgft mice compared to IVC subjects, (wk 1 p=0.0413, wk 4
p<0.01, wk 8, wk 20 p<0.05 and wk 32 ns). Total IgE was higher in the OPEN facility from wk 8
and significantly so from wk 20, (p<0.0006). This study examined the effects of differing environ-
ments on an established murine model of a defective skin barrier due to filaggrin deficiency. The
results indicate that phenotypical differences in disease between the comparative groups of
maflgft/maflgft mice may be dependent on housing/environmental conditions. This suggests that envi-
ronmental priming, in the context of filaggrin deficiency, can influence the development and sever-
ity of cutaneous inflammation and atopy.
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Raman profiles of the stratum corneum and filaggrin genotypes of French individuals with or
without a history of mild to moderate atopic dermatitis
V Mlitz,1 J Latreille,2 S Gardinier,2 L Eckhart,1 C Guinot2,3 and E Tschachler1,2 1 Department of
Dermatology, Medical University of Vienna, Vienna, Austria, 2 CE.R.I.E.S., Neuilly sur Seine,
France and 3 Computer Science Laboratory, University François Rabelais, Tours, France
Atopic dermatitis (AD) is associated with mutations in the filaggrin (FLG) gene. FLG encodes filag-
grin, a putative regulator of the epidermal barrier function and precursor of the natural moisturiz-
ing factor (NMF) of the stratum corneum (SC). In this study, 196 French adults, including 97 with a
history of mild to moderate AD, were genotyped by a novel hybridization probe-based method for
the three major European FLG mutations, R501X, 2282del4 and R2447X, and components of the
NMF, lipids and water content in the SC were determined by Raman spectroscopy. Deleterious muta-
tions of FLG were detected in 4% of controls and 10% of AD patients. The SC concentrations of
total NMF, water, ornithine and urocanic acid (UCA) were significantly smaller in AD patients than
in healthy controls. FLG mutations were associated with reduced concentrations of NMF compo-
nents and increased disease severity. To determine the specificity of associations between individ-
ual NMF components and FLG mutations, cutoff values equivalent to the maximum concentration
observed among carriers of FLG mutations were defined for each NMF component. The concomit-
tant presence of low concentrations of each histidine, alanine, and either glycine or pyrrolidone-5-
carboxylic acid (PCA) in the SC was associated with FLG mutations with more than 90% speci-
ficity. In summary, this study suggests that the prevalence of FLG mutations in patients with mild to
moderate AD is lower than that reported for moderate to severe AD. Our findings support an impor-
tant role of filaggrin in building the NMF of the SC. The combined measurement of several filaggrin
breakdown products in the SC may be useful to predict the presence of FLG null mutations.
356
Human keratinocytes display a restricted unfolded protein response by ER stressors
D Franco1,3 and C Reardon1,2,3 1 Dermatology, Phoenix VA Health Care System, Phoenix, AZ,
2 Medicine, University of Arizona College of Medicine, Phoenix, AZ and 3 Molecular & Cell
Biology, Arizona State University, Tempe, AZ
The accumulation of misfolded proteins in the endoplasmic reticulum (ER) leads to cell stress. In
response to ER stress, the coordination of sensing and chaperoning aberrant proteins, as well as
inducing increased gene expression of specialized ER proteins are mediated through activation of
transduction pathways via a group of ER effectors that make up the unfolded protein response (UPR).
As a UPR sensor for misfolded proteins, Inositol Requiring Enzyme 1 alpha (IRE-1α) activates XBP-
1 that enhances transcription of additional UPR genes. When ER stress overwhelms the UPR, this
protective homeostatic response alters to transmit early apoptotic signals, such as the expression of
C/EBP homologous protein (CHOP). Human transformed epithelial cell lines show a vigorous UPR
response with a 9-fold enhancement of IRE-1α gene expression and a well over 300-fold increase
in CHOP expression when treated with the ER stress-inducing agent, Thapsigargin (TG) for 6 hours.
In contrast to the transformed cells, human foreskin-derived keratinocytes treated with TG elicited
only a modest UPR with only a 2-fold increase in IRE-1α message and a 7-fold increase in CHOP
expression. Because of the likely high level of existing misfolded ER proteins, the transformed cells
would be expected to decompensate when exposed to an exogenous ER stressor and develop a
large UPR, as reflected by the increases in IRE-1α and CHOP expression. However, compared to
transformed cells, keratinocytes possess a restricted ER stress-responsive UPR perhaps as a protec-
tive mechanism so that the many possible exogenous stressors which they may encounter do not
easily promote the UPR and potentially lead to apoptosis induction.
357
p38δ signaling - multiple regulatory interactions drive differentiation in keratinocytes
SR Kanade1 and RL Eckert1,2,3 1 Biochemistry and Molecular Biology, University of Maryland
School of Medicine, Baltimore, MD, 2 Dermatology, University of Maryland School of
Medicine, Baltimore, MD and 3 Reproductive Sciences, University of Maryland School of
Medicine, Baltimore, MD
Recent studies indicate that mitogen-activated protein kinases (MAPK) are key controllers of ker-
atinocyte fate. In particular, p38δ MAPK has a central role in regulating differentiation, as siRNA
knockdown of p38δ eliminates a range of differentiation-associated responses. This signaling is com-
plex and how p38δ achieves this impact is not well understood. Our finding that p38δ interacts with
ERK implies that protein-protein interaction has a key role and suggests potential interaction with
other regulatory proteins. Identifying such partners is an essential step in understanding this regu-
lation and so we now show that p38δ interacts with selected kinases that are part of the PKCδ/MAPK
differentiation control cascade, including PKCα, PKCδ, MEKK1, MEK3, MEK6, PP2A and ERK1 and
ERK2. These interactions are specific, as p38δ does not interact with PKCε or MEK7. These com-
plexes vary in molecular mass from 75 to 1850 kDa, implying that p38δ partners in multiple inter-
active ways. These interactions are dynamic and are influenced by differentiating agents. p38δ inter-
action with ERK1 and ERK2 is an interesting example. ERK1 and ERK2 both interact with p38δ, but
ERK1 interaction is preferred and this interaction requires the unique ERK1 amino terminus. Dif-
ferentiation stimuli and presence of interacting partners influences these complexes. For example,
knockdown of PKCδ has no effect on integrity of the p38δ-ERK complex, but PKCδ knockdown
reduces p38δ interaction with MEK3. Moreover, phorbol ester increases p38δ/ERK interaction, while
OA or H2O2 treatment reduces p38δ level but increases p38δ-phosphorylation. These studies indi-
cate that p38δ regulation of keratinocyte differentiation involves the dynamic formation and disso-
ciation of multiple regulatory complexes and suggest that understanding these dynamics will be
necessary to understand differentiation
358
Protein arginine methyltransferase 5 (PRMT5) is a novel negative regulator of keratinocyte
differentiation
SR Kanade1 and RL Eckert1,2,3 1 Biochemistry and Molecular Biology, University of Maryland
School of Medicine, Baltimore, MD, 2 Dermatology, University of Maryland School of
Medicine, Baltimore, MD and 3 Reproductive Sciences, University of Maryland School of
Medicine, Baltimore, MD
Protein kinase c (PKC) kinases comprise a family of enzymes that play a key role in regulating cell
growth and differentiation. PKCδ stimulates keratinocyte differentiation via activation of p38δ
mitogen-activated protein kinase signaling. An important evolving concept is that p38δ exists in a
complex of interacting regulatory partners. A major goal is identifying these proteins. Using protein
purification and mass spectrometry, we identify protein arginine methyltransferase 5 (PRMT5) as
such a partner. PRMT5 is an important arginine methyltransferase that dimethylates arginine residues
in proteins. Protein arginine dimethylation is a major covalent regulatory modification that influ-
ences target protein function. We show that PRMT5 is a partner in the p38δ signaling complex that
modifies proteins in this complex to suppress keratinocyte differentiation as evidenced by reduced
involucrin expression and promoter activity. Moreover, PRMT5 function is controlled by PKCδ.
Knockdown of PKCδ increases PRMT5 mRNA/protein level and increases PRMT5 activity. Con-
versely, PKCδ activation reduces PRMT5 expression and activity. Thus, PKCδ and PRMT5 are oppos-
ing regulators of differentiation. This is the first evidence of a role for arginine modification signal-
ing in keratinocytes. These novel findings suggest that PRMT5 and MAPK signaling are intertwined
in a common differentiation-control signaling cascade, PKCδ activity drives differentiation, in part
by inhibiting PRMT5 activity, and differentiation depends upon the balance between PKCδ and
PRMT5 activity.
359
The effects of artemisia abrotanum (Southernwood) on multiple levels of the skin
M Russell, M Anthonavage and S Tucker-Samaras Johnson and Johnson, Skillman, NJ
Skin aging is a complex process integrating time and environmental exposure which involves more
than just the surface of the skin. In the epidermis, altered keratinocyte biology contributes to a thin-
ning epidermis giving the skin a fragile transparent look and weak barrier properties. In the dermis,
inappropriate protease activity along with a reduction in matrix production reduces skin’s strength
and elasticity. Even the subcutaneous fat layer, which provides insulation and padding, thins over
time, creating sags and wrinkles. Taken together, aging is a multifactor process that occurs at many
levels in the skin. Therefore, a successful antiaging product should be able to address these weak-
nesses by correcting and restoring balance in multiple layers in the skin. Southernwood (Artemisia
abrotanum) is an attractive bushy shrub that is grown in many cottage gardens as a decorative
plant. Gene chip data derived from epidermal keratinocytes treated with an aqueous extract of south-
ernwood, show positive effects on genes that enhance differentiation, epidermal cohesion, desqua-
mation and ceramide synthesis, data that is coroborated by in vivo analysis. The natural combina-
tion of polyphenols found in this extract deliver antioxidants and an anti-inflammatory component
to the skin as well demonstrated by ORAC testing and skin equivalent testing respectively. In the
dermis, the extract works by strengthening the collagen and elastin network through the prevention
of proteases. Finally, representing the deepest layer of the skin, adipocytes treated with an aqueous
extract of southernwood accumulate more triglycerides than their placebo treated counterparts.
Overall, an aqueous extract of Artemisia abrotanum provides numerous benefits to all layers of the
skin as demonstrated by in-vitro testing models designed to mimic the pathways of aging and skin
imbalance. Taken together, these data support the use of an aqueous extract of southernwood in
topical skin care products for the restoration of balance particularly caused by the progress of time
and environmental exposure.
360
PKCδ suppresses keratinocyte proliferation by increasing p21Cip1 level via a KLF4-dependent
mechanism
YC Chew,1 G Adhikary1 and RL Eckert1,2,3 1 Biochemistry and Molecular Biology, University of
Maryland School of Medicine, Baltimore, MD, 2 Dermatology, University of Maryland School
of Medicine, Baltimore, MD and 3 Reproductive Sciences, University of Maryland School of
Medicine, Baltimore, MD
Keratinocyte differentiation is associated with cessation of proliferation. It has long been suspected
that these processes may be regulated by common signaling pathway. PKCδ, since it regulates dif-
ferentiation and proliferation, is such a candidate regulator. PKCδ regulation of differentiation has
been studied; however, how PKCδ suppresses proliferation is not well understood. We show that
PKCδ regulates p21Cip1 expression. PKCδ increases p21Cip1 mRNA and protein level and promoter
activity, and that dominant-negative PKCδ, PKCδ-siRNA or rottlerin inhibit these events. p21Cip1 pro-
moter activation is mediated by three DNA response elements. A series of GC-rich DNA elements
near the p21Cip1 promoter transcription start site are particularly important and mutation of these
sites results in a loss of response. KLF4 is an important member of the Kruppel-like transcription
factor family. PKCδ expression increases KLF4 mRNA and protein, and this is associated with increased
KLF4 binding to the GC-rich elements in the p21Cip1 promoter. These PKCδ-dependent changes can
be replicated by overexpression of KLF4 and reversed by KLF4 siRNA. PKCδ also stimulates p21Cip1
translocation to the nucleus, which is required for p21Cip1 activity. These findings suggest that PKCδ
signaling coordinately regulates keratinocyte differentiation and proliferation. It is of particular inter-
est that PKCδ signaling increases keratinocyte differentiation by activating AP1 and Sp1 transcrip-
tion factors, but utilizes KLF4 to suppress transcription. The present studies suggest a new function
for KLF4 in epidermis as an activator of a key suppressor of cell division.
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Long noncoding RNA programs active chromatin domain to coordinate homeotic gene expres-
sion
KC Wang,1,2 YW Yang,1 B Liu,3 A Sanyal,4 R Corces-Zimmerman,1 Y Chen,5 BR Lajoie,4
A Protacio,1 RA Flynn,1 RA Gupta,1 J Wysocka,6 M Lei,5 J Dekker,4 JA Helms3 and HY Chang1 1
Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA, 2
Dermatology, Stanford University School of Medicine, Stanford, CA, 3 Surgery, Stanford
University School of Medicine, Stanford, CA, 4 Biochemistry and Molecular Pharmacology,
University of Massachusetts Medical School, Worcester, MA, 5 Howard Hughes Medical
Institute, University of Michigan, Ann Arbor, MI and 6 Chemical and Systems Biology, Stanford
University School of Medicine, Stanford, CA
The genome is extensively transcribed into long intergenic noncoding RNAs (lincRNAs), many of
which are implicated in gene silencing. Potential roles of lincRNAs in gene activation are much less
understood. Development and homeostasis require coordinate regulation of neighboring genes
through a process termed locus control. Some locus control elements and enhancers transcribe lin-
cRNAs, hinting at possible roles in long range control. In vertebrates, 39 Hox genes, encoding home-
odomain transcription factors critical for positional identity, are clustered in four chromosomal
loci; the Hox genes are expressed in nested anterior-posterior and proximal-distal patterns co-lin-
ear with their genomic position from 3’ to 5’of the cluster11. Here we identify HOTTIP, a lincRNA
transcribed from the 5’ tip of the HOXA locus that coordinates the activation of multiple 5’ HOXA
genes in vivo. Chromosomal looping brings HOTTIP into close proximity to its target genes. HOT-
TIP directly binds the adaptor protein WDR5 and targets WDR5/MLL complexes across HOXA, driv-
ing histone H3 lysine 4 trimethylation and gene transcription. Induced proximity is necessary and
sufficient for HOTTIP activation of its target genes. Thus, by serving as key intermediates that trans-
mit information from higher order chromosomal looping into chromatin modifications, lincRNAs
may organize chromatin domains to coordinate long-range gene activation.
375
Copy number variation within the filaggrin gene contributes to risk of atopic dermatitis
SJ Brown,1,2,3 K Kroboth,1 A Sandilands,1 LE Campbell,1 E Pohler,1 AD Irvine,3 HJ Cordell4 and
W McLean1 1 Epithelial Genetics Group, University of Dundee, Dundee, United Kingdom, 2
Ninewells Hospital & Medical School, Dundee, United Kingdom, 3 Trinity College Dublin,
Dublin, Ireland and 4 Institute of Human Genetics, Newcastle University, Newcastle, United
Kingdom
Loss-of-function variants within exon 3 of the filaggrin gene (FLG) confer strong genetic risk of devel-
oping atopic dermatitis (AD). In addition, the FLG locus demonstrates intragenic copy number vari-
ation, with common alleles in the human population encoding 10, 11 or 12 filaggrin monomers.
The relative amount of filaggrin expressed in the epidermis may therefore be affected by copy num-
ber variation. We sought to test the hypothesis that copy number variation within FLG contributes
to the risk of AD, independently of the established FLG null mutations. 876 Irish paediatric AD cases
plus 928 population controls were studied. Size variants within exon 3 of FLG were determined by
long-range PCR and allelic discrimination assays (TaqMan Applied Biosystems, Foster City, CA).
The four most prevalent FLG null mutations were also screened. Individuals with FLG null muta-
tions were excluded from statistical analysis to allow independent assessment of the effect of copy
number variation on AD risk. Chi-square and logistic regression were performed in Stata (StataCorp
LP, College Station, TX). The 11-repeat allele was most prevalent in this population (allele fre-
quency 51.5%); the 10-repeat allele frequency was 33.9% and 12-repeat allele frequency 14.6%.
Controls had a significantly higher number of repeats than AD cases (p=0.043) and the odds ratio
of disease was reduced by a factor of 0.88 (95% confidence interval 0.78 to 0.98) for each addi-
tional unit of copy number. Copy number variation within FLG makes a significant, dose-depend-
ent contribution to AD risk, therefore treatments aimed at increasing filaggrin expression may have
therapeutic effect and this benefit may not be restricted to patients carrying FLG null mutations.
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Increased DNA repair in xeroderma pigmentosum group C cells by induction of readthrough
of stop codons
C Kuschal, JJ DiGiovanna, SG Khan and KH Kraemer Derm Br, NCI, Bethesda, MD
Xeroderma pigmentosum is a rare recessive disorder with sun sensitivity and a 1000-fold increase
in skin cancers due to a defect in nucleotide excision repair (NER). Many XP patients have muta-
tions in the XPC gene that lead to defective NER and result in premature stop codons. Aminogly-
coside antibiotics like Geneticin (G418) block polypeptide synthesis by inhibiting the elongation
step in prokaryotic and eukaryotic cells. Geneticin treated cells are able to ‘read through’ prema-
ture stop codon mutations. This has been reported in several recessive human disorders including
ataxia-telangiectasia, Hurler syndrome, cystic fibrosis, and X-linked Duchenne muscular dystrophy
leading to partial restoration of missing proteins. Here, we investigated the effects of Geneticin on
DNA repair in cell lines from 4 XP-C patients: 3 had premature stop codons (XP59DC, XP62DC
and XP198BE) and 1 had an initiation codon mutation (XP21BE). There was no detectable XPC pro-
tein by Western blotting or by immunofluorescence; nonsense mediated message decay resulted in
markedly reduced levels of XPC mRNA by quantitative RT-PCR; and repair of 6-4 photoproducts
(6-4PP) was not detectable by immunofluorescence or ELISA in the 4 cell lines. Geneticin treat-
ment resulted in increased XPC protein and mRNA in XP59DC and XP62DC but not in XP198BE
or XP21BE cells. In addition, using local UV irradiation and immunofluorescence, XPC protein was
visualized at sites of UV damage followed by recruitment of XPB and XPD DNA repair proteins
with consequent repair of 6-4PP. The ELISA-assay confirmed repair of 6-4PP. Our findings provide
the first evidence that aminoglycosides like Geneticin can partially restore XPC protein in XPC-
deficient cells with specific mutations. Aminoglycosides may serve as a new therapeutic strategy
for preventing skin cancer in XPC-patients harboring premature stop codon mutations by partially
correcting their DNA repair defect.
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Genetic associations of psoriasis in a Pakistani population
PA Shaiq,2,3 PE Stuart,1 GK Raja,2 JJ Voorhees,1 JT Elder,1 R Qamar3 and RP Nair1 1 Dermatology,
Univ Michigan, Ann Arbor, MI, 2 PMAS-Arid Agriculture Univ Rawalpindi, Rawalpindi,
Pakistan and 3 COMSATS Institute of Information Technology, Islamabad, Pakistan
About 2% of people of European descent are affected with psoriasis; prevalence in other popula-
tions is lower. Recent studies have identified 24 genetic loci showing association with psoriasis at
a genome-wide level of significance (p ≤ 5 x 10E-8). Five of these loci were identified in both Chi-
nese and Europeans, five only in Chinese, and the remaining 14 only in Europeans. Genetic analy-
sis in ethnically diverse populations can help fine map and identify DNA variations underlying dis-
ease predisposition. Here we report association analysis in a Pakistani cohort of 25 markers
representing all 20 psoriasis susceptibility loci known at the time the study was initiated. The study
sample consisted of 345 psoriasis cases and 545 unaffected controls collected near Islamabad,
Pakistan. Genotyping was performed using Taqman, Snapshot, paralog ratio or length polymorphism
assays depending on the marker type, and data were analyzed using logistic regression for beta-
defensin copy number and a chi-square test for allelic association for all other markers. HLA-Cw6
showed the strongest association (OR = 2.43, p = 2.3 x 10E-12). Interestingly, HLA-Cw1, which
previously was shown to be associated with psoriasis in Thailand and Japan but not in Europeans,
showed marginally significant association (OR = 1.66, p = 0.049), suggesting that the HLA-Cw1-
B46 risk haplotype may be present in the Pakistani population. Three other loci (IL13, NOS2,
TRAF3IP2) had nominally significant allelic association (p < 0.05). All three markers for IL12B yielded
lower strength of association in Pakistanis compared to a large sample of 4700 Caucasians (OR =
1.04–1.05 vs. 1.47–1.68, heterogeneity p = 0.0010–0.00012). These results show that many of the
psoriasis loci identified in Europeans and Chinese are likely to be represented in Pakistanis, although
their relative contributions to disease risk may differ. A much larger sample will be needed to repli-
cate known susceptibility loci and to identify possible new ones.
374
First case of recessive epidermolysis bullosa simplex due to KRT5 loss of function mutations
leading to splice defects and pseudoexon inclusion
N Pironon,1,2 M Titeux,1,2 S Turczynski,1,2 E Tron,3 S Fraitag,4 S Leclerc-Mercier,4 C Prost,5
C Bodemer6 and A Hovnanian1,2,3 1 Inserm, U781, Paris, France, 2 University Paris V, Paris,
France, 3 Department of Genetics, CHU Necker, Paris, France, 4 Department of Pathology,
CHU Necker, Paris, France, 5 Department of Histology, University Paris XIII, Paris, France and
6 Department of Dermatology, CHU Necker, Paris, France
Epidermolysis bullosa simplex (EBS) is characterized by intra-epidermal blistering upon mild trauma.
Most EBS cases are caused by dominant missense mutations in KRT5 or KRT14 encoding keratin 5
and keratin 14, but few cases of recessively inherited EBS due to KRT14 mutations have been reported.
In this study, we report the case of a 14 months-old girl from unrelated healthy parents, presenting
with severe and extensive skin blistering at birth with partial improvement during childhood. Direct
sequencing of KRT5 from blood leukocyte DNA of the proband and her parents revealed two muta-
tions leading to a frameshift and PTC formation: 1) deletion of the two first bases of exon 3 in KRT5
(c.771_772delGT) inherited from the mother; 2) a T>C transition deep within intron 2 (IVS2-292T>C)
inherited from the father. The latter disrupts KRT5 pre-mRNA splicing and leads to the inclusion of
a 41 bp-length pseudoexon as demonstrated by RT-PCR analyses and sequencing. Thus, the proband
is a compound heterozygote for two novel recessive loss-of-function keratin 5 mutations. Immuno-
histochemistry showed reduced staining of keratin 5 in the basal layer of the epidermis. Western
blot analysis from patient keratinocytes demonstrated reduced level of full-length keratin 5 and no
truncated forms. These results indicate that the intronic mutation is leaky, rescuing the synthesis of
a small amount of wild-type protein. This is consistent with the notion that complete lack of keratin
5 is predicted to be lethal in human as suggested by the Krt5 knock-out mouse model. The lack of
detectable truncated forms of keratin 5 suggests instability of the protein and/or mutant mRNA. This
is the first reported case of recessive EBS due to KRT5 mutations, demonstrating gene dosage effect
in EBS.
378
XPD mutations in trichothiodystrophy fibroblasts inhibit TFIIH-dependent transactivation
mediated by the vitamin D receptor
X Zhou,1,2 SG Khan,1 D Tamura,1 E Compe,3 J Egly,3 T Ueda,1,3 J Boyle,1 JJ DiGiovanna1 and
KH Kraemer1 1 Derm Br, NCI, Bethesda, MD, 2 CRTP, NIH, Bethesda, MD and 3 Institut de
Génétique et de Biologie Moléculaire et Cellulaire, Strasbourg, France
Trichothiodystrophy (TTD) is a rare, autosomal recessive disorder with sulfur deficient, brittle hair,
bone defects and developmental abnormalities including dysmyelination of the brain but no increase
in cancer. TTD patients have defects in DNA repair/transcription genes (XPD, XPB, TTDA) or in
TTDN1, a gene of unknown function. TTD phenotypes may be explained by unique functions of
these causative genes in addition to their role in DNA repair. Xeroderma pigmentosum (XP), in con-
trast, may also arise from XPD gene mutations but XP patients have greatly increased cancer fre-
quency. XPD is a structural bridge that ties the transcription factor IIH (TFIIH) core with the cdk
activating kinase (CAK) complex, which phosphorylates nuclear receptors. We studied TFIIH–depen-
dent transactivation by nuclear receptors [vitamin D nuclear receptor (VDR) and thyroid hormone
receptor (TR)] in fibroblasts derived from 5 patients with XPD mutations but different clinical phe-
notypes: 2 TTD (TTD354BE, TTD412BE), 2 XP (XP29BE, XP34BE) and 1 combined XP/TTD
(XPTTD306BE). Quantitative real-time RT-PCR revealed a significant (p < 0.05) decrease in the
vitamin D induction ratio of VDR responsive genes CYP24 and osteopontin in XP-D mutant fibrob-
lasts from TTD patients compared to normal controls. Interestingly, the expression of CYP24 in TTD
and XP/TTD cells shows a greater reduction than in XP cells. We also found that basal expression
of CYP24, osteopontin and KLF9 (TR response gene) was elevated in TTD cells. These results indi-
cate that nuclear receptor - mediated transactivation is greatly reduced in TTD compared to XP cells.
These differences may contribute to the diverse clinical phenotypes in TTD and XP patients.
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An exceptional mutational event leading to Chanarin-Dorfman syndrome in a large consan-
guineous family
D Fuchs-Telem, L Samuelov-Kinori, O Sarig and E Sprecher Department of Dermatology, Tel
Aviv, Israel
Chanarin–Dorfman syndrome (CDS) is a rare autosomal recessive metabolic disorder featuring con-
genital ichthyosis combined with pleiomorphic visceral manifestations associated with tissue accu-
mulation of cytoplasmic lipid droplets. Mutations in the ABHD5 gene, encoding a crucial cofactor
for various lipases, have been found to underlie all CDS cases reported to date. In the present study,
we ascertained a large consanguineous kindred featuring typical manifestations of the syndrome,
including ichthyosis, liver damage and elevated CPK. Although no pathogenic mutation could be
identified in the coding sequence of the ABHD5 gene, polymorphic marker genotyping analysis
supported linkage to this gene locus. Accordingly, direct sequencing of RT-PCR amplification prod-
ucts generated from patient skin-derived total RNA, revealed in all four patients the presence of a
101 bp insertion between exon 3 and exon 4. Bioinformatic analysis and direct sequencing indi-
cated that this insertion resulted from an exceptional mutational event, namely, the insertion of a
LINE element into intron 3 of the ABHD5 gene, leading to aberrant splicing out of the mutant intron
3. In conclusion, we provide the first example to our knowledge of a human disease caused by inser-
tion of a LINE element, driving aberrant splicing and incorporation of a foreign sequence within a
functional mRNA. The present results confirm genetic homogeneity in CDS and underscore the
importance of RNA studies in the molecular diagnosis of inherited diseases.
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A mutation in LIPN, encoding epidermal Lipase N, causes a late onset form of autosomal
recessive congenital ichthyosis
S Israeli,1 Z Khamaysi,2 D Fuchs-Telem,1 J Nousbeck,1 R Bergman,2 O Sarig1 and E Sprecher1 1
Department of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel and 2
Department of Dermatology, Rambam Medical Center, Haifa, Israel
Autosomal recessive congenital ichthyosis represent a large and heterogeneous group of disorders
of epidermal cornification. Recent data suggest that most of these diseases are due to defective
lipid transport or metabolism. In the present study, we describe a large consanguineous pedigree
of Arab Moslem origin affected with a novel form of late-onset recessive ichthyosis. Homozygosity
mapping revealed a maximal LOD score of 4.11 at marker D10S1687. Haplotype analysis enabled
us to set the disease-associated interval in this family between markers D10S1174 and D10S520.
Candidate gene screening led to the identification of a 2 base pair deletion in the LIPN gene, which
was associated with a strong decrease in the gene expression in patient keratinocytes. The mutation
was found to segregate with the disease phenotype throughout the family and was excluded from
a panel of 925 healthy individuals including 679 individuals of Moslem origin. LIPN encodes Lipase
N, one of 6 acid lipases known in mammals to be involved in triglyceride metabolism. LIPN was
found to be exclusively expressed in the epidermis and to be strongly induced during keratinocyte
differentiation. The present results point to a crucial role played by Lipase N during epidermal dif-
ferentiation.
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A novel mutation in MBTPS2 causes ichthyosis follicularis, alopecia and photophobia syn-
drome in a Chinese family
Y Ding,1 J Wang,2 J Qiao,1 X Mao2 and S Cai2 1 Department of Dermatology, First Affiliated
Hospital, College of Medicine, Zhejiang University, Hang Zhou, China and 2 Department of
Dermatology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hang
Zhou, China
IFAP syndrome (MIM 308205) is a rare genodermatosis characterized by a peculiar triad of follic-
ular ichthyosis, total or subtotal atrichia, and photophobia of varying degree. We reported a Chi-
nese family with IFAP syndrome due to a novel mutation in MBTPS2 gene. The IFAP family had two
male children patients. The proband was 11 years old and his brother was 6 years old. Both of them
born with a full head of black hair but subsequently suffered from obvious photophobia, widespread
follicular papules and patchy alopecia. Their nails, teeth, mucous membranes, hearing, sweat secre-
tion and intelligence were normal. Ophthalmological assessment revealed punctuate corneal ero-
sions. A skin biopsy showed hyperkeratosis with marked follicular plugging; the granular layer of
the infundibulum was thickened; Hair follicles were abortive. Sebaceous glands were completely
absent. Eccrine glands appeared almost normal in number and morphology. The patients’ mother,
a 33-year-old woman, presented with linear lesions of ichthyosiform scaling and atrophoderma fol-
lowing the lines of Blaschko on her extremities and waist, without alopecia, keratotic follicular
papules or photophobic. DNA sequencing revealed two male patients had a similar homozygous
c.1523 A> G (p. Asn 508 Ser) missense mutation in MBTPS2 gene, which has not been previously
reported and can not be detected in 100 unrelated control subjects. Their mother had the het-
erozygous c.1523 A> G mutation, suggesting she was an obligate carrier who presented with a lin-
ear pattern of ichthyosis, representing a visible result of the lionization. The Chinese cases of IFAP
syndrome reported here have added new clinical and genetic information of this disease.
370
Discovery of novel ingredients which stimulate the expression of sirtuins in human skin and
skin cells
J Lyga, S Chen, Q Zheng, P Abad, R Wyborski and D Ptchelintsev Global R&D Center, Avon
Products, Inc., Suffern, NY
Sirtuins are a conserved family of proteins which have been linked to aging, stress resistance, and
metabolic regulation in a number of organisms. In humans, seven sirtuins have been identified; three
are associated with the nucleus (SIRT 1, 6, 7), three are located in the mitochondria (SIRT 3-5), and
one (SITR 2) is located in the cytoplasm. Sirtuins are connected to variety of processes in mam-
malian cells from impacting genomic stability to regulating energy metabolism . We have observed
that the expression of some of these sirtuin genes are altered with aging and UV or oxidative stress
in skin cells. In order to identify active ingredients that can influence the expression of sirtuins in
skin cells, we initiated a screening program using human dermal fibroblasts and quantitative RT_PCR
methods to measure the expression of sirtuin genes. We discovered several novel ingredients that
increase the expression of a number of sirtuin genes in skin cells in vitro. Select ingredients that
were active in the in vitro screen were formulated in a simple vehicle and applied to human skin
in vivo for three weeks under semi-occlusion. We observed an increase in sirtuin protein expres-
sion evaluated by immunohistochemistry for some of the actives which we believe may have the
potential of providing beneficial effects to aging skin.
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Dystrophic epidermolysis bullosa compound heterozygote presents with immunofluorescence
findings evocative of transient bullous dermolysis of the newborn
HI Cohn,1,2 K Tran,3 CW Chow,4 E Palmer,5 A Turner5 and DF Murrell1,3 1 Department of
Dermatology, St George Clinical School, University of New South Wales, Sydney, NSW,
Australia, 2 Department of Dermatology and Cutaneous Biology, Jefferson Medical College,
Thomas Jefferson University, Philadelphia, PA, 3 South Eastern Area Laboratory Services, St
George Hospital, Sydney, NSW, Australia, 4 Anatomical Pathology, Royal Children’s Hospital,
Melbourne, VIC, Australia and 5 Sydney Children’s Hospital, Sydney, NSW, Australia
After an unremarkable pregnancy, a male infant (EB-431) was delivered by Caesarean section for
failure to progress following induction of labor. Skin loss over the left knee and heel, a 1 cm blister
on the dorsal right hand and multiple smaller blood blisters over his trunk and shins were discov-
ered upon examination. Two large blood blisters on his tongue and buccal mucosa were present,
as well as a large circular area of abraded skin across his right cheek most likely subsequent to gen-
tle forceps traction. No family history of blistering was reported upon initial questioning. However,
examination of the father revealed dystrophic toenails with negative staining and cultures for fun-
gus. Immunofluorescence mapping of the newborn skin with collagen VII antibody revealed stip-
pled staining of the basal keratinocytes with a subepidermal blister. Intracytoplasmic organelles in
the basal layer were seen upon electron microscopy. These findings may suggest transient bullous
dermolysis of the newborn (TBDN); however, rarely stippled collagen VII can be a presentation of
dystrophic epidermolysis bullosa (DEB). As there were many milia developing, mutation screening
of COL7A1 was performed. A novel paternal dominant p.G2269R missense mutation in the triple
helical domain and a previously documented maternal recessive p.R2814X mutation was identi-
fied making the diagnosis of DEB compound heterozygote. Thus, we conclude that when confronted
with a patient who has the molecular features of TBDN one should continue to have a high suspi-
cion for DEB. The patient’s family should be informed of the risk and DEB should remain on the dif-
ferential diagnosis until proven otherwise.
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Keratinocyte cell fate decisions are regulated by a novel microRNA-31/factor-inhibiting
hypoxia-inducible factor 1 (FIH-1)/Notch relationship
H Peng, S Getsios and RM Lavker Dermatology, Northwestern University, Chicago, IL
Notch signaling is a major determinant of epidermal proliferation and differentiation, and can have
a tumor suppressor role in non-melanoma skin cancer (NMSC). However, our understanding of how
Notch activation is regulated remains incomplete. We have shown that miRNAs play key roles in
regulating keratinocyte survival and migration. We now demonstrate that the hydroxylase, FIH-1,
is a target of miR-31 that dampens Notch signaling in keratinocytes. Luciferase assays validated FIH-
1 as a direct target of miR-31. Suppression of miR-31 in primary cultures of human epidermal (HEKs)
and corneal epithelial (HCEKs) keratinocytes post- treatment with an antagomir (Antago-31) increased
FIH-1 protein with a coordinated decrease in Notch1 receptor expression. Consistent with the decline
in Notch1 transcriptional activity, expression of its target, Hey2 also decreased. Increasing FIH-1
levels in keratinocytes by Antago-31 treatment or ectopic expression of FIH-1, disrupted calcium-
induced differentiation, as evidenced by diminished induction of keratin 10 (K10), involucrin
(INV), desmoglein1 (Dsg1) and loricrin. In contrast, decreasing FIH-1 levels by gene silencing pro-
moted keratinocyte differentiation even in low calcium. Sustained expression of FIH-1 in HEKs by
retroviral gene delivery modified epidermal morphogenesis in organotypic raft cultures (ORCs). FIH-
1-derived ORC basal cells contained large nuclei with multiple nucleoli, numerous nucleolar organ-
izer regions (NORs), and frequent mitotic figures along with a labeling index (LI) of 23.3 ± 2.28%.
Conversely, control ORC basal cells had nuclei with dispersed chromatin, few NORs, rare mitotic
figures and a LI of 15.8 ± 1.77%. In addition to a more rapidly proliferating phenotype, FIH-1-derived
ORCs exhibited decreased expression of K10, INV, and Dsg1. Collectively these observations define
a novel regulatory network for keratinocyte cell fate decisions where Notch signaling potential is,
in part, controlled through a miR-31/FIH-1 nexus. Targeting FIH-1 may result in innovative treat-
ments for NMSC.
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Long noncoding RNA programs active chromatin domain to coordinate homeotic gene expres-
sion
KC Wang,1,2 YW Yang,1 B Liu,3 A Sanyal,4 R Corces-Zimmerman,1 Y Chen,5 BR Lajoie,4
A Protacio,1 RA Flynn,1 RA Gupta,1 J Wysocka,6 M Lei,5 J Dekker,4 JA Helms3 and HY Chang1 1
Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA, 2
Dermatology, Stanford University School of Medicine, Stanford, CA, 3 Surgery, Stanford
University School of Medicine, Stanford, CA, 4 Biochemistry and Molecular Pharmacology,
University of Massachusetts Medical School, Worcester, MA, 5 Howard Hughes Medical
Institute, University of Michigan, Ann Arbor, MI and 6 Chemical and Systems Biology, Stanford
University School of Medicine, Stanford, CA
The genome is extensively transcribed into long intergenic noncoding RNAs (lincRNAs), many of
which are implicated in gene silencing. Potential roles of lincRNAs in gene activation are much less
understood. Development and homeostasis require coordinate regulation of neighboring genes
through a process termed locus control. Some locus control elements and enhancers transcribe lin-
cRNAs, hinting at possible roles in long range control. In vertebrates, 39 Hox genes, encoding home-
odomain transcription factors critical for positional identity, are clustered in four chromosomal
loci; the Hox genes are expressed in nested anterior-posterior and proximal-distal patterns co-lin-
ear with their genomic position from 3’ to 5’of the cluster11. Here we identify HOTTIP, a lincRNA
transcribed from the 5’ tip of the HOXA locus that coordinates the activation of multiple 5’ HOXA
genes in vivo. Chromosomal looping brings HOTTIP into close proximity to its target genes. HOT-
TIP directly binds the adaptor protein WDR5 and targets WDR5/MLL complexes across HOXA, driv-
ing histone H3 lysine 4 trimethylation and gene transcription. Induced proximity is necessary and
sufficient for HOTTIP activation of its target genes. Thus, by serving as key intermediates that trans-
mit information from higher order chromosomal looping into chromatin modifications, lincRNAs
may organize chromatin domains to coordinate long-range gene activation.
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Copy number variation within the filaggrin gene contributes to risk of atopic dermatitis
SJ Brown,1,2,3 K Kroboth,1 A Sandilands,1 LE Campbell,1 E Pohler,1 AD Irvine,3 HJ Cordell4 and
W McLean1 1 Epithelial Genetics Group, University of Dundee, Dundee, United Kingdom, 2
Ninewells Hospital & Medical School, Dundee, United Kingdom, 3 Trinity College Dublin,
Dublin, Ireland and 4 Institute of Human Genetics, Newcastle University, Newcastle, United
Kingdom
Loss-of-function variants within exon 3 of the filaggrin gene (FLG) confer strong genetic risk of devel-
oping atopic dermatitis (AD). In addition, the FLG locus demonstrates intragenic copy number vari-
ation, with common alleles in the human population encoding 10, 11 or 12 filaggrin monomers.
The relative amount of filaggrin expressed in the epidermis may therefore be affected by copy num-
ber variation. We sought to test the hypothesis that copy number variation within FLG contributes
to the risk of AD, independently of the established FLG null mutations. 876 Irish paediatric AD cases
plus 928 population controls were studied. Size variants within exon 3 of FLG were determined by
long-range PCR and allelic discrimination assays (TaqMan Applied Biosystems, Foster City, CA).
The four most prevalent FLG null mutations were also screened. Individuals with FLG null muta-
tions were excluded from statistical analysis to allow independent assessment of the effect of copy
number variation on AD risk. Chi-square and logistic regression were performed in Stata (StataCorp
LP, College Station, TX). The 11-repeat allele was most prevalent in this population (allele fre-
quency 51.5%); the 10-repeat allele frequency was 33.9% and 12-repeat allele frequency 14.6%.
Controls had a significantly higher number of repeats than AD cases (p=0.043) and the odds ratio
of disease was reduced by a factor of 0.88 (95% confidence interval 0.78 to 0.98) for each addi-
tional unit of copy number. Copy number variation within FLG makes a significant, dose-depend-
ent contribution to AD risk, therefore treatments aimed at increasing filaggrin expression may have
therapeutic effect and this benefit may not be restricted to patients carrying FLG null mutations.
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Increased DNA repair in xeroderma pigmentosum group C cells by induction of readthrough
of stop codons
C Kuschal, JJ DiGiovanna, SG Khan and KH Kraemer Derm Br, NCI, Bethesda, MD
Xeroderma pigmentosum is a rare recessive disorder with sun sensitivity and a 1000-fold increase
in skin cancers due to a defect in nucleotide excision repair (NER). Many XP patients have muta-
tions in the XPC gene that lead to defective NER and result in premature stop codons. Aminogly-
coside antibiotics like Geneticin (G418) block polypeptide synthesis by inhibiting the elongation
step in prokaryotic and eukaryotic cells. Geneticin treated cells are able to ‘read through’ prema-
ture stop codon mutations. This has been reported in several recessive human disorders including
ataxia-telangiectasia, Hurler syndrome, cystic fibrosis, and X-linked Duchenne muscular dystrophy
leading to partial restoration of missing proteins. Here, we investigated the effects of Geneticin on
DNA repair in cell lines from 4 XP-C patients: 3 had premature stop codons (XP59DC, XP62DC
and XP198BE) and 1 had an initiation codon mutation (XP21BE). There was no detectable XPC pro-
tein by Western blotting or by immunofluorescence; nonsense mediated message decay resulted in
markedly reduced levels of XPC mRNA by quantitative RT-PCR; and repair of 6-4 photoproducts
(6-4PP) was not detectable by immunofluorescence or ELISA in the 4 cell lines. Geneticin treat-
ment resulted in increased XPC protein and mRNA in XP59DC and XP62DC but not in XP198BE
or XP21BE cells. In addition, using local UV irradiation and immunofluorescence, XPC protein was
visualized at sites of UV damage followed by recruitment of XPB and XPD DNA repair proteins
with consequent repair of 6-4PP. The ELISA-assay confirmed repair of 6-4PP. Our findings provide
the first evidence that aminoglycosides like Geneticin can partially restore XPC protein in XPC-
deficient cells with specific mutations. Aminoglycosides may serve as a new therapeutic strategy
for preventing skin cancer in XPC-patients harboring premature stop codon mutations by partially
correcting their DNA repair defect.
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Genetic associations of psoriasis in a Pakistani population
PA Shaiq,2,3 PE Stuart,1 GK Raja,2 JJ Voorhees,1 JT Elder,1 R Qamar3 and RP Nair1 1 Dermatology,
Univ Michigan, Ann Arbor, MI, 2 PMAS-Arid Agriculture Univ Rawalpindi, Rawalpindi,
Pakistan and 3 COMSATS Institute of Information Technology, Islamabad, Pakistan
About 2% of people of European descent are affected with psoriasis; prevalence in other popula-
tions is lower. Recent studies have identified 24 genetic loci showing association with psoriasis at
a genome-wide level of significance (p ≤ 5 x 10E-8). Five of these loci were identified in both Chi-
nese and Europeans, five only in Chinese, and the remaining 14 only in Europeans. Genetic analy-
sis in ethnically diverse populations can help fine map and identify DNA variations underlying dis-
ease predisposition. Here we report association analysis in a Pakistani cohort of 25 markers
representing all 20 psoriasis susceptibility loci known at the time the study was initiated. The study
sample consisted of 345 psoriasis cases and 545 unaffected controls collected near Islamabad,
Pakistan. Genotyping was performed using Taqman, Snapshot, paralog ratio or length polymorphism
assays depending on the marker type, and data were analyzed using logistic regression for beta-
defensin copy number and a chi-square test for allelic association for all other markers. HLA-Cw6
showed the strongest association (OR = 2.43, p = 2.3 x 10E-12). Interestingly, HLA-Cw1, which
previously was shown to be associated with psoriasis in Thailand and Japan but not in Europeans,
showed marginally significant association (OR = 1.66, p = 0.049), suggesting that the HLA-Cw1-
B46 risk haplotype may be present in the Pakistani population. Three other loci (IL13, NOS2,
TRAF3IP2) had nominally significant allelic association (p < 0.05). All three markers for IL12B yielded
lower strength of association in Pakistanis compared to a large sample of 4700 Caucasians (OR =
1.04–1.05 vs. 1.47–1.68, heterogeneity p = 0.0010–0.00012). These results show that many of the
psoriasis loci identified in Europeans and Chinese are likely to be represented in Pakistanis, although
their relative contributions to disease risk may differ. A much larger sample will be needed to repli-
cate known susceptibility loci and to identify possible new ones.
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First case of recessive epidermolysis bullosa simplex due to KRT5 loss of function mutations
leading to splice defects and pseudoexon inclusion
N Pironon,1,2 M Titeux,1,2 S Turczynski,1,2 E Tron,3 S Fraitag,4 S Leclerc-Mercier,4 C Prost,5
C Bodemer6 and A Hovnanian1,2,3 1 Inserm, U781, Paris, France, 2 University Paris V, Paris,
France, 3 Department of Genetics, CHU Necker, Paris, France, 4 Department of Pathology,
CHU Necker, Paris, France, 5 Department of Histology, University Paris XIII, Paris, France and
6 Department of Dermatology, CHU Necker, Paris, France
Epidermolysis bullosa simplex (EBS) is characterized by intra-epidermal blistering upon mild trauma.
Most EBS cases are caused by dominant missense mutations in KRT5 or KRT14 encoding keratin 5
and keratin 14, but few cases of recessively inherited EBS due to KRT14 mutations have been reported.
In this study, we report the case of a 14 months-old girl from unrelated healthy parents, presenting
with severe and extensive skin blistering at birth with partial improvement during childhood. Direct
sequencing of KRT5 from blood leukocyte DNA of the proband and her parents revealed two muta-
tions leading to a frameshift and PTC formation: 1) deletion of the two first bases of exon 3 in KRT5
(c.771_772delGT) inherited from the mother; 2) a T>C transition deep within intron 2 (IVS2-292T>C)
inherited from the father. The latter disrupts KRT5 pre-mRNA splicing and leads to the inclusion of
a 41 bp-length pseudoexon as demonstrated by RT-PCR analyses and sequencing. Thus, the proband
is a compound heterozygote for two novel recessive loss-of-function keratin 5 mutations. Immuno-
histochemistry showed reduced staining of keratin 5 in the basal layer of the epidermis. Western
blot analysis from patient keratinocytes demonstrated reduced level of full-length keratin 5 and no
truncated forms. These results indicate that the intronic mutation is leaky, rescuing the synthesis of
a small amount of wild-type protein. This is consistent with the notion that complete lack of keratin
5 is predicted to be lethal in human as suggested by the Krt5 knock-out mouse model. The lack of
detectable truncated forms of keratin 5 suggests instability of the protein and/or mutant mRNA. This
is the first reported case of recessive EBS due to KRT5 mutations, demonstrating gene dosage effect
in EBS.
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XPD mutations in trichothiodystrophy fibroblasts inhibit TFIIH-dependent transactivation
mediated by the vitamin D receptor
X Zhou,1,2 SG Khan,1 D Tamura,1 E Compe,3 J Egly,3 T Ueda,1,3 J Boyle,1 JJ DiGiovanna1 and
KH Kraemer1 1 Derm Br, NCI, Bethesda, MD, 2 CRTP, NIH, Bethesda, MD and 3 Institut de
Génétique et de Biologie Moléculaire et Cellulaire, Strasbourg, France
Trichothiodystrophy (TTD) is a rare, autosomal recessive disorder with sulfur deficient, brittle hair,
bone defects and developmental abnormalities including dysmyelination of the brain but no increase
in cancer. TTD patients have defects in DNA repair/transcription genes (XPD, XPB, TTDA) or in
TTDN1, a gene of unknown function. TTD phenotypes may be explained by unique functions of
these causative genes in addition to their role in DNA repair. Xeroderma pigmentosum (XP), in con-
trast, may also arise from XPD gene mutations but XP patients have greatly increased cancer fre-
quency. XPD is a structural bridge that ties the transcription factor IIH (TFIIH) core with the cdk
activating kinase (CAK) complex, which phosphorylates nuclear receptors. We studied TFIIH–depen-
dent transactivation by nuclear receptors [vitamin D nuclear receptor (VDR) and thyroid hormone
receptor (TR)] in fibroblasts derived from 5 patients with XPD mutations but different clinical phe-
notypes: 2 TTD (TTD354BE, TTD412BE), 2 XP (XP29BE, XP34BE) and 1 combined XP/TTD
(XPTTD306BE). Quantitative real-time RT-PCR revealed a significant (p < 0.05) decrease in the
vitamin D induction ratio of VDR responsive genes CYP24 and osteopontin in XP-D mutant fibrob-
lasts from TTD patients compared to normal controls. Interestingly, the expression of CYP24 in TTD
and XP/TTD cells shows a greater reduction than in XP cells. We also found that basal expression
of CYP24, osteopontin and KLF9 (TR response gene) was elevated in TTD cells. These results indi-
cate that nuclear receptor - mediated transactivation is greatly reduced in TTD compared to XP cells.
These differences may contribute to the diverse clinical phenotypes in TTD and XP patients.
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An exceptional mutational event leading to Chanarin-Dorfman syndrome in a large consan-
guineous family
D Fuchs-Telem, L Samuelov-Kinori, O Sarig and E Sprecher Department of Dermatology, Tel
Aviv, Israel
Chanarin–Dorfman syndrome (CDS) is a rare autosomal recessive metabolic disorder featuring con-
genital ichthyosis combined with pleiomorphic visceral manifestations associated with tissue accu-
mulation of cytoplasmic lipid droplets. Mutations in the ABHD5 gene, encoding a crucial cofactor
for various lipases, have been found to underlie all CDS cases reported to date. In the present study,
we ascertained a large consanguineous kindred featuring typical manifestations of the syndrome,
including ichthyosis, liver damage and elevated CPK. Although no pathogenic mutation could be
identified in the coding sequence of the ABHD5 gene, polymorphic marker genotyping analysis
supported linkage to this gene locus. Accordingly, direct sequencing of RT-PCR amplification prod-
ucts generated from patient skin-derived total RNA, revealed in all four patients the presence of a
101 bp insertion between exon 3 and exon 4. Bioinformatic analysis and direct sequencing indi-
cated that this insertion resulted from an exceptional mutational event, namely, the insertion of a
LINE element into intron 3 of the ABHD5 gene, leading to aberrant splicing out of the mutant intron
3. In conclusion, we provide the first example to our knowledge of a human disease caused by inser-
tion of a LINE element, driving aberrant splicing and incorporation of a foreign sequence within a
functional mRNA. The present results confirm genetic homogeneity in CDS and underscore the
importance of RNA studies in the molecular diagnosis of inherited diseases.
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A mutation in LIPN, encoding epidermal Lipase N, causes a late onset form of autosomal
recessive congenital ichthyosis
S Israeli,1 Z Khamaysi,2 D Fuchs-Telem,1 J Nousbeck,1 R Bergman,2 O Sarig1 and E Sprecher1 1
Department of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel and 2
Department of Dermatology, Rambam Medical Center, Haifa, Israel
Autosomal recessive congenital ichthyosis represent a large and heterogeneous group of disorders
of epidermal cornification. Recent data suggest that most of these diseases are due to defective
lipid transport or metabolism. In the present study, we describe a large consanguineous pedigree
of Arab Moslem origin affected with a novel form of late-onset recessive ichthyosis. Homozygosity
mapping revealed a maximal LOD score of 4.11 at marker D10S1687. Haplotype analysis enabled
us to set the disease-associated interval in this family between markers D10S1174 and D10S520.
Candidate gene screening led to the identification of a 2 base pair deletion in the LIPN gene, which
was associated with a strong decrease in the gene expression in patient keratinocytes. The mutation
was found to segregate with the disease phenotype throughout the family and was excluded from
a panel of 925 healthy individuals including 679 individuals of Moslem origin. LIPN encodes Lipase
N, one of 6 acid lipases known in mammals to be involved in triglyceride metabolism. LIPN was
found to be exclusively expressed in the epidermis and to be strongly induced during keratinocyte
differentiation. The present results point to a crucial role played by Lipase N during epidermal dif-
ferentiation.
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A novel mutation in MBTPS2 causes ichthyosis follicularis, alopecia and photophobia syn-
drome in a Chinese family
Y Ding,1 J Wang,2 J Qiao,1 X Mao2 and S Cai2 1 Department of Dermatology, First Affiliated
Hospital, College of Medicine, Zhejiang University, Hang Zhou, China and 2 Department of
Dermatology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hang
Zhou, China
IFAP syndrome (MIM 308205) is a rare genodermatosis characterized by a peculiar triad of follic-
ular ichthyosis, total or subtotal atrichia, and photophobia of varying degree. We reported a Chi-
nese family with IFAP syndrome due to a novel mutation in MBTPS2 gene. The IFAP family had two
male children patients. The proband was 11 years old and his brother was 6 years old. Both of them
born with a full head of black hair but subsequently suffered from obvious photophobia, widespread
follicular papules and patchy alopecia. Their nails, teeth, mucous membranes, hearing, sweat secre-
tion and intelligence were normal. Ophthalmological assessment revealed punctuate corneal ero-
sions. A skin biopsy showed hyperkeratosis with marked follicular plugging; the granular layer of
the infundibulum was thickened; Hair follicles were abortive. Sebaceous glands were completely
absent. Eccrine glands appeared almost normal in number and morphology. The patients’ mother,
a 33-year-old woman, presented with linear lesions of ichthyosiform scaling and atrophoderma fol-
lowing the lines of Blaschko on her extremities and waist, without alopecia, keratotic follicular
papules or photophobic. DNA sequencing revealed two male patients had a similar homozygous
c.1523 A> G (p. Asn 508 Ser) missense mutation in MBTPS2 gene, which has not been previously
reported and can not be detected in 100 unrelated control subjects. Their mother had the het-
erozygous c.1523 A> G mutation, suggesting she was an obligate carrier who presented with a lin-
ear pattern of ichthyosis, representing a visible result of the lionization. The Chinese cases of IFAP
syndrome reported here have added new clinical and genetic information of this disease.
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Discovery of novel ingredients which stimulate the expression of sirtuins in human skin and
skin cells
J Lyga, S Chen, Q Zheng, P Abad, R Wyborski and D Ptchelintsev Global R&D Center, Avon
Products, Inc., Suffern, NY
Sirtuins are a conserved family of proteins which have been linked to aging, stress resistance, and
metabolic regulation in a number of organisms. In humans, seven sirtuins have been identified; three
are associated with the nucleus (SIRT 1, 6, 7), three are located in the mitochondria (SIRT 3-5), and
one (SITR 2) is located in the cytoplasm. Sirtuins are connected to variety of processes in mam-
malian cells from impacting genomic stability to regulating energy metabolism . We have observed
that the expression of some of these sirtuin genes are altered with aging and UV or oxidative stress
in skin cells. In order to identify active ingredients that can influence the expression of sirtuins in
skin cells, we initiated a screening program using human dermal fibroblasts and quantitative RT_PCR
methods to measure the expression of sirtuin genes. We discovered several novel ingredients that
increase the expression of a number of sirtuin genes in skin cells in vitro. Select ingredients that
were active in the in vitro screen were formulated in a simple vehicle and applied to human skin
in vivo for three weeks under semi-occlusion. We observed an increase in sirtuin protein expres-
sion evaluated by immunohistochemistry for some of the actives which we believe may have the
potential of providing beneficial effects to aging skin.
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Dystrophic epidermolysis bullosa compound heterozygote presents with immunofluorescence
findings evocative of transient bullous dermolysis of the newborn
HI Cohn,1,2 K Tran,3 CW Chow,4 E Palmer,5 A Turner5 and DF Murrell1,3 1 Department of
Dermatology, St George Clinical School, University of New South Wales, Sydney, NSW,
Australia, 2 Department of Dermatology and Cutaneous Biology, Jefferson Medical College,
Thomas Jefferson University, Philadelphia, PA, 3 South Eastern Area Laboratory Services, St
George Hospital, Sydney, NSW, Australia, 4 Anatomical Pathology, Royal Children’s Hospital,
Melbourne, VIC, Australia and 5 Sydney Children’s Hospital, Sydney, NSW, Australia
After an unremarkable pregnancy, a male infant (EB-431) was delivered by Caesarean section for
failure to progress following induction of labor. Skin loss over the left knee and heel, a 1 cm blister
on the dorsal right hand and multiple smaller blood blisters over his trunk and shins were discov-
ered upon examination. Two large blood blisters on his tongue and buccal mucosa were present,
as well as a large circular area of abraded skin across his right cheek most likely subsequent to gen-
tle forceps traction. No family history of blistering was reported upon initial questioning. However,
examination of the father revealed dystrophic toenails with negative staining and cultures for fun-
gus. Immunofluorescence mapping of the newborn skin with collagen VII antibody revealed stip-
pled staining of the basal keratinocytes with a subepidermal blister. Intracytoplasmic organelles in
the basal layer were seen upon electron microscopy. These findings may suggest transient bullous
dermolysis of the newborn (TBDN); however, rarely stippled collagen VII can be a presentation of
dystrophic epidermolysis bullosa (DEB). As there were many milia developing, mutation screening
of COL7A1 was performed. A novel paternal dominant p.G2269R missense mutation in the triple
helical domain and a previously documented maternal recessive p.R2814X mutation was identi-
fied making the diagnosis of DEB compound heterozygote. Thus, we conclude that when confronted
with a patient who has the molecular features of TBDN one should continue to have a high suspi-
cion for DEB. The patient’s family should be informed of the risk and DEB should remain on the dif-
ferential diagnosis until proven otherwise.
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Keratinocyte cell fate decisions are regulated by a novel microRNA-31/factor-inhibiting
hypoxia-inducible factor 1 (FIH-1)/Notch relationship
H Peng, S Getsios and RM Lavker Dermatology, Northwestern University, Chicago, IL
Notch signaling is a major determinant of epidermal proliferation and differentiation, and can have
a tumor suppressor role in non-melanoma skin cancer (NMSC). However, our understanding of how
Notch activation is regulated remains incomplete. We have shown that miRNAs play key roles in
regulating keratinocyte survival and migration. We now demonstrate that the hydroxylase, FIH-1,
is a target of miR-31 that dampens Notch signaling in keratinocytes. Luciferase assays validated FIH-
1 as a direct target of miR-31. Suppression of miR-31 in primary cultures of human epidermal (HEKs)
and corneal epithelial (HCEKs) keratinocytes post- treatment with an antagomir (Antago-31) increased
FIH-1 protein with a coordinated decrease in Notch1 receptor expression. Consistent with the decline
in Notch1 transcriptional activity, expression of its target, Hey2 also decreased. Increasing FIH-1
levels in keratinocytes by Antago-31 treatment or ectopic expression of FIH-1, disrupted calcium-
induced differentiation, as evidenced by diminished induction of keratin 10 (K10), involucrin
(INV), desmoglein1 (Dsg1) and loricrin. In contrast, decreasing FIH-1 levels by gene silencing pro-
moted keratinocyte differentiation even in low calcium. Sustained expression of FIH-1 in HEKs by
retroviral gene delivery modified epidermal morphogenesis in organotypic raft cultures (ORCs). FIH-
1-derived ORC basal cells contained large nuclei with multiple nucleoli, numerous nucleolar organ-
izer regions (NORs), and frequent mitotic figures along with a labeling index (LI) of 23.3 ± 2.28%.
Conversely, control ORC basal cells had nuclei with dispersed chromatin, few NORs, rare mitotic
figures and a LI of 15.8 ± 1.77%. In addition to a more rapidly proliferating phenotype, FIH-1-derived
ORCs exhibited decreased expression of K10, INV, and Dsg1. Collectively these observations define
a novel regulatory network for keratinocyte cell fate decisions where Notch signaling potential is,
in part, controlled through a miR-31/FIH-1 nexus. Targeting FIH-1 may result in innovative treat-
ments for NMSC.
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Combination of free-flow electrophoresis and interactomics to analyze the dysregulated pro-
teins of fibroblasts from atopic dermatitis patients
Y Park1,2,3 and J Yang3 1 College of Biological and Environmental Sciences, Zhejiang Wanli
University, Ningbo, China, 2 Zhejiang Provincial Key Laboratory of Applied Enzymology,
Yangtze Delta Region Institute of Tsinghua University, Jiaxing, China and 3 Dermatology,
Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Republic of
Korea
The rapid development and combination of techniques have enabled researchers to better under-
stand AD and its associated factors. Since the subsequent phase of functional studies is a long and
costly process, the number of target proteins of handling is limited. For this reason, researchers may
employ PPI mapping algorithms to determine target proteins and computational prediction on the
basis of proteomic results is a critical step. In this study, we attempted to profile protein alterations
in AD using patient-derived fibroblasts, in addition to predicting the proteins related to pathogen-
esis as interaction hubs. From the FFE selection, 93 proteins were detected in AD patients that dif-
fered from those of the normal control subjects. We further conducted real-time PCR to validate the
expression levels of candidate proteins and in this way, 16 proteins were further analyzed by real-
time PCR at the transcriptional level. Next, we predicted the hub proteins in AD fibroblasts using
PPI mappings. We identified three hub proteins (YWHAE, I55423, and ARR3) sorting from 250 can-
didates of combining the previously reported results plus candidates by using the PEIMAP algorithm.
In the same way, the PSIMAP algorithm identified 17 hub proteins. Overlapping of the PEIMAP and
PSIMAP algorithms detected four hub proteins: I55423, ARR3, YWHAE, and EEF1A1.
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Non-aminoglycosides can restore type VII collagen function by overcoming premature stop
mutations: implications for DEB therapy
J Cogan,1 Y Hou,1 X Wang,1 L Du,3 R Gatti,3 A South,2 D Woodley1 and M Chen1 1 Dermatology,
University of Southern California, Los Angeles, CA, 2 Ninewell’s Hospital and Medical School,
Dundee, United Kingdom and 3 University of California at Los Angeles, Los Angeles, CA
Dystrophic Epidermolysis Bullosa (DEB) is caused by mutations in the gene encoding type VII col-
lagen (C7). Approximately 30% mutations in DEB are caused by premature stop codon (PTC) muta-
tions. Therefore, a therapeutic approach to suppress PTC mutations could benefit DEB patients. We
showed previously that aminoglycosides were able to induce read through and restore full length
C7 expression and function in RDEB keratinocytes harboring PTCs. Despite clinical promise, amino-
glycosides have potentially severe renal and otic toxicities. Therefore, discovering non-aminogly-
coside agents that promote read through of PTCs in DEB patients without such toxicities would be
an advance. In this study, we evaluated two small, nonaminoglycoside compounds (RTC 13 and
14) that have been shown to induce read through of PTCs in ataxia-telangiectasia and Duchenne
muscular dystrophy for the potential treatment of DEB using two RDEB keratinocyte cell lines.
Incubation of DEB cells with increasing concentrations of RTC 13 and 14 resulted in the synthesis
and secretion of a 290 kDa full-length C7 in a dose-dependent manner. Under the same concen-
tration, RTC 13 and 14 were as effective as gentamicin for inducing read through of PTCs and restor-
ing full length C7. Functionally important, RTC 13 and 14 treated cells exhibited enhanced cell
growth and reversal of the hypermotility phenotype characteristic of RDEB cells. To determine the
general utility of RTC 13 and 14 for DEB harboring different PTC mutations, we used site directed
mutagenesis to engineer 25 PTC mutations associated with RDEB and transfected these mutant con-
structs into 293 cells. Treatment of these transfected cells with both compounds induced read through
and full length C7 expression in 100% of the RDEB mutant transfected cells. These data demon-
strate that RTC13 and 14 may offer a novel therapy for DEB and other inherited skin diseases
caused by PTC mutations.
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Knockdown of endogenous CD44 in human skin models using self-delivery siRNA adminis-
tered by dissolvable microneedle arrays
MF Lara,1,2 EF Gonzalez-Gonzalez,1,2 RP Hickerson,2 TJ Speaker,2 S Chang,2 MA Flores,2
CH Contag,1 D Leake3 and RL Kaspar2,1 1 Pediatrics, Stanford University, Stanford, CA, 2
TransDerm, Santa Cruz, CA and 3 Thermo Fisher Scientific, Lafayette, CO
Development of effective siRNA-based therapeutics for treatment of skin disorders requires potent
and specific inhibitors and also effective delivery methodologies to target appropriate skin cells.
Delivery of functional siRNA to skin epidermis requires: 1. passage through the stratum corneum
barrier and 2. efficient uptake by keratinocytes uptake followed by incorporation into the RNA-
induced silencing complex. We have previously published that microneedle array-mediated admin-
istration of self-delivery (sd) siRNA (Accell) leads to effective silencing of reporter gene expression
in a transgenic reporter mouse model. Furthermore, treatment of human 3D epidermal equivalents
with sd-siRNA results in knockdown of target gene expression. Now we present data demonstrat-
ing in vitro and in vivo knockdown of an endogenous gene (CD44) by sd-siRNA. To demonstrate
that sd-siRNA can inhibit CD44 in skin, we first treated human epidermal skin equivalents in vitro
with CD44 sd-siRNA. CD44 mRNA levels in epidermal equivalents treated six times with sd-CD44
siRNA decreased by 70% (by RT-qPCR) relative to controls. To test the effectiveness of sd-CD44
siRNA in vivo, full-thickness human skin equivalents (Stratatech) were grafted on immunocompro-
mised mice and treated ten consecutive days with CD44 sd-siRNA microneedle arrays. RT-qPCR
revealed that CD44 mRNA levels in the skin grafts treated with sd-CD44 siRNA were reduced 40-
50% compared to grafts treated with sd nonspecific control siRNA. Taken together, these results
demonstrate that sd-siRNAs are able to inhibit target gene expression in human skin models. Treat-
ment with non-modified target-specific siRNA does not result in efficient target knockdown in mice,
human epidermal equivalents, or full-thickness human skin grafts, demonstrating the utility of the
self-delivery modifications.
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Effective preservation and skin delivery of biologically active cargo including live viruses by
dissolvable microneedle arrays (MNAs).
G Erdos,1 C Donahue,1 J Zhang,1 B Ozdoganlar,3 A Gambotto2 and LD Falo1 1 Dermatology,
University of Pittsburgh, Pittsburgh, PA, 2 Surgery, University of Pittsburgh, Pittsburgh, PA and
3 Mechanical Engineeering, Carnegie Mellon University, Pittsburgh, PA
Dissolving microneedle arrays (MNAs) can effectively deliver biologics into the skin, and have the
potential to be an enabling technology for the development of novel therapies for a broad range of
skin and systemic diseases. We recently designed and fabricated MNAs to have several advantages
over existing skin delivery technologies, including geometric advantages for skin penetration, and
the potential to deliver a chemically and physically diverse range of active components including
simple organics, peptides, nucleic acids and viable viruses. Comparison of physical penetration
characteristics of representative MNAs using labeled tracers revealed advantages in delivery capac-
ity and reproducibility of MNAs with obelisk needle geometry in comparison to traditional needle
geometries. Stability assessment demonstrated that immunogenicity of the model antigen ovalbu-
min integrated and stored in MNAs was retained without significant degradation for up to 12 weeks.
Remarkably MNA encapsulated live Ad5 adenovirus retained infectivity for up to 52 weeks when
stored at 4oC. Taken together, these studies demonstrate the capacity of these MNAs to preserve
and deliver a broad range of biologically active cargo, supporting broad applicability for cutaneous
drug delivery. Further, the capacity of MNAs to preserve encapsulated live viruses demonstrates the
novel application of MNAs for viral preservation and delivery relevant to topical gene therapy appli-
cations.
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Association of IL-4 -590 T/C and IL-4 receptor Q551R gene polymorphisms in patients with
acne vulgaris
A Al Robaee,1 AA AlZolibani1 and A Settin2 1 Dermatology, Qassim Medical College, Buraydah,
Saudi Arabia and 2 Pediatrics and Genetics, Qassim Medical College, Buraydah, Saudi Arabia
Acne vulgaris is a common skin disorder. The complete etiology of this disease remains to be iden-
tified but it seems that aberrant expression of cytokine genes might be one of its inducing factors.
The association between genetic polymorphisms related to interleukin 4 promoter (IL-4 -590 T/C)
and its receptor (IL-4R Q551R, A/G) genes in patients with acne valgaris was investigated in the
present study. This study involves 95 acne patients recruited from the Outpatient Dermatology Clin-
ics of Qassim University, Saudi Arabia and their results were compared with 87 normal healthy vol-
unteers of same age and gender matched from the same locality. Genomic DNA was extracted
from peripheral blood using the Magna pure DNA system. Single nucleotide polymorphisms (SNPs)
related to IL-4 590 T/C and IL-4R Q551R (A/G) genes were determined by real-time PCR. A signif-
icant difference was observed between the frequencies of polymorphisms related to IL4-R gene
and IL-4R polymorphic genotypes (p=0.0). Furthermore, acne cases showed higher frequencies of
the combined genotypes IL-4_CC, CT or TT with the IL-4R_GG genotype. However, cases subgroups
related to severity of disease or response to treatment showed no significant difference in the fre-
quencies of all studied IL-4 and IL-4R genotypes (p>0.05). In conclusion, present study provides an
evidence for a significant association of IL-4 receptor Q551R (A/G) with IL-4 -590 T/C genetic poly-
morphisms in acne vulgaris with the susceptibility rather than the severity of disease among Saudi
affected subjects.
390
Interaction between psoriasis susceptibility loci ERAP1 and HLA- Cw6
T Tejasvi,1 PE Stuart,1 RP Nair,1 JJ Voorhees1 and JT Elder1,2 1 Dermatology, University of
Michigan Medical School, Ann Arbor, MI and 2 Ann Arbor Veteran Affairs Medical Center, Ann
Arbor, MI
Recent genome-wide association studies have revealed a total of 24 susceptibility loci for psoria-
sis. Although many of these loci harbor genes relevant to biological pathways involved in disease
pathogenesis, statistically significant interaction between involved loci has been observed for only
two pairs of loci. In both cases, the risk allele for the strongest known susceptibility locus, HLA-
Cw6, showed positive interactions with the risk-predisposing deletion of a segment containing LCE3C
and LCE3B genes in the epidermal differentiation complex on chromosome 1q21 (JID 2010), and
the risk allele of marker rs27524, located in the ERAP1 gene on chromosome 5q15 (Nat Genet
42:985). The epistasis between ERAP1 and HLA-C is particularly interesting, as ERAP1 encodes an
aminopeptidase that regulates the length-dependent binding of peptides to MHC class I molecules
such as HLA-C. In an effort to replicate the reported interaction between ERAP1 and HLA-C, we
genotyped 2,553 psoriasis cases and 2,445 unaffected controls for HLA-Cw6 and rs27524. Analy-
sis of association using logistic regression models with and without a multiplicative interaction
term showed no statistically significant evidence of interaction, although the coefficient of the
interaction term does trend in a positive direction (OR = 1.17, 95% CI = 0.97-1.41, p = 0.091). Strat-
ification analysis revealed that the association of ERAP1 with psoriasis was stronger and more sig-
nificant for carriers of HLA-Cw6 (OR = 1.29, p = 0.0024) than for non-carriers (OR = 1.09, p =
0.098). Although the interaction analysis did not reach statistical significance, our results are con-
sistent with a recent report (Nat Genet 42:985) and identify a trend towards epistasis between these
two loci. Interaction tests are known to have low power, and we are currently extending our analy-
sis to a much larger sample.
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Modulating keratinocyte intracellular Ca2+ via the sphingolipid pathway constitutes a novel
therapeutic target for Darier’s Disease
A Celli, D Mackenzie, Y Zhai, C Tu, D Bikle, W Holleran, Y Uchida and T Mauro Dermatology,
UCSF-VAMC, San Francisco, CA
Abstract: Darier’s Disease (DD), caused by mutations in the endoplasmic reticulum (ER) Ca2+ ATPase
ATP2A2 (SERCA2b), is a skin and neuropsychiatric disease that exhibits impaired epidermal cell-
to-cell adhesion and altered differentiation. There currently is no effective treatment for this dis-
ease. Although previous studies have shown that keratinocyte Ca2+ sequestration and fluxes are
controlled by sphingolipid signaling, the role of this signaling pathway in DD previously has not
been investigated. This study was conducted with the purpose of determining whether modulation
of Keratinocytes calcium homeostasis via the sphingolipid pathway could be a therapeutic target
for DD. Thapsigargin and siRNA silencing were used to inhibit the activity of SERCA2 in human
keratinocytes, and siRNA against Sphingosine 1 Phosphate Lyase (SGPL1) was used to inhibit SGLP1
activity. ER calcium levels were measured by using an ER targeted calcium indicator D1ER. We
show here that sphingosine levels increased and sphingosine kinase expression decreased after inac-
tivating ATP2A2 with the specific ATP2A2 inhibitors thapsigargin (TG) or siRNA. Conversely, inhibit-
ing sphingosine lyase rescued the defects in keratinocyte differentiation, ecadherin localization
and ER Ca2+ sequestration seen in TG-treated keratinocytes. These studies are the first to demon-
strate that the keratinocyte sphingolipid and Ca2+ signaling pathways intersect in ATP2A2- con-
trolled ER Ca2+ sequestration, ecadherin localization and Ca2+ - controlled differentiation, and
thus may be important mediators in DD. Agents that control intracellular or intraorganelle S1P syn-
thesis or breakdown may be novel therapeutic targets in treating DD and other acantholytic skin
diseases.
380
A novel desmoglein 1 mutation in a Japanese patient with striate palmoplantar keratoderma
R Sogame, T Hamada, N Ishii, S Sakaguchi, A Suzuki, T Dainichi, T Karashima, T Nakama,
D Tsuruta and T Hashimoto Department of Dermatology, Kurume University School of
Medicine, and Kurume University Institute of Cutaneous Cell Biology, Kurume, Japan
Inherited palmoplantar keratoderma is a heterogeneous skin disorder showing varied clinical man-
ifestations that primarily affects palmoplantar epidermis. Striate palmoplantar keratoderma (SPPK)
is a rare autosomal dominant skin disease characterized clinically by linear and focal hyperkerato-
sis on the palms and soles, and histopathologically by restricted hyperkeratosis and widening of the
intercellular space in the epidermis. To date, 21 different mutations have been reported in three
genes encoding desmoglein (Dsg) 1, desmoplakin, or keratin 1. In this study, we examined gene
mutation in a 37-year-old Japanese patient who presented with typical clinicopathological features
of SPPK. Light microscopy for biopsy specimen taken from affected palmar skin showed acantho-
sis with hyperkeratosis and hypergranulosis. Widening of the intercellular spaces was evident in the
spinous layers of the epidermis. Direct nucleotide sequencing using the patient’s genomic DNA
revealed a heterozygous T-to-G transition at nucleotide 1017 of the Dsg1 gene (DSG1) that con-
verted a tyrosine residue (TAT) to a premature termination codon (TAG) designated p.Tyr339X. This
mutation has not been reported previously. The haploinsufficiency of Dsg1 is a prevalent mecha-
nism for the dominant inheritance of SPPK. To evaluate regulation of epidermal cell-cell adhesion
in SPPK, we then performed immunohistochemical studies of desmosomal proteins in the lesional
skin. Desmocollin (Dsc) 1 and Dsc3 were highly expressed in the intercellular spaces of the spin-
ous layers than those in healthy control, suggesting partial rescue for impaired cell-cell adhesion
due to Dsg1 haploinsufficiency. In contrast, expression patterns of Dsg2, Dsg3, and Dsc2 in the
lesional skin were almost same as those in the normal sole skin. Our results expand DSG1 muta-
tion database and provide further insight into the role of desmosomal proteins on the epidermal
integration and differentiation.
381
MiR-302b regulates replicative senescence of human dermal fibroblasts by post-transcrip-
tional regulation of cyclin D1 expression
C Chu,1 S Cha,2 M Hsieh,1 H Chiu1 and T Tsai1 1 Department of Dermatology, National Taiwan
University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan and
2 Graduate Institute of Toxicology, National Taiwan University College of Medicine, Taipei,
Taiwan
Replicative senescence is a specific type of cellular senescence that ultimately results from loss of
telomeres. Because senescent cells accumulate with age, they may contribute to age-related declines
in tissue function. microRNAs (miRNAs) are endogenous≈22-nt noncoding small RNAs, which
negatively regulate gene expression in a sequence-specific manner. Recently, miRNAs have been
found to play a role in lifespan regulation. In this study, we identified miRNAs associated with human
dermal fibroblast early senescence. Sequential analysis of the Hs68 cells from P13 to P21 revealed
a trend of decreasing BrdU (+) cells and increasing SA-β-Gal (+) cells. Microarray analysis of miR-
NAs associated with this in vitro senescence model found several miRNAs were significantly changed
in the early rapid senescence. We found 6 miRNAs, miR-422a, miR-203, miR-302b, miR-376b,
miR-135b, and miR-409-5p, were significantly changed more than 2 folds in the early rapid senes-
cence. Further RT-qPCR study also confirmed the consistent down-regulation of miR-302b in either
ccd966 human dermal fibroblast cell line or 2 primarily cultured human dermal fibroblasts, indi-
cating this miRNA might play important roles in regulating dermal fibroblast senescence. In addi-
tion, a recently described senescence marker, cyclin D1, had reciprocal changes to miR-302b lev-
els in our Hs68 senescence model. We also found that miR-302b inhibits replicative senescence of
Hs68 cells by targeting cyclin D1.
382
Ichthyosis with confetti shows widespread somatic reversion via mitotic recombination at
two distinct loci
KA Choate,1,2 Y Lu,2 J Zhou,1 M Choi,2 A Paller,3 P Elias,4 A Farhi,2 C Nelson-Williams,2
D Crumrine,4 M Williams,4 A Nopper,5 A Bree,6 L Milstone1 and R Lifton2 1 Dermatology, Yale,
New Haven, CT, 2 Genetics, Yale, New Haven, CT, 3 Dermatology, Northwestern, Chicago, IL,
4 Dermatology, UCSF, San Francisco, CA, 5 Dermatology, Children’s Mercy Hospital & Clinics,
Kansas City, MO and 6 Dermatology, Texas Children’s Hospital, Houston, TX
Widespread reversion of diseased tissue to an unaffected state is exceedingly rare. For this reason,
the development of hundreds to thousands of normal revertant skin clones observed in individuals
with ichthyosis with confetti (IWC, a.k.a. ichthyosis variegata, congenital ichthyosiform erythro-
derma), a severe autosomal dominant skin disease with two distinct types, is a remarkable phe-
nomenon. We initially predicted that IWC is caused by dominant negative or gain of function
mutations, that loss of heterozygosity (LOH) events could lead to somatic reversion, and that these
events would allow mapping of the disease locus. This was true for Type I IWC which is character-
ized by large patches of normal skin arising on the background of severe erythroderma and mild
palmoplantar keratoderma, in which we found that independent revertant clones showed distinct
copy-neutral LOH events, all occurring on chromosome 17q. This finding permitted mapping of
the disease locus and identification of disease-causing mutations in keratin 10 (KRT10) in nine kin-
dreds. All mutations result in frameshift into the same arginine-rich alternative reading frame, and
the resulting protein accumulates in the nucleolus, rather than in intermediate filaments. We have
further identified that similar LOH events occur at a distinct locus in Type II IWC, which shows
smaller white spots and more severe keratoderma. We have identified mutations in a novel gene as
the cause of this disorder. The high rate of reversion events observed in the two subtypes of IWC
implicates the mutated genes in the generation of reversion events either through direct effects on
mitotic recombination or through selective pressure. Insights from this work may enable reversion
of other dominant mutations.
383
Polyvalent siRNA-gold nanoparticles effectively traverse human epidermis and cause no
demonstrable toxicity in keratinocytes or mouse skin
DL Chen,1 D Zheng,2 D Giljohann,2 H Iordanov,1 C Wilke,2 X Wang,1 CA Mirkin2 and AS Paller1
1 Dermatology, Northwestern Univ, Chicago, IL and 2 Chemistry, Northwestern Univ,
Evanston, IL
The recent demonstration that polyvalent siRNA-conjugated 13 nm gold nanoparticles (siRNA-Au
NPs) are able to traverse mouse epidermis and suppress a variety of targeted genes in cultured ker-
atinocytes at pM concentrations raises the possibility of topically applied genetic therapy in vivo.
However, the ability to penetrate human epidermis and the safe introduction of these conjugated
gold nanoparticles in cultured keratinocytes and mouse skin has not yet been described. Using cul-
tured human skin equivalents and Franz cell chambers with human abdominal skin, we have found
evidence microscopically and by induced coupled plasma-mass spectroscopy (ICP-MS) of pene-
tration of fluorophore-labelled siRNA-AuNPs through epidermis to the basal keratinocytes and
through the basement membrane within 48 h after application. Application to mouse skin of 50 nM
siRNA-gold nanoparticles for up 4 weeks (with three times weekly application) led to no clinical or
histologic adverse effects. Based on measurements with ICP-MS and transmission electron microscopy,
the gold particles progressively cleared after application was discontinued. For example, quantifi-
cation of NPs showed a 75% decrease in skin gold within 5 days after discontinuation. Gold nanopar-
ticles were barely detectable to undetectable after 4 weeks of application in internal organs, includ-
ing the liver, kidneys and lungs, and shown no appreciable increase or decrease over the week
after discontinuation. These results make polyvalent siRNA-Au NPs a promising technology for top-
ical genetic therapy for dermatologic disease.
384
An association between IL-9 and IL-9 receptor gene polymorphisms and atopic dermatitis in
a Korean population
E Kim,1 J Namkung,2 G Park,1 H Yang3 and J Yang1 1 Dermatology, Samsung Medical Center,
Sungkyunkwan University, Seoul, Republic of Korea, 2 Case Western Reserve University
School of Medicine, Cleveland, OH and 3 Undergraduate Biological Sciences, Brown
University, Providence,, RI
The genes encoding IL-9 and IL-9R have recently been implicated in the genetic basis of asthma
and allergy. Although studies performed on transgenic and knockout mice have shown conflicting
results, no evidence of skin changes has ever been reported in these animals. We genotyped 5
SNPs from the IL-9 and IL-9R genes of 1,090 subject samples (631 AD patients and 459 normal
controls). A luciferase assay was then performed for the rs31563 (-4091G/A) SNP located in the IL-
9 gene promoter region. The rs31563 (-4091G/A) SNP in the IL-9 gene was significantly associated
with the AD phenotype, especially allergic-type AD. In the luciferase assay, the rs31563 G con-
struct was observed to have 1.54 times higher activity than the rs31563 A construct. Although no
association was found between SNPs in IL-9R gene and AD, the rs3093467 SNP showed associa-
tion with non-allergic AD. In the gene-gene interaction analysis, we found that IL-9/IL-9R genotype
rs31563 GG/ rs3093467 TT conveyed a greater risk for AD phenotype development. Significant
evidence exists to suggest that the rs31563 SNP (-4091G/A) located in the IL-9 gene is associated
with an increased susceptibility to AD. Similarly, the rs3093467 SNP in IL-9R gene seems to be asso-
ciated with an increased risk for developing non-allergic AD. In a subsequent gene-gene interac-
tion analysis, the rs31563 GG/ rs3093467 TT genotype combination (IL-9 / IL-9R) was found to exert
a synergistic effect in the development of the AD phenotype. As the classes of helper T cells are
diverse and the function of IL-9 cytokine has not been fully described, the cutaneous function of
IL-9 needs to be further explored in future studies.
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Combination of free-flow electrophoresis and interactomics to analyze the dysregulated pro-
teins of fibroblasts from atopic dermatitis patients
Y Park1,2,3 and J Yang3 1 College of Biological and Environmental Sciences, Zhejiang Wanli
University, Ningbo, China, 2 Zhejiang Provincial Key Laboratory of Applied Enzymology,
Yangtze Delta Region Institute of Tsinghua University, Jiaxing, China and 3 Dermatology,
Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Republic of
Korea
The rapid development and combination of techniques have enabled researchers to better under-
stand AD and its associated factors. Since the subsequent phase of functional studies is a long and
costly process, the number of target proteins of handling is limited. For this reason, researchers may
employ PPI mapping algorithms to determine target proteins and computational prediction on the
basis of proteomic results is a critical step. In this study, we attempted to profile protein alterations
in AD using patient-derived fibroblasts, in addition to predicting the proteins related to pathogen-
esis as interaction hubs. From the FFE selection, 93 proteins were detected in AD patients that dif-
fered from those of the normal control subjects. We further conducted real-time PCR to validate the
expression levels of candidate proteins and in this way, 16 proteins were further analyzed by real-
time PCR at the transcriptional level. Next, we predicted the hub proteins in AD fibroblasts using
PPI mappings. We identified three hub proteins (YWHAE, I55423, and ARR3) sorting from 250 can-
didates of combining the previously reported results plus candidates by using the PEIMAP algorithm.
In the same way, the PSIMAP algorithm identified 17 hub proteins. Overlapping of the PEIMAP and
PSIMAP algorithms detected four hub proteins: I55423, ARR3, YWHAE, and EEF1A1.
387
Non-aminoglycosides can restore type VII collagen function by overcoming premature stop
mutations: implications for DEB therapy
J Cogan,1 Y Hou,1 X Wang,1 L Du,3 R Gatti,3 A South,2 D Woodley1 and M Chen1 1 Dermatology,
University of Southern California, Los Angeles, CA, 2 Ninewell’s Hospital and Medical School,
Dundee, United Kingdom and 3 University of California at Los Angeles, Los Angeles, CA
Dystrophic Epidermolysis Bullosa (DEB) is caused by mutations in the gene encoding type VII col-
lagen (C7). Approximately 30% mutations in DEB are caused by premature stop codon (PTC) muta-
tions. Therefore, a therapeutic approach to suppress PTC mutations could benefit DEB patients. We
showed previously that aminoglycosides were able to induce read through and restore full length
C7 expression and function in RDEB keratinocytes harboring PTCs. Despite clinical promise, amino-
glycosides have potentially severe renal and otic toxicities. Therefore, discovering non-aminogly-
coside agents that promote read through of PTCs in DEB patients without such toxicities would be
an advance. In this study, we evaluated two small, nonaminoglycoside compounds (RTC 13 and
14) that have been shown to induce read through of PTCs in ataxia-telangiectasia and Duchenne
muscular dystrophy for the potential treatment of DEB using two RDEB keratinocyte cell lines.
Incubation of DEB cells with increasing concentrations of RTC 13 and 14 resulted in the synthesis
and secretion of a 290 kDa full-length C7 in a dose-dependent manner. Under the same concen-
tration, RTC 13 and 14 were as effective as gentamicin for inducing read through of PTCs and restor-
ing full length C7. Functionally important, RTC 13 and 14 treated cells exhibited enhanced cell
growth and reversal of the hypermotility phenotype characteristic of RDEB cells. To determine the
general utility of RTC 13 and 14 for DEB harboring different PTC mutations, we used site directed
mutagenesis to engineer 25 PTC mutations associated with RDEB and transfected these mutant con-
structs into 293 cells. Treatment of these transfected cells with both compounds induced read through
and full length C7 expression in 100% of the RDEB mutant transfected cells. These data demon-
strate that RTC13 and 14 may offer a novel therapy for DEB and other inherited skin diseases
caused by PTC mutations.
389
Knockdown of endogenous CD44 in human skin models using self-delivery siRNA adminis-
tered by dissolvable microneedle arrays
MF Lara,1,2 EF Gonzalez-Gonzalez,1,2 RP Hickerson,2 TJ Speaker,2 S Chang,2 MA Flores,2
CH Contag,1 D Leake3 and RL Kaspar2,1 1 Pediatrics, Stanford University, Stanford, CA, 2
TransDerm, Santa Cruz, CA and 3 Thermo Fisher Scientific, Lafayette, CO
Development of effective siRNA-based therapeutics for treatment of skin disorders requires potent
and specific inhibitors and also effective delivery methodologies to target appropriate skin cells.
Delivery of functional siRNA to skin epidermis requires: 1. passage through the stratum corneum
barrier and 2. efficient uptake by keratinocytes uptake followed by incorporation into the RNA-
induced silencing complex. We have previously published that microneedle array-mediated admin-
istration of self-delivery (sd) siRNA (Accell) leads to effective silencing of reporter gene expression
in a transgenic reporter mouse model. Furthermore, treatment of human 3D epidermal equivalents
with sd-siRNA results in knockdown of target gene expression. Now we present data demonstrat-
ing in vitro and in vivo knockdown of an endogenous gene (CD44) by sd-siRNA. To demonstrate
that sd-siRNA can inhibit CD44 in skin, we first treated human epidermal skin equivalents in vitro
with CD44 sd-siRNA. CD44 mRNA levels in epidermal equivalents treated six times with sd-CD44
siRNA decreased by 70% (by RT-qPCR) relative to controls. To test the effectiveness of sd-CD44
siRNA in vivo, full-thickness human skin equivalents (Stratatech) were grafted on immunocompro-
mised mice and treated ten consecutive days with CD44 sd-siRNA microneedle arrays. RT-qPCR
revealed that CD44 mRNA levels in the skin grafts treated with sd-CD44 siRNA were reduced 40-
50% compared to grafts treated with sd nonspecific control siRNA. Taken together, these results
demonstrate that sd-siRNAs are able to inhibit target gene expression in human skin models. Treat-
ment with non-modified target-specific siRNA does not result in efficient target knockdown in mice,
human epidermal equivalents, or full-thickness human skin grafts, demonstrating the utility of the
self-delivery modifications.
388
Effective preservation and skin delivery of biologically active cargo including live viruses by
dissolvable microneedle arrays (MNAs).
G Erdos,1 C Donahue,1 J Zhang,1 B Ozdoganlar,3 A Gambotto2 and LD Falo1 1 Dermatology,
University of Pittsburgh, Pittsburgh, PA, 2 Surgery, University of Pittsburgh, Pittsburgh, PA and
3 Mechanical Engineeering, Carnegie Mellon University, Pittsburgh, PA
Dissolving microneedle arrays (MNAs) can effectively deliver biologics into the skin, and have the
potential to be an enabling technology for the development of novel therapies for a broad range of
skin and systemic diseases. We recently designed and fabricated MNAs to have several advantages
over existing skin delivery technologies, including geometric advantages for skin penetration, and
the potential to deliver a chemically and physically diverse range of active components including
simple organics, peptides, nucleic acids and viable viruses. Comparison of physical penetration
characteristics of representative MNAs using labeled tracers revealed advantages in delivery capac-
ity and reproducibility of MNAs with obelisk needle geometry in comparison to traditional needle
geometries. Stability assessment demonstrated that immunogenicity of the model antigen ovalbu-
min integrated and stored in MNAs was retained without significant degradation for up to 12 weeks.
Remarkably MNA encapsulated live Ad5 adenovirus retained infectivity for up to 52 weeks when
stored at 4oC. Taken together, these studies demonstrate the capacity of these MNAs to preserve
and deliver a broad range of biologically active cargo, supporting broad applicability for cutaneous
drug delivery. Further, the capacity of MNAs to preserve encapsulated live viruses demonstrates the
novel application of MNAs for viral preservation and delivery relevant to topical gene therapy appli-
cations.
386
Association of IL-4 -590 T/C and IL-4 receptor Q551R gene polymorphisms in patients with
acne vulgaris
A Al Robaee,1 AA AlZolibani1 and A Settin2 1 Dermatology, Qassim Medical College, Buraydah,
Saudi Arabia and 2 Pediatrics and Genetics, Qassim Medical College, Buraydah, Saudi Arabia
Acne vulgaris is a common skin disorder. The complete etiology of this disease remains to be iden-
tified but it seems that aberrant expression of cytokine genes might be one of its inducing factors.
The association between genetic polymorphisms related to interleukin 4 promoter (IL-4 -590 T/C)
and its receptor (IL-4R Q551R, A/G) genes in patients with acne valgaris was investigated in the
present study. This study involves 95 acne patients recruited from the Outpatient Dermatology Clin-
ics of Qassim University, Saudi Arabia and their results were compared with 87 normal healthy vol-
unteers of same age and gender matched from the same locality. Genomic DNA was extracted
from peripheral blood using the Magna pure DNA system. Single nucleotide polymorphisms (SNPs)
related to IL-4 590 T/C and IL-4R Q551R (A/G) genes were determined by real-time PCR. A signif-
icant difference was observed between the frequencies of polymorphisms related to IL4-R gene
and IL-4R polymorphic genotypes (p=0.0). Furthermore, acne cases showed higher frequencies of
the combined genotypes IL-4_CC, CT or TT with the IL-4R_GG genotype. However, cases subgroups
related to severity of disease or response to treatment showed no significant difference in the fre-
quencies of all studied IL-4 and IL-4R genotypes (p>0.05). In conclusion, present study provides an
evidence for a significant association of IL-4 receptor Q551R (A/G) with IL-4 -590 T/C genetic poly-
morphisms in acne vulgaris with the susceptibility rather than the severity of disease among Saudi
affected subjects.
390
Interaction between psoriasis susceptibility loci ERAP1 and HLA- Cw6
T Tejasvi,1 PE Stuart,1 RP Nair,1 JJ Voorhees1 and JT Elder1,2 1 Dermatology, University of
Michigan Medical School, Ann Arbor, MI and 2 Ann Arbor Veteran Affairs Medical Center, Ann
Arbor, MI
Recent genome-wide association studies have revealed a total of 24 susceptibility loci for psoria-
sis. Although many of these loci harbor genes relevant to biological pathways involved in disease
pathogenesis, statistically significant interaction between involved loci has been observed for only
two pairs of loci. In both cases, the risk allele for the strongest known susceptibility locus, HLA-
Cw6, showed positive interactions with the risk-predisposing deletion of a segment containing LCE3C
and LCE3B genes in the epidermal differentiation complex on chromosome 1q21 (JID 2010), and
the risk allele of marker rs27524, located in the ERAP1 gene on chromosome 5q15 (Nat Genet
42:985). The epistasis between ERAP1 and HLA-C is particularly interesting, as ERAP1 encodes an
aminopeptidase that regulates the length-dependent binding of peptides to MHC class I molecules
such as HLA-C. In an effort to replicate the reported interaction between ERAP1 and HLA-C, we
genotyped 2,553 psoriasis cases and 2,445 unaffected controls for HLA-Cw6 and rs27524. Analy-
sis of association using logistic regression models with and without a multiplicative interaction
term showed no statistically significant evidence of interaction, although the coefficient of the
interaction term does trend in a positive direction (OR = 1.17, 95% CI = 0.97-1.41, p = 0.091). Strat-
ification analysis revealed that the association of ERAP1 with psoriasis was stronger and more sig-
nificant for carriers of HLA-Cw6 (OR = 1.29, p = 0.0024) than for non-carriers (OR = 1.09, p =
0.098). Although the interaction analysis did not reach statistical significance, our results are con-
sistent with a recent report (Nat Genet 42:985) and identify a trend towards epistasis between these
two loci. Interaction tests are known to have low power, and we are currently extending our analy-
sis to a much larger sample.
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Modulating keratinocyte intracellular Ca2+ via the sphingolipid pathway constitutes a novel
therapeutic target for Darier’s Disease
A Celli, D Mackenzie, Y Zhai, C Tu, D Bikle, W Holleran, Y Uchida and T Mauro Dermatology,
UCSF-VAMC, San Francisco, CA
Abstract: Darier’s Disease (DD), caused by mutations in the endoplasmic reticulum (ER) Ca2+ ATPase
ATP2A2 (SERCA2b), is a skin and neuropsychiatric disease that exhibits impaired epidermal cell-
to-cell adhesion and altered differentiation. There currently is no effective treatment for this dis-
ease. Although previous studies have shown that keratinocyte Ca2+ sequestration and fluxes are
controlled by sphingolipid signaling, the role of this signaling pathway in DD previously has not
been investigated. This study was conducted with the purpose of determining whether modulation
of Keratinocytes calcium homeostasis via the sphingolipid pathway could be a therapeutic target
for DD. Thapsigargin and siRNA silencing were used to inhibit the activity of SERCA2 in human
keratinocytes, and siRNA against Sphingosine 1 Phosphate Lyase (SGPL1) was used to inhibit SGLP1
activity. ER calcium levels were measured by using an ER targeted calcium indicator D1ER. We
show here that sphingosine levels increased and sphingosine kinase expression decreased after inac-
tivating ATP2A2 with the specific ATP2A2 inhibitors thapsigargin (TG) or siRNA. Conversely, inhibit-
ing sphingosine lyase rescued the defects in keratinocyte differentiation, ecadherin localization
and ER Ca2+ sequestration seen in TG-treated keratinocytes. These studies are the first to demon-
strate that the keratinocyte sphingolipid and Ca2+ signaling pathways intersect in ATP2A2- con-
trolled ER Ca2+ sequestration, ecadherin localization and Ca2+ - controlled differentiation, and
thus may be important mediators in DD. Agents that control intracellular or intraorganelle S1P syn-
thesis or breakdown may be novel therapeutic targets in treating DD and other acantholytic skin
diseases.
380
A novel desmoglein 1 mutation in a Japanese patient with striate palmoplantar keratoderma
R Sogame, T Hamada, N Ishii, S Sakaguchi, A Suzuki, T Dainichi, T Karashima, T Nakama,
D Tsuruta and T Hashimoto Department of Dermatology, Kurume University School of
Medicine, and Kurume University Institute of Cutaneous Cell Biology, Kurume, Japan
Inherited palmoplantar keratoderma is a heterogeneous skin disorder showing varied clinical man-
ifestations that primarily affects palmoplantar epidermis. Striate palmoplantar keratoderma (SPPK)
is a rare autosomal dominant skin disease characterized clinically by linear and focal hyperkerato-
sis on the palms and soles, and histopathologically by restricted hyperkeratosis and widening of the
intercellular space in the epidermis. To date, 21 different mutations have been reported in three
genes encoding desmoglein (Dsg) 1, desmoplakin, or keratin 1. In this study, we examined gene
mutation in a 37-year-old Japanese patient who presented with typical clinicopathological features
of SPPK. Light microscopy for biopsy specimen taken from affected palmar skin showed acantho-
sis with hyperkeratosis and hypergranulosis. Widening of the intercellular spaces was evident in the
spinous layers of the epidermis. Direct nucleotide sequencing using the patient’s genomic DNA
revealed a heterozygous T-to-G transition at nucleotide 1017 of the Dsg1 gene (DSG1) that con-
verted a tyrosine residue (TAT) to a premature termination codon (TAG) designated p.Tyr339X. This
mutation has not been reported previously. The haploinsufficiency of Dsg1 is a prevalent mecha-
nism for the dominant inheritance of SPPK. To evaluate regulation of epidermal cell-cell adhesion
in SPPK, we then performed immunohistochemical studies of desmosomal proteins in the lesional
skin. Desmocollin (Dsc) 1 and Dsc3 were highly expressed in the intercellular spaces of the spin-
ous layers than those in healthy control, suggesting partial rescue for impaired cell-cell adhesion
due to Dsg1 haploinsufficiency. In contrast, expression patterns of Dsg2, Dsg3, and Dsc2 in the
lesional skin were almost same as those in the normal sole skin. Our results expand DSG1 muta-
tion database and provide further insight into the role of desmosomal proteins on the epidermal
integration and differentiation.
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MiR-302b regulates replicative senescence of human dermal fibroblasts by post-transcrip-
tional regulation of cyclin D1 expression
C Chu,1 S Cha,2 M Hsieh,1 H Chiu1 and T Tsai1 1 Department of Dermatology, National Taiwan
University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan and
2 Graduate Institute of Toxicology, National Taiwan University College of Medicine, Taipei,
Taiwan
Replicative senescence is a specific type of cellular senescence that ultimately results from loss of
telomeres. Because senescent cells accumulate with age, they may contribute to age-related declines
in tissue function. microRNAs (miRNAs) are endogenous≈22-nt noncoding small RNAs, which
negatively regulate gene expression in a sequence-specific manner. Recently, miRNAs have been
found to play a role in lifespan regulation. In this study, we identified miRNAs associated with human
dermal fibroblast early senescence. Sequential analysis of the Hs68 cells from P13 to P21 revealed
a trend of decreasing BrdU (+) cells and increasing SA-β-Gal (+) cells. Microarray analysis of miR-
NAs associated with this in vitro senescence model found several miRNAs were significantly changed
in the early rapid senescence. We found 6 miRNAs, miR-422a, miR-203, miR-302b, miR-376b,
miR-135b, and miR-409-5p, were significantly changed more than 2 folds in the early rapid senes-
cence. Further RT-qPCR study also confirmed the consistent down-regulation of miR-302b in either
ccd966 human dermal fibroblast cell line or 2 primarily cultured human dermal fibroblasts, indi-
cating this miRNA might play important roles in regulating dermal fibroblast senescence. In addi-
tion, a recently described senescence marker, cyclin D1, had reciprocal changes to miR-302b lev-
els in our Hs68 senescence model. We also found that miR-302b inhibits replicative senescence of
Hs68 cells by targeting cyclin D1.
382
Ichthyosis with confetti shows widespread somatic reversion via mitotic recombination at
two distinct loci
KA Choate,1,2 Y Lu,2 J Zhou,1 M Choi,2 A Paller,3 P Elias,4 A Farhi,2 C Nelson-Williams,2
D Crumrine,4 M Williams,4 A Nopper,5 A Bree,6 L Milstone1 and R Lifton2 1 Dermatology, Yale,
New Haven, CT, 2 Genetics, Yale, New Haven, CT, 3 Dermatology, Northwestern, Chicago, IL,
4 Dermatology, UCSF, San Francisco, CA, 5 Dermatology, Children’s Mercy Hospital & Clinics,
Kansas City, MO and 6 Dermatology, Texas Children’s Hospital, Houston, TX
Widespread reversion of diseased tissue to an unaffected state is exceedingly rare. For this reason,
the development of hundreds to thousands of normal revertant skin clones observed in individuals
with ichthyosis with confetti (IWC, a.k.a. ichthyosis variegata, congenital ichthyosiform erythro-
derma), a severe autosomal dominant skin disease with two distinct types, is a remarkable phe-
nomenon. We initially predicted that IWC is caused by dominant negative or gain of function
mutations, that loss of heterozygosity (LOH) events could lead to somatic reversion, and that these
events would allow mapping of the disease locus. This was true for Type I IWC which is character-
ized by large patches of normal skin arising on the background of severe erythroderma and mild
palmoplantar keratoderma, in which we found that independent revertant clones showed distinct
copy-neutral LOH events, all occurring on chromosome 17q. This finding permitted mapping of
the disease locus and identification of disease-causing mutations in keratin 10 (KRT10) in nine kin-
dreds. All mutations result in frameshift into the same arginine-rich alternative reading frame, and
the resulting protein accumulates in the nucleolus, rather than in intermediate filaments. We have
further identified that similar LOH events occur at a distinct locus in Type II IWC, which shows
smaller white spots and more severe keratoderma. We have identified mutations in a novel gene as
the cause of this disorder. The high rate of reversion events observed in the two subtypes of IWC
implicates the mutated genes in the generation of reversion events either through direct effects on
mitotic recombination or through selective pressure. Insights from this work may enable reversion
of other dominant mutations.
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Polyvalent siRNA-gold nanoparticles effectively traverse human epidermis and cause no
demonstrable toxicity in keratinocytes or mouse skin
DL Chen,1 D Zheng,2 D Giljohann,2 H Iordanov,1 C Wilke,2 X Wang,1 CA Mirkin2 and AS Paller1
1 Dermatology, Northwestern Univ, Chicago, IL and 2 Chemistry, Northwestern Univ,
Evanston, IL
The recent demonstration that polyvalent siRNA-conjugated 13 nm gold nanoparticles (siRNA-Au
NPs) are able to traverse mouse epidermis and suppress a variety of targeted genes in cultured ker-
atinocytes at pM concentrations raises the possibility of topically applied genetic therapy in vivo.
However, the ability to penetrate human epidermis and the safe introduction of these conjugated
gold nanoparticles in cultured keratinocytes and mouse skin has not yet been described. Using cul-
tured human skin equivalents and Franz cell chambers with human abdominal skin, we have found
evidence microscopically and by induced coupled plasma-mass spectroscopy (ICP-MS) of pene-
tration of fluorophore-labelled siRNA-AuNPs through epidermis to the basal keratinocytes and
through the basement membrane within 48 h after application. Application to mouse skin of 50 nM
siRNA-gold nanoparticles for up 4 weeks (with three times weekly application) led to no clinical or
histologic adverse effects. Based on measurements with ICP-MS and transmission electron microscopy,
the gold particles progressively cleared after application was discontinued. For example, quantifi-
cation of NPs showed a 75% decrease in skin gold within 5 days after discontinuation. Gold nanopar-
ticles were barely detectable to undetectable after 4 weeks of application in internal organs, includ-
ing the liver, kidneys and lungs, and shown no appreciable increase or decrease over the week
after discontinuation. These results make polyvalent siRNA-Au NPs a promising technology for top-
ical genetic therapy for dermatologic disease.
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An association between IL-9 and IL-9 receptor gene polymorphisms and atopic dermatitis in
a Korean population
E Kim,1 J Namkung,2 G Park,1 H Yang3 and J Yang1 1 Dermatology, Samsung Medical Center,
Sungkyunkwan University, Seoul, Republic of Korea, 2 Case Western Reserve University
School of Medicine, Cleveland, OH and 3 Undergraduate Biological Sciences, Brown
University, Providence,, RI
The genes encoding IL-9 and IL-9R have recently been implicated in the genetic basis of asthma
and allergy. Although studies performed on transgenic and knockout mice have shown conflicting
results, no evidence of skin changes has ever been reported in these animals. We genotyped 5
SNPs from the IL-9 and IL-9R genes of 1,090 subject samples (631 AD patients and 459 normal
controls). A luciferase assay was then performed for the rs31563 (-4091G/A) SNP located in the IL-
9 gene promoter region. The rs31563 (-4091G/A) SNP in the IL-9 gene was significantly associated
with the AD phenotype, especially allergic-type AD. In the luciferase assay, the rs31563 G con-
struct was observed to have 1.54 times higher activity than the rs31563 A construct. Although no
association was found between SNPs in IL-9R gene and AD, the rs3093467 SNP showed associa-
tion with non-allergic AD. In the gene-gene interaction analysis, we found that IL-9/IL-9R genotype
rs31563 GG/ rs3093467 TT conveyed a greater risk for AD phenotype development. Significant
evidence exists to suggest that the rs31563 SNP (-4091G/A) located in the IL-9 gene is associated
with an increased susceptibility to AD. Similarly, the rs3093467 SNP in IL-9R gene seems to be asso-
ciated with an increased risk for developing non-allergic AD. In a subsequent gene-gene interac-
tion analysis, the rs31563 GG/ rs3093467 TT genotype combination (IL-9 / IL-9R) was found to exert
a synergistic effect in the development of the AD phenotype. As the classes of helper T cells are
diverse and the function of IL-9 cytokine has not been fully described, the cutaneous function of
IL-9 needs to be further explored in future studies.
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Developing small molecule drugs to rescue nonsense mutations in disease-causing genes
T Nomura,1 U Gartner,1 S McElroy,2 L Torrie,2 C Pourreyron,3 AP South,3 G Wood,4 A Woodland,4
J Frearson,2 P Wyatt2 and I McLean1 1 Epithelial Genetics Group, Division of Molecular
Medicine, University of Dundee, Dundee, United Kingdom, 2 Drug Discovery Unit, Division
of Biological Chemistry and Drug Discovery, University of Dundee, Dundee, United
Kingdom, 3 Centre for Oncology and Molecular Medicine, Ninewells Hospital and Medical
School, Dundee, United Kingdom and 4 Medical Chemistry Group, Division of Biological
Chemistry and Drug Discovery, University of Dundee, Dundee, United Kingdom
Nonsense mutations lead to premature translational termination and comprise around 10% of all
reported gene mutations, causing over 1,800 inherited disorders. To address the need for a safe and
effective nonsense suppressor therapy for such genetic diseases, we developed several cell-based
assays to enable evaluation of readthrough activity of a UGA stop codon and conducted a high
throughput screening of 68,281 compounds. Primary screening was performed using a firefly
luciferase (FLuc) assay, and a number of ‘lead-like’ hits were identified. Top 102 hits were subse-
quently counter-screened with a yellow fluorescent protein (YFP) assay and eight of them showed
significant readthrough activity at 30μM. Optimization of the hits, involving the design and syn-
thesis of over 250 novel chemical compounds, led to identification of potent lead compounds that
show high readthrough efficacy at single-digit micromolar concentration in three different reporter
gene assays including FLuc, YFP and beta-galactosidase assays. Intriguingly, the compounds were
also shown to suppress UAG and UAA stop codons. Moreover, the compounds yielded a dramatic
increase in type VII collagen expression in primary keratinocytes derived from a patient with reces-
sive dystrophic epidermolysis bullosa who carries UGA nonsense mutations R525X and R578X in
COL7A1 . On the other hand, proteomics analysis revealed that the compounds do not read through
a natural stop codon of KRT6A in HaCaT cells. These results suggest that the compounds identi-
fied here may have broad clinical potential for the treatment of a large group of nonsense muta-
tions related genetic disorders currently with limited or no therapeutic options.
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Gene-environment interaction in extrinsic skin aging: The effect of traffic related pollution is
modified by CYP1B1 gene polymorphism
A Vierkötter,1 T Schikowski,2 D Sugiri,1 M Matsui,3 J Krutmann1 and U Krämer1 1 IUF-Leibniz
Research Institute for Environmental Medicine, Düsseldorf, Germany, 2 Swiss Tropical and
Public Health Institute, Basel, Switzerland and 3 Estee Lauder Inc., Melville, NY
Recently we showed that traffic related particle (PM) exposure was associated with wrinkle and, in
particular, pigment spot formation. The underlying pathogenic mechanisms are currently not known.
Polycyclic aromatic hydrocarbons (PAHs) are often bound to the surface of PM. Also, PAHs are
well known activators of the Aryl Hydrocarbon Receptor (AhR) and this activation is related to extrin-
sic skin aging as we demonstrated in independent studies. In order to further assess the putative
link between PM, PAHs, and extrinsic skin aging, we here investigated effect modification by poly-
morphisms in genes known to be activated via the AhR pathway in human skin. The study cohort
included 400 German women aged 70 to 80 years. Skin aging was evaluated by SCINEXA, a vali-
dated score. Possible confounders were assessed by questionnaire. We determined SNPs (single
nucleotide polymorphisms) of CYP1A1 (rs1048943) and CYP1B1 (rs1056836) known to modify
the respective enzyme activity. PM (soot) concentration was determined by land-use regression and
assigned to each woman’s address. The adjusted impact of genetic variants on the effect of PM on
skin aging was analyzed by linear regression. For both SNPs the effect of soot on spot formation
was restricted to the non-variant genotype. Due to small variant numbers this gene-environment
interaction was not significant for CYP1A1, but significant for CYP1B1. The increase in spot for-
mation was 1.36fold (95%Confidence interval: 1.02-1.81) per interquartile range of soot for the CC
genotype, 1.11(0.89-1.40) for the CG genotype and finally 0.94(0.67-1.32) for the GG genotype.
These results further strengthen the concept that PAHs mediate PM-induced pigment spot forma-
tion by activating AhR-dependent gene expression. They also provide evidence that extrinsic aging
of human skin is influenced by gene-environment interactions.
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Identification of the underlying cause of autosomal recessive exfoliative ichthyosis reveals a
role for a protease inhibitor in cell-cell adhesion.
DC Blaydon,1 D Nitoiu,1 RM Cabral,1 P Bland,1 A Zvulunov,2 HC Hennies3 and DP Kelsell1 1 The
Blizard Institute of Cell and Molecular Sciences, Barts and The London School of Medicine
and Dentistry, Queen Mary University of London, London, United Kingdom, 2 Soroka
University Medical Center and Faculty of Health Sciences, Ben Gurion University, Beer Sheva,
Israel and 3 University Hospital Münster, Münster, Germany
Autosomal recessive exfoliative ichthyosis presents shortly after birth with a fine peeling of non-
erythematous skin on the palms and soles. By means of genome-wide homozygosity SNP mapping
and candidate-gene screening we identified a putative 3’ splice-site mutation in a gene encoding
a protease inhibitor as the underlying cause of this skin disease in a consanguineous Bedouin fam-
ily. Using next-generation sequencing technology, the splice site change was confirmed as the most
likely disease-causing sequence variant in the region of linkage. Furthermore, an in-vitro minigene
splice assay in combination with in-silico protein modelling was used to demonstrate the likely detri-
mental effect of the predicted splice site mutation on protein function. We have since identified an
additional exfoliative ichthyosis family with a homozygous nonsense mutation in the same gene.
This protease inhibitor is thought to be a precursor protein of the cornified cell envelope in ker-
atinocytes. However, analysis of patient skin, using electron microscopy, revealed prominent inter-
cellular oedema and aggregates of keratin filaments at the basal and suprabasal cell layers (Hatsell
et al., 2003), which would indicate an additional role for this protein in cell-cell adhesion in the
lower layers of the epidermis. Employing an in-vitro cell stretch assay, in combination with robust
siRNA knockdown, we demonstrate that this protease inhibitor has an additional novel role in main-
taining cell-cell adhesion via the desmosomes in the basal keratinocyte layer of the epidermis.
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Next-generation sequencing identifies a homozygous deletion mutation in an ADAM gene
underlying autosomal recessive inflammatory skin and bowel disease.
DP Kelsell,1 DC Blaydon,1 P Biancheri,1 W Di,2 V Plagnol,3 RM Cabral,1 TT MacDonald1 and
JI Harper2 1 The Blizard Institute of Cell and Molecular Sciences, Barts and The London School
of Medicince and Dentistry, Queen Mary University of London, London, United Kingdom, 2
UCL Institute of Child Health and Great Ormond Street Hospital, London, United Kingdom
and 3 Cambridge Institute for Medical Research, University of Cambridge, Addenbrooke’s
Hospital, Cambridge, United Kingdom
We studied two siblings with an autosomal recessive syndrome including neo-natal inflammatory
skin and bowel disease. In addition, the scalp hair of both affected individuals was short and dis-
organised, the eyebrows were abnormally short and sparse and the eyelashes also appear to have
an irregular shape, length and distribution. The affected female died aged 12 of parvovirus myocardi-
tis and her brother has a mild cardiomyopathy. Using a combination of homozygosity genome
wide SNP mapping and targeted sequence capture followed by next generation sequencing, we
have identified a novel 4bp deletion in a gene encoding a disintegrin and metalloprotease (ADAM)
as the underlying cause of this syndrome. Western blots and immunohistochemistry using an anti-
body directed against this ADAM showed a dramatic reduction/absence of expression in skin and
small intestine biopsies from the patients. Immunological investigations revealed a highly abnor-
mal immune system. Peripheral blood mononuclear cells from the surviving male patient showed
high endogenous production of IL-1β and IL-6 and dramatically impaired TNF-α release after LPS
stimulation. In addition, immunohistochemical analysis of skin sections and western blot analysis
of primary keratinocytes demonstrated a significant increase in DSG1/2 compared to control which
may, in part, relate to the hair and cardiac phenotypes. This study underlines the power of next gen-
eration sequencing in identifying inherited disease mutations in small pedigrees in addition to link-
ing an ADAM gene with inflammatory disease of the skin and bowel.
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Evidence of endoplasmic reticulum stress response upregulation in Darier keratinocytes which
impairs E-cadherin trafficking, and reduces adherens junctions assembly
M Savignac,1 A Edir,2,3 M Simon2,3 and A Hovnanian2,3,4 1 INSERM, U563, Toulouse, F-31300,
France, 2 INSERM, U781, Paris, F-75015, France, 3 Université Paris V René Descartes, Paris,
F-75015, France and 4 Department of Genetics, Necker Hospital, Paris, F-75015, France
Darier disease is a severe dominant genetic skin disorder characterized by loss of cell-to-cell adhe-
sion (acantholysis) associated with premature and abnormal keratinization (dyskeratosis). We pre-
viously identified ATP2A2 as the defective gene in Darier disease, which encodes SERCA2, a Ca2+-
ATPase pump of the endoplasmic reticulum. Despite the identification of its genetic cause, the
pathogenic mechanisms of the disease remain largely unknown. In this study, we investigated the
impact of SERCA2 dysfunction on endoplasmic reticulum stress and adherens junction formation
that initiate cell-cell contact, in Darier and normal keratinocytes, combining immunofluorescence
and western blotting analyses. We show that loss of SERCA2 function in Darier keratinocytes induces
an endoplasmic reticulum stress response in basal conditions (without stressors) and enhances endo-
plasmic reticulum stress response following thapsigargin treatment. Moreover, we demonstrate that
loss of cell-to-cell adhesion in Darier keratinocytes is characterized by a dramatic rearrangement
of adherens junction molecules at the plasma membrane zone (E-cadherin, α-, β-, γ- and p120-
catenins), as well as actin filaments. SERCA inhibition with thapsigargin leads to the same mor-
phological abnormalities in normal keratinocytes establishing that impaired adherens junction for-
mation in Darier keratinocytes is a direct consequence of loss of function of SERCA2. Finally, we
show intracellular retention and co-localization of E-cadherin with endoplasmic reticulum mark-
ers in Darier keratinocytes. Our results demonstrate that loss of SERCA2 function in Darier ker-
atinocytes induces an endoplasmic reticulum stress response, which is a major determinant of
impaired cell-to-cell adhesion via abnormal E-cadherin processing.
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Homozygosity of dominant missense mutations in keratin 17 leads to alopecia in addition to
severe pachyonychia congenita
NJ Wilson,1 CD Hansen,2 ML Cardenas Perez,3 A Vahlquist,4 ME Schwartz5 and FJ Smith1 1
Molecular Medicine, University of Dundee, Dundee, United Kingdom, 2 University of Utah,
Salt Lake City, UT, 3 University of Valle, Cali, Colombia, 4 Uppsala University, Uppsala,
Sweden and 5 PC Project, Salt Lake City, UT
Pachyonychia congenita (PC) is a rare keratin disorder predominantly characterized by painful pal-
moplantar keratoderma and nail dystrophy. Additional features include oral leukokeratosis, follic-
ular keratoses and epidermal cysts. PC is an autosomal dominant trait due to heterozygous muta-
tions in any one of the genes encoding keratins K6a, K6b, K16 or K17. We recently identified an
Hispanic family where a consanguineous marriage between two affected parents resulted in a child
homozygous for missense mutation p.Asn92Ser in K17. The homozygous patient was more severely
affected than either heterozygous parent with nail dystrophy, palmoplantar blistering, palmoplan-
tar keratoderma and oral leukokeratosis. Unusually, alopecia was also noted in the homozygote
from the age of 7 months. In a second family of Middle Eastern ancestry, the K17 missense muta-
tion p.Arg94Cys was found in the homozygous state in one individual. This patient also developed
alopecia at a young age. Hair loss has not been previously reported in cases of PC confirmed by
genetic testing, however, K17 is expressed in the hair follicle as well as other epidermal appendages.
We hypothesize that a homozygous missense mutation results in greater fragility of epithelial cells
expressing K17, leading to a more widespread and severe PC phenotype that includes hair abnor-
malities. Interestingly, K17 null mice develop hair fragility, changes in follicular histology and
apoptosis in the matrix cells during the first week after birth resulting in severe alopecia. This is
reversible and strain dependent and has been shown to be specifically due to loss of K17. These are
the first cases where homozygous dominant mutations have been identified in PC.
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Correction of recessive dystrophic epidermolysis bullosa by homologous recombination
L Wu,1 C Sun,1 CA Elmets2 and TM Townes1 1 Biochemistry and Molecular Genetics, University
of Alabama at Birmingham, Birmingham, AL and 2 Dermatology, University of Alabama at
Birmingham, Birmingham, AL
Recessive dystrophic epidermolysis bullosa(RDEB) is an autosomal recessive blisteringdisorder
caused by mutations in the COL7A1 gene, which is located on chromosome band 3p21. Mutations
in this gene lead to disruption of the integrity of the dermal-epidermal junction through structurally
defective and reduced numbers of anchoring fibrils. Patients with several phenotypes of RDEB have
widespread bullae and erosions, and more than half of them die from squamous cell carcinomas
before age of 40. Individuals with RDEB develop painful blisters and mucosal erosions, and cur-
rently, there are no effective forms of therapy. Several powerful technologies have been developed
that increase the possibilities for developing therapeutic treatments for RDEB. Recently, six patients
who received immunomyeloablative chemotherapy and allogeneic stem cell transplantation treat-
ment have shown improved healing and increased collagen VII expression (N Engl J Med. 363:629).
These results suggest that gene therapy has potential to restore type VII collagen expression in
RDEB skin cells. Previously, we corrected sickle cell disease in our knockin mouse model by homol-
ogous recombination (Science 318:1920). We reprogrammed skin fibroblasts into iPS (induced
Pluripotent Stem) cells, replaced the defective sickle beta-globin gene with a normal beta globin
gene, differentiated the corrected iPS cells into hematopoietic progenitors and transplanted these
cells into irradiated sickle mouse recipients. Anemia was completely corrected in these animals.
Recently, we successfully generate induced iPS cells from RDEB patients with mutations in the
COL7A1 gene. We have produced a targeting construct that will replace the defective allele by
homologous recombination. After gene correction we plan to differentiate these iPS cells into
hematopoietic stem cells and into skin cells for transplantation. These experiments will provide a
foundation for new therapies for this devastating disorder.
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Interferon regulatory factor 6 is necessary but not sufficient for keratinocyte differentiation
LC Biggs,1,2 L Rhea,2 BC Schutte3,4 and M Dunnwald1,2 1 Interdisciplinary Graduate Program in
Genetics, University of Iowa, Iowa City, IA, 2 Department of Pediatrics, University of Iowa,
Iowa City, IA, 3 Department of Microbiology and Molecular Genetics, Michigan State
University, East Lansing, MI and 4 Department of Pediatrics and Human Development,
Michigan State University, East Lansing, MI
Regulation of epidermal proliferation and differentiation is critical for the maintenance of cutaneous
homeostasis. Interferon Regulatory Factor 6 (Irf6) deficient mice die perinatally and exhibit ectopic
proliferation and defective epidermal differentiation. We sought to determine if these disruptions of
epidermal function were cell autonomous and to use cultured embryonic Irf6-/- keratinocytes to
understand the specific role of Irf6 in keratinocyte proliferation and differentiation. In the absence
of Irf6, keratinocytes were larger and exhibited a heterogeneous phenotype. Irf6-/- keratinocytes
exhibited an increased colony forming efficiency compared to wildtype cells, suggesting that Irf6
represses proliferation. Irf6 was present at low levels in wildtype keratinocytes in culture and was
upregulated after induction of differentiation in vitro, along with upregulation of markers of differ-
entiation. However, Irf6-/- keratinocytes were unable to express markers of terminal differentiation.
Overexpression of Irf6 in wildtype keratinocytes was not sufficient to induce expression of markers
of differentiation under basal growing conditions. Together, these results indicate that Irf6 is neces-
sary, but not sufficient for keratinocyte differentiation. Finally, using a transgenic mouse expressing
Lac-Z under the regulation of an enhancer element 9.7kb upstream of the Irf6 start site, we demon-
strate that this element contributes to the regulation of Irf6 in the epidermis and in keratinocytes in
culture.
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Bone mineral acquisition is meager in children with epidermolysis bullosa
T Fu,1 K Kent,2 LK Bachrach3 and AL Bruckner1,3 1 Dermatology, Stanford University, Stanford,
CA, 2 Medicine, Stanford University, Stanford, CA and 3 Pediatrics, Stanford University,
Stanford, CA
Although epidermolysis bullosa (EB) is primarily a disorder of the skin and mucosa, it affects mul-
tiple organ systems, including bone. Low bone mass and fractures have been identified as compli-
cations of generalized forms of EB, although the mechanisms for this are not clear. To gain insight
into the pathogenesis of low bone mass in children with EB, we evaluated 17 children from a mul-
tidisciplinary EB clinic (15 with recessive dystrophic and 2 Simplex-Dowling Meara) at 2 visits at
least 1 year apart using clinical, laboratory, and dual energy absorptiometry (DXA) studies. Aside
from routine interventions and counseling, a systematic intervention to improve bone mass was not
provided. At study end, subjects gained height and weight and sexual maturity advanced. Mean lab-
oratory values did not change significantly, but the proportion of subjects with insufficient or defi-
cient levels of 25-OH vitamin D increased from 75% to 88%, and the number of subjects with vita-
min D deficiency increased from 1 to 6. Mean bone mineral content increased from 27.29 to 29.39
gm, and mean areal bone mineral density (aBMD) increased from 0.581 to 0.610 gm/cm2. 15 sub-
jects (88%) gained aBMD, while 2 lost. Mean aBMD Z-score did not change significantly (-1.9 to -
2.1), although Z-scores decreased for 8 subjects, and 9 subjects (53%) had aBMD < -2.0 at study
end. In order to account for the effect of small body size on bone mass, aBMD Z-scores were adjusted
for height Z-score (aBMD-HAZ) and mean aBMD-HAZ did not change from baseline to follow-up
(-1.2). 1 subject was diagnosed with new lumbar compression fractures at study end. While chil-
dren with severe forms of generalized EB are building bone, the rate is meager when compared
with their peers, and they are at increased risk for fractures. Interventions to help augment bone
mineral accretion deserve further study in this patient population.
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Biomarkers of skin ageing using genome wide transcriptomics
D Glass,1 L Parts,2 D Knowles,3,7 AC Nica,4,2 J Nisbet,2 A Barrett,5 M Sekowska,2 M Travers,5
S Potter,2 E Grundberg,2,1 K Small,1,2 ÅSA Hedman,5 J Tzenova Bell,5,1 G Surdulescu,1 FO Nestle,6
P di Meglio,6 R Durbin,2 K Ahmadi,1 J Winn,7 V Bataille,1 P Deloukas,2 MI McCarthy,5 TD Spector,1
ET Dermitzakis4 and M For1,2,5 1 Department of Twin Research, King’s College London, London,
United Kingdom, 2 Wellcome Trust Sanger Institute, Hinxton, United Kingdom, 3 Department
of Engineering, University of Cambridge, Cambridge, United Kingdom, 4 Department of
Genetic Medicine and Development, University of Geneva, Geneva, Switzerland, 5 Wellcome
Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom, 6 St John’s
Institute of Dermatology, King’s College London, London, United Kingdom and 7 Microsoft
Research, Cambridge, United Kingdom
Endogenous skin ageing is not fully understood; study of the changes in skin gene expression with
age should further elucidate the mechanisms involved. What are the gene expression signatures of
ageing in skin? How do they compare to gene expression in other tissues? How do they correspond
to global ageing biomarkers? 855 photo-protected abdominal skin samples were taken from female
Caucasian twins aged 40 - 85, abdominal fat and lymphoblastoid cell lines were sampled from the
same individuals. RNA was extracted from all samples and hybridised with the Illumina human Sen-
trix 12 micro-array. A linear mixed model was used to explain gene expression variability by age
and confounding factors; (Significance determined from permutations using false discovery rate
<0.05). Results to be presented include; genes that are differentially expressed in skin with age
(n>2000), age correlated gene pathways, genes that are differentially expressed with age across tis-
sues (n>100), age correlated genes shared with animal models.
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A transcriptional network for keratinocyte differentiation<b/>
A Soto Hopkin,1,2 Q Liu,3 A Ihler3 and B Andersen1,2 1 Medicine, University of California Irvine,
Irvine, CA, 2 Biological Chemistry, University of California Irvine, Irvine, CA and 3 Computer
Science, University of California Irvine, Irvine, CA
The stratified mammalian epidermis develops from somatic ectoderm by the progressive addition
and differentiation of superficial epidermal layers. After the initial morphogenesis, the epidermis is
maintained by homeostatic mechanisms whereby keratinocytes move from the proliferating basal
cell layer towards the surface as they undergo a series of differentiation steps, ultimately undergo-
ing cell death. One role of keratinocyte differentiation is the formation of an effective permeability
barrier, which depends on the regulated expression of a large battery of genes encoding compo-
nents of the cornified and granular layers. Currently our knowledge of the transcriptional regulators
of epidermal differentiation is limited to relatively few transcription factors. Furthermore, we know
very little about the interrelationship between transcriptional regulators and how they target the
genes that execute the differentiation process. To gain further insight into the transcriptional pro-
gram present during keratinocyte differentiation we took a global systems biology approach and
profiled gene expression at various time points throughout human epidermal keratinocyte differ-
entiation. These data were filtered by ANOVA to exclude genes whose expression was not signifi-
cantly changing over the time course, identifying ~6000 genes. Focusing on the transcriptional reg-
ulators present in our gene list, we used an estimator based on the graphical lasso approach to
predict target genes and infer regulatory interactions. As validation, we searched the promoters of
genes that were linked to particular transcriptional regulators for the presence of the specific DNA
binding motif. For a select group of transcriptional regulators we performed RNAi perturbation to
validate specific hubs in the network. These results allowed us to strengthen our network predic-
tions and resulted in the identification of a novel regulatory network of keratinocyte differentiation.
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Epidermal tissue differentiation and lipid barrier function requires the long non-coding RNA
Linc19A
M Kretz, D Webster, Z Siprashvili, A Zehnder, C Lee, R Flockhart, J Chow, G Kim, J Rinn, H Chang
and P Khavari Veterans Affairs Palo Alto Health Care System and Stanford University, Palo Alto,
CA
Long intergenic noncoding RNAs (lincRNAs) range in size from 200bp to >16kb and have been
implicated in a variety of molecular functions. We wished to address a potential role for lincRNAs
in regulating differentiation in skin and other somatic tissues. High throughput full transcriptome
sequencing was undertaken of differentiated and progenitor human keratinocyte populations using
the Illumina paired-end HiSeq platform with a read length of 101 nucleotides at >100 million mapped
reads per sample. The lincRNA with the highest increase in expression of >150-fold during differ-
entiation was provisionally named linc19A. Linc19A is a 3.7kb spliced and polyadenylated lincRNA
located in a gene desert on chromosome 19p13. Linc19A depletion in regenerated human epider-
mal tissue using multiple RNA-interference sequences blocked induction of epidermal differentia-
tion proteins, including filaggrin and loricrin. In addition, linc19A loss led to diminished expres-
sion of key epidermal lipid barrier formation genes, including ELOVL3, ALOXE3, ALOX12B, and
ABCA12. To characterize the mechanism of linc19A function, we developed a high throughput
screening method to test binding of any RNA to >9000 microarrayed recombinant human proteins.
Linc19A bound selectively to Staufen 1 (Stau1), a protein first characterized in Drosophila as a medi-
ator of cellular RNA transport. This RNA-protein interaction was confirmed by linc19A RNA and
Stau1 protein pull-downs. Stau1-deficient epidermal tissue displayed similar differentiation and lipid
barrier defects seen with linc19A loss. These results indicate that the large noncoding RNA linc19A
binds Stau1 protein and that they both to enable normal epidermal differentiation and barrier func-
tion.
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Developing small molecule drugs to rescue nonsense mutations in disease-causing genes
T Nomura,1 U Gartner,1 S McElroy,2 L Torrie,2 C Pourreyron,3 AP South,3 G Wood,4 A Woodland,4
J Frearson,2 P Wyatt2 and I McLean1 1 Epithelial Genetics Group, Division of Molecular
Medicine, University of Dundee, Dundee, United Kingdom, 2 Drug Discovery Unit, Division
of Biological Chemistry and Drug Discovery, University of Dundee, Dundee, United
Kingdom, 3 Centre for Oncology and Molecular Medicine, Ninewells Hospital and Medical
School, Dundee, United Kingdom and 4 Medical Chemistry Group, Division of Biological
Chemistry and Drug Discovery, University of Dundee, Dundee, United Kingdom
Nonsense mutations lead to premature translational termination and comprise around 10% of all
reported gene mutations, causing over 1,800 inherited disorders. To address the need for a safe and
effective nonsense suppressor therapy for such genetic diseases, we developed several cell-based
assays to enable evaluation of readthrough activity of a UGA stop codon and conducted a high
throughput screening of 68,281 compounds. Primary screening was performed using a firefly
luciferase (FLuc) assay, and a number of ‘lead-like’ hits were identified. Top 102 hits were subse-
quently counter-screened with a yellow fluorescent protein (YFP) assay and eight of them showed
significant readthrough activity at 30μM. Optimization of the hits, involving the design and syn-
thesis of over 250 novel chemical compounds, led to identification of potent lead compounds that
show high readthrough efficacy at single-digit micromolar concentration in three different reporter
gene assays including FLuc, YFP and beta-galactosidase assays. Intriguingly, the compounds were
also shown to suppress UAG and UAA stop codons. Moreover, the compounds yielded a dramatic
increase in type VII collagen expression in primary keratinocytes derived from a patient with reces-
sive dystrophic epidermolysis bullosa who carries UGA nonsense mutations R525X and R578X in
COL7A1 . On the other hand, proteomics analysis revealed that the compounds do not read through
a natural stop codon of KRT6A in HaCaT cells. These results suggest that the compounds identi-
fied here may have broad clinical potential for the treatment of a large group of nonsense muta-
tions related genetic disorders currently with limited or no therapeutic options.
399
Gene-environment interaction in extrinsic skin aging: The effect of traffic related pollution is
modified by CYP1B1 gene polymorphism
A Vierkötter,1 T Schikowski,2 D Sugiri,1 M Matsui,3 J Krutmann1 and U Krämer1 1 IUF-Leibniz
Research Institute for Environmental Medicine, Düsseldorf, Germany, 2 Swiss Tropical and
Public Health Institute, Basel, Switzerland and 3 Estee Lauder Inc., Melville, NY
Recently we showed that traffic related particle (PM) exposure was associated with wrinkle and, in
particular, pigment spot formation. The underlying pathogenic mechanisms are currently not known.
Polycyclic aromatic hydrocarbons (PAHs) are often bound to the surface of PM. Also, PAHs are
well known activators of the Aryl Hydrocarbon Receptor (AhR) and this activation is related to extrin-
sic skin aging as we demonstrated in independent studies. In order to further assess the putative
link between PM, PAHs, and extrinsic skin aging, we here investigated effect modification by poly-
morphisms in genes known to be activated via the AhR pathway in human skin. The study cohort
included 400 German women aged 70 to 80 years. Skin aging was evaluated by SCINEXA, a vali-
dated score. Possible confounders were assessed by questionnaire. We determined SNPs (single
nucleotide polymorphisms) of CYP1A1 (rs1048943) and CYP1B1 (rs1056836) known to modify
the respective enzyme activity. PM (soot) concentration was determined by land-use regression and
assigned to each woman’s address. The adjusted impact of genetic variants on the effect of PM on
skin aging was analyzed by linear regression. For both SNPs the effect of soot on spot formation
was restricted to the non-variant genotype. Due to small variant numbers this gene-environment
interaction was not significant for CYP1A1, but significant for CYP1B1. The increase in spot for-
mation was 1.36fold (95%Confidence interval: 1.02-1.81) per interquartile range of soot for the CC
genotype, 1.11(0.89-1.40) for the CG genotype and finally 0.94(0.67-1.32) for the GG genotype.
These results further strengthen the concept that PAHs mediate PM-induced pigment spot forma-
tion by activating AhR-dependent gene expression. They also provide evidence that extrinsic aging
of human skin is influenced by gene-environment interactions.
401
Identification of the underlying cause of autosomal recessive exfoliative ichthyosis reveals a
role for a protease inhibitor in cell-cell adhesion.
DC Blaydon,1 D Nitoiu,1 RM Cabral,1 P Bland,1 A Zvulunov,2 HC Hennies3 and DP Kelsell1 1 The
Blizard Institute of Cell and Molecular Sciences, Barts and The London School of Medicine
and Dentistry, Queen Mary University of London, London, United Kingdom, 2 Soroka
University Medical Center and Faculty of Health Sciences, Ben Gurion University, Beer Sheva,
Israel and 3 University Hospital Münster, Münster, Germany
Autosomal recessive exfoliative ichthyosis presents shortly after birth with a fine peeling of non-
erythematous skin on the palms and soles. By means of genome-wide homozygosity SNP mapping
and candidate-gene screening we identified a putative 3’ splice-site mutation in a gene encoding
a protease inhibitor as the underlying cause of this skin disease in a consanguineous Bedouin fam-
ily. Using next-generation sequencing technology, the splice site change was confirmed as the most
likely disease-causing sequence variant in the region of linkage. Furthermore, an in-vitro minigene
splice assay in combination with in-silico protein modelling was used to demonstrate the likely detri-
mental effect of the predicted splice site mutation on protein function. We have since identified an
additional exfoliative ichthyosis family with a homozygous nonsense mutation in the same gene.
This protease inhibitor is thought to be a precursor protein of the cornified cell envelope in ker-
atinocytes. However, analysis of patient skin, using electron microscopy, revealed prominent inter-
cellular oedema and aggregates of keratin filaments at the basal and suprabasal cell layers (Hatsell
et al., 2003), which would indicate an additional role for this protein in cell-cell adhesion in the
lower layers of the epidermis. Employing an in-vitro cell stretch assay, in combination with robust
siRNA knockdown, we demonstrate that this protease inhibitor has an additional novel role in main-
taining cell-cell adhesion via the desmosomes in the basal keratinocyte layer of the epidermis.
400
Next-generation sequencing identifies a homozygous deletion mutation in an ADAM gene
underlying autosomal recessive inflammatory skin and bowel disease.
DP Kelsell,1 DC Blaydon,1 P Biancheri,1 W Di,2 V Plagnol,3 RM Cabral,1 TT MacDonald1 and
JI Harper2 1 The Blizard Institute of Cell and Molecular Sciences, Barts and The London School
of Medicince and Dentistry, Queen Mary University of London, London, United Kingdom, 2
UCL Institute of Child Health and Great Ormond Street Hospital, London, United Kingdom
and 3 Cambridge Institute for Medical Research, University of Cambridge, Addenbrooke’s
Hospital, Cambridge, United Kingdom
We studied two siblings with an autosomal recessive syndrome including neo-natal inflammatory
skin and bowel disease. In addition, the scalp hair of both affected individuals was short and dis-
organised, the eyebrows were abnormally short and sparse and the eyelashes also appear to have
an irregular shape, length and distribution. The affected female died aged 12 of parvovirus myocardi-
tis and her brother has a mild cardiomyopathy. Using a combination of homozygosity genome
wide SNP mapping and targeted sequence capture followed by next generation sequencing, we
have identified a novel 4bp deletion in a gene encoding a disintegrin and metalloprotease (ADAM)
as the underlying cause of this syndrome. Western blots and immunohistochemistry using an anti-
body directed against this ADAM showed a dramatic reduction/absence of expression in skin and
small intestine biopsies from the patients. Immunological investigations revealed a highly abnor-
mal immune system. Peripheral blood mononuclear cells from the surviving male patient showed
high endogenous production of IL-1β and IL-6 and dramatically impaired TNF-α release after LPS
stimulation. In addition, immunohistochemical analysis of skin sections and western blot analysis
of primary keratinocytes demonstrated a significant increase in DSG1/2 compared to control which
may, in part, relate to the hair and cardiac phenotypes. This study underlines the power of next gen-
eration sequencing in identifying inherited disease mutations in small pedigrees in addition to link-
ing an ADAM gene with inflammatory disease of the skin and bowel.
398
Evidence of endoplasmic reticulum stress response upregulation in Darier keratinocytes which
impairs E-cadherin trafficking, and reduces adherens junctions assembly
M Savignac,1 A Edir,2,3 M Simon2,3 and A Hovnanian2,3,4 1 INSERM, U563, Toulouse, F-31300,
France, 2 INSERM, U781, Paris, F-75015, France, 3 Université Paris V René Descartes, Paris,
F-75015, France and 4 Department of Genetics, Necker Hospital, Paris, F-75015, France
Darier disease is a severe dominant genetic skin disorder characterized by loss of cell-to-cell adhe-
sion (acantholysis) associated with premature and abnormal keratinization (dyskeratosis). We pre-
viously identified ATP2A2 as the defective gene in Darier disease, which encodes SERCA2, a Ca2+-
ATPase pump of the endoplasmic reticulum. Despite the identification of its genetic cause, the
pathogenic mechanisms of the disease remain largely unknown. In this study, we investigated the
impact of SERCA2 dysfunction on endoplasmic reticulum stress and adherens junction formation
that initiate cell-cell contact, in Darier and normal keratinocytes, combining immunofluorescence
and western blotting analyses. We show that loss of SERCA2 function in Darier keratinocytes induces
an endoplasmic reticulum stress response in basal conditions (without stressors) and enhances endo-
plasmic reticulum stress response following thapsigargin treatment. Moreover, we demonstrate that
loss of cell-to-cell adhesion in Darier keratinocytes is characterized by a dramatic rearrangement
of adherens junction molecules at the plasma membrane zone (E-cadherin, α-, β-, γ- and p120-
catenins), as well as actin filaments. SERCA inhibition with thapsigargin leads to the same mor-
phological abnormalities in normal keratinocytes establishing that impaired adherens junction for-
mation in Darier keratinocytes is a direct consequence of loss of function of SERCA2. Finally, we
show intracellular retention and co-localization of E-cadherin with endoplasmic reticulum mark-
ers in Darier keratinocytes. Our results demonstrate that loss of SERCA2 function in Darier ker-
atinocytes induces an endoplasmic reticulum stress response, which is a major determinant of
impaired cell-to-cell adhesion via abnormal E-cadherin processing.
402
Homozygosity of dominant missense mutations in keratin 17 leads to alopecia in addition to
severe pachyonychia congenita
NJ Wilson,1 CD Hansen,2 ML Cardenas Perez,3 A Vahlquist,4 ME Schwartz5 and FJ Smith1 1
Molecular Medicine, University of Dundee, Dundee, United Kingdom, 2 University of Utah,
Salt Lake City, UT, 3 University of Valle, Cali, Colombia, 4 Uppsala University, Uppsala,
Sweden and 5 PC Project, Salt Lake City, UT
Pachyonychia congenita (PC) is a rare keratin disorder predominantly characterized by painful pal-
moplantar keratoderma and nail dystrophy. Additional features include oral leukokeratosis, follic-
ular keratoses and epidermal cysts. PC is an autosomal dominant trait due to heterozygous muta-
tions in any one of the genes encoding keratins K6a, K6b, K16 or K17. We recently identified an
Hispanic family where a consanguineous marriage between two affected parents resulted in a child
homozygous for missense mutation p.Asn92Ser in K17. The homozygous patient was more severely
affected than either heterozygous parent with nail dystrophy, palmoplantar blistering, palmoplan-
tar keratoderma and oral leukokeratosis. Unusually, alopecia was also noted in the homozygote
from the age of 7 months. In a second family of Middle Eastern ancestry, the K17 missense muta-
tion p.Arg94Cys was found in the homozygous state in one individual. This patient also developed
alopecia at a young age. Hair loss has not been previously reported in cases of PC confirmed by
genetic testing, however, K17 is expressed in the hair follicle as well as other epidermal appendages.
We hypothesize that a homozygous missense mutation results in greater fragility of epithelial cells
expressing K17, leading to a more widespread and severe PC phenotype that includes hair abnor-
malities. Interestingly, K17 null mice develop hair fragility, changes in follicular histology and
apoptosis in the matrix cells during the first week after birth resulting in severe alopecia. This is
reversible and strain dependent and has been shown to be specifically due to loss of K17. These are
the first cases where homozygous dominant mutations have been identified in PC.
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Correction of recessive dystrophic epidermolysis bullosa by homologous recombination
L Wu,1 C Sun,1 CA Elmets2 and TM Townes1 1 Biochemistry and Molecular Genetics, University
of Alabama at Birmingham, Birmingham, AL and 2 Dermatology, University of Alabama at
Birmingham, Birmingham, AL
Recessive dystrophic epidermolysis bullosa(RDEB) is an autosomal recessive blisteringdisorder
caused by mutations in the COL7A1 gene, which is located on chromosome band 3p21. Mutations
in this gene lead to disruption of the integrity of the dermal-epidermal junction through structurally
defective and reduced numbers of anchoring fibrils. Patients with several phenotypes of RDEB have
widespread bullae and erosions, and more than half of them die from squamous cell carcinomas
before age of 40. Individuals with RDEB develop painful blisters and mucosal erosions, and cur-
rently, there are no effective forms of therapy. Several powerful technologies have been developed
that increase the possibilities for developing therapeutic treatments for RDEB. Recently, six patients
who received immunomyeloablative chemotherapy and allogeneic stem cell transplantation treat-
ment have shown improved healing and increased collagen VII expression (N Engl J Med. 363:629).
These results suggest that gene therapy has potential to restore type VII collagen expression in
RDEB skin cells. Previously, we corrected sickle cell disease in our knockin mouse model by homol-
ogous recombination (Science 318:1920). We reprogrammed skin fibroblasts into iPS (induced
Pluripotent Stem) cells, replaced the defective sickle beta-globin gene with a normal beta globin
gene, differentiated the corrected iPS cells into hematopoietic progenitors and transplanted these
cells into irradiated sickle mouse recipients. Anemia was completely corrected in these animals.
Recently, we successfully generate induced iPS cells from RDEB patients with mutations in the
COL7A1 gene. We have produced a targeting construct that will replace the defective allele by
homologous recombination. After gene correction we plan to differentiate these iPS cells into
hematopoietic stem cells and into skin cells for transplantation. These experiments will provide a
foundation for new therapies for this devastating disorder.
392
Interferon regulatory factor 6 is necessary but not sufficient for keratinocyte differentiation
LC Biggs,1,2 L Rhea,2 BC Schutte3,4 and M Dunnwald1,2 1 Interdisciplinary Graduate Program in
Genetics, University of Iowa, Iowa City, IA, 2 Department of Pediatrics, University of Iowa,
Iowa City, IA, 3 Department of Microbiology and Molecular Genetics, Michigan State
University, East Lansing, MI and 4 Department of Pediatrics and Human Development,
Michigan State University, East Lansing, MI
Regulation of epidermal proliferation and differentiation is critical for the maintenance of cutaneous
homeostasis. Interferon Regulatory Factor 6 (Irf6) deficient mice die perinatally and exhibit ectopic
proliferation and defective epidermal differentiation. We sought to determine if these disruptions of
epidermal function were cell autonomous and to use cultured embryonic Irf6-/- keratinocytes to
understand the specific role of Irf6 in keratinocyte proliferation and differentiation. In the absence
of Irf6, keratinocytes were larger and exhibited a heterogeneous phenotype. Irf6-/- keratinocytes
exhibited an increased colony forming efficiency compared to wildtype cells, suggesting that Irf6
represses proliferation. Irf6 was present at low levels in wildtype keratinocytes in culture and was
upregulated after induction of differentiation in vitro, along with upregulation of markers of differ-
entiation. However, Irf6-/- keratinocytes were unable to express markers of terminal differentiation.
Overexpression of Irf6 in wildtype keratinocytes was not sufficient to induce expression of markers
of differentiation under basal growing conditions. Together, these results indicate that Irf6 is neces-
sary, but not sufficient for keratinocyte differentiation. Finally, using a transgenic mouse expressing
Lac-Z under the regulation of an enhancer element 9.7kb upstream of the Irf6 start site, we demon-
strate that this element contributes to the regulation of Irf6 in the epidermis and in keratinocytes in
culture.
393
Bone mineral acquisition is meager in children with epidermolysis bullosa
T Fu,1 K Kent,2 LK Bachrach3 and AL Bruckner1,3 1 Dermatology, Stanford University, Stanford,
CA, 2 Medicine, Stanford University, Stanford, CA and 3 Pediatrics, Stanford University,
Stanford, CA
Although epidermolysis bullosa (EB) is primarily a disorder of the skin and mucosa, it affects mul-
tiple organ systems, including bone. Low bone mass and fractures have been identified as compli-
cations of generalized forms of EB, although the mechanisms for this are not clear. To gain insight
into the pathogenesis of low bone mass in children with EB, we evaluated 17 children from a mul-
tidisciplinary EB clinic (15 with recessive dystrophic and 2 Simplex-Dowling Meara) at 2 visits at
least 1 year apart using clinical, laboratory, and dual energy absorptiometry (DXA) studies. Aside
from routine interventions and counseling, a systematic intervention to improve bone mass was not
provided. At study end, subjects gained height and weight and sexual maturity advanced. Mean lab-
oratory values did not change significantly, but the proportion of subjects with insufficient or defi-
cient levels of 25-OH vitamin D increased from 75% to 88%, and the number of subjects with vita-
min D deficiency increased from 1 to 6. Mean bone mineral content increased from 27.29 to 29.39
gm, and mean areal bone mineral density (aBMD) increased from 0.581 to 0.610 gm/cm2. 15 sub-
jects (88%) gained aBMD, while 2 lost. Mean aBMD Z-score did not change significantly (-1.9 to -
2.1), although Z-scores decreased for 8 subjects, and 9 subjects (53%) had aBMD < -2.0 at study
end. In order to account for the effect of small body size on bone mass, aBMD Z-scores were adjusted
for height Z-score (aBMD-HAZ) and mean aBMD-HAZ did not change from baseline to follow-up
(-1.2). 1 subject was diagnosed with new lumbar compression fractures at study end. While chil-
dren with severe forms of generalized EB are building bone, the rate is meager when compared
with their peers, and they are at increased risk for fractures. Interventions to help augment bone
mineral accretion deserve further study in this patient population.
394
Biomarkers of skin ageing using genome wide transcriptomics
D Glass,1 L Parts,2 D Knowles,3,7 AC Nica,4,2 J Nisbet,2 A Barrett,5 M Sekowska,2 M Travers,5
S Potter,2 E Grundberg,2,1 K Small,1,2 ÅSA Hedman,5 J Tzenova Bell,5,1 G Surdulescu,1 FO Nestle,6
P di Meglio,6 R Durbin,2 K Ahmadi,1 J Winn,7 V Bataille,1 P Deloukas,2 MI McCarthy,5 TD Spector,1
ET Dermitzakis4 and M For1,2,5 1 Department of Twin Research, King’s College London, London,
United Kingdom, 2 Wellcome Trust Sanger Institute, Hinxton, United Kingdom, 3 Department
of Engineering, University of Cambridge, Cambridge, United Kingdom, 4 Department of
Genetic Medicine and Development, University of Geneva, Geneva, Switzerland, 5 Wellcome
Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom, 6 St John’s
Institute of Dermatology, King’s College London, London, United Kingdom and 7 Microsoft
Research, Cambridge, United Kingdom
Endogenous skin ageing is not fully understood; study of the changes in skin gene expression with
age should further elucidate the mechanisms involved. What are the gene expression signatures of
ageing in skin? How do they compare to gene expression in other tissues? How do they correspond
to global ageing biomarkers? 855 photo-protected abdominal skin samples were taken from female
Caucasian twins aged 40 - 85, abdominal fat and lymphoblastoid cell lines were sampled from the
same individuals. RNA was extracted from all samples and hybridised with the Illumina human Sen-
trix 12 micro-array. A linear mixed model was used to explain gene expression variability by age
and confounding factors; (Significance determined from permutations using false discovery rate
<0.05). Results to be presented include; genes that are differentially expressed in skin with age
(n>2000), age correlated gene pathways, genes that are differentially expressed with age across tis-
sues (n>100), age correlated genes shared with animal models.
395
A transcriptional network for keratinocyte differentiation<b/>
A Soto Hopkin,1,2 Q Liu,3 A Ihler3 and B Andersen1,2 1 Medicine, University of California Irvine,
Irvine, CA, 2 Biological Chemistry, University of California Irvine, Irvine, CA and 3 Computer
Science, University of California Irvine, Irvine, CA
The stratified mammalian epidermis develops from somatic ectoderm by the progressive addition
and differentiation of superficial epidermal layers. After the initial morphogenesis, the epidermis is
maintained by homeostatic mechanisms whereby keratinocytes move from the proliferating basal
cell layer towards the surface as they undergo a series of differentiation steps, ultimately undergo-
ing cell death. One role of keratinocyte differentiation is the formation of an effective permeability
barrier, which depends on the regulated expression of a large battery of genes encoding compo-
nents of the cornified and granular layers. Currently our knowledge of the transcriptional regulators
of epidermal differentiation is limited to relatively few transcription factors. Furthermore, we know
very little about the interrelationship between transcriptional regulators and how they target the
genes that execute the differentiation process. To gain further insight into the transcriptional pro-
gram present during keratinocyte differentiation we took a global systems biology approach and
profiled gene expression at various time points throughout human epidermal keratinocyte differ-
entiation. These data were filtered by ANOVA to exclude genes whose expression was not signifi-
cantly changing over the time course, identifying ~6000 genes. Focusing on the transcriptional reg-
ulators present in our gene list, we used an estimator based on the graphical lasso approach to
predict target genes and infer regulatory interactions. As validation, we searched the promoters of
genes that were linked to particular transcriptional regulators for the presence of the specific DNA
binding motif. For a select group of transcriptional regulators we performed RNAi perturbation to
validate specific hubs in the network. These results allowed us to strengthen our network predic-
tions and resulted in the identification of a novel regulatory network of keratinocyte differentiation.
396
Epidermal tissue differentiation and lipid barrier function requires the long non-coding RNA
Linc19A
M Kretz, D Webster, Z Siprashvili, A Zehnder, C Lee, R Flockhart, J Chow, G Kim, J Rinn, H Chang
and P Khavari Veterans Affairs Palo Alto Health Care System and Stanford University, Palo Alto,
CA
Long intergenic noncoding RNAs (lincRNAs) range in size from 200bp to >16kb and have been
implicated in a variety of molecular functions. We wished to address a potential role for lincRNAs
in regulating differentiation in skin and other somatic tissues. High throughput full transcriptome
sequencing was undertaken of differentiated and progenitor human keratinocyte populations using
the Illumina paired-end HiSeq platform with a read length of 101 nucleotides at >100 million mapped
reads per sample. The lincRNA with the highest increase in expression of >150-fold during differ-
entiation was provisionally named linc19A. Linc19A is a 3.7kb spliced and polyadenylated lincRNA
located in a gene desert on chromosome 19p13. Linc19A depletion in regenerated human epider-
mal tissue using multiple RNA-interference sequences blocked induction of epidermal differentia-
tion proteins, including filaggrin and loricrin. In addition, linc19A loss led to diminished expres-
sion of key epidermal lipid barrier formation genes, including ELOVL3, ALOXE3, ALOX12B, and
ABCA12. To characterize the mechanism of linc19A function, we developed a high throughput
screening method to test binding of any RNA to >9000 microarrayed recombinant human proteins.
Linc19A bound selectively to Staufen 1 (Stau1), a protein first characterized in Drosophila as a medi-
ator of cellular RNA transport. This RNA-protein interaction was confirmed by linc19A RNA and
Stau1 protein pull-downs. Stau1-deficient epidermal tissue displayed similar differentiation and lipid
barrier defects seen with linc19A loss. These results indicate that the large noncoding RNA linc19A
binds Stau1 protein and that they both to enable normal epidermal differentiation and barrier func-
tion.
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Hairless is a H3K9 histone demethylase
L Liu,1 H Kim,1 A Casta,1 C Luke,1 Y Kobayashi,1 LS Shapiro3 and AM Christiano1,2 1 Dermatology,
Columbia University, New York, NY, 2 Genetics and Development, Columbia University, New
York, NY and 3 Biochemistry and Molecular Biophysics, Columbia University, New York, NY
The hairless (Hr) gene is essential for skin homeostasis, and both humans and mice with mutations
in Hr exhibit congenital hair loss and epidermal abnormalities. Hr has been shown to function in
transcriptional regulation, however, the exact mechanism underlying Hr function in the epidermis
and hair follicle remains elusive. Structural analysis of the HR protein reveals a jumonji C (JmjC)
domain, which is highly conserved among several proteins with histone demethylase (HDM) activ-
ity. Upon modeling the sequence of HR on the basis of the atomic structure of JMJD2, a well-char-
acterized HDM, we found that HR contains metal binding sites for demethylase function. To fur-
ther delineate the HDM activity of HR, we performed a series of biochemical studies, which
demonstrate that HR demethylates mono- or di-methylated histone H3 lysine 9 (H3K9-me1 or -me2)
in vitro. Consistent with these results, ectopic expression of a wild-type Hr in human cells, but not
a mutant form of Hr, resulted in a dramatic demethylation of H3K9-me1. To uncover downstream
target genes of Hr, we performed microarray studies to identify genes that are differentially expressed
in the epidermis between Hr-mutant rh/rh mice and normal littermates. Furthermore, we employed
ChIP-Seq to interrogate genome-wide HR-binding DNA sequences. By integrating our microarray
results with ChIP-Seq analyses, we will test whether differentially expressed genes, such as cas-
pase14, Sostdc1, and filaggrin, are bona fide demethylation and homeostasis targets of Hairless. In
summary, our studies demonstrate for the first time that Hr is a H3K9 histone demethylase with a
novel role as an epigenetic regulator of target genes in hair follicle and epidermal development.
411
Copy number variation (CNV) on ch4q26-27 is associated with Cantu syndrome, with hyper-
trichosis and cardiomegaly
M Kurban,1 C Kim,2 K Fantauzzo1 and AM Christiano1,3 1 Dermatology, Columbia University,
New York, NY, 2 Genetics, University of Sao Paulo, Sao Paulo, Brazil and 3 Genetics and
Development, Columbia University, New York, NY
Cantu syndrome (OMIM 239850) is a rare condition which is characterized clinically by hypertri-
chosis, cardiomegaly and bone abnormalities. Inherited hypertrichoses are very rare human disor-
ders whose incidence has been estimated as low as 1 in 1 billion. The genetic basis of hypertri-
chosis is largely unknown, and currently no single gene has yet been directly implicated in the
pathogenesis of hypertrichosis, although we and others have reported position effects involving the
TRPS1 and SOX9 genes. Here, we analyzed the DNA of a patient with sporadic Cantu syndrome
on the Affymetrix Cytogenetics Whole-Genome 2.7M array for copy number variations (CNVs),
and we identified a 375Kb duplication on chromosome 4q26-27. The duplication region encom-
passed three genes, which included MYOZ2, USP53 and FABP2. We performed genomic copy num-
ber quanitification using qPCR, and gene expression analysis for the genes lying within the region
of the duplication. Of these, MYOZ2 and USP53 are highly expressed in the cardiac muscle, and
Myoz2 -/- mice develop cardiomegaly, consistent with the phenotype of our patient, and we also
found that USP53 is expressed in the hair follicle plucked from an unaffected individual. These data
suggest the presence of a contiguous gene duplication in Cantu syndrome, where the differential
expression of these genes result in cardiac abnormality and hypertrichosis. We propose that CNVs
involving chromosome 4q26-27 are involved in the molecular basis of Cantu syndrome. CNVs span-
ning several genes may help define the molecular basis of disorders such as Cantu syndrome which
have unrelated and seemingly disparate clinical features.
413
Feline lanceolate hair-like disease: Clinical, histological and ultrastructural features
A Rostaher,1 CS Potter,2 J Chen,3 S Bettany,4 KA Silva,2 L Specht,1 RS Mueller1 and JP Sundberg2 1
Centre for Clinical Veterinary Medicine, Ludwig Maximilian University, Munich, Germany, 2
The Jackson Laboratory, Bar Harbor, ME, 3 Department of Dermatology and Charles C. Gates
Center for Regenerative Medicine and Stem Cell Biology, University of Colorado at Denver,
Aurora, CO and 4 Tierdermatologie Deisenhofen, Deisenhofen, Germany
A new feline hair shaft abnormality resembling the lanceolate hair phenotype of mice and rats
occurred in a litter of domestic short hair cats. These cats presented with progressive, multifocal
alopecia of the trunk and head with macroscopically evident short hair shafts with broken or lance
head-shaped ends. The nails, teeth, eyes, and skin did not have apparent abnormalities. Detailed
comparative morphologic evaluation, immunohistochemistry, and immunofluorescence were per-
formed. Light microscopy of the hairs revealed loss of the normal cuticle pattern and bulbous defects
resembling a spear point or lance head. The most striking histologic findings in the skin were focal,
swollen hair fibers, initially above the hair bulb matrix, which could be found in the distal parts of
the shaft as well. This was associated with individual or small clusters of cells in the precortex and
premedulla that were enlarged, rounded, and had abundant pale cytoplasm suggesting that they
were undergoing degenerative changes. Scanning electron microscopy revealed oval defects with
a thin pointed protrusion or blunt end where the hair broke. X-ray based element analysis showed
a statistically significant decrease in sulfur content just bellow the defects. Transmission electron
microscopy of extracted cat hairs revealed that the cells in the medulla were filled with amorphous
deposits, including remnants of nuclei with loss of the septulated architecture. Desmoglein 4 (DSG4)
and keratins (KRT) 14, 71, and 75 were evaluated in the cat’s skin using immunofluorescence. The
cat Dsg4 gene is suspected to be the candidate gene responsible for this novel clinical disease in
cat.
412
The role of Piasy in an imiquimod-induced psoriasis-like mouse model
EE Swanzey, Y Wang, J Lagowski, K Phillips, Y Liu and M Kulesz-Martin Dermatology, Oregon
Health and Science University, Portland, OR
Psoriasis is an inflammatory skin condition that affects an estimated 2-3% of the population, and is
characterized by keratinocyte hyperproliferation and aberrant immune cell infiltration, with current
treatments focused on targeting and abating Th17 responsive immunocytes. Our study is focused
on the role of Piasy in an imiquimod-induced psoriasis-like mouse model that has characteristic
keratinocyte hyperplasia and inflammatory Th17 cytokine response. We have shown that produc-
tion of the psoriatic chemokine CCL20 can be driven by keratinocytes through NF-κB, and inhib-
ited by Piasy through its binding with the RelA/p65 subunit of NF-κB. Furthermore, we have shown
that the E3 ubiquitin ligase Trim32 is overexpressed in human psoriasis, and targets Piasy for degra-
dation, illuminating a pathway that suggests a novel keratinocyte role in psoriasis. Here we show
that imiquimod-treated Piasy KO mice exhibited a more severe psoriasis-like phenotype, com-
pared to the imiquimod-treated WT mice, including histologically defined thickening of the epi-
dermis, hyperkeratosis, and inflammatory cell infiltrates in the dermis. Piasy KO mice also exhib-
ited more pronounced skin folding, a common psoriasis feature in humans. In addition,
immunofluorescent staining of 6-day imiquimod-treated Piasy KO mouse skin showed p65 local-
ization to the nucleus in epidermal keratinocytes, in contrast to the cream controls and both Piasy
WT groups, in which the staining was primarily cytoplasmic. This suggests that the NF-κB pathway
is activated in the epidermis of Piasy KO imiquimod-treated mice, supporting an inhibitory role of
Piasy in psoriasis. Further research, including cytokine profile effects and examination of the effects
of altered Trim32 levels may lead to improved keratinocyte-specific treatments through molecular
targeting of components in this pathway.
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Novel corneodesmosin null mutation and entire gene deletion in two families with inflam-
matory peeling skin syndrome
L Furio,1,2 M Honma,8 C Deraison,3 A Robin,3 E Tron,4 B Sans,5 E Gardini-Fournié,6 S Igawa,8
M Murakami,8 C Prost,7 A Ishida-Yamamoto8 and A Hovnanian1,2,5 1 INSERM U781, Paris,
France, 2 University Paris V, Paris, France, 3 INSERM U563, Toulouse, France, 4 Department
of Genetics, Necker Hospital, Paris, France, 5 Department of Dermatology, Castres Hospital,
Castres, France, 6 Department of Gastro-enterology, Purpan Hospital, Toulouse, France, 7
Histology Laboratory, University Paris XIII, Paris, France and 8 Department of Dermatology,
Asahikawa Medical University, Asahikawa, Japan
Inflammatory Peeling Skin Syndrome (PSS) is a rare autosomal recessive skin disease recently shown
to be caused by loss of corneodesmosin. We report here two new unrelated patients who are homozy-
gous for null mutations in the corneodesmosin gene (CDSN). Patient A is an 8-year-old girl born
from consanguineous parents from Morocco. Since the first days of life she displayed extensive and
continuous cutaneous exfoliation, with shallow erosions. She had severe pruritus leading to insom-
nia. Her hair was normal. Patient B is a 10-year-old boy born from parents originating from the
same region in Japan, but not known to be related. His skin condition was similar to patient A. In
addition, he had a short stature and mental retardation with a normal male karyotype. Both patients
had high IgE levels and antigen specific IgE against multiple allergens. In both patients, transmis-
sion electron microscopy revealed corneocyte layers detachment and corneodesmosomes with less-
electron dense desmoglea. Haplotype analysis showed homozygosity at the CDSN locus. In patient
A, sequencing of CDSN identified a homozygous point mutation leading to a premature termina-
tion codon inherited from each of her parents. In patient B, PCR amplification of CDSN was repeat-
edly unsuccessful. QMPSF analysis showed complete deletion of CDSN inherited from each of his
parents. Corneodesmosin expression was undetectable on skin sections from both patients. Immunos-
taining of skin sections for LEKTI, keratin 1 and 10, filaggrin, involucrin, loricrin, Dsg1, Dsg3 and
Dsc1 was normal. These results expend the diversity of CDSN defects in PSS patients from different
geographic origins.
414
Visualization of functional nucleic acid delivery to mouse and human epidermis
E González-González,1 Y Kim,2 TJ Speacker,3 RP Hickerson,3 R Spitler,1 J Birchall,4 M Lara,1
R Hu,5 Y Liang,5 N Kirkiles-Smith,5 MR Prausnitz,2 LM Milstone,5 CH Contag1 and RL Kaspar3 1
Stanford University, Stanford, CA, 2 Georgia Institute of Technology, Atlanta, GA, 3 TransDerm
Inc, Santa Cruz, CA, 4 Cardiff University, Cardiff, United Kingdom and 5 Yale University, New
Haven, CT
The accessibility of skin makes it an ideal target organ for nucleic acid-based therapeutics; how-
ever effective delivery remains a major obstacle impeding translation to the clinic. Limited delivery
of nucleic acids to skin keratinocytes has been demonstrated using a variety of approaches, but effi-
cient delivery had not been achieved due, in part, to the lack of validated standardized nucleic acids
encoding detectable markers, the absence of rapid noninvasive assays of delivery, and inadequate
skin model systems. To address these issues, we evaluated a set of reporter plasmids expressing a
luciferase/GFP fusion protein under the control of various promoters in mouse skin using intravital
bioluminescence and fluorescence imaging. We have found that the human ubiquitin C promoter
gives high and uniform reporter expression throughout the epidermal strata. These tools were used
to establish and validate a generalizable approach for evaluating nucleic acid skin delivery tech-
nologies using two microneedle array delivery platforms (soluble protrusion array devices and stain-
less-steel microneedle patches) with intradermal injections as a control. In this study, we demon-
strated the use of non-invasive intravital imaging to directly detect, in real time, quantitative
bioluminescence resulting from luciferase expression as well as individual keratinocytes express-
ing GFP using a confocal fluorescence-reflectance imaging system in mouse skin as well as human
skin xenografts. These advances establish a system for testing other skin delivery technologies that
also can be applied to other nucleic acids including triplex-forming oligonucleotides (TFOs) and
small interfering RNAs (siRNAs).
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Induction of microRNA Mir-29 by UV irradiation down-regulates type I procollagen in fibrob-
lasts in human skin 
T He, T Quan, Z Qin, JJ Voorhees and GJ Fisher Dermatology, University of Michigan, Ann
Arbor, MI
Type I collagen (COL) is the most abundant structural protein in human skin. COL is primarily pro-
duced by dermal fibroblasts. UV irradiation markedly represses COL expression. Recent studies
have implicated microRNA Mir-29 in the regulation of COL expression. Here we report that UV
irradiation rapidly induces Mir-29b in human dermis in vivo. Induction was observed within 8 hours
and remained elevated for 24 hours post UV. Maximum induction was 4.6-fold at 8 hours (n=6,
p<0.05). Similar elevations of Mir-29b were observed in cultured skin fibroblasts. Induction was
dose dependent between 10 mJ/cm2 to 40 mJ/cm2, increasing from 2-fold to 5.4 fold (n=3, p<0.05).
Introduction of Mir-29b mimic into cultured skin fibroblasts, reduced COL protein level 39% (n=3,
p<0.05). In contrast, transfection of cultured fibroblasts with antisense Mir-29b inhibitor, increased
COL protein levels 2.5-fold (n=3, p<0.05). In silico analysis identified three potential Mir-29 bind-
ing sites within the 3’ untranslated region of COL mRNA. Insertion of 243 base pair of 3’ untrans-
lated sequences into pMIR-REPORT luciferase reporter construct reduced luciferase expression 54%
(n=4, p<0.05). Deletion and mutation analyses demonstrated that Mir-29 binding sites conferred
the observed inhibition of reporter activity. Repression of activity of reporter construct containing
Mir-29 binding sites was abrogated by introduction of antisense Mir-29b inhibitor. Exposure of fibrob-
lasts to UV irradiation further inhibited reporter activity 27% (n=4. p<0.05). Importantly, introduc-
tion of Mir-29 antisense, inhibitor largely prevented UV irradiation-induced reduction of COL expres-
sion (74%, n=3, p<0.05). These data demonstrate that UV irradiation induces Mir-29b in human
skin in vivo. Furthermore, induction of Mir-29b by UV irradiation mediates, in part, down-regula-
tion of COL protein levels, by directly binding to specific sequences within the 3’untranslated region
of COL mRNA, in human dermal fibroblasts.
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Identification of two novel deletions in KRT10 of one patient with ichthyosis en confettis
B Burger,1 I Spoerri1 and PH Itin2 1 Department of Biomedicine, University Hospital Basel,
Basel, Switzerland and 2 Department of Dermatology, University Hospital Basel, Basel,
Switzerland
Ichthyosis en confettis (IC) is an extremely rare sporadic skin disease, also known as congenital retic-
ular ichthyosiform erythroderma (CRIE), which was first described in 1984. Clinically IC is charac-
terized by erythroderma, prominent scale, and palmoplantar keratoderma. During childhood hun-
dreds to thousands of pale confetti-like spots appear mainly on the trunk and cleavage which increase
in number and size with time. The histological findings are parakeratosis, psoriasiform acanthosis,
vacuolization of the keratinocytes in the upper layers of the epidermis, and a high number of bin-
uclear cells. Electron microscopy showed perinuclear shells built from a three-dimensional network
of fine filaments. Recent study has revealed that IC is caused by mutations in the KRT10 gene on
chromosome 17q21. The spots of normal looking skin are caused by mitotic recombinations, which
lead to a reversion of dominant mutations. All described mutations are heterozygous frameshift
mutations which result in an alternative frame, leading to an arginine-rich protein. We report clin-
ical and molecular findings of a female patient, first described at the age of 5 years, who was peri-
odically investigated aged between 8 weeks and 26 years. In keratinocytes of diseased skin we iden-
tified two heterozygous novel deletions within exon 7 of KRT10. One was a combination of missense
mutation and frameshift-deletion of 5 bp which results in the arginine-rich protein. This mutation
was strongly reduced in keratinocytes of normal appearing skin. Second deletion started 79 bp pre-
viously and was in frame; it was detectable in ichthyotic skin as well as in normal appearing skin.
These results suggest the molecular basis of IC relating to a changing phenotype in the course of 26
years and provide further evidence that mutations in KRT10 which lead to the arginine-rich protein
linked with back mutations induce the phenotype in IC.
405
SSAT overexpression in vivo induces downregulation of hairless and a phenotype similar to
the Hr mutation
CT Luke,1 L Alhonen2 and AM Christiano1,3 1 Dermatology, Columbia University, New York, NY,
2 A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland
and 3 Genetics and Development, Columbia University, New York, NY
Polyamines play a role in a variety of key cellular processes including transcription, translation and
post-translational modification. Over-accumulation of the polyamine putrescine in several animal
models causes hair loss that is reminiscent of the phenotype resulting from mutations in the gene
encoding hairless (Hr). This led us to postulate that polyamines and Hr reside in the same molecu-
lar pathway in the hair follicle. Previous work in our laboratory showed that Hr transcriptionally
represses ornithine decarboxylase, the rate-limiting enzyme that converts L-ornithine into putrescine.
In turn, putrescine transcriptionally represses Hr expression, resulting in a negative feedback loop
between polyamines and Hr expression. The enzyme spermidine/spermine N1-acetyltransferase
(SSAT) is responsible for the catabolic production of putrescine from other polyamines, and there-
fore SSAT overexpression increases intracellular putrescine levels. For the first time, we show here
that in vivo overexpression of SSAT under its endogenous promoter (SSAT-TG) results in the tran-
scriptional repression of Hr. SSAT-TG animals exhibit patchy hair loss beginning at approximately
24 days of age. SSAT-TG animals are characterized by misanchored club fibers and follicular degen-
eration during catagen that blocks hair regrowth in anagen. The entire animal is affected, as the hair-
loss is also seen in the ears and tails, while the vibrissae are cyclically lost with no follicular degen-
eration. Therefore, we postulate that polyamines, particularly putrescine, play a crucial role in hair
cycle regulation, in part via transcriptional regulation of Hr.
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Dissecting the role of SHARPIN in idiopathic hypereosinophilic syndromes
CS Potter,1 Z Wang,2 K Silva,1 V Kennedy,1 L Schultz,1 H HogenEsch2 and JP Sundberg1 1 The
Jackson Laboratory, Bar Harbor, ME and 2 Department of Comparative Pathobiology, Purdue
University School of Veterinary Medicine, West Lafayette, IN
Two allelic mutations of the mouse Sharpin gene result in an idiopathic hyper-eosinophilic syn-
drome similar to that found in humans. Mutant mice develop a systemic disease, including scaly
skin, characterized by hyperproliferation with marked apoptosis of keratinocytes and a granulocytic,
primarily eosinophilic, dermal infiltrate. To dissect the mechanisms underlying this disease, mutant
mice were crossed with mice with known immune system deficiencies. Compound mutants,
Rag1tm1Mom (lack T and B cells) and Sharpincpdm-Dem, developed the chronic proliferative dermatitis
phenotype but it was less severe than in controls. The expression of Th2 cytokines is increased in
Sharpin-deficient mice. Il4ratm1Sz (diminished Th2 helper T cell response, unresponsive to both IL4
and IL13) and Sharpincpdm-Dem compound mutants develop a severe granulocytic dermatitis with
marked epidermal acanthosis, apoptosis, and orthokeratosis with liver failure due to necrosis and
mineralization. SHARPIN null mice have reduced secretion of IL12, possibly due to Sharpin expres-
sion in dendritic cells. Mutant mice treated with recombinant IL12 had diminished disease in a dose
response manner. We previously demonstrated that treatment of Sharpin mutant mice with anti-IL5
reduced eosinophilia but not the severity of skin lesions. This work further supports those findings
suggesting that eosinophils are part of the chronic proliferative disease mutant mouse phenotype,
but eosinophils are not the primary effecter cells.
407
Lesion-specific expression changes in a patient with Proteus syndrome: Potential implications
for the PI3K/AKT pathway
KJ Duffy,1 M Kelly2 and B Drolet1 1 Dermatology, Medical College of Wisconsin, Milwaukee,
WI and 2 Pediatrics, Division of Hematology/Oncology, Medical College of Wisconsin,
Milwaukee, WI
The purpose of this study was to determine if PI3K pathway-specific differential expression patterns
could be found in multiple lesions from a patient with Proteus syndrome, a rare disorder charac-
terized by progressive, asymmetric overgrowth with no known cause. Primary fibroblast cultures
were derived from three separate lesions and normal skin from the patient and total RNA and pro-
tein were isolated. RNA was used to compare relative expression of PI3K pathway genes in normal
versus lesion samples and across lesions. Total protein was used for western blot analysis. Gene
expression analysis revealed 3 to 8 genes significantly up-regulated (p<0.05) and 1 to 6 genes sig-
nificantly down-regulated (p<0.05) in lesion samples compared with normal. Gene expression com-
pared across lesions revealed one gene, platelet-derived growth factor receptor alpha (PDGFRa),
was consistently over-expressed in each of the 3 lesion samples. Western blot confirmed over-expres-
sion of PDGFRa protein in 2 of 3 lesions (1.5- to 2.5-fold change from normal), while the third
showed minimal difference (0.9-fold change from normal). PDGFRa is an activator of the PI3K path-
way and receptor for platelet-derived growth factors, key survival factors that inhibit apoptosis and
promote proliferation. Over-expression of PDGFRa in fibroblasts derived from distinct lesions in
the same patient suggests a role for the receptor in the overgrowth of tissue in Proteus syndrome
individuals. Several drugs targeting the PI3K pathway have been proposed for various overgrowth
syndromes, but there are limited data to support the use of such drugs. Here we show differential
expression of an upstream activator of the PI3K pathway in separate lesions from the same Proteus
patient. These results encourage further investigation of lesion-specific PI3K pathway expression dif-
ferences in additional patients with Proteus and other overgrowth syndromes, as little is known about
their etiology and no effective treatments exist.
408
Targeting keratin 6a gene sequences using small oligonucleotides and PNAs
L Milstone,1 H Zambrano,1 A Majumdar,2 R Alam,2 H Li,2 A Thazhathveetil,2 P Glazer1 and
M Seidman2 1 Yale University, New Haven, CT and 2 National Institute of Aging, Baltimore,
MD
Mutations in keratins generally have a dominant negative effect on epidermis. Elimination of the
mutant allele could be an effective strategy for treating the group of inherited skin diseases caused
by mutations in keratins. We have used homologous “donor” oligonucleotides to achieve correc-
tion of mutant keratin 6a DNA, mutations in which cause pachyonychia congenita. The use of triplex-
forming oligos (TFOs) to foster introduction of sequence-specific alterations in chromosomal genes
is well-established. The goal the present work is to identify TFOs that enhance the frequency of
KRT6a targeting. We used chemical binding assays and two distinct cell-based assays to evaluate
TFOs that bind to three separate sites in the first exon or first intron of KRT6a. Purine oligonucleotides
that formed stable triplex DNA and peptide nucleic acids (PNAs) were tested for ability to enhance
“donor” correction of a mutant keratin 6a-EYFP chimeric gene (mK6-EYFP) in CHO cells. Cor-
rected cells were enumerated by FACS. The most active PNA increased correction 5-fold over
donor alone (frequency = 16x 10-5 vs 3x10-5) and bound to a site in exon 1 that was 57 bases from
the mutation. This PNA was more active than the purine oligos or other PNAs that bound to that
site or to the site in the first intron. A different, but complimentary, assay was used to evaluate pso-
ralen-coupled, chemically modified pyrimidine TFOs (pso-TFOs). The genomic reporter in this case
is the endogenous HPRT locus in CHO cells, which has been engineered to contain the KRT6a
triplex site in the splice acceptor site of the 5th exon of HPRT. TFOs that bind to that site inactivate
the HPRT locus, rendering the cells selectable in 6-thioguanine. Two pso-TFOs, directed at the triplex
site in the KRT6a 1st intron, had good activity in this assay, inactivating HPRT in 1x10-3cells, a fre-
quency 30-fold higher than seen with control oligos. We conclude that some, but not all, keratin
6a sequence-specific TFOs enhance chromosomal gene targeting in reporter cells.
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Hairless is a H3K9 histone demethylase
L Liu,1 H Kim,1 A Casta,1 C Luke,1 Y Kobayashi,1 LS Shapiro3 and AM Christiano1,2 1 Dermatology,
Columbia University, New York, NY, 2 Genetics and Development, Columbia University, New
York, NY and 3 Biochemistry and Molecular Biophysics, Columbia University, New York, NY
The hairless (Hr) gene is essential for skin homeostasis, and both humans and mice with mutations
in Hr exhibit congenital hair loss and epidermal abnormalities. Hr has been shown to function in
transcriptional regulation, however, the exact mechanism underlying Hr function in the epidermis
and hair follicle remains elusive. Structural analysis of the HR protein reveals a jumonji C (JmjC)
domain, which is highly conserved among several proteins with histone demethylase (HDM) activ-
ity. Upon modeling the sequence of HR on the basis of the atomic structure of JMJD2, a well-char-
acterized HDM, we found that HR contains metal binding sites for demethylase function. To fur-
ther delineate the HDM activity of HR, we performed a series of biochemical studies, which
demonstrate that HR demethylates mono- or di-methylated histone H3 lysine 9 (H3K9-me1 or -me2)
in vitro. Consistent with these results, ectopic expression of a wild-type Hr in human cells, but not
a mutant form of Hr, resulted in a dramatic demethylation of H3K9-me1. To uncover downstream
target genes of Hr, we performed microarray studies to identify genes that are differentially expressed
in the epidermis between Hr-mutant rh/rh mice and normal littermates. Furthermore, we employed
ChIP-Seq to interrogate genome-wide HR-binding DNA sequences. By integrating our microarray
results with ChIP-Seq analyses, we will test whether differentially expressed genes, such as cas-
pase14, Sostdc1, and filaggrin, are bona fide demethylation and homeostasis targets of Hairless. In
summary, our studies demonstrate for the first time that Hr is a H3K9 histone demethylase with a
novel role as an epigenetic regulator of target genes in hair follicle and epidermal development.
411
Copy number variation (CNV) on ch4q26-27 is associated with Cantu syndrome, with hyper-
trichosis and cardiomegaly
M Kurban,1 C Kim,2 K Fantauzzo1 and AM Christiano1,3 1 Dermatology, Columbia University,
New York, NY, 2 Genetics, University of Sao Paulo, Sao Paulo, Brazil and 3 Genetics and
Development, Columbia University, New York, NY
Cantu syndrome (OMIM 239850) is a rare condition which is characterized clinically by hypertri-
chosis, cardiomegaly and bone abnormalities. Inherited hypertrichoses are very rare human disor-
ders whose incidence has been estimated as low as 1 in 1 billion. The genetic basis of hypertri-
chosis is largely unknown, and currently no single gene has yet been directly implicated in the
pathogenesis of hypertrichosis, although we and others have reported position effects involving the
TRPS1 and SOX9 genes. Here, we analyzed the DNA of a patient with sporadic Cantu syndrome
on the Affymetrix Cytogenetics Whole-Genome 2.7M array for copy number variations (CNVs),
and we identified a 375Kb duplication on chromosome 4q26-27. The duplication region encom-
passed three genes, which included MYOZ2, USP53 and FABP2. We performed genomic copy num-
ber quanitification using qPCR, and gene expression analysis for the genes lying within the region
of the duplication. Of these, MYOZ2 and USP53 are highly expressed in the cardiac muscle, and
Myoz2 -/- mice develop cardiomegaly, consistent with the phenotype of our patient, and we also
found that USP53 is expressed in the hair follicle plucked from an unaffected individual. These data
suggest the presence of a contiguous gene duplication in Cantu syndrome, where the differential
expression of these genes result in cardiac abnormality and hypertrichosis. We propose that CNVs
involving chromosome 4q26-27 are involved in the molecular basis of Cantu syndrome. CNVs span-
ning several genes may help define the molecular basis of disorders such as Cantu syndrome which
have unrelated and seemingly disparate clinical features.
413
Feline lanceolate hair-like disease: Clinical, histological and ultrastructural features
A Rostaher,1 CS Potter,2 J Chen,3 S Bettany,4 KA Silva,2 L Specht,1 RS Mueller1 and JP Sundberg2 1
Centre for Clinical Veterinary Medicine, Ludwig Maximilian University, Munich, Germany, 2
The Jackson Laboratory, Bar Harbor, ME, 3 Department of Dermatology and Charles C. Gates
Center for Regenerative Medicine and Stem Cell Biology, University of Colorado at Denver,
Aurora, CO and 4 Tierdermatologie Deisenhofen, Deisenhofen, Germany
A new feline hair shaft abnormality resembling the lanceolate hair phenotype of mice and rats
occurred in a litter of domestic short hair cats. These cats presented with progressive, multifocal
alopecia of the trunk and head with macroscopically evident short hair shafts with broken or lance
head-shaped ends. The nails, teeth, eyes, and skin did not have apparent abnormalities. Detailed
comparative morphologic evaluation, immunohistochemistry, and immunofluorescence were per-
formed. Light microscopy of the hairs revealed loss of the normal cuticle pattern and bulbous defects
resembling a spear point or lance head. The most striking histologic findings in the skin were focal,
swollen hair fibers, initially above the hair bulb matrix, which could be found in the distal parts of
the shaft as well. This was associated with individual or small clusters of cells in the precortex and
premedulla that were enlarged, rounded, and had abundant pale cytoplasm suggesting that they
were undergoing degenerative changes. Scanning electron microscopy revealed oval defects with
a thin pointed protrusion or blunt end where the hair broke. X-ray based element analysis showed
a statistically significant decrease in sulfur content just bellow the defects. Transmission electron
microscopy of extracted cat hairs revealed that the cells in the medulla were filled with amorphous
deposits, including remnants of nuclei with loss of the septulated architecture. Desmoglein 4 (DSG4)
and keratins (KRT) 14, 71, and 75 were evaluated in the cat’s skin using immunofluorescence. The
cat Dsg4 gene is suspected to be the candidate gene responsible for this novel clinical disease in
cat.
412
The role of Piasy in an imiquimod-induced psoriasis-like mouse model
EE Swanzey, Y Wang, J Lagowski, K Phillips, Y Liu and M Kulesz-Martin Dermatology, Oregon
Health and Science University, Portland, OR
Psoriasis is an inflammatory skin condition that affects an estimated 2-3% of the population, and is
characterized by keratinocyte hyperproliferation and aberrant immune cell infiltration, with current
treatments focused on targeting and abating Th17 responsive immunocytes. Our study is focused
on the role of Piasy in an imiquimod-induced psoriasis-like mouse model that has characteristic
keratinocyte hyperplasia and inflammatory Th17 cytokine response. We have shown that produc-
tion of the psoriatic chemokine CCL20 can be driven by keratinocytes through NF-κB, and inhib-
ited by Piasy through its binding with the RelA/p65 subunit of NF-κB. Furthermore, we have shown
that the E3 ubiquitin ligase Trim32 is overexpressed in human psoriasis, and targets Piasy for degra-
dation, illuminating a pathway that suggests a novel keratinocyte role in psoriasis. Here we show
that imiquimod-treated Piasy KO mice exhibited a more severe psoriasis-like phenotype, com-
pared to the imiquimod-treated WT mice, including histologically defined thickening of the epi-
dermis, hyperkeratosis, and inflammatory cell infiltrates in the dermis. Piasy KO mice also exhib-
ited more pronounced skin folding, a common psoriasis feature in humans. In addition,
immunofluorescent staining of 6-day imiquimod-treated Piasy KO mouse skin showed p65 local-
ization to the nucleus in epidermal keratinocytes, in contrast to the cream controls and both Piasy
WT groups, in which the staining was primarily cytoplasmic. This suggests that the NF-κB pathway
is activated in the epidermis of Piasy KO imiquimod-treated mice, supporting an inhibitory role of
Piasy in psoriasis. Further research, including cytokine profile effects and examination of the effects
of altered Trim32 levels may lead to improved keratinocyte-specific treatments through molecular
targeting of components in this pathway.
410
Novel corneodesmosin null mutation and entire gene deletion in two families with inflam-
matory peeling skin syndrome
L Furio,1,2 M Honma,8 C Deraison,3 A Robin,3 E Tron,4 B Sans,5 E Gardini-Fournié,6 S Igawa,8
M Murakami,8 C Prost,7 A Ishida-Yamamoto8 and A Hovnanian1,2,5 1 INSERM U781, Paris,
France, 2 University Paris V, Paris, France, 3 INSERM U563, Toulouse, France, 4 Department
of Genetics, Necker Hospital, Paris, France, 5 Department of Dermatology, Castres Hospital,
Castres, France, 6 Department of Gastro-enterology, Purpan Hospital, Toulouse, France, 7
Histology Laboratory, University Paris XIII, Paris, France and 8 Department of Dermatology,
Asahikawa Medical University, Asahikawa, Japan
Inflammatory Peeling Skin Syndrome (PSS) is a rare autosomal recessive skin disease recently shown
to be caused by loss of corneodesmosin. We report here two new unrelated patients who are homozy-
gous for null mutations in the corneodesmosin gene (CDSN). Patient A is an 8-year-old girl born
from consanguineous parents from Morocco. Since the first days of life she displayed extensive and
continuous cutaneous exfoliation, with shallow erosions. She had severe pruritus leading to insom-
nia. Her hair was normal. Patient B is a 10-year-old boy born from parents originating from the
same region in Japan, but not known to be related. His skin condition was similar to patient A. In
addition, he had a short stature and mental retardation with a normal male karyotype. Both patients
had high IgE levels and antigen specific IgE against multiple allergens. In both patients, transmis-
sion electron microscopy revealed corneocyte layers detachment and corneodesmosomes with less-
electron dense desmoglea. Haplotype analysis showed homozygosity at the CDSN locus. In patient
A, sequencing of CDSN identified a homozygous point mutation leading to a premature termina-
tion codon inherited from each of her parents. In patient B, PCR amplification of CDSN was repeat-
edly unsuccessful. QMPSF analysis showed complete deletion of CDSN inherited from each of his
parents. Corneodesmosin expression was undetectable on skin sections from both patients. Immunos-
taining of skin sections for LEKTI, keratin 1 and 10, filaggrin, involucrin, loricrin, Dsg1, Dsg3 and
Dsc1 was normal. These results expend the diversity of CDSN defects in PSS patients from different
geographic origins.
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Visualization of functional nucleic acid delivery to mouse and human epidermis
E González-González,1 Y Kim,2 TJ Speacker,3 RP Hickerson,3 R Spitler,1 J Birchall,4 M Lara,1
R Hu,5 Y Liang,5 N Kirkiles-Smith,5 MR Prausnitz,2 LM Milstone,5 CH Contag1 and RL Kaspar3 1
Stanford University, Stanford, CA, 2 Georgia Institute of Technology, Atlanta, GA, 3 TransDerm
Inc, Santa Cruz, CA, 4 Cardiff University, Cardiff, United Kingdom and 5 Yale University, New
Haven, CT
The accessibility of skin makes it an ideal target organ for nucleic acid-based therapeutics; how-
ever effective delivery remains a major obstacle impeding translation to the clinic. Limited delivery
of nucleic acids to skin keratinocytes has been demonstrated using a variety of approaches, but effi-
cient delivery had not been achieved due, in part, to the lack of validated standardized nucleic acids
encoding detectable markers, the absence of rapid noninvasive assays of delivery, and inadequate
skin model systems. To address these issues, we evaluated a set of reporter plasmids expressing a
luciferase/GFP fusion protein under the control of various promoters in mouse skin using intravital
bioluminescence and fluorescence imaging. We have found that the human ubiquitin C promoter
gives high and uniform reporter expression throughout the epidermal strata. These tools were used
to establish and validate a generalizable approach for evaluating nucleic acid skin delivery tech-
nologies using two microneedle array delivery platforms (soluble protrusion array devices and stain-
less-steel microneedle patches) with intradermal injections as a control. In this study, we demon-
strated the use of non-invasive intravital imaging to directly detect, in real time, quantitative
bioluminescence resulting from luciferase expression as well as individual keratinocytes express-
ing GFP using a confocal fluorescence-reflectance imaging system in mouse skin as well as human
skin xenografts. These advances establish a system for testing other skin delivery technologies that
also can be applied to other nucleic acids including triplex-forming oligonucleotides (TFOs) and
small interfering RNAs (siRNAs).
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Induction of microRNA Mir-29 by UV irradiation down-regulates type I procollagen in fibrob-
lasts in human skin 
T He, T Quan, Z Qin, JJ Voorhees and GJ Fisher Dermatology, University of Michigan, Ann
Arbor, MI
Type I collagen (COL) is the most abundant structural protein in human skin. COL is primarily pro-
duced by dermal fibroblasts. UV irradiation markedly represses COL expression. Recent studies
have implicated microRNA Mir-29 in the regulation of COL expression. Here we report that UV
irradiation rapidly induces Mir-29b in human dermis in vivo. Induction was observed within 8 hours
and remained elevated for 24 hours post UV. Maximum induction was 4.6-fold at 8 hours (n=6,
p<0.05). Similar elevations of Mir-29b were observed in cultured skin fibroblasts. Induction was
dose dependent between 10 mJ/cm2 to 40 mJ/cm2, increasing from 2-fold to 5.4 fold (n=3, p<0.05).
Introduction of Mir-29b mimic into cultured skin fibroblasts, reduced COL protein level 39% (n=3,
p<0.05). In contrast, transfection of cultured fibroblasts with antisense Mir-29b inhibitor, increased
COL protein levels 2.5-fold (n=3, p<0.05). In silico analysis identified three potential Mir-29 bind-
ing sites within the 3’ untranslated region of COL mRNA. Insertion of 243 base pair of 3’ untrans-
lated sequences into pMIR-REPORT luciferase reporter construct reduced luciferase expression 54%
(n=4, p<0.05). Deletion and mutation analyses demonstrated that Mir-29 binding sites conferred
the observed inhibition of reporter activity. Repression of activity of reporter construct containing
Mir-29 binding sites was abrogated by introduction of antisense Mir-29b inhibitor. Exposure of fibrob-
lasts to UV irradiation further inhibited reporter activity 27% (n=4. p<0.05). Importantly, introduc-
tion of Mir-29 antisense, inhibitor largely prevented UV irradiation-induced reduction of COL expres-
sion (74%, n=3, p<0.05). These data demonstrate that UV irradiation induces Mir-29b in human
skin in vivo. Furthermore, induction of Mir-29b by UV irradiation mediates, in part, down-regula-
tion of COL protein levels, by directly binding to specific sequences within the 3’untranslated region
of COL mRNA, in human dermal fibroblasts.
404
Identification of two novel deletions in KRT10 of one patient with ichthyosis en confettis
B Burger,1 I Spoerri1 and PH Itin2 1 Department of Biomedicine, University Hospital Basel,
Basel, Switzerland and 2 Department of Dermatology, University Hospital Basel, Basel,
Switzerland
Ichthyosis en confettis (IC) is an extremely rare sporadic skin disease, also known as congenital retic-
ular ichthyosiform erythroderma (CRIE), which was first described in 1984. Clinically IC is charac-
terized by erythroderma, prominent scale, and palmoplantar keratoderma. During childhood hun-
dreds to thousands of pale confetti-like spots appear mainly on the trunk and cleavage which increase
in number and size with time. The histological findings are parakeratosis, psoriasiform acanthosis,
vacuolization of the keratinocytes in the upper layers of the epidermis, and a high number of bin-
uclear cells. Electron microscopy showed perinuclear shells built from a three-dimensional network
of fine filaments. Recent study has revealed that IC is caused by mutations in the KRT10 gene on
chromosome 17q21. The spots of normal looking skin are caused by mitotic recombinations, which
lead to a reversion of dominant mutations. All described mutations are heterozygous frameshift
mutations which result in an alternative frame, leading to an arginine-rich protein. We report clin-
ical and molecular findings of a female patient, first described at the age of 5 years, who was peri-
odically investigated aged between 8 weeks and 26 years. In keratinocytes of diseased skin we iden-
tified two heterozygous novel deletions within exon 7 of KRT10. One was a combination of missense
mutation and frameshift-deletion of 5 bp which results in the arginine-rich protein. This mutation
was strongly reduced in keratinocytes of normal appearing skin. Second deletion started 79 bp pre-
viously and was in frame; it was detectable in ichthyotic skin as well as in normal appearing skin.
These results suggest the molecular basis of IC relating to a changing phenotype in the course of 26
years and provide further evidence that mutations in KRT10 which lead to the arginine-rich protein
linked with back mutations induce the phenotype in IC.
405
SSAT overexpression in vivo induces downregulation of hairless and a phenotype similar to
the Hr mutation
CT Luke,1 L Alhonen2 and AM Christiano1,3 1 Dermatology, Columbia University, New York, NY,
2 A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland
and 3 Genetics and Development, Columbia University, New York, NY
Polyamines play a role in a variety of key cellular processes including transcription, translation and
post-translational modification. Over-accumulation of the polyamine putrescine in several animal
models causes hair loss that is reminiscent of the phenotype resulting from mutations in the gene
encoding hairless (Hr). This led us to postulate that polyamines and Hr reside in the same molecu-
lar pathway in the hair follicle. Previous work in our laboratory showed that Hr transcriptionally
represses ornithine decarboxylase, the rate-limiting enzyme that converts L-ornithine into putrescine.
In turn, putrescine transcriptionally represses Hr expression, resulting in a negative feedback loop
between polyamines and Hr expression. The enzyme spermidine/spermine N1-acetyltransferase
(SSAT) is responsible for the catabolic production of putrescine from other polyamines, and there-
fore SSAT overexpression increases intracellular putrescine levels. For the first time, we show here
that in vivo overexpression of SSAT under its endogenous promoter (SSAT-TG) results in the tran-
scriptional repression of Hr. SSAT-TG animals exhibit patchy hair loss beginning at approximately
24 days of age. SSAT-TG animals are characterized by misanchored club fibers and follicular degen-
eration during catagen that blocks hair regrowth in anagen. The entire animal is affected, as the hair-
loss is also seen in the ears and tails, while the vibrissae are cyclically lost with no follicular degen-
eration. Therefore, we postulate that polyamines, particularly putrescine, play a crucial role in hair
cycle regulation, in part via transcriptional regulation of Hr.
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Dissecting the role of SHARPIN in idiopathic hypereosinophilic syndromes
CS Potter,1 Z Wang,2 K Silva,1 V Kennedy,1 L Schultz,1 H HogenEsch2 and JP Sundberg1 1 The
Jackson Laboratory, Bar Harbor, ME and 2 Department of Comparative Pathobiology, Purdue
University School of Veterinary Medicine, West Lafayette, IN
Two allelic mutations of the mouse Sharpin gene result in an idiopathic hyper-eosinophilic syn-
drome similar to that found in humans. Mutant mice develop a systemic disease, including scaly
skin, characterized by hyperproliferation with marked apoptosis of keratinocytes and a granulocytic,
primarily eosinophilic, dermal infiltrate. To dissect the mechanisms underlying this disease, mutant
mice were crossed with mice with known immune system deficiencies. Compound mutants,
Rag1tm1Mom (lack T and B cells) and Sharpincpdm-Dem, developed the chronic proliferative dermatitis
phenotype but it was less severe than in controls. The expression of Th2 cytokines is increased in
Sharpin-deficient mice. Il4ratm1Sz (diminished Th2 helper T cell response, unresponsive to both IL4
and IL13) and Sharpincpdm-Dem compound mutants develop a severe granulocytic dermatitis with
marked epidermal acanthosis, apoptosis, and orthokeratosis with liver failure due to necrosis and
mineralization. SHARPIN null mice have reduced secretion of IL12, possibly due to Sharpin expres-
sion in dendritic cells. Mutant mice treated with recombinant IL12 had diminished disease in a dose
response manner. We previously demonstrated that treatment of Sharpin mutant mice with anti-IL5
reduced eosinophilia but not the severity of skin lesions. This work further supports those findings
suggesting that eosinophils are part of the chronic proliferative disease mutant mouse phenotype,
but eosinophils are not the primary effecter cells.
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Lesion-specific expression changes in a patient with Proteus syndrome: Potential implications
for the PI3K/AKT pathway
KJ Duffy,1 M Kelly2 and B Drolet1 1 Dermatology, Medical College of Wisconsin, Milwaukee,
WI and 2 Pediatrics, Division of Hematology/Oncology, Medical College of Wisconsin,
Milwaukee, WI
The purpose of this study was to determine if PI3K pathway-specific differential expression patterns
could be found in multiple lesions from a patient with Proteus syndrome, a rare disorder charac-
terized by progressive, asymmetric overgrowth with no known cause. Primary fibroblast cultures
were derived from three separate lesions and normal skin from the patient and total RNA and pro-
tein were isolated. RNA was used to compare relative expression of PI3K pathway genes in normal
versus lesion samples and across lesions. Total protein was used for western blot analysis. Gene
expression analysis revealed 3 to 8 genes significantly up-regulated (p<0.05) and 1 to 6 genes sig-
nificantly down-regulated (p<0.05) in lesion samples compared with normal. Gene expression com-
pared across lesions revealed one gene, platelet-derived growth factor receptor alpha (PDGFRa),
was consistently over-expressed in each of the 3 lesion samples. Western blot confirmed over-expres-
sion of PDGFRa protein in 2 of 3 lesions (1.5- to 2.5-fold change from normal), while the third
showed minimal difference (0.9-fold change from normal). PDGFRa is an activator of the PI3K path-
way and receptor for platelet-derived growth factors, key survival factors that inhibit apoptosis and
promote proliferation. Over-expression of PDGFRa in fibroblasts derived from distinct lesions in
the same patient suggests a role for the receptor in the overgrowth of tissue in Proteus syndrome
individuals. Several drugs targeting the PI3K pathway have been proposed for various overgrowth
syndromes, but there are limited data to support the use of such drugs. Here we show differential
expression of an upstream activator of the PI3K pathway in separate lesions from the same Proteus
patient. These results encourage further investigation of lesion-specific PI3K pathway expression dif-
ferences in additional patients with Proteus and other overgrowth syndromes, as little is known about
their etiology and no effective treatments exist.
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Targeting keratin 6a gene sequences using small oligonucleotides and PNAs
L Milstone,1 H Zambrano,1 A Majumdar,2 R Alam,2 H Li,2 A Thazhathveetil,2 P Glazer1 and
M Seidman2 1 Yale University, New Haven, CT and 2 National Institute of Aging, Baltimore,
MD
Mutations in keratins generally have a dominant negative effect on epidermis. Elimination of the
mutant allele could be an effective strategy for treating the group of inherited skin diseases caused
by mutations in keratins. We have used homologous “donor” oligonucleotides to achieve correc-
tion of mutant keratin 6a DNA, mutations in which cause pachyonychia congenita. The use of triplex-
forming oligos (TFOs) to foster introduction of sequence-specific alterations in chromosomal genes
is well-established. The goal the present work is to identify TFOs that enhance the frequency of
KRT6a targeting. We used chemical binding assays and two distinct cell-based assays to evaluate
TFOs that bind to three separate sites in the first exon or first intron of KRT6a. Purine oligonucleotides
that formed stable triplex DNA and peptide nucleic acids (PNAs) were tested for ability to enhance
“donor” correction of a mutant keratin 6a-EYFP chimeric gene (mK6-EYFP) in CHO cells. Cor-
rected cells were enumerated by FACS. The most active PNA increased correction 5-fold over
donor alone (frequency = 16x 10-5 vs 3x10-5) and bound to a site in exon 1 that was 57 bases from
the mutation. This PNA was more active than the purine oligos or other PNAs that bound to that
site or to the site in the first intron. A different, but complimentary, assay was used to evaluate pso-
ralen-coupled, chemically modified pyrimidine TFOs (pso-TFOs). The genomic reporter in this case
is the endogenous HPRT locus in CHO cells, which has been engineered to contain the KRT6a
triplex site in the splice acceptor site of the 5th exon of HPRT. TFOs that bind to that site inactivate
the HPRT locus, rendering the cells selectable in 6-thioguanine. Two pso-TFOs, directed at the triplex
site in the KRT6a 1st intron, had good activity in this assay, inactivating HPRT in 1x10-3cells, a fre-
quency 30-fold higher than seen with control oligos. We conclude that some, but not all, keratin
6a sequence-specific TFOs enhance chromosomal gene targeting in reporter cells.
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Gene targeting induced by triplex-forming oligonucleotides in skin
Y Liang,1 FA Rogers,2 PM Glazer2 and LM Milstone1 1 Dermatology, Yale University School of
Medicine, New Haven, CT and 2 Therapeutic Radiology, Yale University School of Medicine,
New Haven, CT
There are nearly 300 distinct clinical genodermatoses and, to date, mutations in 130 causative genes
have been identified. Sequence-specific targeting that corrects or eliminates mutant genes in vivo
is a feasible, though practically still remote, treatment strategy. Systemic administration of triplex-
forming oligonucleotides (TFOs) has been shown previously to induce sequence-specific targeting
in skin at low frequency. The goals of the present work are to demonstrate that targeting can be
achieved following local administration of TFOs, and that keratinocytes are among the cells targeted
in vivo. Mice carrying multiple copies of a λsupF transgene were injected intradermally with AG30,
a 30 base polypurine oligo that forms triplex DNA with the supF gene. At appropriate times, genomic
DNA was harvested from skin tissue or cells for in vitro lambda DNA packaging, followed by a blue-
white phage plaque screen for TFO-induced mutations in the supF gene. Real-time confocal imag-
ing visualized FITC conjugated AG30 in keratinocyte nuclei 6 hour after administration. Ten days
after administration of AG30, supF targeting was found in both dermis and epidermis. Epidermal
targeting was demonstrated in both tail and back skin using 10-50ug TFO. To establish which cells
in epidermis harbored genetic changes in supF, epidermal sheets were made into single cell sus-
pensions and separated by FACS. Keratin 5 positive cells showed a frequency of supF targeting 3-
fold above background. Putative keratinocyte stem cells isolated 33 days after injection as
α6briCD71dim epidermal cells from tail had a targeting frequency 1.5-fold above background. These
data demonstrate gene targeting in epidermal keratinocytes following intradermal administration of
a TFO specific for the supF gene. The reproducible and quantitative nature of this assay can now be
used to identify chemically modified TFOs and physical or chemical improvements in delivery that
will improve targeting frequency.
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Trim32 role in the imiquimod-induced psoriasis-like phenotype in mice, through TLR7/8 recep-
tor signaling to NF-κB
Y Wang, J Lagowski, E Swanzey, K Phillips, Y Liu and M Kulesz-Martin Department of
Dermatology, Oregon Health & Science University, Portland, OR
The underlying molecular pathways that cause or worsen psoriasis are still poorly understood. We
recently showed that the expression of the E3 ubiquitin ligase/scaffold protein Trim32 is increased
in the epidermis of human psoriasis lesions, and that Trim32 regulates the production by keratinocytes
of CCL20, a Th17 chemokine induced in psoriasis. We now find Trim32 effects in the topical
imiquimod (IMQ)-induced psoriasis-like phenotype in mice, mediating Toll-like Receptors 7 and 8
(TLR7/8) signaling to NF-κB, activation of IL-23 and other Th17 cytokines, and induction of psori-
asis-like lesions in mouse skin. IMQ applied to ears and skin of epidermal keratinocyte-targeted
Trim32Tg mice showed more severe skin and ear thickening and inflammatory response compared
to wild type mice, with Trim32 global KO mice the least affected. Trim32KO mice showed dramatic
increases in IκBα protein steady state levels and decreases in the RelA/p65 subunit of NF-κB. In
probing connections between these pathways we found altered levels of TNIP1 relative to Trim32
in Trim32 KO compared to WT mice after IMQ treatment. TNIP1 is a mediator of the NFκB activa-
tion pathway and has been identified as a Trim32 interacting protein (David Hill, Broad Institute,
by yeast two-hybrid screening) and as conferring high risk for psoriasis (by genome-wide associa-
tion studies, GWAS). IMQ also induced Trim32 at both the mRNA and protein levels, in associa-
tion with NF-κB activation, in WT and Trim32Tg mice. These findings suggest that TRIM32 can medi-
ate the IMQ induction of psoriasis-like phenotype in mice. Further, they support a model for induction
of psoriasis, in which activation of Trim32 by pathogenic stimulation of TLR induces NFκB and
inflammation via the Th17 pathway, possibly through altered TNIP1 activity. Trim32 cooperation in
the pathogenesis of psoriasis and psoriasis effector pathways opens new targets for the treatment of
psoriasis in the clinic.
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Suppressing AP1 factor signaling in suprabasal epidermis causes nuclear loricrin accumula-
tion and a progressive symmetric erythrokeratoderma-like phenotype
EA Rorke,1 G Adhikary2 and RL Eckert2,3,4 1 Microbiology and Immunology, University of
Maryland School of Medicine, Baltimore, MD, 2 Biochemistry and Molecular Biology,
University of Maryland School of Medicine, Baltimore, MD, 3 Dermatology, University of
Maryland School of Medicine, Baltimore, MD and 4 Reproductive Sciences, University of
Maryland School of Medicine, Baltimore, MD
The epidermis of patients suffering from progressive symmetric erythrokeratoderma (PSEK) is char-
acterized by the presence of mutant loricrin. These frameshift mutants encode a highly-charged c-
terminal segment and a nuclear localization signal, and nuclear accumulation of mutant loricrin is
a key event driving PSEK pathology. In the present study we report a PSEK-like phenotype in mice
where suprabasal activator protein one transcription factor signaling is inhibited. The epidermis in
these mice is characterized by hyperplasia, hyperkeratosis, parakeratosis and impaired epidermal
barrier function. The skin is scaled, constricting bands encircle the tail, the footpads are thickened
and scaled, and loricrin staining is markedly reduced in the cornified layers and markedly increased
in the nucleus. This remarkable phenotype suggests that accumulation of wild-type murine loricrin
in the nucleus drives PSEK, creation of a nuclear localization signal may not be required for nuclear
loricrin accumulation, reduction of activator protein one signal transduction is associated with
nuclear loricrin translocation, and perturbation of signaling can produce nuclear loricrin accumu-
lation and a PSEK phenotype in the absence of a specific loricrin mutation.
424
Evaluation of siRNA delivery using an inducible reporter model
RP Hickerson,1 Y Cao,2 E Gonzalez-Gonzalez,2 M Lara,1 LM Milstone,3 CH Contag2 and
RL Kaspar1,2 1 TransDerm, Inc., Santa Cruz, CA, 2 Stanford University, Stanford, CA and 3 Yale
University, New Haven, CT
The discovery that siRNAs can effectively silence gene expression in a number of mammalian sys-
tems without inducing an immune response has resulted in intense efforts to develop these inhibitors
as therapeutics for a number of disorders including skin diseases. The development of siRNA ther-
apeutics, however, is hampered by delivery considerations. Despite recent progress in developing
in vivo delivery reagents and initiation of clinical trials for a number of indications, including those
of the skin, there is a clear need for better delivery systems and more effective screening systems.
We have developed an inducible model system in which siRNA delivery results in a positive out-
come (light emission) rather than inhibition (as is traditionally monitored), which is more difficult
to detect and quantitate. This de-repression system uses a modified tetracycline (tet)-regulatable
system in which Luciferase-2/enhanced green fluorescent protein (Luc2/EGFP) bicistronic reporter
expression is controlled by the interaction of the Tetracycline-controlled Transcription Silencer (tTS)
with the Tet Response Element containing seven repeats of the tet operator cloned into the human
ubiquitin C promoter. Co-transfection of the reporter and repressor constructs results in 90% repres-
sion of Luc2/EGFP expression. Reduction of intracellular tTS levels by delivery of tTS-specific siRNA
de-represses reporter gene expression five-fold, which can be visualized using bioluminescence and
fluorescence imaging. This in vitro inducible system is amenable to use in xenograft and transgenic
animal models, which should greatly improve in vivo screening efficiency, as most of the in vivo
screening systems rely on detecting decreased target activity, which can be problematic due to
high animal-to-animal variability, the modest siRNA inhibitory effects often observed and the diffi-
culty of direct analysis of down-regulation of reporter expression in a bright background in targeted
tissues.
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A genetic risk score combining ten psoriasis risk loci improves disease prediction
H Chen,1 A Poon,2,3 C Yeung,2,3 C Helms,4 J Pons,2,3 A Bowcock,4 P Kwok1,2,3 and W Liao1 1
Department of Dermatology, University of California San Francisco, San Francisco, CA, 2
Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA,
3 Institute for Human Genetics, University of California San Francisco, San Francisco, CA and
4 Division of Human Genetics, Washington University School of Medicine, Saint Louis, MO
Recent genetic association studies have identified multiple psoriasis risk loci; however, most of these
loci contribute only modestly to disease risk. We investigated whether a genetic risk score (GRS)
combining multiple loci could improve psoriasis prediction. Two approaches were used to create
a GRS: a simple risk alleles count and a weighted (wGRS) approach. Ten psoriasis risk SNPs were
genotyped in 2815 case-control samples and 858 family samples. We found that the total number
of risk alleles in the cases was significantly higher than in controls, mean 12.94 (SD 1.8) versus
11.80 (SD 1.7). The wGRS captured considerably more risk than any SNP considered alone, with
a psoriasis OR for high-low wGRS quartiles of 9.49 (95% CI 6.96-13.14), p=2.945 E-63. To com-
pare the discriminatory ability of the GRS models, ROC curves were used to calculate the area under
the curve (AUC). The AUC for wGRS was significantly greater than for cGRS (71.5% versus 66.8%,
p=7.44 E-21). Additionally, the AUC for HLA-C alone (rs10484554) was higher than the AUC for
all 9 other risk loci combined (66.6% versus 63.1%, p=0.034), highlighting the dominance of HLA-
C as a risk locus. Logistic regression revealed that the wGRS was significantly associated with two
subphenotypes of psoriasis, age of onset (p=0.0001) and family history of psoriasis (p=0.027). Using
a liability threshold model, we estimated that the 10 risk loci account for only 11.7% of the genetic
variance in psoriasis. In summary, we found that a GRS combining 10 psoriasis risk loci captured
significantly more risk than any individual SNP and was associated with early onset of disease and
a positive family history. Notably, only a small fraction of psoriasis heritability is captured by the
common risk variants identified to date.
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Mutations in TGM1 in Ecuadorians with autosomal recessive congenital ichthyosis
H Zambrano,1 M Montalvan,2 A Farhi,1 Y Lu,1 C Yang,1 J Cabezas,2 R Lifton,1 L Milstone1 and
KA Choate1 1 Yale University, New Haven, CT and 2 Catholic University, Guayaquil, Ecuador
Lamellar Ichthyosis is a subtype of autosomal recessive congenital ichthyosis(ARCI)with an esti-
mated prevalence of 1:250,000. There have been few genetic studies of ARCI in South America and
none have been performed in Ecuador. We set out to determine the genetic basis of ARCI in a
cohort of 11 unrelated Ecuadorian kindreds. Of these kindreds, consanguinity was reported in all,
and in 7 there were multiple affected individuals. We sequenced the exons and exon/intron bound-
aries of transglutaminase-1(TGM1). TGM1 mutations were identified in all index cases. Nine showed
homozygous mutation and two were compound heterozygous. In addition, nine kindreds shared
at least one mutant allele. In 7, a homozygous G to A nucleotide substitution was present in exon
7 (c.1187G>A) resulting in an arginine to histidine amino acid substitution (p.R396H). This homozy-
gous mutation has been described in North American kindreds and changes the charge at the
active enzymatic site in transglutaminase 1. In one kindred, there was a homozygous G to A sub-
stitution in exon 2(c.425G>A) which has been previously reported in North American and Egypt-
ian kindreds and which results in an arginine to histidine amino acid substitution (p.R142H). In
another, there was a novel homozygous deletion of a single nucleotide in exon 13(c.2149delC)
resulting in a frameshift and premature termination (p.L716FfsX33). In two kindreds, compound het-
erozygous mutations were identified: both shared the exon 7 c.1187G>A substitution with one hav-
ing an exon 13 frameshift c.2149delC, and the other demonstrating an exon 14 C to T substitu-
tion(c.2278C>T) which results in premature termination(p.R760X) and which has been previously
described in Norwegian kindreds. Our findings demonstrate a high prevalence of TGM1 mutations
in Ecuadorian ARCI and describe a new mutation not reported in prior studies. The finding of a sin-
gle mutation in multiple unrelated kindreds strongly suggests the possibility of a founder effect which
may account for a large proportion of ARCI cases in Ecuador.
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Zebrafish model of lipoid proteinosis
Q Li,1 A Donahue,1 S Smith,1 JA McGrath,2 N Oyama3 and J Uitto1 1 Department of
Dermatology and Cutaneous Biology, Jefferson Medical College, Philadelphia, PA, 2 St. John’s
Institute of Dermatology, King’s College London (Guy’s Campus), London, United Kingdom
and 3 Department of Dermatology, Fukushima University School of Medicine, Fukushima,
Japan
Lipoid proteinosis is an autosomal recessive disorder characterized by thickening and scarring of
the skin and mucosae. It results from mutations in the extracellular matrix protein 1 gene (ECM1),
which encodes a cytoplasmic and secreted glycoprotein, but precisely how the ECM1 protein exerts
its biological functions in the skin is not known. Moreover, a representative disease model of lipoid
proteinosis is currently lacking. Ecm1-/- mice are not viable and mutant embryos die around implan-
tation, before the onset of gastrulation. As an alternative approach, we used zebrafish to model the
pathophysiology of lipoid proteinosis and to study the role of ECM1 in vivo. By searching the NCBI
zebrafish database, we identified one gene for ecm1 with 43% protein sequence homology to the
equivalent human protein. The identify of ecm1 as the human ECM1 orthologue in zebrafish was
confirmed by morpholino-mediated knockdown coupled with rescue experiments with human
mRNA. A splice site morpholino was designed at the exon 3/intron 3 junction of ecm1 to prevent
pre-mRNA splicing. The morpholino decreased ecm1 expression by >95% and induced a visible
skin phenotype consisting of altered surface contour with micropapules and loss of microridges,
starting at 2 days post-fertilization. Transmission electron microscopy of ecm1 morphants demon-
strated apparent reduplication of basement membranes and accumulation of pinocytotic vesicles
in the periphery of fibroblastic cells within the dermis, findings akin to those seen in lipoid pro-
teinosis. The knockdown phenotype was partially rescued with full-length human ECM1a mRNA.
These results suggest that ecm1 is the ECM1 orthologue in zebrafish and identify zebrafish as a suit-
able model system to explore the role of ecm1 in skin biology.
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ΔNp63α directly regulates grainyhead-like 3 expression during epidermal development to
form a functional barrier
J Tao,1 L Zhang,2 HA Pangburn,2 IF Choi,2 Y Deng,2 A Tan,3 Q Zhang,2 B Andersen4 and DR Roop2
1 Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, 2
Department of Dermatology and Charles C. Gates Center for Regenerative Medicine and
Stem Cell Biology, University of Colorado Denver, Aurora, CO, 3 Division of Medical
Oncology, University of Colorado Denver, Aurora, CO and 4 Department of Medicine and
Biological Chemistry, University of California, Irvine, CA
Epidermal development and differentiation in mammals are tightly regulated processes that culmi-
nate in the formation of a functional barrier. The essential roles of both p63 and Grainyhead-like 3
(Grhl3) in regulating these processes have been unequivocally demonstrated by the severe barrier
defects in mice deficient for either gene. Here we test the hypothesis that epidermal development
is regulated by functional interactions between Grhl3 and p63, with Grhl3 acting downstream of
p63. Deletion of p63 abolished Grhl3 expression in the early developing epidermis. Over-express-
ing the predominant p63 isoform, ΔNp63α, in cultured primary mouse keratinocytes, was shown
to not only induce endogenous Grhl3 expression, but also activate the expression of a reporter
gene driven by the Grhl3 promoter. Interestingly, activation of the Grhl3 promoter by ΔNp63α was
increased when keratinocytes were cultured under differentiating conditions, and dependent on the
presence of both the 1st and 3rd of four conserved p63-binding sites in the Grhl3 promoter. Using
Chromatin-immunoprecipitation (ChIP) assays, we demonstrated that p63 occupied the Grhl3 pro-
moter in both developing epidermis in vivo and cultured keratinocytes in vitro. Using ChIP-sequenc-
ing analysis, we demonstrated that only the 1st and 3rd p63-binding sites in the Grhl3 promoter
were occupied by p63 in undifferentiated keratinocytes. Taken together, these results demonstrate
that p63 directly regulates Grhl3 expression, which in turn orchestrates a critical pathway required
for formation of an epidermal barrier.
417
Buschuke-Ollendorff syndrome associated with hypertrophic scar formation: A novel splice-
site mutation in the LEMD3 gene
A Korekawa,1 H Nakano,1 E Akasaka,1 D Rokunohe,1 N Takiyoshi,1 Y Mitsuhashi2 and
D Sawamura1 1 Dermatology, Hirosaki University School of Medicine, Hirosaki, Japan and 2
Dermatology, Tokyo Medical University, Tokyo, Japan
Buschuke-Ollendorff syndrome (BOS; OMIM number 166700) is a rare autosomal dominant con-
dition developing multiple connective tissue nevi in association with osteopoikilosis and occa-
sionally with melorheostosis. The clinical expression of this syndrome is known to be quite variable
and skin and skeletal lesions may arise independently in the affected family members. BOS has been
demonstrated to result from loss-of-function mutations in the LEMD3 gene, coding for a potent
negative regulator of transforming growth factor-beta and bone morphogenic protein signaling path-
ways. We here report a Japanese family with BOS, in which a novel splice-site mutation in the
LEMD3 gene was identified. Of particular interest, hypertrophic scar after traumatic injury was
demonstrated in the affected individuals. We discuss the possible pathogenic mechanism of HS in
relation to the defect of LEMD3 function.
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Hereditary leukonychia/ porcelain nails results from mutations in PLCD1 gene
M Kiuru,1 M Kurban,1 M Itoh,1 L Petukhova,1 Y Shimomura,1 M Wajid,1 RH Rice2 and
AM Christiano1,3 1 Dermatology, Columbia University, New York, NY, 2 Enviromental
Toxicology, University of California, Davis, CA and 3 Development and Genetics, Columbia
University, New York, NY
Hereditary leukonychia (porcelain nails or white nails, OMIM 151600) is a rare nail disorder with
an unknown genetic basis. To identify a gene underlying this phenotype, we identified three fami-
lies of Pakistani origin showing features of hereditary leukonychia, which included consanguineous
marriages consistent with recessive inheritance. All 20 nails of each affected individual were chalky
and white in appearance, consistent with total leukonychia, with no other cutaneous, appendageal,
or systemic findings. We performed genetic linkage analysis in the families, using the Affymetrix
10K SNP array and found that two of the three families linked to a 2.0 Mb region in chromosome
3p22-p21.3 with a lod score (Z) of 5.1. We identified segregating pathogenic mutations in the
PLCD1gene, which encodes phosphoinositide-specific phospholipase C delta 1 subunit, a key
enzyme in phosphoinositide metabolism. PLCD1 was recently identified as a component of the
human nail plate by proteomic analysis and is expressed in the matrix of human nails. The activity
of mutant PLCD1 was assessed in vitro by measuring levels of a downstream metabolite, inositol
monophosphate (IP1), which showed a reduced activity. Interestingly, Plcd1 is a downstream tar-
get gene of Foxn1and Plcd1 -/- mice share striking phenotypic hair loss to the Foxn1-deficient nude
mice. While a nail plate phenotype was not described for Plcd1-/- mice, nude mice have a nail
phenotype with short abnormally bent nails, parakeratosis of the dorsal nail plate due to dysplasia
and impaired cornification of the nail matrix, and lower nail plate sulfur concentrations. This study
shows that defects in PLCD1 underlie hereditary leukonychia in humans, but with no effect on hair
growth, revealing a novel gene specifically involved in molecular control of nail growth.
419
Mining for hair follicle genes at the interface of GWAS and linkage in alopecia areata
L Petukhova1,2 and AM Christiano1,3 1 Dermatology, Columbia University, NY, NY, 2
Epidemiology, Columbia University, NY, NY and 3 Genetics & Development, Columbia
University, NY, NY
Recently, genome-wide association studies (GWAS) in autoimmune diseases, including our work
in alopecia areata (AA), have been tremendously successful in identifying many robust associations,
although the vast majority of these reside in immune response genes and reveal very little about the
end-organ. We postulate that this occurs because of an inherent feature of GWAS, that the method
relies upon the assumption that the disease allele will be common in the population. Since immune
response genes are subject to positive selection (which increases allele frequencies), this class of
genes is particularly amenable to detection by GWAS. Likewise, we postulate that AA susceptibil-
ity genes specific to the hair follicle (HF) may fail to achieve statistical significance because of low
allele frequencies, thus eluding detection by GWAS. These genes should be amenable to detection
by a method well-suited for rare variants, e.g. linkage. In this study, we aimed to identify HF genes
in AA using convergent evidence between our GWAS and linkage studies in AA. To probe for HF
genes in our GWAS data, we chose a liberal threshold for significance (p<0.01) and mapped the
top 5000 SNPs to a set of 3347 genes. We then extracted a set of 476 genes with evidence for expres-
sion in the HF. Of these, only 5 genes contained SNPs that exceeded statistical significance in the
GWAS (p<5x10-7; PPP1R14C, CREBL1, SUOX, CDK2, STX17), while the vast majority (471) con-
tained SNPs that achieved only nominal significance. We next integrated these results with our two
previous linkage analyses in AA, and found that 121 genes fell into regions with at least suggestive
evidence for linkage (1<LOD<4). We found that a number of linkage peaks contain clusters of HF
genes that are nested within our nominally significant GWAS findings. This study demonstrates that
integration of diverse genetic mapping approaches with expression data can allow us to gain novel
insight into the genetics of autoimmunity, in particular, identifying genes of the target organ.
420
Exploring the therapeutic potential of induced pluripotent stem cells for the treatment of
epidermolytic hyperkeratosis and epidermolysis bullosa simplex
G Bilousova, J Chen and DR Roop Department of Dermatology, Charles C. Gates Center for
Regenerative Medicine and Stem Cell Biology, University of Colorado Denver, Aurora, CO
Recent advances in reprogramming somatic cells into induced pluripotent stem cells (iPSCs) offer
the possibility of developing new therapeutic approaches for the treatment of inherited skin diseases
such as epidermolysis bullosa simplex (EBS) and epidermolytic hyperkeratosis (EHK). Despite the
almost limitless therapeutic potential of iPSCs for tissue repair, several obstacles must still be over-
come before iPSCs can be applied clinically for the treatment of skin diseases. One of these obsta-
cles is the efficient differentiation of iPSCs into functional keratinocytes. We have recently published
a protocol for the differentiation of mouse iPSC into a multipotent keratinocyte lineage. Based on
our published work, we have now developed an efficient protocol for the differentiation of human
iPSCs (hiPSCs) into keratinocytes. We have generated hiPSCs from primary human fibroblasts by
transiently expressing Oct4, Sox2, Klf4, and c-Myc via adenoviruses. Using non-integrating aden-
oviruses instead of retroviruses for the delivery of reprogramming factors permits the generation of
genetically unmodified iPSCs without the risk for insertional mutagenesis. Differentiation of hiPSCs
into a keratinocyte lineage was performed through sequential applications of retinoic acid and bone-
morphogenetic protein-4. Keratinocytes derived from iPSCs were analyzed with respect to protein
expression, as well as their ability to differentiate in vitro. We are currently generating iPSCs from
patients with EBS and EHK using an integration-free adenoviral-based approach and analyzing the
potential of these patient specific iPSCs to differentiate into keratinocytes with the aim of recapitu-
lating the skin phenotypes observed in EBS and EHK patients in a mouse xenograft model. The devel-
opment of such xenograft models will enable us to determine whether genetically corrected iPSCs
can be used to generate a permanent corrective therapy for patients with EBS and EHK.
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Gene targeting induced by triplex-forming oligonucleotides in skin
Y Liang,1 FA Rogers,2 PM Glazer2 and LM Milstone1 1 Dermatology, Yale University School of
Medicine, New Haven, CT and 2 Therapeutic Radiology, Yale University School of Medicine,
New Haven, CT
There are nearly 300 distinct clinical genodermatoses and, to date, mutations in 130 causative genes
have been identified. Sequence-specific targeting that corrects or eliminates mutant genes in vivo
is a feasible, though practically still remote, treatment strategy. Systemic administration of triplex-
forming oligonucleotides (TFOs) has been shown previously to induce sequence-specific targeting
in skin at low frequency. The goals of the present work are to demonstrate that targeting can be
achieved following local administration of TFOs, and that keratinocytes are among the cells targeted
in vivo. Mice carrying multiple copies of a λsupF transgene were injected intradermally with AG30,
a 30 base polypurine oligo that forms triplex DNA with the supF gene. At appropriate times, genomic
DNA was harvested from skin tissue or cells for in vitro lambda DNA packaging, followed by a blue-
white phage plaque screen for TFO-induced mutations in the supF gene. Real-time confocal imag-
ing visualized FITC conjugated AG30 in keratinocyte nuclei 6 hour after administration. Ten days
after administration of AG30, supF targeting was found in both dermis and epidermis. Epidermal
targeting was demonstrated in both tail and back skin using 10-50ug TFO. To establish which cells
in epidermis harbored genetic changes in supF, epidermal sheets were made into single cell sus-
pensions and separated by FACS. Keratin 5 positive cells showed a frequency of supF targeting 3-
fold above background. Putative keratinocyte stem cells isolated 33 days after injection as
α6briCD71dim epidermal cells from tail had a targeting frequency 1.5-fold above background. These
data demonstrate gene targeting in epidermal keratinocytes following intradermal administration of
a TFO specific for the supF gene. The reproducible and quantitative nature of this assay can now be
used to identify chemically modified TFOs and physical or chemical improvements in delivery that
will improve targeting frequency.
423
Trim32 role in the imiquimod-induced psoriasis-like phenotype in mice, through TLR7/8 recep-
tor signaling to NF-κB
Y Wang, J Lagowski, E Swanzey, K Phillips, Y Liu and M Kulesz-Martin Department of
Dermatology, Oregon Health & Science University, Portland, OR
The underlying molecular pathways that cause or worsen psoriasis are still poorly understood. We
recently showed that the expression of the E3 ubiquitin ligase/scaffold protein Trim32 is increased
in the epidermis of human psoriasis lesions, and that Trim32 regulates the production by keratinocytes
of CCL20, a Th17 chemokine induced in psoriasis. We now find Trim32 effects in the topical
imiquimod (IMQ)-induced psoriasis-like phenotype in mice, mediating Toll-like Receptors 7 and 8
(TLR7/8) signaling to NF-κB, activation of IL-23 and other Th17 cytokines, and induction of psori-
asis-like lesions in mouse skin. IMQ applied to ears and skin of epidermal keratinocyte-targeted
Trim32Tg mice showed more severe skin and ear thickening and inflammatory response compared
to wild type mice, with Trim32 global KO mice the least affected. Trim32KO mice showed dramatic
increases in IκBα protein steady state levels and decreases in the RelA/p65 subunit of NF-κB. In
probing connections between these pathways we found altered levels of TNIP1 relative to Trim32
in Trim32 KO compared to WT mice after IMQ treatment. TNIP1 is a mediator of the NFκB activa-
tion pathway and has been identified as a Trim32 interacting protein (David Hill, Broad Institute,
by yeast two-hybrid screening) and as conferring high risk for psoriasis (by genome-wide associa-
tion studies, GWAS). IMQ also induced Trim32 at both the mRNA and protein levels, in associa-
tion with NF-κB activation, in WT and Trim32Tg mice. These findings suggest that TRIM32 can medi-
ate the IMQ induction of psoriasis-like phenotype in mice. Further, they support a model for induction
of psoriasis, in which activation of Trim32 by pathogenic stimulation of TLR induces NFκB and
inflammation via the Th17 pathway, possibly through altered TNIP1 activity. Trim32 cooperation in
the pathogenesis of psoriasis and psoriasis effector pathways opens new targets for the treatment of
psoriasis in the clinic.
425
Suppressing AP1 factor signaling in suprabasal epidermis causes nuclear loricrin accumula-
tion and a progressive symmetric erythrokeratoderma-like phenotype
EA Rorke,1 G Adhikary2 and RL Eckert2,3,4 1 Microbiology and Immunology, University of
Maryland School of Medicine, Baltimore, MD, 2 Biochemistry and Molecular Biology,
University of Maryland School of Medicine, Baltimore, MD, 3 Dermatology, University of
Maryland School of Medicine, Baltimore, MD and 4 Reproductive Sciences, University of
Maryland School of Medicine, Baltimore, MD
The epidermis of patients suffering from progressive symmetric erythrokeratoderma (PSEK) is char-
acterized by the presence of mutant loricrin. These frameshift mutants encode a highly-charged c-
terminal segment and a nuclear localization signal, and nuclear accumulation of mutant loricrin is
a key event driving PSEK pathology. In the present study we report a PSEK-like phenotype in mice
where suprabasal activator protein one transcription factor signaling is inhibited. The epidermis in
these mice is characterized by hyperplasia, hyperkeratosis, parakeratosis and impaired epidermal
barrier function. The skin is scaled, constricting bands encircle the tail, the footpads are thickened
and scaled, and loricrin staining is markedly reduced in the cornified layers and markedly increased
in the nucleus. This remarkable phenotype suggests that accumulation of wild-type murine loricrin
in the nucleus drives PSEK, creation of a nuclear localization signal may not be required for nuclear
loricrin accumulation, reduction of activator protein one signal transduction is associated with
nuclear loricrin translocation, and perturbation of signaling can produce nuclear loricrin accumu-
lation and a PSEK phenotype in the absence of a specific loricrin mutation.
424
Evaluation of siRNA delivery using an inducible reporter model
RP Hickerson,1 Y Cao,2 E Gonzalez-Gonzalez,2 M Lara,1 LM Milstone,3 CH Contag2 and
RL Kaspar1,2 1 TransDerm, Inc., Santa Cruz, CA, 2 Stanford University, Stanford, CA and 3 Yale
University, New Haven, CT
The discovery that siRNAs can effectively silence gene expression in a number of mammalian sys-
tems without inducing an immune response has resulted in intense efforts to develop these inhibitors
as therapeutics for a number of disorders including skin diseases. The development of siRNA ther-
apeutics, however, is hampered by delivery considerations. Despite recent progress in developing
in vivo delivery reagents and initiation of clinical trials for a number of indications, including those
of the skin, there is a clear need for better delivery systems and more effective screening systems.
We have developed an inducible model system in which siRNA delivery results in a positive out-
come (light emission) rather than inhibition (as is traditionally monitored), which is more difficult
to detect and quantitate. This de-repression system uses a modified tetracycline (tet)-regulatable
system in which Luciferase-2/enhanced green fluorescent protein (Luc2/EGFP) bicistronic reporter
expression is controlled by the interaction of the Tetracycline-controlled Transcription Silencer (tTS)
with the Tet Response Element containing seven repeats of the tet operator cloned into the human
ubiquitin C promoter. Co-transfection of the reporter and repressor constructs results in 90% repres-
sion of Luc2/EGFP expression. Reduction of intracellular tTS levels by delivery of tTS-specific siRNA
de-represses reporter gene expression five-fold, which can be visualized using bioluminescence and
fluorescence imaging. This in vitro inducible system is amenable to use in xenograft and transgenic
animal models, which should greatly improve in vivo screening efficiency, as most of the in vivo
screening systems rely on detecting decreased target activity, which can be problematic due to
high animal-to-animal variability, the modest siRNA inhibitory effects often observed and the diffi-
culty of direct analysis of down-regulation of reporter expression in a bright background in targeted
tissues.
422
A genetic risk score combining ten psoriasis risk loci improves disease prediction
H Chen,1 A Poon,2,3 C Yeung,2,3 C Helms,4 J Pons,2,3 A Bowcock,4 P Kwok1,2,3 and W Liao1 1
Department of Dermatology, University of California San Francisco, San Francisco, CA, 2
Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA,
3 Institute for Human Genetics, University of California San Francisco, San Francisco, CA and
4 Division of Human Genetics, Washington University School of Medicine, Saint Louis, MO
Recent genetic association studies have identified multiple psoriasis risk loci; however, most of these
loci contribute only modestly to disease risk. We investigated whether a genetic risk score (GRS)
combining multiple loci could improve psoriasis prediction. Two approaches were used to create
a GRS: a simple risk alleles count and a weighted (wGRS) approach. Ten psoriasis risk SNPs were
genotyped in 2815 case-control samples and 858 family samples. We found that the total number
of risk alleles in the cases was significantly higher than in controls, mean 12.94 (SD 1.8) versus
11.80 (SD 1.7). The wGRS captured considerably more risk than any SNP considered alone, with
a psoriasis OR for high-low wGRS quartiles of 9.49 (95% CI 6.96-13.14), p=2.945 E-63. To com-
pare the discriminatory ability of the GRS models, ROC curves were used to calculate the area under
the curve (AUC). The AUC for wGRS was significantly greater than for cGRS (71.5% versus 66.8%,
p=7.44 E-21). Additionally, the AUC for HLA-C alone (rs10484554) was higher than the AUC for
all 9 other risk loci combined (66.6% versus 63.1%, p=0.034), highlighting the dominance of HLA-
C as a risk locus. Logistic regression revealed that the wGRS was significantly associated with two
subphenotypes of psoriasis, age of onset (p=0.0001) and family history of psoriasis (p=0.027). Using
a liability threshold model, we estimated that the 10 risk loci account for only 11.7% of the genetic
variance in psoriasis. In summary, we found that a GRS combining 10 psoriasis risk loci captured
significantly more risk than any individual SNP and was associated with early onset of disease and
a positive family history. Notably, only a small fraction of psoriasis heritability is captured by the
common risk variants identified to date.
426
Mutations in TGM1 in Ecuadorians with autosomal recessive congenital ichthyosis
H Zambrano,1 M Montalvan,2 A Farhi,1 Y Lu,1 C Yang,1 J Cabezas,2 R Lifton,1 L Milstone1 and
KA Choate1 1 Yale University, New Haven, CT and 2 Catholic University, Guayaquil, Ecuador
Lamellar Ichthyosis is a subtype of autosomal recessive congenital ichthyosis(ARCI)with an esti-
mated prevalence of 1:250,000. There have been few genetic studies of ARCI in South America and
none have been performed in Ecuador. We set out to determine the genetic basis of ARCI in a
cohort of 11 unrelated Ecuadorian kindreds. Of these kindreds, consanguinity was reported in all,
and in 7 there were multiple affected individuals. We sequenced the exons and exon/intron bound-
aries of transglutaminase-1(TGM1). TGM1 mutations were identified in all index cases. Nine showed
homozygous mutation and two were compound heterozygous. In addition, nine kindreds shared
at least one mutant allele. In 7, a homozygous G to A nucleotide substitution was present in exon
7 (c.1187G>A) resulting in an arginine to histidine amino acid substitution (p.R396H). This homozy-
gous mutation has been described in North American kindreds and changes the charge at the
active enzymatic site in transglutaminase 1. In one kindred, there was a homozygous G to A sub-
stitution in exon 2(c.425G>A) which has been previously reported in North American and Egypt-
ian kindreds and which results in an arginine to histidine amino acid substitution (p.R142H). In
another, there was a novel homozygous deletion of a single nucleotide in exon 13(c.2149delC)
resulting in a frameshift and premature termination (p.L716FfsX33). In two kindreds, compound het-
erozygous mutations were identified: both shared the exon 7 c.1187G>A substitution with one hav-
ing an exon 13 frameshift c.2149delC, and the other demonstrating an exon 14 C to T substitu-
tion(c.2278C>T) which results in premature termination(p.R760X) and which has been previously
described in Norwegian kindreds. Our findings demonstrate a high prevalence of TGM1 mutations
in Ecuadorian ARCI and describe a new mutation not reported in prior studies. The finding of a sin-
gle mutation in multiple unrelated kindreds strongly suggests the possibility of a founder effect which
may account for a large proportion of ARCI cases in Ecuador.
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Zebrafish model of lipoid proteinosis
Q Li,1 A Donahue,1 S Smith,1 JA McGrath,2 N Oyama3 and J Uitto1 1 Department of
Dermatology and Cutaneous Biology, Jefferson Medical College, Philadelphia, PA, 2 St. John’s
Institute of Dermatology, King’s College London (Guy’s Campus), London, United Kingdom
and 3 Department of Dermatology, Fukushima University School of Medicine, Fukushima,
Japan
Lipoid proteinosis is an autosomal recessive disorder characterized by thickening and scarring of
the skin and mucosae. It results from mutations in the extracellular matrix protein 1 gene (ECM1),
which encodes a cytoplasmic and secreted glycoprotein, but precisely how the ECM1 protein exerts
its biological functions in the skin is not known. Moreover, a representative disease model of lipoid
proteinosis is currently lacking. Ecm1-/- mice are not viable and mutant embryos die around implan-
tation, before the onset of gastrulation. As an alternative approach, we used zebrafish to model the
pathophysiology of lipoid proteinosis and to study the role of ECM1 in vivo. By searching the NCBI
zebrafish database, we identified one gene for ecm1 with 43% protein sequence homology to the
equivalent human protein. The identify of ecm1 as the human ECM1 orthologue in zebrafish was
confirmed by morpholino-mediated knockdown coupled with rescue experiments with human
mRNA. A splice site morpholino was designed at the exon 3/intron 3 junction of ecm1 to prevent
pre-mRNA splicing. The morpholino decreased ecm1 expression by >95% and induced a visible
skin phenotype consisting of altered surface contour with micropapules and loss of microridges,
starting at 2 days post-fertilization. Transmission electron microscopy of ecm1 morphants demon-
strated apparent reduplication of basement membranes and accumulation of pinocytotic vesicles
in the periphery of fibroblastic cells within the dermis, findings akin to those seen in lipoid pro-
teinosis. The knockdown phenotype was partially rescued with full-length human ECM1a mRNA.
These results suggest that ecm1 is the ECM1 orthologue in zebrafish and identify zebrafish as a suit-
able model system to explore the role of ecm1 in skin biology.
416
ΔNp63α directly regulates grainyhead-like 3 expression during epidermal development to
form a functional barrier
J Tao,1 L Zhang,2 HA Pangburn,2 IF Choi,2 Y Deng,2 A Tan,3 Q Zhang,2 B Andersen4 and DR Roop2
1 Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, 2
Department of Dermatology and Charles C. Gates Center for Regenerative Medicine and
Stem Cell Biology, University of Colorado Denver, Aurora, CO, 3 Division of Medical
Oncology, University of Colorado Denver, Aurora, CO and 4 Department of Medicine and
Biological Chemistry, University of California, Irvine, CA
Epidermal development and differentiation in mammals are tightly regulated processes that culmi-
nate in the formation of a functional barrier. The essential roles of both p63 and Grainyhead-like 3
(Grhl3) in regulating these processes have been unequivocally demonstrated by the severe barrier
defects in mice deficient for either gene. Here we test the hypothesis that epidermal development
is regulated by functional interactions between Grhl3 and p63, with Grhl3 acting downstream of
p63. Deletion of p63 abolished Grhl3 expression in the early developing epidermis. Over-express-
ing the predominant p63 isoform, ΔNp63α, in cultured primary mouse keratinocytes, was shown
to not only induce endogenous Grhl3 expression, but also activate the expression of a reporter
gene driven by the Grhl3 promoter. Interestingly, activation of the Grhl3 promoter by ΔNp63α was
increased when keratinocytes were cultured under differentiating conditions, and dependent on the
presence of both the 1st and 3rd of four conserved p63-binding sites in the Grhl3 promoter. Using
Chromatin-immunoprecipitation (ChIP) assays, we demonstrated that p63 occupied the Grhl3 pro-
moter in both developing epidermis in vivo and cultured keratinocytes in vitro. Using ChIP-sequenc-
ing analysis, we demonstrated that only the 1st and 3rd p63-binding sites in the Grhl3 promoter
were occupied by p63 in undifferentiated keratinocytes. Taken together, these results demonstrate
that p63 directly regulates Grhl3 expression, which in turn orchestrates a critical pathway required
for formation of an epidermal barrier.
417
Buschuke-Ollendorff syndrome associated with hypertrophic scar formation: A novel splice-
site mutation in the LEMD3 gene
A Korekawa,1 H Nakano,1 E Akasaka,1 D Rokunohe,1 N Takiyoshi,1 Y Mitsuhashi2 and
D Sawamura1 1 Dermatology, Hirosaki University School of Medicine, Hirosaki, Japan and 2
Dermatology, Tokyo Medical University, Tokyo, Japan
Buschuke-Ollendorff syndrome (BOS; OMIM number 166700) is a rare autosomal dominant con-
dition developing multiple connective tissue nevi in association with osteopoikilosis and occa-
sionally with melorheostosis. The clinical expression of this syndrome is known to be quite variable
and skin and skeletal lesions may arise independently in the affected family members. BOS has been
demonstrated to result from loss-of-function mutations in the LEMD3 gene, coding for a potent
negative regulator of transforming growth factor-beta and bone morphogenic protein signaling path-
ways. We here report a Japanese family with BOS, in which a novel splice-site mutation in the
LEMD3 gene was identified. Of particular interest, hypertrophic scar after traumatic injury was
demonstrated in the affected individuals. We discuss the possible pathogenic mechanism of HS in
relation to the defect of LEMD3 function.
418
Hereditary leukonychia/ porcelain nails results from mutations in PLCD1 gene
M Kiuru,1 M Kurban,1 M Itoh,1 L Petukhova,1 Y Shimomura,1 M Wajid,1 RH Rice2 and
AM Christiano1,3 1 Dermatology, Columbia University, New York, NY, 2 Enviromental
Toxicology, University of California, Davis, CA and 3 Development and Genetics, Columbia
University, New York, NY
Hereditary leukonychia (porcelain nails or white nails, OMIM 151600) is a rare nail disorder with
an unknown genetic basis. To identify a gene underlying this phenotype, we identified three fami-
lies of Pakistani origin showing features of hereditary leukonychia, which included consanguineous
marriages consistent with recessive inheritance. All 20 nails of each affected individual were chalky
and white in appearance, consistent with total leukonychia, with no other cutaneous, appendageal,
or systemic findings. We performed genetic linkage analysis in the families, using the Affymetrix
10K SNP array and found that two of the three families linked to a 2.0 Mb region in chromosome
3p22-p21.3 with a lod score (Z) of 5.1. We identified segregating pathogenic mutations in the
PLCD1gene, which encodes phosphoinositide-specific phospholipase C delta 1 subunit, a key
enzyme in phosphoinositide metabolism. PLCD1 was recently identified as a component of the
human nail plate by proteomic analysis and is expressed in the matrix of human nails. The activity
of mutant PLCD1 was assessed in vitro by measuring levels of a downstream metabolite, inositol
monophosphate (IP1), which showed a reduced activity. Interestingly, Plcd1 is a downstream tar-
get gene of Foxn1and Plcd1 -/- mice share striking phenotypic hair loss to the Foxn1-deficient nude
mice. While a nail plate phenotype was not described for Plcd1-/- mice, nude mice have a nail
phenotype with short abnormally bent nails, parakeratosis of the dorsal nail plate due to dysplasia
and impaired cornification of the nail matrix, and lower nail plate sulfur concentrations. This study
shows that defects in PLCD1 underlie hereditary leukonychia in humans, but with no effect on hair
growth, revealing a novel gene specifically involved in molecular control of nail growth.
419
Mining for hair follicle genes at the interface of GWAS and linkage in alopecia areata
L Petukhova1,2 and AM Christiano1,3 1 Dermatology, Columbia University, NY, NY, 2
Epidemiology, Columbia University, NY, NY and 3 Genetics & Development, Columbia
University, NY, NY
Recently, genome-wide association studies (GWAS) in autoimmune diseases, including our work
in alopecia areata (AA), have been tremendously successful in identifying many robust associations,
although the vast majority of these reside in immune response genes and reveal very little about the
end-organ. We postulate that this occurs because of an inherent feature of GWAS, that the method
relies upon the assumption that the disease allele will be common in the population. Since immune
response genes are subject to positive selection (which increases allele frequencies), this class of
genes is particularly amenable to detection by GWAS. Likewise, we postulate that AA susceptibil-
ity genes specific to the hair follicle (HF) may fail to achieve statistical significance because of low
allele frequencies, thus eluding detection by GWAS. These genes should be amenable to detection
by a method well-suited for rare variants, e.g. linkage. In this study, we aimed to identify HF genes
in AA using convergent evidence between our GWAS and linkage studies in AA. To probe for HF
genes in our GWAS data, we chose a liberal threshold for significance (p<0.01) and mapped the
top 5000 SNPs to a set of 3347 genes. We then extracted a set of 476 genes with evidence for expres-
sion in the HF. Of these, only 5 genes contained SNPs that exceeded statistical significance in the
GWAS (p<5x10-7; PPP1R14C, CREBL1, SUOX, CDK2, STX17), while the vast majority (471) con-
tained SNPs that achieved only nominal significance. We next integrated these results with our two
previous linkage analyses in AA, and found that 121 genes fell into regions with at least suggestive
evidence for linkage (1<LOD<4). We found that a number of linkage peaks contain clusters of HF
genes that are nested within our nominally significant GWAS findings. This study demonstrates that
integration of diverse genetic mapping approaches with expression data can allow us to gain novel
insight into the genetics of autoimmunity, in particular, identifying genes of the target organ.
420
Exploring the therapeutic potential of induced pluripotent stem cells for the treatment of
epidermolytic hyperkeratosis and epidermolysis bullosa simplex
G Bilousova, J Chen and DR Roop Department of Dermatology, Charles C. Gates Center for
Regenerative Medicine and Stem Cell Biology, University of Colorado Denver, Aurora, CO
Recent advances in reprogramming somatic cells into induced pluripotent stem cells (iPSCs) offer
the possibility of developing new therapeutic approaches for the treatment of inherited skin diseases
such as epidermolysis bullosa simplex (EBS) and epidermolytic hyperkeratosis (EHK). Despite the
almost limitless therapeutic potential of iPSCs for tissue repair, several obstacles must still be over-
come before iPSCs can be applied clinically for the treatment of skin diseases. One of these obsta-
cles is the efficient differentiation of iPSCs into functional keratinocytes. We have recently published
a protocol for the differentiation of mouse iPSC into a multipotent keratinocyte lineage. Based on
our published work, we have now developed an efficient protocol for the differentiation of human
iPSCs (hiPSCs) into keratinocytes. We have generated hiPSCs from primary human fibroblasts by
transiently expressing Oct4, Sox2, Klf4, and c-Myc via adenoviruses. Using non-integrating aden-
oviruses instead of retroviruses for the delivery of reprogramming factors permits the generation of
genetically unmodified iPSCs without the risk for insertional mutagenesis. Differentiation of hiPSCs
into a keratinocyte lineage was performed through sequential applications of retinoic acid and bone-
morphogenetic protein-4. Keratinocytes derived from iPSCs were analyzed with respect to protein
expression, as well as their ability to differentiate in vitro. We are currently generating iPSCs from
patients with EBS and EHK using an integration-free adenoviral-based approach and analyzing the
potential of these patient specific iPSCs to differentiate into keratinocytes with the aim of recapitu-
lating the skin phenotypes observed in EBS and EHK patients in a mouse xenograft model. The devel-
opment of such xenograft models will enable us to determine whether genetically corrected iPSCs
can be used to generate a permanent corrective therapy for patients with EBS and EHK.
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Reliability and validity of a photographic method for measuring facial hair density in men
J Wan, A Musiek, K Abuabara, SK Kurd, JM Steinemann, CC Vittorio and JM Gelfand Department
of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, PA
Although various methods of assessing hair growth or loss exist, most are performed manually and
can be labor-intensive. Here, we describe a simple, non-invasive method of hair counting devel-
oped as part of a randomized, placebo-controlled trial of a topical agent for hair growth prevention
and assess its reliability and validity. We evaluated hair density within a circular target area (2.5 cen-
timeters diameter) of the beard area in a split-face design in 14 male subjects by taking digital pho-
tographs of the target area, viewing them using standard imaging software, and counting the total
number of hairs ≥ 1 millimeter long with follicles located within the target area. Two independent
reviewers completed hair counts on all 130 photographs to assess inter-rater reliability. One of the
reviewers re-counted all the photographs 5 months after the initial measurement in order to assess
intra-rater (test-retest) reliability. Validity was evaluated by comparing total hair counts with respect
to their corresponding Physician’s Global Assessment (PGA) ratings of hair density, which is assessed
on a scale ranging from 0 (total alopecia) to 5 (very dense). We observed an intra-class correlation
coefficient (ICC) of 0.81 (95% confidence interval (CI) 0.74-0.86) for inter-rater reliability. Intra-rater
reliability analyses demonstrated an ICC of 0.90 (0.86-0.93) and a Spearman’s ρ correlation of 0.88
(0.84-0.92). As few photographs corresponded with the extreme values of PGA, a pair-wise com-
parison of mean total hair counts between PGA 3 versus 4 was performed, which showed a signif-
icantly lower mean hair count in samples with PGA 3 than in samples with PGA 4 (p<0.01). Our
hair counting method thus demonstrates excellent inter-rater and intra-rater reliability as well as dis-
crimination validity based on comparison to a PGA and should be considered for further evalua-
tion as a simple, non-invasive, quantitative assessment tool for hair growth or loss.
435
Hair shaft defects in the rough coat (rc) mice
M Miteva,1 AG Leiva,1 JJ Jimenez,1 K Csiszar2 and TC Wikramanayake1 1 Department of
Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami,
FL and 2 John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI
The rough coat (rc) is an autosomal recessive mutation that arose spontaneously in the C57BL/6J
inbred mouse strain. Homozygous rc mice are born indistinguishable from their normal littermates,
but start to show unkempt hair coat 2 weeks after birth, and develop severe skin and hair abnor-
malities thereafter. They develop cycles of hair loss and re-growth: hair loss during telogen, and re-
growth during the subsequent anagen. As the rc/rc mice age, they show a patchy hair coat of some-
times shorter and thinner new hair shafts, which may exhibit abnormal pigmentation and texture.
Hair plucked from rc/rc mice is attached to the bulb, indicating that hair loss is not due to hair shaft
breakage. However, hair shafts from the rc/rc mice appear much smoother than those from normal
C57BL/6J mice. Older rc/rc mice develop severe defects in the hair shafts. They are of a flattened,
“ribbon”-like shape with less prominent cuticle, show abnormal pigmentation (color and shape)
and few irregularities along the length. Abnormal shape and pigmentation of the hair shafts have
been confirmed on transverse histological sections of the rc/rc skin. Another feature observed on
vertical sections is sebaceous hypertrophy. In a previous study to identify the genetic basis of the rc
phenotype, we detected a missense mutation in a novel immunoglobulin protein gene Mpzl3 in
the rc mapping interval. We have detected abundant Mpzl3 expression in skin keratinocytes. Taken
together, these results suggest that Mpzl3 plays an indispensible role in the hair follicles. A better
characterization of the hair phenotype in the rc/rc mice will lead to a better understanding of
Mpzl3 function and hair shaft formation, and the rc/rc mice may serve as a model for hair shaft dis-
orders.
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Protection of melanin content in the hair follicle
C Meyrignac,1 A Perrin,1 S Ratz,1 V Lequoy,1 K Cucumel,1 C Gondran,1 C Dal Farra2 and
N Domloge1 1 Global Skin Research Center, ISP Vincience, Sophia Antipolis, France and 2 ISP
Corporate Research Center, ISP, Wayne, NJ
Hair graying is a natural process accompanying human aging. The recent theories of hair graying
involve different mechanisms including exhaustion of the enzymes implicated in melanogenesis,
depletion of melanocyte stem cells, and oxidative stress. In hair follicle, melanin synthesis takes
place in melanocytes of the hair matrix, during the anagen phase. In the present study, we were
interested in studying the effect of a compound (IV10.001) that exhibits a selective activity on pro-
teins involved in melanin synthesis pathway. We investigated this effect first on normal human epi-
dermal melanocytes (NHEM), and then on hair follicle from human scalp skin. NHEM were treated
with IV10.001for 48h, then the following markers were examined by immunostaining: MITF, as mas-
ter transcriptional regulator of pigmentation, its downstream melanogenic proteins tyrosinase, TRP-
1 and Pmel17, and finally the receptor of stem cell factor, c-kit. Melanin content in the hair follicle
was studied by Fontana-Masson staining. Our results showed that the main proteins of the
melanogenic pathway were increased following application of IV10.001. Regarding MITF expres-
sion, we observed an increase both in the cytoplasm and in the nucleus of treated cells. Treated cells
also showed a higher level of c-kit, whose enhancement is closely related to the level of hair pig-
mentation. Moreover, treated hair follicles revealed an increased level of melanin content. Appli-
cation of a denaturing stress such as SDS resulted in damaged structure of the hair bulb, impair-
ment of melanocyte morphology and disorganization of melanin distribution. Interestingly, application
of IV10.001 helped to maintain follicle structure and melanin distribution in the hair bulb. In con-
clusion, protection of melanin content in the hair follicle has to be taken into account in case of
external stress and in hair aging.
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A novel rat model for chemotherapy-induced alopecia
TC Wikramanayake,1 S Amini,1 J Simon,1 LM Mauro,2 G Elgart,1 LA Schachner1 and JJ Jimenez1 1
Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of
Medicine, Miami, FL and 2 Department of Biochemistry and Molecular Biology, University of
Miami Miller School of Medicine, Miami, FL
More than half of all people diagnosed with cancer receive chemotherapy, and approximately 65%
of them develop chemotherapy-induced alopecia (CIA), a side effect with significant negative psy-
chological impact. To date, very few animal models are available for the study of the mechanism
and prevention of CIA. In this study, we aimed to develop a clinically relevant adult rat model for
CIA in the pigmented Long-Evans rats. We first determined that Long-Evans pups developed alope-
cia in response to chemotherapeutic agents etoposide and cyclophosphamide as observed in other
murine models for CIA. We then determined whether they developed CIA as adults. In this exper-
iment, the dorsal hair of Long-Evans rats was clipped at the onset of the first telogen to synchronize
the hair cycle, and rats were then treated with etoposide for 3 days starting two weeks later. Upon
clipping of the hair shaft, we observed synchronized anagen induction. Shortly after etoposide treat-
ment, alopecia was observed in the areas that were clipped two weeks earlier, but not in the non-
clipped areas or control rats. Hair follicles in the clipped areas showed typical chemotherapy-induced
follicular dystrophy (dystrophic catagen). When the hair re-grew in pigmented alopecic areas, they
showed normal pigmentation. In summary, we have established a novel, pigmented adult rat model
for CIA. By hair shaft clipping during early telogen, synchronized anagen entry was induced that
resulted in alopecia in response to chemotherapy. This is the first clinically relevant adult rat model
for CIA, and will be a useful tool to test agents for the prevention and treatment of CIA.
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New strategy to modulate alopecia using a combination of 2 specific and unique ingredients
E Loing,1 M Hocquaux2 and I Lacasse1 1 R&D, Unipex Innovations, Quebec, QC, Canada and
2 R&D, Unipex Innovations, Ramonville St Agne, France
Although causes of hair loss are still not yet fully understood, it can be the result of several factors.
The objective of our work is the study of a specific and unique combination of 2 ingredients in elic-
iting biological responses in hair loss mechanisms. The first ingredient is a biomimetic peptide derived
from a signal peptide which has potent tissue protective properties and stimulates tissue renewal
for a better hair anchoring. The second active is Biochanin A (red clover extract) known to be an
effective inhibitor of 5 alpha reductase activity. The 5α-reductase is known to modulate the con-
version of testosterone into DHT causing hair follicle miniaturization. The efficacy of the ingredi-
ents was studied in human fibroblasts and skin biopsies in order to demonstrate the efficacy of the
peptide on the matrix extracellular proteins renewal. The efficacy of the peptide on isolated hair
follicle growth was demonstrated using the particular and distinctive Philpott methodology. A clin-
ical study on human volunteers (Active vs placebo) was done using a professional Trichoscan for
the measurement of human hair after 4 months treatment. The peptide stimulates several extracel-
lular matrix proteins favoring a better hair anchoring for a direct effect on hair follicle integrity, while
the biochamin A found in the red clover extract inhibits the 5-alpha reductase activity responsible
for androgenic alopecia. The hair follicle growth is stimulated in comparison with Minoxidil after
7 days culture. The clinical study showed significant increase of the anagen phase (growth phase)
and a decrease of the telogen phase (resting phase) after 4 months treatment with the combination
of the 2 ingredients (peptide + red clover extract). The efficacy of this new active is based on the
combined action of its two ingredients, allowing direct action on DHT preventing the hair cycle to
shorten and hair follicle miniaturization, improving the ECM proteins in dermal papilla surround-
ing hair papilla for better anchoring and promoting increase of follicle size.
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A new approach to promote VEGF expression in hair follicle
S Ratz,1 A Perrin,1 C Meyrignac,1 L Mur,1 C Gondran,1 C Dal farra2 and N Domloge1 1 Global
Skin Research Center, ISP Vincience, Sophia Antipolis, France and 2 ISP Corporate Research
Center, ISP, Wayne, NJ
Vascular Endothelial Growth Factor (VEGF) plays an essential role in hair growth maintenance, by
improving the exchanges between hair follicle and capillary network. In addition to promoting per-
ifollicular vascularization, VEGF may also act on fibroblasts and endothelial cells in the dermal
papilla. In order to enhance VEGF expression, we developed a specific compound that could improve
VEGF expression in the hair follicle. This activity was first screened on several cell types, including
normal human keratinocytes (NHK), human dermal papilla cells (HDPC) and human umbilical
vein endothelial cells (HUVEC), using immunofluorescence techniques. Interestingly, VEGF expres-
sion was boosted in these different cell types following 48h application. In the same conditions, the
receptor of VEGF, Flk1, was also increased. Conditioned medium of HDPC pre-treated with the
active was applied on cultured HUVEC. This conditioned medium seems to enhance VEGF pro-
duction and allow better organization of HUVEC network. Then, the activity of the selected com-
pound was investigated at the level of the hair follicle. For this purpose, scalp skin biopsies were
treated topically with a daily application on the active compound. This treatment leads to an increase
in VEGF staining especially observed in outer root sheath (ORS). This effect was accompanied by
an enhancement of CD34, indicator of blood vessel network in the perifollicular environment. More-
over, the improvement of keratin-14 observed after application of the treatment could be in favor
of a reinforcement of ORS structure in treated hair follicles. Taken together, these results suggest
that promoting VEGF expression in cells of the hair follicle may provide optimal conditions for hair
growth and quality.
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Genomewide association study (GWAS) of infantile hemangiomas (IH)
B Drolet, D Siegel, K Duffy, Y Chiu, R Lorier, A Stoddard and U Broeckel Dermatology, Genetics,
MCW, Milwaukee, WI
Infantile hemangiomas (IH) are benign tumors composed of proliferating endothelial-like cells. The
duration and rate of growth is highly variable. Recently, we have shown that both environmental
and genetic factors impact the development of IH, as demonstrated by striking ethnic predisposi-
tion in Caucasians, familial clustering, and association with low birth weight. In order to advance
our understanding of the genetic component, we performed a family-based GWAS analysis to
identify pathogenic genes and pathways in the development of IH. The Affymetrix 6.0 chip was used
to assay 906,600 single nucleotide polymorphisms (SNPs) in 224 family trios. Thirty-six SNPs achieved
statistical significance, and 13 of these were within or near 9 candidate genes. One of the SNPs,
rs7588452 with a genome-wide significant p = 5.8x10-9, is immediately located downstream of the
NOSTRIN gene. NOSTRIN is expressed in vascular endothelial cells and increases endothelial nitric
oxide synthase (eNOS) production of nitric oxide. Through regulation of nitric oxide production,
NOSTRIN is a potent mediator of neurotransmission, inflammatory response, and vascular home-
ostasis. Preliminary association analysis on the above 13 SNPs was also performed using 3 differ-
ent clinical outcome measures that reflect proliferative potential of IH: size, severity, and number
of lesions. SNP rs9903855 was shown to be significantly associated with both severity (p-value=0.02)
and size of IH (p-value=0.03) in this secondary analysis. This SNP is within the PELP1 gene, which
is expressed in placenta, blood, and the skin. PELP1 is a coactivator of estrogen receptor-mediated
transcription and promotes cell proliferation. PELP1 holds promise as a candidate gene given the
association of IH with female sex and placental abnormalities such as pre-eclampsia. Taken together,
we report the first GWAS study for IH and identify a number of significant SNPs associated with the
risk and severity of IH.
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Copy number variation analysis in PHACE syndrome
D Siegel,1 D Gibbs,3 I Frieden,4 B Drolet1 and U Broeckel2 1 Dermatology, Medical College of
Wisconsin, Milwaukee, WI, 2 Medicine and Physiology, Medical College of Wisconsin,
Milwaukee, WI, 3 Biostatistics, OHSU, Portland, OR and 4 Dermatology, UCSF, San Francisco,
CA
PHACE syndrome is an acronym for posterior fossa brain malformations, infantile hemangiomas,
arterial anomalies, cardiac defects and eye abnormalities. The PHACE syndrome International Clin-
ical Registry and Genetic Repository was established in 2006 and now contains over 160 samples
from individuals with PHACE syndrome. This repository was used to screen for copy number vari-
ants using Affymetrix 6.0 SNP arrays on 81 subjects. SNP CNV analysis for the preliminary data con-
sisted of 16 subjects from the PHACE genetic repository who are of Northern European descent and
for whom parental 6.0 SNP data was also created. These trios were evaluated using the PennCNV
protocol for high-resolution copy number variation detection. There were 561 rare CNV regions
across all subjects. There were a total of 218 deNovo CNV events, one of which was not in the Data-
base of Genomic Variants. In the second phase of the analysis, all 81 subjects were analyzed using
3 different algorithms; Aroma Affymetrix, Birdsuite and PennCN, focusing on rare CNVR greater
than 150Kb. Initial results show several regions of copy number variation, including deletions in
the regions Xp11.3, 7q33, and 17q11.2, and duplications in the regions Xq21.31, 3p24.3 and
1p36.21. In the next phase of analysis, genes from validated CNVR will be prioritized based on
expression patterns and predicted function and then will be sequenced in the larger cohort.
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A review of the clinical phenotype in 254 patients with genetically-confirmed pachyonychia
congenita
MJ Eliason,1 SA Leachman,1 B Feng,1 ME Schwartz2 and CD Hansen1 1 Department of
Dermatology, University of Utah, Salt Lake City, UT and 2 Pachyonychia Congenita Project,
Salt Lake City, UT
Pachyonychia congenita (PC) is a group of autosomal dominant keratinizing disorders caused by a
mutation in one of four keratin genes. To clarify the prevalence of clinical features associated with
PC we surveyed 254 individuals with confirmed keratin mutations. While the onset of clinical symp-
toms varied considerably among our subjects, a diagnostic triad of toenail thickening, plantar ker-
atoderma and plantar pain was reported by 97% of PC patients by age 10. Plantar pain had the
most profound impact on quality of life. Other clinical findings reported by our subjects included
fingernail dystrophy, oral leukokeratosis, palmar keratoderma, follicular hyperkeratosis, hyperhidrosis,
cysts, hoarseness, and natal teeth. We observed significant differences between keratin sub-groups
among the less common clinical findings, specifically, a higher likelihood of oral leukokeratosis in
individuals harboring KRT6A mutations, and a strong association of natal teeth and cysts in carri-
ers of a KRT17 mutation. Most keratin sub-groups expressed a mixed constellation of findings his-
torically reported as PC-1 and PC-2. We propose a new classification for PC based on the specific
keratin gene affected (e.g. PC-6a, PC-16, etc). This large clinical dataset, fully linked to molecular
data, will help clinicians improve their diagnostic and prognostic accuracy, correct spurious asso-
ciations, and improve therapeutic development.
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Wound healing milieu protects against chemotherapy induced alopecia
J Escandon, O Stojadinovic, LM Mauro, T Cao Wikramanayake, M Tomic-Canic and JJ Jimenez
Dermatology and Cutaneous Surgery, University of Miami, Miami, FL
Background: Alopecia is a distressing side effect of Chemotherapy with negative psychosocial impli-
cations. One of the most widely used animal models of Chemotherapy Induced Alopecia (CIA) is
the neonatal rat model which correlates with human CIA. Using this model, we observed that pro-
tection from CIA occurred around wounds in a specific stage of wound healing (WH). As hair growth
has been shown to occur in previously wounded sites and neofolliculogenesis has been reported
after wounding we hypothesize that the WH milieu might protect hair from CIA. Methods: After
IACUC approval, we created 1cm long incision on the backs of 3, 8 or 11 days old Long Evans
neonatal rats. On day 11, rats received either three days of Etoposide (1.5mg/kg) or one day of
Cyclophosphamide (35mg/kg). Daily evaluation and photography were performed. Histology was
performed on day 21 (when we evidenced grossly hair presence) with H&E and BrdU. Results: Rats
wounded on days 8 and 11 did not achieve CIA protection, only day 3 wounded rats achieved CIA
protection. On day 21, hair was visible next to the wound in contrast to alopecia in the rest of the
body. Histologically, on day 21, we found granulation tissue and epithelialization of the wound
and anagen follicles on its sides, all the remaining follicles were in telogen. Strong BrdU staining
was seen in the follicles closest to the wound correlating with anagen. Conclusions: Our results
strongly suggest that the wound healing milieu protects the proliferating progenitors responsible for
terminal hair. Thus, mimicking a specific stage of the WH milieu may provide a translational approach
to treat CIA by identifying the actual factor(s) responsible for this effect. Furthermore, understand-
ing the relation of WH and hair proliferation may facilitate the discernment of the pathophysiology
of other alopecias.
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Spermidine promotes human hair follicle growth and modulates human epithelial stem cell
functions
Y Ramot,1,2 S Tiede,2 T Biró,3 M Abu Bakar,2,4 B Toth,3 M Philpott,5 W Harrison,5 K Sugawara2 and
R Paus2,6 1 Hadassah-Hebrew University Medical Center, Jerusalem, Israel, 2 University of
Lübeck, Lübeck, Germany, 3 University of Debrecen, Debrecen, Hungary, 4 Universiti Sains
Malaysia, Kelantan, Malaysia, 5 The London School of Medicine and Dentistry, London,
United Kingdom and 6 University of Manchester, Manchester, United Kingdom
Polyamines are vital for the growth of rapidly regenerating tissues; therefore, they also have an impor-
tant role in hair growth. Indeed, eflornithine, an inhibitor of polyamine synthesis, inhibits hair growth.
However, the role of polyamines in human hair follicle (HF) biology remains largely unknown. In
order to explore this, we have studied the effects of the prototypic polyamine spermidine (0.1-1
μM) on human scalp HFs and human HF epithelial stem cells in serum-free organ culture. Spermi-
dine upregulated expression of K15 and K19, the epithelial stem cell-associated keratins, changed
K15-promoter activity in situ, and altered colony forming capacities, cell proliferation and apopto-
sis, as well as K15 expression of isolated K15-GFP+ cells in vitro. Instead, eflornithine downregu-
lated K15 expression. These findings suggest that spermidine has a novel role in the regulation of
stem cell functions. HF organ culture experiments revealed that spermidine significantly promoted
hair shaft elongation and prolonged the anagen phase. Moreover, it led to downregulation of ornithine
decarboxylase expression, activating the negative feedback regulation. Additionally, spermidine
enhanced the proliferation of cultured primary human keratinocytes, and slightly promoted the accu-
mulation of cells in the S/G2-M phases. Microarray analyses detected that spermidine differentially
up-regulated multiple target genes, which are important in maintaining homeostasis of normal cell
functions (e.g. SYVN1, NACA, SLC25A3). These results provide evidence for a direct role of sper-
midine in the control of human hair growth and human epithelial stem cells. Therefore, the role of
polyamines in hair biology extends far beyond mere proliferation-stimulatory properties.
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The murine areola: Postnatal model of specialized epidermal growth
CD Offutt,1 S Koyama2 and J Foley1,3 1 Medical Sciences, Indiana University School of
Medicine, Bloomington, IN, 2 Psychology, Indiana University, Bloomington, IN and 3
Dermatology, Indiana University School of Medicine, Indianapolis, IN
Specialized epidermis is found in the palmoplantar, facial, anal genital regions, and nipples of mam-
mals. The novel characteristics of these regions result from epidermal interactions with unique fields
of mesenchyme produced during embryonic development. Many examples of specialized skin min-
imally change in postnatal life; however, the murine nipple undergoes a major restructuring. The
virgin mouse has nipples closely surrounded by hair, but after the first lactation it becomes encir-
cled by a thickened relatively glabrous epidermis similar to the areola of other mammals. The are-
ola becomes evident at 2-days of lactation, reaches maximum size in 7-days and is retained there-
after. The areola expressed epidermal markers characteristic of the nipple, and the underlying
connective tissue contained smooth muscle bands and matrix similar to that found within the nip-
ple core. At 2-days of lactation a transient BrdU incorporation occurred in the connective tissue.
The telogen hair follicles of the areola produced enlarged sebaceous glands and an expanded neck
region. At 2-days of lactation, PTHrP gene expression levels were dramatically increased in the reor-
ganizing hair follicles, and nuclear phospho-SMAD 1,5,8 was observed in the connective tissue.
We used tissue recombination between the epidermis and dermis of the nipple-like ventral skin of
the K14-PTHrP mouse and wild type skin to determine if hairy epidermis could be reporgrammed
by nipple connective tissue. Combinations of dermal fibroblasts from wild type mice produced hair
regardless the source of keratinocytes. In contrast, grafts that contained dermal cells from the ven-
tral K14-PTHrP mouse produced glabrous skin with a thickened epidermis. These findings suggest
that the murine areola is formed by a reactivation of the developmental programs that direct the
formation of the nipple.
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Reliability and validity of a photographic method for measuring facial hair density in men
J Wan, A Musiek, K Abuabara, SK Kurd, JM Steinemann, CC Vittorio and JM Gelfand Department
of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, PA
Although various methods of assessing hair growth or loss exist, most are performed manually and
can be labor-intensive. Here, we describe a simple, non-invasive method of hair counting devel-
oped as part of a randomized, placebo-controlled trial of a topical agent for hair growth prevention
and assess its reliability and validity. We evaluated hair density within a circular target area (2.5 cen-
timeters diameter) of the beard area in a split-face design in 14 male subjects by taking digital pho-
tographs of the target area, viewing them using standard imaging software, and counting the total
number of hairs ≥ 1 millimeter long with follicles located within the target area. Two independent
reviewers completed hair counts on all 130 photographs to assess inter-rater reliability. One of the
reviewers re-counted all the photographs 5 months after the initial measurement in order to assess
intra-rater (test-retest) reliability. Validity was evaluated by comparing total hair counts with respect
to their corresponding Physician’s Global Assessment (PGA) ratings of hair density, which is assessed
on a scale ranging from 0 (total alopecia) to 5 (very dense). We observed an intra-class correlation
coefficient (ICC) of 0.81 (95% confidence interval (CI) 0.74-0.86) for inter-rater reliability. Intra-rater
reliability analyses demonstrated an ICC of 0.90 (0.86-0.93) and a Spearman’s ρ correlation of 0.88
(0.84-0.92). As few photographs corresponded with the extreme values of PGA, a pair-wise com-
parison of mean total hair counts between PGA 3 versus 4 was performed, which showed a signif-
icantly lower mean hair count in samples with PGA 3 than in samples with PGA 4 (p<0.01). Our
hair counting method thus demonstrates excellent inter-rater and intra-rater reliability as well as dis-
crimination validity based on comparison to a PGA and should be considered for further evalua-
tion as a simple, non-invasive, quantitative assessment tool for hair growth or loss.
435
Hair shaft defects in the rough coat (rc) mice
M Miteva,1 AG Leiva,1 JJ Jimenez,1 K Csiszar2 and TC Wikramanayake1 1 Department of
Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami,
FL and 2 John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI
The rough coat (rc) is an autosomal recessive mutation that arose spontaneously in the C57BL/6J
inbred mouse strain. Homozygous rc mice are born indistinguishable from their normal littermates,
but start to show unkempt hair coat 2 weeks after birth, and develop severe skin and hair abnor-
malities thereafter. They develop cycles of hair loss and re-growth: hair loss during telogen, and re-
growth during the subsequent anagen. As the rc/rc mice age, they show a patchy hair coat of some-
times shorter and thinner new hair shafts, which may exhibit abnormal pigmentation and texture.
Hair plucked from rc/rc mice is attached to the bulb, indicating that hair loss is not due to hair shaft
breakage. However, hair shafts from the rc/rc mice appear much smoother than those from normal
C57BL/6J mice. Older rc/rc mice develop severe defects in the hair shafts. They are of a flattened,
“ribbon”-like shape with less prominent cuticle, show abnormal pigmentation (color and shape)
and few irregularities along the length. Abnormal shape and pigmentation of the hair shafts have
been confirmed on transverse histological sections of the rc/rc skin. Another feature observed on
vertical sections is sebaceous hypertrophy. In a previous study to identify the genetic basis of the rc
phenotype, we detected a missense mutation in a novel immunoglobulin protein gene Mpzl3 in
the rc mapping interval. We have detected abundant Mpzl3 expression in skin keratinocytes. Taken
together, these results suggest that Mpzl3 plays an indispensible role in the hair follicles. A better
characterization of the hair phenotype in the rc/rc mice will lead to a better understanding of
Mpzl3 function and hair shaft formation, and the rc/rc mice may serve as a model for hair shaft dis-
orders.
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Protection of melanin content in the hair follicle
C Meyrignac,1 A Perrin,1 S Ratz,1 V Lequoy,1 K Cucumel,1 C Gondran,1 C Dal Farra2 and
N Domloge1 1 Global Skin Research Center, ISP Vincience, Sophia Antipolis, France and 2 ISP
Corporate Research Center, ISP, Wayne, NJ
Hair graying is a natural process accompanying human aging. The recent theories of hair graying
involve different mechanisms including exhaustion of the enzymes implicated in melanogenesis,
depletion of melanocyte stem cells, and oxidative stress. In hair follicle, melanin synthesis takes
place in melanocytes of the hair matrix, during the anagen phase. In the present study, we were
interested in studying the effect of a compound (IV10.001) that exhibits a selective activity on pro-
teins involved in melanin synthesis pathway. We investigated this effect first on normal human epi-
dermal melanocytes (NHEM), and then on hair follicle from human scalp skin. NHEM were treated
with IV10.001for 48h, then the following markers were examined by immunostaining: MITF, as mas-
ter transcriptional regulator of pigmentation, its downstream melanogenic proteins tyrosinase, TRP-
1 and Pmel17, and finally the receptor of stem cell factor, c-kit. Melanin content in the hair follicle
was studied by Fontana-Masson staining. Our results showed that the main proteins of the
melanogenic pathway were increased following application of IV10.001. Regarding MITF expres-
sion, we observed an increase both in the cytoplasm and in the nucleus of treated cells. Treated cells
also showed a higher level of c-kit, whose enhancement is closely related to the level of hair pig-
mentation. Moreover, treated hair follicles revealed an increased level of melanin content. Appli-
cation of a denaturing stress such as SDS resulted in damaged structure of the hair bulb, impair-
ment of melanocyte morphology and disorganization of melanin distribution. Interestingly, application
of IV10.001 helped to maintain follicle structure and melanin distribution in the hair bulb. In con-
clusion, protection of melanin content in the hair follicle has to be taken into account in case of
external stress and in hair aging.
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A novel rat model for chemotherapy-induced alopecia
TC Wikramanayake,1 S Amini,1 J Simon,1 LM Mauro,2 G Elgart,1 LA Schachner1 and JJ Jimenez1 1
Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of
Medicine, Miami, FL and 2 Department of Biochemistry and Molecular Biology, University of
Miami Miller School of Medicine, Miami, FL
More than half of all people diagnosed with cancer receive chemotherapy, and approximately 65%
of them develop chemotherapy-induced alopecia (CIA), a side effect with significant negative psy-
chological impact. To date, very few animal models are available for the study of the mechanism
and prevention of CIA. In this study, we aimed to develop a clinically relevant adult rat model for
CIA in the pigmented Long-Evans rats. We first determined that Long-Evans pups developed alope-
cia in response to chemotherapeutic agents etoposide and cyclophosphamide as observed in other
murine models for CIA. We then determined whether they developed CIA as adults. In this exper-
iment, the dorsal hair of Long-Evans rats was clipped at the onset of the first telogen to synchronize
the hair cycle, and rats were then treated with etoposide for 3 days starting two weeks later. Upon
clipping of the hair shaft, we observed synchronized anagen induction. Shortly after etoposide treat-
ment, alopecia was observed in the areas that were clipped two weeks earlier, but not in the non-
clipped areas or control rats. Hair follicles in the clipped areas showed typical chemotherapy-induced
follicular dystrophy (dystrophic catagen). When the hair re-grew in pigmented alopecic areas, they
showed normal pigmentation. In summary, we have established a novel, pigmented adult rat model
for CIA. By hair shaft clipping during early telogen, synchronized anagen entry was induced that
resulted in alopecia in response to chemotherapy. This is the first clinically relevant adult rat model
for CIA, and will be a useful tool to test agents for the prevention and treatment of CIA.
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New strategy to modulate alopecia using a combination of 2 specific and unique ingredients
E Loing,1 M Hocquaux2 and I Lacasse1 1 R&D, Unipex Innovations, Quebec, QC, Canada and
2 R&D, Unipex Innovations, Ramonville St Agne, France
Although causes of hair loss are still not yet fully understood, it can be the result of several factors.
The objective of our work is the study of a specific and unique combination of 2 ingredients in elic-
iting biological responses in hair loss mechanisms. The first ingredient is a biomimetic peptide derived
from a signal peptide which has potent tissue protective properties and stimulates tissue renewal
for a better hair anchoring. The second active is Biochanin A (red clover extract) known to be an
effective inhibitor of 5 alpha reductase activity. The 5α-reductase is known to modulate the con-
version of testosterone into DHT causing hair follicle miniaturization. The efficacy of the ingredi-
ents was studied in human fibroblasts and skin biopsies in order to demonstrate the efficacy of the
peptide on the matrix extracellular proteins renewal. The efficacy of the peptide on isolated hair
follicle growth was demonstrated using the particular and distinctive Philpott methodology. A clin-
ical study on human volunteers (Active vs placebo) was done using a professional Trichoscan for
the measurement of human hair after 4 months treatment. The peptide stimulates several extracel-
lular matrix proteins favoring a better hair anchoring for a direct effect on hair follicle integrity, while
the biochamin A found in the red clover extract inhibits the 5-alpha reductase activity responsible
for androgenic alopecia. The hair follicle growth is stimulated in comparison with Minoxidil after
7 days culture. The clinical study showed significant increase of the anagen phase (growth phase)
and a decrease of the telogen phase (resting phase) after 4 months treatment with the combination
of the 2 ingredients (peptide + red clover extract). The efficacy of this new active is based on the
combined action of its two ingredients, allowing direct action on DHT preventing the hair cycle to
shorten and hair follicle miniaturization, improving the ECM proteins in dermal papilla surround-
ing hair papilla for better anchoring and promoting increase of follicle size.
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A new approach to promote VEGF expression in hair follicle
S Ratz,1 A Perrin,1 C Meyrignac,1 L Mur,1 C Gondran,1 C Dal farra2 and N Domloge1 1 Global
Skin Research Center, ISP Vincience, Sophia Antipolis, France and 2 ISP Corporate Research
Center, ISP, Wayne, NJ
Vascular Endothelial Growth Factor (VEGF) plays an essential role in hair growth maintenance, by
improving the exchanges between hair follicle and capillary network. In addition to promoting per-
ifollicular vascularization, VEGF may also act on fibroblasts and endothelial cells in the dermal
papilla. In order to enhance VEGF expression, we developed a specific compound that could improve
VEGF expression in the hair follicle. This activity was first screened on several cell types, including
normal human keratinocytes (NHK), human dermal papilla cells (HDPC) and human umbilical
vein endothelial cells (HUVEC), using immunofluorescence techniques. Interestingly, VEGF expres-
sion was boosted in these different cell types following 48h application. In the same conditions, the
receptor of VEGF, Flk1, was also increased. Conditioned medium of HDPC pre-treated with the
active was applied on cultured HUVEC. This conditioned medium seems to enhance VEGF pro-
duction and allow better organization of HUVEC network. Then, the activity of the selected com-
pound was investigated at the level of the hair follicle. For this purpose, scalp skin biopsies were
treated topically with a daily application on the active compound. This treatment leads to an increase
in VEGF staining especially observed in outer root sheath (ORS). This effect was accompanied by
an enhancement of CD34, indicator of blood vessel network in the perifollicular environment. More-
over, the improvement of keratin-14 observed after application of the treatment could be in favor
of a reinforcement of ORS structure in treated hair follicles. Taken together, these results suggest
that promoting VEGF expression in cells of the hair follicle may provide optimal conditions for hair
growth and quality.
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Genomewide association study (GWAS) of infantile hemangiomas (IH)
B Drolet, D Siegel, K Duffy, Y Chiu, R Lorier, A Stoddard and U Broeckel Dermatology, Genetics,
MCW, Milwaukee, WI
Infantile hemangiomas (IH) are benign tumors composed of proliferating endothelial-like cells. The
duration and rate of growth is highly variable. Recently, we have shown that both environmental
and genetic factors impact the development of IH, as demonstrated by striking ethnic predisposi-
tion in Caucasians, familial clustering, and association with low birth weight. In order to advance
our understanding of the genetic component, we performed a family-based GWAS analysis to
identify pathogenic genes and pathways in the development of IH. The Affymetrix 6.0 chip was used
to assay 906,600 single nucleotide polymorphisms (SNPs) in 224 family trios. Thirty-six SNPs achieved
statistical significance, and 13 of these were within or near 9 candidate genes. One of the SNPs,
rs7588452 with a genome-wide significant p = 5.8x10-9, is immediately located downstream of the
NOSTRIN gene. NOSTRIN is expressed in vascular endothelial cells and increases endothelial nitric
oxide synthase (eNOS) production of nitric oxide. Through regulation of nitric oxide production,
NOSTRIN is a potent mediator of neurotransmission, inflammatory response, and vascular home-
ostasis. Preliminary association analysis on the above 13 SNPs was also performed using 3 differ-
ent clinical outcome measures that reflect proliferative potential of IH: size, severity, and number
of lesions. SNP rs9903855 was shown to be significantly associated with both severity (p-value=0.02)
and size of IH (p-value=0.03) in this secondary analysis. This SNP is within the PELP1 gene, which
is expressed in placenta, blood, and the skin. PELP1 is a coactivator of estrogen receptor-mediated
transcription and promotes cell proliferation. PELP1 holds promise as a candidate gene given the
association of IH with female sex and placental abnormalities such as pre-eclampsia. Taken together,
we report the first GWAS study for IH and identify a number of significant SNPs associated with the
risk and severity of IH.
428
Copy number variation analysis in PHACE syndrome
D Siegel,1 D Gibbs,3 I Frieden,4 B Drolet1 and U Broeckel2 1 Dermatology, Medical College of
Wisconsin, Milwaukee, WI, 2 Medicine and Physiology, Medical College of Wisconsin,
Milwaukee, WI, 3 Biostatistics, OHSU, Portland, OR and 4 Dermatology, UCSF, San Francisco,
CA
PHACE syndrome is an acronym for posterior fossa brain malformations, infantile hemangiomas,
arterial anomalies, cardiac defects and eye abnormalities. The PHACE syndrome International Clin-
ical Registry and Genetic Repository was established in 2006 and now contains over 160 samples
from individuals with PHACE syndrome. This repository was used to screen for copy number vari-
ants using Affymetrix 6.0 SNP arrays on 81 subjects. SNP CNV analysis for the preliminary data con-
sisted of 16 subjects from the PHACE genetic repository who are of Northern European descent and
for whom parental 6.0 SNP data was also created. These trios were evaluated using the PennCNV
protocol for high-resolution copy number variation detection. There were 561 rare CNV regions
across all subjects. There were a total of 218 deNovo CNV events, one of which was not in the Data-
base of Genomic Variants. In the second phase of the analysis, all 81 subjects were analyzed using
3 different algorithms; Aroma Affymetrix, Birdsuite and PennCN, focusing on rare CNVR greater
than 150Kb. Initial results show several regions of copy number variation, including deletions in
the regions Xp11.3, 7q33, and 17q11.2, and duplications in the regions Xq21.31, 3p24.3 and
1p36.21. In the next phase of analysis, genes from validated CNVR will be prioritized based on
expression patterns and predicted function and then will be sequenced in the larger cohort.
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A review of the clinical phenotype in 254 patients with genetically-confirmed pachyonychia
congenita
MJ Eliason,1 SA Leachman,1 B Feng,1 ME Schwartz2 and CD Hansen1 1 Department of
Dermatology, University of Utah, Salt Lake City, UT and 2 Pachyonychia Congenita Project,
Salt Lake City, UT
Pachyonychia congenita (PC) is a group of autosomal dominant keratinizing disorders caused by a
mutation in one of four keratin genes. To clarify the prevalence of clinical features associated with
PC we surveyed 254 individuals with confirmed keratin mutations. While the onset of clinical symp-
toms varied considerably among our subjects, a diagnostic triad of toenail thickening, plantar ker-
atoderma and plantar pain was reported by 97% of PC patients by age 10. Plantar pain had the
most profound impact on quality of life. Other clinical findings reported by our subjects included
fingernail dystrophy, oral leukokeratosis, palmar keratoderma, follicular hyperkeratosis, hyperhidrosis,
cysts, hoarseness, and natal teeth. We observed significant differences between keratin sub-groups
among the less common clinical findings, specifically, a higher likelihood of oral leukokeratosis in
individuals harboring KRT6A mutations, and a strong association of natal teeth and cysts in carri-
ers of a KRT17 mutation. Most keratin sub-groups expressed a mixed constellation of findings his-
torically reported as PC-1 and PC-2. We propose a new classification for PC based on the specific
keratin gene affected (e.g. PC-6a, PC-16, etc). This large clinical dataset, fully linked to molecular
data, will help clinicians improve their diagnostic and prognostic accuracy, correct spurious asso-
ciations, and improve therapeutic development.
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Wound healing milieu protects against chemotherapy induced alopecia
J Escandon, O Stojadinovic, LM Mauro, T Cao Wikramanayake, M Tomic-Canic and JJ Jimenez
Dermatology and Cutaneous Surgery, University of Miami, Miami, FL
Background: Alopecia is a distressing side effect of Chemotherapy with negative psychosocial impli-
cations. One of the most widely used animal models of Chemotherapy Induced Alopecia (CIA) is
the neonatal rat model which correlates with human CIA. Using this model, we observed that pro-
tection from CIA occurred around wounds in a specific stage of wound healing (WH). As hair growth
has been shown to occur in previously wounded sites and neofolliculogenesis has been reported
after wounding we hypothesize that the WH milieu might protect hair from CIA. Methods: After
IACUC approval, we created 1cm long incision on the backs of 3, 8 or 11 days old Long Evans
neonatal rats. On day 11, rats received either three days of Etoposide (1.5mg/kg) or one day of
Cyclophosphamide (35mg/kg). Daily evaluation and photography were performed. Histology was
performed on day 21 (when we evidenced grossly hair presence) with H&E and BrdU. Results: Rats
wounded on days 8 and 11 did not achieve CIA protection, only day 3 wounded rats achieved CIA
protection. On day 21, hair was visible next to the wound in contrast to alopecia in the rest of the
body. Histologically, on day 21, we found granulation tissue and epithelialization of the wound
and anagen follicles on its sides, all the remaining follicles were in telogen. Strong BrdU staining
was seen in the follicles closest to the wound correlating with anagen. Conclusions: Our results
strongly suggest that the wound healing milieu protects the proliferating progenitors responsible for
terminal hair. Thus, mimicking a specific stage of the WH milieu may provide a translational approach
to treat CIA by identifying the actual factor(s) responsible for this effect. Furthermore, understand-
ing the relation of WH and hair proliferation may facilitate the discernment of the pathophysiology
of other alopecias.
431
Spermidine promotes human hair follicle growth and modulates human epithelial stem cell
functions
Y Ramot,1,2 S Tiede,2 T Biró,3 M Abu Bakar,2,4 B Toth,3 M Philpott,5 W Harrison,5 K Sugawara2 and
R Paus2,6 1 Hadassah-Hebrew University Medical Center, Jerusalem, Israel, 2 University of
Lübeck, Lübeck, Germany, 3 University of Debrecen, Debrecen, Hungary, 4 Universiti Sains
Malaysia, Kelantan, Malaysia, 5 The London School of Medicine and Dentistry, London,
United Kingdom and 6 University of Manchester, Manchester, United Kingdom
Polyamines are vital for the growth of rapidly regenerating tissues; therefore, they also have an impor-
tant role in hair growth. Indeed, eflornithine, an inhibitor of polyamine synthesis, inhibits hair growth.
However, the role of polyamines in human hair follicle (HF) biology remains largely unknown. In
order to explore this, we have studied the effects of the prototypic polyamine spermidine (0.1-1
μM) on human scalp HFs and human HF epithelial stem cells in serum-free organ culture. Spermi-
dine upregulated expression of K15 and K19, the epithelial stem cell-associated keratins, changed
K15-promoter activity in situ, and altered colony forming capacities, cell proliferation and apopto-
sis, as well as K15 expression of isolated K15-GFP+ cells in vitro. Instead, eflornithine downregu-
lated K15 expression. These findings suggest that spermidine has a novel role in the regulation of
stem cell functions. HF organ culture experiments revealed that spermidine significantly promoted
hair shaft elongation and prolonged the anagen phase. Moreover, it led to downregulation of ornithine
decarboxylase expression, activating the negative feedback regulation. Additionally, spermidine
enhanced the proliferation of cultured primary human keratinocytes, and slightly promoted the accu-
mulation of cells in the S/G2-M phases. Microarray analyses detected that spermidine differentially
up-regulated multiple target genes, which are important in maintaining homeostasis of normal cell
functions (e.g. SYVN1, NACA, SLC25A3). These results provide evidence for a direct role of sper-
midine in the control of human hair growth and human epithelial stem cells. Therefore, the role of
polyamines in hair biology extends far beyond mere proliferation-stimulatory properties.
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The murine areola: Postnatal model of specialized epidermal growth
CD Offutt,1 S Koyama2 and J Foley1,3 1 Medical Sciences, Indiana University School of
Medicine, Bloomington, IN, 2 Psychology, Indiana University, Bloomington, IN and 3
Dermatology, Indiana University School of Medicine, Indianapolis, IN
Specialized epidermis is found in the palmoplantar, facial, anal genital regions, and nipples of mam-
mals. The novel characteristics of these regions result from epidermal interactions with unique fields
of mesenchyme produced during embryonic development. Many examples of specialized skin min-
imally change in postnatal life; however, the murine nipple undergoes a major restructuring. The
virgin mouse has nipples closely surrounded by hair, but after the first lactation it becomes encir-
cled by a thickened relatively glabrous epidermis similar to the areola of other mammals. The are-
ola becomes evident at 2-days of lactation, reaches maximum size in 7-days and is retained there-
after. The areola expressed epidermal markers characteristic of the nipple, and the underlying
connective tissue contained smooth muscle bands and matrix similar to that found within the nip-
ple core. At 2-days of lactation a transient BrdU incorporation occurred in the connective tissue.
The telogen hair follicles of the areola produced enlarged sebaceous glands and an expanded neck
region. At 2-days of lactation, PTHrP gene expression levels were dramatically increased in the reor-
ganizing hair follicles, and nuclear phospho-SMAD 1,5,8 was observed in the connective tissue.
We used tissue recombination between the epidermis and dermis of the nipple-like ventral skin of
the K14-PTHrP mouse and wild type skin to determine if hairy epidermis could be reporgrammed
by nipple connective tissue. Combinations of dermal fibroblasts from wild type mice produced hair
regardless the source of keratinocytes. In contrast, grafts that contained dermal cells from the ven-
tral K14-PTHrP mouse produced glabrous skin with a thickened epidermis. These findings suggest
that the murine areola is formed by a reactivation of the developmental programs that direct the
formation of the nipple.
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Development of a melanotic inbred strain of the Long Evans rat: A model for hair pigmenta-
tion
JJ Jimenez, J Escandon, TC Wikramanayake, LM Mauro and LA Schachner Department of
Dermatology & Cutaneous Surgery, University of Miami, Miller School of Medicine, Miami, FL
The hair pigmentary bulge cells play a key role in hair pigmentation, and their dysfunction or death
leads to hair graying. Much process has been hampered in the area of hair graying and melano-
genesis by the limited number of animal models. In this regard, we have developed a melanotic
strain of inbred Long Evans (MLE) rats. The melanotic mutation was first observed in a male found
in a colony of otherwise normal LE rats. Breeding of the melanotic specimen with normal LE rats
yielded litters with fifty percent of the melanotic phenotype and fifty percent of the normal LE phe-
notype, indicating that it was transmitted in an autosomal dominant mode. We now have an inbred
colony of 20 generations. During breeding, we observed that older males and females developed
spontaneous hair graying in the dorsal area. We therefore proposed that multiple anagen phases
may play a role in the development of hair graying in the MLE rat. Thus, we documented the inci-
dence of hair graying in the first, second and third anagen. Synchronized second and third anagen
phases were induced by hair clipping. During the first anagen, no hair graying was observed, whereas
a few white hairs were visible in the second anagen phase. In contrast, during the third anagen phase
there were a significant number of white hairs in the dorsum. These findings were confirmed by
histopathology. Thus, the MLE rat could serve as a model for hair pigmentation to study hair gray-
ing. In addition, since the strain is inbred it could also serve to study the effects of hair bulge pig-
mentary cells in other pathologies.
447
Eclipta prostrata extract inhibits adipogenesis in primary human subcutaneous adipocytes
C Hwang, M Randhawa, J Lyga and U Santhanam Global R& D, Avon Products, Inc., Suffern,
NY
Cellulite is a topographic skin condition that gives the skin an orange peel or mattress appearance,
located mainly on the thighs, on the buttocks or even on the abdomen. The presence of cellulite is
a common aesthetic problem for most post-adolescent women. The uneven surface texture is due
to protrusion of subcutaneous fat into the dermis. An increase in the number and size of adipocytes
plays a major role in cellulite development. Development of products to improve the appearance
of cellulite requires technologies that can affect adipogenesis in adipocytes. In this study, we eval-
uated the effect of a proprietary Eclipta prostrata extract on the adipogenesis in primary human
subcutaneous adipocytes. Primary human preadipocytes were differentiated and treated with Eclipta
prostrata extract for a period of time. Intracellular levels of fat in adipocytes were visualized by Oil
Red O staining and quantified by the triglyceride assay. The results indicated that Eclipta prostrata
extract significantly reduced lipid accumulation in adipocytes. In order to understand the mecha-
nism by which Eclipta prostrate extract affected lipid accumulation, mRNA expression levels of
peroxisome proliferator-activator receptor-gamma (PPAR-γ) and steroyl-CoA desaturase-1 (SCD1)
were determined by qRT-PCR. Eclipta prostrata extract was found to inhibit the expression of both
PPAR-γ and SCD1 in primary human subcutaneous adipocytes, which might explain at least in
part, its effects on adipogenesis. This study suggests that Eclipta prostrata extract can be used as a
novel ingredient that works via a novel target, SCD-1, against cellulite.
449
Hdac1 and Hdac2 act redundantly to control p63 and p53 functions in epidermal progeni-
tor cells
M LeBoeuf,1 A Terrell,1 S Trivedi,1 X Zhao,1 S Sinha,3 J Epstein,2 E Olson,4 E Morrisey2 and
SE Millar1 1 Dermatology, University of Pennsylvania School of Medicine, Philadelphia, PA, 2
Cardiology, University of Pennsylvania School of Medicine, Philadelphia, PA, 3 Biochemistry,
SUNY Buffalo, Buffalo, NY and 4 Molecular Biology, SUNY Buffalo, Dallas, TX
Histone deacetylases (HDACs) alter gene expression programs through modification of chromatin
and transcription factors. HDAC inhibitors show promise for therapy of a wide range of tumors,
highlighting the importance of determining precise HDAC functions in normal and tumor tissue.
We have used genetic approaches to determine the contributions of two related HDACs, HDAC1
and HDAC2, in embryonic epidermal development and postnatal homeostasis. We find that loss of
Hdac1/2 in embryonic surface ectoderm results in a dramatic failure of hair follicle specification
and epidermal proliferation and stratification, phenocopying loss of the key ectodermal transcrip-
tion factor p63. While expression of p63 and its positively regulated basal cell targets is maintained
in Hdac1/2 deficient embryonic ectoderm, targets of p63-mediated repression, including p21, 14-
3-3σ and p16/INK4a, are ectopically expressed, and HDACs bind and are active at their promoter
regions in normal undifferentiated keratinocytes. Mutant embryos display increased levels of acety-
lated p53, which opposes p63 functions, and p53 is required for HDAC inhibitor-mediated p21
expression in keratinocytes. These data reveal critical requirements for HDAC1/2 in epidermal devel-
opment, and indicate that, in this context, HDAC1/2 directly mediate repressive functions of p63,
and suppress p53 activity. Interestingly, by contrast with the effects of embryonic Hdac1/2 deletion,
topical application of HDAC inhibitor, or inducible genetic loss of Hdac1/2, in adult skin produces
epidermal hyperproliferation, indicating that HDAC functions in the epidermis are highly stage- and
context-dependent.
448
Discovery of stable RNAs in the human hair shaft by RNA-seq: implications for serial testing
in personalized medicine
GK Lefkowitz,1,2,3 CA Cowing-Zitron,2,3,4 A Mukhopadhyay2,3,4 and BD Yu2,3,4 1 Biomedical
Sciences, UC San Diego, La Jolla, CA, 2 Institute for Genomic Medicine, UC San Diego, La
Jolla, CA, 3 Dermatology, UC San Diego, La Jolla, CA and 4 Stem Cell Program, UC San Diego,
La Jolla, CA
Advances in RNA sequencing technology allow for potential applications in areas of personal
genomics and molecular diagnostics. However, a rate-limiting step in the broader use of transcrip-
tome data is the restricted access to viable tissue samples. During hair follicle development, the
progeny of the hair matrix are incorporated into the emerging hair shaft. We hypothesized that sta-
ble RNAs such as microRNAs might still be present in the hair shaft and potentially serves as a record
of the developmental history of the hair matrix. Mouse and human were examined for persistence
of RNA in the hair shaft. Guided by previously generated mouse skin microRNA libraries, we iden-
tified follicular-specific microRNAs and the relative exclusion of epidermal-specific microRNAs in
mouse hair shafts by qPCR. To study human hair, RNA from the hair shaft of five individuals was
isolated and characterized by RNA-seq. 13.5 million reads were obtained and aligned to more than
2 million unique loci in the human genome. Of these loci, 449 represented previously discovered
microRNAs. Also present were other RNA species, including genes characteristic of cuticle and
cortex, indicating the representation of at least two lineages of the hair matrix. Validation by qPCR
revealed predictable decay rates and detection of both specific microRNA and mRNAs out to 25
cm, approximately 10 months of developmental history. The application of this approach to nor-
mal and congenital conditions such RAS/MAPK syndromes will be demonstrated. In summary, using
next-generation sequencing, we discovered that the hair shaft is a rich, stable source of microRNA,
mRNA, and other RNA species. These studies, which represent the first generation of a human hair
shaft library, reveal that hair shaft is tissue with unique properties ideal for developmental, clinical,
forensic, and pharmacogenomic studies.
446
Role of vitamin D receptor in hair follicle cycling through local expression
A Teichert, H Elalieh and D Bikle UCSF, San Francisco, CA
The vitamin D receptor (VDR) and its ligand, 1,25(OH)2D3, play numerous roles in mammalian
physiology including bone metabolism, immune system regulation, and epidermal differentiation
and hair follicle cycling. The most pronounced phenotype of mice lacking VDR is the alopecia and
skin tumor predisposition, phenotypes not reproduced in mice unable to produce 1,25(OH)2D3.
Hunting the oscillator mechanism that drives these hair follicle and skin transformations is one of
the pre-eminent challenges of skin research. Lack or alteration of VDR in both human and mouse
leads to an absence of adult hair follicle cycling, with a defect in anagen re-initiation, accompa-
nied by a progressive hair loss. However, lack of VDR does not affect embryonic hair development
and differentiation of epidermal keratinocytes, showing the specificity of VDR action in adult hair
follicle cycling. Lack of VDR in mouse also predisposes them to develop skin tumors if exposed to
chemical carcinogen or UVB. The study objective was to assess the local versus systemic action of
VDR, through the comparison of skin phenotypes in mice lacking VDR globally or only in epider-
mal tissues, following excision by the Cre recombinase under Keratin 14 (K14) promoter expres-
sion. Our results show that K14 specific VDR deficient mice display a comparable alopecia com-
pared to mice lacking VDR globally, and a comparable susceptibility to UVB induced skin tumor
formation. Since beta-catenin control of expression by and interaction with VDR is a potential key
element in these actions of VDR, we analyzed beta-catenin activity through the first hair follicle
cycle in mice lacking VDR specifically in the epidermis and observed that its transcriptional activ-
ity was increased compared to wild-type animals. These results indicate that VDR actions in the con-
trol of hair follicle cycling and repression of skin tumorigenesis are keratinocyte specific and demon-
strate autocrine control of beta-catenin signaling by VDR in keratinocytes, independent of
1,25(OH)2D3, and potentially underlying the defects in hair follicle cycling and predisposition to
cancer of the VDR null mice.
450
A mouse model for in vivo tracking of canonical wnt/beta-catenin signalling in skin
SS Hodgson and K Khosrotehrani University of Queensland Centre for Clinical Research,
Brisbane, QLD, Australia
Wnt signalling through its canonical pathway promotes hair follicle development and differentia-
tion via the stabilization of nuclear beta-catenin. This signalling pathway has been shown to be
important for the developing hair follicle and essential for the induction of each hair cycle. Despite
numerous studies on the matter, reliable quantitative evaluation of the activation of this pathway
has remained difficult in vivo. Using in vivo quantitative monitoring of beta-catenin activity we aim
to follow hair cycle dynamics on whole animal. We created mice harbouring a luciferase reporter
gene under the control of beta-catenin binding sites LEF/TCF inducible promoter. We have tracked
hair follicle cycles in live mice by in vivo bioluminescence imaging. Bioluminescence was signifi-
cantly higher in transgenic vs wild type mice at P1 (p<0.03) and was most prominent in the whiskers.
Luciferase expression subsequently spread from upper to lower back, to the front and hind limbs
from P7 and to the ears from P11. These finding were confirmed by histology. Beta-catenin activity
in the skin was seen to increase at a steady rate from birth peaking at P9 with >400 fold increase
compared with newborns. This signal was exclusively originating from the skin and was not con-
taminated by internal organs at a significant level. In adults, hair plucking in telogen phase induced
beta-catenin activity from day 6 that peaked at day 10. In conclusion, our model allows in vivo
tracking of beta-catenin activity and demonstrates that hair follicle cycling in neonates occurs in
rostro-caudal waves.
www.jidonline.org   S75
SID11_Abstracts-5  2/28/11  9:27 AM  Page S75
ABSTRACTS
439
Mesenchymal aging impairs hair follicle epithelial-mesenchymal interaction
Y Huang,1 K Huang,1 C Chan,1,2 J Hong,3,2 R Tsai,5 J Wu4 and S Lin1,2 1 Institute of Biomedical
Engineering, National Taiwan University, Taipei, Taiwan, 2 Dermatology, National Taiwan
University Hospital & College of Medicine, Taipei, Taiwan, 3 Dermatology, National Taiwan
University Hospital Yun-Lin Branch, Douliu, Taiwan, 4 Institute of Molecular Medicine,
National Taiwan University, Taipei, Taiwan and 5 Dermatology, Taipei Medical University,
Taipei, Taiwan
Aging affects overall organ function and size. Normal hair follicle (HF) function relies on the inter-
action between epithelium and mesenchyme within HFs as well as between HFs and the macro-
or systemic environment. Androgenetic alopecia (AGA), an example of premature organ aging, is
characterized by the alteration of normal cycling and organ atrophy. Although keratinocyte stem
cells are present in aged HFs, how the function and size of HFs deteriorate in AGA is poorly under-
stood. There is evidence that dermal papilla cells (DPC) undergo premature aging in AGA, but the
role of DP aging on HF functional loss is yet to be determined. To clarify the effect of mesenchymal
aging in HF, we induce premature DPC aging and investigate the effect on HF epithelial-mesenchymal
interaction. DPCs with induced premature aging show signs of senescence that is characterized by
morphological change, growth arrest, expression of senescence-associated β-galactosidase activ-
ity, and elevated levels of p16 and p21. Interestingly, these senescent cells do not adopt a fibrob-
last fate and still preserve DPC signature gene expression including Wnt5a, BMP6, Hey1, versican,
alkaline phosphatase, etc. Functionally, senescent DPCs are impaired in self-aggregating and in sup-
porting the growth of keratinocyte/stem cells. In addition, they have decreased alkaline phosphatase
activity and the ability to induce HF neogenesis is impaired. We also found that certain growth fac-
tors are able to rescue the arrested growth behavior of DPCs. We conclude that senescent DPCs
have impaired ability to stimulate and instruct keratinocytes and this compromised epithelial-mes-
enchymal interaction may lead to the functional loss of HF. Preventing DPC senescence may help
to halt the deterioration of HF function in diseased states.
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A Japanese case of monilethrix caused by compound heterozygous mutations in the desmoglein
4 (DSG4) gene
M Farooq,1 M Ito2 and Y Shimomura1 1 Laboratory of Genetic skin Diseases, Niigata University
School of Medicine, Niigata, Japan and 2 Department of Dermatology, Niigata University
School of Medicine, Niigata, Japan
Monilethrix is a rare condition characterized by a hair shaft anomaly known as moniliform or beaded
hair. It can show either an autosomal dominant or recessive inheritance pattern. Autosomal domi-
nant form of monilethrix is caused by mutations in basic hair keratin genes KRT81, KRT83, or KRT86,
while autosomal recessive form is resulting from mutations in desmoglein 4 (DSG4) gene. We recently
identified a Japanese boy with sparse and fragile scalp hairs. He also shows a dry skin, as well as
diffuse follicular papules on the scalp and extremities. Microscopic observation of the hair clearly
showed a moniliform appearance. Both parents are unaffected and there are no consanguinities
between them. Direct sequencing analysis led to the identification of compound heterozygous muta-
tions in the DSG4 gene of the patient. One of these mutations is a nonsense mutation within the
last exon of the DSG4 gene, which is predicted to encode an aberrant DSG4 protein lacking a part
of the cytoplasmic domain. Co-immunoprecipitation assays demonstrated that the mutation severely
affects the affinity with plakoglobin protein. Our results further underscore the crucial role of the
DSG4 gene in differentiation of the hair shaft in humans.
441
Combination of human epidermal-dermal equivalents and primary human sebocyte cultures
for evaluating topical sebum inhibitors
W Li, A Pappas, M Eisinger and L Zhang Skin Research Center, unit of Johnson and Johnson
Consumer Companies, Inc., Skillman, NJ
Agents that inhibit sebum production could potentially prevent or treat skin conditions such as
acne and seborrhea. We developed an in vitro model system for the quick evaluation of topical
agents for their effect on the production of sebaceous lipids. The system is composed of epidermal-
dermal equivalents overlaying cultured primary sebocytes, and lipid production following topical
treatment is assessed both visually and by Nile red fluorescence. We have previously reported that
sebocytes isolated from human facial skins could be cultured and induced to differentiate by cholera
toxin (ChT) via the up-regulation of the melanocortin-5 receptor (MC5R). We chose to combine
this monolayer culture with epidermal-dermal equivalents, which enable topical treatment, and to
quantify sebaceous lipid production by Nile Red, a fluorescent dye that selectively binds to neutral
lipids. Using agents known to suppress sebum production in the clinic, we showed the predictability
of the new in vitro system. An MC5R antagonist (MC5RA) was shown earlier to inhibit ChT-induced
sebaceous lipid production by the primary sebocytes culture. This result was in correlation with the
inhibition of sebaceous lipid production upon topical MC5RA treatment of human skins grafted
onto immuno-suppressed mice. When the same MC5RA preparation was topically applied daily,
for 5 days, onto the epidermal-dermal equivalents overlaying the cultured sebocytes, a similar
inhibitory effect was documented, confirming the usefulness of the new co-culture system. In con-
clusion, we developed an in vitro combination system for evaluating topical agents for their poten-
tial to affect the production of sebaceous lipids.
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Genetic deletion of Egfr results in resistance to cyclophosphamide-induced alopecia
KJ Bichsel, N Gogia, T Malouff, E Forney and LA Hansen Biomedical Sciences, Creighton
University, Omaha, NE
Treatment of cancer patients with chemotherapeutics like cyclophosphamide (CYP) causes alope-
cia, a significant side effect. Chemotherapy-induced alopecia results from premature and aberrant
catagen. Because we showed that the epidermal growth factor receptor (EGFR) signals anagen hair
follicles to enter catagen, we hypothesized that EGFR signaling may be necessary for CYP-induced
alopecia. This hypothesis was investigated using skin-targeted Egfr mutant mice, generated by
crossing floxed Egfr mice with Keratin 14 promoter-driven Cre recombinase mice. As expected,
CYP treatment of control mice resulted in catagen induction by 2 d, which was rapidly followed by
alopecia within 5-6 d of treatment. Consistent with our hypothesis, Egfr mutant hair follicles were
resistant to CYP-induced alopecia, retaining their hair coat through 8 d post-injection. Analysis of
hair cycle stage using published criteria, localization of the dermal papilla marker alkaline phos-
phatase, and measurement of follicular proliferation and apoptosis revealed that CYP-treated con-
trol mice entered catagen by 1-2 d and progressed to telogen by 4 d. Analysis of Egfr mutant skin
revealed a change in the shape of the dermal papilla, consistent with the earliest stages of catagen
at 2 d, but no progression to later catagen. Proliferation was decreased in both CYP-treated control
and mutant skin, consistent with catagen entry in the mutants as well. Apoptosis was increased in
Egfr mutant follicles by 2 d after CYP, but was not sustained beyond this time point, in contrast to
the apoptosis continuing until telogen in CYP-treated controls. Because p53 deficiency has been
linked to resistance to CYP-induced alopecia, p53 localization was also assessed. p53 was upreg-
ulated at all time points after treatment of control skin while Egfr mutant matrix keratinocytes had
increased numbers of p53-positive cells between 2 and 4 d after CYP that were largely lost by 8 d.
Taken together, these data reveal that EGFR is necessary for progression through the later stages of
catagen and alopecia in response to CYP treatment.
443
The Hairmax LaserComb enhances hair rRegrowth in post-chemotherapy alopecia
R Rodriguez, TC Wikramanayake, LM Mauro, LA Schachner and JJ Jimenez Department of
Dermatology & Cutaneous Surgery, University of Miami, Miller School of Medicine, Miami, FL
Alopecia is one of the most distressing side effects of antineoplastic therapy for which there is no
interventional approach. Great strides have been made in the field of chemotherapy-induced alope-
cia (CIA) using the young rat model, the only CIA model which has been directly correlated with
humans. The Hairmax LaserComb is a device which has been used to promote regrowth of hair in
androgenetic alopecia. Furthermore, we have demonstrated that the LaserComb induced hair growth
in a time-dependent manner in alopecic lesions in the C3H/HeJ mouse model of Alopecia Areata.
In the current study, we have applied these findings in a model of Post-Chemotherapy Alopecia
(PCA). To this effect we have employed the young rat model of CIA using cyclophosphamide,
etoposide, and a combination of cyclophosphamide and paclitaxel. Rats were randomized into three
cohorts: one received chemotherapy alone; the other received immediate treatment with the Hair-
max LaserComb daily for 10 days turned off and the third was treated with the LaserComb turned
on. Seven to ten days later, grade four alopecia ensued in all groups. The group receiving treatment
with the Hairmax Lasercomb regrew the hair 5 days earlier than the untreated and sham groups.
These findings were confirmed by histopathology. Thus, treatment with the Hairmax Lasercomb may
provide a means of accelerating hair regrowth in PCA. These findings should be extrapolated to the
treatment of PCA in patients because the Hairmax Lasercomb provides a user friendly and non-inva-
sive approach which could be translated to increased patient compliance and improved efficacy.
444
Intu controls hair follicle formation through regulating primary cilia formation in epidermal
keratinocytes
D Dai,1 L Li,1 H Zeng,2 A Liu2 and J Chen1 1 Department of Dermatology and Charles C. Gates
Center for Regenerative Medicine   and Stem Cell Biology, University of Colorado Denver,
Aurora, CO and 2 Department of Biology, Pennsylvania State University, University Park, PA
Planar cell polarity (PCP) signaling, a form of non-canonical Wnt (Wnt/PCP) signaling, is an evolu-
tionarily conserved signaling mechanism, controlling hair follicle orientation and differentiation in
mice. Recently, we discovered that Fuz, a tissue-specific PCP effector gene of the PCP signaling
pathway, is required for hair follicle differentiation by controlling primary cilia formation and hedge-
hog signaling. To further determine if this group of tissue-specific PCP effector genes has conserved
functions in hair follicle formation, we investigated the role of Intu, another known mammalian tis-
sue-specific PCP effector gene, during hair follicle formation. Disruption of Intu in the epidermis
resulted in a reduced number of hair follicles, and the developmental stages of the hair follicles that
formed were also significantly delayed in both embryonic and newborn skin. Consistent with these
observations, we discovered that the primary cilia present on epidermal keratinocytes and cells
within the hair follicles were severely truncated. Therefore, these results for Intu, taken together with
our recently reported findings for Fuz, suggest that tissue-specific PCP effector genes of the PCP sig-
naling pathway use a common mechanism to control the development of hair follicles.
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Development of a melanotic inbred strain of the Long Evans rat: A model for hair pigmenta-
tion
JJ Jimenez, J Escandon, TC Wikramanayake, LM Mauro and LA Schachner Department of
Dermatology & Cutaneous Surgery, University of Miami, Miller School of Medicine, Miami, FL
The hair pigmentary bulge cells play a key role in hair pigmentation, and their dysfunction or death
leads to hair graying. Much process has been hampered in the area of hair graying and melano-
genesis by the limited number of animal models. In this regard, we have developed a melanotic
strain of inbred Long Evans (MLE) rats. The melanotic mutation was first observed in a male found
in a colony of otherwise normal LE rats. Breeding of the melanotic specimen with normal LE rats
yielded litters with fifty percent of the melanotic phenotype and fifty percent of the normal LE phe-
notype, indicating that it was transmitted in an autosomal dominant mode. We now have an inbred
colony of 20 generations. During breeding, we observed that older males and females developed
spontaneous hair graying in the dorsal area. We therefore proposed that multiple anagen phases
may play a role in the development of hair graying in the MLE rat. Thus, we documented the inci-
dence of hair graying in the first, second and third anagen. Synchronized second and third anagen
phases were induced by hair clipping. During the first anagen, no hair graying was observed, whereas
a few white hairs were visible in the second anagen phase. In contrast, during the third anagen phase
there were a significant number of white hairs in the dorsum. These findings were confirmed by
histopathology. Thus, the MLE rat could serve as a model for hair pigmentation to study hair gray-
ing. In addition, since the strain is inbred it could also serve to study the effects of hair bulge pig-
mentary cells in other pathologies.
447
Eclipta prostrata extract inhibits adipogenesis in primary human subcutaneous adipocytes
C Hwang, M Randhawa, J Lyga and U Santhanam Global R& D, Avon Products, Inc., Suffern,
NY
Cellulite is a topographic skin condition that gives the skin an orange peel or mattress appearance,
located mainly on the thighs, on the buttocks or even on the abdomen. The presence of cellulite is
a common aesthetic problem for most post-adolescent women. The uneven surface texture is due
to protrusion of subcutaneous fat into the dermis. An increase in the number and size of adipocytes
plays a major role in cellulite development. Development of products to improve the appearance
of cellulite requires technologies that can affect adipogenesis in adipocytes. In this study, we eval-
uated the effect of a proprietary Eclipta prostrata extract on the adipogenesis in primary human
subcutaneous adipocytes. Primary human preadipocytes were differentiated and treated with Eclipta
prostrata extract for a period of time. Intracellular levels of fat in adipocytes were visualized by Oil
Red O staining and quantified by the triglyceride assay. The results indicated that Eclipta prostrata
extract significantly reduced lipid accumulation in adipocytes. In order to understand the mecha-
nism by which Eclipta prostrate extract affected lipid accumulation, mRNA expression levels of
peroxisome proliferator-activator receptor-gamma (PPAR-γ) and steroyl-CoA desaturase-1 (SCD1)
were determined by qRT-PCR. Eclipta prostrata extract was found to inhibit the expression of both
PPAR-γ and SCD1 in primary human subcutaneous adipocytes, which might explain at least in
part, its effects on adipogenesis. This study suggests that Eclipta prostrata extract can be used as a
novel ingredient that works via a novel target, SCD-1, against cellulite.
449
Hdac1 and Hdac2 act redundantly to control p63 and p53 functions in epidermal progeni-
tor cells
M LeBoeuf,1 A Terrell,1 S Trivedi,1 X Zhao,1 S Sinha,3 J Epstein,2 E Olson,4 E Morrisey2 and
SE Millar1 1 Dermatology, University of Pennsylvania School of Medicine, Philadelphia, PA, 2
Cardiology, University of Pennsylvania School of Medicine, Philadelphia, PA, 3 Biochemistry,
SUNY Buffalo, Buffalo, NY and 4 Molecular Biology, SUNY Buffalo, Dallas, TX
Histone deacetylases (HDACs) alter gene expression programs through modification of chromatin
and transcription factors. HDAC inhibitors show promise for therapy of a wide range of tumors,
highlighting the importance of determining precise HDAC functions in normal and tumor tissue.
We have used genetic approaches to determine the contributions of two related HDACs, HDAC1
and HDAC2, in embryonic epidermal development and postnatal homeostasis. We find that loss of
Hdac1/2 in embryonic surface ectoderm results in a dramatic failure of hair follicle specification
and epidermal proliferation and stratification, phenocopying loss of the key ectodermal transcrip-
tion factor p63. While expression of p63 and its positively regulated basal cell targets is maintained
in Hdac1/2 deficient embryonic ectoderm, targets of p63-mediated repression, including p21, 14-
3-3σ and p16/INK4a, are ectopically expressed, and HDACs bind and are active at their promoter
regions in normal undifferentiated keratinocytes. Mutant embryos display increased levels of acety-
lated p53, which opposes p63 functions, and p53 is required for HDAC inhibitor-mediated p21
expression in keratinocytes. These data reveal critical requirements for HDAC1/2 in epidermal devel-
opment, and indicate that, in this context, HDAC1/2 directly mediate repressive functions of p63,
and suppress p53 activity. Interestingly, by contrast with the effects of embryonic Hdac1/2 deletion,
topical application of HDAC inhibitor, or inducible genetic loss of Hdac1/2, in adult skin produces
epidermal hyperproliferation, indicating that HDAC functions in the epidermis are highly stage- and
context-dependent.
448
Discovery of stable RNAs in the human hair shaft by RNA-seq: implications for serial testing
in personalized medicine
GK Lefkowitz,1,2,3 CA Cowing-Zitron,2,3,4 A Mukhopadhyay2,3,4 and BD Yu2,3,4 1 Biomedical
Sciences, UC San Diego, La Jolla, CA, 2 Institute for Genomic Medicine, UC San Diego, La
Jolla, CA, 3 Dermatology, UC San Diego, La Jolla, CA and 4 Stem Cell Program, UC San Diego,
La Jolla, CA
Advances in RNA sequencing technology allow for potential applications in areas of personal
genomics and molecular diagnostics. However, a rate-limiting step in the broader use of transcrip-
tome data is the restricted access to viable tissue samples. During hair follicle development, the
progeny of the hair matrix are incorporated into the emerging hair shaft. We hypothesized that sta-
ble RNAs such as microRNAs might still be present in the hair shaft and potentially serves as a record
of the developmental history of the hair matrix. Mouse and human were examined for persistence
of RNA in the hair shaft. Guided by previously generated mouse skin microRNA libraries, we iden-
tified follicular-specific microRNAs and the relative exclusion of epidermal-specific microRNAs in
mouse hair shafts by qPCR. To study human hair, RNA from the hair shaft of five individuals was
isolated and characterized by RNA-seq. 13.5 million reads were obtained and aligned to more than
2 million unique loci in the human genome. Of these loci, 449 represented previously discovered
microRNAs. Also present were other RNA species, including genes characteristic of cuticle and
cortex, indicating the representation of at least two lineages of the hair matrix. Validation by qPCR
revealed predictable decay rates and detection of both specific microRNA and mRNAs out to 25
cm, approximately 10 months of developmental history. The application of this approach to nor-
mal and congenital conditions such RAS/MAPK syndromes will be demonstrated. In summary, using
next-generation sequencing, we discovered that the hair shaft is a rich, stable source of microRNA,
mRNA, and other RNA species. These studies, which represent the first generation of a human hair
shaft library, reveal that hair shaft is tissue with unique properties ideal for developmental, clinical,
forensic, and pharmacogenomic studies.
446
Role of vitamin D receptor in hair follicle cycling through local expression
A Teichert, H Elalieh and D Bikle UCSF, San Francisco, CA
The vitamin D receptor (VDR) and its ligand, 1,25(OH)2D3, play numerous roles in mammalian
physiology including bone metabolism, immune system regulation, and epidermal differentiation
and hair follicle cycling. The most pronounced phenotype of mice lacking VDR is the alopecia and
skin tumor predisposition, phenotypes not reproduced in mice unable to produce 1,25(OH)2D3.
Hunting the oscillator mechanism that drives these hair follicle and skin transformations is one of
the pre-eminent challenges of skin research. Lack or alteration of VDR in both human and mouse
leads to an absence of adult hair follicle cycling, with a defect in anagen re-initiation, accompa-
nied by a progressive hair loss. However, lack of VDR does not affect embryonic hair development
and differentiation of epidermal keratinocytes, showing the specificity of VDR action in adult hair
follicle cycling. Lack of VDR in mouse also predisposes them to develop skin tumors if exposed to
chemical carcinogen or UVB. The study objective was to assess the local versus systemic action of
VDR, through the comparison of skin phenotypes in mice lacking VDR globally or only in epider-
mal tissues, following excision by the Cre recombinase under Keratin 14 (K14) promoter expres-
sion. Our results show that K14 specific VDR deficient mice display a comparable alopecia com-
pared to mice lacking VDR globally, and a comparable susceptibility to UVB induced skin tumor
formation. Since beta-catenin control of expression by and interaction with VDR is a potential key
element in these actions of VDR, we analyzed beta-catenin activity through the first hair follicle
cycle in mice lacking VDR specifically in the epidermis and observed that its transcriptional activ-
ity was increased compared to wild-type animals. These results indicate that VDR actions in the con-
trol of hair follicle cycling and repression of skin tumorigenesis are keratinocyte specific and demon-
strate autocrine control of beta-catenin signaling by VDR in keratinocytes, independent of
1,25(OH)2D3, and potentially underlying the defects in hair follicle cycling and predisposition to
cancer of the VDR null mice.
450
A mouse model for in vivo tracking of canonical wnt/beta-catenin signalling in skin
SS Hodgson and K Khosrotehrani University of Queensland Centre for Clinical Research,
Brisbane, QLD, Australia
Wnt signalling through its canonical pathway promotes hair follicle development and differentia-
tion via the stabilization of nuclear beta-catenin. This signalling pathway has been shown to be
important for the developing hair follicle and essential for the induction of each hair cycle. Despite
numerous studies on the matter, reliable quantitative evaluation of the activation of this pathway
has remained difficult in vivo. Using in vivo quantitative monitoring of beta-catenin activity we aim
to follow hair cycle dynamics on whole animal. We created mice harbouring a luciferase reporter
gene under the control of beta-catenin binding sites LEF/TCF inducible promoter. We have tracked
hair follicle cycles in live mice by in vivo bioluminescence imaging. Bioluminescence was signifi-
cantly higher in transgenic vs wild type mice at P1 (p<0.03) and was most prominent in the whiskers.
Luciferase expression subsequently spread from upper to lower back, to the front and hind limbs
from P7 and to the ears from P11. These finding were confirmed by histology. Beta-catenin activity
in the skin was seen to increase at a steady rate from birth peaking at P9 with >400 fold increase
compared with newborns. This signal was exclusively originating from the skin and was not con-
taminated by internal organs at a significant level. In adults, hair plucking in telogen phase induced
beta-catenin activity from day 6 that peaked at day 10. In conclusion, our model allows in vivo
tracking of beta-catenin activity and demonstrates that hair follicle cycling in neonates occurs in
rostro-caudal waves.
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Mesenchymal aging impairs hair follicle epithelial-mesenchymal interaction
Y Huang,1 K Huang,1 C Chan,1,2 J Hong,3,2 R Tsai,5 J Wu4 and S Lin1,2 1 Institute of Biomedical
Engineering, National Taiwan University, Taipei, Taiwan, 2 Dermatology, National Taiwan
University Hospital & College of Medicine, Taipei, Taiwan, 3 Dermatology, National Taiwan
University Hospital Yun-Lin Branch, Douliu, Taiwan, 4 Institute of Molecular Medicine,
National Taiwan University, Taipei, Taiwan and 5 Dermatology, Taipei Medical University,
Taipei, Taiwan
Aging affects overall organ function and size. Normal hair follicle (HF) function relies on the inter-
action between epithelium and mesenchyme within HFs as well as between HFs and the macro-
or systemic environment. Androgenetic alopecia (AGA), an example of premature organ aging, is
characterized by the alteration of normal cycling and organ atrophy. Although keratinocyte stem
cells are present in aged HFs, how the function and size of HFs deteriorate in AGA is poorly under-
stood. There is evidence that dermal papilla cells (DPC) undergo premature aging in AGA, but the
role of DP aging on HF functional loss is yet to be determined. To clarify the effect of mesenchymal
aging in HF, we induce premature DPC aging and investigate the effect on HF epithelial-mesenchymal
interaction. DPCs with induced premature aging show signs of senescence that is characterized by
morphological change, growth arrest, expression of senescence-associated β-galactosidase activ-
ity, and elevated levels of p16 and p21. Interestingly, these senescent cells do not adopt a fibrob-
last fate and still preserve DPC signature gene expression including Wnt5a, BMP6, Hey1, versican,
alkaline phosphatase, etc. Functionally, senescent DPCs are impaired in self-aggregating and in sup-
porting the growth of keratinocyte/stem cells. In addition, they have decreased alkaline phosphatase
activity and the ability to induce HF neogenesis is impaired. We also found that certain growth fac-
tors are able to rescue the arrested growth behavior of DPCs. We conclude that senescent DPCs
have impaired ability to stimulate and instruct keratinocytes and this compromised epithelial-mes-
enchymal interaction may lead to the functional loss of HF. Preventing DPC senescence may help
to halt the deterioration of HF function in diseased states.
440
A Japanese case of monilethrix caused by compound heterozygous mutations in the desmoglein
4 (DSG4) gene
M Farooq,1 M Ito2 and Y Shimomura1 1 Laboratory of Genetic skin Diseases, Niigata University
School of Medicine, Niigata, Japan and 2 Department of Dermatology, Niigata University
School of Medicine, Niigata, Japan
Monilethrix is a rare condition characterized by a hair shaft anomaly known as moniliform or beaded
hair. It can show either an autosomal dominant or recessive inheritance pattern. Autosomal domi-
nant form of monilethrix is caused by mutations in basic hair keratin genes KRT81, KRT83, or KRT86,
while autosomal recessive form is resulting from mutations in desmoglein 4 (DSG4) gene. We recently
identified a Japanese boy with sparse and fragile scalp hairs. He also shows a dry skin, as well as
diffuse follicular papules on the scalp and extremities. Microscopic observation of the hair clearly
showed a moniliform appearance. Both parents are unaffected and there are no consanguinities
between them. Direct sequencing analysis led to the identification of compound heterozygous muta-
tions in the DSG4 gene of the patient. One of these mutations is a nonsense mutation within the
last exon of the DSG4 gene, which is predicted to encode an aberrant DSG4 protein lacking a part
of the cytoplasmic domain. Co-immunoprecipitation assays demonstrated that the mutation severely
affects the affinity with plakoglobin protein. Our results further underscore the crucial role of the
DSG4 gene in differentiation of the hair shaft in humans.
441
Combination of human epidermal-dermal equivalents and primary human sebocyte cultures
for evaluating topical sebum inhibitors
W Li, A Pappas, M Eisinger and L Zhang Skin Research Center, unit of Johnson and Johnson
Consumer Companies, Inc., Skillman, NJ
Agents that inhibit sebum production could potentially prevent or treat skin conditions such as
acne and seborrhea. We developed an in vitro model system for the quick evaluation of topical
agents for their effect on the production of sebaceous lipids. The system is composed of epidermal-
dermal equivalents overlaying cultured primary sebocytes, and lipid production following topical
treatment is assessed both visually and by Nile red fluorescence. We have previously reported that
sebocytes isolated from human facial skins could be cultured and induced to differentiate by cholera
toxin (ChT) via the up-regulation of the melanocortin-5 receptor (MC5R). We chose to combine
this monolayer culture with epidermal-dermal equivalents, which enable topical treatment, and to
quantify sebaceous lipid production by Nile Red, a fluorescent dye that selectively binds to neutral
lipids. Using agents known to suppress sebum production in the clinic, we showed the predictability
of the new in vitro system. An MC5R antagonist (MC5RA) was shown earlier to inhibit ChT-induced
sebaceous lipid production by the primary sebocytes culture. This result was in correlation with the
inhibition of sebaceous lipid production upon topical MC5RA treatment of human skins grafted
onto immuno-suppressed mice. When the same MC5RA preparation was topically applied daily,
for 5 days, onto the epidermal-dermal equivalents overlaying the cultured sebocytes, a similar
inhibitory effect was documented, confirming the usefulness of the new co-culture system. In con-
clusion, we developed an in vitro combination system for evaluating topical agents for their poten-
tial to affect the production of sebaceous lipids.
442
Genetic deletion of Egfr results in resistance to cyclophosphamide-induced alopecia
KJ Bichsel, N Gogia, T Malouff, E Forney and LA Hansen Biomedical Sciences, Creighton
University, Omaha, NE
Treatment of cancer patients with chemotherapeutics like cyclophosphamide (CYP) causes alope-
cia, a significant side effect. Chemotherapy-induced alopecia results from premature and aberrant
catagen. Because we showed that the epidermal growth factor receptor (EGFR) signals anagen hair
follicles to enter catagen, we hypothesized that EGFR signaling may be necessary for CYP-induced
alopecia. This hypothesis was investigated using skin-targeted Egfr mutant mice, generated by
crossing floxed Egfr mice with Keratin 14 promoter-driven Cre recombinase mice. As expected,
CYP treatment of control mice resulted in catagen induction by 2 d, which was rapidly followed by
alopecia within 5-6 d of treatment. Consistent with our hypothesis, Egfr mutant hair follicles were
resistant to CYP-induced alopecia, retaining their hair coat through 8 d post-injection. Analysis of
hair cycle stage using published criteria, localization of the dermal papilla marker alkaline phos-
phatase, and measurement of follicular proliferation and apoptosis revealed that CYP-treated con-
trol mice entered catagen by 1-2 d and progressed to telogen by 4 d. Analysis of Egfr mutant skin
revealed a change in the shape of the dermal papilla, consistent with the earliest stages of catagen
at 2 d, but no progression to later catagen. Proliferation was decreased in both CYP-treated control
and mutant skin, consistent with catagen entry in the mutants as well. Apoptosis was increased in
Egfr mutant follicles by 2 d after CYP, but was not sustained beyond this time point, in contrast to
the apoptosis continuing until telogen in CYP-treated controls. Because p53 deficiency has been
linked to resistance to CYP-induced alopecia, p53 localization was also assessed. p53 was upreg-
ulated at all time points after treatment of control skin while Egfr mutant matrix keratinocytes had
increased numbers of p53-positive cells between 2 and 4 d after CYP that were largely lost by 8 d.
Taken together, these data reveal that EGFR is necessary for progression through the later stages of
catagen and alopecia in response to CYP treatment.
443
The Hairmax LaserComb enhances hair rRegrowth in post-chemotherapy alopecia
R Rodriguez, TC Wikramanayake, LM Mauro, LA Schachner and JJ Jimenez Department of
Dermatology & Cutaneous Surgery, University of Miami, Miller School of Medicine, Miami, FL
Alopecia is one of the most distressing side effects of antineoplastic therapy for which there is no
interventional approach. Great strides have been made in the field of chemotherapy-induced alope-
cia (CIA) using the young rat model, the only CIA model which has been directly correlated with
humans. The Hairmax LaserComb is a device which has been used to promote regrowth of hair in
androgenetic alopecia. Furthermore, we have demonstrated that the LaserComb induced hair growth
in a time-dependent manner in alopecic lesions in the C3H/HeJ mouse model of Alopecia Areata.
In the current study, we have applied these findings in a model of Post-Chemotherapy Alopecia
(PCA). To this effect we have employed the young rat model of CIA using cyclophosphamide,
etoposide, and a combination of cyclophosphamide and paclitaxel. Rats were randomized into three
cohorts: one received chemotherapy alone; the other received immediate treatment with the Hair-
max LaserComb daily for 10 days turned off and the third was treated with the LaserComb turned
on. Seven to ten days later, grade four alopecia ensued in all groups. The group receiving treatment
with the Hairmax Lasercomb regrew the hair 5 days earlier than the untreated and sham groups.
These findings were confirmed by histopathology. Thus, treatment with the Hairmax Lasercomb may
provide a means of accelerating hair regrowth in PCA. These findings should be extrapolated to the
treatment of PCA in patients because the Hairmax Lasercomb provides a user friendly and non-inva-
sive approach which could be translated to increased patient compliance and improved efficacy.
444
Intu controls hair follicle formation through regulating primary cilia formation in epidermal
keratinocytes
D Dai,1 L Li,1 H Zeng,2 A Liu2 and J Chen1 1 Department of Dermatology and Charles C. Gates
Center for Regenerative Medicine   and Stem Cell Biology, University of Colorado Denver,
Aurora, CO and 2 Department of Biology, Pennsylvania State University, University Park, PA
Planar cell polarity (PCP) signaling, a form of non-canonical Wnt (Wnt/PCP) signaling, is an evolu-
tionarily conserved signaling mechanism, controlling hair follicle orientation and differentiation in
mice. Recently, we discovered that Fuz, a tissue-specific PCP effector gene of the PCP signaling
pathway, is required for hair follicle differentiation by controlling primary cilia formation and hedge-
hog signaling. To further determine if this group of tissue-specific PCP effector genes has conserved
functions in hair follicle formation, we investigated the role of Intu, another known mammalian tis-
sue-specific PCP effector gene, during hair follicle formation. Disruption of Intu in the epidermis
resulted in a reduced number of hair follicles, and the developmental stages of the hair follicles that
formed were also significantly delayed in both embryonic and newborn skin. Consistent with these
observations, we discovered that the primary cilia present on epidermal keratinocytes and cells
within the hair follicles were severely truncated. Therefore, these results for Intu, taken together with
our recently reported findings for Fuz, suggest that tissue-specific PCP effector genes of the PCP sig-
naling pathway use a common mechanism to control the development of hair follicles.
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Epidermal DN-Mastermind-like 1 induces skin carcinomas, hair defects, and genital abnor-
malities
X Yang, L Zhao, H Nishida, T Dentchev, W Pear, S Millar and J Seykora Dermatology, Univ. of
Pennsylvania, Philadelphia, PA
Notch regulates key processes in the skin including cell fate decisions, hair follicle maintenance,
and neoplasia. Canonical Notch signaling can be blocked by expressing dominant-negative mas-
termind-like 1 (DNMAML1). We hypothesized that canonical Notch signaling is important for epi-
dermal and hair follicle homeostasis. To evaluate this hypothesis, we blocked canonical Notch sig-
naling in the hair follicles and epidermis by overexpressing dominant-negative Mastermind-like 1
(DNMAML1) in keratin 14 expressing cells using a K14-Cre; ROSA-lox p stop-DNMAML1 system.
Increased DNMAML1 expression in resulted in a complex hair phenotype and epidermal hyper-
plasia. K14-Cre/DNMAML1 mice demonstrated shortened hair by day 10 and a cyclical alopecia
initiating at day 20 during telogen. Hair regrowth occurred during the second hair cycle followed
by alopecia during telogen of the second hair cycle. Persistent alopecia associated with loss of hair
shafts and keratin cyst formation occurred after the second hair cycle. Hair pull analysis at day 18
demonstrated marked abnormalities in the shape, cortical thickness, length, and hair shaft pig-
mentation consistent with multiple deficits in hair shaft differentiation. Deficient anchoring of tel-
ogen hairs was confirmed using a ‘scotch-tape test’ and histology revealed follicular acantholysis.
K14-Cre/DNMAML1 mice were 70% smaller at day 40 than single transgenic littermate controls,
p = 0.006. K14-Cre/DNMAML1 mice demonstrate cutaneous pustules consistent with acute folli-
culitis on the snout and genital regions after six months. K14-Cre/DNMAML1 mice spontaneously
developed well-differentiated cutaneous squamous cell carcinomas resembling keratoacanthomas
between 12-15 months. Female K14-Cre/DNMAML1 mice exhibited malformed external genitalia
and were infertile. Aged-matched single transgenic controls did not demonstrate these phenotypes
(N > 50). In summary, canonical Notch signaling is critical for hair shaft and hair follicle mainte-
nance, epidermal homeostasis, and female genital development.
459
Early loss of sebaceous gland in scarring alopecia
T Al-Zaid,1 S Vanderweil,2 Z Guo,2 A Zembowicz3 and S Lyle2 1 MD Anderson Cancer Center,
Houston, TX, 2 Cancer Biology, UMass Medical School, Worcester, MA and 3 Dept. of
Pathology, Lahey Clinic, Tufts Univ. Medical Center, Burlington, MA
Primary scarring alopecias comprise a group of disorders with poorly defined etiologies. Improv-
ing diagnostic and therapeutic capabilities requires a better understanding of their pathogenesis. To
assess the frequency and timing of sebaceous gland loss in scarring alopecia and to identify the role
of sebaceous gland and sebaceous gland duct inflammation in the pathogenesis of scarring alope-
cia, we evaluated 90 biopsy specimens submitted with a clinical history of alopecia (both scarring
and non-scarring). Samples were scored based upon sebaceous gland, sebaceous duct, and folli-
cle inflammation. Sebaceous gland loss was much more common in cases of scarring alopecia
(>53% of follicles on average) than non-scarring alopecia (<5% of follicles on average). Many
cases of scarring alopecia showed residual affected follicles with an absence of sebaceous glands.
In cases of early follicular degeneration syndrome (central centrifugal cicatricial alopecia) some
affected follicles show absence of sebaceous gland yet presence of keratin 15-positive bulge stem
cells suggesting that gland destruction is an early event and not secondary to stem cell depletion.
Sebaceous gland duct inflammation was also more frequent and severe than gland inflammation in
scarring alopecia. This study demonstrates that sebaceous gland loss is a common and early find-
ing among scarring alopecias. Additionally, sebaceous gland and/or duct inflammation may play a
role in initiating or accelerating follicular damage during the development of scarring alopecia.
461
Positive and negative effects of RAS on Shh transcription are both mediated through ETV4
A Mukhopadhyay,1,2,3 SR Krishnaswami,1,2,3 CC Zitron,1,2,3 S Kumar1,2,3 and BD Yu1,2,3 1
Dermatology, Medicine, University of California, San Diego, San Diego, CA, 2 UCSD Institute
for Genomic Medicine, UCSD, San Diego, CA and 3 UCSD Stem Cell Program, UCSD, San
Diego, CA
Activating mutations in RAS (KRAS, HRAS and NRAS) can be found in approximately one-third of
all human cancers. Germline mutations in RAS are also associated with congenital defects in syn-
dromes known as RAS/MAPK syndromes. Understanding how these developmental defects occur,
is important to identifying in vivo downstream effectors of overactive RAS. Recently, KRAS was
reported to play a role in activating SHH expression in the setting of pancreatic cancer. In this
study, we examine whether KRAS plays a similar role in the hair follicle. Surprisingly, we find that
mouse hair follicles expressing the activated KrasG12D express approximately five-fold less Shh.
Moreover, treatment of wildtype hair follicles, with growth factors including FGF2, FGF7, FGF10,
EGF, or PDGF, rapidly repress Shh transcription (within 30-90 minutes). Moreover, pharmacologic
inhibition of BRAF/MEK or PI-3-kinase results in a 2 to 3-fold increase in Shh transcription. These
findings indicate that KRAS has an opposite role in regulating Shh in the hair follicle than in pan-
creatic cancer. To further study the transcriptional mechanisms of Shh regulation, multiple cell lines
were screened to identify cells which demonstrate this activity. We found that some cell lines demon-
strate Shh repression in response to RAS stimulation, while others respond by inducing Shh. Sur-
prisingly, we found that ETV4, a transcription factor which responds to RAS stimulation, mediates
both activating and repressing activities depending on the cellular context. Overexpression of
ETV4 results in a 2-fold decrease in Shh transcription in a breast cancer model, MCF7, while in a
lung cancer model, H2199, ETV4 induces a 3-fold increase in Shh transcription. Furthermore, we
identify a proximal promoter region, which appears to regulate both responses. In summary, RAS
activates and represses Shh transcription via ETV4 in cell type specific manner.
460
Constitutive expression of Aryl Hydrocarbon Receptor in keratinocytes causes scarring Alope-
cia
SP Panicker,1 T Ganguly,1 AA Lattif,1 MC Consolo,1 M Yamamoto,3 K Honda1,2 and P Karnik1,2 1
Dermatology, Case Western Reserve Univ, Cleveland, OH, 2 Univ Hosp Case Med Ctr,
Cleveland, OH and 3 Center for TARA, Univ of Tsukuba, Tsukuba, Japan
We previously showed that there is a mutual repression between PPARγ and AhR in hair follicle
outer root sheath cells and that the loss of PPARγ signaling in primary cicatricial alopecia may be
caused by negative feed-back regulation of Aryl Hydrocarbon Receptor (AhR). AhR is a ligand-acti-
vated transcription factor that plays a major role in the regulation of stem cell populations and in
the mediation of xenobiotic metabolism. Here, we investigate the direct contribution of the AhR
signaling pathway to hair follicles in transgenic mice that constitutively express AhR in keratinocytes
under the regulation of the keratin 14 promoter. The phenotype of the AhR transgenic mice resem-
bles human scarring alopecia and displays the following: Progressive alopecia after 5 weeks end-
ing with total alopecia by 7-10 weeks, histology of hair follicles show follicular cysts, perifollicular
inflammation, loss of sebaceous glands, and follicular scarring in advanced disease, and decreased
PPARγ signaling and cholesterol biosynthesis and increased expression of connective tissue genes
reminiscent of that seen in human scalp biopsies of cicatricial alopecia patients. This mouse model
provides strong evidence that the AhR signaling pathway and cholesterol biosynthesis intermedi-
ates may be critical inducers of scarring alopecia. These studies suggest a novel mechanism for the
etiology of cicatricial alopecia after exposure to occupational and environmental xenobiotics.
458
Pharmacodynamic effects on anagen inhibition after oral administration of the Smoothened
inhibitors LDE225 or GDC0449.
FS Kalthoff, H Aschauer, E Foglar, L Mudde-Boer, N Schoefmann, P Stuchlik, A Stuetz and B Wolff-
Winiski Dermatology, Novartis Institutes for Biomedical Research, Vienna, Austria
Uncontrolled activation of Smoothened (Smo) due to mutations of the tumor suppressor gene Patched1
(Ptch1) may lead to Hedgehog pathway-dependent cancer growth. LDE225 and GDC0449 are potent
and specific antagonists of Hedgehog (Hh) signaling via direct inhibition of Smo. Both drugs are
now in clinical development for advanced solid tumors and a topical formulation of LDE225 is also
developed for Basal Cell Carcinoma. Given the relevance of the Hh pathway to the anagen phase
of the hair growth cycle, the efficacies of orally administered LDE225 and GDC0449 to inhibit Hh
pathway-activated genes and hair re-growth in depilated C57BL/6 mice were compared. Both
drugs were fed by gavage once daily for 10 days to different cohorts of mice (n=9 each) using 2 dif-
ferent doses (10 or 20mg/kg for LDE225, and 20 or 50mg/kg for GDC0449). One cohort received
vehicle solution only. Even when used at 50mg/kg, GDC0449 was less efficacious in inhibiting the
switch to anagen and hair growth than the 20mg/kg dose of LDE225, as seen by daily scoring of
skin pigmentation intensity during treatment and the photographic documentation of visible hair
growth on day 10. Hh-induced gene expression was assessed using RNA prepared from skin biop-
sies taken after the last dose on day 10. Quantitative RT-PCR revealed that Gli1, Gli2 and N-myc
were almost completely in the 20mg/kg LDE225 cohort, in contrast to the cohort dosed at 50mg/kg
GDC0449, which showed 49% inhibition for Gli1 and only 35% reduction for Gli2 and N-myc.
Moreover, dose-dependency of Hh target gene inhibition was seen for LDE225 but not GDC0449.
When comparing the 20mg/kg dose levels for both drugs, GDC0449 yielded two-fold higher blood
exposures in samples drawn 2 hours after the last dose on day 10. Conversely, LDE225 yielded 7-
fold higher skin concentrations than GDC0449. These data demonstrate that LDE225 preferentially
distributes to skin and is more efficacious in prevention of anagen hair growth and Hh gene acti-
vation than GDC0449.
462
Regulation of hair morphology by the dermal papilla.
W Chi,1,2 D Enshell-Seijffers1,2 and BA Morgan1,2 1 Cutaneous Biology Research Center,
Harvard Medical School, Boston, MA and 2 Mass General Hospital, Boston, MA
The activity of keratinocytes in the hair follicle is regulated in part by signals from the dermal
papilla (DP). By ablating single genes in the DP and characterizing the resultant changes in DP
gene expression and keratinocyte behavior, we have begun to unravel the complex feedback between
these two compartments that controls the size, shape and growth rate of the hair generated during
the anagen phase. Pigmentation of the hair shaft is also regulated in part by the DP through mech-
anisms that are coupled to those regulating hair growth. Deletion of Sox2 specifically in the der-
mal papilla in vivo reveals a complex role for this transcription factor in regulating both hair mor-
phology and pigmentation that will be discussed in the context of signal integration in the DP.
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Regulation of hair growth by microRNA miR-31: Implications of its target gene STK40
T Andl and L Luan Vanderbilt University, Nashville, TN
Hair follicle formation and growth are complex processes requiring the execution of well-orches-
trated and tightly controlled gene expression. A major improvement of the accuracy of elaborate
genetic programs has been made possible by the emergence of microRNAs (miRNAs) during evo-
lution. Hair follicles are one of the most complex mini-organs of mammals and require miRNAs for
their formation and maintenance. However, there are few data indentifying individual miRNAs
important for hair follicle biology. A promising candidate miRNA is miR-31. Therefore, we have
developed a mouse model for overexpression of miR-31 in the skin. Induction of miR-31 during
embryogenesis results in the loss of hair follicles. Its postnatal induction prevents normal hair growth
during the natural hair growth cycle and after hair plucking and eventually leads to hair loss. miR-
31 overexpression during wound healing and wound induced hair follicle neogenesis leads to
massive proliferation in hair follicles and eventually the formation of pseudoepitheliomatous hyper-
plasia/keratoacanthoma. Therefore, we tested the expression of miR-31 in human BCCs and skin
SCCs and found that miR-31 expression is up-regulated on average about 60-fold. Similarly, in
healing burn wounds and verruca vulgaris we can detect induction of miR-31 expression. To define
the mechanisms underlying miR-31 induction, we identified TGFbeta and the combination of TGF-
beta and EGF as inducers of miR-31 expression in HaCaT cells, while KGF suppresses miR-31. Since
the main function of miRNAs is to post-transcriptionally regulated the stability of mRNAs through
directing the RNA-induced silencing complex (RISC) toward the 3’ untranslated region (UTR) of
target mRNAs, we tested 16 3’UTRs of predicted miR-31 target genes. STK40, a kinase-dead mem-
ber of serine/threonine kinase family, was the most miR-31-responsive gene in HaCaT cells and pri-
mary human keratinocytes. STK40 is a modulator of NFkB signaling and is highly expressed in
embryonal mouse epidermis. STK40 therefore may play a pivotal role in hair follicle biology and
skin tumorigenesis and is regulated by miR-31.
452
Efficiency and efficacy of hair regeneration: Effect of dermal papilla cells on hair inductivity
and quality
C Chan,1,2 W Lin,1 J Chan,3 T Tsai4 and S Lin1,2 1 Institute of Biomedical Engineering, National
Taiwan University, Taipei, Taiwan, 2 Dermatology, National Taiwan University Hospital &
College of Medicine, Taipei, Taiwan, 3 Dermatology, Cathay General Hospital, Taipei, Taiwan
and 4 Dermatology, Far Eastern Memorial Hospital, New Taipei, Taiwan
A reliable efficiency and the ability to control of the quality of regenerated hairs are vital to future
application of bioengineering for hair follicle (HF) regeneration. Dermal papilla (DP) cells are able
to induce HF neogenesis when transplanted as aggregates. However, the effect of DP quality on
inductivity and quality of hairs is yet to be determined. A scalable method for generation of qual-
ity-controlled DP microtissues is needed for reproducible experiments and clinical trials. Here we
demonstrate a method enabling simple mass preparation of quality-controlled DP microtissues.
We found hydrophilic poly-vinyl alcohol (PVA) is non-adhesive to DP as compared to hydropho-
bic poly-ethylene or polystyrene culture plates. DP cells do not attach on PVA-coated commercially
available PCR tubes and quickly aggregate into single spheroidal microtissues in the limited space.
The volume of microtissue shows dynamic change due to tissue compaction. Varying seeded cell
number and culture period enables us to generate DP microtissues of controllable size/cell num-
ber. Compared with hanging drop method, DP microtissues obtained here have higher viability
and preserve DP signature gene expression. A proof of principle experiment demonstrated the
quality of DP microtissues on HF regeneration. Both human and rat DP microtissues are able to
induce HF neogenesis, but induction efficiency varies between DP cells of different origin. For DP
microtissues from each cell origin, efficiency of HF regeneration is progressively enhanced by increas-
ing size/cell number in each microtissue until an optimal size/cell number is reached. However,
the quality/size of the regenerated hairs seems to be stochastic and does not correlate with size/cell
number in preformed DP spheroid.Our results have implications on the controllability in efficiency
and quality of HF regeneration via bioengineering.
453
The presence of antigen-specific CTLs to melanin-associated protein, MAGE3, in the patients
with alopecia areata
T Ito, H Hashizume, M Takigawa and Y Tokura Dermatology, Hamamatsu University School of
Medinine, Hamamatsu, Japan
Recent studies have revealed that alopecia areata (AA) is a tissue-restricted autoimmune disease and
possibly induced by melanin-associated autoantigens such as tyrosinase, MART-1, TRP-2, and MAGEs.
In this study, we analyzed melanin-specific CTLs using MHC Class I Pro5-Pentamers that bind directly
to T cell receptors, determined by the MHC allele and peptide combination. PBMCs obtained from
healthy control and patients with AA multiplex or alopecia totalis (AT) with HLA-A0201 were stained
with anti-CD8, anti-CD45 and MHC Class I Pro5-Pentamers for Mart-1 (ELAGIGILTV). PBMCs from
control/patients with HLA-2402 were stained with anti-CD8, anti-CD45 and MHC Class I Pro5-Pen-
tamers for tyrosinase (AFLPWHRLF), MAGE2 (EYLQLVFGI), MAGE3 (IMPKAGLLI). The ratio of MAGE3
specific CD8+ T cells from PBMC was significantly higher in acute phase AA multiplex and AT
patients compared to healthy control. However, chronic phase AA did not show any difference
against healthy control. There were no significant results of specific CTLs to MAGE2, tyrosinase and
Mart1 except for one patient who are suffered from not only AA but also vitiligo. This patient showed
higher number of CTLs against tyrosinase. So far, MAGE3 has been detected in testis and malignant
tumors such as melanoma. However, there has been no report of MAGE3 expression in human skin
tissue. This is the first report of immunoreactivity and mRNA expression of MAGE3 in AA lesions.
Skin-infiltrating cells obtained from acute AA patient were co-cultured with MAGE3 for 8hrs and
then, stimulated with anti CD3 antibody. Intracellular IFN-γ expression in CD8+ T cells was signif-
icantly higher than healthy control. After the treatment with SADBE, the number of MAGE3-spe-
cific CTLs was reduced with remarkable improvement of hair loss in AA patient. Taken together, the
patients with acute phase AT/AA multiplex may have higher number of specific CTLs against melanin-
associated hair follicle autoantigens which induce autoimmune reaction against hair follicles.
454
Protection from free radical formation on the scalp
F Liebel, G Nystrand and P Bargo Johnson & Johnson Consumer Products, Inc., Skillman, NJ
Hair is a protective barrier for the body against external aggressors such as solar radiation. People
with bald scalps or thinning hair do not benefit from this protective barrier. It is known that solar
exposure can induce oxidative stress to the skin; however not many studies have examined the
potential for oxidative damage to the scalp. Free radicals produced by these stressors can lead to
the generation of pro-inflammatory cytokines, MMP’s and the breakdown of collagen and elastin.
They can also inhibit proliferation and induce apoptosis in hair follicles. In order to determine
whether scalp skin is a potential target of oxidative stress, we developed a non-invasive method to
assess the generation of free radicals from measuring the chemiluminescence signal in skin. Sig-
nificant free-radical production was detected from the scalp after exposure to dose of visible light
(400-700nm). Traditional sunscreens block only the UV (290-400um) wavelengths of solar light,
leaving the longer wavelengths to stimulate and produce free radicals in the skin. A photostable
UVA/UVB sunscreen combined with a triple combination of natural antioxidants including a Partheno-
lide-free Feverfew Extract, a natural extract known to be a potent antioxidant, was developed to
reduce the production of free radicals from the scalp. Topical application of the triple antioxidant
sunscreen significantly reduced the amount of generated free radicals on the scalp. These results
demonstrate that the scalps of men and women with thinning to bald scalps are a potential target
of oxidative damage. Excessive damage to the hair follicle could lead to decreased proliferation
and be a contributing factor to hair loss. This study suggests the need for a sunscreen with potent
antioxidants to protect the scalp from the free radical induced damage from solar exposure.
455
Trps1 and its target gene Sox9 regulate epithelial proliferation in the developing hair follicle
and are associated with hypertrichosis
KA Fantauzzo1 and AM Christiano1,2 1 Dermatology, Columbia University, New York, NY and
2 Genetics and Development, Columbia University, New York, NY
Trichorhinophalangeal syndrome I (TRPS1) is a vertebrate transcription factor that is expressed in
the dermal papilla and proliferative epithelial cells of adult mouse and human hair follicles. Here,
we aimed to define the function of Trps1 in the developing hair follicle and identify the transcrip-
tional targets through which Trps1 exerts its effect. We found that mice in which the GATA domain
of Trps1 has been deleted (Trps1Δgt) have a reduced number of vibrissae follicles during embryoge-
nesis which are irregularly-spaced and smaller than wild-type vibrissae. Immunofluorescence analy-
ses revealed that Trps1 Δgt/Δgt vibrissae exhibit increased proliferation and decreased expression of
Shh. We demonstrated that Trps1 and Shh colocalize in the matrix and inner root sheath of vibris-
sae in ShhIres-nLacZ reporter mice. Quantitative RT-PCR analyses revealed reduced expression of mul-
tiple Shh pathway transcripts in Trps1Δgt/Δgt whisker pads, and co-immunoprecipitation assays indi-
cated that Trps1 forms stable complexes with Gli2. Additionally, we demonstrated that the ShhGFP-cre
null allele is able to rescue the vibrissae phenotype of Trps1Δgt embryos in compound heterozygous
mice. Sox9 is a transcription factor required for specification of hair follicle stem cells whose expres-
sion depends on Shh signaling. We found that Sox9 was upregulated in Trps1Δgt/Δgt vibrissae and we
showed that Trps1 binds consensus GATA sequences in the SOX9 promoter and represses its tran-
scription in a dose-dependent manner. We identified a copy number variation less than 1 Mb upstream
of SOX9 in a family with congenital universal hypertrichosis. We have previously shown that a
position effect on TRPS1 is associated with hypertrichosis. Our findings uncover a novel transcrip-
tional regulatory hierarchy in the hair follicle in which Trps1, Shh and Sox9 regulate epithelial pro-
liferation and contribute to hair follicle density.
456
Lhx2 is a part of the hair follicle-specific signaling/transcription network and regulates expres-
sion of stem cell-associated genes during skin development and regeneration
A Mardaryev,1 K Poterlowicz,1 T Sharova,2 M Fessing,1 A Sharov2 and V Botchkarev1,2 1 Centre
for Skin Sciences, University of Bradford, Bradford, United Kingdom and 2 Dermatology,
Boston University, Boston, MA
During skin development, multi-potent progenitor cells establish distinct programs of gene expres-
sion specifying their differentiation into specialized cell types. Lhx2 transcription factor is expressed
in the epithelial bud of the developing hair follicles, and in the bulge/secondary germ of telogen
hair follicles. Based on the global microarray profiling of the epithelial buds and bulge/secondary
germ cells obtained by laser capture microdissection, we reconstructed the signaling networks dis-
tinct for the embryonic and postnatal hair follicle progenitor cells. Lhx2 forms an epithelial bud-
specific network and interacts with key signaling pathways involved in the control of hair follicle
development. In postnatal skin, Lhx2 forms stem cell-specific network and regulate expression of
the selected stem cell markers (Sox9, Tcf4, Lgr5) in epithelial progenitor cells. During wound heal-
ing, Lhx2 promotes re-epithelization via positive regulation of Sox9 and Tcf4, while it simultane-
ously inhibits hair follicle cycling via negative regulation of Lgr5. Thus, Lhx2 is an important com-
ponent of the signaling/ transcription networks that control hair follicle development and cycling.
Lhx2 also operates as a switchboard regulator of epithelial stem cell activity during skin response
to injury.
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Epidermal DN-Mastermind-like 1 induces skin carcinomas, hair defects, and genital abnor-
malities
X Yang, L Zhao, H Nishida, T Dentchev, W Pear, S Millar and J Seykora Dermatology, Univ. of
Pennsylvania, Philadelphia, PA
Notch regulates key processes in the skin including cell fate decisions, hair follicle maintenance,
and neoplasia. Canonical Notch signaling can be blocked by expressing dominant-negative mas-
termind-like 1 (DNMAML1). We hypothesized that canonical Notch signaling is important for epi-
dermal and hair follicle homeostasis. To evaluate this hypothesis, we blocked canonical Notch sig-
naling in the hair follicles and epidermis by overexpressing dominant-negative Mastermind-like 1
(DNMAML1) in keratin 14 expressing cells using a K14-Cre; ROSA-lox p stop-DNMAML1 system.
Increased DNMAML1 expression in resulted in a complex hair phenotype and epidermal hyper-
plasia. K14-Cre/DNMAML1 mice demonstrated shortened hair by day 10 and a cyclical alopecia
initiating at day 20 during telogen. Hair regrowth occurred during the second hair cycle followed
by alopecia during telogen of the second hair cycle. Persistent alopecia associated with loss of hair
shafts and keratin cyst formation occurred after the second hair cycle. Hair pull analysis at day 18
demonstrated marked abnormalities in the shape, cortical thickness, length, and hair shaft pig-
mentation consistent with multiple deficits in hair shaft differentiation. Deficient anchoring of tel-
ogen hairs was confirmed using a ‘scotch-tape test’ and histology revealed follicular acantholysis.
K14-Cre/DNMAML1 mice were 70% smaller at day 40 than single transgenic littermate controls,
p = 0.006. K14-Cre/DNMAML1 mice demonstrate cutaneous pustules consistent with acute folli-
culitis on the snout and genital regions after six months. K14-Cre/DNMAML1 mice spontaneously
developed well-differentiated cutaneous squamous cell carcinomas resembling keratoacanthomas
between 12-15 months. Female K14-Cre/DNMAML1 mice exhibited malformed external genitalia
and were infertile. Aged-matched single transgenic controls did not demonstrate these phenotypes
(N > 50). In summary, canonical Notch signaling is critical for hair shaft and hair follicle mainte-
nance, epidermal homeostasis, and female genital development.
459
Early loss of sebaceous gland in scarring alopecia
T Al-Zaid,1 S Vanderweil,2 Z Guo,2 A Zembowicz3 and S Lyle2 1 MD Anderson Cancer Center,
Houston, TX, 2 Cancer Biology, UMass Medical School, Worcester, MA and 3 Dept. of
Pathology, Lahey Clinic, Tufts Univ. Medical Center, Burlington, MA
Primary scarring alopecias comprise a group of disorders with poorly defined etiologies. Improv-
ing diagnostic and therapeutic capabilities requires a better understanding of their pathogenesis. To
assess the frequency and timing of sebaceous gland loss in scarring alopecia and to identify the role
of sebaceous gland and sebaceous gland duct inflammation in the pathogenesis of scarring alope-
cia, we evaluated 90 biopsy specimens submitted with a clinical history of alopecia (both scarring
and non-scarring). Samples were scored based upon sebaceous gland, sebaceous duct, and folli-
cle inflammation. Sebaceous gland loss was much more common in cases of scarring alopecia
(>53% of follicles on average) than non-scarring alopecia (<5% of follicles on average). Many
cases of scarring alopecia showed residual affected follicles with an absence of sebaceous glands.
In cases of early follicular degeneration syndrome (central centrifugal cicatricial alopecia) some
affected follicles show absence of sebaceous gland yet presence of keratin 15-positive bulge stem
cells suggesting that gland destruction is an early event and not secondary to stem cell depletion.
Sebaceous gland duct inflammation was also more frequent and severe than gland inflammation in
scarring alopecia. This study demonstrates that sebaceous gland loss is a common and early find-
ing among scarring alopecias. Additionally, sebaceous gland and/or duct inflammation may play a
role in initiating or accelerating follicular damage during the development of scarring alopecia.
461
Positive and negative effects of RAS on Shh transcription are both mediated through ETV4
A Mukhopadhyay,1,2,3 SR Krishnaswami,1,2,3 CC Zitron,1,2,3 S Kumar1,2,3 and BD Yu1,2,3 1
Dermatology, Medicine, University of California, San Diego, San Diego, CA, 2 UCSD Institute
for Genomic Medicine, UCSD, San Diego, CA and 3 UCSD Stem Cell Program, UCSD, San
Diego, CA
Activating mutations in RAS (KRAS, HRAS and NRAS) can be found in approximately one-third of
all human cancers. Germline mutations in RAS are also associated with congenital defects in syn-
dromes known as RAS/MAPK syndromes. Understanding how these developmental defects occur,
is important to identifying in vivo downstream effectors of overactive RAS. Recently, KRAS was
reported to play a role in activating SHH expression in the setting of pancreatic cancer. In this
study, we examine whether KRAS plays a similar role in the hair follicle. Surprisingly, we find that
mouse hair follicles expressing the activated KrasG12D express approximately five-fold less Shh.
Moreover, treatment of wildtype hair follicles, with growth factors including FGF2, FGF7, FGF10,
EGF, or PDGF, rapidly repress Shh transcription (within 30-90 minutes). Moreover, pharmacologic
inhibition of BRAF/MEK or PI-3-kinase results in a 2 to 3-fold increase in Shh transcription. These
findings indicate that KRAS has an opposite role in regulating Shh in the hair follicle than in pan-
creatic cancer. To further study the transcriptional mechanisms of Shh regulation, multiple cell lines
were screened to identify cells which demonstrate this activity. We found that some cell lines demon-
strate Shh repression in response to RAS stimulation, while others respond by inducing Shh. Sur-
prisingly, we found that ETV4, a transcription factor which responds to RAS stimulation, mediates
both activating and repressing activities depending on the cellular context. Overexpression of
ETV4 results in a 2-fold decrease in Shh transcription in a breast cancer model, MCF7, while in a
lung cancer model, H2199, ETV4 induces a 3-fold increase in Shh transcription. Furthermore, we
identify a proximal promoter region, which appears to regulate both responses. In summary, RAS
activates and represses Shh transcription via ETV4 in cell type specific manner.
460
Constitutive expression of Aryl Hydrocarbon Receptor in keratinocytes causes scarring Alope-
cia
SP Panicker,1 T Ganguly,1 AA Lattif,1 MC Consolo,1 M Yamamoto,3 K Honda1,2 and P Karnik1,2 1
Dermatology, Case Western Reserve Univ, Cleveland, OH, 2 Univ Hosp Case Med Ctr,
Cleveland, OH and 3 Center for TARA, Univ of Tsukuba, Tsukuba, Japan
We previously showed that there is a mutual repression between PPARγ and AhR in hair follicle
outer root sheath cells and that the loss of PPARγ signaling in primary cicatricial alopecia may be
caused by negative feed-back regulation of Aryl Hydrocarbon Receptor (AhR). AhR is a ligand-acti-
vated transcription factor that plays a major role in the regulation of stem cell populations and in
the mediation of xenobiotic metabolism. Here, we investigate the direct contribution of the AhR
signaling pathway to hair follicles in transgenic mice that constitutively express AhR in keratinocytes
under the regulation of the keratin 14 promoter. The phenotype of the AhR transgenic mice resem-
bles human scarring alopecia and displays the following: Progressive alopecia after 5 weeks end-
ing with total alopecia by 7-10 weeks, histology of hair follicles show follicular cysts, perifollicular
inflammation, loss of sebaceous glands, and follicular scarring in advanced disease, and decreased
PPARγ signaling and cholesterol biosynthesis and increased expression of connective tissue genes
reminiscent of that seen in human scalp biopsies of cicatricial alopecia patients. This mouse model
provides strong evidence that the AhR signaling pathway and cholesterol biosynthesis intermedi-
ates may be critical inducers of scarring alopecia. These studies suggest a novel mechanism for the
etiology of cicatricial alopecia after exposure to occupational and environmental xenobiotics.
458
Pharmacodynamic effects on anagen inhibition after oral administration of the Smoothened
inhibitors LDE225 or GDC0449.
FS Kalthoff, H Aschauer, E Foglar, L Mudde-Boer, N Schoefmann, P Stuchlik, A Stuetz and B Wolff-
Winiski Dermatology, Novartis Institutes for Biomedical Research, Vienna, Austria
Uncontrolled activation of Smoothened (Smo) due to mutations of the tumor suppressor gene Patched1
(Ptch1) may lead to Hedgehog pathway-dependent cancer growth. LDE225 and GDC0449 are potent
and specific antagonists of Hedgehog (Hh) signaling via direct inhibition of Smo. Both drugs are
now in clinical development for advanced solid tumors and a topical formulation of LDE225 is also
developed for Basal Cell Carcinoma. Given the relevance of the Hh pathway to the anagen phase
of the hair growth cycle, the efficacies of orally administered LDE225 and GDC0449 to inhibit Hh
pathway-activated genes and hair re-growth in depilated C57BL/6 mice were compared. Both
drugs were fed by gavage once daily for 10 days to different cohorts of mice (n=9 each) using 2 dif-
ferent doses (10 or 20mg/kg for LDE225, and 20 or 50mg/kg for GDC0449). One cohort received
vehicle solution only. Even when used at 50mg/kg, GDC0449 was less efficacious in inhibiting the
switch to anagen and hair growth than the 20mg/kg dose of LDE225, as seen by daily scoring of
skin pigmentation intensity during treatment and the photographic documentation of visible hair
growth on day 10. Hh-induced gene expression was assessed using RNA prepared from skin biop-
sies taken after the last dose on day 10. Quantitative RT-PCR revealed that Gli1, Gli2 and N-myc
were almost completely in the 20mg/kg LDE225 cohort, in contrast to the cohort dosed at 50mg/kg
GDC0449, which showed 49% inhibition for Gli1 and only 35% reduction for Gli2 and N-myc.
Moreover, dose-dependency of Hh target gene inhibition was seen for LDE225 but not GDC0449.
When comparing the 20mg/kg dose levels for both drugs, GDC0449 yielded two-fold higher blood
exposures in samples drawn 2 hours after the last dose on day 10. Conversely, LDE225 yielded 7-
fold higher skin concentrations than GDC0449. These data demonstrate that LDE225 preferentially
distributes to skin and is more efficacious in prevention of anagen hair growth and Hh gene acti-
vation than GDC0449.
462
Regulation of hair morphology by the dermal papilla.
W Chi,1,2 D Enshell-Seijffers1,2 and BA Morgan1,2 1 Cutaneous Biology Research Center,
Harvard Medical School, Boston, MA and 2 Mass General Hospital, Boston, MA
The activity of keratinocytes in the hair follicle is regulated in part by signals from the dermal
papilla (DP). By ablating single genes in the DP and characterizing the resultant changes in DP
gene expression and keratinocyte behavior, we have begun to unravel the complex feedback between
these two compartments that controls the size, shape and growth rate of the hair generated during
the anagen phase. Pigmentation of the hair shaft is also regulated in part by the DP through mech-
anisms that are coupled to those regulating hair growth. Deletion of Sox2 specifically in the der-
mal papilla in vivo reveals a complex role for this transcription factor in regulating both hair mor-
phology and pigmentation that will be discussed in the context of signal integration in the DP.
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Regulation of hair growth by microRNA miR-31: Implications of its target gene STK40
T Andl and L Luan Vanderbilt University, Nashville, TN
Hair follicle formation and growth are complex processes requiring the execution of well-orches-
trated and tightly controlled gene expression. A major improvement of the accuracy of elaborate
genetic programs has been made possible by the emergence of microRNAs (miRNAs) during evo-
lution. Hair follicles are one of the most complex mini-organs of mammals and require miRNAs for
their formation and maintenance. However, there are few data indentifying individual miRNAs
important for hair follicle biology. A promising candidate miRNA is miR-31. Therefore, we have
developed a mouse model for overexpression of miR-31 in the skin. Induction of miR-31 during
embryogenesis results in the loss of hair follicles. Its postnatal induction prevents normal hair growth
during the natural hair growth cycle and after hair plucking and eventually leads to hair loss. miR-
31 overexpression during wound healing and wound induced hair follicle neogenesis leads to
massive proliferation in hair follicles and eventually the formation of pseudoepitheliomatous hyper-
plasia/keratoacanthoma. Therefore, we tested the expression of miR-31 in human BCCs and skin
SCCs and found that miR-31 expression is up-regulated on average about 60-fold. Similarly, in
healing burn wounds and verruca vulgaris we can detect induction of miR-31 expression. To define
the mechanisms underlying miR-31 induction, we identified TGFbeta and the combination of TGF-
beta and EGF as inducers of miR-31 expression in HaCaT cells, while KGF suppresses miR-31. Since
the main function of miRNAs is to post-transcriptionally regulated the stability of mRNAs through
directing the RNA-induced silencing complex (RISC) toward the 3’ untranslated region (UTR) of
target mRNAs, we tested 16 3’UTRs of predicted miR-31 target genes. STK40, a kinase-dead mem-
ber of serine/threonine kinase family, was the most miR-31-responsive gene in HaCaT cells and pri-
mary human keratinocytes. STK40 is a modulator of NFkB signaling and is highly expressed in
embryonal mouse epidermis. STK40 therefore may play a pivotal role in hair follicle biology and
skin tumorigenesis and is regulated by miR-31.
452
Efficiency and efficacy of hair regeneration: Effect of dermal papilla cells on hair inductivity
and quality
C Chan,1,2 W Lin,1 J Chan,3 T Tsai4 and S Lin1,2 1 Institute of Biomedical Engineering, National
Taiwan University, Taipei, Taiwan, 2 Dermatology, National Taiwan University Hospital &
College of Medicine, Taipei, Taiwan, 3 Dermatology, Cathay General Hospital, Taipei, Taiwan
and 4 Dermatology, Far Eastern Memorial Hospital, New Taipei, Taiwan
A reliable efficiency and the ability to control of the quality of regenerated hairs are vital to future
application of bioengineering for hair follicle (HF) regeneration. Dermal papilla (DP) cells are able
to induce HF neogenesis when transplanted as aggregates. However, the effect of DP quality on
inductivity and quality of hairs is yet to be determined. A scalable method for generation of qual-
ity-controlled DP microtissues is needed for reproducible experiments and clinical trials. Here we
demonstrate a method enabling simple mass preparation of quality-controlled DP microtissues.
We found hydrophilic poly-vinyl alcohol (PVA) is non-adhesive to DP as compared to hydropho-
bic poly-ethylene or polystyrene culture plates. DP cells do not attach on PVA-coated commercially
available PCR tubes and quickly aggregate into single spheroidal microtissues in the limited space.
The volume of microtissue shows dynamic change due to tissue compaction. Varying seeded cell
number and culture period enables us to generate DP microtissues of controllable size/cell num-
ber. Compared with hanging drop method, DP microtissues obtained here have higher viability
and preserve DP signature gene expression. A proof of principle experiment demonstrated the
quality of DP microtissues on HF regeneration. Both human and rat DP microtissues are able to
induce HF neogenesis, but induction efficiency varies between DP cells of different origin. For DP
microtissues from each cell origin, efficiency of HF regeneration is progressively enhanced by increas-
ing size/cell number in each microtissue until an optimal size/cell number is reached. However,
the quality/size of the regenerated hairs seems to be stochastic and does not correlate with size/cell
number in preformed DP spheroid.Our results have implications on the controllability in efficiency
and quality of HF regeneration via bioengineering.
453
The presence of antigen-specific CTLs to melanin-associated protein, MAGE3, in the patients
with alopecia areata
T Ito, H Hashizume, M Takigawa and Y Tokura Dermatology, Hamamatsu University School of
Medinine, Hamamatsu, Japan
Recent studies have revealed that alopecia areata (AA) is a tissue-restricted autoimmune disease and
possibly induced by melanin-associated autoantigens such as tyrosinase, MART-1, TRP-2, and MAGEs.
In this study, we analyzed melanin-specific CTLs using MHC Class I Pro5-Pentamers that bind directly
to T cell receptors, determined by the MHC allele and peptide combination. PBMCs obtained from
healthy control and patients with AA multiplex or alopecia totalis (AT) with HLA-A0201 were stained
with anti-CD8, anti-CD45 and MHC Class I Pro5-Pentamers for Mart-1 (ELAGIGILTV). PBMCs from
control/patients with HLA-2402 were stained with anti-CD8, anti-CD45 and MHC Class I Pro5-Pen-
tamers for tyrosinase (AFLPWHRLF), MAGE2 (EYLQLVFGI), MAGE3 (IMPKAGLLI). The ratio of MAGE3
specific CD8+ T cells from PBMC was significantly higher in acute phase AA multiplex and AT
patients compared to healthy control. However, chronic phase AA did not show any difference
against healthy control. There were no significant results of specific CTLs to MAGE2, tyrosinase and
Mart1 except for one patient who are suffered from not only AA but also vitiligo. This patient showed
higher number of CTLs against tyrosinase. So far, MAGE3 has been detected in testis and malignant
tumors such as melanoma. However, there has been no report of MAGE3 expression in human skin
tissue. This is the first report of immunoreactivity and mRNA expression of MAGE3 in AA lesions.
Skin-infiltrating cells obtained from acute AA patient were co-cultured with MAGE3 for 8hrs and
then, stimulated with anti CD3 antibody. Intracellular IFN-γ expression in CD8+ T cells was signif-
icantly higher than healthy control. After the treatment with SADBE, the number of MAGE3-spe-
cific CTLs was reduced with remarkable improvement of hair loss in AA patient. Taken together, the
patients with acute phase AT/AA multiplex may have higher number of specific CTLs against melanin-
associated hair follicle autoantigens which induce autoimmune reaction against hair follicles.
454
Protection from free radical formation on the scalp
F Liebel, G Nystrand and P Bargo Johnson & Johnson Consumer Products, Inc., Skillman, NJ
Hair is a protective barrier for the body against external aggressors such as solar radiation. People
with bald scalps or thinning hair do not benefit from this protective barrier. It is known that solar
exposure can induce oxidative stress to the skin; however not many studies have examined the
potential for oxidative damage to the scalp. Free radicals produced by these stressors can lead to
the generation of pro-inflammatory cytokines, MMP’s and the breakdown of collagen and elastin.
They can also inhibit proliferation and induce apoptosis in hair follicles. In order to determine
whether scalp skin is a potential target of oxidative stress, we developed a non-invasive method to
assess the generation of free radicals from measuring the chemiluminescence signal in skin. Sig-
nificant free-radical production was detected from the scalp after exposure to dose of visible light
(400-700nm). Traditional sunscreens block only the UV (290-400um) wavelengths of solar light,
leaving the longer wavelengths to stimulate and produce free radicals in the skin. A photostable
UVA/UVB sunscreen combined with a triple combination of natural antioxidants including a Partheno-
lide-free Feverfew Extract, a natural extract known to be a potent antioxidant, was developed to
reduce the production of free radicals from the scalp. Topical application of the triple antioxidant
sunscreen significantly reduced the amount of generated free radicals on the scalp. These results
demonstrate that the scalps of men and women with thinning to bald scalps are a potential target
of oxidative damage. Excessive damage to the hair follicle could lead to decreased proliferation
and be a contributing factor to hair loss. This study suggests the need for a sunscreen with potent
antioxidants to protect the scalp from the free radical induced damage from solar exposure.
455
Trps1 and its target gene Sox9 regulate epithelial proliferation in the developing hair follicle
and are associated with hypertrichosis
KA Fantauzzo1 and AM Christiano1,2 1 Dermatology, Columbia University, New York, NY and
2 Genetics and Development, Columbia University, New York, NY
Trichorhinophalangeal syndrome I (TRPS1) is a vertebrate transcription factor that is expressed in
the dermal papilla and proliferative epithelial cells of adult mouse and human hair follicles. Here,
we aimed to define the function of Trps1 in the developing hair follicle and identify the transcrip-
tional targets through which Trps1 exerts its effect. We found that mice in which the GATA domain
of Trps1 has been deleted (Trps1Δgt) have a reduced number of vibrissae follicles during embryoge-
nesis which are irregularly-spaced and smaller than wild-type vibrissae. Immunofluorescence analy-
ses revealed that Trps1 Δgt/Δgt vibrissae exhibit increased proliferation and decreased expression of
Shh. We demonstrated that Trps1 and Shh colocalize in the matrix and inner root sheath of vibris-
sae in ShhIres-nLacZ reporter mice. Quantitative RT-PCR analyses revealed reduced expression of mul-
tiple Shh pathway transcripts in Trps1Δgt/Δgt whisker pads, and co-immunoprecipitation assays indi-
cated that Trps1 forms stable complexes with Gli2. Additionally, we demonstrated that the ShhGFP-cre
null allele is able to rescue the vibrissae phenotype of Trps1Δgt embryos in compound heterozygous
mice. Sox9 is a transcription factor required for specification of hair follicle stem cells whose expres-
sion depends on Shh signaling. We found that Sox9 was upregulated in Trps1Δgt/Δgt vibrissae and we
showed that Trps1 binds consensus GATA sequences in the SOX9 promoter and represses its tran-
scription in a dose-dependent manner. We identified a copy number variation less than 1 Mb upstream
of SOX9 in a family with congenital universal hypertrichosis. We have previously shown that a
position effect on TRPS1 is associated with hypertrichosis. Our findings uncover a novel transcrip-
tional regulatory hierarchy in the hair follicle in which Trps1, Shh and Sox9 regulate epithelial pro-
liferation and contribute to hair follicle density.
456
Lhx2 is a part of the hair follicle-specific signaling/transcription network and regulates expres-
sion of stem cell-associated genes during skin development and regeneration
A Mardaryev,1 K Poterlowicz,1 T Sharova,2 M Fessing,1 A Sharov2 and V Botchkarev1,2 1 Centre
for Skin Sciences, University of Bradford, Bradford, United Kingdom and 2 Dermatology,
Boston University, Boston, MA
During skin development, multi-potent progenitor cells establish distinct programs of gene expres-
sion specifying their differentiation into specialized cell types. Lhx2 transcription factor is expressed
in the epithelial bud of the developing hair follicles, and in the bulge/secondary germ of telogen
hair follicles. Based on the global microarray profiling of the epithelial buds and bulge/secondary
germ cells obtained by laser capture microdissection, we reconstructed the signaling networks dis-
tinct for the embryonic and postnatal hair follicle progenitor cells. Lhx2 forms an epithelial bud-
specific network and interacts with key signaling pathways involved in the control of hair follicle
development. In postnatal skin, Lhx2 forms stem cell-specific network and regulate expression of
the selected stem cell markers (Sox9, Tcf4, Lgr5) in epithelial progenitor cells. During wound heal-
ing, Lhx2 promotes re-epithelization via positive regulation of Sox9 and Tcf4, while it simultane-
ously inhibits hair follicle cycling via negative regulation of Lgr5. Thus, Lhx2 is an important com-
ponent of the signaling/ transcription networks that control hair follicle development and cycling.
Lhx2 also operates as a switchboard regulator of epithelial stem cell activity during skin response
to injury.
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Bimatoprost, a prostamide F2α analogue used for glaucoma, stimulates scalp hair follicle
growth via follicular receptors; Is this a new approach for alopecia?
KG Khidhir,1 NP Farjo,2 BK Farjo,2 DF Woodward,3 SM Picksley1 and VA Randall1 1 Centre for
Skin Sciences, University of Bradford, Bradford, United Kingdom, 2 Farjo Medical Centre,
Manchester, United Kingdom and 3 Allergan Inc, Irvine, CA
Prostaglandin F2α-related drugs stimulate eyelash growth when used for glaucoma (ocular hyper-
tension); bimatoprost (Latisse) recently gained FDA approval as eyelash hypotrichosis therapy. How
they work is unknown; possibilities include direct action on hair follicles or stimulating follicular
blood flow. Human hair follicle responses differ with body site; androgens stimulate beard, inhibit
scalp, but have no effect on eyelash follicles. To determine whether scalp follicles can respond to
such drugs and check whether any effect is via follicular receptors, scalp follicles were cultured with
bimatoprost, with or without, a receptor antagonist and the expression of prostaglandin F2α (FP)
and prostamide F2α receptors (5 FP-variants)investigated. Human hair follicles, individually microdis-
sected from non-balding scalp skin from healthy individuals (n=15), were cultured for 9 days with
daily examination, photography and measurement or used for RT-PCR and immunohistochemistry.
Bimatoprost (10nM, 100nM & 1μM) significantly stimulated the hair follicle growth rate, percent-
age of growing follicles, and overall amount of hair produced (n=10; P<0.05-0.01) in a dose respon-
sive manner. The antagonist, AGN211336, (1μM) blocked these stimulatory effects (n=5; P<0.05-
0.01). RT-PCR identified FP, altFP4 & altFP1 gene expression in hair follicles (n=5) and
immunohistochemistry located FP protein expression in the regulatory dermal papilla. Therefore,
isolated human scalp hair follicles can respond biologically to bimatoprost in organ culture via fol-
licular receptors and express the genes and protein for FP and prostamide F2α receptors. Bimato-
prost and related drugs appear to offer an exciting, novel approach for treating alopecia; this mer-
its further investigation.
471
Intermediate hair follicles: A novel, androgen-responsive human model system
BH Miranda, DJ Tobin, DT Sharpe and VA Randall Centre for Skin Sciences, Plastic Surgery &
Burns Research Unit, Bradford, United Kingdom
Androgens are the main regulator of human hair growth, in contrast to most other mammals. They
stimulate vellus follicles, producing tiny hairs, to enlarge and form bigger, terminal hairs in many
areas, e.g. beard, at puberty and in hirsutism. In contrast, they have no effect on eyelashes but may
inhibit scalp follicles, causing alopecia. Androgen-stimulated hair disorders are poorly controlled,
but our understanding is hampered by the lack of an androgen-sensitive model system. The aim of
this study was to see if our recently established, more clinically-relevant in vitro model based on
human intermediate hair follicles (Miranda et al (2010) Br J Dermatol 163:287-95) could offer this
by responding to androgens in organ culture. Matched terminal and intermediate hair follicles
were microdissected from healthy female pre-auricular facelift skin and observed, measured and
photographed over 9 days of organ culture with, or without, 10nM testosterone and the antiandro-
gen, cyproterone acetate (CPA; 1μM) alone and in combination (840 follicles; n=6). Androgen recep-
tor gene expression was examined by PCR methods. Intermediate follicles grew less than terminal
follicles (p<0.001) in organ culture. Testosterone stimulated their growth significantly (p<0.001) to
that of terminal follicles (c.31%); terminal follicles were unaffected. CPA blocked this stimulation,
indicating a receptor-mediated effect. Both follicle types exhibited androgen receptor gene expres-
sion by RT-PCR (n=5); quantitative real-time PCR confirmed that intermediate follicles expressed
higher levels (x3.5) than terminal ones (n=6; p=0.04). Thus, smaller intermediate follicles showed
marked differences to their matched terminal follicles in vitro and in vivo and contained higher lev-
els of androgen receptors. Only the intermediate follicles responded in a biologically relevant way
(synthesising more keratin) to physiologically-relevant levels of androgens in organ culture via andro-
gen receptors. Such intermediate hair follicles offer an exciting, unique system for studying andro-
gen action.
473
The circadian transcriptome in skin is hair growth cycle dependent
M Geyfman,1 Q Liu,3 A Ihler,3 P Smyth3 and B Andersen1,2,3 1 Department of Biological
Chemistry, University of California, Irvine, Irvine, CA, 2 Department of Medicine, University
of California, Irvine, Irvine, CA and 3 Department of Computer Science, University of
California, Irvine, Irvine, CA
The circadian clock is a highly conserved transcriptional-translational autoregulatory loop that
governs anticipation of an organism to environmental changes occurring over the 24-hour solar day.
While clocks are thought to be active in every cell, synchronization of the clocks in individual cells
and whole organs requires a central pacemaker located in the suprachiasmatic nucleus of the
hypothalamus. Circadian clocks regulate expression of multitude of genes in most mammalian tis-
sues, but the identity of the oscillating genes appears to be largely unique to the specific tissue. We,
therefore, sought to uncover aspects of skin biology under regulation of circadian clocks by per-
forming gene expression profiling experiments on mouse skin samples collected over a 48-hour
time course from two different synchronized stages of the hair growth cycle. ANOVA-based and
sinusoidal expression statistical detectors were combined to define genes with circadian expres-
sion in skin. We identified over 1500 genes, approximately 6% of expressed genes, with circadian
expression in telogen and approximately 550 genes with circadian expression in anagen skin. The
two phases of the hair growth cycle we examined possessed largely unique set of circadian genes,
indicating specific circadian programs during different phases of the regenerative hair follicle cycle.
Among the most prominent functional categories of circadian genes during telogen are cell cycle,
immediate wound response, DNA repair and metabolism. Our study uncovered that many genes
participating in essential skin functions such as epidermal cell turnover, wound response, DNA
repair and metabolism are modulated by the circadian clock. Furthermore, genes belonging to the
categories of anabolic metabolism and cell cycle regulation have anti-phasic expression patterns,
suggesting a temporal segregation of metabolic processes and cell division in skin.
472
Coordinated activation of Wnt signaling in epithelial and melanocyte stem cells in a shared
niche initiates pigmented hair follicle regeneration
P Rabbani,1 M Takeo,1 W Chou,1 P Myung,5 M Taketo,2 L Chin,3 M Bosenberg4 and M Ito1 1 New
York University, New York, NY, 2 Kyoto University, Kyoto, Japan, 3 Harvard University, Boston,
MA, 4 Yale University, New Haven, CT and 5 University Hospitals Case Western Reserve,
Cleveland, OH
Melanocyte stem cells (McSCs) intimately interact with epithelial stem cells (EpSCs) in the hair fol-
licle bulge. Together, these stem cells undergo activation and differentiation to regenerate pigmented
hair. However, the mechanisms behind this coordinated stem cell behavior have not been eluci-
dated. Here, we reveal the presence of a functional interaction between McSCs and EpSCs, and
identify Wnt signaling as a key pathway governing this communication. EpSCs and McSCs coordi-
nately activate Wnt signaling, at the onset of hair follicle regeneration. Using genetic mouse mod-
els that specifically target either EpSCs or McSCs, we show that Wnt activation in McSCs drives
their differentiation into pigment-producing melanocytes. Additionally, EpSC Wnt signaling not only
dictates hair formation, but also regulates McSC proliferation during hair regeneration. Our data
define a novel role for Wnt signaling in the regulation of McSCs and also illustrate a mechanism for
regeneration of complex organs through heterotypic interactions between stem cells.
470
Dermal papilla cells promote trichogenesis in engineered skin substitutes
P Sriwiriyanont,1 EA Maier,2 KA Lynch,3 DM Supp2,3 and ST Boyce1,2,3 1 Biomedical Engineering,
University of Cincinnati, Cincinnati, OH, 2 Research, Shriners Hospitals for Children,
Cincinnati, OH and 3 Surgery, University of Cincinnati, Cincinnati, OH
Autologous engineered skin substitutes (ESS) have been used successfully to treat severe burn patients
but lack cutaneous appendages. Hypothetically, hair could be regenerated in ESS by incorporation
of dermal papilla cells (DPCs). Dermal constructs were inoculated with: 1) layers of human fibrob-
lasts (hF) and hDPCs, 2) a layer of hF and punctate deposits of hDPCs, 3) a layer of hF followed by
a mixture of hF and hDPCs or 4) a layer of hDPCs. After twenty-four hours, human keratinocytes
(hK) were inoculated onto all dermal constructs prior to air-lifting according to a standard protocol.
Of all conditions tested, only conditions 1 and 4 exhibited adequate epithelial maturation. ESS
from condition 1 had morphology resembling typical ESS, whereas condition 4 developed several
epidermal intruding structures analogous to follicular structures. Therefore, condition 4 was selected
for studies in which hK were transduced with an inducible β-catenin expression vector. Expressions
of Wnt/β-catenin and epidermal placode genes, including lef-1, jagged-1, wnt10a and wnt10b, were
evaluated after grafting and were found to be higher in ESS following β-catenin induction com-
pared to controls, suggesting that β-catenin may facilitate placode formation in this model. The der-
mal cell source was also evaluated in β-catenin-modified grafts. ESS prepared with murine papilla
cells (mDPCs) demonstrated the highest expression of hair related genes relative to ESS prepared
with either hDPCs or with hF. These results were corroborated by a finding of putative hair follicles
in ESS with mDPCs, which were not found in ESS with hDPCs or with hF. Taken together, these data
suggest that ESS can be modified to form hair, and that greater regulation of the trichogenesis path-
way will be required to regenerate fully functional human hair in ESS.
474
Epigenetic modulation of skin morphogenesis via global histone acetylation
MW Hughes, T Jiang, S Lin, R Widelitz and C Chuong Pathology, USC, Los Angeles, CA
The purpose of this study was to investigate the role of histone acetylation in the morphogenesis of
the skin organ. We utilized the cre-lox system controlled by the K14 promoter to inhibit the activ-
ity of HDAC1 in the epithelium of mouse skin. Immunostaining of wild type C57BL/6 skin showed
HDAC1 is predominantly located in the epidermal basal layer, sebaceous glands, inner and outer
root sheaths, and matrix of pelage and vibrissae hair follicles. K14creHDAC1fl/fl mice exhibited a
reduction in size and weight, hyperkeratosis, alopecia, dermal cysts, sebaceous hyperplasia and nail
pathologies including: extra nails, elongated nails, and pigmented nail plates. The dorsal skin of
K14creHDAC1fl/fl mice exhibited hair loss, pigmented dermal cysts, disrupted hair patterning, and
abnormal hair alignment. Hair fibers of K14creHDAC1fl/fl were smaller in length, thinner in diam-
eter, and malformed. The ability to distinguish between awl, auchene, and zigzag hairs was dimin-
ished as most of the K14creHDAC1fl/fl pelage hairs exhibited zigzag morphology. Paws and nails
were affected resulting in abnormal pigmentation and nail malformation. Tunel assay showed an
increase in apoptotic cells in the epidermal basal layer of the K14creHDAC1fl/fl mice where HDAC1
is normally expressed. This suggests a role for HDAC1 in the maintenance of the basal layer. Semi-
quantative PCR showed differential expression of K10, K14, Involucrin, b-catenin, and others, and
immunohistochemistry showed altered protein distributions, when compared to wild type. This sug-
gests that HDAC1 may help modulate keratinocyte differentiation. These data collectively suggest
that HDAC1 modulates skin, nail, and hair developmental regulators. In conclusion, HDAC1 activ-
ity is required for normal skin morphogenesis. Perturbance of HDAC1 results in altered gene expres-
sion and in turn, results in abnormal hair and skin phenotypes characterized by hyperkeratosis, mal-
formed hair follicles and fibers, the presence of dermal cysts, and nail phenotypes.
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The role of p63 in hair follicle stem cell activation
V Balaiya, M Ariefdjohan, PJ Koch and MI Koster Department of Dermatology, University of
Colorado Denver, Aurora, CO
The transcription factor p63 plays an important role in the development and homeostasis of the
skin and skin appendages. This is underscored by the finding that epidermal fragility and hair folli-
cle (HF) abnormalities occur in mice that misexpress p63 as well as in human patients with ecto-
dermal dysplasias caused by p63 mutations. We and others have demonstrated that, within the epi-
dermis, p63 is required for various processes, including proliferation, adhesion, differentiation, and
barrier formation. Although the role for p63 in the epidermis has been well-established, the cellu-
lar and molecular functions of p63 in HF have remained largely elusive. Since p63 has been asso-
ciated with stem cell functions in other tissues, we hypothesized that p63 plays a role in HF stem
cells, specifically those that reside in the bulge region of the HF. To address this hypothesis, we gen-
erated K15.CrePR1/p63fl/fl/ROSA26 (experimental) and K15.CrePR1/p63fl/+/ROSA26 (control) mice.
In experimental mice, topical RU486 (inducer) treatment resulted in the simultaneous ablation of
p63 and expression of β-galactosidase in bulge stem cells, but not in other cell types of the skin.
Using this mouse model, we found that p63 ablation from bulge stem cells resulted in a significant
delay in spontaneous as well as in depilation-induced anagen induction. Once experimental mice
initiated anagen, we detected β-galactosidase-expressing cells, i.e. daughter cells of p63-ablated
bulge stem cells throughout the HF. Further, p63-negative cells were present in all differentiated
compartments of the HF, including the outer root sheath and matrix, suggesting that p63 is not
required for differentiation of HF cells. Collectively, our data demonstrate an essential role for p63
in bulge stem cell activation. Future experiments are aimed at dissecting the molecular role of p63
in this process. These data will contribute to the understanding of HF abnormalities in ectodermal
dysplasia patients and may ultimately lead to the development of novel therapies for the treatment
of hair abnormalities in these patients.
464
Vitamin D levels in alopecia areata (AA)
A Levin,1 A Junqueira Bertin,2 I Katz,2 H Guo,3 Q Wang3 and MK Hordinsky2 1 Kansas City
School of Medicine, U of MO, Kansas City, MO, 2 Dermatology, U of MN, Minneapolis, MN
and 3 Clinical and Translational Science Institute, U of MN, Minneapolis, MN
The role of Vitamin D in autoimmune disease is evolving. Variability in laboratory assays and paucity
of data regarding the contribution of dietary Vitamin D2 creates difficulty in performing consistent,
accurate studies. The purpose of this study was to examine Vitamin D levels in patients with AA. A
cross sectional chart review was performed on 37 AA patients - 4 (11%) were male, 7 (19%) were
under age 18, and 8 (22%) had extensive AA. The patients were seem in between May 2009 and
May 2010. 25-OH Vitamin D2 and D3 levels were measured by liquid chromatography - tandem
mass spectrometry. 18 (49%) patients were receiving oral supplementation in the form of a multi-
vitamin or Vitamin D supplement, and of these, 5 (14%) patients had detectable levels of Vitamin
D2 contributing to their total. The mean (std) of Vitamin D3 level is 31.27 (9.78) ng/mL for the study
sample, on the lower end of currently recommended limits for sufficiency (30-100 ng/mL). 16 patients
(43%) had insufficient 25-OH Vitamin D3 (<30 ng/mL) and 3 of these (8%) would be classified as
deficient (<20 ng/mL). When detectable 25-OH Vitamin D2 was added to these measurements, the
average total increased to 34.41 (std=12.65) ng/mL, the amount of insufficient patients decreased
to 14 (38%), and 2 remained classified as deficient (5%). Further comparisons of the Vitamin D lev-
els across above factors using two-sample t-tests or ANOVA tests revealed a significant association
(p=.008) between total levels and dietary supplementation. Our results indicate that the contribu-
tion of dietary Vitamin D2 is often overlooked and that the traditional measurement of 25-OH D3
levels alone may incorrectly identify insufficiency. Because these results show a borderline insuffi-
cient average level in patients with AA, a larger sampling of patients such as available in the National
AA Registry with standardized laboratory assay equipment is recommended for an improved under-
standing of this association.
465
Altered lymphatic architecture in the scalp skin from patients with extensive alopecia areata
(AA)
S Kavand,1 J Nugent,1 M Hordinsky,1 K Gupta2 and M Ericson1 1 Dermatology, University of
Minnesota, Minneapolis, MN and 2 Medicine, University of Minnesota, Minneapolis, MN
The lymphatic system is an open-ended system that maintains fluid homeostasis and is essential for
immune cell trafficking. Though the lymphatic system plays an integral role in cutaneous physiol-
ogy, its role in hair growth and hair disease is virtually unknown. Preliminary work from our lab
revealed an intimate association between the hair follicle and lymphatics in the dorsal skin of the
C57Bl6J mouse. To date, there is no information on the role of lymphatic vessels in AA, an autoim-
mune disorder resulting in non-scarring hair loss. Our aim in this study was to evaluate the lym-
phatic vessel structure in the scalp skin of patients with extensive AA and compare results with the
control subjects. Four mm skin biopsy specimens were obtained from the scalp of 3 patients with
extensive AA (>95% scalp hair loss) and 3 healthy controls. Tissue samples were cut into 120 micron
thick sections and immunostained with antibodies to protein gene product 9.5, Substance P, and
an antibody against the Lyve1 antigen, which is specifically expressed in lymphatic vessels. All sec-
tions were also incubated with the plant lectin Ulex europeaous conjugated to fluorescein. Sec-
tions were examined by confocal laser scanning microscopy and lymphatic vessels were counted
in the papillary and reticular dermis using a histomorphometric counting technique developed in
our lab. Data were analyzed using the Student’s t test. We found a reduction in the size of lym-
phatic vessels in the upper and mid-dermis in AA patients as compared with the control subjects.
We postulate that the observed reduction of lymphatic structures is similar to that seen in the cuta-
neous vasculature reported around miniaturized follicles in AA. Whether the observed reduction in
lymphatic structures plays a role in the pathogenesis of this disease remains to be determined.
466
Role of Aurora Kinase-A in skin development
EC Torchia,1 L Zhang,1 AJ Huebner,1 S Sen2 and DR Roop1 1 Dermatology, University of
Colorado Denver at Anschutz Medical Campus, Aurora, CO and 2 Molecular Pathology,
University of Texas M.D. Anderson Cancer Center, Houston, TX
Aurora Kinase-A (Aurora-A) plays a fundamental role in cell division by promoting the timely entry
into mitosis, centrosome maturation, and formation of bipolar spindles. Moreover, Aurora-A is an
oncogene that is implicated in cancers of numerous tissues including skin. To characterize the role
of Aurora-A in skin development, we deleted Aurora-A by interbreeding K14.Cre mice with mice
containing a floxed Aurora-A allele (Aurora-Afl). Aurora-Afl/fl;K14Cre mice were born alive, but died
shortly after birth.The skin of these mice was translucent and histological evaluation showed that
the dorsal skin was very thin and fragile with areas of frank erosions. To gain further insight into the
role of Aurora-A during development, we examined Aurora-Afl/fl;K14Cre mice at different embry-
onic stages. A marked delay in stratification and differentiation was readily apparent at E16.5, and
areas with basal cell lysis were already present in E18.5 embryos. Basal keratinocytes in Aurora-A-
/- embryonic skin had enlarged nuclei with multiple nucleoli and the orientation of these keratinocytes
was altered, with the position of the nuclei relative to the centrosome appearing random, instead
of the predominant perpendicular orientation to the dermis of basal keratinocytes seen in Aurora-
A+/+ skin. Although marker analysis revealed the expression of basal layer markers, K5 and K14 and
differentiation markers, K1, K10, and loricrin in Aurora-A-/- skin, there was a marked reduction in
the number of basal and suprabasal layers. Furthermore, we observed the induction of the stress
keratin, K6, in Aurora-A-/- skin and dye exclusion assays indicated defects in barrier function. There-
fore, the deletion of Aurora-A in the developing epidermis altered the polarity of basal cells and
markedly impaired their ability to divide and stratify.
467
Female nonscarring alopecia (FNA) and nutritional deficiencies
A Junqueira Bertin,1 A Levin,2 N Bertin Suguitani,3 R Farah,1 H Guo,4 Q Wang4 and
MK Hordinsky1 1 Department of Dermatology, University of Minnesota, Minneapolis, MN, 2
Kansas City School of Medicine, University of MO, Kansas City, MO, 3 Department of Surgery,
University of Minnesota, Minneapolis, MN and 4 Clinical and Translational Science Institute,
University of Minnesota, Minneapolis, MN
In this study we reviewed the prevalence of nutritional deficiencies, previous supplementation and
impact of nutritional supplementation on improvement of FNA. We performed a retrospective chart
review (N=132, F, 14-83 y, 05/2009-05/2010) in which FNA was diagnosed as either female pat-
tern alopecia or chronic telogen effluvium. We examined serum levels of ferritin (Fe), vitamin D3(D3),
zinc(Z), thiamine(B1) and total protein(TP). Data were analyzed using t-tests and Fisher exact test
or chi-square test .The statistical analyses revealed that 81.82% of the patients were already taking
some type of supplement at the time of study; 4.63% were Z deficient ; 7.21%, 32.43% and 63.06%
were Fe deficient (cut offs at 15, 40 and 70ug/l respectively); 25.93% were D3 deficient; 9.68% B1
deficient and 3.41% TP deficient. Of note, 14.52% had high B1 levels. Clinical improvement of hair
loss was observed in 81.25%.When examining those who took supplementation prior to study higher
mean values of B1, D3 and TP were found but statistical significance (p=.0004) was noted only for
B1. When examining those who demonstrated clinical improvement, higher mean levels of D3, Z,
Fe, and TP were found but statistical significance (p= .03) was noted only for D3, with a mean level
of 27.56 ng/ml in those without clinical improvement(Std 15.2)and 42.48 ng/ml for the ones who
improved(Std 13.4). Mistakes on supplemenation were noted,10.63% of the non supplemented
patients had low Fe levels and 63.37% of the supplemented patients had Fe > 40ng/ml.Nutritional
abnormalities are commonly seen in women with NPA and these abnormalities may be playing a
role in their hair loss. Supplementation is frequently inadequate. Clinical improvement and attain-
ment of appropriate blood levels remains to be proven in prospective clinical trials.
468
In situ labeling of DNA may be used to predict probability of success of forensic genotyping
of hair
L Eckhart,1 S Szabo,1 K Jaeger,1 J Scherz,1 H Fischer,1 W Parson2 and E Tschachler1 1 Department
of Dermatology, Medical University of Vienna, Vienna, Austria and 2 Institute of Legal
Medicine, Innsbruck Medical University, Innsbruck, Austria
Hair fibers are formed by keratinocytes of the hair follicle in a process that involves the breakdown
of the nucleus including DNA. Accordingly, DNA can be isolated with high yield from the hair
bulb which contains living keratinocytes whereas it is difficult to prepare from the distal portions of
hair fibers and from shed hair. Nevertheless, forensic investigations are successful in a fraction of
shed hair samples found at crime scenes. Here we report that inter-individual differences in the com-
pleteness of DNA removal from hair corneocytes are major determinants of DNA content and suc-
cess rates of forensic investigations of hair. Distal hair samples were permeabilized with ammonia
and incubated with the DNA-specific dye Hoechst 33258 to label DNA in situ. Residual nuclear
DNA was visualized under a fluorescence microscope. Hair from some donors did not contain any
stainable nuclei whereas hair from other donors contained a variable number of DNA-positive
nuclear remnants. The number of DNA-containing nuclear remnants per millimeter of hair corre-
lated with the amount of DNA that could be extracted and amplified by quantitative PCR. When
individual hairs were investigated, only hairs, in which DNA could be labeled in situ, gave positive
results in short tandem repeat (STR) typing. This study reveals that the completeness of DNA degra-
dation during cornification of the hair is a polymorphic trait. Furthermore, our results suggest that
in situ labeling of DNA in hair may be used to predict the probability of success of forensic analy-
sis of nuclear DNA in shed hair.
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Bimatoprost, a prostamide F2α analogue used for glaucoma, stimulates scalp hair follicle
growth via follicular receptors; Is this a new approach for alopecia?
KG Khidhir,1 NP Farjo,2 BK Farjo,2 DF Woodward,3 SM Picksley1 and VA Randall1 1 Centre for
Skin Sciences, University of Bradford, Bradford, United Kingdom, 2 Farjo Medical Centre,
Manchester, United Kingdom and 3 Allergan Inc, Irvine, CA
Prostaglandin F2α-related drugs stimulate eyelash growth when used for glaucoma (ocular hyper-
tension); bimatoprost (Latisse) recently gained FDA approval as eyelash hypotrichosis therapy. How
they work is unknown; possibilities include direct action on hair follicles or stimulating follicular
blood flow. Human hair follicle responses differ with body site; androgens stimulate beard, inhibit
scalp, but have no effect on eyelash follicles. To determine whether scalp follicles can respond to
such drugs and check whether any effect is via follicular receptors, scalp follicles were cultured with
bimatoprost, with or without, a receptor antagonist and the expression of prostaglandin F2α (FP)
and prostamide F2α receptors (5 FP-variants)investigated. Human hair follicles, individually microdis-
sected from non-balding scalp skin from healthy individuals (n=15), were cultured for 9 days with
daily examination, photography and measurement or used for RT-PCR and immunohistochemistry.
Bimatoprost (10nM, 100nM & 1μM) significantly stimulated the hair follicle growth rate, percent-
age of growing follicles, and overall amount of hair produced (n=10; P<0.05-0.01) in a dose respon-
sive manner. The antagonist, AGN211336, (1μM) blocked these stimulatory effects (n=5; P<0.05-
0.01). RT-PCR identified FP, altFP4 & altFP1 gene expression in hair follicles (n=5) and
immunohistochemistry located FP protein expression in the regulatory dermal papilla. Therefore,
isolated human scalp hair follicles can respond biologically to bimatoprost in organ culture via fol-
licular receptors and express the genes and protein for FP and prostamide F2α receptors. Bimato-
prost and related drugs appear to offer an exciting, novel approach for treating alopecia; this mer-
its further investigation.
471
Intermediate hair follicles: A novel, androgen-responsive human model system
BH Miranda, DJ Tobin, DT Sharpe and VA Randall Centre for Skin Sciences, Plastic Surgery &
Burns Research Unit, Bradford, United Kingdom
Androgens are the main regulator of human hair growth, in contrast to most other mammals. They
stimulate vellus follicles, producing tiny hairs, to enlarge and form bigger, terminal hairs in many
areas, e.g. beard, at puberty and in hirsutism. In contrast, they have no effect on eyelashes but may
inhibit scalp follicles, causing alopecia. Androgen-stimulated hair disorders are poorly controlled,
but our understanding is hampered by the lack of an androgen-sensitive model system. The aim of
this study was to see if our recently established, more clinically-relevant in vitro model based on
human intermediate hair follicles (Miranda et al (2010) Br J Dermatol 163:287-95) could offer this
by responding to androgens in organ culture. Matched terminal and intermediate hair follicles
were microdissected from healthy female pre-auricular facelift skin and observed, measured and
photographed over 9 days of organ culture with, or without, 10nM testosterone and the antiandro-
gen, cyproterone acetate (CPA; 1μM) alone and in combination (840 follicles; n=6). Androgen recep-
tor gene expression was examined by PCR methods. Intermediate follicles grew less than terminal
follicles (p<0.001) in organ culture. Testosterone stimulated their growth significantly (p<0.001) to
that of terminal follicles (c.31%); terminal follicles were unaffected. CPA blocked this stimulation,
indicating a receptor-mediated effect. Both follicle types exhibited androgen receptor gene expres-
sion by RT-PCR (n=5); quantitative real-time PCR confirmed that intermediate follicles expressed
higher levels (x3.5) than terminal ones (n=6; p=0.04). Thus, smaller intermediate follicles showed
marked differences to their matched terminal follicles in vitro and in vivo and contained higher lev-
els of androgen receptors. Only the intermediate follicles responded in a biologically relevant way
(synthesising more keratin) to physiologically-relevant levels of androgens in organ culture via andro-
gen receptors. Such intermediate hair follicles offer an exciting, unique system for studying andro-
gen action.
473
The circadian transcriptome in skin is hair growth cycle dependent
M Geyfman,1 Q Liu,3 A Ihler,3 P Smyth3 and B Andersen1,2,3 1 Department of Biological
Chemistry, University of California, Irvine, Irvine, CA, 2 Department of Medicine, University
of California, Irvine, Irvine, CA and 3 Department of Computer Science, University of
California, Irvine, Irvine, CA
The circadian clock is a highly conserved transcriptional-translational autoregulatory loop that
governs anticipation of an organism to environmental changes occurring over the 24-hour solar day.
While clocks are thought to be active in every cell, synchronization of the clocks in individual cells
and whole organs requires a central pacemaker located in the suprachiasmatic nucleus of the
hypothalamus. Circadian clocks regulate expression of multitude of genes in most mammalian tis-
sues, but the identity of the oscillating genes appears to be largely unique to the specific tissue. We,
therefore, sought to uncover aspects of skin biology under regulation of circadian clocks by per-
forming gene expression profiling experiments on mouse skin samples collected over a 48-hour
time course from two different synchronized stages of the hair growth cycle. ANOVA-based and
sinusoidal expression statistical detectors were combined to define genes with circadian expres-
sion in skin. We identified over 1500 genes, approximately 6% of expressed genes, with circadian
expression in telogen and approximately 550 genes with circadian expression in anagen skin. The
two phases of the hair growth cycle we examined possessed largely unique set of circadian genes,
indicating specific circadian programs during different phases of the regenerative hair follicle cycle.
Among the most prominent functional categories of circadian genes during telogen are cell cycle,
immediate wound response, DNA repair and metabolism. Our study uncovered that many genes
participating in essential skin functions such as epidermal cell turnover, wound response, DNA
repair and metabolism are modulated by the circadian clock. Furthermore, genes belonging to the
categories of anabolic metabolism and cell cycle regulation have anti-phasic expression patterns,
suggesting a temporal segregation of metabolic processes and cell division in skin.
472
Coordinated activation of Wnt signaling in epithelial and melanocyte stem cells in a shared
niche initiates pigmented hair follicle regeneration
P Rabbani,1 M Takeo,1 W Chou,1 P Myung,5 M Taketo,2 L Chin,3 M Bosenberg4 and M Ito1 1 New
York University, New York, NY, 2 Kyoto University, Kyoto, Japan, 3 Harvard University, Boston,
MA, 4 Yale University, New Haven, CT and 5 University Hospitals Case Western Reserve,
Cleveland, OH
Melanocyte stem cells (McSCs) intimately interact with epithelial stem cells (EpSCs) in the hair fol-
licle bulge. Together, these stem cells undergo activation and differentiation to regenerate pigmented
hair. However, the mechanisms behind this coordinated stem cell behavior have not been eluci-
dated. Here, we reveal the presence of a functional interaction between McSCs and EpSCs, and
identify Wnt signaling as a key pathway governing this communication. EpSCs and McSCs coordi-
nately activate Wnt signaling, at the onset of hair follicle regeneration. Using genetic mouse mod-
els that specifically target either EpSCs or McSCs, we show that Wnt activation in McSCs drives
their differentiation into pigment-producing melanocytes. Additionally, EpSC Wnt signaling not only
dictates hair formation, but also regulates McSC proliferation during hair regeneration. Our data
define a novel role for Wnt signaling in the regulation of McSCs and also illustrate a mechanism for
regeneration of complex organs through heterotypic interactions between stem cells.
470
Dermal papilla cells promote trichogenesis in engineered skin substitutes
P Sriwiriyanont,1 EA Maier,2 KA Lynch,3 DM Supp2,3 and ST Boyce1,2,3 1 Biomedical Engineering,
University of Cincinnati, Cincinnati, OH, 2 Research, Shriners Hospitals for Children,
Cincinnati, OH and 3 Surgery, University of Cincinnati, Cincinnati, OH
Autologous engineered skin substitutes (ESS) have been used successfully to treat severe burn patients
but lack cutaneous appendages. Hypothetically, hair could be regenerated in ESS by incorporation
of dermal papilla cells (DPCs). Dermal constructs were inoculated with: 1) layers of human fibrob-
lasts (hF) and hDPCs, 2) a layer of hF and punctate deposits of hDPCs, 3) a layer of hF followed by
a mixture of hF and hDPCs or 4) a layer of hDPCs. After twenty-four hours, human keratinocytes
(hK) were inoculated onto all dermal constructs prior to air-lifting according to a standard protocol.
Of all conditions tested, only conditions 1 and 4 exhibited adequate epithelial maturation. ESS
from condition 1 had morphology resembling typical ESS, whereas condition 4 developed several
epidermal intruding structures analogous to follicular structures. Therefore, condition 4 was selected
for studies in which hK were transduced with an inducible β-catenin expression vector. Expressions
of Wnt/β-catenin and epidermal placode genes, including lef-1, jagged-1, wnt10a and wnt10b, were
evaluated after grafting and were found to be higher in ESS following β-catenin induction com-
pared to controls, suggesting that β-catenin may facilitate placode formation in this model. The der-
mal cell source was also evaluated in β-catenin-modified grafts. ESS prepared with murine papilla
cells (mDPCs) demonstrated the highest expression of hair related genes relative to ESS prepared
with either hDPCs or with hF. These results were corroborated by a finding of putative hair follicles
in ESS with mDPCs, which were not found in ESS with hDPCs or with hF. Taken together, these data
suggest that ESS can be modified to form hair, and that greater regulation of the trichogenesis path-
way will be required to regenerate fully functional human hair in ESS.
474
Epigenetic modulation of skin morphogenesis via global histone acetylation
MW Hughes, T Jiang, S Lin, R Widelitz and C Chuong Pathology, USC, Los Angeles, CA
The purpose of this study was to investigate the role of histone acetylation in the morphogenesis of
the skin organ. We utilized the cre-lox system controlled by the K14 promoter to inhibit the activ-
ity of HDAC1 in the epithelium of mouse skin. Immunostaining of wild type C57BL/6 skin showed
HDAC1 is predominantly located in the epidermal basal layer, sebaceous glands, inner and outer
root sheaths, and matrix of pelage and vibrissae hair follicles. K14creHDAC1fl/fl mice exhibited a
reduction in size and weight, hyperkeratosis, alopecia, dermal cysts, sebaceous hyperplasia and nail
pathologies including: extra nails, elongated nails, and pigmented nail plates. The dorsal skin of
K14creHDAC1fl/fl mice exhibited hair loss, pigmented dermal cysts, disrupted hair patterning, and
abnormal hair alignment. Hair fibers of K14creHDAC1fl/fl were smaller in length, thinner in diam-
eter, and malformed. The ability to distinguish between awl, auchene, and zigzag hairs was dimin-
ished as most of the K14creHDAC1fl/fl pelage hairs exhibited zigzag morphology. Paws and nails
were affected resulting in abnormal pigmentation and nail malformation. Tunel assay showed an
increase in apoptotic cells in the epidermal basal layer of the K14creHDAC1fl/fl mice where HDAC1
is normally expressed. This suggests a role for HDAC1 in the maintenance of the basal layer. Semi-
quantative PCR showed differential expression of K10, K14, Involucrin, b-catenin, and others, and
immunohistochemistry showed altered protein distributions, when compared to wild type. This sug-
gests that HDAC1 may help modulate keratinocyte differentiation. These data collectively suggest
that HDAC1 modulates skin, nail, and hair developmental regulators. In conclusion, HDAC1 activ-
ity is required for normal skin morphogenesis. Perturbance of HDAC1 results in altered gene expres-
sion and in turn, results in abnormal hair and skin phenotypes characterized by hyperkeratosis, mal-
formed hair follicles and fibers, the presence of dermal cysts, and nail phenotypes.
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The role of p63 in hair follicle stem cell activation
V Balaiya, M Ariefdjohan, PJ Koch and MI Koster Department of Dermatology, University of
Colorado Denver, Aurora, CO
The transcription factor p63 plays an important role in the development and homeostasis of the
skin and skin appendages. This is underscored by the finding that epidermal fragility and hair folli-
cle (HF) abnormalities occur in mice that misexpress p63 as well as in human patients with ecto-
dermal dysplasias caused by p63 mutations. We and others have demonstrated that, within the epi-
dermis, p63 is required for various processes, including proliferation, adhesion, differentiation, and
barrier formation. Although the role for p63 in the epidermis has been well-established, the cellu-
lar and molecular functions of p63 in HF have remained largely elusive. Since p63 has been asso-
ciated with stem cell functions in other tissues, we hypothesized that p63 plays a role in HF stem
cells, specifically those that reside in the bulge region of the HF. To address this hypothesis, we gen-
erated K15.CrePR1/p63fl/fl/ROSA26 (experimental) and K15.CrePR1/p63fl/+/ROSA26 (control) mice.
In experimental mice, topical RU486 (inducer) treatment resulted in the simultaneous ablation of
p63 and expression of β-galactosidase in bulge stem cells, but not in other cell types of the skin.
Using this mouse model, we found that p63 ablation from bulge stem cells resulted in a significant
delay in spontaneous as well as in depilation-induced anagen induction. Once experimental mice
initiated anagen, we detected β-galactosidase-expressing cells, i.e. daughter cells of p63-ablated
bulge stem cells throughout the HF. Further, p63-negative cells were present in all differentiated
compartments of the HF, including the outer root sheath and matrix, suggesting that p63 is not
required for differentiation of HF cells. Collectively, our data demonstrate an essential role for p63
in bulge stem cell activation. Future experiments are aimed at dissecting the molecular role of p63
in this process. These data will contribute to the understanding of HF abnormalities in ectodermal
dysplasia patients and may ultimately lead to the development of novel therapies for the treatment
of hair abnormalities in these patients.
464
Vitamin D levels in alopecia areata (AA)
A Levin,1 A Junqueira Bertin,2 I Katz,2 H Guo,3 Q Wang3 and MK Hordinsky2 1 Kansas City
School of Medicine, U of MO, Kansas City, MO, 2 Dermatology, U of MN, Minneapolis, MN
and 3 Clinical and Translational Science Institute, U of MN, Minneapolis, MN
The role of Vitamin D in autoimmune disease is evolving. Variability in laboratory assays and paucity
of data regarding the contribution of dietary Vitamin D2 creates difficulty in performing consistent,
accurate studies. The purpose of this study was to examine Vitamin D levels in patients with AA. A
cross sectional chart review was performed on 37 AA patients - 4 (11%) were male, 7 (19%) were
under age 18, and 8 (22%) had extensive AA. The patients were seem in between May 2009 and
May 2010. 25-OH Vitamin D2 and D3 levels were measured by liquid chromatography - tandem
mass spectrometry. 18 (49%) patients were receiving oral supplementation in the form of a multi-
vitamin or Vitamin D supplement, and of these, 5 (14%) patients had detectable levels of Vitamin
D2 contributing to their total. The mean (std) of Vitamin D3 level is 31.27 (9.78) ng/mL for the study
sample, on the lower end of currently recommended limits for sufficiency (30-100 ng/mL). 16 patients
(43%) had insufficient 25-OH Vitamin D3 (<30 ng/mL) and 3 of these (8%) would be classified as
deficient (<20 ng/mL). When detectable 25-OH Vitamin D2 was added to these measurements, the
average total increased to 34.41 (std=12.65) ng/mL, the amount of insufficient patients decreased
to 14 (38%), and 2 remained classified as deficient (5%). Further comparisons of the Vitamin D lev-
els across above factors using two-sample t-tests or ANOVA tests revealed a significant association
(p=.008) between total levels and dietary supplementation. Our results indicate that the contribu-
tion of dietary Vitamin D2 is often overlooked and that the traditional measurement of 25-OH D3
levels alone may incorrectly identify insufficiency. Because these results show a borderline insuffi-
cient average level in patients with AA, a larger sampling of patients such as available in the National
AA Registry with standardized laboratory assay equipment is recommended for an improved under-
standing of this association.
465
Altered lymphatic architecture in the scalp skin from patients with extensive alopecia areata
(AA)
S Kavand,1 J Nugent,1 M Hordinsky,1 K Gupta2 and M Ericson1 1 Dermatology, University of
Minnesota, Minneapolis, MN and 2 Medicine, University of Minnesota, Minneapolis, MN
The lymphatic system is an open-ended system that maintains fluid homeostasis and is essential for
immune cell trafficking. Though the lymphatic system plays an integral role in cutaneous physiol-
ogy, its role in hair growth and hair disease is virtually unknown. Preliminary work from our lab
revealed an intimate association between the hair follicle and lymphatics in the dorsal skin of the
C57Bl6J mouse. To date, there is no information on the role of lymphatic vessels in AA, an autoim-
mune disorder resulting in non-scarring hair loss. Our aim in this study was to evaluate the lym-
phatic vessel structure in the scalp skin of patients with extensive AA and compare results with the
control subjects. Four mm skin biopsy specimens were obtained from the scalp of 3 patients with
extensive AA (>95% scalp hair loss) and 3 healthy controls. Tissue samples were cut into 120 micron
thick sections and immunostained with antibodies to protein gene product 9.5, Substance P, and
an antibody against the Lyve1 antigen, which is specifically expressed in lymphatic vessels. All sec-
tions were also incubated with the plant lectin Ulex europeaous conjugated to fluorescein. Sec-
tions were examined by confocal laser scanning microscopy and lymphatic vessels were counted
in the papillary and reticular dermis using a histomorphometric counting technique developed in
our lab. Data were analyzed using the Student’s t test. We found a reduction in the size of lym-
phatic vessels in the upper and mid-dermis in AA patients as compared with the control subjects.
We postulate that the observed reduction of lymphatic structures is similar to that seen in the cuta-
neous vasculature reported around miniaturized follicles in AA. Whether the observed reduction in
lymphatic structures plays a role in the pathogenesis of this disease remains to be determined.
466
Role of Aurora Kinase-A in skin development
EC Torchia,1 L Zhang,1 AJ Huebner,1 S Sen2 and DR Roop1 1 Dermatology, University of
Colorado Denver at Anschutz Medical Campus, Aurora, CO and 2 Molecular Pathology,
University of Texas M.D. Anderson Cancer Center, Houston, TX
Aurora Kinase-A (Aurora-A) plays a fundamental role in cell division by promoting the timely entry
into mitosis, centrosome maturation, and formation of bipolar spindles. Moreover, Aurora-A is an
oncogene that is implicated in cancers of numerous tissues including skin. To characterize the role
of Aurora-A in skin development, we deleted Aurora-A by interbreeding K14.Cre mice with mice
containing a floxed Aurora-A allele (Aurora-Afl). Aurora-Afl/fl;K14Cre mice were born alive, but died
shortly after birth.The skin of these mice was translucent and histological evaluation showed that
the dorsal skin was very thin and fragile with areas of frank erosions. To gain further insight into the
role of Aurora-A during development, we examined Aurora-Afl/fl;K14Cre mice at different embry-
onic stages. A marked delay in stratification and differentiation was readily apparent at E16.5, and
areas with basal cell lysis were already present in E18.5 embryos. Basal keratinocytes in Aurora-A-
/- embryonic skin had enlarged nuclei with multiple nucleoli and the orientation of these keratinocytes
was altered, with the position of the nuclei relative to the centrosome appearing random, instead
of the predominant perpendicular orientation to the dermis of basal keratinocytes seen in Aurora-
A+/+ skin. Although marker analysis revealed the expression of basal layer markers, K5 and K14 and
differentiation markers, K1, K10, and loricrin in Aurora-A-/- skin, there was a marked reduction in
the number of basal and suprabasal layers. Furthermore, we observed the induction of the stress
keratin, K6, in Aurora-A-/- skin and dye exclusion assays indicated defects in barrier function. There-
fore, the deletion of Aurora-A in the developing epidermis altered the polarity of basal cells and
markedly impaired their ability to divide and stratify.
467
Female nonscarring alopecia (FNA) and nutritional deficiencies
A Junqueira Bertin,1 A Levin,2 N Bertin Suguitani,3 R Farah,1 H Guo,4 Q Wang4 and
MK Hordinsky1 1 Department of Dermatology, University of Minnesota, Minneapolis, MN, 2
Kansas City School of Medicine, University of MO, Kansas City, MO, 3 Department of Surgery,
University of Minnesota, Minneapolis, MN and 4 Clinical and Translational Science Institute,
University of Minnesota, Minneapolis, MN
In this study we reviewed the prevalence of nutritional deficiencies, previous supplementation and
impact of nutritional supplementation on improvement of FNA. We performed a retrospective chart
review (N=132, F, 14-83 y, 05/2009-05/2010) in which FNA was diagnosed as either female pat-
tern alopecia or chronic telogen effluvium. We examined serum levels of ferritin (Fe), vitamin D3(D3),
zinc(Z), thiamine(B1) and total protein(TP). Data were analyzed using t-tests and Fisher exact test
or chi-square test .The statistical analyses revealed that 81.82% of the patients were already taking
some type of supplement at the time of study; 4.63% were Z deficient ; 7.21%, 32.43% and 63.06%
were Fe deficient (cut offs at 15, 40 and 70ug/l respectively); 25.93% were D3 deficient; 9.68% B1
deficient and 3.41% TP deficient. Of note, 14.52% had high B1 levels. Clinical improvement of hair
loss was observed in 81.25%.When examining those who took supplementation prior to study higher
mean values of B1, D3 and TP were found but statistical significance (p=.0004) was noted only for
B1. When examining those who demonstrated clinical improvement, higher mean levels of D3, Z,
Fe, and TP were found but statistical significance (p= .03) was noted only for D3, with a mean level
of 27.56 ng/ml in those without clinical improvement(Std 15.2)and 42.48 ng/ml for the ones who
improved(Std 13.4). Mistakes on supplemenation were noted,10.63% of the non supplemented
patients had low Fe levels and 63.37% of the supplemented patients had Fe > 40ng/ml.Nutritional
abnormalities are commonly seen in women with NPA and these abnormalities may be playing a
role in their hair loss. Supplementation is frequently inadequate. Clinical improvement and attain-
ment of appropriate blood levels remains to be proven in prospective clinical trials.
468
In situ labeling of DNA may be used to predict probability of success of forensic genotyping
of hair
L Eckhart,1 S Szabo,1 K Jaeger,1 J Scherz,1 H Fischer,1 W Parson2 and E Tschachler1 1 Department
of Dermatology, Medical University of Vienna, Vienna, Austria and 2 Institute of Legal
Medicine, Innsbruck Medical University, Innsbruck, Austria
Hair fibers are formed by keratinocytes of the hair follicle in a process that involves the breakdown
of the nucleus including DNA. Accordingly, DNA can be isolated with high yield from the hair
bulb which contains living keratinocytes whereas it is difficult to prepare from the distal portions of
hair fibers and from shed hair. Nevertheless, forensic investigations are successful in a fraction of
shed hair samples found at crime scenes. Here we report that inter-individual differences in the com-
pleteness of DNA removal from hair corneocytes are major determinants of DNA content and suc-
cess rates of forensic investigations of hair. Distal hair samples were permeabilized with ammonia
and incubated with the DNA-specific dye Hoechst 33258 to label DNA in situ. Residual nuclear
DNA was visualized under a fluorescence microscope. Hair from some donors did not contain any
stainable nuclei whereas hair from other donors contained a variable number of DNA-positive
nuclear remnants. The number of DNA-containing nuclear remnants per millimeter of hair corre-
lated with the amount of DNA that could be extracted and amplified by quantitative PCR. When
individual hairs were investigated, only hairs, in which DNA could be labeled in situ, gave positive
results in short tandem repeat (STR) typing. This study reveals that the completeness of DNA degra-
dation during cornification of the hair is a polymorphic trait. Furthermore, our results suggest that
in situ labeling of DNA in hair may be used to predict the probability of success of forensic analy-
sis of nuclear DNA in shed hair.
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Skin physiology in neonates and young children of different age groups compared to adults:
A randomized study
JW Fluhr,1 N Lachmann,2 C Baudouin,2 C de Belilovsky,3 P Msika2 and J Hachem4 1 Dermatology
Department, Charite University Clinic, Berlin, Germany, 2 Innovation R&D Direction,
Laboratoires Expanscience, Epernon, France, 3 Dermatology Department, Institut Alfred
Fournier, Paris, France and 4 Dermatology Research, Vrije Universiteit, Brussels, Belgium
The aim of this study was to investigate skin parameters (transepidermal water loss (TEWL), stratum
corneum (SC) hydration, surface pH) and the biochemical skin composition (water profile and bulk
NMF) to characterize neonatal skin in comparison to different children age groups and adults skin.
The study was performed in healthy male and female volunteers (n=108) of 6 age groups (n= 18
each group: newborns (1-15 days), five-week, six-month, 1-2 yrs., 4-5 yrs and adults aged 20-35
yrs.). Biophysical parameters (TEWL, capacitance and surface pH) were measured on the volar
forearms and water- and bulk NMF-profiles were assessed with Raman Spectroscopy (RS). The low-
est SC hydration was noted in newborns compared to other age groups representing a dry SC in
newborns. The mean skin surface pH-value was highest in newborns. A decrease of 1 pH unit was
observed over the first 5 weeks and comparable to all other age groups, indicating a quick pH sta-
bilization within the first weeks after birth. All mean TEWL values were below 10 g/m2/h reflecting
a normal and competent basal barrier function in all groups. An increase in SC hydration within the
first weeks of life was detected (RS). The increase in water content profile, correlated to increasing
skin depth, was lower for newborns. Newborns showed greater bulk NMF concentrations. Neona-
tal and infant skin is mainly competent under basal conditions except SC water content and NMF
components regulating the SC hydration level. Newborns are adapting to the dry environment by
compensating the lack of water with increased NMF.
483
Evaluation of psoriasis area and severity index, static physician’s global assessment, and lat-
tice system-physician’s global assessment for assessing psoriasis severity
C Chow,1 Z Zhang,2 MT Goldfarb,1 MJ Simpson1 and CN Ellis1 1 Dermatology, Univ of
Michigan, Ann Arbor, MI and 2 Statistics, Univ of Michigan, Ann Arbor, MI
Consistent, accurate, and repeatable measurement of psoriasis severity is critical in assessing responses
to treatment in clinical trials. We investigated changes over the course of treatment in the Psoriasis
Area and Severity Index (PASI), Static Physician’s Global Assessment (SPGA), and Lattice System-
Physician’s Global Assessment (LS-PGA) in a randomized, multicenter, 24-week study of chronic
plaque psoriasis. Of 652 enrolled patients, 455 had complete data and were included in our analy-
ses. The treatment group had 366 patients who received either cyclosporine or voclosporin. In this
group at trial entry, there was poorer Spearman correlation of SPGA with PASI (r=0.45) and LS-PGA
(0.39) than between PASI and LS-PGA (0.68). After therapy, all correlations were stronger, but
SPGA continued to be less well correlated (with PASI, 0.85; with LS-PGA, 0.79) than PASI with LS-
PGA (0.90). Assessment of body surface area (BSA) affected by psoriasis showed much stronger
correlations before and after treatment, respectively, with LS-PGA (0.75, 0.93) and PASI (0.71,
0.86) than with SPGA (0.18, 0.67). A similar pattern of results occurred in 89 patients receiving
placebo. Median scores at pretherapy and after 12 and 24 weeks of active therapy were 16.5, 3.8,
3.6 for PASI (maximum possible score 72), 3, 2, 2 for SPGA (max 5), and 6, 3, 2 for LS-PGA (max
7). When placebo patients crossed over to active therapy, the scores showed the same pattern. All
measures showed statistically significant efficacy of treatment compared to placebo (P<.05) and for
change from before to end of active treatment (P<.0001). BSA is not a specified component of SPGA,
which may account for the poorer correlation of SPGA with the other severity measures. Weaker
correlations at study entry may reflect vagaries of enrollment criteria. SPGA showed the poorest
responsiveness to therapy. PASI and LS-PGA are highly correlated measures of change in psoriasis
severity during effective therapy.
485
Persicaria hydropiper (L.) Spach and its flavonoid components, isoquercitrin and isorham-
netin, activate the Wnt/β-catenin pathway and inhibit the adipocyte differentiation of 3T3-
L1 cells
B Kim,1 S Lee,2 M Oh,1 J Kim,1 S Lee,1 J Yoon,2 H Kim,2 K Lee,1 H Kim,1 J Lee1 and K Choi2 1 R&D
Center of Skin Science and Cosmetics, Enprani Co., Ltd., Incheon, Republic of Korea and 2
Translational Research Center for Protein Function Control, College of Life Science and
Biotechnology, Yonsei University,, Seoul, Republic of Korea
Obesity, which is related with metabolic syndrome and associated with liver diseases, represents
an epidemic problem and resulting in demands for effective therapeutic strategies. Growing evi-
dences show that the Wnt/β-catenin pathway is closely related with obesity, and that small mole-
cules regulating the Wnt/β-catenin pathway potentially can control adipogenesis related with obe-
sity. In this regard, natural products derived from plants influencing adipogenesis attract growing
attention for the treatment of obesity. We screened 11 plant extracts activating the Wnt/β-catenin
pathway by using the HEK 293-TOP cells retaining the Wnt/β-catenin signaling reporter gene in its
chromosome. We identified an extract of Persicaria hydropiper (L.) Spach (P. hydropiper), which was
found to activate the Wnt/β-catenin signaling among the 11 natural plant extracts we tested. P.
hydropiper is distributed worldwide in temperate climates and is widely found in Southeast Asia.
The P. hydropiper extract inhibited adipocyte differentiation of 3T3-L1 cells. Isoquercitrin and iso-
hamnetin, the active compounds in P. hydropiper, also activated the Wnt/β-catenin signaling and
suppressed adipocyte differentiation of 3T3-L1 cells. These results indicate that the isoquercitrin in
P. hydropiper suppress adipogenesis of 3T3-L1 cells via inhibition of the Wnt/β-catenin signaling.
Taken together, P. hydropiper or isoquercitrin potentially be applied for therapeutics of obesity and
its associated disorders.
484
Effect of extracorporeal photopheresis on dendritic cell populations in patients with Sézary
syndrome and graft-versus-host disease and its correlation with the clinical response
L Shiue,1 M Duvic,1 M Goswami,1 A Alousi,2 C Hosing2 and X Ni1 1 Dermatology, UT-MD
Anderson Cancer Center, Houston, TX and 2 Stem Cell Transplantation, UT-MD Anderson
Cancer Center, Houston, TX
Dendritic cells (DC) orchestrate the innate and adaptive immune systems to induce tolerance and
immunity. Defective DC populations are found in patients with Sézary syndrome (SS) and Graft-
versus-Host disease (GvHD) and may contribute to impaired immunity. Extracorporeal photopheresis
(ECP) is an effective therapy for SS and GvHD, but the mechanism of ECP is not fully understood.
In this study, we assessed the effect of ECP on CD11c+ myeloid DCs (mDC) and CD123+ plasma-
cytoid DCs (pDC) in peripheral blood from 18 SS and 5 GvHD patients (pt) by flow cytometry. The
HLA-DR expression was also assessed for DC maturation. Five of 5 GvHD pts had lower number
of mDCs (0.10%) and pDCs (0.04%) pre-ECP than those of normal donors (ND) (0.65%; 0.68%).
Ratios of pDC/mDC were significantly decreased (0.29) compared to ND (1.35). At 1-3 month (M)
post-ECP, 3 of 4 GvHD pts had increased mDC and pDC numbers and 4 of 4 had significantly
increased ratios of pDC/mDC. Among 18 SS pts, 12 had low mDCs (0.24%) and 10 had low pDCs
(0.13%) pre-ECP, and increased in both mDCs (9 of 12, 75.0%) and pDCs (7 of 10, 70.0%) 6M
post-ECP. Although ratios of mDC/pDC and pDC/mDC were normal in 15 of 18 SS pts (83.3%) pre-
ECP, mDC/ pDC ratio increased in 11 of 15 (73.3%) while pDC/mDC ratio decreased post-ECP.
HLA-DR expression in mDC was decreased in16 of 18 pts pre-ECP, and increased in 10 of 16 (62.5%)
at 6M post-ECP. Clinically, 11 of 18 SS patients had partial responses (61.1%), 4 stable disease
(22.2%) and 3 progressive disease (16.7%). Six of 11 responders (54.5 %) had increased mDC/pDC
ratios, 3 had a decrease (27.3%), and 2 unchanged (18.2%). Eight of 11 responders (72.7%) showed
an increased HLA-DR expression in mDCs, and 3 had a decrease (27.3%). Our results suggest that
ECP has effect on mDCs and pDCs in their number, ratio, and mature status, which may help to
restore impaired immunity in SS and GvHD.
482
Use of a magnet-containing barbell in the tongue to operate the tongue drive system
J Minocha,1 J Holbrook,1 B Yousefi,2 J Kim,2 X Huo,2 D Rowles,3 B Bartlett,1 L Ruppert,3 S Johnson-
Bice,1 D West,1 E Veledar,4 E Roth,3 M Ghovanloo2 and A Laumann1 1 Dermatology,
Northwestern University, Chicago, IL, 2 GT Bionics Lab, Georgia Institute of Technology,
Atlanta, GA, 3 Physical Medicine and Rehabilitation, Northwestern University, Chicago, IL and
4 Medicine, Emory University, Atlanta, GA
The Tongue Drive System (TDS) uses a magnet attached to the tongue to assist individuals with severe
neurological disorders interact wirelessly with the environment. The TDS has been operated via a
magnet temporarily attached with tissue adhesive. The aim was to place a more permanent magnet
on the tongue using an inserted barbell and to confirm its safety and efficacy with the TDS. Two
groups of subjects were recruited; Group A included subjects with an existing tongue piercing,
Group B included subjects willing to receive a tongue piercing. Group A had their existing tongue
barbells exchanged for magnet-containing titanium barbells. Group B received a tongue piercing
and placement of a standard barbell under controlled conditions. After 4-6 weeks the barbells were
exchanged for magnetic barbells. Testing included five 4-6 hour sessions over 5-6 weeks using the
TDS to perform computer tasks e.g. moving a cursor to a target, selecting a target, moving a cursor
through a maze, and playing games; and to navigate a powered wheelchair through an obstacle
course. 38 healthy able-bodied adults were enrolled. 14/17 Group A subjects completed all 5 test-
ing sessions. 9/21 Group B subjects completed all 5 testing sessions. All subjects were able to uti-
lize the TDS to perform all computer tasks and drive a powered wheelchair. The use of the mag-
netic barbell proved effective in able-bodied adults and this substantiates further investigation in
those with severe neurological disorders. In addition, this research demonstrates the value of multi-
disciplinary collaboration.
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Serum proteins responsible for pruritus in cutaneous T cell lymphoma
H Suga, M Sugaya, T Miyagaki, H Ohmatsu, H Fujita and S Sato Dermatology, University of
Tokyo, Tokyo, Japan
Not a few patients with mycosis fungoides (MF) or Sezary syndrome (SS) suffer from severe pruri-
tus. Nerve growth factor (NGF) is known to act as a potent mediator in neuroinflammatory processes
such as atopic dermatitis. In this study, we evaluated serum beta-NGF levels in MF/SS patients. In
addition, we examined correlations between antihistamine use and serum levels of various pro-
teins to elucidate the mechanism of pruritus in MF/SS. Serum samples included in this study were
as follows; 44 patients with MF/SS (22 cases of patch stage MF, 7 cases of plaque stage MF, 10 cases
of tumor stage MF, and 5 cases of SS), 35 patients with atopic dermatitis (AD), and 32 healthy con-
trols. Oral antihistamines were prescribed in 14% of patch MF, 29% of plaque MF, 40% of tumor
MF, and 60% of SS patients, suggesting that pruritus was more common in SS than in MF. Serum
beta-NGF levels in patients with MF/SS, AD, or in healthy controls were 34.7 ± 43.5 pg/ml, 55.7 ±
171.0 pg/ml, and 36.1 ± 26.0 pg/ml, respectively (no significant difference). Serum beta-NGF lev-
els in patients with patch MF, plaque MF, tumor MF, and SS were 21.4 ± 22.9 pg/ml, 16.2 ± 22.4
pg/ml, 39.6 ± 48.7 pg/ml, and 109.1 ± 54.3 pg/ml, respectively. Serum beta-NGF levels with SS
were significantly higher than patch MF, plaque MF, and tumor MF (P < 0.01, 0.01, and 0.05, respec-
tively). There was, however, no correlation between antihistamine use and serum beta-NGF levels.
We next examined correlations between antihistamine use and serum levels of CCL1, CCL11, CCL17,
CCL26, CCL27, IL-27, lactate dehydrogenase (LDH), IgE, and soluble IL-2 receptor. When we ana-
lyzed all MF/SS cases, serum levels of CCL1, CCL17, CCL26, CCL27, LDH, IgE, and soluble IL-2
receptor significantly correlated with antihistamine use. When only cases at advanced stages (plaque
MF, tumor MF, and SS) were examined, only serum CCL26 levels significantly correlated with anti-
histamine use. These results suggested that beta-NGF might be associated with SS rather than MF
and that CCL26 might be associated with pruritus in MF/SS patients.
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Non-lesional atopic dermatitis skin is characterized by broad terminal differentiation defects
and variable immune abnormalities
S Tintle*,1,6 M Suárez-Fariñas*,1,6 A Shemer,2 A Chiricozzi,1,4 K Nograles,1 I Cardinale,1 S Duan,5
A Bowcock,5 JG Krueger1 and E Guttman-Yassky1,3 1 Laboratory for Investigative Dermatology,
Rockefeller University, New York, NY, 2 Department of Dermatology, Tel-Hashomer Hospital
and Tel-Aviv University, Tel-Aviv, Israel, 3 Department of Dermatology, Weill-Cornell Medical
College, Cornell University, New York, NY, 4 Department of Dermatology, Tor Vergata
University of Rome, Rome, Italy, 5 Department of Genetics, Washington University School of
Medicine, St. Louis, MO and 6 Rockefeller University Center for Clinical and Translational
Science, New York, NY
Atopic dermatitis (AD) is a common inflammatory disease with a Th2 and “T22” immune polarity.
Despite recent data showing a genetic predisposition to epidermal barrier defects in some patients,
a fundamental debate exists regarding the role of barrier abnormalities versus immune responses
in initiating the disease. In order to explore an intrinsic predisposition to barrier abnormalities and/or
background immune activation in AD patients, an extensive study of non-lesional AD (ANL) skin is
necessary. To determine whether epidermal differentiation and immune abnormalities that charac-
terize lesional AD (AL) are also reflected in ANL skin, we performed a comprehensive histologic
and genomic analysis of both ANL and AL skin lesions (n=12 each) compared to normal human
skin (n=10). We found that ANL skin, in comparison to normal skin, has terminal differentiation
abnormalities, some immune abnormalities and an expansion of cutaneous T-cells. We also showed
that ANL skin has a considerably variable immune phenotype, which is largely determined by dis-
ease extent and severity. Whereas broad terminal differentiation abnormalities were mostly similar
between non-lesional and lesional AD skin, increased expression of immune-related genes were
among the most obvious differences between AL and ANL skin, potentially reflecting the “clinical
disease phenotype.” Our study implies that immune activation may play a role in alteration of the
normal epidermal phenotype, as suggested by the high correlation with disease extent and sever-
ity.
476
Digital image speckle correlation (DISC) analysis for quantifying the effect and duration of
cosmetic treatment with botulinum toxin(BT) type A
D Bhatnagar,1 M Rafailovich,1 N Conkling,2 BT Phillips,3 SU Khan,3 DT Bui3 and AB Dagum3 1
Materials Science and Engineering, Stony Brook University, Stony Brook, NY, 2 School of
Medicine, Stony Brook University, Stony Brook, NY and 3 Department of Surgery, Division of
Plastic and Reconstructive Surgery, Stony Brook, NY
In this study, we successfully quantified the effect of BT treatment by DISC analysis. BT injections
were dosed to cosmetic effect in the forehead, glabellar, and crow’s feet areas. Patient volunteers
were photographed before and after treatment and at subsequent time points using a head stabi-
lizer in the following position:raising eyebrows, frowning, blinking, and with the face at rest. The
DISC software was then used to calculate the magnitude of facial muscle paralysis and to deter-
mine the point at which the toxins effect fully dissipates by monitoring the return of contractile
strength. DISC was also used to identify the facial muscle vectors responsible for producing wrin-
kles in individual patients. Quantitative analysis was correlated with patient-reported data using
the validated (FLO-11) Questionnaire and SPA Measure. The analysis of our 4 patients demonstrated
dramatic facial muscle paralysis beginning at 1 week and varying degrees of recovery by 8 weeks.
In patient 1, the frontalis muscle showed a 73% decrease in magnitude of muscle contraction com-
pared to baseline at Week 1, with subsequent rapid recovery, whereas, the effect on glabellar
region took atleast 2 weeks to reach its maximum paralysis, which was greater in magnitude and
slower in recovery. Meanwhile, patient perception of effect only began to decrease slightly at the
8-week time point, as measured by FLO-11 (from 90.9 at week 4 to 82.7 at week 8) and no change
in SPA. Thus,our analysis provides a sensitive, non-invasive measure of facial muscle dynamics,
and has the potential to serve as an objective metric for dermatologists administering Botulinim
toxin injections, enhancing clinical judgment in tailoring treatment to individual patients.DISC can
also be used to monitor the recovery following nerve repair and facial transplant.
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Response to antimalarials in cutaneous lupus erythematosus
AY Chang,1,2 EW Piette,1,2 KP Foering,1,2,3 TR Tenhave,4 J Okawa1,2 and VP Werth1,2 1 Phila VAMC,
Phila, PA, 2 Dept of Derm, UPenn, Phila, PA, 3 Inst Transl Med & Ther, UPenn, Phila, PA and
4 Ctr for Clin Epi & Biostats, UPenn, Phila, PA
There are few studies that support antimalarial use in treating cutaneous lupus erythematosus
(CLE). This is a prospective, longitudinal cohort study that evaluates response to antimalarials in
CLE patients using a validated outcome measure, the CLE Disease Area and Severity Index (CLASI).
128 patients, who presented from Jan 2007 to Jul 2010 at a university’s cutaneous autoimmune dis-
ease clinic, met criteria for having CLE, and had at least two visits with CLASI scores measured, were
included. Of these patients, those initiated or continued on hydroxychloroquine (HCQ), hydroxy-
chloroquine-quinacrine (HCQ-Qn), chloroquine (CQ), or chloroquine-quinacrine (CQ-Qn) were
identified. Patients also on immunosuppressives or non-antimalarial immunomodulators were
excluded. Response was defined by a 4-point or 20% decrease in CLASI activity score. Response
to initiation was determined by the CLASI score before treatment and at the first visit at least 2 months
after treatment. Response to continuation was determined with the CLASI score at the first visit and
most recent visit on treatment. Of 11 patients initiated on HCQ, 55% were responders with a decrease
in median (range) CLASI score from 8.0 (2.0-16) to 3.0 (1.0-11) (p=0.04). Of 15 patients who had
failed HCQ, 67% were responders to initiation of HCQ-Qn, with a decrease in CLASI score from
6.0 (4-20) to 3.0 (0-7) (p=0.006). Of 6 patients who had failed HCQ and HCQ-Qn, 2 were respon-
ders to initiation of CQ-Qn, with a decrease in CLASI score from 26 (24-28) to 8.5 (0-17). About
40% of patients continued on HCQ or HCQ-Qn were responders with a decrease in CLASI score
from 6.0 (1.0-15) to 1.0 (0-9.0) (p=0.009) and 8.0 (3.0-30) to 4.0 (0-25) (p=0.01), respectively.
There was no difference in age, sex, and smoking status between responders and non-responders
in each treatment group. The use of Qn with HCQ can be beneficial in patients who fail HCQ
monotherapy. Further reduction in disease activity can be seen with continuation of antimalarial
therapy.
478
Association of the numbers of CD163+ macrophages in lesional skin and serum levels of sol-
uble CD163 with disease progression of cutaneous T cell lymphoma
M Sugaya, T Miyagaki, H Ohmatsu, H Suga, H Kai, M Kamata, Y Tada and S Sato Department of
Dermatology, University of Tokyo, Tokyo, Japan
Classically activated macrophages produce IL-12, IL-23, and TNF-α, whereas alternatively activated
macrophages (M2 cells) produce IL-10 and express several receptors such as mannose receptor
and CD163. Tumor-associated macrophages exhibit M2 phenotype, whose presence has been asso-
ciated with poor prognosis in various tumors. In this study, we investigated distribution of CD163+
macrophages in lesional skin of cutaneous T cell lymphoma (CTCL). By immunohistochemistry, we
found that the numbers of CD163+ macrophages in psoriatic skin and in CTCL were 39.0 ± 7.9
cells/high power field (HPF) and 45.2 ± 21.5 cells/HPF, respectively, which were significantly larger
than in normal skin (7.3 ± 2.5 cells/HPF; P < 0.05 and P < 0.05, respectively). In CTCL with patch
stage (n = 5), plaque stage (n = 4), tumor stage (n = 4), and erythroderma (n = 4), the numbers of
CD163+ macrophages were 28.6 ± 7.2 cells/HPF, 47.5 ± 9.3 cells/HPF, 63.5 ± 34.6 cells/HPF, and
45.5 ± 14.4 cells/HPF, respectively. The numbers in patients with plaque stage and tumor stage
were significantly larger than those with patch stage (P < 0.05 and P < 0.05, respectively). Serum
levels of soluble CD163 (sCD163) in patients with CTCL (n = 35), atopic dermatitis (n = 42), or pso-
riasis vulgaris (n = 44) were 487.4 ± 131.3 pg/ml, 503.6 ± 149.0 pg/ml, and 617.1 ± 181.3 pg/ml,
respectively, which were significantly higher than those in normal controls (406.3 ± 113.9 pg/ml;
P < 0.05 for all comparisons). In patients with CTCL, serum sCD163 levels significantly correlated
with serum soluble interleukin-2 receptor and CCL17 levels (r = 0.40, P < 0.05, and r = 0.59, P <
0.05, respectively). Moreover, sCD163 levels significantly correlated with the numbers of CD163+
macrophages infiltrating in the lesional skin (r = 0.63, P < 0.05). Thus, these data demonstrated that
the numbers of CD163+ macrophages in lesional skin and serum sCD163 levels were associated
with disease progression of CTCL.
479
Pralatrexate selectively induces apoptosis and synergizes with bexarotene through up-regu-
lation of p53/Bax/PUMA in cutaneous T-cell lymphoma cells
S Rangwala, X Zhang, C Zhang and M Duvic Dermatology, The University of Texas MD
Anderson Cancer Center, Houston, TX
Pralatrexate (PDX), a targeted antifolate, was designed for preferential uptake and accumulation in
tumor cells based on its high affinity for reduced folate carrier-1 and efficient polyglutamation by
folypolyglutamyl synthetase. PDX is approved by the FDA for relapsed or refractory peripheral T-
cell lymphoma, and clinical studies are ongoing in cutaneous T-cell lymphoma (CTCL). Bexarotene
(BEX), approved for treatment of CTCL, is an RXR-selective retinoid. Here we investigated the ther-
apeutic mechanisms of PDX and whether PDX combined with BEX has synergistic anti-tumor effects
in CTCL. Cell viability was examined by MTS assay and apoptosis by FACS analysis. Expression of
apoptosis-associated proteins was analyzed by Western blotting. PDX (1-5 nM for 24 and 48 hrs)
decreased cell viability and induced apoptosis in a time- and dose-dependent manner in 4 CTCL
cell lines (MJ, Hut78, HH, and HH/VOR). PDX (1-5 nM for 48 hrs) also caused significantly more
apoptosis of CD4+ T cells from 4 Sézary Syndrome (SS) patients with high percentages (74-96%) of
circulating CD4+CD26- T cells compared to CD4+ T cells from 3 healthy donors (p < 0.05). More-
over, PDX at low dose (2 nM) combined with BEX (10 μM) induced up to 12-fold increase in apop-
tosis compared to either drug alone in all four CTCL cell lines and in SS patient’s CD4+ T cells. Addi-
tionally, PDX combined with BEX synergistically increased the tumor suppressor p53, and the
p53-regulated pro-apoptosis proteins, Bax, and PUMA. In conclusion, our results show that PDX at
low nanomolar concentrations selectively induces apoptosis in CTCL cell lines and SS patients’
CD4+ T cells, and PDX combined with BEX exerts a synergistic pro-apoptosis effect through up-
regulation of p53/Bax/PUMA in CTCL. These findings support the ongoing phase 1 clinical trial of
PDX/BEX and provide the rationale for future studies of this combination in CTCL patients.
480
NVP-BFH772, a potent inhibitor of VEGF receptor tyrosine kinases, is effective in models of
skin inflammation
JG Meingassner,1 H Fahrngruber,1 E Kowalsky,1 A Billich,2 G Bold,2 A Littlewood-Evans2 and
A Stuetz1 1 Novartis Institutes for BioMedical Research, Vienna, Austria and 2 Novartis
Institutes for BioMedical Research, Basel, Switzerland
Vascular endothelial growth factor (VEGF) is a key regulator of angiogenesis under normal and
pathological conditions. There is increasing evidence that angiogenesis plays a substantial role in
chronic inflammatory skin diseases. Here we report on biological properties of the novel low-molec-
ular-weight VEGF receptor tyrosine kinase (TK) inhibitor NVP-BFH772 in vitro and in vivo models
of skin inflammation. In vitro, NVP-BFH772 shows potent and selective inhibition of VEGF recep-
tor 2 TK (KDR) and KDR autophosphorylation, with IC50 values of 42nM and 4nM, respectively.
The compound inhibits also c-Kit, PDGFR and Tie2, albeit with a lower potency, but is inactive
against a large panel of other kinases. NVP-BFH772 penetrates well into human skin in vitro using
a standard solvent. In vivo after topical application, it significantly and dose-dependently inhibits
experimental chronic allergic contact dermatitis (ACD) in VEGF-tg+/- mice, spontaneous chronic
dermatitis in VEGF-tg+/+ mice, and acute ACD in normal mice and domestic pigs. Furthermore, the
compound inhibits VEGF-induced intradermal extravasation in mice and pigs and microvascular
perfusion in UVB-induced erythema in pigs. After oral application, it inhibits skin inflammation in
acute ACD in mice in a significant and dose-dependent manner. Taken together, the data indicate
that topical application of the VEGF receptor TK inhibitor NVP-BFH772 may be beneficial in the
treatment of inflammatory conditions of the skin.
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Skin physiology in neonates and young children of different age groups compared to adults:
A randomized study
JW Fluhr,1 N Lachmann,2 C Baudouin,2 C de Belilovsky,3 P Msika2 and J Hachem4 1 Dermatology
Department, Charite University Clinic, Berlin, Germany, 2 Innovation R&D Direction,
Laboratoires Expanscience, Epernon, France, 3 Dermatology Department, Institut Alfred
Fournier, Paris, France and 4 Dermatology Research, Vrije Universiteit, Brussels, Belgium
The aim of this study was to investigate skin parameters (transepidermal water loss (TEWL), stratum
corneum (SC) hydration, surface pH) and the biochemical skin composition (water profile and bulk
NMF) to characterize neonatal skin in comparison to different children age groups and adults skin.
The study was performed in healthy male and female volunteers (n=108) of 6 age groups (n= 18
each group: newborns (1-15 days), five-week, six-month, 1-2 yrs., 4-5 yrs and adults aged 20-35
yrs.). Biophysical parameters (TEWL, capacitance and surface pH) were measured on the volar
forearms and water- and bulk NMF-profiles were assessed with Raman Spectroscopy (RS). The low-
est SC hydration was noted in newborns compared to other age groups representing a dry SC in
newborns. The mean skin surface pH-value was highest in newborns. A decrease of 1 pH unit was
observed over the first 5 weeks and comparable to all other age groups, indicating a quick pH sta-
bilization within the first weeks after birth. All mean TEWL values were below 10 g/m2/h reflecting
a normal and competent basal barrier function in all groups. An increase in SC hydration within the
first weeks of life was detected (RS). The increase in water content profile, correlated to increasing
skin depth, was lower for newborns. Newborns showed greater bulk NMF concentrations. Neona-
tal and infant skin is mainly competent under basal conditions except SC water content and NMF
components regulating the SC hydration level. Newborns are adapting to the dry environment by
compensating the lack of water with increased NMF.
483
Evaluation of psoriasis area and severity index, static physician’s global assessment, and lat-
tice system-physician’s global assessment for assessing psoriasis severity
C Chow,1 Z Zhang,2 MT Goldfarb,1 MJ Simpson1 and CN Ellis1 1 Dermatology, Univ of
Michigan, Ann Arbor, MI and 2 Statistics, Univ of Michigan, Ann Arbor, MI
Consistent, accurate, and repeatable measurement of psoriasis severity is critical in assessing responses
to treatment in clinical trials. We investigated changes over the course of treatment in the Psoriasis
Area and Severity Index (PASI), Static Physician’s Global Assessment (SPGA), and Lattice System-
Physician’s Global Assessment (LS-PGA) in a randomized, multicenter, 24-week study of chronic
plaque psoriasis. Of 652 enrolled patients, 455 had complete data and were included in our analy-
ses. The treatment group had 366 patients who received either cyclosporine or voclosporin. In this
group at trial entry, there was poorer Spearman correlation of SPGA with PASI (r=0.45) and LS-PGA
(0.39) than between PASI and LS-PGA (0.68). After therapy, all correlations were stronger, but
SPGA continued to be less well correlated (with PASI, 0.85; with LS-PGA, 0.79) than PASI with LS-
PGA (0.90). Assessment of body surface area (BSA) affected by psoriasis showed much stronger
correlations before and after treatment, respectively, with LS-PGA (0.75, 0.93) and PASI (0.71,
0.86) than with SPGA (0.18, 0.67). A similar pattern of results occurred in 89 patients receiving
placebo. Median scores at pretherapy and after 12 and 24 weeks of active therapy were 16.5, 3.8,
3.6 for PASI (maximum possible score 72), 3, 2, 2 for SPGA (max 5), and 6, 3, 2 for LS-PGA (max
7). When placebo patients crossed over to active therapy, the scores showed the same pattern. All
measures showed statistically significant efficacy of treatment compared to placebo (P<.05) and for
change from before to end of active treatment (P<.0001). BSA is not a specified component of SPGA,
which may account for the poorer correlation of SPGA with the other severity measures. Weaker
correlations at study entry may reflect vagaries of enrollment criteria. SPGA showed the poorest
responsiveness to therapy. PASI and LS-PGA are highly correlated measures of change in psoriasis
severity during effective therapy.
485
Persicaria hydropiper (L.) Spach and its flavonoid components, isoquercitrin and isorham-
netin, activate the Wnt/β-catenin pathway and inhibit the adipocyte differentiation of 3T3-
L1 cells
B Kim,1 S Lee,2 M Oh,1 J Kim,1 S Lee,1 J Yoon,2 H Kim,2 K Lee,1 H Kim,1 J Lee1 and K Choi2 1 R&D
Center of Skin Science and Cosmetics, Enprani Co., Ltd., Incheon, Republic of Korea and 2
Translational Research Center for Protein Function Control, College of Life Science and
Biotechnology, Yonsei University,, Seoul, Republic of Korea
Obesity, which is related with metabolic syndrome and associated with liver diseases, represents
an epidemic problem and resulting in demands for effective therapeutic strategies. Growing evi-
dences show that the Wnt/β-catenin pathway is closely related with obesity, and that small mole-
cules regulating the Wnt/β-catenin pathway potentially can control adipogenesis related with obe-
sity. In this regard, natural products derived from plants influencing adipogenesis attract growing
attention for the treatment of obesity. We screened 11 plant extracts activating the Wnt/β-catenin
pathway by using the HEK 293-TOP cells retaining the Wnt/β-catenin signaling reporter gene in its
chromosome. We identified an extract of Persicaria hydropiper (L.) Spach (P. hydropiper), which was
found to activate the Wnt/β-catenin signaling among the 11 natural plant extracts we tested. P.
hydropiper is distributed worldwide in temperate climates and is widely found in Southeast Asia.
The P. hydropiper extract inhibited adipocyte differentiation of 3T3-L1 cells. Isoquercitrin and iso-
hamnetin, the active compounds in P. hydropiper, also activated the Wnt/β-catenin signaling and
suppressed adipocyte differentiation of 3T3-L1 cells. These results indicate that the isoquercitrin in
P. hydropiper suppress adipogenesis of 3T3-L1 cells via inhibition of the Wnt/β-catenin signaling.
Taken together, P. hydropiper or isoquercitrin potentially be applied for therapeutics of obesity and
its associated disorders.
484
Effect of extracorporeal photopheresis on dendritic cell populations in patients with Sézary
syndrome and graft-versus-host disease and its correlation with the clinical response
L Shiue,1 M Duvic,1 M Goswami,1 A Alousi,2 C Hosing2 and X Ni1 1 Dermatology, UT-MD
Anderson Cancer Center, Houston, TX and 2 Stem Cell Transplantation, UT-MD Anderson
Cancer Center, Houston, TX
Dendritic cells (DC) orchestrate the innate and adaptive immune systems to induce tolerance and
immunity. Defective DC populations are found in patients with Sézary syndrome (SS) and Graft-
versus-Host disease (GvHD) and may contribute to impaired immunity. Extracorporeal photopheresis
(ECP) is an effective therapy for SS and GvHD, but the mechanism of ECP is not fully understood.
In this study, we assessed the effect of ECP on CD11c+ myeloid DCs (mDC) and CD123+ plasma-
cytoid DCs (pDC) in peripheral blood from 18 SS and 5 GvHD patients (pt) by flow cytometry. The
HLA-DR expression was also assessed for DC maturation. Five of 5 GvHD pts had lower number
of mDCs (0.10%) and pDCs (0.04%) pre-ECP than those of normal donors (ND) (0.65%; 0.68%).
Ratios of pDC/mDC were significantly decreased (0.29) compared to ND (1.35). At 1-3 month (M)
post-ECP, 3 of 4 GvHD pts had increased mDC and pDC numbers and 4 of 4 had significantly
increased ratios of pDC/mDC. Among 18 SS pts, 12 had low mDCs (0.24%) and 10 had low pDCs
(0.13%) pre-ECP, and increased in both mDCs (9 of 12, 75.0%) and pDCs (7 of 10, 70.0%) 6M
post-ECP. Although ratios of mDC/pDC and pDC/mDC were normal in 15 of 18 SS pts (83.3%) pre-
ECP, mDC/ pDC ratio increased in 11 of 15 (73.3%) while pDC/mDC ratio decreased post-ECP.
HLA-DR expression in mDC was decreased in16 of 18 pts pre-ECP, and increased in 10 of 16 (62.5%)
at 6M post-ECP. Clinically, 11 of 18 SS patients had partial responses (61.1%), 4 stable disease
(22.2%) and 3 progressive disease (16.7%). Six of 11 responders (54.5 %) had increased mDC/pDC
ratios, 3 had a decrease (27.3%), and 2 unchanged (18.2%). Eight of 11 responders (72.7%) showed
an increased HLA-DR expression in mDCs, and 3 had a decrease (27.3%). Our results suggest that
ECP has effect on mDCs and pDCs in their number, ratio, and mature status, which may help to
restore impaired immunity in SS and GvHD.
482
Use of a magnet-containing barbell in the tongue to operate the tongue drive system
J Minocha,1 J Holbrook,1 B Yousefi,2 J Kim,2 X Huo,2 D Rowles,3 B Bartlett,1 L Ruppert,3 S Johnson-
Bice,1 D West,1 E Veledar,4 E Roth,3 M Ghovanloo2 and A Laumann1 1 Dermatology,
Northwestern University, Chicago, IL, 2 GT Bionics Lab, Georgia Institute of Technology,
Atlanta, GA, 3 Physical Medicine and Rehabilitation, Northwestern University, Chicago, IL and
4 Medicine, Emory University, Atlanta, GA
The Tongue Drive System (TDS) uses a magnet attached to the tongue to assist individuals with severe
neurological disorders interact wirelessly with the environment. The TDS has been operated via a
magnet temporarily attached with tissue adhesive. The aim was to place a more permanent magnet
on the tongue using an inserted barbell and to confirm its safety and efficacy with the TDS. Two
groups of subjects were recruited; Group A included subjects with an existing tongue piercing,
Group B included subjects willing to receive a tongue piercing. Group A had their existing tongue
barbells exchanged for magnet-containing titanium barbells. Group B received a tongue piercing
and placement of a standard barbell under controlled conditions. After 4-6 weeks the barbells were
exchanged for magnetic barbells. Testing included five 4-6 hour sessions over 5-6 weeks using the
TDS to perform computer tasks e.g. moving a cursor to a target, selecting a target, moving a cursor
through a maze, and playing games; and to navigate a powered wheelchair through an obstacle
course. 38 healthy able-bodied adults were enrolled. 14/17 Group A subjects completed all 5 test-
ing sessions. 9/21 Group B subjects completed all 5 testing sessions. All subjects were able to uti-
lize the TDS to perform all computer tasks and drive a powered wheelchair. The use of the mag-
netic barbell proved effective in able-bodied adults and this substantiates further investigation in
those with severe neurological disorders. In addition, this research demonstrates the value of multi-
disciplinary collaboration.
486
Serum proteins responsible for pruritus in cutaneous T cell lymphoma
H Suga, M Sugaya, T Miyagaki, H Ohmatsu, H Fujita and S Sato Dermatology, University of
Tokyo, Tokyo, Japan
Not a few patients with mycosis fungoides (MF) or Sezary syndrome (SS) suffer from severe pruri-
tus. Nerve growth factor (NGF) is known to act as a potent mediator in neuroinflammatory processes
such as atopic dermatitis. In this study, we evaluated serum beta-NGF levels in MF/SS patients. In
addition, we examined correlations between antihistamine use and serum levels of various pro-
teins to elucidate the mechanism of pruritus in MF/SS. Serum samples included in this study were
as follows; 44 patients with MF/SS (22 cases of patch stage MF, 7 cases of plaque stage MF, 10 cases
of tumor stage MF, and 5 cases of SS), 35 patients with atopic dermatitis (AD), and 32 healthy con-
trols. Oral antihistamines were prescribed in 14% of patch MF, 29% of plaque MF, 40% of tumor
MF, and 60% of SS patients, suggesting that pruritus was more common in SS than in MF. Serum
beta-NGF levels in patients with MF/SS, AD, or in healthy controls were 34.7 ± 43.5 pg/ml, 55.7 ±
171.0 pg/ml, and 36.1 ± 26.0 pg/ml, respectively (no significant difference). Serum beta-NGF lev-
els in patients with patch MF, plaque MF, tumor MF, and SS were 21.4 ± 22.9 pg/ml, 16.2 ± 22.4
pg/ml, 39.6 ± 48.7 pg/ml, and 109.1 ± 54.3 pg/ml, respectively. Serum beta-NGF levels with SS
were significantly higher than patch MF, plaque MF, and tumor MF (P < 0.01, 0.01, and 0.05, respec-
tively). There was, however, no correlation between antihistamine use and serum beta-NGF levels.
We next examined correlations between antihistamine use and serum levels of CCL1, CCL11, CCL17,
CCL26, CCL27, IL-27, lactate dehydrogenase (LDH), IgE, and soluble IL-2 receptor. When we ana-
lyzed all MF/SS cases, serum levels of CCL1, CCL17, CCL26, CCL27, LDH, IgE, and soluble IL-2
receptor significantly correlated with antihistamine use. When only cases at advanced stages (plaque
MF, tumor MF, and SS) were examined, only serum CCL26 levels significantly correlated with anti-
histamine use. These results suggested that beta-NGF might be associated with SS rather than MF
and that CCL26 might be associated with pruritus in MF/SS patients.
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Non-lesional atopic dermatitis skin is characterized by broad terminal differentiation defects
and variable immune abnormalities
S Tintle*,1,6 M Suárez-Fariñas*,1,6 A Shemer,2 A Chiricozzi,1,4 K Nograles,1 I Cardinale,1 S Duan,5
A Bowcock,5 JG Krueger1 and E Guttman-Yassky1,3 1 Laboratory for Investigative Dermatology,
Rockefeller University, New York, NY, 2 Department of Dermatology, Tel-Hashomer Hospital
and Tel-Aviv University, Tel-Aviv, Israel, 3 Department of Dermatology, Weill-Cornell Medical
College, Cornell University, New York, NY, 4 Department of Dermatology, Tor Vergata
University of Rome, Rome, Italy, 5 Department of Genetics, Washington University School of
Medicine, St. Louis, MO and 6 Rockefeller University Center for Clinical and Translational
Science, New York, NY
Atopic dermatitis (AD) is a common inflammatory disease with a Th2 and “T22” immune polarity.
Despite recent data showing a genetic predisposition to epidermal barrier defects in some patients,
a fundamental debate exists regarding the role of barrier abnormalities versus immune responses
in initiating the disease. In order to explore an intrinsic predisposition to barrier abnormalities and/or
background immune activation in AD patients, an extensive study of non-lesional AD (ANL) skin is
necessary. To determine whether epidermal differentiation and immune abnormalities that charac-
terize lesional AD (AL) are also reflected in ANL skin, we performed a comprehensive histologic
and genomic analysis of both ANL and AL skin lesions (n=12 each) compared to normal human
skin (n=10). We found that ANL skin, in comparison to normal skin, has terminal differentiation
abnormalities, some immune abnormalities and an expansion of cutaneous T-cells. We also showed
that ANL skin has a considerably variable immune phenotype, which is largely determined by dis-
ease extent and severity. Whereas broad terminal differentiation abnormalities were mostly similar
between non-lesional and lesional AD skin, increased expression of immune-related genes were
among the most obvious differences between AL and ANL skin, potentially reflecting the “clinical
disease phenotype.” Our study implies that immune activation may play a role in alteration of the
normal epidermal phenotype, as suggested by the high correlation with disease extent and sever-
ity.
476
Digital image speckle correlation (DISC) analysis for quantifying the effect and duration of
cosmetic treatment with botulinum toxin(BT) type A
D Bhatnagar,1 M Rafailovich,1 N Conkling,2 BT Phillips,3 SU Khan,3 DT Bui3 and AB Dagum3 1
Materials Science and Engineering, Stony Brook University, Stony Brook, NY, 2 School of
Medicine, Stony Brook University, Stony Brook, NY and 3 Department of Surgery, Division of
Plastic and Reconstructive Surgery, Stony Brook, NY
In this study, we successfully quantified the effect of BT treatment by DISC analysis. BT injections
were dosed to cosmetic effect in the forehead, glabellar, and crow’s feet areas. Patient volunteers
were photographed before and after treatment and at subsequent time points using a head stabi-
lizer in the following position:raising eyebrows, frowning, blinking, and with the face at rest. The
DISC software was then used to calculate the magnitude of facial muscle paralysis and to deter-
mine the point at which the toxins effect fully dissipates by monitoring the return of contractile
strength. DISC was also used to identify the facial muscle vectors responsible for producing wrin-
kles in individual patients. Quantitative analysis was correlated with patient-reported data using
the validated (FLO-11) Questionnaire and SPA Measure. The analysis of our 4 patients demonstrated
dramatic facial muscle paralysis beginning at 1 week and varying degrees of recovery by 8 weeks.
In patient 1, the frontalis muscle showed a 73% decrease in magnitude of muscle contraction com-
pared to baseline at Week 1, with subsequent rapid recovery, whereas, the effect on glabellar
region took atleast 2 weeks to reach its maximum paralysis, which was greater in magnitude and
slower in recovery. Meanwhile, patient perception of effect only began to decrease slightly at the
8-week time point, as measured by FLO-11 (from 90.9 at week 4 to 82.7 at week 8) and no change
in SPA. Thus,our analysis provides a sensitive, non-invasive measure of facial muscle dynamics,
and has the potential to serve as an objective metric for dermatologists administering Botulinim
toxin injections, enhancing clinical judgment in tailoring treatment to individual patients.DISC can
also be used to monitor the recovery following nerve repair and facial transplant.
477
Response to antimalarials in cutaneous lupus erythematosus
AY Chang,1,2 EW Piette,1,2 KP Foering,1,2,3 TR Tenhave,4 J Okawa1,2 and VP Werth1,2 1 Phila VAMC,
Phila, PA, 2 Dept of Derm, UPenn, Phila, PA, 3 Inst Transl Med & Ther, UPenn, Phila, PA and
4 Ctr for Clin Epi & Biostats, UPenn, Phila, PA
There are few studies that support antimalarial use in treating cutaneous lupus erythematosus
(CLE). This is a prospective, longitudinal cohort study that evaluates response to antimalarials in
CLE patients using a validated outcome measure, the CLE Disease Area and Severity Index (CLASI).
128 patients, who presented from Jan 2007 to Jul 2010 at a university’s cutaneous autoimmune dis-
ease clinic, met criteria for having CLE, and had at least two visits with CLASI scores measured, were
included. Of these patients, those initiated or continued on hydroxychloroquine (HCQ), hydroxy-
chloroquine-quinacrine (HCQ-Qn), chloroquine (CQ), or chloroquine-quinacrine (CQ-Qn) were
identified. Patients also on immunosuppressives or non-antimalarial immunomodulators were
excluded. Response was defined by a 4-point or 20% decrease in CLASI activity score. Response
to initiation was determined by the CLASI score before treatment and at the first visit at least 2 months
after treatment. Response to continuation was determined with the CLASI score at the first visit and
most recent visit on treatment. Of 11 patients initiated on HCQ, 55% were responders with a decrease
in median (range) CLASI score from 8.0 (2.0-16) to 3.0 (1.0-11) (p=0.04). Of 15 patients who had
failed HCQ, 67% were responders to initiation of HCQ-Qn, with a decrease in CLASI score from
6.0 (4-20) to 3.0 (0-7) (p=0.006). Of 6 patients who had failed HCQ and HCQ-Qn, 2 were respon-
ders to initiation of CQ-Qn, with a decrease in CLASI score from 26 (24-28) to 8.5 (0-17). About
40% of patients continued on HCQ or HCQ-Qn were responders with a decrease in CLASI score
from 6.0 (1.0-15) to 1.0 (0-9.0) (p=0.009) and 8.0 (3.0-30) to 4.0 (0-25) (p=0.01), respectively.
There was no difference in age, sex, and smoking status between responders and non-responders
in each treatment group. The use of Qn with HCQ can be beneficial in patients who fail HCQ
monotherapy. Further reduction in disease activity can be seen with continuation of antimalarial
therapy.
478
Association of the numbers of CD163+ macrophages in lesional skin and serum levels of sol-
uble CD163 with disease progression of cutaneous T cell lymphoma
M Sugaya, T Miyagaki, H Ohmatsu, H Suga, H Kai, M Kamata, Y Tada and S Sato Department of
Dermatology, University of Tokyo, Tokyo, Japan
Classically activated macrophages produce IL-12, IL-23, and TNF-α, whereas alternatively activated
macrophages (M2 cells) produce IL-10 and express several receptors such as mannose receptor
and CD163. Tumor-associated macrophages exhibit M2 phenotype, whose presence has been asso-
ciated with poor prognosis in various tumors. In this study, we investigated distribution of CD163+
macrophages in lesional skin of cutaneous T cell lymphoma (CTCL). By immunohistochemistry, we
found that the numbers of CD163+ macrophages in psoriatic skin and in CTCL were 39.0 ± 7.9
cells/high power field (HPF) and 45.2 ± 21.5 cells/HPF, respectively, which were significantly larger
than in normal skin (7.3 ± 2.5 cells/HPF; P < 0.05 and P < 0.05, respectively). In CTCL with patch
stage (n = 5), plaque stage (n = 4), tumor stage (n = 4), and erythroderma (n = 4), the numbers of
CD163+ macrophages were 28.6 ± 7.2 cells/HPF, 47.5 ± 9.3 cells/HPF, 63.5 ± 34.6 cells/HPF, and
45.5 ± 14.4 cells/HPF, respectively. The numbers in patients with plaque stage and tumor stage
were significantly larger than those with patch stage (P < 0.05 and P < 0.05, respectively). Serum
levels of soluble CD163 (sCD163) in patients with CTCL (n = 35), atopic dermatitis (n = 42), or pso-
riasis vulgaris (n = 44) were 487.4 ± 131.3 pg/ml, 503.6 ± 149.0 pg/ml, and 617.1 ± 181.3 pg/ml,
respectively, which were significantly higher than those in normal controls (406.3 ± 113.9 pg/ml;
P < 0.05 for all comparisons). In patients with CTCL, serum sCD163 levels significantly correlated
with serum soluble interleukin-2 receptor and CCL17 levels (r = 0.40, P < 0.05, and r = 0.59, P <
0.05, respectively). Moreover, sCD163 levels significantly correlated with the numbers of CD163+
macrophages infiltrating in the lesional skin (r = 0.63, P < 0.05). Thus, these data demonstrated that
the numbers of CD163+ macrophages in lesional skin and serum sCD163 levels were associated
with disease progression of CTCL.
479
Pralatrexate selectively induces apoptosis and synergizes with bexarotene through up-regu-
lation of p53/Bax/PUMA in cutaneous T-cell lymphoma cells
S Rangwala, X Zhang, C Zhang and M Duvic Dermatology, The University of Texas MD
Anderson Cancer Center, Houston, TX
Pralatrexate (PDX), a targeted antifolate, was designed for preferential uptake and accumulation in
tumor cells based on its high affinity for reduced folate carrier-1 and efficient polyglutamation by
folypolyglutamyl synthetase. PDX is approved by the FDA for relapsed or refractory peripheral T-
cell lymphoma, and clinical studies are ongoing in cutaneous T-cell lymphoma (CTCL). Bexarotene
(BEX), approved for treatment of CTCL, is an RXR-selective retinoid. Here we investigated the ther-
apeutic mechanisms of PDX and whether PDX combined with BEX has synergistic anti-tumor effects
in CTCL. Cell viability was examined by MTS assay and apoptosis by FACS analysis. Expression of
apoptosis-associated proteins was analyzed by Western blotting. PDX (1-5 nM for 24 and 48 hrs)
decreased cell viability and induced apoptosis in a time- and dose-dependent manner in 4 CTCL
cell lines (MJ, Hut78, HH, and HH/VOR). PDX (1-5 nM for 48 hrs) also caused significantly more
apoptosis of CD4+ T cells from 4 Sézary Syndrome (SS) patients with high percentages (74-96%) of
circulating CD4+CD26- T cells compared to CD4+ T cells from 3 healthy donors (p < 0.05). More-
over, PDX at low dose (2 nM) combined with BEX (10 μM) induced up to 12-fold increase in apop-
tosis compared to either drug alone in all four CTCL cell lines and in SS patient’s CD4+ T cells. Addi-
tionally, PDX combined with BEX synergistically increased the tumor suppressor p53, and the
p53-regulated pro-apoptosis proteins, Bax, and PUMA. In conclusion, our results show that PDX at
low nanomolar concentrations selectively induces apoptosis in CTCL cell lines and SS patients’
CD4+ T cells, and PDX combined with BEX exerts a synergistic pro-apoptosis effect through up-
regulation of p53/Bax/PUMA in CTCL. These findings support the ongoing phase 1 clinical trial of
PDX/BEX and provide the rationale for future studies of this combination in CTCL patients.
480
NVP-BFH772, a potent inhibitor of VEGF receptor tyrosine kinases, is effective in models of
skin inflammation
JG Meingassner,1 H Fahrngruber,1 E Kowalsky,1 A Billich,2 G Bold,2 A Littlewood-Evans2 and
A Stuetz1 1 Novartis Institutes for BioMedical Research, Vienna, Austria and 2 Novartis
Institutes for BioMedical Research, Basel, Switzerland
Vascular endothelial growth factor (VEGF) is a key regulator of angiogenesis under normal and
pathological conditions. There is increasing evidence that angiogenesis plays a substantial role in
chronic inflammatory skin diseases. Here we report on biological properties of the novel low-molec-
ular-weight VEGF receptor tyrosine kinase (TK) inhibitor NVP-BFH772 in vitro and in vivo models
of skin inflammation. In vitro, NVP-BFH772 shows potent and selective inhibition of VEGF recep-
tor 2 TK (KDR) and KDR autophosphorylation, with IC50 values of 42nM and 4nM, respectively.
The compound inhibits also c-Kit, PDGFR and Tie2, albeit with a lower potency, but is inactive
against a large panel of other kinases. NVP-BFH772 penetrates well into human skin in vitro using
a standard solvent. In vivo after topical application, it significantly and dose-dependently inhibits
experimental chronic allergic contact dermatitis (ACD) in VEGF-tg+/- mice, spontaneous chronic
dermatitis in VEGF-tg+/+ mice, and acute ACD in normal mice and domestic pigs. Furthermore, the
compound inhibits VEGF-induced intradermal extravasation in mice and pigs and microvascular
perfusion in UVB-induced erythema in pigs. After oral application, it inhibits skin inflammation in
acute ACD in mice in a significant and dose-dependent manner. Taken together, the data indicate
that topical application of the VEGF receptor TK inhibitor NVP-BFH772 may be beneficial in the
treatment of inflammatory conditions of the skin.
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Antagonism of p40 cytokines in psoriasis patients may promote paradoxical cardiovascular
risk
C Ryan,1 C Leonardi,2 J Krueger,3 A Kimball,4 B Strober,5 K Gordon,6 R Langley,7 D Kaplan8 and
A Menter1 1 Baylor Research Institute, Dallas, TX, 2 St Louis University, Saint Louis, MO, 3 The
Rockefeller University, New York, NY, 4 Massachusetts General Hospital, Boston, MA, 5 New
York University Medical Center, New York, NY, 6 University of Chicago, Chicago, IL, 7
Dalhousie University, Halifax, NS, Canada and 8 University of Minnesota, Minneapolis, MN
Ustekinumab and briakinumab have shown efficacy in the treatment of chronic plaque psoriasis
(CPP). The finding of 18 major adverse cardiovascular events (MACE), including four deaths, in a
study of briakinumab for the treatment of CPP, however, has prompted concern. An independent
consensus meeting was convened and a meta-analysis performed to evaluate a possible associa-
tion between biologic therapies for CPP and MACE. The meta-analysis included all RCTs of anti-IL-
12/23 agents and anti-TNF agents for the treatment of CPP identified by systematic electronic liter-
ature searches in the Cochrane Central Register of Controlled Trials, Clinicaltrials.gov and Medline.
The primary outcome measure was MACE, a composite endpoint of myocardial infarction, cere-
brovascular accident, or cardiovascular death. Absolute risk differences were used as an effect meas-
ure and the study results were combined using the Mantel-Haenszel fixed effects method. A total
of 20 RCTs comprising 9941 patients met the predefined inclusion criteria. During the placebo-con-
trolled phases of the anti-IL-12/23 studies, 10 of the 3118 patients treated with anti-IL-12/23 ther-
apies had a MACE compared with zero events in the 1414 patients treated with placebo (risk dif-
ference 0.003 [95% CI: -0.001, 0.007], p=0.11), while only one of the 3799 patients treated with
anti-TNF treatments had a MACE compared with one of the 1750 treated with placebo (risk differ-
ence 0.0001 [95% CI: -0.003, 0.003], p=0.94). An elevated, but not statistically significant, rate of
increased MACE was observed in patients receiving anti-IL-12/23 antibody therapies, but not those
receiving anti-TNF treatments. These findings raise concern about the cardiovascular safety of anti-
IL-12/23 agents.
495
Oral administration of a hydrophilic extract of Polypodium leucotomos for the prevention of
polymorphic light eruption
A Tanew,1 S Radakovic,1 S Gonzalez,2 E Reyes,3 M Venturini4 and P Calzavara-Pinton4 1
Dermatology, Medical University of Vienna, Vienna, Austria, 2 Dermatology Service, Memorial
Sloan-Kettering Cancer Center, New York, NY, 3 Medicine, Alcala University, Alcala de
Henares, Spain and 4 Dermatology, Spedali Civili and University, Brescia, Italy
Background: Polymorphic light eruption (PLE) is the most common idiopathic photodermatosis.
Reactive oxygen species have been implicated in the pathogenesis of PLE. Polypodium leucotomos
(PL) is a natural extract from tropical fern leaves with potent antioxidant and antiinflammatory
properties. Objective: In the present study we sought to evaluate whether a concentrated hydrophilic
extract of PL might prevent or delay the photoinduction of typical PLE lesions by artificial UV radi-
ation. Methods: 35 patients with long-standing PLE were included in this open, uncontrolled bicen-
ter study. PLE was induced by photoprovocation with artificial UVB and UVA light, thereafter oral
treatment with PL was initiated. Two weeks later a second photoprovocation was performed while
the patients were still taking PL. Results: 30 patients developed PLE lesions after repeated irradia-
tion with UVA. Out of these, 18 patients also responded to UVB. After PL treatment, 9 (30%) and
5 (28%) patients, respectively, were unresponsive to repeated UVA and UVB exposure. In the remain-
ing patients, the mean number of UVA and UVB irradiations required to elicit PLE increased sig-
nificantly from 1.95 to 2.62 (p=0.005) and from 2.38 to 2.92 (p=0.047), respectively. Limitations:
The study was open and uncontrolled and included a relatively small number of patients. Conclu-
sion: Our data indicate that oral PL treatment might be beneficial for the prevention of PLE.
497
Distinctive pattern activation of pain and itch in human brain cortex by near infra-red (NIR)
optical topography
C Hong,1 T Yoshioka,5 A Kudo,3 F Fujino,3 Y Chen,4 M Sakata5 and C Lee2,6 1 Dermatology,
Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, 2 Dermatology, Kaohsiung Medical
University, Kaohsiung, Taiwan, 3 Dental Hygiene, Shohnan College, Yokosuka, Japan, 4
Nuclear Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, 5 Graduate Institute of
Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan and 6 Dermatology, Kaohsiung
Municipal Hsiao-Kang Hospital, Kaohsiung, Taiwan
Despite of the recent great advances in neurophysiology, it remains difficult to recognize and local-
ize the difference in pain and itch signals by non-invasive brain imaging modalities. Having high
spatial resolution, PET and functional MRI have made a great stride in the pain and itch studies.
However, the regional activity of human brain obtained does not exhibit acceptable time depend-
ent dynamic brain images. Near infrared (NIR) imaging, also known as NIR optical topography, is
a potential tool to solve the limited time resolution in functional MRI and PET. It can demonstrate
neural activity by measuring dynamic change of oxygenated hemoglobin (HbO2) in the capillary
network near activated neural network in real time. In this study, we found distinctive pattern acti-
vations in the prefrontal cortex for acute pain and histamine-induced itch. In the prefrontal cortex
area we found a pain specific belt type zone which showed the same type of dynamic responses in
each subject. However, we could not identify such a specific zone for itch stimulations. More impor-
tantly, we also found intensities of prefrontal responses for pain stimulations were in proportional
to grades of subjective pain perception. We concluded that prefrontal responses in terms of [HbO2]
amplitude in NIRS imaging correlate to human subjective pain perception.
496
The hemangioma investigator group (HIG): A cost-effective, collaborative model for clinical
research
B Drolet,1 M Chapman1 and I Frieden2 1 MCW, Milwaukee, WI and 2 UCSF, San Francisco, CA
The HIG, a multi-institutional research network, was formed in 1999 by a group of pediatric der-
matologists interested in infantile hemangiomas (IH). IH are very common, but there are no FDA-
approved treatments. Physicians lack uniform guidelines for risk-stratification and management of
affected infants, and must rely on observational reports. The objective of HIG was to use clinical
insights to study hemangiomas via targeted, cost-effective research. A formal leadership infrastruc-
ture was developed with an emphasis on collaboration and group success. HIG members used
their knowledge as front-line caregivers, while incorporating interdisciplinary expertise, to develop
pertinent clinical questions. Initial start-up funding included small philanthropic donations and 3
Dermatology Foundation awards. To date, the HIG has published 22 peer-reviewed studies divided
into 3 phases: 1) descriptive clinical research, 2) comparative-effectiveness research, and 3) trans-
lational research. Phase 1 identified risk factors for development of IH and clinical features that
predicted complications, ultimately generating guidelines for referral. Phase 2 studied high-risk
hemangiomas, those at risk for PHACE, neural tube defects, and hepatic IH, which yielded imag-
ing guidelines and the PHACE diagnostic criteria. This data lead to ongoing phase 3 projects, now
funded at the federal level. These include clinical trials for IH, validation of quality of life and sever-
ity scales for IH, family-based GWAS analysis, neurodevelopmental outcomes for infants with
IH/PHACE, and genetic analysis of PHACE. In conclusion, the HIG structure facilitated sustained
research success and rapid translation of pertinent data in a cost-effective model. Results from HIG
studies raise further inquiry, and several “reverse” translational studies are now being performed at
the basic science level, which, in turn, could provide data to be translated back into clinical appli-
cation.
494
Type I interferon-inducible genes are up-regulated in the peripheral blood of discoid lupus
patients
L Tseng,1 S Chang,1 LS Davis,2 QZ Li,2 C Mohan2 and BF Chong1 1 Dermatology, University of
Texas Southwestern Medical Center, Dallas, TX and 2 Internal Medicine, University of Texas
Southwestern Medical Center, Dallas, TX
Discoid lupus erythematous (DLE) is a scarring photosensitive skin condition whose genetic pro-
files are not well characterized. Comparing gene expression between DLE patients and normal
controls would reveal valuable insight into the pathogenesis of DLE and identify new drug targets
in DLE patients, whose current treatment options cannot reverse cicatrization. Based on previous
microarray studies showing that type I interferon (IFN) – regulated genes are up-regulated in the
peripheral blood of systemic lupus patients, we postulate that peripheral blood from DLE patients
will have higher expression of type I IFN-inducible genes compared to that from healthy controls.
Using the Illumina HumanHT-12 v.4.0 Expression BeadChip, cDNA microarray analysis of whole
peripheral blood of 20 DLE patients and 10 age-, gender-, and ethnicity-matched controls was per-
formed. DLE patients expressed a total of 43 and 26 genes that were up-regulated and down-regu-
lated, respectively, at least 1.5-fold compared to normals (p<0.05). Gene ontology analysis of up-
regulated genes in the blood samples from DLE patients revealed a predominance of genes in the
“response to stimulus” and “immune system process” categories. Pathway analysis showed that the
significant signaling cascades in these differentially expressed genes included molecules intimately
involved in IFN signaling. 28 out of 43 (65.1%) up-regulated genes in DLE blood were identified
as type I IFN-inducible genes, which were previously identified from stimulating normal peripheral
blood mononuclear cells with IFN-α. While these results confirm previous studies that demonstrated
enhanced expression of selected IFN-inducible proteins, such as the GTPase MxA, they also pro-
vide a panoramic view of the extent of influence these genes have in DLE. Thus, novel monoclonal
antibodies against IFN-α that are currently being tested in systemic lupus patients may have poten-
tial in effectively treating DLE patients.
498
The study about transmission of Staphylococcus aureus from mothers to children with atopic
dermatitis
J Lee, S Na and J Roh Gilhospital, Gachon Medical School, Incheon City, Republic of Korea
Patients with atopic dermatitis are more frequently colonized by Staphylococcus aureus on their
skin lesions than healthy people and the toxins secreted by S. aureus are considered to be an
important aggravating factor in the atopic dermatitis. The aim of this study was to evaluate the rela-
tionship among the skin barrier function, colonization of S. aureus and the clinical severity of atopic
dermatitis. The toxin genes of S. aureus were compared to estimate the possibility of transmission
from mother to child. Seventeen children with atopic dermatitis were evaluated for the clinical sever-
ity and the skin barrier function by using the severity scoring in atopic dermatitis (SCORAD) index
and transepidermal water loss (TEWL). S. aureus was isolated from the forearm, popliteal fossa and
anterior nares of the children and anterior nares of their mothers. The toxin genes were analyzed
by performing multiplex PCR. The loss of skin barrier function showed a statistically significant cor-
relation with the clinical severity in the children with atopic dermatitis(p <0.05), but the correla-
tion between clinical severity and colonization rate was not statistically significant. Of the 17 chil-
dren and their mothers, S. aureus strains were isolated in 14 children(82.4%) and 3 mothers(17.6%).
Among the children, the predominant toxin gene was sea only, which was produced in 71.4% and
the coexistence of sea and tsst-1 (21.4%) and sec only (7.1%) followed. From the 3 pairs of child
and mother, identical toxin genes were detected. The skin barrier dysfunction showed a statistically
significant correlation with the clinical severity in children with atopic dermatitis. The most fre-
quently found toxin gene was sea in Korean children with atopic dermatitis. Identical toxin genes
were detected in child and their mother. This result indicates that the colonization of S. aureus of
the mother may influence to the outbreak of the atopic dermatitis and make worse the disease of
their child.
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IL-10 is a therapeutic target for intense pulsed light in acne vulgaris
M Taylor and M Gonzalez Dermatology & Wound Healing, Cardiff University, Cardiff, United
Kingdom
Recently, interleukin 10 (IL-10) has been identified as a potential therapeutic target in acne vul-
garis. Acne patients have fewer IL-10+ CD14+ blood monocytes than normal controls. When sup-
plemented with IL-10, these monocytes demonstrated a reduction in IL-8 & tumour necrosis factor
α (TNF-α) secretion. In vivo, intense pulsed light (IPL) reduces inflammatory acne lesions and in
vitro, increases IL-10 expression in cultured keratinocytes. This study aimed to determine whether
the anti-inflammatory action of IPL was associated with increased IL-10 expression in vivo. Through-
out a course of IPL (530-950 nm), 3 punch biopsies from treated, non-involved skin were taken:
before therapy, 48 hours after the first irradiation and 1 week after the fourth and final irradiation.
After Trizol® RNA extraction of 21 biopsies from 7 acne patients, RT-PCR was performed. Taq-
Man® Low Density Arrays were run in triplicate for IL-10 and its intermediary signalling molecules:
signal transducer and activator of transcription 3 (STAT-3), nuclear factor κB (NFκB), IL-8, TNF-α,
TNF receptor and IL-6. SYBR® Green qPCR for IL-10 was performed on 6 cases, 3 of which were
duplicated with TLDA. Analyses of the mean expressions were performed via t- testing. At the end
of therapy, IL-10 expression increased by 95.0% in response to a 328.3%, 6.5% and 5.6% increase
of IL-6, STAT3 and NFκB expression respectively (p> 0.05). QPCR also showed an increase in IL-
10 expression by 83.23% of (p > 0.05). The transcripts of pro-inflammatory molecules TNFα and
TNF receptor fell by 17.6% and 37.6%. However, IL-8 expression increased by 135.5% (p>0.05).
In keeping with published in vitro findings, our results show that IPL also induces IL-10 transcrip-
tion in vivo possibly contributing to its anti-inflammatory action in acne. However, in contrast to in
vitro findings, IL-8 expression was not suppressed. IL-10 is known to have numerous immunoreg-
ulatory effects and therefore, in vivo, complex intra- and intercellular mechanisms are at play that
may not be not fully characterised in vitro, justifying the need for further study.
488
Modulating survivin expression in the skin helps against UV damage. In vivo study
Y Guerif ferreira,1 L Bergeron,1 A Lebleu,1 G Oberto,1 A Berghi,1 K Cucumel,1 J Botto,1 C Dal
Farra2 and N Domloge1 1 ISP Global Skin Research Center, ISP Vincience, Sophia Antipolis,
France and 2 ISP Corporate Research Center, ISP, Wayne, NJ
Homeostasis of skin is fueled by adult stem cells which replace keratinocytes loss either through
normal differentiation and tissue turnover, or through cell death following stress. Our previous in
vitro studies have showed that IV08.009, a compound developed for its selective effect on survivin,
a key protein involved in mitosis regulation, helps to protect from DNA damage by decreasing the
formation of cyclobutane pyrimidine dimer (CPD) in cells. In order to confirm the benefit in vivo,
IV08.009 was clinically tested. Ten volunteers (with informed consent) have participated in a dou-
ble blind study comparing IV08.009 compound versus placebo. They applied the inducer-contain-
ing cream and placebo cream, twice a day on 2 defined zones of the thigh for 14 days. At D7, solar
spectrum irradiation of UVA and UVB of 2 MED was applied on the two treated zones. The pro-
tective effect of IV08.009 was evaluated by in vivo confocal microscopy (VivaScope® 1500) at D8
(24h after stress), D9 (48h after stress) and D13 (1 week after stress). The results revealed a signifi-
cant decrease in the number of Sunburn Cells in the skin treated with IV08.009 cream. Moreover,
after UV stress, Vivascope images showed a better organization and well preserved cell morphol-
ogy in granular and spinous layer for the induced-side. These results, together with other results on
DNA protection, suggest that modulating surviving expression in skin offers, in vivo, protection from
UV damage.
489
Immunologic dysregulation in acneiform eruption due to EGFR inhibitor therapy
F Wang,1 W Lee,1 T Do,1 N Smith,1 D Sachs,1 M Zalupski,2 JJ Voorhees,1 S Kang3 and GJ Fisher1 1
Dermatology, University of Michigan, Ann Arbor, MI, 2 Internal Medicine, University of
Michigan, Ann Arbor, MI and 3 Dermatology, Johns Hopkins University, Baltimore, MD
Acneiform eruption can result from cancer therapies that target epidermal growth factor receptor
(EGFR). To investigate mechanisms of this eruption, we obtained skin biopsies from patients with
colon cancer prior to therapy (PRE) with the EGFR inhibitor cetuximab, as well as uninvolved (UNINV)
skin and involved (INV) papulopustules within 2-4 weeks of rash onset. In UNINV the antimicro-
bial protein (AMP) cathelicidin (hCAP18) showed decreased epidermal immunostaining (N=6) and
decreased gene expression in 8/10 subjects by 56%, compared with PRE. In INV gene expression
of hCAP18 was increased (11-fold, N=10, P=0.008), but mRNA levels of the key hCAP18 process-
ing enzyme stratum corneum tryptic enzyme (SCTE) were decreased by 53% (N=10, P=0.001). Com-
pared with UNINV, INV showed increased immunostaining of neutrophils (neutrophil elastase, N=4),
as well as increased mRNA levels of the neutrophil chemoattractants CXCL1 (65-fold) and CXCL8
(2154-fold) and the AMPs defensin-α1 (248-fold), neutrophil gelatinase-associated lipocalin (NGAL,
16-fold), and human β-defensins 2 (17916-fold) and 3 (124-fold) (all N=10, P<0.01). INV also exhib-
ited increased mRNA levels of IL-1β (8-fold, N=10, P=0.002), but not IL-1R2, a decoy receptor that
dampens the actions of IL-1. Lastly, INV showed increased epidermal thickening and immunos-
taining of CK16 (N=5), as well as increased mRNA levels of IL-20 (19-fold, N=10, P<0.0001), which
stimulates epidermal hyperplasia and CK16 expression. These data suggest that aberrant expression
and processing of hCAP18 may occur with EGFR blockade. This finding raises the possibility that
altered containment of microbes, including resident flora, may promote development of cutaneous
inflammation, which is mediated by chemokine-induced influx of neutrophils, increased levels of
certain AMPs, and unopposed activity of IL-1β. Additionally, the papular (raised) nature of lesions
may result from epidermal thickening driven, in part, by IL-20.
490
FDG PET/CT demonstrates increased vascular inflammation in patients with severe psoriasis
NN Mehta, Y Yu, B Saboury, N Foroughi, A Raper, A Baer, R Ochotny, P Krishnamoorthy, J Antigua,
A Van Voorhees, DA Torigian, A Alavi and JM Gelfand University of Pennsylvania School of
Medicine, Philadelphia, PA
Psoriasis is a Th-1/17 inflammatory disease affecting 2-4% of the adult population. Studies indicate
that psoriasis, especially if severe, is independently associated with increased risk of myocardial
infarction, stroke, and cardiovascular mortality, but the mechanism is unknown. Utilizing 18-fluo-
rodeoxyglucose (FDG) PET/CT, a validated technique to quantify vascular inflammation, we assessed
in vivo aortic vascular inflammation, a marker of aortic atherosclerosis, in psoriasis patients and
healthy controls. We prospectively enrolled subjects with psoriasis (n=5) affecting ≥10% body sur-
face area and compared them to prospectively enrolled age/sex matched controls (n=5). Patients
with diabetes, known cardiac disease or tobacco use were excluded. Subjects underwent a whole
body FDG PET/CT scan and data for the aorta (ascending, arch, thoracic, suprarenal abdominal,
infrarenal abdominal) were analyzed using third party software. The degree of vascular inflamma-
tion is represented by standardized uptake volume (SUV). Patients with psoriasis (n=5, 80% male,
age 49.5±7.7) had similar, low-risk cardiovascular profiles compared to controls (n=5, 80% male,
age 45.4±5.7). However, vascular inflammation in each segment of the aorta was greater in psori-
asis (p<0.001). After controlling for cardiac risk factors (age, gender, BMI, hypertension, LDL cho-
lesterol), vascular inflammation remained greater in psoriasis for all segments of the aorta (p<0.001).
The mean SUV difference was 0.20 in the fully adjusted model, representing a degree of excess
vascular inflammation in psoriasis patients normally seen over two decades of aging. In conclu-
sion, using a novel application of FDG PET/CT, we demonstrate that psoriasis is associated with
increased vascular inflammation in the aorta compared to age and sex matched controls, suggest-
ing a potential mechanism for increased cardiovascular risk.
491
Reversion of aging-related gene expression and clinical benefits of a Saccharina longicruris
extract
A Thibodeau Innovacos, St-Augustin, QC, Canada
Aging process triggers a modification of the gene expression level as observed in old, or senescent,
skin cells. The gene expression pattern in senescent skin cells includes reduced expression level of
genes coding for structural (collagens) and functional (antioxidants) molecules and increased expres-
sion of genes coding for catabolic enzymes (matrix metalloproteases). Such changes are likely to
negatively affect the skin ultrastructural integrity eventually causing the appearance of signs of aging.
Saccharina longicruris is an algae that can develop thickened segments in adaption to water move-
ments and also can store compounds to survive harsh environments. To gain insight in the func-
tionality of a Saccharina longicruris extract, we examined its efficacy to promote keratinocyte dif-
ferentiation and to reverse the gene expression level of senescent human fibroblasts. The algae extract
was shown to promote keratinocyte differentiation through the activation of transglutaminase K
(+349%). Topical applications of a formulation containing 3% of the algae extract for 60 days resulted
in an improvement of the integrity of the stratum corneum as supported by a reduction of transepi-
dermal water loss (-13.4%) and an increase in skin hydration (+24%). Incubation of human senes-
cent skin fibroblasts in the presence of the algae extract reversed the gene expression level of
cytoskeletal and extracellular matrix components as well as collagen degrading and antioxidant
enzymes close to what was observed in young fibroblasts. In a 60-day controlled clinical trial, the
algae extract improved parameters associated with skin aging such as surface smoothness (+17.8%),
wrinkling density (-11.5%), wrinkle volume (-15.7%) and skin visco-elastic properties (+13.0%).
Results obtained are compatible with physiological attributes guarding the survival of the algae in
its natural challenging environment. The Saccharina longicruris extract restored the expression level
of specific genes in senescent fibroblasts and proved to be a potent anti-aging ingredient.
492
A pilot study of an oral phosphodiesterase inhibitor (apremilast) for atopic dermatitis
A Samrao, T Berry and E Simpson Dermatology, Oregon Health & Science University, Portland,
OR
Monocytes from patients with atopic dermatitis (AD)display elevated cyclic AMP phosphodiesterase
(PDE) activity leading to immune responses skewed towards a Th2 profile. Topical PDE-4 inhibitors
improve AD, although the effects are modest. We aimed to gather preliminary safety and efficacy
data of a novel oral PDE-4 inhibitor, apremilast, in a small cohort of adults with AD. We performed
an open-label prospective trial of apremilast at 20mg BID in 6 subjects (cohort 1) and 30mg BID in
7 subjects (cohort 2) for 12 weeks. The primary outcome was incidence of adverse events (AE) with
secondary outcomes focusing on disease severity measures and peripheral whole blood gene expres-
sion changes. Efficacy of apremilast was assessed at each study visit using the Eczema Area Sever-
ity Index (EASI), Dermatology Life Quality Index (DLQI) and the Visual Analog Scale (VAS) for pru-
ritus. Nausea was the most common AE and appeared to be dose-related (67% cohort 1, 86% cohort
2). In all subjects the nausea was rated as mild-moderate and improved over time. Other AEs included
headache, fatigue, diarrhea, bloating, and vomiting and were rated as mild-moderate. One subject
developed herpes zoster and was discontinued from the study. In both cohorts 1 and 2, a trend
toward improvement was seen in all outcomes. Statistically significant improvement in VAS and
DLQI was found in cohort 1 (p<0.022 and p<0.004, respectively) and DLQI in cohort 2 (p<0.011).
Combined data showed statistically significant improvement in all outcomes. EASI reduced from a
mean baseline of 25.2 to 18.2 (p<0.018), VAS reduced from a mean baseline of 50.9 to 32.9 (p<
0.019) and DLQI reduced from a mean baseline of 11.1 to 4.8 (p<0.001). Apremilast was shown
to be a safe and well-tolerated medication in subjects with AD. Gastrointestinal side effects were
most common but were generally mild and improved with time. Our preliminary data indicate that
apremilast significantly improves inflammation, pruritus and quality of life in AD. Larger controlled
studies are needed to further assess its safety and efficacy in this population.
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Antagonism of p40 cytokines in psoriasis patients may promote paradoxical cardiovascular
risk
C Ryan,1 C Leonardi,2 J Krueger,3 A Kimball,4 B Strober,5 K Gordon,6 R Langley,7 D Kaplan8 and
A Menter1 1 Baylor Research Institute, Dallas, TX, 2 St Louis University, Saint Louis, MO, 3 The
Rockefeller University, New York, NY, 4 Massachusetts General Hospital, Boston, MA, 5 New
York University Medical Center, New York, NY, 6 University of Chicago, Chicago, IL, 7
Dalhousie University, Halifax, NS, Canada and 8 University of Minnesota, Minneapolis, MN
Ustekinumab and briakinumab have shown efficacy in the treatment of chronic plaque psoriasis
(CPP). The finding of 18 major adverse cardiovascular events (MACE), including four deaths, in a
study of briakinumab for the treatment of CPP, however, has prompted concern. An independent
consensus meeting was convened and a meta-analysis performed to evaluate a possible associa-
tion between biologic therapies for CPP and MACE. The meta-analysis included all RCTs of anti-IL-
12/23 agents and anti-TNF agents for the treatment of CPP identified by systematic electronic liter-
ature searches in the Cochrane Central Register of Controlled Trials, Clinicaltrials.gov and Medline.
The primary outcome measure was MACE, a composite endpoint of myocardial infarction, cere-
brovascular accident, or cardiovascular death. Absolute risk differences were used as an effect meas-
ure and the study results were combined using the Mantel-Haenszel fixed effects method. A total
of 20 RCTs comprising 9941 patients met the predefined inclusion criteria. During the placebo-con-
trolled phases of the anti-IL-12/23 studies, 10 of the 3118 patients treated with anti-IL-12/23 ther-
apies had a MACE compared with zero events in the 1414 patients treated with placebo (risk dif-
ference 0.003 [95% CI: -0.001, 0.007], p=0.11), while only one of the 3799 patients treated with
anti-TNF treatments had a MACE compared with one of the 1750 treated with placebo (risk differ-
ence 0.0001 [95% CI: -0.003, 0.003], p=0.94). An elevated, but not statistically significant, rate of
increased MACE was observed in patients receiving anti-IL-12/23 antibody therapies, but not those
receiving anti-TNF treatments. These findings raise concern about the cardiovascular safety of anti-
IL-12/23 agents.
495
Oral administration of a hydrophilic extract of Polypodium leucotomos for the prevention of
polymorphic light eruption
A Tanew,1 S Radakovic,1 S Gonzalez,2 E Reyes,3 M Venturini4 and P Calzavara-Pinton4 1
Dermatology, Medical University of Vienna, Vienna, Austria, 2 Dermatology Service, Memorial
Sloan-Kettering Cancer Center, New York, NY, 3 Medicine, Alcala University, Alcala de
Henares, Spain and 4 Dermatology, Spedali Civili and University, Brescia, Italy
Background: Polymorphic light eruption (PLE) is the most common idiopathic photodermatosis.
Reactive oxygen species have been implicated in the pathogenesis of PLE. Polypodium leucotomos
(PL) is a natural extract from tropical fern leaves with potent antioxidant and antiinflammatory
properties. Objective: In the present study we sought to evaluate whether a concentrated hydrophilic
extract of PL might prevent or delay the photoinduction of typical PLE lesions by artificial UV radi-
ation. Methods: 35 patients with long-standing PLE were included in this open, uncontrolled bicen-
ter study. PLE was induced by photoprovocation with artificial UVB and UVA light, thereafter oral
treatment with PL was initiated. Two weeks later a second photoprovocation was performed while
the patients were still taking PL. Results: 30 patients developed PLE lesions after repeated irradia-
tion with UVA. Out of these, 18 patients also responded to UVB. After PL treatment, 9 (30%) and
5 (28%) patients, respectively, were unresponsive to repeated UVA and UVB exposure. In the remain-
ing patients, the mean number of UVA and UVB irradiations required to elicit PLE increased sig-
nificantly from 1.95 to 2.62 (p=0.005) and from 2.38 to 2.92 (p=0.047), respectively. Limitations:
The study was open and uncontrolled and included a relatively small number of patients. Conclu-
sion: Our data indicate that oral PL treatment might be beneficial for the prevention of PLE.
497
Distinctive pattern activation of pain and itch in human brain cortex by near infra-red (NIR)
optical topography
C Hong,1 T Yoshioka,5 A Kudo,3 F Fujino,3 Y Chen,4 M Sakata5 and C Lee2,6 1 Dermatology,
Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, 2 Dermatology, Kaohsiung Medical
University, Kaohsiung, Taiwan, 3 Dental Hygiene, Shohnan College, Yokosuka, Japan, 4
Nuclear Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, 5 Graduate Institute of
Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan and 6 Dermatology, Kaohsiung
Municipal Hsiao-Kang Hospital, Kaohsiung, Taiwan
Despite of the recent great advances in neurophysiology, it remains difficult to recognize and local-
ize the difference in pain and itch signals by non-invasive brain imaging modalities. Having high
spatial resolution, PET and functional MRI have made a great stride in the pain and itch studies.
However, the regional activity of human brain obtained does not exhibit acceptable time depend-
ent dynamic brain images. Near infrared (NIR) imaging, also known as NIR optical topography, is
a potential tool to solve the limited time resolution in functional MRI and PET. It can demonstrate
neural activity by measuring dynamic change of oxygenated hemoglobin (HbO2) in the capillary
network near activated neural network in real time. In this study, we found distinctive pattern acti-
vations in the prefrontal cortex for acute pain and histamine-induced itch. In the prefrontal cortex
area we found a pain specific belt type zone which showed the same type of dynamic responses in
each subject. However, we could not identify such a specific zone for itch stimulations. More impor-
tantly, we also found intensities of prefrontal responses for pain stimulations were in proportional
to grades of subjective pain perception. We concluded that prefrontal responses in terms of [HbO2]
amplitude in NIRS imaging correlate to human subjective pain perception.
496
The hemangioma investigator group (HIG): A cost-effective, collaborative model for clinical
research
B Drolet,1 M Chapman1 and I Frieden2 1 MCW, Milwaukee, WI and 2 UCSF, San Francisco, CA
The HIG, a multi-institutional research network, was formed in 1999 by a group of pediatric der-
matologists interested in infantile hemangiomas (IH). IH are very common, but there are no FDA-
approved treatments. Physicians lack uniform guidelines for risk-stratification and management of
affected infants, and must rely on observational reports. The objective of HIG was to use clinical
insights to study hemangiomas via targeted, cost-effective research. A formal leadership infrastruc-
ture was developed with an emphasis on collaboration and group success. HIG members used
their knowledge as front-line caregivers, while incorporating interdisciplinary expertise, to develop
pertinent clinical questions. Initial start-up funding included small philanthropic donations and 3
Dermatology Foundation awards. To date, the HIG has published 22 peer-reviewed studies divided
into 3 phases: 1) descriptive clinical research, 2) comparative-effectiveness research, and 3) trans-
lational research. Phase 1 identified risk factors for development of IH and clinical features that
predicted complications, ultimately generating guidelines for referral. Phase 2 studied high-risk
hemangiomas, those at risk for PHACE, neural tube defects, and hepatic IH, which yielded imag-
ing guidelines and the PHACE diagnostic criteria. This data lead to ongoing phase 3 projects, now
funded at the federal level. These include clinical trials for IH, validation of quality of life and sever-
ity scales for IH, family-based GWAS analysis, neurodevelopmental outcomes for infants with
IH/PHACE, and genetic analysis of PHACE. In conclusion, the HIG structure facilitated sustained
research success and rapid translation of pertinent data in a cost-effective model. Results from HIG
studies raise further inquiry, and several “reverse” translational studies are now being performed at
the basic science level, which, in turn, could provide data to be translated back into clinical appli-
cation.
494
Type I interferon-inducible genes are up-regulated in the peripheral blood of discoid lupus
patients
L Tseng,1 S Chang,1 LS Davis,2 QZ Li,2 C Mohan2 and BF Chong1 1 Dermatology, University of
Texas Southwestern Medical Center, Dallas, TX and 2 Internal Medicine, University of Texas
Southwestern Medical Center, Dallas, TX
Discoid lupus erythematous (DLE) is a scarring photosensitive skin condition whose genetic pro-
files are not well characterized. Comparing gene expression between DLE patients and normal
controls would reveal valuable insight into the pathogenesis of DLE and identify new drug targets
in DLE patients, whose current treatment options cannot reverse cicatrization. Based on previous
microarray studies showing that type I interferon (IFN) – regulated genes are up-regulated in the
peripheral blood of systemic lupus patients, we postulate that peripheral blood from DLE patients
will have higher expression of type I IFN-inducible genes compared to that from healthy controls.
Using the Illumina HumanHT-12 v.4.0 Expression BeadChip, cDNA microarray analysis of whole
peripheral blood of 20 DLE patients and 10 age-, gender-, and ethnicity-matched controls was per-
formed. DLE patients expressed a total of 43 and 26 genes that were up-regulated and down-regu-
lated, respectively, at least 1.5-fold compared to normals (p<0.05). Gene ontology analysis of up-
regulated genes in the blood samples from DLE patients revealed a predominance of genes in the
“response to stimulus” and “immune system process” categories. Pathway analysis showed that the
significant signaling cascades in these differentially expressed genes included molecules intimately
involved in IFN signaling. 28 out of 43 (65.1%) up-regulated genes in DLE blood were identified
as type I IFN-inducible genes, which were previously identified from stimulating normal peripheral
blood mononuclear cells with IFN-α. While these results confirm previous studies that demonstrated
enhanced expression of selected IFN-inducible proteins, such as the GTPase MxA, they also pro-
vide a panoramic view of the extent of influence these genes have in DLE. Thus, novel monoclonal
antibodies against IFN-α that are currently being tested in systemic lupus patients may have poten-
tial in effectively treating DLE patients.
498
The study about transmission of Staphylococcus aureus from mothers to children with atopic
dermatitis
J Lee, S Na and J Roh Gilhospital, Gachon Medical School, Incheon City, Republic of Korea
Patients with atopic dermatitis are more frequently colonized by Staphylococcus aureus on their
skin lesions than healthy people and the toxins secreted by S. aureus are considered to be an
important aggravating factor in the atopic dermatitis. The aim of this study was to evaluate the rela-
tionship among the skin barrier function, colonization of S. aureus and the clinical severity of atopic
dermatitis. The toxin genes of S. aureus were compared to estimate the possibility of transmission
from mother to child. Seventeen children with atopic dermatitis were evaluated for the clinical sever-
ity and the skin barrier function by using the severity scoring in atopic dermatitis (SCORAD) index
and transepidermal water loss (TEWL). S. aureus was isolated from the forearm, popliteal fossa and
anterior nares of the children and anterior nares of their mothers. The toxin genes were analyzed
by performing multiplex PCR. The loss of skin barrier function showed a statistically significant cor-
relation with the clinical severity in the children with atopic dermatitis(p <0.05), but the correla-
tion between clinical severity and colonization rate was not statistically significant. Of the 17 chil-
dren and their mothers, S. aureus strains were isolated in 14 children(82.4%) and 3 mothers(17.6%).
Among the children, the predominant toxin gene was sea only, which was produced in 71.4% and
the coexistence of sea and tsst-1 (21.4%) and sec only (7.1%) followed. From the 3 pairs of child
and mother, identical toxin genes were detected. The skin barrier dysfunction showed a statistically
significant correlation with the clinical severity in children with atopic dermatitis. The most fre-
quently found toxin gene was sea in Korean children with atopic dermatitis. Identical toxin genes
were detected in child and their mother. This result indicates that the colonization of S. aureus of
the mother may influence to the outbreak of the atopic dermatitis and make worse the disease of
their child.
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IL-10 is a therapeutic target for intense pulsed light in acne vulgaris
M Taylor and M Gonzalez Dermatology & Wound Healing, Cardiff University, Cardiff, United
Kingdom
Recently, interleukin 10 (IL-10) has been identified as a potential therapeutic target in acne vul-
garis. Acne patients have fewer IL-10+ CD14+ blood monocytes than normal controls. When sup-
plemented with IL-10, these monocytes demonstrated a reduction in IL-8 & tumour necrosis factor
α (TNF-α) secretion. In vivo, intense pulsed light (IPL) reduces inflammatory acne lesions and in
vitro, increases IL-10 expression in cultured keratinocytes. This study aimed to determine whether
the anti-inflammatory action of IPL was associated with increased IL-10 expression in vivo. Through-
out a course of IPL (530-950 nm), 3 punch biopsies from treated, non-involved skin were taken:
before therapy, 48 hours after the first irradiation and 1 week after the fourth and final irradiation.
After Trizol® RNA extraction of 21 biopsies from 7 acne patients, RT-PCR was performed. Taq-
Man® Low Density Arrays were run in triplicate for IL-10 and its intermediary signalling molecules:
signal transducer and activator of transcription 3 (STAT-3), nuclear factor κB (NFκB), IL-8, TNF-α,
TNF receptor and IL-6. SYBR® Green qPCR for IL-10 was performed on 6 cases, 3 of which were
duplicated with TLDA. Analyses of the mean expressions were performed via t- testing. At the end
of therapy, IL-10 expression increased by 95.0% in response to a 328.3%, 6.5% and 5.6% increase
of IL-6, STAT3 and NFκB expression respectively (p> 0.05). QPCR also showed an increase in IL-
10 expression by 83.23% of (p > 0.05). The transcripts of pro-inflammatory molecules TNFα and
TNF receptor fell by 17.6% and 37.6%. However, IL-8 expression increased by 135.5% (p>0.05).
In keeping with published in vitro findings, our results show that IPL also induces IL-10 transcrip-
tion in vivo possibly contributing to its anti-inflammatory action in acne. However, in contrast to in
vitro findings, IL-8 expression was not suppressed. IL-10 is known to have numerous immunoreg-
ulatory effects and therefore, in vivo, complex intra- and intercellular mechanisms are at play that
may not be not fully characterised in vitro, justifying the need for further study.
488
Modulating survivin expression in the skin helps against UV damage. In vivo study
Y Guerif ferreira,1 L Bergeron,1 A Lebleu,1 G Oberto,1 A Berghi,1 K Cucumel,1 J Botto,1 C Dal
Farra2 and N Domloge1 1 ISP Global Skin Research Center, ISP Vincience, Sophia Antipolis,
France and 2 ISP Corporate Research Center, ISP, Wayne, NJ
Homeostasis of skin is fueled by adult stem cells which replace keratinocytes loss either through
normal differentiation and tissue turnover, or through cell death following stress. Our previous in
vitro studies have showed that IV08.009, a compound developed for its selective effect on survivin,
a key protein involved in mitosis regulation, helps to protect from DNA damage by decreasing the
formation of cyclobutane pyrimidine dimer (CPD) in cells. In order to confirm the benefit in vivo,
IV08.009 was clinically tested. Ten volunteers (with informed consent) have participated in a dou-
ble blind study comparing IV08.009 compound versus placebo. They applied the inducer-contain-
ing cream and placebo cream, twice a day on 2 defined zones of the thigh for 14 days. At D7, solar
spectrum irradiation of UVA and UVB of 2 MED was applied on the two treated zones. The pro-
tective effect of IV08.009 was evaluated by in vivo confocal microscopy (VivaScope® 1500) at D8
(24h after stress), D9 (48h after stress) and D13 (1 week after stress). The results revealed a signifi-
cant decrease in the number of Sunburn Cells in the skin treated with IV08.009 cream. Moreover,
after UV stress, Vivascope images showed a better organization and well preserved cell morphol-
ogy in granular and spinous layer for the induced-side. These results, together with other results on
DNA protection, suggest that modulating surviving expression in skin offers, in vivo, protection from
UV damage.
489
Immunologic dysregulation in acneiform eruption due to EGFR inhibitor therapy
F Wang,1 W Lee,1 T Do,1 N Smith,1 D Sachs,1 M Zalupski,2 JJ Voorhees,1 S Kang3 and GJ Fisher1 1
Dermatology, University of Michigan, Ann Arbor, MI, 2 Internal Medicine, University of
Michigan, Ann Arbor, MI and 3 Dermatology, Johns Hopkins University, Baltimore, MD
Acneiform eruption can result from cancer therapies that target epidermal growth factor receptor
(EGFR). To investigate mechanisms of this eruption, we obtained skin biopsies from patients with
colon cancer prior to therapy (PRE) with the EGFR inhibitor cetuximab, as well as uninvolved (UNINV)
skin and involved (INV) papulopustules within 2-4 weeks of rash onset. In UNINV the antimicro-
bial protein (AMP) cathelicidin (hCAP18) showed decreased epidermal immunostaining (N=6) and
decreased gene expression in 8/10 subjects by 56%, compared with PRE. In INV gene expression
of hCAP18 was increased (11-fold, N=10, P=0.008), but mRNA levels of the key hCAP18 process-
ing enzyme stratum corneum tryptic enzyme (SCTE) were decreased by 53% (N=10, P=0.001). Com-
pared with UNINV, INV showed increased immunostaining of neutrophils (neutrophil elastase, N=4),
as well as increased mRNA levels of the neutrophil chemoattractants CXCL1 (65-fold) and CXCL8
(2154-fold) and the AMPs defensin-α1 (248-fold), neutrophil gelatinase-associated lipocalin (NGAL,
16-fold), and human β-defensins 2 (17916-fold) and 3 (124-fold) (all N=10, P<0.01). INV also exhib-
ited increased mRNA levels of IL-1β (8-fold, N=10, P=0.002), but not IL-1R2, a decoy receptor that
dampens the actions of IL-1. Lastly, INV showed increased epidermal thickening and immunos-
taining of CK16 (N=5), as well as increased mRNA levels of IL-20 (19-fold, N=10, P<0.0001), which
stimulates epidermal hyperplasia and CK16 expression. These data suggest that aberrant expression
and processing of hCAP18 may occur with EGFR blockade. This finding raises the possibility that
altered containment of microbes, including resident flora, may promote development of cutaneous
inflammation, which is mediated by chemokine-induced influx of neutrophils, increased levels of
certain AMPs, and unopposed activity of IL-1β. Additionally, the papular (raised) nature of lesions
may result from epidermal thickening driven, in part, by IL-20.
490
FDG PET/CT demonstrates increased vascular inflammation in patients with severe psoriasis
NN Mehta, Y Yu, B Saboury, N Foroughi, A Raper, A Baer, R Ochotny, P Krishnamoorthy, J Antigua,
A Van Voorhees, DA Torigian, A Alavi and JM Gelfand University of Pennsylvania School of
Medicine, Philadelphia, PA
Psoriasis is a Th-1/17 inflammatory disease affecting 2-4% of the adult population. Studies indicate
that psoriasis, especially if severe, is independently associated with increased risk of myocardial
infarction, stroke, and cardiovascular mortality, but the mechanism is unknown. Utilizing 18-fluo-
rodeoxyglucose (FDG) PET/CT, a validated technique to quantify vascular inflammation, we assessed
in vivo aortic vascular inflammation, a marker of aortic atherosclerosis, in psoriasis patients and
healthy controls. We prospectively enrolled subjects with psoriasis (n=5) affecting ≥10% body sur-
face area and compared them to prospectively enrolled age/sex matched controls (n=5). Patients
with diabetes, known cardiac disease or tobacco use were excluded. Subjects underwent a whole
body FDG PET/CT scan and data for the aorta (ascending, arch, thoracic, suprarenal abdominal,
infrarenal abdominal) were analyzed using third party software. The degree of vascular inflamma-
tion is represented by standardized uptake volume (SUV). Patients with psoriasis (n=5, 80% male,
age 49.5±7.7) had similar, low-risk cardiovascular profiles compared to controls (n=5, 80% male,
age 45.4±5.7). However, vascular inflammation in each segment of the aorta was greater in psori-
asis (p<0.001). After controlling for cardiac risk factors (age, gender, BMI, hypertension, LDL cho-
lesterol), vascular inflammation remained greater in psoriasis for all segments of the aorta (p<0.001).
The mean SUV difference was 0.20 in the fully adjusted model, representing a degree of excess
vascular inflammation in psoriasis patients normally seen over two decades of aging. In conclu-
sion, using a novel application of FDG PET/CT, we demonstrate that psoriasis is associated with
increased vascular inflammation in the aorta compared to age and sex matched controls, suggest-
ing a potential mechanism for increased cardiovascular risk.
491
Reversion of aging-related gene expression and clinical benefits of a Saccharina longicruris
extract
A Thibodeau Innovacos, St-Augustin, QC, Canada
Aging process triggers a modification of the gene expression level as observed in old, or senescent,
skin cells. The gene expression pattern in senescent skin cells includes reduced expression level of
genes coding for structural (collagens) and functional (antioxidants) molecules and increased expres-
sion of genes coding for catabolic enzymes (matrix metalloproteases). Such changes are likely to
negatively affect the skin ultrastructural integrity eventually causing the appearance of signs of aging.
Saccharina longicruris is an algae that can develop thickened segments in adaption to water move-
ments and also can store compounds to survive harsh environments. To gain insight in the func-
tionality of a Saccharina longicruris extract, we examined its efficacy to promote keratinocyte dif-
ferentiation and to reverse the gene expression level of senescent human fibroblasts. The algae extract
was shown to promote keratinocyte differentiation through the activation of transglutaminase K
(+349%). Topical applications of a formulation containing 3% of the algae extract for 60 days resulted
in an improvement of the integrity of the stratum corneum as supported by a reduction of transepi-
dermal water loss (-13.4%) and an increase in skin hydration (+24%). Incubation of human senes-
cent skin fibroblasts in the presence of the algae extract reversed the gene expression level of
cytoskeletal and extracellular matrix components as well as collagen degrading and antioxidant
enzymes close to what was observed in young fibroblasts. In a 60-day controlled clinical trial, the
algae extract improved parameters associated with skin aging such as surface smoothness (+17.8%),
wrinkling density (-11.5%), wrinkle volume (-15.7%) and skin visco-elastic properties (+13.0%).
Results obtained are compatible with physiological attributes guarding the survival of the algae in
its natural challenging environment. The Saccharina longicruris extract restored the expression level
of specific genes in senescent fibroblasts and proved to be a potent anti-aging ingredient.
492
A pilot study of an oral phosphodiesterase inhibitor (apremilast) for atopic dermatitis
A Samrao, T Berry and E Simpson Dermatology, Oregon Health & Science University, Portland,
OR
Monocytes from patients with atopic dermatitis (AD)display elevated cyclic AMP phosphodiesterase
(PDE) activity leading to immune responses skewed towards a Th2 profile. Topical PDE-4 inhibitors
improve AD, although the effects are modest. We aimed to gather preliminary safety and efficacy
data of a novel oral PDE-4 inhibitor, apremilast, in a small cohort of adults with AD. We performed
an open-label prospective trial of apremilast at 20mg BID in 6 subjects (cohort 1) and 30mg BID in
7 subjects (cohort 2) for 12 weeks. The primary outcome was incidence of adverse events (AE) with
secondary outcomes focusing on disease severity measures and peripheral whole blood gene expres-
sion changes. Efficacy of apremilast was assessed at each study visit using the Eczema Area Sever-
ity Index (EASI), Dermatology Life Quality Index (DLQI) and the Visual Analog Scale (VAS) for pru-
ritus. Nausea was the most common AE and appeared to be dose-related (67% cohort 1, 86% cohort
2). In all subjects the nausea was rated as mild-moderate and improved over time. Other AEs included
headache, fatigue, diarrhea, bloating, and vomiting and were rated as mild-moderate. One subject
developed herpes zoster and was discontinued from the study. In both cohorts 1 and 2, a trend
toward improvement was seen in all outcomes. Statistically significant improvement in VAS and
DLQI was found in cohort 1 (p<0.022 and p<0.004, respectively) and DLQI in cohort 2 (p<0.011).
Combined data showed statistically significant improvement in all outcomes. EASI reduced from a
mean baseline of 25.2 to 18.2 (p<0.018), VAS reduced from a mean baseline of 50.9 to 32.9 (p<
0.019) and DLQI reduced from a mean baseline of 11.1 to 4.8 (p<0.001). Apremilast was shown
to be a safe and well-tolerated medication in subjects with AD. Gastrointestinal side effects were
most common but were generally mild and improved with time. Our preliminary data indicate that
apremilast significantly improves inflammation, pruritus and quality of life in AD. Larger controlled
studies are needed to further assess its safety and efficacy in this population.
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Safety and efficacy of AN2728 ointment in a Phase 2b dose-ranging, bilateral study of mild-
to-moderate plaque psoriasis
LT Zane,1 M Toledo-Bahena,2 MH Hughes1 and FA Heerinckx1 1 Anacor Pharmaceuticals, Palo
Alto, CA and 2 IMIC, Mexico City, Mexico
To determine the safety and efficacy of AN2728 Ointment, 2% and 0.5%, administered once daily
(QD) or twice daily (BID), compared to Ointment vehicle in the treatment of mild-to-moderate
plaque-type psoriasis. Multicenter, Phase 2b, randomized, double-blind, vehicle-controlled, 12-
week, bilateral comparison study. 145 adult patients with mild-to-moderate plaque type psoriasis
were randomized (1:1:1:1) to receive 1 of 4 treatment regimens: AN2728 Ointment (2% or 0.5%)
vs. Ointment vehicle applied QD or BID to two similar target plaques on the trunk or upper extrem-
ities for 12 weeks. Plaque severity was measured using 9-point static scales for Overall Target Plaque
Severity Score (OTPSS), erythema, scaling, and plaque elevation. Compared with those treated
with vehicle, psoriasis plaques treated with AN2728 Ointment achieved greater improvement in
OTPSS in a significantly higher proportion of patients after 6 weeks in the 2% AN2728 Ointment
BID dosing group (P <0.001). A dose-response was observed across the 4 dosing groups for this
outcome. Of those plaques treated for 12 weeks with 2% AN2728 Ointment BID, 54% achieved
complete or near complete clearance with ≥2-grade improvement from their baseline severity score.
No serious adverse events were observed in the trial. Treatment appeared generally safe and well-
tolerated. Overall, these Phase 2b efficacy results show that AN2728 Ointment is effective in reduc-
ing the severity and signs of plaque psoriasis and that increasing treatment effects are generally cor-
related with increasing concentration and frequency of application. These results consistently suggest
that of the 4 treatment regimens, AN2728 Ointment, 2% BID may provide the greatest therapeutic
benefit. In general, AN2728 Ointment appears safe and well-tolerated in adult patients with stable
mild-to-moderate plaque-type psoriasis.
507
Treatment and outcomes in nephrogenic systemic fibrosis
KN Christensen1 and MR Pittelkow2 1 Mayo Medical School, Mayo Clinic, Rochester, MN and
2 Department of Dermatology, Mayo Clinic, Rochester, MN
Nephrogenic Systemic Fibrosis (NSF) is a progressive, potentially fatal disease in renal insufficiency
patients exposed to gadolinium (Gd) based contrast agents. Non-chelated Gd in tissue induces
CD34+ procollagen I fibrocytes to migrate and deposit mucin, elastin and collagen. We have demon-
strated a significant 23 fold increase in Gd levels of involved vs non-lesional skin, which supports
the role of differential free Gd deposition in NSF. A standard of care for NSF is lacking. This study
describes treatments and outcomes of NSF patients managed at our institution. Between 2002-09,
28 biopsy proven NSF patients with >3 months follow-up were treated. Data were collected by
review of patient records. 12 of 28 patients had improvement of skin fibrosis ranging from mild to
dramatic recovery of mobility. In 13 patients skin fibrosis stabilized, and in 3 cases fibrosis pro-
gressed despite intervention. Therapeutic strategies included erythropoietin reduction, prednisone,
hydroxychloroquine, pentoxifylline, minocycline, UVA-1 phototherapy, physical therapy, Gd chela-
tion, plasmapheresis and renal transplantation. Multiple modalities were often attempted before
identifying a beneficial approach, and treatment combinations were common. The 3 most frequently
used therapies were hydroxychloroquine, renal transplantation, and UVA-1 phototherapy, in 15,
14 and 11 patients, respectively. Hydroxychloroquine led to improvement in 8, stabilization in 4,
and progression in 3 patients. Renal transplantation led to improvement in 5, stabilization in 1, and
progression in 8 patients. UVA-1 therapy led to improvement in 5, stabilization in 4, and progres-
sion in 2 patients. Gd chelation therapy was instituted in a kidney transplant patient. There was
increased urine Gd levels but no regression of skin fibrosis. Many therapies have been proposed for
NSF patients. Improvement was mostly associated with multiple treatment combinations. Despite
the correlation between increased Gd levels and disease pathogenesis, decreasing the Gd body bur-
den may not be sufficient for disease improvement.
509
Using a RNAi-based screen to identify targets to be combined with BRAF inhibitors for treat-
ing melanomas
YG Shellman, KA Partyka, C Porter, M Casas, A Tan, J Kim, M Gregory, S Smith, M Fujita,
J DeGregori and DA Norris UC Denver, Aurora, CO
A high frequency of the BRAFV600E mutation occurs in melanoma, making it a promising thera-
peutic target. Ongoing clinical trials with a BRAFV600E inhibitor showed exciting results for patients
carrying this mutation. However, many patients relapse after long term exposure to treatment. Thus,
combination treatments will be important tools to overcome melanoma resistance to BRAF inhibitors.
In order to identify genes and pathways whose inhibition sensitizes melanoma cells to killing by a
BRAF inhibitor, we performed a large scale RNAi-based synthetic lethal screen with a BRAF inhibitor,
PLX4720. We used a lentiviral-expressed genome-wide human short-hairpin RNA (shRNA) library
which targeted 47,000 human transcripts each with 3-5 shRNAs per target gene. A stable cell line
expressing the library was made with A375, melanoma cell line carrying BRAFV600E. We termed
these genes identified from our screen as SLPs (Synthetic Lethal with PLX4720). We have identified
744 SLPs and several potential pathways using a set statistical cut-off. Interestingly, preliminary tar-
gets included the PDGF and PI3K signal pathways, which have been recently published by others
as pathways contributing to melanoma resistance to BRAF inhibitors. Validation experiments with
individual shRNAs and compounds are on-going, and one example of confirmed targets with indi-
vidual shRNAs is MCL-1. Thus, these results validated our approach for identifying potential drug-
gable targets for combination treatment with BRAF inhibitors to overcome melanoma resistance.
508
Association of skin aging severity with blood isoprostane levels in healthy middle-aged Japan-
ese women
TC Chang,1 B Lingala,1 DG Kern,2 SM Wood,2 H Toyoda,2 H Knaggs2 and AS Chang1 1
Dermatology, Stanford University School of Medicine, Redwood City, CA and 2 NuSkin
International, Provo, UT
One of the central mechanisms of aging is hypothesized to be oxidative stress. To date, quantifica-
tion of oxidative stress in human organ systems has been difficult. One of the best methods cur-
rently available is blood isoprostane levels which not only reflect systemic oxidative damage, but
are also associated with oxidative stress in multiple non-dermatologic organ systems. We explored
the connection between human skin aging and oxidative stress as measured through blood iso-
prostane levels. The purpose was to determine whether human skin aging severity associates with
blood isoprostane levels, specifically PGF2a, 8-iso-PGF2a, and 15R-8-iso-PFG2a, while controlling
for covariates such as sun exposure, diet, medication or supplement use. We designed a prospec-
tive cohort study using a community setting in the Tokyo, Japan metropolitan area with participants
that included 36 healthy, nonsmoking middle-aged Japanese women aged 45-60 years with body
mass index (BMI) within 1 standard deviation of the mean, out of an original 70 volunteers seeking
participation. The main outcome measure(s) included statistically significant increase in PGF2a, 8-
iso-PGF2a, and 15R-8-iso-PGF2a isoprostane levels in participants with increased skin aging. Our
results showed that mean blood isoprostane levels of PGF2a and 8-iso-PGF2a was significantly
increased in the group of subjects whose skin age was assessed to exceed chronological age, with
p-values of <0.01 for both. When these mean values were adjusted for age, BMI, education level,
UV exposure, work stress, diet, medication and supplement use, the p-values for these 2 isoprostanes
remained <0.01 for both. In conclusion, this study represents the first report in the medical litera-
ture that increased skin aging phenotype may be reflected in systemic levels of PGF2a and 8-iso-
PGF2a isoprostanes.
506
Inhibition of cathelicidin processing enzymes as therapy for rosacea
KN Kanada,1 T Nakatsuji,1 EY Huang2 and RL Gallo1 1 Dermatology, University of California
San Diego, La Jolla, CA and 2 Skin Epibiotics Inc., San Diego, CA
Abnormally high and aberrantly processed levels of cathelicidin antimicrobial peptide LL-37 have
been implicated in the pathogenesis of rosacea. Local trypsin-like serine proteinase kallikrein (KLK)
5 controls the proteolytic cleavage of propeptide hCAP18 to LL-37’s active form. KLK5 is overex-
pressed in rosacea lesions, suggesting that an excess of this processing enzyme could contribute to
the disproportionate amount of LL-37 found in lesional skin. We hypothesize that blocking the pro-
teolytic activation of hCAP18 by KLK5 may have a therapeutic capacity to relieve the inflammation
of rosacea. First, to examine the potential of serine protease inhibitors to inhibit cutaneous serine
protease activity, skin tape strip extracts were incubated with a fluorogenic substrate in the pres-
ence of various concentrations of SE103, a proprietary formulation with serine protease inhibition
activity. SE103 dose–dependently inhibited serine protease activity with an IC50 of 0.2M and 80%
inhibition at 0.5M. The data suggest that SE103 directly inhibits serine proteinase activity from skin.
Second, as KLKs can be activated in turn by the action of matrix metalloproteinases (MMPs), we
examined whether a non-specific MMP inhibitor, doxycycline, indirectly inhibits the more proxi-
mal cutaneous serine protease processing of KLK5. Incubating doxycycline with normal human epi-
dermal keratinocytes strongly suppressed activity of both cellular and secreted MMP, thereby decreas-
ing activity of KLK5. These findings suggest that SE103 and doxycycline, through direct and indirect
suppression of KLK serine proteinases respectively, can normalize LL-37 expression by preventing
its processing from hCAP18. In this way, use of serine protease inhibitors may prove to be a novel
therapy for rosacea by directly targeting a recently identified key unbalanced step in epidermal
homeostasis. Furthermore this suggests a likely mechanism of action previously unknown for sub-
antimicrobial doses of doxycycline, the only systemic medication approved for rosacea.
510
Open-label, multiple-application pharmacokinetic (PK) study of naftifine 2% cream (NAFT-
2) in subjects with tinea cruris & tinea pedis
B Olayinka, EJ Pappert and B Hardas Merz Pharmaceuticals, LLC, Greensboro, NC
The primary objective of this study was to quantify the PK of NAFT-2 in subjects with tinea cruris &
pedis under maximal clinical use conditions (both feet & bikini area affected) for 2 weeks of once-
daily application (8 grams/day: 2 grams/foot & 4 grams/bikini area). The secondary objectives were
to evaluate efficacy & subject tolerability & safety. PK blood samples were drawn on Days 1 & 14
for 24 hrs at 0 hour (pre-application) & 1, 2, 4, 6, 8, 12, 16 & 24 hrs post-application. Pre-applica-
tion samples were collected on Days 3, 7, 11, 12, 14. Samples were also collected at Day 21 (1
week post last application) & Day 28 (2 weeks post last application). PK urine samples were obtained
on Days 1 & 14. PK analysis of plasma & urine samples from 21 subjects treated with the max dose
of NAFT-2 once daily for 14 days showed increased exposure over the treatment period with accu-
mulation < 2-fold. After 14 days, the Cmax was 11 ng/mL (geometric mean). AUC0-24 was 117
ng*hr/mL (CV% 41.2) on Day 1 & AUC0-t of 204 ng*hr/mL (CV% 28.5) on Day 14. Complete cure
(negative myology & negative signs & symptoms) & treatment effectiveness (negative KOH, nega-
tive culture & a Physician Global Score of 1 or 2) was evaluated on Days 14 & 28. Complete cure
of tinea cruris was shown in 7/21 (33.3%) subjects & 12/21 (57.1%) subjects on Days 14 & Day 28,
respectively. Complete cure of tinea pedis was shown in 1/21 (4.8%) subjects & 3/21 (14.3%) sub-
jects on Days 14 & 28, respectively. Treatment effectiveness for tinea cruris was shown in 16/21
(76.2%) & 18/21 (85.7%) by Days 14 & 28, respectively. For tinea pedis, treatment effectiveness was
observed in 15/21 (71.4%) subjects & 12/21 (57.1%) subjects on Days 14 & 28, respectively. NAFT-
2 was well-tolerated by all 21 subjects; with no treatment-related adverse events. No clinically sig-
nificant results were seen in other safety evaluations. NAFT-2, at maximal clinical use, showed accu-
mulation of < 2-fold, was effective in tinea pedis & cruris & was well-tolerated.
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Quality of life in patients with uremic xerosis
P Dupuy,1 J Szepietowski,2 E Balaskas3 and K Taube4 1 Division of Research and Development,
Orfagen, Toulouse, France, 2 Department of Dermatology, Venereology and Allergology,
University of Medicine, Wroclaw, Poland, 3 Department of Nephrology, Ahepa University
Hospital, Thessaloniki, Greece and 4 Department of Dermatology, Martin Luther University,
Halle, Germany
Although uremic xerosis (rough and scaly skin affecting patients with end-stage renal disease, ESRD)
is a neglected disease, it is a prominent feature that aggravates uremic pruritus and may have some
psychological and social consequences. Three hundred and thirty four (334) ESRD patients with
moderate-to-severe uremic xerosis were surveyed for quality of life (QoL) assessment, using the
generic Short-Form (SF-12) scale and the Dermatology Life Quality Index (DLQI). In parallel, the
intensity of xerosis on 4 sites (the two lower legs, chest, forearm without arterio-venous shunt) was
assessed, using a 5-point lesional intensity score. Pruritus was auto-assessed by the patients, using
a 100-mm visual analogue scale (VAS). Uremic xerosis patients had a marked deterioration of the
Physical Component Summary (PCS) of SF-12 (mean ± SD: 34.92 ± 9.98) and DLQI (5.06 ± 4.73).
Younger age (r = - 0.20), xerosis intensity (r = 0.14), and the presence of pruritus (p < 0.0001) and
its intensity (r = 0.50) were shown to be significant worsening factors of DLQI. Because a weak but
significant correlation between the intensity of xerosis and pruritus was also demonstrated (r =
0.18, p = 0.001), the direct contribution of age, xerosis and pruritus on DLQI was analysed in a
multiple linear regression model. Age and pruritus intensity, but not xerosis intensity, were found
to be independent contributors to DLQI deterioration (p < 0.0005). On the other hand, uremic xero-
sis without associated pruritus still resulted in DLQI alteration (3.24 ± 3.99). It was concluded that
young age and intensity of uremic pruritus compromise QoL in uremic xerosis patients. Some char-
acteristics of uremic xerosis other than xerosis intensity may also be involved in QoL alteration.
500
The anti-inflammatory benefits of tridecylcarboxyethylate
H Meldrum, J Bajor, J Alicea, V Foy, J O’Leary, B Harirchian and C Bosko BioScience, Unilever,
Trumbull, CT
Topical skin care products containing alpha hydroxy acids and retinoids are effective in preventing
the visible signs of ageing but can also be irritating, especially at high concentrations. Thus, the
inclusion of anti-inflammatory compounds could provide added consumer benefits. To address this
area, we examined the role of the thromboxane A2 receptor in mediating glycolic acid and retinol
induced irritation. Through the use of an in vitro receptor competition assay, it was discovered that
tridecyl propionic acid or more simply, tridecylcarboxyethylate, significantly inhibited ligand bind-
ing by 54% and 99% at 10 and 100 microMolar concentrations respectively. Furthermore, in a ran-
domized clinical study involving 12 females, 5% tridecylcarboxyethylate in a simple vehicle resulted
in a significant decrease in glycolic acid (10%, pH 3.5) and retinol (0.1%) induced irritation at sev-
eral time points. These results collectively demonstrate the in vivo anti-inflammatory activity of tride-
cylcarboxyethylate and suggest the mechanism of action is through inhibition of the thromboxane
A2 receptor.
501
An internet-based survey and contest: A novel method for improving acne outcomes
BA Yentzer, AA Wood, MJ Sagransky, JL O’Neill, AR Clark, LL Williams and SR Feldman
Dermatology, Wake Forest University School of Medicine, Winston Salem, NC
Non-adherence to topical medications is a major cause of treatment failures in acne vulgaris. The
purpose of this study is to evaluate whether participation in an internet-based survey improves adher-
ence to topical acne therapy. Twenty subjects aged 13 to 18 years with mild to moderate acne were
enrolled in this investigator-blinded, randomized, prospective study. All subjects were given topi-
cal benzoyl peroxide 5% gel to apply daily for 12 weeks. Half of study subjects received a weekly
email with a link to an internet survey about their acne treatment. For each completed survey, sub-
jects had a chance to win an iPod Nano. Subjects that completed at least 5 surveys in a 6 week
period received a $5 gift card. Adherence was monitored electronically, and subjects and clinical
assessors were blinded to the adherence data. Fifteen of the 20 enrolled subjects completed the 12-
week study. Mean adherence was 33% and 89% in the control and intervention groups, respec-
tively (P<.01). While the Internet group demonstrated superior mean percent reduction of nonin-
flammatory and total lesion counts, this difference did not reach statistical significance. Adherence
to topical acne medications in adolescents is dramatically improved using a weekly internet sur-
vey. This pilot study provides the foundation for larger trials using internet-based surveys to improve
adherence to medical therapy.
502
ANA and anti-dsDNA in patients under treatment with Infliximab – A potential predictor for
non-response to infliximab
J Hoffmann, M Hartmann, AH Enk and EN Hadaschik Dermatology, University of Heidelberg,
Heidelberg, Germany
Infliximab is a chimeric monoclonal anti-TNF-alpha antibody that has been successfully used to
treat Psoriasis and Psoriasis-arthritis. However, some patients do respond initially to Infliximab
therapy, but after several cycles loose therapeutic response. In some patients antibodies to the murine
part of Infliximab (Infliximab-abs) are induced during treatment and those antibodies are thought
to be associated with a clinical non-response. However, routine screening for Infliximab-abs is
expensive and not regularly performed. A reliable and affordable method to identify patients who
are at risk for non-response would therefore be desirable. Since antinuclear antibodies (ANA) and
anti-dsDNA antibodies develop in a proportion of patients receiving Infliximab, we analyzed if there
is a correlation between the development of ANA/anti-dsDNA and Infliximab-abs and if conse-
quently screening for ANA/anti-dsDNA could be used to predict non-responsive patients. Among
the patients treated with Infliximab for psoriasis in our department, we identified patients in whom
ANA-titers and anti-dsDNA values were regularly monitored and for whom baseline ANA-titers
and ds-DNA values were available (n= 32). For 29 of these patients sera were tested for Infliximab-
abs by ELISA. ANA-titers and anti-dsDNA were monitored every visit. 62.5% (20 of 32) of the patients
were ANA-naïve at baseline. 91% of the ANA-naive patients had become ANA-positive at infusion
cycle 10. None of the ANA-naïve patients converted after infusion cycle 10. Anti-dsDNA [IU/ml]
in this study increased slightly during the treatment with Infliximab infusions but remained nega-
tive on average. Infliximab-antibodies were found in 6 of 29 patients (20.7%). Patients tested posi-
tive for Infliximab-antibodies had a significantly higher anti-dsDNA at baseline (4.1 vs 14.3, p<0.001,
students two tailed t-test) and were significantly more often ANA-positive at baseline (67% vs 35%,
p<0.05, chi-square test) than patients without Infliximab-antibodies.
503
Positive results of a pivotal phase II trial testing a manufactured 0.02% mechlorethamine gel
in mycosis fungoides (MF)
S Lessin,1 M Duvic,2 J Guitart,3 A Pandya,4 B Strober,5 E Olsen,6 C Hull,7 E Knobler,8 A Rook,9
E Kim,9 M Naylor,10 D Adelson,10 A Kimball,11 G Wood,12 H Wu,1 B Walker13 and Y Kim14 1 Fox
Chase Cancer Center, Philadelphia, PA, 2 MD Anderson Cancer Center, Houston, TX, 3
Northwestern University, Chicago, IL, 4 University of Texas Southwestern, Dallas, TX, 5 New
York University, New York, NY, 6 Duke University, Durham, NC, 7 University of Utah, Salt Lake
City, UT, 8 Columbia University, New York, NY, 9 University of Pennsylvania, Philadelphia, PA,
10 University of Oklahoma, Oklahoma City, OK, 11 Harvard Medical School, Boston, MA, 12
University of Wisconsin, Madison, WI, 13 Yaupon Therapeutics, Radnor, PA and 14 Stanford
University, Palo Alto, CA
The efficacy of mechlorethamine (an alkylating agent also known as nitrogen mustard (NM)) as a
topical agent mixed in aqueous solution or compounded into a petrolatum-based ointment in the
treatment of MF has been reported in large case series. Yet, there has been no formal regulatory
approval of NM topical formulations. A multi-center, randomized, observer-blinded clinical trial
was conducted to determine if the efficacy and safety of a manufactured 0.02% NM gel was non-
inferior (lower confidence interval (CI) ≥ 0.75) to a compounded 0.02% NM petrolatum-based
ointment in MF. 260 stage I-IIA MF patients applied NM once daily for 12 months. The ratio of the
response rates (RR) of NM gel to ointment, based on the primary efficacy endpoint (CAILS), was 1.23
(CI = 0.95-1.55; ≥ 0.75). RR for NM gel and ointment were 59% vs. 48% by CAILS and 47.7% vs.
46.2% by the secondary efficacy endpoint (mSWAT), respectively. NM gel & ointment were effec-
tive when applied to limited (stage IA) and generalized skin lesions (Stage IB/IIA). No serious or
unexpected drug-related adverse events were seen and no system absorption was detected by HPLC
serum assay. These results confirm the non-inferiority of a manufactured 0.02% NM gel and address
an important unmet medical need in MF.
504
An investigator-initiated, open-label study evaluating the efficacy and safety of ustekinumab
in patients with moderate to severe palmar plantar psoriasis
AC Wang,1 TA Kerensky,1 S Au,1 S Yaniv,2 M Michelon,3 I Andrews,4 N Dumont1 and AB Gottlieb1
1 Dermatology, Tufts Medical Center, Boston, MA, 2 Albert Einstein College of Medicine,
Bronx, NY, 3 Tufts University School of Medicine, Boston, MA and 4 The Medical School for
International Health, Beer-Sheva, Israel
Palmar plantar psoriasis (PPP) is a disabling and disfiguring form of psoriasis that is typically chronic
and difficult to treat. PPP may be characterized by the existence of sterile pustules and fissures on
the palms and soles in addition to the presence of well-demarcated, erythematous, scaly plaques.
Ustekinumab is a fully human IL-12/23 monoclonal antibody that is well tolerated and effective for
treatment of adults with moderate to severe plaque psoriasis. We designed a small, open-label, 24
week study to evaluate the safety and efficacy of ustekinumab in patients with moderate to severe
palmar plantar psoriasis. Eligible subjects < 100 kg received 45 mg of ustekinumab subcutaneously,
while subjects ≥ 100 kg received 90 mg at weeks 0, 4, and 16. Clinical assessments of outcomes
included: physician global assessment (PGA), pustule and fissure counts, dermatology life quality
index (DLQI), as well as pruritus and pain visual analogue scale (VAS) assessments. Preliminary
results of nine patients who have completed the primary efficacy end point of week 16 of the study
indicate that ustekinumab is well tolerated and may be effective at improving PPP. Mean PGA
improved from 3.4 to 2.0 (p = 0.01) and DLQI improved from 14.5 to 4.6 (p = 0.03) from week 0
to week 16. Ustekinumab is well tolerated and may be effective at improving clinical outcomes
and quality of life in patients with moderate to severe palmar plantar psoriasis.
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Safety and efficacy of AN2728 ointment in a Phase 2b dose-ranging, bilateral study of mild-
to-moderate plaque psoriasis
LT Zane,1 M Toledo-Bahena,2 MH Hughes1 and FA Heerinckx1 1 Anacor Pharmaceuticals, Palo
Alto, CA and 2 IMIC, Mexico City, Mexico
To determine the safety and efficacy of AN2728 Ointment, 2% and 0.5%, administered once daily
(QD) or twice daily (BID), compared to Ointment vehicle in the treatment of mild-to-moderate
plaque-type psoriasis. Multicenter, Phase 2b, randomized, double-blind, vehicle-controlled, 12-
week, bilateral comparison study. 145 adult patients with mild-to-moderate plaque type psoriasis
were randomized (1:1:1:1) to receive 1 of 4 treatment regimens: AN2728 Ointment (2% or 0.5%)
vs. Ointment vehicle applied QD or BID to two similar target plaques on the trunk or upper extrem-
ities for 12 weeks. Plaque severity was measured using 9-point static scales for Overall Target Plaque
Severity Score (OTPSS), erythema, scaling, and plaque elevation. Compared with those treated
with vehicle, psoriasis plaques treated with AN2728 Ointment achieved greater improvement in
OTPSS in a significantly higher proportion of patients after 6 weeks in the 2% AN2728 Ointment
BID dosing group (P <0.001). A dose-response was observed across the 4 dosing groups for this
outcome. Of those plaques treated for 12 weeks with 2% AN2728 Ointment BID, 54% achieved
complete or near complete clearance with ≥2-grade improvement from their baseline severity score.
No serious adverse events were observed in the trial. Treatment appeared generally safe and well-
tolerated. Overall, these Phase 2b efficacy results show that AN2728 Ointment is effective in reduc-
ing the severity and signs of plaque psoriasis and that increasing treatment effects are generally cor-
related with increasing concentration and frequency of application. These results consistently suggest
that of the 4 treatment regimens, AN2728 Ointment, 2% BID may provide the greatest therapeutic
benefit. In general, AN2728 Ointment appears safe and well-tolerated in adult patients with stable
mild-to-moderate plaque-type psoriasis.
507
Treatment and outcomes in nephrogenic systemic fibrosis
KN Christensen1 and MR Pittelkow2 1 Mayo Medical School, Mayo Clinic, Rochester, MN and
2 Department of Dermatology, Mayo Clinic, Rochester, MN
Nephrogenic Systemic Fibrosis (NSF) is a progressive, potentially fatal disease in renal insufficiency
patients exposed to gadolinium (Gd) based contrast agents. Non-chelated Gd in tissue induces
CD34+ procollagen I fibrocytes to migrate and deposit mucin, elastin and collagen. We have demon-
strated a significant 23 fold increase in Gd levels of involved vs non-lesional skin, which supports
the role of differential free Gd deposition in NSF. A standard of care for NSF is lacking. This study
describes treatments and outcomes of NSF patients managed at our institution. Between 2002-09,
28 biopsy proven NSF patients with >3 months follow-up were treated. Data were collected by
review of patient records. 12 of 28 patients had improvement of skin fibrosis ranging from mild to
dramatic recovery of mobility. In 13 patients skin fibrosis stabilized, and in 3 cases fibrosis pro-
gressed despite intervention. Therapeutic strategies included erythropoietin reduction, prednisone,
hydroxychloroquine, pentoxifylline, minocycline, UVA-1 phototherapy, physical therapy, Gd chela-
tion, plasmapheresis and renal transplantation. Multiple modalities were often attempted before
identifying a beneficial approach, and treatment combinations were common. The 3 most frequently
used therapies were hydroxychloroquine, renal transplantation, and UVA-1 phototherapy, in 15,
14 and 11 patients, respectively. Hydroxychloroquine led to improvement in 8, stabilization in 4,
and progression in 3 patients. Renal transplantation led to improvement in 5, stabilization in 1, and
progression in 8 patients. UVA-1 therapy led to improvement in 5, stabilization in 4, and progres-
sion in 2 patients. Gd chelation therapy was instituted in a kidney transplant patient. There was
increased urine Gd levels but no regression of skin fibrosis. Many therapies have been proposed for
NSF patients. Improvement was mostly associated with multiple treatment combinations. Despite
the correlation between increased Gd levels and disease pathogenesis, decreasing the Gd body bur-
den may not be sufficient for disease improvement.
509
Using a RNAi-based screen to identify targets to be combined with BRAF inhibitors for treat-
ing melanomas
YG Shellman, KA Partyka, C Porter, M Casas, A Tan, J Kim, M Gregory, S Smith, M Fujita,
J DeGregori and DA Norris UC Denver, Aurora, CO
A high frequency of the BRAFV600E mutation occurs in melanoma, making it a promising thera-
peutic target. Ongoing clinical trials with a BRAFV600E inhibitor showed exciting results for patients
carrying this mutation. However, many patients relapse after long term exposure to treatment. Thus,
combination treatments will be important tools to overcome melanoma resistance to BRAF inhibitors.
In order to identify genes and pathways whose inhibition sensitizes melanoma cells to killing by a
BRAF inhibitor, we performed a large scale RNAi-based synthetic lethal screen with a BRAF inhibitor,
PLX4720. We used a lentiviral-expressed genome-wide human short-hairpin RNA (shRNA) library
which targeted 47,000 human transcripts each with 3-5 shRNAs per target gene. A stable cell line
expressing the library was made with A375, melanoma cell line carrying BRAFV600E. We termed
these genes identified from our screen as SLPs (Synthetic Lethal with PLX4720). We have identified
744 SLPs and several potential pathways using a set statistical cut-off. Interestingly, preliminary tar-
gets included the PDGF and PI3K signal pathways, which have been recently published by others
as pathways contributing to melanoma resistance to BRAF inhibitors. Validation experiments with
individual shRNAs and compounds are on-going, and one example of confirmed targets with indi-
vidual shRNAs is MCL-1. Thus, these results validated our approach for identifying potential drug-
gable targets for combination treatment with BRAF inhibitors to overcome melanoma resistance.
508
Association of skin aging severity with blood isoprostane levels in healthy middle-aged Japan-
ese women
TC Chang,1 B Lingala,1 DG Kern,2 SM Wood,2 H Toyoda,2 H Knaggs2 and AS Chang1 1
Dermatology, Stanford University School of Medicine, Redwood City, CA and 2 NuSkin
International, Provo, UT
One of the central mechanisms of aging is hypothesized to be oxidative stress. To date, quantifica-
tion of oxidative stress in human organ systems has been difficult. One of the best methods cur-
rently available is blood isoprostane levels which not only reflect systemic oxidative damage, but
are also associated with oxidative stress in multiple non-dermatologic organ systems. We explored
the connection between human skin aging and oxidative stress as measured through blood iso-
prostane levels. The purpose was to determine whether human skin aging severity associates with
blood isoprostane levels, specifically PGF2a, 8-iso-PGF2a, and 15R-8-iso-PFG2a, while controlling
for covariates such as sun exposure, diet, medication or supplement use. We designed a prospec-
tive cohort study using a community setting in the Tokyo, Japan metropolitan area with participants
that included 36 healthy, nonsmoking middle-aged Japanese women aged 45-60 years with body
mass index (BMI) within 1 standard deviation of the mean, out of an original 70 volunteers seeking
participation. The main outcome measure(s) included statistically significant increase in PGF2a, 8-
iso-PGF2a, and 15R-8-iso-PGF2a isoprostane levels in participants with increased skin aging. Our
results showed that mean blood isoprostane levels of PGF2a and 8-iso-PGF2a was significantly
increased in the group of subjects whose skin age was assessed to exceed chronological age, with
p-values of <0.01 for both. When these mean values were adjusted for age, BMI, education level,
UV exposure, work stress, diet, medication and supplement use, the p-values for these 2 isoprostanes
remained <0.01 for both. In conclusion, this study represents the first report in the medical litera-
ture that increased skin aging phenotype may be reflected in systemic levels of PGF2a and 8-iso-
PGF2a isoprostanes.
506
Inhibition of cathelicidin processing enzymes as therapy for rosacea
KN Kanada,1 T Nakatsuji,1 EY Huang2 and RL Gallo1 1 Dermatology, University of California
San Diego, La Jolla, CA and 2 Skin Epibiotics Inc., San Diego, CA
Abnormally high and aberrantly processed levels of cathelicidin antimicrobial peptide LL-37 have
been implicated in the pathogenesis of rosacea. Local trypsin-like serine proteinase kallikrein (KLK)
5 controls the proteolytic cleavage of propeptide hCAP18 to LL-37’s active form. KLK5 is overex-
pressed in rosacea lesions, suggesting that an excess of this processing enzyme could contribute to
the disproportionate amount of LL-37 found in lesional skin. We hypothesize that blocking the pro-
teolytic activation of hCAP18 by KLK5 may have a therapeutic capacity to relieve the inflammation
of rosacea. First, to examine the potential of serine protease inhibitors to inhibit cutaneous serine
protease activity, skin tape strip extracts were incubated with a fluorogenic substrate in the pres-
ence of various concentrations of SE103, a proprietary formulation with serine protease inhibition
activity. SE103 dose–dependently inhibited serine protease activity with an IC50 of 0.2M and 80%
inhibition at 0.5M. The data suggest that SE103 directly inhibits serine proteinase activity from skin.
Second, as KLKs can be activated in turn by the action of matrix metalloproteinases (MMPs), we
examined whether a non-specific MMP inhibitor, doxycycline, indirectly inhibits the more proxi-
mal cutaneous serine protease processing of KLK5. Incubating doxycycline with normal human epi-
dermal keratinocytes strongly suppressed activity of both cellular and secreted MMP, thereby decreas-
ing activity of KLK5. These findings suggest that SE103 and doxycycline, through direct and indirect
suppression of KLK serine proteinases respectively, can normalize LL-37 expression by preventing
its processing from hCAP18. In this way, use of serine protease inhibitors may prove to be a novel
therapy for rosacea by directly targeting a recently identified key unbalanced step in epidermal
homeostasis. Furthermore this suggests a likely mechanism of action previously unknown for sub-
antimicrobial doses of doxycycline, the only systemic medication approved for rosacea.
510
Open-label, multiple-application pharmacokinetic (PK) study of naftifine 2% cream (NAFT-
2) in subjects with tinea cruris & tinea pedis
B Olayinka, EJ Pappert and B Hardas Merz Pharmaceuticals, LLC, Greensboro, NC
The primary objective of this study was to quantify the PK of NAFT-2 in subjects with tinea cruris &
pedis under maximal clinical use conditions (both feet & bikini area affected) for 2 weeks of once-
daily application (8 grams/day: 2 grams/foot & 4 grams/bikini area). The secondary objectives were
to evaluate efficacy & subject tolerability & safety. PK blood samples were drawn on Days 1 & 14
for 24 hrs at 0 hour (pre-application) & 1, 2, 4, 6, 8, 12, 16 & 24 hrs post-application. Pre-applica-
tion samples were collected on Days 3, 7, 11, 12, 14. Samples were also collected at Day 21 (1
week post last application) & Day 28 (2 weeks post last application). PK urine samples were obtained
on Days 1 & 14. PK analysis of plasma & urine samples from 21 subjects treated with the max dose
of NAFT-2 once daily for 14 days showed increased exposure over the treatment period with accu-
mulation < 2-fold. After 14 days, the Cmax was 11 ng/mL (geometric mean). AUC0-24 was 117
ng*hr/mL (CV% 41.2) on Day 1 & AUC0-t of 204 ng*hr/mL (CV% 28.5) on Day 14. Complete cure
(negative myology & negative signs & symptoms) & treatment effectiveness (negative KOH, nega-
tive culture & a Physician Global Score of 1 or 2) was evaluated on Days 14 & 28. Complete cure
of tinea cruris was shown in 7/21 (33.3%) subjects & 12/21 (57.1%) subjects on Days 14 & Day 28,
respectively. Complete cure of tinea pedis was shown in 1/21 (4.8%) subjects & 3/21 (14.3%) sub-
jects on Days 14 & 28, respectively. Treatment effectiveness for tinea cruris was shown in 16/21
(76.2%) & 18/21 (85.7%) by Days 14 & 28, respectively. For tinea pedis, treatment effectiveness was
observed in 15/21 (71.4%) subjects & 12/21 (57.1%) subjects on Days 14 & 28, respectively. NAFT-
2 was well-tolerated by all 21 subjects; with no treatment-related adverse events. No clinically sig-
nificant results were seen in other safety evaluations. NAFT-2, at maximal clinical use, showed accu-
mulation of < 2-fold, was effective in tinea pedis & cruris & was well-tolerated.
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Quality of life in patients with uremic xerosis
P Dupuy,1 J Szepietowski,2 E Balaskas3 and K Taube4 1 Division of Research and Development,
Orfagen, Toulouse, France, 2 Department of Dermatology, Venereology and Allergology,
University of Medicine, Wroclaw, Poland, 3 Department of Nephrology, Ahepa University
Hospital, Thessaloniki, Greece and 4 Department of Dermatology, Martin Luther University,
Halle, Germany
Although uremic xerosis (rough and scaly skin affecting patients with end-stage renal disease, ESRD)
is a neglected disease, it is a prominent feature that aggravates uremic pruritus and may have some
psychological and social consequences. Three hundred and thirty four (334) ESRD patients with
moderate-to-severe uremic xerosis were surveyed for quality of life (QoL) assessment, using the
generic Short-Form (SF-12) scale and the Dermatology Life Quality Index (DLQI). In parallel, the
intensity of xerosis on 4 sites (the two lower legs, chest, forearm without arterio-venous shunt) was
assessed, using a 5-point lesional intensity score. Pruritus was auto-assessed by the patients, using
a 100-mm visual analogue scale (VAS). Uremic xerosis patients had a marked deterioration of the
Physical Component Summary (PCS) of SF-12 (mean ± SD: 34.92 ± 9.98) and DLQI (5.06 ± 4.73).
Younger age (r = - 0.20), xerosis intensity (r = 0.14), and the presence of pruritus (p < 0.0001) and
its intensity (r = 0.50) were shown to be significant worsening factors of DLQI. Because a weak but
significant correlation between the intensity of xerosis and pruritus was also demonstrated (r =
0.18, p = 0.001), the direct contribution of age, xerosis and pruritus on DLQI was analysed in a
multiple linear regression model. Age and pruritus intensity, but not xerosis intensity, were found
to be independent contributors to DLQI deterioration (p < 0.0005). On the other hand, uremic xero-
sis without associated pruritus still resulted in DLQI alteration (3.24 ± 3.99). It was concluded that
young age and intensity of uremic pruritus compromise QoL in uremic xerosis patients. Some char-
acteristics of uremic xerosis other than xerosis intensity may also be involved in QoL alteration.
500
The anti-inflammatory benefits of tridecylcarboxyethylate
H Meldrum, J Bajor, J Alicea, V Foy, J O’Leary, B Harirchian and C Bosko BioScience, Unilever,
Trumbull, CT
Topical skin care products containing alpha hydroxy acids and retinoids are effective in preventing
the visible signs of ageing but can also be irritating, especially at high concentrations. Thus, the
inclusion of anti-inflammatory compounds could provide added consumer benefits. To address this
area, we examined the role of the thromboxane A2 receptor in mediating glycolic acid and retinol
induced irritation. Through the use of an in vitro receptor competition assay, it was discovered that
tridecyl propionic acid or more simply, tridecylcarboxyethylate, significantly inhibited ligand bind-
ing by 54% and 99% at 10 and 100 microMolar concentrations respectively. Furthermore, in a ran-
domized clinical study involving 12 females, 5% tridecylcarboxyethylate in a simple vehicle resulted
in a significant decrease in glycolic acid (10%, pH 3.5) and retinol (0.1%) induced irritation at sev-
eral time points. These results collectively demonstrate the in vivo anti-inflammatory activity of tride-
cylcarboxyethylate and suggest the mechanism of action is through inhibition of the thromboxane
A2 receptor.
501
An internet-based survey and contest: A novel method for improving acne outcomes
BA Yentzer, AA Wood, MJ Sagransky, JL O’Neill, AR Clark, LL Williams and SR Feldman
Dermatology, Wake Forest University School of Medicine, Winston Salem, NC
Non-adherence to topical medications is a major cause of treatment failures in acne vulgaris. The
purpose of this study is to evaluate whether participation in an internet-based survey improves adher-
ence to topical acne therapy. Twenty subjects aged 13 to 18 years with mild to moderate acne were
enrolled in this investigator-blinded, randomized, prospective study. All subjects were given topi-
cal benzoyl peroxide 5% gel to apply daily for 12 weeks. Half of study subjects received a weekly
email with a link to an internet survey about their acne treatment. For each completed survey, sub-
jects had a chance to win an iPod Nano. Subjects that completed at least 5 surveys in a 6 week
period received a $5 gift card. Adherence was monitored electronically, and subjects and clinical
assessors were blinded to the adherence data. Fifteen of the 20 enrolled subjects completed the 12-
week study. Mean adherence was 33% and 89% in the control and intervention groups, respec-
tively (P<.01). While the Internet group demonstrated superior mean percent reduction of nonin-
flammatory and total lesion counts, this difference did not reach statistical significance. Adherence
to topical acne medications in adolescents is dramatically improved using a weekly internet sur-
vey. This pilot study provides the foundation for larger trials using internet-based surveys to improve
adherence to medical therapy.
502
ANA and anti-dsDNA in patients under treatment with Infliximab – A potential predictor for
non-response to infliximab
J Hoffmann, M Hartmann, AH Enk and EN Hadaschik Dermatology, University of Heidelberg,
Heidelberg, Germany
Infliximab is a chimeric monoclonal anti-TNF-alpha antibody that has been successfully used to
treat Psoriasis and Psoriasis-arthritis. However, some patients do respond initially to Infliximab
therapy, but after several cycles loose therapeutic response. In some patients antibodies to the murine
part of Infliximab (Infliximab-abs) are induced during treatment and those antibodies are thought
to be associated with a clinical non-response. However, routine screening for Infliximab-abs is
expensive and not regularly performed. A reliable and affordable method to identify patients who
are at risk for non-response would therefore be desirable. Since antinuclear antibodies (ANA) and
anti-dsDNA antibodies develop in a proportion of patients receiving Infliximab, we analyzed if there
is a correlation between the development of ANA/anti-dsDNA and Infliximab-abs and if conse-
quently screening for ANA/anti-dsDNA could be used to predict non-responsive patients. Among
the patients treated with Infliximab for psoriasis in our department, we identified patients in whom
ANA-titers and anti-dsDNA values were regularly monitored and for whom baseline ANA-titers
and ds-DNA values were available (n= 32). For 29 of these patients sera were tested for Infliximab-
abs by ELISA. ANA-titers and anti-dsDNA were monitored every visit. 62.5% (20 of 32) of the patients
were ANA-naïve at baseline. 91% of the ANA-naive patients had become ANA-positive at infusion
cycle 10. None of the ANA-naïve patients converted after infusion cycle 10. Anti-dsDNA [IU/ml]
in this study increased slightly during the treatment with Infliximab infusions but remained nega-
tive on average. Infliximab-antibodies were found in 6 of 29 patients (20.7%). Patients tested posi-
tive for Infliximab-antibodies had a significantly higher anti-dsDNA at baseline (4.1 vs 14.3, p<0.001,
students two tailed t-test) and were significantly more often ANA-positive at baseline (67% vs 35%,
p<0.05, chi-square test) than patients without Infliximab-antibodies.
503
Positive results of a pivotal phase II trial testing a manufactured 0.02% mechlorethamine gel
in mycosis fungoides (MF)
S Lessin,1 M Duvic,2 J Guitart,3 A Pandya,4 B Strober,5 E Olsen,6 C Hull,7 E Knobler,8 A Rook,9
E Kim,9 M Naylor,10 D Adelson,10 A Kimball,11 G Wood,12 H Wu,1 B Walker13 and Y Kim14 1 Fox
Chase Cancer Center, Philadelphia, PA, 2 MD Anderson Cancer Center, Houston, TX, 3
Northwestern University, Chicago, IL, 4 University of Texas Southwestern, Dallas, TX, 5 New
York University, New York, NY, 6 Duke University, Durham, NC, 7 University of Utah, Salt Lake
City, UT, 8 Columbia University, New York, NY, 9 University of Pennsylvania, Philadelphia, PA,
10 University of Oklahoma, Oklahoma City, OK, 11 Harvard Medical School, Boston, MA, 12
University of Wisconsin, Madison, WI, 13 Yaupon Therapeutics, Radnor, PA and 14 Stanford
University, Palo Alto, CA
The efficacy of mechlorethamine (an alkylating agent also known as nitrogen mustard (NM)) as a
topical agent mixed in aqueous solution or compounded into a petrolatum-based ointment in the
treatment of MF has been reported in large case series. Yet, there has been no formal regulatory
approval of NM topical formulations. A multi-center, randomized, observer-blinded clinical trial
was conducted to determine if the efficacy and safety of a manufactured 0.02% NM gel was non-
inferior (lower confidence interval (CI) ≥ 0.75) to a compounded 0.02% NM petrolatum-based
ointment in MF. 260 stage I-IIA MF patients applied NM once daily for 12 months. The ratio of the
response rates (RR) of NM gel to ointment, based on the primary efficacy endpoint (CAILS), was 1.23
(CI = 0.95-1.55; ≥ 0.75). RR for NM gel and ointment were 59% vs. 48% by CAILS and 47.7% vs.
46.2% by the secondary efficacy endpoint (mSWAT), respectively. NM gel & ointment were effec-
tive when applied to limited (stage IA) and generalized skin lesions (Stage IB/IIA). No serious or
unexpected drug-related adverse events were seen and no system absorption was detected by HPLC
serum assay. These results confirm the non-inferiority of a manufactured 0.02% NM gel and address
an important unmet medical need in MF.
504
An investigator-initiated, open-label study evaluating the efficacy and safety of ustekinumab
in patients with moderate to severe palmar plantar psoriasis
AC Wang,1 TA Kerensky,1 S Au,1 S Yaniv,2 M Michelon,3 I Andrews,4 N Dumont1 and AB Gottlieb1
1 Dermatology, Tufts Medical Center, Boston, MA, 2 Albert Einstein College of Medicine,
Bronx, NY, 3 Tufts University School of Medicine, Boston, MA and 4 The Medical School for
International Health, Beer-Sheva, Israel
Palmar plantar psoriasis (PPP) is a disabling and disfiguring form of psoriasis that is typically chronic
and difficult to treat. PPP may be characterized by the existence of sterile pustules and fissures on
the palms and soles in addition to the presence of well-demarcated, erythematous, scaly plaques.
Ustekinumab is a fully human IL-12/23 monoclonal antibody that is well tolerated and effective for
treatment of adults with moderate to severe plaque psoriasis. We designed a small, open-label, 24
week study to evaluate the safety and efficacy of ustekinumab in patients with moderate to severe
palmar plantar psoriasis. Eligible subjects < 100 kg received 45 mg of ustekinumab subcutaneously,
while subjects ≥ 100 kg received 90 mg at weeks 0, 4, and 16. Clinical assessments of outcomes
included: physician global assessment (PGA), pustule and fissure counts, dermatology life quality
index (DLQI), as well as pruritus and pain visual analogue scale (VAS) assessments. Preliminary
results of nine patients who have completed the primary efficacy end point of week 16 of the study
indicate that ustekinumab is well tolerated and may be effective at improving PPP. Mean PGA
improved from 3.4 to 2.0 (p = 0.01) and DLQI improved from 14.5 to 4.6 (p = 0.03) from week 0
to week 16. Ustekinumab is well tolerated and may be effective at improving clinical outcomes
and quality of life in patients with moderate to severe palmar plantar psoriasis.
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Staphylococcus aureus colonization does not increase the rate of infection among psoriasis
patients using biologic therapy
K Griffith-Bauer,1 CD Varley,1 KL Winthrop,1 A Blauvelt,1 AA Deodhar,1 A Bakke,1 R Vega2 and
BD Ehst1 1 Oregon Health & Science University, Portland, OR and 2 Oregon State Public
Health laboratory, Portland, OR
Staphylococcus aureus colonizes approximately 30% of the general public, although the rate of col-
onization is not well characterized in psoriasis patients, many of whom use biologic therapies that
potentially increase their risk of serious infections. To evaluate the rate of S. aureus colonization,
the risk of serious infection in psoriatics colonized with S. aureus, and the relationship of anti-TNF
therapy with these outcomes, we prospectively enrolled psoriatic patients from the dermatology
clinic at OHSU who were either receiving or being considered for anti-TNF therapy. At enrollment
we assessed patients by culture for S. aureus colonization. We assessed a subset of these patients 3
to 18 months later with follow-up culture and review of medical records to document infectious
events. Of the 147 patients that were enrolled, 79 (54%) were on anti-TNF therapy at baseline. 64
(44%) of the 147 were colonized with S. aureus, of which 8 (13%) had MRSA. Baseline coloniza-
tion rates were not significantly different between anti-TNF users and non-users (49% and 37%,
p=0.12). At follow-up, however, those who were persistently colonized were more likely to be
exposed to anti-TNF agents between enrollment and follow-up, RR = 1.83 (95% CI 0.95 – 3.54, p
= 0.06). 60 patients (41%) developed a total of 90 infections in 108 patient-years of follow-up time.
Most were skin infections (33%), URIs (27%), or LRIs (23%). Persistent S. aureus colonization was
not associated with infection, RR = 0.96 (95% CI 0.63 – 1.46, p = 0.85), nor was anti-TNF therapy,
RR = 1.64 (95% CI 0.19 – 14.13, p = 1.00).
519
Disseminated granuloma annulare: Successful anti-TNF-alpha treatment with adalimumab.
A case series in 6 patients: clinical course and immunohistochemistry
RE Schopf and E Peresics Dermatology, Johannes Gutenberg Univ., Mainz, Germany
Disseminated granuloma annulare, a necrobiotic granulomatous dermatitis degrading collagen, is
difficult to treat. Its pathogenesis is not well understood. We report the successful anti-TNF treat-
ment of 6 patients with adalimumab; moreover, we examined biopsies before and after 12 weeks’
treatment by immunohistology; no such studies have been reported previously. In an open label
study female patients aged 50 to 68 years were treated subcutaneously with an initial dose of adal-
imumab of 80 mg followed by 40 mg after one week and 40 mg every other week. Biopsies of skin
lesions were taken before treatment and after 12 weeks and stained with H&E, anti-CD3, -CD4, -
CD8, -CD54 (ICAM-1), -HLA-DR (MHC class-II), -CD1a, and –CD163 (activated macrophages)
and evaluated microscopically. Skin lesions were photographed at weeks 0 and 12. We found a dra-
matic improvement of skin lesions in all patients studied. Before treatment there was an increase in
all immunohistological markers, the most consistent strongest staining occurred with anti-CD54, -
HLA-DR and –CD163. Clearing of skin lesions was accompanied with a varying decrease of CD3,
CD4, CD8 and CD1a; however, there was a massive decrease of CD54, HLA-DR and CD163 after
treatment in all patients. We conclude that the clearing of disseminated granuloma annulare by
adalimumab therapy is accompanied by a dramtatic reduction of cellular inflammatory markers
most notably ICAM-1, HLA class II and activated macrophages. This suggests that the necrobiotic
inflammation in disseminated granuloma annulare TNF-alpha-driven. Anti-TNF-alpha treatment
should be considered as first choice for disseminated granuloma annulare.
521
Collagen deposition during the early phase of remodeling is similar in young and aged human
skin
L Rittié, JS Orringer, DL Sachs, JJ Voorhees and GJ Fisher Dermatology, University of Michigan,
Ann Arbor, MI
Wound healing reaction comprises three phases, namely inflammatory, proliferative, and remod-
eling phases. The later phase involves deposition of collagen fibrils in the wound site (first month),
assembly, and maturation of collagen fibers (can continue for several years). Scarring, which results
from excess production and abnormal organization of collagen fibers, is commonly less in aged vs
young skin. Molecular mechanisms underlying this difference are largely unknown. Since collagen
production declines with aging, we asked whether reduced collagen production during the depo-
sition phase of wound healing contributes to less scarring in aged skin. Partial thickness wounds
were generated on forearms of six healthy young (<40 yo) and aged (>70 yo) individuals by CO2
laser, which reproducibly ablates the epidermis and the papillary dermis. Collagen synthesis was
assessed by measurement of procollagen in skin biopsies taken 1, 2, 3, and 4 weeks post-wound-
ing. Analyses of unwounded skin showed that procollagen levels are reduced (77±9%, n=6, p<0.05)
in aged vs young skin. Interestingly, we observed that collagen production is induced to a greater
extent in aged vs young skin (31-fold vs 5.6-fold, n=6, p<0.05) during wound repair. This enhanced
stimulation of collagen production in aged skin resulted in similar amounts of new collagen pro-
duction in aged and young skin during the first month of wound repair. Consistent results were
obtained using multiple methods including laser capture microdissection-coupled real-time RT-PCR,
immunohistochemistry, and ELISA. Our data demonstrate that in spite of low collagen levels prior
to wounding, aged skin is able to produce sufficient amounts of collagen during wound repair, sim-
ilar to levels produced in young skin. The biochemical basis of reduced scar formation observed in
the elderly does not derive from decreased deposition of collagen in the wound site. Our data sug-
gest that collagen fiber remodeling, which occurs during the later stage of wound repair, may dif-
fer between young and aged human skin.
520
The histone deacetylase inhibitor, romidepsin, suppresses in vivo immune functions of cuta-
neous T-cell lymphoma patients
MJ Kelly-Sell,1 B Benoit,1 YH Kim,2 C Harrison,2 K Sutherland,2 LC Showe,3 M Wysocka1 and
AH Rook1 1 Dermatology, University of Pennsylvania, Philadelphia, PA, 2 Dermatology,
Stanford University, Palo Alto, CA and 3 The Wistar Institute, Philadelphia, PA
Our previous data suggests that histone deacytelase inhibitors (HDACi), several of which are approved
for cutaneous T-cell lymphoma (CTCL), may suppress the host immune response through poorly
understood mechanisms. As it is desirable to preserve the immune response of patients with CTCL
during therapy, we examined the in vivo effects of the recently approved HDACi, romidepsin, on
the cellular immune functions of CTCL patients. Serial peripheral blood mononuclear cells (PBMC)
were collected from 8 CTCL patients prior to and during 3 months of treatment with IV romidepsin.
Although natural killer (NK) cell cytolytic activity and the ability to upregulate the activation marker
CD69 declined during therapy, culture of cells in vitro with a potent Toll-like receptor (TLR) 7/8
agonist, preserved killing function. Throughout treatment, CD11c+ myeloid dendritic cells remained
stable in numbers, but expression of CD80, a molecule critical for co-stimulating T-cells, was pro-
gressively suppressed on most patients’ cells, and, remained suppressed despite stimulation with a
TLR agonist. An increase of CD25+Hi T-cells, the hallmark of regulatory T-cells, was not observed
during therapy. In conclusion, our in vivo observations demonstrate that romidepsin suppresses
certain functions of NK cells and dendritic cells without generating increased numbers of regula-
tory T-cells. Importantly, we have shown that an immune-stimulating agent, such as a TLR agonist,
is able to partially limit this suppression and activate patient’s cytolytic cells, even after multiple
infusions of romidepsin. This finding supports the use of immunostimulatory agents concurrently
with HDACi in CTCL patients to better preserve the host immune response.
518
Hair growth stimulation by mesenchymal stem cell-derived proteins
C Won,1 J Kim,1 S Chang,1 C Kim,1 B Park2,3 and W Kim4 1 Department of Dermatology, Asan
Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea, 2 Leaders
Clinic, Seoul, Republic of Korea, 3 Division of Stem Cell Research, Prostemics Research
Institute, Seoul, Republic of Korea and 4 Department of Dermatology, Kangbuk Samsung
Hospital, Sungkyunkwan, Seoul, Republic of Korea
Adipose tissue-derived stem cells (ADSCs) produce many kinds of growth factors including insulin-
like growth factor binding protein precursors, vascular endothelial growth factor, hepatocyte growth
factor, platelet-derived growth factor and keratinocyte growth factor. Previously, we reported ADSCs
could promote hair growth in vitro and in the experimental mice. Our results showed that the ADSC-
CM increased the proliferation of the dermal papilla cells (DPCs) and the HaCaT cells. In addition,
ADSC-CM induced the anagen phase and promoted hair growth in the experimental mice as well
as enhanced the elongation of hair shafts in the ex-vivo human hair organ cultures. To elucidate
more solid mechanisms, we investigated these paracrine effects of ADSC derived proteins on human
dermal papilla cells (hDPCs) and outer root sheath cells (hORSCs) further. We found that ADSC
derived proteins can be beneficial for the growth and protection against cytotoxic injury by andro-
gen and reactive oxygen species in hDPCs. Moreover, we treated patients with hair loss using
ADSC derived proteins. A total of 6 male patients (mean age 35.8) with AGA (Hamilton-Norwood
classification type III–V) and 4 female patients with telogen effluvium (mean age 41.8) were recruited.
The changes in total hair count and mean hair diameter were assessed by phototrichogram. We
observed the increases in the total hair count counts in the treated side as compared to the vehicle
treated side after 12 weeks of therapy. Given that adipose tissue derived stem cells (ADSC) are one
of the most accessible sources of mesenchymal stem cells, our findings suggest that ADSC derived
proteins might be clinically feasible therapeutic agents for the treatment of hair loss.
522
Label-free microarray-based protein profiling in human serum
BL Miller,1,2,3 R Sriram,3 AR Yadav,4 S Tobis,5 JA Carter,6 CC Striemer,6 SD Mehta,6 MV Mungillo6
and CR Mace2 1 Dermatology, University of Rochester, Rochester, NY, 2 Biochemistry and
Biophysics, University of Rochester, Rochester, NY, 3 Biomedical Engineering, University of
Rochester, Rochester, NY, 4 Physics, University of Rochester, Rochester, NY, 5 Urology,
University of Rochester, Rochester, NY and 6 Adarza BioSystems, Henrietta, NY
The detection and quantification of proteins in human serum is a critical analytical task in a broad
range of basic research and clinical activities. Traditional protein detection methods (such as the
venerable ELISA assay) require complex experimental protocols and are difficult to multiplex. We
are developing Arrayed Imaging Reflectometry (AIR), a label-free microarray method, as a simple,
sensitive, and quantitative alternative for protein detection. AIR relies on the creation and protein
binding-induced destruction of an antireflective condition on the surface of a silicon chip. We have
previously described the use of AIR for the detection of bacterial proteins; here, we extend the
methodology to the detection of human proteins in serum. We find that AIR is suitable for multi-
plex detection of cytokines and putative cancer biomarkers (including FGF-2 and VEGF) in serum
with limits-of-detection comparable to ELISA assays (low pg/mL). Quantitative performance is a pre-
dictable function of the antibody-antigen binding constant, as measured using complementary tech-
niques.
www.jidonline.org   S87
SID11_Abstracts-5  2/28/11  9:27 AM  Page S87
ABSTRACTS
511
Evaluation of the phototoxicity & photoallergenicity potential of naftifine 2% cream (NAFT-
2)
EJ Pappert and B Hardas Merz Pharmaceuticals, LLC, Greensboro, NC
2 controlled, open-label, blinded studies of UV radiation (UVR) were conducted to evaluate the
phototoxicity & photoallergenicity potential of higher than normal dosing of NAFT-2. Study 1: objec-
tive was to evaluate the phototoxicity potential of NAFT-2 by comparing responses of test sites with
test product alone, test product irradiated & no treatment. The grading scale for erythema responses
ranged from 0=no erythema to 6=intense erythema with sharp borders & edema. The blinded eval-
uator assessed 24 & 48 hr responses to a single dose of UVA & UVB radiation of the skin after 24
hr of occluded exposure to NAFT-2. 34 subjects were enrolled, 1 subject dropped out. There were
no irritation grades >2 & relatively few instances of grade=2 (no difference between NAFT-2 & irra-
diated control). Study 2: objective was to evaluate the photoallergenicity potential of NAFT-2 by
comparing responses of sites with test product alone, test product irradiated with UVR & no treat-
ment. 53 subjects were enrolled. This study consisted of an induction phase, a resting phase & a
challenge phase. The induction phase consisted of 6 duplicate, 24 hr exposures to NAFT-2 in occlu-
sive chambers, 1 site received UV & 1 site received no UV. Duplicate, untreated control sites were
also covered with chambers. Before administration of UV doses, chambers were removed, all sites
were evaluated & a thin film of NAFT-2 was re-applied to 1 of the sites that was treated with NAFT-
2. UVR doses of 3 Minimal Erythema Doses of UVA & UVB were then administered to that site &
1 control site that received an empty chamber. Responses were graded immediately by a blinded
evaluator using the Irritation Response Grading Scale (0=no reaction & 7=large vesiculo-bullous
reaction). The entire procedure was repeated 5X more over 3 weeks. No clinically significant irri-
tation occurred in any of the groups. In this study, NAFT-2 did not show evidence of phototoxicity
or photoallergenicity potential.
512
Evaluation of the sensitization & irritation potential of naftifine 2% cream (NAFT-2) in healthy
human volunteers
B Hardas and EJ Pappert Merz Pharmaceuticals, LLC, Greensboro, NC
The objective of this single-blind, randomized, assessor-blind, controlled study was to evaluate the
sensitization potential & degree of skin irritation of NAFT-2 on intact skin of healthy volunteers.
There were 3 test articles: NAFT-2; positive (pos) irritant control sodium lauryl sulfate 0.05% (w/v),
USP in sterile, distilled water for injection, USP & negative (neg) irritant control, distilled water for
injection, USP. The test articles were applied to the upper outer arms during the induction phase &
on the mid to upper back during the challenge phase. Rechallenges, if necessary, were conducted
2-4 weeks after resolution of the original reactions. The placement of the test articles was random-
ized. The design was based on the Jordan-King modification of the Draize procedure involving
continuous contact time of the test articles during the irritation phase, followed by a rest phase in
which no drug was applied & a challenge phase (48 hrs occluded application of each test article
applied to naïve skin sites; scoring for skin reactions occurred ~30 min, 24, 48 & 72 hrs after patch
removal). 250 subjects enrolled, 242 completed irritation phase & 237 completed challenge phase.
Responses were evaluated by a blinded assessor. The pos & neg controls demonstrated irritation
responses consistent with expectations/historical knowledge. NAFT-2 demonstrated irritation
responses similar to, but slightly greater than the neg irritation control suggesting it has a low propen-
sity for irritation in clinical use. The primary endpoint for the sensitization analysis was the assess-
ment of whether a subject showed a sensitization reaction. One NAFT-2 subject demonstrated a
potential sensitization response in the challenge phase; however, in the re-challenge, no reaction
was observed. The AEs reported were mild to moderate in intensity with no serious AEs. The data
indicate that NAFT-2 would not be considered as a primary sensitizer nor would likely demonstrate
a maximal population rate of 1.5% likelihood for observing sensitization in clinical use.
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The impact of smoking in cutaneous lupus erythematosus and dermatomyositis
EW Piette,1,2 KP Foering,1,2 AY Chang,1,2 J Okawa1,2 and VP Werth1,2 1 Philadelphia Veterans
Affairs Medical Center, Philadelphia, PA and 2 University of PA School of Medicine,
Philadelphia, PA
We investigated the impact of cigarette smoking in cutaneous lupus erythematosus (CLE) and der-
matomyositis (DM). 197 CLE and 52 DM patients were included in this prospective, longitudinal
cohort study. For CLE patients, the CLE Disease Area and Severity Index (CLASI) was used to quan-
tify disease activity and evaluate treatment response. At enrollment, 34% with CLE and 4% with
DM reported being current smokers (p <0.0001). 149 CLE patients had CLASI scores >0 at enroll-
ment, and of these, 63 (42%) were never smokers, 36 (24%) were past, and 50 (34%) were current
smokers. Current smokers had significantly higher median CLASI scores (9.5, R 1-45) than never (7,
R 1-34) or past (6, R 1-34) smokers (p=0.018). Current smokers also had worse quality of life (QoL)
with all Skindex subscales trending higher than never and past smokers. Among 50 CLE patients
treated with antimalarial (AM) monotherapy, 17 were never smokers (34%), 14 (28%) were past,
and 19 (38%) were current smokers. Of this group, current smokers had greater improvement than
never smokers at a follow-up visit after enrollment (p=0.02). Of 57 CLE patients treated with AMs
plus immunomodulator(s), 29 (51%) were never smokers, 9 (16%) were past, and 19 (33%) were
current smokers. Of these 57, current smokers had less improvement than never smokers at a fol-
low-up visit >8 months after enrollment (median CLASI change +3.5 (R -11 to 19) for current; -1 (R
-32 to 11) for never, p=0.04). Additionally, 6 CLE patients quit smoking during this study. Three of
six subjects improved, with a median CLASI change of -4 after smoking cessation (R -11 to -2). Three
of six did not improve, with a median CLASI change of +2 (R 0 to +2) after quitting. In conclusion,
our data suggests cigarette smoking may have a larger impact on disease in our CLE referral popu-
lation, as compared to DM. Additionally, CLE patients who smoke appear to have worse disease,
worse QoL, and are more refractory to therapy when requiring treatment with AMs and at least one
immunomodulator.
515
First-time-in-man, safety/tolerability and pharmacokinetics of ascending oral doses of apremi-
last (APR) in healthy subjects (HS) 
A Wu and M Scheffler Celgene Corporation, Summit, NJ
This was a double-blind, placebo-controlled, randomized, ascending oral dose study to evaluate
the safety/tolerability and preliminary pharmacokinetics (PK) of APR in HS. Daily APR doses of 10,
20, and 40 mg (QD), 80 and 100 mg (BID) were administered to a total of 40 HS. At each of the
dose levels, 6 subjects received APR and 2 received placebo (PLB) in the fasted state. Each subject
received a single daily dose followed by multiple daily doses over a period of 5 days. Serial plasma
and urine samples were collected and concentrations were measured by liquid chromatography
mass spectrometer, and PK parameters were determined using WinNonLin. Twenty-six (65%) sub-
jects reported a total of 64 treatment-emergent adverse events (TEAEs) after APR or PLB dosing. The
majority of TEAEs were mild in severity (55 mild, 9 moderate) and resolved without treatment. The
most frequently reported AEs during the study were headache, nausea, dizziness, and back pain.
There were slight increases in both the frequency of adverse events (AEs) and the number of sub-
jects reporting AEs following APR at the higher doses of 40, 80, and 100 mg/day compared to PLB
and low doses of 10 and 20 mg/day. There were no clinically significant findings on clinical labo-
ratory, vital signs, 12-lead ECGs, or physical exams. The PK of APR was characterized by rapid
absorption, with maximum plasma concentrations (Cmax) occurring at a median tmax of 1-3 hours
(hrs) post all doses. Following Cmax, plasma concentration of APR declined in an apparent bipha-
sic manner. The mean apparent elimination half-life was estimated to be between approximately 5-
7 hrs and steady state was achieved by 24 hrs. There was no accumulation following QD and slight
accumulation following BID dosing. Less than 2 % of APR dose was excreted in the urine over 48-
hr period postdose. Apremilast had an acceptable safety/tolerability profile in HS. APR systemic
exposure (Cmax and AUC) increased in a dose-related manner across the dose range tested. APR
was subject to non-renal clearance mechanisms.
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The immunomodulatory effect of intense pulsed light on acne vulgaris
MM Ali, ML Gonzalez, FS Ruge and RM Porter Dermatology, Cardiff University, Cardiff, United
Kingdom
Current evidence suggests that inflammation plays a key role in the pathogenesis of acne vulgaris.
Matrix metalloproteinases (MMPs) and interleukin (IL-8) have been shown to be prominently upreg-
ulated in inflammatory acne lesions. Curbing the production of these inflammatory mediators may
assist the resolution of acne. Transforming growth factor beta (TGF-β) a key immunomodulatory
cytokine has been demonstrated to prevent cytokine-induced MMP-1 gene expression and inflam-
matory cytokine production through a Smad3-mediated signalling pathway. Furthermore, intense
pulsed light (IPL) a recently introduced acne treatment modality when used for photorejuvenation
enhances the expression of TGF-β1. Therefore, we sought to determine whether IPL induced TGF-
β1 expression plays a role in the resolution of inflammatory acne vulgaris. Punch biopsies were
obtained at baseline and post-IPL treatment (VPL Energist Ultra®; 530-950 nm Settings: 40 Jcm-2,
20x5x15, 2 passes) from 20 patients with mild to moderate inflammatory acne vulgaris. Immuno-
histochemistry was performed on frozen sections to detect the expression of TGF-β1, Smad3, MMP-
1 and IL-8. Immunohistochemical analysis demonstrated a consistent upregulation in the expres-
sion of TGF-β1 and a downregulation in the expression of MMP-1 and IL-8 in the post IPL samples
compared to baseline. Immunolocalisation of Smad3 to the nucleus in the post-IPL samples indi-
cates that IPL not only upregulates expression of TGF-β1, but also activates its signalling. These
findings suggest that TGF-β may be important in promoting resolution of inflammation and pre-
venting matrix degradation in acne vulgaris through a Smad3 mediated pathway. Further studies
are warranted to corroborate these findings.
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Staphylococcus aureus colonization does not increase the rate of infection among psoriasis
patients using biologic therapy
K Griffith-Bauer,1 CD Varley,1 KL Winthrop,1 A Blauvelt,1 AA Deodhar,1 A Bakke,1 R Vega2 and
BD Ehst1 1 Oregon Health & Science University, Portland, OR and 2 Oregon State Public
Health laboratory, Portland, OR
Staphylococcus aureus colonizes approximately 30% of the general public, although the rate of col-
onization is not well characterized in psoriasis patients, many of whom use biologic therapies that
potentially increase their risk of serious infections. To evaluate the rate of S. aureus colonization,
the risk of serious infection in psoriatics colonized with S. aureus, and the relationship of anti-TNF
therapy with these outcomes, we prospectively enrolled psoriatic patients from the dermatology
clinic at OHSU who were either receiving or being considered for anti-TNF therapy. At enrollment
we assessed patients by culture for S. aureus colonization. We assessed a subset of these patients 3
to 18 months later with follow-up culture and review of medical records to document infectious
events. Of the 147 patients that were enrolled, 79 (54%) were on anti-TNF therapy at baseline. 64
(44%) of the 147 were colonized with S. aureus, of which 8 (13%) had MRSA. Baseline coloniza-
tion rates were not significantly different between anti-TNF users and non-users (49% and 37%,
p=0.12). At follow-up, however, those who were persistently colonized were more likely to be
exposed to anti-TNF agents between enrollment and follow-up, RR = 1.83 (95% CI 0.95 – 3.54, p
= 0.06). 60 patients (41%) developed a total of 90 infections in 108 patient-years of follow-up time.
Most were skin infections (33%), URIs (27%), or LRIs (23%). Persistent S. aureus colonization was
not associated with infection, RR = 0.96 (95% CI 0.63 – 1.46, p = 0.85), nor was anti-TNF therapy,
RR = 1.64 (95% CI 0.19 – 14.13, p = 1.00).
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Disseminated granuloma annulare: Successful anti-TNF-alpha treatment with adalimumab.
A case series in 6 patients: clinical course and immunohistochemistry
RE Schopf and E Peresics Dermatology, Johannes Gutenberg Univ., Mainz, Germany
Disseminated granuloma annulare, a necrobiotic granulomatous dermatitis degrading collagen, is
difficult to treat. Its pathogenesis is not well understood. We report the successful anti-TNF treat-
ment of 6 patients with adalimumab; moreover, we examined biopsies before and after 12 weeks’
treatment by immunohistology; no such studies have been reported previously. In an open label
study female patients aged 50 to 68 years were treated subcutaneously with an initial dose of adal-
imumab of 80 mg followed by 40 mg after one week and 40 mg every other week. Biopsies of skin
lesions were taken before treatment and after 12 weeks and stained with H&E, anti-CD3, -CD4, -
CD8, -CD54 (ICAM-1), -HLA-DR (MHC class-II), -CD1a, and –CD163 (activated macrophages)
and evaluated microscopically. Skin lesions were photographed at weeks 0 and 12. We found a dra-
matic improvement of skin lesions in all patients studied. Before treatment there was an increase in
all immunohistological markers, the most consistent strongest staining occurred with anti-CD54, -
HLA-DR and –CD163. Clearing of skin lesions was accompanied with a varying decrease of CD3,
CD4, CD8 and CD1a; however, there was a massive decrease of CD54, HLA-DR and CD163 after
treatment in all patients. We conclude that the clearing of disseminated granuloma annulare by
adalimumab therapy is accompanied by a dramtatic reduction of cellular inflammatory markers
most notably ICAM-1, HLA class II and activated macrophages. This suggests that the necrobiotic
inflammation in disseminated granuloma annulare TNF-alpha-driven. Anti-TNF-alpha treatment
should be considered as first choice for disseminated granuloma annulare.
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Collagen deposition during the early phase of remodeling is similar in young and aged human
skin
L Rittié, JS Orringer, DL Sachs, JJ Voorhees and GJ Fisher Dermatology, University of Michigan,
Ann Arbor, MI
Wound healing reaction comprises three phases, namely inflammatory, proliferative, and remod-
eling phases. The later phase involves deposition of collagen fibrils in the wound site (first month),
assembly, and maturation of collagen fibers (can continue for several years). Scarring, which results
from excess production and abnormal organization of collagen fibers, is commonly less in aged vs
young skin. Molecular mechanisms underlying this difference are largely unknown. Since collagen
production declines with aging, we asked whether reduced collagen production during the depo-
sition phase of wound healing contributes to less scarring in aged skin. Partial thickness wounds
were generated on forearms of six healthy young (<40 yo) and aged (>70 yo) individuals by CO2
laser, which reproducibly ablates the epidermis and the papillary dermis. Collagen synthesis was
assessed by measurement of procollagen in skin biopsies taken 1, 2, 3, and 4 weeks post-wound-
ing. Analyses of unwounded skin showed that procollagen levels are reduced (77±9%, n=6, p<0.05)
in aged vs young skin. Interestingly, we observed that collagen production is induced to a greater
extent in aged vs young skin (31-fold vs 5.6-fold, n=6, p<0.05) during wound repair. This enhanced
stimulation of collagen production in aged skin resulted in similar amounts of new collagen pro-
duction in aged and young skin during the first month of wound repair. Consistent results were
obtained using multiple methods including laser capture microdissection-coupled real-time RT-PCR,
immunohistochemistry, and ELISA. Our data demonstrate that in spite of low collagen levels prior
to wounding, aged skin is able to produce sufficient amounts of collagen during wound repair, sim-
ilar to levels produced in young skin. The biochemical basis of reduced scar formation observed in
the elderly does not derive from decreased deposition of collagen in the wound site. Our data sug-
gest that collagen fiber remodeling, which occurs during the later stage of wound repair, may dif-
fer between young and aged human skin.
520
The histone deacetylase inhibitor, romidepsin, suppresses in vivo immune functions of cuta-
neous T-cell lymphoma patients
MJ Kelly-Sell,1 B Benoit,1 YH Kim,2 C Harrison,2 K Sutherland,2 LC Showe,3 M Wysocka1 and
AH Rook1 1 Dermatology, University of Pennsylvania, Philadelphia, PA, 2 Dermatology,
Stanford University, Palo Alto, CA and 3 The Wistar Institute, Philadelphia, PA
Our previous data suggests that histone deacytelase inhibitors (HDACi), several of which are approved
for cutaneous T-cell lymphoma (CTCL), may suppress the host immune response through poorly
understood mechanisms. As it is desirable to preserve the immune response of patients with CTCL
during therapy, we examined the in vivo effects of the recently approved HDACi, romidepsin, on
the cellular immune functions of CTCL patients. Serial peripheral blood mononuclear cells (PBMC)
were collected from 8 CTCL patients prior to and during 3 months of treatment with IV romidepsin.
Although natural killer (NK) cell cytolytic activity and the ability to upregulate the activation marker
CD69 declined during therapy, culture of cells in vitro with a potent Toll-like receptor (TLR) 7/8
agonist, preserved killing function. Throughout treatment, CD11c+ myeloid dendritic cells remained
stable in numbers, but expression of CD80, a molecule critical for co-stimulating T-cells, was pro-
gressively suppressed on most patients’ cells, and, remained suppressed despite stimulation with a
TLR agonist. An increase of CD25+Hi T-cells, the hallmark of regulatory T-cells, was not observed
during therapy. In conclusion, our in vivo observations demonstrate that romidepsin suppresses
certain functions of NK cells and dendritic cells without generating increased numbers of regula-
tory T-cells. Importantly, we have shown that an immune-stimulating agent, such as a TLR agonist,
is able to partially limit this suppression and activate patient’s cytolytic cells, even after multiple
infusions of romidepsin. This finding supports the use of immunostimulatory agents concurrently
with HDACi in CTCL patients to better preserve the host immune response.
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Hair growth stimulation by mesenchymal stem cell-derived proteins
C Won,1 J Kim,1 S Chang,1 C Kim,1 B Park2,3 and W Kim4 1 Department of Dermatology, Asan
Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea, 2 Leaders
Clinic, Seoul, Republic of Korea, 3 Division of Stem Cell Research, Prostemics Research
Institute, Seoul, Republic of Korea and 4 Department of Dermatology, Kangbuk Samsung
Hospital, Sungkyunkwan, Seoul, Republic of Korea
Adipose tissue-derived stem cells (ADSCs) produce many kinds of growth factors including insulin-
like growth factor binding protein precursors, vascular endothelial growth factor, hepatocyte growth
factor, platelet-derived growth factor and keratinocyte growth factor. Previously, we reported ADSCs
could promote hair growth in vitro and in the experimental mice. Our results showed that the ADSC-
CM increased the proliferation of the dermal papilla cells (DPCs) and the HaCaT cells. In addition,
ADSC-CM induced the anagen phase and promoted hair growth in the experimental mice as well
as enhanced the elongation of hair shafts in the ex-vivo human hair organ cultures. To elucidate
more solid mechanisms, we investigated these paracrine effects of ADSC derived proteins on human
dermal papilla cells (hDPCs) and outer root sheath cells (hORSCs) further. We found that ADSC
derived proteins can be beneficial for the growth and protection against cytotoxic injury by andro-
gen and reactive oxygen species in hDPCs. Moreover, we treated patients with hair loss using
ADSC derived proteins. A total of 6 male patients (mean age 35.8) with AGA (Hamilton-Norwood
classification type III–V) and 4 female patients with telogen effluvium (mean age 41.8) were recruited.
The changes in total hair count and mean hair diameter were assessed by phototrichogram. We
observed the increases in the total hair count counts in the treated side as compared to the vehicle
treated side after 12 weeks of therapy. Given that adipose tissue derived stem cells (ADSC) are one
of the most accessible sources of mesenchymal stem cells, our findings suggest that ADSC derived
proteins might be clinically feasible therapeutic agents for the treatment of hair loss.
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Label-free microarray-based protein profiling in human serum
BL Miller,1,2,3 R Sriram,3 AR Yadav,4 S Tobis,5 JA Carter,6 CC Striemer,6 SD Mehta,6 MV Mungillo6
and CR Mace2 1 Dermatology, University of Rochester, Rochester, NY, 2 Biochemistry and
Biophysics, University of Rochester, Rochester, NY, 3 Biomedical Engineering, University of
Rochester, Rochester, NY, 4 Physics, University of Rochester, Rochester, NY, 5 Urology,
University of Rochester, Rochester, NY and 6 Adarza BioSystems, Henrietta, NY
The detection and quantification of proteins in human serum is a critical analytical task in a broad
range of basic research and clinical activities. Traditional protein detection methods (such as the
venerable ELISA assay) require complex experimental protocols and are difficult to multiplex. We
are developing Arrayed Imaging Reflectometry (AIR), a label-free microarray method, as a simple,
sensitive, and quantitative alternative for protein detection. AIR relies on the creation and protein
binding-induced destruction of an antireflective condition on the surface of a silicon chip. We have
previously described the use of AIR for the detection of bacterial proteins; here, we extend the
methodology to the detection of human proteins in serum. We find that AIR is suitable for multi-
plex detection of cytokines and putative cancer biomarkers (including FGF-2 and VEGF) in serum
with limits-of-detection comparable to ELISA assays (low pg/mL). Quantitative performance is a pre-
dictable function of the antibody-antigen binding constant, as measured using complementary tech-
niques.
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Evaluation of the phototoxicity & photoallergenicity potential of naftifine 2% cream (NAFT-
2)
EJ Pappert and B Hardas Merz Pharmaceuticals, LLC, Greensboro, NC
2 controlled, open-label, blinded studies of UV radiation (UVR) were conducted to evaluate the
phototoxicity & photoallergenicity potential of higher than normal dosing of NAFT-2. Study 1: objec-
tive was to evaluate the phototoxicity potential of NAFT-2 by comparing responses of test sites with
test product alone, test product irradiated & no treatment. The grading scale for erythema responses
ranged from 0=no erythema to 6=intense erythema with sharp borders & edema. The blinded eval-
uator assessed 24 & 48 hr responses to a single dose of UVA & UVB radiation of the skin after 24
hr of occluded exposure to NAFT-2. 34 subjects were enrolled, 1 subject dropped out. There were
no irritation grades >2 & relatively few instances of grade=2 (no difference between NAFT-2 & irra-
diated control). Study 2: objective was to evaluate the photoallergenicity potential of NAFT-2 by
comparing responses of sites with test product alone, test product irradiated with UVR & no treat-
ment. 53 subjects were enrolled. This study consisted of an induction phase, a resting phase & a
challenge phase. The induction phase consisted of 6 duplicate, 24 hr exposures to NAFT-2 in occlu-
sive chambers, 1 site received UV & 1 site received no UV. Duplicate, untreated control sites were
also covered with chambers. Before administration of UV doses, chambers were removed, all sites
were evaluated & a thin film of NAFT-2 was re-applied to 1 of the sites that was treated with NAFT-
2. UVR doses of 3 Minimal Erythema Doses of UVA & UVB were then administered to that site &
1 control site that received an empty chamber. Responses were graded immediately by a blinded
evaluator using the Irritation Response Grading Scale (0=no reaction & 7=large vesiculo-bullous
reaction). The entire procedure was repeated 5X more over 3 weeks. No clinically significant irri-
tation occurred in any of the groups. In this study, NAFT-2 did not show evidence of phototoxicity
or photoallergenicity potential.
512
Evaluation of the sensitization & irritation potential of naftifine 2% cream (NAFT-2) in healthy
human volunteers
B Hardas and EJ Pappert Merz Pharmaceuticals, LLC, Greensboro, NC
The objective of this single-blind, randomized, assessor-blind, controlled study was to evaluate the
sensitization potential & degree of skin irritation of NAFT-2 on intact skin of healthy volunteers.
There were 3 test articles: NAFT-2; positive (pos) irritant control sodium lauryl sulfate 0.05% (w/v),
USP in sterile, distilled water for injection, USP & negative (neg) irritant control, distilled water for
injection, USP. The test articles were applied to the upper outer arms during the induction phase &
on the mid to upper back during the challenge phase. Rechallenges, if necessary, were conducted
2-4 weeks after resolution of the original reactions. The placement of the test articles was random-
ized. The design was based on the Jordan-King modification of the Draize procedure involving
continuous contact time of the test articles during the irritation phase, followed by a rest phase in
which no drug was applied & a challenge phase (48 hrs occluded application of each test article
applied to naïve skin sites; scoring for skin reactions occurred ~30 min, 24, 48 & 72 hrs after patch
removal). 250 subjects enrolled, 242 completed irritation phase & 237 completed challenge phase.
Responses were evaluated by a blinded assessor. The pos & neg controls demonstrated irritation
responses consistent with expectations/historical knowledge. NAFT-2 demonstrated irritation
responses similar to, but slightly greater than the neg irritation control suggesting it has a low propen-
sity for irritation in clinical use. The primary endpoint for the sensitization analysis was the assess-
ment of whether a subject showed a sensitization reaction. One NAFT-2 subject demonstrated a
potential sensitization response in the challenge phase; however, in the re-challenge, no reaction
was observed. The AEs reported were mild to moderate in intensity with no serious AEs. The data
indicate that NAFT-2 would not be considered as a primary sensitizer nor would likely demonstrate
a maximal population rate of 1.5% likelihood for observing sensitization in clinical use.
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The impact of smoking in cutaneous lupus erythematosus and dermatomyositis
EW Piette,1,2 KP Foering,1,2 AY Chang,1,2 J Okawa1,2 and VP Werth1,2 1 Philadelphia Veterans
Affairs Medical Center, Philadelphia, PA and 2 University of PA School of Medicine,
Philadelphia, PA
We investigated the impact of cigarette smoking in cutaneous lupus erythematosus (CLE) and der-
matomyositis (DM). 197 CLE and 52 DM patients were included in this prospective, longitudinal
cohort study. For CLE patients, the CLE Disease Area and Severity Index (CLASI) was used to quan-
tify disease activity and evaluate treatment response. At enrollment, 34% with CLE and 4% with
DM reported being current smokers (p <0.0001). 149 CLE patients had CLASI scores >0 at enroll-
ment, and of these, 63 (42%) were never smokers, 36 (24%) were past, and 50 (34%) were current
smokers. Current smokers had significantly higher median CLASI scores (9.5, R 1-45) than never (7,
R 1-34) or past (6, R 1-34) smokers (p=0.018). Current smokers also had worse quality of life (QoL)
with all Skindex subscales trending higher than never and past smokers. Among 50 CLE patients
treated with antimalarial (AM) monotherapy, 17 were never smokers (34%), 14 (28%) were past,
and 19 (38%) were current smokers. Of this group, current smokers had greater improvement than
never smokers at a follow-up visit after enrollment (p=0.02). Of 57 CLE patients treated with AMs
plus immunomodulator(s), 29 (51%) were never smokers, 9 (16%) were past, and 19 (33%) were
current smokers. Of these 57, current smokers had less improvement than never smokers at a fol-
low-up visit >8 months after enrollment (median CLASI change +3.5 (R -11 to 19) for current; -1 (R
-32 to 11) for never, p=0.04). Additionally, 6 CLE patients quit smoking during this study. Three of
six subjects improved, with a median CLASI change of -4 after smoking cessation (R -11 to -2). Three
of six did not improve, with a median CLASI change of +2 (R 0 to +2) after quitting. In conclusion,
our data suggests cigarette smoking may have a larger impact on disease in our CLE referral popu-
lation, as compared to DM. Additionally, CLE patients who smoke appear to have worse disease,
worse QoL, and are more refractory to therapy when requiring treatment with AMs and at least one
immunomodulator.
515
First-time-in-man, safety/tolerability and pharmacokinetics of ascending oral doses of apremi-
last (APR) in healthy subjects (HS) 
A Wu and M Scheffler Celgene Corporation, Summit, NJ
This was a double-blind, placebo-controlled, randomized, ascending oral dose study to evaluate
the safety/tolerability and preliminary pharmacokinetics (PK) of APR in HS. Daily APR doses of 10,
20, and 40 mg (QD), 80 and 100 mg (BID) were administered to a total of 40 HS. At each of the
dose levels, 6 subjects received APR and 2 received placebo (PLB) in the fasted state. Each subject
received a single daily dose followed by multiple daily doses over a period of 5 days. Serial plasma
and urine samples were collected and concentrations were measured by liquid chromatography
mass spectrometer, and PK parameters were determined using WinNonLin. Twenty-six (65%) sub-
jects reported a total of 64 treatment-emergent adverse events (TEAEs) after APR or PLB dosing. The
majority of TEAEs were mild in severity (55 mild, 9 moderate) and resolved without treatment. The
most frequently reported AEs during the study were headache, nausea, dizziness, and back pain.
There were slight increases in both the frequency of adverse events (AEs) and the number of sub-
jects reporting AEs following APR at the higher doses of 40, 80, and 100 mg/day compared to PLB
and low doses of 10 and 20 mg/day. There were no clinically significant findings on clinical labo-
ratory, vital signs, 12-lead ECGs, or physical exams. The PK of APR was characterized by rapid
absorption, with maximum plasma concentrations (Cmax) occurring at a median tmax of 1-3 hours
(hrs) post all doses. Following Cmax, plasma concentration of APR declined in an apparent bipha-
sic manner. The mean apparent elimination half-life was estimated to be between approximately 5-
7 hrs and steady state was achieved by 24 hrs. There was no accumulation following QD and slight
accumulation following BID dosing. Less than 2 % of APR dose was excreted in the urine over 48-
hr period postdose. Apremilast had an acceptable safety/tolerability profile in HS. APR systemic
exposure (Cmax and AUC) increased in a dose-related manner across the dose range tested. APR
was subject to non-renal clearance mechanisms.
516
The immunomodulatory effect of intense pulsed light on acne vulgaris
MM Ali, ML Gonzalez, FS Ruge and RM Porter Dermatology, Cardiff University, Cardiff, United
Kingdom
Current evidence suggests that inflammation plays a key role in the pathogenesis of acne vulgaris.
Matrix metalloproteinases (MMPs) and interleukin (IL-8) have been shown to be prominently upreg-
ulated in inflammatory acne lesions. Curbing the production of these inflammatory mediators may
assist the resolution of acne. Transforming growth factor beta (TGF-β) a key immunomodulatory
cytokine has been demonstrated to prevent cytokine-induced MMP-1 gene expression and inflam-
matory cytokine production through a Smad3-mediated signalling pathway. Furthermore, intense
pulsed light (IPL) a recently introduced acne treatment modality when used for photorejuvenation
enhances the expression of TGF-β1. Therefore, we sought to determine whether IPL induced TGF-
β1 expression plays a role in the resolution of inflammatory acne vulgaris. Punch biopsies were
obtained at baseline and post-IPL treatment (VPL Energist Ultra®; 530-950 nm Settings: 40 Jcm-2,
20x5x15, 2 passes) from 20 patients with mild to moderate inflammatory acne vulgaris. Immuno-
histochemistry was performed on frozen sections to detect the expression of TGF-β1, Smad3, MMP-
1 and IL-8. Immunohistochemical analysis demonstrated a consistent upregulation in the expres-
sion of TGF-β1 and a downregulation in the expression of MMP-1 and IL-8 in the post IPL samples
compared to baseline. Immunolocalisation of Smad3 to the nucleus in the post-IPL samples indi-
cates that IPL not only upregulates expression of TGF-β1, but also activates its signalling. These
findings suggest that TGF-β may be important in promoting resolution of inflammation and pre-
venting matrix degradation in acne vulgaris through a Smad3 mediated pathway. Further studies
are warranted to corroborate these findings.
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Sensitization to benzalkonium chloride and benzethonium chloride
H Dao,1 ST Nedorost1,3 and C Fricker2 1 Department of Dermatology, University Hospitals Case
Medical Center, Cleveland, OH, 2 GOJO Industries, Inc., Akron, OH and 3 School of
Medicine, Case Western Reserve University, Cleveland, OH
The purpose of our study was to determine the prevalence of relevant and irrelevant positive patch
tests to benzalkonium chloride (BAK) and benzethonium chloride (BEC), in patients suspected of
having allergic contact dermatitis (ACD). We also sought to find optimal patch test concentrations
and vehicles for patch testing. In this single-center trial, 142 patients undergoing routine patch test-
ing were enrolled to undergo additional patch testing to a series of BAK 0.15% aqueous (aq), BAK
0.15% petrolatum (pet), BEC 0.15% aq, and BEC 0.5% aq. BAK 0.1% aq was already included in
the standard screening series. Early and late patch test readings were performed at 48-96 hours and
7 days, respectively. Avoidance of suspected allergens was advised, and a 1-month follow-up visit
scheduled. 20% of study subjects had a doubtful or 1+ reaction at patch test readings. Long-term
phone call follow-up with patients with doubtful, irritant, or positive patch test reactions to BAK
and/or BEC helped to categorize patients into three categories: definite ACD to BAK/BEC (n=1),
possible ACD to BAK/BEC (n=13), and unlikely ACD to BAK/BEC (n=15). The most frequent causative
agents in patients with definite or possible ACD to BAK/BEC were cleansing wipes and eye drops.
In this subgroup, 4 patients reacted only to BAK 0.15% pet of the study tray, and BAK 0.1% aq iden-
tified only 8% of patients in this subgroup. Reactions to BEC occurred in 61.5% of patients with
possible ACD to BAK/BEC, with 75% of them having co-reactions with BAK. Though rare, sensiti-
zation to BAK and BEC occurs. Co-reaction to BEC should be assumed if BAK sensitization is pres-
ent. Adding BAK in a petrolatum vehicle and replacing BAK 0.1% aq with BAK 0.15% aq can increase
the sensitivity of identifying patients with BAK sensitization. Extended clinical follow-up is neces-
sary to determine relevance. Any reaction present at the day 7 read may in fact be allergic even if
interpreted as irritant based on morphology or decrescendo pattern.
531
Disposition, metabolism and mass balance of [14C]apremilast following oral administration 
M Hoffmann,1 G Kumar,1 P Schafer,1 D Cedzik,1 L Capone,1 K Fong,2 Z Gu,3 D Heller,3 H Feng,3
S Surapaneni,1 O Laskin1 and A Wu1 1 Celgene Corporation, Summit, NJ, 2 Accellient Partners
LLC, Berkeley, CA and 3 XenoBiotic Laboratories, Plainsboro, NJ
Apremilast is a novel, orally available small molecule that specifically inhibits PDE4 and thus mod-
ulates multiple pro- and anti-inflammatory mediators. Apremilast is currently under clinical devel-
opment for the treatment of psoriasis, psoriatic arthritis, and rheumatoid arthritis. The pharmacoki-
netics, metabolism and excretion of [14C]apremilast were investigated following a single oral
suspension dose (20 mg, 100 μCi) to six healthy male subjects. Mean maximum plasma concen-
trations (Cmax), area under the plasma concentration-time curve (AUC0-∞), time to maximum plasma
concentration (tmax) and terminal elimination half-life (t½) values for apremilast in plasma were
333 ng/mL, 1970 ng*hr/mL, 1.5 hr and 6.8 hr. Approximately 58% of the radioactive dose was
excreted in urine, while feces contained 39% of the radioactive dose. Apremilast was extensively
metabolized via multiple metabolic pathways, with unchanged drug representing 45% of the cir-
culating radioactivity and less than 7% of the excreted radioactivity. O-Demethylation followed by
glucuronidation was the major metabolic pathway for apremilast, with the O-demethyl glucuronide
metabolite representing 39% of the plasma radioactivity and accounting for 34% of the excreted
radioactivity. The only other radioactive components that represented >4% of the excreted radioac-
tivity were O-demethylated apremilast and its hydrolysis product. Additional minor circulating and
excreted compounds were formed via O-demethylation, O-deethylation, N-deacetylation, hydrox-
ylation, glucuronidation, and/or hydrolysis. In conclusion, metabolic clearance of apremilast was
the major route of elimination, while non-enzymatic hydrolysis and excretion of unchanged drug
were involved to a lesser extent.
533
Hair follicle organ culture combined with cytotoxic lymphocytes yields a novel bioassay for
screening drugs for immune mediated hair disorders
P Singh,1 L Xing,2 C Higgins,1 R Clynes2 and AM Christiano1 1 Department of Dermatology,
Columbia University College of Physicians and Surgeons, New York, NY and 2 Department of
Medicine, Columbia University College of Physicians and Surgeons, New York, NY
Hair follicle (HF) organ culture is an established technique, routinely used to assess the growth
parameters of the hair shaft under differential conditions and to assess drug efficacy ex vivo. Like-
wise, target-effecter cell co-culture is classically used to test immune mediated cytotoxicity in vitro.
We hypothesize that autoimmune disorders are precipitated by inflammation-induced expression
of ‘danger signals’ such as MHC-I and NKG2D ligands on an otherwise immune privileged HF sur-
face which recruit the cytotoxic cells to the follicle, mediating immune infiltration and HF dystro-
phy as seen in Alopecia Areata (AA). To test this, we devised a novel methodology to assay a tar-
geted cytolytic response against organ cultured HFs in 3D in the presence of inflammatory cytokines:
IFNγ, TNFα and TLR ligands (LPS and dI:dC). These treatments induced surface expression of NKG2D
ligands as shown by elevated expression of MICA, ULBP3 and pan-NKG2D ligand in the dermal
sheath (DS) layer. Incubation of the treated HFs with LAK (lymphokine activated killer) cells caused
greater lymphocytic recruitment to the follicular surface and higher level of apoptosis in the DS layer
as shown by TUNEL staining. The specificity of this interaction was assessed using lactate dehy-
drogenase release based cytotoxicity assay using cultured DS cells. The DS cytolysis by LAK cells
was blocked by anti-NKG2D or MHC-I antibodies, thus confirming the dependence of cytotoxic-
ity on these signals. Transcriptional profiling of AA skin has yielded several differentially regulated
signaling pathways which can be further assessed using this co-culture assay. We have demonstrated
that the ex vivo organ cultured HF and LAK cell interaction can be used to screen putative drug tar-
gets for AA as well as other inflammatory diseases of the hair follicle.
532
Administration of vitamin K does not counteract the ectopic mineralization of connective
tissues in Abcc6-/- mice, a model for pseudoxanthoma elasticum
Q Jiang,1 Q Li,1 AE Grand-Pierre,1 LJ Schurgers2 and J Uitto1 1 Department of Dermatology and
Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA and 2 The Cardiovascular
Research Institute and VitaK, University of Maastricht, Maastricht, Netherlands
Pseudoxanthoma elasticum (PXE), a heritable multisystem disorder characterized by ectopic min-
eralization of peripheral connective tissues, is caused by mutations in the ABCC6 gene. Alterations
in vitamin K metabolism have been suggested to contribute to the pathomechanisms of the miner-
alization process through mechanisms that involve γ-glutamyl carboxylation of Gla-proteins serv-
ing as circulating anti-mineralization factors, such as matrix gla-protein. To test the hypothesis that
vitamin K deficiency contributes to ectopic mineralization in PXE, we administered vitamin K or its
glutathione conjugate (K3-GSH) into Abcc6-/- mice, a model system that recapitulates genetic,
histopathologic and ultrastructural features of PXE. Oral administration of vitamin K2 for 8 weeks
in dosages which vastly exceed the amounts in control mouse diet or the recommended doses for
humans did not counteract the ectopic mineralization in Abcc6-/- mice. Similarly, a long term (8
weeks) intravenous administration of K3-GSH did not alter the degree of mineralization in these
mice. Testing of vitamin K2, K3 and K3-GSH in an in vitro calcification system provided no evidence
of mineralization inhibition by these compounds. Collectively, our data suggest that vitamin K defi-
ciency in the peripheral tissues is not a simple explanation for development of mineral deposits in
PXE and that vitamin K intake may not improve the clinical course of PXE in humans, as has been
recently speculated.
530
Crosstalk between UV-induced PI-3 kinase/Akt/mTOR and Fyn/RSK2 signaling pathways:
Implications in skin carcinogenesis
Y Bermudez,1 SP Stratton,1 C Curiel-Lewandrowski,1 J Warneke,1 GT Bowden,1 Z Dong,2
AM Bode,2 CA Hurst,1 JE Lang,1 DS Alberts1 and JG Einspahr1 1 Arizona Cancer Center,
University of Arizona, Tucson, AZ and 2 The Hormel Institute, University of Minnesota, Austin,
MN
Solar ultraviolet (UV) irradiation is the most significant environmental carcinogen leading to the
development of skin tumors. Since the ozone layer blocks UVC, research efforts have focused mainly
on studying the individual effects of UVA- and UVB-induced skin carcinogenesis. However, little
work has been done to determine the effects of solar-simulated light (SSL), both UVA and UVB
together, on the activation of signaling pathways important in cellular regulation. In this study, we
evaluate the modulation of SSL-activated PI-3 kinase/Akt/mTOR and Fyn/RSK2 signaling pathways
in normal human skin and solar simulated light-irradiated human skin to determine the expression
profiles of upstream and downstream phosphorylated proteins p38, p44/42 MAPK, histone H3, RSK-
2, Akt, mTOR, S6 ribosomal protein, Fyn-src, AMPK, and 4E-BP1. SSL irradiation at two to three
times the minimal erythemic dose was applied to unexposed skin. Punch biopsies were taken at
baseline, 5 minutes, 1 h, 5 h, and 24 h post-irradiation and immediately fixed in 10% formalin for
immunohistochemistry analysis. Marked SSL-induced changes in epidermis were seen in the expres-
sion of phosphorylated histone H3, S6 ribosomal protein, and 4E-BP1 at 1 h, 5 h, and 24 h post-
SSL as compared to control. A linear increase in phosphorylated p44/42 MAPK expression was
observed at 1 h, 5 h, and 24 h post-SSL as compared to control. Phosphorylated Akt expression
increased post-SSL, and appears dependent on duration and intensity of SSL exposure. Understanding
the expression profile patterns of phosphorylated proteins in the PI-3 kinase/Akt/mTOR and Fyn/RSK2
pathways during exposure of physiological relevant SSL could lead to the use of these proteins as
specific targets for the prevention and control of skin tumors.
534
T cells in the skin lesions of stage I mycosis fungoides show markedly suppressed cytokine
production
R Watanabe, M Tawa, N Adams, A Dorosario, DC Fisher, TS Kupper and RA Clark The Dana
Farber/Brigham and Women’s Cancer Center, Boston, MA
In mycosis fungoides (MF), malignant T cells are confined to inflammatory skin lesions and are
admixed with benign infiltrating T cells. We recently reported that both malignant benign T cells in
the blood of leukemic CTCL (L-CTCL) patients are markedly Th2 biased, suggesting global bias of
the T cell repertoire. In this study, we isolated T cells from skin lesions of 16 stage I MF patients, 7
L-CTCL patients and the normal skin of seven healthy controls. Cytokine production was analyzed
by intracellular flow cytometry. In 8/16 patients with stage I CTCL, there was marked global sup-
pression of T cell cytokine production, including TNFα, IFNγ, IL-17, IL-4, IL-10, TGFβ, IL-13 and
IL-22 (anergic pattern) compared to T cells from normal skin. In 6/16 patients, production of IFNγ
was markedly increased above normal (Th1 pattern); in these patients, TNFα production approxi-
mated that of T cells from normal skin. T cell cytokine production approximated that observed in
normal skin in only 2/16 MF patients. T cells isolated from L-CTCL skin lesions differed in that high
levels of IL-4 were produced; non-Th2 T cell cytokine production resembled that from MF with com-
parable Th1 levels and global suppression of Th17 cytokines.Two L-CTCL patients treated with alem-
tuzumab showed further enhancement of IFNγ/TNFα production by benign T cells in skin follow-
ing therapy, in agreement with prior studies showing improved Th1 responses following
immunomodulation. In summary, there is significant functional anergy in MF lesional T cells, with
markedly suppressed cytokine production despite the isolation of these T cells from clinically inflamed
skin. In the skin lesions of L-CTCL patients, T cells were Th2 biased, consistent with the pruritus
observed in these patients. Successful treatment with alemtuzumab reversed this Th2 bias and
enhanced Th1 responses but production of IL-17 remained reduced.
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A cross-sectional study of resistin in psoriasis patients
D Kast, N Borkar, I Grozdev, D Carlson, R Feig, P Pujari, D Babineau, E Kern, T McCormick,
K Cooper and N Korman Dermatology, Univ Hospitals Case Med Ctr, Murdough Family Center
for Psoriasis, Cleveland, OH
Psoriasis, a systemic inflammatory disease, has been associated with obesity, metabolic syndrome,
diabetes and CVD. Serum resistin levels are associated with insulin resistance, inflammation, and
atherosclerosis. A cross-sectional study of 202 psoriasis patients and 75 controls without inflam-
matory skin disease showed resistin levels were 45% greater in psoriasis patients than controls (OR
1.45 [95% CI: 1.17, 1.81], p=0.0009). After adjusting for age, gender, race, BMI, smoking, HTN,
HDL, and hsCRP this association remained significant (OR 1.29 [95% CI: 1.03, 1.61], p=0.0269).
In addition, psoriasis severity measured by BSA was associated with increased resistin levels (OR
1.11 [95% CI: 1.01, 1.22], p=0.023). Adjusting for age, gender, race and BMI did not alter the asso-
ciation; adjustment for smoking, HTN, and HDL attenuated this relationship. Psoriatic arthritis was
associated with increased resistin levels after adjusting for age, gender, race, BMI, smoking, HTN,
HDL, and hsCRP (OR 0.76 [95% CI: 0.58, 0.99], p=0.0444). Interestingly, resistin levels of psoria-
sis patients currently on TNF-α inhibitors (n=38) was significantly less than those not currently on
TNF-α inhibitors (n=164) (OR 0.72 [95% CI: 0.54, 0.97], p=0.030). This association was sustained
throughout adjustment for age, gender, race, BMI, smoking, HTN, HDL, and hsCRP (OR 0.75 [95%
CI: 0.56, 0.99], p=0.0497). Our study using a well characterized US psoriasis cohort provides ini-
tial evidence that serum resistin levels are increased in psoriasis patients compared to controls while
adjusting for potential confounding metabolic syndrome variables. Resistin levels were also asso-
ciated with psoriasis severity, BSA, and psoriatic arthritis. Patients treated with TNF-α inhibitors
exhibit statistically significant decreases in serum resistin levels even when accounting for potent
pro-inflammatory molecules including CRP. Resistin, an established metabolic adipokine, reflects
psoriasis severity and may be a crucial link to psoriasis co-morbidities.
524
The degree of correlation between the physician’s global assessment (PGA) and psoriasis
area and severity index (PASI) in randomized controlled trials of biologic agents for moder-
ate to severe plaque psoriasis
AH Robinson, M Kardos and AB Kimball Dermatology, Massachusetts General Hospital,
Boston, MA
The purpose of this study was to determine the degree of correlation between the PASI and PGA
when used in clinical trials of systemic therapies for moderate to severe plaque psoriasis. Follow-
ing the PRISMA guidelines, a literature search was performed to review randomized controlled tri-
als for biologic therapies, phototherapy, cyclosporine, and methotrexate. Papers publishing both the
PASI 75 and PGA 0,1 were included. The percentages of patients achieving the endpoint values
were recorded. The two assessment tools were plotted against each other to obtain the correlation
coefficient. A p-value was obtained using the Pearson Product-Moment Correlation Coefficient. Of
the 123 studies reviewed, 30 trials, all performed between 2001-2010, met inclusion criteria. The
correlation coefficient was 0.9157 for PGA 0,1 and PASI 75 assessments between study weeks 8-
16 (p < 0.01.). The correlation between the tools was tighter for more effective therapies. For stud-
ies with < 25% of patients achieving PASI 75, the correlation coefficient was 0.0612. We conclude
that at least for relatively efficacious therapies (those with at least 25% of patients achieving PASI
75) for moderate to severe psoriasis, the PGA and PASI are redundant. Given that the tools diverge
with decreased therapeutic efficacy, we recommend that both tools be used for phase II studies, but
that the PASI alone should be sufficient for phase III trials of drugs previously proven to be effective
in getting at least 25% of patients to PASI 75.
525
Clinical efficacy of a new natural ingredient that simultaneously addresses multiple facets of
acne pathogenesis
J Guay and B Page Biopharmacopae, Quebec City, QC, Canada
Recent developments in our understanding of acne pathogenesis have involved four main axes:
hyperseborrhea, hyperkeratosis, microbial colonization, and inflammation. Having discovered that
hydro-glycolic extracts prepared from the leaves of a Canadian plant have strong in vitro anti-inflam-
matory, anti-bacterial, and wound healing properties, as well as in vivo anti-inflammatory and anti-
redness effects, we hypothesized that these Canadian plant-derived extracts could be effective in
the treatment of acne. To validate the anti-acne potential of the most promising extract (BDI-35), a
double-blinded, randomized, comparative, exploratory trial was performed on humans. Twelve vol-
unteers (6 women and 6 men) ages 18 to 34 years, suffering from bilateral moderate acne, ran-
domly applied a formulation containing extract BDI-35 (5%) on one hemi-face, the other being
treated with the same formulation without the extract (placebo). Topical application was performed
twice daily for 42 days. Clinical evaluation of the number of both retentional and inflammatory acne
lesions was performed by a trained dermatologist, and high resolution photographs were taken at
T=0, T=28, and T=42 days. The results obtained on visual evaluation of the hemi-faces demonstrate
that the BDI-35 treatment significantly reduces (p<0.05)retentional lesions (closed and opened come-
dones) by 38% and the total number of lesions (including inflammatory lesions) by 31% following
42 days of application compared to T=0; while application of the placebo has no significant effect.
This exploratory study, although based on a small numbers of volunteers, demonstrates that BDI-
35, a specific glycolic extract prepared from the leaves of a Canadian plant, has a significant effect
against acne and is a good candidate as an active ingredient for formulations dedicated to the reduc-
tion of acneic lesions.
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Blood involvement in stage IA Mycosis Fungoides by flow cytometry predicts or is associated
with higher rate of progression
R Talpur,1 L Singh,1 A Shah,1 S Daulat,1 P Liu2 and M Duvic1 1 Dermatology, Univ. of Texas, MD
Anderson Cancer Center, Houston, TX and 2 Biostatistics, Univ. of Texas, MD Anderson
Cancer Center, Houston, TX
Early stage Mycosis fungoides (MF) (T1, IA) has an excellent prognosis compared to Sézary Syn-
drome with a 5.4 year median overall survival (Vidulich et al, Int J Dermatol. 2009;48(3):243-52).
Kim et al found only 10% of IA patients progress. The objectives were to determine the overall, dis-
ease related, and progression free survival of Stage IA MF patients at MD Anderson Cancer Center
studied prospectively between 1982-2009. Blood involvement was defined as B0 < 500; B1 >500;
and B2 >1000 or > 35% CD4+CD26- cells. Method of Kaplan and Meier estimated median over-
all survival (OS), disease free (DFS) and progression-free survival (PFS). Cox’s proportional hazards
regression model tested the statistical significance of potential prognostic factors. At initial staging,
522 of 1263 (41.3%) were T1 (IA). Thirty-four died and median OS was not reached. Only 2% (10
of 43) of deaths were attributable to MF; DFS was not reached. Forty-three patients (8.2%) pro-
gressed; 476 (91.2%) remained as stage IA with 3 lost to follow up. Older age at diagnosis and
black race were significantly associated with reduced OS and PFS. Twelve of 490 IA patients (2.4%)
had baseline flow cytometry; ten were B1 and two were B2. Nine patients were T1a (patch) and 3,
including the two B2 patients, were T1b (patch and plaque). Four with initial blood involvement
progressed to higher stages including two with folliculotropic MF dead from disease. Both IA/B2
patients progressed to SS. One after complete durable response to CD4 antibody relapsed with IVB
CNS involvement. In summary, 4 of 12 IA patients (33%) with baseline blood involvement pro-
gressed compared to a 6% (31/510) rate of progression in IA-B0 patients. In conclusion, although
the incidence of peripheral blood involvement detected at baseline by flow in stage IA patients is
quite low (2%), flow may still be helpful as a biomarker to identify patients who are more likely to
progress to SS or die from their disease.
527
Evaluation of itch and pain as presenting symptoms in non-melanoma skin cancer
KC Mills,2 AN Feneran,1 A Zeitany,1 HL Tey,1 A Lee,1 OP Sangüeza,1,2 P Williford,1 D Pearce1 and
G Yosipovitch1 1 Dermatology, Wake Forest University Baptist Medical Center, Winston-Salem,
NC and 2 Pathology, Wake Forest University Baptist Medical Center, Winston-Salem, NC
Itch and pain are common complaints in dermatology clinics, however, the data on the frequency
of itch and pain in skin tumors is sparse. Previous investigators have demonstrated that itch is com-
mon in both basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). To our knowledge,
pain has not been examined as an endpoint presenting feature of non-melanoma skin cancer (NMSC).
In this study we examine the prevalence of both itch and pain at the time of diagnosis in NMSC.
This study includes 314 skin neoplasms and is part of a larger investigation of approximately 1000
cutaneous tumors designed to examine the correlation of the aforementioned symptoms with can-
cer subtype, tumor size, tumor location, and several histologic features including the amount and
type of inflammation, the presence of perineural invasion, and the presence of lymphovascular inva-
sion. Participants were recruited from the patient population presenting to the department of der-
matologic surgery at Wake Forest University Baptist Medical Center. The subjects were asked via
visual analog scale to identify their perceived initial symptoms of both itch and pain. For the pur-
poses of exploratory analysis, 211 BCCs and 103 SCCs were included in this substudy. Itch in the
absence of pain was reported in 22% of all examined BCCs and in 21% of all examined SCCs. Pain
in the absence of itch was reported in 9% of all examined BCCs and in 18% of all examined SCCs.
The symptoms of either itch or pain, or both itch and pain together were identified in 43% of BCCs
and in 64% SCCs. Our study supports previous findings which indicate that itch is common in
NMSC. Furthermore, it demonstrates that pain is a common symptom present in these cancer types
and that these symptoms are common at the time of diagnosis in BCC and SCC alike.
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Triple antibiotic ointment for the eradication of Staph aureus in healthcare workers
E Grossman, J Gordon, A Haley, M Dubina and P Lio Dermatology, Northwestern University,
Chicago, IL
The prevalence of Staphylococcus aureus (SA) colonization of healthcare workers was recently
reported to be approximately 30%, with 2% being colonized with methicillin-resistant SA (MRSA).
The anterior nares are the most frequent site of colonization of SA, representing a nidus for health-
care acquired infection and potential complications in hospitalized patients. Mupirocin ointment
is considered the standard of care for eradication of nasal SA colonization, with decolonization rates
reported as high as 80%. However, rapid development of resistance to antibiotics is very common
in Staph species and resistance to mupirocin has already been described, dropping decolonization
rates to 27%. Triple antibiotic ointment (TAO) may be a suitable alternative to mupirocin. A prospec-
tive study was performed with healthcare workers from Northwestern Hospital system consisting of
two visits, two weeks apart. At the first visit, a culture for SA was performed on the anterior nares
of healthcare workers. Within 48 hours, culture results were reviewed and if positive, subjects were
given TAO to apply to their nares twice daily for five days. One week after treatment completion,
subjects were re-cultured to see if nasal colonization had been eradicated. A total of 216 health-
care workers enrolled and 45 subjects were found to have a positive culture for SA. Of these 45
subjects, 3 were found to be positive for MRSA. Thirty subjects completed the study, and a clear-
ance rate of 53.3% was found in subjects using TAO. The rate of SA colonization of healthcare work-
ers in our study was below recently published statistics. With the wide-spread use of intranasal
mupirocin for SA, it is possible that rates of resistance will continue to climb. TAO has been shown
to be active against MRSA and MSSA. We report a 53% clearance rate when using TAO for nasal
SA colonization. Triple antibiotic ointment is an inexpensive, widely available non-prescription
medication, and is a viable option in the event that mupirocin-resistant bacteria strains become
more prevalent.
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Sensitization to benzalkonium chloride and benzethonium chloride
H Dao,1 ST Nedorost1,3 and C Fricker2 1 Department of Dermatology, University Hospitals Case
Medical Center, Cleveland, OH, 2 GOJO Industries, Inc., Akron, OH and 3 School of
Medicine, Case Western Reserve University, Cleveland, OH
The purpose of our study was to determine the prevalence of relevant and irrelevant positive patch
tests to benzalkonium chloride (BAK) and benzethonium chloride (BEC), in patients suspected of
having allergic contact dermatitis (ACD). We also sought to find optimal patch test concentrations
and vehicles for patch testing. In this single-center trial, 142 patients undergoing routine patch test-
ing were enrolled to undergo additional patch testing to a series of BAK 0.15% aqueous (aq), BAK
0.15% petrolatum (pet), BEC 0.15% aq, and BEC 0.5% aq. BAK 0.1% aq was already included in
the standard screening series. Early and late patch test readings were performed at 48-96 hours and
7 days, respectively. Avoidance of suspected allergens was advised, and a 1-month follow-up visit
scheduled. 20% of study subjects had a doubtful or 1+ reaction at patch test readings. Long-term
phone call follow-up with patients with doubtful, irritant, or positive patch test reactions to BAK
and/or BEC helped to categorize patients into three categories: definite ACD to BAK/BEC (n=1),
possible ACD to BAK/BEC (n=13), and unlikely ACD to BAK/BEC (n=15). The most frequent causative
agents in patients with definite or possible ACD to BAK/BEC were cleansing wipes and eye drops.
In this subgroup, 4 patients reacted only to BAK 0.15% pet of the study tray, and BAK 0.1% aq iden-
tified only 8% of patients in this subgroup. Reactions to BEC occurred in 61.5% of patients with
possible ACD to BAK/BEC, with 75% of them having co-reactions with BAK. Though rare, sensiti-
zation to BAK and BEC occurs. Co-reaction to BEC should be assumed if BAK sensitization is pres-
ent. Adding BAK in a petrolatum vehicle and replacing BAK 0.1% aq with BAK 0.15% aq can increase
the sensitivity of identifying patients with BAK sensitization. Extended clinical follow-up is neces-
sary to determine relevance. Any reaction present at the day 7 read may in fact be allergic even if
interpreted as irritant based on morphology or decrescendo pattern.
531
Disposition, metabolism and mass balance of [14C]apremilast following oral administration 
M Hoffmann,1 G Kumar,1 P Schafer,1 D Cedzik,1 L Capone,1 K Fong,2 Z Gu,3 D Heller,3 H Feng,3
S Surapaneni,1 O Laskin1 and A Wu1 1 Celgene Corporation, Summit, NJ, 2 Accellient Partners
LLC, Berkeley, CA and 3 XenoBiotic Laboratories, Plainsboro, NJ
Apremilast is a novel, orally available small molecule that specifically inhibits PDE4 and thus mod-
ulates multiple pro- and anti-inflammatory mediators. Apremilast is currently under clinical devel-
opment for the treatment of psoriasis, psoriatic arthritis, and rheumatoid arthritis. The pharmacoki-
netics, metabolism and excretion of [14C]apremilast were investigated following a single oral
suspension dose (20 mg, 100 μCi) to six healthy male subjects. Mean maximum plasma concen-
trations (Cmax), area under the plasma concentration-time curve (AUC0-∞), time to maximum plasma
concentration (tmax) and terminal elimination half-life (t½) values for apremilast in plasma were
333 ng/mL, 1970 ng*hr/mL, 1.5 hr and 6.8 hr. Approximately 58% of the radioactive dose was
excreted in urine, while feces contained 39% of the radioactive dose. Apremilast was extensively
metabolized via multiple metabolic pathways, with unchanged drug representing 45% of the cir-
culating radioactivity and less than 7% of the excreted radioactivity. O-Demethylation followed by
glucuronidation was the major metabolic pathway for apremilast, with the O-demethyl glucuronide
metabolite representing 39% of the plasma radioactivity and accounting for 34% of the excreted
radioactivity. The only other radioactive components that represented >4% of the excreted radioac-
tivity were O-demethylated apremilast and its hydrolysis product. Additional minor circulating and
excreted compounds were formed via O-demethylation, O-deethylation, N-deacetylation, hydrox-
ylation, glucuronidation, and/or hydrolysis. In conclusion, metabolic clearance of apremilast was
the major route of elimination, while non-enzymatic hydrolysis and excretion of unchanged drug
were involved to a lesser extent.
533
Hair follicle organ culture combined with cytotoxic lymphocytes yields a novel bioassay for
screening drugs for immune mediated hair disorders
P Singh,1 L Xing,2 C Higgins,1 R Clynes2 and AM Christiano1 1 Department of Dermatology,
Columbia University College of Physicians and Surgeons, New York, NY and 2 Department of
Medicine, Columbia University College of Physicians and Surgeons, New York, NY
Hair follicle (HF) organ culture is an established technique, routinely used to assess the growth
parameters of the hair shaft under differential conditions and to assess drug efficacy ex vivo. Like-
wise, target-effecter cell co-culture is classically used to test immune mediated cytotoxicity in vitro.
We hypothesize that autoimmune disorders are precipitated by inflammation-induced expression
of ‘danger signals’ such as MHC-I and NKG2D ligands on an otherwise immune privileged HF sur-
face which recruit the cytotoxic cells to the follicle, mediating immune infiltration and HF dystro-
phy as seen in Alopecia Areata (AA). To test this, we devised a novel methodology to assay a tar-
geted cytolytic response against organ cultured HFs in 3D in the presence of inflammatory cytokines:
IFNγ, TNFα and TLR ligands (LPS and dI:dC). These treatments induced surface expression of NKG2D
ligands as shown by elevated expression of MICA, ULBP3 and pan-NKG2D ligand in the dermal
sheath (DS) layer. Incubation of the treated HFs with LAK (lymphokine activated killer) cells caused
greater lymphocytic recruitment to the follicular surface and higher level of apoptosis in the DS layer
as shown by TUNEL staining. The specificity of this interaction was assessed using lactate dehy-
drogenase release based cytotoxicity assay using cultured DS cells. The DS cytolysis by LAK cells
was blocked by anti-NKG2D or MHC-I antibodies, thus confirming the dependence of cytotoxic-
ity on these signals. Transcriptional profiling of AA skin has yielded several differentially regulated
signaling pathways which can be further assessed using this co-culture assay. We have demonstrated
that the ex vivo organ cultured HF and LAK cell interaction can be used to screen putative drug tar-
gets for AA as well as other inflammatory diseases of the hair follicle.
532
Administration of vitamin K does not counteract the ectopic mineralization of connective
tissues in Abcc6-/- mice, a model for pseudoxanthoma elasticum
Q Jiang,1 Q Li,1 AE Grand-Pierre,1 LJ Schurgers2 and J Uitto1 1 Department of Dermatology and
Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA and 2 The Cardiovascular
Research Institute and VitaK, University of Maastricht, Maastricht, Netherlands
Pseudoxanthoma elasticum (PXE), a heritable multisystem disorder characterized by ectopic min-
eralization of peripheral connective tissues, is caused by mutations in the ABCC6 gene. Alterations
in vitamin K metabolism have been suggested to contribute to the pathomechanisms of the miner-
alization process through mechanisms that involve γ-glutamyl carboxylation of Gla-proteins serv-
ing as circulating anti-mineralization factors, such as matrix gla-protein. To test the hypothesis that
vitamin K deficiency contributes to ectopic mineralization in PXE, we administered vitamin K or its
glutathione conjugate (K3-GSH) into Abcc6-/- mice, a model system that recapitulates genetic,
histopathologic and ultrastructural features of PXE. Oral administration of vitamin K2 for 8 weeks
in dosages which vastly exceed the amounts in control mouse diet or the recommended doses for
humans did not counteract the ectopic mineralization in Abcc6-/- mice. Similarly, a long term (8
weeks) intravenous administration of K3-GSH did not alter the degree of mineralization in these
mice. Testing of vitamin K2, K3 and K3-GSH in an in vitro calcification system provided no evidence
of mineralization inhibition by these compounds. Collectively, our data suggest that vitamin K defi-
ciency in the peripheral tissues is not a simple explanation for development of mineral deposits in
PXE and that vitamin K intake may not improve the clinical course of PXE in humans, as has been
recently speculated.
530
Crosstalk between UV-induced PI-3 kinase/Akt/mTOR and Fyn/RSK2 signaling pathways:
Implications in skin carcinogenesis
Y Bermudez,1 SP Stratton,1 C Curiel-Lewandrowski,1 J Warneke,1 GT Bowden,1 Z Dong,2
AM Bode,2 CA Hurst,1 JE Lang,1 DS Alberts1 and JG Einspahr1 1 Arizona Cancer Center,
University of Arizona, Tucson, AZ and 2 The Hormel Institute, University of Minnesota, Austin,
MN
Solar ultraviolet (UV) irradiation is the most significant environmental carcinogen leading to the
development of skin tumors. Since the ozone layer blocks UVC, research efforts have focused mainly
on studying the individual effects of UVA- and UVB-induced skin carcinogenesis. However, little
work has been done to determine the effects of solar-simulated light (SSL), both UVA and UVB
together, on the activation of signaling pathways important in cellular regulation. In this study, we
evaluate the modulation of SSL-activated PI-3 kinase/Akt/mTOR and Fyn/RSK2 signaling pathways
in normal human skin and solar simulated light-irradiated human skin to determine the expression
profiles of upstream and downstream phosphorylated proteins p38, p44/42 MAPK, histone H3, RSK-
2, Akt, mTOR, S6 ribosomal protein, Fyn-src, AMPK, and 4E-BP1. SSL irradiation at two to three
times the minimal erythemic dose was applied to unexposed skin. Punch biopsies were taken at
baseline, 5 minutes, 1 h, 5 h, and 24 h post-irradiation and immediately fixed in 10% formalin for
immunohistochemistry analysis. Marked SSL-induced changes in epidermis were seen in the expres-
sion of phosphorylated histone H3, S6 ribosomal protein, and 4E-BP1 at 1 h, 5 h, and 24 h post-
SSL as compared to control. A linear increase in phosphorylated p44/42 MAPK expression was
observed at 1 h, 5 h, and 24 h post-SSL as compared to control. Phosphorylated Akt expression
increased post-SSL, and appears dependent on duration and intensity of SSL exposure. Understanding
the expression profile patterns of phosphorylated proteins in the PI-3 kinase/Akt/mTOR and Fyn/RSK2
pathways during exposure of physiological relevant SSL could lead to the use of these proteins as
specific targets for the prevention and control of skin tumors.
534
T cells in the skin lesions of stage I mycosis fungoides show markedly suppressed cytokine
production
R Watanabe, M Tawa, N Adams, A Dorosario, DC Fisher, TS Kupper and RA Clark The Dana
Farber/Brigham and Women’s Cancer Center, Boston, MA
In mycosis fungoides (MF), malignant T cells are confined to inflammatory skin lesions and are
admixed with benign infiltrating T cells. We recently reported that both malignant benign T cells in
the blood of leukemic CTCL (L-CTCL) patients are markedly Th2 biased, suggesting global bias of
the T cell repertoire. In this study, we isolated T cells from skin lesions of 16 stage I MF patients, 7
L-CTCL patients and the normal skin of seven healthy controls. Cytokine production was analyzed
by intracellular flow cytometry. In 8/16 patients with stage I CTCL, there was marked global sup-
pression of T cell cytokine production, including TNFα, IFNγ, IL-17, IL-4, IL-10, TGFβ, IL-13 and
IL-22 (anergic pattern) compared to T cells from normal skin. In 6/16 patients, production of IFNγ
was markedly increased above normal (Th1 pattern); in these patients, TNFα production approxi-
mated that of T cells from normal skin. T cell cytokine production approximated that observed in
normal skin in only 2/16 MF patients. T cells isolated from L-CTCL skin lesions differed in that high
levels of IL-4 were produced; non-Th2 T cell cytokine production resembled that from MF with com-
parable Th1 levels and global suppression of Th17 cytokines.Two L-CTCL patients treated with alem-
tuzumab showed further enhancement of IFNγ/TNFα production by benign T cells in skin follow-
ing therapy, in agreement with prior studies showing improved Th1 responses following
immunomodulation. In summary, there is significant functional anergy in MF lesional T cells, with
markedly suppressed cytokine production despite the isolation of these T cells from clinically inflamed
skin. In the skin lesions of L-CTCL patients, T cells were Th2 biased, consistent with the pruritus
observed in these patients. Successful treatment with alemtuzumab reversed this Th2 bias and
enhanced Th1 responses but production of IL-17 remained reduced.
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A cross-sectional study of resistin in psoriasis patients
D Kast, N Borkar, I Grozdev, D Carlson, R Feig, P Pujari, D Babineau, E Kern, T McCormick,
K Cooper and N Korman Dermatology, Univ Hospitals Case Med Ctr, Murdough Family Center
for Psoriasis, Cleveland, OH
Psoriasis, a systemic inflammatory disease, has been associated with obesity, metabolic syndrome,
diabetes and CVD. Serum resistin levels are associated with insulin resistance, inflammation, and
atherosclerosis. A cross-sectional study of 202 psoriasis patients and 75 controls without inflam-
matory skin disease showed resistin levels were 45% greater in psoriasis patients than controls (OR
1.45 [95% CI: 1.17, 1.81], p=0.0009). After adjusting for age, gender, race, BMI, smoking, HTN,
HDL, and hsCRP this association remained significant (OR 1.29 [95% CI: 1.03, 1.61], p=0.0269).
In addition, psoriasis severity measured by BSA was associated with increased resistin levels (OR
1.11 [95% CI: 1.01, 1.22], p=0.023). Adjusting for age, gender, race and BMI did not alter the asso-
ciation; adjustment for smoking, HTN, and HDL attenuated this relationship. Psoriatic arthritis was
associated with increased resistin levels after adjusting for age, gender, race, BMI, smoking, HTN,
HDL, and hsCRP (OR 0.76 [95% CI: 0.58, 0.99], p=0.0444). Interestingly, resistin levels of psoria-
sis patients currently on TNF-α inhibitors (n=38) was significantly less than those not currently on
TNF-α inhibitors (n=164) (OR 0.72 [95% CI: 0.54, 0.97], p=0.030). This association was sustained
throughout adjustment for age, gender, race, BMI, smoking, HTN, HDL, and hsCRP (OR 0.75 [95%
CI: 0.56, 0.99], p=0.0497). Our study using a well characterized US psoriasis cohort provides ini-
tial evidence that serum resistin levels are increased in psoriasis patients compared to controls while
adjusting for potential confounding metabolic syndrome variables. Resistin levels were also asso-
ciated with psoriasis severity, BSA, and psoriatic arthritis. Patients treated with TNF-α inhibitors
exhibit statistically significant decreases in serum resistin levels even when accounting for potent
pro-inflammatory molecules including CRP. Resistin, an established metabolic adipokine, reflects
psoriasis severity and may be a crucial link to psoriasis co-morbidities.
524
The degree of correlation between the physician’s global assessment (PGA) and psoriasis
area and severity index (PASI) in randomized controlled trials of biologic agents for moder-
ate to severe plaque psoriasis
AH Robinson, M Kardos and AB Kimball Dermatology, Massachusetts General Hospital,
Boston, MA
The purpose of this study was to determine the degree of correlation between the PASI and PGA
when used in clinical trials of systemic therapies for moderate to severe plaque psoriasis. Follow-
ing the PRISMA guidelines, a literature search was performed to review randomized controlled tri-
als for biologic therapies, phototherapy, cyclosporine, and methotrexate. Papers publishing both the
PASI 75 and PGA 0,1 were included. The percentages of patients achieving the endpoint values
were recorded. The two assessment tools were plotted against each other to obtain the correlation
coefficient. A p-value was obtained using the Pearson Product-Moment Correlation Coefficient. Of
the 123 studies reviewed, 30 trials, all performed between 2001-2010, met inclusion criteria. The
correlation coefficient was 0.9157 for PGA 0,1 and PASI 75 assessments between study weeks 8-
16 (p < 0.01.). The correlation between the tools was tighter for more effective therapies. For stud-
ies with < 25% of patients achieving PASI 75, the correlation coefficient was 0.0612. We conclude
that at least for relatively efficacious therapies (those with at least 25% of patients achieving PASI
75) for moderate to severe psoriasis, the PGA and PASI are redundant. Given that the tools diverge
with decreased therapeutic efficacy, we recommend that both tools be used for phase II studies, but
that the PASI alone should be sufficient for phase III trials of drugs previously proven to be effective
in getting at least 25% of patients to PASI 75.
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Clinical efficacy of a new natural ingredient that simultaneously addresses multiple facets of
acne pathogenesis
J Guay and B Page Biopharmacopae, Quebec City, QC, Canada
Recent developments in our understanding of acne pathogenesis have involved four main axes:
hyperseborrhea, hyperkeratosis, microbial colonization, and inflammation. Having discovered that
hydro-glycolic extracts prepared from the leaves of a Canadian plant have strong in vitro anti-inflam-
matory, anti-bacterial, and wound healing properties, as well as in vivo anti-inflammatory and anti-
redness effects, we hypothesized that these Canadian plant-derived extracts could be effective in
the treatment of acne. To validate the anti-acne potential of the most promising extract (BDI-35), a
double-blinded, randomized, comparative, exploratory trial was performed on humans. Twelve vol-
unteers (6 women and 6 men) ages 18 to 34 years, suffering from bilateral moderate acne, ran-
domly applied a formulation containing extract BDI-35 (5%) on one hemi-face, the other being
treated with the same formulation without the extract (placebo). Topical application was performed
twice daily for 42 days. Clinical evaluation of the number of both retentional and inflammatory acne
lesions was performed by a trained dermatologist, and high resolution photographs were taken at
T=0, T=28, and T=42 days. The results obtained on visual evaluation of the hemi-faces demonstrate
that the BDI-35 treatment significantly reduces (p<0.05)retentional lesions (closed and opened come-
dones) by 38% and the total number of lesions (including inflammatory lesions) by 31% following
42 days of application compared to T=0; while application of the placebo has no significant effect.
This exploratory study, although based on a small numbers of volunteers, demonstrates that BDI-
35, a specific glycolic extract prepared from the leaves of a Canadian plant, has a significant effect
against acne and is a good candidate as an active ingredient for formulations dedicated to the reduc-
tion of acneic lesions.
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Blood involvement in stage IA Mycosis Fungoides by flow cytometry predicts or is associated
with higher rate of progression
R Talpur,1 L Singh,1 A Shah,1 S Daulat,1 P Liu2 and M Duvic1 1 Dermatology, Univ. of Texas, MD
Anderson Cancer Center, Houston, TX and 2 Biostatistics, Univ. of Texas, MD Anderson
Cancer Center, Houston, TX
Early stage Mycosis fungoides (MF) (T1, IA) has an excellent prognosis compared to Sézary Syn-
drome with a 5.4 year median overall survival (Vidulich et al, Int J Dermatol. 2009;48(3):243-52).
Kim et al found only 10% of IA patients progress. The objectives were to determine the overall, dis-
ease related, and progression free survival of Stage IA MF patients at MD Anderson Cancer Center
studied prospectively between 1982-2009. Blood involvement was defined as B0 < 500; B1 >500;
and B2 >1000 or > 35% CD4+CD26- cells. Method of Kaplan and Meier estimated median over-
all survival (OS), disease free (DFS) and progression-free survival (PFS). Cox’s proportional hazards
regression model tested the statistical significance of potential prognostic factors. At initial staging,
522 of 1263 (41.3%) were T1 (IA). Thirty-four died and median OS was not reached. Only 2% (10
of 43) of deaths were attributable to MF; DFS was not reached. Forty-three patients (8.2%) pro-
gressed; 476 (91.2%) remained as stage IA with 3 lost to follow up. Older age at diagnosis and
black race were significantly associated with reduced OS and PFS. Twelve of 490 IA patients (2.4%)
had baseline flow cytometry; ten were B1 and two were B2. Nine patients were T1a (patch) and 3,
including the two B2 patients, were T1b (patch and plaque). Four with initial blood involvement
progressed to higher stages including two with folliculotropic MF dead from disease. Both IA/B2
patients progressed to SS. One after complete durable response to CD4 antibody relapsed with IVB
CNS involvement. In summary, 4 of 12 IA patients (33%) with baseline blood involvement pro-
gressed compared to a 6% (31/510) rate of progression in IA-B0 patients. In conclusion, although
the incidence of peripheral blood involvement detected at baseline by flow in stage IA patients is
quite low (2%), flow may still be helpful as a biomarker to identify patients who are more likely to
progress to SS or die from their disease.
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Evaluation of itch and pain as presenting symptoms in non-melanoma skin cancer
KC Mills,2 AN Feneran,1 A Zeitany,1 HL Tey,1 A Lee,1 OP Sangüeza,1,2 P Williford,1 D Pearce1 and
G Yosipovitch1 1 Dermatology, Wake Forest University Baptist Medical Center, Winston-Salem,
NC and 2 Pathology, Wake Forest University Baptist Medical Center, Winston-Salem, NC
Itch and pain are common complaints in dermatology clinics, however, the data on the frequency
of itch and pain in skin tumors is sparse. Previous investigators have demonstrated that itch is com-
mon in both basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). To our knowledge,
pain has not been examined as an endpoint presenting feature of non-melanoma skin cancer (NMSC).
In this study we examine the prevalence of both itch and pain at the time of diagnosis in NMSC.
This study includes 314 skin neoplasms and is part of a larger investigation of approximately 1000
cutaneous tumors designed to examine the correlation of the aforementioned symptoms with can-
cer subtype, tumor size, tumor location, and several histologic features including the amount and
type of inflammation, the presence of perineural invasion, and the presence of lymphovascular inva-
sion. Participants were recruited from the patient population presenting to the department of der-
matologic surgery at Wake Forest University Baptist Medical Center. The subjects were asked via
visual analog scale to identify their perceived initial symptoms of both itch and pain. For the pur-
poses of exploratory analysis, 211 BCCs and 103 SCCs were included in this substudy. Itch in the
absence of pain was reported in 22% of all examined BCCs and in 21% of all examined SCCs. Pain
in the absence of itch was reported in 9% of all examined BCCs and in 18% of all examined SCCs.
The symptoms of either itch or pain, or both itch and pain together were identified in 43% of BCCs
and in 64% SCCs. Our study supports previous findings which indicate that itch is common in
NMSC. Furthermore, it demonstrates that pain is a common symptom present in these cancer types
and that these symptoms are common at the time of diagnosis in BCC and SCC alike.
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Triple antibiotic ointment for the eradication of Staph aureus in healthcare workers
E Grossman, J Gordon, A Haley, M Dubina and P Lio Dermatology, Northwestern University,
Chicago, IL
The prevalence of Staphylococcus aureus (SA) colonization of healthcare workers was recently
reported to be approximately 30%, with 2% being colonized with methicillin-resistant SA (MRSA).
The anterior nares are the most frequent site of colonization of SA, representing a nidus for health-
care acquired infection and potential complications in hospitalized patients. Mupirocin ointment
is considered the standard of care for eradication of nasal SA colonization, with decolonization rates
reported as high as 80%. However, rapid development of resistance to antibiotics is very common
in Staph species and resistance to mupirocin has already been described, dropping decolonization
rates to 27%. Triple antibiotic ointment (TAO) may be a suitable alternative to mupirocin. A prospec-
tive study was performed with healthcare workers from Northwestern Hospital system consisting of
two visits, two weeks apart. At the first visit, a culture for SA was performed on the anterior nares
of healthcare workers. Within 48 hours, culture results were reviewed and if positive, subjects were
given TAO to apply to their nares twice daily for five days. One week after treatment completion,
subjects were re-cultured to see if nasal colonization had been eradicated. A total of 216 health-
care workers enrolled and 45 subjects were found to have a positive culture for SA. Of these 45
subjects, 3 were found to be positive for MRSA. Thirty subjects completed the study, and a clear-
ance rate of 53.3% was found in subjects using TAO. The rate of SA colonization of healthcare work-
ers in our study was below recently published statistics. With the wide-spread use of intranasal
mupirocin for SA, it is possible that rates of resistance will continue to climb. TAO has been shown
to be active against MRSA and MSSA. We report a 53% clearance rate when using TAO for nasal
SA colonization. Triple antibiotic ointment is an inexpensive, widely available non-prescription
medication, and is a viable option in the event that mupirocin-resistant bacteria strains become
more prevalent.
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11β-hydroxysteroid dehydrogenase type 1 increases with age and photoexposure in human
skin ex vivo
A Tiganescu,1 EA Walker,1 AE Mayes2 and PM Stewart1 1 University of Birmingham,
Birmingham, United Kingdom and 2 Unilever Discover, Bedford, United Kingdom
Skin aging shares many of the clinical features associated with both local (topical steroid therapies)
and systemic (Cushing’s syndrome) glucocorticoid (GC) excess including dryness, itching, der-
mal/epidermal thinning, increased fragility and reduced wound healing. Locally, GC concentrations
are modulated by the enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) which acti-
vates cortisol from cortisone. We have previously reported increased expression of 11β-HSD1 as a
function of donor age in primary human dermal fibroblasts (HDF) which, concomitant with a for-
ward-feedback upregulation by cortisol, may increase dermal tissue GC exposure in the elderly.
Interestingly, 11β-HSD1 expression was also increased in donor-matched photoexposed vs. pho-
toprotected site-derived HDF. Our current study aimed to confirm these in vitro results using skin
punch biopsies from healthy young (18-30 years old) and older (60+ years old) volunteers. Follow-
ing ethical approval and consent, two 3mm biopsies were obtained from both the lower outer
(photoexposed) and inner upper (photoprotected) arm. Biopsies were incubated for 24h with 200nM
cortisone/tritiated cortisone tracer and conversion to cortisol was determined following steroid extrac-
tion and quantification. Results (given as mean % conversion ± S.E) indicated increased cortisone
conversion in older compared to younger photoprotected biopsies (10.2±1.5 vs. 5.6±0.6, p<0.01,
n=10). Additionally, young donor biopsies displayed increased cortisone conversion in photoex-
posed biopsies compared to donor-matched photoprotected (8.9±0.9 vs. 5.6±0.6, p<0.01, n=10).
These results strongly support our previous in vitro data suggesting a shift towards increased corti-
sol activation by 11β-HSD1 in photoexposed human skin and interestingly with age in photopro-
tected human skin. Ongoing studies are focused on establishing functional consequences of these
changes on potential glucocorticoid target genes that may be involved in the photoaging and chrono-
logical aging process in human skin.
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A role for PD-1 in suppressing T cell activity in human merkel cell carcinomas
M Dowlatshahi, L Wang, JE Teague, MK Lichtman, A Gehad, R Watanabe, WJ Crisler, TS Kupper
and RA Clark The Dana Farber/Brigham and Women’s Cancer Center, Boston, MA
Merkel cell carcinoma (MCC) is a rare but highly malignant skin cancer associated with a novel
polyoma virus. We previously observed that MCC tumors contain T cells with characteristics of
tumor-specific T cells, but that the activation of these T cells was markedly suppressed. We now
report that MCC transplanted to immunodeficient mice failed to grow unless activated T cells were
depleted by infusion of denileukin diftitox, suggesting at least a subset of MCC contain T cells capa-
ble of controlling tumor growth. To identify molecules that could underlie the suppressed T cell
activity observed in these tumors, we carried out luminex studies of tumor supernatants identify
immunosuppressive cytokines and immunostained MCC for known co-signaling molecules expressed
on the cell surface. Comprehensive luminex studies of MCC supernatants failed to detect signifi-
cant quantities of immunosuppressive cytokines. Immunostaining of MCC showed that Merkel tumor
cells lacked expression of GITRL, CD80, CD86, PD-1, PD-L1 and PD-L2. However, CD3+ T cells
within tumors expressed PD-1 by immunostaining. Flow cytometry of T cells isolated from MCC
confirmed that mean 52% of T cells expressed PD-1, despite the fact that these cells were CD69-
CD25- non-activated T cells. PD-1 is expressed by activated T cells but when expressed on T cells
in the tumor microenvironment in the presence of its ligands PD-L1 or PD-L2, it is a marker of T
cell exhaustion. We also observed expression of PD-L2 by a discrete population of non-tumor cells
in MCC tumors. TILs expanded in IL-2 and IL-15 showed increased production of IL-17, IFNγ and
TNFα, suggesting recovery of T cell function. In summary, MCC contain tumor specific T cells but
elements within the tumor microenvironment suppress the activity of these cells. We have identi-
fied PD-1 as a candidate that may mediate T cell suppression. Our work suggests that agents that
block PD-1, currently in clinical trials for the treatment of other malignancies, may have efficacy in
the treatment of MCC.
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Early rituximab therapy of autoimmune blistering disease is associated with better clinical
response
L Lunardon,1 KJ Tsai,2 N Fett,1 JR Stanley,1 DE Tsai,2 VP Werth1,3 and AS Payne2 1 Dermatology,
Univ of Pennsylvania, Phila, PA, 2 Hematology/Oncology, Univ of Pennsylvania, Phila, PA and
3 Philadelphia VAMC, Phila, PA
Rituximab (RTX) is a chimeric monoclonal anti-CD20 antibody that has recently emerged as an
effective therapeutic option for autoimmune blistering diseases (ABD). We conducted a single cen-
ter retrospective study of 35 ABD patients treated with RTX (13 men, 22 women; 21 pemphigus
vulgaris, 6 pemphigus foliaceus, 4 bullous pemphigoid, 1 mucous membrane pemphigoid, 1 lin-
ear IgA bullous dermatosis, 1 bullous lupus, 1 epidermolysis bullosa acquisita). We examined two
primary endpoints: complete healing of mucocutaneous lesions and ability to discontinue systemic
immunosuppressants. 15 patients (43%) had complete healing of mucocutaneous lesions after
RTX. 11 patients (31%) discontinued systemic immunosuppressants; 4 relapsed after a median dura-
tion of 17 months (range 10-20), and 7 have remained off systemic therapy for a median duration
of 10 months (range 3-65). Endpoints were associated with early RTX therapy; the median duration
of disease prior to RTX in those achieving either endpoint (n=19) was 22 months, compared to 80
months in those not achieving either endpoint (n=16) (p=0.016). Sera from 4 of 10 patients demon-
strated human anti-chimeric antibodies (HACA) by ELISA, which was associated with need for repeat
courses of RTX for disease control or poor response to subsequent courses of RTX. Serious adverse
events (SAE) were observed in 5 patients after RTX (Pneumocystis pneumonia, perirectal phleg-
mon, fatal upper gastrointestinal bleed, melanoma, bladder cancer); only phlegmon was attributed
to RTX. Median duration of disease for patients with SAE after RTX was 124 months, compared to
66 months for those without. SAE were also observed in 6 patients on systemic immunosuppres-
sants prior to RTX (avascular necrosis, vertebral fracture, bleeding gastric ulcer, pulmonary embolism,
MSSA bacteremia, and HSV/MRSA/Pseudomonas superinfection.) These data suggest that early
RTX therapy of ABD leads to better clinical response and that HACA should be monitored.
544
Vitamin encapsulated nanosomes affect changes in Syk and Erk1/2 induced by skin UV expo-
sure
C Sunkari,1 Z Huang,1 J Uitto2 and E Papazoglou1 1 School of Biomedical Engineering, Science
and Health Systems, Drexel University, Philadelphia, PA and 2 Department of Dermatology
and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA
Retinoids, maintain the normal immune functions of the various layers of skin. Exposure of skin to
Ultraviolet Radiation greatly reduces the concentrations of inherent retinoids in skin. Various stud-
ies have shown that the deleterious effects of Solar UV exposure can be mitigated by the pretreat-
ment of the region of interest with various retinoids, particularly Retinol and Retinoic acid. Retinol,
the most active among the forms of Vitamin A is extremely sensitive to oxygen and light. Hence we
employ nano-sized vesicles to encapsulate Retinol and preserve its potency as well as optimize the
delivery of the Retinol to the skin layers. Retinol, α-tocopherol and ascorbic acid encapsulated
“nanosomes” were made with DOPC and sonicated to achieve the required optimal size of
100±32nm. SKH1 Hairless mice were pretreated with the above mentioned liposomes as well as
only retinol and only α-tocopherol and ascorbic acid as controls. The animals were exposed to solar
simulated UV radiation for a period of 10 weeks with above mentioned treatments, after which the
animals were sacrificed. Their skin was harvested and analyzed. Western blots demonstrated a
marked decrease in Erk1/2 and Syk production post UV exposure in the Vitamin loaded nanosome
treated animals as compared to the other treatment groups. Remarkably, the efficacy of the nanosome
encapsulated vitamins is 50% higher compared to the naked vitamins, on a concentration basis.
Therefore,vitamin encapsulation in optimally sized nanosomes stabilizes them and offers a supe-
rior UV protecting agent.
542
Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell trans-
plantation in advanced mycosis fungoides and sezary syndrome
L Singh,1 C Hosing2 and M Duvic1 1 Dermatology, Univ of Texas MD Anderson, Houston, TX
and 2 Stem Cell Transplant, Univ of Texas MD Anderson, Houston, TX
Mycosis fungoides and Sézary (SS) Syndrome are incurable cutaneous T-cell lymphomas with
helper/memory phenotypes. The purpose of this trial was to evaluate safety and efficacy of com-
bining total body skin electron beam with non-ablative allogeniec stem-cell transplant in advanced
patients. Between July 2001 and Nov 2010, 33 CTCL patients -19 females & 14 males with median
age 51.5 (range 19-72) and median of 4 prior treatments (range 1-7) were enrolled. Thiry first received
total body skin electron beam and 31 received the conditioning regimen fludarabine, melphalan
plus thymoglobulin (for mismatched donors). Graft-versus-host-disease (GVHD) prophylaxis was
with tacrolimus/methotrexate. Median time from diagnosis to transplant was 1.7 years (range 0.67
– 9 years). Thirty patients achieved engraftment, two died of early sepsis, and one did not engraft.
Eighteen patients experienced acute GVHD; 13 experienced chronic GVHD. The overall response
rate was 72% (24 of 33). Sixteen patients (48%) are alive in complete remission, five are alive with
relapsed skin lesions, and twelve (36%) are deceased. Five of 14 with relapsed disease, responded
to donor lymphocyte infusions. Causes of death were sepsis (3), progressive disease (6), and non-
CTCL events in four CRs (lung cancer, ARDS, or infection). Large cell transformation (LCT) was
present in 12 pts and two with SS and died with PD. One of 4 pts with folliculotropic MF had a CR,
2 relapsed in skin, and one died. Sixteen of 18 pts with SS achieved CRs in skin and blood and are
ongoing in ten. Overall survival from time of diagnosis is 9.7 years. Overall survival from time of
transplant was not reached. The median progression-free survival from date of transplant is 2.24
years. In conclusion, Total skin electron beam followed by non-ablative allogeneic stem-cell trans-
plant may be curative treatment, especially for patients with Sézary Syndrome.
546
Functional MRI investigations of brain processing of itch sensation in end-stage-renal-dis-
ease patients with chronic pruritus
AD Papoiu, R Coghill, L Banari, R Kraft and G Yosipovitch Wake Forest University Health
Sciences, Winston-Salem, NC
Uremic pruritus represents a significant health problem with a serious impact on the quality of life
of the affected patients and its treatment still poses a challenge to the medical community. Itch can
be experimentally induced using histamine or a tropical plant, cowhage (Mucuna pruriens). Both
forms of itch are transmitted via distinct unmyelinated C nerve fibers to the spinal cord and further
relayed via 2 distinct spinothalamic pathways. Cowhage itch is mediated via proteinase activated
receptors-2 (PAR2). Recent studies suggested that itch could be conveyed at least in part by PAR2
receptors and endogenous proteases, therefore, cowhage itch could serve as a model for pruritus.
In this study, we sought to investigate and contrast by functional MRI the central processing of the
two forms of itch, in uremic patients with chronic pruritus and in healthy volunteers. Fifteen healthy
subjects and eight End Stage Renal Disease (ESRD) patients presenting chronic itch were included.
The functional MRI used Arterial Spin Labeling (ASL) designed to capture long-term effects on cere-
bral perfusion. Functional MRI data was analyzed using FSL software (FMRIB, Oxford, UK) and Gen-
eral Linear Models. Current analyses suggest that in contrast with healthy subjects, the processing
of the two forms of itch slightly differ in ESRD patients. Although cowhage and histamine itches acti-
vate a set of common areas in healthy subjects, the activation appears different in uremic itch. His-
tamine itch activates precuneus, cuneus and the posterior cingulate cortex (PCC), while cowhage
itch is dominantly represented in the anterior cingulate cortex (ACC), PCC, insula & claustrum. A
notable finding is that cowhage itch activates more extensively areas of ACC in ESRD patients. In
conclusion, the divergent pattern of activation induced by cowhage and histamine itch in uremic
patients subtly contrasts with the pattern observed in healthy subjects, and suggests an altered cen-
tral processing of itch sensation in this pathological state.
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Hematopoietic and mesenchymal stem cell transplantation for recessive dystrophic and junc-
tional epidermolysis bullosa
J Tolar,1 JA McGrath,2 DR Keene,3 M Hordinsky,4 MJ Osborn,1 MJ Riddle,1 A Bertin,4 D Woodley,5
M Chen,5 A Hovnanian,6 K Tamai,7 BR Blazar1 and JE Wagner1 1 Pediatric Blood and Marrow
Transplantation, University of Minnesota, Minneapolis, MN, 2 St. John’s Institute of
Dermatology, London, United Kingdom, 3 Shriners Hospital, Portland, OR, 4 Dermatology,
University of Minnesota, Minneapolis, MN, 5 Dermatology, University of Southern California,
Los Angeles, CA, 6 INSERM, Paris, France and 7 Stem Cell Science, Osaka University School
of Medicine, Osaka, Japan
Cellular therapies for recessive dystrophic epidermolysis bullosa (RDEB) resulted in increased col-
lagen type VII (C7) with amelioration of disease. In follow up to a prior study that evaluated allo-
geneic HSC transplantation (HCT) in RDEB, we hypothesized that children with junctional EB (JEB)
might also respond favorably to HCT, and that both RDEB and JEB patients might benefit from the
co-infusion of mesenchymal stem cells (MSCs). 8 children were treated (6 RDEB and 2 JEB) with
HCT followed by infusion of third-party MSCs. HSCs were obtained from siblings (n=3), unrelated
marrow donors (n=2), or unrelated cord blood donors (n=3). As of January 2011, 6 of 8 are alive
13 to 327 days after HCT; one child with JEB died 44 days (unrelated marrow donor) and one child
with RDEB died 101 days (sibling donor) after HCT. Marrow recovery occurred in all patients with
one patient with RDEB having autologous recovery. Of the four remaining patients with RDEB, two
had increased levels of C7, one had no change and one is too early to evaluate. In all patients with
hematopoietic donor engraftment, 6-33% of the skin cells were derived from the HSC donor; in
one patient, 4% of the skin cells were derived from the MSC donor. Notably, two patients with
increased C7 had improved wound healing, and resistance to blister formation. In the one evalu-
able patient with JEB, blistering and erosions markedly decreased. In summary, allogeneic HCT/MSC
transplantation can result in the skin chimerism from both the HSC and MSC donor and in clinical
improvement in patients with JEB as well as RDEB.
536
Curcumin intervention and plasma biomarkers for radiation dermatitis in breast cancer patients
JL Ryan,1,2 M Ling,2 J Williams,2 GR Morrow2 and AP Pentland1 1 Dermatology, University of
Rochester Medical Center, Rochester, NY and 2 Radiation Oncology, University of Rochester
Medical Center, Rochester, NY
Radiation dermatitis occurs in 95% of cancer patients receiving radiation therapy. Currently, there
are no useful treatments or predictive markers for these skin reactions. We conducted a random-
ized, double-blind, placebo-controlled clinical pilot study to examine the use of curcumin for radi-
ation dermatitis. Alterations in pro-inflammatory cytokines and chemokines may be a novel indi-
cator for radiation-induced skin damage and curcumin activity. After informed consent, 30 female
breast cancer patients (93% White, mean age = 58) took twelve 500mg capsules of curcumin or
placebo daily during their course of radiation treatment. Radiation dermatitis severity was meas-
ured weekly using Radiation Dermatitis Score (RDS) ranging from 0 to 4 with 0.5 increments. The
Milliplex® MAP Human Panel I Assay was used to measure plasma levels (pg/ml) of 42 different
cytokines/chemokines in blood collected midway through radiation treatment (mid-RT). ANOVA
analyses, with significance level of 0.05, showed that radiation dermatitis severity was significantly
lower in curcumin-treated patients compared to placebo (mean RDS = 2.57 and 3.41 respectively;
p = 0.005). Correlative and regression analyses revealed that mid-RT plasma levels of Eotaxin (r2 =
0.212; p=0.011) and sIL-2RA (r2 = 0.197; p = 0.014) were predictive of radiation dermatitis sever-
ity at the end of treatment. Logistic regression and tree-based modeling identified mid-RT plasma
levels of Eotaxin (≥ 111 pg/ml; p = 0.02), EGF (≥ 121.9 pg/ml; p =0.014), and GMCSF (≥ 128.5
pg/ml; p=0.009) as potential biomarkers for curcumin. In conclusion, curcumin is a promising
non-toxic intervention for radiation dermatitis in breast cancer patients and specific plasma bio-
markers could be used to monitor radiation dermatitis severity and curcumin treatment. Support:
IND 75,444, Dermatology Foundation, KL2 RR024136, NCI PHS 1R25CA10618, NIAID-U19-
AI067733.
537
Oral azathioprine therapy improves the clinical and cutaneous antimicrobial response in chil-
dren with moderate to severe atopic dermatitis
W Tom,1,2 P Kotol,1 D Audish,1 T Cosan2 and R Gallo1 1 Division of Dermatology, University of
California, San Diego, San Diego, CA and 2 Rady Children’s Hospital, San Diego, CA
This prospective study assessed the cutaneous and immunologic effects of systemic immunosup-
pressive therapy with azathioprine on moderate to severe atopic dermatitis (AD), including the
impact on antimicrobial peptide production and defense against secondary infection. Ten children
ages 2 to 18 were treated with oral azathioprine for 24 weeks and compared to 10 children who
remained on topical forms of anti-inflammatory therapy. Primary outcome measures were disease
severity as measured by the SCORAD index, frequency of bacterial and viral skin infections, Staph
aureus bacterial load, and expression of cathelicidin LL-37 as measured by tape stripping at lesional
and nonlesional skin. Subjects in the two arms were of similar median age (azathioprine: 9.5yrs,
range 5-18 yrs; topicals: 9yrs, range 6-15 yrs). The objective SCORAD index decreased from 63.9
+/- 4.7 (mean +/- SD) at baseline to 34.7 +/- 16.2 at 24 weeks of azathioprine therapy (p<0.001).
Pruritus, sleep, investigator global, and subject global scores also improved. Those who remained
on topical therapies had a SCORAD change of 12.3 +/- 11.6 over 24 weeks. The frequency of sec-
ondary infections declined by a greater degree in those given oral azathioprine than those treated
with topical therapy alone. Cathelicidin expression at lesional skin correlated with the intensity sub-
score of SCORAD, but not with serum IgE levels or Staph aureus bacterial load measured at the
same site. On analysis of individual subjects receiving azathioprine, several showed improvement
in LL-37 expression as cutaneous disease was improving, followed by a decline once there was lit-
tle inciting inflammation on the skin. The improvement in AD by azathioprine and reduction in
secondary skin infections may be explained at least in part by enhanced antimicrobial peptide
expression during therapy.
538
T4 endonuclease V liposome (T4N5) treatment ameliorates gene expression profile in actinic
keratoses and sun-exposed skin of renal transplant patients
R Shafi,1 W Cantrell,1 WE Grizzle,2,3 M Athar1,3 and CA Elmets1,2,3 1 Dermatology, University of
Alabama at Birmingham, Birmingham, AL, 2 Pathology, University of Alabama at Birmingham,
Birmingham, AL and 3 Skin Diseases Research Center, University of Alabama at Birmingham,
Birmingham, AL
People who have had kidney transplants are approximately 250 times more likely than the general
population to develop non-melanoma skin cancer (NMSCs) as well as carcinoma in situ (Bowen’s
disease) and actinic keratoses (AK). T4 endonuclease V (T4N5), a DNA repair enzyme encapsu-
lated in an engineered liposome delivery vehicle, has shown promise as a chemopreventive agent.
In this study, we investigated changes in the gene expression profile in AK lesions and sun-exposed
skin in renal transplant patients who had been treated with T4N5. We employed DNA microarray
analysis using high density affymetrix chips. A total of 1169 genes showed a differential gene expres-
sion pattern between AK pre-treatment versus AK post-treatment samples. Of these, 485 genes
were upregulated while the remaining genes were down-regulated. The major clusters of genes that
were regulated by T4N5 were those which are known to be involved in regulation of development
(49%), immune responses (22%), muscle/ cytoskeleton (18%), and DNA damage/apoptosis (11%).
Comparison of the gene expression profile with non-sun-exposed skin revealed that T4N5 treatment
was effective in reversing the gene expression patterns related to the pathogenesis of AK. The strin-
gent genes regulated by T4N5 included STAT1, JUN, PML, BCL2L11 and IF-16 In this regard, T4N5
therapy partially or fully reversed the aberrant expression of genes observed in the untreated AK
thus suggesting a role for T4N5 in normalizing gene expression in AKs. We have selected some of
the biomarkers related to apoptosis and proliferation to validate the gene expression profile. We
observed that T4N5 induces apoptosis and apoptosis-regulating genes in these lesions. Our data
suggest that augmenting the repair of damaged genes can restore the gene expression profile found
in normal non-sun-exposed skin.
539
Anthralin successfully treats alopecia areata: A half-side comparison
R Schopf Dermatology, Johannes Gutenberg Univ., Mainz, Germany
Anthralin application is an option for topical immunosuppressant treatment of alopecia areata
(AA). No controlled trials have been done. We report the successful treatment of AA by anthralin
as demonstrated by half-side comparison. Seven patients, 5 female, 2 male, aged 12 to 52 years
(median 36 years) suffering from almost total AA or AA totalis for at least 2 years were treated daily
with 1 or 3% anthralin cream on one half of the scalp only. In addition, 5% minoxidil solution was
applied to the entire scalp twice daily. Skin biopsies were obtained for pathohistology. Scalp pho-
tographs were also taken. In the 7 patients treated, hair growth on the anthralin-treated half of the
scalp set in around 5 months and continued to increase up to 18 months. After definite hair growth
on the treated side, anthralin was also applied to the other half of the scalp. No side effects other
than slight burning and brownish discoloration were noted. In scalp biopsies from treated areas
exhibiting regrowth of hair, the lymphocytic infiltrates surrounding hair follicles tended to vanish,
and the scalp tissue normalized, there were no signs of allergic contact dermatitis. Our results indi-
cate that topical immunosuppressant treatment of alopecia areata for 5 to 18 months with anthralin
combined with topical minoxidil is a safe and efficacious treatment associated with normalization
of scalp tissue.
540
Efficient and reliable skin responses with unconventional low-dose total skin electron beam
therapy in mycosis fungoides: A phase II study
C Harrison,1 D Navi,1 B Lingala,1 R Armstrong,1 W Weng,1 U Sundram,1 B Dabaja,2 L Singh,2
M Duvic,2 RT Hoppe1 and YH Kim1 1 Stanford University, Stanford, CA and 2 MD Anderson
Cancer Center, Houston, TX
Standard dose (36 Gy) total skin electron beam therapy (TSEBT) is a highly effective treatment in
mycosis fungoides (MF). The regimen is time intensive and associated with significant treatment
related toxicities. Our retrospective analysis identified 10-15 Gy as a low-dose range with promis-
ing responses in MF. This study was designed to assess the efficacy and safety profile of 12 Gy
TSEBT prospectively. TSEBT naive pts with MF stage IB-IIIB were eligible. TSEBT was given over 3
wks for a total of 12 Gy. Response by mSWAT was assessed at wk 0, 4, and monthly thereafter.
Clinical response was defined as >50% reduction of mSWAT. 15 pts received TSEBT alone, and 5
were treated with TSEBT combined with other agents. Of the TSEBT monotherapy pts (n=15), median
age was 67 yrs (19-83 yrs); 9 were IB, 5 IIB, and 1 IIIA. Median number of prior therapies was 4
(range 1-8). Overall response rate was 87%, with 2 CR. Pts with LCT (IIB) and folliculotropic MF
(IB, IIB) responded. Median time to response and duration of response was 8 wks (4-12 wks) and
22 wks (4-35 wks), respectively. Median time to progression has not been attained at time of analy-
sis. All 5 pts receiving TSEBT with other agents had objective skin responses. TSEBT related toxici-
ties included temporary partial alopecia, reversible nail changes, and mild radiation dermatitis.
Pre/post TSEBT peripheral blood analysis of CD4+, CD8+, CD56+, and FoxP3+ lymphocytes showed
no significant immunosuppression. Our data support that an unconventional low-dose TSEBT is an
effective skin treatment in MF. The responses are efficient/reliable and toxicity minimal as compared
with other treatment options in refractory stage IB-IIIB MF. The low-dose has the advantage of
allowing multiple re-treatments over the course of the disease. Combination therapy with a radia-
tion enhancing agent to improve the clinical outcome is currently being investigated in a multi-
center trial.
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11β-hydroxysteroid dehydrogenase type 1 increases with age and photoexposure in human
skin ex vivo
A Tiganescu,1 EA Walker,1 AE Mayes2 and PM Stewart1 1 University of Birmingham,
Birmingham, United Kingdom and 2 Unilever Discover, Bedford, United Kingdom
Skin aging shares many of the clinical features associated with both local (topical steroid therapies)
and systemic (Cushing’s syndrome) glucocorticoid (GC) excess including dryness, itching, der-
mal/epidermal thinning, increased fragility and reduced wound healing. Locally, GC concentrations
are modulated by the enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) which acti-
vates cortisol from cortisone. We have previously reported increased expression of 11β-HSD1 as a
function of donor age in primary human dermal fibroblasts (HDF) which, concomitant with a for-
ward-feedback upregulation by cortisol, may increase dermal tissue GC exposure in the elderly.
Interestingly, 11β-HSD1 expression was also increased in donor-matched photoexposed vs. pho-
toprotected site-derived HDF. Our current study aimed to confirm these in vitro results using skin
punch biopsies from healthy young (18-30 years old) and older (60+ years old) volunteers. Follow-
ing ethical approval and consent, two 3mm biopsies were obtained from both the lower outer
(photoexposed) and inner upper (photoprotected) arm. Biopsies were incubated for 24h with 200nM
cortisone/tritiated cortisone tracer and conversion to cortisol was determined following steroid extrac-
tion and quantification. Results (given as mean % conversion ± S.E) indicated increased cortisone
conversion in older compared to younger photoprotected biopsies (10.2±1.5 vs. 5.6±0.6, p<0.01,
n=10). Additionally, young donor biopsies displayed increased cortisone conversion in photoex-
posed biopsies compared to donor-matched photoprotected (8.9±0.9 vs. 5.6±0.6, p<0.01, n=10).
These results strongly support our previous in vitro data suggesting a shift towards increased corti-
sol activation by 11β-HSD1 in photoexposed human skin and interestingly with age in photopro-
tected human skin. Ongoing studies are focused on establishing functional consequences of these
changes on potential glucocorticoid target genes that may be involved in the photoaging and chrono-
logical aging process in human skin.
543
A role for PD-1 in suppressing T cell activity in human merkel cell carcinomas
M Dowlatshahi, L Wang, JE Teague, MK Lichtman, A Gehad, R Watanabe, WJ Crisler, TS Kupper
and RA Clark The Dana Farber/Brigham and Women’s Cancer Center, Boston, MA
Merkel cell carcinoma (MCC) is a rare but highly malignant skin cancer associated with a novel
polyoma virus. We previously observed that MCC tumors contain T cells with characteristics of
tumor-specific T cells, but that the activation of these T cells was markedly suppressed. We now
report that MCC transplanted to immunodeficient mice failed to grow unless activated T cells were
depleted by infusion of denileukin diftitox, suggesting at least a subset of MCC contain T cells capa-
ble of controlling tumor growth. To identify molecules that could underlie the suppressed T cell
activity observed in these tumors, we carried out luminex studies of tumor supernatants identify
immunosuppressive cytokines and immunostained MCC for known co-signaling molecules expressed
on the cell surface. Comprehensive luminex studies of MCC supernatants failed to detect signifi-
cant quantities of immunosuppressive cytokines. Immunostaining of MCC showed that Merkel tumor
cells lacked expression of GITRL, CD80, CD86, PD-1, PD-L1 and PD-L2. However, CD3+ T cells
within tumors expressed PD-1 by immunostaining. Flow cytometry of T cells isolated from MCC
confirmed that mean 52% of T cells expressed PD-1, despite the fact that these cells were CD69-
CD25- non-activated T cells. PD-1 is expressed by activated T cells but when expressed on T cells
in the tumor microenvironment in the presence of its ligands PD-L1 or PD-L2, it is a marker of T
cell exhaustion. We also observed expression of PD-L2 by a discrete population of non-tumor cells
in MCC tumors. TILs expanded in IL-2 and IL-15 showed increased production of IL-17, IFNγ and
TNFα, suggesting recovery of T cell function. In summary, MCC contain tumor specific T cells but
elements within the tumor microenvironment suppress the activity of these cells. We have identi-
fied PD-1 as a candidate that may mediate T cell suppression. Our work suggests that agents that
block PD-1, currently in clinical trials for the treatment of other malignancies, may have efficacy in
the treatment of MCC.
545
Early rituximab therapy of autoimmune blistering disease is associated with better clinical
response
L Lunardon,1 KJ Tsai,2 N Fett,1 JR Stanley,1 DE Tsai,2 VP Werth1,3 and AS Payne2 1 Dermatology,
Univ of Pennsylvania, Phila, PA, 2 Hematology/Oncology, Univ of Pennsylvania, Phila, PA and
3 Philadelphia VAMC, Phila, PA
Rituximab (RTX) is a chimeric monoclonal anti-CD20 antibody that has recently emerged as an
effective therapeutic option for autoimmune blistering diseases (ABD). We conducted a single cen-
ter retrospective study of 35 ABD patients treated with RTX (13 men, 22 women; 21 pemphigus
vulgaris, 6 pemphigus foliaceus, 4 bullous pemphigoid, 1 mucous membrane pemphigoid, 1 lin-
ear IgA bullous dermatosis, 1 bullous lupus, 1 epidermolysis bullosa acquisita). We examined two
primary endpoints: complete healing of mucocutaneous lesions and ability to discontinue systemic
immunosuppressants. 15 patients (43%) had complete healing of mucocutaneous lesions after
RTX. 11 patients (31%) discontinued systemic immunosuppressants; 4 relapsed after a median dura-
tion of 17 months (range 10-20), and 7 have remained off systemic therapy for a median duration
of 10 months (range 3-65). Endpoints were associated with early RTX therapy; the median duration
of disease prior to RTX in those achieving either endpoint (n=19) was 22 months, compared to 80
months in those not achieving either endpoint (n=16) (p=0.016). Sera from 4 of 10 patients demon-
strated human anti-chimeric antibodies (HACA) by ELISA, which was associated with need for repeat
courses of RTX for disease control or poor response to subsequent courses of RTX. Serious adverse
events (SAE) were observed in 5 patients after RTX (Pneumocystis pneumonia, perirectal phleg-
mon, fatal upper gastrointestinal bleed, melanoma, bladder cancer); only phlegmon was attributed
to RTX. Median duration of disease for patients with SAE after RTX was 124 months, compared to
66 months for those without. SAE were also observed in 6 patients on systemic immunosuppres-
sants prior to RTX (avascular necrosis, vertebral fracture, bleeding gastric ulcer, pulmonary embolism,
MSSA bacteremia, and HSV/MRSA/Pseudomonas superinfection.) These data suggest that early
RTX therapy of ABD leads to better clinical response and that HACA should be monitored.
544
Vitamin encapsulated nanosomes affect changes in Syk and Erk1/2 induced by skin UV expo-
sure
C Sunkari,1 Z Huang,1 J Uitto2 and E Papazoglou1 1 School of Biomedical Engineering, Science
and Health Systems, Drexel University, Philadelphia, PA and 2 Department of Dermatology
and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA
Retinoids, maintain the normal immune functions of the various layers of skin. Exposure of skin to
Ultraviolet Radiation greatly reduces the concentrations of inherent retinoids in skin. Various stud-
ies have shown that the deleterious effects of Solar UV exposure can be mitigated by the pretreat-
ment of the region of interest with various retinoids, particularly Retinol and Retinoic acid. Retinol,
the most active among the forms of Vitamin A is extremely sensitive to oxygen and light. Hence we
employ nano-sized vesicles to encapsulate Retinol and preserve its potency as well as optimize the
delivery of the Retinol to the skin layers. Retinol, α-tocopherol and ascorbic acid encapsulated
“nanosomes” were made with DOPC and sonicated to achieve the required optimal size of
100±32nm. SKH1 Hairless mice were pretreated with the above mentioned liposomes as well as
only retinol and only α-tocopherol and ascorbic acid as controls. The animals were exposed to solar
simulated UV radiation for a period of 10 weeks with above mentioned treatments, after which the
animals were sacrificed. Their skin was harvested and analyzed. Western blots demonstrated a
marked decrease in Erk1/2 and Syk production post UV exposure in the Vitamin loaded nanosome
treated animals as compared to the other treatment groups. Remarkably, the efficacy of the nanosome
encapsulated vitamins is 50% higher compared to the naked vitamins, on a concentration basis.
Therefore,vitamin encapsulation in optimally sized nanosomes stabilizes them and offers a supe-
rior UV protecting agent.
542
Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell trans-
plantation in advanced mycosis fungoides and sezary syndrome
L Singh,1 C Hosing2 and M Duvic1 1 Dermatology, Univ of Texas MD Anderson, Houston, TX
and 2 Stem Cell Transplant, Univ of Texas MD Anderson, Houston, TX
Mycosis fungoides and Sézary (SS) Syndrome are incurable cutaneous T-cell lymphomas with
helper/memory phenotypes. The purpose of this trial was to evaluate safety and efficacy of com-
bining total body skin electron beam with non-ablative allogeniec stem-cell transplant in advanced
patients. Between July 2001 and Nov 2010, 33 CTCL patients -19 females & 14 males with median
age 51.5 (range 19-72) and median of 4 prior treatments (range 1-7) were enrolled. Thiry first received
total body skin electron beam and 31 received the conditioning regimen fludarabine, melphalan
plus thymoglobulin (for mismatched donors). Graft-versus-host-disease (GVHD) prophylaxis was
with tacrolimus/methotrexate. Median time from diagnosis to transplant was 1.7 years (range 0.67
– 9 years). Thirty patients achieved engraftment, two died of early sepsis, and one did not engraft.
Eighteen patients experienced acute GVHD; 13 experienced chronic GVHD. The overall response
rate was 72% (24 of 33). Sixteen patients (48%) are alive in complete remission, five are alive with
relapsed skin lesions, and twelve (36%) are deceased. Five of 14 with relapsed disease, responded
to donor lymphocyte infusions. Causes of death were sepsis (3), progressive disease (6), and non-
CTCL events in four CRs (lung cancer, ARDS, or infection). Large cell transformation (LCT) was
present in 12 pts and two with SS and died with PD. One of 4 pts with folliculotropic MF had a CR,
2 relapsed in skin, and one died. Sixteen of 18 pts with SS achieved CRs in skin and blood and are
ongoing in ten. Overall survival from time of diagnosis is 9.7 years. Overall survival from time of
transplant was not reached. The median progression-free survival from date of transplant is 2.24
years. In conclusion, Total skin electron beam followed by non-ablative allogeneic stem-cell trans-
plant may be curative treatment, especially for patients with Sézary Syndrome.
546
Functional MRI investigations of brain processing of itch sensation in end-stage-renal-dis-
ease patients with chronic pruritus
AD Papoiu, R Coghill, L Banari, R Kraft and G Yosipovitch Wake Forest University Health
Sciences, Winston-Salem, NC
Uremic pruritus represents a significant health problem with a serious impact on the quality of life
of the affected patients and its treatment still poses a challenge to the medical community. Itch can
be experimentally induced using histamine or a tropical plant, cowhage (Mucuna pruriens). Both
forms of itch are transmitted via distinct unmyelinated C nerve fibers to the spinal cord and further
relayed via 2 distinct spinothalamic pathways. Cowhage itch is mediated via proteinase activated
receptors-2 (PAR2). Recent studies suggested that itch could be conveyed at least in part by PAR2
receptors and endogenous proteases, therefore, cowhage itch could serve as a model for pruritus.
In this study, we sought to investigate and contrast by functional MRI the central processing of the
two forms of itch, in uremic patients with chronic pruritus and in healthy volunteers. Fifteen healthy
subjects and eight End Stage Renal Disease (ESRD) patients presenting chronic itch were included.
The functional MRI used Arterial Spin Labeling (ASL) designed to capture long-term effects on cere-
bral perfusion. Functional MRI data was analyzed using FSL software (FMRIB, Oxford, UK) and Gen-
eral Linear Models. Current analyses suggest that in contrast with healthy subjects, the processing
of the two forms of itch slightly differ in ESRD patients. Although cowhage and histamine itches acti-
vate a set of common areas in healthy subjects, the activation appears different in uremic itch. His-
tamine itch activates precuneus, cuneus and the posterior cingulate cortex (PCC), while cowhage
itch is dominantly represented in the anterior cingulate cortex (ACC), PCC, insula & claustrum. A
notable finding is that cowhage itch activates more extensively areas of ACC in ESRD patients. In
conclusion, the divergent pattern of activation induced by cowhage and histamine itch in uremic
patients subtly contrasts with the pattern observed in healthy subjects, and suggests an altered cen-
tral processing of itch sensation in this pathological state.
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Hematopoietic and mesenchymal stem cell transplantation for recessive dystrophic and junc-
tional epidermolysis bullosa
J Tolar,1 JA McGrath,2 DR Keene,3 M Hordinsky,4 MJ Osborn,1 MJ Riddle,1 A Bertin,4 D Woodley,5
M Chen,5 A Hovnanian,6 K Tamai,7 BR Blazar1 and JE Wagner1 1 Pediatric Blood and Marrow
Transplantation, University of Minnesota, Minneapolis, MN, 2 St. John’s Institute of
Dermatology, London, United Kingdom, 3 Shriners Hospital, Portland, OR, 4 Dermatology,
University of Minnesota, Minneapolis, MN, 5 Dermatology, University of Southern California,
Los Angeles, CA, 6 INSERM, Paris, France and 7 Stem Cell Science, Osaka University School
of Medicine, Osaka, Japan
Cellular therapies for recessive dystrophic epidermolysis bullosa (RDEB) resulted in increased col-
lagen type VII (C7) with amelioration of disease. In follow up to a prior study that evaluated allo-
geneic HSC transplantation (HCT) in RDEB, we hypothesized that children with junctional EB (JEB)
might also respond favorably to HCT, and that both RDEB and JEB patients might benefit from the
co-infusion of mesenchymal stem cells (MSCs). 8 children were treated (6 RDEB and 2 JEB) with
HCT followed by infusion of third-party MSCs. HSCs were obtained from siblings (n=3), unrelated
marrow donors (n=2), or unrelated cord blood donors (n=3). As of January 2011, 6 of 8 are alive
13 to 327 days after HCT; one child with JEB died 44 days (unrelated marrow donor) and one child
with RDEB died 101 days (sibling donor) after HCT. Marrow recovery occurred in all patients with
one patient with RDEB having autologous recovery. Of the four remaining patients with RDEB, two
had increased levels of C7, one had no change and one is too early to evaluate. In all patients with
hematopoietic donor engraftment, 6-33% of the skin cells were derived from the HSC donor; in
one patient, 4% of the skin cells were derived from the MSC donor. Notably, two patients with
increased C7 had improved wound healing, and resistance to blister formation. In the one evalu-
able patient with JEB, blistering and erosions markedly decreased. In summary, allogeneic HCT/MSC
transplantation can result in the skin chimerism from both the HSC and MSC donor and in clinical
improvement in patients with JEB as well as RDEB.
536
Curcumin intervention and plasma biomarkers for radiation dermatitis in breast cancer patients
JL Ryan,1,2 M Ling,2 J Williams,2 GR Morrow2 and AP Pentland1 1 Dermatology, University of
Rochester Medical Center, Rochester, NY and 2 Radiation Oncology, University of Rochester
Medical Center, Rochester, NY
Radiation dermatitis occurs in 95% of cancer patients receiving radiation therapy. Currently, there
are no useful treatments or predictive markers for these skin reactions. We conducted a random-
ized, double-blind, placebo-controlled clinical pilot study to examine the use of curcumin for radi-
ation dermatitis. Alterations in pro-inflammatory cytokines and chemokines may be a novel indi-
cator for radiation-induced skin damage and curcumin activity. After informed consent, 30 female
breast cancer patients (93% White, mean age = 58) took twelve 500mg capsules of curcumin or
placebo daily during their course of radiation treatment. Radiation dermatitis severity was meas-
ured weekly using Radiation Dermatitis Score (RDS) ranging from 0 to 4 with 0.5 increments. The
Milliplex® MAP Human Panel I Assay was used to measure plasma levels (pg/ml) of 42 different
cytokines/chemokines in blood collected midway through radiation treatment (mid-RT). ANOVA
analyses, with significance level of 0.05, showed that radiation dermatitis severity was significantly
lower in curcumin-treated patients compared to placebo (mean RDS = 2.57 and 3.41 respectively;
p = 0.005). Correlative and regression analyses revealed that mid-RT plasma levels of Eotaxin (r2 =
0.212; p=0.011) and sIL-2RA (r2 = 0.197; p = 0.014) were predictive of radiation dermatitis sever-
ity at the end of treatment. Logistic regression and tree-based modeling identified mid-RT plasma
levels of Eotaxin (≥ 111 pg/ml; p = 0.02), EGF (≥ 121.9 pg/ml; p =0.014), and GMCSF (≥ 128.5
pg/ml; p=0.009) as potential biomarkers for curcumin. In conclusion, curcumin is a promising
non-toxic intervention for radiation dermatitis in breast cancer patients and specific plasma bio-
markers could be used to monitor radiation dermatitis severity and curcumin treatment. Support:
IND 75,444, Dermatology Foundation, KL2 RR024136, NCI PHS 1R25CA10618, NIAID-U19-
AI067733.
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Oral azathioprine therapy improves the clinical and cutaneous antimicrobial response in chil-
dren with moderate to severe atopic dermatitis
W Tom,1,2 P Kotol,1 D Audish,1 T Cosan2 and R Gallo1 1 Division of Dermatology, University of
California, San Diego, San Diego, CA and 2 Rady Children’s Hospital, San Diego, CA
This prospective study assessed the cutaneous and immunologic effects of systemic immunosup-
pressive therapy with azathioprine on moderate to severe atopic dermatitis (AD), including the
impact on antimicrobial peptide production and defense against secondary infection. Ten children
ages 2 to 18 were treated with oral azathioprine for 24 weeks and compared to 10 children who
remained on topical forms of anti-inflammatory therapy. Primary outcome measures were disease
severity as measured by the SCORAD index, frequency of bacterial and viral skin infections, Staph
aureus bacterial load, and expression of cathelicidin LL-37 as measured by tape stripping at lesional
and nonlesional skin. Subjects in the two arms were of similar median age (azathioprine: 9.5yrs,
range 5-18 yrs; topicals: 9yrs, range 6-15 yrs). The objective SCORAD index decreased from 63.9
+/- 4.7 (mean +/- SD) at baseline to 34.7 +/- 16.2 at 24 weeks of azathioprine therapy (p<0.001).
Pruritus, sleep, investigator global, and subject global scores also improved. Those who remained
on topical therapies had a SCORAD change of 12.3 +/- 11.6 over 24 weeks. The frequency of sec-
ondary infections declined by a greater degree in those given oral azathioprine than those treated
with topical therapy alone. Cathelicidin expression at lesional skin correlated with the intensity sub-
score of SCORAD, but not with serum IgE levels or Staph aureus bacterial load measured at the
same site. On analysis of individual subjects receiving azathioprine, several showed improvement
in LL-37 expression as cutaneous disease was improving, followed by a decline once there was lit-
tle inciting inflammation on the skin. The improvement in AD by azathioprine and reduction in
secondary skin infections may be explained at least in part by enhanced antimicrobial peptide
expression during therapy.
538
T4 endonuclease V liposome (T4N5) treatment ameliorates gene expression profile in actinic
keratoses and sun-exposed skin of renal transplant patients
R Shafi,1 W Cantrell,1 WE Grizzle,2,3 M Athar1,3 and CA Elmets1,2,3 1 Dermatology, University of
Alabama at Birmingham, Birmingham, AL, 2 Pathology, University of Alabama at Birmingham,
Birmingham, AL and 3 Skin Diseases Research Center, University of Alabama at Birmingham,
Birmingham, AL
People who have had kidney transplants are approximately 250 times more likely than the general
population to develop non-melanoma skin cancer (NMSCs) as well as carcinoma in situ (Bowen’s
disease) and actinic keratoses (AK). T4 endonuclease V (T4N5), a DNA repair enzyme encapsu-
lated in an engineered liposome delivery vehicle, has shown promise as a chemopreventive agent.
In this study, we investigated changes in the gene expression profile in AK lesions and sun-exposed
skin in renal transplant patients who had been treated with T4N5. We employed DNA microarray
analysis using high density affymetrix chips. A total of 1169 genes showed a differential gene expres-
sion pattern between AK pre-treatment versus AK post-treatment samples. Of these, 485 genes
were upregulated while the remaining genes were down-regulated. The major clusters of genes that
were regulated by T4N5 were those which are known to be involved in regulation of development
(49%), immune responses (22%), muscle/ cytoskeleton (18%), and DNA damage/apoptosis (11%).
Comparison of the gene expression profile with non-sun-exposed skin revealed that T4N5 treatment
was effective in reversing the gene expression patterns related to the pathogenesis of AK. The strin-
gent genes regulated by T4N5 included STAT1, JUN, PML, BCL2L11 and IF-16 In this regard, T4N5
therapy partially or fully reversed the aberrant expression of genes observed in the untreated AK
thus suggesting a role for T4N5 in normalizing gene expression in AKs. We have selected some of
the biomarkers related to apoptosis and proliferation to validate the gene expression profile. We
observed that T4N5 induces apoptosis and apoptosis-regulating genes in these lesions. Our data
suggest that augmenting the repair of damaged genes can restore the gene expression profile found
in normal non-sun-exposed skin.
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Anthralin successfully treats alopecia areata: A half-side comparison
R Schopf Dermatology, Johannes Gutenberg Univ., Mainz, Germany
Anthralin application is an option for topical immunosuppressant treatment of alopecia areata
(AA). No controlled trials have been done. We report the successful treatment of AA by anthralin
as demonstrated by half-side comparison. Seven patients, 5 female, 2 male, aged 12 to 52 years
(median 36 years) suffering from almost total AA or AA totalis for at least 2 years were treated daily
with 1 or 3% anthralin cream on one half of the scalp only. In addition, 5% minoxidil solution was
applied to the entire scalp twice daily. Skin biopsies were obtained for pathohistology. Scalp pho-
tographs were also taken. In the 7 patients treated, hair growth on the anthralin-treated half of the
scalp set in around 5 months and continued to increase up to 18 months. After definite hair growth
on the treated side, anthralin was also applied to the other half of the scalp. No side effects other
than slight burning and brownish discoloration were noted. In scalp biopsies from treated areas
exhibiting regrowth of hair, the lymphocytic infiltrates surrounding hair follicles tended to vanish,
and the scalp tissue normalized, there were no signs of allergic contact dermatitis. Our results indi-
cate that topical immunosuppressant treatment of alopecia areata for 5 to 18 months with anthralin
combined with topical minoxidil is a safe and efficacious treatment associated with normalization
of scalp tissue.
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Efficient and reliable skin responses with unconventional low-dose total skin electron beam
therapy in mycosis fungoides: A phase II study
C Harrison,1 D Navi,1 B Lingala,1 R Armstrong,1 W Weng,1 U Sundram,1 B Dabaja,2 L Singh,2
M Duvic,2 RT Hoppe1 and YH Kim1 1 Stanford University, Stanford, CA and 2 MD Anderson
Cancer Center, Houston, TX
Standard dose (36 Gy) total skin electron beam therapy (TSEBT) is a highly effective treatment in
mycosis fungoides (MF). The regimen is time intensive and associated with significant treatment
related toxicities. Our retrospective analysis identified 10-15 Gy as a low-dose range with promis-
ing responses in MF. This study was designed to assess the efficacy and safety profile of 12 Gy
TSEBT prospectively. TSEBT naive pts with MF stage IB-IIIB were eligible. TSEBT was given over 3
wks for a total of 12 Gy. Response by mSWAT was assessed at wk 0, 4, and monthly thereafter.
Clinical response was defined as >50% reduction of mSWAT. 15 pts received TSEBT alone, and 5
were treated with TSEBT combined with other agents. Of the TSEBT monotherapy pts (n=15), median
age was 67 yrs (19-83 yrs); 9 were IB, 5 IIB, and 1 IIIA. Median number of prior therapies was 4
(range 1-8). Overall response rate was 87%, with 2 CR. Pts with LCT (IIB) and folliculotropic MF
(IB, IIB) responded. Median time to response and duration of response was 8 wks (4-12 wks) and
22 wks (4-35 wks), respectively. Median time to progression has not been attained at time of analy-
sis. All 5 pts receiving TSEBT with other agents had objective skin responses. TSEBT related toxici-
ties included temporary partial alopecia, reversible nail changes, and mild radiation dermatitis.
Pre/post TSEBT peripheral blood analysis of CD4+, CD8+, CD56+, and FoxP3+ lymphocytes showed
no significant immunosuppression. Our data support that an unconventional low-dose TSEBT is an
effective skin treatment in MF. The responses are efficient/reliable and toxicity minimal as compared
with other treatment options in refractory stage IB-IIIB MF. The low-dose has the advantage of
allowing multiple re-treatments over the course of the disease. Combination therapy with a radia-
tion enhancing agent to improve the clinical outcome is currently being investigated in a multi-
center trial.
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The population pharmacokinetics of briakinumab in subjects with moderate to severe plaque
psoriasis
M Hruska,1 S Paulson,1 M Kaul,2 W Awni3 and P Noertersheuser4 1 Clinical Pharmacokinetics
and Pharmacodynamics, Abbott Laboratories, Abbott Park, IL, 2 Abbott GmbH & Co.,
Ludwigshafen, Germany, 3 Clinical Pharmacology and Pharmacometrics, Abbott Laboratories,
Abbott Park, IL and 4 Pharmacometrics, Abbott GmbH & Co., Ludwigshafen, Germany
The population pharmacokinetics (Pop PK) of briakinumab were characterized using data from one
Phase 1 study in healthy volunteers, and one Phase 2 and four Phase 3 studies in subjects with
moderate to severe plaque psoriasis. The Pop PK model described the relationships between briak-
inumab serum concentration-time data and subject-specific covariates to explain variability. The
model was built using nonlinear mixed effect modeling (NONMEM) based on NONMEM VI with
the Intel Fortran compiler (Version 9). The first-order conditional estimation method (FOCE) with
INTERACTION (FOCEI) was employed within NONMEM. Briakinumab pharmacokinetics were
described as a two compartment model. Clearance (CL) and volume of distribution in the central
compartment (Vc) estimates were 0.779 L/day and 6.04 L, with interindividual variabilities of 7.0%
and 16.9%, respectively. Statistically significant effects of body weight, gender, and presence of
binding and neutralizing anti-drug antibodies on CL, race on Vc, and weight on volume of distri-
bution of peripheral compartment (Vp) were found. Other tested covariates did not statistically sig-
nificantly affect these parameters. A power function was found to be most appropriate for the resid-
ual error model. Model evaluation including bootstrapping and visual predictive checks suggested
that the final pharmacokinetic model was robust.
555
Biosensor system to detect the tumor reactive population in bulk tumor infiltrating T cells
T Inozume,1,2 K Hanada,2 SA Rosenberg,2 S Shimada1 and JC Yang2 1 Dermatology, Yamanashi
University, Chuo, Japan and 2 National Cancer Institute, Bethesda, MD
Adoptive transfer of in vitro expanded tumor-infiltrating lymphocyte (cultured-TIL) can be clinically
effective in patients with advanced melanoma (objective responsive rates of 49 –72%) with some
patients maintaining complete responses beyond 5 years. This may imply that melanoma infiltrat-
ing T-cells contain the population that can abrogate metastatic tumors in vivo, if appropriately
expanded in vitro and returned to the patients. To develop the methods to enrich the tumor reac-
tive population from uncultured bulk melanoma TILs, we utilized the self-inactivating retroviral vec-
tor containing multiple nuclear factor of activated T-cell (NFAT)-binding sites, followed by the min-
imal IL-2 promoter and the reporter gene GFP (Blood, 2000). First, We tested the GFP expression
in tumor specific CD8+ and CD4+ T cell lines that transduced with this construct, and we could
confirm that T cells transduced with this construct can express GFP by stimulation with specific
tumor antigens. Also we could confirm that the GFP positive populations are functional, by intra-
cellular IFN-gamma staining after the stimulation. Then, we attempted to isolate the tumor specific
population from uncultured bulk melanoma tumor digests using this system. T cells in tumor digests
were transduced with the construct (estimated transduction efficiency was 40-80%) and stimulated
with HLA-class I matched stimulator cells pulsed with melanoma antigen peptides. After the stim-
ulation, GFP positive populations were successfully induced. Sorted and expanded GFP positive
populations showed significantly higher reactivity to the cells expressing the cognate HLA-antigen
complex, compared with unsorted bulk populations. This technique would be useful to isolate not
only melanoma antigen specific T cells, but also various kinds of antigen specific T cells from bulk
T cells.
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β2-adrenergic agonists bias TLR-2- and-NOD2-activated dendritic cells towards inducing an
IL-17 immune response
M Manni,1 RD Granstein1 and G Maestroni2 1 Dermatology, Weill Cornell Medical College,
New York, NY and 2 Center for Experimental Pathology, Cantonal Institute of Pathology,
Locarno, Switzerland
Initiation and polarization of the adaptive immune response is controlled by innate immune recog-
nition mediated by dendritic cells (DCs). Previous studies demonstrated that adrenergic receptors
(ARs) modulate cytokine production by DCs and affect their T helper (Th) cell priming ability. In this
study we tested the hypothesis that activation of β2-ARs on DCs influences nucleotide-binding
oligomerization domain 2 (NOD2) signaling along with its cross-talk with Toll-like receptor-2 (TLR-
2) resulting in an altered Th cell priming ability. We show that the β2-ARs agonist salbutamol enhanced
IL-6 production in murine bone marrow-derived DCs stimulated with the NOD2 ligand muramyl
dipeptide (MDP). However, when the TLR-2 ligand Pam3CysSK4 was added, salbutamol inhibited
IL-12 but did not alter IL-6 and IL-23 production. Gene expression analysis showed that salbuta-
mol inhibited the IL-12 and IL-23 shared p40 subunit as well as IL-12p35, while IL-23p19 was
stimulated. Therefore, β2-AR-modulated cytokine production resulted in a cytokine pattern sug-
gestive of Th17 cell priming. Indeed, when antigen-pulsed DCs stimulated by MDP or
Pam3CysSK4+MDP in the presence of salbutamol were used for in vivo immunization, the result-
ing Th17/Th1 cell ratio was increased as evaluated by IL-17 and IFN-γ production. In addition, direct
intradermal injection of norepinephrine along with Pam3CysSK4 and MDP increased the Th17
response to an immunogenic protein. This effect was reversed by a β2-AR antagonist. Thus, β2-ARs
represent an important mechanism by which the adaptive immune response to certain pathogens
is regulated. Remarkably, β2-ARs might be involved in defense against extracellular bacteria and in
the pathogenesis of inflammatory diseases by modulating Th17 polarization.
556
Preferential expression of miR-10a in regulatory T cells
H Takahashi, Y Kanno, S Nakayamada, S Kuchen-Brandes, R Casellas and JJ O’Shea National
Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health,
Bethesda, MD
MicroRNAs (miRNAs) are small non-coding, single-stranded RNAs of 21-23 nucleotides in length,
which regulate gene expression by causing degradation of target mRNA or by blocking mRNA trans-
lation into protein. Recently new roles of miRNAs in immune cells have started to emerge. In order
to capture the global view of miRNA expression in various lymphocyte subsets, we have used deep
sequencing to establish a comprehensive map of miRNA expression (microRNome) for T helper
cell lineages including naïve CD4+ T cells, Th1, Th2, Th17, nTreg and iTreg. Of over 600 mouse miR-
NAs, 145 miRNAs were detected at more than 100 sequence tags per million in at least one of
these Th subsets. By comparing the levels of miRNAs expressed in nTreg with those in all other Th
effector subsets, miR-10a-5p was identified as one of the most selective miRNAs specifically expressed
in regulatory T cell populations. Quantitative PCR analysis further confirmed the selective expres-
sion of miR-10a-5p to Tregs, suggesting its potential role in shaping Treg phenotype. Interestingly,
retinoic acid (RA), which is a well-known reagent to enhance iTreg differentiation, strongly induced
miR-10a-5p expression in CD4+ T cells in combination with TGF-β. It was found that the RA effect
on miR-10a-5p expression was mediated by RA receptor α. To gain insights into the roles of miR-
10a in Tregs, we have generated lentiviral vectors for over-expressing or sequestering miR-10a-5p.
Successful over-expression was achieved by using splicing mechanism of CD19 intron with miR-
10a sequence placed within the CD19 intron cassette. Functional knock down of miR-10a was
achieved by expressing d4EGFP that carries multimerized “sponge target sequence” for miR-10a-
5p at its end to sequester endogenously expressed miR-10a. These tools will be useful to explore
the roles of miR-10a-5p in Tregs via RA signaling pathway.
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HIV infection and non-melanoma skin cancer risk 
MJ Silverberg,1 W Leyden,1 E Warton,1 EA Engles2 and MM Asgari1 1 Division of Research, Kaiser
Permanente Northern California, Oakland, CA and 2 Division of Cancer Epidemiology and
Genetics, National Cancer Institute, Rockville, MD
HIV patients have a higher risk of several cancers, particularly those with known viral etiology,
such as Kaposi sarcoma and anal cancer. However it is unknown whether non-melanoma skin can-
cers (NMSCs) are also increased since cancer registries typically do not record these cancers. We
identified all adult HIV+ members of white race (n=6,567) and age-, sex- and race-matched HIV-
individuals (n=36,887) enrolled in Kaiser Permanente Northern California (KPNC), an integrated
health system caring for over 3 million Californians. NMSC diagnoses, identified through review of
KPNC pathology records, included the first biopsy-proven basal cell carcinoma (BCC, n=2,078) and
squamous cell carcinoma (SCC, n=626) from 1996-2008. The cohort was followed from first KPNC
enrollment after 1996 until the earliest skin cancer diagnosis, loss to follow-up, or 12/31/2008.
Adjusted rate ratios (aRR) were obtained from Poisson regression models with adjustment for age,
sex, tobacco use, obesity and census-based median household income. The HIV+ cohort was 89%
male, 72.2% men who have sex with men, with a mean age of 42.2 years. BCC occurrence per
100,000 person-years was 1,188 for HIV+ subjects and 661 for HIV- subjects, corresponding to an
aRR of 2.0 (95% CI: 1.8-2.3; P<0.001). SCC occurrence was 410 for HIV+ subjects and 186 for HIV-
subjects, yielding an aRR of 2.6 (95% CI: 2.1-3.1; P<0.001). SCC risk was increased in HIV+ men
and women equally (p-interaction = 0.90), but BCC risk was increased in HIV+ men only (p-inter-
action = 0.041). The higher rate of NMSCs in HIV+ individuals may be due, in part, to alterations
in the immune system, although other explanations such as a screening bias, or differential risk
behaviors, such as increased sun exposure, need further exploration.
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A class 4 semaphorin, Sema4B regulates activation of basophils
Y Nakagawa,1 H Takamatsu,2 I Katayama1 and A Kumanogoh2 1 Department of Dermatology,
Osaka University Graduate School of Medicine, Suita, Japan and 2 Department of Respiratory
Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine,
Suita, Japan
Although semaphorins are originally identified as axon guidance cues in the nervous system, recent
evidence has indicated that they are crucially involved in various phases of immune responses. The
class 4 semaphorin subclass, that are transmembrane-type proteins, consist of seven members,
Sema4A-4G. We have previously reported that Sema4A and Sema4D have co-stimulatory mole-
cule-like activities to stimulate T cells and B cells, respectively. In particular, Sema4A plays an impor-
tant role in helper T cell (Th) differentiation, of which defects result in the development of atopic
dermatitis. These findings indicate roles of class 4 semaphorins in the immune system. We here pres-
ent a novel immune semaphorin, Sema4B for regulating basophil activation. In a screen for sema-
phorins that function in the immune system, we determined that Sema4B is expressed in T cells and
B cells. Interestingly, Sema4B-deficient mice had considerably elevated serum IgE levels despite
normal lymphocyte and dendritic cell functions. Recombinant Sema4B significantly inhibited IL-4
and IL-6 production from basophils in response to various stimuli including IL-3, papain and FcεRI-
crosslinking. In addition, T cell-derived Sema4B, which accumulated at contact sites between
basophils and CD4+ T cells, suppressed basophil-mediated Th2 skewing, suggesting that Sema4B
regulates basophil responses through cognate cell-cell contacts. Furthermore, Sema4B-deficient
mice had enhanced basophil-mediated memory IgE production, which was abolished by treating
with an anti-FcεRIα antibody. Collectively, these results indicate that Sema4B negatively regulates
basophil-mediated Th2 and humoral memory responses.
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Reversal of local immune evasion mechanisms and regression of human Merkel cell carci-
noma by intralesional injection of interferon-beta
K Paulson,1 A Tegeder,1 C Willmes,3 J Iyer,1 D Schrama,3 D Koelle,1 M Cleary,2 S Bhatia,1 J Becker3
and P Nghiem1 1 Medicine/Dermatology, University of Washington, Seattle, WA, 2 Merck
Research Laboratories, North Wales, PA and 3 Dermatology, University of Graz, Graz, Austria
Merkel cell carcinoma (MCC) is an often-lethal neuroendocrine skin cancer associated with a recently
discovered, common polyomavirus. Virus-encoded oncoproteins are persistently expressed in ~75%
of MCCs, and these non-self proteins should generate cellular immune responses. Although several
forms of T-cell immunosuppression are associated with increased risk of MCC, over 90% of MCC
patients have no known systemic immune suppression, and in these cases, T-cell evasion may be
driven locally by the tumor. Here we report that 51% of MCCs (n=114) demonstrate tumor-specific
down-regulation of class I MHC, an effective mechanism for evasion of cytotoxic T cells, which have
been strongly associated with improved survival in this cancer. In MCC cell lines, MHC-I down-
regulation was reversible by treatment with any of several interferons. Re-expression of MHC-I was
persistent and stable in MCC cells after transient exposure to interferon followed by washout. Indeed,
systemic interferon has been previously explored in the management of MCC but has been inef-
fective. Systemic administration may fail because of insufficient drug delivery to the tumor microen-
vironment, compensatory systemic immunoregulatory processes, or lack of a gradient in concen-
tration focused at the tumor. Intralesional injection of interferon into MCC tumors was explored to
potentially overcome these problems. This treatment led to restoration of MHC-I expression, recruit-
ment of CD8+ lymphocytes to the tumor, and local MCC regression in each of four cases. MCC
tumors thus exhibit evidence of local immune evasion and intralesional cytokine therapy may be
useful in promoting T cell recognition of this virus-associated malignancy.
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Psoriasis family history portends earlier age of onset, higher incidence of psoriatic arthritis,
and increased likelihood of biologic treatment in psoriasis patients
N Borkar, D Kast, I Grozdev, D Carlson, L Cao, R Feig, P Pujari, B Schmotzer, D Babineau,
T McCormick, K Cooper and N Korman Dermatology, Murdough Family Center for Psoriasis,
Case Western Reserve University and University Hospitals Case Medical Center, Cleveland,
OH
Few studies correlating family history (FH) of psoriasis (self-reported) with endpoints and comor-
bidities such as psoriasis severity, age of onset, cardiovascular (CV) history, diagnosis of psoriatic
arthritis, and biologic therapy status exist. We enrolled 512 psoriasis patients in the Murdough
Family Center for Psoriasis database, which included self-reporting of family members with psori-
asis. A positive FH was defined as a first-degree relative or grandparent with psoriasis. FH of psori-
asis was correlated to disease severity, mean age of onset, history of PsA, CV events, (MI, aneurysm,
stroke, coronary stent or bypass, blockage of arteries on angiography, carotid artery or peripheral
artery revascularization), and treatment with biologics. 44% of patients (n=228) had a FH of psori-
asis while 56% (n=284) did not. Confirming previous reports, the average age of psoriasis onset in
patients with a FH of psoriasis was 24.5 years, while the average age of psoriasis onset in patients
with no FH of psoriasis was 32.5 years (p<0.001). 31.9% of patients with a FH of psoriasis had pso-
riatic arthritis, while 19.9% of patients with no FH of psoriasis had psoriatic arthritis (p=0.002).
26.3% of patients with a FH of psoriasis were currently being treated with a biologic for their pso-
riasis, while 18.3% of patients with no FH of psoriasis were currently being treated with a biologic
(p=0.03). There were no differences in the severity of psoriasis (as defined by PASI or BSA) or the
incidence of CV events or frequency of hypertension, diabetes, and metabolic syndrome, between
patients with and without a FH of psoriasis. In conclusion, our data demonstrates that FH of psori-
asis predicts earlier onset of psoriasis, likelihood of developing PsA as well as treatment with bio-
logics. We therefore suggest that clinicians caring for psoriasis patients collect FH data.
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An investigator-initiated, phase II randomized, double-blind, placebo-controlled trial of GDC-
0449 for prevention of BCCs in basal cell nevus syndrome (BCNS) patients 
JY Tang,1,2 JM Mackay-Wiggan,3 M Aszterbaum,1 J Lindgren,1 K Chang,1 C Coppola,3 A Campbell,3
A Chanana,1 J Marji,3 DR Bickers3 and EH Epstein1 1 Children’s Hospital of Oakland Research
Institute, Oakland, CA, 2 Dermatology, Stanford University, Redwood City, CA and 3
Dermatology, Columbia University, New York, NY
GDC-0449 (Genentech) is a new Hedgehog Pathway inhibitor that has been shown in a Phase I
trial to reduce locally aggressive/metastatic BCCs. We tested the anti-BCC efficacy of GDC-0449 in
a randomized, double-blind, placebo-controlled trial in patients with BCNS. We enrolled 41 BCNS
subjects at 3 clinical centers from September 2009 to January 2011. Subjects were randomized to
receive daily oral GDC-0449 (150mg) or placebo (2:1) for 18 months. The primary endpoint was
reduction of new surgically eligible BCCs after 3 months; secondary endpoints included reducing
existing BCCs and safety/tolerability. Twenty-nine subjects have been followed for an average of 6
months. Upon review of results at the interim analysis, the DSMB voted to end the placebo arm of
the trial due to statistically significant differences between the 2 groups. GDC-0449 reduced the
rate of new BCCs compared to the placebo group (0.07 new BCCs per month vs. 1.74 BCCs per
month placebo, p<0.0001) and reduced the size of existing BCCs (-24cm vs. -3cm placebo, p=0.006).
Some subjects achieved near complete remission with no BCC developing resistance. Subjects on
GDC-0449 had significant increases in grade 1-2 taste loss, muscle cramps, and weight loss com-
pared to placebo (p<0.01). Two subjects experienced grade 3-4 adverse events. Overall 20% of
GDC-0449 subjects discontinued drug participation due to adverse events. In conclusion, dramatic
anti-BCC efficacy in BCNS patients and may be a potential new drug for BCC prevention.
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Clinical benefits of topical application of Artemisia abrotanum (Southernwood)) on photo-
damaged skin
M Russell, T Zedayko, C Saliou and S Tucker-Samaras Johnson and Johnson, Skillman, NJ
Skin aging is a complex process integrating time and environmental exposure which involves more
than just the surface of the skin. There are effects in all three layers of the skin, which results in the
outward appearance of the aging process. Aqueous extracts of Southernwood provide numerous
benefits to all layers of the skin as demonstrated by in-vitro testing in models designed to mimic the
pathways of aging and skin imbalance. Two studies were performed to assess the activity of this
extract in vivo. Fifteen patients with mild to moderate dryness on the outer aspect of the lower leg
were enrolled in the first study. Panelists applied the aqueous extract on one leg, and a placebo on
the other, twice a day for two weeks. Moisturization was measured by Skicon, and TEWL was
measured to correlate to the in vitro data suggesting lipid upregulation in the epidermis. In addition
samples were obtained to measure the lipid content of the stratum corneum to further correlate the
data. In the second study, twenty patients with moderate coarse wrinkling in the crow’s feet and
upper cheek areas, moderate pigmentation, bilateral overall photodamage and moderate sagging
were enrolled in the study. The design was a double-blind split face study where the patients applied
the facial moisturizer and placebo twice a day to the appropriate side of the face. Clinical evalua-
tions and imaging demonstrated the moisturizer’s multiple skin benefits throughout the study. The
facial treatment was particularly effective in improvement of fine lines, mottled pigmentation and
radiance(p<0.05) versus a placebo treatment, while also providing significant improvements in over-
all photodamage. Taken together these studies show that the aqueous extract of southernwood to
provide meaningful benefits in the visual appearance of aging skin.
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Age-matched multiplex analysis reveals global immune dysregulation in patients with CTCL
LJ Geskin,1,2 OE Akilov,1 DE Linzer,2 Y Lin,2 LD Falo1 and AE Lokshin2 1 Dermatology, University
of Pittsburgh, Pittsburgh, PA and 2 University of Pittsburgh Cancer Institute, Hillman Cancer
Center, Pittsburgh, PA
Cutaneous T cell lymphoma (CTCL) is a heterogeneous group of epidermotropic extranodal non-
Hodgkin’s lymphomas. There are no definitive specific biomarkers available which can predict prog-
nosis and clinical responses to therapies. To evaluate global immunologic environment in CTCL
patients, serum samples from 30 CTCL patients and 756 healthy volunteers were analyzed by Luminex
multi-analyte bioassay detection system for over 30 serum biomarkers. Age-adjusted expression
differs significantly among cases and controls for the following: EGF, EOTAXIN (CCL11), HGF, IL-
8, IL-12p40, IP10, TNFR1, G-CSF, IFN-γ, IL-5, IL-7, MIP-1B, and TNF-α (p<0.05). Among younger
patients, there was a significant difference in expression of DR5, IFN-α, and MIP-1A (p<0.05). Con-
sistent with prior observations, we found increase in IL-7, which promotes malignant T-cell prolif-
eration; increase in IL-8 associated with systemic activation of neutrophils; increase in eotaxin
(CCL11), an eosinophil-selective chemoattractant, associated with high eosinophil counts and pru-
ritus, especially in older patients. CCL11 is secreted in response to Th2-inflammatory cytokines and
TNF-α and shares common chemokine receptor 5 (CCR5) with MIP-1B (elevated in our patients);
CCR5 is important in skin homing of malignant lymphocytes in CTCL. In conclusion, we con-
ducted comprehensive evaluation of serum immunologic markers in CTCL. Our data demonstrates
global immune dysbalances in CTCL, including, but not limited to markers associated with neu-
trophil and eosinophil activation; increase in IP-10 and IFN-γ, which may be reflective of host anti-
tumor responses, all of which may be important in pathophysiology of CTCL. Clinical correlation
of abnormally expressed markers with the stage of CTCL, prognosis and response to therapy and in
vitro evaluation of abnormally expressed biomarkers on all compartments of immune system, includ-
ing lymphocytes, neutrophils, eosinophils, and keratinocytes are warranted.
552
The comorbidities associated with serum vitamin D deficiency in veteran patients with pso-
riasis
C Young,2,1 S Fatima,1 B Workman,1 J Kado1 and L Savoy2 1 Dermatology, Wayne State
University, Detroit, MI and 2 Dermatology, John D Dingell VA Medical Center, Detroit, MI
The objectives of this study were to assess serum vitamin D in a group of veteran patients with pso-
riasis and to ascertain associations between vitamin D status and key clinical factors and disease
severity. In addition the effect of oral supplemental vitamin D3 on serum 25(OH) vitamin D level
in psoriasis patients were studied. The comorbidities associated each psoriatic patient were evalu-
ated. The study was a randomized controlled trial and conducted at John D Dingell Veterans Med-
ical center in Detroit Michigan. Data were drawn from 65 psoriatic patients seen in VA outpatient
clinic. 25(OH)Vitamin D levels were evaluated along with markers of disease activity, physician and
patient global assessments, PASI score calculated. Vitamin D deficiency was defined as 25(OH)D
levels<32 ng/ml. Among psoriasis patients with hypovitaminosis D [25(OH)D < 32 ng/ml], randomly
divided into four groups, each group received oral vitamin D3 (cholecalciferol) therapy at a dose
of 400 IU daily, 1000 IU daily, 4000 IU daily or 50,000 IU weekly respectively for 52 weeks. Blood
samples were drawn before, at the week 26 at week 52. Serum measurements of 25(OH)D, PTH,
calcium, Comprehensive metabolic panel and homocysteine and C-reactive protein were meas-
ured. Blood 25(OH) Vitamin D level from 60 patients with hypovitaminosis D increased in all four
groups patients with psoriasis, however rapidly and significantly increased in patients receiving vita-
min D3 supplement at doses of 4000 IU daily No direct correlation was observed between PASI
score improvement and vitamin D treatment. Vitamin D3 supplemental at doses 4000 IU daily are
efficient and safe way to raise deficient serum 25(OH) vitamin D levels to a preferred target levels.
The metabolic syndrome comorbidities associated with each psoriatic patient before and after
treatment of Vitamin D were evaluated. The health benefits of vitamin D3 oral supplements on meta-
bolic syndrome comorbidities associated with psoriasis were elucidated and discussed.
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The population pharmacokinetics of briakinumab in subjects with moderate to severe plaque
psoriasis
M Hruska,1 S Paulson,1 M Kaul,2 W Awni3 and P Noertersheuser4 1 Clinical Pharmacokinetics
and Pharmacodynamics, Abbott Laboratories, Abbott Park, IL, 2 Abbott GmbH & Co.,
Ludwigshafen, Germany, 3 Clinical Pharmacology and Pharmacometrics, Abbott Laboratories,
Abbott Park, IL and 4 Pharmacometrics, Abbott GmbH & Co., Ludwigshafen, Germany
The population pharmacokinetics (Pop PK) of briakinumab were characterized using data from one
Phase 1 study in healthy volunteers, and one Phase 2 and four Phase 3 studies in subjects with
moderate to severe plaque psoriasis. The Pop PK model described the relationships between briak-
inumab serum concentration-time data and subject-specific covariates to explain variability. The
model was built using nonlinear mixed effect modeling (NONMEM) based on NONMEM VI with
the Intel Fortran compiler (Version 9). The first-order conditional estimation method (FOCE) with
INTERACTION (FOCEI) was employed within NONMEM. Briakinumab pharmacokinetics were
described as a two compartment model. Clearance (CL) and volume of distribution in the central
compartment (Vc) estimates were 0.779 L/day and 6.04 L, with interindividual variabilities of 7.0%
and 16.9%, respectively. Statistically significant effects of body weight, gender, and presence of
binding and neutralizing anti-drug antibodies on CL, race on Vc, and weight on volume of distri-
bution of peripheral compartment (Vp) were found. Other tested covariates did not statistically sig-
nificantly affect these parameters. A power function was found to be most appropriate for the resid-
ual error model. Model evaluation including bootstrapping and visual predictive checks suggested
that the final pharmacokinetic model was robust.
555
Biosensor system to detect the tumor reactive population in bulk tumor infiltrating T cells
T Inozume,1,2 K Hanada,2 SA Rosenberg,2 S Shimada1 and JC Yang2 1 Dermatology, Yamanashi
University, Chuo, Japan and 2 National Cancer Institute, Bethesda, MD
Adoptive transfer of in vitro expanded tumor-infiltrating lymphocyte (cultured-TIL) can be clinically
effective in patients with advanced melanoma (objective responsive rates of 49 –72%) with some
patients maintaining complete responses beyond 5 years. This may imply that melanoma infiltrat-
ing T-cells contain the population that can abrogate metastatic tumors in vivo, if appropriately
expanded in vitro and returned to the patients. To develop the methods to enrich the tumor reac-
tive population from uncultured bulk melanoma TILs, we utilized the self-inactivating retroviral vec-
tor containing multiple nuclear factor of activated T-cell (NFAT)-binding sites, followed by the min-
imal IL-2 promoter and the reporter gene GFP (Blood, 2000). First, We tested the GFP expression
in tumor specific CD8+ and CD4+ T cell lines that transduced with this construct, and we could
confirm that T cells transduced with this construct can express GFP by stimulation with specific
tumor antigens. Also we could confirm that the GFP positive populations are functional, by intra-
cellular IFN-gamma staining after the stimulation. Then, we attempted to isolate the tumor specific
population from uncultured bulk melanoma tumor digests using this system. T cells in tumor digests
were transduced with the construct (estimated transduction efficiency was 40-80%) and stimulated
with HLA-class I matched stimulator cells pulsed with melanoma antigen peptides. After the stim-
ulation, GFP positive populations were successfully induced. Sorted and expanded GFP positive
populations showed significantly higher reactivity to the cells expressing the cognate HLA-antigen
complex, compared with unsorted bulk populations. This technique would be useful to isolate not
only melanoma antigen specific T cells, but also various kinds of antigen specific T cells from bulk
T cells.
557
β2-adrenergic agonists bias TLR-2- and-NOD2-activated dendritic cells towards inducing an
IL-17 immune response
M Manni,1 RD Granstein1 and G Maestroni2 1 Dermatology, Weill Cornell Medical College,
New York, NY and 2 Center for Experimental Pathology, Cantonal Institute of Pathology,
Locarno, Switzerland
Initiation and polarization of the adaptive immune response is controlled by innate immune recog-
nition mediated by dendritic cells (DCs). Previous studies demonstrated that adrenergic receptors
(ARs) modulate cytokine production by DCs and affect their T helper (Th) cell priming ability. In this
study we tested the hypothesis that activation of β2-ARs on DCs influences nucleotide-binding
oligomerization domain 2 (NOD2) signaling along with its cross-talk with Toll-like receptor-2 (TLR-
2) resulting in an altered Th cell priming ability. We show that the β2-ARs agonist salbutamol enhanced
IL-6 production in murine bone marrow-derived DCs stimulated with the NOD2 ligand muramyl
dipeptide (MDP). However, when the TLR-2 ligand Pam3CysSK4 was added, salbutamol inhibited
IL-12 but did not alter IL-6 and IL-23 production. Gene expression analysis showed that salbuta-
mol inhibited the IL-12 and IL-23 shared p40 subunit as well as IL-12p35, while IL-23p19 was
stimulated. Therefore, β2-AR-modulated cytokine production resulted in a cytokine pattern sug-
gestive of Th17 cell priming. Indeed, when antigen-pulsed DCs stimulated by MDP or
Pam3CysSK4+MDP in the presence of salbutamol were used for in vivo immunization, the result-
ing Th17/Th1 cell ratio was increased as evaluated by IL-17 and IFN-γ production. In addition, direct
intradermal injection of norepinephrine along with Pam3CysSK4 and MDP increased the Th17
response to an immunogenic protein. This effect was reversed by a β2-AR antagonist. Thus, β2-ARs
represent an important mechanism by which the adaptive immune response to certain pathogens
is regulated. Remarkably, β2-ARs might be involved in defense against extracellular bacteria and in
the pathogenesis of inflammatory diseases by modulating Th17 polarization.
556
Preferential expression of miR-10a in regulatory T cells
H Takahashi, Y Kanno, S Nakayamada, S Kuchen-Brandes, R Casellas and JJ O’Shea National
Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health,
Bethesda, MD
MicroRNAs (miRNAs) are small non-coding, single-stranded RNAs of 21-23 nucleotides in length,
which regulate gene expression by causing degradation of target mRNA or by blocking mRNA trans-
lation into protein. Recently new roles of miRNAs in immune cells have started to emerge. In order
to capture the global view of miRNA expression in various lymphocyte subsets, we have used deep
sequencing to establish a comprehensive map of miRNA expression (microRNome) for T helper
cell lineages including naïve CD4+ T cells, Th1, Th2, Th17, nTreg and iTreg. Of over 600 mouse miR-
NAs, 145 miRNAs were detected at more than 100 sequence tags per million in at least one of
these Th subsets. By comparing the levels of miRNAs expressed in nTreg with those in all other Th
effector subsets, miR-10a-5p was identified as one of the most selective miRNAs specifically expressed
in regulatory T cell populations. Quantitative PCR analysis further confirmed the selective expres-
sion of miR-10a-5p to Tregs, suggesting its potential role in shaping Treg phenotype. Interestingly,
retinoic acid (RA), which is a well-known reagent to enhance iTreg differentiation, strongly induced
miR-10a-5p expression in CD4+ T cells in combination with TGF-β. It was found that the RA effect
on miR-10a-5p expression was mediated by RA receptor α. To gain insights into the roles of miR-
10a in Tregs, we have generated lentiviral vectors for over-expressing or sequestering miR-10a-5p.
Successful over-expression was achieved by using splicing mechanism of CD19 intron with miR-
10a sequence placed within the CD19 intron cassette. Functional knock down of miR-10a was
achieved by expressing d4EGFP that carries multimerized “sponge target sequence” for miR-10a-
5p at its end to sequester endogenously expressed miR-10a. These tools will be useful to explore
the roles of miR-10a-5p in Tregs via RA signaling pathway.
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HIV infection and non-melanoma skin cancer risk 
MJ Silverberg,1 W Leyden,1 E Warton,1 EA Engles2 and MM Asgari1 1 Division of Research, Kaiser
Permanente Northern California, Oakland, CA and 2 Division of Cancer Epidemiology and
Genetics, National Cancer Institute, Rockville, MD
HIV patients have a higher risk of several cancers, particularly those with known viral etiology,
such as Kaposi sarcoma and anal cancer. However it is unknown whether non-melanoma skin can-
cers (NMSCs) are also increased since cancer registries typically do not record these cancers. We
identified all adult HIV+ members of white race (n=6,567) and age-, sex- and race-matched HIV-
individuals (n=36,887) enrolled in Kaiser Permanente Northern California (KPNC), an integrated
health system caring for over 3 million Californians. NMSC diagnoses, identified through review of
KPNC pathology records, included the first biopsy-proven basal cell carcinoma (BCC, n=2,078) and
squamous cell carcinoma (SCC, n=626) from 1996-2008. The cohort was followed from first KPNC
enrollment after 1996 until the earliest skin cancer diagnosis, loss to follow-up, or 12/31/2008.
Adjusted rate ratios (aRR) were obtained from Poisson regression models with adjustment for age,
sex, tobacco use, obesity and census-based median household income. The HIV+ cohort was 89%
male, 72.2% men who have sex with men, with a mean age of 42.2 years. BCC occurrence per
100,000 person-years was 1,188 for HIV+ subjects and 661 for HIV- subjects, corresponding to an
aRR of 2.0 (95% CI: 1.8-2.3; P<0.001). SCC occurrence was 410 for HIV+ subjects and 186 for HIV-
subjects, yielding an aRR of 2.6 (95% CI: 2.1-3.1; P<0.001). SCC risk was increased in HIV+ men
and women equally (p-interaction = 0.90), but BCC risk was increased in HIV+ men only (p-inter-
action = 0.041). The higher rate of NMSCs in HIV+ individuals may be due, in part, to alterations
in the immune system, although other explanations such as a screening bias, or differential risk
behaviors, such as increased sun exposure, need further exploration.
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A class 4 semaphorin, Sema4B regulates activation of basophils
Y Nakagawa,1 H Takamatsu,2 I Katayama1 and A Kumanogoh2 1 Department of Dermatology,
Osaka University Graduate School of Medicine, Suita, Japan and 2 Department of Respiratory
Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine,
Suita, Japan
Although semaphorins are originally identified as axon guidance cues in the nervous system, recent
evidence has indicated that they are crucially involved in various phases of immune responses. The
class 4 semaphorin subclass, that are transmembrane-type proteins, consist of seven members,
Sema4A-4G. We have previously reported that Sema4A and Sema4D have co-stimulatory mole-
cule-like activities to stimulate T cells and B cells, respectively. In particular, Sema4A plays an impor-
tant role in helper T cell (Th) differentiation, of which defects result in the development of atopic
dermatitis. These findings indicate roles of class 4 semaphorins in the immune system. We here pres-
ent a novel immune semaphorin, Sema4B for regulating basophil activation. In a screen for sema-
phorins that function in the immune system, we determined that Sema4B is expressed in T cells and
B cells. Interestingly, Sema4B-deficient mice had considerably elevated serum IgE levels despite
normal lymphocyte and dendritic cell functions. Recombinant Sema4B significantly inhibited IL-4
and IL-6 production from basophils in response to various stimuli including IL-3, papain and FcεRI-
crosslinking. In addition, T cell-derived Sema4B, which accumulated at contact sites between
basophils and CD4+ T cells, suppressed basophil-mediated Th2 skewing, suggesting that Sema4B
regulates basophil responses through cognate cell-cell contacts. Furthermore, Sema4B-deficient
mice had enhanced basophil-mediated memory IgE production, which was abolished by treating
with an anti-FcεRIα antibody. Collectively, these results indicate that Sema4B negatively regulates
basophil-mediated Th2 and humoral memory responses.
www.jidonline.org   S93
SID11_Abstracts-5  2/28/11  9:27 AM  Page S93
ABSTRACTS
547
Reversal of local immune evasion mechanisms and regression of human Merkel cell carci-
noma by intralesional injection of interferon-beta
K Paulson,1 A Tegeder,1 C Willmes,3 J Iyer,1 D Schrama,3 D Koelle,1 M Cleary,2 S Bhatia,1 J Becker3
and P Nghiem1 1 Medicine/Dermatology, University of Washington, Seattle, WA, 2 Merck
Research Laboratories, North Wales, PA and 3 Dermatology, University of Graz, Graz, Austria
Merkel cell carcinoma (MCC) is an often-lethal neuroendocrine skin cancer associated with a recently
discovered, common polyomavirus. Virus-encoded oncoproteins are persistently expressed in ~75%
of MCCs, and these non-self proteins should generate cellular immune responses. Although several
forms of T-cell immunosuppression are associated with increased risk of MCC, over 90% of MCC
patients have no known systemic immune suppression, and in these cases, T-cell evasion may be
driven locally by the tumor. Here we report that 51% of MCCs (n=114) demonstrate tumor-specific
down-regulation of class I MHC, an effective mechanism for evasion of cytotoxic T cells, which have
been strongly associated with improved survival in this cancer. In MCC cell lines, MHC-I down-
regulation was reversible by treatment with any of several interferons. Re-expression of MHC-I was
persistent and stable in MCC cells after transient exposure to interferon followed by washout. Indeed,
systemic interferon has been previously explored in the management of MCC but has been inef-
fective. Systemic administration may fail because of insufficient drug delivery to the tumor microen-
vironment, compensatory systemic immunoregulatory processes, or lack of a gradient in concen-
tration focused at the tumor. Intralesional injection of interferon into MCC tumors was explored to
potentially overcome these problems. This treatment led to restoration of MHC-I expression, recruit-
ment of CD8+ lymphocytes to the tumor, and local MCC regression in each of four cases. MCC
tumors thus exhibit evidence of local immune evasion and intralesional cytokine therapy may be
useful in promoting T cell recognition of this virus-associated malignancy.
548
Psoriasis family history portends earlier age of onset, higher incidence of psoriatic arthritis,
and increased likelihood of biologic treatment in psoriasis patients
N Borkar, D Kast, I Grozdev, D Carlson, L Cao, R Feig, P Pujari, B Schmotzer, D Babineau,
T McCormick, K Cooper and N Korman Dermatology, Murdough Family Center for Psoriasis,
Case Western Reserve University and University Hospitals Case Medical Center, Cleveland,
OH
Few studies correlating family history (FH) of psoriasis (self-reported) with endpoints and comor-
bidities such as psoriasis severity, age of onset, cardiovascular (CV) history, diagnosis of psoriatic
arthritis, and biologic therapy status exist. We enrolled 512 psoriasis patients in the Murdough
Family Center for Psoriasis database, which included self-reporting of family members with psori-
asis. A positive FH was defined as a first-degree relative or grandparent with psoriasis. FH of psori-
asis was correlated to disease severity, mean age of onset, history of PsA, CV events, (MI, aneurysm,
stroke, coronary stent or bypass, blockage of arteries on angiography, carotid artery or peripheral
artery revascularization), and treatment with biologics. 44% of patients (n=228) had a FH of psori-
asis while 56% (n=284) did not. Confirming previous reports, the average age of psoriasis onset in
patients with a FH of psoriasis was 24.5 years, while the average age of psoriasis onset in patients
with no FH of psoriasis was 32.5 years (p<0.001). 31.9% of patients with a FH of psoriasis had pso-
riatic arthritis, while 19.9% of patients with no FH of psoriasis had psoriatic arthritis (p=0.002).
26.3% of patients with a FH of psoriasis were currently being treated with a biologic for their pso-
riasis, while 18.3% of patients with no FH of psoriasis were currently being treated with a biologic
(p=0.03). There were no differences in the severity of psoriasis (as defined by PASI or BSA) or the
incidence of CV events or frequency of hypertension, diabetes, and metabolic syndrome, between
patients with and without a FH of psoriasis. In conclusion, our data demonstrates that FH of psori-
asis predicts earlier onset of psoriasis, likelihood of developing PsA as well as treatment with bio-
logics. We therefore suggest that clinicians caring for psoriasis patients collect FH data.
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An investigator-initiated, phase II randomized, double-blind, placebo-controlled trial of GDC-
0449 for prevention of BCCs in basal cell nevus syndrome (BCNS) patients 
JY Tang,1,2 JM Mackay-Wiggan,3 M Aszterbaum,1 J Lindgren,1 K Chang,1 C Coppola,3 A Campbell,3
A Chanana,1 J Marji,3 DR Bickers3 and EH Epstein1 1 Children’s Hospital of Oakland Research
Institute, Oakland, CA, 2 Dermatology, Stanford University, Redwood City, CA and 3
Dermatology, Columbia University, New York, NY
GDC-0449 (Genentech) is a new Hedgehog Pathway inhibitor that has been shown in a Phase I
trial to reduce locally aggressive/metastatic BCCs. We tested the anti-BCC efficacy of GDC-0449 in
a randomized, double-blind, placebo-controlled trial in patients with BCNS. We enrolled 41 BCNS
subjects at 3 clinical centers from September 2009 to January 2011. Subjects were randomized to
receive daily oral GDC-0449 (150mg) or placebo (2:1) for 18 months. The primary endpoint was
reduction of new surgically eligible BCCs after 3 months; secondary endpoints included reducing
existing BCCs and safety/tolerability. Twenty-nine subjects have been followed for an average of 6
months. Upon review of results at the interim analysis, the DSMB voted to end the placebo arm of
the trial due to statistically significant differences between the 2 groups. GDC-0449 reduced the
rate of new BCCs compared to the placebo group (0.07 new BCCs per month vs. 1.74 BCCs per
month placebo, p<0.0001) and reduced the size of existing BCCs (-24cm vs. -3cm placebo, p=0.006).
Some subjects achieved near complete remission with no BCC developing resistance. Subjects on
GDC-0449 had significant increases in grade 1-2 taste loss, muscle cramps, and weight loss com-
pared to placebo (p<0.01). Two subjects experienced grade 3-4 adverse events. Overall 20% of
GDC-0449 subjects discontinued drug participation due to adverse events. In conclusion, dramatic
anti-BCC efficacy in BCNS patients and may be a potential new drug for BCC prevention.
550
Clinical benefits of topical application of Artemisia abrotanum (Southernwood)) on photo-
damaged skin
M Russell, T Zedayko, C Saliou and S Tucker-Samaras Johnson and Johnson, Skillman, NJ
Skin aging is a complex process integrating time and environmental exposure which involves more
than just the surface of the skin. There are effects in all three layers of the skin, which results in the
outward appearance of the aging process. Aqueous extracts of Southernwood provide numerous
benefits to all layers of the skin as demonstrated by in-vitro testing in models designed to mimic the
pathways of aging and skin imbalance. Two studies were performed to assess the activity of this
extract in vivo. Fifteen patients with mild to moderate dryness on the outer aspect of the lower leg
were enrolled in the first study. Panelists applied the aqueous extract on one leg, and a placebo on
the other, twice a day for two weeks. Moisturization was measured by Skicon, and TEWL was
measured to correlate to the in vitro data suggesting lipid upregulation in the epidermis. In addition
samples were obtained to measure the lipid content of the stratum corneum to further correlate the
data. In the second study, twenty patients with moderate coarse wrinkling in the crow’s feet and
upper cheek areas, moderate pigmentation, bilateral overall photodamage and moderate sagging
were enrolled in the study. The design was a double-blind split face study where the patients applied
the facial moisturizer and placebo twice a day to the appropriate side of the face. Clinical evalua-
tions and imaging demonstrated the moisturizer’s multiple skin benefits throughout the study. The
facial treatment was particularly effective in improvement of fine lines, mottled pigmentation and
radiance(p<0.05) versus a placebo treatment, while also providing significant improvements in over-
all photodamage. Taken together these studies show that the aqueous extract of southernwood to
provide meaningful benefits in the visual appearance of aging skin.
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Age-matched multiplex analysis reveals global immune dysregulation in patients with CTCL
LJ Geskin,1,2 OE Akilov,1 DE Linzer,2 Y Lin,2 LD Falo1 and AE Lokshin2 1 Dermatology, University
of Pittsburgh, Pittsburgh, PA and 2 University of Pittsburgh Cancer Institute, Hillman Cancer
Center, Pittsburgh, PA
Cutaneous T cell lymphoma (CTCL) is a heterogeneous group of epidermotropic extranodal non-
Hodgkin’s lymphomas. There are no definitive specific biomarkers available which can predict prog-
nosis and clinical responses to therapies. To evaluate global immunologic environment in CTCL
patients, serum samples from 30 CTCL patients and 756 healthy volunteers were analyzed by Luminex
multi-analyte bioassay detection system for over 30 serum biomarkers. Age-adjusted expression
differs significantly among cases and controls for the following: EGF, EOTAXIN (CCL11), HGF, IL-
8, IL-12p40, IP10, TNFR1, G-CSF, IFN-γ, IL-5, IL-7, MIP-1B, and TNF-α (p<0.05). Among younger
patients, there was a significant difference in expression of DR5, IFN-α, and MIP-1A (p<0.05). Con-
sistent with prior observations, we found increase in IL-7, which promotes malignant T-cell prolif-
eration; increase in IL-8 associated with systemic activation of neutrophils; increase in eotaxin
(CCL11), an eosinophil-selective chemoattractant, associated with high eosinophil counts and pru-
ritus, especially in older patients. CCL11 is secreted in response to Th2-inflammatory cytokines and
TNF-α and shares common chemokine receptor 5 (CCR5) with MIP-1B (elevated in our patients);
CCR5 is important in skin homing of malignant lymphocytes in CTCL. In conclusion, we con-
ducted comprehensive evaluation of serum immunologic markers in CTCL. Our data demonstrates
global immune dysbalances in CTCL, including, but not limited to markers associated with neu-
trophil and eosinophil activation; increase in IP-10 and IFN-γ, which may be reflective of host anti-
tumor responses, all of which may be important in pathophysiology of CTCL. Clinical correlation
of abnormally expressed markers with the stage of CTCL, prognosis and response to therapy and in
vitro evaluation of abnormally expressed biomarkers on all compartments of immune system, includ-
ing lymphocytes, neutrophils, eosinophils, and keratinocytes are warranted.
552
The comorbidities associated with serum vitamin D deficiency in veteran patients with pso-
riasis
C Young,2,1 S Fatima,1 B Workman,1 J Kado1 and L Savoy2 1 Dermatology, Wayne State
University, Detroit, MI and 2 Dermatology, John D Dingell VA Medical Center, Detroit, MI
The objectives of this study were to assess serum vitamin D in a group of veteran patients with pso-
riasis and to ascertain associations between vitamin D status and key clinical factors and disease
severity. In addition the effect of oral supplemental vitamin D3 on serum 25(OH) vitamin D level
in psoriasis patients were studied. The comorbidities associated each psoriatic patient were evalu-
ated. The study was a randomized controlled trial and conducted at John D Dingell Veterans Med-
ical center in Detroit Michigan. Data were drawn from 65 psoriatic patients seen in VA outpatient
clinic. 25(OH)Vitamin D levels were evaluated along with markers of disease activity, physician and
patient global assessments, PASI score calculated. Vitamin D deficiency was defined as 25(OH)D
levels<32 ng/ml. Among psoriasis patients with hypovitaminosis D [25(OH)D < 32 ng/ml], randomly
divided into four groups, each group received oral vitamin D3 (cholecalciferol) therapy at a dose
of 400 IU daily, 1000 IU daily, 4000 IU daily or 50,000 IU weekly respectively for 52 weeks. Blood
samples were drawn before, at the week 26 at week 52. Serum measurements of 25(OH)D, PTH,
calcium, Comprehensive metabolic panel and homocysteine and C-reactive protein were meas-
ured. Blood 25(OH) Vitamin D level from 60 patients with hypovitaminosis D increased in all four
groups patients with psoriasis, however rapidly and significantly increased in patients receiving vita-
min D3 supplement at doses of 4000 IU daily No direct correlation was observed between PASI
score improvement and vitamin D treatment. Vitamin D3 supplemental at doses 4000 IU daily are
efficient and safe way to raise deficient serum 25(OH) vitamin D levels to a preferred target levels.
The metabolic syndrome comorbidities associated with each psoriatic patient before and after
treatment of Vitamin D were evaluated. The health benefits of vitamin D3 oral supplements on meta-
bolic syndrome comorbidities associated with psoriasis were elucidated and discussed.
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Inhibition of the effector phase of contact hypersensitivity in sensitized mice via in vivo induc-
tion of Foxp3+ regulatory T cells by UV radiation
A Schwarz,1 F Navid,1 T Sparwasser,2 B Clausen3 and T Schwarz1 1 University Kiel, Kiel,
Germany, 2 Institute of Infection Immunology, Hannover, Germany and 3 Erasmus University
Medical Center, Rotterdam, Netherlands
Ultraviolet radiation (UV) induced regulatory T cells (UV-Treg) inhibit the sensitization but not the
elicitation of contact hypersensitivity (CHS) when injected i.v. since UV-Treg express lymph node,
but not skin homing receptors and thus migrate into the lymph nodes but not into the skin. We
observed that the homing receptor expression and the migration of UV-Treg can be altered by tis-
sue-specific antigen presenting cells both in vitro and in vivo. Mice sensitized against dinitrofluo-
robencene (DNFB) through the abdomen were exposed to UV on the back followed by epicuta-
neous application of DNFB on the UV-exposed skin to induce UV-Treg. Since these cells migrate
into the lymph nodes the effector phase of CHS is not suppressed. However, when UV-Treg located
in the lymph nodes were stimulated in vivo by antigen presenting cells from the epidermis via
application of DNFB on the flank, UV-Treg migrated into the skin and thus inhibited the elicitation
of CHS in sensitized mice. The stimulation of UV-Treg by antigen presenting cells from the skin is
crucial, since the inhibitory effect was lost upon depletion of langerin-positive cells, as demonstrated
in langerin diphtheria-toxin (DT) receptor knock in mice treated with DT. Treg induced in vivo by
UV express Foxp3 since the inhibitory effect was lost in mice expressing a DT receptor–enhanced
green fluorescent protein fusion protein under the control of the foxp3 gene locus, allowing selec-
tive and efficient depletion of Foxp3+ Treg upon DT injection. These data demonstrate that Treg can
be induced in vivo by UV in sensitized mice and that these cells can be altered in such a way that
they inhibit the elicitation of immune reactions in sensitized individuals. This indicates a first in
vivo strategy to utilize Treg not only for the prevention but also for the treatment of immune-medi-
ated diseases.
567
N-acetyl-S-farnesyl-L-cysteine (AFC) inhibits Langerhans cell (LC) antigen presenting capa-
bility
J Lee,1 L Englander,1 M Schierl,1 R Moquete,1 W Ding,1 JS Gordon,2 JR Fernandez,2 E Perez,2
M Stock2 and RD Granstein1 1 Weill Cornell Medical College, New York, NY and 2 Signum
Biosciences, Inc, Monmouth Junction, NJ
AFC, the naturally occurring archetypical isoprenylcysteine (IPC), is a small molecule that inhibits
small G protein- and G protein-coupled signaling with a number of anti-inflammatory effects. AFC
inhibits local skin inflammation, including erythema, ear swelling and leukocyte infiltration in a
murine contact irritation model. AFC also inhibits macrophage chemotaxis and platelet aggrega-
tion. Topical application of AFC to the mouse ear results in a dose-dependent decrease in elicita-
tion of contact hypersensitivity at that site in previously immunized mice. We now have tested the
hypothesis that AFC inhibits LC antigen presenting capability. BALB/c LCs were prepared to ~95%
homogeneity by a standard technique. LCs were then cultured in dilutions of AFC or medium alone
for 90 min. Keyhole limpet hemocyanin (KLH) was added and culture continued for another 90
min still in the presence of AFC or medium alone. LCs were then washed x 3 and co-cultured for
72 h with cells of the TH1 clone HDK-1. HDK-1 cells respond to presentation of KLH by I-Ad. Expo-
sure to AFC dose-dependently decreased the ability of LCs to present KLH to HDK-1 cells as assessed
by interferon gamma (IFNγ) production. In an additional experiment, LCs were treated with dilu-
tions of AFC or medium alone for 3 h, washed x 3 and cultured with T cells from BALB/c background
DO11.10 transgenic mice in the presence of a fragment of chicken ovalbumin (cOVA323-339). These
mice carry a transgene containing rearranged α and β chain genes of their T cell receptor that enable
T cells to spontaneously recognize cOVA323-339. After 48 h of culture, supernatants were harvested
and IFNγ content assessed by ELISA. AFC treatment also dose-dependently inhibited antigen pres-
entation in this model. These data indicate that AFC inhibits the maturation of LCs in vitro and their
capacity to present antigen. Other agents in this class may prove to be pharmacologically useful for
diseases involving inappropriate adaptive immunity.
569
Epidermal growth factor receptor inhibitors augment the expression of MHC class I and
class II genes
BP Pollack,1,2,3 B Sapkota1 and TV Cartee1 1 Dermatology, Emory University, Atlanta, GA, 2
Pathology and Laboratory Medicine, Emory University, Atlanta, GA and 3 Atlanta VA Medical
Center, Decatur, GA
The cutaneous inflammation induced by epidermal growth factor receptor (EGFR) inhibitors (EGFRIs)
is widely recognized. While this inflammation can cause significant morbidity, the development of
skin inflammation in response to EGFRIs portents a favorable anti-tumor response suggesting a link
between EGFRI-induced inflammation and anti-tumor effects. Since EGFR ligands are known to
attenuate MHC class II (MHCII) expression, we hypothesized that EGFRIs would have the opposite
effect and augment MHCII expression. To test this hypothesis, we pre-treated A431 malignant ker-
atinocytes and primary human keratinocytes (PHKs) with EGFR inhibitors (EGFRIs) before exposure
to IFN-γ and measured the induction of MHCII. We found that EGFR-blocking antibodies (cetux-
imab) and EGFR-tyrosine kinase inhibitors (TKIs) augmented the induction of MHCII molecules by
IFN-γ. We also measured the impact of EGFRIs on MHCI expression and found that EGFRIs aug-
mented the induction of MHCI by IFN-γ. Further, even in the absence of IFN-γ, EGFRIs augmented
MHCI expression. Consistent with our in vitro findings, we found that the epidermal expression of
MHCI is increased in human skin during therapy with an EGFRI independent of clinical or micro-
scopic inflammation. Taken together, these results suggest that EGFRIs may influence adaptive immune
responses by directly modulating MHCI and MHCII expression, and provide a novel explanation
for the diverse immune-related effects of EGFRIs.
568
Tobacco smoke extract inhibits Langerhans cell (LC) antigen presenting capability
W Ding, M Schierl, R Moquete, D Patel, AJ Dannenberg and RD Granstein Weill Cornell Medical
College, New York, NY
Tobacco smoke (TS) is a risk factor for oral cavity cancers. We have previously shown that C3H/HeN
mice that breathe TS for 1 h daily for 21 d have decreased contact hypersensitivity responses after
immunization through TS-exposed oral mucosa. A preliminary experiment indicated that such
mice developed immunologic tolerance as demonstrated by inability to be fully immunized by
later re-immunization on the glabrous skin and this has now been confirmed. To test the hypothe-
sis that these phenomena occur, at least in part, from alterations in LC function, we examined the
ability of an aqueous extract of TS to influence LC antigen presenting capability in vitro. The extract
was prepared by drawing TS from 2R4F research reference cigarettes (2 sec/puff, 1 puff/min, 35
ml/puff) into a premeasured amount of PBS under sterile conditions. TS content was quantified in
puffs/ml of PBS. LCs were prepared to ~95% homogeneity by a standard protocol from BALB/c mice.
LCs were exposed to TS extract or PBS alone for 3 h followed by washing x 4. LCs were then co-
cultured with CD4+ T-cells from BALB/c background DO11.10 transgenic mice [these mice carry
transgenic α and β chain T cell receptor genes encoding a TCR that recognizes a fragment of chicken
OVA (cOVA323-339) presented by I-A
d]. cOVA323-339 was added and supernatants harvested 48 h
later. Cytokine content of supernatants was assessed by ELISA. Exposure of LCs to TS induced a dose-
dependent decrease in the production of interferon gamma, interleukin (IL)-4, and IL-17. Exposure
of LCs to TS for 24 h failed to induce cellular toxicity as measured by lactic dehydrogenase release.
These data support the hypothesis that TS prevents maturation of LCs and their antigen presenting
capability. Oral cancers induced by TS might occur, in part, due to changes in the ability of acti-
vated LCs to present putative tumor antigens on incipient epithelial malignancies for an immuno-
logic response.
566
Langerhans cells are critical in the pathogenesis of atopic dermatitis via TSLP receptor sig-
naling
S Nakajima, Y Miyachi and K Kabashima Dermatology, Kyoto University, Kyoto, Japan
Dendritic cells (DCs) play an important role in the initiation of acquired immune responses. In the
skin, there exist at least two populations of DCs, epidermal Langerhans cells (LCs) and dermal DCs.
It has been reported that cutaneous DCs mediate the pathogenesis of atopic dermatitis (AD), but it
remain unknown which subset is directly involved. When FITC-conjugated OVA was applied to the
mouse skin, OVA was observed tot be retained above the epidermis using a flurescent microscopy.
Therefore, we hypothesize that epidermal LCs initiate AD by capturing protein allergens. Using mice
with Langerin-diphtheria toxin receptor, we found that LC depletion showed much milder clinical
manifestations together with lower serum IgE levels in a topical OVA application-induced AD-like
mouse model. In addition, LC depletion impaired OVA-specific T cell proliferation and IL-4 pro-
duction in the draining lymph nodes. Recent work has identified thymic stromal lymphopoietin
(TSLP) as promoting Th2-dominant inflammations. However, it remains unknown whether TSLP is
directly involved in the establishment of AD. Since TSLP is expressed in the epidermis, we hypoth-
esize that TSLP secreted by keratinocytes acts on epidermal LCs to prime naïve T cells into Th2
cells. To this end, we used TSLP receptor-deficient mice and newly generated LC-specific TSLP recep-
tor-deficient mice by bone marrow reconstitution of wild-type mice into irradiated TSLP-receptor
deficient mice by taking advantage of radio-resistance of LCs. We induced AD-like skin conditions
to these mice by sensitization with OVA percutaneously. We found that LC-specific TSLP receptor-
deficient mice showed much milder clinical and histological findings together with lower IL-4 and
IgE levels. Taken together, these results suggest that epidermal LCs play a critical role in the devel-
opment of AD via TSLP-TSLP receptor signaling.
570
Disruption of the epidermal barrier induces regulatory T cells in a Langerhans cell-depend-
ent fashion
F Navid,1 B Clausen,2 T Schwarz1 and A Schwarz1 1 University Kiel, Kiel, Germany and 2
Erasmus University Medical Center, Rotterdam, Netherlands
Ultraviolet radiation (UV) suppresses the adaptive immune response in an antigen-specific fashion
via induction of regulatory T cells (Treg). In contrast, the innate immune response appears to be
induced by UV, as shown by the release of antimicrobial peptides (AMPs), thereby protecting the
skin against microbes. Recently, we observed that AMPs contribute to photoimmunosuppresssion
via induction of regulatory T cells (Treg). As disruption of the epidermal barrier induces AMPs and
as UV disrupts the epidermal barrier, we asked whether disturbance of the epidermal barrier by itself
can also suppress the adaptive immune response via induction of Treg. Thus, mice were tape stripped
on their backs before sensitization with dinitrofluorobenzene (DNFB). After 5 days ear challenge
was performed and contact hypersensitivity (CHS) was measured. Application of DNFB onto tape
stripped skin did not result in sensitization, but induced Treg as demonstrated by adoptive transfer
experiments. Tape stripping increased the number of apoptotic antigen presenting cells (APCs) in
the draining lymph nodes, suggesting that barrier disruption like UV might damage epidermal
APCs and thereby induce Treg. The crucial role of Langerhans cells in the induction of Treg was
demonstrated by using langerin diphtheria-toxin receptor knock-in mice (LDTR). The suppression
of CHS upon tape stripping was lost after depletion of langerin positive cells in LDTR mice treated
with diphtheria-toxin (DT). Additionally, the CHS response was not reduced in wild type recipients
upon adoptive transfer of lymphocytes obtained from tape stripped and DT injected LDTR donors,
indicating that the induction of Treg upon tape stripping is Langerhans cell dependent. Disruption
of the epidermal barrier enables the penetration of allergens and the induction of inflammation.
Hence, induction of tolerance via generation of Treg upon barrier disturbance may be part of a com-
pensatory protection mechanism avoiding excessive sensitization to environmental agents.
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Epidermal CCR6+ γδ T Cells are essential producers of IL22 and IL17 in an IL23-mediated
murine model of psoriasiform dermatitis
T Mabuchi, T Takekoshi and ST Hwang Department of Dermatology, Medical College of
Wisconsin, Milwaukee, WI
Cytokine components of Th17 pathway, including IL23, IL17, and IL22, play vital roles in human
psoriasis by supporting inflammation and epidermal proliferation. While evidence supports the
importance of conventional αβT cells in psoriasis, the role of γδT cells in psoriasis is largely unknown.
Herein, we induced psoriasiform dermatitis in mice with 3 injections (every other day) of IL23 in
the dorsal ear skin and analyzed cytokine mRNA expression by qRT-PCR and cellular infiltrates by
flow cytometry. By mechanically separating dermis from epidermis, we showed that epidermal cells
express high levels of IL22 and IL17A. Surprisingly, IL22, IL17A, and the IL23 receptor mRNA expres-
sion was strongly enriched (by 20-200 fold vs. resident γδ T cells) in an epidermal population of
CCR6-positive, γδ T cell receptor low-expressing (GDL) T cells that accumulated in mouse epider-
mis after IL23 treatment. Phenotypically, these GDL T cells differed from resident epidermal γδ-
high T cells that showed little change in numbers and did not express IL22, IL17A, and CCR6 with
IL23 treatment. CCL20, the CCR6 ligand, was strongly upregulated in murine epidermis within 24
hr of IL23 injection, and CCR6-deficient mice failed to accumulate GDL T cells in epidermis fol-
lowing IL23 treatment. Lastly, γδ T cell-deficient mice failed to exhibit ear swelling and increased
expression of IL22 and IL17A in the epidermis following IL23 injection, suggesting that γδ T cells
are functionally involved in promoting psoriasisform dermatitis. In summary, we show that GDL T
cells accumulate in epidermis upon IL23 treatment. These cells synthesize high levels of Th17
cytokines, especially IL22, that drive epidermal proliferation. Epidermal recruitment of GDL T cells
is likely mediated through CCR6. Our data suggest that a subset of γδ T cells may be novel targets
for therapy in psoriasis.
560
A novel STAT3 inhibitor (rR9-GRIM19) markedly enhances antitumor effects by Treg sup-
pression when combined with Th1-type immunotherapy in melanoma-bearing mice
T Okamoto, N Shibagaki, F Hanawa and S Shimada Department of Dermatology, University of
Yamanashi, Yamanashi, Japan
Constitutive activation of STAT3 in cancer cells induces the immunosuppression in cancer-bearing
hosts. To investigate the antitumor effects by inhibiting the STAT3-mediated signaling cascade in
cancer microenvironment, we generated R9-protein transduction domain-containing-GRIM-19
fusion protein (rR9-GRIM19) since GRIM-19 could physically interact with STAT3. In culture, rR9-
GRIM19 treatment of cancer cells which were constitutively activated STAT3 significantly reduced
STAT3-dependent transcription. Previously, we demonstrated that intratumoral (i.t.) injections of
rR9-GRIM19 induced the complete rejection in A20 (B-cell lymphoma)-bearing mice by eliciting
innate and A20-specific acquired immune responses. Recently, we found that Foxp3+ cells were
markedly decreased in the A20 tumor mass after i.t. injections of rR9-GRIM19 by histopathologi-
cal analysis. Although i.t. injections of rR9-GRIM19 suppressed tumor growth in B16-bearing mice,
the complete rejection was not observed. Previously, we have demonstrated that i.t. injections of
R9-containing immunogenic foreign Ag (rR9-OVA) elicited strong antitumor effects in B16-bearing
mice with the induction of B16-specific CTL and Th1-type immune responses. Then, we investigated
whether rR9-GRIM19 could enhance antitumor effects when combined with cancer immunother-
apy. The combination of i.t. injections of rR9-GRIM19 and rR9-OVA, but not rR9-irrelevant proteins,
enhanced antitumor effects in B16-bearing mice. Interestingly, this combination therapy inhibited
the induction of Foxp3+ CD4+ regulatory T cell in sentinel lymph node, and Th1/ iTreg ratio was
well correlated with antitumor effects. Combination with rR9-GRIM19 and CpG also enhanced anti-
tumor effects. However, combination with rR9-GRIM19 and vaccination therapy using Trp2-pep-
tide-DC did not enhance antitumor effects. These results indicate that i.t. injections of rR9-GRIM19
have potential as a novel immunological modifier when combined with cancer immunotherapy.
561
Production of SJS/TEN model mice using patients PBMCs and skin
N Saito, R Abe, N Yoshioka, H Qiao, Y Fujita, D Hoshina and H Shimizu Dermatology, Hokkaido
University Graduate School of Medicine, Sapporo, Japan
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening cutaneous
adverse drug reactions. Currently, there is no murine model to reproduce SJS/TEN symptoms. Here,
we report a novel murine model of SJS/TEN. Peripheral blood mononuclear cells (PBMCs) from
patients with SJS/TEN or ordinary drug skin reaction (ODSR) were injected intravenously into immuno-
compromised NOG (NOD/Shi- scid , IL-2R γnull ) mice, followed by the oral administration of a
causative drug. We examined these drug-administered mice in the first 12 days after administration
to exclude GVHR, since GVHR symptoms and increase of human cells in peripheral blood occurred
in NOG mice around 20 days after human PBMCs injection. Drug-administered mice showed
hemorrhage of the conjunctiva 12 days after PBMCs injection, whereas control mice showed no
symptoms. TUNEL stain demonstrated that over 75% of cells were apoptotic in the conjunctival
epithelium of SJS/TEN mice, compared only 10% in control mice. In analysis of drug-specific human
T cells in spleen, 80 cells per 2x105 splenocytes from SJS/TEN PBMCs mice were detected using a
human IFN-γ specific ELISPOT assay, whereas only 3 cells in the control. However, these models
did not show any skin symptoms or keratinocyte apoptosis. Therefore, we generated a human skin
transplanted mice. The patient’s PBMCs were injected intravenously into mice transplanted same
patient’s skin, followed by the oral administration of the causative drug. Skin transplanted mice
showed necrotic appearance in skin graft areas 8 days after PBMCs injection. Cleaved caspase 3
stain indicated 5% apoptotic cells in SJS/TEN patient’s skin graft areas compared with 0.7% in healthy
control. Unexpectedly, there were no difference in the numbers of human CD4 + and CD8 + cells
in the graft between SJS/TEN patient and healthy control. In summary, we successfully established
the SJS/TEN model mice using SJS/TEN patients’ samples.
562
Generation of tumor-specific anti-melanoma T-cell responses by extracorporeal pho-
tochemotherapy-induced dendritic cells
AK Engberg, CL Berger, DJ Hanlon and RL Edelson Dermatology, Yale University, New Haven,
CT
Extracorporeal photochemotherapy (ECP) is a widely used immunotherapy for advanced cutaneous
T-cell lymphoma (CTCL). ECP’s capacity to expand CD8 T-cell populations with specificity for
CTCL cells, as well as generate large scale rapid maturation of monocytes into functional dendritic
antigen presenting cells (DC), suggests that the treatment may also be applicable to immunother-
apy of solid tumors (Blood 116:4838-47, 2010). To test this premise, we assessed the capacity of
ECP-induced DC to efficiently stimulate in vitro anti-melanoma T-cell responses. ECP-induced DC
were loaded with the melanoma-associated antigen (Ag) gp100 which had been encapsulated in
poly(lactic-co-glycolic)acid (PLGA) nanoparticles (NP). We had previously reported that NP encap-
sulation enhances cross-presentation of Ag into the class I major histocompatibility complex (MHC),
recognized by CD8 T cells. ECP-generated DC were pulsed overnight with either no antigen, empty
PLGA NP, PLGA-encapsulated gp100, or soluble gp100. DC were then co-cultured with either autol-
ogous CD4/CD8 cells or a gp100-specific T-cell line, and supernatant was analyzed for IFN-γ pro-
duction. DC phenotype was confirmed by flow cytometry, showing ECP-derived DC were 95.21%
CD11c+, 17% CD80/86+, and 24.2% DR/CD83+. Utilizing the gp100-specific T-cell line as an indi-
cator for responding CD8 T cells, DC loaded with PLGA-encapsulated gp100 stimulated more
(p=0.0032) IFN-γ production (125.12 pg/ml) than did pulsing with no antigen (9.42 pg/ml) or a series
of negative controls. These results reveal that the maturationally synchronized DC that are induced
on a large scale by ECP, in a single day without added cytokines, can stimulate vigorous anti-
melanoma CD8 T-cell responses. These responses compared favorably with DC conventionally gen-
erated and tumor antigen loaded over a full week in the presence of supra-pharmacologic doses of
cytokines. ECP-induced DC offer an attractive source of antigen presenting cells for potential anti-
melanoma immunotherapy trials.
563
Granulocyte-derived dendritic cells (grDC) are specialized for bacterial antigen presentation
S Geng,1 H Matsushima,1 P Kotol,2 R Gallo2 and A Takashima1 1 Department of Medical
Microbiology and Immunology, University of Toledo, Toledo, OH and 2 Division of
Dermatology, University of California San Diego, San Diego, CA
We recently reported a novel DC subset, termed grDC, derived from immature granulocytes. grDC
exhibit dendritic morphology, express typical DC markers (MHC class II, CD11c, and CD205), and
present OVA peptides to both OT-II CD4 T cells and OT-I CD8 T cells. Importantly, grDC retain sur-
face expression of a granulocyte marker Ly6G, which is not detectable on any of the currently known
DC subsets. The purpose of this study was to determine specific function(s) of grDC. Ly6G+ grDC
were found to uptake FITC-dextran, latex particles, and live E. coli more (P<0.001) efficiently than
Ly6G- conventional DC (cDC). GeneChip analyses revealed 170 genes preferentially (>2-fold, P<0.05)
expressed by grDC, and this cluster included cathelicidin (CRAMP). Predominant CRAMP produc-
tion by grDC was confirmed at mRNA (real-time PCR), protein (immune-blotting and immune-flu-
orescence staining) and functional (bacterial killing) levels. Furthermore, wild-type grDC, but not
CRAMP-deficient grDC, killed internalized bacteria more rapidly than did cDC counterparts. Large
numbers of grDC became detectable in the peritoneal cavity within 24 h after i.p. injection of live
E. coli. To study in vivo function, we i.p. injected OVA-transduced E. coli, purified grDC and cDC
by FACS from the peritoneal cavity, and then compared their abilities to activate OT-II CD4 T cells
– grDC were again more (>3-fold, P<0.001) efficient than cDC, documenting potent abilities of
grDC to uptake and kill bacteria and to process and present bacterial antigens to T cells. We pro-
pose that immature granulocytes emerging at bacterial infection sites can give rise to a unique DC
subset specialized for initiating adaptive immunity against bacterial antigens.
564
Melanoma secretes the T cell inhibitor DC-HIL: A novel mechanism of tumor-induced sys-
temic immunosuppression
K Tamura, J Chung, PD Cruz and K Ariizumi Dermatology, University of Texas Southwestern
Medical Center, Dallas, TX
Having published that DC-HIL expressed on melanoma cells potently inhibits T cell activation by
binding syndecan-4 on activated T cells and that this function regulates tumor growth locally, we
posited that melanoma may also secrete a soluble form of DC-HIL. Indeed, we detected abundant
levels of secreted DC-HIL (98 KDa) within culture supernatant of B16 melanoma. Moreover, fol-
lowing subcutaneous implantation of B16 melanoma into syngeneic mice, we noted a positive cor-
relation (Pearson’s r = 0.967) between tumor volume and serum DC-HIL, with the largest tumors (4
cm3) associated with the highest DC-HIL level (500 nM). A similar correlation (r = 0.952) was
noted with melanoma metastasis to lungs. To decipher the function of secreted DC-HIL, sera from
melanoma-bearing mice were absorbed with beads laden with control IgG or anti-DC-HIL Ab, and
then added to gp100-TCR+ T cells in culture. Sera absorbed with control IgG beads inhibited T cell
activation by 80%, whereas sera absorbed with anti-DC-HIL Ab restored T cell function up to 80%,
thereby confirming that secreted DC-HIL is inhibitory. Finally, to probe whether suppression of T
cell activation by secreted DC-HIL is linked to tumor growth, we transfected LL2 carcinoma cells
(devoid of DC-HIL expression) with a gene encoding secreted DC-HIL whose expression is con-
trolled by doxycycline (Dox). Treatment with Dox (shuts off gene expression) had no effect on
tumor growth, whereas no treatment (gene expressed) augmented tumor growth (0.8±0.2 vs. 0.3±0.1
cm3). Dox’s influence was affirmed by lack of DC-HIL expression in tumors of treated mice and by
reduced proliferation of infused gp100-T cells in untreated mice. We conclude that B16 melanoma
not only expresses DC-HIL responsible for inactivating T cells proximal to the tumor, but that it also
secretes DC-HIL into circulation, endowing it with the ability to suppress tumor immune responses
in a systemic manner.
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Inhibition of the effector phase of contact hypersensitivity in sensitized mice via in vivo induc-
tion of Foxp3+ regulatory T cells by UV radiation
A Schwarz,1 F Navid,1 T Sparwasser,2 B Clausen3 and T Schwarz1 1 University Kiel, Kiel,
Germany, 2 Institute of Infection Immunology, Hannover, Germany and 3 Erasmus University
Medical Center, Rotterdam, Netherlands
Ultraviolet radiation (UV) induced regulatory T cells (UV-Treg) inhibit the sensitization but not the
elicitation of contact hypersensitivity (CHS) when injected i.v. since UV-Treg express lymph node,
but not skin homing receptors and thus migrate into the lymph nodes but not into the skin. We
observed that the homing receptor expression and the migration of UV-Treg can be altered by tis-
sue-specific antigen presenting cells both in vitro and in vivo. Mice sensitized against dinitrofluo-
robencene (DNFB) through the abdomen were exposed to UV on the back followed by epicuta-
neous application of DNFB on the UV-exposed skin to induce UV-Treg. Since these cells migrate
into the lymph nodes the effector phase of CHS is not suppressed. However, when UV-Treg located
in the lymph nodes were stimulated in vivo by antigen presenting cells from the epidermis via
application of DNFB on the flank, UV-Treg migrated into the skin and thus inhibited the elicitation
of CHS in sensitized mice. The stimulation of UV-Treg by antigen presenting cells from the skin is
crucial, since the inhibitory effect was lost upon depletion of langerin-positive cells, as demonstrated
in langerin diphtheria-toxin (DT) receptor knock in mice treated with DT. Treg induced in vivo by
UV express Foxp3 since the inhibitory effect was lost in mice expressing a DT receptor–enhanced
green fluorescent protein fusion protein under the control of the foxp3 gene locus, allowing selec-
tive and efficient depletion of Foxp3+ Treg upon DT injection. These data demonstrate that Treg can
be induced in vivo by UV in sensitized mice and that these cells can be altered in such a way that
they inhibit the elicitation of immune reactions in sensitized individuals. This indicates a first in
vivo strategy to utilize Treg not only for the prevention but also for the treatment of immune-medi-
ated diseases.
567
N-acetyl-S-farnesyl-L-cysteine (AFC) inhibits Langerhans cell (LC) antigen presenting capa-
bility
J Lee,1 L Englander,1 M Schierl,1 R Moquete,1 W Ding,1 JS Gordon,2 JR Fernandez,2 E Perez,2
M Stock2 and RD Granstein1 1 Weill Cornell Medical College, New York, NY and 2 Signum
Biosciences, Inc, Monmouth Junction, NJ
AFC, the naturally occurring archetypical isoprenylcysteine (IPC), is a small molecule that inhibits
small G protein- and G protein-coupled signaling with a number of anti-inflammatory effects. AFC
inhibits local skin inflammation, including erythema, ear swelling and leukocyte infiltration in a
murine contact irritation model. AFC also inhibits macrophage chemotaxis and platelet aggrega-
tion. Topical application of AFC to the mouse ear results in a dose-dependent decrease in elicita-
tion of contact hypersensitivity at that site in previously immunized mice. We now have tested the
hypothesis that AFC inhibits LC antigen presenting capability. BALB/c LCs were prepared to ~95%
homogeneity by a standard technique. LCs were then cultured in dilutions of AFC or medium alone
for 90 min. Keyhole limpet hemocyanin (KLH) was added and culture continued for another 90
min still in the presence of AFC or medium alone. LCs were then washed x 3 and co-cultured for
72 h with cells of the TH1 clone HDK-1. HDK-1 cells respond to presentation of KLH by I-Ad. Expo-
sure to AFC dose-dependently decreased the ability of LCs to present KLH to HDK-1 cells as assessed
by interferon gamma (IFNγ) production. In an additional experiment, LCs were treated with dilu-
tions of AFC or medium alone for 3 h, washed x 3 and cultured with T cells from BALB/c background
DO11.10 transgenic mice in the presence of a fragment of chicken ovalbumin (cOVA323-339). These
mice carry a transgene containing rearranged α and β chain genes of their T cell receptor that enable
T cells to spontaneously recognize cOVA323-339. After 48 h of culture, supernatants were harvested
and IFNγ content assessed by ELISA. AFC treatment also dose-dependently inhibited antigen pres-
entation in this model. These data indicate that AFC inhibits the maturation of LCs in vitro and their
capacity to present antigen. Other agents in this class may prove to be pharmacologically useful for
diseases involving inappropriate adaptive immunity.
569
Epidermal growth factor receptor inhibitors augment the expression of MHC class I and
class II genes
BP Pollack,1,2,3 B Sapkota1 and TV Cartee1 1 Dermatology, Emory University, Atlanta, GA, 2
Pathology and Laboratory Medicine, Emory University, Atlanta, GA and 3 Atlanta VA Medical
Center, Decatur, GA
The cutaneous inflammation induced by epidermal growth factor receptor (EGFR) inhibitors (EGFRIs)
is widely recognized. While this inflammation can cause significant morbidity, the development of
skin inflammation in response to EGFRIs portents a favorable anti-tumor response suggesting a link
between EGFRI-induced inflammation and anti-tumor effects. Since EGFR ligands are known to
attenuate MHC class II (MHCII) expression, we hypothesized that EGFRIs would have the opposite
effect and augment MHCII expression. To test this hypothesis, we pre-treated A431 malignant ker-
atinocytes and primary human keratinocytes (PHKs) with EGFR inhibitors (EGFRIs) before exposure
to IFN-γ and measured the induction of MHCII. We found that EGFR-blocking antibodies (cetux-
imab) and EGFR-tyrosine kinase inhibitors (TKIs) augmented the induction of MHCII molecules by
IFN-γ. We also measured the impact of EGFRIs on MHCI expression and found that EGFRIs aug-
mented the induction of MHCI by IFN-γ. Further, even in the absence of IFN-γ, EGFRIs augmented
MHCI expression. Consistent with our in vitro findings, we found that the epidermal expression of
MHCI is increased in human skin during therapy with an EGFRI independent of clinical or micro-
scopic inflammation. Taken together, these results suggest that EGFRIs may influence adaptive immune
responses by directly modulating MHCI and MHCII expression, and provide a novel explanation
for the diverse immune-related effects of EGFRIs.
568
Tobacco smoke extract inhibits Langerhans cell (LC) antigen presenting capability
W Ding, M Schierl, R Moquete, D Patel, AJ Dannenberg and RD Granstein Weill Cornell Medical
College, New York, NY
Tobacco smoke (TS) is a risk factor for oral cavity cancers. We have previously shown that C3H/HeN
mice that breathe TS for 1 h daily for 21 d have decreased contact hypersensitivity responses after
immunization through TS-exposed oral mucosa. A preliminary experiment indicated that such
mice developed immunologic tolerance as demonstrated by inability to be fully immunized by
later re-immunization on the glabrous skin and this has now been confirmed. To test the hypothe-
sis that these phenomena occur, at least in part, from alterations in LC function, we examined the
ability of an aqueous extract of TS to influence LC antigen presenting capability in vitro. The extract
was prepared by drawing TS from 2R4F research reference cigarettes (2 sec/puff, 1 puff/min, 35
ml/puff) into a premeasured amount of PBS under sterile conditions. TS content was quantified in
puffs/ml of PBS. LCs were prepared to ~95% homogeneity by a standard protocol from BALB/c mice.
LCs were exposed to TS extract or PBS alone for 3 h followed by washing x 4. LCs were then co-
cultured with CD4+ T-cells from BALB/c background DO11.10 transgenic mice [these mice carry
transgenic α and β chain T cell receptor genes encoding a TCR that recognizes a fragment of chicken
OVA (cOVA323-339) presented by I-A
d]. cOVA323-339 was added and supernatants harvested 48 h
later. Cytokine content of supernatants was assessed by ELISA. Exposure of LCs to TS induced a dose-
dependent decrease in the production of interferon gamma, interleukin (IL)-4, and IL-17. Exposure
of LCs to TS for 24 h failed to induce cellular toxicity as measured by lactic dehydrogenase release.
These data support the hypothesis that TS prevents maturation of LCs and their antigen presenting
capability. Oral cancers induced by TS might occur, in part, due to changes in the ability of acti-
vated LCs to present putative tumor antigens on incipient epithelial malignancies for an immuno-
logic response.
566
Langerhans cells are critical in the pathogenesis of atopic dermatitis via TSLP receptor sig-
naling
S Nakajima, Y Miyachi and K Kabashima Dermatology, Kyoto University, Kyoto, Japan
Dendritic cells (DCs) play an important role in the initiation of acquired immune responses. In the
skin, there exist at least two populations of DCs, epidermal Langerhans cells (LCs) and dermal DCs.
It has been reported that cutaneous DCs mediate the pathogenesis of atopic dermatitis (AD), but it
remain unknown which subset is directly involved. When FITC-conjugated OVA was applied to the
mouse skin, OVA was observed tot be retained above the epidermis using a flurescent microscopy.
Therefore, we hypothesize that epidermal LCs initiate AD by capturing protein allergens. Using mice
with Langerin-diphtheria toxin receptor, we found that LC depletion showed much milder clinical
manifestations together with lower serum IgE levels in a topical OVA application-induced AD-like
mouse model. In addition, LC depletion impaired OVA-specific T cell proliferation and IL-4 pro-
duction in the draining lymph nodes. Recent work has identified thymic stromal lymphopoietin
(TSLP) as promoting Th2-dominant inflammations. However, it remains unknown whether TSLP is
directly involved in the establishment of AD. Since TSLP is expressed in the epidermis, we hypoth-
esize that TSLP secreted by keratinocytes acts on epidermal LCs to prime naïve T cells into Th2
cells. To this end, we used TSLP receptor-deficient mice and newly generated LC-specific TSLP recep-
tor-deficient mice by bone marrow reconstitution of wild-type mice into irradiated TSLP-receptor
deficient mice by taking advantage of radio-resistance of LCs. We induced AD-like skin conditions
to these mice by sensitization with OVA percutaneously. We found that LC-specific TSLP receptor-
deficient mice showed much milder clinical and histological findings together with lower IL-4 and
IgE levels. Taken together, these results suggest that epidermal LCs play a critical role in the devel-
opment of AD via TSLP-TSLP receptor signaling.
570
Disruption of the epidermal barrier induces regulatory T cells in a Langerhans cell-depend-
ent fashion
F Navid,1 B Clausen,2 T Schwarz1 and A Schwarz1 1 University Kiel, Kiel, Germany and 2
Erasmus University Medical Center, Rotterdam, Netherlands
Ultraviolet radiation (UV) suppresses the adaptive immune response in an antigen-specific fashion
via induction of regulatory T cells (Treg). In contrast, the innate immune response appears to be
induced by UV, as shown by the release of antimicrobial peptides (AMPs), thereby protecting the
skin against microbes. Recently, we observed that AMPs contribute to photoimmunosuppresssion
via induction of regulatory T cells (Treg). As disruption of the epidermal barrier induces AMPs and
as UV disrupts the epidermal barrier, we asked whether disturbance of the epidermal barrier by itself
can also suppress the adaptive immune response via induction of Treg. Thus, mice were tape stripped
on their backs before sensitization with dinitrofluorobenzene (DNFB). After 5 days ear challenge
was performed and contact hypersensitivity (CHS) was measured. Application of DNFB onto tape
stripped skin did not result in sensitization, but induced Treg as demonstrated by adoptive transfer
experiments. Tape stripping increased the number of apoptotic antigen presenting cells (APCs) in
the draining lymph nodes, suggesting that barrier disruption like UV might damage epidermal
APCs and thereby induce Treg. The crucial role of Langerhans cells in the induction of Treg was
demonstrated by using langerin diphtheria-toxin receptor knock-in mice (LDTR). The suppression
of CHS upon tape stripping was lost after depletion of langerin positive cells in LDTR mice treated
with diphtheria-toxin (DT). Additionally, the CHS response was not reduced in wild type recipients
upon adoptive transfer of lymphocytes obtained from tape stripped and DT injected LDTR donors,
indicating that the induction of Treg upon tape stripping is Langerhans cell dependent. Disruption
of the epidermal barrier enables the penetration of allergens and the induction of inflammation.
Hence, induction of tolerance via generation of Treg upon barrier disturbance may be part of a com-
pensatory protection mechanism avoiding excessive sensitization to environmental agents.
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Epidermal CCR6+ γδ T Cells are essential producers of IL22 and IL17 in an IL23-mediated
murine model of psoriasiform dermatitis
T Mabuchi, T Takekoshi and ST Hwang Department of Dermatology, Medical College of
Wisconsin, Milwaukee, WI
Cytokine components of Th17 pathway, including IL23, IL17, and IL22, play vital roles in human
psoriasis by supporting inflammation and epidermal proliferation. While evidence supports the
importance of conventional αβT cells in psoriasis, the role of γδT cells in psoriasis is largely unknown.
Herein, we induced psoriasiform dermatitis in mice with 3 injections (every other day) of IL23 in
the dorsal ear skin and analyzed cytokine mRNA expression by qRT-PCR and cellular infiltrates by
flow cytometry. By mechanically separating dermis from epidermis, we showed that epidermal cells
express high levels of IL22 and IL17A. Surprisingly, IL22, IL17A, and the IL23 receptor mRNA expres-
sion was strongly enriched (by 20-200 fold vs. resident γδ T cells) in an epidermal population of
CCR6-positive, γδ T cell receptor low-expressing (GDL) T cells that accumulated in mouse epider-
mis after IL23 treatment. Phenotypically, these GDL T cells differed from resident epidermal γδ-
high T cells that showed little change in numbers and did not express IL22, IL17A, and CCR6 with
IL23 treatment. CCL20, the CCR6 ligand, was strongly upregulated in murine epidermis within 24
hr of IL23 injection, and CCR6-deficient mice failed to accumulate GDL T cells in epidermis fol-
lowing IL23 treatment. Lastly, γδ T cell-deficient mice failed to exhibit ear swelling and increased
expression of IL22 and IL17A in the epidermis following IL23 injection, suggesting that γδ T cells
are functionally involved in promoting psoriasisform dermatitis. In summary, we show that GDL T
cells accumulate in epidermis upon IL23 treatment. These cells synthesize high levels of Th17
cytokines, especially IL22, that drive epidermal proliferation. Epidermal recruitment of GDL T cells
is likely mediated through CCR6. Our data suggest that a subset of γδ T cells may be novel targets
for therapy in psoriasis.
560
A novel STAT3 inhibitor (rR9-GRIM19) markedly enhances antitumor effects by Treg sup-
pression when combined with Th1-type immunotherapy in melanoma-bearing mice
T Okamoto, N Shibagaki, F Hanawa and S Shimada Department of Dermatology, University of
Yamanashi, Yamanashi, Japan
Constitutive activation of STAT3 in cancer cells induces the immunosuppression in cancer-bearing
hosts. To investigate the antitumor effects by inhibiting the STAT3-mediated signaling cascade in
cancer microenvironment, we generated R9-protein transduction domain-containing-GRIM-19
fusion protein (rR9-GRIM19) since GRIM-19 could physically interact with STAT3. In culture, rR9-
GRIM19 treatment of cancer cells which were constitutively activated STAT3 significantly reduced
STAT3-dependent transcription. Previously, we demonstrated that intratumoral (i.t.) injections of
rR9-GRIM19 induced the complete rejection in A20 (B-cell lymphoma)-bearing mice by eliciting
innate and A20-specific acquired immune responses. Recently, we found that Foxp3+ cells were
markedly decreased in the A20 tumor mass after i.t. injections of rR9-GRIM19 by histopathologi-
cal analysis. Although i.t. injections of rR9-GRIM19 suppressed tumor growth in B16-bearing mice,
the complete rejection was not observed. Previously, we have demonstrated that i.t. injections of
R9-containing immunogenic foreign Ag (rR9-OVA) elicited strong antitumor effects in B16-bearing
mice with the induction of B16-specific CTL and Th1-type immune responses. Then, we investigated
whether rR9-GRIM19 could enhance antitumor effects when combined with cancer immunother-
apy. The combination of i.t. injections of rR9-GRIM19 and rR9-OVA, but not rR9-irrelevant proteins,
enhanced antitumor effects in B16-bearing mice. Interestingly, this combination therapy inhibited
the induction of Foxp3+ CD4+ regulatory T cell in sentinel lymph node, and Th1/ iTreg ratio was
well correlated with antitumor effects. Combination with rR9-GRIM19 and CpG also enhanced anti-
tumor effects. However, combination with rR9-GRIM19 and vaccination therapy using Trp2-pep-
tide-DC did not enhance antitumor effects. These results indicate that i.t. injections of rR9-GRIM19
have potential as a novel immunological modifier when combined with cancer immunotherapy.
561
Production of SJS/TEN model mice using patients PBMCs and skin
N Saito, R Abe, N Yoshioka, H Qiao, Y Fujita, D Hoshina and H Shimizu Dermatology, Hokkaido
University Graduate School of Medicine, Sapporo, Japan
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening cutaneous
adverse drug reactions. Currently, there is no murine model to reproduce SJS/TEN symptoms. Here,
we report a novel murine model of SJS/TEN. Peripheral blood mononuclear cells (PBMCs) from
patients with SJS/TEN or ordinary drug skin reaction (ODSR) were injected intravenously into immuno-
compromised NOG (NOD/Shi- scid , IL-2R γnull ) mice, followed by the oral administration of a
causative drug. We examined these drug-administered mice in the first 12 days after administration
to exclude GVHR, since GVHR symptoms and increase of human cells in peripheral blood occurred
in NOG mice around 20 days after human PBMCs injection. Drug-administered mice showed
hemorrhage of the conjunctiva 12 days after PBMCs injection, whereas control mice showed no
symptoms. TUNEL stain demonstrated that over 75% of cells were apoptotic in the conjunctival
epithelium of SJS/TEN mice, compared only 10% in control mice. In analysis of drug-specific human
T cells in spleen, 80 cells per 2x105 splenocytes from SJS/TEN PBMCs mice were detected using a
human IFN-γ specific ELISPOT assay, whereas only 3 cells in the control. However, these models
did not show any skin symptoms or keratinocyte apoptosis. Therefore, we generated a human skin
transplanted mice. The patient’s PBMCs were injected intravenously into mice transplanted same
patient’s skin, followed by the oral administration of the causative drug. Skin transplanted mice
showed necrotic appearance in skin graft areas 8 days after PBMCs injection. Cleaved caspase 3
stain indicated 5% apoptotic cells in SJS/TEN patient’s skin graft areas compared with 0.7% in healthy
control. Unexpectedly, there were no difference in the numbers of human CD4 + and CD8 + cells
in the graft between SJS/TEN patient and healthy control. In summary, we successfully established
the SJS/TEN model mice using SJS/TEN patients’ samples.
562
Generation of tumor-specific anti-melanoma T-cell responses by extracorporeal pho-
tochemotherapy-induced dendritic cells
AK Engberg, CL Berger, DJ Hanlon and RL Edelson Dermatology, Yale University, New Haven,
CT
Extracorporeal photochemotherapy (ECP) is a widely used immunotherapy for advanced cutaneous
T-cell lymphoma (CTCL). ECP’s capacity to expand CD8 T-cell populations with specificity for
CTCL cells, as well as generate large scale rapid maturation of monocytes into functional dendritic
antigen presenting cells (DC), suggests that the treatment may also be applicable to immunother-
apy of solid tumors (Blood 116:4838-47, 2010). To test this premise, we assessed the capacity of
ECP-induced DC to efficiently stimulate in vitro anti-melanoma T-cell responses. ECP-induced DC
were loaded with the melanoma-associated antigen (Ag) gp100 which had been encapsulated in
poly(lactic-co-glycolic)acid (PLGA) nanoparticles (NP). We had previously reported that NP encap-
sulation enhances cross-presentation of Ag into the class I major histocompatibility complex (MHC),
recognized by CD8 T cells. ECP-generated DC were pulsed overnight with either no antigen, empty
PLGA NP, PLGA-encapsulated gp100, or soluble gp100. DC were then co-cultured with either autol-
ogous CD4/CD8 cells or a gp100-specific T-cell line, and supernatant was analyzed for IFN-γ pro-
duction. DC phenotype was confirmed by flow cytometry, showing ECP-derived DC were 95.21%
CD11c+, 17% CD80/86+, and 24.2% DR/CD83+. Utilizing the gp100-specific T-cell line as an indi-
cator for responding CD8 T cells, DC loaded with PLGA-encapsulated gp100 stimulated more
(p=0.0032) IFN-γ production (125.12 pg/ml) than did pulsing with no antigen (9.42 pg/ml) or a series
of negative controls. These results reveal that the maturationally synchronized DC that are induced
on a large scale by ECP, in a single day without added cytokines, can stimulate vigorous anti-
melanoma CD8 T-cell responses. These responses compared favorably with DC conventionally gen-
erated and tumor antigen loaded over a full week in the presence of supra-pharmacologic doses of
cytokines. ECP-induced DC offer an attractive source of antigen presenting cells for potential anti-
melanoma immunotherapy trials.
563
Granulocyte-derived dendritic cells (grDC) are specialized for bacterial antigen presentation
S Geng,1 H Matsushima,1 P Kotol,2 R Gallo2 and A Takashima1 1 Department of Medical
Microbiology and Immunology, University of Toledo, Toledo, OH and 2 Division of
Dermatology, University of California San Diego, San Diego, CA
We recently reported a novel DC subset, termed grDC, derived from immature granulocytes. grDC
exhibit dendritic morphology, express typical DC markers (MHC class II, CD11c, and CD205), and
present OVA peptides to both OT-II CD4 T cells and OT-I CD8 T cells. Importantly, grDC retain sur-
face expression of a granulocyte marker Ly6G, which is not detectable on any of the currently known
DC subsets. The purpose of this study was to determine specific function(s) of grDC. Ly6G+ grDC
were found to uptake FITC-dextran, latex particles, and live E. coli more (P<0.001) efficiently than
Ly6G- conventional DC (cDC). GeneChip analyses revealed 170 genes preferentially (>2-fold, P<0.05)
expressed by grDC, and this cluster included cathelicidin (CRAMP). Predominant CRAMP produc-
tion by grDC was confirmed at mRNA (real-time PCR), protein (immune-blotting and immune-flu-
orescence staining) and functional (bacterial killing) levels. Furthermore, wild-type grDC, but not
CRAMP-deficient grDC, killed internalized bacteria more rapidly than did cDC counterparts. Large
numbers of grDC became detectable in the peritoneal cavity within 24 h after i.p. injection of live
E. coli. To study in vivo function, we i.p. injected OVA-transduced E. coli, purified grDC and cDC
by FACS from the peritoneal cavity, and then compared their abilities to activate OT-II CD4 T cells
– grDC were again more (>3-fold, P<0.001) efficient than cDC, documenting potent abilities of
grDC to uptake and kill bacteria and to process and present bacterial antigens to T cells. We pro-
pose that immature granulocytes emerging at bacterial infection sites can give rise to a unique DC
subset specialized for initiating adaptive immunity against bacterial antigens.
564
Melanoma secretes the T cell inhibitor DC-HIL: A novel mechanism of tumor-induced sys-
temic immunosuppression
K Tamura, J Chung, PD Cruz and K Ariizumi Dermatology, University of Texas Southwestern
Medical Center, Dallas, TX
Having published that DC-HIL expressed on melanoma cells potently inhibits T cell activation by
binding syndecan-4 on activated T cells and that this function regulates tumor growth locally, we
posited that melanoma may also secrete a soluble form of DC-HIL. Indeed, we detected abundant
levels of secreted DC-HIL (98 KDa) within culture supernatant of B16 melanoma. Moreover, fol-
lowing subcutaneous implantation of B16 melanoma into syngeneic mice, we noted a positive cor-
relation (Pearson’s r = 0.967) between tumor volume and serum DC-HIL, with the largest tumors (4
cm3) associated with the highest DC-HIL level (500 nM). A similar correlation (r = 0.952) was
noted with melanoma metastasis to lungs. To decipher the function of secreted DC-HIL, sera from
melanoma-bearing mice were absorbed with beads laden with control IgG or anti-DC-HIL Ab, and
then added to gp100-TCR+ T cells in culture. Sera absorbed with control IgG beads inhibited T cell
activation by 80%, whereas sera absorbed with anti-DC-HIL Ab restored T cell function up to 80%,
thereby confirming that secreted DC-HIL is inhibitory. Finally, to probe whether suppression of T
cell activation by secreted DC-HIL is linked to tumor growth, we transfected LL2 carcinoma cells
(devoid of DC-HIL expression) with a gene encoding secreted DC-HIL whose expression is con-
trolled by doxycycline (Dox). Treatment with Dox (shuts off gene expression) had no effect on
tumor growth, whereas no treatment (gene expressed) augmented tumor growth (0.8±0.2 vs. 0.3±0.1
cm3). Dox’s influence was affirmed by lack of DC-HIL expression in tumors of treated mice and by
reduced proliferation of infused gp100-T cells in untreated mice. We conclude that B16 melanoma
not only expresses DC-HIL responsible for inactivating T cells proximal to the tumor, but that it also
secretes DC-HIL into circulation, endowing it with the ability to suppress tumor immune responses
in a systemic manner.
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Corticotropin-releasing hormone downregulates IL-10 production by adaptive FoxP3- regu-
latory T cells in atopic dermatitis patients
SH Oh, CO Park, WH Wu, JY Kim, S Jin, BG Bae, S Noh, JY Noh and KH Lee Department of
Dermatology and Cutaneous Biology Research Institute, Yonsei University College of
Medicine, Seoul, Republic of Korea
Atopic dermatitis (AD), which is a highly pruritic, chronic relapsing inflammatory skin disease, is
known to be triggered by or exacerbated by psychologic factors like stress. Corticotropin-releasing
hormone (CRH), the central mediator of the stress hormone system, has additional peripheral roles
such as effects on the gastrointestinal tract, cardiovascular system, and skin. However, the expres-
sion of CRH receptors (CRHRs) on peripheral T cells are still poorly evaluated and no direct effect
of CRH on the subtypes of CD4+ T cells has been demonstrated in AD characterized by marked T
cell infiltration. Here, we investigated whether T cells have CRHRs and whether CRH has direct
effect on peripheral TH1, TH2, and regulatory T (Treg) cells in patients with AD. CRHR1/R2 proteins
and mRNAs were expressed on T cells. T cells of patients with AD expressed significantly lower lev-
els of CRHR1/R2 mRNAs than those of healthy controls (HCs). CRH upregulated IL-4 production
by TH2 cells and downregulated IFN-γ production by TH1 cells in HCs, while the TH1/TH2 cells
in patients with AD did not properly respond to TH2 polarization after CRH treatment. CRH reduced
only IL-10 secretion from FoxP3-CD4+ Treg cells significantly, but not from FoxP3+CD4+ Treg cells,
along with no significant change of FoxP3+CD4+CD25+ Treg cells after CRH treatment in patients
with AD. These results suggest that inducible, or adaptive FoxP3- Treg cells producing IL-10 might
be significantly affected by CRH among patients with AD. CRH-mediated IL-10 secreting Treg cell
suppression might explain one mechanism leading to stress-related exacerbations in atopic der-
matitis.
579
IRF8 is an essential regulator of CD8 T cell effector function
F Miyagawa,1 H Zhang,1 K Ozato,2 Y Tagaya3 and S Katz1 1 Dermatology, NCI, Bethesda, MD,
2 NICHD, Bethesda, MD and 3 Metabolism, NCI, Bethesda, MD
To better delineate the mechanisms involved in CD8 T cell-mediated graft v host disease (GvHD),
we developed an in vitro assay that utilized microarrays to identify CD8 T cell genes of interest. We
found that, in addition to T-bet and Eomes transcription factors, interferon regulatory factor 8 (IRF8),
a transcription factor that belongs to IRF family, was persistently and strongly upregulated in fully
functional CD8 T cells. Upon Ag stimulation, Ag-specific CD8 T cells clonally expand and acquire
effector functions that include IFN-γ production and cytotoxicity. The acquisition of effector func-
tions by CD8 T cells is critical for the control of intracellular pathogens and tumors. Because little
is known about the role of IRF8 in CD8 T cells, we determined its role in CD8 T cell activation
using a CD8 T cell–mediated mouse model of GvHD. We generated OT-I mice [with T cell speci-
ficity for ovalbumin (OVA) and H-2b] on an IRF8KO background and transferred OT-I/IRF8KO cells
into K14-mOVA mice that express membrane-bound OVA that is expressed under the K14 promoter
in squamous epithelia. Transfer of syngeneic CD8OT-I cells that recognize OVA as a nominal Ag
results in GvHD-like disease. However, when OT-I/IRF8KO cells were injected into K14-mOVA mice
little or no disease ensued. CFSE dilution analysis showed that OT-I cells and OT-I/IRF8KO cells
proliferated in the similar manner, however, the expression of activation markers in OT-I/IRF8KO
cells was partially impaired. Intracellular cytokine staining showed OT-I/IRF8KO cells injected into
K14-mOVA mice produced less IFN-γ than OT-I cells and comparable levels of TNF-α. An in vivo
cytotoxicity assay showed that OT-I/IRF8KO cells was less efficient in eliminating OVA-expressing
target cells. These results suggest that IRF8 is one of the key regulators in CD8 T cell effector func-
tion in addition to T-bet and Eomes. Furthermore, OT-I/IRF8KO cells expressed similar levels of T-
bet and Eomes to OT-I cells upon Ag stimulation, suggesting that IRF8 may control effector func-
tions through a T-bet and Eomes independent pathway.
581
Re-thinking the role of chemokine receptor CCR7 in generating skin-imprinted memory and
effector T cells
B Vander Lugt, NJ Tubo, M Boes, RC Fuhlbrigge, TS Kupper and JJ Campbell Department of
Dermatology, Brigham and Women’s Hospital, Boston, MA
The in vivo study of CCR7-mediated T lymphocyte trafficking is complicated by profound anom-
alies that occur within the architecture of lymphoid organs found in mice that congenitally lack
CCR7 or its ligands. To circumvent this limitation, we have developed models in which WT lym-
phocytes compete with CCR7-/- lymphocytes to access various tissues within otherwise normal
mice. Our findings confirm that CCR7 deficiency profoundly reduces accumulation of naïve T cells
within LN. This reduction does not correlate with proposed roles for CCR7 in early T cell develop-
ment, as the thymus produces equal numbers of mature SP thymocytes from both WT and CCR7-/-
precursors. Long-term homing assays suggest that Ag-experienced T cells are entirely independent
of CCR7 for their accumulation within LN. Shorter-term assays confirm this finding, but suggest that
unlike naïve T cells, most Ag-experienced CD4 T cells enter LN indirectly from non-lymphoid tis-
sues (via the afferent lymph), rather than directly from the blood. Contrary to previous studies, we
find that CCR7-deficiency does not affect CD4 T cell migration from skin to LN through the affer-
ent lymph. This independence contrasts strikingly with the behavior of migratory DC subsets, which
we confirmed to be entirely dependent on CCR7 for migration to LN from skin. WT and CCR7-/-
CD4 T cells were imprinted equally well to express E-lig during anamnestic but not primary immune
responses. This suggests the existence of an alternative tissue-imprinting mechanism that is active
only after multiple immunizations, and is independent of CCR7-mediated entry of naïve T cells into
tissue-draining LN.
580
Human dermal-derived interfollicular mesenchymal stem cells drive the differentiation of
naive helper T cells towards a regulatory phenotype without provision of costimulatory mol-
ecules
K Pfisterer,1 C Vaculik,1 G Kramer,2 D Strunk3 and A Elbe-Bürger1 1 Department of Dermatology,
Division of Immunology, Allergy and Infectious Diseases (DIAID), Medical University of
Vienna, Vienna, Austria, 2 Department of Urology, Medical University of Vienna, Vienna,
Austria and 3 Department of Hematology, Medical University of Graz, Graz, Austria
We found that phenotypically-defined, plastic-adherent human dermal mesenchymal stem cells
(MSCs) have immunomodulatory capacities. To test, whether regulatory T cells (Tregs) are involved,
total adherent dermal cells, defined adherent dermal MSC subsets and, as a control, bone marrow-
derived (BM-)MSCs, which all lack the expression of CD80/86, were subjected to functional in
vitro assays with CD25-depleted naive helper T (Th) cells and stimulation with αCD3 or αCD3/CD28
mAbs. Using flow cytometry, T cell proliferation was visualized via carboxyfluorescein succinimidyl
ester dilution and the differentiation of dividing cells into Tregs was evaluated by counterstaining
of the transcription factor FoxP3. Stimulation of naive Th cells with αCD3/CD28 and coculture with
total adherent dermal cells or BM-MSCs led to a low, but significant, increase of FoxP3-expressing
T cells (7.13±2.5 vs. 4.45±0.62, P<0.05, n=2), while stimulation with αCD3 alone highly increased
the percentage of FoxP3-expressing cells from a value of 4.48%±3.00 in stimulated T cells alone,
to 15.03%±4.52 after coculture with dermal cells (P<0.001, n=8) and 10.39%±4.74 with BM-
MCSs (P<0.05, n=7). We also found that CD90+ dermal cells significantly induced more FoxP3-
expressing T cells than CD90- cells (17.42%±6.64 vs. 8.81%±2.78, P<0.05, n=4). Furthermore, a
higher percentage of FoxP3-expressing Th cells, though not significant, was generated upon cocul-
ture with CD271- dermal cells compared with CD271+ cells (n=5). Our data imply that skin-resi-
dent MSCs may coordinate the interactions that are necessary to initiate the induction/proliferation
of Tregs to maintain the immune homeostasis in human skin and to prevent excessive immunopathol-
ogy.
578
Active transport of contact allergens modulates their activation of human monocyte derived
dendritic cells
HF Merk, R Heise, H Ott, K Czaja, Y Marquardt, JM Baron and C Skazik Department of
Dermatology, University Hospital RWTH, Aachen, Germany
Allergic contact dermatitis (ACD) is a delayed hypersensitivity reaction to small molecular weight
compounds (SMWC). ATP-binding cassette (ABC) transport proteins can actively transport many
SMWC including xenobiotica, but also physiological substrates including steroids and inflamma-
tory mediators such as prostaglandins either directly or conjugated to acidic ligands, such as glu-
tathione, glucuronate, or sulfate out of the cell. So far, knowledge on the transport of SMWC, par-
ticularly prohaptens, is limited. Recent studies revealed that antigen presenting cells like monocytes,
macrophages and also monocyte-derived dendritic cells (moDCs) constitutively express MRP1 as
well as MRP3-6. Therefore we studied the role of MRP proteins in antigen presenting cells and could
provide evidence for a functional MRP-mediated efflux activity in moDCs, using in vitro transport
and DC-activation assays. Treatment with the specific MRP inhibitor indomethacin in a concentra-
tion of 500 μM inhibited MRP dependent efflux transport and therefore increased the intracellular
concentration of [3H]eugenol up to 170% and of [3H]isoeugenol up to 182% in moDCs in com-
parison to untreated cells. Hence, to survey the functionality of this efflux the effect of the specific
MRP inhibitor indomethacin on the stimulation of IL-8 and TRIM16 regulation by these contact
sensitizers was measured by a DC-based in vitro assay. After co-incubation of moDCs with
indomethacin and isoeugenol IL-8 and TRIM16 mRNA expression was significantly enhanced
compared to cells which were not preincubated with indomethacin. This effect might be applied to
improve the sensitivity of novel in vitro test systems which are currently used to predict the skin
sensitizing capacity of a chemical and especially of weak or moderate contact allergens.
582
Signaling via neurokinin-1 receptor promotes type-1 DTH by abrogating IL-10 secretion in
myeloid dendritic cells
BM Janelsins,1,3 TL Sumpter,1 AR Mathers,1,3 O Tkacheva,1 W Shufesky,2 AE Morelli2,3 and
AT Larregina1,3 1 Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 2
Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA and 3 Immunology,
University of Pittsburgh School of Medicine, Pittsburgh, PA
Neuropeptides regulate the initiation and outcomes of innate and adaptive immunity. As an immune
competent organ the skin is richly innervated and cutaneous cells, express neuropeptide receptors
like the pro-inflammatory neurokinin-1 receptor (NK1R). By binding the NK1R, the tachykinins sub-
stance P and hemokinin-1 favor cellular immunity. Cutaneous myeloid dendritic cells (DC) link
innate and adaptive immunity and express NK1R. Yet, the ability of NK1R agonists to control T cell-
stimulatory functions of DC remains unknown. Here we analyzed the effects of signaling mouse
myeloid DC via NK1R (NK1R-DC) on their abilities to stimulate cutaneous T-cell immunity to hap-
tens (DNCB) and protein Ag (chicken ovoalbumin (OVA)). We demonstrate that DC express func-
tional NK1R which increased following LPS exposure as detected by qRT-PCR. NK1R-DC decreased
the translocation of pCREB into their nuclei resulting in DC maturation and inhibition of IL-10 secre-
tion, without increasing IL-12p70. Adoptive transfer of NK1R-DC to C57BL/6 mice induced hap-
ten/Ag-specific CD4+Th1 and CD8+Tc1 immunity followed by robust skin DTH responses that were
inhibited by restoring IL-10 secretion in the adoptively transferred DC. As Th1 and Tc1 responses
required IL12p70, we analyzed the source of IL-12p70 in our model by comparing the immune
response elicited by NK1R-DC injected to C57BL/6-wild type,IL-12p35-/- or CD11c+DTR mice (the
latter depleted of endogenous DCs). In these conditions type-1 immunity required lacking of IL-10
by the transferred DC and secretion of IL-12p70 by secondary lymphoid organ DC. In conclusion
we show that NK1R signaling of Ag-bearing myeloid DC results in potent Th1 and Tc1 immunity
mediated by pro-inflammatory myeloid DC with ability to regulate the immune stimulatory func-
tion of lymphoid organ resident DC.
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Ontogeny of CD45+CD36+ cells in developing prenatal human skin
C Schuster,1 C Vaculik,1 C Fiala,3 G Stingl,1 W Eppel2 and A Elbe-Bürger1 1 DIAID, Medical
University of Vienna, Vienna, Austria, 2 Department of Gynaecology and Obstetrics, Medical
University of Vienna, Vienna, Austria and 3 Gynmed-Ambulatorium, Vienna, Austria
Despite a considerable number of studies, the precise phenotype of skin dendritic cell precursors
has not yet been determined in humans. Clues about these precursors can be obtained by the study
of their ontogeny. CD36+HLA-DR+/- cells of unknown nature have previously been identified in
the primitive epidermis in embryonic skin. To further characterize their phenotype, the expression
of selected markers was evaluated on single cell suspensions and frozen sections of embryonic and
fetal human skin. Using flow cytometry, we found that 65.3% of CD45+ leukocytes exhibit the scav-
enger receptor CD36 at 9 weeks estimated gestational age. In addition, we discovered that CD14
is expressed on 54.7% of CD36+ leukocytes in embryonic skin, which is comparable to what has
been described in adult skin. Strikingly, significantly fewer CD45+CD36+ cells in embryonic skin
express HLA-DR compared to adult skin (38.4% vs. 98.3%). Immunofluorescence staining of embry-
onic skin sections locates CD45+CD36+ cells predominantly in the dermis, but occasionally also
in the epidermis. A subset of these epidermal leukocytes coexpresses CD14 and HLA-DR in the first
trimester. Intriguingly, CD45+ epidermal cells that neither express CD36, CD14 nor HLA-DR are
occasionally found during the first trimester. In the dermis, various subsets of CD36+ leukocytes can
be identified in developing prenatal and adult skin with regard to the expression of some pattern
recognition receptors. Assessment of the expression of CD206 and CD209 revealed that these mark-
ers are restricted to dermal cells during all stages of prenatal development and in adult skin. Flow
cytometric analysis showed that CD206+ leukocytes coexpress CD36 and that CD206+CD36+
leukocytes in developing skin express comparable levels of CD14 but lower levels of HLA-DR than
in adult skin. We found that similar to what has been described in various mouse models immature
skin leukocytes acquire HLA-DR during development in the skin.
572
Effects of repeated application of Dermatophagoides farinae (D.farinae) on the expressions
of atopic dermatitis(AD)-like inflammatory skin mediators in NC/Nga mice
J Kim, M Jeong, K Park, K Li and S Seo Department of Dermatology, Chung Ang University
College of Medicine, Seoul, Republic of Korea
Atopic dermatitis (AD) is a chronic, relapsing, multifactorial skin disorder with complex interactions
of genetic predisposition and environmental factors. This study was performed to examine the effects
of repeated applications of Dermatophagoides farinae (D. farinae) on AD-like skin inflammatory
mediators such as immunoglobulin (Ig) subtypes, Th1, Th2, and Th17 cytokines in NC/Nga mice.
To evaluate the effects of D. farinae on the development of AD-like skin lesion, the measurement
of clinical skin severity scoring (SCORAD), epidermal thickening, mast cell infiltration/degranula-
tion, the levels of total and D.farinae-specific plasma Ig isotypes (IgE, IgG1, and IgG2a), the mRNA
and protein expression levels of cytokines (IL-4, IL-5, IL-13, IL-17, IFN-γ, and TNF-α), Toll-like recep-
tors (TLR2 and 4) and β-defensin 2 (BD-2) were done on D. farinae-induced AD-like skin lesions
and splenocytes in NC/Nga mice. Repeated applications of D. farinae aggravated the clinical der-
matitis severity, increased the epidermal thickness, the dermal infiltration/degranulation of mast cell
and total plasma IgE, IgG1 and IgG2a. The increase in total plasma IgE, IgG1 and IgG2a was accom-
panied with increasing IL-4 and IFN-γ expressions in the skin and splenocytes. Interestingly, the
mRNA and protein expression levels of IL-17 and TLR2 were significantly increased by D. farinae-
administration in skin and splenocyte, whereas mRNA expression of BD-2 was decreased in AD-
like skin lesions. In conclusion, we confirmed that the repeated skin exposure of D. farinae might
be associated with aggravation of AD-like skin lesion through the modulation of Th1, Th2 and Th17
cytokine, the overproduction of Th2-mediated IgE, and the downregulation of BD-2 expression.
573
Effects of repeated formaldehyde (FA) exposure on atopic dermatitis (AD)-like immune
responses in NC/Nga mice
K Li, J Kim, M Jeong, D Kim and S Seo Department of Dermatology, Chung Ang University
College of Medicine, Seoul, Republic of Korea
Formaldehyde (FA), as an environmental agent, has been considered to be associated with the
increase in the prevalence of allergic diseases including asthma and atopic dermatitis (AD). We
investigated whether repeated FA exposure has an effect on AD-like immune responses depending
on the presence or absence of Dermatophagoides farnae (D.farinae) priming. To evaluate the influ-
ence of repeated FA exposure, four groups of NC/Nga mice were exposed to 0.0, 0.2, 1.0, and 5.0
ppm FA for 6 h per day, Wednesday through Monday, over a period of 2 weeks, respectively. After
repeated FA exposure, one group of mice was treated with D.farinae extract ointment and another
group was treated with vehicle ointment for 2 weeks. The levels of total Ig isotypes (IgE, IgG1, and
IgG2a) as well as cytokines (IL-4, IL-5, IL-13, IL-17, and IFN-γ) were examined in the plasma and
splenocytes of each group of mice, respectively. In this study, we examined an association between
FA exposure levels and the presence of AD-like immune responses and suggested that repeated FA
exposure might be associated with increasing risk factor for allergic sensitization to D.farinae. The
mechanism by which repeated FA exposure could affect the skin aggravation of AD-like lesion is
unclear. However, greater severity of the allergic sensitization might be associated with the levels
of FA exposure. Low level of FA exposure group of mice showed significant difference between
groups. Therefore, we suggested that repeated FA exposure might have different effects on AD-like
immune responses according to the exposure levels of FA.
574
Statins inhibit chemotactic interaction between CCL20 and CCR6 in vitro: Possible rele-
vance to psoriasis treatment
T Kim, D Byamba, W Wu, H Jee, D Kim and M Lee Dermatology, Yonsei University, College of
Medicine, Seoul, Republic of Korea
Psoriasis is a common and chronic inflammatory skin disease which is associated with IL-23/Th17
pathway. An increased expression of CC chemokine ligand 20 (CCL20) in psoriatic lesions can attract
CC chemokine receptor 6 (CCR6)-expressing Th17 cells into the lesions. Lipid-lowering drugs, statins,
possess other immune-modulating functions. We explored whether specific types of statins could
inhibit CCL20 production in HaCaT cells. We also investigated whether statins could attenuate the
chemotactic migration of CD4+ T cells toward CCL20. We used enzyme-linked immunosorbent
assay to evaluate CCL20 release from HaCaT cells stimulated by psoriasis-associated cytokines with
or without statins. We performed fluorescence-activated cell sorting to investigate the level of sur-
face CCR6 and CD45RO expression on human CD4+ T cells in various conditions. Functionally,
the in vitro chemotaxis migration assay was performed and the number of migrating cells was ana-
lyzed using a flow cytometry. We demonstrated that IL-1β, TNF-α, and IL-17A significantly increased
CCL20 production from HaCaT cells in a dose-dependent manner. However, these increments were
significantly inhibited by the addition of fluvastatin and simvastatin, but not by pravastatin. In the
in vitro chemotaxis migration assay, pretreatment with fluvastatin and simvastatin, but not with
pravastatin, inhibited the chemotactic migration of human CD4+ T cells toward CCL20. However
the level of surface expression of CCR6 on CD4+ T cells was not altered by statins. Our results sug-
gest that not all, but specific types of statins may be of benefit in managing psoriasis partially via
interrupting the chemotactic interaction of CCL20/CCR6, the mechanism which eventually lessen
the infiltration of lesional Th17 cells.
575
Brn2 exerts its possible role as positive feedback regulator of TNF-α in lichenoid tissue reac-
tion
K Whang,1 J Sim,1 J Kim,1 G Lee,1 N Jeung,2 K Sohn,2 D Choi,2 Y Lee,2 Y Seo,2 C Kim2 and J Lee2
1 Department of Dermatology, Soonchunhyang University Hospital, Seoul, Republic of Korea
and 2 Department of Dermatology and Research Institute for Medical Sciences, School of
Medicine, Chungnam National University, Daejeon, Republic of Korea
In our previous studies, we found the histologic features of the Brn2 injected rat skin are very sim-
ilar with the histopathology of lichen planus. Because lichen planus share several clinical and his-
tological features with GVHD, we hypothesize that similar mechanisms might be involved in estab-
lishing lichenoid tissue reaction of cutaneous GVHD. To delineate the possible role of Brn2 in
lichenoid tissue reaction, we examined Brn2 protein expression in cutaneous GVHD, lichen planus
and normal human skin by immunohistochemistry. Interestingly, Brn2 have been shown to be
expressed in all nuclei of the thickend epidermis of lichen planus and to be highly expressed in the
GVHD all of the epidermis and sup-dermis. Next, we examined Brn2 mRNA and protein expres-
sion in cultured normal human epidermal keratinocytes (NHEKs) exposed to TNF-α, critical factor
in keratinocyte apoptosis in cytotoxic GVHD. We demonstrated that Brn2 expression in NHEKs
was markedly increased by TNF-α and apparent correlation with concentration and decreased by
exposed to cyclosporine, a calcineurin inhibitor, used to prevent GVHD. These results suggest that
Brn2 may acts the important role in TNF-α associated lichenoid tissue reaction. Finally, we deter-
mined the effect of ectopic over-expression of Brn2 proteins in keratinocytes using transduction of
recombinant adenoviruses expressing Brn2. We confirmed that Brn2 mRNA and proteins were over-
expressed dose-dependently by TNF-α and Brn2 increased the mRNA level of pro-inflammatory
cytokines, such as TNF- α. These results demonstrated that Brn2 functionally expressed by ker-
atinocyte and exerts its role as a positive feedback regulator on TNF-α in lichenoid tissue reaction.
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Blocking galectin-1 ligand biosynthesis enhances immunity against melanoma
F Cedeno-Laurent,1,3 M Opperman,1 SR Barthel,1 D Hays,1 T Schatton,1,4 Q Zhan,2 MH Frank,1,4
GF Murphy2 and CJ Dimitroff1,2,3 1 Dermatology, Brigham and Women’s Hospital, Boston, MA,
2 Pathology, Brigham and Women’s Hospital, Boston, MA, 3 Immunology, Harvard Medical
School, Boston, MA and 4 Transplantation Research Center, Children’s Hospital, Boston, MA
Galectin-1 (Gal-1), the prototype S-type lectin, has been speculated to play a major role in tumor
immune evasion by its ability to induce apoptosis in Gal-1 ligand+ anti-tumor leukocytes and pro-
mote expansion of FoxP3+ and type 1 (Tr1) regulatory T cell subsets. We hypothesize that interfer-
ence of the Gal-1 – Gal-1 ligand binding axis will spare Gal-1-mediated immune suppression and
accentuate anti-tumor immunity. Here, we first show that Gal-1 is strategically localized in human
melanomas to shield effector T cells from infiltrating melanomas. Interestingly, Gal-1 was spatially
distributed in curvilinear arrays surrounding nests of ABCB5+ melanoma-initiating cells, reminis-
cent of an immune-privileged site. While targeting Gal-1 has been previously shown as an effica-
cious approach for treating melanomas, we centered our strategy on inhibiting the synthesis of
counter-receptor Gal-1 ligand with peracetylated 4-fluoro-glucosamine, 4-F-GlcNAc, a metabolic
inhibitor of Gal-1 binding determinant, N-acetyllactosamine. In mice bearing syngeneic B16
melanomas, 4-F-GlcNAc treatment caused significantly attenuated growth of nascent and estab-
lished tumors concomitant with increasing levels of anti-tumor CD4+ and CD8+ T cells and NK cells.
These cells expressed robust levels of Gal-1 ligand and elevated levels of IFN-γ, though markedly
diminished levels of IL-10. Furthermore, 4-F-GlcNAc-treated mice exhibited similar elevations of
IFN-γ+ T cells and reductions in IL-10+ T cells as those in mice bearing B16 melanomas deficient in
Gal-1 or in candidate Gal-1 ligand, CD43. These data implicate tumor-derived Gal-1 and T cell Gal-
1 ligand, CD43, as key regulators in generating anti-melanoma immunity and demonstrate the util-
ity of inhibitors against Gal-1 ligand expression for boosting anti-melanoma immune responses.
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Corticotropin-releasing hormone downregulates IL-10 production by adaptive FoxP3- regu-
latory T cells in atopic dermatitis patients
SH Oh, CO Park, WH Wu, JY Kim, S Jin, BG Bae, S Noh, JY Noh and KH Lee Department of
Dermatology and Cutaneous Biology Research Institute, Yonsei University College of
Medicine, Seoul, Republic of Korea
Atopic dermatitis (AD), which is a highly pruritic, chronic relapsing inflammatory skin disease, is
known to be triggered by or exacerbated by psychologic factors like stress. Corticotropin-releasing
hormone (CRH), the central mediator of the stress hormone system, has additional peripheral roles
such as effects on the gastrointestinal tract, cardiovascular system, and skin. However, the expres-
sion of CRH receptors (CRHRs) on peripheral T cells are still poorly evaluated and no direct effect
of CRH on the subtypes of CD4+ T cells has been demonstrated in AD characterized by marked T
cell infiltration. Here, we investigated whether T cells have CRHRs and whether CRH has direct
effect on peripheral TH1, TH2, and regulatory T (Treg) cells in patients with AD. CRHR1/R2 proteins
and mRNAs were expressed on T cells. T cells of patients with AD expressed significantly lower lev-
els of CRHR1/R2 mRNAs than those of healthy controls (HCs). CRH upregulated IL-4 production
by TH2 cells and downregulated IFN-γ production by TH1 cells in HCs, while the TH1/TH2 cells
in patients with AD did not properly respond to TH2 polarization after CRH treatment. CRH reduced
only IL-10 secretion from FoxP3-CD4+ Treg cells significantly, but not from FoxP3+CD4+ Treg cells,
along with no significant change of FoxP3+CD4+CD25+ Treg cells after CRH treatment in patients
with AD. These results suggest that inducible, or adaptive FoxP3- Treg cells producing IL-10 might
be significantly affected by CRH among patients with AD. CRH-mediated IL-10 secreting Treg cell
suppression might explain one mechanism leading to stress-related exacerbations in atopic der-
matitis.
579
IRF8 is an essential regulator of CD8 T cell effector function
F Miyagawa,1 H Zhang,1 K Ozato,2 Y Tagaya3 and S Katz1 1 Dermatology, NCI, Bethesda, MD,
2 NICHD, Bethesda, MD and 3 Metabolism, NCI, Bethesda, MD
To better delineate the mechanisms involved in CD8 T cell-mediated graft v host disease (GvHD),
we developed an in vitro assay that utilized microarrays to identify CD8 T cell genes of interest. We
found that, in addition to T-bet and Eomes transcription factors, interferon regulatory factor 8 (IRF8),
a transcription factor that belongs to IRF family, was persistently and strongly upregulated in fully
functional CD8 T cells. Upon Ag stimulation, Ag-specific CD8 T cells clonally expand and acquire
effector functions that include IFN-γ production and cytotoxicity. The acquisition of effector func-
tions by CD8 T cells is critical for the control of intracellular pathogens and tumors. Because little
is known about the role of IRF8 in CD8 T cells, we determined its role in CD8 T cell activation
using a CD8 T cell–mediated mouse model of GvHD. We generated OT-I mice [with T cell speci-
ficity for ovalbumin (OVA) and H-2b] on an IRF8KO background and transferred OT-I/IRF8KO cells
into K14-mOVA mice that express membrane-bound OVA that is expressed under the K14 promoter
in squamous epithelia. Transfer of syngeneic CD8OT-I cells that recognize OVA as a nominal Ag
results in GvHD-like disease. However, when OT-I/IRF8KO cells were injected into K14-mOVA mice
little or no disease ensued. CFSE dilution analysis showed that OT-I cells and OT-I/IRF8KO cells
proliferated in the similar manner, however, the expression of activation markers in OT-I/IRF8KO
cells was partially impaired. Intracellular cytokine staining showed OT-I/IRF8KO cells injected into
K14-mOVA mice produced less IFN-γ than OT-I cells and comparable levels of TNF-α. An in vivo
cytotoxicity assay showed that OT-I/IRF8KO cells was less efficient in eliminating OVA-expressing
target cells. These results suggest that IRF8 is one of the key regulators in CD8 T cell effector func-
tion in addition to T-bet and Eomes. Furthermore, OT-I/IRF8KO cells expressed similar levels of T-
bet and Eomes to OT-I cells upon Ag stimulation, suggesting that IRF8 may control effector func-
tions through a T-bet and Eomes independent pathway.
581
Re-thinking the role of chemokine receptor CCR7 in generating skin-imprinted memory and
effector T cells
B Vander Lugt, NJ Tubo, M Boes, RC Fuhlbrigge, TS Kupper and JJ Campbell Department of
Dermatology, Brigham and Women’s Hospital, Boston, MA
The in vivo study of CCR7-mediated T lymphocyte trafficking is complicated by profound anom-
alies that occur within the architecture of lymphoid organs found in mice that congenitally lack
CCR7 or its ligands. To circumvent this limitation, we have developed models in which WT lym-
phocytes compete with CCR7-/- lymphocytes to access various tissues within otherwise normal
mice. Our findings confirm that CCR7 deficiency profoundly reduces accumulation of naïve T cells
within LN. This reduction does not correlate with proposed roles for CCR7 in early T cell develop-
ment, as the thymus produces equal numbers of mature SP thymocytes from both WT and CCR7-/-
precursors. Long-term homing assays suggest that Ag-experienced T cells are entirely independent
of CCR7 for their accumulation within LN. Shorter-term assays confirm this finding, but suggest that
unlike naïve T cells, most Ag-experienced CD4 T cells enter LN indirectly from non-lymphoid tis-
sues (via the afferent lymph), rather than directly from the blood. Contrary to previous studies, we
find that CCR7-deficiency does not affect CD4 T cell migration from skin to LN through the affer-
ent lymph. This independence contrasts strikingly with the behavior of migratory DC subsets, which
we confirmed to be entirely dependent on CCR7 for migration to LN from skin. WT and CCR7-/-
CD4 T cells were imprinted equally well to express E-lig during anamnestic but not primary immune
responses. This suggests the existence of an alternative tissue-imprinting mechanism that is active
only after multiple immunizations, and is independent of CCR7-mediated entry of naïve T cells into
tissue-draining LN.
580
Human dermal-derived interfollicular mesenchymal stem cells drive the differentiation of
naive helper T cells towards a regulatory phenotype without provision of costimulatory mol-
ecules
K Pfisterer,1 C Vaculik,1 G Kramer,2 D Strunk3 and A Elbe-Bürger1 1 Department of Dermatology,
Division of Immunology, Allergy and Infectious Diseases (DIAID), Medical University of
Vienna, Vienna, Austria, 2 Department of Urology, Medical University of Vienna, Vienna,
Austria and 3 Department of Hematology, Medical University of Graz, Graz, Austria
We found that phenotypically-defined, plastic-adherent human dermal mesenchymal stem cells
(MSCs) have immunomodulatory capacities. To test, whether regulatory T cells (Tregs) are involved,
total adherent dermal cells, defined adherent dermal MSC subsets and, as a control, bone marrow-
derived (BM-)MSCs, which all lack the expression of CD80/86, were subjected to functional in
vitro assays with CD25-depleted naive helper T (Th) cells and stimulation with αCD3 or αCD3/CD28
mAbs. Using flow cytometry, T cell proliferation was visualized via carboxyfluorescein succinimidyl
ester dilution and the differentiation of dividing cells into Tregs was evaluated by counterstaining
of the transcription factor FoxP3. Stimulation of naive Th cells with αCD3/CD28 and coculture with
total adherent dermal cells or BM-MSCs led to a low, but significant, increase of FoxP3-expressing
T cells (7.13±2.5 vs. 4.45±0.62, P<0.05, n=2), while stimulation with αCD3 alone highly increased
the percentage of FoxP3-expressing cells from a value of 4.48%±3.00 in stimulated T cells alone,
to 15.03%±4.52 after coculture with dermal cells (P<0.001, n=8) and 10.39%±4.74 with BM-
MCSs (P<0.05, n=7). We also found that CD90+ dermal cells significantly induced more FoxP3-
expressing T cells than CD90- cells (17.42%±6.64 vs. 8.81%±2.78, P<0.05, n=4). Furthermore, a
higher percentage of FoxP3-expressing Th cells, though not significant, was generated upon cocul-
ture with CD271- dermal cells compared with CD271+ cells (n=5). Our data imply that skin-resi-
dent MSCs may coordinate the interactions that are necessary to initiate the induction/proliferation
of Tregs to maintain the immune homeostasis in human skin and to prevent excessive immunopathol-
ogy.
578
Active transport of contact allergens modulates their activation of human monocyte derived
dendritic cells
HF Merk, R Heise, H Ott, K Czaja, Y Marquardt, JM Baron and C Skazik Department of
Dermatology, University Hospital RWTH, Aachen, Germany
Allergic contact dermatitis (ACD) is a delayed hypersensitivity reaction to small molecular weight
compounds (SMWC). ATP-binding cassette (ABC) transport proteins can actively transport many
SMWC including xenobiotica, but also physiological substrates including steroids and inflamma-
tory mediators such as prostaglandins either directly or conjugated to acidic ligands, such as glu-
tathione, glucuronate, or sulfate out of the cell. So far, knowledge on the transport of SMWC, par-
ticularly prohaptens, is limited. Recent studies revealed that antigen presenting cells like monocytes,
macrophages and also monocyte-derived dendritic cells (moDCs) constitutively express MRP1 as
well as MRP3-6. Therefore we studied the role of MRP proteins in antigen presenting cells and could
provide evidence for a functional MRP-mediated efflux activity in moDCs, using in vitro transport
and DC-activation assays. Treatment with the specific MRP inhibitor indomethacin in a concentra-
tion of 500 μM inhibited MRP dependent efflux transport and therefore increased the intracellular
concentration of [3H]eugenol up to 170% and of [3H]isoeugenol up to 182% in moDCs in com-
parison to untreated cells. Hence, to survey the functionality of this efflux the effect of the specific
MRP inhibitor indomethacin on the stimulation of IL-8 and TRIM16 regulation by these contact
sensitizers was measured by a DC-based in vitro assay. After co-incubation of moDCs with
indomethacin and isoeugenol IL-8 and TRIM16 mRNA expression was significantly enhanced
compared to cells which were not preincubated with indomethacin. This effect might be applied to
improve the sensitivity of novel in vitro test systems which are currently used to predict the skin
sensitizing capacity of a chemical and especially of weak or moderate contact allergens.
582
Signaling via neurokinin-1 receptor promotes type-1 DTH by abrogating IL-10 secretion in
myeloid dendritic cells
BM Janelsins,1,3 TL Sumpter,1 AR Mathers,1,3 O Tkacheva,1 W Shufesky,2 AE Morelli2,3 and
AT Larregina1,3 1 Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 2
Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA and 3 Immunology,
University of Pittsburgh School of Medicine, Pittsburgh, PA
Neuropeptides regulate the initiation and outcomes of innate and adaptive immunity. As an immune
competent organ the skin is richly innervated and cutaneous cells, express neuropeptide receptors
like the pro-inflammatory neurokinin-1 receptor (NK1R). By binding the NK1R, the tachykinins sub-
stance P and hemokinin-1 favor cellular immunity. Cutaneous myeloid dendritic cells (DC) link
innate and adaptive immunity and express NK1R. Yet, the ability of NK1R agonists to control T cell-
stimulatory functions of DC remains unknown. Here we analyzed the effects of signaling mouse
myeloid DC via NK1R (NK1R-DC) on their abilities to stimulate cutaneous T-cell immunity to hap-
tens (DNCB) and protein Ag (chicken ovoalbumin (OVA)). We demonstrate that DC express func-
tional NK1R which increased following LPS exposure as detected by qRT-PCR. NK1R-DC decreased
the translocation of pCREB into their nuclei resulting in DC maturation and inhibition of IL-10 secre-
tion, without increasing IL-12p70. Adoptive transfer of NK1R-DC to C57BL/6 mice induced hap-
ten/Ag-specific CD4+Th1 and CD8+Tc1 immunity followed by robust skin DTH responses that were
inhibited by restoring IL-10 secretion in the adoptively transferred DC. As Th1 and Tc1 responses
required IL12p70, we analyzed the source of IL-12p70 in our model by comparing the immune
response elicited by NK1R-DC injected to C57BL/6-wild type,IL-12p35-/- or CD11c+DTR mice (the
latter depleted of endogenous DCs). In these conditions type-1 immunity required lacking of IL-10
by the transferred DC and secretion of IL-12p70 by secondary lymphoid organ DC. In conclusion
we show that NK1R signaling of Ag-bearing myeloid DC results in potent Th1 and Tc1 immunity
mediated by pro-inflammatory myeloid DC with ability to regulate the immune stimulatory func-
tion of lymphoid organ resident DC.
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Ontogeny of CD45+CD36+ cells in developing prenatal human skin
C Schuster,1 C Vaculik,1 C Fiala,3 G Stingl,1 W Eppel2 and A Elbe-Bürger1 1 DIAID, Medical
University of Vienna, Vienna, Austria, 2 Department of Gynaecology and Obstetrics, Medical
University of Vienna, Vienna, Austria and 3 Gynmed-Ambulatorium, Vienna, Austria
Despite a considerable number of studies, the precise phenotype of skin dendritic cell precursors
has not yet been determined in humans. Clues about these precursors can be obtained by the study
of their ontogeny. CD36+HLA-DR+/- cells of unknown nature have previously been identified in
the primitive epidermis in embryonic skin. To further characterize their phenotype, the expression
of selected markers was evaluated on single cell suspensions and frozen sections of embryonic and
fetal human skin. Using flow cytometry, we found that 65.3% of CD45+ leukocytes exhibit the scav-
enger receptor CD36 at 9 weeks estimated gestational age. In addition, we discovered that CD14
is expressed on 54.7% of CD36+ leukocytes in embryonic skin, which is comparable to what has
been described in adult skin. Strikingly, significantly fewer CD45+CD36+ cells in embryonic skin
express HLA-DR compared to adult skin (38.4% vs. 98.3%). Immunofluorescence staining of embry-
onic skin sections locates CD45+CD36+ cells predominantly in the dermis, but occasionally also
in the epidermis. A subset of these epidermal leukocytes coexpresses CD14 and HLA-DR in the first
trimester. Intriguingly, CD45+ epidermal cells that neither express CD36, CD14 nor HLA-DR are
occasionally found during the first trimester. In the dermis, various subsets of CD36+ leukocytes can
be identified in developing prenatal and adult skin with regard to the expression of some pattern
recognition receptors. Assessment of the expression of CD206 and CD209 revealed that these mark-
ers are restricted to dermal cells during all stages of prenatal development and in adult skin. Flow
cytometric analysis showed that CD206+ leukocytes coexpress CD36 and that CD206+CD36+
leukocytes in developing skin express comparable levels of CD14 but lower levels of HLA-DR than
in adult skin. We found that similar to what has been described in various mouse models immature
skin leukocytes acquire HLA-DR during development in the skin.
572
Effects of repeated application of Dermatophagoides farinae (D.farinae) on the expressions
of atopic dermatitis(AD)-like inflammatory skin mediators in NC/Nga mice
J Kim, M Jeong, K Park, K Li and S Seo Department of Dermatology, Chung Ang University
College of Medicine, Seoul, Republic of Korea
Atopic dermatitis (AD) is a chronic, relapsing, multifactorial skin disorder with complex interactions
of genetic predisposition and environmental factors. This study was performed to examine the effects
of repeated applications of Dermatophagoides farinae (D. farinae) on AD-like skin inflammatory
mediators such as immunoglobulin (Ig) subtypes, Th1, Th2, and Th17 cytokines in NC/Nga mice.
To evaluate the effects of D. farinae on the development of AD-like skin lesion, the measurement
of clinical skin severity scoring (SCORAD), epidermal thickening, mast cell infiltration/degranula-
tion, the levels of total and D.farinae-specific plasma Ig isotypes (IgE, IgG1, and IgG2a), the mRNA
and protein expression levels of cytokines (IL-4, IL-5, IL-13, IL-17, IFN-γ, and TNF-α), Toll-like recep-
tors (TLR2 and 4) and β-defensin 2 (BD-2) were done on D. farinae-induced AD-like skin lesions
and splenocytes in NC/Nga mice. Repeated applications of D. farinae aggravated the clinical der-
matitis severity, increased the epidermal thickness, the dermal infiltration/degranulation of mast cell
and total plasma IgE, IgG1 and IgG2a. The increase in total plasma IgE, IgG1 and IgG2a was accom-
panied with increasing IL-4 and IFN-γ expressions in the skin and splenocytes. Interestingly, the
mRNA and protein expression levels of IL-17 and TLR2 were significantly increased by D. farinae-
administration in skin and splenocyte, whereas mRNA expression of BD-2 was decreased in AD-
like skin lesions. In conclusion, we confirmed that the repeated skin exposure of D. farinae might
be associated with aggravation of AD-like skin lesion through the modulation of Th1, Th2 and Th17
cytokine, the overproduction of Th2-mediated IgE, and the downregulation of BD-2 expression.
573
Effects of repeated formaldehyde (FA) exposure on atopic dermatitis (AD)-like immune
responses in NC/Nga mice
K Li, J Kim, M Jeong, D Kim and S Seo Department of Dermatology, Chung Ang University
College of Medicine, Seoul, Republic of Korea
Formaldehyde (FA), as an environmental agent, has been considered to be associated with the
increase in the prevalence of allergic diseases including asthma and atopic dermatitis (AD). We
investigated whether repeated FA exposure has an effect on AD-like immune responses depending
on the presence or absence of Dermatophagoides farnae (D.farinae) priming. To evaluate the influ-
ence of repeated FA exposure, four groups of NC/Nga mice were exposed to 0.0, 0.2, 1.0, and 5.0
ppm FA for 6 h per day, Wednesday through Monday, over a period of 2 weeks, respectively. After
repeated FA exposure, one group of mice was treated with D.farinae extract ointment and another
group was treated with vehicle ointment for 2 weeks. The levels of total Ig isotypes (IgE, IgG1, and
IgG2a) as well as cytokines (IL-4, IL-5, IL-13, IL-17, and IFN-γ) were examined in the plasma and
splenocytes of each group of mice, respectively. In this study, we examined an association between
FA exposure levels and the presence of AD-like immune responses and suggested that repeated FA
exposure might be associated with increasing risk factor for allergic sensitization to D.farinae. The
mechanism by which repeated FA exposure could affect the skin aggravation of AD-like lesion is
unclear. However, greater severity of the allergic sensitization might be associated with the levels
of FA exposure. Low level of FA exposure group of mice showed significant difference between
groups. Therefore, we suggested that repeated FA exposure might have different effects on AD-like
immune responses according to the exposure levels of FA.
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Statins inhibit chemotactic interaction between CCL20 and CCR6 in vitro: Possible rele-
vance to psoriasis treatment
T Kim, D Byamba, W Wu, H Jee, D Kim and M Lee Dermatology, Yonsei University, College of
Medicine, Seoul, Republic of Korea
Psoriasis is a common and chronic inflammatory skin disease which is associated with IL-23/Th17
pathway. An increased expression of CC chemokine ligand 20 (CCL20) in psoriatic lesions can attract
CC chemokine receptor 6 (CCR6)-expressing Th17 cells into the lesions. Lipid-lowering drugs, statins,
possess other immune-modulating functions. We explored whether specific types of statins could
inhibit CCL20 production in HaCaT cells. We also investigated whether statins could attenuate the
chemotactic migration of CD4+ T cells toward CCL20. We used enzyme-linked immunosorbent
assay to evaluate CCL20 release from HaCaT cells stimulated by psoriasis-associated cytokines with
or without statins. We performed fluorescence-activated cell sorting to investigate the level of sur-
face CCR6 and CD45RO expression on human CD4+ T cells in various conditions. Functionally,
the in vitro chemotaxis migration assay was performed and the number of migrating cells was ana-
lyzed using a flow cytometry. We demonstrated that IL-1β, TNF-α, and IL-17A significantly increased
CCL20 production from HaCaT cells in a dose-dependent manner. However, these increments were
significantly inhibited by the addition of fluvastatin and simvastatin, but not by pravastatin. In the
in vitro chemotaxis migration assay, pretreatment with fluvastatin and simvastatin, but not with
pravastatin, inhibited the chemotactic migration of human CD4+ T cells toward CCL20. However
the level of surface expression of CCR6 on CD4+ T cells was not altered by statins. Our results sug-
gest that not all, but specific types of statins may be of benefit in managing psoriasis partially via
interrupting the chemotactic interaction of CCL20/CCR6, the mechanism which eventually lessen
the infiltration of lesional Th17 cells.
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Brn2 exerts its possible role as positive feedback regulator of TNF-α in lichenoid tissue reac-
tion
K Whang,1 J Sim,1 J Kim,1 G Lee,1 N Jeung,2 K Sohn,2 D Choi,2 Y Lee,2 Y Seo,2 C Kim2 and J Lee2
1 Department of Dermatology, Soonchunhyang University Hospital, Seoul, Republic of Korea
and 2 Department of Dermatology and Research Institute for Medical Sciences, School of
Medicine, Chungnam National University, Daejeon, Republic of Korea
In our previous studies, we found the histologic features of the Brn2 injected rat skin are very sim-
ilar with the histopathology of lichen planus. Because lichen planus share several clinical and his-
tological features with GVHD, we hypothesize that similar mechanisms might be involved in estab-
lishing lichenoid tissue reaction of cutaneous GVHD. To delineate the possible role of Brn2 in
lichenoid tissue reaction, we examined Brn2 protein expression in cutaneous GVHD, lichen planus
and normal human skin by immunohistochemistry. Interestingly, Brn2 have been shown to be
expressed in all nuclei of the thickend epidermis of lichen planus and to be highly expressed in the
GVHD all of the epidermis and sup-dermis. Next, we examined Brn2 mRNA and protein expres-
sion in cultured normal human epidermal keratinocytes (NHEKs) exposed to TNF-α, critical factor
in keratinocyte apoptosis in cytotoxic GVHD. We demonstrated that Brn2 expression in NHEKs
was markedly increased by TNF-α and apparent correlation with concentration and decreased by
exposed to cyclosporine, a calcineurin inhibitor, used to prevent GVHD. These results suggest that
Brn2 may acts the important role in TNF-α associated lichenoid tissue reaction. Finally, we deter-
mined the effect of ectopic over-expression of Brn2 proteins in keratinocytes using transduction of
recombinant adenoviruses expressing Brn2. We confirmed that Brn2 mRNA and proteins were over-
expressed dose-dependently by TNF-α and Brn2 increased the mRNA level of pro-inflammatory
cytokines, such as TNF- α. These results demonstrated that Brn2 functionally expressed by ker-
atinocyte and exerts its role as a positive feedback regulator on TNF-α in lichenoid tissue reaction.
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Blocking galectin-1 ligand biosynthesis enhances immunity against melanoma
F Cedeno-Laurent,1,3 M Opperman,1 SR Barthel,1 D Hays,1 T Schatton,1,4 Q Zhan,2 MH Frank,1,4
GF Murphy2 and CJ Dimitroff1,2,3 1 Dermatology, Brigham and Women’s Hospital, Boston, MA,
2 Pathology, Brigham and Women’s Hospital, Boston, MA, 3 Immunology, Harvard Medical
School, Boston, MA and 4 Transplantation Research Center, Children’s Hospital, Boston, MA
Galectin-1 (Gal-1), the prototype S-type lectin, has been speculated to play a major role in tumor
immune evasion by its ability to induce apoptosis in Gal-1 ligand+ anti-tumor leukocytes and pro-
mote expansion of FoxP3+ and type 1 (Tr1) regulatory T cell subsets. We hypothesize that interfer-
ence of the Gal-1 – Gal-1 ligand binding axis will spare Gal-1-mediated immune suppression and
accentuate anti-tumor immunity. Here, we first show that Gal-1 is strategically localized in human
melanomas to shield effector T cells from infiltrating melanomas. Interestingly, Gal-1 was spatially
distributed in curvilinear arrays surrounding nests of ABCB5+ melanoma-initiating cells, reminis-
cent of an immune-privileged site. While targeting Gal-1 has been previously shown as an effica-
cious approach for treating melanomas, we centered our strategy on inhibiting the synthesis of
counter-receptor Gal-1 ligand with peracetylated 4-fluoro-glucosamine, 4-F-GlcNAc, a metabolic
inhibitor of Gal-1 binding determinant, N-acetyllactosamine. In mice bearing syngeneic B16
melanomas, 4-F-GlcNAc treatment caused significantly attenuated growth of nascent and estab-
lished tumors concomitant with increasing levels of anti-tumor CD4+ and CD8+ T cells and NK cells.
These cells expressed robust levels of Gal-1 ligand and elevated levels of IFN-γ, though markedly
diminished levels of IL-10. Furthermore, 4-F-GlcNAc-treated mice exhibited similar elevations of
IFN-γ+ T cells and reductions in IL-10+ T cells as those in mice bearing B16 melanomas deficient in
Gal-1 or in candidate Gal-1 ligand, CD43. These data implicate tumor-derived Gal-1 and T cell Gal-
1 ligand, CD43, as key regulators in generating anti-melanoma immunity and demonstrate the util-
ity of inhibitors against Gal-1 ligand expression for boosting anti-melanoma immune responses.
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Langerin+ Dermal DC, but not Langerhans cells, are required for effective CD8 mediated
immune responses after skin scarification (S.S.) with Vaccinia virus (VACV)
J Seneschal,1,2 X Jiang1 and TS Kupper1 1 Dermatology, Brigham and Women’s Hospital,
Boston, MA and 2 Dermatology, INSERM U876 Université de Bordeaux, Bordeaux, France
Dendritic Cells (DC) are professional antigen presenting cells that are required for naïve T cell
priming and activation. Three subsets of skin resident DC have been identified: Langerhans Cells
(LC), Dermal Langerin+ DC (Ln+dDC) and Dermal Langerin- DC (Ln-dDC). The relative role of these
DC in the induction of immune response after s.s. with VACV has not been studied. Transgenic
mice expressing the diphtheria toxin receptor (DTR) under the control of the murine langerin pro-
moter (Lang-DTR mouse model) allow for the conditional ablation of Ln+ expressing cells after injec-
tion of DT. Injection of DT ablates LC for several weeks, whereas Ln+dDC are replenished within
few days. Taking advantage of this model we selectively depleted either LC alone, or both LC and
Ln+ DC. We used recombinant VACV that expressed the ovalbumin peptide OVA257-264 (rVV-ova)
and adoptive transfer of OT-1 TCR transgenic CD8+ T cells specifc for this peptide. We then ana-
lyzed activated OT-1 cells in lymph nodes and other tissues at various times after s.s. We demon-
strated that Ln+dDC, but not LC, are absolutely required for the induction of a rapid and robust
antigen-specific CD8+ T cell response after s.s. with VACV. The depleteion of LC had no discern-
able effect on immunity after s.s. However, the absence of Ln+dDC, led to a significant delay in the
priming and proliferation of antigen-specific CD8+ T cells. Moreover CD8+ T cells generated after
VACV s.s. in the absence of Ln+dDC lacked effector cytotoxic functions both in vitro and in vivo.
While s.s-immunized WT and LC depleted mice controlled the progression of OVA257-264 express-
ing T cell lymphoma (injected intradermally), the depletion of Ln+dDC leds to rapid lymphoma pro-
gression and mortality. These data indicate that of all skin DC subsets, only Ln+dDC are critical for
the generation of robust CD8+ T cell immunity after s.s. with VACV.
591
A broad-spectrum Human Papillomavirus (HPV) vaccine to prevent mucosal and cutaneous
HPV infections
C Schellenbacher,1 K Kwak,3 S Shafti-Keramat,1 H Faust,2 J Dillner,2 R Roden3 and R Kirnbauer1
1 Division of Immunology, Allergy and Infectious Diseases, Department of Dermatology,
Medical University Vienna, Vienna, Austria, 2 Department of Laboratory Medicine, Lund
University, Malmoe, Sweden and 3 Department of Pathology, Johns Hopkins University,
Baltimore, MD
Licensed human papillomavirus (HPV) vaccines are based on virus-like particles (VLP) self-assem-
bled from major capsid protein L1. These vaccines protect against two of the 15 high-risk HPV, yet
cross-protect against non-vaccine genital types only at low-level. Conversely, the minor capsid pro-
tein L2 contains type-common epitopes and thus can induce cross-protection against heterologous
papillomavirus types in animal studies. We have established an HPV16 VLP based vaccine (RG1-
VLP) that displays a key cross-neutralization L2 epitope (RG1) on the surface of L1 VLP. We find that
insertion of L2 induces broadly cross-neutralizing antisera to a number of high-risk and low-risk
mucosal HPV, without compromising type-restricted L1-specific immunity. Immunization with RG1-
VLP using a human applicable adjuvant (alum-MPL) induced broadly cross-neutralizing antibodies
against mucosal high-risk HPV16/18/31/45/52/58, mucosal low-risk HPV6/11 and cutaneous HPV5
in both rabbits and mice (Schellenbacher et al, J Virol, 2009). To evaluate the full spectrum of vac-
cine efficacy, neutralization assays were established based on novel pseudovirions and infectious
virus isolated from patients’ warts. Antisera to RG1-VLP additionally cross-neutralized mucosal high-
risk HPV26/33/35/39/68/56/59/68/73, mucosal low-risk HPV32, and cutaneous HPV2/27/3/76, but
not HPV1 and 4. Passive transfer of RG1-VLP immune serum protected mice against experimental
vaginal challenge with pseudovirions of phylogenetically divergent mucosal high-risk
HPV16/45/73/56/59. RG1-VLP in adjuvant applicable for human use is a potential broad-spectrum
vaccine to protect against mucosal and cutaneous HPV infections and diseases.
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Migration patterns of TEM and TCM in humans: Lessons from CTCL lesional morphology
RA Clark, R Watanabe, M Tawa, N Adams, A Dorosario, DC Fisher and TS Kupper The Dana
Farber/Brigham and Women’s Cancer Center, Boston, MA
We recently reported that malignant T cells in mycosis fungoides (MF) have the phenotype of effec-
tor memory T cells (TEM,) and those in Sézary syndrome (L-CTCL) have the phenotype of central
memory cells (TCM). In mice, tissue resident TEM are sessile cells whereas TCM are highly migratory;
this has never been shown in humans. Malignant T cells can be identified in CTCL, and this allows
correlation of T cell phenotype with the skin lesions they induce. We identified three CTCL T cell
phenotypes and correlated them with the skin lesions they produced. MF patients with stable skin
disease had stable, well demarcated plaques that contained malignant T cells lacking both L-selectin
and CCR7 (fixed TEM) . In mice, CCR7 expression is required for T cells to exit skin and enter lym-
phatics. Lesions from patients whose skin disease was worsening (e.g, increasing number and size
of plaques, Stage IA->IB) contained malignant T cells that expressed CCR7 but not L-selectin (mobile
TEM). These T cells could leave skin, enter the draining LN, be released into blood, but could only
home back to skin. Finally, L-CTCL patients had malignant T cells in skin that expressed both L-
selectin and CCR7 (TCM phenotype). L-CTCL skin lesions showed diffuse erythema with indistinct
borders, consistent with the ability of TCM to migrate within the skin, and demonstrated diffuse lym-
phadenopathy, consistent with their ability to enter lymph nodes from both blood and skin. Only
CLA+/CCR4+ CTCL T cells were found in the skin, although CLA-/CCR4+ T cells were frequent in the
circulation. In summary, CTCL patients demonstrate in humans that TEM are sessile and give rise to
fixed plaques, while TCM are highly migratory and induce diffuse erythema. Thus, clinical skin lesion
morphology is an accurate index of pathogenic T cell trafficking marker phenotype, which can be
used to guide therapy and to better understand the basic biology of CTCL and other skin diseases.
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Epidermal LC mediate constitutive stimulation of skin resident tregs and thereby control the
inadvertent activation of skin effector memory T cells (TRM) in normal skin
J Seneschal,1,2 RA Clark1 and TS Kupper1 1 Dermatology, Brigham and Women’s Hospital,
Boston, MA and 2 Dermatology, INSERM U876 Université de Bordeaux, Bordeaux, France
We recently demonstrated that normal adult human skin contains 20 billion skin-homing, multi-
functional resident memory T cells (TRM). These TRM are specific for antigens previously encoun-
tered through skin, and provide potent protection against future infectious challenge. Inappropri-
ate activation of this population of TRM in normal skin must be tightly controlled, though the
mechanisms are unknown. Langerhans cells (LC) reside in the epidermis, and it has long been pre-
sumed that their major function is to exit epidermis and migrate to lymph node to activate naïve T
cells to antigens encountered through skin. Their putative interactions with skin TRM have not been
explored. To better understand the relation between LC and TRM in normal human skin, we care-
fully extracted both TRM and resident LC from the same normal human donor. We could readily
demonstrate that human LC strongly induced the proliferation of a small subset of TRM. On further
study, these proliferating TRM uniformly reproducibly expressed the phenotype of Treg and could
block the proliferation of non-Treg TRM. Treg proliferation was blocked by antibodies to class II
MHC, IL-2, and IL-15Rα. We next explored this phenomenon in intact normal human skin. By
immunofluoresence microscopy, we showed that LC and FoxP3+ Treg TRM co-localized in epider-
mis and follicular epithelium, and many of these Treg TRM were positive for the proliferation
marker Ki67. These data strongly suggest that LC constitutively stimulate Treg in normal skin. This
stimulation of Treg could be reversed in the presence of foreign antigen in a dose-dependant fash-
ion, as the addition of C.albicans to LC and TRM led to diminished Treg proliferation and increased
TEM proliferation. These findings establish a novel immunological role for LC in human skin,
allowing for the constitutive maintenance of tolerance, while also permitting the stimulation of res-
ident immune memory in response to infectious challenge.
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Cell volume regulation by the Taurine transporter Taut determines T cell responses
S Kaesler,1 M Sobiesiak,2 T Volz,1 F Lang2 and T Biedermann1 1 Dermatology, Eberhard-Karls-
University, Tübingen, Germany and 2 Physiology, Eberhard-Karls-University, Tübingen,
Germany
T cell activation and subsequent transformation of activated T cells into T cell blasts require pro-
found changes in cell volume. However, the impact of cell volume regulation for T cell immunol-
ogy has not been characterized. Here we studied the role of cell volume regulating osmolyte trans-
porter Taut for T cell activation in Taut deficient mice. T cell mediated recall responses were severely
impaired in taut deficient (taut-/-) mice as shown with B16 melanoma rejection and hapten-induced
contact hypersensitivity. CD4+ and CD8+ T cells were unequivocally located within peripheral
lymph nodes of unprimed taut-/- mice but significantly decreased in taut-/- compared to taut+/+
mice following in vivo activation. Further analysis revealed that Taut is critical for rescuing T cells
from activation-induced cell death in vitro and in vivo as shown with TCR, superantigen, and anti-
gen-specific activation. Consequently, reduction of CD4+ and CD8+ T cells in taut-/- mice upon
antigen challenge resulted in impaired in vivo generation of T cell memory. These findings disclose
for the first time that volume regulation in T cells is an element in the regulation of adaptive immune
responses and that the osmolyte transport Taut is crucial for T cell survival and T cell mediated
immune reactions.
594
MyD88 signaling in Langerhans Cells is required for efficient generation of Th17 cells, but
not migration
K Haley,1 B Igyártó,1 A Bobr,1 S Kashem,1 D Ortner,1 D Schenten,2 R Medzhitov2 and DH Kaplan1
1 University of Minnesota, Minneapolis, MN and 2 Yale University, New Haven, CT
Langerhans cell (LC) migration is thought to require LC sensitivity to the cytokines IL-1b and IL-18
as well as recognition of microbial products. Since the adaptor molecule MyD88 is required for
both these functions, we generated Langerin-Cre MyD88-flox mice to test this hypothesis. We eval-
uated the mice during steady state conditions, after hapten application, and after C. albicans skin
infection. We found that the number of LC in skin and skin draining lymph nodes was unaltered.
LC activation as measured by increased surface expression of costimulatory molecules was also
unaffected. We have previously shown that contact hypersensitivity (CHS) responses to hapten were
increased in mice lacking LC. Langerin-Cre MyD88-flox mice, however, develop normally CHS
responses. Interestingly, skin infection with C. albicans which is known to express TLR-2 ligands,
led to reduced proliferation of antigen-specific T cells and inefficient generation of Th17 cells in
both Langerin-Cre MyD88-flox mice and mice lacking LC. Compared with LC isolated from WT
mice, MyD88-deficient LC produced less IL-1b, IL-6, and IL-23 in response of C. albicans infec-
tion. Thus, IL-1, IL-18, and MyD88-mediated toll-like receptor signaling are not required for LC
migration or increased expression of surface costimulatory molecules. However, in the setting of
pathogen infection, MyD88-dependent signals are required for production of inflammatory cytokines
and appropriate activation of naïve T cells.
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Autocrine TGFβ is required to prevent Langerhans cell migration
A Bobr,1 BZ Igyarto,1 KM Haley,1 MO Li,2 RA Flavell3 and DH Kaplan1 1 Department of
Dermatology and Center for Immunology, University of Minnesota, Minneapolis, MN, 2
Immunology Program, Memorial Sloan-Kettering Cancer Center, New York, NY and 3 Section
of Immunobiology, Yale University School of Medicine, New Haven, CT
Langerhans cells (LC) are skin resident dendritic cells located in the epidermis. We have demon-
strated using mice with a LC-specific ablation of TGFβ (Langerin-Cre x TGFβ-flox) that LC ontogeny
requires autocrine TGFβ in vivo. Since these mice have a constitutive absence of LC, the effect of
TGFβ on adult LC could not be evaluated. We have now developed Langerin Cre-ERT2 mice that
allow for tamoxifen-inducible gene excision. Using ROSA26.YFP Cre reporter mice, we confirmed
that Cre-ERT2 expression is specific for LC and highly efficient. We next generated Langerin Cre-
ERT2 x TGFβ-flox mice. Tamoxifen-inducible excision of TGFβ led to increased expression of cos-
timulatory molecules on LC followed by migration to the regional lymph node. Interestingly, in the
lymph node, surface expression of costimulatory molecules and expression of cytokines were sim-
ilar to WT LC. This suggests that migration in the absence of TGFβ recapitulates migration of LC in
the steady state. We observed an identical phenotype in Langerin Cre-ERT2x TGFβRII-flox mice.
Therefore, we conclude that LC-derived TGFβ acts directly on LC in an autocrine/paracrine fashion
and serves as epidermal retention factors to prevent LC migration. This may be an important mech-
anism preventing inappropriate immune responses against skin commensal microorganisms.
584
Skin-resident DC subsets promote distinct and opposing antigen-specific T helper responses
BZ Igyártó,1 K Haley,1 D Ortner,1 M Gerami-Nejad,1 SM Zurawski,2 B Malissen,3 G Zurawski,2
J Berman1 and DH Kaplan1 1 University of Minnesota, Minneapolis, MN, 2 Baylor Institute,
Dallas, TX and 3 Université de la Méditerranée, Marseille, France
Skin-resident dendritic cells (DC) are well positioned to encounter cutaneous pathogens and are
required for the initiation of adaptive responses. There are at least 3 subsets of skin DC—Langer-
hans cells(LC), Langerin+ dermal DC (dDC), and classic dDC. Our present understanding of the in
vivo function of these DC subsets has been hampered by the absence of a technique to examine
antigen-specific T cell responses after antigen has been targeted to LC and other skin DC-subsets in
a physiological manner. To overcome this, we have developed a novel skin infection model with
the dimorphic fungi, Candida albicans that we have engineered to express several model T cell
antigens. To study the antigen-specific T-cell responses, we infected mice with absent or defective
skin DC and examined the effects on adoptively transferred (OT-I, TEα) T cells. Infection with recom-
binant but not wild-type Candida albicans produced a brisk Th1 and Th17 type response as well as
a robust CD8 expansion. Mice lacking LC developed normal CTL and Th1 responses but failed to
generate Th17 cells. In addition, selectively targeting antigen to LC by injecting huLangerin trans-
genic mice with anti-huLangerin-Eα antibody conjugates during infection with wild-type Candida
albicans efficiently promoted the development of Th17 TEα cells. Thus, in response to Candida infec-
tion, LC are necessary and sufficient for the development a Th17 response. In mice lacking Lan-
gerin+ dDC, cross-presentation of antigen to CD8 T cells and the development of Th1 was abro-
gated but the Th17 response was unaffected. Langerin+ dDC also inhibited the ability of LC and
classic DC to promote Th17 responses. This work demonstrates that skin-resident DC subsets pro-
mote distinct and opposing antigen-specific responses.
585
Continuous antigen exposure elicits increased IL-10 production, but intermittent antigen
exposure induces IL-4 production
K Yamanaka, K Tsuda, T Akeda, T Nakanishi, H Kitagawa, M Kakeda and H Mizutani
Dermatology, Mie University, Graduate School of Medicine, Tsu, Japan
Allergen-specific immunotherapy (SIT) is currently used as the curative therapy for allergic disor-
ders including allergic rhinitis and atopic dermatitis. The circulating IL-10-producing regulatory T
cell (Tr1) number is decreased in pollinosis patients compared to that in normal controls, and after
successful SIT, the circulating Tr1 numbers recovered to the normal level. IL-10, a strong anti-inflam-
matory cytokine has critical roles in the induction of specific T cell tolerance. We then hypothesized
continuous antigen exposure induces IL-10 production. 100uL of 0.5% oxazolone (OX) was applied
to C57BL/6 mouse ear every other day for 4 weeks. 24 hours after last OX challenge, the ear skins
were sampled. Cytokine expressions in the ear skin were analyzed, and found IL-10 mRNA expres-
sion was increased than that of IL-4. However, when the antigen application is finished after 4 weeks
challenge, and then repeated the same application again later on the same mice, the mice showed
severe ear swellings and increased IL-4 mRNA expression compared to that of IL-10. These finding
suggests that in the SIT, antigen application should be continued even at the low dose in the non-
scattering season.
586
Pregnane X Receptor (PXR) regulates cutaneous immunity
M Schmuth,1 A Elentner,1 F Gonzalez2 and S Dubrac1 1 Dermatology, Innsbruck Medical
School, Innsbruck, Austria and 2 Laboratory of Metabolism, National Cancer Institute,
National Institutes of Health, Bethesda, MD
The pregnane X receptor (PXR) is a ligand-activated transcription factor regulating genes central to
drug and hormone metabolism in the liver. We here show that topical application of PCN, a well-
known activator of mouse PXR, ameliorates irritant and allergic contact dermatitis in a PXR-depend-
ent manner. Moreover, rifampicin, a well-known activator of human PXR, when applied topically,
improves allergic contact dermatitis in mice humanized for PXR (Tg-hPXR) and for PXR and CYP3A4
(Tg-CYP3A4/hPXR). Rifampicin down-regulates the expression of IL-1beta in a hPXR-mediated man-
ner in PXR-humanized keratinocytes stimulated with a contact allergen and rifampicin down-reg-
ulates iNOS and IL-1beta in activated keratinocytes. Notably, Tg-CYP3A4/hPXR mice respond
more readily to rifampicin than Tg-hPXR mice. Co-expression of CYP3A4 with hPXR in transgenic
mice has additive effects when compared to hPXR expression only, suggesting a link between CYP3A4
and the rifampicin-mediated anti-inflammatory response. Moreover, PXR deficient mice exhibit
exaggerated ear swelling when sensitized and challenged with a contact allergen which correlates
with increased numbers of dermal T-lymphocytes, mostly consisting in CD4+ cells. Finally, PXR is
expressed in lymphocyte-rich infiltrates of various human inflammatory skin disorders. In sum-
mary, PXR plays a role in the skin immune system, and CYP3A4, the key enzyme of drug metabo-
lism regulated by PXR, modulates the PXR-mediated anti-inflammatory activity.
587
Adenosine produced by regulatory T cells acts as chemo-attractant for dendritic cells and pro-
motes formation of Treg-DC clusters
S Ring, AH Enk and K Mahnke Dermatology, Ruprecht-Karls University Heidelberg,
Heidelberg, Germany
Our previous studies have shown that CD4+CD25+Foxp3+ regulatory T-cells (Treg) suppress the
sensitization phase of contact hypersensitivity (CHS) reactions by interacting with dendritic cells
(DC) in the draining lymph nodes. The molecular means of this interaction are not entirely clear,
however, we and others have recently demonstrated that production of adenosine by Treg plays an
important role in suppressing the elicitation phase of CHS responses. Therefore we asked whether
adenosine also affects the sensitization phase by modulating the interaction between Treg and DC.
In in vitro cocultures of isolated murine Treg with bone marrow derived DC, or with ex vivo iso-
lated MHC II+ DC, we observed rapid formation of clusters between these two cell populations. In
contrast, conventional CD4+ T- cells and DC did not establish any stable contacts. To unravel the
role of adenosine in this Treg-DC interaction, we blocked the adenosine production by Treg using
the CD39 inhibitor POM-1. This led to abrogation of cluster formation in the Treg-DC cocultures.
Vice versa, addition of exogenous adenosine to cocultures of conventional CD4+ T-cells and DC
induced formation of CD4+ T-cell-DC clusters. Life images of Treg-DC cocultures sampled over 2h,
demonstrated fast movement of DC in direction of the rather immobile Treg. Analyzing the chemo-
tactic activity of Treg or adenosine, respectively, using Boyden-chambers, we observed that the
migration rate of DC towards Treg or adenosine was significantly higher as compared to the migra-
tion rate towards conventional CD4+ T-cells or medium. Blocking of the adenosine production by
Treg using POM-1, caused a complete inhibition of the chemotactic activity of Treg on DC. In con-
clusion our data indicate that Treg derived adenosine acts as chemo-attractant for DC and pro-
motes the formation of clusters between Treg and DC, which is required for the immunosuppres-
sive action exerted from Treg on DC.
588
Rhealba® oat plantlets interest in the management of atopic patients
M Aries,1 A Mandeau,1 N Castex-Rizzi,1 J Nicolas,2 T Bieber,3 M Ambonati1 and C Coutanceau1 1
Dermo Cosmetic Department, Pierre FABRE Research and Development Center, Toulouse,
France, 2 Department of Clinical Allergology and Immunology, Lyon Sud Hospital, Lyon,
France and 3 Department of Dermatology and Allergology, Bonn University, Bonn, Germany
Oat extract-containing emollients are particularly adapted to the treatment of atopic dermatitis (AD).
To improve the efficacy and safety of oat extracts, Pierre Fabre Laboratories scientists have devel-
oped new protein-free oat extracts from Rhealba® Oat Plantlets, the young plants collected at the
growing stage prior to earing. This part of the oat is not consumed by humans and contains specific
metabolites (C-glycosylated flavonoids and steroidal saponins) which possess potent anti-inflam-
matory, anti-allergic and immuno-modulating properties. The Plantlets extracts were analyzed by
electrophoresis, ELISA and Western Blot to verify the absence of protein contamination. The immuno-
modulating properties of the extract was tested on: i) the production of lymphocyte cytokines; ii)
the functions of mature dendritic cells; iii) the production of PG6KF1α. Coomassie blue staining
SDS-Page showed that the Plantlet extract does not contain any detectable proteins. ELISA and West-
ern Blot tests showed no cross-reactivity to grain proteins, eliminating any risk of dietary pre-sensi-
tization. Concerning biological properties, the extract showed potent immuno-modulating and anti-
inflammatory activities including: i) direct inhibition of the T cell cytokine (IL2, IL4, IL13) secretion;
ii) reduction of DC-induced T cell activation; iii) inhibition of the production of PG6KF1α by 57%.
Therefore, this study shows that this new Rhealba® Oat Plantlet extract combines optimal safety
(absence of proteins) and efficiency (immuno-inflammation modulation) providing a specially adapted
solution for the treatment of barrier alteration in AD patients. This extract is now used in the new
EXOMEGA range.
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Langerin+ Dermal DC, but not Langerhans cells, are required for effective CD8 mediated
immune responses after skin scarification (S.S.) with Vaccinia virus (VACV)
J Seneschal,1,2 X Jiang1 and TS Kupper1 1 Dermatology, Brigham and Women’s Hospital,
Boston, MA and 2 Dermatology, INSERM U876 Université de Bordeaux, Bordeaux, France
Dendritic Cells (DC) are professional antigen presenting cells that are required for naïve T cell
priming and activation. Three subsets of skin resident DC have been identified: Langerhans Cells
(LC), Dermal Langerin+ DC (Ln+dDC) and Dermal Langerin- DC (Ln-dDC). The relative role of these
DC in the induction of immune response after s.s. with VACV has not been studied. Transgenic
mice expressing the diphtheria toxin receptor (DTR) under the control of the murine langerin pro-
moter (Lang-DTR mouse model) allow for the conditional ablation of Ln+ expressing cells after injec-
tion of DT. Injection of DT ablates LC for several weeks, whereas Ln+dDC are replenished within
few days. Taking advantage of this model we selectively depleted either LC alone, or both LC and
Ln+ DC. We used recombinant VACV that expressed the ovalbumin peptide OVA257-264 (rVV-ova)
and adoptive transfer of OT-1 TCR transgenic CD8+ T cells specifc for this peptide. We then ana-
lyzed activated OT-1 cells in lymph nodes and other tissues at various times after s.s. We demon-
strated that Ln+dDC, but not LC, are absolutely required for the induction of a rapid and robust
antigen-specific CD8+ T cell response after s.s. with VACV. The depleteion of LC had no discern-
able effect on immunity after s.s. However, the absence of Ln+dDC, led to a significant delay in the
priming and proliferation of antigen-specific CD8+ T cells. Moreover CD8+ T cells generated after
VACV s.s. in the absence of Ln+dDC lacked effector cytotoxic functions both in vitro and in vivo.
While s.s-immunized WT and LC depleted mice controlled the progression of OVA257-264 express-
ing T cell lymphoma (injected intradermally), the depletion of Ln+dDC leds to rapid lymphoma pro-
gression and mortality. These data indicate that of all skin DC subsets, only Ln+dDC are critical for
the generation of robust CD8+ T cell immunity after s.s. with VACV.
591
A broad-spectrum Human Papillomavirus (HPV) vaccine to prevent mucosal and cutaneous
HPV infections
C Schellenbacher,1 K Kwak,3 S Shafti-Keramat,1 H Faust,2 J Dillner,2 R Roden3 and R Kirnbauer1
1 Division of Immunology, Allergy and Infectious Diseases, Department of Dermatology,
Medical University Vienna, Vienna, Austria, 2 Department of Laboratory Medicine, Lund
University, Malmoe, Sweden and 3 Department of Pathology, Johns Hopkins University,
Baltimore, MD
Licensed human papillomavirus (HPV) vaccines are based on virus-like particles (VLP) self-assem-
bled from major capsid protein L1. These vaccines protect against two of the 15 high-risk HPV, yet
cross-protect against non-vaccine genital types only at low-level. Conversely, the minor capsid pro-
tein L2 contains type-common epitopes and thus can induce cross-protection against heterologous
papillomavirus types in animal studies. We have established an HPV16 VLP based vaccine (RG1-
VLP) that displays a key cross-neutralization L2 epitope (RG1) on the surface of L1 VLP. We find that
insertion of L2 induces broadly cross-neutralizing antisera to a number of high-risk and low-risk
mucosal HPV, without compromising type-restricted L1-specific immunity. Immunization with RG1-
VLP using a human applicable adjuvant (alum-MPL) induced broadly cross-neutralizing antibodies
against mucosal high-risk HPV16/18/31/45/52/58, mucosal low-risk HPV6/11 and cutaneous HPV5
in both rabbits and mice (Schellenbacher et al, J Virol, 2009). To evaluate the full spectrum of vac-
cine efficacy, neutralization assays were established based on novel pseudovirions and infectious
virus isolated from patients’ warts. Antisera to RG1-VLP additionally cross-neutralized mucosal high-
risk HPV26/33/35/39/68/56/59/68/73, mucosal low-risk HPV32, and cutaneous HPV2/27/3/76, but
not HPV1 and 4. Passive transfer of RG1-VLP immune serum protected mice against experimental
vaginal challenge with pseudovirions of phylogenetically divergent mucosal high-risk
HPV16/45/73/56/59. RG1-VLP in adjuvant applicable for human use is a potential broad-spectrum
vaccine to protect against mucosal and cutaneous HPV infections and diseases.
593
Migration patterns of TEM and TCM in humans: Lessons from CTCL lesional morphology
RA Clark, R Watanabe, M Tawa, N Adams, A Dorosario, DC Fisher and TS Kupper The Dana
Farber/Brigham and Women’s Cancer Center, Boston, MA
We recently reported that malignant T cells in mycosis fungoides (MF) have the phenotype of effec-
tor memory T cells (TEM,) and those in Sézary syndrome (L-CTCL) have the phenotype of central
memory cells (TCM). In mice, tissue resident TEM are sessile cells whereas TCM are highly migratory;
this has never been shown in humans. Malignant T cells can be identified in CTCL, and this allows
correlation of T cell phenotype with the skin lesions they induce. We identified three CTCL T cell
phenotypes and correlated them with the skin lesions they produced. MF patients with stable skin
disease had stable, well demarcated plaques that contained malignant T cells lacking both L-selectin
and CCR7 (fixed TEM) . In mice, CCR7 expression is required for T cells to exit skin and enter lym-
phatics. Lesions from patients whose skin disease was worsening (e.g, increasing number and size
of plaques, Stage IA->IB) contained malignant T cells that expressed CCR7 but not L-selectin (mobile
TEM). These T cells could leave skin, enter the draining LN, be released into blood, but could only
home back to skin. Finally, L-CTCL patients had malignant T cells in skin that expressed both L-
selectin and CCR7 (TCM phenotype). L-CTCL skin lesions showed diffuse erythema with indistinct
borders, consistent with the ability of TCM to migrate within the skin, and demonstrated diffuse lym-
phadenopathy, consistent with their ability to enter lymph nodes from both blood and skin. Only
CLA+/CCR4+ CTCL T cells were found in the skin, although CLA-/CCR4+ T cells were frequent in the
circulation. In summary, CTCL patients demonstrate in humans that TEM are sessile and give rise to
fixed plaques, while TCM are highly migratory and induce diffuse erythema. Thus, clinical skin lesion
morphology is an accurate index of pathogenic T cell trafficking marker phenotype, which can be
used to guide therapy and to better understand the basic biology of CTCL and other skin diseases.
592
Epidermal LC mediate constitutive stimulation of skin resident tregs and thereby control the
inadvertent activation of skin effector memory T cells (TRM) in normal skin
J Seneschal,1,2 RA Clark1 and TS Kupper1 1 Dermatology, Brigham and Women’s Hospital,
Boston, MA and 2 Dermatology, INSERM U876 Université de Bordeaux, Bordeaux, France
We recently demonstrated that normal adult human skin contains 20 billion skin-homing, multi-
functional resident memory T cells (TRM). These TRM are specific for antigens previously encoun-
tered through skin, and provide potent protection against future infectious challenge. Inappropri-
ate activation of this population of TRM in normal skin must be tightly controlled, though the
mechanisms are unknown. Langerhans cells (LC) reside in the epidermis, and it has long been pre-
sumed that their major function is to exit epidermis and migrate to lymph node to activate naïve T
cells to antigens encountered through skin. Their putative interactions with skin TRM have not been
explored. To better understand the relation between LC and TRM in normal human skin, we care-
fully extracted both TRM and resident LC from the same normal human donor. We could readily
demonstrate that human LC strongly induced the proliferation of a small subset of TRM. On further
study, these proliferating TRM uniformly reproducibly expressed the phenotype of Treg and could
block the proliferation of non-Treg TRM. Treg proliferation was blocked by antibodies to class II
MHC, IL-2, and IL-15Rα. We next explored this phenomenon in intact normal human skin. By
immunofluoresence microscopy, we showed that LC and FoxP3+ Treg TRM co-localized in epider-
mis and follicular epithelium, and many of these Treg TRM were positive for the proliferation
marker Ki67. These data strongly suggest that LC constitutively stimulate Treg in normal skin. This
stimulation of Treg could be reversed in the presence of foreign antigen in a dose-dependant fash-
ion, as the addition of C.albicans to LC and TRM led to diminished Treg proliferation and increased
TEM proliferation. These findings establish a novel immunological role for LC in human skin,
allowing for the constitutive maintenance of tolerance, while also permitting the stimulation of res-
ident immune memory in response to infectious challenge.
590
Cell volume regulation by the Taurine transporter Taut determines T cell responses
S Kaesler,1 M Sobiesiak,2 T Volz,1 F Lang2 and T Biedermann1 1 Dermatology, Eberhard-Karls-
University, Tübingen, Germany and 2 Physiology, Eberhard-Karls-University, Tübingen,
Germany
T cell activation and subsequent transformation of activated T cells into T cell blasts require pro-
found changes in cell volume. However, the impact of cell volume regulation for T cell immunol-
ogy has not been characterized. Here we studied the role of cell volume regulating osmolyte trans-
porter Taut for T cell activation in Taut deficient mice. T cell mediated recall responses were severely
impaired in taut deficient (taut-/-) mice as shown with B16 melanoma rejection and hapten-induced
contact hypersensitivity. CD4+ and CD8+ T cells were unequivocally located within peripheral
lymph nodes of unprimed taut-/- mice but significantly decreased in taut-/- compared to taut+/+
mice following in vivo activation. Further analysis revealed that Taut is critical for rescuing T cells
from activation-induced cell death in vitro and in vivo as shown with TCR, superantigen, and anti-
gen-specific activation. Consequently, reduction of CD4+ and CD8+ T cells in taut-/- mice upon
antigen challenge resulted in impaired in vivo generation of T cell memory. These findings disclose
for the first time that volume regulation in T cells is an element in the regulation of adaptive immune
responses and that the osmolyte transport Taut is crucial for T cell survival and T cell mediated
immune reactions.
594
MyD88 signaling in Langerhans Cells is required for efficient generation of Th17 cells, but
not migration
K Haley,1 B Igyártó,1 A Bobr,1 S Kashem,1 D Ortner,1 D Schenten,2 R Medzhitov2 and DH Kaplan1
1 University of Minnesota, Minneapolis, MN and 2 Yale University, New Haven, CT
Langerhans cell (LC) migration is thought to require LC sensitivity to the cytokines IL-1b and IL-18
as well as recognition of microbial products. Since the adaptor molecule MyD88 is required for
both these functions, we generated Langerin-Cre MyD88-flox mice to test this hypothesis. We eval-
uated the mice during steady state conditions, after hapten application, and after C. albicans skin
infection. We found that the number of LC in skin and skin draining lymph nodes was unaltered.
LC activation as measured by increased surface expression of costimulatory molecules was also
unaffected. We have previously shown that contact hypersensitivity (CHS) responses to hapten were
increased in mice lacking LC. Langerin-Cre MyD88-flox mice, however, develop normally CHS
responses. Interestingly, skin infection with C. albicans which is known to express TLR-2 ligands,
led to reduced proliferation of antigen-specific T cells and inefficient generation of Th17 cells in
both Langerin-Cre MyD88-flox mice and mice lacking LC. Compared with LC isolated from WT
mice, MyD88-deficient LC produced less IL-1b, IL-6, and IL-23 in response of C. albicans infec-
tion. Thus, IL-1, IL-18, and MyD88-mediated toll-like receptor signaling are not required for LC
migration or increased expression of surface costimulatory molecules. However, in the setting of
pathogen infection, MyD88-dependent signals are required for production of inflammatory cytokines
and appropriate activation of naïve T cells.
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Autocrine TGFβ is required to prevent Langerhans cell migration
A Bobr,1 BZ Igyarto,1 KM Haley,1 MO Li,2 RA Flavell3 and DH Kaplan1 1 Department of
Dermatology and Center for Immunology, University of Minnesota, Minneapolis, MN, 2
Immunology Program, Memorial Sloan-Kettering Cancer Center, New York, NY and 3 Section
of Immunobiology, Yale University School of Medicine, New Haven, CT
Langerhans cells (LC) are skin resident dendritic cells located in the epidermis. We have demon-
strated using mice with a LC-specific ablation of TGFβ (Langerin-Cre x TGFβ-flox) that LC ontogeny
requires autocrine TGFβ in vivo. Since these mice have a constitutive absence of LC, the effect of
TGFβ on adult LC could not be evaluated. We have now developed Langerin Cre-ERT2 mice that
allow for tamoxifen-inducible gene excision. Using ROSA26.YFP Cre reporter mice, we confirmed
that Cre-ERT2 expression is specific for LC and highly efficient. We next generated Langerin Cre-
ERT2 x TGFβ-flox mice. Tamoxifen-inducible excision of TGFβ led to increased expression of cos-
timulatory molecules on LC followed by migration to the regional lymph node. Interestingly, in the
lymph node, surface expression of costimulatory molecules and expression of cytokines were sim-
ilar to WT LC. This suggests that migration in the absence of TGFβ recapitulates migration of LC in
the steady state. We observed an identical phenotype in Langerin Cre-ERT2x TGFβRII-flox mice.
Therefore, we conclude that LC-derived TGFβ acts directly on LC in an autocrine/paracrine fashion
and serves as epidermal retention factors to prevent LC migration. This may be an important mech-
anism preventing inappropriate immune responses against skin commensal microorganisms.
584
Skin-resident DC subsets promote distinct and opposing antigen-specific T helper responses
BZ Igyártó,1 K Haley,1 D Ortner,1 M Gerami-Nejad,1 SM Zurawski,2 B Malissen,3 G Zurawski,2
J Berman1 and DH Kaplan1 1 University of Minnesota, Minneapolis, MN, 2 Baylor Institute,
Dallas, TX and 3 Université de la Méditerranée, Marseille, France
Skin-resident dendritic cells (DC) are well positioned to encounter cutaneous pathogens and are
required for the initiation of adaptive responses. There are at least 3 subsets of skin DC—Langer-
hans cells(LC), Langerin+ dermal DC (dDC), and classic dDC. Our present understanding of the in
vivo function of these DC subsets has been hampered by the absence of a technique to examine
antigen-specific T cell responses after antigen has been targeted to LC and other skin DC-subsets in
a physiological manner. To overcome this, we have developed a novel skin infection model with
the dimorphic fungi, Candida albicans that we have engineered to express several model T cell
antigens. To study the antigen-specific T-cell responses, we infected mice with absent or defective
skin DC and examined the effects on adoptively transferred (OT-I, TEα) T cells. Infection with recom-
binant but not wild-type Candida albicans produced a brisk Th1 and Th17 type response as well as
a robust CD8 expansion. Mice lacking LC developed normal CTL and Th1 responses but failed to
generate Th17 cells. In addition, selectively targeting antigen to LC by injecting huLangerin trans-
genic mice with anti-huLangerin-Eα antibody conjugates during infection with wild-type Candida
albicans efficiently promoted the development of Th17 TEα cells. Thus, in response to Candida infec-
tion, LC are necessary and sufficient for the development a Th17 response. In mice lacking Lan-
gerin+ dDC, cross-presentation of antigen to CD8 T cells and the development of Th1 was abro-
gated but the Th17 response was unaffected. Langerin+ dDC also inhibited the ability of LC and
classic DC to promote Th17 responses. This work demonstrates that skin-resident DC subsets pro-
mote distinct and opposing antigen-specific responses.
585
Continuous antigen exposure elicits increased IL-10 production, but intermittent antigen
exposure induces IL-4 production
K Yamanaka, K Tsuda, T Akeda, T Nakanishi, H Kitagawa, M Kakeda and H Mizutani
Dermatology, Mie University, Graduate School of Medicine, Tsu, Japan
Allergen-specific immunotherapy (SIT) is currently used as the curative therapy for allergic disor-
ders including allergic rhinitis and atopic dermatitis. The circulating IL-10-producing regulatory T
cell (Tr1) number is decreased in pollinosis patients compared to that in normal controls, and after
successful SIT, the circulating Tr1 numbers recovered to the normal level. IL-10, a strong anti-inflam-
matory cytokine has critical roles in the induction of specific T cell tolerance. We then hypothesized
continuous antigen exposure induces IL-10 production. 100uL of 0.5% oxazolone (OX) was applied
to C57BL/6 mouse ear every other day for 4 weeks. 24 hours after last OX challenge, the ear skins
were sampled. Cytokine expressions in the ear skin were analyzed, and found IL-10 mRNA expres-
sion was increased than that of IL-4. However, when the antigen application is finished after 4 weeks
challenge, and then repeated the same application again later on the same mice, the mice showed
severe ear swellings and increased IL-4 mRNA expression compared to that of IL-10. These finding
suggests that in the SIT, antigen application should be continued even at the low dose in the non-
scattering season.
586
Pregnane X Receptor (PXR) regulates cutaneous immunity
M Schmuth,1 A Elentner,1 F Gonzalez2 and S Dubrac1 1 Dermatology, Innsbruck Medical
School, Innsbruck, Austria and 2 Laboratory of Metabolism, National Cancer Institute,
National Institutes of Health, Bethesda, MD
The pregnane X receptor (PXR) is a ligand-activated transcription factor regulating genes central to
drug and hormone metabolism in the liver. We here show that topical application of PCN, a well-
known activator of mouse PXR, ameliorates irritant and allergic contact dermatitis in a PXR-depend-
ent manner. Moreover, rifampicin, a well-known activator of human PXR, when applied topically,
improves allergic contact dermatitis in mice humanized for PXR (Tg-hPXR) and for PXR and CYP3A4
(Tg-CYP3A4/hPXR). Rifampicin down-regulates the expression of IL-1beta in a hPXR-mediated man-
ner in PXR-humanized keratinocytes stimulated with a contact allergen and rifampicin down-reg-
ulates iNOS and IL-1beta in activated keratinocytes. Notably, Tg-CYP3A4/hPXR mice respond
more readily to rifampicin than Tg-hPXR mice. Co-expression of CYP3A4 with hPXR in transgenic
mice has additive effects when compared to hPXR expression only, suggesting a link between CYP3A4
and the rifampicin-mediated anti-inflammatory response. Moreover, PXR deficient mice exhibit
exaggerated ear swelling when sensitized and challenged with a contact allergen which correlates
with increased numbers of dermal T-lymphocytes, mostly consisting in CD4+ cells. Finally, PXR is
expressed in lymphocyte-rich infiltrates of various human inflammatory skin disorders. In sum-
mary, PXR plays a role in the skin immune system, and CYP3A4, the key enzyme of drug metabo-
lism regulated by PXR, modulates the PXR-mediated anti-inflammatory activity.
587
Adenosine produced by regulatory T cells acts as chemo-attractant for dendritic cells and pro-
motes formation of Treg-DC clusters
S Ring, AH Enk and K Mahnke Dermatology, Ruprecht-Karls University Heidelberg,
Heidelberg, Germany
Our previous studies have shown that CD4+CD25+Foxp3+ regulatory T-cells (Treg) suppress the
sensitization phase of contact hypersensitivity (CHS) reactions by interacting with dendritic cells
(DC) in the draining lymph nodes. The molecular means of this interaction are not entirely clear,
however, we and others have recently demonstrated that production of adenosine by Treg plays an
important role in suppressing the elicitation phase of CHS responses. Therefore we asked whether
adenosine also affects the sensitization phase by modulating the interaction between Treg and DC.
In in vitro cocultures of isolated murine Treg with bone marrow derived DC, or with ex vivo iso-
lated MHC II+ DC, we observed rapid formation of clusters between these two cell populations. In
contrast, conventional CD4+ T- cells and DC did not establish any stable contacts. To unravel the
role of adenosine in this Treg-DC interaction, we blocked the adenosine production by Treg using
the CD39 inhibitor POM-1. This led to abrogation of cluster formation in the Treg-DC cocultures.
Vice versa, addition of exogenous adenosine to cocultures of conventional CD4+ T-cells and DC
induced formation of CD4+ T-cell-DC clusters. Life images of Treg-DC cocultures sampled over 2h,
demonstrated fast movement of DC in direction of the rather immobile Treg. Analyzing the chemo-
tactic activity of Treg or adenosine, respectively, using Boyden-chambers, we observed that the
migration rate of DC towards Treg or adenosine was significantly higher as compared to the migra-
tion rate towards conventional CD4+ T-cells or medium. Blocking of the adenosine production by
Treg using POM-1, caused a complete inhibition of the chemotactic activity of Treg on DC. In con-
clusion our data indicate that Treg derived adenosine acts as chemo-attractant for DC and pro-
motes the formation of clusters between Treg and DC, which is required for the immunosuppres-
sive action exerted from Treg on DC.
588
Rhealba® oat plantlets interest in the management of atopic patients
M Aries,1 A Mandeau,1 N Castex-Rizzi,1 J Nicolas,2 T Bieber,3 M Ambonati1 and C Coutanceau1 1
Dermo Cosmetic Department, Pierre FABRE Research and Development Center, Toulouse,
France, 2 Department of Clinical Allergology and Immunology, Lyon Sud Hospital, Lyon,
France and 3 Department of Dermatology and Allergology, Bonn University, Bonn, Germany
Oat extract-containing emollients are particularly adapted to the treatment of atopic dermatitis (AD).
To improve the efficacy and safety of oat extracts, Pierre Fabre Laboratories scientists have devel-
oped new protein-free oat extracts from Rhealba® Oat Plantlets, the young plants collected at the
growing stage prior to earing. This part of the oat is not consumed by humans and contains specific
metabolites (C-glycosylated flavonoids and steroidal saponins) which possess potent anti-inflam-
matory, anti-allergic and immuno-modulating properties. The Plantlets extracts were analyzed by
electrophoresis, ELISA and Western Blot to verify the absence of protein contamination. The immuno-
modulating properties of the extract was tested on: i) the production of lymphocyte cytokines; ii)
the functions of mature dendritic cells; iii) the production of PG6KF1α. Coomassie blue staining
SDS-Page showed that the Plantlet extract does not contain any detectable proteins. ELISA and West-
ern Blot tests showed no cross-reactivity to grain proteins, eliminating any risk of dietary pre-sensi-
tization. Concerning biological properties, the extract showed potent immuno-modulating and anti-
inflammatory activities including: i) direct inhibition of the T cell cytokine (IL2, IL4, IL13) secretion;
ii) reduction of DC-induced T cell activation; iii) inhibition of the production of PG6KF1α by 57%.
Therefore, this study shows that this new Rhealba® Oat Plantlet extract combines optimal safety
(absence of proteins) and efficiency (immuno-inflammation modulation) providing a specially adapted
solution for the treatment of barrier alteration in AD patients. This extract is now used in the new
EXOMEGA range.
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GILT modulates CD4+ T cell tolerance to the melanoma antigen TRP1
MP Rausch,1 TC Metzger,2 MS Anderson2 and KT Hastings1 1 University of Arizona College of
Medicine, Phoenix, AZ and 2 University of California, San Francisco, CA
Regulating the balance between T cell activation and tolerance is critical for generating effective
immunotherapy for melanoma and in controlling the development of autoimmune vitiligo. We have
shown that gamma-interferon-inducible lysosomal thiol reductase (GILT) is essential for efficient
MHC class II-restricted processing of a skin-restricted antigen expressed by melanocytes and
melanoma cells, tyrosinase-related protein 1 (TRP1). GILT’s function in antigen presenting cells
accelerates the onset and severity of vitiligo mediated by TRP1-specific CD4+ T cells. Using MHC
class II-restricted TRP1-specific T cell receptor transgenic mice, here we identify a novel role for
GILT in the maintenance of tolerance to TRP1. T cells specific for TRP1 are centrally deleted in mice
expressing both GILT and TRP1 on the RAG-/- background. In contrast, CD4 single positive thy-
mocytes and peripheral CD4+ T cells develop in the absence of either GILT or TRP1, demonstrat-
ing that GILT is required for thymic deletion of TRP1-specific T cells. GILT’s role in central tolerance
is supported by GILT and TRP1 expression in thymic stromal cells. Although TRP1-specific CD4+ T
cells escape thymic deletion in the absence of GILT, they are tolerant to TRP1 and do not induce
vitiligo. Unlike TRP1-specific CD4+ T cells that develop in the absence of antigen, T cells that develop
in the absence of GILT have diminished IFN-γ and IL-2 production. Furthermore, GILT-deficient mice
contain three-fold more TRP1-specific CD4+CD25+Foxp3+ regulatory T (Treg) cells than TRP1-defi-
cient mice. Treg cell depletion partially restores the ability of GILT-deficient TRP1-specific CD4+ T
cells to induce vitiligo following adoptive transfer, suggesting that Treg cells contribute to TRP1-
specific T cell tolerance. These studies highlight a critical role for GILT in shaping the CD4+ T cell
repertoire specific for skin-restricted antigens.
603
Skin resident memory T Cells (Trm) accumulate globally throughout skin in response to
repetitive antigenic challenges
X Jiang, RA Clark and TS Kupper Dermatology, Brigham and Women’s Hospital, Boston, MA
More than five years ago, we reported that human skin contains a large population of resident
memory T cells (Trm). We speculated that these cells were recruited to skin over the lifetime of the
individual in response to antigens encountered through skin, with the immune response in the drain-
ing lymph node engendering skin homing memory T cells. To further explore this hypothesis, we
used a vaccinia virus (VACV) encoding the ovalubumin peptide OVA257-264, and immunized mice
previously loaded with OT-1 cells (CD8 T cells specific for this peptide) via skin scarification on the
left ear. We then assessed the accumulation of OT-1 cells in the infected (left) and uninfected (right)
ears. OT-1 T cells were first detectable in the left ear at day 3, and also appeared in the uninfected
ear, although they were less abundant. Peak recruitment to the infected and uninfected ear skin
occurred at day 7, with roughly 10-fold more OT-1 cells in infected than uninfected skin. These Trm
persisted in both ears for many months, though their numbers diminished. We then asked if multi-
ple subsequent infections would lead to an increase in the number of OT-1 Trm in never infected
skin. We thus compared mice that were infected (as before) only on the left ear, to another group
of mice infected first on the left ear, but then 20 days later on the tail, and 30 days later on the flank.
In both groups, the number of OT-1 cells in the originally infected ear was compared to the unin-
fected ear. There was a > 3-fold increase in the number of OT-1 Trm cells in the uninfected ear of
the repetitively infected mice, indicating that multiple encounters with antigen at any site increase
antigen specific Trm throughout the skin. Finally, we demonstrated that Trm in never infected skin
were highly effective in clearing virus after skin infection with VACV. These experiments support the
hypothesis that skin Trm accumulate over time, and represent an antigen experienced population
of memory T cells that arises in response to antigen challenges through skin.
605
Targeting of antigen–loaded nanoparticle-based vaccine into differential skin layers induces
distinct arms of immunity
C Liard,1 S Munier,2 B Verrier,2 M Arias,3 D Duffy,1 R Shattock3 and B Combadiere1 1 Infection
and Immunity, INSERM U945, Paris, France, 2 Institut de Biologie et de Chimie des Proteines,
CNRS UMR5086, Lyon, France and 3 Center for Infection, SGUl, London, United Kingdom
Professional APCs such as Langerhans cells (LCs) in the epidermis and Dendritic Cells (DCs) in the
dermis are found at high densities in the skin and can therefore be effective targets for immuniza-
tion. Thus, different skin layers, i.e. epidermis, dermis and to a lesser extent subcutis, offer access
to a large variety and numbers of APCs. Interestingly, we have recently observed in a Phase I clin-
ical trial in Humans that epidermal Influenza vaccination induced preferentially Influenza-specific
CD8 T cells, whereas classical intramuscular (IM) route did not (Combadiere et al Plos One 2010).
One can thus question the impact of the skin route of administration on the outcome of immune
responses and consequently on the control of infectious diseases. Skin routes of immunization
such as subcutaneous (SC), intradermal (ID) and transcutaneous (TC) administration are utilized for
vaccination against various pathogens, without understanding their potential impact on the out-
come of immune responses. We demonstrated that SC immunization induced HIV-1 p24 specific
IgG in absence of antigen-specific CD8 T cells, whereas the ID route induced both cellular and
humoral responses. Interestingly, TC application through empty hair follicular ducts, targeting epi-
dermal Langerhans Cells (LCs), induced major CD8 effector cells, in the absence of IgG. However,
high levels of mucosal IgA, were localized in the stratified epithelium of the vagina after TC prime.
We propose that re-directing the immune responses by targeting differential skin immunization
routes, offers enormous potential for innovative vaccination strategies.
604
CD45RO loss in histopathological specimens of lymphomatoid papulosis
DV Chan,1 S Aneja,2 KS Honda1,2 and KD Cooper1,2 1 Department of Dermatology, University
Hospitals Case Medical Center & Case Western Reserve University, Cleveland, OH and 2 Case
Western Reserve University School of Medicine, Cleveland, OH
The definitive diagnosis of lymphomatoid papulosis (LyP) is challenging. In the absence of clinico-
pathological correlations this disorder can be mistaken for CD30+ anaplastic large-cell lymphomas
and other cutaneous lymphomas because the histopathological pattern of LyP may resemble malig-
nant processes. We have previously reported that 85.5% of atypical cells in patients with a clini-
copathological diagnosis of mycosis fungoides-type cutaneous T cell lymphoma (CTCL) express dis-
cordance between the CD45RB and CD45RO isoforms. Specifically, CD45RO loss is exhibited in
CD45RB positive epidermotropic cells. The objective of this study was to determine if atypical cells
in histopathological specimens from patients diagnosed with LyP express discordance between
CD45RB and CD45RO in a retrospective analysis. To assemble the cohort, records of all patients
diagnosed with lymphomatoid papulosis by consensus at the Multidisciplinary Cutaneous Lym-
phoma Tumor Board at Case Medical Center from 1997 to 2010 were reviewed. Patient informa-
tion was reviewed to compile data on demographics, diagnosis, location, histopathogical charac-
teristics, immunopathology, and gene rearrangement studies. The male to female ratio in this cohort
was 6:8, and the average age was 51.7 years. Of the 14 cases of definitive LyP, CD45RO loss on
atypical lymphocytes occurred in 42.8% (6/14) of all cases, distributed as follows: 25.0% of LyP
type A (2/8) cases, 66.7% of LyP type B (2/3) cases, 50% of LyP type C (1/2) cases, as well as one
LyP type D case. CD45RO staining was not found to correlate with CD30 positivity, and gene rear-
rangment studies are ongoing. In conclusion, CD45RO loss in atypical cells was found among
each of the LyP subtypes, and overall, is less than that exhibited in mycosis fungoides.
602
Virus specific CD8 effector memory T cells (Tem) can be recruited to skin in the absence of
CD4 T cells, but their persistence as long term resident memory T cells (Trm) is impaired
X Jiang,1 JJ Campbell,1 L Liu,1 Z Beck,1 N Tubo,1 J Seneschal,1,2 R Purwar,1 T Tian1 and TS Kupper1
1 Dermatology, Brigham and Women’s Hospital, Boston, MA and 2 Dermatology, INSERM
U876 Universite de Bordeaux, Bordeaux, France
CD8 Tem recruitment to herpes simplex virus (HSV) infected reproductive mucosa was recently
shown to require CD4+ T cells. These CD4+ T cells entered infected mucosa and facilitated CD8
Tem recruitment by local release of IFNγ, which induced chemokines that attracted CD8 Tem cells.
We asked recruitment of CD8 Tem after cutaneous viral infection also required CD4+ T cells. After
skin infection with vaccinia virus (VACV), we assessed the recruitment of virus-specific CD8 T cells
to skin at various times after infection. Surprisingly, we found that recruitment of CD8+ Tem to
infected skin was not inhibited in CD4-/- mice but rather was enhanced. Similar augmentation of
CD8 Tem recruitment was seen in mice where CD4 T cells were antibody depleted. Moreover, CD8+
Tem recruitment to skin was not impaired in IFNγ-/- mice, indicating that host IFNγwas not involved.
Thus, VACV specific CD8+ Tem migrated to infected skin through a mechanism that did not involve
CD4 T cell help. As expected, this migration was dependant on inflammation and dermal vascular
induction of E and P selectin, since CD8 Tem cells from fucosyl transferase IV/VII -/- mice (which
lack E and P selectin ligands) did not efficiently enter infected skin. Thus, innate immune inflam-
mation of skin, but not CD4 T cell help, was required for acute recruitment of CD8 VACV specific
T cells. Finally, we asked if the absence of CD4+ T cells could impair the long term memory response
to subsequent VACV skin infection by tissue resident (Trm) viral specific CD8 Tem. Challenge of
previously infected mice 60 days after primary infection demonstrated that virus could still be cleared
from the skin of CD4-/- mice, but that this viral clearance was less efficient in these CD8 T cell defi-
cient mice. Therefore, CD4 cells appear to influence the persistence of CD8 Trm cells in skin over
time, but not their acute recruitment to infected skin.
606
Intradermal immunization triggers epidermal langerhans-cell mobilization required For CD8
T-cell immune responses
C Liard,1 S Menier,2 A Joulin-Giet,1 A Vogt,3 O Bonduelle,1 S Hadam,3 D Duffy,1 B Verrier2 and
B Combadiere1 1 Infection and Immunity, INSERM U945, Paris, France, 2 Institut de Biologie
et de Chimie des Proteines, CNRS UMR5086, Lyon, France and 3 Clinical Research Center for
Hair and Skin Science, Charité, Berlin, Germany
The skin constitutes a unique immunological environment endowed with specific resident and infil-
trating antigen presenting cells (APCs) such as Langerhans cells (LCs) in the epidermis and dermal
dendritic cells (DDCs) in the dermis. In particular, the availability of functionally active APCs at the
site of vaccine inoculation is crucial for the optimal presentation of vaccine-derived antigens to the
immune system. The potential of the immune system of the skin for the generation of both power-
ful humoral and cellular immune responses is now well established. However, the mechanisms
responsible for the efficacy of skin vaccination still remain to be elucidated. We have previously
demonstrated that preferential LC targeting by transcutaneous (TC) immunization shapes immune
responses toward vaccine-specific CD8 T cells in human clinical trials; while others have shown
that intradermal (ID) inoculation of antigens to exploit high densities of dermal Antigen Presenting
Cells (APCs) mobilizes both the cellular and humoral arms. Here, we investigated the participation
of epidermal LCs in the response to ID immunization. When human or mouse skin was injected ID
with a particle-based vaccine, we observed significant modifications in the morphology of LCs in
the epidermis and their mobilization to the dermis. We further established that this LC recruitment
was essential for the induction of antigen-specific CD8 T cells after ID administration, but was
however dispensable for the generation of specific CD4 T cells and neutralizing antibodies. Thus,
epidermal and dermal APCs shape the outcome of immune responses to ID vaccine delivery. Their
combined potential provides new avenues for the development of vaccination strategies against
infectious diseases.
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IL-9 is a potent mediator of tumor immunity, and its expression is negatively regulated by the
Th17 transcription factor RORγ
R Purwar,1 S Xiao,1 Y Takeda,2 W Elyaman,1 X Jiang,1 A Jetten,2 S Khoury,1 R Fuhlbrigge,1
V Kuchroo1 and T Kupper1 1 Dermatology, Brigham and Women’s Hospital,, Boston, MA and
2 NIH/NIEHS, Triangle Park, NC
Cytokines binding to receptors containing a common γ chain, such as IL-2, IL-7, IL-15, and IL-21,
enhance T cell growth and have been used clinically in cancer patients to enhance tumor immu-
nity. IL-9 is a cytokine that also binds to a receptor containing this common γ chain, but its role in
tumor immunity has not been explored. Using a subcutaneous injection of B16 melanoma cells,
we found that tumors grew much more rapidly in IL-9-/- mice than in control mice. Daily admin-
istration of rIL-9 to mice with B16 tumors dramatically reduced tumor growth, while administration
of a blocking antibody to IL-9 enhanced tumor growth. We next polarized T cells under conditions
favoring Th1, Th2, Th9, and Th17 cells, and found that Th9 polarized cells were superior at inhibit-
ing tumor growth after adoptive transfer. Th9 cells enhanced proliferation of CD8 tumor specific T
cells, and also had direct cytotoxic effects on B16 cells in vitro. IL-9 itself did not inhibit B16
growth in vitro. RORγ is a transcription factor important for Th17 cell development. Transcriptional
profiling experiments done in RORγ deficient mouse T cells had demonstrated that upon activation,
IL-23R and IL-17 were strongly downregulated, but IL-9 was strongly upregulated, a novel finding.
We therefore explored tumor immunity in RORγ -/- mice, and found a dramatic decrease in tumor
growth, which could be reversed significantly by administration of blocking antibodies to IL-9, sug-
gesting a prominent role for this cytokine in tumor growth suppression. Additional studies showed
that IL-23R-/- mice showed enhanced tumor immunity, and this could be abrogated significantly
by the administration of anti-IL-9 antibody. We conclude that IL-9 strongly enhances tumor immu-
nity, and is negatively regulated by RORγ, a previously unappreciated role for this transcription fac-
tor. Moreover, genes positively regulated by RORγ, such as IL-23R and IL-17, are associated with
reduced tumor immunity.
596
Correlation of intra- and extraepidermal CD8 T cell numbers with development of psoriatic
epidermal pathology
A Navarini,1 G Tonel1 and C Conrad1,2 1 Department of Dermatology, University Hospital
Zurich, Zurich, Switzerland and 2 Department of Dermatology, University Hospital Lausanne,
Lausanne, Switzerland
The development of psoriatic plaques is T cell dependent. Recently, Th17 CD4 T cells have been
proposed to be the main effector cells. However, development of psoriasis is critically dependent
on accumulation of epidermal T cells, among the majority express CD8. Here we show that num-
bers of epidermal CD8 T cells correlated with development of psoriasis in human biopsies, and that
blockade of CD8 T cells by depleting antibodies inhibited development of psoriasis in the AGR xeno-
transplantation mouse model. In human dermis, both CD4 and CD8 T cell numbers correlated sig-
nificantly with epidermal pathology, indicating a role for dermal CD4 T cells in orchestrating the
development of psoriasiform changes induced by epidermis-infiltrating CD8 T cells.
597
Tissue-based cytokine immunotherapy for skin cancer
M Lokuta, A Comer, B Soto, M Vander Zanden, M Bucholtz and L Allen-Hoffmann Stratatech
Corp., Madison, WI
Annually, more than 1 million cases of non-melanoma skin cancer and more than 68,000 new cases
of melanoma are diagnosed in the US. Approximately 10% of primary or recurrent non-melanoma
skin cancers present as complex, perineural, or locally-invasive tumors which are difficult to man-
age by surgery alone. Tumor resection using Mohs’ surgery frequently results in a large wound that
requires adjunctive therapy to expedite wound healing. Tumor recurrence near the primary tumor
following surgical excision remains the predominant cause of treatment failure and is often associ-
ated with a poor prognosis. Interleukin-12 (IL-12) is one of the most promising cytokines for tumor
immunotherapy due to its potent anti-tumor activity, ability to synergize with other cytokines, and
role in stimulating both innate and adaptive tumor responses. It is likely that sustained local expres-
sion of IL-12 will facilitate the clearance of residual local tumor cells which were not removed sur-
gically. This project is aimed at developing a bio-engineered tissue therapeutic that will prevent the
spread or recurrence of locally-invasive or complex skin cancers through the sustained, local expres-
sion of IL-12 at the site of a recently resected tumor. We have generated an IL-12 fusion construct
and generated a panel of stably-transfected NIKS keratinocyte clones (NIKSIL-12) stably expressing
and secreting a wide range of IL-12 concentrations, as detected by RT-PCR, Western blot, and ELISA.
Skin tissues generated using these clones exhibit appropriate epidermal differentiation. In addition,
exogenous expression of IL-12 in NIKS keratinocytes does not adversely affect tissue architecture,
barrier function, or cellular viability. We have shown that the IL-12 produced by the skin tissues
can induce PHA-activated human T lymphoblast proliferation. Taken together, these results demon-
strate the feasibility of using bio-engineered skin tissue to provide local, sustained expression of
bioactive IL-12 at the site of a recently-resected skin tumor.
598
Ifng pathway signature dominates the gene expression profile of C3H/HeJ mouse model of
alopecia areata
S Harel,1 C Higgins,1 L Petukhova,1,2 JP Sundberg,3 RA Clynes4 and AM Christiano1,5 1
Dermatology, Columbia University, New York, NY, 2 Epidemiology, Columbia University, New
York, NY, 3 The Jackson Laboratory, Bar Harbor, ME, 4 Medicine, Columbia University, New
York, NY and 5 Genetics and Development, Columbia University, New York, NY
Alopecia Areata (AA) is among the most prevalent human autoimmune diseases and leads to dis-
figuring, yet reversible, hair loss which results from autoimmunity against the hair follicle. Evidence
for a genetic basis for AA includes our previous linkage and genome-wide association studies (GWAS).
C3H/HeJ mice develop spontaneous hair loss that shows clinical, histopathological and immuno-
logical features of human AA, thus providing a robust animal model for the disease. To corroborate
results of previous linkage studies in C3H/HeJ mice and our GWAS, we analyzed the gene expres-
sion profile of alopecic skin from C3H/HeJ mice. The expression signature of alopecic C3H skin was
determined from unaffected and affected age-matched mice which develop the disease sponta-
neously. Total RNA was isolated from whole skin, and hybridized to the Affymetrix Mouse 430 2.0
Genechip. Using Genespring, we obtained 485 transcripts that were significantly (p≤0.05) and dif-
ferentially regulated (≥2X). Unexpectedly, our gene profiling experiments provided striking evidence
for the Ifng response in AA, in that 16 of the top 20 induced genes, including the chemokines
Cxcl9/10/11, were known to be IFN-response genes. This signature is likely due to Ifng since Type
I interferons were not induced in AA skin. We independently validated this finding by utilizing an
interferon signaling and response qPCR array (StellarrayTM). Genes including Icos, Tap2 and Ifng
were upregulated in alopecic mice and reside within chromosomal regions significantly associated
with AA in our GWAS. These findings support previous studies demonstrating that Ifng null mice
are resistant to development of AA in a transplantation model. We have uncovered a striking Ifng
signature in C3H/HeJ mice, allowing us to further investigate the mechanisms of Ifng response acti-
vation in AA.
599
Evaluation of the NF kappa B pathway in a mouse model of psoriasis
B Poligone,1 K Gillespie,1 S Toth1 and S Ghosh2 1 Dermatology, University of Rochester,
Rochester, NY and 2 Microbiology and Immunology, Columbia University, New York, NY
We have evaluated the importance of the NF kappa B pathway in the K14-VEGF mouse model of
psoriasis. Through our studies, we have discovered that there appears to be two stages of psoriasis
and NF kappa B is important in one. In light of the recent data on the genetic pathways important
in human psoriasis, our findings likely have importance in both the pathogenesis and treatment
potential of the human disease. We have identified a defect in an NF kappa B related protein in our
mice may also be important in the human disease.
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GILT modulates CD4+ T cell tolerance to the melanoma antigen TRP1
MP Rausch,1 TC Metzger,2 MS Anderson2 and KT Hastings1 1 University of Arizona College of
Medicine, Phoenix, AZ and 2 University of California, San Francisco, CA
Regulating the balance between T cell activation and tolerance is critical for generating effective
immunotherapy for melanoma and in controlling the development of autoimmune vitiligo. We have
shown that gamma-interferon-inducible lysosomal thiol reductase (GILT) is essential for efficient
MHC class II-restricted processing of a skin-restricted antigen expressed by melanocytes and
melanoma cells, tyrosinase-related protein 1 (TRP1). GILT’s function in antigen presenting cells
accelerates the onset and severity of vitiligo mediated by TRP1-specific CD4+ T cells. Using MHC
class II-restricted TRP1-specific T cell receptor transgenic mice, here we identify a novel role for
GILT in the maintenance of tolerance to TRP1. T cells specific for TRP1 are centrally deleted in mice
expressing both GILT and TRP1 on the RAG-/- background. In contrast, CD4 single positive thy-
mocytes and peripheral CD4+ T cells develop in the absence of either GILT or TRP1, demonstrat-
ing that GILT is required for thymic deletion of TRP1-specific T cells. GILT’s role in central tolerance
is supported by GILT and TRP1 expression in thymic stromal cells. Although TRP1-specific CD4+ T
cells escape thymic deletion in the absence of GILT, they are tolerant to TRP1 and do not induce
vitiligo. Unlike TRP1-specific CD4+ T cells that develop in the absence of antigen, T cells that develop
in the absence of GILT have diminished IFN-γ and IL-2 production. Furthermore, GILT-deficient mice
contain three-fold more TRP1-specific CD4+CD25+Foxp3+ regulatory T (Treg) cells than TRP1-defi-
cient mice. Treg cell depletion partially restores the ability of GILT-deficient TRP1-specific CD4+ T
cells to induce vitiligo following adoptive transfer, suggesting that Treg cells contribute to TRP1-
specific T cell tolerance. These studies highlight a critical role for GILT in shaping the CD4+ T cell
repertoire specific for skin-restricted antigens.
603
Skin resident memory T Cells (Trm) accumulate globally throughout skin in response to
repetitive antigenic challenges
X Jiang, RA Clark and TS Kupper Dermatology, Brigham and Women’s Hospital, Boston, MA
More than five years ago, we reported that human skin contains a large population of resident
memory T cells (Trm). We speculated that these cells were recruited to skin over the lifetime of the
individual in response to antigens encountered through skin, with the immune response in the drain-
ing lymph node engendering skin homing memory T cells. To further explore this hypothesis, we
used a vaccinia virus (VACV) encoding the ovalubumin peptide OVA257-264, and immunized mice
previously loaded with OT-1 cells (CD8 T cells specific for this peptide) via skin scarification on the
left ear. We then assessed the accumulation of OT-1 cells in the infected (left) and uninfected (right)
ears. OT-1 T cells were first detectable in the left ear at day 3, and also appeared in the uninfected
ear, although they were less abundant. Peak recruitment to the infected and uninfected ear skin
occurred at day 7, with roughly 10-fold more OT-1 cells in infected than uninfected skin. These Trm
persisted in both ears for many months, though their numbers diminished. We then asked if multi-
ple subsequent infections would lead to an increase in the number of OT-1 Trm in never infected
skin. We thus compared mice that were infected (as before) only on the left ear, to another group
of mice infected first on the left ear, but then 20 days later on the tail, and 30 days later on the flank.
In both groups, the number of OT-1 cells in the originally infected ear was compared to the unin-
fected ear. There was a > 3-fold increase in the number of OT-1 Trm cells in the uninfected ear of
the repetitively infected mice, indicating that multiple encounters with antigen at any site increase
antigen specific Trm throughout the skin. Finally, we demonstrated that Trm in never infected skin
were highly effective in clearing virus after skin infection with VACV. These experiments support the
hypothesis that skin Trm accumulate over time, and represent an antigen experienced population
of memory T cells that arises in response to antigen challenges through skin.
605
Targeting of antigen–loaded nanoparticle-based vaccine into differential skin layers induces
distinct arms of immunity
C Liard,1 S Munier,2 B Verrier,2 M Arias,3 D Duffy,1 R Shattock3 and B Combadiere1 1 Infection
and Immunity, INSERM U945, Paris, France, 2 Institut de Biologie et de Chimie des Proteines,
CNRS UMR5086, Lyon, France and 3 Center for Infection, SGUl, London, United Kingdom
Professional APCs such as Langerhans cells (LCs) in the epidermis and Dendritic Cells (DCs) in the
dermis are found at high densities in the skin and can therefore be effective targets for immuniza-
tion. Thus, different skin layers, i.e. epidermis, dermis and to a lesser extent subcutis, offer access
to a large variety and numbers of APCs. Interestingly, we have recently observed in a Phase I clin-
ical trial in Humans that epidermal Influenza vaccination induced preferentially Influenza-specific
CD8 T cells, whereas classical intramuscular (IM) route did not (Combadiere et al Plos One 2010).
One can thus question the impact of the skin route of administration on the outcome of immune
responses and consequently on the control of infectious diseases. Skin routes of immunization
such as subcutaneous (SC), intradermal (ID) and transcutaneous (TC) administration are utilized for
vaccination against various pathogens, without understanding their potential impact on the out-
come of immune responses. We demonstrated that SC immunization induced HIV-1 p24 specific
IgG in absence of antigen-specific CD8 T cells, whereas the ID route induced both cellular and
humoral responses. Interestingly, TC application through empty hair follicular ducts, targeting epi-
dermal Langerhans Cells (LCs), induced major CD8 effector cells, in the absence of IgG. However,
high levels of mucosal IgA, were localized in the stratified epithelium of the vagina after TC prime.
We propose that re-directing the immune responses by targeting differential skin immunization
routes, offers enormous potential for innovative vaccination strategies.
604
CD45RO loss in histopathological specimens of lymphomatoid papulosis
DV Chan,1 S Aneja,2 KS Honda1,2 and KD Cooper1,2 1 Department of Dermatology, University
Hospitals Case Medical Center & Case Western Reserve University, Cleveland, OH and 2 Case
Western Reserve University School of Medicine, Cleveland, OH
The definitive diagnosis of lymphomatoid papulosis (LyP) is challenging. In the absence of clinico-
pathological correlations this disorder can be mistaken for CD30+ anaplastic large-cell lymphomas
and other cutaneous lymphomas because the histopathological pattern of LyP may resemble malig-
nant processes. We have previously reported that 85.5% of atypical cells in patients with a clini-
copathological diagnosis of mycosis fungoides-type cutaneous T cell lymphoma (CTCL) express dis-
cordance between the CD45RB and CD45RO isoforms. Specifically, CD45RO loss is exhibited in
CD45RB positive epidermotropic cells. The objective of this study was to determine if atypical cells
in histopathological specimens from patients diagnosed with LyP express discordance between
CD45RB and CD45RO in a retrospective analysis. To assemble the cohort, records of all patients
diagnosed with lymphomatoid papulosis by consensus at the Multidisciplinary Cutaneous Lym-
phoma Tumor Board at Case Medical Center from 1997 to 2010 were reviewed. Patient informa-
tion was reviewed to compile data on demographics, diagnosis, location, histopathogical charac-
teristics, immunopathology, and gene rearrangement studies. The male to female ratio in this cohort
was 6:8, and the average age was 51.7 years. Of the 14 cases of definitive LyP, CD45RO loss on
atypical lymphocytes occurred in 42.8% (6/14) of all cases, distributed as follows: 25.0% of LyP
type A (2/8) cases, 66.7% of LyP type B (2/3) cases, 50% of LyP type C (1/2) cases, as well as one
LyP type D case. CD45RO staining was not found to correlate with CD30 positivity, and gene rear-
rangment studies are ongoing. In conclusion, CD45RO loss in atypical cells was found among
each of the LyP subtypes, and overall, is less than that exhibited in mycosis fungoides.
602
Virus specific CD8 effector memory T cells (Tem) can be recruited to skin in the absence of
CD4 T cells, but their persistence as long term resident memory T cells (Trm) is impaired
X Jiang,1 JJ Campbell,1 L Liu,1 Z Beck,1 N Tubo,1 J Seneschal,1,2 R Purwar,1 T Tian1 and TS Kupper1
1 Dermatology, Brigham and Women’s Hospital, Boston, MA and 2 Dermatology, INSERM
U876 Universite de Bordeaux, Bordeaux, France
CD8 Tem recruitment to herpes simplex virus (HSV) infected reproductive mucosa was recently
shown to require CD4+ T cells. These CD4+ T cells entered infected mucosa and facilitated CD8
Tem recruitment by local release of IFNγ, which induced chemokines that attracted CD8 Tem cells.
We asked recruitment of CD8 Tem after cutaneous viral infection also required CD4+ T cells. After
skin infection with vaccinia virus (VACV), we assessed the recruitment of virus-specific CD8 T cells
to skin at various times after infection. Surprisingly, we found that recruitment of CD8+ Tem to
infected skin was not inhibited in CD4-/- mice but rather was enhanced. Similar augmentation of
CD8 Tem recruitment was seen in mice where CD4 T cells were antibody depleted. Moreover, CD8+
Tem recruitment to skin was not impaired in IFNγ-/- mice, indicating that host IFNγwas not involved.
Thus, VACV specific CD8+ Tem migrated to infected skin through a mechanism that did not involve
CD4 T cell help. As expected, this migration was dependant on inflammation and dermal vascular
induction of E and P selectin, since CD8 Tem cells from fucosyl transferase IV/VII -/- mice (which
lack E and P selectin ligands) did not efficiently enter infected skin. Thus, innate immune inflam-
mation of skin, but not CD4 T cell help, was required for acute recruitment of CD8 VACV specific
T cells. Finally, we asked if the absence of CD4+ T cells could impair the long term memory response
to subsequent VACV skin infection by tissue resident (Trm) viral specific CD8 Tem. Challenge of
previously infected mice 60 days after primary infection demonstrated that virus could still be cleared
from the skin of CD4-/- mice, but that this viral clearance was less efficient in these CD8 T cell defi-
cient mice. Therefore, CD4 cells appear to influence the persistence of CD8 Trm cells in skin over
time, but not their acute recruitment to infected skin.
606
Intradermal immunization triggers epidermal langerhans-cell mobilization required For CD8
T-cell immune responses
C Liard,1 S Menier,2 A Joulin-Giet,1 A Vogt,3 O Bonduelle,1 S Hadam,3 D Duffy,1 B Verrier2 and
B Combadiere1 1 Infection and Immunity, INSERM U945, Paris, France, 2 Institut de Biologie
et de Chimie des Proteines, CNRS UMR5086, Lyon, France and 3 Clinical Research Center for
Hair and Skin Science, Charité, Berlin, Germany
The skin constitutes a unique immunological environment endowed with specific resident and infil-
trating antigen presenting cells (APCs) such as Langerhans cells (LCs) in the epidermis and dermal
dendritic cells (DDCs) in the dermis. In particular, the availability of functionally active APCs at the
site of vaccine inoculation is crucial for the optimal presentation of vaccine-derived antigens to the
immune system. The potential of the immune system of the skin for the generation of both power-
ful humoral and cellular immune responses is now well established. However, the mechanisms
responsible for the efficacy of skin vaccination still remain to be elucidated. We have previously
demonstrated that preferential LC targeting by transcutaneous (TC) immunization shapes immune
responses toward vaccine-specific CD8 T cells in human clinical trials; while others have shown
that intradermal (ID) inoculation of antigens to exploit high densities of dermal Antigen Presenting
Cells (APCs) mobilizes both the cellular and humoral arms. Here, we investigated the participation
of epidermal LCs in the response to ID immunization. When human or mouse skin was injected ID
with a particle-based vaccine, we observed significant modifications in the morphology of LCs in
the epidermis and their mobilization to the dermis. We further established that this LC recruitment
was essential for the induction of antigen-specific CD8 T cells after ID administration, but was
however dispensable for the generation of specific CD4 T cells and neutralizing antibodies. Thus,
epidermal and dermal APCs shape the outcome of immune responses to ID vaccine delivery. Their
combined potential provides new avenues for the development of vaccination strategies against
infectious diseases.
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IL-9 is a potent mediator of tumor immunity, and its expression is negatively regulated by the
Th17 transcription factor RORγ
R Purwar,1 S Xiao,1 Y Takeda,2 W Elyaman,1 X Jiang,1 A Jetten,2 S Khoury,1 R Fuhlbrigge,1
V Kuchroo1 and T Kupper1 1 Dermatology, Brigham and Women’s Hospital,, Boston, MA and
2 NIH/NIEHS, Triangle Park, NC
Cytokines binding to receptors containing a common γ chain, such as IL-2, IL-7, IL-15, and IL-21,
enhance T cell growth and have been used clinically in cancer patients to enhance tumor immu-
nity. IL-9 is a cytokine that also binds to a receptor containing this common γ chain, but its role in
tumor immunity has not been explored. Using a subcutaneous injection of B16 melanoma cells,
we found that tumors grew much more rapidly in IL-9-/- mice than in control mice. Daily admin-
istration of rIL-9 to mice with B16 tumors dramatically reduced tumor growth, while administration
of a blocking antibody to IL-9 enhanced tumor growth. We next polarized T cells under conditions
favoring Th1, Th2, Th9, and Th17 cells, and found that Th9 polarized cells were superior at inhibit-
ing tumor growth after adoptive transfer. Th9 cells enhanced proliferation of CD8 tumor specific T
cells, and also had direct cytotoxic effects on B16 cells in vitro. IL-9 itself did not inhibit B16
growth in vitro. RORγ is a transcription factor important for Th17 cell development. Transcriptional
profiling experiments done in RORγ deficient mouse T cells had demonstrated that upon activation,
IL-23R and IL-17 were strongly downregulated, but IL-9 was strongly upregulated, a novel finding.
We therefore explored tumor immunity in RORγ -/- mice, and found a dramatic decrease in tumor
growth, which could be reversed significantly by administration of blocking antibodies to IL-9, sug-
gesting a prominent role for this cytokine in tumor growth suppression. Additional studies showed
that IL-23R-/- mice showed enhanced tumor immunity, and this could be abrogated significantly
by the administration of anti-IL-9 antibody. We conclude that IL-9 strongly enhances tumor immu-
nity, and is negatively regulated by RORγ, a previously unappreciated role for this transcription fac-
tor. Moreover, genes positively regulated by RORγ, such as IL-23R and IL-17, are associated with
reduced tumor immunity.
596
Correlation of intra- and extraepidermal CD8 T cell numbers with development of psoriatic
epidermal pathology
A Navarini,1 G Tonel1 and C Conrad1,2 1 Department of Dermatology, University Hospital
Zurich, Zurich, Switzerland and 2 Department of Dermatology, University Hospital Lausanne,
Lausanne, Switzerland
The development of psoriatic plaques is T cell dependent. Recently, Th17 CD4 T cells have been
proposed to be the main effector cells. However, development of psoriasis is critically dependent
on accumulation of epidermal T cells, among the majority express CD8. Here we show that num-
bers of epidermal CD8 T cells correlated with development of psoriasis in human biopsies, and that
blockade of CD8 T cells by depleting antibodies inhibited development of psoriasis in the AGR xeno-
transplantation mouse model. In human dermis, both CD4 and CD8 T cell numbers correlated sig-
nificantly with epidermal pathology, indicating a role for dermal CD4 T cells in orchestrating the
development of psoriasiform changes induced by epidermis-infiltrating CD8 T cells.
597
Tissue-based cytokine immunotherapy for skin cancer
M Lokuta, A Comer, B Soto, M Vander Zanden, M Bucholtz and L Allen-Hoffmann Stratatech
Corp., Madison, WI
Annually, more than 1 million cases of non-melanoma skin cancer and more than 68,000 new cases
of melanoma are diagnosed in the US. Approximately 10% of primary or recurrent non-melanoma
skin cancers present as complex, perineural, or locally-invasive tumors which are difficult to man-
age by surgery alone. Tumor resection using Mohs’ surgery frequently results in a large wound that
requires adjunctive therapy to expedite wound healing. Tumor recurrence near the primary tumor
following surgical excision remains the predominant cause of treatment failure and is often associ-
ated with a poor prognosis. Interleukin-12 (IL-12) is one of the most promising cytokines for tumor
immunotherapy due to its potent anti-tumor activity, ability to synergize with other cytokines, and
role in stimulating both innate and adaptive tumor responses. It is likely that sustained local expres-
sion of IL-12 will facilitate the clearance of residual local tumor cells which were not removed sur-
gically. This project is aimed at developing a bio-engineered tissue therapeutic that will prevent the
spread or recurrence of locally-invasive or complex skin cancers through the sustained, local expres-
sion of IL-12 at the site of a recently resected tumor. We have generated an IL-12 fusion construct
and generated a panel of stably-transfected NIKS keratinocyte clones (NIKSIL-12) stably expressing
and secreting a wide range of IL-12 concentrations, as detected by RT-PCR, Western blot, and ELISA.
Skin tissues generated using these clones exhibit appropriate epidermal differentiation. In addition,
exogenous expression of IL-12 in NIKS keratinocytes does not adversely affect tissue architecture,
barrier function, or cellular viability. We have shown that the IL-12 produced by the skin tissues
can induce PHA-activated human T lymphoblast proliferation. Taken together, these results demon-
strate the feasibility of using bio-engineered skin tissue to provide local, sustained expression of
bioactive IL-12 at the site of a recently-resected skin tumor.
598
Ifng pathway signature dominates the gene expression profile of C3H/HeJ mouse model of
alopecia areata
S Harel,1 C Higgins,1 L Petukhova,1,2 JP Sundberg,3 RA Clynes4 and AM Christiano1,5 1
Dermatology, Columbia University, New York, NY, 2 Epidemiology, Columbia University, New
York, NY, 3 The Jackson Laboratory, Bar Harbor, ME, 4 Medicine, Columbia University, New
York, NY and 5 Genetics and Development, Columbia University, New York, NY
Alopecia Areata (AA) is among the most prevalent human autoimmune diseases and leads to dis-
figuring, yet reversible, hair loss which results from autoimmunity against the hair follicle. Evidence
for a genetic basis for AA includes our previous linkage and genome-wide association studies (GWAS).
C3H/HeJ mice develop spontaneous hair loss that shows clinical, histopathological and immuno-
logical features of human AA, thus providing a robust animal model for the disease. To corroborate
results of previous linkage studies in C3H/HeJ mice and our GWAS, we analyzed the gene expres-
sion profile of alopecic skin from C3H/HeJ mice. The expression signature of alopecic C3H skin was
determined from unaffected and affected age-matched mice which develop the disease sponta-
neously. Total RNA was isolated from whole skin, and hybridized to the Affymetrix Mouse 430 2.0
Genechip. Using Genespring, we obtained 485 transcripts that were significantly (p≤0.05) and dif-
ferentially regulated (≥2X). Unexpectedly, our gene profiling experiments provided striking evidence
for the Ifng response in AA, in that 16 of the top 20 induced genes, including the chemokines
Cxcl9/10/11, were known to be IFN-response genes. This signature is likely due to Ifng since Type
I interferons were not induced in AA skin. We independently validated this finding by utilizing an
interferon signaling and response qPCR array (StellarrayTM). Genes including Icos, Tap2 and Ifng
were upregulated in alopecic mice and reside within chromosomal regions significantly associated
with AA in our GWAS. These findings support previous studies demonstrating that Ifng null mice
are resistant to development of AA in a transplantation model. We have uncovered a striking Ifng
signature in C3H/HeJ mice, allowing us to further investigate the mechanisms of Ifng response acti-
vation in AA.
599
Evaluation of the NF kappa B pathway in a mouse model of psoriasis
B Poligone,1 K Gillespie,1 S Toth1 and S Ghosh2 1 Dermatology, University of Rochester,
Rochester, NY and 2 Microbiology and Immunology, Columbia University, New York, NY
We have evaluated the importance of the NF kappa B pathway in the K14-VEGF mouse model of
psoriasis. Through our studies, we have discovered that there appears to be two stages of psoriasis
and NF kappa B is important in one. In light of the recent data on the genetic pathways important
in human psoriasis, our findings likely have importance in both the pathogenesis and treatment
potential of the human disease. We have identified a defect in an NF kappa B related protein in our
mice may also be important in the human disease.
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Psoriatic patients show enhanced cathelicidin expression after injury and this is normalized
by TNF-α inhibition
J Miller, T Hata, P Kotol, M Jackson, D Alexandrescu, F Kabigting, M Gerber, Y Lai and R Gallo
Medicine, UC San Diego, La Jolla, CA
Cathelicidin and TLR9 interactions have been hypothesized to be pathogenic in the etiology of Pso-
riasis (PS). TNF-alpha inhibition is a therapy for moderate to severe PS. We sought to examine the
innate immune response in PS patients as measured by cathelicidin (CAMP) and TLR9 mRNA to
determine if the response of these genes is abnormal and if this is mediated by TNF-alpha. 5 PS
patients had a baseline visit (V1a) with 2mm biopsies of lesional and uninvolved skin. After 6
weeks of TNF-α inhibition by etanercept (ET), these patients underwent repeat 2mm biopsies (V1b).
3 to 5 days later (V2), each patient underwent a 4mm biopsy directly over the healing 2mm biopsy
site to assess changes in TLR9 and CAMP induced by the prior 2mm biopsy. V1b and V2 were also
completed by 10 healthy patients and 8 PS patients not on ET. After wounding, median TLR9 mRNA
expression increased 64.8 fold (p<0.05) in healthy patients but much less (4.9 fold, p=0.0547) in
non-lesional PS . Median CAMP mRNA expression increased 8.2 fold (p<0.05) in healthy patients.
In non-lesional PS, median CAMP increased much more (30.0 fold, p<0.05) but only 16.2 fold
(p=0.095) in non-lesional PS on ET. ET therapy decreased baseline lesional CAMP expression by
50% (p=0.73). The robust CAMP induction seen in non-lesional PS skin may be pathogenic in PS
as the product of CAMP, LL-37, enhances recognition of self-DNA by TLR9. ET’s ability to blunt this
response may be a mechanism by which it is therapeutic in PS patients. In addition, after 6 weeks
of ET therapy, lesional PS skin showed a 50% decrease in CAMP levels but retained the ability to
induce CAMP. Together, these data suggest that: 1) PS patients mount an excessive cathelicidin
response that may contribute to the disease pathogenesis, and 2) ET can normalize the excessive
cathelicidin response in PS patients while still maintaining the capacity to mount an innate immune
defense.
615
Regulation of TSLP expression in the skin by the inflammasome and its impact on T cell fate
S Schuepbach-Mallepell,1 V Philippe,1 S Roques1 and O Gaide1,2 1 Dept of Dermatology-
Venereology, Geneva University Hospital, Geneva, Switzerland and 2 Harvard Skin Disease
Research Center, Harvard Institute of Medicine, Boston, MA
Contact and atopic dermatitis are clinical situations that critically depend on the interplay of innate
and adaptive immunity. The inflammasome controls an IL-1β dependent cytokine cascade that drives
T cell priming in contact dermatitis. Very recently, it has also been proposed to control the activa-
tion of TSLP, a key mediator of atopic dermatitis and asthma. We have initiated a study of the activ-
ity of the inflamamsome on TSLP expression in vitro (mouse and human cells) and in vivo (mice) in
the context of a model of experimental atopy (dibutylphtalate fluorescein isothiocyanate model).
We provide compelling in that, in the skin, inflammasome activation is not required for DBP-FITC
mediated Th2 response or TSLP induction. In fact, we found that inflammasome activation blocks
the induction of TSLP in vitro and in vivo, in an IL-1R dependent manner. Finally, we show that sol-
vents can influence the activation of IL-1β and TSLP in the skin, thus directing T cell fate to a given
hapten (di-nitro-thiocyano-benzene). Taken together, our data strongly suggest that Th1 vs Th2 cell
fate decision is regulated at multiple levels and starts with innate immune events within peripheral
epithelial tissues.
617
Neutrophils express IL-17 and form extracellular traps in cutaneous lupus erythematosus
R Khandpur,1 AM Lin,1 CJ Rubin,1 ML Riblett,1 S Yalavarthi,2 EC Villanueva,2 MJ Kaplan2 and
AT Bruce1 1 Department of Dermatology, University of Michigan, Ann Arbor, MI and 2
Division of Rheumatology, University of Michigan, Ann Arbor, MI
Recent studies have shown that stimulated neutrophils form extracellular traps (NETs) that function
to bind and kill microbes and play a significant role in autoimmune diseases, such as small vessel
vasculitis and lupus nephritis. The cytokine IL-17 has also been implicated in the immunopatho-
genesis of autoimmune diseases, such as psoriasis and systemic lupus erythematosus (LE). The pur-
pose of our study was to investigate the presence and distribution of NETs and IL-17 in cutaneous
LE. We performed dual color immunofluorescence for IL-17 and myeloperoxidase with DAPI coun-
terstain for nucleic acid on biopsies from skin affected by several types of LE (n=11). No neutrophil
infiltration was observed in skin biopsies from 10 healthy control individuals. We found that all types
of cutaneous LE, including discoid LE, subacute cutaneous LE, systemic LE, and LE panniculitis,
were infiltrated with numerous neutrophils, many of which had formed NETs. Anatomically, NETs
were enriched near the dermal-epidermal junction, in perivascular and periadnexal locations in
the papillary and reticular dermis, and in lobular adipose tissue. Overall, 7.0% of all neutrophils in
the epidermis, 24.3% of neutrophils in the papillary dermis and 25.4% of neutrophils in the retic-
ular dermis and subcutis (p<0.05% for reticular vs epidermal neutrophils) had formed NETs. Intact
neutrophils located within dermal blood vessels and in the dermal interstitium stained brightly with
IL-17, whereas NETs rarely contained IL-17. In total, 51.7% of IL-17-expressing cells in LE skin were
neutrophils, and 22.3% of all neutrophils contained IL-17. While the precise temporal events sur-
rounding neutrophil extravasation, migration, and NETosis in cutaneous LE require further study,
our observations are consistent with a model where intact neutrophils exit dermal blood vessels and
undergo NETosis, releasing IL-17 in the process.
616
Viral envelopes induce mast cell degranulation through sphingosine 1-phosphate receptor-2
pathway
Z Wang and A Di Nardo University of California San Diego, La Jolla, CA
We previously reported that mast cells (MCs) degranulation and cathelicidin release are responsi-
ble for mast cell activity against vaccinia virus. However, the mechanism used by MCs to degran-
ulate in response to enveloped viruses is still under investigation. Because viral penetration is not
required for mast cell degranulation, we hypothesized that the envelope component of the vac-
cinia virus (VV) was necessary and sufficient to induce mast cell response to viruses; specifically,
we focused on membrane related lipid pathway activation. When a lipid micelle fuses with the mast
cell membranes, this leads to a chain of events, which includes the formation of sphingosine-1-
phosphate (S1P) that activates the S1P receptor 2 (S1PR2) to stimulate degranulation. To verify that
this is the exact pathway involved in mast cell-vaccinia virus degranulation, we added JTE013 for
blocking S1PR2, specifically. We show that MCs treated with JTE013 failed to degranulate in response
to VV; moreover, they were more susceptible to virus-induced cell death and exhibited a higher viral
load. Because the use of JTE013 at the required blocking concentration may raise the question of
the specificity of its effects, we also challenged S1PR2-/- mice bone marrow derived MCs with VV.
These cells were much more prone to viral infection. These data demonstrate that mast cell inter-
action with virus is mediated by viral lipid envelope; and the lipid envelope, loaded on the cell
membrane, generates a response that triggers degranulation. This observation also further proves
that mast cell capacity to kill viruses is strictly connected to their degranulation and that the pri-
mary response involves a membrane pathway of degranulation.
614
Ultraviolet damage to non-coding RNA triggers skin inflammation
JJ Bernard, C Cowing-Zitron, T Nakatsuji, BD Yu and RL Gallo Dermatology, University of
California, San Diego, San Diego, CA
Ultraviolet B (UVB) induces DNA damage and triggers cytokine release, but the mechanism by
which UV initiates inflammation is unknown. We previously demonstrated that keratinocytes treated
with UVB (UV-kers), when added to cultures of normal human keratinocytes (NHEK), activated
toll-like receptor 3 (TLR3) (Lai et al. Nat Med 2009 (12):1377-82). Based on the activation of TLR3,
we hypothesized a unique nucleic acid resulted from UV exposure. To test this, UV-kers, or unir-
radiated sonicated keratinocytes (control), were added to NHEKs and cytokine response measured.
UV-kers increased NHEK TNF-α and IL-6 mRNA (12-fold and 6-fold, p<.001) as measured by qPCR
and increased TNF-α and IL-6 protein ca. 10-fold (p<.001) as measured by ELISA, but treatment
with control had no effect. Pre-treatment of UV-kers with RNase inhibited this activity, thus the trig-
ger induced by UVB was likely to be an RNA species. To identify this RNA, UV-kers or controls
were subjected to whole-transcriptome sequencing through RNA-Seq analysis. RNA-Seq identified
that after UVB treatment the non-coding small nuclear (sn) RNA U1 underwent major changes in
sequence reads at specific sites, thus suggesting U1 to be altered by UVB. U1 was then confirmed
to be pro-inflammatory since pure synthetic U1 RNA after UVB exposure, but not unirradiated U1,
induced NF-κB activation and TNF-α and IL-6 in NHEKs and PBMCs. This was also confirmed in
vivo as U1 injected into wild-type C57BL/6 mice induced inflammation in skin. Furthermore,
TLR3-/- or TRIF-/- mice could not respond to injected U1 and these knock-out mice also had 125-
fold less cutaneous TNF-α after irradiation with 5 kJ/m2 UVB when compared to wild-type controls
mice (p<.01). Finally, the domains of U1 identified by RNA-Seq were shown to be the inflamma-
tory stimuli as synthetic oligonucleotides based on theses sequences were active when added to
cultured cells. These findings establish UV damage to U1 snRNA, and subsequent recognition by
TLR3, as fundamental elements of the UV inflammatory response.
618
Staphylococcus aureus infection in mouse skin induces antimicrobial peptide expression –
the effect is partially regulated by IL-1
K Ahrens,1 JS Cho,2 J Harder,1 LS Miller2 and E Proksch1 1 Department of Dermatology,
University of Kiel, Germany, Kiel, Germany and 2 Division of Dermatology, David Geffen
School of Medicine at UCLA, Los Angeles, Los Angeles, CA
Staphylococcus aureus is the most common cause of skin infections, such as impetigo, cellulitis,
folliculitis/furunculosis, and abscesses. A major cutaneous defense mechanism against S. aureus is
induction of antimicrobial peptides (AMPs). We examined 1) whether skin infection by S. aureus in
vivo promoted expression of AMPs that have microbicidal activity against S. aureus and 2) whether
the expression of AMPs is regulated by IL-1. Scalpel cuts of the back skin of wildtype or IL-1R-defi-
cient mice were inoculated with S. aureus or PBS (control) and mRNA and protein expression of
mBD-1, mBD-3, mBD-14 and CRAMP was determined by QPCR and by immuno-histochemistry
at 6 and 24 hours after infection. mRNA expression of mBD-3 and CRAMP, but not mBD-1 and
mBD-14, was increased after S. aureus infection at 6 and 24 hours after infection. Immunohistol-
ogy revealed a slight increase in mBD-1 and a moderate to strong increase in mBD-3, mBD-14 and
CRAMP protein expression at 24 hours after infection. In IL-1R-deficient mice the increased mRNA
expression of CRAMP was slightly reduced compared to wild type mice. In IL-1R-deficient mice
the protein expression of mBD-3 and mBD-14 was reduced whereas the expression of mBD-1 and
CRAMP expression was similar to wild type mice. In summary, these data demonstrate a mecha-
nism by which S. aureus skin infection induces mBD-3, mBD-14 and CRAMP expression and the
expression of mBD-3 and mBD-14 but not CRAMP is regulated by IL-1.
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Interaction of regulatory T cells and tolerogenic CD11c+ dendritic cells prevents contact
allergy in mice
U Luckey,1 N Pfender,2 N Lorenz,1 T Schmidt,1 SM Martin,2 T Jakob2 and K Steinbrink1 1
Department of Dermatology, University Medical Center Mainz, Mainz, Germany and 2
Department of Dermatology, University of Freiburg, Freiburg, Germany
Tolerance induction by repeated low dose contact allergen exposure, i.e. low zone tolerance (LZT)
is a main protective mechanism in those who do not develop allergies. In LZT, hapten-specific CD8+
suppressor T cells are generated that prevent the development of contact hypersensitivity (CHS). In
this study, we analyzed the role and function of naturally occurring CD4+CD25+FOXP3+ regula-
tory T cells (nTregs) in LZT. We demonstrated that depletion of nTregs during tolerization (by use of
anti-CD25-Ab, DEREG mice, cyclophosphamide) completely abolished the development of LZT
resulting in a pronounced CHS response (significant ear swelling, hapten-specific T cell prolifera-
tion, Tc1 cytokine pattern). IL-10 is critically required for the suppressor activity of Tregs. Depletion
of CD11+ DC and adoptive transfers of CD11c+ DC revealed that tolerogenic CD11c+ DC located
in the lymph nodes were also essential for LZT. Notably, in the absence of Tregs, the tolerogenic
phenotype of CD11c+ DC was completely abrogated, indicating a pivotal interaction of activated
Tregs with lymph node CD11c+ DC mediated by IL-10. Subsequently, induction of tolerogenic
CD11c+ DC allowed for the generation of hapten-specific CD8+ suppressor T cells which protect
from CHS. Our data demonstrate a consecutive activation of regulatory T cell subsets and tolero-
genic DC during the course of LZT induction as important modulators in the network of allergic T
cell-related immune responses.
608
IL-37 suppresses contact hypersensitivity by inhibiting maturation of dendritic cells
X Cai,1,2 Y Luo,1 CA Nold-Petry,3 MF Nold,3 P Bufler,4 CA Dinarello3 and M Fujita1 1 Dermatology,
University of Colorado Denver, Aurora, CO, 2 Plastic and Reconstruct Surgery, The First
Affiliated Hospital of Shantou University Medical College, Shantou, China, 3 Medicine,
University of Colorado Denver, Aurora, CO and 4 Children’s Hospital, Ludwig-Maximilians
University, Munich, Germany
The interleukin-1 family member IL-37 is a novel inhibitor of innate inflammatory and immune
responses. In human PBMC, a pro-inflammatory milieu induces IL-37, which in turn suppresses pro-
inflammatory but not anti-inflammatory cytokines. Here we used a strain of transgenic mice express-
ing human IL-37 (IL-37 Tg). The efficient development of contact hypersensitivity (CHS) requires
activation of the adaptive and innate immune systems. We investigated the possible involvement of
IL-37 in IL-37 Tg mice subjected to CHS. We compared CHS responses to DNFB using wild-type
(WT) and IL-37 Tg mice. Not expressed in the resting state, IL-37 was induced in the skin of IL-37
Tg mice 6 hours following application of DNFB. There was marked impairment of CHS to hapten
challenge in IL-37 Tg mice compared to WT mice. The distribution, phagocytotic activity and migra-
tion of skin dendritic cells (DCs) to regional lymph nodes in IL-37 Tg mice were comparable to those
from WT mice. However, the expected increase in costimulatory molecules of DCs (skin DCs, splenic
DCs and bone-marrow-derived DCs) was impaired in IL-37 Tg mice during in vitro and in vivo mat-
uration. Moreover, the induction of TNFα and IL-1β, the major pro-inflammatory cytokines secreted
by mature DCs, was decreased (47.8% in TNFα and 33.3% in IL-1β) in DCs from IL-37 Tg mice.
Consistent with these data, DCs from IL-37 Tg mice exhibited decreased ability to stimulate naïve
T cells and hapten-sensitized T cells. These findings provide evidence that induction of IL-37 in
DCs impairs their maturation, thereby suppressing activation of T effector responses. IL-37 thus
emerges as an inhibitor of adaptive immunity.
609
Proteasome inhibition with bortezomib suppresses T cell proliferation in a CTLA-4-depend-
ent manner
H Gibson,1,2 T Hake,2 P Porcu2 and H Wong2 1 Immunology and Microbiology, Wayne State
University, Detroit, MI and 2 Comprehensive Cancer Center, Ohio State University, Columbus,
OH
Cytotoxic T-lymphocyte antigen 4 (CTLA-4) is a costimulatory molecule that functions as an
immunomodulator generally associated with suppression of T cell proliferation. Though struc-
turally similar to CD28, which is expressed constitutively on T cells, transcription of CTLA-4 is highly
regulated and is inducible in effector CD4 T cells. We show treatment of CD4 T cells in vitro with
the proteasome inhibitor bortezomib results in a dose-dependent increase in surface CTLA-4 expres-
sion upon stimulation with PMA/A23187 and the increased CTLA-4 is measurable at the transcrip-
tional level. The increase in CTLA-4 on the surface of bortezomib-treated cells persists through 72
hrs, while untreated cells lose expression within 24hrs in culture. To test whether the bortezomib-
induced elevated CTLA-4 has a functional impact on cell proliferation, we measured growth of CD4
T cells pre-stimulated and either treated or untreated with 10uM bortezomib for 9hrs and mixed
with mytomycin C-fixed allogenic PBMCs. We find bortezomib suppresses proliferation when
compared to stimulation alone. Blockade of CTLA-4 with a specific antibody restores proliferation
when compared to an IgG control. This work provides insight into potential effects on T cell func-
tion from proteasome inhibition with bortezomib. Bortezomib’s effects may suggest its use as an
immunosuppressant in T cell-mediated inflammatory diseases and explain its effectiveness in graft
versus host disease (GVHD).
610
Treatment of nascent melanoma with anti-CTLA-4 and anti-PLD-1 promotes tumor growth
and expansion of regulatory T cells
B Srivastava,1 W Damsky,1 M Bosenberg1 and S Kaech2 1 Dermatology, Yale School of Medicine,
New Haven, CT and 2 Immunobiology, Yale School of Medicine, New Haven, CT
Blockade of molecules that inhibit T-cell activation is a promising therapy for advanced melanoma.
Using an inducible mouse model of melanoma produced by activating mutations in Braf and loss
of Pten, we demonstrate that combined blockade of the CTLA-4 and PD-1 pathways early after tumor
induction paradoxically promotes tumor growth. This effect is associated with expansion of tumor-
infiltrating CD4+ Foxp3+ regulatory T cells that express high levels of PD-1. In contrast, prelimi-
nary data suggests that the same therapy in mice with established melanomas slows tumor growth
and is predominantly associated with activation of tumor-infiltrating CD8 T cells. These data indi-
cate that the stage of tumor growth is a critical determinant of response to CTLA-4 and PD-1 block-
ade, and imply that blockade of costimulatory molecules might be harmful in certain clinical set-
tings.
611
Autoantibody to HSC70 in patients with tumor stage of mycosis fungoides
OE Akilov,1 PE Yeh,1 B Hood,2 TP Conrads,2 LD Falo1 and LJ Geskin1 1 Dermatology, University
of Pittsburgh, Pittsburgh, PA and 2 Cancer Biomarkers Facility, University of Pittsburgh Cancer
Institute, Pittsburgh, PA
Th2 skewing and increase in IL-4 in advanced cutaneous T-cell lymphoma (CTCL) could be asso-
ciated with autoantibody production. The purpose of the study was to evaluate the serum of advanced
CTCL patients for presence of antibodies towards autologous malignant lymphocytes. Malignant
CD4+CD26- lymphocytes were isolated from patients with tumor stage of mycosis fungoides (MF)
or with Sézary syndrome (SzS). Blood from healthy volunteers served as a control. IgG/IgM immuno-
precipitation of protein lysate from CD4+CD26- lymphocytes and patient serum revealed unique
peptides, which were characterized by liquid chromatography-tandem mass spectrometry (LC-
MS/MS) and identified by SEQUEST against the human proteome database. IHC was performed to
validate expression of discovered proteins in tissue samples. Affymetrix gene expression profile of
malignant lymphocytes from 3 patients with tumor MF vs. CD4+ lymphocytes from 3 healthy vol-
unteer was performed to evaluate the potential role of discovered proteins. We found that patients
with tumors consistently exhibited unique 70kDa proteins, not present in patients with SzS or in
healthy controls. LC-MS/MS identified heat shock cognate 71 kDa protein (HSC70), which were
immunogenic only in patients with tumors. HSC70 was overexpressed in 3/5 skin biopsies from
tumor MF and was down-regulated in 4/5 skin biopsies of patients with SzS. Ex vivo, we have demon-
strated that malignant lymphocyte are resistant to TNF-α-induced apoptosis. Analysis of gene expres-
sion profile confirmed that HSC70 appeared to interfere with several different steps in apoptosis by
increasing Bcl-2 expression and interfering with Apaf-1 and preventing recruitment of pro-caspase-
9 into the apoptosome. In conclusion, we found unique subset of antibodies to HSC70 in tumor
stage MF, but not other subsets of patients. HSC70 could present a potential therapeutic target in
patients with tumor stage MF, since neutralization of HSC70 may provide pro-apoptotic effect on
malignant lymphocytes.
612
Characterization of a novel skin resident IL-10 producing regulatory dendritic cell subset
C Chu,1 P Di Meglio,1 A Skowera,2 N Ali,1,3 K Grys,1 L Napolitano,1 M Peakman,2 G Lombardi3
and FO Nestle1 1 St. John’s Institute of Dermatology, King’s College London and NIHR
Biomedical Research Centre, London, United Kingdom, 2 Department of Immunobiology,
King’s College London and NIHR Biomedical Research Centre, London, United Kingdom and
3 Department of Nephrology and Transplantation, King’s College London and MRC Centre for
Transplantation, London, United Kingdom
Healthy human skin harbors a complex network of dendritic cells (DCs) which regulate skin immune
responses and are implicated in the pathogenesis of inflammatory skin diseases, such as psoriasis.
Subsets of skin DCs have been characterized previously based on certain phenotypic and functional
features. We have identified a distinct population of CD141+ DCs residing in the dermis of human
skin and exhibiting regulatory features. Dermal CD141+ DCs co-expressed CD1c at low levels,
CD11c, and CD14, and had a dendritic morphology. They possessed migratory capacity in vitro and
in vivo whilst maintaining an immature phenotype. Ex vivo isolated dermal CD141+ DCs sponta-
neously produced high levels of IL-10 and showed a reduced capacity to stimulate T cell prolifer-
ation. Nevertheless, CD4+ T cells stimulated by dermal CD141+ DCs displayed elevated levels of
CTLA-4 and were unresponsive to secondary alloantigen re-stimulation compared to T cells stimu-
lated by dermal CD1c+ DCs. Dermal CD141+ DCs expressed a gene profile that resembled mouse
CD8α+ DCs and were able to cross-present autoantigens to CD8+ T cells. In psoriatic lesions, a
reduced CD141+ DC/CD3+ T cell ratio was observed when compared with normal skin. Our results
reveal a novel subset of skin resident immunoregulatory CD141+ DC which may be essential for
the maintenance of skin homeostasis, potentially through the induction of cross-tolerance under
steady-state conditions. Dysregulation of this cell type might contribute to inflammatory skin patholo-
gies such as psoriasis.
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Psoriatic patients show enhanced cathelicidin expression after injury and this is normalized
by TNF-α inhibition
J Miller, T Hata, P Kotol, M Jackson, D Alexandrescu, F Kabigting, M Gerber, Y Lai and R Gallo
Medicine, UC San Diego, La Jolla, CA
Cathelicidin and TLR9 interactions have been hypothesized to be pathogenic in the etiology of Pso-
riasis (PS). TNF-alpha inhibition is a therapy for moderate to severe PS. We sought to examine the
innate immune response in PS patients as measured by cathelicidin (CAMP) and TLR9 mRNA to
determine if the response of these genes is abnormal and if this is mediated by TNF-alpha. 5 PS
patients had a baseline visit (V1a) with 2mm biopsies of lesional and uninvolved skin. After 6
weeks of TNF-α inhibition by etanercept (ET), these patients underwent repeat 2mm biopsies (V1b).
3 to 5 days later (V2), each patient underwent a 4mm biopsy directly over the healing 2mm biopsy
site to assess changes in TLR9 and CAMP induced by the prior 2mm biopsy. V1b and V2 were also
completed by 10 healthy patients and 8 PS patients not on ET. After wounding, median TLR9 mRNA
expression increased 64.8 fold (p<0.05) in healthy patients but much less (4.9 fold, p=0.0547) in
non-lesional PS . Median CAMP mRNA expression increased 8.2 fold (p<0.05) in healthy patients.
In non-lesional PS, median CAMP increased much more (30.0 fold, p<0.05) but only 16.2 fold
(p=0.095) in non-lesional PS on ET. ET therapy decreased baseline lesional CAMP expression by
50% (p=0.73). The robust CAMP induction seen in non-lesional PS skin may be pathogenic in PS
as the product of CAMP, LL-37, enhances recognition of self-DNA by TLR9. ET’s ability to blunt this
response may be a mechanism by which it is therapeutic in PS patients. In addition, after 6 weeks
of ET therapy, lesional PS skin showed a 50% decrease in CAMP levels but retained the ability to
induce CAMP. Together, these data suggest that: 1) PS patients mount an excessive cathelicidin
response that may contribute to the disease pathogenesis, and 2) ET can normalize the excessive
cathelicidin response in PS patients while still maintaining the capacity to mount an innate immune
defense.
615
Regulation of TSLP expression in the skin by the inflammasome and its impact on T cell fate
S Schuepbach-Mallepell,1 V Philippe,1 S Roques1 and O Gaide1,2 1 Dept of Dermatology-
Venereology, Geneva University Hospital, Geneva, Switzerland and 2 Harvard Skin Disease
Research Center, Harvard Institute of Medicine, Boston, MA
Contact and atopic dermatitis are clinical situations that critically depend on the interplay of innate
and adaptive immunity. The inflammasome controls an IL-1β dependent cytokine cascade that drives
T cell priming in contact dermatitis. Very recently, it has also been proposed to control the activa-
tion of TSLP, a key mediator of atopic dermatitis and asthma. We have initiated a study of the activ-
ity of the inflamamsome on TSLP expression in vitro (mouse and human cells) and in vivo (mice) in
the context of a model of experimental atopy (dibutylphtalate fluorescein isothiocyanate model).
We provide compelling in that, in the skin, inflammasome activation is not required for DBP-FITC
mediated Th2 response or TSLP induction. In fact, we found that inflammasome activation blocks
the induction of TSLP in vitro and in vivo, in an IL-1R dependent manner. Finally, we show that sol-
vents can influence the activation of IL-1β and TSLP in the skin, thus directing T cell fate to a given
hapten (di-nitro-thiocyano-benzene). Taken together, our data strongly suggest that Th1 vs Th2 cell
fate decision is regulated at multiple levels and starts with innate immune events within peripheral
epithelial tissues.
617
Neutrophils express IL-17 and form extracellular traps in cutaneous lupus erythematosus
R Khandpur,1 AM Lin,1 CJ Rubin,1 ML Riblett,1 S Yalavarthi,2 EC Villanueva,2 MJ Kaplan2 and
AT Bruce1 1 Department of Dermatology, University of Michigan, Ann Arbor, MI and 2
Division of Rheumatology, University of Michigan, Ann Arbor, MI
Recent studies have shown that stimulated neutrophils form extracellular traps (NETs) that function
to bind and kill microbes and play a significant role in autoimmune diseases, such as small vessel
vasculitis and lupus nephritis. The cytokine IL-17 has also been implicated in the immunopatho-
genesis of autoimmune diseases, such as psoriasis and systemic lupus erythematosus (LE). The pur-
pose of our study was to investigate the presence and distribution of NETs and IL-17 in cutaneous
LE. We performed dual color immunofluorescence for IL-17 and myeloperoxidase with DAPI coun-
terstain for nucleic acid on biopsies from skin affected by several types of LE (n=11). No neutrophil
infiltration was observed in skin biopsies from 10 healthy control individuals. We found that all types
of cutaneous LE, including discoid LE, subacute cutaneous LE, systemic LE, and LE panniculitis,
were infiltrated with numerous neutrophils, many of which had formed NETs. Anatomically, NETs
were enriched near the dermal-epidermal junction, in perivascular and periadnexal locations in
the papillary and reticular dermis, and in lobular adipose tissue. Overall, 7.0% of all neutrophils in
the epidermis, 24.3% of neutrophils in the papillary dermis and 25.4% of neutrophils in the retic-
ular dermis and subcutis (p<0.05% for reticular vs epidermal neutrophils) had formed NETs. Intact
neutrophils located within dermal blood vessels and in the dermal interstitium stained brightly with
IL-17, whereas NETs rarely contained IL-17. In total, 51.7% of IL-17-expressing cells in LE skin were
neutrophils, and 22.3% of all neutrophils contained IL-17. While the precise temporal events sur-
rounding neutrophil extravasation, migration, and NETosis in cutaneous LE require further study,
our observations are consistent with a model where intact neutrophils exit dermal blood vessels and
undergo NETosis, releasing IL-17 in the process.
616
Viral envelopes induce mast cell degranulation through sphingosine 1-phosphate receptor-2
pathway
Z Wang and A Di Nardo University of California San Diego, La Jolla, CA
We previously reported that mast cells (MCs) degranulation and cathelicidin release are responsi-
ble for mast cell activity against vaccinia virus. However, the mechanism used by MCs to degran-
ulate in response to enveloped viruses is still under investigation. Because viral penetration is not
required for mast cell degranulation, we hypothesized that the envelope component of the vac-
cinia virus (VV) was necessary and sufficient to induce mast cell response to viruses; specifically,
we focused on membrane related lipid pathway activation. When a lipid micelle fuses with the mast
cell membranes, this leads to a chain of events, which includes the formation of sphingosine-1-
phosphate (S1P) that activates the S1P receptor 2 (S1PR2) to stimulate degranulation. To verify that
this is the exact pathway involved in mast cell-vaccinia virus degranulation, we added JTE013 for
blocking S1PR2, specifically. We show that MCs treated with JTE013 failed to degranulate in response
to VV; moreover, they were more susceptible to virus-induced cell death and exhibited a higher viral
load. Because the use of JTE013 at the required blocking concentration may raise the question of
the specificity of its effects, we also challenged S1PR2-/- mice bone marrow derived MCs with VV.
These cells were much more prone to viral infection. These data demonstrate that mast cell inter-
action with virus is mediated by viral lipid envelope; and the lipid envelope, loaded on the cell
membrane, generates a response that triggers degranulation. This observation also further proves
that mast cell capacity to kill viruses is strictly connected to their degranulation and that the pri-
mary response involves a membrane pathway of degranulation.
614
Ultraviolet damage to non-coding RNA triggers skin inflammation
JJ Bernard, C Cowing-Zitron, T Nakatsuji, BD Yu and RL Gallo Dermatology, University of
California, San Diego, San Diego, CA
Ultraviolet B (UVB) induces DNA damage and triggers cytokine release, but the mechanism by
which UV initiates inflammation is unknown. We previously demonstrated that keratinocytes treated
with UVB (UV-kers), when added to cultures of normal human keratinocytes (NHEK), activated
toll-like receptor 3 (TLR3) (Lai et al. Nat Med 2009 (12):1377-82). Based on the activation of TLR3,
we hypothesized a unique nucleic acid resulted from UV exposure. To test this, UV-kers, or unir-
radiated sonicated keratinocytes (control), were added to NHEKs and cytokine response measured.
UV-kers increased NHEK TNF-α and IL-6 mRNA (12-fold and 6-fold, p<.001) as measured by qPCR
and increased TNF-α and IL-6 protein ca. 10-fold (p<.001) as measured by ELISA, but treatment
with control had no effect. Pre-treatment of UV-kers with RNase inhibited this activity, thus the trig-
ger induced by UVB was likely to be an RNA species. To identify this RNA, UV-kers or controls
were subjected to whole-transcriptome sequencing through RNA-Seq analysis. RNA-Seq identified
that after UVB treatment the non-coding small nuclear (sn) RNA U1 underwent major changes in
sequence reads at specific sites, thus suggesting U1 to be altered by UVB. U1 was then confirmed
to be pro-inflammatory since pure synthetic U1 RNA after UVB exposure, but not unirradiated U1,
induced NF-κB activation and TNF-α and IL-6 in NHEKs and PBMCs. This was also confirmed in
vivo as U1 injected into wild-type C57BL/6 mice induced inflammation in skin. Furthermore,
TLR3-/- or TRIF-/- mice could not respond to injected U1 and these knock-out mice also had 125-
fold less cutaneous TNF-α after irradiation with 5 kJ/m2 UVB when compared to wild-type controls
mice (p<.01). Finally, the domains of U1 identified by RNA-Seq were shown to be the inflamma-
tory stimuli as synthetic oligonucleotides based on theses sequences were active when added to
cultured cells. These findings establish UV damage to U1 snRNA, and subsequent recognition by
TLR3, as fundamental elements of the UV inflammatory response.
618
Staphylococcus aureus infection in mouse skin induces antimicrobial peptide expression –
the effect is partially regulated by IL-1
K Ahrens,1 JS Cho,2 J Harder,1 LS Miller2 and E Proksch1 1 Department of Dermatology,
University of Kiel, Germany, Kiel, Germany and 2 Division of Dermatology, David Geffen
School of Medicine at UCLA, Los Angeles, Los Angeles, CA
Staphylococcus aureus is the most common cause of skin infections, such as impetigo, cellulitis,
folliculitis/furunculosis, and abscesses. A major cutaneous defense mechanism against S. aureus is
induction of antimicrobial peptides (AMPs). We examined 1) whether skin infection by S. aureus in
vivo promoted expression of AMPs that have microbicidal activity against S. aureus and 2) whether
the expression of AMPs is regulated by IL-1. Scalpel cuts of the back skin of wildtype or IL-1R-defi-
cient mice were inoculated with S. aureus or PBS (control) and mRNA and protein expression of
mBD-1, mBD-3, mBD-14 and CRAMP was determined by QPCR and by immuno-histochemistry
at 6 and 24 hours after infection. mRNA expression of mBD-3 and CRAMP, but not mBD-1 and
mBD-14, was increased after S. aureus infection at 6 and 24 hours after infection. Immunohistol-
ogy revealed a slight increase in mBD-1 and a moderate to strong increase in mBD-3, mBD-14 and
CRAMP protein expression at 24 hours after infection. In IL-1R-deficient mice the increased mRNA
expression of CRAMP was slightly reduced compared to wild type mice. In IL-1R-deficient mice
the protein expression of mBD-3 and mBD-14 was reduced whereas the expression of mBD-1 and
CRAMP expression was similar to wild type mice. In summary, these data demonstrate a mecha-
nism by which S. aureus skin infection induces mBD-3, mBD-14 and CRAMP expression and the
expression of mBD-3 and mBD-14 but not CRAMP is regulated by IL-1.
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Interaction of regulatory T cells and tolerogenic CD11c+ dendritic cells prevents contact
allergy in mice
U Luckey,1 N Pfender,2 N Lorenz,1 T Schmidt,1 SM Martin,2 T Jakob2 and K Steinbrink1 1
Department of Dermatology, University Medical Center Mainz, Mainz, Germany and 2
Department of Dermatology, University of Freiburg, Freiburg, Germany
Tolerance induction by repeated low dose contact allergen exposure, i.e. low zone tolerance (LZT)
is a main protective mechanism in those who do not develop allergies. In LZT, hapten-specific CD8+
suppressor T cells are generated that prevent the development of contact hypersensitivity (CHS). In
this study, we analyzed the role and function of naturally occurring CD4+CD25+FOXP3+ regula-
tory T cells (nTregs) in LZT. We demonstrated that depletion of nTregs during tolerization (by use of
anti-CD25-Ab, DEREG mice, cyclophosphamide) completely abolished the development of LZT
resulting in a pronounced CHS response (significant ear swelling, hapten-specific T cell prolifera-
tion, Tc1 cytokine pattern). IL-10 is critically required for the suppressor activity of Tregs. Depletion
of CD11+ DC and adoptive transfers of CD11c+ DC revealed that tolerogenic CD11c+ DC located
in the lymph nodes were also essential for LZT. Notably, in the absence of Tregs, the tolerogenic
phenotype of CD11c+ DC was completely abrogated, indicating a pivotal interaction of activated
Tregs with lymph node CD11c+ DC mediated by IL-10. Subsequently, induction of tolerogenic
CD11c+ DC allowed for the generation of hapten-specific CD8+ suppressor T cells which protect
from CHS. Our data demonstrate a consecutive activation of regulatory T cell subsets and tolero-
genic DC during the course of LZT induction as important modulators in the network of allergic T
cell-related immune responses.
608
IL-37 suppresses contact hypersensitivity by inhibiting maturation of dendritic cells
X Cai,1,2 Y Luo,1 CA Nold-Petry,3 MF Nold,3 P Bufler,4 CA Dinarello3 and M Fujita1 1 Dermatology,
University of Colorado Denver, Aurora, CO, 2 Plastic and Reconstruct Surgery, The First
Affiliated Hospital of Shantou University Medical College, Shantou, China, 3 Medicine,
University of Colorado Denver, Aurora, CO and 4 Children’s Hospital, Ludwig-Maximilians
University, Munich, Germany
The interleukin-1 family member IL-37 is a novel inhibitor of innate inflammatory and immune
responses. In human PBMC, a pro-inflammatory milieu induces IL-37, which in turn suppresses pro-
inflammatory but not anti-inflammatory cytokines. Here we used a strain of transgenic mice express-
ing human IL-37 (IL-37 Tg). The efficient development of contact hypersensitivity (CHS) requires
activation of the adaptive and innate immune systems. We investigated the possible involvement of
IL-37 in IL-37 Tg mice subjected to CHS. We compared CHS responses to DNFB using wild-type
(WT) and IL-37 Tg mice. Not expressed in the resting state, IL-37 was induced in the skin of IL-37
Tg mice 6 hours following application of DNFB. There was marked impairment of CHS to hapten
challenge in IL-37 Tg mice compared to WT mice. The distribution, phagocytotic activity and migra-
tion of skin dendritic cells (DCs) to regional lymph nodes in IL-37 Tg mice were comparable to those
from WT mice. However, the expected increase in costimulatory molecules of DCs (skin DCs, splenic
DCs and bone-marrow-derived DCs) was impaired in IL-37 Tg mice during in vitro and in vivo mat-
uration. Moreover, the induction of TNFα and IL-1β, the major pro-inflammatory cytokines secreted
by mature DCs, was decreased (47.8% in TNFα and 33.3% in IL-1β) in DCs from IL-37 Tg mice.
Consistent with these data, DCs from IL-37 Tg mice exhibited decreased ability to stimulate naïve
T cells and hapten-sensitized T cells. These findings provide evidence that induction of IL-37 in
DCs impairs their maturation, thereby suppressing activation of T effector responses. IL-37 thus
emerges as an inhibitor of adaptive immunity.
609
Proteasome inhibition with bortezomib suppresses T cell proliferation in a CTLA-4-depend-
ent manner
H Gibson,1,2 T Hake,2 P Porcu2 and H Wong2 1 Immunology and Microbiology, Wayne State
University, Detroit, MI and 2 Comprehensive Cancer Center, Ohio State University, Columbus,
OH
Cytotoxic T-lymphocyte antigen 4 (CTLA-4) is a costimulatory molecule that functions as an
immunomodulator generally associated with suppression of T cell proliferation. Though struc-
turally similar to CD28, which is expressed constitutively on T cells, transcription of CTLA-4 is highly
regulated and is inducible in effector CD4 T cells. We show treatment of CD4 T cells in vitro with
the proteasome inhibitor bortezomib results in a dose-dependent increase in surface CTLA-4 expres-
sion upon stimulation with PMA/A23187 and the increased CTLA-4 is measurable at the transcrip-
tional level. The increase in CTLA-4 on the surface of bortezomib-treated cells persists through 72
hrs, while untreated cells lose expression within 24hrs in culture. To test whether the bortezomib-
induced elevated CTLA-4 has a functional impact on cell proliferation, we measured growth of CD4
T cells pre-stimulated and either treated or untreated with 10uM bortezomib for 9hrs and mixed
with mytomycin C-fixed allogenic PBMCs. We find bortezomib suppresses proliferation when
compared to stimulation alone. Blockade of CTLA-4 with a specific antibody restores proliferation
when compared to an IgG control. This work provides insight into potential effects on T cell func-
tion from proteasome inhibition with bortezomib. Bortezomib’s effects may suggest its use as an
immunosuppressant in T cell-mediated inflammatory diseases and explain its effectiveness in graft
versus host disease (GVHD).
610
Treatment of nascent melanoma with anti-CTLA-4 and anti-PLD-1 promotes tumor growth
and expansion of regulatory T cells
B Srivastava,1 W Damsky,1 M Bosenberg1 and S Kaech2 1 Dermatology, Yale School of Medicine,
New Haven, CT and 2 Immunobiology, Yale School of Medicine, New Haven, CT
Blockade of molecules that inhibit T-cell activation is a promising therapy for advanced melanoma.
Using an inducible mouse model of melanoma produced by activating mutations in Braf and loss
of Pten, we demonstrate that combined blockade of the CTLA-4 and PD-1 pathways early after tumor
induction paradoxically promotes tumor growth. This effect is associated with expansion of tumor-
infiltrating CD4+ Foxp3+ regulatory T cells that express high levels of PD-1. In contrast, prelimi-
nary data suggests that the same therapy in mice with established melanomas slows tumor growth
and is predominantly associated with activation of tumor-infiltrating CD8 T cells. These data indi-
cate that the stage of tumor growth is a critical determinant of response to CTLA-4 and PD-1 block-
ade, and imply that blockade of costimulatory molecules might be harmful in certain clinical set-
tings.
611
Autoantibody to HSC70 in patients with tumor stage of mycosis fungoides
OE Akilov,1 PE Yeh,1 B Hood,2 TP Conrads,2 LD Falo1 and LJ Geskin1 1 Dermatology, University
of Pittsburgh, Pittsburgh, PA and 2 Cancer Biomarkers Facility, University of Pittsburgh Cancer
Institute, Pittsburgh, PA
Th2 skewing and increase in IL-4 in advanced cutaneous T-cell lymphoma (CTCL) could be asso-
ciated with autoantibody production. The purpose of the study was to evaluate the serum of advanced
CTCL patients for presence of antibodies towards autologous malignant lymphocytes. Malignant
CD4+CD26- lymphocytes were isolated from patients with tumor stage of mycosis fungoides (MF)
or with Sézary syndrome (SzS). Blood from healthy volunteers served as a control. IgG/IgM immuno-
precipitation of protein lysate from CD4+CD26- lymphocytes and patient serum revealed unique
peptides, which were characterized by liquid chromatography-tandem mass spectrometry (LC-
MS/MS) and identified by SEQUEST against the human proteome database. IHC was performed to
validate expression of discovered proteins in tissue samples. Affymetrix gene expression profile of
malignant lymphocytes from 3 patients with tumor MF vs. CD4+ lymphocytes from 3 healthy vol-
unteer was performed to evaluate the potential role of discovered proteins. We found that patients
with tumors consistently exhibited unique 70kDa proteins, not present in patients with SzS or in
healthy controls. LC-MS/MS identified heat shock cognate 71 kDa protein (HSC70), which were
immunogenic only in patients with tumors. HSC70 was overexpressed in 3/5 skin biopsies from
tumor MF and was down-regulated in 4/5 skin biopsies of patients with SzS. Ex vivo, we have demon-
strated that malignant lymphocyte are resistant to TNF-α-induced apoptosis. Analysis of gene expres-
sion profile confirmed that HSC70 appeared to interfere with several different steps in apoptosis by
increasing Bcl-2 expression and interfering with Apaf-1 and preventing recruitment of pro-caspase-
9 into the apoptosome. In conclusion, we found unique subset of antibodies to HSC70 in tumor
stage MF, but not other subsets of patients. HSC70 could present a potential therapeutic target in
patients with tumor stage MF, since neutralization of HSC70 may provide pro-apoptotic effect on
malignant lymphocytes.
612
Characterization of a novel skin resident IL-10 producing regulatory dendritic cell subset
C Chu,1 P Di Meglio,1 A Skowera,2 N Ali,1,3 K Grys,1 L Napolitano,1 M Peakman,2 G Lombardi3
and FO Nestle1 1 St. John’s Institute of Dermatology, King’s College London and NIHR
Biomedical Research Centre, London, United Kingdom, 2 Department of Immunobiology,
King’s College London and NIHR Biomedical Research Centre, London, United Kingdom and
3 Department of Nephrology and Transplantation, King’s College London and MRC Centre for
Transplantation, London, United Kingdom
Healthy human skin harbors a complex network of dendritic cells (DCs) which regulate skin immune
responses and are implicated in the pathogenesis of inflammatory skin diseases, such as psoriasis.
Subsets of skin DCs have been characterized previously based on certain phenotypic and functional
features. We have identified a distinct population of CD141+ DCs residing in the dermis of human
skin and exhibiting regulatory features. Dermal CD141+ DCs co-expressed CD1c at low levels,
CD11c, and CD14, and had a dendritic morphology. They possessed migratory capacity in vitro and
in vivo whilst maintaining an immature phenotype. Ex vivo isolated dermal CD141+ DCs sponta-
neously produced high levels of IL-10 and showed a reduced capacity to stimulate T cell prolifer-
ation. Nevertheless, CD4+ T cells stimulated by dermal CD141+ DCs displayed elevated levels of
CTLA-4 and were unresponsive to secondary alloantigen re-stimulation compared to T cells stimu-
lated by dermal CD1c+ DCs. Dermal CD141+ DCs expressed a gene profile that resembled mouse
CD8α+ DCs and were able to cross-present autoantigens to CD8+ T cells. In psoriatic lesions, a
reduced CD141+ DC/CD3+ T cell ratio was observed when compared with normal skin. Our results
reveal a novel subset of skin resident immunoregulatory CD141+ DC which may be essential for
the maintenance of skin homeostasis, potentially through the induction of cross-tolerance under
steady-state conditions. Dysregulation of this cell type might contribute to inflammatory skin patholo-
gies such as psoriasis.
S102 Journal of Investigative Dermatology (2011), Volume 131
SID11_Abstracts-5  2/28/11  9:27 AM  Page S102
ABSTRACTS
625
The anti-inflammatory mechanism of action of pkc-alpha inhibitor in skin.
Y Sagiv, M Ben Hamo, M Gartsbein, L Braiman-Wiksman and T Tennenbaum HealOr Ltd.,
Rehovot, Israel
Protein Kinase C (PKC) is a family of Serine/Threonine kinases that play a key role in skin physiol-
ogy and pathology. We have found that PKCα inhibition by a selective inhibitor (MPDY-1) show a
clear anti-inflammatory effect in skin, demonstrated by decreased leukocytes recruitment in capil-
laries and a reduced infiltration to the wound area. In order to characterize the immunological mech-
anism of action of PKCα inhibition, we studied the direct effect of MPDY-1 on mice derived ker-
atinocytes and macrophages. In addition, we have characterized MPDY-1 immunological effect
in-vivo using skin wound model. Mice-derived cells were immunologically stimulated in the pres-
ence or absence of MPDY-1, followed by a measurement of secreted cytokines by a Luminex fluo-
rometric system. In addition, the immunological effect of MPDY-1 was studied in-vivo, by measur-
ing immune cells infiltration and activation using immunohistochemistry staining. MPDY-1
significantly reduces keratinocytes and macrophages secretion of the pro-inflammatory cytokines
IL-1, IL-6 and TNFα (i.e. IL-1: 90% and 60% reduction in keratinocytes and macrophages, respec-
tively). Chemokines (i.e. KC: 60% and 40% reduction in keratinocytes and macrophages, respec-
tively). Similar data was obtained with systemic immune factors (G-CSF, GM-CSF), and Th1 cytokines
(30% reduction of IL-12p70 in macrophages and 40% of IP-10 in keratinocytes). In-vivo, MPDY-1
demonstrates a marked effect on resident skin immune cells such as decreased expression of the
adhesion molecule ICAM-1 in blood-vessels endothelial cells and basal keratinocytes, as well as
decreased expression of macrophages activation marker 2 (mac-2) in wounds. These anti-inflam-
matory effects, in-turn, lead to a marked reduction in the recruitment of Neutrophils, macrophages
and T-cells to the wound area. The data emphasize the role of PKCα in the wound healing process
and holds promises for other cutaneous pathological conditions, such as psoriasis and atopic der-
matitis.
627
Defective epidermal innate immunity and resultant dermatophytosis in adult T cell
leukemia/lymphoma
Y Sawada,1 M Nakamura,1 M Kobayashi1 and Y Tokura1,2 1 Department of Dermatology,
University of Occupational and Environmental Health, Kitakyushu, Japan and 2 Department
of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan
Adult T cell leukemia/lymphoma (ATLL) is a malignancy of mature CD4+ T cells caused by human
T-cell leukemia virus type I (HTVL-1). Dermatophytosis, such as tinea pedis et unguium and can-
didiasis, is quite common in ATLL patients, as more than 50% of the patients have these infectious
conditions. Since superficially infected fungi cannot directly contact infiltrating T cells, some per-
turbation of epidermal immunity has been postulated. In particular, dysfunction of cutaneous innate
immunity in ATLL patients is an issue to be elucidated. IL-17 producing helper T cells (Th17) can
induce the production of antimicrobial peptides such as human β defensin-2 (HBD-2) and LL-37,
which play essential roles in cutaneous innate immunity. We investigated the frequency of Th17
cells, serum levels of cytokines, and epidermal expression and serum levels of HBD-2 and LL-37
in ATLL patients. Seven ATLL patients with tinea unguium, 5 ATLL patients without dermatophyto-
sis, 5 non-ATLL patients with tinea unguium, and 5 healthy controls without dermatophytosis were
enrolled in this study. In ATLL patients, the frequency of peripheral Th17 cells and the serum IL-6
level were significantly decreased, while serum TGF-β concentration was significantly increased
compared with non-ATLL controls. Further investigation demonstrated significantly higher TGF-β
levels and lower IL-6 concentration in ATLL patients with tinea unguium than those without der-
matophytosis. Moreover, immunohistochemical and ELISA studies revealed that both epidermal
expression and serum levels of HBD-2 and LL-37 were significantly lower in ATLL patients with
tinea unguium than those in non-ATLL patients with tinea unguium or healthy controls. Taken together,
these results suggest that the keratinocyte production of antimicrobial peptide promoted by Th17
cells is reduced in ATLL patients, leading to the perturbed innate immunity and frequent occur-
rence of dermatophytosis.
629
Function of Hypoxia-Inducible Factor (HIF)1α in dendritic cells
T Köhler,1 B Reizis,2 R Johnson,3 J Krutmann,1 H Weighardt1 and I Förster1 1 Molecular
Immunology, IUF – Leibniz Research Institute for Environmental Medicine, Düsseldorf,
Germany, 2 Dept. of Microbiology and Immunology, Columbia University, New York, NY and
3 University of California, San Diego, CA
Hypoxia has been reported to be a key feature of skin, and especially the epidermis, and oxygen
concentrations can be particularly low upon inflammation. HIF1α is responsible for major alter-
ations in gene expression as part of the cellular adaptation to hypoxia. Since dendritic cells (DC)
are the main antigen presenting cells in the skin and need to act under conditions of extremely low
oxygen, we investigated the function of HIF1α in DC. Therefore, we generated mice deficient for
HIF1α in DC. DC differentiation from bone marrow precursors under hypoxic conditions revealed
reduced growth and increased maturation of DC. Additionally, cytokines were measured in DC
culture supernatants, revealing reduced secretion of IL-12, IL-10, IL-1β, IL-6 and TNFα. In contrast,
secretion of IL-22 was strongly enhanced under hypoxic conditions in a HIF1α-dependent manner.
Studying the role of HIF1α in DC migration, we found an upregulation of CCR7 and a downregu-
lation of CCR5 in a HIF1α-dependent manner in hypoxia. The production of the chemokines CCL17
and CCL22, which are known to be associated with the pathogenesis of atopic dermatitis, was
increased in conditions of low oxygen. Using an adoptive transfer assay, we observed an enhanced
migratory capability of hypoxic DC, which was absent in HIF1α-deficient DC. As it is known that
in infection severe hypoxia can occur, we also studied the influence of HIF1α on bactericidal activ-
ity of DC. When DC were challenged with E.coli DC lacking HIF1α were clearly impaired in their
ability to kill phagocytosed bacteria efficiently in hypoxia. We also have established a skin infec-
tion model in which mice are challenged with S. aureus after disruption of the skin barrier. With
the help of cell-type specific HIF1α-knockout mice we now want to clarify if HIF1α expression in
DC affects bacterial load of infected mice or migration of immune cells to the draining lymph nodes.
628
Morbidity of HSV and VZV infections in pancreas and kidney/pancreas organ transplant recip-
ients
E Netchiporouk,1,3 R Munk,1 S Paraskevas,2 J Tchervenkov2 and RC Billick1 1 Dermatology,
McGill University, Montreal, QC, Canada, 2 Transplant and Hepatobiliary Surgery, McGill
University, Montreal, QC, Canada and 3 Faculty of Medicine, University of Montreal,
Montreal, QC, Canada
Solid organ transplant recipients are at increased risk of infection due to chronic immunosuppres-
sion. The incidence of herpes simplex (HSV) and varicella zoster (VZV) infections is known to be
increased in these patients in comparison to the immunocompetent population. Previous reports
suggest that these patients are likely to experience a morbid disease course with up to 40% risk of
dissemination to multiple organ systems and 4-34% risk of mortality. No data currently exists on
the course of these infections in pancreas or kidney/pancreas transplant recipients. Also, it is cur-
rently unclear whether a presence of disseminated HSV or VZV skin eruptions correlates with the
disease severity in these patients. In this work, we searched the McGill University patient database
to identify 137 pancreas and simultaneous kidney/pancreas transplant cases performed between
1999 and 2010. Our analysis reveals that 19 of 137 patients had post transplant HSV or VZV infec-
tions. The majority (>85%) of patients experienced a mild disease course and only a minority of
patients was at risk of developing life-threatening complications. Stratification of patients based on
organ system involvement (OSI) revealed two prognosis clusters (favorable and poor). Patients with
≤3 OSI had no adverse events during their admission and a short hospital stay (median: 2 days). In
contrast, patients with ≥4 OSI had a significant number of adverse events during their hospitaliza-
tion (50% rate of ICU admission +/- death) and a prolonged hospital stay (median: 8.5 days). In addi-
tion, our results indicate that the presence of disseminated skin eruption does not correlate with
disease severity. This data for the first time describes the course of HSV and VZV infections in pan-
creas and kidney/pancreas transplant recipients and suggests that these patients may be stratified
into favorable and poor outcome clusters based on OSI at presentation.
626
Modulation of Toll-like receptor responses by bone morphogenic protein 4 (BMP4)
N Ezra,1 M Gutierrez,2 R Teles,1 D Montoya,1 M Ochoa,1 D Lee,1 D Cruz2 and R Modlin1 1
Dermatology, UCLA, Los Angeles, CA and 2 Cardiology, UCLA, Los Angeles, CA
The clinical forms of leprosy constitute an immunologic and clinical spectrum: patients with tuber-
culoid leprosy (T-lep) develop effective antimicrobial responses, with self-curing lesions, whereas
patients with lepromatous leprosy (L-lep) possess ineffective immunity against Mycobacterium lep-
rae and thus have disseminated lesions. The underlying mechanisms by which T-lep patients are able
to contain disease are incompletely defined. Gene expression arrays from leprosy skin biopsies iden-
tified increased bone morphogenic protein 4 (BMP4) in the self-curing, T-lep lesions. BMP4 protein
expression was confirmed by immunohistochemistry in T-lep, but not L-lep lesions. By confocal
microscopy, BMP4 co-localized with the vasculature in T-lep lesions, which raised the possibility
that BMP4-expressing endothelium could regulate monocytes transmigrating into T-lep lesions. Pri-
mary human monocytes primed with BMP4 exhibited augmented innate immune responses includ-
ing: (1) increased toll like receptor 2/1 (TLR2/1)-mediated cytokine production in response to the
mycobacterial lipopeptide (19kD), (2) increased TLR2/1-induction of the vitamin D dependent antimi-
crobial peptide, cathelicidin, and (3) enhanced induction of cathelicidin by infection with live
mycobacteria. Together, these results suggest that in the self-curing form of leprosy, the vasculature-
by expressing BMP4- may prime monocytes to mount an effective immune response against the
pathogen.
630
DNase 2 degrades DNA on the skin surface
H Fischer,1 J Scherz,1 S Szabo,1 M Mildner,1 C Benarafa,2 A Torriglia,3 E Tschachler1,4 and
L Eckhart1 1 Department of Dermatology, Medical University of Vienna, Vienna, Austria, 2
Theodor Kocher Institute, University of Bern, Bern, Switzerland, 3 Physiopathologie des mal-
adies oculaires, Centre de Recherches des Cordeliers, Paris, France and 4 Centre de
Recherches et d’Investigations Epidermiques et Sensorielles, Paris, France
The stratum corneum is an efficient barrier to the passage of genetic material, i.e. nucleic acids. It
contains enzymes that degrade RNA and DNA which originate from either the living part of the epi-
dermis or from infectious agents of the environment. However, the molecular identities of these
nucleases are only incompletely known at present. Here we performed biochemical and genetic
experiments to determine the main DNase activity of the stratum corneum. DNA degradation assays
and zymographic analyses identified the acid endonucleases L-DNase II, which is derived from
serpinB1, and DNase 2 as candidate DNases of the stratum corneum. siRNA-mediated knockdown
of serpinB1 in human in vitro skin models and the investigation of mice deficient in serpinB1 demon-
strated that serpinB1-derived L-DNase II is dispensable for epidermal DNase activity. By contrast,
knockdown of DNase 2 reduced DNase activity in human in vitro skin models. Moreover, the genetic
ablation of DNase 2 in the mouse abolished acid DNase activity in the stratum corneum in vivo.
The degradation of endogenous DNA in the course of cornification of keratinocytes was not impaired
by the absence of DNase 2. Taken together, these data identify DNase 2 as the predominant DNase
on the mammalian skin surface and indicate that its activity is primarily targeted to exogenous DNA.
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An orally delivered CCR5 inhibitor, Maraviroc prevents HIV-1 acquisition in Langerhans
cells and transmission to CD4+ T cells
Y Ogawa,1 T Kawamura,1 A Blauvelt2 and S Shimada1 1 Dermatology, University of Yamanashi,
Yamanashi, Japan and 2 Dermatology, Oregon Health & Science University, Portland, OR
Background: CCR5-using R5 HIV is isolated exclusively in sexual transmission of HIV. Maraviroc
(MVC) is a novel orally available antagonist of CCR5 receptor, which acts as HIV-1 coreceptor. In
clinically, MVC reduces viral load in HIV-1-infected individuals, but its ability to prevent HIV-1
acquisition is untested. The purpose is that since Langerhans cells (LCs) are thought as initial cellu-
lar targets in sexual transmission of HIV, we test whether orally delivered MVC inhibits HIV infec-
tion of LCs by using ex vivo skin explant model. HIV-1 sero-negative volunteers were divided into
three groups, and then each group was orally administrated MVC (600mg/day) for 1, 3 and 14 days,
respectively. Before and after MVC administration, skin explants were obtained from volunteers by
suction blister technique. In addition, the concentration of MVC in sera and epidermis (each sam-
ple was 50mg and the extract was adjusted at 500μl) were measured. To assess HIV-1 acquisition
in LCs, epithelial sheets were exposed with R5 HIV-1 BaL and then floated on culture medium. The
emigrating LCs were collected 3 days after the HIV exposure. HIV-infected LCs were assessed using
HIV p24 intracellular staining by flow cytometry. In addition, to assess HIV-1 transmission from LCs
to CD4+ T cells, the emigrating LCs and allo CD4+ T cells were cocultured and then the culture
supernatants were collected. HIV p24 antigens in supernatants were measured by ELISA. Our results
showed that after administration of MVC for 3 and 14 days, both HIV-1 acquisition and HIV-1
transmission completely prevented in all volunteers. However, administration of MVC for 1 day did
not completely inhibit them. MVC concentration in sera reached a plateau after administration for
3 days and the mean MVC concentration was 900nM. Interestingly, MVC was also detected in epi-
dermis and the mean MVC concentration was 15.6nM. In conclusion, taken together, our data sug-
gested that the administration of MVC over 3 days could prevent sexual transmission of HIV-1.
620
In vivo imaging of behavioral responses of dendritic epidermal T cells to mechanical stress
R Lu,1 RE Tigelaar2 and A Takashima1 1 University of Toledo, Health Sciense Campus, Toledo,
OH and 2 Yale University, School of Medicine, New Haven, CT
The epidermal compartment of mouse skin contains two dendritic shaped leukocyte populations:
a) Langerhans cells (LC), which are antigen presenting cells of the dendritic cell family, and b) den-
dritic epidermal T cells (DETC), which are epithelial tissue-resident gamma/delta T cells. We previ-
ously reported motile activities of LC by recording time-lapse images of EGFP+ LC in the IA beta-
EGFP knock-in mice under confocal microscopy. They exhibited a unique motion termed dSEARCH
characterized by repetitive extension and retraction of dendrites, and inflammatory stimuli (e.g.,
tape stripping and hapten painting) augmented their dSEARCH motion. The purpose of this study
was to visualize motile behaviors of DETC. We found the CX3CR1-EGFP knock-in mice to contain
large numbers (773 ± 104 cells/mm2, n = 3) of EGFP+ epidermal cells with elongated dendrites –
they uniformly expressed Thy-1 antigen and gamma/delta T cell receptor, but not MHC class II mol-
ecule, verifying their identity as DETC. We recorded time-lapse videos of EGFP+ DETC in the ear
skin of anesthetized CX3CR1-EGFP knock-in mice. In the steady state, DETC exhibited modest
dSEARCH movement at the levels comparable to those observed with LC. Within 8 h after tape strip-
ping, a majority of DETC began to withdraw their dendrites, while the remaining cells showed sig-
nificantly (P<0.0001) exacerbated dSEARCH motion. This observation was confirmed by measur-
ing complexity of the cell shape: the shape factor values increased from 0.12 ± 0.07 before tape
stripping (n = 100) to 0.37 ± 0.13 at 8 h (P<0.01, n = 121) and 0.66 ± 0.14 at 24 h (P<0.001, n =
107). A significant (29.7 ± 0.2%) reduction in DETC numbers was also observed at 24 h after tape
stripping. In marked contrast, LC exhibited amplified dSEARCH motion, but not dendrite withdrawal
or reduced cell numbers by 24 h after the same treatment. This is the first report unveiling in vivo
motile behaviors of DETC, and our results imply that LC and DETC respond differently to a given
mechanical stress.
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The dermis is not sterile: Discovery of a microbiome within and beneath the epidermis
T Nakatsuji, SB Jiang, KN Kanada and RL Gallo Dermatology, University of California, San
Diego, San Diego, CA
Cellular components of the immune system actively respond in vivo to commensal microbes to
maintain the skin’s inflammatory homeostasis and optimize resistance to infection. Since many of
the cell types that react to microbial products exist at locations previously assumed to be sterile,
we deduced that physiological responses to the normal microbiome indicates that bacteria interact
with host cells at unexpected sites, and stroma thought to be sterile outside of appendageal struc-
tures may in fact harbor a microbiome. Normal human skin samples were obtained from sterile
surgery and carefully prepped to avoid cross-contamination. Gram-staining, immunofluorescence
with anti-LTA, and in situ hybridization with 16S rRNA probes of transverse sections, detected bac-
teria throughout dermis and superficial adipose tissue. Bacterial abundance in 75 sequential 30μm
horizontal sections of human skin was quantified by qPCR, and this technique confirmed the exis-
tence of microbial 16S rRNA reflective of up to 7.4×103 CFU/cm2 1.2mm below the surface in pal-
mar skin, and a signal was not lost until 1.9mm deep. Similar results were seen in 5 different indi-
viduals and sites. Diversity was analyzed by 16S pyrosequencing from 4 representative sections at
0.1, 0.3, 1.0 and 1.2 mm deep, revealing 58 distinct bacterial genera in the deepest section. Staphy-
lococcus were the most predominant genus in all layers analyzed (12.6-29.3%). Pseudomonas and
Escherichia were highly represented in the outer epithelial layer (9.4 and 4.8%), but less represented
in the subdermal layer (3.7 and 2.1%). In contrast, Bacteroidacea and Clostridiales were highly rep-
resented in the subdermal layer (10.6 and 8.2%), and less represented in the outer epithelial layer
(0.8 and 1.1%). These results indicate that previously unknown microflora exist in the dermal stroma
and this microbiome may be different from the surface. Interaction of commensal microbes with
cells previously thought to be restricted to a sterile environment further emphasizes the importance
of understanding the skin’s microbiome and its functions.
622
Interferon gamma enhances innate immune response of epidermis through TLR3 in ker-
atinocytes
A Kajita,1 S Morizane,1 K Yamasaki,2 Y Aoyama1 and K Iwatsuki1 1 Dermatology, Okayama
University Graduate School of Medicine, Dentistry, Pharmaceutical Sciences, Okayama, Japan
and 2 Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan
Epidermis is the first line of innate host defense against microbial invasion. Among Toll-like recep-
tors (TLR), which recognize specific microbial products, TLR3 recognizes double-stranded RNA and
is considered to play roles in viral skin infection. However, the regulation of TLR3 expression and
the function in keratinocytes are not fully understood. We first confirmed high TLR3 expression in
keratinocytes surrounding vesicles of herpes zoster by immunohistochemistry (n=3). To understand
regulation of TLR3 in keratinocytes, we examined factors that affect TLR3 expression in normal
human epidermal keratinocytes (NHEKs) in vitro. Among a panel of cytokines, a Th1 cytokine inter-
feron gamma (IFNγ, 2 ng/ml) increased TLR3 mRNA expression (76.7-fold, p=0.0108) in NHEKs,
while Th2 cytokines IL-4 and IL-13, or Th17 cytokines including IL-17A, IL-22 and IL-23 did not.
IFNγ increased TLR3 mRNA expression in a dose-dependent manner, and the highest induction
was observed at 48 hours after the IFNγ stimulation. A functional significance of TLR3 increase by
IFNγ was confirmed as co-stimulation with IFNγ (2 ng/ml) and TLR3 ligand poly(I:C) (0.1 μg/ml)
synergistically increased mRNA expression of beta-defensin-2 (45.11-fold, p<0.0001), IL-6 (22.79-
fold, p<0.0001), IL-8 (3.46-fold, p=0.0012) and IFNβ (7.96-fold, p=0.0014) in NHEKs, compared
to stimulation with poly(I:C) alone. Corresponding increases of protein were also confirmed by
ELISA. Chloroquine (50 μg/ml), an endosomal acidification inhibitor that suppress TLR3 functional
activity, inhibited the cytokine inductions by co-stimulation with IFNγ and poly(I:C). These results
suggest that a Th1 cytokine IFNγ induces TLR3 in keratinocytes and amplifies responsiveness to
viral ds-RNA, as antimicrobial peptides and cytokines induction. Thus, epidermal keratinocytes are
active components of innate immune defense against viral infection.
623
Scavenger receptor antagonism blocks HSV-1 infection of keratinocytes and limits cutaneous
disease
DT MacLeod,1,2 K Yamasaki,1,2 L Kobzik3 and RL Gallo1,2 1 Medicine; Division of Dermatology,
University of California, San Diego, La Jolla, CA, 2 Veterans Affairs San Diego Healthcare
System, San Diego, CA and 3 Environmental Health, Harvard School of Public Health, Boston,
MA
Cutaneous infection by HSV-1 can occasionally cause severe infections, especially in patients with
impaired immunity. These infections are incompletely controlled by drugs such as Acyclovir, high-
lighting the need for additional therapeutics. We previously determined that ligands that bind and
antagonize scavenger receptors were able to prevent HSV-1 infection in keratinocytes in vitro by
more than 99.9% (P<0.001). To confirm the importance of these findings in vivo, we infected immuno-
compromised mice with HSV-1. Mice treated with the scavenger receptor ligand Poly(I) had 55%
smaller skin lesions six days post-infection (P<0.001) and had fewer symptoms of disseminated
infection such as hind-limb paralysis, compared to PBS treated mice. Poly(C), a control ligand that
does not bind scavenger receptors, had no effect on lesion size or symptoms of infection. Next, we
sought to explain these effects by identifying a specific class A scavenger receptor capable of inter-
acting with HSV-1. We found a number of scavenger receptors to be expressed on keratinocytes,
including Macrophage receptor with collagenous structure (MARCO). By employing a fluorescent
proximity ligation assay, we specifically detected the colocalization of MARCO and HSV-1 on the
surface of keratinocytes bound with HSV-1, unambiguously demonstrating that they reside within
less than 40nm from each other. Additionally, the interaction between HSV-1 and MARCO is func-
tionally important, as bone marrow-derived macrophages from MARCO knockout mice had 45%
less viral DNA (P=0.0051) when infected with HSV-1 at an MOI of 5 and 43-66% less viral RNA
across a range of MOI from 1 to 100 (P=0.0009). These findings demonstrate that HSV-1 binds to
scavenger receptors such as MARCO and that blocking this interaction can significantly improve
the outcome of cutaneous HSV-1 infection.
624
Real-time kinetics and mechanism of IL-1β production during a S. aureus skin infection in
vivo
JS Cho,1 F Hebroni,1 RI Ramos,1 H Matsushima,2 A Takashima2 and L Miller1 1 Dermatology,
University of California Los Angeles, Los Angeles, CA and 2 Medical Microbiology and
Immunology, University of Toledo College of Medicine, Toledo, OH
Staphylococcus aureus is a major cause of bacterial skin infections in the United States. To deter-
mine the primary immune response induced during a S. aureus skin infection, a genome-wide
microarray analysis at 0 and 4 h after a S. aureus infection of mouse skin was performed. IL-1β/IL-
R1 was the most induced cytokine/cytokine receptor pair (78- and 91-fold, respectively; p<0.01).
To determine the kinetics of IL-1β gene induction in comparison with bacterial burden in vivo, an
IL 1β-dsRed reporter mouse line was combined with bioluminescent bacteria and in vivo fluores-
cence and bioluminescent imaging was performed (Xenogen IVIS). IL-1β expression was detected
by 8 h, peaked at 24 h and correlated with the bacterial burden. IL-1β expression also correlated
with neutrophil recruitment as measured by in vivo imaging of LysEGFP mice, which possess fluo-
rescent neutrophils. Confocal microscopy of histologic sections taken at 4 and 24 h after infection
demonstrated that neutrophils (7/4+ cells) were the predominant source of IL-1β production with a
minority of IL-1β produced by monocytes/macrophages (Moma-2+/CD11b+). Finally, this IL-1β pro-
duction was dependent upon activation of Toll-like receptor 2 (TLR2) and formyl-peptide receptor
1 (FPR1) as IL-1β protein levels were significantly decreased in mice deficient in these receptors
(~41 and 24 percent, respectively; p<0.05). Taken together, these results provide a mechanism by
which IL-1β is produced by neutrophils at the site of infection and its production requires both
TLR2 and FPR1 activation.
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The anti-inflammatory mechanism of action of pkc-alpha inhibitor in skin.
Y Sagiv, M Ben Hamo, M Gartsbein, L Braiman-Wiksman and T Tennenbaum HealOr Ltd.,
Rehovot, Israel
Protein Kinase C (PKC) is a family of Serine/Threonine kinases that play a key role in skin physiol-
ogy and pathology. We have found that PKCα inhibition by a selective inhibitor (MPDY-1) show a
clear anti-inflammatory effect in skin, demonstrated by decreased leukocytes recruitment in capil-
laries and a reduced infiltration to the wound area. In order to characterize the immunological mech-
anism of action of PKCα inhibition, we studied the direct effect of MPDY-1 on mice derived ker-
atinocytes and macrophages. In addition, we have characterized MPDY-1 immunological effect
in-vivo using skin wound model. Mice-derived cells were immunologically stimulated in the pres-
ence or absence of MPDY-1, followed by a measurement of secreted cytokines by a Luminex fluo-
rometric system. In addition, the immunological effect of MPDY-1 was studied in-vivo, by measur-
ing immune cells infiltration and activation using immunohistochemistry staining. MPDY-1
significantly reduces keratinocytes and macrophages secretion of the pro-inflammatory cytokines
IL-1, IL-6 and TNFα (i.e. IL-1: 90% and 60% reduction in keratinocytes and macrophages, respec-
tively). Chemokines (i.e. KC: 60% and 40% reduction in keratinocytes and macrophages, respec-
tively). Similar data was obtained with systemic immune factors (G-CSF, GM-CSF), and Th1 cytokines
(30% reduction of IL-12p70 in macrophages and 40% of IP-10 in keratinocytes). In-vivo, MPDY-1
demonstrates a marked effect on resident skin immune cells such as decreased expression of the
adhesion molecule ICAM-1 in blood-vessels endothelial cells and basal keratinocytes, as well as
decreased expression of macrophages activation marker 2 (mac-2) in wounds. These anti-inflam-
matory effects, in-turn, lead to a marked reduction in the recruitment of Neutrophils, macrophages
and T-cells to the wound area. The data emphasize the role of PKCα in the wound healing process
and holds promises for other cutaneous pathological conditions, such as psoriasis and atopic der-
matitis.
627
Defective epidermal innate immunity and resultant dermatophytosis in adult T cell
leukemia/lymphoma
Y Sawada,1 M Nakamura,1 M Kobayashi1 and Y Tokura1,2 1 Department of Dermatology,
University of Occupational and Environmental Health, Kitakyushu, Japan and 2 Department
of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan
Adult T cell leukemia/lymphoma (ATLL) is a malignancy of mature CD4+ T cells caused by human
T-cell leukemia virus type I (HTVL-1). Dermatophytosis, such as tinea pedis et unguium and can-
didiasis, is quite common in ATLL patients, as more than 50% of the patients have these infectious
conditions. Since superficially infected fungi cannot directly contact infiltrating T cells, some per-
turbation of epidermal immunity has been postulated. In particular, dysfunction of cutaneous innate
immunity in ATLL patients is an issue to be elucidated. IL-17 producing helper T cells (Th17) can
induce the production of antimicrobial peptides such as human β defensin-2 (HBD-2) and LL-37,
which play essential roles in cutaneous innate immunity. We investigated the frequency of Th17
cells, serum levels of cytokines, and epidermal expression and serum levels of HBD-2 and LL-37
in ATLL patients. Seven ATLL patients with tinea unguium, 5 ATLL patients without dermatophyto-
sis, 5 non-ATLL patients with tinea unguium, and 5 healthy controls without dermatophytosis were
enrolled in this study. In ATLL patients, the frequency of peripheral Th17 cells and the serum IL-6
level were significantly decreased, while serum TGF-β concentration was significantly increased
compared with non-ATLL controls. Further investigation demonstrated significantly higher TGF-β
levels and lower IL-6 concentration in ATLL patients with tinea unguium than those without der-
matophytosis. Moreover, immunohistochemical and ELISA studies revealed that both epidermal
expression and serum levels of HBD-2 and LL-37 were significantly lower in ATLL patients with
tinea unguium than those in non-ATLL patients with tinea unguium or healthy controls. Taken together,
these results suggest that the keratinocyte production of antimicrobial peptide promoted by Th17
cells is reduced in ATLL patients, leading to the perturbed innate immunity and frequent occur-
rence of dermatophytosis.
629
Function of Hypoxia-Inducible Factor (HIF)1α in dendritic cells
T Köhler,1 B Reizis,2 R Johnson,3 J Krutmann,1 H Weighardt1 and I Förster1 1 Molecular
Immunology, IUF – Leibniz Research Institute for Environmental Medicine, Düsseldorf,
Germany, 2 Dept. of Microbiology and Immunology, Columbia University, New York, NY and
3 University of California, San Diego, CA
Hypoxia has been reported to be a key feature of skin, and especially the epidermis, and oxygen
concentrations can be particularly low upon inflammation. HIF1α is responsible for major alter-
ations in gene expression as part of the cellular adaptation to hypoxia. Since dendritic cells (DC)
are the main antigen presenting cells in the skin and need to act under conditions of extremely low
oxygen, we investigated the function of HIF1α in DC. Therefore, we generated mice deficient for
HIF1α in DC. DC differentiation from bone marrow precursors under hypoxic conditions revealed
reduced growth and increased maturation of DC. Additionally, cytokines were measured in DC
culture supernatants, revealing reduced secretion of IL-12, IL-10, IL-1β, IL-6 and TNFα. In contrast,
secretion of IL-22 was strongly enhanced under hypoxic conditions in a HIF1α-dependent manner.
Studying the role of HIF1α in DC migration, we found an upregulation of CCR7 and a downregu-
lation of CCR5 in a HIF1α-dependent manner in hypoxia. The production of the chemokines CCL17
and CCL22, which are known to be associated with the pathogenesis of atopic dermatitis, was
increased in conditions of low oxygen. Using an adoptive transfer assay, we observed an enhanced
migratory capability of hypoxic DC, which was absent in HIF1α-deficient DC. As it is known that
in infection severe hypoxia can occur, we also studied the influence of HIF1α on bactericidal activ-
ity of DC. When DC were challenged with E.coli DC lacking HIF1α were clearly impaired in their
ability to kill phagocytosed bacteria efficiently in hypoxia. We also have established a skin infec-
tion model in which mice are challenged with S. aureus after disruption of the skin barrier. With
the help of cell-type specific HIF1α-knockout mice we now want to clarify if HIF1α expression in
DC affects bacterial load of infected mice or migration of immune cells to the draining lymph nodes.
628
Morbidity of HSV and VZV infections in pancreas and kidney/pancreas organ transplant recip-
ients
E Netchiporouk,1,3 R Munk,1 S Paraskevas,2 J Tchervenkov2 and RC Billick1 1 Dermatology,
McGill University, Montreal, QC, Canada, 2 Transplant and Hepatobiliary Surgery, McGill
University, Montreal, QC, Canada and 3 Faculty of Medicine, University of Montreal,
Montreal, QC, Canada
Solid organ transplant recipients are at increased risk of infection due to chronic immunosuppres-
sion. The incidence of herpes simplex (HSV) and varicella zoster (VZV) infections is known to be
increased in these patients in comparison to the immunocompetent population. Previous reports
suggest that these patients are likely to experience a morbid disease course with up to 40% risk of
dissemination to multiple organ systems and 4-34% risk of mortality. No data currently exists on
the course of these infections in pancreas or kidney/pancreas transplant recipients. Also, it is cur-
rently unclear whether a presence of disseminated HSV or VZV skin eruptions correlates with the
disease severity in these patients. In this work, we searched the McGill University patient database
to identify 137 pancreas and simultaneous kidney/pancreas transplant cases performed between
1999 and 2010. Our analysis reveals that 19 of 137 patients had post transplant HSV or VZV infec-
tions. The majority (>85%) of patients experienced a mild disease course and only a minority of
patients was at risk of developing life-threatening complications. Stratification of patients based on
organ system involvement (OSI) revealed two prognosis clusters (favorable and poor). Patients with
≤3 OSI had no adverse events during their admission and a short hospital stay (median: 2 days). In
contrast, patients with ≥4 OSI had a significant number of adverse events during their hospitaliza-
tion (50% rate of ICU admission +/- death) and a prolonged hospital stay (median: 8.5 days). In addi-
tion, our results indicate that the presence of disseminated skin eruption does not correlate with
disease severity. This data for the first time describes the course of HSV and VZV infections in pan-
creas and kidney/pancreas transplant recipients and suggests that these patients may be stratified
into favorable and poor outcome clusters based on OSI at presentation.
626
Modulation of Toll-like receptor responses by bone morphogenic protein 4 (BMP4)
N Ezra,1 M Gutierrez,2 R Teles,1 D Montoya,1 M Ochoa,1 D Lee,1 D Cruz2 and R Modlin1 1
Dermatology, UCLA, Los Angeles, CA and 2 Cardiology, UCLA, Los Angeles, CA
The clinical forms of leprosy constitute an immunologic and clinical spectrum: patients with tuber-
culoid leprosy (T-lep) develop effective antimicrobial responses, with self-curing lesions, whereas
patients with lepromatous leprosy (L-lep) possess ineffective immunity against Mycobacterium lep-
rae and thus have disseminated lesions. The underlying mechanisms by which T-lep patients are able
to contain disease are incompletely defined. Gene expression arrays from leprosy skin biopsies iden-
tified increased bone morphogenic protein 4 (BMP4) in the self-curing, T-lep lesions. BMP4 protein
expression was confirmed by immunohistochemistry in T-lep, but not L-lep lesions. By confocal
microscopy, BMP4 co-localized with the vasculature in T-lep lesions, which raised the possibility
that BMP4-expressing endothelium could regulate monocytes transmigrating into T-lep lesions. Pri-
mary human monocytes primed with BMP4 exhibited augmented innate immune responses includ-
ing: (1) increased toll like receptor 2/1 (TLR2/1)-mediated cytokine production in response to the
mycobacterial lipopeptide (19kD), (2) increased TLR2/1-induction of the vitamin D dependent antimi-
crobial peptide, cathelicidin, and (3) enhanced induction of cathelicidin by infection with live
mycobacteria. Together, these results suggest that in the self-curing form of leprosy, the vasculature-
by expressing BMP4- may prime monocytes to mount an effective immune response against the
pathogen.
630
DNase 2 degrades DNA on the skin surface
H Fischer,1 J Scherz,1 S Szabo,1 M Mildner,1 C Benarafa,2 A Torriglia,3 E Tschachler1,4 and
L Eckhart1 1 Department of Dermatology, Medical University of Vienna, Vienna, Austria, 2
Theodor Kocher Institute, University of Bern, Bern, Switzerland, 3 Physiopathologie des mal-
adies oculaires, Centre de Recherches des Cordeliers, Paris, France and 4 Centre de
Recherches et d’Investigations Epidermiques et Sensorielles, Paris, France
The stratum corneum is an efficient barrier to the passage of genetic material, i.e. nucleic acids. It
contains enzymes that degrade RNA and DNA which originate from either the living part of the epi-
dermis or from infectious agents of the environment. However, the molecular identities of these
nucleases are only incompletely known at present. Here we performed biochemical and genetic
experiments to determine the main DNase activity of the stratum corneum. DNA degradation assays
and zymographic analyses identified the acid endonucleases L-DNase II, which is derived from
serpinB1, and DNase 2 as candidate DNases of the stratum corneum. siRNA-mediated knockdown
of serpinB1 in human in vitro skin models and the investigation of mice deficient in serpinB1 demon-
strated that serpinB1-derived L-DNase II is dispensable for epidermal DNase activity. By contrast,
knockdown of DNase 2 reduced DNase activity in human in vitro skin models. Moreover, the genetic
ablation of DNase 2 in the mouse abolished acid DNase activity in the stratum corneum in vivo.
The degradation of endogenous DNA in the course of cornification of keratinocytes was not impaired
by the absence of DNase 2. Taken together, these data identify DNase 2 as the predominant DNase
on the mammalian skin surface and indicate that its activity is primarily targeted to exogenous DNA.
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An orally delivered CCR5 inhibitor, Maraviroc prevents HIV-1 acquisition in Langerhans
cells and transmission to CD4+ T cells
Y Ogawa,1 T Kawamura,1 A Blauvelt2 and S Shimada1 1 Dermatology, University of Yamanashi,
Yamanashi, Japan and 2 Dermatology, Oregon Health & Science University, Portland, OR
Background: CCR5-using R5 HIV is isolated exclusively in sexual transmission of HIV. Maraviroc
(MVC) is a novel orally available antagonist of CCR5 receptor, which acts as HIV-1 coreceptor. In
clinically, MVC reduces viral load in HIV-1-infected individuals, but its ability to prevent HIV-1
acquisition is untested. The purpose is that since Langerhans cells (LCs) are thought as initial cellu-
lar targets in sexual transmission of HIV, we test whether orally delivered MVC inhibits HIV infec-
tion of LCs by using ex vivo skin explant model. HIV-1 sero-negative volunteers were divided into
three groups, and then each group was orally administrated MVC (600mg/day) for 1, 3 and 14 days,
respectively. Before and after MVC administration, skin explants were obtained from volunteers by
suction blister technique. In addition, the concentration of MVC in sera and epidermis (each sam-
ple was 50mg and the extract was adjusted at 500μl) were measured. To assess HIV-1 acquisition
in LCs, epithelial sheets were exposed with R5 HIV-1 BaL and then floated on culture medium. The
emigrating LCs were collected 3 days after the HIV exposure. HIV-infected LCs were assessed using
HIV p24 intracellular staining by flow cytometry. In addition, to assess HIV-1 transmission from LCs
to CD4+ T cells, the emigrating LCs and allo CD4+ T cells were cocultured and then the culture
supernatants were collected. HIV p24 antigens in supernatants were measured by ELISA. Our results
showed that after administration of MVC for 3 and 14 days, both HIV-1 acquisition and HIV-1
transmission completely prevented in all volunteers. However, administration of MVC for 1 day did
not completely inhibit them. MVC concentration in sera reached a plateau after administration for
3 days and the mean MVC concentration was 900nM. Interestingly, MVC was also detected in epi-
dermis and the mean MVC concentration was 15.6nM. In conclusion, taken together, our data sug-
gested that the administration of MVC over 3 days could prevent sexual transmission of HIV-1.
620
In vivo imaging of behavioral responses of dendritic epidermal T cells to mechanical stress
R Lu,1 RE Tigelaar2 and A Takashima1 1 University of Toledo, Health Sciense Campus, Toledo,
OH and 2 Yale University, School of Medicine, New Haven, CT
The epidermal compartment of mouse skin contains two dendritic shaped leukocyte populations:
a) Langerhans cells (LC), which are antigen presenting cells of the dendritic cell family, and b) den-
dritic epidermal T cells (DETC), which are epithelial tissue-resident gamma/delta T cells. We previ-
ously reported motile activities of LC by recording time-lapse images of EGFP+ LC in the IA beta-
EGFP knock-in mice under confocal microscopy. They exhibited a unique motion termed dSEARCH
characterized by repetitive extension and retraction of dendrites, and inflammatory stimuli (e.g.,
tape stripping and hapten painting) augmented their dSEARCH motion. The purpose of this study
was to visualize motile behaviors of DETC. We found the CX3CR1-EGFP knock-in mice to contain
large numbers (773 ± 104 cells/mm2, n = 3) of EGFP+ epidermal cells with elongated dendrites –
they uniformly expressed Thy-1 antigen and gamma/delta T cell receptor, but not MHC class II mol-
ecule, verifying their identity as DETC. We recorded time-lapse videos of EGFP+ DETC in the ear
skin of anesthetized CX3CR1-EGFP knock-in mice. In the steady state, DETC exhibited modest
dSEARCH movement at the levels comparable to those observed with LC. Within 8 h after tape strip-
ping, a majority of DETC began to withdraw their dendrites, while the remaining cells showed sig-
nificantly (P<0.0001) exacerbated dSEARCH motion. This observation was confirmed by measur-
ing complexity of the cell shape: the shape factor values increased from 0.12 ± 0.07 before tape
stripping (n = 100) to 0.37 ± 0.13 at 8 h (P<0.01, n = 121) and 0.66 ± 0.14 at 24 h (P<0.001, n =
107). A significant (29.7 ± 0.2%) reduction in DETC numbers was also observed at 24 h after tape
stripping. In marked contrast, LC exhibited amplified dSEARCH motion, but not dendrite withdrawal
or reduced cell numbers by 24 h after the same treatment. This is the first report unveiling in vivo
motile behaviors of DETC, and our results imply that LC and DETC respond differently to a given
mechanical stress.
621
The dermis is not sterile: Discovery of a microbiome within and beneath the epidermis
T Nakatsuji, SB Jiang, KN Kanada and RL Gallo Dermatology, University of California, San
Diego, San Diego, CA
Cellular components of the immune system actively respond in vivo to commensal microbes to
maintain the skin’s inflammatory homeostasis and optimize resistance to infection. Since many of
the cell types that react to microbial products exist at locations previously assumed to be sterile,
we deduced that physiological responses to the normal microbiome indicates that bacteria interact
with host cells at unexpected sites, and stroma thought to be sterile outside of appendageal struc-
tures may in fact harbor a microbiome. Normal human skin samples were obtained from sterile
surgery and carefully prepped to avoid cross-contamination. Gram-staining, immunofluorescence
with anti-LTA, and in situ hybridization with 16S rRNA probes of transverse sections, detected bac-
teria throughout dermis and superficial adipose tissue. Bacterial abundance in 75 sequential 30μm
horizontal sections of human skin was quantified by qPCR, and this technique confirmed the exis-
tence of microbial 16S rRNA reflective of up to 7.4×103 CFU/cm2 1.2mm below the surface in pal-
mar skin, and a signal was not lost until 1.9mm deep. Similar results were seen in 5 different indi-
viduals and sites. Diversity was analyzed by 16S pyrosequencing from 4 representative sections at
0.1, 0.3, 1.0 and 1.2 mm deep, revealing 58 distinct bacterial genera in the deepest section. Staphy-
lococcus were the most predominant genus in all layers analyzed (12.6-29.3%). Pseudomonas and
Escherichia were highly represented in the outer epithelial layer (9.4 and 4.8%), but less represented
in the subdermal layer (3.7 and 2.1%). In contrast, Bacteroidacea and Clostridiales were highly rep-
resented in the subdermal layer (10.6 and 8.2%), and less represented in the outer epithelial layer
(0.8 and 1.1%). These results indicate that previously unknown microflora exist in the dermal stroma
and this microbiome may be different from the surface. Interaction of commensal microbes with
cells previously thought to be restricted to a sterile environment further emphasizes the importance
of understanding the skin’s microbiome and its functions.
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Interferon gamma enhances innate immune response of epidermis through TLR3 in ker-
atinocytes
A Kajita,1 S Morizane,1 K Yamasaki,2 Y Aoyama1 and K Iwatsuki1 1 Dermatology, Okayama
University Graduate School of Medicine, Dentistry, Pharmaceutical Sciences, Okayama, Japan
and 2 Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan
Epidermis is the first line of innate host defense against microbial invasion. Among Toll-like recep-
tors (TLR), which recognize specific microbial products, TLR3 recognizes double-stranded RNA and
is considered to play roles in viral skin infection. However, the regulation of TLR3 expression and
the function in keratinocytes are not fully understood. We first confirmed high TLR3 expression in
keratinocytes surrounding vesicles of herpes zoster by immunohistochemistry (n=3). To understand
regulation of TLR3 in keratinocytes, we examined factors that affect TLR3 expression in normal
human epidermal keratinocytes (NHEKs) in vitro. Among a panel of cytokines, a Th1 cytokine inter-
feron gamma (IFNγ, 2 ng/ml) increased TLR3 mRNA expression (76.7-fold, p=0.0108) in NHEKs,
while Th2 cytokines IL-4 and IL-13, or Th17 cytokines including IL-17A, IL-22 and IL-23 did not.
IFNγ increased TLR3 mRNA expression in a dose-dependent manner, and the highest induction
was observed at 48 hours after the IFNγ stimulation. A functional significance of TLR3 increase by
IFNγ was confirmed as co-stimulation with IFNγ (2 ng/ml) and TLR3 ligand poly(I:C) (0.1 μg/ml)
synergistically increased mRNA expression of beta-defensin-2 (45.11-fold, p<0.0001), IL-6 (22.79-
fold, p<0.0001), IL-8 (3.46-fold, p=0.0012) and IFNβ (7.96-fold, p=0.0014) in NHEKs, compared
to stimulation with poly(I:C) alone. Corresponding increases of protein were also confirmed by
ELISA. Chloroquine (50 μg/ml), an endosomal acidification inhibitor that suppress TLR3 functional
activity, inhibited the cytokine inductions by co-stimulation with IFNγ and poly(I:C). These results
suggest that a Th1 cytokine IFNγ induces TLR3 in keratinocytes and amplifies responsiveness to
viral ds-RNA, as antimicrobial peptides and cytokines induction. Thus, epidermal keratinocytes are
active components of innate immune defense against viral infection.
623
Scavenger receptor antagonism blocks HSV-1 infection of keratinocytes and limits cutaneous
disease
DT MacLeod,1,2 K Yamasaki,1,2 L Kobzik3 and RL Gallo1,2 1 Medicine; Division of Dermatology,
University of California, San Diego, La Jolla, CA, 2 Veterans Affairs San Diego Healthcare
System, San Diego, CA and 3 Environmental Health, Harvard School of Public Health, Boston,
MA
Cutaneous infection by HSV-1 can occasionally cause severe infections, especially in patients with
impaired immunity. These infections are incompletely controlled by drugs such as Acyclovir, high-
lighting the need for additional therapeutics. We previously determined that ligands that bind and
antagonize scavenger receptors were able to prevent HSV-1 infection in keratinocytes in vitro by
more than 99.9% (P<0.001). To confirm the importance of these findings in vivo, we infected immuno-
compromised mice with HSV-1. Mice treated with the scavenger receptor ligand Poly(I) had 55%
smaller skin lesions six days post-infection (P<0.001) and had fewer symptoms of disseminated
infection such as hind-limb paralysis, compared to PBS treated mice. Poly(C), a control ligand that
does not bind scavenger receptors, had no effect on lesion size or symptoms of infection. Next, we
sought to explain these effects by identifying a specific class A scavenger receptor capable of inter-
acting with HSV-1. We found a number of scavenger receptors to be expressed on keratinocytes,
including Macrophage receptor with collagenous structure (MARCO). By employing a fluorescent
proximity ligation assay, we specifically detected the colocalization of MARCO and HSV-1 on the
surface of keratinocytes bound with HSV-1, unambiguously demonstrating that they reside within
less than 40nm from each other. Additionally, the interaction between HSV-1 and MARCO is func-
tionally important, as bone marrow-derived macrophages from MARCO knockout mice had 45%
less viral DNA (P=0.0051) when infected with HSV-1 at an MOI of 5 and 43-66% less viral RNA
across a range of MOI from 1 to 100 (P=0.0009). These findings demonstrate that HSV-1 binds to
scavenger receptors such as MARCO and that blocking this interaction can significantly improve
the outcome of cutaneous HSV-1 infection.
624
Real-time kinetics and mechanism of IL-1β production during a S. aureus skin infection in
vivo
JS Cho,1 F Hebroni,1 RI Ramos,1 H Matsushima,2 A Takashima2 and L Miller1 1 Dermatology,
University of California Los Angeles, Los Angeles, CA and 2 Medical Microbiology and
Immunology, University of Toledo College of Medicine, Toledo, OH
Staphylococcus aureus is a major cause of bacterial skin infections in the United States. To deter-
mine the primary immune response induced during a S. aureus skin infection, a genome-wide
microarray analysis at 0 and 4 h after a S. aureus infection of mouse skin was performed. IL-1β/IL-
R1 was the most induced cytokine/cytokine receptor pair (78- and 91-fold, respectively; p<0.01).
To determine the kinetics of IL-1β gene induction in comparison with bacterial burden in vivo, an
IL 1β-dsRed reporter mouse line was combined with bioluminescent bacteria and in vivo fluores-
cence and bioluminescent imaging was performed (Xenogen IVIS). IL-1β expression was detected
by 8 h, peaked at 24 h and correlated with the bacterial burden. IL-1β expression also correlated
with neutrophil recruitment as measured by in vivo imaging of LysEGFP mice, which possess fluo-
rescent neutrophils. Confocal microscopy of histologic sections taken at 4 and 24 h after infection
demonstrated that neutrophils (7/4+ cells) were the predominant source of IL-1β production with a
minority of IL-1β produced by monocytes/macrophages (Moma-2+/CD11b+). Finally, this IL-1β pro-
duction was dependent upon activation of Toll-like receptor 2 (TLR2) and formyl-peptide receptor
1 (FPR1) as IL-1β protein levels were significantly decreased in mice deficient in these receptors
(~41 and 24 percent, respectively; p<0.05). Taken together, these results provide a mechanism by
which IL-1β is produced by neutrophils at the site of infection and its production requires both
TLR2 and FPR1 activation.
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Staphylococcus aureus-derived PGN enhances the integrity of epidermal tight junctions
I Kuo,1,2 A De Benedetto,1 T Yoshida1 and LA Beck1 1 Dermatology, University of Rochester
Medical Center, Rochester, NY and 2 Pathology and Laboratory Medicine, University of
Rochester Medical Center, Rochester, NY
Atopic dermatitis (AD) is caused in part by barrier disruption and is characterized by cutaneous
colonization and infection with S. aureus. Recent studies have suggested that there may be crosstalk
between the innate immune system and epidermal barrier. We have shown that nonlesional skin
from subjects with AD have dysfunctional tight junctions (TJ). Here we report that S.aureus-respon-
sive innate receptors expressed on keratinocytes affect TJ function. Transepithelial electrical resist-
ance (TEER) and expression of TJ proteins were measured in primary keratinocyte (KC) incubated
with S. aureus-derived peptidoglycan (PGN) and related molecules by qPCR and Western blot. Epi-
dermal mRNA expression of S. aureus-responsive innate receptors were examined in nonlesional
skin from AD subjects (n=6-8) and nonatopics (NA; n=6-15). The results showed tht PGN stimula-
tion increased TEER (1.4±0.3 fold, n=3-7, P=0.002) and enhanced expression of TJ proteins, claudin
(CLDN)1, CLDN23, occludin and ZO-1. The toll-like receptor (TLR) 2 agonists, Pam3CSK4 (TLR1/2
specific) and Malp-2 (TLR2/6 specific) increased TEER (1.4±0.3 fold, n=3-6, P=0.03 & 1.7±0.3 fold,
n=5, P=0.001, respectively) and CLDN1, CLDN23, occludin and ZO-1 expression. No significant
effect was noted with LTA (TLR2/6 agonist), LPS (TLR4 agonist) and poly I:C (TLR3 agonist) stimu-
lation. A blocking TLR2 antibody inhibited PGN-induced TJ protein expression and barrier enhance-
ment. Expression of TLR1 and 2 was reduced in AD epithelium compared to NA (RVU ratio: TLR2
- 1.4±1.7 vs. 0.6±0.3, P=0.04 & TLR1 - 3.6±2.2 vs. 1.6±0.3, P=0.06). No differences were observed
in the expression of NOD2, TLR6, PGLYRP-3 and PGLYRP-4. In conclusion, TLR2 enhances epi-
dermal TJ function which may be due to enhanced expression of key TJ proteins. The reduced epi-
dermal expression of TLR2 observed in AD subjects may impair the barrier repair response that
should develop in response to S. aureus.
639
Antimicrobial and anti-inflammatory effects of newly synthetic Cecropin A (1-8)-Magainin 2
(1-12) hybrid peptide (CA-MA) and its analogue P5 against Propionibacterium acnes infec-
tion in human keratinocytes
PI Song,1 S Ryu,1 S Acharya,1 Y Park,2 C Gurley1 and CA Armstrong1 1 Dermatology, University
of Arkansas for Medical Sciences, Little Rock, AR and 2 Research Center for Proteineous
Materials, Chosun University School of Medicine, Gwangju, Republic of Korea
Acne vulgaris is one of the most common disorders of human skin affecting over 50 million peo-
ple in the United States. Propionibacterium acnes (P. acnes), a resident of the normal skin microflora
that is present in abnormally high numbers in the pilosebaceous follicles of patients with acne, is
an ubiquitous gram-positive bacteria that plays an important role in the pathogenesis of acne. Cur-
rent standard treatments for acne vulgaris include oral and topical antibiotics and retinoids and
topical benzoyl peroxide. However, there are major limitations of available acne therapies includ-
ing side effects and poor efficacy in many patients. There is recent evidence from our group that
synthetic antimicrobial peptides can alter P. acnes function. In this study, we demonstrated newly
designed synthetic exogenous cecropin A(1-8)-magainin 2(1-12) hybrid peptide (CA-MA) and its
analogue P5 are capable of regulating host inflammatory responses against P. acnes in the skin
through direct bacterial killing effects and modulation of cutaneous innate immune responses. Incu-
bation of P. acnes with CA-MA and P5 yielded 0.8 μM minimal inhibitory concentration (MIC) val-
ues without cytotoxicity to keratinocytes, which is 180 times lower than those of benzoyl peroxide
(150 μM MIC). Moreover, P5 significantly decreased the expression of both mRNA and protein lev-
els of inflammatory cytokines IL-8 and TNFα through NF-κB signaling pathways and efficiently
blocked a rapid fluctuation of keratinocyte intracellular calcium as compared to control studies.
Our data suggest that these newly synthetic peptides may represent a whole new therapeutic approach
to acne vulgaris.
641
Retinoid-related orphan receptor (ROR)gt roles in T cell neoplasia and lymphoid tissue devel-
opment are genetically influenced
S Roberts, R Filler and M Girardi Yale University School of Medicine, New Haven, CT
Given the critical role of T cells in immune-mediated skin disease as well as in cutaneous T cell lym-
phoma, the investigative dermatologist is fundamentally interested in T cell development and mech-
anisms of T cell neoplasia. The retinoid-related orphan receptor (ROR)gt has been shown to play
critical roles in lymphoid tissue development, thymic T cell development, and T cell differentiation.
On a variety of genetic backgrounds, mice mutant at both RORgt alleles have revealed a complete
deficiency of Peyer’s patches and lymph nodes, as well as a propensity for adult-onset T cell lym-
phoma. However, we found that on the cancer susceptible genetic background FVB/N, RORgt-
deficient mice were capable of both axillary and mesenteric lymph node development, yet consis-
tently lacked the capacity to form inguinal lymph nodes or Peyer’s patches. Normal populations of
both CD4+ and CD8+ T cells were demonstrated by flow cytometric analysis of both peripheral
blood and axillary lymph nodes. However, by adulthood, most of the RORgt-deficient FVB/N mice
manifested spontaneous CD4+CD8+ systemic T cell lymphoma with enlarged thymus and spleen.
Intercrosses between C57BL/6 and FVB/N strains confirmed that RORgt-independent regional lym-
phoid tissue and aggressive T cell lymphoma was conferred by dominant FVB/N genetic influ-
ences. These findings indicate that lymphoid tissue development may be differentially regionally
regulated by RORgt-dependent and -independent pathways. In addition, RORgt-deficient FVB mice
may provide a model of spontaneous peripheral T cell lymphoma for in vivo testing of emerging
therapeutics.
640
Interference with the IL-1 network leads to impaired cutaneous response to vaccinia virus
scarification
T Tian,1 Q Jin,2 K Dubin,1 GF Murphy,1 TS Kupper1 and RC Fuhlbrigge1 1 Dermatology, Brigham
and Women’s Hospital, Boston, MA and 2 Stanford University, Palo Alto, CA
One of the best characterized strategies adopted by vaccinia virus (VV) to evade the host immune
system is expression of a homolog of IL-1 receptor that can bind and sequester IL-1β. However, the
host response to VV skin infection under the condition of IL-1 deficiency has not been reported. We
found that IL-1R1-/- mice developed markedly larger primary lesions, numerous satellite lesions and
higher virus counts in skin than WT mice after VV scarification. Following their recovery,these IL-
1R1-/- mice were fully protected against intranasal challenge with a lethal dose of VV,indicating an
effective systemic immune response. The functional systemic immune response of IL-1R1-/- mice
was further demonstrated by comparable production of VV-specific IFNγin spleen and draining
lymph nodes as wild-type (WT) mice following VV scarification. Furthermore, IL-1R1-/- mice effi-
ciently recruited granulocytes and T cells to the inoculated skin. Interestingly, WT BMÇIL-1R1-/-
chimeric mice, but not IL-1-/-BMÇWT chimeric mice, reproduced the exacerbated lesions following
VV scarification seen in IL-1R1-/- mice, indicating that IL-1R1 deficiency in skin resident or stromal
cells was responsible for the impaired cutaneous immune response. To investigate the role of IL-1α
or IL-1β respectively, we applied VV to mice deficient in IL-1α or IL-1β individually. Surprisingly,
we found that both IL-1α-/- and IL-1β-/- mice developed larger skin lesions compared to their WT
controls, which indicates that IL-1α and IL-1β can not replace each other and both are required for
an optimal host response to cutaneous VV infection. Our data suggest that ablation of the IL-1/IL-
1R1 pathway leads to a skin-specific immune deficiency and both IL-1α and IL-1β play crucial
roles in supporting a successful immune defense to VV skin infection.
638
Reduced skin microbiome diversity is associated with atopic dermatitis severity and disease
status
HH Kong,1 J Oh,2 EA Grice,2 SP Conlan,2 C Deming,2 PR Murray,3 ML Turner1 and JA Segre2 1
Dermatology Branch, CCR, NCI, NIH, Bethesda, MD, 2 GMBB, NHGRI, NIH, Bethesda, MD
and 3 Microbiology, DLM, CC, NIH, Bethesda, MD
Atopic dermatitis (AD) affects ~15% of U.S. children and ~2% of adults and is associated with
Staphylococcus aureus colonization and infection. 16S ribosomal RNA (rRNA) genomic sequenc-
ing enables a more comprehensive identification of resident microbes than routine cultures. To
analyze the AD skin microbiome, we studied 10 children with moderate to severe AD at baseline,
flare, and post-flare, and healthy controls. Severity was quantified using SCORAD. Samples were
obtained from characteristically affected areas (antecubital/popliteal fossa), a control site (volar fore-
arm), and a common reservoir for S. aureus (nares). 16S rRNA-based microbial diversity was dra-
matically reduced during flare as compared to post-flare and controls. By analyzing relative abun-
dance of 16S sequences, staphylococcus predominated more during flare (69.1 ± 8.3%, mean ± SE)
than baseline (36.5 ± 7.4%; n=10, p<0.0043, Wilcoxon rank sum test) or post-flare (19.2 ± 4.0%;
n=10, p<0.0001, Wilcoxon rank sum test) and accounted for most of the reduction in diversity. Uti-
lizing a custom-curated reference genome database, speciation of staphylococcal sequences demon-
strated that S. aureus accounted for this selective shift. Initial analysis indicated that reduced micro-
bial diversity (Shannon index) was correlated with higher SCORAD (r=-0.75, Pearson correlation,
p<0.0001 corrected), a finding that will be investigated further in our complete cohort. Future stud-
ies will address changes in the skin microbiome in relation to AD skin barrier function. Our stud-
ies provide comprehensive characterization of skin microbes in AD and controls, confirm the fre-
quent culture-based isolation of S. aureus in AD flares, demonstrate how microbial genomics
complement culture methods in the study of microbes in skin diseases, and represent one of the
earliest longitudinal investigations of the skin microbiome in a dermatologic disorder.
642
Cutaneous TLR2 ligands induce systemic immune regulation mediated by myeloid-derived
suppressor cells
Y Skabytska, M Koeberle, K Chen, S Kaesler and T Biedermann Dermatology, Eberhard-Karls-
University, Tuebingen, Germany
It is well established that Gram positive bacteria colonize the skin, especially inflammatory skin
lesions in atopic dermatitis (AD). It is not well understood how innate immune sensing of Gram pos-
itive bacteria influences cutaneous and systemic immune responses. In order to investigate conse-
quences of microbial substances on AD skin, Th2 dominated contact hypersensitivity (CHS) to the
hapten FITC was investigated. Lipoproteins are important components of Gram positive bacteria
and function as TLR2 ligands. Therefore we applied FITC with or without TLR2 ligands Pam2Cys
and Pam3Cys to FITC sensitized nice to mimic the presence of Gram positive bacteria on skin lesions.
The course of subsequently induced CHS inflammation was not changed in mice that previously
received Pam3Cys. In sharp contrast, in mice previously treated with Pam2Cys, ear swelling was
significantly reduced by > 80%. In addition, FITC-specific IgE and IgG1 antibodies and FITC-spe-
cific T-cell proliferation were also significantly decreased and these effects were TLR2 dependent.
Investigating underlying mechanisms, we identified Gr1+CD11b+ myeloid derived suppressor cells
(MDSCs) to be massively increased after Pam2Cys treatment only and this increase correlated with
in vivo reduction of CD4+ and CD8+ T cells. Inhibition of antigen specific T cell proliferation and
cytokine production by MDSC was cell contact dependent, associated with the induction of IL-10++
DC and not due to T cell apoptosis. Moreover, these regulatory functions of MDSC were depend-
ent on inducible NO synthase (iNOS) and NO production. Collectively, we show for the first time
that the presence of certain lipoproteins on skin is sufficient to regulate systemic immune responses
and that TLR2 ligands are capable to induce MDSCs. Further research is needed to characterize the
natural source of the different lipoproteins, which may be pathogens or non-pathogenic commen-
sals. These findings are crucial for the development of new therapeutic strategies for chronic inflam-
matory skin diseases.
www.jidonline.org   S107
SID11_Abstracts-5  2/28/11  9:27 AM  Page S107
ABSTRACTS
631
Interplay of vitamin D and innate immune responses affects bacterial skin infection
B Muehleisen,1 DD Bikle2 and RL Gallo1 1 Div. of Dermatology, University of California, San
Diego, CA and 2 Dept. of Dermatology, University of California, San Francisco, CA
Vitamin D influences immune recognition and response to microbes. When optimally stimulated
by vitamin D, keratinocytes can directly kill bacteria. Based on these observations we developed a
mouse model to test the importance of vitamin D to bacterial infection in vivo. Mice lacking 1α-
hydroxylase that converts 25-D3 to more potent 1,25-D3 (CYP27B1-/-) and controls were fed a diet
devoid of D3 for 4 weeks and compared to similar mice receiving 2.2 IU/g of D3 in their diet (n=6).
Serum 25-D3 levels decreased off dietary D3 in CYP27B1-/- (36 to 17 ng/ml, p<0.05) and WT mice
(24 to 9 ng/ml, p<0.01). D3 deficiency resulted in decreased neutrophil action as blood from WT
mice on a normal diet caused a 2.9-fold reduction in Group A Streptococcus (GAS), and blood
from CYP27B1-/- mice on a normal diet a 2.2-fold reduction in GAS growth, compared to blood on
the D3 deficient diet (p<0.01, p<0.05 respectively). Thus, in blood killing, dietary D3 but not 1α-
hydroxylase was critical for action. In contrast, in skin, 3 days after s.c. injection with 107 CFU
GAS, only the combination of CYP27B1-/- mice on D3 deficient diet had increased infectious lesions
(30.4±14.95mm vs. 5.72±1.12mm, p<0.05) and more bacteria in skin and spleen (2-fold increase,
p<0.05), but WT mice on a D3 deficient diet and CYP27B1-/- mice on normal diet did not develop
increased skin infections. A molecular explanation for this pattern was seen as CYP27B1-/- mouse
skin on D3 showed elevated beta-defensin4 (mBD4) mRNA (28-fold) compared to WT mice but
CYP27B1-/- mice off D3 had a 5-fold decrease in mBD4 expression while WT mice had no decrease
off dietary D3. Our results show that vitamin D3 intake may protect from bacterial infection in vitro
and in vivo but complex compensatory mechanisms exist that may mask direct associations with
diet under normal conditions.
632
A role for CCR2 in the recruitment of myeloid-derived suppressor cells to human squamous
cell carcinomas
JE Teague, A Gehad, WJ Crisler, MK Lichtman, CD Schmults, Y Jiang, M Dowlatshahi, R Watanabe,
TS Kupper and RA Clark Department of Dermatology, Brigham and Women’s Hospital, Boston,
MA
Squamous cell carcinomas (SCC) are sun-induced skin cancers that are particularly numerous and
aggressive in immunosuppressed individuals. We find that SCC contain iNOS-expressing CD11b+
CD11c- HLA-DR- myeloid-derived suppressor cells (MDSC). Nitric oxide (NO) production by MDSC
inhibits tumor vessel E-selectin expression and likely inhibits T cell homing to SCC. To examine the
mechanism of MDSC recruitment to SCC, we examined the expression of homing receptors on
MDSC isolated from SCC tumors using quantitative RT-PCR, flow cytometry and immunostaining
of tumor cryosections. Flow cytometry staining and RT-PCR of flow sorted SCC MDSC demonstrated
strong and selective expression of CCR2 by iNOS+CD11b+ CD33+ HLA-DR- MDSC but not by
FOXP3+ regulatory T cells in SCC. Immunostaining of SCC cryosections confirmed high CCR2 expres-
sion by iNOS+ MDSC. In vitro migration assays confirmed that CCR2 on MDSC was functional and
mediated chemotaxis of MDSC to CCR2 ligands. Agilent whole genome microarray analysis, quan-
titative RT-PCR and luminex analysis of tumor supernatants demonstrated production of 3 CCR2
ligands, CCL7, CCL13 and CCL2 in SCC. In summary, MDSC play a critical role in SCC immune
evasion by producing NO that impairs vascular E-selectin expression and likely inhibits T cell entry
into SCC. Understanding the mechanism of MDSC recruitment to SCC is therefore critical to enhanc-
ing T cell anti-tumor responses. We find that the MDSC but not the T cells in SCC express functional
CCR2. Three separate ligands for CCR2 are produced by SCC tumors and may mediate recruitment
of MDSC to SCC. Our studies suggest that CCR2 inhibitors, several of which are commercially avail-
able, may have efficacy in blocking MDSC migration to SCC and thus enhancing T cell responses
to SCC.
633
Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis
AM Lin,1 CJ Rubin,1 R Khandpur,1 JY Wang,1 M Riblett,1 S Yalavarthi,2 EC Villanueva,2 P Shah,1
MJ Kaplan2 and AT Bruce1 1 Department of Dermatology, University of Michigan, Ann Arbor,
MI and 2 Division of Rheumatology, Department of Internal Medicine, University of Michigan,
Ann Arbor, MI
IL-17 and IL-23 are absolutely central to psoriasis pathogenesis as drugs targeting either cytokine
are highly effective treatments for this disease. To further understand the complex pathophysiology
of psoriasis, it is imperative to define the precise cellular sources of IL-17 and the mechanisms medi-
ating IL-17 release. Therefore, we sought to visualize and quantify IL-17+ mast cells and neu-
trophils in psoriatic lesions through immunofluorescence staining. Surprisingly, we observe that
most IL-17+ cells in normal and psoriatic skin are mast cells, not T cells. Additionally, neutrophils
in well-developed psoriasis lesions also express IL-17. These IL-17+ mast cells and neutrophils are
found at higher densities in psoriasis lesions compared to uninvolved psoriatic skin or normal skin.
High-powered magnification reveals that lesional mast cells and neutrophils frequently release IL-
17 in the process of forming extracellular traps (MCETs, NETs). Typically formed in response to extra-
cellular pathogens but also seen in vasculitis, ETs are specialized structures where nuclear chro-
matin extrudes into web-like threads covered with antimicrobial proteins which function to trap
microbes. Interestingly, in control human skin explants treated with IL-23 and IL-1β, mast cells read-
ily form ETs with resultant IL-17 release, suggesting a novel mechanism driving ETosis and IL-17
release from mast cells. This study demonstrates that innate immune cells in psoriasis contribute to
the release of IL-17 through the formation of extracellular traps, and that IL-23 and IL-1β provide a
novel mechanistic stimulus for this phenomenon. In conclusion, these observations suggest that
innate IL-17 may be central to the pathogenesis of psoriasis and potentially other diseases, repre-
senting a fundamental mechanism by which the IL-23-IL-17 axis mediates host defense and autoim-
munity.
634
Distinct single chain fragment variable-gp-100 conjugates, targeting dendritic cells in vivo,
have different efficiencies to induce anti-tumor immunity in a RET melanoma model
M Maas, S Ring, AH Enk and K Mahnke Dermatology, Ruprecht-Karls University Heidelberg,
Heidelberg, Germany
Dendritic cells (DC) express the endocytosis receptor CD205, recognized by the antibody NLDC.
By coupling the tumor antigen gp-100 to NLDC antibodies and injecting these conjugates together
with CpG into C57/bl6 mice, we established anti-melanoma immunity in a B16 model. To gener-
ate a recombinant vaccine, utilizing the DC loading properties of antibody-gp-100 conjugates, we
expressed two different single chain fragment variables (scFv) specific for CD205, fused with gp-
100 (CD205:scFv-gp-100). Although the two scFv are distinct in their amino acid sequence, we
show by immunofluorescence microscopy that both conjugates bind to DC in vitro and are being
taken up and transported into MHC II+/LAMP-1+ compartments. To assess their efficiency in target-
ing DC in vivo, scFv conjugates were injected s.c. into C57/bl6 mice. Inguinal lymph nodes (LN)
were removed 24h later and cryosections were stained with scFv-gp-100 specific antibodies. We
show that both CD205:scFv-gp-100 conjugates were detectable in LN DC. In contrast, control con-
jugates containing galactosidase-specific scFv did not target DC. To test for the induction of anti-
melanoma immunity, CD205:scFv-gp-100 and control conjugates, together with CpG, were biweekly
injected into mice for two weeks, followed by s.c. injection of 105 RET tumor cells. When moni-
toring the tumor growth we show that mice immunized with CD205:scFv-gp-100 conjugates exhib-
ited a significantly lower incidence of tumor growth as compared to controls. Even more interest-
ing, one of the CD205:scFv-gp-100 conjugates was superior in inducing anti-tumor immunity, as
6/7 vaccinated mice rejected the tumors completely. Thus, although distinct scFv conjugates bind
the same surface antigen on DC with similar efficacy in vitro, in vivo binding and/or targeting prop-
erties of different scFv-antigen conjugates has to be tested to determine their value for development
of novel anti-melanoma therapies.
635
IFN-γ activation of a vitamin D-dependent antimicrobial response depends on skin pigmen-
tation
M Fabri1,3 and RL Modlin1,2 1 Department of Medicine, Division of Dermatology, David Geffen
School of Medicine at UCLA, Los Angeles, CA, 2 Department of Microbiology, Immunology
and Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA and 3
Department of Dermatology, University of Cologne, Cologne, Germany
The mechanisms by which the human T cell response contributes to host defense against microbial
pathogens remain unclear. We demonstrate that T cells via IFN-γ secretion induce a host response
in macrophages that includes the generation of antimicrobial peptides, autophagy and phagosomal
maturation and is dependent on the serum availability of vitamin D. Furthermore, in human
macrophage cultures with vitamin D-sufficient [serum 25D level>30ng/ml] but not insufficient serum
[serum 25D level<30ng/ml], IFN-γ activation directly induced an antimicrobial activity against intra-
cellular mycobacteria, resulting in a 51±5% [p<0.001] inhibition of bacterial growth as compared
to media. Strikingly, sera from African-American individuals, known to be vitamin D insufficient
because of skin pigmentation were inefficient in supporting IFN-γ induced cathelicidin and DEFB4
antimicrobial peptide gene expression as compared to sera from white individuals that were vita-
min D sufficient [cathelicidin mRNA fold change 1.7±0.08 vs. 1.0±0.21, p<0.05; DEFB4 mRNA
fold change 2.3±0.21 vs. 1.2±0.39, p<0.05]. In summary, our findings may explain how the regu-
lation of vitamin D serum levels by skin pigmentation is linked to T cell host defense pathways
against microbial infection.
636
Characterization of microbial communities in non-healed versus healed venous insufficiency
wounds using deep sequencing methods
MS Tuttle,1 E Mostow,2,1 MA Ghannoum,2 FZ Hu,3 R Melton-Kreft,3 G Ehrlich3 and SE Dowd4 1
Dermatology, Case Western Reserve University, Cleveland, OH, 2 Akron General Medical
Center, Akron, OH, 3 Center for Genomic Sciences, Allegheny-Singer Research Institute,
Pittsburgh, PA and 4 Medical Biofilm Research Institute and Research and Testing Laboratory,
Lubbock, TX
Non-healing wounds are an increasing public health burden, and microbial infections are recog-
nized as one of the many destructive processes that delay wound healing. Chronic wounds are
inhabited with polymicrobial communities in which microbial interactions can alter virulence and
pathogenicity. Further study is needed to understand the effect of the composition of microbial com-
munities (or microbiome) on wound healing parameters. In this study, we analyzed debridement
samples from lower extremity venous insufficiency wounds using 16s 454 FLX pyrosequencing, the
Ibis T5000 universal biosensor (Ibis), as well as fungal and anaerobic and aerobic bacterial cul-
tures. Wound debridement samples were obtained at baseline (10 patients) as well as within 10 to
14 weeks of baseline (4 patients). Patients were followed for at least six months, at which point five
of the ten sampled wounds had healed. Pyrosequencing data revealed significantly higher micro-
bial abundances and diversity as well as higher levels of the phyla Bacteroidetes and Actinobacte-
ria in wounds that had not healed at six months. No significant differences were found when
patient samples were grouped according to wound surface area, duration, or with analysis by Ibis
or traditional culture. Thus, pyrosequencing more clearly defined differences between polymicro-
bial communities in non-healed versus healed wounds, furthering our understanding of potentially
unique microbiome characteristics of chronic wounds that could lead to novel therapeutic strate-
gies to improve healing.
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Staphylococcus aureus-derived PGN enhances the integrity of epidermal tight junctions
I Kuo,1,2 A De Benedetto,1 T Yoshida1 and LA Beck1 1 Dermatology, University of Rochester
Medical Center, Rochester, NY and 2 Pathology and Laboratory Medicine, University of
Rochester Medical Center, Rochester, NY
Atopic dermatitis (AD) is caused in part by barrier disruption and is characterized by cutaneous
colonization and infection with S. aureus. Recent studies have suggested that there may be crosstalk
between the innate immune system and epidermal barrier. We have shown that nonlesional skin
from subjects with AD have dysfunctional tight junctions (TJ). Here we report that S.aureus-respon-
sive innate receptors expressed on keratinocytes affect TJ function. Transepithelial electrical resist-
ance (TEER) and expression of TJ proteins were measured in primary keratinocyte (KC) incubated
with S. aureus-derived peptidoglycan (PGN) and related molecules by qPCR and Western blot. Epi-
dermal mRNA expression of S. aureus-responsive innate receptors were examined in nonlesional
skin from AD subjects (n=6-8) and nonatopics (NA; n=6-15). The results showed tht PGN stimula-
tion increased TEER (1.4±0.3 fold, n=3-7, P=0.002) and enhanced expression of TJ proteins, claudin
(CLDN)1, CLDN23, occludin and ZO-1. The toll-like receptor (TLR) 2 agonists, Pam3CSK4 (TLR1/2
specific) and Malp-2 (TLR2/6 specific) increased TEER (1.4±0.3 fold, n=3-6, P=0.03 & 1.7±0.3 fold,
n=5, P=0.001, respectively) and CLDN1, CLDN23, occludin and ZO-1 expression. No significant
effect was noted with LTA (TLR2/6 agonist), LPS (TLR4 agonist) and poly I:C (TLR3 agonist) stimu-
lation. A blocking TLR2 antibody inhibited PGN-induced TJ protein expression and barrier enhance-
ment. Expression of TLR1 and 2 was reduced in AD epithelium compared to NA (RVU ratio: TLR2
- 1.4±1.7 vs. 0.6±0.3, P=0.04 & TLR1 - 3.6±2.2 vs. 1.6±0.3, P=0.06). No differences were observed
in the expression of NOD2, TLR6, PGLYRP-3 and PGLYRP-4. In conclusion, TLR2 enhances epi-
dermal TJ function which may be due to enhanced expression of key TJ proteins. The reduced epi-
dermal expression of TLR2 observed in AD subjects may impair the barrier repair response that
should develop in response to S. aureus.
639
Antimicrobial and anti-inflammatory effects of newly synthetic Cecropin A (1-8)-Magainin 2
(1-12) hybrid peptide (CA-MA) and its analogue P5 against Propionibacterium acnes infec-
tion in human keratinocytes
PI Song,1 S Ryu,1 S Acharya,1 Y Park,2 C Gurley1 and CA Armstrong1 1 Dermatology, University
of Arkansas for Medical Sciences, Little Rock, AR and 2 Research Center for Proteineous
Materials, Chosun University School of Medicine, Gwangju, Republic of Korea
Acne vulgaris is one of the most common disorders of human skin affecting over 50 million peo-
ple in the United States. Propionibacterium acnes (P. acnes), a resident of the normal skin microflora
that is present in abnormally high numbers in the pilosebaceous follicles of patients with acne, is
an ubiquitous gram-positive bacteria that plays an important role in the pathogenesis of acne. Cur-
rent standard treatments for acne vulgaris include oral and topical antibiotics and retinoids and
topical benzoyl peroxide. However, there are major limitations of available acne therapies includ-
ing side effects and poor efficacy in many patients. There is recent evidence from our group that
synthetic antimicrobial peptides can alter P. acnes function. In this study, we demonstrated newly
designed synthetic exogenous cecropin A(1-8)-magainin 2(1-12) hybrid peptide (CA-MA) and its
analogue P5 are capable of regulating host inflammatory responses against P. acnes in the skin
through direct bacterial killing effects and modulation of cutaneous innate immune responses. Incu-
bation of P. acnes with CA-MA and P5 yielded 0.8 μM minimal inhibitory concentration (MIC) val-
ues without cytotoxicity to keratinocytes, which is 180 times lower than those of benzoyl peroxide
(150 μM MIC). Moreover, P5 significantly decreased the expression of both mRNA and protein lev-
els of inflammatory cytokines IL-8 and TNFα through NF-κB signaling pathways and efficiently
blocked a rapid fluctuation of keratinocyte intracellular calcium as compared to control studies.
Our data suggest that these newly synthetic peptides may represent a whole new therapeutic approach
to acne vulgaris.
641
Retinoid-related orphan receptor (ROR)gt roles in T cell neoplasia and lymphoid tissue devel-
opment are genetically influenced
S Roberts, R Filler and M Girardi Yale University School of Medicine, New Haven, CT
Given the critical role of T cells in immune-mediated skin disease as well as in cutaneous T cell lym-
phoma, the investigative dermatologist is fundamentally interested in T cell development and mech-
anisms of T cell neoplasia. The retinoid-related orphan receptor (ROR)gt has been shown to play
critical roles in lymphoid tissue development, thymic T cell development, and T cell differentiation.
On a variety of genetic backgrounds, mice mutant at both RORgt alleles have revealed a complete
deficiency of Peyer’s patches and lymph nodes, as well as a propensity for adult-onset T cell lym-
phoma. However, we found that on the cancer susceptible genetic background FVB/N, RORgt-
deficient mice were capable of both axillary and mesenteric lymph node development, yet consis-
tently lacked the capacity to form inguinal lymph nodes or Peyer’s patches. Normal populations of
both CD4+ and CD8+ T cells were demonstrated by flow cytometric analysis of both peripheral
blood and axillary lymph nodes. However, by adulthood, most of the RORgt-deficient FVB/N mice
manifested spontaneous CD4+CD8+ systemic T cell lymphoma with enlarged thymus and spleen.
Intercrosses between C57BL/6 and FVB/N strains confirmed that RORgt-independent regional lym-
phoid tissue and aggressive T cell lymphoma was conferred by dominant FVB/N genetic influ-
ences. These findings indicate that lymphoid tissue development may be differentially regionally
regulated by RORgt-dependent and -independent pathways. In addition, RORgt-deficient FVB mice
may provide a model of spontaneous peripheral T cell lymphoma for in vivo testing of emerging
therapeutics.
640
Interference with the IL-1 network leads to impaired cutaneous response to vaccinia virus
scarification
T Tian,1 Q Jin,2 K Dubin,1 GF Murphy,1 TS Kupper1 and RC Fuhlbrigge1 1 Dermatology, Brigham
and Women’s Hospital, Boston, MA and 2 Stanford University, Palo Alto, CA
One of the best characterized strategies adopted by vaccinia virus (VV) to evade the host immune
system is expression of a homolog of IL-1 receptor that can bind and sequester IL-1β. However, the
host response to VV skin infection under the condition of IL-1 deficiency has not been reported. We
found that IL-1R1-/- mice developed markedly larger primary lesions, numerous satellite lesions and
higher virus counts in skin than WT mice after VV scarification. Following their recovery,these IL-
1R1-/- mice were fully protected against intranasal challenge with a lethal dose of VV,indicating an
effective systemic immune response. The functional systemic immune response of IL-1R1-/- mice
was further demonstrated by comparable production of VV-specific IFNγin spleen and draining
lymph nodes as wild-type (WT) mice following VV scarification. Furthermore, IL-1R1-/- mice effi-
ciently recruited granulocytes and T cells to the inoculated skin. Interestingly, WT BMÇIL-1R1-/-
chimeric mice, but not IL-1-/-BMÇWT chimeric mice, reproduced the exacerbated lesions following
VV scarification seen in IL-1R1-/- mice, indicating that IL-1R1 deficiency in skin resident or stromal
cells was responsible for the impaired cutaneous immune response. To investigate the role of IL-1α
or IL-1β respectively, we applied VV to mice deficient in IL-1α or IL-1β individually. Surprisingly,
we found that both IL-1α-/- and IL-1β-/- mice developed larger skin lesions compared to their WT
controls, which indicates that IL-1α and IL-1β can not replace each other and both are required for
an optimal host response to cutaneous VV infection. Our data suggest that ablation of the IL-1/IL-
1R1 pathway leads to a skin-specific immune deficiency and both IL-1α and IL-1β play crucial
roles in supporting a successful immune defense to VV skin infection.
638
Reduced skin microbiome diversity is associated with atopic dermatitis severity and disease
status
HH Kong,1 J Oh,2 EA Grice,2 SP Conlan,2 C Deming,2 PR Murray,3 ML Turner1 and JA Segre2 1
Dermatology Branch, CCR, NCI, NIH, Bethesda, MD, 2 GMBB, NHGRI, NIH, Bethesda, MD
and 3 Microbiology, DLM, CC, NIH, Bethesda, MD
Atopic dermatitis (AD) affects ~15% of U.S. children and ~2% of adults and is associated with
Staphylococcus aureus colonization and infection. 16S ribosomal RNA (rRNA) genomic sequenc-
ing enables a more comprehensive identification of resident microbes than routine cultures. To
analyze the AD skin microbiome, we studied 10 children with moderate to severe AD at baseline,
flare, and post-flare, and healthy controls. Severity was quantified using SCORAD. Samples were
obtained from characteristically affected areas (antecubital/popliteal fossa), a control site (volar fore-
arm), and a common reservoir for S. aureus (nares). 16S rRNA-based microbial diversity was dra-
matically reduced during flare as compared to post-flare and controls. By analyzing relative abun-
dance of 16S sequences, staphylococcus predominated more during flare (69.1 ± 8.3%, mean ± SE)
than baseline (36.5 ± 7.4%; n=10, p<0.0043, Wilcoxon rank sum test) or post-flare (19.2 ± 4.0%;
n=10, p<0.0001, Wilcoxon rank sum test) and accounted for most of the reduction in diversity. Uti-
lizing a custom-curated reference genome database, speciation of staphylococcal sequences demon-
strated that S. aureus accounted for this selective shift. Initial analysis indicated that reduced micro-
bial diversity (Shannon index) was correlated with higher SCORAD (r=-0.75, Pearson correlation,
p<0.0001 corrected), a finding that will be investigated further in our complete cohort. Future stud-
ies will address changes in the skin microbiome in relation to AD skin barrier function. Our stud-
ies provide comprehensive characterization of skin microbes in AD and controls, confirm the fre-
quent culture-based isolation of S. aureus in AD flares, demonstrate how microbial genomics
complement culture methods in the study of microbes in skin diseases, and represent one of the
earliest longitudinal investigations of the skin microbiome in a dermatologic disorder.
642
Cutaneous TLR2 ligands induce systemic immune regulation mediated by myeloid-derived
suppressor cells
Y Skabytska, M Koeberle, K Chen, S Kaesler and T Biedermann Dermatology, Eberhard-Karls-
University, Tuebingen, Germany
It is well established that Gram positive bacteria colonize the skin, especially inflammatory skin
lesions in atopic dermatitis (AD). It is not well understood how innate immune sensing of Gram pos-
itive bacteria influences cutaneous and systemic immune responses. In order to investigate conse-
quences of microbial substances on AD skin, Th2 dominated contact hypersensitivity (CHS) to the
hapten FITC was investigated. Lipoproteins are important components of Gram positive bacteria
and function as TLR2 ligands. Therefore we applied FITC with or without TLR2 ligands Pam2Cys
and Pam3Cys to FITC sensitized nice to mimic the presence of Gram positive bacteria on skin lesions.
The course of subsequently induced CHS inflammation was not changed in mice that previously
received Pam3Cys. In sharp contrast, in mice previously treated with Pam2Cys, ear swelling was
significantly reduced by > 80%. In addition, FITC-specific IgE and IgG1 antibodies and FITC-spe-
cific T-cell proliferation were also significantly decreased and these effects were TLR2 dependent.
Investigating underlying mechanisms, we identified Gr1+CD11b+ myeloid derived suppressor cells
(MDSCs) to be massively increased after Pam2Cys treatment only and this increase correlated with
in vivo reduction of CD4+ and CD8+ T cells. Inhibition of antigen specific T cell proliferation and
cytokine production by MDSC was cell contact dependent, associated with the induction of IL-10++
DC and not due to T cell apoptosis. Moreover, these regulatory functions of MDSC were depend-
ent on inducible NO synthase (iNOS) and NO production. Collectively, we show for the first time
that the presence of certain lipoproteins on skin is sufficient to regulate systemic immune responses
and that TLR2 ligands are capable to induce MDSCs. Further research is needed to characterize the
natural source of the different lipoproteins, which may be pathogens or non-pathogenic commen-
sals. These findings are crucial for the development of new therapeutic strategies for chronic inflam-
matory skin diseases.
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Interplay of vitamin D and innate immune responses affects bacterial skin infection
B Muehleisen,1 DD Bikle2 and RL Gallo1 1 Div. of Dermatology, University of California, San
Diego, CA and 2 Dept. of Dermatology, University of California, San Francisco, CA
Vitamin D influences immune recognition and response to microbes. When optimally stimulated
by vitamin D, keratinocytes can directly kill bacteria. Based on these observations we developed a
mouse model to test the importance of vitamin D to bacterial infection in vivo. Mice lacking 1α-
hydroxylase that converts 25-D3 to more potent 1,25-D3 (CYP27B1-/-) and controls were fed a diet
devoid of D3 for 4 weeks and compared to similar mice receiving 2.2 IU/g of D3 in their diet (n=6).
Serum 25-D3 levels decreased off dietary D3 in CYP27B1-/- (36 to 17 ng/ml, p<0.05) and WT mice
(24 to 9 ng/ml, p<0.01). D3 deficiency resulted in decreased neutrophil action as blood from WT
mice on a normal diet caused a 2.9-fold reduction in Group A Streptococcus (GAS), and blood
from CYP27B1-/- mice on a normal diet a 2.2-fold reduction in GAS growth, compared to blood on
the D3 deficient diet (p<0.01, p<0.05 respectively). Thus, in blood killing, dietary D3 but not 1α-
hydroxylase was critical for action. In contrast, in skin, 3 days after s.c. injection with 107 CFU
GAS, only the combination of CYP27B1-/- mice on D3 deficient diet had increased infectious lesions
(30.4±14.95mm vs. 5.72±1.12mm, p<0.05) and more bacteria in skin and spleen (2-fold increase,
p<0.05), but WT mice on a D3 deficient diet and CYP27B1-/- mice on normal diet did not develop
increased skin infections. A molecular explanation for this pattern was seen as CYP27B1-/- mouse
skin on D3 showed elevated beta-defensin4 (mBD4) mRNA (28-fold) compared to WT mice but
CYP27B1-/- mice off D3 had a 5-fold decrease in mBD4 expression while WT mice had no decrease
off dietary D3. Our results show that vitamin D3 intake may protect from bacterial infection in vitro
and in vivo but complex compensatory mechanisms exist that may mask direct associations with
diet under normal conditions.
632
A role for CCR2 in the recruitment of myeloid-derived suppressor cells to human squamous
cell carcinomas
JE Teague, A Gehad, WJ Crisler, MK Lichtman, CD Schmults, Y Jiang, M Dowlatshahi, R Watanabe,
TS Kupper and RA Clark Department of Dermatology, Brigham and Women’s Hospital, Boston,
MA
Squamous cell carcinomas (SCC) are sun-induced skin cancers that are particularly numerous and
aggressive in immunosuppressed individuals. We find that SCC contain iNOS-expressing CD11b+
CD11c- HLA-DR- myeloid-derived suppressor cells (MDSC). Nitric oxide (NO) production by MDSC
inhibits tumor vessel E-selectin expression and likely inhibits T cell homing to SCC. To examine the
mechanism of MDSC recruitment to SCC, we examined the expression of homing receptors on
MDSC isolated from SCC tumors using quantitative RT-PCR, flow cytometry and immunostaining
of tumor cryosections. Flow cytometry staining and RT-PCR of flow sorted SCC MDSC demonstrated
strong and selective expression of CCR2 by iNOS+CD11b+ CD33+ HLA-DR- MDSC but not by
FOXP3+ regulatory T cells in SCC. Immunostaining of SCC cryosections confirmed high CCR2 expres-
sion by iNOS+ MDSC. In vitro migration assays confirmed that CCR2 on MDSC was functional and
mediated chemotaxis of MDSC to CCR2 ligands. Agilent whole genome microarray analysis, quan-
titative RT-PCR and luminex analysis of tumor supernatants demonstrated production of 3 CCR2
ligands, CCL7, CCL13 and CCL2 in SCC. In summary, MDSC play a critical role in SCC immune
evasion by producing NO that impairs vascular E-selectin expression and likely inhibits T cell entry
into SCC. Understanding the mechanism of MDSC recruitment to SCC is therefore critical to enhanc-
ing T cell anti-tumor responses. We find that the MDSC but not the T cells in SCC express functional
CCR2. Three separate ligands for CCR2 are produced by SCC tumors and may mediate recruitment
of MDSC to SCC. Our studies suggest that CCR2 inhibitors, several of which are commercially avail-
able, may have efficacy in blocking MDSC migration to SCC and thus enhancing T cell responses
to SCC.
633
Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis
AM Lin,1 CJ Rubin,1 R Khandpur,1 JY Wang,1 M Riblett,1 S Yalavarthi,2 EC Villanueva,2 P Shah,1
MJ Kaplan2 and AT Bruce1 1 Department of Dermatology, University of Michigan, Ann Arbor,
MI and 2 Division of Rheumatology, Department of Internal Medicine, University of Michigan,
Ann Arbor, MI
IL-17 and IL-23 are absolutely central to psoriasis pathogenesis as drugs targeting either cytokine
are highly effective treatments for this disease. To further understand the complex pathophysiology
of psoriasis, it is imperative to define the precise cellular sources of IL-17 and the mechanisms medi-
ating IL-17 release. Therefore, we sought to visualize and quantify IL-17+ mast cells and neu-
trophils in psoriatic lesions through immunofluorescence staining. Surprisingly, we observe that
most IL-17+ cells in normal and psoriatic skin are mast cells, not T cells. Additionally, neutrophils
in well-developed psoriasis lesions also express IL-17. These IL-17+ mast cells and neutrophils are
found at higher densities in psoriasis lesions compared to uninvolved psoriatic skin or normal skin.
High-powered magnification reveals that lesional mast cells and neutrophils frequently release IL-
17 in the process of forming extracellular traps (MCETs, NETs). Typically formed in response to extra-
cellular pathogens but also seen in vasculitis, ETs are specialized structures where nuclear chro-
matin extrudes into web-like threads covered with antimicrobial proteins which function to trap
microbes. Interestingly, in control human skin explants treated with IL-23 and IL-1β, mast cells read-
ily form ETs with resultant IL-17 release, suggesting a novel mechanism driving ETosis and IL-17
release from mast cells. This study demonstrates that innate immune cells in psoriasis contribute to
the release of IL-17 through the formation of extracellular traps, and that IL-23 and IL-1β provide a
novel mechanistic stimulus for this phenomenon. In conclusion, these observations suggest that
innate IL-17 may be central to the pathogenesis of psoriasis and potentially other diseases, repre-
senting a fundamental mechanism by which the IL-23-IL-17 axis mediates host defense and autoim-
munity.
634
Distinct single chain fragment variable-gp-100 conjugates, targeting dendritic cells in vivo,
have different efficiencies to induce anti-tumor immunity in a RET melanoma model
M Maas, S Ring, AH Enk and K Mahnke Dermatology, Ruprecht-Karls University Heidelberg,
Heidelberg, Germany
Dendritic cells (DC) express the endocytosis receptor CD205, recognized by the antibody NLDC.
By coupling the tumor antigen gp-100 to NLDC antibodies and injecting these conjugates together
with CpG into C57/bl6 mice, we established anti-melanoma immunity in a B16 model. To gener-
ate a recombinant vaccine, utilizing the DC loading properties of antibody-gp-100 conjugates, we
expressed two different single chain fragment variables (scFv) specific for CD205, fused with gp-
100 (CD205:scFv-gp-100). Although the two scFv are distinct in their amino acid sequence, we
show by immunofluorescence microscopy that both conjugates bind to DC in vitro and are being
taken up and transported into MHC II+/LAMP-1+ compartments. To assess their efficiency in target-
ing DC in vivo, scFv conjugates were injected s.c. into C57/bl6 mice. Inguinal lymph nodes (LN)
were removed 24h later and cryosections were stained with scFv-gp-100 specific antibodies. We
show that both CD205:scFv-gp-100 conjugates were detectable in LN DC. In contrast, control con-
jugates containing galactosidase-specific scFv did not target DC. To test for the induction of anti-
melanoma immunity, CD205:scFv-gp-100 and control conjugates, together with CpG, were biweekly
injected into mice for two weeks, followed by s.c. injection of 105 RET tumor cells. When moni-
toring the tumor growth we show that mice immunized with CD205:scFv-gp-100 conjugates exhib-
ited a significantly lower incidence of tumor growth as compared to controls. Even more interest-
ing, one of the CD205:scFv-gp-100 conjugates was superior in inducing anti-tumor immunity, as
6/7 vaccinated mice rejected the tumors completely. Thus, although distinct scFv conjugates bind
the same surface antigen on DC with similar efficacy in vitro, in vivo binding and/or targeting prop-
erties of different scFv-antigen conjugates has to be tested to determine their value for development
of novel anti-melanoma therapies.
635
IFN-γ activation of a vitamin D-dependent antimicrobial response depends on skin pigmen-
tation
M Fabri1,3 and RL Modlin1,2 1 Department of Medicine, Division of Dermatology, David Geffen
School of Medicine at UCLA, Los Angeles, CA, 2 Department of Microbiology, Immunology
and Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA and 3
Department of Dermatology, University of Cologne, Cologne, Germany
The mechanisms by which the human T cell response contributes to host defense against microbial
pathogens remain unclear. We demonstrate that T cells via IFN-γ secretion induce a host response
in macrophages that includes the generation of antimicrobial peptides, autophagy and phagosomal
maturation and is dependent on the serum availability of vitamin D. Furthermore, in human
macrophage cultures with vitamin D-sufficient [serum 25D level>30ng/ml] but not insufficient serum
[serum 25D level<30ng/ml], IFN-γ activation directly induced an antimicrobial activity against intra-
cellular mycobacteria, resulting in a 51±5% [p<0.001] inhibition of bacterial growth as compared
to media. Strikingly, sera from African-American individuals, known to be vitamin D insufficient
because of skin pigmentation were inefficient in supporting IFN-γ induced cathelicidin and DEFB4
antimicrobial peptide gene expression as compared to sera from white individuals that were vita-
min D sufficient [cathelicidin mRNA fold change 1.7±0.08 vs. 1.0±0.21, p<0.05; DEFB4 mRNA
fold change 2.3±0.21 vs. 1.2±0.39, p<0.05]. In summary, our findings may explain how the regu-
lation of vitamin D serum levels by skin pigmentation is linked to T cell host defense pathways
against microbial infection.
636
Characterization of microbial communities in non-healed versus healed venous insufficiency
wounds using deep sequencing methods
MS Tuttle,1 E Mostow,2,1 MA Ghannoum,2 FZ Hu,3 R Melton-Kreft,3 G Ehrlich3 and SE Dowd4 1
Dermatology, Case Western Reserve University, Cleveland, OH, 2 Akron General Medical
Center, Akron, OH, 3 Center for Genomic Sciences, Allegheny-Singer Research Institute,
Pittsburgh, PA and 4 Medical Biofilm Research Institute and Research and Testing Laboratory,
Lubbock, TX
Non-healing wounds are an increasing public health burden, and microbial infections are recog-
nized as one of the many destructive processes that delay wound healing. Chronic wounds are
inhabited with polymicrobial communities in which microbial interactions can alter virulence and
pathogenicity. Further study is needed to understand the effect of the composition of microbial com-
munities (or microbiome) on wound healing parameters. In this study, we analyzed debridement
samples from lower extremity venous insufficiency wounds using 16s 454 FLX pyrosequencing, the
Ibis T5000 universal biosensor (Ibis), as well as fungal and anaerobic and aerobic bacterial cul-
tures. Wound debridement samples were obtained at baseline (10 patients) as well as within 10 to
14 weeks of baseline (4 patients). Patients were followed for at least six months, at which point five
of the ten sampled wounds had healed. Pyrosequencing data revealed significantly higher micro-
bial abundances and diversity as well as higher levels of the phyla Bacteroidetes and Actinobacte-
ria in wounds that had not healed at six months. No significant differences were found when
patient samples were grouped according to wound surface area, duration, or with analysis by Ibis
or traditional culture. Thus, pyrosequencing more clearly defined differences between polymicro-
bial communities in non-healed versus healed wounds, furthering our understanding of potentially
unique microbiome characteristics of chronic wounds that could lead to novel therapeutic strate-
gies to improve healing.
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Three dimentional (3D) reconstructed psoriatic tissue model
S Ayehunie,1 C Hedin,1 T Landry,1 A Wang,1 M Spratt,1 R Clark,2 T Kupper2 and M Klausner1 1
MatTek Corporation, Ashland, MA and 2 Brigham and Womens Hospital, Boston, MA
Psoriasis is a chronic skin disease that affects about 2% of the global population. Availability of
well characterized in vitro psoriatic tissue model will enhance our understanding of the disease
and the development of therapeutic strategies. In this study, an in vitro three-dimensional psoriatic-
like tissue model was reconstructed, culture conditions were optimized, and the model was char-
acterized using H& E staining (morphology), immunohistochemistry (proliferation of basal cells as
demonstrated by the Ki67 staining profile, psoriasin expression), RT-PCR (gene expression levels),
and ELISA assays (cytokine analysis). Results showed that the reconstructed psoriatic 3-D tissue
model has phenotypic and architectural similarity to the in vivo counterpart in that the tissue model
showed over expression of biomarkers associated with psoriasis including human beta defensin-2
(HBD-2), psoriasin, and CXCR2. Similar to the in vivo situation, cytokine analysis of culture super-
natants from the psoriatic-like tissue model showed increased release of IL-6 (7 fold), IL-8 (5.5
fold), and GRO-α (3.8 fold) by the psoriatic tissue model when compared to normal reconstructed
epidermal tissues. Topical exposure of the psoriatic-like tissue to IL-4 showed a dose dependent
decrease in HBD-2 gene expression and IL-6 release (3.0-4.3 fold). In conclusion, the psoriatic tis-
sue model mimics the in vivo counterpart in terms of tissue morphology, tissue structure, gene expres-
sion (CXCR2, beta defensin, and psoriasis), and cytokine release (IL-6, IL-8, GRO-α). The model
can serve as a valuable tool to study the biology of psoriasis and for preclinical assessment of tox-
icity and proinflammatory effects of therapeutic candidates.
651
Non-neuronal cholinergic activation dampens the antimicrobial peptide response to bacte-
ria in keratinocytes
BJ Curtis and KA Radek Loyola University, Chicago, IL
Antimicrobial peptide (AMP) production is critical for cutaneous innate immune homeostasis. Ker-
atinocyte cells (KC) possess a non-neuronal cholinergic system comprised of acetylcholine (ACh)
and acetylcholine nicotinic (nAChR) and muscarinic receptors. We previously determined that sys-
temic cholinergic activation via psychological stress (PS) in mice diminished epidermal AMP expres-
sion, which was restored by topical application of the α7-nAChR antagonist, α-Bungarotoxin (α-
Bung). In parallel, we observed an increased susceptibility to bacterial infection, supporting clinical
observations that PS promotes or exacerbates many skin disorders associated with AMP dysregula-
tion. However, it is unknown whether this response is due to non-neuronal KC regulation of AMPs
by ACh. We hypothesized that local, non-neuronal cholinergic activation of KC by ACh is enough
to dampen the AMP response to infection in KC. To test this, we stimulated KC organotypic raft cul-
tures with 1,25-dihydroxy Vitamin D3 (VD3) and the Toll-like receptor (TLR) 2/6 ligand Macrophage-
activating lipoprotein-2 (MALP2) to induce AMP expression. Rafts co-stimulated with 0.01nM ACh
exhibited a robust reduction in cathelicidin gene and protein expression compared to VD3/MALP2
alone, as measured by qPCR and immunohistochemistry. This suppression was reversed by the
nAChR antagonists, α-Bung and Catestatin. Furthermore, dexamethasone, a synthetic glucocorti-
coid, increased the expression of the α7-nAChR subtype, suggesting a positive local neuroendocrine
feedback loop involved in KC AMP suppression. Finally, we found that in the presence of VD3/MALP2,
ACh decreased the surface expression of TLR2 in cultured KCs, where VD3 can facilitate detection
of microbial components by KC through TLR2 and respond by increasing AMP production. These
data indicate that local nAChR activation by ACh dampens the AMP response to microbes in KC.
Thus, excess or prolonged non-neuronal nAChR activation in the epidermis may promote AMP
dysregulation and subsequent infection or inflammatory disease progression.
653
An expanding role for novel polyomaviruses in skin disease
JC Browning,1 MR Matthews,2 RC Wang,3 L Matthews,3 R Law,4 G Hosler,4 J Susa,5 C Cockerell5
and KB Yancey3 1 Medicine and Pediatrics, UT Health Sciences Center, San Antonio, TX, 2
Pathology, Christus Santa Rosa Children’s Hospital, San Antonio, TX, 3 Dermatology, UT
Southwestern Medical Center, Dallas, TX, 4 Pathology, ProPath Laboratories, Dallas, TX and 5
Pathology, Dermpath Diagnostics, Dallas, TX
Polyomaviruses are small, dsDNA viruses best known for their tumorigenic properties. Merkel cell
polyomavirus (MCPyV) and Trichodysplasia spinulosa polyomavirus (TSPyV) are recently discov-
ered human polyomaviruses named after their eponymous skin diseases. MCPyV has been found
to be integrated into the genome of Merkel cell carcinoma (MCC) and has been implicated in the
development of this rare neuroendocrine carcinoma. Because MCPyV has also been detected in
normal human appendix and small intestinal tissue, we studied whether MCPyV was present in
MCC and neuroendocrine tumors of the GI tract and adjacent normal tissues. Trichodysplasia spin-
ulosa (TS) is a rare dermatosis of immunosuppressed patients characterized by alopecia and fol-
liculocentric spiny papules. Electron microscopic studies of our case of TS revealed intracellular
viral particles with a size and shape consistent with a polyomavirus. Thus, we studied whether
MCPyV or the recently cloned TSPyV were present in this case of TS. DNA was extracted from for-
malin fixed paraffin embedded tumors (24 Merkel cell carcinomas, 10 neuroendocrine tumors
with adjacent normal GI mucosa, and 1 biopsy from trichodysplasia spinulosa). Using primers based
on the published sequences of MCPyV and TSPyV, MCPyV was detected in 16/24 (67%) of MCC
samples; 0/10 (0%) of neuroendocrine tumors, 1/8 (12.5%) of normal GI control tissue. Moreover,
sequences from TSPyV, but not MCPyV, were detected in this case of TS. Although our study was
limited in scope, we have no evidence that MCPyV integration plays a role in the pathogenesis of
GI neuroendocrine tumors or TS. In addition, we report the first case of TS with both molecular and
ultrastructural evidence for a viral etiology.
652
Imiquimod-induced TLR7 signaling enhances repair of DNA Damage Induced by UVL in bone
marrow-derived cells
R Fishelevich,1 Y Zhao,1 P Tuchinda,1 H Liu,1 TC Meng,2 J Lee2 and A Gaspari1 1 Dermatology,
University of Maryland, Baltimore, MD and 2 Graceway Pharmaceuticals, Exton, PA
To test our hypothesis that IM enhances DNA repair as a mechanism for its anticancer activity, the
nucleotide excision repair gene XPA gene expression was studied in bone marrow derived cells. IM
enhanced XPA gene expression (qPCR analysis) by 2-4 fold in a number of mouse cell lines (P388,
XS52, A20) compared to the control cells. IM treatment of P388 resulted in an increased nuclear
localization of the DNA repair enzyme XPA (western blotting). This IM effect was dependent on
MyD88, as cells from MyD88-/- mice did not increase XPA gene expression, and did not enhance
the survival after UVB exposure as was observed in cells from MyD88+/+ mice. The NF-kB inhibitor
BAY 11-7085, inhibited IM induced increase in XPA gene expression, and IM-induced nuclear local-
ization of XPA as well as inhibited the ability of IM to enhance cell survival after UVL exposures.
IM enhanced DNA repair of UVL irradiated gene expression constructs, and accelerated the reso-
lution of cyclobutane pyrimidine dimers (CPD) after UVL exposures in P388 and XS52. The ability
of IM to enhance the survival of lymphoblasts from a healthy control or from an XPA patient was
studied. Control lymphoblasts responded IM with enhanced survival after exposure to UVL, whereas
lymphoblasts from an XPA patient failed to respond at all. Topical treatment of mouse skin with 5%
IM cream prior to UVL irradiation resulted in a decrease in the number of CPD positive, APC that
were found in local lymph nodes 24 hours after UVL irradiation. In total, these data support the
idea that TLR7 agonists such as IM enhance DNA repair in bone marrow derived cells, and is likely
to be an important mechanism for its anti-cancer effects.
650
Galectin-3 regulates the innate immune response of human monocytes
A Chung,1 R Teles,1 D Montoya,1 S Krutzik,1 J Krahenbuhl,2 D Hsu,3 F Liu,3 EN Sarno,4 TH Rea,5
RL Modlin1 and DJ Lee1 1 Medicine, Division of Dermatology, David Geffen School of
Medicine at UCLA, Los Angeles, CA, 2 School of Veterinary Medicine, Louisiana State
University, Baton Rouge, LA, 3 Department of Dermatology, University of California Davis
School of Medicine, Sacramento, CA, 4 Leprosy Laboratory Institute Oswaldo Cruz, Rio de
Janeiro, Brazil and 5 Department of Dermatology, University of Southern California School of
Medicine, Los Angeles, CA
Leprosy is a spectral disease in which the clinical outcome to infection with Mycobacterium lep-
rae correlates with the cellular immune response to the pathogen. Gene expression analysis of lep-
rosy lesions revealed comparatively increased expression of galectin-3 in the progressive leproma-
tous leprosy lesions versus the self-limited tuberculoid leprosy lesions. The expression of galectin-3
was similarly increased at the protein level by immunohistochemistry labeling. We hypothesized
that the correlation of galectin-3 with progressive infection contributes to the immune unrespon-
siveness observed in lepromatous leprosy by regulating the innate immune response of monocytes.
First, galectin-3 enhanced the ability of monocytes to bind live Mycobacterium leprae by 2.3-fold.
Second, given the importance of TLR2/1 for innate immune recognition of Mycobacterium leprae,
we determined whether galectin-3 could regulate TLR2/1-mediated activation of monocytes. Galectin-
3 enhanced the TLR2/1-mediated production of IL-10 by 4.15-fold while IL-12 was slightly inhib-
ited. Third, galectin-3 diminished the ability of GM-CSF to trigger CD1b expression on human mono-
cytes by 41%, suggesting an impairment of dendritic cell differentiation. Together, these data suggest
a role for galectin-3 in leprosy by regulating the innate immune response of monocytes, contribut-
ing to the progressive infection observed in patients with lepromatous leprosy.
654
Toll like receptor-4 (TLR4) deficiency prevents ultraviolet (UV) radiation induced cutaneous
photoimmunosuppression by DNA repair mechanism
N Yusuf Dermatology, University of Alabama at Birmingham, Birmingham, AL
UVB radiation is a potent immunosuppressive agent that inhibits cell-mediated immune responses.
UV-induced DNA damage, predominantly in the form of cyclobutane pyrimidine dimers (CPD), has
been recognized as an important molecular trigger for the suppression of immune responses. IL-10
causes UVB induced immunosuppression, whereas IL-12 prevents UV-induced immune suppres-
sion by stimulation of DNA repair enzymes and augments the repair of UVB damaged DNA. Pre-
vious studies from our laboratory indicate that TLR4 is involved in UVB induced cutaneous pho-
toimmunosuppression in mice. The purpose of this study was to determine the mechanism through
which TLR4 contributed to UV-induced suppression of contact hypersensitivity responses. Mice were
exposed to acute UVB (90 mJ/cm2) radiation and thereafter sacrificed at 24 h. Skin samples were
obtained and analyzed for CPD. There were significantly fewer CPD (p<0.05) in the skin of TLR4-
/- mice than in the skin of TLR4+/+ mice. Cytokine profiles indicated that IL-10 was significantly
upregulated (p<0.05), and IL-12 was significantly downregulated (p<0.05) in TLR4+/+ mice after
UV exposure. CPD were repaired more rapidly in the skin of TLR4-/- mice than in the skin of TLR4+/+
mouse indicating an efficient DNA repair mechanism in TLR4-/- mice. Thus, blocking TLR4 may
lead to efficient repair of DNA damage in the form of CPD and can be useful in the prevention of
photoimmunosuppression.
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Cutaneous papillomatosis due to a novel laboratory mouse papillomavirus (MusPV) infec-
tion
JP Sundberg,1 CS Potter,1 KA Silva,1 A Ingle,3 J Joh,2 SJ Gim2 and AB Jenson2 1 The Jackson
Laboratory, Bar Harbor, ME, 2 James Graham Brown Cancer Center, University of Louisville,
Louisville, KY and 3 Tata Memorial Centre, ACTREC,, Mumbai, India
Spontaneous, florid papillomatosis arose in a colony of NMRI-Foxn1nu/Foxn1nu (nude) mice and
were transmissible to both immunocompetent and immunodeficient mice. Lesions appeared at the
mucocutaneous junctions of the nose and mouth affecting hair follicles. Histologically, lesions were
classical papillomas with epidermal hyperplasia on thin fibrovascular stalks in a verrucous pattern.
Koilocytotic cells were observed in the stratum granulosum of the papillomatous lesions. Koilo-
cytes were positive for PV group-specific antigens. Virus particles were observed in crystalline intranu-
clear inclusions within keratinocytes. The MusPV genome is 7510 bp in length, is organized simi-
lar to other PVs, and has at least 7 open reading frames (E1, E2, E4, E6, E7, L1, and L2). Phylogenetic
analysis indicates that MusPV belongs to the pi-genus together with 4 other rodent PVs (McPV2,
MaPV1, MmiPV, and RnPV1). Of the rodent PVs, MusPV appears most closely related to Mastomys
coucha PV (McPV2), with 65% genomic homogeneity and 80% L1 amino acid similarity. Rodent
PVs, except for MnPV1, do not contain any identifiable RB binding sites. MusPV has one putative
RB binding site on the E6 protein but not on the E7 protein. Non-coding regions (NCRs) of PVs main-
tain multiple binding sites for transcription factors (TFs). The NCR of MusPV has numerous sites for
TF binding, of which at least 13 TFs are common to all PVs in the pi-genus. MusPV provides a poten-
tially valuable novel mouse model to study mechanisms of infection, oncology, and preventive and
therapeutic approaches in mice that can be translated to diseases caused by human PVs.
644
Nitric oxide from myeloid-derived suppressor cells inhibits vascular E-selectin expression in
human squamous cell carcinomas
A Gehad, MK Lichtman, CD Schmults, JE Teague, WJ Crisler, M Dowlatshahi, R Watanabe,
TS Kupper and RA Clark Department of Dermatology, Brigham and Women’s Hospital, Boston,
MA
Squamous cell carcinomas (SCC) are sun-induced skin cancers that are particularly numerous and
aggressive in immunosuppressed individuals. SCC vessels lack expression of the skin homing addressin
E-selectin and exclude CLA+ skin homing T cells. Topical treatment with the TLR7 agonist imiquimod
leads to induction of vascular E-selectin, infiltration of CLA+ T cells and histologic evidence of tumor
regression, suggesting that primed T cells exist within the circulation of these patients but cannot
access the tumor. We report that SCC contain high numbers of iNOS-expressing CD11b+ CD11c-
HLA-DR- myeloid-derived suppressor cells. Nitric oxide (NO) was present in detectable levels in
tumor supernatants. NO inhibited the expression of E-selectin on human dermal microvascular
endothelial cells in vitro, suggesting it may contribute to E-selectin suppression in tumors. SCC
treated in vitro with the iNOS inhibitor L-NNA showed marked induction of E-selectin expression
on tumor vessels. Treatment with iNOS inhibitors induced E-selectin expression at levels compara-
ble to SCC undergoing immunologic destruction after topical treatment with TLR7 agonist. Our
results suggest that NO inhibits vascular expression of E-selectin in SCC. Treatment with iNOS
inhibitors restores vascular addressin expression and may be effective in the treatment of SCC and
their premalignant precursor lesions, actinic keratoses.
645
Irritant induced production of IL-6 is mediated via EGFR and NFkB independent mecha-
nisms
KJ White,1 VJ Maffei2 and RA Swerlick1,2 1 Dermatology, Emory University, Atlanta, GA and 2
Dermatology, Atlanta VA, Decatur, GA
Irritant contact dermatitis is a common skin condition associated with significant morbidity, par-
ticularly in service workers. The early molecular events of ICD are incompletely defined. Interleukin-
6 (IL-6), a pro-inflammatory cytokine, is rapidly induced by injury, including irritant injury in skin.
The mechanisms of induction and the source of this mediator in skin are not well defined. In order
to examine whether direct irritant action on keratinocytes may induce IL-6 production, we used an
in vitro model using HaCaT cells and the model irritant sodium lauryl sulfate (SLS). Following treat-
ment of HaCaT cells with 0.004% SLS, we observed time-dependent increases in both IL-6 mRNA
(42 + 29 and 162 + 129 fold at 1 and 2 hrs) and secreted protein (42 + 59 and 109 + 140 pg after
4 and 6 hrs). We previously established that SLS-mediated induction of egr-1, VEGF, and IL-8, are
independent of NF-kB activation but highly dependent on metalloprotease-mediated induction of
EGFR signaling. Similarly the proteasome inhibitor MG132 failed to inhibit SLS-induced IL-6,
while blocking TNFα-mediated IL-6 induction, thus supporting an NF-kB independent pathway for
SLS-induced IL-6. SLS activation of EGFR is mediated by ATP release and activation of purinergic
receptors. Consistent with our previous observations, purine treatment (ATP, ADP, and UTP) were
inducers of IL-6, consistent with a common purine release-mediated irritant induced activation path-
way. However, SLS-mediated induction of IL-6 occurred in the presence of small molecule EGFR
inhibitors (PD168393) and the broad spectrum protease inhibitor marimastat, not supporting a role
for EGFR or metalloproteases in irritant-induced IL-6 production. Furthermore, the broad spectrum
purinergic receptor inhibitor suramin had no significant effect on SLS-induced IL-6 mRNA expres-
sion, despite consistent inhibition of egr-1 induction. These data support our hypothesis that direct
irritant effects on keratinocytes induce IL-6 production but do so via pathways independent of NF-
kB and EGFR signaling.
646
Immune modulation by isotretinoin in vivo
MC Dispenza,1 AM Nelson,2 KL Gilliland,1 Z Cong1 and DM Thiboutot1 1 Department of
Dermatology, Penn State University College of Medicine, Hershey, PA and 2 Department of
Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD
Isotretinoin is the only agent that induces a permanent remission of acne, but the mechanism under-
lying its long-term efficacy is unknown. Studies suggest that patients’ specific immune responses to
P.acnes play a larger role in acne than the pathogenicity of P.acnes itself. We hypothesized that mod-
ulation of the immune response to P.acnes is key to isotretinoin’s ability to induce long-term or per-
manent remissions of acne. This study is the first to investigate changes in peripheral immune cells
associated with isotretinoin treatment in acne patients in vivo. Peripheral blood samples were obtained
from acne patients before starting isotretinoin therapy (baseline) and at 1, 4, 8, and 20 weeks after
starting isotretinoin therapy. Monocytes and lymphocytes were isolated, activated in vitro, and ana-
lyzed for subset markers by flow cytometry and for cytokine secretion by bead arrays. Acne patients’
monocytes expressed higher levels of TLR-2 and secreted more IL-1β, IL-6, IL-8, and IL-10 in response
to P. acnes than monocytes from normal volunteers. Isotretinoin therapy significantly decreased TLR-
2 expression on acne patients’ monocytes compared to baseline. Additionally, untreated and P.acnes-
treated monocytes from acne patients secreted less IL-1β, IL-6, IL-8, and IL-10 during isotretinoin
therapy compared to baseline. P.acnes-induced lymphocyte proliferation was significantly higher
in non-acne volunteers than in acne patients at baseline and throughout isotretinoin treatment. These
results suggest that isotretinoin can modulate the in vivo immune response to P.acnes in acne patients.
647
An in-vitro model to investigate the mechanisms involved in inflammatory acne
M Ingrassia, V Ionita Manzatu, J Lombardi and T Mammone Estee Lauder Co., Melville, NY
We developed an in-vitro model to study the mechanisms involved in inflammatory acne. To accom-
plish this SZ95 sebocytes (immortalized human sebocytes) and normal human epidermal keratinocytes
(HEKn) were exposed to lysate of P. acnes and the levels of secreted pro-inflammatory mediators
were evaluated by protein microarray designed specifically to evaluate expression of multiple pro-
inflammatory mediators using cell culture supernatants. In these experiments we observed increases
in the expression of IL6 and IL8 from SZ95 sebocytes and IL8 from HEKn following a 24 hour expo-
sure to P. acnes lysate. Viability of these cultures assessed by MTS conversion to a soluble blue for-
mazan displayed no associated toxicity from the addition of the lysate of P. acnes to SZ95 or HEKn
cells. Subsequent studies were carried out to quantitate the amount of IL6 and IL8 and to determine
if these increases were acting downstream of the p38 arm of the MAPK pathway. Media supernatants
from SZ95 cells incubated with P. acne lysate were measured using ELISA’s specific for either IL6
or IL8. Increases of 70 and 248% in the levels of these secreted cytokines were observed respec-
tively. When cells were co-incubated with both P. acnes lysate and the selective p38 inhibitor
SB202190, we observed attenuation of P. acnes induced levels of IL6 and IL8, indicating that P.
acnes lysate is acting at least in part through the p38 arm of the MAPK pathway.
648
Effect of lactobacillus extract on acne
N Muizzuddin, W Maher, M Sullivan, S Schnittger and T Mammone Estee Lauder Co., Melville,
NY
Normal human skin can produce a range of anti-microbial chemicals that play an important part
in eliminating potential cutaneous pathogens. Lactobacillus plantarum is a Gram-positive bacteria
that produces antimicrobial peptides which when applied to skin can enhance the antimicrobial
properties of skin. Clinical studies were conducted to determine the effect of Lactobacillus extract
on skin microflora and reduction of acne. Results show that Lactobacillus extract was effective in
reducing skin microflora. In addition it was effective in reducing acne lesion size and erythema at
5%, but not at 1%. After 6 weeks of use of Lactobacillus extract there was a 30% reduction in acne
lesions. Based on the results of these studies Lactobacillus extract appears to be a promising topi-
cal agent for control of acne lesions.
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Three dimentional (3D) reconstructed psoriatic tissue model
S Ayehunie,1 C Hedin,1 T Landry,1 A Wang,1 M Spratt,1 R Clark,2 T Kupper2 and M Klausner1 1
MatTek Corporation, Ashland, MA and 2 Brigham and Womens Hospital, Boston, MA
Psoriasis is a chronic skin disease that affects about 2% of the global population. Availability of
well characterized in vitro psoriatic tissue model will enhance our understanding of the disease
and the development of therapeutic strategies. In this study, an in vitro three-dimensional psoriatic-
like tissue model was reconstructed, culture conditions were optimized, and the model was char-
acterized using H& E staining (morphology), immunohistochemistry (proliferation of basal cells as
demonstrated by the Ki67 staining profile, psoriasin expression), RT-PCR (gene expression levels),
and ELISA assays (cytokine analysis). Results showed that the reconstructed psoriatic 3-D tissue
model has phenotypic and architectural similarity to the in vivo counterpart in that the tissue model
showed over expression of biomarkers associated with psoriasis including human beta defensin-2
(HBD-2), psoriasin, and CXCR2. Similar to the in vivo situation, cytokine analysis of culture super-
natants from the psoriatic-like tissue model showed increased release of IL-6 (7 fold), IL-8 (5.5
fold), and GRO-α (3.8 fold) by the psoriatic tissue model when compared to normal reconstructed
epidermal tissues. Topical exposure of the psoriatic-like tissue to IL-4 showed a dose dependent
decrease in HBD-2 gene expression and IL-6 release (3.0-4.3 fold). In conclusion, the psoriatic tis-
sue model mimics the in vivo counterpart in terms of tissue morphology, tissue structure, gene expres-
sion (CXCR2, beta defensin, and psoriasis), and cytokine release (IL-6, IL-8, GRO-α). The model
can serve as a valuable tool to study the biology of psoriasis and for preclinical assessment of tox-
icity and proinflammatory effects of therapeutic candidates.
651
Non-neuronal cholinergic activation dampens the antimicrobial peptide response to bacte-
ria in keratinocytes
BJ Curtis and KA Radek Loyola University, Chicago, IL
Antimicrobial peptide (AMP) production is critical for cutaneous innate immune homeostasis. Ker-
atinocyte cells (KC) possess a non-neuronal cholinergic system comprised of acetylcholine (ACh)
and acetylcholine nicotinic (nAChR) and muscarinic receptors. We previously determined that sys-
temic cholinergic activation via psychological stress (PS) in mice diminished epidermal AMP expres-
sion, which was restored by topical application of the α7-nAChR antagonist, α-Bungarotoxin (α-
Bung). In parallel, we observed an increased susceptibility to bacterial infection, supporting clinical
observations that PS promotes or exacerbates many skin disorders associated with AMP dysregula-
tion. However, it is unknown whether this response is due to non-neuronal KC regulation of AMPs
by ACh. We hypothesized that local, non-neuronal cholinergic activation of KC by ACh is enough
to dampen the AMP response to infection in KC. To test this, we stimulated KC organotypic raft cul-
tures with 1,25-dihydroxy Vitamin D3 (VD3) and the Toll-like receptor (TLR) 2/6 ligand Macrophage-
activating lipoprotein-2 (MALP2) to induce AMP expression. Rafts co-stimulated with 0.01nM ACh
exhibited a robust reduction in cathelicidin gene and protein expression compared to VD3/MALP2
alone, as measured by qPCR and immunohistochemistry. This suppression was reversed by the
nAChR antagonists, α-Bung and Catestatin. Furthermore, dexamethasone, a synthetic glucocorti-
coid, increased the expression of the α7-nAChR subtype, suggesting a positive local neuroendocrine
feedback loop involved in KC AMP suppression. Finally, we found that in the presence of VD3/MALP2,
ACh decreased the surface expression of TLR2 in cultured KCs, where VD3 can facilitate detection
of microbial components by KC through TLR2 and respond by increasing AMP production. These
data indicate that local nAChR activation by ACh dampens the AMP response to microbes in KC.
Thus, excess or prolonged non-neuronal nAChR activation in the epidermis may promote AMP
dysregulation and subsequent infection or inflammatory disease progression.
653
An expanding role for novel polyomaviruses in skin disease
JC Browning,1 MR Matthews,2 RC Wang,3 L Matthews,3 R Law,4 G Hosler,4 J Susa,5 C Cockerell5
and KB Yancey3 1 Medicine and Pediatrics, UT Health Sciences Center, San Antonio, TX, 2
Pathology, Christus Santa Rosa Children’s Hospital, San Antonio, TX, 3 Dermatology, UT
Southwestern Medical Center, Dallas, TX, 4 Pathology, ProPath Laboratories, Dallas, TX and 5
Pathology, Dermpath Diagnostics, Dallas, TX
Polyomaviruses are small, dsDNA viruses best known for their tumorigenic properties. Merkel cell
polyomavirus (MCPyV) and Trichodysplasia spinulosa polyomavirus (TSPyV) are recently discov-
ered human polyomaviruses named after their eponymous skin diseases. MCPyV has been found
to be integrated into the genome of Merkel cell carcinoma (MCC) and has been implicated in the
development of this rare neuroendocrine carcinoma. Because MCPyV has also been detected in
normal human appendix and small intestinal tissue, we studied whether MCPyV was present in
MCC and neuroendocrine tumors of the GI tract and adjacent normal tissues. Trichodysplasia spin-
ulosa (TS) is a rare dermatosis of immunosuppressed patients characterized by alopecia and fol-
liculocentric spiny papules. Electron microscopic studies of our case of TS revealed intracellular
viral particles with a size and shape consistent with a polyomavirus. Thus, we studied whether
MCPyV or the recently cloned TSPyV were present in this case of TS. DNA was extracted from for-
malin fixed paraffin embedded tumors (24 Merkel cell carcinomas, 10 neuroendocrine tumors
with adjacent normal GI mucosa, and 1 biopsy from trichodysplasia spinulosa). Using primers based
on the published sequences of MCPyV and TSPyV, MCPyV was detected in 16/24 (67%) of MCC
samples; 0/10 (0%) of neuroendocrine tumors, 1/8 (12.5%) of normal GI control tissue. Moreover,
sequences from TSPyV, but not MCPyV, were detected in this case of TS. Although our study was
limited in scope, we have no evidence that MCPyV integration plays a role in the pathogenesis of
GI neuroendocrine tumors or TS. In addition, we report the first case of TS with both molecular and
ultrastructural evidence for a viral etiology.
652
Imiquimod-induced TLR7 signaling enhances repair of DNA Damage Induced by UVL in bone
marrow-derived cells
R Fishelevich,1 Y Zhao,1 P Tuchinda,1 H Liu,1 TC Meng,2 J Lee2 and A Gaspari1 1 Dermatology,
University of Maryland, Baltimore, MD and 2 Graceway Pharmaceuticals, Exton, PA
To test our hypothesis that IM enhances DNA repair as a mechanism for its anticancer activity, the
nucleotide excision repair gene XPA gene expression was studied in bone marrow derived cells. IM
enhanced XPA gene expression (qPCR analysis) by 2-4 fold in a number of mouse cell lines (P388,
XS52, A20) compared to the control cells. IM treatment of P388 resulted in an increased nuclear
localization of the DNA repair enzyme XPA (western blotting). This IM effect was dependent on
MyD88, as cells from MyD88-/- mice did not increase XPA gene expression, and did not enhance
the survival after UVB exposure as was observed in cells from MyD88+/+ mice. The NF-kB inhibitor
BAY 11-7085, inhibited IM induced increase in XPA gene expression, and IM-induced nuclear local-
ization of XPA as well as inhibited the ability of IM to enhance cell survival after UVL exposures.
IM enhanced DNA repair of UVL irradiated gene expression constructs, and accelerated the reso-
lution of cyclobutane pyrimidine dimers (CPD) after UVL exposures in P388 and XS52. The ability
of IM to enhance the survival of lymphoblasts from a healthy control or from an XPA patient was
studied. Control lymphoblasts responded IM with enhanced survival after exposure to UVL, whereas
lymphoblasts from an XPA patient failed to respond at all. Topical treatment of mouse skin with 5%
IM cream prior to UVL irradiation resulted in a decrease in the number of CPD positive, APC that
were found in local lymph nodes 24 hours after UVL irradiation. In total, these data support the
idea that TLR7 agonists such as IM enhance DNA repair in bone marrow derived cells, and is likely
to be an important mechanism for its anti-cancer effects.
650
Galectin-3 regulates the innate immune response of human monocytes
A Chung,1 R Teles,1 D Montoya,1 S Krutzik,1 J Krahenbuhl,2 D Hsu,3 F Liu,3 EN Sarno,4 TH Rea,5
RL Modlin1 and DJ Lee1 1 Medicine, Division of Dermatology, David Geffen School of
Medicine at UCLA, Los Angeles, CA, 2 School of Veterinary Medicine, Louisiana State
University, Baton Rouge, LA, 3 Department of Dermatology, University of California Davis
School of Medicine, Sacramento, CA, 4 Leprosy Laboratory Institute Oswaldo Cruz, Rio de
Janeiro, Brazil and 5 Department of Dermatology, University of Southern California School of
Medicine, Los Angeles, CA
Leprosy is a spectral disease in which the clinical outcome to infection with Mycobacterium lep-
rae correlates with the cellular immune response to the pathogen. Gene expression analysis of lep-
rosy lesions revealed comparatively increased expression of galectin-3 in the progressive leproma-
tous leprosy lesions versus the self-limited tuberculoid leprosy lesions. The expression of galectin-3
was similarly increased at the protein level by immunohistochemistry labeling. We hypothesized
that the correlation of galectin-3 with progressive infection contributes to the immune unrespon-
siveness observed in lepromatous leprosy by regulating the innate immune response of monocytes.
First, galectin-3 enhanced the ability of monocytes to bind live Mycobacterium leprae by 2.3-fold.
Second, given the importance of TLR2/1 for innate immune recognition of Mycobacterium leprae,
we determined whether galectin-3 could regulate TLR2/1-mediated activation of monocytes. Galectin-
3 enhanced the TLR2/1-mediated production of IL-10 by 4.15-fold while IL-12 was slightly inhib-
ited. Third, galectin-3 diminished the ability of GM-CSF to trigger CD1b expression on human mono-
cytes by 41%, suggesting an impairment of dendritic cell differentiation. Together, these data suggest
a role for galectin-3 in leprosy by regulating the innate immune response of monocytes, contribut-
ing to the progressive infection observed in patients with lepromatous leprosy.
654
Toll like receptor-4 (TLR4) deficiency prevents ultraviolet (UV) radiation induced cutaneous
photoimmunosuppression by DNA repair mechanism
N Yusuf Dermatology, University of Alabama at Birmingham, Birmingham, AL
UVB radiation is a potent immunosuppressive agent that inhibits cell-mediated immune responses.
UV-induced DNA damage, predominantly in the form of cyclobutane pyrimidine dimers (CPD), has
been recognized as an important molecular trigger for the suppression of immune responses. IL-10
causes UVB induced immunosuppression, whereas IL-12 prevents UV-induced immune suppres-
sion by stimulation of DNA repair enzymes and augments the repair of UVB damaged DNA. Pre-
vious studies from our laboratory indicate that TLR4 is involved in UVB induced cutaneous pho-
toimmunosuppression in mice. The purpose of this study was to determine the mechanism through
which TLR4 contributed to UV-induced suppression of contact hypersensitivity responses. Mice were
exposed to acute UVB (90 mJ/cm2) radiation and thereafter sacrificed at 24 h. Skin samples were
obtained and analyzed for CPD. There were significantly fewer CPD (p<0.05) in the skin of TLR4-
/- mice than in the skin of TLR4+/+ mice. Cytokine profiles indicated that IL-10 was significantly
upregulated (p<0.05), and IL-12 was significantly downregulated (p<0.05) in TLR4+/+ mice after
UV exposure. CPD were repaired more rapidly in the skin of TLR4-/- mice than in the skin of TLR4+/+
mouse indicating an efficient DNA repair mechanism in TLR4-/- mice. Thus, blocking TLR4 may
lead to efficient repair of DNA damage in the form of CPD and can be useful in the prevention of
photoimmunosuppression.
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Cutaneous papillomatosis due to a novel laboratory mouse papillomavirus (MusPV) infec-
tion
JP Sundberg,1 CS Potter,1 KA Silva,1 A Ingle,3 J Joh,2 SJ Gim2 and AB Jenson2 1 The Jackson
Laboratory, Bar Harbor, ME, 2 James Graham Brown Cancer Center, University of Louisville,
Louisville, KY and 3 Tata Memorial Centre, ACTREC,, Mumbai, India
Spontaneous, florid papillomatosis arose in a colony of NMRI-Foxn1nu/Foxn1nu (nude) mice and
were transmissible to both immunocompetent and immunodeficient mice. Lesions appeared at the
mucocutaneous junctions of the nose and mouth affecting hair follicles. Histologically, lesions were
classical papillomas with epidermal hyperplasia on thin fibrovascular stalks in a verrucous pattern.
Koilocytotic cells were observed in the stratum granulosum of the papillomatous lesions. Koilo-
cytes were positive for PV group-specific antigens. Virus particles were observed in crystalline intranu-
clear inclusions within keratinocytes. The MusPV genome is 7510 bp in length, is organized simi-
lar to other PVs, and has at least 7 open reading frames (E1, E2, E4, E6, E7, L1, and L2). Phylogenetic
analysis indicates that MusPV belongs to the pi-genus together with 4 other rodent PVs (McPV2,
MaPV1, MmiPV, and RnPV1). Of the rodent PVs, MusPV appears most closely related to Mastomys
coucha PV (McPV2), with 65% genomic homogeneity and 80% L1 amino acid similarity. Rodent
PVs, except for MnPV1, do not contain any identifiable RB binding sites. MusPV has one putative
RB binding site on the E6 protein but not on the E7 protein. Non-coding regions (NCRs) of PVs main-
tain multiple binding sites for transcription factors (TFs). The NCR of MusPV has numerous sites for
TF binding, of which at least 13 TFs are common to all PVs in the pi-genus. MusPV provides a poten-
tially valuable novel mouse model to study mechanisms of infection, oncology, and preventive and
therapeutic approaches in mice that can be translated to diseases caused by human PVs.
644
Nitric oxide from myeloid-derived suppressor cells inhibits vascular E-selectin expression in
human squamous cell carcinomas
A Gehad, MK Lichtman, CD Schmults, JE Teague, WJ Crisler, M Dowlatshahi, R Watanabe,
TS Kupper and RA Clark Department of Dermatology, Brigham and Women’s Hospital, Boston,
MA
Squamous cell carcinomas (SCC) are sun-induced skin cancers that are particularly numerous and
aggressive in immunosuppressed individuals. SCC vessels lack expression of the skin homing addressin
E-selectin and exclude CLA+ skin homing T cells. Topical treatment with the TLR7 agonist imiquimod
leads to induction of vascular E-selectin, infiltration of CLA+ T cells and histologic evidence of tumor
regression, suggesting that primed T cells exist within the circulation of these patients but cannot
access the tumor. We report that SCC contain high numbers of iNOS-expressing CD11b+ CD11c-
HLA-DR- myeloid-derived suppressor cells. Nitric oxide (NO) was present in detectable levels in
tumor supernatants. NO inhibited the expression of E-selectin on human dermal microvascular
endothelial cells in vitro, suggesting it may contribute to E-selectin suppression in tumors. SCC
treated in vitro with the iNOS inhibitor L-NNA showed marked induction of E-selectin expression
on tumor vessels. Treatment with iNOS inhibitors induced E-selectin expression at levels compara-
ble to SCC undergoing immunologic destruction after topical treatment with TLR7 agonist. Our
results suggest that NO inhibits vascular expression of E-selectin in SCC. Treatment with iNOS
inhibitors restores vascular addressin expression and may be effective in the treatment of SCC and
their premalignant precursor lesions, actinic keratoses.
645
Irritant induced production of IL-6 is mediated via EGFR and NFkB independent mecha-
nisms
KJ White,1 VJ Maffei2 and RA Swerlick1,2 1 Dermatology, Emory University, Atlanta, GA and 2
Dermatology, Atlanta VA, Decatur, GA
Irritant contact dermatitis is a common skin condition associated with significant morbidity, par-
ticularly in service workers. The early molecular events of ICD are incompletely defined. Interleukin-
6 (IL-6), a pro-inflammatory cytokine, is rapidly induced by injury, including irritant injury in skin.
The mechanisms of induction and the source of this mediator in skin are not well defined. In order
to examine whether direct irritant action on keratinocytes may induce IL-6 production, we used an
in vitro model using HaCaT cells and the model irritant sodium lauryl sulfate (SLS). Following treat-
ment of HaCaT cells with 0.004% SLS, we observed time-dependent increases in both IL-6 mRNA
(42 + 29 and 162 + 129 fold at 1 and 2 hrs) and secreted protein (42 + 59 and 109 + 140 pg after
4 and 6 hrs). We previously established that SLS-mediated induction of egr-1, VEGF, and IL-8, are
independent of NF-kB activation but highly dependent on metalloprotease-mediated induction of
EGFR signaling. Similarly the proteasome inhibitor MG132 failed to inhibit SLS-induced IL-6,
while blocking TNFα-mediated IL-6 induction, thus supporting an NF-kB independent pathway for
SLS-induced IL-6. SLS activation of EGFR is mediated by ATP release and activation of purinergic
receptors. Consistent with our previous observations, purine treatment (ATP, ADP, and UTP) were
inducers of IL-6, consistent with a common purine release-mediated irritant induced activation path-
way. However, SLS-mediated induction of IL-6 occurred in the presence of small molecule EGFR
inhibitors (PD168393) and the broad spectrum protease inhibitor marimastat, not supporting a role
for EGFR or metalloproteases in irritant-induced IL-6 production. Furthermore, the broad spectrum
purinergic receptor inhibitor suramin had no significant effect on SLS-induced IL-6 mRNA expres-
sion, despite consistent inhibition of egr-1 induction. These data support our hypothesis that direct
irritant effects on keratinocytes induce IL-6 production but do so via pathways independent of NF-
kB and EGFR signaling.
646
Immune modulation by isotretinoin in vivo
MC Dispenza,1 AM Nelson,2 KL Gilliland,1 Z Cong1 and DM Thiboutot1 1 Department of
Dermatology, Penn State University College of Medicine, Hershey, PA and 2 Department of
Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD
Isotretinoin is the only agent that induces a permanent remission of acne, but the mechanism under-
lying its long-term efficacy is unknown. Studies suggest that patients’ specific immune responses to
P.acnes play a larger role in acne than the pathogenicity of P.acnes itself. We hypothesized that mod-
ulation of the immune response to P.acnes is key to isotretinoin’s ability to induce long-term or per-
manent remissions of acne. This study is the first to investigate changes in peripheral immune cells
associated with isotretinoin treatment in acne patients in vivo. Peripheral blood samples were obtained
from acne patients before starting isotretinoin therapy (baseline) and at 1, 4, 8, and 20 weeks after
starting isotretinoin therapy. Monocytes and lymphocytes were isolated, activated in vitro, and ana-
lyzed for subset markers by flow cytometry and for cytokine secretion by bead arrays. Acne patients’
monocytes expressed higher levels of TLR-2 and secreted more IL-1β, IL-6, IL-8, and IL-10 in response
to P. acnes than monocytes from normal volunteers. Isotretinoin therapy significantly decreased TLR-
2 expression on acne patients’ monocytes compared to baseline. Additionally, untreated and P.acnes-
treated monocytes from acne patients secreted less IL-1β, IL-6, IL-8, and IL-10 during isotretinoin
therapy compared to baseline. P.acnes-induced lymphocyte proliferation was significantly higher
in non-acne volunteers than in acne patients at baseline and throughout isotretinoin treatment. These
results suggest that isotretinoin can modulate the in vivo immune response to P.acnes in acne patients.
647
An in-vitro model to investigate the mechanisms involved in inflammatory acne
M Ingrassia, V Ionita Manzatu, J Lombardi and T Mammone Estee Lauder Co., Melville, NY
We developed an in-vitro model to study the mechanisms involved in inflammatory acne. To accom-
plish this SZ95 sebocytes (immortalized human sebocytes) and normal human epidermal keratinocytes
(HEKn) were exposed to lysate of P. acnes and the levels of secreted pro-inflammatory mediators
were evaluated by protein microarray designed specifically to evaluate expression of multiple pro-
inflammatory mediators using cell culture supernatants. In these experiments we observed increases
in the expression of IL6 and IL8 from SZ95 sebocytes and IL8 from HEKn following a 24 hour expo-
sure to P. acnes lysate. Viability of these cultures assessed by MTS conversion to a soluble blue for-
mazan displayed no associated toxicity from the addition of the lysate of P. acnes to SZ95 or HEKn
cells. Subsequent studies were carried out to quantitate the amount of IL6 and IL8 and to determine
if these increases were acting downstream of the p38 arm of the MAPK pathway. Media supernatants
from SZ95 cells incubated with P. acne lysate were measured using ELISA’s specific for either IL6
or IL8. Increases of 70 and 248% in the levels of these secreted cytokines were observed respec-
tively. When cells were co-incubated with both P. acnes lysate and the selective p38 inhibitor
SB202190, we observed attenuation of P. acnes induced levels of IL6 and IL8, indicating that P.
acnes lysate is acting at least in part through the p38 arm of the MAPK pathway.
648
Effect of lactobacillus extract on acne
N Muizzuddin, W Maher, M Sullivan, S Schnittger and T Mammone Estee Lauder Co., Melville,
NY
Normal human skin can produce a range of anti-microbial chemicals that play an important part
in eliminating potential cutaneous pathogens. Lactobacillus plantarum is a Gram-positive bacteria
that produces antimicrobial peptides which when applied to skin can enhance the antimicrobial
properties of skin. Clinical studies were conducted to determine the effect of Lactobacillus extract
on skin microflora and reduction of acne. Results show that Lactobacillus extract was effective in
reducing skin microflora. In addition it was effective in reducing acne lesion size and erythema at
5%, but not at 1%. After 6 weeks of use of Lactobacillus extract there was a 30% reduction in acne
lesions. Based on the results of these studies Lactobacillus extract appears to be a promising topi-
cal agent for control of acne lesions.
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Seasonal changes in 25-hydroxyvitamin D serum level and pigment protection factor in Pol-
ish children
M Rogowski-Tylman, A Lesiak, A Sysa-Jedrzejowska and J Narbutt Department of Dermatology,
Medical University of Lodz, Lodz, Poland
Environmental factors, mainly ultraviolet radiation and nutrition are considered as major determi-
nants of vitamin D status. Over 90% of daily vitamin D demand is produced in the skin under sun-
light. However we still lack data on vitamin D synthesis due to natural solar exposure in children.
Thus, the aim of our study, within the EC-funded ICEPURE project, was to assess the seasonal impact
of solar irradiation on serum 25-hydroxyvitamin D (25(OH)D) concentrations and pigment protec-
tion factor (PPF)values within the year. The study group was 32 Caucasian children (mean age 8.9
y, phototypes I-IV). In each child the serum level of 25 (OH)D and PPF on upper arm were meas-
ured four times 1st: before going to 2- week summer holiday at the Baltic Sea just after school year;
2nd -24h after returning home; 3rd in mid October and 4th in mid January. The mean serum con-
centration of 25 (OH)D was 22.5 ng/ml, 27.4ng/ml, 25.3 ng/ml and 20.5 ng/ml, respectively and
these changes were statistically significant (p=0.0076). Analysing the seasonal changes in PPF value
the highest PPF was observed during 2nd reading while the lowest one before going to the holidays
(1st reading). PPF changes were s also statistically significant (p<0.0001), however we did not find
positive correlation between 25(OH)D and PPF seasonal fluctuations. We conclude that vitamin D
synthesis is regulated by seasonal intensity of insolation and this phenomenon is not associated with
skin pigmentation. Although we observed the significant increase in serum 25(OH)D level after sum-
mer holiday it should be underlined that vitamin D values were below optimal concentration.
663
Effect of UVB irradiation on human cutaneous innervation and mast cells
IG Panoutsopoulou,1 E Benlhabib,1 G Wendelschafer-Crabb,3 GL Wilcox,1,2,4 WR Kennedy3 and
MK Hordinsky1 1 Dermatology, University of Minnesota, Minneapolis, MN, 2 Neuroscience,
University of Minnesota, Minneapolis, MN, 3 Neurology, University of Minnesota,
Minneapolis, MN and 4 Pharmacoloy, University of Minnesota, Minneapolis, MN
The purpose of the project was to study the effect of UVB irradiation on human mast cells, epider-
mal nerve fibers, and Nogo A, a neurite growth inhibitor, in order to better understand their role in
the UVB-induced erythema and pruritus. A 2-mm skin biopsy specimen was obtained from the ante-
rior forearm of each of four healthy Caucasian volunteers at 0h (baseline), 2h, 7h, and 24h post UVB
irradiation using the minimum erythema dose of each volunteer. These sixteen biopsy specimens
were sectioned and triple-immunostained using a series of antibodies including PGP 9.5 (pan-neu-
ronal marker), S100 (a marker of Schwann cells, melanocytes and Langerhans cells), tubulin-1β,
Nogo A, tryptase (mast cell marker), CD1a (Langerhans cell marker) and type IV collagen. Antigen
expression was studied using confocal microscopy and epidermal nerve fiber density was measured
using Neurolucida software. Examination of the pre-UVB-irradiated specimens revealed co-expres-
sion of Nogo A, tubulin 1β, PGP 9.5, and S100 on dermal nerve bundles. Nogo A was strongly
expressed on epidermal and follicular keratinocytes. The epidermal nerve fiber density trended down
at 7h post UVB while the mast cell density and degranulation trended up at 7h, a time which cor-
related with the peak of noted erythema and pruritus intensity. Qualitative observations of Nogo A
expression on epidermal keratinocytes revealed decreased expression at 24h post UVB-irradiation.
In conclusion, UVB affected the antibody expression on cells located in both epidermis and der-
mis. The neurite growth inhibitor Nogo A was found to be expressed in normal cutaneous cells and
decreased after UVB irradiation, which may suggest that during the first 24h after UVB challenge,
human epidermal cells alter protein expression to invite neurite extension.
665
Hesperidin promotes cyclobutane pyrimidine dimer repair in UVB exposed mice epidermis
D Luo and B Zhou Department of Dermatology, Nanjing Medical University, Nanjing, China
Our purpose was to investigate whether topical application of Hesperidin affords protecting Balb/C
mice epidermis from UVB-induced cyclobutane pyrimidine dimer (CPDs). A DNA damage model
of UVB irradiation-induced mice epidermis was established. The immunohistochemical staining,
southwestern dot blotting were used for CPDs detection; western blotting was used for P53 detec-
tion. Topical application of hesperidin on Balb/C mice skin significantly decreased the amount of
epidermal CPDs 24 and 48 h after 180mJ/cm 2 of UVB irradiation as compared to untreated mice.
UVB-induced p53 expression was more pronounced in Hesperidin treated mice epidermis com-
pared to that of untreated mice. In conclusion, taken together, these results suggest that topical
Hesperidin application promotes DNA photo-damage repair. Hesperidin is therefore a promising
protective substance against UVB radiation.
664
Quercetin inhibits UV irradiation induced inflammatory cytokine production in primary human
keratinocytes by suppressing NF-κB pathway
Y Xu,1 FT Vicentini,2 T He,1 Y Shao,1 MJ Fonseca,2 WA Verri3 and GJ Fisher1 1 Dermatology,
University of Michigan, Ann Arbor, MI, 2 Faculdade de Ciências Farmacêuticas de Riberirão,
Universidade de São Paulo, São Paulo, Brazil and 3 Centro de Ciências Biológicas,
Universidade Estadual de Londrina, Londrina, Brazil
Topical antioxidants, such as the flavonoid quercetin, have been shown to reduce ultraviolet (UV)
irradiation-mediated oxidative damage to human and mouse skin. However, mechanisms and sig-
naling pathways involved in this protective effect are not clearly understood. Nuclear factor kappa
B (NF-κB) and activator protein-1 (AP-1) pathways are two major effectors of mammalian cellular
responses to UV irradiation. NF-κB activation by UV irradiation promotes inflammatory cytokines
production, while activation of AP-1 pathway promotes matrix metalloproteinase (MMP) produc-
tion. Both pathways contribute to UV irradiation-induced skin damage. The present study investi-
gates the effects of quercetin on these two key UV irradiation-activated signaling pathways in pri-
mary human keratinocytes. Quercetin substantially inhibited NF-κB nuclear translocation and
DNA-binding 80%, (n=3, p<0.05). Interestingly, quercetin had no effect on the observed degrada-
tion of the NF-κB inhibitor IκB-α. Consequently, quercetin suppressed UV irradiation-induced expres-
sion of IL-1β (~60%), IL-6 (~80%), IL-8 (~76%) and TNF-α (~69%). In contrast, quercetin did not
alter UV irradiation activation of MAP kinases, ERK, JNK, or p38. Accordingly, induction of AP-1
target genes such as MMP-1 and MMP-3 was not suppressed. Finally, in a hairless mouse model,
quercetin nearly abolished UV irradiation-induced neutrophil infiltration, measured by Myeloper-
oxidase (MPO) activity. Taken together, these data indicate that the ability of quercetin to block UV
irradiation-induced skin inflammation is mediated, at least in part, by its inhibitory effect on NF-κB
activation and inflammatory cytokine production.
662
Photoprotective effect of a Polypodium leucotomos extract against ultraviolet radiation on
human peripheral blood monocytes
Z Moreno,1 D Diaz,1 E Reyes,1,2 S Gonzalez3 and M Alvarez-Mon1,4 1 Laboratory of
Immunology. Research and Development Associated Unit CSIC, University of Alcalá, Alcala
de Henares, Spain, 2 R&D, IFC, Madrid, Spain, 3 Service of Dermatology, Memorial Sloan-
Kettering Cancer Center, New York, NY and 4 Service of Immune Diseases and Rheumatology,
Hospital Univeritario Príncipe de Asturias, Alcala de Henares, Spain
Exposure to ultraviolet radiation (UVR) induces local and systemic damage on the skin and on the
immune system, mainly due to oxidative stress. We have previously reported that a Polypodium leu-
cotomos extract (PL) possesses antioxidant and immunoprotective properties against UVR. Our
objective was to determine the effects of PL on the viability of peripheral blood classical or inflam-
matory and resident monocytes after UVR. Human peripheral blood mononuclear cells were iso-
lated from 6 healthy donors, cultured in presence of several dilutions of PL (4 mg/ml to 0.0625
mg/ml) for 1 hr and then were radiated with an UVA-emitting lamp (I=1319W/m2) during 7 min.
Later, cells were cultured for additional 24 hrs and analyzed by flow cytometry using 1) fluorochrome-
labeled monoclonal antibodies to identify classical (CD14+CD16-) or inflammatory and resident
(CD16+) monocytes, 2) 7-aminoactinomycin (viable cells) and 3) microbeads as an internal refer-
ence for absolute cell count. The % of protection conferred by PL (%P) was calculated dividing the
absolute number of viable UV-irradiated monocytes by the absolute number of control non-irradi-
ated viable monocytes. Results: %P granted by PL against UV-induced damage on CD14+CD16-
classical monocytes was dose-dependent. %P ranged from 29.87 (0.06 mg/ml) to 123.07 (4 mg/ml).
We found full UV protection at PL doses of 1 mg/ml (%P=96.13) and 2 mg/ml (%P=97.73). Sur-
prisingly, PL had not protective effect on the CD16+ monocyte which completely disappeared after
UV irradiation. in conclusion, our data indicate that PL exerts dose-dependent protection against
UVR on human peripheral blood monocytes. They also show that classical monocytes are much
more resistant to UVR than inflammatory and resident subsets.
666
Mitochondria protection against oxidative stress with a new dimethionine derivative
M Frechet,1 L Valenti,2 E Lomonte,2 F Maccario,2 P Prouheze1 and J Nicolaÿ1 1 EXSYMOL,
Monaco, Monaco and 2 Laboratoire Sedifa, Monaco, Monaco
Mitochondria play a crucial role in the maintenance of cellular homeostasis. This organelle’s major
role is to supply energy to the cell, but it is also a key regulator of cell differentiation and cell death.
Oxidative damages accumulation in mitochondria has been shown to impair mitochondrial func-
tions, and probably is an important contributor to the aging process. Ultraviolet radiation (UVB and
more specifically UVA), one of the most challenging environmental factors for the skin, damage
mitochondria.UVA may impair respiratory chain leading to ROS production, a major determinant
of skin aging, and induce mitochondrial DNA alteration, which accumulates in photoaged skin. An
antioxidant dipeptide derivative, N-acetylmethionyl-decarboxymethionine (AMDM), was designed
for mitochondria protection of cutaneous cells. AMDM scavenges several mitochondria-damaging
ROS, including hydroxyl radical and peroxinitrite that irreversibly inhibits mitochondria respiration.
Besides, we demonstrate that AMDM does not affect mitochondrial metabolic function (respiration
and energy production) and also preserve it under oxidative stress conditions. Live cell imaging
was performed on keratinocytes and showed that AMDM opposes to H2O2-induced intramito-
chondrial ROS overproduction, and limits mitochondrial biogenesis in response to oxidative stress.
Finally, an ex vivo test with human skin explants exposed to UVA showed that topically applied
AMDM protects epidermis against apoptosis, and limits stress-mediated mitochondria response.
Mitochondria preservation from ROS damages was confirmed by electron microscope examination.
We have designed a bioavailable antioxidant peptidomimetic providing stress protection to the
skin by preserving the mitochondrial homeostasis.
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The transmission of skin microflora from mother to infant
K Capone,1 M Green,1 GN Stamatas2 and J Nikolovski1 1 JOHNSON & JOHNSON Consumer
Companies, Inc., Skillman, NJ and 2 JOHNSON & JOHNSON Sante Beaute France, Issy-les-
Moulineaux, France
While our previous work describes the microbiome of infant skin during the first year of life, the
origin of these microbial partners has not yet been defined. The purpose of this study was to deter-
mine if the caregiver(s) are a source of bacterial strains colonizing infant skin. Towards that end,
skin microflora from 5 babies and their caregivers was harvested using a cup scrub technique. Col-
lected samples were then cultured for single colonies of the commensal bacterium Propionibac-
terium acnes (P. acnes). DNA was extracted from each clone and unique P. acnes strains were iden-
tified using random amplification of polymorphic DNA analysis, where agarose gel banding patterns
denote differences between strains. When a comparison of P. acnes strains from mothers, fathers
(where applicable), and infants was performed, samples from infant skin were found to have at
least one, but typically more, identical stains of P. acnes in common with their mothers. Compar-
isons made within a subset of the subjects with their fathers revealed a lesser number of strains in
common. The results of this study reveal the vertical transmission of specific bacterial strains (using
P. acnes as a marker) between mothers and their babies. In addition, there appears to be a prefer-
ential colonization of infant skin by bacteria derived from the mother compared with those derived
from the father. Many factors may contribute to this, including the possibility of more skin to skin
contact between mothers and their babies, or a preferential immunocompetence for maternally
derived bacteria. Further research aimed at elucidating the composition and source of the skin micro-
biome may facilitate a deeper understanding of immune-mediated disorders and diseases of infant
skin such as atopy and eczema.
656
Haploid genetic screen identifies host factors important in Chlamydia trachomatis infection
D Rosmarin,1,2 J Carette,2 T Brummelkamp2 and HL Ploegh2 1 Dermatology, Brigham and
Women’s Hospital, Boston, MA and 2 Biology, Whitehead Institute for Biomedical Research,
Boston, MA
A haploid genetic screen was performed to find human proteins important in Chlamydia trachomatis
infection. Chlamydia trachomatis is the leading cause of preventable blindness in the world. It is
also the most common bacterial sexually transmitted disease, affecting about 90 million people per
year. Sequelae from chlamydia infection include pelvic inflammatory disease, ectopic pregnan-
cies, and infertility. Because Chlamydia is an obligate intracellular pathogen and there is a lack of
a genetic system to alter or add to the Chlamydia genome, it is very difficult to study this organism.
A loss of function genetic screen was performed using insertional mutagenesis to generate null alle-
les in a haploid human cell line. One hundred million cells were then inoculated with the Chlamy-
dia trachomatis L2 serovar. While most cells died, from the survivors, three highly significant host
genes were identified: B3GAT3, B4GALT7, and SLC35B2 which encode glucuronosyltransferase I,
galactosyltransferase I, and 3’-phosphoadenosine 5’-phosphosulfate transporter I, respectively. These
three genes are all involved in the heparan sulfate pathway. B3GAT3, B4GALT7, and SLC35B2
mutants are resistant to chlamydia infection, a phenotype reverted by complementing the mutant
cells with the corresponding cDNAs. This work represents the first time a haploid genetic screen
has been used to identify important host proteins for a bacterial infection.
657
UVA induces lesions resembling seborrheic keratoses in mice with keratinocyte-specific PTEN
down-regulation
M Ming,1 CR Shea,1 L Feng,2 K Soltani1 and Y He1 1 University of Chicago, Chicago, IL and 2
NIEHS, Research Triangle Park, NC
Seborrheic keratoses (SK) are among the most common benign tumors in human, occurring in 80-
100% of people over 50 years. Although SK occur at both sun-exposed and non-sun-exposed skin,
cumulative exposure to sunlight and aging have been proposed as independent risk factors for their
development. Here we report that in mice with a targeted PTEN down-regulation in their epider-
mis, UVA causes the formation of tumors resembling human SK, as well as of squamous cell car-
cinoma (SCC). In the absence of UVA, Pten+/+ and Pten+/- did not grow tumors throughout the
study period. UVA did not cause tumor formation in Pten+/+ mice. However, Pten+/- mice started
to develop skin tumors at 37 weeks of UVA irradiation. Histopathologic analysis of the tumors
showed that in UVA-exposed Pten+/- mice 67% of tumors were of SK type, whereas 33% were SCC.
The skin lesions observed in our mouse model share several histological features in common with
human SK including acanthosis, hyperkeratosis, papillomatosis, and keratin-filled structures (horn
cysts and pseudo-horn cysts) while lacking significant cytologic atypia. Immunoblot analysis showed
that, as compared with normal Pten+/- skin, PTEN was significantly down-regulated in both UVA-
induced SK and SCC. AKT phosphorylation was significantly increased in AK and SCC. Real-time
RT-PCR analysis showed that there were no significant differences in GLTSCR2 mRNA levels between
+/+, +/-, and SKs, suggesting that GLTSCR2, a tumor suppressor that stabilizes PTEN and is down-
regulated in SKs, is not involved in our SK mouse model. PTEN down-regulation significantly increased
AKT and ERK phosphorylation post-UVA irradiation. Acute re-expression of PTEN in PTEN+/- ker-
atinocytes significantly inhibited cell growth in sham-irradiated cells. These data indicate that
PTEN reduction plays a critical role in UVA-induced development of SK as well as SCC, likely
through the AKT and ERK pathways.
658
Sunscreens may prevent UV-induced facial fat loss by blocking the production of IL-11
W Li, A Pappas, L Zhang and D Cavender Skin Research Center, a Unit of Johnson and Johnson
Consumer Companies, Inc., Skillman, NJ
Interleukin-11 (IL-11) is produced by fibroblasts upon exposure to various cytokines (IL-1α; TGF-β)
or to phorbol esters. Exposure to IL-11 results in the inhibition of preadipocytes differentiation in
vitro. We hypothesized that ultraviolet (UV) irradiation may induce dermal fibroblasts to produce
IL-11, which, in turn, would inhibit preadipocyte differentiation and therefore contributes to the loss
of subcutaneous fat in sun-exposed skin. Using human epidermal-dermal equivalents exposed to a
physiological dose of radiation (5 J/cm2) from a solar simulator, we showed a marked increase in
IL-11 expression and secretion. Pretreatment with a sunscreen blocked the production of IL-11 by
the dermal fibroblasts. Conditioned medium from equivalents exposed to solar radiation inhibited
the differentiation of human facial preadipocytes in vitro. However, preadipocytes incubated with
conditioned medium from equivalents pretreated with a sunscreen, but not placebo, continued to
differentiate normally. These results support the hypothesis that solar radiation-induced IL-11 is
involved in the loss of subcutaneous fat and photoaging. Inhibition of this process by sunscreens
may slow or reverse photoagig-induced changes in facial contouring.
659
Effects of topical cholesterol, linoleic acid, and synthetic ceramide III, and an equimolar
mixture, on UV-induced skin responses in tape-stripped human skin in vivo
H Byun,1,2,3 K Cho,1,2,3 M Lee,1,2,3 Y Lee,1,2,3 S Lee,1,2,3 K Kim1,2,3 and J Chung1,2,3 1 Dermatology,
Seoul National University College of Medicine, Seoul, Republic of Korea, 2 Institute of
Dermatological Science, Medical Research Center, Seoul National University, Seoul, Republic
of Korea and 3 Laboratory of Cutaneous Aging Research, Clinical Research Institute, Seoul
National University Hospital, Seoul, Republic of Korea
The effects of moisturizers on the viable layers underneath the stratum corneum have rarely been
reported. To evaluate the effects of the major lipids in moisturizers (cholesterol, linoleic acid, a syn-
thetic analog of ceramide III, and an equimolar mixture) on UV-induced skin responses, healthy vol-
unteers were recruited (11~12 volunteers / group; mean age, 44.8 ± 9.7 years). The buttock skins
were tape-stripped, then each lipid (20 mg/ml) and its vehicle (octyldodecanol) were applied on
the tape-stripped buttock skin under occlusion. After 2 days of lipid application, the lipid-treated
areas were irradiated with UV (2 MED), and skin samples were obtained 24 hours after irradiation.
The mRNA levels of MMP-1, MMP-9, IL-6, COX-2, IL-1β, and procollagen were measured using
real-time PCR, and the histologic changes were evaluated. Cholesterol significantly suppressed the
basal MMP-1 expression and the mixture suppressed the basal MMP-9 expression. Ceramide and
linoleic acid showed no effects on the basal levels of the targets. Cholesterol and the mixture sig-
nificantly suppressed UV-induced MMP-1, IL-6, and IL-1β expression, whereas linoleic acid increased
UV-induced MMP-1 and IL-6 expression. Ceramide increased UV-induced MMP-1 and IL-6 expres-
sion, and suppressed COX-2 expression. Cholesterol significantly decreased the degree of dermal
inflammatory infiltrates and exocytosis, and the mixture decreased the extent of dermal inflamma-
tory infiltrates. Linoleic acid increased the epidermal thickness and the number of apoptotic cells,
and ceramide increased epidermal thickness. Our results provide new insight into the composition
of moisturizers.
660
The expression of methylenetetrahydrofolate reductase in the skin under low suberythemal
doses of ultraviolet radiation B
A Lesiak,1 K Wodz-Naskiewicz,2 R Pawliczak,2 M Rogowski-Tylman,1 A Sysa-Jedrzejowska1 and
J Narbutt1 1 Dermatology, Medical University of Lodz, Lodz, Poland and 2 Immunopathology,
Medical University of Lodz, Lodz, Poland
Ultraviolet radiation (UVR) is one of the major factors involved in skin photocancerogenesis. Although
it is well known that UVA can destroy foliate, the effect of UVB on foliate status is still not clear.
Some data indicate that foliates, especially its metabolite 5-metyltetrahydrofolate, can protect DNA
from UV induced strand breaks. Methylenetetrahydrofolate reductase (MTHFR) plays an essential
role in foliate metabolic pathway. Thus the aim of the study was to assess the expression of MTHFR
in UVB exposed skin. The study consisted of 4 groups of healthy individuals who were whole-body
UVB irradiated for 10 days with 0.7 MED on each occasion, or whole-body irradiated as before fol-
lowed by a single high dose of UVB (10x10 cm), or were irradiated only with a single dose of UVB
(3 MED) on the small area of the body, or were unirradiated. Skin biopsies were taken in all par-
ticipants and MTHFR expression was assessed (Western blot). The MTHFR expression was signifi-
cantly higher in the volunteers who were whole-body irradiated for 10 days when compared to the
subjects who were whole-body irradiated for 10 days followed by a single 3 MED UVB (p<0.05).
The enhanced expression of MTHFR in human skin under the repeated low doses of UVB might be
a proof for photoprotective properties of foliates .
S110 Journal of Investigative Dermatology (2011), Volume 131
SID11_Abstracts-5  2/28/11  9:27 AM  Page S110
ABSTRACTS
661
Seasonal changes in 25-hydroxyvitamin D serum level and pigment protection factor in Pol-
ish children
M Rogowski-Tylman, A Lesiak, A Sysa-Jedrzejowska and J Narbutt Department of Dermatology,
Medical University of Lodz, Lodz, Poland
Environmental factors, mainly ultraviolet radiation and nutrition are considered as major determi-
nants of vitamin D status. Over 90% of daily vitamin D demand is produced in the skin under sun-
light. However we still lack data on vitamin D synthesis due to natural solar exposure in children.
Thus, the aim of our study, within the EC-funded ICEPURE project, was to assess the seasonal impact
of solar irradiation on serum 25-hydroxyvitamin D (25(OH)D) concentrations and pigment protec-
tion factor (PPF)values within the year. The study group was 32 Caucasian children (mean age 8.9
y, phototypes I-IV). In each child the serum level of 25 (OH)D and PPF on upper arm were meas-
ured four times 1st: before going to 2- week summer holiday at the Baltic Sea just after school year;
2nd -24h after returning home; 3rd in mid October and 4th in mid January. The mean serum con-
centration of 25 (OH)D was 22.5 ng/ml, 27.4ng/ml, 25.3 ng/ml and 20.5 ng/ml, respectively and
these changes were statistically significant (p=0.0076). Analysing the seasonal changes in PPF value
the highest PPF was observed during 2nd reading while the lowest one before going to the holidays
(1st reading). PPF changes were s also statistically significant (p<0.0001), however we did not find
positive correlation between 25(OH)D and PPF seasonal fluctuations. We conclude that vitamin D
synthesis is regulated by seasonal intensity of insolation and this phenomenon is not associated with
skin pigmentation. Although we observed the significant increase in serum 25(OH)D level after sum-
mer holiday it should be underlined that vitamin D values were below optimal concentration.
663
Effect of UVB irradiation on human cutaneous innervation and mast cells
IG Panoutsopoulou,1 E Benlhabib,1 G Wendelschafer-Crabb,3 GL Wilcox,1,2,4 WR Kennedy3 and
MK Hordinsky1 1 Dermatology, University of Minnesota, Minneapolis, MN, 2 Neuroscience,
University of Minnesota, Minneapolis, MN, 3 Neurology, University of Minnesota,
Minneapolis, MN and 4 Pharmacoloy, University of Minnesota, Minneapolis, MN
The purpose of the project was to study the effect of UVB irradiation on human mast cells, epider-
mal nerve fibers, and Nogo A, a neurite growth inhibitor, in order to better understand their role in
the UVB-induced erythema and pruritus. A 2-mm skin biopsy specimen was obtained from the ante-
rior forearm of each of four healthy Caucasian volunteers at 0h (baseline), 2h, 7h, and 24h post UVB
irradiation using the minimum erythema dose of each volunteer. These sixteen biopsy specimens
were sectioned and triple-immunostained using a series of antibodies including PGP 9.5 (pan-neu-
ronal marker), S100 (a marker of Schwann cells, melanocytes and Langerhans cells), tubulin-1β,
Nogo A, tryptase (mast cell marker), CD1a (Langerhans cell marker) and type IV collagen. Antigen
expression was studied using confocal microscopy and epidermal nerve fiber density was measured
using Neurolucida software. Examination of the pre-UVB-irradiated specimens revealed co-expres-
sion of Nogo A, tubulin 1β, PGP 9.5, and S100 on dermal nerve bundles. Nogo A was strongly
expressed on epidermal and follicular keratinocytes. The epidermal nerve fiber density trended down
at 7h post UVB while the mast cell density and degranulation trended up at 7h, a time which cor-
related with the peak of noted erythema and pruritus intensity. Qualitative observations of Nogo A
expression on epidermal keratinocytes revealed decreased expression at 24h post UVB-irradiation.
In conclusion, UVB affected the antibody expression on cells located in both epidermis and der-
mis. The neurite growth inhibitor Nogo A was found to be expressed in normal cutaneous cells and
decreased after UVB irradiation, which may suggest that during the first 24h after UVB challenge,
human epidermal cells alter protein expression to invite neurite extension.
665
Hesperidin promotes cyclobutane pyrimidine dimer repair in UVB exposed mice epidermis
D Luo and B Zhou Department of Dermatology, Nanjing Medical University, Nanjing, China
Our purpose was to investigate whether topical application of Hesperidin affords protecting Balb/C
mice epidermis from UVB-induced cyclobutane pyrimidine dimer (CPDs). A DNA damage model
of UVB irradiation-induced mice epidermis was established. The immunohistochemical staining,
southwestern dot blotting were used for CPDs detection; western blotting was used for P53 detec-
tion. Topical application of hesperidin on Balb/C mice skin significantly decreased the amount of
epidermal CPDs 24 and 48 h after 180mJ/cm 2 of UVB irradiation as compared to untreated mice.
UVB-induced p53 expression was more pronounced in Hesperidin treated mice epidermis com-
pared to that of untreated mice. In conclusion, taken together, these results suggest that topical
Hesperidin application promotes DNA photo-damage repair. Hesperidin is therefore a promising
protective substance against UVB radiation.
664
Quercetin inhibits UV irradiation induced inflammatory cytokine production in primary human
keratinocytes by suppressing NF-κB pathway
Y Xu,1 FT Vicentini,2 T He,1 Y Shao,1 MJ Fonseca,2 WA Verri3 and GJ Fisher1 1 Dermatology,
University of Michigan, Ann Arbor, MI, 2 Faculdade de Ciências Farmacêuticas de Riberirão,
Universidade de São Paulo, São Paulo, Brazil and 3 Centro de Ciências Biológicas,
Universidade Estadual de Londrina, Londrina, Brazil
Topical antioxidants, such as the flavonoid quercetin, have been shown to reduce ultraviolet (UV)
irradiation-mediated oxidative damage to human and mouse skin. However, mechanisms and sig-
naling pathways involved in this protective effect are not clearly understood. Nuclear factor kappa
B (NF-κB) and activator protein-1 (AP-1) pathways are two major effectors of mammalian cellular
responses to UV irradiation. NF-κB activation by UV irradiation promotes inflammatory cytokines
production, while activation of AP-1 pathway promotes matrix metalloproteinase (MMP) produc-
tion. Both pathways contribute to UV irradiation-induced skin damage. The present study investi-
gates the effects of quercetin on these two key UV irradiation-activated signaling pathways in pri-
mary human keratinocytes. Quercetin substantially inhibited NF-κB nuclear translocation and
DNA-binding 80%, (n=3, p<0.05). Interestingly, quercetin had no effect on the observed degrada-
tion of the NF-κB inhibitor IκB-α. Consequently, quercetin suppressed UV irradiation-induced expres-
sion of IL-1β (~60%), IL-6 (~80%), IL-8 (~76%) and TNF-α (~69%). In contrast, quercetin did not
alter UV irradiation activation of MAP kinases, ERK, JNK, or p38. Accordingly, induction of AP-1
target genes such as MMP-1 and MMP-3 was not suppressed. Finally, in a hairless mouse model,
quercetin nearly abolished UV irradiation-induced neutrophil infiltration, measured by Myeloper-
oxidase (MPO) activity. Taken together, these data indicate that the ability of quercetin to block UV
irradiation-induced skin inflammation is mediated, at least in part, by its inhibitory effect on NF-κB
activation and inflammatory cytokine production.
662
Photoprotective effect of a Polypodium leucotomos extract against ultraviolet radiation on
human peripheral blood monocytes
Z Moreno,1 D Diaz,1 E Reyes,1,2 S Gonzalez3 and M Alvarez-Mon1,4 1 Laboratory of
Immunology. Research and Development Associated Unit CSIC, University of Alcalá, Alcala
de Henares, Spain, 2 R&D, IFC, Madrid, Spain, 3 Service of Dermatology, Memorial Sloan-
Kettering Cancer Center, New York, NY and 4 Service of Immune Diseases and Rheumatology,
Hospital Univeritario Príncipe de Asturias, Alcala de Henares, Spain
Exposure to ultraviolet radiation (UVR) induces local and systemic damage on the skin and on the
immune system, mainly due to oxidative stress. We have previously reported that a Polypodium leu-
cotomos extract (PL) possesses antioxidant and immunoprotective properties against UVR. Our
objective was to determine the effects of PL on the viability of peripheral blood classical or inflam-
matory and resident monocytes after UVR. Human peripheral blood mononuclear cells were iso-
lated from 6 healthy donors, cultured in presence of several dilutions of PL (4 mg/ml to 0.0625
mg/ml) for 1 hr and then were radiated with an UVA-emitting lamp (I=1319W/m2) during 7 min.
Later, cells were cultured for additional 24 hrs and analyzed by flow cytometry using 1) fluorochrome-
labeled monoclonal antibodies to identify classical (CD14+CD16-) or inflammatory and resident
(CD16+) monocytes, 2) 7-aminoactinomycin (viable cells) and 3) microbeads as an internal refer-
ence for absolute cell count. The % of protection conferred by PL (%P) was calculated dividing the
absolute number of viable UV-irradiated monocytes by the absolute number of control non-irradi-
ated viable monocytes. Results: %P granted by PL against UV-induced damage on CD14+CD16-
classical monocytes was dose-dependent. %P ranged from 29.87 (0.06 mg/ml) to 123.07 (4 mg/ml).
We found full UV protection at PL doses of 1 mg/ml (%P=96.13) and 2 mg/ml (%P=97.73). Sur-
prisingly, PL had not protective effect on the CD16+ monocyte which completely disappeared after
UV irradiation. in conclusion, our data indicate that PL exerts dose-dependent protection against
UVR on human peripheral blood monocytes. They also show that classical monocytes are much
more resistant to UVR than inflammatory and resident subsets.
666
Mitochondria protection against oxidative stress with a new dimethionine derivative
M Frechet,1 L Valenti,2 E Lomonte,2 F Maccario,2 P Prouheze1 and J Nicolaÿ1 1 EXSYMOL,
Monaco, Monaco and 2 Laboratoire Sedifa, Monaco, Monaco
Mitochondria play a crucial role in the maintenance of cellular homeostasis. This organelle’s major
role is to supply energy to the cell, but it is also a key regulator of cell differentiation and cell death.
Oxidative damages accumulation in mitochondria has been shown to impair mitochondrial func-
tions, and probably is an important contributor to the aging process. Ultraviolet radiation (UVB and
more specifically UVA), one of the most challenging environmental factors for the skin, damage
mitochondria.UVA may impair respiratory chain leading to ROS production, a major determinant
of skin aging, and induce mitochondrial DNA alteration, which accumulates in photoaged skin. An
antioxidant dipeptide derivative, N-acetylmethionyl-decarboxymethionine (AMDM), was designed
for mitochondria protection of cutaneous cells. AMDM scavenges several mitochondria-damaging
ROS, including hydroxyl radical and peroxinitrite that irreversibly inhibits mitochondria respiration.
Besides, we demonstrate that AMDM does not affect mitochondrial metabolic function (respiration
and energy production) and also preserve it under oxidative stress conditions. Live cell imaging
was performed on keratinocytes and showed that AMDM opposes to H2O2-induced intramito-
chondrial ROS overproduction, and limits mitochondrial biogenesis in response to oxidative stress.
Finally, an ex vivo test with human skin explants exposed to UVA showed that topically applied
AMDM protects epidermis against apoptosis, and limits stress-mediated mitochondria response.
Mitochondria preservation from ROS damages was confirmed by electron microscope examination.
We have designed a bioavailable antioxidant peptidomimetic providing stress protection to the
skin by preserving the mitochondrial homeostasis.
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The transmission of skin microflora from mother to infant
K Capone,1 M Green,1 GN Stamatas2 and J Nikolovski1 1 JOHNSON & JOHNSON Consumer
Companies, Inc., Skillman, NJ and 2 JOHNSON & JOHNSON Sante Beaute France, Issy-les-
Moulineaux, France
While our previous work describes the microbiome of infant skin during the first year of life, the
origin of these microbial partners has not yet been defined. The purpose of this study was to deter-
mine if the caregiver(s) are a source of bacterial strains colonizing infant skin. Towards that end,
skin microflora from 5 babies and their caregivers was harvested using a cup scrub technique. Col-
lected samples were then cultured for single colonies of the commensal bacterium Propionibac-
terium acnes (P. acnes). DNA was extracted from each clone and unique P. acnes strains were iden-
tified using random amplification of polymorphic DNA analysis, where agarose gel banding patterns
denote differences between strains. When a comparison of P. acnes strains from mothers, fathers
(where applicable), and infants was performed, samples from infant skin were found to have at
least one, but typically more, identical stains of P. acnes in common with their mothers. Compar-
isons made within a subset of the subjects with their fathers revealed a lesser number of strains in
common. The results of this study reveal the vertical transmission of specific bacterial strains (using
P. acnes as a marker) between mothers and their babies. In addition, there appears to be a prefer-
ential colonization of infant skin by bacteria derived from the mother compared with those derived
from the father. Many factors may contribute to this, including the possibility of more skin to skin
contact between mothers and their babies, or a preferential immunocompetence for maternally
derived bacteria. Further research aimed at elucidating the composition and source of the skin micro-
biome may facilitate a deeper understanding of immune-mediated disorders and diseases of infant
skin such as atopy and eczema.
656
Haploid genetic screen identifies host factors important in Chlamydia trachomatis infection
D Rosmarin,1,2 J Carette,2 T Brummelkamp2 and HL Ploegh2 1 Dermatology, Brigham and
Women’s Hospital, Boston, MA and 2 Biology, Whitehead Institute for Biomedical Research,
Boston, MA
A haploid genetic screen was performed to find human proteins important in Chlamydia trachomatis
infection. Chlamydia trachomatis is the leading cause of preventable blindness in the world. It is
also the most common bacterial sexually transmitted disease, affecting about 90 million people per
year. Sequelae from chlamydia infection include pelvic inflammatory disease, ectopic pregnan-
cies, and infertility. Because Chlamydia is an obligate intracellular pathogen and there is a lack of
a genetic system to alter or add to the Chlamydia genome, it is very difficult to study this organism.
A loss of function genetic screen was performed using insertional mutagenesis to generate null alle-
les in a haploid human cell line. One hundred million cells were then inoculated with the Chlamy-
dia trachomatis L2 serovar. While most cells died, from the survivors, three highly significant host
genes were identified: B3GAT3, B4GALT7, and SLC35B2 which encode glucuronosyltransferase I,
galactosyltransferase I, and 3’-phosphoadenosine 5’-phosphosulfate transporter I, respectively. These
three genes are all involved in the heparan sulfate pathway. B3GAT3, B4GALT7, and SLC35B2
mutants are resistant to chlamydia infection, a phenotype reverted by complementing the mutant
cells with the corresponding cDNAs. This work represents the first time a haploid genetic screen
has been used to identify important host proteins for a bacterial infection.
657
UVA induces lesions resembling seborrheic keratoses in mice with keratinocyte-specific PTEN
down-regulation
M Ming,1 CR Shea,1 L Feng,2 K Soltani1 and Y He1 1 University of Chicago, Chicago, IL and 2
NIEHS, Research Triangle Park, NC
Seborrheic keratoses (SK) are among the most common benign tumors in human, occurring in 80-
100% of people over 50 years. Although SK occur at both sun-exposed and non-sun-exposed skin,
cumulative exposure to sunlight and aging have been proposed as independent risk factors for their
development. Here we report that in mice with a targeted PTEN down-regulation in their epider-
mis, UVA causes the formation of tumors resembling human SK, as well as of squamous cell car-
cinoma (SCC). In the absence of UVA, Pten+/+ and Pten+/- did not grow tumors throughout the
study period. UVA did not cause tumor formation in Pten+/+ mice. However, Pten+/- mice started
to develop skin tumors at 37 weeks of UVA irradiation. Histopathologic analysis of the tumors
showed that in UVA-exposed Pten+/- mice 67% of tumors were of SK type, whereas 33% were SCC.
The skin lesions observed in our mouse model share several histological features in common with
human SK including acanthosis, hyperkeratosis, papillomatosis, and keratin-filled structures (horn
cysts and pseudo-horn cysts) while lacking significant cytologic atypia. Immunoblot analysis showed
that, as compared with normal Pten+/- skin, PTEN was significantly down-regulated in both UVA-
induced SK and SCC. AKT phosphorylation was significantly increased in AK and SCC. Real-time
RT-PCR analysis showed that there were no significant differences in GLTSCR2 mRNA levels between
+/+, +/-, and SKs, suggesting that GLTSCR2, a tumor suppressor that stabilizes PTEN and is down-
regulated in SKs, is not involved in our SK mouse model. PTEN down-regulation significantly increased
AKT and ERK phosphorylation post-UVA irradiation. Acute re-expression of PTEN in PTEN+/- ker-
atinocytes significantly inhibited cell growth in sham-irradiated cells. These data indicate that
PTEN reduction plays a critical role in UVA-induced development of SK as well as SCC, likely
through the AKT and ERK pathways.
658
Sunscreens may prevent UV-induced facial fat loss by blocking the production of IL-11
W Li, A Pappas, L Zhang and D Cavender Skin Research Center, a Unit of Johnson and Johnson
Consumer Companies, Inc., Skillman, NJ
Interleukin-11 (IL-11) is produced by fibroblasts upon exposure to various cytokines (IL-1α; TGF-β)
or to phorbol esters. Exposure to IL-11 results in the inhibition of preadipocytes differentiation in
vitro. We hypothesized that ultraviolet (UV) irradiation may induce dermal fibroblasts to produce
IL-11, which, in turn, would inhibit preadipocyte differentiation and therefore contributes to the loss
of subcutaneous fat in sun-exposed skin. Using human epidermal-dermal equivalents exposed to a
physiological dose of radiation (5 J/cm2) from a solar simulator, we showed a marked increase in
IL-11 expression and secretion. Pretreatment with a sunscreen blocked the production of IL-11 by
the dermal fibroblasts. Conditioned medium from equivalents exposed to solar radiation inhibited
the differentiation of human facial preadipocytes in vitro. However, preadipocytes incubated with
conditioned medium from equivalents pretreated with a sunscreen, but not placebo, continued to
differentiate normally. These results support the hypothesis that solar radiation-induced IL-11 is
involved in the loss of subcutaneous fat and photoaging. Inhibition of this process by sunscreens
may slow or reverse photoagig-induced changes in facial contouring.
659
Effects of topical cholesterol, linoleic acid, and synthetic ceramide III, and an equimolar
mixture, on UV-induced skin responses in tape-stripped human skin in vivo
H Byun,1,2,3 K Cho,1,2,3 M Lee,1,2,3 Y Lee,1,2,3 S Lee,1,2,3 K Kim1,2,3 and J Chung1,2,3 1 Dermatology,
Seoul National University College of Medicine, Seoul, Republic of Korea, 2 Institute of
Dermatological Science, Medical Research Center, Seoul National University, Seoul, Republic
of Korea and 3 Laboratory of Cutaneous Aging Research, Clinical Research Institute, Seoul
National University Hospital, Seoul, Republic of Korea
The effects of moisturizers on the viable layers underneath the stratum corneum have rarely been
reported. To evaluate the effects of the major lipids in moisturizers (cholesterol, linoleic acid, a syn-
thetic analog of ceramide III, and an equimolar mixture) on UV-induced skin responses, healthy vol-
unteers were recruited (11~12 volunteers / group; mean age, 44.8 ± 9.7 years). The buttock skins
were tape-stripped, then each lipid (20 mg/ml) and its vehicle (octyldodecanol) were applied on
the tape-stripped buttock skin under occlusion. After 2 days of lipid application, the lipid-treated
areas were irradiated with UV (2 MED), and skin samples were obtained 24 hours after irradiation.
The mRNA levels of MMP-1, MMP-9, IL-6, COX-2, IL-1β, and procollagen were measured using
real-time PCR, and the histologic changes were evaluated. Cholesterol significantly suppressed the
basal MMP-1 expression and the mixture suppressed the basal MMP-9 expression. Ceramide and
linoleic acid showed no effects on the basal levels of the targets. Cholesterol and the mixture sig-
nificantly suppressed UV-induced MMP-1, IL-6, and IL-1β expression, whereas linoleic acid increased
UV-induced MMP-1 and IL-6 expression. Ceramide increased UV-induced MMP-1 and IL-6 expres-
sion, and suppressed COX-2 expression. Cholesterol significantly decreased the degree of dermal
inflammatory infiltrates and exocytosis, and the mixture decreased the extent of dermal inflamma-
tory infiltrates. Linoleic acid increased the epidermal thickness and the number of apoptotic cells,
and ceramide increased epidermal thickness. Our results provide new insight into the composition
of moisturizers.
660
The expression of methylenetetrahydrofolate reductase in the skin under low suberythemal
doses of ultraviolet radiation B
A Lesiak,1 K Wodz-Naskiewicz,2 R Pawliczak,2 M Rogowski-Tylman,1 A Sysa-Jedrzejowska1 and
J Narbutt1 1 Dermatology, Medical University of Lodz, Lodz, Poland and 2 Immunopathology,
Medical University of Lodz, Lodz, Poland
Ultraviolet radiation (UVR) is one of the major factors involved in skin photocancerogenesis. Although
it is well known that UVA can destroy foliate, the effect of UVB on foliate status is still not clear.
Some data indicate that foliates, especially its metabolite 5-metyltetrahydrofolate, can protect DNA
from UV induced strand breaks. Methylenetetrahydrofolate reductase (MTHFR) plays an essential
role in foliate metabolic pathway. Thus the aim of the study was to assess the expression of MTHFR
in UVB exposed skin. The study consisted of 4 groups of healthy individuals who were whole-body
UVB irradiated for 10 days with 0.7 MED on each occasion, or whole-body irradiated as before fol-
lowed by a single high dose of UVB (10x10 cm), or were irradiated only with a single dose of UVB
(3 MED) on the small area of the body, or were unirradiated. Skin biopsies were taken in all par-
ticipants and MTHFR expression was assessed (Western blot). The MTHFR expression was signifi-
cantly higher in the volunteers who were whole-body irradiated for 10 days when compared to the
subjects who were whole-body irradiated for 10 days followed by a single 3 MED UVB (p<0.05).
The enhanced expression of MTHFR in human skin under the repeated low doses of UVB might be
a proof for photoprotective properties of foliates .
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UVB suppresses PTEN expression by upregulating miR-141 in HaCaT cells
W Li, B Zhou and D Luo Department of Dermatology, the First Affiliated Hospital of Nanjing
Medical University, Nanjing, China
Background: MicroRNAs (miRNAs) are 21 to 24 nucleotide, non-coding RNA molecules that post-
transcriptionally regulate the expression of target genes. Ultraviolet B (UVB) radiation has been
shown to inhibit phosphatase and tensin homolog deleted on chromosome 10 (PTEN) expression
in HaCaT cells through an unknown mechanism. Aim: In this study, we assessed whether miR-141
can regulate UVB exposure-mediated inhibition of PTEN expression. Methods: Real-time RT-PCR,
Annexin V/Fluorescein isothiocyanate staining, western blotting and anti-miRNA oligonucleotide
transfection were employed in this study. Results: Upregulation of miR-141 expression after UVB
irradiation was inversely correlated with PTEN expression levels in HaCaT cells. Furthermore, miR-
141 expression increased apoptosis, while anti-miR-141 partly restored PTEN expression and reversed
the pro-apoptosis effect of UVB. Conclusion: UVB suppresses the expression of PTEN by upregu-
lating miR-141 in HaCaT cells. Therefore, miR-141 is a potential gene therapy target for UVB-induced
photodamage.
675
Microarray analysis of microRNA expression in skin of Xpc+/− mice and wildtype mice
D Luo and B Zhou Department of Dermatology, the First Affiliated Hospital of Nanjing
Medical University, Nanjing, China
Background and Aim: MicroRNAs (miRNAs) are non-coding RNA molecules of 21 to 24 nt that reg-
ulate the expression of target genes in a post-transcriptional manner. Evidence indicates that miR-
NAs play essential roles in embryogenesis, cell differentiation, and pathogenesis of human diseases
including skin cancer. To investigate possible mechanisms of photocarcinogenesis, we describe a
comparison between miRNA expression profile of Xpc heterozygous partially repair-deficient mice
and WT repair-proficient mice. Methods: We analyzed the miRNA expression profiles in 2 pairs of
Xpc+/− mice and WT mice, using a mammalian miRNA microarray containing whole mice mature
and precursor miRNA sequences. MiRBase and GO-analysis were employed for the prediction of
miRNA targets. Results: A total of 20 miRNAs were differentially expressed in which 13 miRNAs
down-regulated and 7 miRNAs up-regulated in Xpc heterozygous mice compared with WT coun-
terpart. Differentially expressed miRNAs were predicted to have some relationships with several sig-
naling pathway in skin cells, of which regulation of epidermal growth factor receptor signaling path-
way and transforming growth factor beta receptor signaling pathway should be noted. Conclusion:
Our data thus indicate that miRNAs were potentially involved in the pathogenesis of photocar-
cinogenesis, and miRNAs may help to diagnosis, treat and prevent UV-induced skin cancers.
677
Confocal microscopic features of radiation dermatitis
S Vano-Galvan,1 E Fernández-Lizarbe,3 V Sánchez,1 M Truchuelo,1 B Diaz-Ley,1 L Ríos,1 E Vañó,2
P Jaén1 and S González4,1 1 Dermatology, Ramón y Cajal Hospital, Madrid, Spain, 2 Medical
Physics, Clínico San Carlos Hospital, Madrid, Spain, 3 Radiotherapy, Ramón y Cajal Hospital,
Madrid, Spain and 4 Dermatology, Memorial Sloan-Kettering Cancer Center, Nueva York,
USA, New York, NY
The dynamic changes that the skin undergoes in response to radiotherapy have been scarcely doc-
umented. Reflectance confocal microscopy (RCM) is a novel technique that enables the non-inva-
sive imaging of human skin at cellular resolution and reveals dynamic histopathological changes
in the skin over time. Objective: To describe the major RCM features of radiation dermatitis Prospec-
tive descriptive study. Five women diagnosed of breast cancer undergoing the same regimen of adju-
vant radiotherapy were included. Clinical, dermoscopic and RCM evaluation were performed on
days 0 (pre), 1, 15, 30 and 45 after starting radiotherapy treatment. RCM evaluations were carried
out using a commercial reflectance confocal microscope (VivaScope® 1500, Lucid Inc., Rochester,
NY) equipped with an 830-nm laser as the source of illumination. The submammary fold was
examined and RCM features were reviewed and evaluated by three observers. Clinically, detectable
radiation dermatitis emerged after 30 days average; however, confocal changes were detectable
after a mean time of 15 days. The major RCM features included a decrease of basal cells, epider-
mal streaming, spongiosis, exocytosis, dendritic cells, basal layer pigmentation, presence of inflam-
matory cells / melanophages, geographic papillae and effacement of rete ridges. In conclusion, RCM
may detect the cutaneous histological changes induced by ionizing radiation at a potentially ear-
lier stage than clinically examination, suggesting its potential application to predict skin damage
during radiotherapy or interventional procedures.
676
Protective effect of Baicalin on multiple ultraviolet B exposure-mediated damages in C57BL/6
mouse skin
D Wu, B Zhou and D Luo Department of Dermatology, the First Affiliated Hospital of Nanjing
Medical University, Nanjing, China
Multiple exposures to solar ultraviolet (UV) radiation cause critical damages that may lead to the
development of several cutaneous disorders including skin cancer. Protection against sun-induced
damage is therefore a highly desirable goal. Chemoprevention via plant-based agents may be a
useful approach for the management of UV-induced neoplasia. In this study, we assessed whether
Baicalin afford protective effect on multiple UVB exposure-mediated damages in C57BL/6 mice
skin and the underlying mechanisms. C57BL/6 mice were topically pretreated with baicalin (1
mg/cm2 skin area/mouse/100 μL acetone) and were exposed to UVB 30 minutes later (180 mJ/cm2,
on alternate days ×10 exposures). The animals were sacrificed 24 h after the last UVB exposure.
Skin edema, histopathology changes, Ki-67, PCNA, COX-2 were assesed to determine the multiple
UVB induced photodamage. Multiple UVB exposures to C57BL/6 mice resulted in an increase in
skin edema and hyperplasia. Topical application of baicalin prior to UVB radiation resulted in a sig-
nificant inhibition of Ki-67, PCNA and COX-2. These protective effects of baicalin are supposed to
inhibit UVB-induced skin carcinogenesis. Based on this data, we suggest that baicalin could be
developed as an agent for the management of conditions elicited by multiple UV exposure includ-
ing skin cancer.
674
Modification of microRNA expression by baicalin in UVB irradiated mouse skin using a
microRNA microarray
D Luo and B Zhou Department of Dermatology, the First Affiliated Hospital of Nanjing Medical
University, Nanjing, China
MicroRNAs (miRNAs) are non-coding RNA molecules of 21 to 24 nt that regulate the expression of
target genes in a post-transcriptional manner. Evidence indicates that miRNAs play essential roles
in embryogenesis, cell differentiation, and pathogenesis of human diseases including skin cancer.
To assess the effects of baicalin on UVB-mediated miRNAs expression changes in mice skin. We
analyzed the miRNA expression profiles in 3 pairs of UVB irradiated mice, baicalin treated irradi-
ated mice, and untreated mice. Real-time RT-PCR analysis was used for confirm the miRNA expres-
sion changes. TargetScan and GO-analysis were employed for the prediction of miRNA targets. 3
miRNAs are down-regulated and 3 miRNAs are up-regulated in UVB irradiated mice compared with
untreated counterpart. Differentially expressed miRNAs were predicted to have some relationships
with photocarcinogenesis, hypomethylation and apoptosis. 3 miRNAs are down-regulated and 1
miRNA are up-regulated in baicalin treated irradiated mice compared with UVB irradiated mice.
Differentially expressed miRNAs were predicted to have some relationships with DNA repair sig-
naling. MiRNAs were potentially involved in the pathogenesis of photodamage, and differentially
expressed miRNAs in baicalin treated group may help to treat and prevent UV-induced dermatoses.
678
Bath-psoralen UVA and narrow-band UVB reduce circulating Th17 cells and induce circu-
lating regulatory T cells in psoriasis
T Furuhashi, C Saito, K Torii, E Nishida and A Morita Department of Geriatric and
Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences,
Nagoya, Japan
Photochemotherapy, such as bath water delivery of 8-methoxypsoralen and subsequent UVA-irra-
diation (bath-PUVA) and narrow-band UVB (NB-UVB), is a widely used effective treatment for pso-
riasis. An imbalance of Th17 cells and regulatory T cells (Treg) is thought to contribute to the patho-
genesis of psoriasis; therefore, we examined the effect of phototherapy on those circulating cells in
patients with psoriasis. Peripheral blood was obtained from patients with psoriasis treated with bath-
PUVA (n=41) or NB-UVB (n=18) and healthy volunteers (n=26). CD4+ T cells were isolated from
peripheral blood monocytes. After stimulation with phorbol 12-myristate 13-acetate and ionomycin,
cells were stained with interleukin (IL)-17 and analyzed by fluorescence–activated cell sorting (n=51)
to estimate the number of Th17 cells. CD4+ CD25+ Foxp3+ cells were analyzed (n= 46) to esti-
mate the number of Treg. The ratio of Th17 to CD4+ T cells was higher in patients with psoriasis
than in healthy volunteers. To evaluate whether phototherapy attenuates the increase in Th17 cells,
CD4+ T cells from patients (n=11) with increased Th17 (Th17/CD4; >3.3 [mean+SD of healthy vol-
unteers]) were analyzed before and after phototherapy. Th17 cells were significantly reduced after
phototherapy (Th17/CD4; 2.9 ± 3.0%) compared with before therapy (6.1 ± 2.2%). In contrast, Treg
were significantly increased after phototherapy (4.5 ± 2.2%) compared with before therapy (3.5 ±
1.4%) in patients treated previously with only topical application. In addition, IL-6 and thymus-
activated-and-regulated-chemokine levels were significantly decreased in patients treated with bath-
PUVA (from 1720 ± 4549, 14.6 ± 18.2 to 1260 ± 3805, 8.2 ± 8.2, respectively). These findings indi-
cate that phototherapy induces a decrease in Th17 and an increase in Treg in the peripheral blood
of patients with psoriasis, and therefore resolves the Th17 and Treg imbalance in these patients.
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Differential ku 70 expression patterns in t cells following photodynamic therapy with pc 4
and other apoptosis-inducing modalities
PC Jou,1,2 M Lam,1,2 K Ferenczi,5 NL Oleinick,2,3 KD Cooper1,2,4 and ED Baron1,2,4 1 Dermatology,
CWRU/UH CMC, Cleveland, OH, 2 CCCC, CWRU/UH CMC, Cleveland, OH, 3 Radiation
Oncology, CWRU/UH CMC, Cleveland, OH, 4 LSVA Med. Ctr., Cleveland, OH and 5
Dermatology, UCHC, Farmington, CT
Malignant T cells in cutaneous T cell lymphoma (CTCL) have been found to have decreased levels
of Ku 70, an anti-apoptotic protein in the cytoplasm. Early evidence has shown that photodynamic
therapy (PDT) with the photosensitizer silicon phthalocyanine 4 (Pc 4) strongly induced apoptosis
in T cells, in vitro, and that activated T cells were even more susceptible to its effects. Thus, we
asked how Ku 70 expression may change in T cells in vitro due to Pc 4-PDT and other apoptosis-
inducing modalities as examined by immunofluorescent staining and confocal microscopy. In nor-
mal T cells, Pc 4-PDT increases cytoplasmic Ku 70 expression in a globular pattern suggesting that
Ku 70 is aggregating or located within membrane-bound structures. With UVB treatment, Ku 70
signals exhibited a dose response with increased diffused cytoplasmic Ku 70 expression between
12.5-50mJ/cm2. Dosages above 75mJ/cm2 did not affect Ku 70 staining when compared to untreated
cells. Additionally, although vorinostat, a CTCL treatment, did not increase Ku 70 expression, vorino-
stat plus UVB between 25-50mJ/cm2 enhanced Ku 70 staining; however, Ku 70 remained diffuse in
the cytoplasm as oppose to the globular pattern induced by Pc 4-PDT. In malignant T cells of leukemic
CTCL, cytoplasmic Ku 70 signal is similarly increased in a globular pattern; however it is unchanged
with extracorporeal photophoresis, another CTCL treatment. It has been shown in MCF-7 cells that
Pc 4-PDT induces both apoptosis and autophagy. Thus apoptosis is not a good measure of the cel-
lular responses to Pc 4-PDT and a marker is needed that encompasses both apoptosis and autophagy.
The increased expression of Ku 70 post-Pc 4-PDT in a globular pattern in the cytoplasm suggests
that autophagy may be activated, though this must be confirmed by further research. Thus, Ku 70
may potentially be a useful biomarker of T cell response to Pc 4-PDT.
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Nucleotide excision repair of UV radiation photoproducts requires protein kinase C delta
C Negro, E LaGory and MF Denning Loyola University Chicago, Maywood, IL
Bulky, helix-distorting DNA adducts, such as cyclopyrimidine dimers (CPDs) induced by UV radi-
ation, are repaired by nucleotide excision repair (NER). Defects in NER complementation group
genes give rise to familial cancer syndromes such as xeroderma pigmentosum, supporting the impor-
tant tumor suppressive effects of NER. Protein kinase C delta (PKCδ) expression is lost in squamous
cell carcinomas where it functions as a tumor suppressor gene. PKCδ is activated in response to
DNA damage downstream ATM/ATR, and participates in inducing apoptosis and maintaining the
G2/M cell cycle checkpoint in response to UV radiation. Since cell cycle checkpoints are coupled
to DNA damage repair pathways, we examined the role of PKCδ in NER of UV-induced CPDs.
Wild type mouse embryo fibroblasts (MEFs) exposed to a non-apoptotic dose of UV (5 mJ/cm2)
were competent at repairing CPDs as determined by quantitative immunofluorescence microscopy.
In contrast, PKCδ null MEFs had significantly (p<0.001) reduced repair of UV-induced CPD adducts.
These results were confirmed with Southwestern blotting for CPDs in DNA isolated from wild type
and PKCδ null cells exposed to even higher doses of UV radiation. Activation of NER involves the
induction and recruitment of repair proteins, such as XPA, to sites of DNA damage. XPA is a criti-
cal NER protein which binds damaged DNA and requires cell cycle checkpoint signaling by ATR
for nuclear recruitment. To explore the molecular mechanism of how lack of PKCδ impairs repair
of CPDs, we performed immunofluorescence analysis of XPA on wild type and PKCδ null MEFs.
UV radiation induced the nuclear localization of XPA in wild type, but not PKCδ null MEFs (p<0.001)
48 hours post UV irradiation. Since XPA recruitment is common to both Global Genomic-NER and
Transcription Coupled-NER, these results suggest that PKCδ loss would inhibit both components of
NER. Overall, our findings have identified a novel role for PKCδ in NER which may contribute to
its tumor suppressor function and help provide a mechanistic link between the G2/M cell cycle
checkpoint and NER of UV-induced DNA damage.
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Evaluation of extracorporeal photopheresis for prevention and the treatment of bronchioli-
tis obliterans syndrome after lung transplantation
R Knobler,1 U Just1 and P Jaksch2 1 Dermatology, Medical University of Vienna, Vienna, Austria
and 2 Surgery, Medical University of Vienna, Vienna, Austria
After its use in CTCL Photopheresis(ECP) was first introduced in 1995 for treatment of acute and
chronic rejection in lung transplantat recipients (off label use). Data supporting the use of ECP for
treatment and prevention of bronchiolitis obliterans syndrome (BOS) after lung transplantation are
limited. Efficacy and safety of ECP for progressive BOS was evaluated at a single institution in a
prospective manner. Between October 2000, and June 2010, 47 lung allograft recipients were treated
with ECP for progressive BOS. Only patients with a minimum follow up period of 6 months were
included ( n=45). Time from lung transplantation to BOS grade 1 was 1216±898 days (mean±SD)(range
161-4306 days). The interval between initiation of BOS 1 and first f ECP treatment was 255±332
days. Mean number of ECP cycles was 16. Our results showed that during the 6-month period before
the initiation of ECP, the average rate of decline in forced expiratory volume in 1 second (FEV1) was
-123.0 ml/month, but the slope decreased to -13 ml/month during the 3-month period after the ini-
tiation of ECP and -16ml/month during the 12 month period. The mean difference in the rate of
decline between this 12-month period and the period before ECP was 42/month (95% CI, 71-130
ml/month; p =0,006). The FEV1 improved in 17% of patients for more than 1 year after the initia-
tion of ECP, 11% showed an improvement for only 3-6 months, FEV1 stabilized in 36% and showed
a progressive decline in 36%. Treatment was well tolerated. In conclusion, ECP can reduce the rate
of decline in lung function associated with progressive BOS. Subgroups of patients responded with
an improvement or stabilization of FEV1 for more than 1 year. Future studies are warranted.
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Molecular effects of fractional laser on photo-aged skin
PC Jou,1 A Potaracke,1 M Lam,1,2 ED Baron1,2,3 and J Garcia-Zuazaga1 1 Dermatology,
CWRU/UH CMC, Cleveland, OH, 2 Case SDRC, CWRU/UH CMC, Cleveland, OH and 3
LSVA Med. Ctr., Cleveland, OH
It is thought that fractional photothermolysis (FP), a non-ablative laser therapy, provides its clinical
benefits mainly by promoting a wound healing response that results in neocollagenesis. The effec-
tiveness of FP in the treatment of photodamaged skin has been assessed primarily on clinical out-
comes with reported improvements following treatment. However, its mechanisms on the molec-
ular level are not well understood. To optimize methodologies, we investigated the fractional laser’s
molecular effects on photo-aged skin and further characterized the dynamic alterations involved in
dermal matrix remodeling after FP laser treatment. Punch biopsies were taken from Caucasian
females ages 42, 62, and 64 with Fitzpatrick skin types II, III and IV treated with the FP laser using
the following parameters: energy=30mJ, treatment level=8, number of passes=8. Tissue samples
underwent immunostaining to evaluate HSP70, MMP1, and collagen expression via confocal
immunofluorescence (IF) imaging and analyzed using Volocity and MetaMorph software. In addi-
tion, quantitative real-time polymerase chain reaction (qRT-PCR) experiments were performed fol-
lowing the isolation of RNAs from all punch biopsies. An array of mRNAs, such as MMP-1,-3,-9;
COL1A1, COL3A1; and PCOLCE, were examined. IF staining showed that HSP70 was significantly
upregulated 1 day post FP and returned to baseline levels by day 7. qRT-PCR showed a minor decrease
in both COL1A1 and COL3A1 mRNA 1 day post FP. However, after 7 days, these collagen mark-
ers demonstrated a 6-fold increase. Our results are consistent with substantial dermal matrix remod-
eling, including collagen production, within a week after a single FP laser treatment at the given
dose and treatment level. Additional studies are needed to determine the duration of remodeling
parameters after a single treatment and the effects of multiple FP sessions on the magnitude and
duration of neocollagenesis. Such surrogate analysis may help define optimum parameters in the
treatment of photo-aging.
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Impact of UVA+ UVB full spectrum compared to UVA or UVB mono-wavelength on fibrob-
lasts
A Amoyel,1 S Pinacolo,1 R Chabert,1 N Garcia,1 F Portolan,1 C Dal Farra2 and N Domloge1 1
Global Skin Research Center, ISP Vincience, Sophia antipolis, France and 2 Corporate
Research Center, ISP, Wayne, NJ
Sunlight includes infra-red, visible and ultra-violet light. It’s known that human UV exposure is
mainly to full spectrum radiation. However, scientific studies on skin response to sunlight irradia-
tion are mainly performed using mono-wavelength UVB or UVA. It is also known that whereas
UVB induces DNA double-strand breaks, UVA is implicated in oxidative stress. Therefore, in this
study, we were interested in comparing the impact of UVA+UVB full spectrum to mono-wave-
length UV-stress, on human fibroblasts. Cells were irradiated with biologically relevant dose of
UVA+UVB full spectrum wavelength in order to determine the dose inducing 20% of cell death.
Dose course studies of 1 to 20J/cm2 (UVA 365 nm sensor) showed that 5J/cm2 of UVA+UVB is the
dose of choice for these in vitro studies. Using this dose, we compared, by comet assay, DNA frag-
mentation in fibroblast irradiated with UVA+UVB full spectrum or with mono-wavelength UVA
and UVB. Surprisingly, only 40mJ/cm2 of UVB induced DNA alterations, demonstrating greater tail
moment than UVA+UVB full spectrum (2.3J/cm2, UVB 312nm sensor). Subsequently to these results,
we performed a kinetic study to observe DNA alteration after UVB mono-wavelength irradiation.
We showed that the maximal damage appeared 20 hours after stress. Using IV.09008, a compound
designed for DNA protection, we demonstrated a protective effect from UVB damage reducing the
DNA alteration. These results confirm that UVB mono-wavelength (compared to full spectrum),
remains the most appropriate to study in vitro DNA fragmentation.
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Silymarin inhibits UV-induced immunosuppression through inactivation of CD4+ T cells and
stimulation of CD8+ effector T cells
M Vaid,1 T Singh1 and SK Katiyar1,2 1 University of Alabama at Birmingham, Birmingham, AL
and 2 Birmingham VA Medical Center, Birmingham, AL
Experimental and clinical evidences indicate that ultraviolet (UV) radiation-induced immunosup-
pression is a risk factor for skin cancer development. We have shown that topical application of sily-
marin, a plant flavanoid from milk thistle (Silybum marianum), inhibits UVB-induced immunosup-
pression in mice, but the molecular mechanisms underlying this inhibitory effect of silymarin are
not clearly understood. To characterize the cell population responsible for the silymarin-mediated
inhibition of UVB-induced immunosuppression, we used an adoptive transfer approach using
C3H/HeN mouse model. Spleens and lymph nodes were harvested from mice that had been treated
with silymarin (0.5 or 1.0 mg/cm2 skin area), exposed to UVB, and sensitized by application of
2,4-dinitrofluorobenzene (DNFB) onto the UVB-exposed skin. CD8+ and CD4+ T cells were posi-
tively selected and transferred into naïve mice that were subsequently challenged by application of
DNFB on the ear skin. Naïve recipients that received CD8+ T cells from silymarin-treated, UVB-
irradiated donors exhibited full contact hypersensitivity (CHS) response. Naïve mice that received
CD4+ T cells from silymarin-treated, UVB-exposed mice were able to mount a partial but signifi-
cant CHS response after sensitization and subsequent challenge with DNFB. On culture, the CD8+
T cells from silymarin-treated, UVB-exposed mice secreted higher levels of Th1 cytokines (IL-2, IFNγ)
than CD8+ T cells from UVB-irradiated mice not treated with silymarin. CD4+ T cells from sily-
marin-treated, UVB-exposed mice secreted significantly lower levels of Th2 cytokines than CD4+
T cells from UVB-exposed mice not treated with silymarin. These data suggest that silymarin inhibits
UVB-induced immunosuppression by stimulating CD8+ effector T cells and diminishing regulatory
CD4+ T cells. This property of silymarin can be used as an alternative strategy to augment the
induction of CD8+ T cells and to diminish the development of CD4+ T cells and that may lead to
the prevention of skin cancer risk.
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UVB suppresses PTEN expression by upregulating miR-141 in HaCaT cells
W Li, B Zhou and D Luo Department of Dermatology, the First Affiliated Hospital of Nanjing
Medical University, Nanjing, China
Background: MicroRNAs (miRNAs) are 21 to 24 nucleotide, non-coding RNA molecules that post-
transcriptionally regulate the expression of target genes. Ultraviolet B (UVB) radiation has been
shown to inhibit phosphatase and tensin homolog deleted on chromosome 10 (PTEN) expression
in HaCaT cells through an unknown mechanism. Aim: In this study, we assessed whether miR-141
can regulate UVB exposure-mediated inhibition of PTEN expression. Methods: Real-time RT-PCR,
Annexin V/Fluorescein isothiocyanate staining, western blotting and anti-miRNA oligonucleotide
transfection were employed in this study. Results: Upregulation of miR-141 expression after UVB
irradiation was inversely correlated with PTEN expression levels in HaCaT cells. Furthermore, miR-
141 expression increased apoptosis, while anti-miR-141 partly restored PTEN expression and reversed
the pro-apoptosis effect of UVB. Conclusion: UVB suppresses the expression of PTEN by upregu-
lating miR-141 in HaCaT cells. Therefore, miR-141 is a potential gene therapy target for UVB-induced
photodamage.
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Microarray analysis of microRNA expression in skin of Xpc+/− mice and wildtype mice
D Luo and B Zhou Department of Dermatology, the First Affiliated Hospital of Nanjing
Medical University, Nanjing, China
Background and Aim: MicroRNAs (miRNAs) are non-coding RNA molecules of 21 to 24 nt that reg-
ulate the expression of target genes in a post-transcriptional manner. Evidence indicates that miR-
NAs play essential roles in embryogenesis, cell differentiation, and pathogenesis of human diseases
including skin cancer. To investigate possible mechanisms of photocarcinogenesis, we describe a
comparison between miRNA expression profile of Xpc heterozygous partially repair-deficient mice
and WT repair-proficient mice. Methods: We analyzed the miRNA expression profiles in 2 pairs of
Xpc+/− mice and WT mice, using a mammalian miRNA microarray containing whole mice mature
and precursor miRNA sequences. MiRBase and GO-analysis were employed for the prediction of
miRNA targets. Results: A total of 20 miRNAs were differentially expressed in which 13 miRNAs
down-regulated and 7 miRNAs up-regulated in Xpc heterozygous mice compared with WT coun-
terpart. Differentially expressed miRNAs were predicted to have some relationships with several sig-
naling pathway in skin cells, of which regulation of epidermal growth factor receptor signaling path-
way and transforming growth factor beta receptor signaling pathway should be noted. Conclusion:
Our data thus indicate that miRNAs were potentially involved in the pathogenesis of photocar-
cinogenesis, and miRNAs may help to diagnosis, treat and prevent UV-induced skin cancers.
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Confocal microscopic features of radiation dermatitis
S Vano-Galvan,1 E Fernández-Lizarbe,3 V Sánchez,1 M Truchuelo,1 B Diaz-Ley,1 L Ríos,1 E Vañó,2
P Jaén1 and S González4,1 1 Dermatology, Ramón y Cajal Hospital, Madrid, Spain, 2 Medical
Physics, Clínico San Carlos Hospital, Madrid, Spain, 3 Radiotherapy, Ramón y Cajal Hospital,
Madrid, Spain and 4 Dermatology, Memorial Sloan-Kettering Cancer Center, Nueva York,
USA, New York, NY
The dynamic changes that the skin undergoes in response to radiotherapy have been scarcely doc-
umented. Reflectance confocal microscopy (RCM) is a novel technique that enables the non-inva-
sive imaging of human skin at cellular resolution and reveals dynamic histopathological changes
in the skin over time. Objective: To describe the major RCM features of radiation dermatitis Prospec-
tive descriptive study. Five women diagnosed of breast cancer undergoing the same regimen of adju-
vant radiotherapy were included. Clinical, dermoscopic and RCM evaluation were performed on
days 0 (pre), 1, 15, 30 and 45 after starting radiotherapy treatment. RCM evaluations were carried
out using a commercial reflectance confocal microscope (VivaScope® 1500, Lucid Inc., Rochester,
NY) equipped with an 830-nm laser as the source of illumination. The submammary fold was
examined and RCM features were reviewed and evaluated by three observers. Clinically, detectable
radiation dermatitis emerged after 30 days average; however, confocal changes were detectable
after a mean time of 15 days. The major RCM features included a decrease of basal cells, epider-
mal streaming, spongiosis, exocytosis, dendritic cells, basal layer pigmentation, presence of inflam-
matory cells / melanophages, geographic papillae and effacement of rete ridges. In conclusion, RCM
may detect the cutaneous histological changes induced by ionizing radiation at a potentially ear-
lier stage than clinically examination, suggesting its potential application to predict skin damage
during radiotherapy or interventional procedures.
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Protective effect of Baicalin on multiple ultraviolet B exposure-mediated damages in C57BL/6
mouse skin
D Wu, B Zhou and D Luo Department of Dermatology, the First Affiliated Hospital of Nanjing
Medical University, Nanjing, China
Multiple exposures to solar ultraviolet (UV) radiation cause critical damages that may lead to the
development of several cutaneous disorders including skin cancer. Protection against sun-induced
damage is therefore a highly desirable goal. Chemoprevention via plant-based agents may be a
useful approach for the management of UV-induced neoplasia. In this study, we assessed whether
Baicalin afford protective effect on multiple UVB exposure-mediated damages in C57BL/6 mice
skin and the underlying mechanisms. C57BL/6 mice were topically pretreated with baicalin (1
mg/cm2 skin area/mouse/100 μL acetone) and were exposed to UVB 30 minutes later (180 mJ/cm2,
on alternate days ×10 exposures). The animals were sacrificed 24 h after the last UVB exposure.
Skin edema, histopathology changes, Ki-67, PCNA, COX-2 were assesed to determine the multiple
UVB induced photodamage. Multiple UVB exposures to C57BL/6 mice resulted in an increase in
skin edema and hyperplasia. Topical application of baicalin prior to UVB radiation resulted in a sig-
nificant inhibition of Ki-67, PCNA and COX-2. These protective effects of baicalin are supposed to
inhibit UVB-induced skin carcinogenesis. Based on this data, we suggest that baicalin could be
developed as an agent for the management of conditions elicited by multiple UV exposure includ-
ing skin cancer.
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Modification of microRNA expression by baicalin in UVB irradiated mouse skin using a
microRNA microarray
D Luo and B Zhou Department of Dermatology, the First Affiliated Hospital of Nanjing Medical
University, Nanjing, China
MicroRNAs (miRNAs) are non-coding RNA molecules of 21 to 24 nt that regulate the expression of
target genes in a post-transcriptional manner. Evidence indicates that miRNAs play essential roles
in embryogenesis, cell differentiation, and pathogenesis of human diseases including skin cancer.
To assess the effects of baicalin on UVB-mediated miRNAs expression changes in mice skin. We
analyzed the miRNA expression profiles in 3 pairs of UVB irradiated mice, baicalin treated irradi-
ated mice, and untreated mice. Real-time RT-PCR analysis was used for confirm the miRNA expres-
sion changes. TargetScan and GO-analysis were employed for the prediction of miRNA targets. 3
miRNAs are down-regulated and 3 miRNAs are up-regulated in UVB irradiated mice compared with
untreated counterpart. Differentially expressed miRNAs were predicted to have some relationships
with photocarcinogenesis, hypomethylation and apoptosis. 3 miRNAs are down-regulated and 1
miRNA are up-regulated in baicalin treated irradiated mice compared with UVB irradiated mice.
Differentially expressed miRNAs were predicted to have some relationships with DNA repair sig-
naling. MiRNAs were potentially involved in the pathogenesis of photodamage, and differentially
expressed miRNAs in baicalin treated group may help to treat and prevent UV-induced dermatoses.
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Bath-psoralen UVA and narrow-band UVB reduce circulating Th17 cells and induce circu-
lating regulatory T cells in psoriasis
T Furuhashi, C Saito, K Torii, E Nishida and A Morita Department of Geriatric and
Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences,
Nagoya, Japan
Photochemotherapy, such as bath water delivery of 8-methoxypsoralen and subsequent UVA-irra-
diation (bath-PUVA) and narrow-band UVB (NB-UVB), is a widely used effective treatment for pso-
riasis. An imbalance of Th17 cells and regulatory T cells (Treg) is thought to contribute to the patho-
genesis of psoriasis; therefore, we examined the effect of phototherapy on those circulating cells in
patients with psoriasis. Peripheral blood was obtained from patients with psoriasis treated with bath-
PUVA (n=41) or NB-UVB (n=18) and healthy volunteers (n=26). CD4+ T cells were isolated from
peripheral blood monocytes. After stimulation with phorbol 12-myristate 13-acetate and ionomycin,
cells were stained with interleukin (IL)-17 and analyzed by fluorescence–activated cell sorting (n=51)
to estimate the number of Th17 cells. CD4+ CD25+ Foxp3+ cells were analyzed (n= 46) to esti-
mate the number of Treg. The ratio of Th17 to CD4+ T cells was higher in patients with psoriasis
than in healthy volunteers. To evaluate whether phototherapy attenuates the increase in Th17 cells,
CD4+ T cells from patients (n=11) with increased Th17 (Th17/CD4; >3.3 [mean+SD of healthy vol-
unteers]) were analyzed before and after phototherapy. Th17 cells were significantly reduced after
phototherapy (Th17/CD4; 2.9 ± 3.0%) compared with before therapy (6.1 ± 2.2%). In contrast, Treg
were significantly increased after phototherapy (4.5 ± 2.2%) compared with before therapy (3.5 ±
1.4%) in patients treated previously with only topical application. In addition, IL-6 and thymus-
activated-and-regulated-chemokine levels were significantly decreased in patients treated with bath-
PUVA (from 1720 ± 4549, 14.6 ± 18.2 to 1260 ± 3805, 8.2 ± 8.2, respectively). These findings indi-
cate that phototherapy induces a decrease in Th17 and an increase in Treg in the peripheral blood
of patients with psoriasis, and therefore resolves the Th17 and Treg imbalance in these patients.
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Differential ku 70 expression patterns in t cells following photodynamic therapy with pc 4
and other apoptosis-inducing modalities
PC Jou,1,2 M Lam,1,2 K Ferenczi,5 NL Oleinick,2,3 KD Cooper1,2,4 and ED Baron1,2,4 1 Dermatology,
CWRU/UH CMC, Cleveland, OH, 2 CCCC, CWRU/UH CMC, Cleveland, OH, 3 Radiation
Oncology, CWRU/UH CMC, Cleveland, OH, 4 LSVA Med. Ctr., Cleveland, OH and 5
Dermatology, UCHC, Farmington, CT
Malignant T cells in cutaneous T cell lymphoma (CTCL) have been found to have decreased levels
of Ku 70, an anti-apoptotic protein in the cytoplasm. Early evidence has shown that photodynamic
therapy (PDT) with the photosensitizer silicon phthalocyanine 4 (Pc 4) strongly induced apoptosis
in T cells, in vitro, and that activated T cells were even more susceptible to its effects. Thus, we
asked how Ku 70 expression may change in T cells in vitro due to Pc 4-PDT and other apoptosis-
inducing modalities as examined by immunofluorescent staining and confocal microscopy. In nor-
mal T cells, Pc 4-PDT increases cytoplasmic Ku 70 expression in a globular pattern suggesting that
Ku 70 is aggregating or located within membrane-bound structures. With UVB treatment, Ku 70
signals exhibited a dose response with increased diffused cytoplasmic Ku 70 expression between
12.5-50mJ/cm2. Dosages above 75mJ/cm2 did not affect Ku 70 staining when compared to untreated
cells. Additionally, although vorinostat, a CTCL treatment, did not increase Ku 70 expression, vorino-
stat plus UVB between 25-50mJ/cm2 enhanced Ku 70 staining; however, Ku 70 remained diffuse in
the cytoplasm as oppose to the globular pattern induced by Pc 4-PDT. In malignant T cells of leukemic
CTCL, cytoplasmic Ku 70 signal is similarly increased in a globular pattern; however it is unchanged
with extracorporeal photophoresis, another CTCL treatment. It has been shown in MCF-7 cells that
Pc 4-PDT induces both apoptosis and autophagy. Thus apoptosis is not a good measure of the cel-
lular responses to Pc 4-PDT and a marker is needed that encompasses both apoptosis and autophagy.
The increased expression of Ku 70 post-Pc 4-PDT in a globular pattern in the cytoplasm suggests
that autophagy may be activated, though this must be confirmed by further research. Thus, Ku 70
may potentially be a useful biomarker of T cell response to Pc 4-PDT.
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Nucleotide excision repair of UV radiation photoproducts requires protein kinase C delta
C Negro, E LaGory and MF Denning Loyola University Chicago, Maywood, IL
Bulky, helix-distorting DNA adducts, such as cyclopyrimidine dimers (CPDs) induced by UV radi-
ation, are repaired by nucleotide excision repair (NER). Defects in NER complementation group
genes give rise to familial cancer syndromes such as xeroderma pigmentosum, supporting the impor-
tant tumor suppressive effects of NER. Protein kinase C delta (PKCδ) expression is lost in squamous
cell carcinomas where it functions as a tumor suppressor gene. PKCδ is activated in response to
DNA damage downstream ATM/ATR, and participates in inducing apoptosis and maintaining the
G2/M cell cycle checkpoint in response to UV radiation. Since cell cycle checkpoints are coupled
to DNA damage repair pathways, we examined the role of PKCδ in NER of UV-induced CPDs.
Wild type mouse embryo fibroblasts (MEFs) exposed to a non-apoptotic dose of UV (5 mJ/cm2)
were competent at repairing CPDs as determined by quantitative immunofluorescence microscopy.
In contrast, PKCδ null MEFs had significantly (p<0.001) reduced repair of UV-induced CPD adducts.
These results were confirmed with Southwestern blotting for CPDs in DNA isolated from wild type
and PKCδ null cells exposed to even higher doses of UV radiation. Activation of NER involves the
induction and recruitment of repair proteins, such as XPA, to sites of DNA damage. XPA is a criti-
cal NER protein which binds damaged DNA and requires cell cycle checkpoint signaling by ATR
for nuclear recruitment. To explore the molecular mechanism of how lack of PKCδ impairs repair
of CPDs, we performed immunofluorescence analysis of XPA on wild type and PKCδ null MEFs.
UV radiation induced the nuclear localization of XPA in wild type, but not PKCδ null MEFs (p<0.001)
48 hours post UV irradiation. Since XPA recruitment is common to both Global Genomic-NER and
Transcription Coupled-NER, these results suggest that PKCδ loss would inhibit both components of
NER. Overall, our findings have identified a novel role for PKCδ in NER which may contribute to
its tumor suppressor function and help provide a mechanistic link between the G2/M cell cycle
checkpoint and NER of UV-induced DNA damage.
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Evaluation of extracorporeal photopheresis for prevention and the treatment of bronchioli-
tis obliterans syndrome after lung transplantation
R Knobler,1 U Just1 and P Jaksch2 1 Dermatology, Medical University of Vienna, Vienna, Austria
and 2 Surgery, Medical University of Vienna, Vienna, Austria
After its use in CTCL Photopheresis(ECP) was first introduced in 1995 for treatment of acute and
chronic rejection in lung transplantat recipients (off label use). Data supporting the use of ECP for
treatment and prevention of bronchiolitis obliterans syndrome (BOS) after lung transplantation are
limited. Efficacy and safety of ECP for progressive BOS was evaluated at a single institution in a
prospective manner. Between October 2000, and June 2010, 47 lung allograft recipients were treated
with ECP for progressive BOS. Only patients with a minimum follow up period of 6 months were
included ( n=45). Time from lung transplantation to BOS grade 1 was 1216±898 days (mean±SD)(range
161-4306 days). The interval between initiation of BOS 1 and first f ECP treatment was 255±332
days. Mean number of ECP cycles was 16. Our results showed that during the 6-month period before
the initiation of ECP, the average rate of decline in forced expiratory volume in 1 second (FEV1) was
-123.0 ml/month, but the slope decreased to -13 ml/month during the 3-month period after the ini-
tiation of ECP and -16ml/month during the 12 month period. The mean difference in the rate of
decline between this 12-month period and the period before ECP was 42/month (95% CI, 71-130
ml/month; p =0,006). The FEV1 improved in 17% of patients for more than 1 year after the initia-
tion of ECP, 11% showed an improvement for only 3-6 months, FEV1 stabilized in 36% and showed
a progressive decline in 36%. Treatment was well tolerated. In conclusion, ECP can reduce the rate
of decline in lung function associated with progressive BOS. Subgroups of patients responded with
an improvement or stabilization of FEV1 for more than 1 year. Future studies are warranted.
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Molecular effects of fractional laser on photo-aged skin
PC Jou,1 A Potaracke,1 M Lam,1,2 ED Baron1,2,3 and J Garcia-Zuazaga1 1 Dermatology,
CWRU/UH CMC, Cleveland, OH, 2 Case SDRC, CWRU/UH CMC, Cleveland, OH and 3
LSVA Med. Ctr., Cleveland, OH
It is thought that fractional photothermolysis (FP), a non-ablative laser therapy, provides its clinical
benefits mainly by promoting a wound healing response that results in neocollagenesis. The effec-
tiveness of FP in the treatment of photodamaged skin has been assessed primarily on clinical out-
comes with reported improvements following treatment. However, its mechanisms on the molec-
ular level are not well understood. To optimize methodologies, we investigated the fractional laser’s
molecular effects on photo-aged skin and further characterized the dynamic alterations involved in
dermal matrix remodeling after FP laser treatment. Punch biopsies were taken from Caucasian
females ages 42, 62, and 64 with Fitzpatrick skin types II, III and IV treated with the FP laser using
the following parameters: energy=30mJ, treatment level=8, number of passes=8. Tissue samples
underwent immunostaining to evaluate HSP70, MMP1, and collagen expression via confocal
immunofluorescence (IF) imaging and analyzed using Volocity and MetaMorph software. In addi-
tion, quantitative real-time polymerase chain reaction (qRT-PCR) experiments were performed fol-
lowing the isolation of RNAs from all punch biopsies. An array of mRNAs, such as MMP-1,-3,-9;
COL1A1, COL3A1; and PCOLCE, were examined. IF staining showed that HSP70 was significantly
upregulated 1 day post FP and returned to baseline levels by day 7. qRT-PCR showed a minor decrease
in both COL1A1 and COL3A1 mRNA 1 day post FP. However, after 7 days, these collagen mark-
ers demonstrated a 6-fold increase. Our results are consistent with substantial dermal matrix remod-
eling, including collagen production, within a week after a single FP laser treatment at the given
dose and treatment level. Additional studies are needed to determine the duration of remodeling
parameters after a single treatment and the effects of multiple FP sessions on the magnitude and
duration of neocollagenesis. Such surrogate analysis may help define optimum parameters in the
treatment of photo-aging.
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Impact of UVA+ UVB full spectrum compared to UVA or UVB mono-wavelength on fibrob-
lasts
A Amoyel,1 S Pinacolo,1 R Chabert,1 N Garcia,1 F Portolan,1 C Dal Farra2 and N Domloge1 1
Global Skin Research Center, ISP Vincience, Sophia antipolis, France and 2 Corporate
Research Center, ISP, Wayne, NJ
Sunlight includes infra-red, visible and ultra-violet light. It’s known that human UV exposure is
mainly to full spectrum radiation. However, scientific studies on skin response to sunlight irradia-
tion are mainly performed using mono-wavelength UVB or UVA. It is also known that whereas
UVB induces DNA double-strand breaks, UVA is implicated in oxidative stress. Therefore, in this
study, we were interested in comparing the impact of UVA+UVB full spectrum to mono-wave-
length UV-stress, on human fibroblasts. Cells were irradiated with biologically relevant dose of
UVA+UVB full spectrum wavelength in order to determine the dose inducing 20% of cell death.
Dose course studies of 1 to 20J/cm2 (UVA 365 nm sensor) showed that 5J/cm2 of UVA+UVB is the
dose of choice for these in vitro studies. Using this dose, we compared, by comet assay, DNA frag-
mentation in fibroblast irradiated with UVA+UVB full spectrum or with mono-wavelength UVA
and UVB. Surprisingly, only 40mJ/cm2 of UVB induced DNA alterations, demonstrating greater tail
moment than UVA+UVB full spectrum (2.3J/cm2, UVB 312nm sensor). Subsequently to these results,
we performed a kinetic study to observe DNA alteration after UVB mono-wavelength irradiation.
We showed that the maximal damage appeared 20 hours after stress. Using IV.09008, a compound
designed for DNA protection, we demonstrated a protective effect from UVB damage reducing the
DNA alteration. These results confirm that UVB mono-wavelength (compared to full spectrum),
remains the most appropriate to study in vitro DNA fragmentation.
672
Silymarin inhibits UV-induced immunosuppression through inactivation of CD4+ T cells and
stimulation of CD8+ effector T cells
M Vaid,1 T Singh1 and SK Katiyar1,2 1 University of Alabama at Birmingham, Birmingham, AL
and 2 Birmingham VA Medical Center, Birmingham, AL
Experimental and clinical evidences indicate that ultraviolet (UV) radiation-induced immunosup-
pression is a risk factor for skin cancer development. We have shown that topical application of sily-
marin, a plant flavanoid from milk thistle (Silybum marianum), inhibits UVB-induced immunosup-
pression in mice, but the molecular mechanisms underlying this inhibitory effect of silymarin are
not clearly understood. To characterize the cell population responsible for the silymarin-mediated
inhibition of UVB-induced immunosuppression, we used an adoptive transfer approach using
C3H/HeN mouse model. Spleens and lymph nodes were harvested from mice that had been treated
with silymarin (0.5 or 1.0 mg/cm2 skin area), exposed to UVB, and sensitized by application of
2,4-dinitrofluorobenzene (DNFB) onto the UVB-exposed skin. CD8+ and CD4+ T cells were posi-
tively selected and transferred into naïve mice that were subsequently challenged by application of
DNFB on the ear skin. Naïve recipients that received CD8+ T cells from silymarin-treated, UVB-
irradiated donors exhibited full contact hypersensitivity (CHS) response. Naïve mice that received
CD4+ T cells from silymarin-treated, UVB-exposed mice were able to mount a partial but signifi-
cant CHS response after sensitization and subsequent challenge with DNFB. On culture, the CD8+
T cells from silymarin-treated, UVB-exposed mice secreted higher levels of Th1 cytokines (IL-2, IFNγ)
than CD8+ T cells from UVB-irradiated mice not treated with silymarin. CD4+ T cells from sily-
marin-treated, UVB-exposed mice secreted significantly lower levels of Th2 cytokines than CD4+
T cells from UVB-exposed mice not treated with silymarin. These data suggest that silymarin inhibits
UVB-induced immunosuppression by stimulating CD8+ effector T cells and diminishing regulatory
CD4+ T cells. This property of silymarin can be used as an alternative strategy to augment the
induction of CD8+ T cells and to diminish the development of CD4+ T cells and that may lead to
the prevention of skin cancer risk.
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Spectral imaging detects physiologic parameters that contribute to photoaging among twins
CL Malbasa,1 ED Baron,1,4 P Fu,2 MS Matsui,3 C Fthenakis,3 G Vanderover,3 P Cummins3 and
KD Cooper1,4 1 Dept of Dermatology, Univ Hosp Case Medical Ctr, Cleveland, OH, 2 Dept of
Epidemiology & Biostats, CWRU, Cleveland, OH, 3 Estee Lauder Research Div, Melville, NY
and 4 VA Medical Ctr, Cleveland, OH
Photoaging, the most characterized form of extrinsic skin aging, is primarily assessed visually, using
validated photographic photodamage scoring systems such as the Griffiths scale. However such
scales do not allow quantitation of specific variables contributing to the photoaged face. In previ-
ous studies we evaluated environmental factors on skin aging by using a twin cohort to control for
genetic susceptibility. Here we present a new approach using spectral imaging to reveal cutaneous
physiologic factors underlying the photoaged appearance not quantifiable with visual grading alone.
Forty-five twin pairs completed a questionnaire detailing environmental factors that may be asso-
ciated with photoaging. Facial aging in these volunteers was assessed using the 9-point photonu-
meric Griffiths system, determined by grading characteristics such as wrinkling and dyspigmenta-
tion. Among these pairs, 17 (38%) exhibited intra-twin differences in photoaging scores. All 17 pairs
were photographed using a spectral imaging system and analyzed with a previously reported algo-
rithm (Jacques et al submitted to J Biomedical Optics) to quantitate blood (B) and melanin (M) con-
tent, oxygen saturation of hemoglobin (S), and dermal scattering (D). We propose a visual percep-
tion algorithm (ΔV) integrating BMSD in order to examine how those factors contribute to the
photoaging score. The 17 pairs showed a 55% correlation (p = 4.94E-06) between their photoag-
ing score difference and ΔV for all 4 values combined. This correlation increases to 61% (p =
6.92E-12) when only melanin and oxygen saturation are included suggesting these two variables
have the most impact on the photoaging score compared to blood content and dermal scattering.
We have found that spectral imaging can delineate the physiologic phenomena that significantly
contribute to visually appreciable photoaging features.
687
Ultraviolet B radiation augments melanoma tumor growth through its ability to generate
Platelet-activating factor agonists
RP Sahu,1 S Da Silva,1 C Touloukian,3 RL Konger2,1 and JB Travers1 1 Dermatology, Indiana
University, Indianapolis, IN, 2 Pathology, Indiana University, Indianapolis, IN and 3 Surgery,
Indiana University, Indianapolis, IN
Platelet-activating factor (1-alkyl-2-acetyl-glycerophosphocholine; PAF) is a potent lipid mediator
with diverse activities. Ultraviolet B radiation (UVB) stimulates the production of PAF and novel
oxidatively modified glycerophosphocholines with PAF activity, and these lipids mediate systemic
immunosuppression in a process involving IL-10. The current studies sought to define whether
UVB irradiation could modulate experimental murine melanoma tumor growth. Treatment of shaved
upper back skin of C57BL6 mice with UVB at doses that induce systemic immunosuppression
resulted in the enhanced growth of subcutaneous B16F10 melanoma implanted in dorsal hind flank
unirradiated skin. Several lines of evidence implicated the PAF system in the UVB-mediated aug-
mentation of tumor growth. First, UVB-mediated augmentation of tumor growth was absent in PAF-
R-deficient mice, and, second, intraperitoneal injection of the PAF agonist carbamoyl-PAF (CPAF)
mimicked the UVB effect. A neutralizing antibody against IL-10 blocked both CPAF- and UVB-medi-
ated augmentation of B16F10 tumor growth. The next studies were designed to define whether the
PAF-R effect on tumor growth was due to direct effects on B16F10 cells or due to effects on host.
Quantitative RT-PCR demonstrated that B16F10 cells expressed low levels of PAF-R mRNA, and
these cells failed to respond with an intracellular Ca2+ flux in response to CPAF. Transplantation of
B16F10 cells overexpressing the PAF-R using a retroviral vector into mice did not result in an increased
rate of tumor growth over control B16F10 cells either alone, or in response to UVB or CPAF. These
findings indicate that the PAF-R effects are exerted on the host, not the tumor. These studies provide
a novel unreported effect of UVB-mediated PAF agonists, namely, that they can augment melanoma
tumor growth via systemic immunosuppressive response of the host involving the immunomodu-
latory cytokine IL-10.
689
Reflectance analysis – A non-invasive method to study skin biochemical pathways in vitro and
in vivo
D Turgeman,1 M Frusic-Zlotkin,2 Y Soroka,2 FM Bregegere,2 E Ben-Dor1 and Y Milner2 1
Department of Geography, Tel Aviv University, Tel Aviv, Israel and 2 Myers Skin Laboratory,
Department of Biological Chemistry, The Hebrew University, Jerusalem, Israel
Using UVB-irradiated skin organ culture as an experimental model of photodamage, we have inves-
tigated reflectance spectrometry as a tool for non-invasive analysis of skin condition. Two hours after
irradiation of organ cultures, skin reflectance spectra displayed specific changes attributable to a
decrease in reduced versus oxidized hemoglobin ratio. This move was reversed after one day, and
was shown to be kinetically correlated with the total anti-oxidant capacity of epidermis, measured
by cyclic voltammetry. We also observed transient changes in infrared absorption occuring 30 min
after irradiation, presumably due to oxidation of CH3/CH2/CH groups. These were correlated with
a decrease in antioxidants ascorbic acid and uric acid in epidermis and in dermis, and upon UVB
dose variation they were correlated with epidermal ROS levels monitored with fluorogenic probes.
These results suggest that UVB-induced ROS production by epidermis may be the cause of oxida-
tive alterations in the dermis. And indeed, when we separated the epidermis from the dermis and
analyzed their spectra, we observed that most skin reflectance characteristics subjected to UVB-
induced alterations depend on the dermis. Since UVB photochemical effects are limited to the epi-
dermis, repercussions in the dermis have to be mediated by epidermal products. Our results sug-
gest that epidermal ROS are likely to be such mediators. On the other hand, we have observed that
in vivo reflectance spectra of psoriatic lesional versus non-involved skin display a number of dif-
ferences at defined wavelengths. Since we showed that reflectance spectrometry can be used in skin
organ culture to produce evidence that dermal photodamage is mediated by epidermal ROS pro-
duction, an organ culture model of psoriatic skin may also be an ideal tool to analyze lesion-spe-
cific reflectance spectra and underlying biochemical changes in well-defined, fairly controlled con-
ditions.
688
Novel oxidatively-modified glycerophosphocholines with Platelet-activating Factor activity
mediate UVB photosensitivity in Xeroderma Pigmentosum A deficiency
JB Travers,1 KA Harrison,2 RC Murphy2 and RL Konger1 1 Dermatology, Indiana University,
Indianapolis, IN and 2 Pharmacology, Unviersity of Colorado, Aurora, CO
Xeroderma pigmentosum type A (XPA) is characterized clinically by photosensitivity and increased
risk of developing skin cancers due to the defect in nucleotide excision repair of ultraviolet (UV)-
induced DNA lesions. There is evidence that XPA deficiency also results in increased reactive oxy-
gen species (ROS). Since ROS can trigger production of the lipid mediator platelet-activating fac-
tor (1-alkyl-2-acetyl-glycerophosphocholine; PAF) but also related sn-2 short-chained alkyl
glycerophosphocholines (GPC) formed by oxidative damage (Ox-GPCs) having PAF activity, these
studies assessed involvement of these potent pro-inflammatory lipid mediators in the abnormal reac-
tions to UVB associated with XPA deficiency. We demonstrate that UVB irradiation of human XP
group A (XPA)-deficient fibroblasts, in comparison to XPA gene corrected cells, resulted in increased
levels of ROS and PAF-receptor (PAF-R) agonistic activity, both of which were inhibited by anti-oxi-
dants vitamin C and N-acetylcysteine. Similarly, UVB irradiation of XPA-deficient mouse skin resulted
in increased levels of PAF-R agonists over SKH-1 control mice, which was significantly blocked by
feeding the mice vitamin C-enriched (10 g/kg) chow for 10 days. UVB irradiation of XPA-deficient
mice resulted in increased skin inflammation over control SKH-1 mice. This augmentation of UVB-
induced skin inflammation in XPA-deficient mice was suppressed by PAF-R antagonists, indicating
that the increased PAF-R species generated in XPA-deficient mice upon UVB irradiation was bio-
logically relevant. Mass spectrometry analysis of UVB-irradiated XPA-deficient cells revealed sig-
nificant levels of native PAF, as well as novel Ox-GPCs with sn-2 chains consisting of 4, 5, 7 and 9
carbon species, compounds never previously associated with biological systems. These studies
demonstrate a pivotal role for novel PAF agonists produced non-enzymatically via ROS in the pho-
tosensitivity associated with XPA deficiency.
686
Melatonin suppresses UV-induced DNA damage represented by cyclobutane pyrimidine dimers
formation via enhancing antioxidative enzymes in a human full skin model in vitro
K Kleszczynski, LH Hardkop, N Kruse, D Zillikens and TW Fischer Department of Dermatology,
University of Lubeck, Lubeck, Germany
Melatonin is present in all organisms from single cells to vertebrates and in the human, and exerts
a wide range of endocrine properties, while it is also recognized to modulate numerous additional
functions ranging from scavenging free radicals to immunomodulation-mediated DNA repair and
antiapoptotic activity. Here, we investigated the protective effects of melatonin against ultraviolet
radiation (UVR)-induced DNA damage and oxidative stress in a human full skin model using a
wide range of UV doses (25-600 mJ/cm2) at the observation time points of 0, 24 and 48 h post-UV
irradiation. UVR induced significant structural disturbances in the skin (HE staining) represented by
appearance of sunburn cells (SBCs) and cleft formation being significant compared to non-irradi-
ated skin at 200 mJ/cm2 (+54.54%) and 75 mJ/cm2 (+77.27%) after 24 and 48 h, respectively. Pres-
ence of melatonin (10-3 M) exerted significant protective effects already at the UV-dose of 100
mJ/cm2 at 48 h and up to 600 mJ/cm2. Immunofluorescence analysis of cyclobutane pyrimidine
dimers (CPDs) confirmed UVR as a major factor for crucial DNA damage which occurred directly
at 0 h at 300 mJ/cm2 reaching 30.53% up-regulation while ongoing incubation (48 h) triggered this
effect leading to maximum up-regulation of 341.92% at 600 mJ/cm2. Presence of melatonin effec-
tively suppressed CPD formation by 143.95% (24 h) and 232.72% (48 h) at 600 mJ/cm2, respec-
tively. Parallely, melatonin reduced apoptotic markers such as p53 protein or effector caspase-3,
and decreased consumption of anti-oxidative enzymes (catalase, gluthatione peroxidase, superox-
ide dismutase). In conclusion, melatonin presented excellent evidence for strong protection against
UV-induced structural skin and nuclear DNA damage by enhancing antioxidative radical scaveng-
ing enzymes and reduction of the apoptotis-mediating pathway in human full skin.
690
Involvement of the epidermal platelet-activating factor receptor and cytoplasmic phospho-
lipase A2 in UVB-mediated platelet-activating factor agonist production
MJ Turner, M Al-hassani, A Thompson, JT Travers, RL Konger and JB Travers Dermatology, Indiana
University, Indianapolis, IN
The glycerophosphocholine, platelet-activating factor (PAF) stimulates the PAF receptor (PAF-R) to
mediate diverse biological functions and is implicated in photosensitivity and systemic immuno-
suppression. UVB radiation stimulates the production of PAF and other oxidatively modified glyc-
erophosphocholines (Ox-GPCs) that are PAF agonists. PAF is synthesized enzymatically by cytoso-
lic phospholipase A2 (cPLA2), and we previously identified an alternative pathway of UVB-induced
PAF and Ox-GPCs production. The alternative pathway is inhibited by antioxidants and acts via a
non-enzymatic mechanism through free radical-mediated cleavage of a precursor 1-alkyl glyc-
erophosphocholine phospholipid. The current study further characterizes the mechanism by which
UVB induces the generation of PAF species in skin. UVB irradiation induced significantly more PAF
agonist activity in a PAF-R sufficient human epithelial cell line (rescued with retroviral PAF-R expres-
sion vector) compared to the PAF-R deficient parent cell line (KB). Moreover, UVB-induced pro-
duction of PAF-R agonists was greater in skin from wild type (C57BL/6) compared to PAF-R-defi-
cient mice. The cPLA2 inhibitor, AACOCF3, was used to assess the role of this enzyme in UVB-induced
production of PAF-R agonists in the skin. AACOCF3 attenuated PAF-R agonists production in UVB
irradiated KB cells, skin from PAF-R deficient mice and in human skin explants. These studies indi-
cate that UVB-induced production of PAF agonistic activity in skin is a complex process involving
reactive oxygen species, the PAF-R, and both non-enzymatic and enzymatic synthesis of these potent
lipid mediators.
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The aryl hydrocarbon receptor (AhR) is a negative regulator of nucleotide excision repair
(NER)
T Haarmann-Stemmann,1 K Frauenstein,1 T Douki,2 M Majora,1 J Tigges,1 S Grether-Beck,1
C Esser,1 J Abel,1 E Fritsche1,3 and J Krutmann1 1 IUF - Leibniz Research Institute for
Environmental Medicine, Düsseldorf, Germany, 2 Laboratoire Lésions des Acides Nucléiques,
Service de Chimie Inorganique et Biologique, CEA-Grenoble, Grenoble, France and 3
Department of Dermatology, University Hospital RWTH, Aachen, Germany
Efficient removal of UVB-induced DNA damage in human skin critically depends on NER. Although
it was shown that cytokines like IL-12 can enhance NER activity in keratinocytes, its complex reg-
ulation is still poorly understood. We now report that keratinocytes are also equipped with a neg-
ative regulator of NER: the AhR. The AhR is a cytosol-located, ligand-dependent transcription fac-
tor that rapidly shuttles into the nucleus upon ligand-binding to stimulate gene expression. We
have previously shown that 6-formylindolo[3,2b]carbazole, a tryptophan photoproduct that is intra-
cellularly formed upon absorption of UVB by free tryptophan, is a strong AhR ligand, which trig-
gers the DNA damage-independent part of the UVB response. Now, we have investigated if AhR
activation also impacts on the DNA damage-dependent UVB response. We have found that chem-
ical inhibition of the AhR in human keratinocyte cell lines leads to a faster repair of UVB-induced
cyclobutan pyrimidine dimers (CPD). This was confirmed by using AhR-/- keratinocytes, which exhib-
ited significantly lower amounts of CPDs, 6h and 24h after UVB-irradiation, as the control cells. In
order to assess the in vivo relevance of these observations, we irradiated AhR+/+ and AhR-/- SKH-
1 mice with 180J/m2 UVB. The CPD amount in skin samples was measured by HPLC-MS/MS
immediately, 24h and 48h after UVB exposure. Strikingly, 48h after irradiation, the skin of AhR-/-
mice contained only 50% of the CPDs measured in skin samples from AhR+/+ mice. Ongoing mech-
anistic in vitro studies indicate that the AhR represses the expression of NER-stimulating cytokines
and influences cell-cycle regulation. Thus, the AhR is a negative regulator of NER that may repre-
sent a novel target for chemoprevention against UVB-induced skin damage like skin cancer.
680
UV modulation of subcutaneous fat metabolism
E Kim,1,2,3 Y Kim,1,2,3 J Kim,1,2,3 S Kim,1,2,3 M Kim,1,2,3 C Park1,2,3 and J Chung1,2,3 1 Department of
Dermatology, Seoul National University College of Medicine, Seoul, Republic of Korea, 2
Laboratory of Cutaneous Aging Research, Clinical Research Institute, Seoul National
University Hospital, Seoul, Republic of Korea and 3 Institute of Dermatological Science, Seoul
National University, Seoul, Republic of Korea
Adipose tissue is not a homogeneous organ. Visceral (VIS) fat accumulation is associated with ath-
erosclerosis and metabolic syndrome, but peripheral subcutaneous (SC) fat accumulation may be
protective. Human skin is continuously exposed to UV light. UV can penetrate the epidermis and
into the mid-dermis, but not into the SC fat tissue of human skin. However, we here show that SC
fat tissue in chronically sun-damaged skin contains less fat than naturally aged skin, and even a sin-
gle UV exposure of human skin reduced lipid synthesis in the underlying SC fat tissue through tran-
scriptional regulation of the lipogenic enzymes, acetyl CoA carboxylase (ACC), fatty acid synthase
(FAS) and stearoyl CoA desaturase (SCD), of their transcription activator sterol regulatory element
binding protein-1 (SREBP-1), and of two key adipogenic transcription factors, CCAAT/enhancer bind-
ing protein α (C/EBPα) and peroxisome proliferator-activated receptor γ (PPARγ). The cytokines IL-
6, IL-8, monocyte chemoattractant protein (MCP)-3, and placental growth factor (PlGF), produced
by keratinocytes and fibroblasts in response to UV, may be responsible for the reduction of SC fat,
and these cytokines, except MCP-3, may act via upregulation of suppressor of cytokine signaling-
3 (SOCS-3) expression. Our data demonstrate the inhibitory effects of UV light on SC lipid synthe-
sis and provide proof of concept for targeting cytokines for SC fat tissue modification.
681
Ultraviolet B (UVB) radiation and reactive oxygen species (ROS) modulate IL-31 expression
in T-lymphocytes, monocytes and dendritic cells
C Cornelissen,2,1 R Brans,1 K Czaja,1 C Skazik,1 Y Marquardt,1 G Zwadlo-Klarwasser,3 A Kim,4
DR Bickers,4 J Lüscher-Firzlaff,2 B Lüscher2 and JM Baron1 1 Department of Dermatology and
Allergology, RWTH Aachen University, Aachen, Germany, 2 Institute of Biochemistry and
Molecular Biology, RWTH Aachen University, Aachen, Germany, 3 IZKF Aachen, RWTH
Aachen University, Aachen, Germany and 4 Department of Dermatology, Columbia
University, College of Physicians and Surgeons, New York, NY
IL-31 is a novel TH2 T cell cytokine that induces pruritus and dermatitis in transgenic mice. While
enhanced mRNA expression of this cytokine is detected in skin samples of inflammatory skin dis-
eases, the regulation of IL-31 expression is poorly understood. Therefore we analyzed the effects of
UVB radiation and H2O2 on IL-31 mRNA and protein expression in skin and different peripheral
blood mononuclear cells. Treatment of cells with UVB radiation and H2O2 strongly induced IL-31
mRNA and protein expression in human peripheral blood mononuclear cells (PBMCs) and in the
skin of SKH-1 mice. Following exposure to UVB or H2O2, we observed increased expression of IL-
31 mRNA in T cells, monocytes, macrophages, immature and especially mature dendritic cells.
H2O2 treatment but not UVB radiation leads to a moderate upregulation of IL-31 mRNA expression
in epidermal keratinocytes and dermal fibroblasts. Pretreatment of T-lymphocytes with the MAPK
p38 inhibitor SB203580 or the MEK1 inhibitor U0126 reduced the stimulatory effect of H2O2. These
experiments suggest that p38 is involved in the regulation of IL-31 expression in human skin. In con-
clusion, our studies revealed that UVB and ROS stimulate the expression of IL-31 in PBMC and skin,
especially in T cells, monocytes and monocyte-derived dendritic cells.
682
Photoprotection against UVAR: Naturally occuring actives require a chemical structure that
confers cell membrane lipid raft stabilizing properties
M Bayer,2 P Proksch,3 I Felsner,1 H Brenden,1 Z Kohne,1 R Walli,1 T Ngoc Duong,4 J Krutmann1
and S Grether-Beck1 1 IUF—Leibniz Research Institute for Environmental Medicine,
Duesseldorf, Germany, 2 Caesar & Loretz GmbH, Hilden, Germany, 3 Institute of
Pharmaceutical Biology and Biotechnology, University of Duesseldorf, Duesseldorf, Germany
and 4 Institute of Chemistry, Vietnamese Academy of Sciences and Technology, Hanoi, Viet
Nam
UVA radiation damages human skin by eliciting a stress response in human keratinocytes which is
(i) initiated at the level of lipid rich cell membrane microdomains termed “rafts”, (ii) involves the
subsequent release of 2nd messenger ceramide and (iii) ultimately leads to an altered gene expres-
sion pattern. In order to develop novel strategies for UVA photoprotection of human skin, we have
screened 32 naturally occurring steroids and triterpenoids for their capacity to prevent the UVA-
radiation induced stress response in primary human epidermal keratinocytes. We corroborate and
extend our previous notion that sterols such as cholesterol are highly effective in this regard. In addi-
tion we identify 5 naturally occurring steroids and triterpenoids, i.e. 14-dehydroergosterol, ergos-
terol-peroxide, lichesterol, 29-norcycloarterneol and oleanolic acid as molecules which are able to
protect from UVA stress responses. The protective effect depends on the chemical structure of the
molecule because oleanolic acid, but not its isomer ursolic acid abrogates UVAR-induced ceramide
release and gene induction although both molecules integrate into rafts. This observation strongly
indicates that stereo- or regiochemical properties of triterpenoids are of key importance for their
capacity to abrogate UVA radiation-induced signaling by stabilizing raft architecture due to their
capacity for tight packing with sphingomyelin and glycosphingolipids. These observations provide
first insight into the structural properties of lipid rafts that determine their UVA responsiveness and
will help to foster the development of novel actives for UVA photoprotection of human skin.
683
Apoptosis induced by photodynamic therapy with the photosensitizer Pc 4 in Candida albi-
cans
M Lam,1,2,3 PC Jou,1 CL Malbasa,1 AA Lattif,1 Y Lee,1 PK Mukherjee,4 NL Oleinick,2,5
MA Ghannoum,4 KD Cooper1,2,6 and ED Baron1,2,6 1 Dermatology, CWRU, Cleveland, OH, 2
Case Comprehensive Cancer Center, CWRU, Cleveland, OH, 3 Case Skin Diseases Research
Center, CWRU, Cleveland, OH, 4 Center for Medical Mycology, CWRU/UH Case Medical
Center, Cleveland, OH, 5 Radiation Oncology, CWRU, Cleveland, OH and 6 Dermatology,
Louis-Stokes VA Medical Center, Cleveland, OH
The high prevalence of drug resistance necessitates the development of novel antifungal agents
against infections caused by opportunistic fungal pathogens such as Candida albicans. Elucidation
of apoptosis, or programmed cell death, in yeast-like fungi may provide a basis for future therapies.
In mammalian cells, photodynamic therapy (PDT) has been demonstrated to generate reactive oxy-
gen species, such as singlet oxygen, leading to immediate oxidative modifications of biological mol-
ecules, including lipids and proteins, resulting in apoptotic cell death. In this study, we assessed the
in vitro cytotoxicity and mechanism of PDT using the investigational second-generation photosen-
sitizer Pc 4, in planktonic C. albicans. Confocal image analysis confirmed that Pc 4 penetrates C.
albicans cell membrane and localizes to cytosolic organelles, including mitochondria, after as lit-
tle as 15 minutes of incubation at 37oC. CFU (colony formation units) counts showed that 1.0 μM
Pc 4 followed by light at 2.0 J/cm2 reduced cell survival by 3 to 4 logs. Pc 4-PDT impaired fungal
metabolic activity, as measured by the XTT assay and supported by the loss of FUN-1 fluorescence.
Furthermore, changes in nuclear morphology characteristic of apoptosis were observed by confo-
cal microscopy following Pc 4-PDT. Pc 4-PDT-induced apoptosis in C. albicans was substantiated
by the increased externalization of phosphatidylserine, as indicated by positive FITC-labeled Annexin-
V signal and by DNA fragmentation. These data strongly suggest that Pc 4-PDT induces apoptosis
in C. albicans, and a comprehensive understanding of this fundamental mechanism is essential, as
Pc 4-PDT could serve as an alternative mode of therapy against candidiasis.
684
Different microRNA-34a responses following p53 upregulation after exposure to ultraviolet
radiation and ionising radiation.
E Vavatsikou,1 T Sanchez-Elsner,2 C Pickard1 and E Healy1 1 Dermatopharmacology, University
of Southampton, Southampton, United Kingdom and 2 JunkRNA Lab, University of
Southampton, Southampton, United Kingdom
Ultraviolet radiation (UVR) has multiple effects on skin, including the ability to activate the p53
protein, which in turn transcriptionally activates downstream genes involved in cell cycle arrest,
DNA repair and apoptosis. It has previously been reported that p53 upregulation by ionising radi-
ation results in the induction of microRNA-34a (miR-34a) which can repress silent information reg-
ulator 1 (SIRT-1) and promote apoptosis. In the current study, we have investigated whether UVB
induces transcriptional activation of miR-34a and inhibition of SIRT-1 in cells and skin. Exposure
of HCT116 human colon cancer cells (containing wild type p53) and primary human keratinocytes
to ionising radiation resulted in significant increases in p53 and miR-34a. Culture of both these cell
types with nutlin-3 (an MDM2 inhibitor) and the anthracycline cytotoxic agent adriamycin (dox-
orubicin) similarly led to significant increases in p53 and miR-34a. Despite elevation of the p53
protein by UVR, miR-34a was not increased by this stimulus in HCT116 and in primary keratinocytes.
Ionising radiation also caused p53 upregulation and accumulation of miR-34a in human skin ex
vivo, however, although UVB irradiation of human skin increased the levels of p53, no elevation of
miR-34a was detected in this tissue. In addition, a reduction in SIRT-1 protein was evident after
exposure to ionising radiation and adriamycin, but this was not observed following UVR. The results
of this study demonstrate that, in contrast to ionising radiation, UVB does not activate miR-34a,
and suggest that miR-34a does not play a role in UVR-induced cell cycle arrest or apoptosis.
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Spectral imaging detects physiologic parameters that contribute to photoaging among twins
CL Malbasa,1 ED Baron,1,4 P Fu,2 MS Matsui,3 C Fthenakis,3 G Vanderover,3 P Cummins3 and
KD Cooper1,4 1 Dept of Dermatology, Univ Hosp Case Medical Ctr, Cleveland, OH, 2 Dept of
Epidemiology & Biostats, CWRU, Cleveland, OH, 3 Estee Lauder Research Div, Melville, NY
and 4 VA Medical Ctr, Cleveland, OH
Photoaging, the most characterized form of extrinsic skin aging, is primarily assessed visually, using
validated photographic photodamage scoring systems such as the Griffiths scale. However such
scales do not allow quantitation of specific variables contributing to the photoaged face. In previ-
ous studies we evaluated environmental factors on skin aging by using a twin cohort to control for
genetic susceptibility. Here we present a new approach using spectral imaging to reveal cutaneous
physiologic factors underlying the photoaged appearance not quantifiable with visual grading alone.
Forty-five twin pairs completed a questionnaire detailing environmental factors that may be asso-
ciated with photoaging. Facial aging in these volunteers was assessed using the 9-point photonu-
meric Griffiths system, determined by grading characteristics such as wrinkling and dyspigmenta-
tion. Among these pairs, 17 (38%) exhibited intra-twin differences in photoaging scores. All 17 pairs
were photographed using a spectral imaging system and analyzed with a previously reported algo-
rithm (Jacques et al submitted to J Biomedical Optics) to quantitate blood (B) and melanin (M) con-
tent, oxygen saturation of hemoglobin (S), and dermal scattering (D). We propose a visual percep-
tion algorithm (ΔV) integrating BMSD in order to examine how those factors contribute to the
photoaging score. The 17 pairs showed a 55% correlation (p = 4.94E-06) between their photoag-
ing score difference and ΔV for all 4 values combined. This correlation increases to 61% (p =
6.92E-12) when only melanin and oxygen saturation are included suggesting these two variables
have the most impact on the photoaging score compared to blood content and dermal scattering.
We have found that spectral imaging can delineate the physiologic phenomena that significantly
contribute to visually appreciable photoaging features.
687
Ultraviolet B radiation augments melanoma tumor growth through its ability to generate
Platelet-activating factor agonists
RP Sahu,1 S Da Silva,1 C Touloukian,3 RL Konger2,1 and JB Travers1 1 Dermatology, Indiana
University, Indianapolis, IN, 2 Pathology, Indiana University, Indianapolis, IN and 3 Surgery,
Indiana University, Indianapolis, IN
Platelet-activating factor (1-alkyl-2-acetyl-glycerophosphocholine; PAF) is a potent lipid mediator
with diverse activities. Ultraviolet B radiation (UVB) stimulates the production of PAF and novel
oxidatively modified glycerophosphocholines with PAF activity, and these lipids mediate systemic
immunosuppression in a process involving IL-10. The current studies sought to define whether
UVB irradiation could modulate experimental murine melanoma tumor growth. Treatment of shaved
upper back skin of C57BL6 mice with UVB at doses that induce systemic immunosuppression
resulted in the enhanced growth of subcutaneous B16F10 melanoma implanted in dorsal hind flank
unirradiated skin. Several lines of evidence implicated the PAF system in the UVB-mediated aug-
mentation of tumor growth. First, UVB-mediated augmentation of tumor growth was absent in PAF-
R-deficient mice, and, second, intraperitoneal injection of the PAF agonist carbamoyl-PAF (CPAF)
mimicked the UVB effect. A neutralizing antibody against IL-10 blocked both CPAF- and UVB-medi-
ated augmentation of B16F10 tumor growth. The next studies were designed to define whether the
PAF-R effect on tumor growth was due to direct effects on B16F10 cells or due to effects on host.
Quantitative RT-PCR demonstrated that B16F10 cells expressed low levels of PAF-R mRNA, and
these cells failed to respond with an intracellular Ca2+ flux in response to CPAF. Transplantation of
B16F10 cells overexpressing the PAF-R using a retroviral vector into mice did not result in an increased
rate of tumor growth over control B16F10 cells either alone, or in response to UVB or CPAF. These
findings indicate that the PAF-R effects are exerted on the host, not the tumor. These studies provide
a novel unreported effect of UVB-mediated PAF agonists, namely, that they can augment melanoma
tumor growth via systemic immunosuppressive response of the host involving the immunomodu-
latory cytokine IL-10.
689
Reflectance analysis – A non-invasive method to study skin biochemical pathways in vitro and
in vivo
D Turgeman,1 M Frusic-Zlotkin,2 Y Soroka,2 FM Bregegere,2 E Ben-Dor1 and Y Milner2 1
Department of Geography, Tel Aviv University, Tel Aviv, Israel and 2 Myers Skin Laboratory,
Department of Biological Chemistry, The Hebrew University, Jerusalem, Israel
Using UVB-irradiated skin organ culture as an experimental model of photodamage, we have inves-
tigated reflectance spectrometry as a tool for non-invasive analysis of skin condition. Two hours after
irradiation of organ cultures, skin reflectance spectra displayed specific changes attributable to a
decrease in reduced versus oxidized hemoglobin ratio. This move was reversed after one day, and
was shown to be kinetically correlated with the total anti-oxidant capacity of epidermis, measured
by cyclic voltammetry. We also observed transient changes in infrared absorption occuring 30 min
after irradiation, presumably due to oxidation of CH3/CH2/CH groups. These were correlated with
a decrease in antioxidants ascorbic acid and uric acid in epidermis and in dermis, and upon UVB
dose variation they were correlated with epidermal ROS levels monitored with fluorogenic probes.
These results suggest that UVB-induced ROS production by epidermis may be the cause of oxida-
tive alterations in the dermis. And indeed, when we separated the epidermis from the dermis and
analyzed their spectra, we observed that most skin reflectance characteristics subjected to UVB-
induced alterations depend on the dermis. Since UVB photochemical effects are limited to the epi-
dermis, repercussions in the dermis have to be mediated by epidermal products. Our results sug-
gest that epidermal ROS are likely to be such mediators. On the other hand, we have observed that
in vivo reflectance spectra of psoriatic lesional versus non-involved skin display a number of dif-
ferences at defined wavelengths. Since we showed that reflectance spectrometry can be used in skin
organ culture to produce evidence that dermal photodamage is mediated by epidermal ROS pro-
duction, an organ culture model of psoriatic skin may also be an ideal tool to analyze lesion-spe-
cific reflectance spectra and underlying biochemical changes in well-defined, fairly controlled con-
ditions.
688
Novel oxidatively-modified glycerophosphocholines with Platelet-activating Factor activity
mediate UVB photosensitivity in Xeroderma Pigmentosum A deficiency
JB Travers,1 KA Harrison,2 RC Murphy2 and RL Konger1 1 Dermatology, Indiana University,
Indianapolis, IN and 2 Pharmacology, Unviersity of Colorado, Aurora, CO
Xeroderma pigmentosum type A (XPA) is characterized clinically by photosensitivity and increased
risk of developing skin cancers due to the defect in nucleotide excision repair of ultraviolet (UV)-
induced DNA lesions. There is evidence that XPA deficiency also results in increased reactive oxy-
gen species (ROS). Since ROS can trigger production of the lipid mediator platelet-activating fac-
tor (1-alkyl-2-acetyl-glycerophosphocholine; PAF) but also related sn-2 short-chained alkyl
glycerophosphocholines (GPC) formed by oxidative damage (Ox-GPCs) having PAF activity, these
studies assessed involvement of these potent pro-inflammatory lipid mediators in the abnormal reac-
tions to UVB associated with XPA deficiency. We demonstrate that UVB irradiation of human XP
group A (XPA)-deficient fibroblasts, in comparison to XPA gene corrected cells, resulted in increased
levels of ROS and PAF-receptor (PAF-R) agonistic activity, both of which were inhibited by anti-oxi-
dants vitamin C and N-acetylcysteine. Similarly, UVB irradiation of XPA-deficient mouse skin resulted
in increased levels of PAF-R agonists over SKH-1 control mice, which was significantly blocked by
feeding the mice vitamin C-enriched (10 g/kg) chow for 10 days. UVB irradiation of XPA-deficient
mice resulted in increased skin inflammation over control SKH-1 mice. This augmentation of UVB-
induced skin inflammation in XPA-deficient mice was suppressed by PAF-R antagonists, indicating
that the increased PAF-R species generated in XPA-deficient mice upon UVB irradiation was bio-
logically relevant. Mass spectrometry analysis of UVB-irradiated XPA-deficient cells revealed sig-
nificant levels of native PAF, as well as novel Ox-GPCs with sn-2 chains consisting of 4, 5, 7 and 9
carbon species, compounds never previously associated with biological systems. These studies
demonstrate a pivotal role for novel PAF agonists produced non-enzymatically via ROS in the pho-
tosensitivity associated with XPA deficiency.
686
Melatonin suppresses UV-induced DNA damage represented by cyclobutane pyrimidine dimers
formation via enhancing antioxidative enzymes in a human full skin model in vitro
K Kleszczynski, LH Hardkop, N Kruse, D Zillikens and TW Fischer Department of Dermatology,
University of Lubeck, Lubeck, Germany
Melatonin is present in all organisms from single cells to vertebrates and in the human, and exerts
a wide range of endocrine properties, while it is also recognized to modulate numerous additional
functions ranging from scavenging free radicals to immunomodulation-mediated DNA repair and
antiapoptotic activity. Here, we investigated the protective effects of melatonin against ultraviolet
radiation (UVR)-induced DNA damage and oxidative stress in a human full skin model using a
wide range of UV doses (25-600 mJ/cm2) at the observation time points of 0, 24 and 48 h post-UV
irradiation. UVR induced significant structural disturbances in the skin (HE staining) represented by
appearance of sunburn cells (SBCs) and cleft formation being significant compared to non-irradi-
ated skin at 200 mJ/cm2 (+54.54%) and 75 mJ/cm2 (+77.27%) after 24 and 48 h, respectively. Pres-
ence of melatonin (10-3 M) exerted significant protective effects already at the UV-dose of 100
mJ/cm2 at 48 h and up to 600 mJ/cm2. Immunofluorescence analysis of cyclobutane pyrimidine
dimers (CPDs) confirmed UVR as a major factor for crucial DNA damage which occurred directly
at 0 h at 300 mJ/cm2 reaching 30.53% up-regulation while ongoing incubation (48 h) triggered this
effect leading to maximum up-regulation of 341.92% at 600 mJ/cm2. Presence of melatonin effec-
tively suppressed CPD formation by 143.95% (24 h) and 232.72% (48 h) at 600 mJ/cm2, respec-
tively. Parallely, melatonin reduced apoptotic markers such as p53 protein or effector caspase-3,
and decreased consumption of anti-oxidative enzymes (catalase, gluthatione peroxidase, superox-
ide dismutase). In conclusion, melatonin presented excellent evidence for strong protection against
UV-induced structural skin and nuclear DNA damage by enhancing antioxidative radical scaveng-
ing enzymes and reduction of the apoptotis-mediating pathway in human full skin.
690
Involvement of the epidermal platelet-activating factor receptor and cytoplasmic phospho-
lipase A2 in UVB-mediated platelet-activating factor agonist production
MJ Turner, M Al-hassani, A Thompson, JT Travers, RL Konger and JB Travers Dermatology, Indiana
University, Indianapolis, IN
The glycerophosphocholine, platelet-activating factor (PAF) stimulates the PAF receptor (PAF-R) to
mediate diverse biological functions and is implicated in photosensitivity and systemic immuno-
suppression. UVB radiation stimulates the production of PAF and other oxidatively modified glyc-
erophosphocholines (Ox-GPCs) that are PAF agonists. PAF is synthesized enzymatically by cytoso-
lic phospholipase A2 (cPLA2), and we previously identified an alternative pathway of UVB-induced
PAF and Ox-GPCs production. The alternative pathway is inhibited by antioxidants and acts via a
non-enzymatic mechanism through free radical-mediated cleavage of a precursor 1-alkyl glyc-
erophosphocholine phospholipid. The current study further characterizes the mechanism by which
UVB induces the generation of PAF species in skin. UVB irradiation induced significantly more PAF
agonist activity in a PAF-R sufficient human epithelial cell line (rescued with retroviral PAF-R expres-
sion vector) compared to the PAF-R deficient parent cell line (KB). Moreover, UVB-induced pro-
duction of PAF-R agonists was greater in skin from wild type (C57BL/6) compared to PAF-R-defi-
cient mice. The cPLA2 inhibitor, AACOCF3, was used to assess the role of this enzyme in UVB-induced
production of PAF-R agonists in the skin. AACOCF3 attenuated PAF-R agonists production in UVB
irradiated KB cells, skin from PAF-R deficient mice and in human skin explants. These studies indi-
cate that UVB-induced production of PAF agonistic activity in skin is a complex process involving
reactive oxygen species, the PAF-R, and both non-enzymatic and enzymatic synthesis of these potent
lipid mediators.
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The aryl hydrocarbon receptor (AhR) is a negative regulator of nucleotide excision repair
(NER)
T Haarmann-Stemmann,1 K Frauenstein,1 T Douki,2 M Majora,1 J Tigges,1 S Grether-Beck,1
C Esser,1 J Abel,1 E Fritsche1,3 and J Krutmann1 1 IUF - Leibniz Research Institute for
Environmental Medicine, Düsseldorf, Germany, 2 Laboratoire Lésions des Acides Nucléiques,
Service de Chimie Inorganique et Biologique, CEA-Grenoble, Grenoble, France and 3
Department of Dermatology, University Hospital RWTH, Aachen, Germany
Efficient removal of UVB-induced DNA damage in human skin critically depends on NER. Although
it was shown that cytokines like IL-12 can enhance NER activity in keratinocytes, its complex reg-
ulation is still poorly understood. We now report that keratinocytes are also equipped with a neg-
ative regulator of NER: the AhR. The AhR is a cytosol-located, ligand-dependent transcription fac-
tor that rapidly shuttles into the nucleus upon ligand-binding to stimulate gene expression. We
have previously shown that 6-formylindolo[3,2b]carbazole, a tryptophan photoproduct that is intra-
cellularly formed upon absorption of UVB by free tryptophan, is a strong AhR ligand, which trig-
gers the DNA damage-independent part of the UVB response. Now, we have investigated if AhR
activation also impacts on the DNA damage-dependent UVB response. We have found that chem-
ical inhibition of the AhR in human keratinocyte cell lines leads to a faster repair of UVB-induced
cyclobutan pyrimidine dimers (CPD). This was confirmed by using AhR-/- keratinocytes, which exhib-
ited significantly lower amounts of CPDs, 6h and 24h after UVB-irradiation, as the control cells. In
order to assess the in vivo relevance of these observations, we irradiated AhR+/+ and AhR-/- SKH-
1 mice with 180J/m2 UVB. The CPD amount in skin samples was measured by HPLC-MS/MS
immediately, 24h and 48h after UVB exposure. Strikingly, 48h after irradiation, the skin of AhR-/-
mice contained only 50% of the CPDs measured in skin samples from AhR+/+ mice. Ongoing mech-
anistic in vitro studies indicate that the AhR represses the expression of NER-stimulating cytokines
and influences cell-cycle regulation. Thus, the AhR is a negative regulator of NER that may repre-
sent a novel target for chemoprevention against UVB-induced skin damage like skin cancer.
680
UV modulation of subcutaneous fat metabolism
E Kim,1,2,3 Y Kim,1,2,3 J Kim,1,2,3 S Kim,1,2,3 M Kim,1,2,3 C Park1,2,3 and J Chung1,2,3 1 Department of
Dermatology, Seoul National University College of Medicine, Seoul, Republic of Korea, 2
Laboratory of Cutaneous Aging Research, Clinical Research Institute, Seoul National
University Hospital, Seoul, Republic of Korea and 3 Institute of Dermatological Science, Seoul
National University, Seoul, Republic of Korea
Adipose tissue is not a homogeneous organ. Visceral (VIS) fat accumulation is associated with ath-
erosclerosis and metabolic syndrome, but peripheral subcutaneous (SC) fat accumulation may be
protective. Human skin is continuously exposed to UV light. UV can penetrate the epidermis and
into the mid-dermis, but not into the SC fat tissue of human skin. However, we here show that SC
fat tissue in chronically sun-damaged skin contains less fat than naturally aged skin, and even a sin-
gle UV exposure of human skin reduced lipid synthesis in the underlying SC fat tissue through tran-
scriptional regulation of the lipogenic enzymes, acetyl CoA carboxylase (ACC), fatty acid synthase
(FAS) and stearoyl CoA desaturase (SCD), of their transcription activator sterol regulatory element
binding protein-1 (SREBP-1), and of two key adipogenic transcription factors, CCAAT/enhancer bind-
ing protein α (C/EBPα) and peroxisome proliferator-activated receptor γ (PPARγ). The cytokines IL-
6, IL-8, monocyte chemoattractant protein (MCP)-3, and placental growth factor (PlGF), produced
by keratinocytes and fibroblasts in response to UV, may be responsible for the reduction of SC fat,
and these cytokines, except MCP-3, may act via upregulation of suppressor of cytokine signaling-
3 (SOCS-3) expression. Our data demonstrate the inhibitory effects of UV light on SC lipid synthe-
sis and provide proof of concept for targeting cytokines for SC fat tissue modification.
681
Ultraviolet B (UVB) radiation and reactive oxygen species (ROS) modulate IL-31 expression
in T-lymphocytes, monocytes and dendritic cells
C Cornelissen,2,1 R Brans,1 K Czaja,1 C Skazik,1 Y Marquardt,1 G Zwadlo-Klarwasser,3 A Kim,4
DR Bickers,4 J Lüscher-Firzlaff,2 B Lüscher2 and JM Baron1 1 Department of Dermatology and
Allergology, RWTH Aachen University, Aachen, Germany, 2 Institute of Biochemistry and
Molecular Biology, RWTH Aachen University, Aachen, Germany, 3 IZKF Aachen, RWTH
Aachen University, Aachen, Germany and 4 Department of Dermatology, Columbia
University, College of Physicians and Surgeons, New York, NY
IL-31 is a novel TH2 T cell cytokine that induces pruritus and dermatitis in transgenic mice. While
enhanced mRNA expression of this cytokine is detected in skin samples of inflammatory skin dis-
eases, the regulation of IL-31 expression is poorly understood. Therefore we analyzed the effects of
UVB radiation and H2O2 on IL-31 mRNA and protein expression in skin and different peripheral
blood mononuclear cells. Treatment of cells with UVB radiation and H2O2 strongly induced IL-31
mRNA and protein expression in human peripheral blood mononuclear cells (PBMCs) and in the
skin of SKH-1 mice. Following exposure to UVB or H2O2, we observed increased expression of IL-
31 mRNA in T cells, monocytes, macrophages, immature and especially mature dendritic cells.
H2O2 treatment but not UVB radiation leads to a moderate upregulation of IL-31 mRNA expression
in epidermal keratinocytes and dermal fibroblasts. Pretreatment of T-lymphocytes with the MAPK
p38 inhibitor SB203580 or the MEK1 inhibitor U0126 reduced the stimulatory effect of H2O2. These
experiments suggest that p38 is involved in the regulation of IL-31 expression in human skin. In con-
clusion, our studies revealed that UVB and ROS stimulate the expression of IL-31 in PBMC and skin,
especially in T cells, monocytes and monocyte-derived dendritic cells.
682
Photoprotection against UVAR: Naturally occuring actives require a chemical structure that
confers cell membrane lipid raft stabilizing properties
M Bayer,2 P Proksch,3 I Felsner,1 H Brenden,1 Z Kohne,1 R Walli,1 T Ngoc Duong,4 J Krutmann1
and S Grether-Beck1 1 IUF—Leibniz Research Institute for Environmental Medicine,
Duesseldorf, Germany, 2 Caesar & Loretz GmbH, Hilden, Germany, 3 Institute of
Pharmaceutical Biology and Biotechnology, University of Duesseldorf, Duesseldorf, Germany
and 4 Institute of Chemistry, Vietnamese Academy of Sciences and Technology, Hanoi, Viet
Nam
UVA radiation damages human skin by eliciting a stress response in human keratinocytes which is
(i) initiated at the level of lipid rich cell membrane microdomains termed “rafts”, (ii) involves the
subsequent release of 2nd messenger ceramide and (iii) ultimately leads to an altered gene expres-
sion pattern. In order to develop novel strategies for UVA photoprotection of human skin, we have
screened 32 naturally occurring steroids and triterpenoids for their capacity to prevent the UVA-
radiation induced stress response in primary human epidermal keratinocytes. We corroborate and
extend our previous notion that sterols such as cholesterol are highly effective in this regard. In addi-
tion we identify 5 naturally occurring steroids and triterpenoids, i.e. 14-dehydroergosterol, ergos-
terol-peroxide, lichesterol, 29-norcycloarterneol and oleanolic acid as molecules which are able to
protect from UVA stress responses. The protective effect depends on the chemical structure of the
molecule because oleanolic acid, but not its isomer ursolic acid abrogates UVAR-induced ceramide
release and gene induction although both molecules integrate into rafts. This observation strongly
indicates that stereo- or regiochemical properties of triterpenoids are of key importance for their
capacity to abrogate UVA radiation-induced signaling by stabilizing raft architecture due to their
capacity for tight packing with sphingomyelin and glycosphingolipids. These observations provide
first insight into the structural properties of lipid rafts that determine their UVA responsiveness and
will help to foster the development of novel actives for UVA photoprotection of human skin.
683
Apoptosis induced by photodynamic therapy with the photosensitizer Pc 4 in Candida albi-
cans
M Lam,1,2,3 PC Jou,1 CL Malbasa,1 AA Lattif,1 Y Lee,1 PK Mukherjee,4 NL Oleinick,2,5
MA Ghannoum,4 KD Cooper1,2,6 and ED Baron1,2,6 1 Dermatology, CWRU, Cleveland, OH, 2
Case Comprehensive Cancer Center, CWRU, Cleveland, OH, 3 Case Skin Diseases Research
Center, CWRU, Cleveland, OH, 4 Center for Medical Mycology, CWRU/UH Case Medical
Center, Cleveland, OH, 5 Radiation Oncology, CWRU, Cleveland, OH and 6 Dermatology,
Louis-Stokes VA Medical Center, Cleveland, OH
The high prevalence of drug resistance necessitates the development of novel antifungal agents
against infections caused by opportunistic fungal pathogens such as Candida albicans. Elucidation
of apoptosis, or programmed cell death, in yeast-like fungi may provide a basis for future therapies.
In mammalian cells, photodynamic therapy (PDT) has been demonstrated to generate reactive oxy-
gen species, such as singlet oxygen, leading to immediate oxidative modifications of biological mol-
ecules, including lipids and proteins, resulting in apoptotic cell death. In this study, we assessed the
in vitro cytotoxicity and mechanism of PDT using the investigational second-generation photosen-
sitizer Pc 4, in planktonic C. albicans. Confocal image analysis confirmed that Pc 4 penetrates C.
albicans cell membrane and localizes to cytosolic organelles, including mitochondria, after as lit-
tle as 15 minutes of incubation at 37oC. CFU (colony formation units) counts showed that 1.0 μM
Pc 4 followed by light at 2.0 J/cm2 reduced cell survival by 3 to 4 logs. Pc 4-PDT impaired fungal
metabolic activity, as measured by the XTT assay and supported by the loss of FUN-1 fluorescence.
Furthermore, changes in nuclear morphology characteristic of apoptosis were observed by confo-
cal microscopy following Pc 4-PDT. Pc 4-PDT-induced apoptosis in C. albicans was substantiated
by the increased externalization of phosphatidylserine, as indicated by positive FITC-labeled Annexin-
V signal and by DNA fragmentation. These data strongly suggest that Pc 4-PDT induces apoptosis
in C. albicans, and a comprehensive understanding of this fundamental mechanism is essential, as
Pc 4-PDT could serve as an alternative mode of therapy against candidiasis.
684
Different microRNA-34a responses following p53 upregulation after exposure to ultraviolet
radiation and ionising radiation.
E Vavatsikou,1 T Sanchez-Elsner,2 C Pickard1 and E Healy1 1 Dermatopharmacology, University
of Southampton, Southampton, United Kingdom and 2 JunkRNA Lab, University of
Southampton, Southampton, United Kingdom
Ultraviolet radiation (UVR) has multiple effects on skin, including the ability to activate the p53
protein, which in turn transcriptionally activates downstream genes involved in cell cycle arrest,
DNA repair and apoptosis. It has previously been reported that p53 upregulation by ionising radi-
ation results in the induction of microRNA-34a (miR-34a) which can repress silent information reg-
ulator 1 (SIRT-1) and promote apoptosis. In the current study, we have investigated whether UVB
induces transcriptional activation of miR-34a and inhibition of SIRT-1 in cells and skin. Exposure
of HCT116 human colon cancer cells (containing wild type p53) and primary human keratinocytes
to ionising radiation resulted in significant increases in p53 and miR-34a. Culture of both these cell
types with nutlin-3 (an MDM2 inhibitor) and the anthracycline cytotoxic agent adriamycin (dox-
orubicin) similarly led to significant increases in p53 and miR-34a. Despite elevation of the p53
protein by UVR, miR-34a was not increased by this stimulus in HCT116 and in primary keratinocytes.
Ionising radiation also caused p53 upregulation and accumulation of miR-34a in human skin ex
vivo, however, although UVB irradiation of human skin increased the levels of p53, no elevation of
miR-34a was detected in this tissue. In addition, a reduction in SIRT-1 protein was evident after
exposure to ionising radiation and adriamycin, but this was not observed following UVR. The results
of this study demonstrate that, in contrast to ionising radiation, UVB does not activate miR-34a,
and suggest that miR-34a does not play a role in UVR-induced cell cycle arrest or apoptosis.
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Reevaluating the toxicity and mutagenicity of photoactivated Rose Bengal in Chinese ham-
ster ovary cells
L Hunter,1 S Wang,2 J Wickliffe2 and M Wilkerson1 1 University of Texas Medical Branch,
Galveston, TX and 2 Tulane University Health Science Center, New Orleans, LA
Rose Bengal (RB) is being investigated as a photosuturing agent in hopes of improving standard
dermatologic surgical closure techniques. Concentrations of photoactivated RB as high as 0.1% are
currently being investigated in humans. RB is known to produce ROS, e.g., singlet oxygen (SO),
and its mutagenic potential must be considered in its clinical application. We investigated the tox-
icity, mutagenicity, and SO production of photoactivated RB on the epithelial Chinese hamster ovary
cell line. Cells were exposed to the following RB concentrations: 0.1, 0.01, 0.001, 0.0001, and
0.00001%. Cultures were irradiated for 400 s using a high-intensity visible wavelength lamp. Con-
trols were maintained in the dark. Cell viability was assessed using the XTT assay, mutagenicity using
the Hprt gene mutation assay, and SO using the Sensor Green reagent. RB concentrations >0.001%
resulted in significant cytotoxicity regardless of irradiation. XTT assay showed cell viabilities were
not influenced by ≤ 0.0001% RB maintained in the dark or after 30 min of incubation. Roughly 49%
of irradiated cells were lost after 24 h of incubation in 0.0001% RB. At ≥0.001% RB, >90% of cells
were lost. Sensor Green revealed that irradiating 0.00001-0.001% RB increased amounts of SO,
although levels dropped significantly between 0.01-0.1%. Controls exhibited almost no SO pro-
duction. The Hprt gene mutation assay suggested RB was not mutagenic at 0.0001 or 0.00001%.
There is an obvious increase in SO induction between 0.00001–0.001%, with reduced production
at higher concentrations. Perhaps photoactivated RB undergoes auto-exhaustion at higher concen-
trations. An initial pilot study suggested irradiated 0.0001% RB is mutagenic in vitro, however the
current data suggests RB is not mutagenic. The contribution of RB’s cytotoxicity on observed clini-
cal improvement of scars and its mutagenic potential remains unclear and requires further study.
699
The GS-nitroxide JP4-039 is a potent topical antioxidant that mitigates skin damage from
ionizing radiation.
R Brand,1 M Epperly,2 J Stottlemyer,1 R Cline,1 H Kim,2 X Gao,3 S Li,3 S Huq,2 P Wipf,4 V Kagan,4
J Greenberger2 and LD Falo1 1 Dermatology, University of Pittsburgh, Pittsburgh, PA, 2
Radiation Oncology, University of Pittsburgh, Pittsburgh, PA, 3 Pharmacology, University of
Pittsburgh, Pittsburgh, PA and 4 Medicine, University of Pittsburgh, Pittsburgh, PA
Topical agents capable of preventing ionizing irradiation induced cutaneous injury have the poten-
tial to prevent radiotherapy induced dermatitis. Further, in the event of an accidental radiation expo-
sure or terrorist attack, there would be a critical need for topical therapies capable of mitigating
cutaneous radiation damage. Importantly, to be therapeutically valuable subsequent to an accidental
or terrorist radiation exposure, the agent must be capable of blocking or reversing radiation induced
processes leading to skin damage that have been initiated by prior radiation exposure. Since mito-
chondrial damage is a critical factor in ionizing irradiation-induced cellular apoptosis and tissue
injury, we designed a small molecule nitroxide, JP4-039, that combines several important anti-oxi-
dant and electron-scavenging properties in a single mitochondrial-targeted functional moiety. In ini-
tial studies we demonstrated that topically applied JP4-039 can preventing radiation induced skin
damage. To determine the capacity of JP4-039 to mitigate skin damage when applied after radia-
tion exposure, as would likely be the case in an accidental or terrorist event, we applied JP4-039
topically to the hind legs of mice irradiated (35 GY) 24 hours earlier. Three weeks later mice were
evaluated 1) photographically for visual evidence of skin damage, and 2) for leg contracture as a
functional measure of fibrosis. Further, we preformed histologic comparisons to evaluate 3) skin
thickening and 4) cellular infiltrates characteristic of radiation induced skin damage. Taken together,
these results demonstrate that topically applied JP4-039 can prevent irradiation damage, and can
mitigate damage even when applied 24 hours after radiation exposure.
701
The pathomechanistic role of ABCC6 in pseudoxanthoma elasticum – The vitamin K connec-
tion
Q Jiang,1 K Fülöp,2 V Pomozi,2 A Grand-Pierre,1 S Siu,2 H de Boussac,2 G Köblös,2 P Szabó,2
T Arányi,2 A Várdi2 and J Uitto1 1 Thomas Jefferson University, Philadelphia, PA and 2
Hungarian Academy of Sciences, Budapest, Hungary
Pseudoxanthoma elasticum (PXE), caused by mutations in the ABCC6 gene, manifests with calcifi-
cation of peripheral connective tissues. The mechanisms of PXE are currently unknown, but recent
demonstrations of PXE-like cutaneous findings in patients with mutations in the GGCX gene have
suggested a role for vitamin K. Specifically, GGCX encodes γ-glutamyl carboxylase, a vitamin K
dependent enzyme responsible for post-translational carboxylation of Gla-domain containing pro-
teins, conferring them antimineralization properties. These observations have then raised the ques-
tion:“Does the absence of ABCC6 in PXE prevent the liver from providing sufficient vitamin K to
the periphery“? To address this question, we have utilized the Abcc6-/- mouse model, with appro-
priate wild type controls, for liver perfusion experiments to gain information on the metabolism
and transport of vitamin K. First, vitamin K3 was introduced into the liver through portal vein and
the efflux fluid was collected through the inferior vena cava and analyzed by high sensitivity HPLC-
MS. No significant difference of vitamin K3 and its glutathione conjugate in efflux was observed
between the wild type and the Abcc6-/- animals. The finding was confirmed by an in vitro Sf9 cell
based vesicular transport system overexpressing human ABCC6. No difference in the vitamin K3
and its glutathione conjugate transport kinetics was noted in this system with and without trans-
fected ABCC6. Instead, the results suggested that the K3-glutathione conjugate is transported by
ABCC1 to the circulation and by ABCC2 into the bile. These observations, taken together with ongo-
ing vitamin K feeding experiments in Abcc6-/- mice, do not support the hypothesis that PXE phe-
notype is a simple consequence of deficiency of peripheral vitamin K3 or its glutathione conjugate.
700
Skin compartments of different body areas harbour different amounts of mitochondrial dele-
tions in aged wildtype mice
J Knoch,1 Y Kamenisch,1 H Geiger,2 M Röcken,1 K Scharffetter-Kochanek2 and M Berneburg1 1
Department of Dermatology, Eberhard-Karls University, Tuebingen, Germany and 2
Department of Dermatology and  Allergology, University of Ulm, Ulm, Germany
Mutations of mitochondrial DNA play a causative role in aging of the skin including subcutaneous
fat. We could previously show that the so called mitochondrial common deletion, a long-term marker
for oxidative stress, is increasing in an age-associated manner in subcutaneous fat from the facial
area of mice deficient in the repair of oxidative stress. Here, we investigated whether these muta-
tions are also present in aged wildtype mice and whether reduction of subcutaneous fat is also
associated with increased mutations of mitochondrial DNA at other body sites than the face. To
address this question, skin samples of wildtype mice of different ages (3-4months and 18-24 months)
and different body areas (forehead, cheek, neck, shoulder, lower and medial back, breast and pads
of the fore limbs and hind limbs) were taken, dissected in epidermal, dermal and subcutaneous fat
compartments and subsequently screened for mitochondrial DNA deletions. Dermal and epider-
mal compartments showed low levels of mitochondrial deletions and no significant age dependent
increase of mitochondrial deletions in any investigated body areas. While epidermal and dermal
compartments of all investigated body areas display only mild accumulation of mitochondrial
deletions, there is an age dependant increase of the mitochondrial deletion in subcutaneous fat. This
is particularly increased in the pads of the fore limbs compared to all other body sites. These results
indicate that mitochondrial DNA deletions are increased in those areas of the body where promi-
nent reduction of subcutaneous loss is observed in humans during the normal aging process.
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Ultraviolet as a regulator of stress system in the human skin
C Skobowiat,1 JC Dowdy,2 RM Sayre,3 RC Tuckey4 and A Slominski1 1 Pathology and Laboratory
Medicine, University of Tennessee Health Science Center, Memphis, TN, 2 Dermatology,
University of Tennessee Health Science Center, Memphis, TN, 3 Rapid Precision Testing
Laboratories, Cordova, TN and 4 Biomolecular and Chemical Sciences, University of Western
Australia, Crawley, WA, Australia
Mammalian skin expresses a local equivalent of the hypothalamic-pituitary-adrenal (HPA) axis which
modulates internal homeostasis against external environment. Skin expresses corticotrophin releas-
ing hormone (CRH), proopiomelanocortin (POMC) which its further processed to β-endorphin (β-
END), adrenocorticotropin (ACTH), and melanocyte stimulating hormone (MSH) following the cen-
tral way of organization. Since ultraviolet (UV) radiation (UVR) is a tissue-specific stressor for the
skin, we investigated the steps involved in the induction of the CRHÇCRH-R1ÇPOMCÇβ-
END/ACTHÇMC2RÇglucocorticoids (GC) responses to UVR. In our comparative studies we used
different wavelength of UVR and time of incubation. Experiments were performed in two reliable
skin equivalents: organ culture of full thickness biopsies and co-cultured keratinocytes/melanocytes.
To achieve the results we employed the real time PCR (RT-PCR), ELISA, Western blotting and immuno-
histochemistry (IHC) analyses. We found the enhanced expression of “upper arm” of HPA axis (CRH,
POMC-derived β-END and ACTH) after all UVR with the pick for UVC (1-5mJ/cm2), next UVB (50-
200mJ/cm2) and slightly after UVA (20-50J/cm2) exposition. However, the lower arm of HPA axis
(MC2R, CYP11A1 CYP11B1 and cortisol) was stimulated only after UVB and UVC but without
markedly effects after UVA irradiation. The enhanced production of cortrisol after UVB and UVC
irradiation was followed by a decreased expression of GC receptor (GR). The study report that UVR
can stimulate the “local equivalent” of HPA axis in the epidermis of the human skin. The subse-
quent decreases in GR expressions may indicate an epidermal mechanism to attenuate long-term
immunosuppressive effects of cortisol by down-regulating expression of its receptor, in order to
restore the biological barrier.
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Mechanistically-based optimization of UV radiation therapy in psoriasis
D Carlson,3 S Agaiby,1 N Lu,1 TS McCormick1 and KD Cooper2 1 Dermatology, Case Western
Reserve University, Cleveland, OH, 2 Dermatology, VA Medical Center, Cleveland, OH and 3
Dermatology, University Hospitals Case Medical Center, Cleveland, OH
Psoriasis is a chronic inflammatory skin disease that affects 4.5 million people in the US. While the
exact pathogenesis of psoriasis remains unknown, treatments targeted against T cells and APC-T cell
interactions have shown promise. Recently, single wavelength, 308nm UVB phototherapy with
excimer laser has emerged as an effective treatment. A drawback of UVB treatment is that the high
doses required for therapeutic effect may predispose patients to skin damage and even cancer. We
hypothesize that imiquimod, a TLR7/8 ligand and potent immune activator, can increase suscepti-
bility of psoriatic lesional T cells to UVB (excimer) laser-induced apoptosis and allow for lower doses
of UVB treatment. We initiated a single-blind, vehicle-controlled comparison of imiquimod com-
bined with excimer UVB phototherapy. Patients with moderate to severe psoriasis were recruited
for the study and underwent a washout period of two weeks. Following a 5 day course of treatment
with topical imiquimod excimer laser treatment was applied at either 3 or 47 hours after the last
topical treatment. Lesional psoriasis area severity index plaque (L-PASI), assessments were performed
and epidermal thickness, apoptosis and mRNA gene expression were also recorded. Our prelimi-
nary results demonstrated no significant difference in L-PASI between patients treated with vehicle
control or imiquimod for 5 days followed by excimer laser treatment 3 hours later (decrease in L-
PASI of 33 + 13% vs. 29 + 12%, respectively). Only one of five patients developed a transient increase
in erythema in plaques pre-treated with imiquimod compared to the vehicle treated plaques. Quan-
titative PCR was performed on biopsy tissue to measure levels of Mx A (myxovirus resistance 1), a
surrogate marker of local type I IFN (α/β) production. qPCR data revealed higher mRNA levels of
Mx A in untreated psoriatic skin when compared to normal skin and an augmented signal follow-
ing Imiquimod application.
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Solar ultraviolet irradiation induced Decorin degradation renders type I collagen susceptible
to cleavage by Matrix Metalloproteinase-1 in human skin
Y Li, W Xia, Y Liu, Y Shao, JJ Voorhees and GJ Fisher Dermatology, University of Michigan, Ann
Arbor, MI
Decorin is the predominant proteoglycan in human dermis. Decorin binds to type I collagen fibrils
(COL), which comprise the bulk of the dermal extracellular matrix (ECM). Interactions of decorin
with COL regulate the organization and physical properties of the ECM, and protect COL from pro-
teolytic degradation. Solar ultraviolet (UV) irradiation induces matrix metalloproteinases (MMP),
which degrade collagen fibrils, thereby impairing the structural integrity of skin and contributing to
photoaging. We have investigated regulation and function of decorin by UV irradiation in human
skin. UV irradiation (2 minimal erythemal doses) stimulated rapid degradation of decorin; reduced
37% 24 hours post UV irradiation (N=6, P<0.05). This degradation coincided accumulation of
decorin fragments, which were increased 15-fold (N=6, P<0.05). The major fragment was 19kDa.
The time frame of decorin degradation (beginning at 6 hours, peak at 24 hours and return to basal
level at 72 hours post UV irradiation, N=3) correlated with neutrophil infiltration. Topical anti-inflam-
matory steroid reduced decorin degradation 55% (N=3, P<0.05). Proteases released from isolated
human neutrophils in vitro generated decorin fragments with the same molecular weights as observed
in vivo. Fragmentation was blocked (96% inhibition, N=5, P<0.01) by specific inhibitors of neu-
trophil elastase, but not other protease inhibitors. Purified neutrophil elastase generated decorin
fragments with the same molecular weights as observed in vivo. Cleavage occurred near the mid-
dle of the molecule at amino acid 222. UV irradiation-induced decorin degradation augmented
COL cleavage (2.4-fold) by MMP-1 in human skin ex vivo (N=9, P<0.001). The present study indi-
cates that degradation of decorin by neutrophil elastase renders collagen susceptible to MMP-1
cleavage, in UV-irradiated human skin. Specific inhibitors of neutrophil elastase could be utilized
to protect decorin and consequently collagen in human skin from damage by sun exposure.
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Sex differences in UVB-induced cutaneous tumor development in Skh-1 mice following top-
ical antioxidant/anti-inflammatory treatment
EM Burns,1 KL Tober,1 NJ Sullivan,1 JS Schick,1 JA Riggenbach,1 GS Young,2 GB Lesinski3 and
TM Oberyszyn1 1 Pathology, The Ohio State University, Columbus, OH, 2 Center for
Biostatistics, The Ohio State University, Columbus, OH and 3 Internal Medicine, The Ohio
State University, Columbus, OH
While it is known that males have a greater risk of developing cutaneous squamous cell carcinoma
than females, the mechanisms that contribute to this disparity are poorly understood. We have pre-
viously shown that when chronically exposed to equivalent UVB doses, male mice exhibited greater
tumor multiplicity, burden, and grade than female mice. Additionally, when acutely exposed to
equivalent UVB doses, male mice displayed lower levels of cutaneous inflammation and total antiox-
idants but greater levels of epidermal DNA damage than female mice. Therefore, the purpose of
this study was to examine if topical treatment with antioxidants (vitamin E, catalase, or CE Ferulic),
or an NSAID (Diclofenac) differentially affected tumor development or progression between the
sexes after chronic UVB exposure. Male and female Skh-1 mice were exposed to 2240 J/m2 UVB
3 times weekly on non-consecutive days for 10 wks. For the next 15 wks, mice were only treated
topically with one of the aforementioned agents 3 times weekly on non-consecutive days. Our study
revealed a sex specific response to the various treatments. Male mice demonstrated the greatest
decrease in tumor burden with Soloraze treatment followed by CE Ferulic, catalase and Vitamin E.
Female mice likewise demonstrated the highest level of decrease in tumor burden with Solaraze
treatment followed by CE Ferulic and catalase. Interestingly in female skin Vitamin E had no effect
on decreasing tumor burden as compared to controls. These data confirm our previous findings that
male mice have increased tumor development after exposure to equivalent, chronic doses of UVB
compared to female mice. Importantly this data demonstrates a differential response between the
sexes to topical antioxidant treatments underscoring the need for the development of personalized
prevention and treatment options.
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Cysteine-rich Protein 61 (CCN1) mediates upregulation of IL-1β by UV irradiation in human
skin fibroblasts.
Z Qin, JJ Voorhees, GJ Fisher and T Quan Dermatology, University of Michigan, Ann Arbor, MI
Exposure of the human skin to solar ultraviolet (UV) irradiation induces primary cytokines such as
interleukin-1 beta (IL-1β) that stimulate inflammation and induce expression of matrix metallopro-
teinase, which degrade the collagenous dermal extracellular matrix (ECM). With repeated exposure
to solar UV irradiation, dermal ECM fragmentation accumulates, eventually impairing the struc-
tural integrity of skin and contributing to clinical photoaging. Here we report that cysteine-rich pro-
tein 61 (CCN1), a novel mediator of collagen homeostasis, promotes connective tissue damage
through upregulation of the proinflammatory cytokine 1-β, in UV-irradiated and photoaged human
skin. Both CCN1 and IL-1β are strikingly induced (35-fold and 140-fold, respectively, N=6, P<0.01)
by acute UV irradiation in human skin in vivo, and are constitutively elevated in photoaged human
skin (3-fold and 5-fold, respectively, N=6, P<0.05). In primary adult human skin fibroblasts, IL-1β
is markedly up-regulated by transfection of CCN1 expression vector (9-fold, n=3, P<0.05) or UV
irradiation (14-fold, N=3, P<0.05, 30mJ/cm2 UVB). Exposure of fibroblasts to purified human recom-
binant IL-1β negatively regulates collagen homeostasis by inducing collagen-degrading matrix
metalloproteinase-1 (3-fold, N=3, P<0.05) and repressing expression of type I procollagen (2-fold,
n=3, P<0.05). Importantly, induction of IL-1β by UV irradiation is significantly reduced (50%, n=3,
P<0.05) by siRNA-mediated knockdown of CCN1. These data indicate that induction of CCN1 drives
upregulation of IL-1β in response to UV irradiation in human dermal fibroblasts. Elevated expres-
sion of CCN1 is likely a key mediator of inflammation and connective tissue damage in photoaged
human skin. Understanding molecular mechanisms of CCN1 actions will provide novel targets for
therapeutic interventions to mitigate photoaging.
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Key features of short-term photodamage in vivo require TNFα: Infiltration of inflammatory
cells, collagenase induction in dermis, and dermal collagen loss.
MR Sharma1,2 and VP Werth1,2 1 Philadelphia VAMC, Philadelphia, PA and 2 Dermatology,
Univ of Pennsylvania, Philadelphia, PA
Short-term irradiation of mice with UVB (100 mJ/cm2/day for 5 days) decreases total collagen in skin
by about 50%, and we recently demonstrated that this collagen loss can be entirely blocked by pre-
treatment each day with etanercept (4mg/kg/day), a TNFα inhibitor (Sharma et al, J Invest Derma-
tol (abstr), 130 (Suppl 1): S135, 2010). We now sought to identify cellular and molecular mecha-
nisms. Female C57BL/6J mice were treated without or with etanercept, without (sham) or with daily
UVB irradiation for 5 days, and then skin samples were harvested 3h after the fifth exposure to
UVB. Using special stains, we found that UVB significantly increased the density of dermal mast
cells (5.9±0.48 UVB vs. 2.2±0.46 sham, p<0.01), T-lymphocytes (16.11±1.2 UVB vs. 10.8±0.62
sham, p<0.01), and especially neutrophils (91.55±16.23 vs 0±0 cells per high-power field,
mean±SEM, n=6, p<0.001). Pretreatments with etanercept significantly inhibited mast cell (3.0±0.2,
p<0.01) and T-cell (10.16±1.0, p<0.01) infiltrations after UVB irradiation, and completely blocked
the UVB-induced neutrophil influx into dermis (0±0, p<0.01). Next, we evaluated MMP-13, a major
collagenase in mouse skin. UVB significantly increased MMP-13 band intensity on immunoblot
(0.90±0.02 UVB vs. 0.50±0.07 sham; p <0.01). Etanercept non-significantly lowered basal MMP-
13 levels in sham-irradiated mice (0.32±0.06), but this trend was unaccompanied by any increase
in dermal collagen content. MMP-13 levels in the skin of mice treated with etanercept and UVB
(0.58±0.09) were statistically indistinguishable from the values in untreated control mice. Overall,
our results indicate that key features of short-term photodamage in vivo require TNFα. Our results
also suggest a connection among UVB-induced cell recruitment to skin, collagenase induction,
and collagen loss in UVB-irradiated skin.
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A plant extract protects from cutaneous photoaging via protection of collagen and elastin
networks
V Cenizo, A Lhost, S Bonnet, A Boher, C Gaillard, N Abdul-Malak, N Bechetoille and V André-
Frei BASF Beauty Care Solutions France, Lyon, France
Photoaging is the main cause of premature skin aging. UVA radiation generates reactive oxygen
species (ROS) that denature proteins, cause DNA mutations and deregulate gene expression in the
dermis. Solar elastosis is a sign of photoaging in which non functional elastin deposits accumulate.
Elastin expression increases while macrophages and neutrophils secrete elastases. We observed that,
while UVA radiation rapidly induced MMP-1 and elastin mRNA in cultured dermal fibroblasts, Lysyl
oxidase-Like (LOXL) mRNA remained unchanged. Since LOXL normally cross-links elastin monomers,
increasing LOXL could be a way to turn elastin accumulation into functional fibers. We thus searched
for a global protective agent that would inhibit elastase activity, increase LOXL expression and dis-
play good radical scavenging properties. We identified a plant extract that decreased the free radi-
cal DPPH by 60%, inhibited human neutrophil elastase activity by 46% and doubled LOXL mRNA
expression in cultured fibroblasts when used at 2%. Moreover, the extract inhibited activity of type
IV collagenase (MMP-2) by 30% and activity of macrophage elastase (MMP-12) by 65%. When
applied on confluent fibroblasts in vitro for 5 days, LOXL labeling was more intense and appeared
as droplets on thin fibrils. A double labeling with fibrillin-1 or elastin is required to confirm that
these latter are elastin-associated microfibrils. The plant extract also boosted collagen deposition.
Interestingly, the deposited collagen fibers were thicker than those observed after treatment with
ascorbic acid 50μM. Moreover, whereas collagen fibers deposited parallel to each other after treat-
ment with TGF-β1, those formed in the presence of the plant extract deposited randomly. These in
vitro results suggest that the selected plant extract used alone or in combination with sunscreens
could be an effective protective agent to help prevent signs of photoaging.
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The inside-out of photaging: UV-inducible mitochondrial DNA deletions in dermal fibroblasts
drive epidermal aging
M Majora,1 BA Schuermann,1 S Franke,1 C Goetz,1 S Grether-Beck1 and F Bernerd2 1 Molecular
Aging Research, IUF-Leibniz Institut fuer umweltmedizinische Forschung, Duesseldorf,
Germany and 2 L’Oreal Recherche, Clichy, France
Photoaging of human skin affects both the dermal as well as epidermal compartment of human skin.
We have previously shown that mitochondrial DNA (mtDNA) mutagenesis could contribute to der-
mal photoaging as the presence of UV-inducible large scale deletions (e.g. the common deletion)
in mtDNA of dermal fibroblasts leads to increased MMP-1 expression and activity. We now report
that the consequences of dermal mtDNA mutagenesis are not restricted to the dermal compartment
but instead include the epidermis as well. Accordingly, human skin equivalents (HSE) were gener-
ated by seeding keratinocytes from healthy donors on collagen lattices containing fibroblasts either
derived from skin of Kearns Sayre syndrome (KSS) patients harboring high levels of the common
deletion or normal human fibroblasts (NHF). In KSS-HSE epidermal atrophy was notable in com-
parison to NHF-HSE. This was due to impaired keratinocyte proliferation in KSS-HSE as indicated
by decreased BrdU incorporation. Accordingly, gene expression profiling revealed increased filag-
grin expression in the epidermis of KSS-HSE, a finding known to be associated with decreased pro-
liferation and cell cycle arrest in keratinocytes. Most interestingly, KSS-HSE showed a significant
decrease in the expression of the antimicrobial peptide (AMP) β-defensin 2. In contrast to the pre-
viously mentioned changes, altered AMP expression was not yet known to be a feature of photoaged
skin. We therefore thought to validate this finding by studying epidermal skin samples derived from
sun-protected (buttock) and sun-exposed (neck) skin of young and aged human volunteers. Similar
to KSS-HSE, we found that in aged, and to a lesser extent in young neck skin, expression of β-defensin
2 was significantly decreased. Thus, dermal mtDNA mutagenesis appears to be of pathogenetic rel-
evance for photoaging of epidermal skin, in particular by compromising skin barrier function includ-
ing AMP production and affecting keratinocyte proliferation.
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Reevaluating the toxicity and mutagenicity of photoactivated Rose Bengal in Chinese ham-
ster ovary cells
L Hunter,1 S Wang,2 J Wickliffe2 and M Wilkerson1 1 University of Texas Medical Branch,
Galveston, TX and 2 Tulane University Health Science Center, New Orleans, LA
Rose Bengal (RB) is being investigated as a photosuturing agent in hopes of improving standard
dermatologic surgical closure techniques. Concentrations of photoactivated RB as high as 0.1% are
currently being investigated in humans. RB is known to produce ROS, e.g., singlet oxygen (SO),
and its mutagenic potential must be considered in its clinical application. We investigated the tox-
icity, mutagenicity, and SO production of photoactivated RB on the epithelial Chinese hamster ovary
cell line. Cells were exposed to the following RB concentrations: 0.1, 0.01, 0.001, 0.0001, and
0.00001%. Cultures were irradiated for 400 s using a high-intensity visible wavelength lamp. Con-
trols were maintained in the dark. Cell viability was assessed using the XTT assay, mutagenicity using
the Hprt gene mutation assay, and SO using the Sensor Green reagent. RB concentrations >0.001%
resulted in significant cytotoxicity regardless of irradiation. XTT assay showed cell viabilities were
not influenced by ≤ 0.0001% RB maintained in the dark or after 30 min of incubation. Roughly 49%
of irradiated cells were lost after 24 h of incubation in 0.0001% RB. At ≥0.001% RB, >90% of cells
were lost. Sensor Green revealed that irradiating 0.00001-0.001% RB increased amounts of SO,
although levels dropped significantly between 0.01-0.1%. Controls exhibited almost no SO pro-
duction. The Hprt gene mutation assay suggested RB was not mutagenic at 0.0001 or 0.00001%.
There is an obvious increase in SO induction between 0.00001–0.001%, with reduced production
at higher concentrations. Perhaps photoactivated RB undergoes auto-exhaustion at higher concen-
trations. An initial pilot study suggested irradiated 0.0001% RB is mutagenic in vitro, however the
current data suggests RB is not mutagenic. The contribution of RB’s cytotoxicity on observed clini-
cal improvement of scars and its mutagenic potential remains unclear and requires further study.
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The GS-nitroxide JP4-039 is a potent topical antioxidant that mitigates skin damage from
ionizing radiation.
R Brand,1 M Epperly,2 J Stottlemyer,1 R Cline,1 H Kim,2 X Gao,3 S Li,3 S Huq,2 P Wipf,4 V Kagan,4
J Greenberger2 and LD Falo1 1 Dermatology, University of Pittsburgh, Pittsburgh, PA, 2
Radiation Oncology, University of Pittsburgh, Pittsburgh, PA, 3 Pharmacology, University of
Pittsburgh, Pittsburgh, PA and 4 Medicine, University of Pittsburgh, Pittsburgh, PA
Topical agents capable of preventing ionizing irradiation induced cutaneous injury have the poten-
tial to prevent radiotherapy induced dermatitis. Further, in the event of an accidental radiation expo-
sure or terrorist attack, there would be a critical need for topical therapies capable of mitigating
cutaneous radiation damage. Importantly, to be therapeutically valuable subsequent to an accidental
or terrorist radiation exposure, the agent must be capable of blocking or reversing radiation induced
processes leading to skin damage that have been initiated by prior radiation exposure. Since mito-
chondrial damage is a critical factor in ionizing irradiation-induced cellular apoptosis and tissue
injury, we designed a small molecule nitroxide, JP4-039, that combines several important anti-oxi-
dant and electron-scavenging properties in a single mitochondrial-targeted functional moiety. In ini-
tial studies we demonstrated that topically applied JP4-039 can preventing radiation induced skin
damage. To determine the capacity of JP4-039 to mitigate skin damage when applied after radia-
tion exposure, as would likely be the case in an accidental or terrorist event, we applied JP4-039
topically to the hind legs of mice irradiated (35 GY) 24 hours earlier. Three weeks later mice were
evaluated 1) photographically for visual evidence of skin damage, and 2) for leg contracture as a
functional measure of fibrosis. Further, we preformed histologic comparisons to evaluate 3) skin
thickening and 4) cellular infiltrates characteristic of radiation induced skin damage. Taken together,
these results demonstrate that topically applied JP4-039 can prevent irradiation damage, and can
mitigate damage even when applied 24 hours after radiation exposure.
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The pathomechanistic role of ABCC6 in pseudoxanthoma elasticum – The vitamin K connec-
tion
Q Jiang,1 K Fülöp,2 V Pomozi,2 A Grand-Pierre,1 S Siu,2 H de Boussac,2 G Köblös,2 P Szabó,2
T Arányi,2 A Várdi2 and J Uitto1 1 Thomas Jefferson University, Philadelphia, PA and 2
Hungarian Academy of Sciences, Budapest, Hungary
Pseudoxanthoma elasticum (PXE), caused by mutations in the ABCC6 gene, manifests with calcifi-
cation of peripheral connective tissues. The mechanisms of PXE are currently unknown, but recent
demonstrations of PXE-like cutaneous findings in patients with mutations in the GGCX gene have
suggested a role for vitamin K. Specifically, GGCX encodes γ-glutamyl carboxylase, a vitamin K
dependent enzyme responsible for post-translational carboxylation of Gla-domain containing pro-
teins, conferring them antimineralization properties. These observations have then raised the ques-
tion:“Does the absence of ABCC6 in PXE prevent the liver from providing sufficient vitamin K to
the periphery“? To address this question, we have utilized the Abcc6-/- mouse model, with appro-
priate wild type controls, for liver perfusion experiments to gain information on the metabolism
and transport of vitamin K. First, vitamin K3 was introduced into the liver through portal vein and
the efflux fluid was collected through the inferior vena cava and analyzed by high sensitivity HPLC-
MS. No significant difference of vitamin K3 and its glutathione conjugate in efflux was observed
between the wild type and the Abcc6-/- animals. The finding was confirmed by an in vitro Sf9 cell
based vesicular transport system overexpressing human ABCC6. No difference in the vitamin K3
and its glutathione conjugate transport kinetics was noted in this system with and without trans-
fected ABCC6. Instead, the results suggested that the K3-glutathione conjugate is transported by
ABCC1 to the circulation and by ABCC2 into the bile. These observations, taken together with ongo-
ing vitamin K feeding experiments in Abcc6-/- mice, do not support the hypothesis that PXE phe-
notype is a simple consequence of deficiency of peripheral vitamin K3 or its glutathione conjugate.
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Skin compartments of different body areas harbour different amounts of mitochondrial dele-
tions in aged wildtype mice
J Knoch,1 Y Kamenisch,1 H Geiger,2 M Röcken,1 K Scharffetter-Kochanek2 and M Berneburg1 1
Department of Dermatology, Eberhard-Karls University, Tuebingen, Germany and 2
Department of Dermatology and  Allergology, University of Ulm, Ulm, Germany
Mutations of mitochondrial DNA play a causative role in aging of the skin including subcutaneous
fat. We could previously show that the so called mitochondrial common deletion, a long-term marker
for oxidative stress, is increasing in an age-associated manner in subcutaneous fat from the facial
area of mice deficient in the repair of oxidative stress. Here, we investigated whether these muta-
tions are also present in aged wildtype mice and whether reduction of subcutaneous fat is also
associated with increased mutations of mitochondrial DNA at other body sites than the face. To
address this question, skin samples of wildtype mice of different ages (3-4months and 18-24 months)
and different body areas (forehead, cheek, neck, shoulder, lower and medial back, breast and pads
of the fore limbs and hind limbs) were taken, dissected in epidermal, dermal and subcutaneous fat
compartments and subsequently screened for mitochondrial DNA deletions. Dermal and epider-
mal compartments showed low levels of mitochondrial deletions and no significant age dependent
increase of mitochondrial deletions in any investigated body areas. While epidermal and dermal
compartments of all investigated body areas display only mild accumulation of mitochondrial
deletions, there is an age dependant increase of the mitochondrial deletion in subcutaneous fat. This
is particularly increased in the pads of the fore limbs compared to all other body sites. These results
indicate that mitochondrial DNA deletions are increased in those areas of the body where promi-
nent reduction of subcutaneous loss is observed in humans during the normal aging process.
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Ultraviolet as a regulator of stress system in the human skin
C Skobowiat,1 JC Dowdy,2 RM Sayre,3 RC Tuckey4 and A Slominski1 1 Pathology and Laboratory
Medicine, University of Tennessee Health Science Center, Memphis, TN, 2 Dermatology,
University of Tennessee Health Science Center, Memphis, TN, 3 Rapid Precision Testing
Laboratories, Cordova, TN and 4 Biomolecular and Chemical Sciences, University of Western
Australia, Crawley, WA, Australia
Mammalian skin expresses a local equivalent of the hypothalamic-pituitary-adrenal (HPA) axis which
modulates internal homeostasis against external environment. Skin expresses corticotrophin releas-
ing hormone (CRH), proopiomelanocortin (POMC) which its further processed to β-endorphin (β-
END), adrenocorticotropin (ACTH), and melanocyte stimulating hormone (MSH) following the cen-
tral way of organization. Since ultraviolet (UV) radiation (UVR) is a tissue-specific stressor for the
skin, we investigated the steps involved in the induction of the CRHÇCRH-R1ÇPOMCÇβ-
END/ACTHÇMC2RÇglucocorticoids (GC) responses to UVR. In our comparative studies we used
different wavelength of UVR and time of incubation. Experiments were performed in two reliable
skin equivalents: organ culture of full thickness biopsies and co-cultured keratinocytes/melanocytes.
To achieve the results we employed the real time PCR (RT-PCR), ELISA, Western blotting and immuno-
histochemistry (IHC) analyses. We found the enhanced expression of “upper arm” of HPA axis (CRH,
POMC-derived β-END and ACTH) after all UVR with the pick for UVC (1-5mJ/cm2), next UVB (50-
200mJ/cm2) and slightly after UVA (20-50J/cm2) exposition. However, the lower arm of HPA axis
(MC2R, CYP11A1 CYP11B1 and cortisol) was stimulated only after UVB and UVC but without
markedly effects after UVA irradiation. The enhanced production of cortrisol after UVB and UVC
irradiation was followed by a decreased expression of GC receptor (GR). The study report that UVR
can stimulate the “local equivalent” of HPA axis in the epidermis of the human skin. The subse-
quent decreases in GR expressions may indicate an epidermal mechanism to attenuate long-term
immunosuppressive effects of cortisol by down-regulating expression of its receptor, in order to
restore the biological barrier.
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Mechanistically-based optimization of UV radiation therapy in psoriasis
D Carlson,3 S Agaiby,1 N Lu,1 TS McCormick1 and KD Cooper2 1 Dermatology, Case Western
Reserve University, Cleveland, OH, 2 Dermatology, VA Medical Center, Cleveland, OH and 3
Dermatology, University Hospitals Case Medical Center, Cleveland, OH
Psoriasis is a chronic inflammatory skin disease that affects 4.5 million people in the US. While the
exact pathogenesis of psoriasis remains unknown, treatments targeted against T cells and APC-T cell
interactions have shown promise. Recently, single wavelength, 308nm UVB phototherapy with
excimer laser has emerged as an effective treatment. A drawback of UVB treatment is that the high
doses required for therapeutic effect may predispose patients to skin damage and even cancer. We
hypothesize that imiquimod, a TLR7/8 ligand and potent immune activator, can increase suscepti-
bility of psoriatic lesional T cells to UVB (excimer) laser-induced apoptosis and allow for lower doses
of UVB treatment. We initiated a single-blind, vehicle-controlled comparison of imiquimod com-
bined with excimer UVB phototherapy. Patients with moderate to severe psoriasis were recruited
for the study and underwent a washout period of two weeks. Following a 5 day course of treatment
with topical imiquimod excimer laser treatment was applied at either 3 or 47 hours after the last
topical treatment. Lesional psoriasis area severity index plaque (L-PASI), assessments were performed
and epidermal thickness, apoptosis and mRNA gene expression were also recorded. Our prelimi-
nary results demonstrated no significant difference in L-PASI between patients treated with vehicle
control or imiquimod for 5 days followed by excimer laser treatment 3 hours later (decrease in L-
PASI of 33 + 13% vs. 29 + 12%, respectively). Only one of five patients developed a transient increase
in erythema in plaques pre-treated with imiquimod compared to the vehicle treated plaques. Quan-
titative PCR was performed on biopsy tissue to measure levels of Mx A (myxovirus resistance 1), a
surrogate marker of local type I IFN (α/β) production. qPCR data revealed higher mRNA levels of
Mx A in untreated psoriatic skin when compared to normal skin and an augmented signal follow-
ing Imiquimod application.
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Solar ultraviolet irradiation induced Decorin degradation renders type I collagen susceptible
to cleavage by Matrix Metalloproteinase-1 in human skin
Y Li, W Xia, Y Liu, Y Shao, JJ Voorhees and GJ Fisher Dermatology, University of Michigan, Ann
Arbor, MI
Decorin is the predominant proteoglycan in human dermis. Decorin binds to type I collagen fibrils
(COL), which comprise the bulk of the dermal extracellular matrix (ECM). Interactions of decorin
with COL regulate the organization and physical properties of the ECM, and protect COL from pro-
teolytic degradation. Solar ultraviolet (UV) irradiation induces matrix metalloproteinases (MMP),
which degrade collagen fibrils, thereby impairing the structural integrity of skin and contributing to
photoaging. We have investigated regulation and function of decorin by UV irradiation in human
skin. UV irradiation (2 minimal erythemal doses) stimulated rapid degradation of decorin; reduced
37% 24 hours post UV irradiation (N=6, P<0.05). This degradation coincided accumulation of
decorin fragments, which were increased 15-fold (N=6, P<0.05). The major fragment was 19kDa.
The time frame of decorin degradation (beginning at 6 hours, peak at 24 hours and return to basal
level at 72 hours post UV irradiation, N=3) correlated with neutrophil infiltration. Topical anti-inflam-
matory steroid reduced decorin degradation 55% (N=3, P<0.05). Proteases released from isolated
human neutrophils in vitro generated decorin fragments with the same molecular weights as observed
in vivo. Fragmentation was blocked (96% inhibition, N=5, P<0.01) by specific inhibitors of neu-
trophil elastase, but not other protease inhibitors. Purified neutrophil elastase generated decorin
fragments with the same molecular weights as observed in vivo. Cleavage occurred near the mid-
dle of the molecule at amino acid 222. UV irradiation-induced decorin degradation augmented
COL cleavage (2.4-fold) by MMP-1 in human skin ex vivo (N=9, P<0.001). The present study indi-
cates that degradation of decorin by neutrophil elastase renders collagen susceptible to MMP-1
cleavage, in UV-irradiated human skin. Specific inhibitors of neutrophil elastase could be utilized
to protect decorin and consequently collagen in human skin from damage by sun exposure.
692
Sex differences in UVB-induced cutaneous tumor development in Skh-1 mice following top-
ical antioxidant/anti-inflammatory treatment
EM Burns,1 KL Tober,1 NJ Sullivan,1 JS Schick,1 JA Riggenbach,1 GS Young,2 GB Lesinski3 and
TM Oberyszyn1 1 Pathology, The Ohio State University, Columbus, OH, 2 Center for
Biostatistics, The Ohio State University, Columbus, OH and 3 Internal Medicine, The Ohio
State University, Columbus, OH
While it is known that males have a greater risk of developing cutaneous squamous cell carcinoma
than females, the mechanisms that contribute to this disparity are poorly understood. We have pre-
viously shown that when chronically exposed to equivalent UVB doses, male mice exhibited greater
tumor multiplicity, burden, and grade than female mice. Additionally, when acutely exposed to
equivalent UVB doses, male mice displayed lower levels of cutaneous inflammation and total antiox-
idants but greater levels of epidermal DNA damage than female mice. Therefore, the purpose of
this study was to examine if topical treatment with antioxidants (vitamin E, catalase, or CE Ferulic),
or an NSAID (Diclofenac) differentially affected tumor development or progression between the
sexes after chronic UVB exposure. Male and female Skh-1 mice were exposed to 2240 J/m2 UVB
3 times weekly on non-consecutive days for 10 wks. For the next 15 wks, mice were only treated
topically with one of the aforementioned agents 3 times weekly on non-consecutive days. Our study
revealed a sex specific response to the various treatments. Male mice demonstrated the greatest
decrease in tumor burden with Soloraze treatment followed by CE Ferulic, catalase and Vitamin E.
Female mice likewise demonstrated the highest level of decrease in tumor burden with Solaraze
treatment followed by CE Ferulic and catalase. Interestingly in female skin Vitamin E had no effect
on decreasing tumor burden as compared to controls. These data confirm our previous findings that
male mice have increased tumor development after exposure to equivalent, chronic doses of UVB
compared to female mice. Importantly this data demonstrates a differential response between the
sexes to topical antioxidant treatments underscoring the need for the development of personalized
prevention and treatment options.
693
Cysteine-rich Protein 61 (CCN1) mediates upregulation of IL-1β by UV irradiation in human
skin fibroblasts.
Z Qin, JJ Voorhees, GJ Fisher and T Quan Dermatology, University of Michigan, Ann Arbor, MI
Exposure of the human skin to solar ultraviolet (UV) irradiation induces primary cytokines such as
interleukin-1 beta (IL-1β) that stimulate inflammation and induce expression of matrix metallopro-
teinase, which degrade the collagenous dermal extracellular matrix (ECM). With repeated exposure
to solar UV irradiation, dermal ECM fragmentation accumulates, eventually impairing the struc-
tural integrity of skin and contributing to clinical photoaging. Here we report that cysteine-rich pro-
tein 61 (CCN1), a novel mediator of collagen homeostasis, promotes connective tissue damage
through upregulation of the proinflammatory cytokine 1-β, in UV-irradiated and photoaged human
skin. Both CCN1 and IL-1β are strikingly induced (35-fold and 140-fold, respectively, N=6, P<0.01)
by acute UV irradiation in human skin in vivo, and are constitutively elevated in photoaged human
skin (3-fold and 5-fold, respectively, N=6, P<0.05). In primary adult human skin fibroblasts, IL-1β
is markedly up-regulated by transfection of CCN1 expression vector (9-fold, n=3, P<0.05) or UV
irradiation (14-fold, N=3, P<0.05, 30mJ/cm2 UVB). Exposure of fibroblasts to purified human recom-
binant IL-1β negatively regulates collagen homeostasis by inducing collagen-degrading matrix
metalloproteinase-1 (3-fold, N=3, P<0.05) and repressing expression of type I procollagen (2-fold,
n=3, P<0.05). Importantly, induction of IL-1β by UV irradiation is significantly reduced (50%, n=3,
P<0.05) by siRNA-mediated knockdown of CCN1. These data indicate that induction of CCN1 drives
upregulation of IL-1β in response to UV irradiation in human dermal fibroblasts. Elevated expres-
sion of CCN1 is likely a key mediator of inflammation and connective tissue damage in photoaged
human skin. Understanding molecular mechanisms of CCN1 actions will provide novel targets for
therapeutic interventions to mitigate photoaging.
694
Key features of short-term photodamage in vivo require TNFα: Infiltration of inflammatory
cells, collagenase induction in dermis, and dermal collagen loss.
MR Sharma1,2 and VP Werth1,2 1 Philadelphia VAMC, Philadelphia, PA and 2 Dermatology,
Univ of Pennsylvania, Philadelphia, PA
Short-term irradiation of mice with UVB (100 mJ/cm2/day for 5 days) decreases total collagen in skin
by about 50%, and we recently demonstrated that this collagen loss can be entirely blocked by pre-
treatment each day with etanercept (4mg/kg/day), a TNFα inhibitor (Sharma et al, J Invest Derma-
tol (abstr), 130 (Suppl 1): S135, 2010). We now sought to identify cellular and molecular mecha-
nisms. Female C57BL/6J mice were treated without or with etanercept, without (sham) or with daily
UVB irradiation for 5 days, and then skin samples were harvested 3h after the fifth exposure to
UVB. Using special stains, we found that UVB significantly increased the density of dermal mast
cells (5.9±0.48 UVB vs. 2.2±0.46 sham, p<0.01), T-lymphocytes (16.11±1.2 UVB vs. 10.8±0.62
sham, p<0.01), and especially neutrophils (91.55±16.23 vs 0±0 cells per high-power field,
mean±SEM, n=6, p<0.001). Pretreatments with etanercept significantly inhibited mast cell (3.0±0.2,
p<0.01) and T-cell (10.16±1.0, p<0.01) infiltrations after UVB irradiation, and completely blocked
the UVB-induced neutrophil influx into dermis (0±0, p<0.01). Next, we evaluated MMP-13, a major
collagenase in mouse skin. UVB significantly increased MMP-13 band intensity on immunoblot
(0.90±0.02 UVB vs. 0.50±0.07 sham; p <0.01). Etanercept non-significantly lowered basal MMP-
13 levels in sham-irradiated mice (0.32±0.06), but this trend was unaccompanied by any increase
in dermal collagen content. MMP-13 levels in the skin of mice treated with etanercept and UVB
(0.58±0.09) were statistically indistinguishable from the values in untreated control mice. Overall,
our results indicate that key features of short-term photodamage in vivo require TNFα. Our results
also suggest a connection among UVB-induced cell recruitment to skin, collagenase induction,
and collagen loss in UVB-irradiated skin.
695
A plant extract protects from cutaneous photoaging via protection of collagen and elastin
networks
V Cenizo, A Lhost, S Bonnet, A Boher, C Gaillard, N Abdul-Malak, N Bechetoille and V André-
Frei BASF Beauty Care Solutions France, Lyon, France
Photoaging is the main cause of premature skin aging. UVA radiation generates reactive oxygen
species (ROS) that denature proteins, cause DNA mutations and deregulate gene expression in the
dermis. Solar elastosis is a sign of photoaging in which non functional elastin deposits accumulate.
Elastin expression increases while macrophages and neutrophils secrete elastases. We observed that,
while UVA radiation rapidly induced MMP-1 and elastin mRNA in cultured dermal fibroblasts, Lysyl
oxidase-Like (LOXL) mRNA remained unchanged. Since LOXL normally cross-links elastin monomers,
increasing LOXL could be a way to turn elastin accumulation into functional fibers. We thus searched
for a global protective agent that would inhibit elastase activity, increase LOXL expression and dis-
play good radical scavenging properties. We identified a plant extract that decreased the free radi-
cal DPPH by 60%, inhibited human neutrophil elastase activity by 46% and doubled LOXL mRNA
expression in cultured fibroblasts when used at 2%. Moreover, the extract inhibited activity of type
IV collagenase (MMP-2) by 30% and activity of macrophage elastase (MMP-12) by 65%. When
applied on confluent fibroblasts in vitro for 5 days, LOXL labeling was more intense and appeared
as droplets on thin fibrils. A double labeling with fibrillin-1 or elastin is required to confirm that
these latter are elastin-associated microfibrils. The plant extract also boosted collagen deposition.
Interestingly, the deposited collagen fibers were thicker than those observed after treatment with
ascorbic acid 50μM. Moreover, whereas collagen fibers deposited parallel to each other after treat-
ment with TGF-β1, those formed in the presence of the plant extract deposited randomly. These in
vitro results suggest that the selected plant extract used alone or in combination with sunscreens
could be an effective protective agent to help prevent signs of photoaging.
696
The inside-out of photaging: UV-inducible mitochondrial DNA deletions in dermal fibroblasts
drive epidermal aging
M Majora,1 BA Schuermann,1 S Franke,1 C Goetz,1 S Grether-Beck1 and F Bernerd2 1 Molecular
Aging Research, IUF-Leibniz Institut fuer umweltmedizinische Forschung, Duesseldorf,
Germany and 2 L’Oreal Recherche, Clichy, France
Photoaging of human skin affects both the dermal as well as epidermal compartment of human skin.
We have previously shown that mitochondrial DNA (mtDNA) mutagenesis could contribute to der-
mal photoaging as the presence of UV-inducible large scale deletions (e.g. the common deletion)
in mtDNA of dermal fibroblasts leads to increased MMP-1 expression and activity. We now report
that the consequences of dermal mtDNA mutagenesis are not restricted to the dermal compartment
but instead include the epidermis as well. Accordingly, human skin equivalents (HSE) were gener-
ated by seeding keratinocytes from healthy donors on collagen lattices containing fibroblasts either
derived from skin of Kearns Sayre syndrome (KSS) patients harboring high levels of the common
deletion or normal human fibroblasts (NHF). In KSS-HSE epidermal atrophy was notable in com-
parison to NHF-HSE. This was due to impaired keratinocyte proliferation in KSS-HSE as indicated
by decreased BrdU incorporation. Accordingly, gene expression profiling revealed increased filag-
grin expression in the epidermis of KSS-HSE, a finding known to be associated with decreased pro-
liferation and cell cycle arrest in keratinocytes. Most interestingly, KSS-HSE showed a significant
decrease in the expression of the antimicrobial peptide (AMP) β-defensin 2. In contrast to the pre-
viously mentioned changes, altered AMP expression was not yet known to be a feature of photoaged
skin. We therefore thought to validate this finding by studying epidermal skin samples derived from
sun-protected (buttock) and sun-exposed (neck) skin of young and aged human volunteers. Similar
to KSS-HSE, we found that in aged, and to a lesser extent in young neck skin, expression of β-defensin
2 was significantly decreased. Thus, dermal mtDNA mutagenesis appears to be of pathogenetic rel-
evance for photoaging of epidermal skin, in particular by compromising skin barrier function includ-
ing AMP production and affecting keratinocyte proliferation.
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Suppression of human malignant melanoma cell proliferation and invasion by gamma-
tocotrienol, a constituent of palm vitamin E
W Yap,1 A Chen,1 S Lee,1 S Ong,1 V Teo,1 M Ling,2 Y Wong3 and Y Yap1 1 Cancer Research
Laboratory, Davos Life Science Pte. Ltd., Singapore, Singapore, 2 Australian Prostate Cancer
Research Centre-Queensland Institute of Health and Biomedical Innovation (IHBI),
Queensland University of Technology, Brisbane, QLD, Australia and 3 Department of
Anatomy, The University of Hong Kong, Hong Kong, Hong Kong
This study aimed to elucidate gamma-tocotrienol’s anti-cancer property in malignant melanoma
cells. MTT cell proliferation assay and flow cytometry were performed to investigate gamma-
tocotrienol-induced cell cytotoxicity and cell cycle arrest. Cell invasion was studied using matrigel-
invasion assay. Mechanisms of action responsible for its anti-cancer activity were analyzed by
western blotting. Darcabazine and Docetaxel were used in the chemosensitisation studies. Our data
showed that the inhibitory effect of gamma-tocotrienol was most potent, which resulted in induc-
tion of apoptosis as evidenced by activation of pro-caspases and the accumulation of sub-G1 cell
population. Examination of the pro-survival genes revealed that the gamma-tocotrienol induced cell
death was associated with suppression of NF-kappaB, EGF-R, and Id family proteins. Meanwhile,
gamma-tocotrienol treatment also resulted in induction of JNK signaling pathway and inhibition of
JNK activity by selective inhibitor was able to partially block the effect of gamma-tocotrienol. Inter-
estingly, gamma-tocotrienol treatment led to suppression of mesenchymal markers and the restora-
tion of E-cadherin and gamma-catenin expression, which was associated with suppression of cell
invasion capability. Furthermore, synergistic effect was observed when cells were co-treated with
gamma-tocotrienol and chemotherapy drugs. In conclusion, our results demonstrated the anti-
invasion and chemosensitisation effect of gamma-tocotrienol against human malignant melanoma
cells.
711
Omeprazole (proton pump inhibitor) inhibits melanin synthesis by decrease pH in acidic cell
compartment
Y Niki,1 M Yoshida,2 H Ando,1,2 MS Matsui,3 DB Yarosh3 and M Ichihashi1,2 1 Kobe Skin Research
Insititute, Kobe, Japan, 2 Skin Aging and Photo-aging Research Center, Doshisha University,
Kizugawa, Japan and 3 Estee Lauder Companies Inc., Melville, NY
Proton pump inhibitors (PPIs), which act by irreversibly blocking the H+/K+ ATPase of the gastric
parietal cells, are used in the treatment of peptic ulcer and gastro-esophageal reflux. During a screen-
ing test using B16F10 mouse melanoma cells, we found that PPIs reduce melanogenesis. Among
14 different PPIs, omeprazole (OPZ) was the most potent at reducing cellular melanin content with
low cytotoxicity. OPZ also inhibited melanin synthesis in a reconstructed human skin model. Although
OPZ slightly decreased tyrosinase DOPA oxidase activity of mushroom and B16F10 cell extract in
vitro, in situ tyrosine hydroxylase activity of tyrosinase was decreased significantly in OPZ-treated
B16F10 cells. We also examined the effects of OPZ on mRNA and protein levels of melanin syn-
thesis-related proteins, including tyrosinase, tyrosinase related protein-2, microphthalmia-associ-
ated transcription factor (Mitf) and Pmel17 using B16F10 cells. OPZ did not inhibit transcription at
non-cytotoxic concentrations. However, western-blotting revealed that treatment of B16F10 with
50 μM OPZ for 72 h decreased tyrosinase protein level to approximately 50% that of control cells.
Other research groups have showed that the pH of cell organelles, such as ER, Golgi and melanosomes
may have an important regulatory role in melanogenesis. But the detailed mechanisms of pH effect
on melanogenesis have not been clear yet. We therefore investigated the effect of OPZ on melanocyte
pH using an acidic probe, 3-(2,4-dinitroanilino)-3′-amino-N-methylpropylamine (DAMP). DAMP-
treated B16F10 cells demonstrated lower pH in the acidic compartment within 4 h of exposure to
OPZ. These results suggest that OPZ may inhibit melanin synthesis via a decrease in melanosomal
pH, leading to the inhibition of tyrosinase activity, increased tyrosinase degradation, and/or to the
suppression of tyrosinase trafficking.
713
Green tea catechins inhibit melanoma cell migration and invasion by inhibiting the expres-
sion of cyclooxygenase-2 and NF-κB activation
SK Katiyar1,2 and T Singh1 1 University of Alabama at Birmingham, Birmingham, AL and 2
Birmingham VA Medical Center, Birmingham, AL
Melanoma is the leading cause of death from skin disease due, in large part, to its propensity to
metastasize. An approach that decreases its metastatic ability may facilitate the development of an
effective strategy for its treatment and/or prevention. Here, we assessed the comparative effect of
major green tea catechins, such as, (-)-epicatechin (EC), (-)-epigallocatechin (EGC), (-)-epicatechin
gallate (ECG) and (-)-epigallocatechin-3-gallate (EGCG), on human melanoma cancer cell migra-
tion/invasion and the molecular mechanisms underlying these effects using melanoma cell lines,
A375 and Hs294t. Using an in vitro cell migration (wound healing assay) and cell invasion (Boy-
den chamber) assays, we show that overexpression of cyclooxygenase-2 (COX-2) and its metabo-
lite PGE2, promote the migration of cells. We found that treatment of A375 and Hs294t cells with
equimolar (25 μM) concentration of catechins for 24 h resulted in inhibition of migration and inva-
sion of these cells. The inhibitory effect of catechins on melanoma cell migration and cell invasion
was in the order of: EGCG>ECG>EGC>EC. The inhibitory effect of EGCG, a most active compo-
nent of green tea, was associated with a reduction in the levels of COX-2 and its metabolite PGE2.
Treatment of cells with celecoxib, a COX-2 inhibitor, or transient transfection of cells with COX-2
small interfering RNA, also inhibited cell invasion. Treatment of the cells with 12-O-tetrade-
canoylphorbol-13-acetate (TPA), an inducer of COX-2 or PGE2, enhanced cell invasion whereas
EGCG inhibited TPA- or PGE2-promoted cell migration. Moreover, EGCG inhibited the activation
of NF-κB, an upstream regulator of COX-2, in melanoma cells, and treatment of cells with caffeic
acid phenethyl ester or oridonin, inhibitors of NF-κB, inhibited cell migration/invasion. Together,
these results indicate that green tea catechin, EGCG, inhibits melanoma cell migration and inva-
sion, an essential step in metastasis, by inhibiting COX-2 expression and NF-κB activation.
712
Differential effects of UV irradiation and visible light on skin pigmentation in vitro
CB Lin,1 N Chen,2 D Rossetti,1 Y Hu,1 J Zhang,1 P Bargo,1 T Chen1 and M Seiberg1 1 Skin Biology,
The Johnson & Johnson Skin Research Center, unit of Johnson and Johnson Consumer
Companies, Inc., Skillman, NJ and 2 Former J&J employee, Skillman, NJ
The effects of different UV wavelengths on skin pigmentation are heavily documented, however lit-
tle is known about the effects of visible light on pigment production and deposition. Therefore, we
used in vitro model systems to examine the possible effects of visible light on skin pigmentation
and compared the relative efficiency and kinetics of UVA, UVB and visible light in this process.
Using pigmented epidermal equivalents, we demonstrated that exposure to UVA, UVB or visible
light induces visible darkening and increases melanin deposition within the tissues. The induction
of melanin deposition by visible light and UVA was more evident at earlier time points, while the
increased melanin deposition induced by UVB was more significant at later time points. In addi-
tion, equivalents exposed to UVA exhibited a thinner viable epidermal layer and a thicker and highly
pigmented stratum corneum, suggesting a UVA effect on keratinocyte differentiation and melanin
distribution. Similar effects were observed using human skin explants. At earlier times, UVA, UVB
and visible light induced comparable levels of melanin deposition, while UVB stimulated the high-
est level of melanin production and deposition at later times. The induced pigment production was
more evident in darkly-pigmented vs. lightly pigmented skins, which was in correlation with their
induced expression of Tyrosinase and melanocortin-1 receptor genes. Topical pretreatment of human
skin explants with 2.5% non-denatured soybean extracts reduced both basal, UV and visible light-
induced melanin levels. These results shed lights on the mechanism of tanning induced by UV and
visible light wavelengths. Additionally, this study demonstrates that topical application of non-dena-
tured soybean extracts could potentially reduce UV and visible light-induced skin darkening.
710
Melanin inhibition by tocotrienols through suppressing of constitutive and uv-induced tyrosi-
nase activation
A Chen,1 W Yap,1 S Lee,1 S Ong,1 V Teo,1 S Shunichi2 and Y Yap1 1 Skin Research Laboratory,
Davos Life Science Pte. Ltd., Singapore, Singapore and 2 Phytopharma Co Ltd, Yokohama,
Japan
The objective was to extend our current understanding of tocotrienol (T3) and tyrosinase, we inves-
tigate T3 isomers ability in inhibiting tyrosinase activity in murine and human melanoma cell lines.
In addition, our study explores the synergistic interaction of T3 with tyrosinase inhibitors and UVB-
induced tyrosinase activation. Melanogenesis activity was performed to investigate gamma- and
delta-T3-suppressed tyrosinase and melanin expression in murine B16 melanoma cells. Mechanism
of action responsible for the tyrosinase inhibition was analyzed by western blot. In vivo xenograft
models of B16, A375 and WM793B were used in evaluating the ability of T3 in tumor shrinkage
and melanogenesis inhibition. Kojic acid and sodium lactate were used as tyrosinase inhibitors in
the chemosensitization studies. Our data showed that with the exception of alpha-T3, the other T3
isomers (beta, gamma, and delta), palm T3-rich fraction (TRF), palm TRF acetate and tyrosinase
inhibitors (kojic acid, and sodium lactate) suppressed tyrosinase protein expression in murine B16,
human A375 and WM793B melanoma cells in dose-dependent fashion. Examination of the melanin
and tyrosinase activity content on days 5 and 9 revealed that co-treatment between TRF and kojic
acid or sodium lactate possessing synergistic effect. Pigmentation of the in vivo solid tumors became
fairer compared to controls after 14 days of oral gamma T3 supplementary (100mg/kg/day), and the
tumor size was significantly smaller for the gamma T3 group. Delta T3 has been found to be more
potent than gamma T3 in suppressing short term (<10min) UVB-induced tyrosinase activation, while
their long- term inhibitory effects were comparable. Gamma-, delta-T3 and palm TRF possess higher
sun protection factor (SPF) compared to alpha T and palm TRF acetate. In conclusion, our results
suggested that the anti-melanogenesis effect of gamma- and delta-T3 may be mediated through mul-
tiple signaling pathways leading to the downregulation of tyrosinase protein.
714
87 cases of vulvar melanoma: The Duke experience
JY Tcheung,1 MA Selim,1,2 J Marcello,3 AP Abernethy4 and KC Nelson1 1 Dermatology, Duke
University Medical Center, Durham, NC, 2 Pathology, Duke University Medical Center,
Durham, NC, 3 Cancer Center Biostatistics, Duke University Medical Center, Durham, NC
and 4 Internal Medicine, Duke University Medical Center, Durham, NC
Malignant melanoma is the most serious form of skin cancer, and vulvar melanoma has an espe-
cially poor overall prognosis—5-year survival rates have been cited between 8-55% (mean 36%).
Because of delay in diagnosis and the aggressiveness of this disease, despite treatment, high mor-
bidity and mortality persist. To examine prognostic factors influencing survival, the Duke Melanoma
and Tumor Registry Databases were queried for patients with a diagnosis of vulvar melanoma between
1970 and 2009. 87 subjects (80 Caucasians, 5 African-Americans, 1 Hispanic, 1 race-not-reported)
with a mean age of 60.2 years (range, 19-93years) were identified. Median follow-up time was 8.3
years (95% confidence-interval: 5.9 to 13.6 years) with 51 subjects experiencing melanoma-related
mortality. Cohort survival rates were as follows: 85.3% (1-year), 50.7% (5-year), and 29.7% (10-
year). Available pathologic specimens from 32 subjects were also reviewed by a dermatopatholo-
gist and revealed the following features: 15 melanomas with ulceration, 2 originating from a nevus,
15 stemming from mucosal skin, 3 with regression, 20 with pigmentation, 11 with atypical
melanocytic hyperplasia, and mitotic rate ranging from less than one to 40 per mm squared(7.4 per
mm squared, mean). Breslow thickness, lymph node status, systemic therapy, and surgery were
examined for differences in survival distributions using the logrank test. Correlating with melanoma
of cutaneous sites, survival was inversely correlated with Breslow depth and extent of nodal involve-
ment. Reflective of disease extent guiding therapeutic plan and provision of systemic therapy, a
higher survival rate was observed among those who received wide local excision, p-value=0.02. In
summary, subjects with thinner vulvar melanomas amenable to surgical resection had a better prog-
nosis than those with more extensive, metastatic disease at presentation.
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Fungicidal photodynamic effect in vitro of hypericin on dermatophytes
M Paz-Cristobal,1,2 A Rezusta,1,2 M Alejandre,1,2 C Aspiroz,3,2 M Revillo1,2 and Y Gilaberte4,2 1
Microbiology, University Hospital Miguel Servet, Zaragoza, Spain, 2 Health Science Institute
of Aragon, Zaragoza, Spain, 3 Microbiology, Hospital Royo Villanova, Zaragoza, Spain and 4
Dermatology, Hospital San Jorge, Huesca, Spain
Hypericin is a potent natural photosensitizer that is being considered for the new generation of
photodynamic therapy (PDT) drugs. PDT is also being increasingly scrutinized as a novel thera-
peutic modality for the treatment of localized microbial infections. The aim of this study was to eval-
uate the in-vitro fungicidal effect of PDT using hypericin as photosensitizer on dermatophytes. Tri-
chophyton rubrum (ATCC 28188), 7-9 days-old, and Trichophyton mentagrophytes (ATCC 9533),
10-12 days-old cultures at 0.5 (± 0.05) McFarland were used. 90 μL of this inoculum was diluted
to 100 μL with several concentrations of hypericin (SIGMA). Fungi were irradiated with a light-emit-
ting diode lamp (LED) emitting at 602 nm (±10nm) (power of 1,22mW; delivered fluence of 37
J/cm2). Irradiated samples were cultured on Sabouraud-Chloramphenicol agar plates and were incu-
bated at least 6 days at 30 centigrate. Toxic effect was studied combining irradiation times with dif-
ferent concentrations of hypericin. Agar plates with or without hypericin and/or light were used as
controls. Hypericin successfully photoinactivate in vitro T. rubrum and T. mentagrophytes in a drug-
dose and light-dose dependent manner. The minimal fungicidal concentration of hypericin was
higher for T. mentagrophytes (50 μM) than for T.rubrum (20μM). PDT using hypericin has an excel-
lent fungicidal effect on T. rubrum and T. mentagrophytes, although, it seems to be differences sus-
ceptibility between species.
704
Molecular characterization of squamous cell carcinoma cells resistant to photodynamic ther-
apy
A Juarranz,1 L Milla,2 F Sanz-Rodríguez,2 M Matabuena,1 V Rivarola,2 S González,3 J Vera-Alvarez4
and Y Gilaberte4 1 Biology, Universidad Autonoma, Madrid, Spain, 2 Molecular Biology,
Universidad Nacional de Río Cuarto, Río Cuarto, Argentina, 3 Dermatology Service, Memorial
Sloan-Kettering Cancer Center, New York, NY and 4 Pathology and Dermatology, Hospital de
San Jorge de Huesca, Huesca, Spain
Photodynamic therapy (PDT) with methyl-aminolevulinate (Me-ALA) is used for non-melanoma skin
cancer (NMSC) treatment. However, one of its limitations is the persistence in some of the PDT-
treated tumors, probably due to the development of resistant cell populations. The aim of this study
was to analyze the resistance mechanisms of squamous cell carcinoma (SCC-13 cells) to Me-ALA-
PDT. SCC-13 original cell population (parental) was repeatedly exposed to PDT with Me-ALA and
resistant cell populations were obtained. The cellular morphology was evaluated using toluidine
blue stain. The expression of cellular adhesion proteins (E-cadherin, β-catenin, β1-integrin, vin-
culin and phospho-FAK) and the inhibitor of apoptosis protein survivin were analyzed by immuno-
fluorescence and western blot for both parental and resistant cells. Additionally, the histopatho-
logical study of some human cutaneous squamous cell carcinomas that were resistant to clinical
Me-PDT was performed. The results indicated that resistant cells showed a more fibroblastic mor-
phology, more expression of cell-substrate adhesion proteins (β1-integrin, vinculin and FAK) and
higher expression of phospho-survivin. Tumorigenicity assays were performed by injecting parental
or resistant PDT cells into the flanks of immunodeficiency mice, and showed a greater number and
sizes of the tumors induced by resistant cells than in those induced by untreated parental cells. Con-
cerning clinical study, the persistent tumors become histologically less differentiated, more fibrob-
lastic and/or acquiring an infiltrative pattern. In conclusion SCC-13 cells may modify protein expres-
sion of the cell-substrate and cell death as a PDT resistance strategy.
705
Proteomic identification of cathepsin B as a novel target of UVA photodamage upstream of
autophagic-lysosomal dysregulation in human skin fibroblasts
SD Lamore, S Qiao and GT Wondrak Pharmacology and Toxicology, College of Pharmacy and
Arizona Cancer Center, University of Arizona, Tucson, AZ
Cutaneous exposure to solar UVA radiation contributes to photoaging and photocarcinogenesis, but
the molecular identity of specific targets causatively involved in UVA photodamage remains largely
undefined. Using 2D-DIGE (differential-in-gel-electrophoresis)/mass spectrometry we have identi-
fied cathepsin B as a novel UVA target causing dysregulation of the autophagic-lysosomal pathway
in human Hs27 skin fibroblasts. In cells exposed to non-cytotoxic doses of solar simulated UVA
(9.9 J/cm2, twice a week, 3 weeks) the protein displaying the most pronounced downregulation in
response to UVA (7 fold) was identified as the lysosomal cysteine protease cathepsin B (gi|741376),
a finding confirmed by immunodetection and loss of specific enzymatic activity. UVA-induced lyso-
somal dysfunction was indicated by visualization of autofluorescent and osmiophilic aggregates
colocalizing with lysosomes. Autophagy RT2 ProfilerTM PCR array analysis revealed UVA-induced
upregulation of heat shock gene expression (HSPA6, HSPA1A) and autophagic-lysosomal dysregu-
lation. Pronounced upregulation of p62 (sequestosome 1, SQSTM1), a selective autophagy substrate
and cargo receptor for autophagic degradation of ubiquitinated target proteins, occurred at the
mRNA and protein level. UVA exposure upregulated expression of the lipidated autophagosomal
membrane constituent LC3-II and LAMP1 (lysosomal-associated membrane protein 1). However,
UVA did not alter expression of beclin 1 (BECN1), essential for initiation of autophagosome for-
mation. Strikingly, UVA effects on p62, LC3-II, and LAMP1 could be mimicked using the pharma-
cological cathepsin B antagonist CA074Me, suggesting that UVA-induced autophagic-lysosomal
alteration occurs through blockade of autophagic flux due to lysosomal cathepsin B deficiency.
Taken together our data suggest that functional impairment of cathepsin B is a causative event in
cutaneous UVA photodamage upstream of autophagic-lysosomal dysregulation.
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Ultraviolet radiation from ambient light sources: Incandescent and compact fluorescent bulbs
MM Van Acker,1 T Chen2 and QL Erickson3 1 Michigan State University College of Osteopathic
Medicine, East Lansing, MI, 2 University of Texas M.D. Anderson Cancer Center, Houston, TX
and 3 Department of Dermatology, Saint Louis University School of Medicine, Saint Louis, MO
Numerous studies have established ultraviolet (UV) radiation as a main cause of skin cancer. With
incidences rising, research on detrimental effects of UV exposure has mainly focused on tanning
beds and solar radiation. Daily ambient UV exposure, in contrast, has not been studied as exten-
sively. In 2007, the Energy Independence and Security Act (EISA) was passed banning incandescent
light bulbs (ICL) use by 2014. As ICL bulbs are a primary source of ambient light, further research
on ICL bulbs and its proposed replacement [compact fluorescent light (CFL) bulbs] is warranted.
The purpose of this pilot study was to evaluate the amount of UV radiation emitted from ICL and
CFL bulbs. A spectrometer (USB2000, Ocean Optics, Dunedin, FL) was used for detection of UVA
(315-400 nm) and UVB (280-315 nm) wavelengths from a 14 watt (W) CFL bulb and a 60 W ICL
bulb. Data was collected over 10 ms at 4, 8, 12, and 16 inches (in) from the source. Spectrometer
measurements are calculated as “counts” relative to a 4W UV bulb in terms of counts per watt (c/W).
The 60 W ICL bulb demonstrated: 1.18 ± 0.04 c/W (avg ± std dev) at 4 in; 0.57 ± 0.03 c/W at 8 in;
0.43 ± 0.02 c/W at 12 in; and 0.26 ± 0.01 c/W at 16 in distances. The 14 W CFL bulb demon-
strated: 272.76 ± 13.63 c/W at 4 in; 253.26 ± 16.26 c/W at 8 in; 129.46 ± 8.66 c/W at 12 in; and
55.82 ± 3.41 c/W at 16 in distances. Primary study limitation was measurements conducted in a
laboratory setting do not reflect that of daily exposure. The value of further research, proper edu-
cation, and protective measures against unnecessary UV radiation exposure to ambient light will
not only benefit photosensitive individuals but the population as a whole. Further research is war-
ranted before the EISA constitutes the ban on the use of ICL bulbs.
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Cumulative ultraviolet radiation flux and risk for incident psoriasis in the United States
RA Vleugels,1 J Han1,2 and AA Qureshi1,2 1 Clinical Research Program, Department of
Dermatology, Brigham and Women’s Hospital, Boston, MA and 2 Channing Laboratory,
Brigham and Women’s Hospital, Boston, MA
Psoriasis is a chronic inflammatory skin disease that affects between 1% and 3% of the population.
Although it is widely accepted that phototherapy can be used therapeutically in the treatment of
psoriasis given the immunosuppressive nature of UV radiation, the association between cumula-
tive sun exposure and incident psoriasis is not known. We evaluated the association between cumu-
lative ultraviolet (UV) radiation flux and incident psoriasis in the Nurses’ Health Study (NHS). UV
radiation flux has previously been established as a measure that can be used to assess cumulative
sun exposure that is less influenced by recall bias than traditional modalities. Exposure was defined
as UV flux at birth, age 15, and age 30, measured in a geo-coded population of women living across
the United States and updated every two years with address changes. Outcome was defined as
incident self-reported psoriasis (92% validity of self-reports for psoriasis has previously been demon-
strated in NHS II). Multivariate analyses were simultaneously adjusted for age, race, body mass
index, physical activity, alcohol intake, and current smoking status. A total of 826 cases of incident
psoriasis occurred over the 8 year follow-up (2000-2008) in 68,995 women residing at various loca-
tions in the US. Multivariate risk for psoriasis was not significantly different when comparing women
living in the lowest quintile of cumulative UV flux to women living in the highest quintile at birth
(relative risk (RR), 0.99, 95% CI: (0.79-1.24). Similarly, there was no material difference in UV flux
at age 15 and at age 30 and new onset psoriasis (RR, 1.01, 95% CI: (0.81–1.27) and RR, 0.84, 95%
CI: (0.67–1.06), respectively). Cumulative UV flux over the study follow-up and time varying UV
flux were not associated with psoriasis risk (p, trend, 0.71 and 0.39, respectively). In this study, we
found no significant association between UV flux and risk for psoriasis.
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Persistent pigment development is induced by a single day of recreational sun exposure in
Hispanic children and is not predicted by native pigmentation levels
M Mack, GN Stamatas, N Kollias and KM Martin Johnson & Johnson Consumer Companies,
Skillman, NJ
Development of facultative pigmentation in response to solar and/or simulated solar irradiation has
been widely researched but remains incompletely understood. Recently, we demonstrated that fac-
ultative pigmentation due to incidental sun exposure is detectable as early as the first summer of
life in Caucasian infants. To further our understanding of the effects of sun exposure in young chil-
dren, we evaluated the changes in skin properties of Caucasian and Hispanic children aged 2 to 5
years during acute, recreational sun exposure (vacation day at the beach in New Jersey). Biologi-
cal mothers of the children were included for comparative purposes. Subjects were instructed to
follow their normal routine during a vacation day at the beach. Sunscreen (SPF 50) was provided.
Diffuse reflectance spectra of the skin were acquired on the dorsal forearm and upper inner arm on
the morning before the beach day, the evening of the beach day, the morning of the next day (approx-
imately 24 hours after sun exposure) and one week after the beach day. Apparent melanin con-
centration was calculated in the long wavelengths (630-700 nm) of the skin spectra. Apparent melanin
concentration increased at the evening after beach day timepoint for all subjects (early pigment
development). Hispanic children (but not Hispanic adults or Caucasian subjects) displayed persist-
ent increases in melanin concentration one week after the beach day (persistent pigment darken-
ing, PPD). The correlation between early pigment development and native melanin concentration
(measured at baseline on the upper inner arm) was significant (p = 0.02) but not predictive (r2 =
0.04). There was no correlation between PPD and native melanin concentration (p = 0.66, r2 =
0.001). These results demonstrate that native melanin concentration measured at long wavelengths
does not predict induced melanin production, and an individual’s response to sun exposure can-
not be predicted by their visually perceptible complexion.
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Suppression of human malignant melanoma cell proliferation and invasion by gamma-
tocotrienol, a constituent of palm vitamin E
W Yap,1 A Chen,1 S Lee,1 S Ong,1 V Teo,1 M Ling,2 Y Wong3 and Y Yap1 1 Cancer Research
Laboratory, Davos Life Science Pte. Ltd., Singapore, Singapore, 2 Australian Prostate Cancer
Research Centre-Queensland Institute of Health and Biomedical Innovation (IHBI),
Queensland University of Technology, Brisbane, QLD, Australia and 3 Department of
Anatomy, The University of Hong Kong, Hong Kong, Hong Kong
This study aimed to elucidate gamma-tocotrienol’s anti-cancer property in malignant melanoma
cells. MTT cell proliferation assay and flow cytometry were performed to investigate gamma-
tocotrienol-induced cell cytotoxicity and cell cycle arrest. Cell invasion was studied using matrigel-
invasion assay. Mechanisms of action responsible for its anti-cancer activity were analyzed by
western blotting. Darcabazine and Docetaxel were used in the chemosensitisation studies. Our data
showed that the inhibitory effect of gamma-tocotrienol was most potent, which resulted in induc-
tion of apoptosis as evidenced by activation of pro-caspases and the accumulation of sub-G1 cell
population. Examination of the pro-survival genes revealed that the gamma-tocotrienol induced cell
death was associated with suppression of NF-kappaB, EGF-R, and Id family proteins. Meanwhile,
gamma-tocotrienol treatment also resulted in induction of JNK signaling pathway and inhibition of
JNK activity by selective inhibitor was able to partially block the effect of gamma-tocotrienol. Inter-
estingly, gamma-tocotrienol treatment led to suppression of mesenchymal markers and the restora-
tion of E-cadherin and gamma-catenin expression, which was associated with suppression of cell
invasion capability. Furthermore, synergistic effect was observed when cells were co-treated with
gamma-tocotrienol and chemotherapy drugs. In conclusion, our results demonstrated the anti-
invasion and chemosensitisation effect of gamma-tocotrienol against human malignant melanoma
cells.
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Omeprazole (proton pump inhibitor) inhibits melanin synthesis by decrease pH in acidic cell
compartment
Y Niki,1 M Yoshida,2 H Ando,1,2 MS Matsui,3 DB Yarosh3 and M Ichihashi1,2 1 Kobe Skin Research
Insititute, Kobe, Japan, 2 Skin Aging and Photo-aging Research Center, Doshisha University,
Kizugawa, Japan and 3 Estee Lauder Companies Inc., Melville, NY
Proton pump inhibitors (PPIs), which act by irreversibly blocking the H+/K+ ATPase of the gastric
parietal cells, are used in the treatment of peptic ulcer and gastro-esophageal reflux. During a screen-
ing test using B16F10 mouse melanoma cells, we found that PPIs reduce melanogenesis. Among
14 different PPIs, omeprazole (OPZ) was the most potent at reducing cellular melanin content with
low cytotoxicity. OPZ also inhibited melanin synthesis in a reconstructed human skin model. Although
OPZ slightly decreased tyrosinase DOPA oxidase activity of mushroom and B16F10 cell extract in
vitro, in situ tyrosine hydroxylase activity of tyrosinase was decreased significantly in OPZ-treated
B16F10 cells. We also examined the effects of OPZ on mRNA and protein levels of melanin syn-
thesis-related proteins, including tyrosinase, tyrosinase related protein-2, microphthalmia-associ-
ated transcription factor (Mitf) and Pmel17 using B16F10 cells. OPZ did not inhibit transcription at
non-cytotoxic concentrations. However, western-blotting revealed that treatment of B16F10 with
50 μM OPZ for 72 h decreased tyrosinase protein level to approximately 50% that of control cells.
Other research groups have showed that the pH of cell organelles, such as ER, Golgi and melanosomes
may have an important regulatory role in melanogenesis. But the detailed mechanisms of pH effect
on melanogenesis have not been clear yet. We therefore investigated the effect of OPZ on melanocyte
pH using an acidic probe, 3-(2,4-dinitroanilino)-3′-amino-N-methylpropylamine (DAMP). DAMP-
treated B16F10 cells demonstrated lower pH in the acidic compartment within 4 h of exposure to
OPZ. These results suggest that OPZ may inhibit melanin synthesis via a decrease in melanosomal
pH, leading to the inhibition of tyrosinase activity, increased tyrosinase degradation, and/or to the
suppression of tyrosinase trafficking.
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Green tea catechins inhibit melanoma cell migration and invasion by inhibiting the expres-
sion of cyclooxygenase-2 and NF-κB activation
SK Katiyar1,2 and T Singh1 1 University of Alabama at Birmingham, Birmingham, AL and 2
Birmingham VA Medical Center, Birmingham, AL
Melanoma is the leading cause of death from skin disease due, in large part, to its propensity to
metastasize. An approach that decreases its metastatic ability may facilitate the development of an
effective strategy for its treatment and/or prevention. Here, we assessed the comparative effect of
major green tea catechins, such as, (-)-epicatechin (EC), (-)-epigallocatechin (EGC), (-)-epicatechin
gallate (ECG) and (-)-epigallocatechin-3-gallate (EGCG), on human melanoma cancer cell migra-
tion/invasion and the molecular mechanisms underlying these effects using melanoma cell lines,
A375 and Hs294t. Using an in vitro cell migration (wound healing assay) and cell invasion (Boy-
den chamber) assays, we show that overexpression of cyclooxygenase-2 (COX-2) and its metabo-
lite PGE2, promote the migration of cells. We found that treatment of A375 and Hs294t cells with
equimolar (25 μM) concentration of catechins for 24 h resulted in inhibition of migration and inva-
sion of these cells. The inhibitory effect of catechins on melanoma cell migration and cell invasion
was in the order of: EGCG>ECG>EGC>EC. The inhibitory effect of EGCG, a most active compo-
nent of green tea, was associated with a reduction in the levels of COX-2 and its metabolite PGE2.
Treatment of cells with celecoxib, a COX-2 inhibitor, or transient transfection of cells with COX-2
small interfering RNA, also inhibited cell invasion. Treatment of the cells with 12-O-tetrade-
canoylphorbol-13-acetate (TPA), an inducer of COX-2 or PGE2, enhanced cell invasion whereas
EGCG inhibited TPA- or PGE2-promoted cell migration. Moreover, EGCG inhibited the activation
of NF-κB, an upstream regulator of COX-2, in melanoma cells, and treatment of cells with caffeic
acid phenethyl ester or oridonin, inhibitors of NF-κB, inhibited cell migration/invasion. Together,
these results indicate that green tea catechin, EGCG, inhibits melanoma cell migration and inva-
sion, an essential step in metastasis, by inhibiting COX-2 expression and NF-κB activation.
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Differential effects of UV irradiation and visible light on skin pigmentation in vitro
CB Lin,1 N Chen,2 D Rossetti,1 Y Hu,1 J Zhang,1 P Bargo,1 T Chen1 and M Seiberg1 1 Skin Biology,
The Johnson & Johnson Skin Research Center, unit of Johnson and Johnson Consumer
Companies, Inc., Skillman, NJ and 2 Former J&J employee, Skillman, NJ
The effects of different UV wavelengths on skin pigmentation are heavily documented, however lit-
tle is known about the effects of visible light on pigment production and deposition. Therefore, we
used in vitro model systems to examine the possible effects of visible light on skin pigmentation
and compared the relative efficiency and kinetics of UVA, UVB and visible light in this process.
Using pigmented epidermal equivalents, we demonstrated that exposure to UVA, UVB or visible
light induces visible darkening and increases melanin deposition within the tissues. The induction
of melanin deposition by visible light and UVA was more evident at earlier time points, while the
increased melanin deposition induced by UVB was more significant at later time points. In addi-
tion, equivalents exposed to UVA exhibited a thinner viable epidermal layer and a thicker and highly
pigmented stratum corneum, suggesting a UVA effect on keratinocyte differentiation and melanin
distribution. Similar effects were observed using human skin explants. At earlier times, UVA, UVB
and visible light induced comparable levels of melanin deposition, while UVB stimulated the high-
est level of melanin production and deposition at later times. The induced pigment production was
more evident in darkly-pigmented vs. lightly pigmented skins, which was in correlation with their
induced expression of Tyrosinase and melanocortin-1 receptor genes. Topical pretreatment of human
skin explants with 2.5% non-denatured soybean extracts reduced both basal, UV and visible light-
induced melanin levels. These results shed lights on the mechanism of tanning induced by UV and
visible light wavelengths. Additionally, this study demonstrates that topical application of non-dena-
tured soybean extracts could potentially reduce UV and visible light-induced skin darkening.
710
Melanin inhibition by tocotrienols through suppressing of constitutive and uv-induced tyrosi-
nase activation
A Chen,1 W Yap,1 S Lee,1 S Ong,1 V Teo,1 S Shunichi2 and Y Yap1 1 Skin Research Laboratory,
Davos Life Science Pte. Ltd., Singapore, Singapore and 2 Phytopharma Co Ltd, Yokohama,
Japan
The objective was to extend our current understanding of tocotrienol (T3) and tyrosinase, we inves-
tigate T3 isomers ability in inhibiting tyrosinase activity in murine and human melanoma cell lines.
In addition, our study explores the synergistic interaction of T3 with tyrosinase inhibitors and UVB-
induced tyrosinase activation. Melanogenesis activity was performed to investigate gamma- and
delta-T3-suppressed tyrosinase and melanin expression in murine B16 melanoma cells. Mechanism
of action responsible for the tyrosinase inhibition was analyzed by western blot. In vivo xenograft
models of B16, A375 and WM793B were used in evaluating the ability of T3 in tumor shrinkage
and melanogenesis inhibition. Kojic acid and sodium lactate were used as tyrosinase inhibitors in
the chemosensitization studies. Our data showed that with the exception of alpha-T3, the other T3
isomers (beta, gamma, and delta), palm T3-rich fraction (TRF), palm TRF acetate and tyrosinase
inhibitors (kojic acid, and sodium lactate) suppressed tyrosinase protein expression in murine B16,
human A375 and WM793B melanoma cells in dose-dependent fashion. Examination of the melanin
and tyrosinase activity content on days 5 and 9 revealed that co-treatment between TRF and kojic
acid or sodium lactate possessing synergistic effect. Pigmentation of the in vivo solid tumors became
fairer compared to controls after 14 days of oral gamma T3 supplementary (100mg/kg/day), and the
tumor size was significantly smaller for the gamma T3 group. Delta T3 has been found to be more
potent than gamma T3 in suppressing short term (<10min) UVB-induced tyrosinase activation, while
their long- term inhibitory effects were comparable. Gamma-, delta-T3 and palm TRF possess higher
sun protection factor (SPF) compared to alpha T and palm TRF acetate. In conclusion, our results
suggested that the anti-melanogenesis effect of gamma- and delta-T3 may be mediated through mul-
tiple signaling pathways leading to the downregulation of tyrosinase protein.
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87 cases of vulvar melanoma: The Duke experience
JY Tcheung,1 MA Selim,1,2 J Marcello,3 AP Abernethy4 and KC Nelson1 1 Dermatology, Duke
University Medical Center, Durham, NC, 2 Pathology, Duke University Medical Center,
Durham, NC, 3 Cancer Center Biostatistics, Duke University Medical Center, Durham, NC
and 4 Internal Medicine, Duke University Medical Center, Durham, NC
Malignant melanoma is the most serious form of skin cancer, and vulvar melanoma has an espe-
cially poor overall prognosis—5-year survival rates have been cited between 8-55% (mean 36%).
Because of delay in diagnosis and the aggressiveness of this disease, despite treatment, high mor-
bidity and mortality persist. To examine prognostic factors influencing survival, the Duke Melanoma
and Tumor Registry Databases were queried for patients with a diagnosis of vulvar melanoma between
1970 and 2009. 87 subjects (80 Caucasians, 5 African-Americans, 1 Hispanic, 1 race-not-reported)
with a mean age of 60.2 years (range, 19-93years) were identified. Median follow-up time was 8.3
years (95% confidence-interval: 5.9 to 13.6 years) with 51 subjects experiencing melanoma-related
mortality. Cohort survival rates were as follows: 85.3% (1-year), 50.7% (5-year), and 29.7% (10-
year). Available pathologic specimens from 32 subjects were also reviewed by a dermatopatholo-
gist and revealed the following features: 15 melanomas with ulceration, 2 originating from a nevus,
15 stemming from mucosal skin, 3 with regression, 20 with pigmentation, 11 with atypical
melanocytic hyperplasia, and mitotic rate ranging from less than one to 40 per mm squared(7.4 per
mm squared, mean). Breslow thickness, lymph node status, systemic therapy, and surgery were
examined for differences in survival distributions using the logrank test. Correlating with melanoma
of cutaneous sites, survival was inversely correlated with Breslow depth and extent of nodal involve-
ment. Reflective of disease extent guiding therapeutic plan and provision of systemic therapy, a
higher survival rate was observed among those who received wide local excision, p-value=0.02. In
summary, subjects with thinner vulvar melanomas amenable to surgical resection had a better prog-
nosis than those with more extensive, metastatic disease at presentation.
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Fungicidal photodynamic effect in vitro of hypericin on dermatophytes
M Paz-Cristobal,1,2 A Rezusta,1,2 M Alejandre,1,2 C Aspiroz,3,2 M Revillo1,2 and Y Gilaberte4,2 1
Microbiology, University Hospital Miguel Servet, Zaragoza, Spain, 2 Health Science Institute
of Aragon, Zaragoza, Spain, 3 Microbiology, Hospital Royo Villanova, Zaragoza, Spain and 4
Dermatology, Hospital San Jorge, Huesca, Spain
Hypericin is a potent natural photosensitizer that is being considered for the new generation of
photodynamic therapy (PDT) drugs. PDT is also being increasingly scrutinized as a novel thera-
peutic modality for the treatment of localized microbial infections. The aim of this study was to eval-
uate the in-vitro fungicidal effect of PDT using hypericin as photosensitizer on dermatophytes. Tri-
chophyton rubrum (ATCC 28188), 7-9 days-old, and Trichophyton mentagrophytes (ATCC 9533),
10-12 days-old cultures at 0.5 (± 0.05) McFarland were used. 90 μL of this inoculum was diluted
to 100 μL with several concentrations of hypericin (SIGMA). Fungi were irradiated with a light-emit-
ting diode lamp (LED) emitting at 602 nm (±10nm) (power of 1,22mW; delivered fluence of 37
J/cm2). Irradiated samples were cultured on Sabouraud-Chloramphenicol agar plates and were incu-
bated at least 6 days at 30 centigrate. Toxic effect was studied combining irradiation times with dif-
ferent concentrations of hypericin. Agar plates with or without hypericin and/or light were used as
controls. Hypericin successfully photoinactivate in vitro T. rubrum and T. mentagrophytes in a drug-
dose and light-dose dependent manner. The minimal fungicidal concentration of hypericin was
higher for T. mentagrophytes (50 μM) than for T.rubrum (20μM). PDT using hypericin has an excel-
lent fungicidal effect on T. rubrum and T. mentagrophytes, although, it seems to be differences sus-
ceptibility between species.
704
Molecular characterization of squamous cell carcinoma cells resistant to photodynamic ther-
apy
A Juarranz,1 L Milla,2 F Sanz-Rodríguez,2 M Matabuena,1 V Rivarola,2 S González,3 J Vera-Alvarez4
and Y Gilaberte4 1 Biology, Universidad Autonoma, Madrid, Spain, 2 Molecular Biology,
Universidad Nacional de Río Cuarto, Río Cuarto, Argentina, 3 Dermatology Service, Memorial
Sloan-Kettering Cancer Center, New York, NY and 4 Pathology and Dermatology, Hospital de
San Jorge de Huesca, Huesca, Spain
Photodynamic therapy (PDT) with methyl-aminolevulinate (Me-ALA) is used for non-melanoma skin
cancer (NMSC) treatment. However, one of its limitations is the persistence in some of the PDT-
treated tumors, probably due to the development of resistant cell populations. The aim of this study
was to analyze the resistance mechanisms of squamous cell carcinoma (SCC-13 cells) to Me-ALA-
PDT. SCC-13 original cell population (parental) was repeatedly exposed to PDT with Me-ALA and
resistant cell populations were obtained. The cellular morphology was evaluated using toluidine
blue stain. The expression of cellular adhesion proteins (E-cadherin, β-catenin, β1-integrin, vin-
culin and phospho-FAK) and the inhibitor of apoptosis protein survivin were analyzed by immuno-
fluorescence and western blot for both parental and resistant cells. Additionally, the histopatho-
logical study of some human cutaneous squamous cell carcinomas that were resistant to clinical
Me-PDT was performed. The results indicated that resistant cells showed a more fibroblastic mor-
phology, more expression of cell-substrate adhesion proteins (β1-integrin, vinculin and FAK) and
higher expression of phospho-survivin. Tumorigenicity assays were performed by injecting parental
or resistant PDT cells into the flanks of immunodeficiency mice, and showed a greater number and
sizes of the tumors induced by resistant cells than in those induced by untreated parental cells. Con-
cerning clinical study, the persistent tumors become histologically less differentiated, more fibrob-
lastic and/or acquiring an infiltrative pattern. In conclusion SCC-13 cells may modify protein expres-
sion of the cell-substrate and cell death as a PDT resistance strategy.
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Proteomic identification of cathepsin B as a novel target of UVA photodamage upstream of
autophagic-lysosomal dysregulation in human skin fibroblasts
SD Lamore, S Qiao and GT Wondrak Pharmacology and Toxicology, College of Pharmacy and
Arizona Cancer Center, University of Arizona, Tucson, AZ
Cutaneous exposure to solar UVA radiation contributes to photoaging and photocarcinogenesis, but
the molecular identity of specific targets causatively involved in UVA photodamage remains largely
undefined. Using 2D-DIGE (differential-in-gel-electrophoresis)/mass spectrometry we have identi-
fied cathepsin B as a novel UVA target causing dysregulation of the autophagic-lysosomal pathway
in human Hs27 skin fibroblasts. In cells exposed to non-cytotoxic doses of solar simulated UVA
(9.9 J/cm2, twice a week, 3 weeks) the protein displaying the most pronounced downregulation in
response to UVA (7 fold) was identified as the lysosomal cysteine protease cathepsin B (gi|741376),
a finding confirmed by immunodetection and loss of specific enzymatic activity. UVA-induced lyso-
somal dysfunction was indicated by visualization of autofluorescent and osmiophilic aggregates
colocalizing with lysosomes. Autophagy RT2 ProfilerTM PCR array analysis revealed UVA-induced
upregulation of heat shock gene expression (HSPA6, HSPA1A) and autophagic-lysosomal dysregu-
lation. Pronounced upregulation of p62 (sequestosome 1, SQSTM1), a selective autophagy substrate
and cargo receptor for autophagic degradation of ubiquitinated target proteins, occurred at the
mRNA and protein level. UVA exposure upregulated expression of the lipidated autophagosomal
membrane constituent LC3-II and LAMP1 (lysosomal-associated membrane protein 1). However,
UVA did not alter expression of beclin 1 (BECN1), essential for initiation of autophagosome for-
mation. Strikingly, UVA effects on p62, LC3-II, and LAMP1 could be mimicked using the pharma-
cological cathepsin B antagonist CA074Me, suggesting that UVA-induced autophagic-lysosomal
alteration occurs through blockade of autophagic flux due to lysosomal cathepsin B deficiency.
Taken together our data suggest that functional impairment of cathepsin B is a causative event in
cutaneous UVA photodamage upstream of autophagic-lysosomal dysregulation.
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Ultraviolet radiation from ambient light sources: Incandescent and compact fluorescent bulbs
MM Van Acker,1 T Chen2 and QL Erickson3 1 Michigan State University College of Osteopathic
Medicine, East Lansing, MI, 2 University of Texas M.D. Anderson Cancer Center, Houston, TX
and 3 Department of Dermatology, Saint Louis University School of Medicine, Saint Louis, MO
Numerous studies have established ultraviolet (UV) radiation as a main cause of skin cancer. With
incidences rising, research on detrimental effects of UV exposure has mainly focused on tanning
beds and solar radiation. Daily ambient UV exposure, in contrast, has not been studied as exten-
sively. In 2007, the Energy Independence and Security Act (EISA) was passed banning incandescent
light bulbs (ICL) use by 2014. As ICL bulbs are a primary source of ambient light, further research
on ICL bulbs and its proposed replacement [compact fluorescent light (CFL) bulbs] is warranted.
The purpose of this pilot study was to evaluate the amount of UV radiation emitted from ICL and
CFL bulbs. A spectrometer (USB2000, Ocean Optics, Dunedin, FL) was used for detection of UVA
(315-400 nm) and UVB (280-315 nm) wavelengths from a 14 watt (W) CFL bulb and a 60 W ICL
bulb. Data was collected over 10 ms at 4, 8, 12, and 16 inches (in) from the source. Spectrometer
measurements are calculated as “counts” relative to a 4W UV bulb in terms of counts per watt (c/W).
The 60 W ICL bulb demonstrated: 1.18 ± 0.04 c/W (avg ± std dev) at 4 in; 0.57 ± 0.03 c/W at 8 in;
0.43 ± 0.02 c/W at 12 in; and 0.26 ± 0.01 c/W at 16 in distances. The 14 W CFL bulb demon-
strated: 272.76 ± 13.63 c/W at 4 in; 253.26 ± 16.26 c/W at 8 in; 129.46 ± 8.66 c/W at 12 in; and
55.82 ± 3.41 c/W at 16 in distances. Primary study limitation was measurements conducted in a
laboratory setting do not reflect that of daily exposure. The value of further research, proper edu-
cation, and protective measures against unnecessary UV radiation exposure to ambient light will
not only benefit photosensitive individuals but the population as a whole. Further research is war-
ranted before the EISA constitutes the ban on the use of ICL bulbs.
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Cumulative ultraviolet radiation flux and risk for incident psoriasis in the United States
RA Vleugels,1 J Han1,2 and AA Qureshi1,2 1 Clinical Research Program, Department of
Dermatology, Brigham and Women’s Hospital, Boston, MA and 2 Channing Laboratory,
Brigham and Women’s Hospital, Boston, MA
Psoriasis is a chronic inflammatory skin disease that affects between 1% and 3% of the population.
Although it is widely accepted that phototherapy can be used therapeutically in the treatment of
psoriasis given the immunosuppressive nature of UV radiation, the association between cumula-
tive sun exposure and incident psoriasis is not known. We evaluated the association between cumu-
lative ultraviolet (UV) radiation flux and incident psoriasis in the Nurses’ Health Study (NHS). UV
radiation flux has previously been established as a measure that can be used to assess cumulative
sun exposure that is less influenced by recall bias than traditional modalities. Exposure was defined
as UV flux at birth, age 15, and age 30, measured in a geo-coded population of women living across
the United States and updated every two years with address changes. Outcome was defined as
incident self-reported psoriasis (92% validity of self-reports for psoriasis has previously been demon-
strated in NHS II). Multivariate analyses were simultaneously adjusted for age, race, body mass
index, physical activity, alcohol intake, and current smoking status. A total of 826 cases of incident
psoriasis occurred over the 8 year follow-up (2000-2008) in 68,995 women residing at various loca-
tions in the US. Multivariate risk for psoriasis was not significantly different when comparing women
living in the lowest quintile of cumulative UV flux to women living in the highest quintile at birth
(relative risk (RR), 0.99, 95% CI: (0.79-1.24). Similarly, there was no material difference in UV flux
at age 15 and at age 30 and new onset psoriasis (RR, 1.01, 95% CI: (0.81–1.27) and RR, 0.84, 95%
CI: (0.67–1.06), respectively). Cumulative UV flux over the study follow-up and time varying UV
flux were not associated with psoriasis risk (p, trend, 0.71 and 0.39, respectively). In this study, we
found no significant association between UV flux and risk for psoriasis.
708
Persistent pigment development is induced by a single day of recreational sun exposure in
Hispanic children and is not predicted by native pigmentation levels
M Mack, GN Stamatas, N Kollias and KM Martin Johnson & Johnson Consumer Companies,
Skillman, NJ
Development of facultative pigmentation in response to solar and/or simulated solar irradiation has
been widely researched but remains incompletely understood. Recently, we demonstrated that fac-
ultative pigmentation due to incidental sun exposure is detectable as early as the first summer of
life in Caucasian infants. To further our understanding of the effects of sun exposure in young chil-
dren, we evaluated the changes in skin properties of Caucasian and Hispanic children aged 2 to 5
years during acute, recreational sun exposure (vacation day at the beach in New Jersey). Biologi-
cal mothers of the children were included for comparative purposes. Subjects were instructed to
follow their normal routine during a vacation day at the beach. Sunscreen (SPF 50) was provided.
Diffuse reflectance spectra of the skin were acquired on the dorsal forearm and upper inner arm on
the morning before the beach day, the evening of the beach day, the morning of the next day (approx-
imately 24 hours after sun exposure) and one week after the beach day. Apparent melanin con-
centration was calculated in the long wavelengths (630-700 nm) of the skin spectra. Apparent melanin
concentration increased at the evening after beach day timepoint for all subjects (early pigment
development). Hispanic children (but not Hispanic adults or Caucasian subjects) displayed persist-
ent increases in melanin concentration one week after the beach day (persistent pigment darken-
ing, PPD). The correlation between early pigment development and native melanin concentration
(measured at baseline on the upper inner arm) was significant (p = 0.02) but not predictive (r2 =
0.04). There was no correlation between PPD and native melanin concentration (p = 0.66, r2 =
0.001). These results demonstrate that native melanin concentration measured at long wavelengths
does not predict induced melanin production, and an individual’s response to sun exposure can-
not be predicted by their visually perceptible complexion.
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Linking UVB irradiation to pigmentation induction through FGF2-STAT3-PAX3 signaling in
melanocytes
Y Li, L Dong, E Pier and R Cui Boston University School of Medicine, Boston, MA
Excessive UV exposure induces skin damage, and in the long run, could lead to skin diseases includ-
ing the deadly malignant melanomas. Minimizing sun exposure represents an effective strategy to
prevent UV-related skin diseases. On the other hand, moderate sun exposure is beneficial to over-
all health. Therefore, it is important to be able to provide the public with effective therapeutic
strategies for enhancing pigmentation, especially to individuals with genetic defects in UV-induced
pigmentation pathways such as MSH/MC1R signaling. Towards this end, we will need to compre-
hensively understand the signaling network modulating this biological process. Here we have focused
our attention on PAX3, a key transcriptional regulator of the neural crest lineage, and aim to better
understand its function in pigment cells especially its role in regulating melanin synthesis. PAX3 is
known to play an important role in melanocyte development through modulation of MITF tran-
scription. Here we found that PAX3 transcriptional activity could be regulated through FGF2-
STAT3 signaling in the pigment cells. We further identified TBX2 as a direct transcriptional target of
PAX3 in melanocytes. To study its function in vivo, we have generated a transgenic mouse model
expressing PAX3 driven by tyrosinase promoter in a tissue-specific fashion. These animals exhibit
hyperpigmentation in epidermis, evident in the skin color of their ears and tails. We showed that
the darker skin color results from both increased melanocyte numbers and melanin synthesis. Together,
our study delineated a novel pathway in the melanocyte lineage, linking FGF2-STAT3 signaling to
increased TBX2 transcription through PAX3. Moreover, our results suggest that this pathway might
contribute to the regulation of melanocyte numbers and melanin levels, and thereby provide an
alternative strategy to induce pigmentation which could effectively reducing or even completely
preventing UV-induced skin damages.
723
WIPI1 coordinates melanogenic gene transcription and melanosome formation via TORC1
inhibition
H Ho, R Kapadia, S Al-Tahan, S Ahmad and A Ganesan Dermatology, University of California,
Irvine, Irvine, CA
Recent studies have implicated a role for WD repeat domain, phosphoinositide interacting 1 (WIPI1)
in the biogenesis of melanosomes, a cell type-specific lysosome-related organelle. In this study, we
determine that WIPI1, an ATG18 homologue that localizes to both autophagosomes and early endo-
somes, inhibits molecular Target Of Rapamycin (mTOR) signaling, leading to increased transcrip-
tion of melanogenic enzymes and the formation of mature melanosomes. WIPI1 suppresses the Tar-
get of Rapamycin Complex 1 (TORC1) activity, resulting in Glycogen Synthase Kinase 3β (GSK3β)
inhibition, β-Catenin stabilization, and increased transcription of Micropthalmia Transcription Fac-
tor (MITF) and MITF target genes. WIPI1 depleted cells accumulate stage I melanosomes, but lack
stage III-IV melanosomes. Inhibition of TORC1 by rapamycin treatment results in the accumulation
of stage IV melanosomes but not autophagosomes, while starvation results in the accumulation of
autophagosomes but not increased melanin. Taken together, our studies define a distinct role for
TORC1 signaling in controlling the transcription of melanogenic enzymes and melanosome matu-
ration, a process which is distinct from conventional autophagy.
725
The MEF2C transcription factor regulates melanocyte development, interacts directly with
SOX10 and is a candidate gene for Waardenburg Syndrome.
ML Wei,1,2 P Agarwal,1 M Verzi,1 T Nguyen,1,2 D McCulley,1 S Xu,1 E Dodou,1 J Anderson1 and
B Black1 1 Universitiy of California, San Francisco, CA and 2 Veterans Affairs Medical Center,
San Francisco, CA
Waardenburg syndromes are characterized by pigmentation and innervation defects, and mutations
in genes encoding transcription factors that control neural crest specification and differentiation
are often associated with Waardenburg and related disorders. For example, mutations in SOX10
result in a severe form of Waardenburg syndrome, Type IV, also known as Hirschsprung disease,
characterized by neural crest and pigmentation defects. Sox10 controls neural crest development
through interactions with other transcription factors. The MADS box transcription factor MEF2C is
an important regulator of brain, skeleton, lymphocyte, and cardiovascular development and is
required in the neural crest for craniofacial development. Here, we establish a novel role for MEF2C
in melanocyte development. Inactivation of Mef2c in the neural crest of mice results in reduced
expression of melanocyte genes during development and a significant loss of pigmentation at birth
due to defective differentiation and reduced abundance of melanocytes. We identify a novel tran-
scriptional enhancer from the Mef2c locus that directs expression to the neural crest and its deriv-
atives, including melanocytes, in transgenic mouse embryos. This novel Mef2c neural crest enhancer
contains three functional Sox10 binding sites and a single essential MEF2 site, and we demonstrate
that Mef2c is a direct transcriptional target of Sox10 and MEF2 via this evolutionarily conserved
enhancer. Furthermore, we show that Sox10 and MEF2C physically interact and function coopera-
tively to activate the Mef2c gene itself in a feed-forward transcriptional circuit, suggesting that MEF2C
may serve as a potentiator of the transcriptional pathways affected in Waardenburg syndromes.
724
Myeloid derived suppressor cells (MDSC) express DC-HIL, which is responsible for their potent
T cell-inhibitory and melanoma growth-promoting effects
J Chung,1 K Tamura,1 RR Sharma,2 PD Cruz1 and K Ariizumi1 1 Dermatology, University of Texas
Southwestern Medical Center, Dallas, TX and 2 Surgery, University of Texas Southwestern
Medical Center, Dallas, TX
MDSC are the most potent suppressors of T cell function and their exponential proliferation during
cancer progression severely restricts efficacy of immunotherapy. Having discovered DC-HIL as an
inhibitor of T cell activation, we asked whether MDSC express DC-HIL and whether it is required
for MDSC function. We found that DC-HIL is expressed by CD11b+/Gr-1+ MDSC from mice with
B16 melanoma, but not those without. Similarly, DC-HIL was expressed in the vast majority (86±10%)
of peripheral blood (CD14+/HLA-DR-/low) MDSC from 3 patients with metastatic melanoma, but
not (3.6±1%) healthy donors. We next examined the ability of MDSC from melanoma-bearing
mice to inhibit activation of gp100-TCR+ T cells in the presence of anti-DC-HIL Ab. MDSC abro-
gated T cell activation, which was reversed completely by addition of anti-DC-HIL (but not control)
Ab. For in vivo relevance, we generated DC-HIL-/- mice and confirmed null expression by MDSC.
In these mice, growth of subcutaneous melanoma (0.6±0.1 vs. 2.5±0.3 cm3) and metastases (194±105
vs. 1280±636 foci) were inhibited markedly. DC-HIL-/- MDSC failed to suppress T cell activation
and to promote tumor growth when co-implanted with B16 cells into naive mice. Having shown
that DC-HIL mediates inhibition by binding syndecan-4 (SD-4) on T cells, we blocked SD-4 func-
tion by gene deletion or specific Ab treatment. Either intervention neutralized MDSC function,
indicating that the inhibitory effect given by DC-HIL on MDSC is also mediated through SD-4. Finally,
we injected mice bearing melanoma with anti-DC-HIL every other day (i.p. 200 μg/mouse, 5 times).
Anti-DC-HIL Ab reduced circulating MDSC by 80% and markedly suppressed tumor growth. Thus,
DC-HIL expression by MDSC in mice with melanoma is responsible for their suppressive function.
We are testing the same hypothesis in humans, which if proved correct should make the DC-HIL/SD-
4 pathway a promising target for anti-melanoma therapy.
722
Identifying novel therapeutic agents for vitiligo
AU Tan, SJ Orlow and P Manga Dermatology, New York University School of Medicine, New
York, NY
Vitiligo is an acquired disorder characterized by depigmented skin lesions resulting from melanocyte
death. Vitiligo affects 1-2% of people worldwide. In most cases, the instigating factors are unknown
(idiopathic vitiligo). However a subset of individuals develop contact vitiligo following exposure to
certain chemicals such as 4-tertiary butyl phenol (4-TBP) and monobenzyl ether of hydroquinone
(MBEH), which are preferentially toxic to melanocytes. As there is currently no consistently effec-
tive treatment for vitiligo, this study is thus aimed at identifying compounds that prevent melanocyte
destruction as potential novel therapeutic agents. We have used chemically induced vitiligo as a
paradigm for idiopathic vitiligo since the two forms are indistinguishable after disease onset. We
performed a chemical library screen to determine whether any compounds from the 2320 com-
pound Spectrum Collection modulate the toxicity of 4-TBP and MBEH in mouse melanocytes.
Cells were treated with either 300μM 4-TBP or 250μM MBEH and 1μM of each library compound.
An MTT assay was performed to determine cell viability and lead compounds were selected based
on ability to increase viability by greater than 50% compared to cells treated with either 4-TBP or
MBEH alone. A number of compounds were identified by virtue of their ability to inhibit melanocyte
death induced by 4-TBP, MBEH or both. Additional mechanistic studies are being performed to
elucidate the means by which these compounds protect melanocytes from chemical induced death.
726
MAPK pathway regulates the expression of p18INK4c and p21Waf1/Cip1 cyclin-dependent
kinase inhibitors through the AP-1 transcription factor
A Jalili,1 C Wagner,1 KD Mertz,1 M Pashenkov,2 G Stingl,1 S Ramaswamy3 and SN Wagner1 1
DIAD, Department of Dermatology, Medical University of Vienna, Vienna, Austria, 2
Laboratory of Clinical Immunology, National Research Center Institute of Immunology,
Moscow, Russian Federation and 3 Massachusetts General Hospital Cancer Center, Boston,
MA
Gain-of-function mutations in upstream members of the MAPK pathway, BRAF and NRAS are among
the most common alterations in human melanoma. Single agent BRAF or MEK inhibitors only show
a very short-lasting or no meaningful clinical activity in human melanoma, respectively. MAPK activ-
ity is context-dependent as the result of a dynamic and complex regulatory network of diverse pro-
tein kinases. We therefore hypothesized that downstream effectors of MAPK pathway would be
better suited for therapeutic intervention. However, these downstream effectors are largely unde-
fined in melanoma. Here, we show that BRAFV600E can induce the AP-1 transcription factor. In
human melanoma cell lines interference with AP-1 activity by overexpressing dominant negative
AP-1 or c-Jun siRNAs resulted in G1 cell cycle arrest, reduced cell proliferation and induced apop-
totic cell death both in vitro and in vivo. Induction of G1 cell cycle arrest upon AP-1 deactivation
was mediated through combined induction of p18INK4c and p21Waf1/Cip1 cyclin-dependent
kinase (CDK) inhibitors. AP-1 repressed p18INK4c expression through direct binding to its promoter
and the p21Waf1/Cip1 indirectly through its upstream negative regulator Tbx2 but not p53 or c-
Myc. Combined silencing of p18INK4c and p21Waf1/Cip1 was able to completely rescue the human
melanoma cell death upon AP-1 deactivation. Interestingly, simultaneous pharmacological inhibi-
tion of p18INK4c and p21Waf1/Cip1 targets CDK2 and CDK4, in combination with or without
MAPK inhibitors resulted in decreased human melanoma cell viability in vitro and in vivo. Our
results demonstrate how MAPK activity can be linked to cell cycle control in a specific cellular
context (BRAF activating mutation) in human melanoma and identify novel therapeutic strategies.
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Targeting deregulated HIF1 signaling in human melanoma by conditional HIF1 knockdown
promotes tumor progression
KT Nash, AE Ayar, ME Verhaegen, TM Johnson and AA Dlugosz Dermatology, University of
Michigan, Ann Arbor, MI
Melanoma remains the most deadly cutaneous malignancy due to its potential to metastasize and
ability to resist therapy. Hypoxia-inducible factor-1 alpha (HIF1) is a tightly regulated transcriptional
activator of adaptive hypoxic gene expression but can drive normoxic gene expression in cancer
when deregulated by common oncogenic pathways. Although it is over expressed in many can-
cers, correlates with poor prognosis, and is being considered for targeted therapy, the role of HIF1
signaling in melanoma is unclear. In this study, we sought to confirm whether HIF1 signaling is
deregulated in melanoma and what role selective targeting of HIF1 has on tumorigenesis. Metasta-
tic human melanoma cell lines SK-Mel-103 and UACC-257 were stably transduced with a doxy-
cycline inducible lentiviral shRNA “knock-down” vector, containing either a scramble sequence or
two independent sequences targeting HIF1 (H1 or H2). Cells were grown in normoxic culture in
the presence or absence of doxycycline. In both cell lines expressing H1 or H2 shRNA, HIF1
mRNA levels were reduced by 66-82% (P<0.05), and target gene expression (VEGF, Glut-1, Glut-
3, HK-2 and PDK-1) was reduced by 18-66% (P<0.05). To assess the effects of HIF1 knock-down
on tumorigenesis, 1x10e6 shRNA transduced melanoma cells were injected into the subcutis of
athymic mice that were fed normal or doxycycline-containing chow. Surprisingly, by 12 or 14 days,
H1 or H2 expressing tumors were significantly larger (32-78%) than tumors in mice fed normal
chow (P<0.05). Importantly, analysis of RNA collected from H1 and H2-expressing xenografts at 14
days confirmed sustained HIF1 knockdown. In summary, we have shown that selective down reg-
ulation of HIF1 can promote, rather than inhibit, tumorigenesis of human melanoma cell lines that
harbor deregulated HIF1 activity. These data highlight the need for characterization of oncogenic
pathways in distinct tumor types before targeting these pathways in patients.
716
Modeling combinational drug therapies in melanoma: A conundrum of monolayer versus
anchorage independent systems
SA Rosenberg, S Niglio, B Jeong, S Shin, Y Wen, J Li, J Fukui, J Chan and J Goydos Surgical
Oncology, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ
Questions have recently arisen about the effectiveness of assays that use monolayer cell culture
models to predict clinical response to single or combinatorial therapies. In this study we examine
the different responses of melanoma cell lines to either single or combinatorial therapies in mono-
layer (2-D) or anchorage independent (3-D) systems. Our group reported that the majority of human
melanomas (>60%) express the metabotropic glutamate receptor 1 (Grm1) and that the glutamate
release-inhibitor Riluzole, a drug currently used to treat ALS, can inhibit proliferation and induce
apoptosis in Grm1-expressing melanoma cells. We have continued our pre-clinical studies of Rilu-
zole and its effect on the melanoma cells alone and in combination with the mTOR inhibitor, Tem-
sirolimus. The melanoma cell lines C8161(GRM1+,Braf/NrasWT) and UACC903(GRM1+,BRAFV600E) were used
to compare a monolayer (MTT/MTS) versus an anchorage independent system (soft agar colony for-
mation/NCP) with single or combinational treatments. Single agent treatments had little effect on
cell viability or colony formation. However, Riluzole in combination with Temsirolimus showed a
significant inhibition of colony formation (3-D), while the effects of combinational therapy in the
2-D model were significantly less pronounced. Furthermore, combination drug treatment in the 3-
D model showed decreased Akt and ERK activation, while combinatorial therapy in the 2-D system
showed increased Akt activation and little effect on ERK activation. Results from our xenograft model
show Riluzole in combination with Temsirolimus is effective at halting melanoma progression,
consistent with the 3-D model results. We conclude that the combination of Riluzole and Tem-
sirolimus is a more effective treatment for melanoma than either agent alone. Our results show that
the anchorage independent (3-D) model more accurately reflects in vivo tumor biology and may
be a superior in vitro method for use in pre-clinical studies.
717
Examination of skin lightening ingredients via genomic microarrays
JV Gruber1 and R Holtz2 1 Arch Personal Care, South Plainfield, NJ and 2 Bioinnovation
Laboratory, Jefferson, CO
Skin lightening remains a topic of extensive commercial and technical significance. It seems that
new skin lightening ingredients appear daily that are proposed to work better than stalwart indus-
try standards such as hydroquinone or kojic acid. While considerable research has been conducted
on mechanisms of skin lightening, broad examination of multiple skin lighteners in common mod-
els has not occurred. Human genomic microarrays allow for rapid examination of ingredients and
the influence such ingredients have on individual cell lines at the genomic level. Recently, a study
was commenced to examine how five ingredients reported to have skin lightening abilities function
when applied at sub-lethal doses to human melanoctyes (HM). These ingredients included Hydro-
quinone (HQ), Kojic Acid (KA), Niacinamide (NA), Glabridin (GB) and a glycosylated vitamin C
derivative (AA2G). Each of these ingredients was allow into come into contact with HM for 24 hours
and then gene transcription was analyzed using human microarrays (Agilent Technologies). It was
found, surprisingly, that in every case examined, the gene for Tyrosinase (TYR) was upregulated by
these ingredients within the 24 timeframe of the testing. This finding appears to be in contrast to
what would be anticipated. In addition, an important gene known to protect cells against sever iron
poisoning, ferritin (FTH1), was also strongly upregulated by each of these ingredients within the 24
hour timeframe of the test. The data for the iron binding protein gene upregulation is curious as it
suggests that the process of melanogenesis is creating a significant amount of toxic ferric ions (Fe+3).
Mechanisms by which iron might be playing a significant role in melanogenesis will be discussed.
718
Possible involvement of shedding vesicle system in the melanosome transfer pathway
H Ando,1,2 Y Niki,1 M Ito,3 MS Matsui,4 DB Yarosh4 and M Ichihashi1,2 1 Kobe Skin Research
Institute, Kobe, Japan, 2 Skin Aging and Photo-aging Research Center, Doshisha University,
Kyoto, Japan, 3 Department of Dermatology, Niigata University, Niigata, Japan and 4 The
Estee Lauder Companies Inc., Melville, NY
Recent studies have shed light on the shedding vesicles as physiological conveyers of intracellular
components among neighboring cells. Here we report that melanosome is one of the examples for
the contents of shedding vesicles. The pigment vesicles surrounded by a plasma membrane of
melanocyte were observed to be released from various portions of cultured normal human
melanocytes. These vesicles contained multiple melanosomes and a small number of mitochondria.
The pigment vesicles were incorporated by cultured normal human keratinocytes in a PAR-2-depend-
ent manner, wherein surrounded by a double membrane. After the pigment vesicles were incorpo-
rated in keratinocytes, the double membrane that surrounds melanosome cluster was gradually
degraded and the melanosomes were spread into the cytosol and accumulated in the perinuclear
area of keratinocytes. These results suggest a new role of shedding vesicle in melanosome transfer
pathway, in which melanosomes are transferred from melanocytes to keratinocytes via the shed-
ding vesicle system.
719
The comparative study in treatment of solar lentigines with trichloroacetic acid 40% vs.
cryotherapy
M Goldust, F Golforoushan, M Sadeghi and E Rezaee Tabriz University of medical sciences,
Tabriz, Islamic Republic of Iran
Solar lentigo is local and benign proliferation of melanocytes at dermo-epidermal junction. The
major concern on these lesions is related to cosmetic issues and most of the people may look for
treatment. Although there are different choices for treatment of these lesions such as photo selec-
tive lasers, cryotherapy and trichloroacetic acid (TCA) solution are inexpensive alternatives in the
treatment of solar lentigines. So the aim of this study was to comprise the efficiency and side effects
of TCA 40% vs. cryotherapy in treatment of solar lentigo. This study performed on 68 individuals
suffered from solar lentigo on their hands. One side was treated with cryotherapy and the other side
with TCA 40%, accidentally. This treatment was repeated after one month. Photographs of the hands
were taken prior to and 2 months following the treatment and degree of improvement (lightening)
of lesions and the resulted side effects were comprised. The results demonstrated that Cryosurgery
was more likely to produce lightening of the lentigines than 40% TCA solution but this difference
was not significant (P=0.32) Cryosurgery was more painful and took longer to heal. In concluion,
although Cryosurgery had better results than TCA 40% in lower Fitzpatrick skin types but this dif-
ference was no significant, wholly. In addition the side effects of Cryosurgery were more in com-
parison to TCA 40%.
720
Role of oxidative stress and unfolded protein response in development of vitiligo
S Toosi, SJ Orlow and P Manga Dermatology, New York University School of Medicine, New
York, NY
Vitiligo affects 1-2 % of the world’s population and significantly reduces quality of life due to char-
acteristic depigmented skin lesions. While the etiology of vitiligo is unclear, a number of studies
have implicated oxidative stress in disease onset. Sustained oxidative stress disrupts the Endoplas-
mic Reticulum (ER) where redox balance is critical for protein folding. Accumulation of immature
polypeptides triggers activation of the unfolded protein response (UPR). The UPR, consisting of three
pathways initiated by IRE1, PERK or ATF6 respectively, promotes restoration of ER homeostasis and
survival, but under sustained stress, can trigger apoptosis. IRE1 activation induces splicing of mRNA
encoding XBP1, a transcription factor that modulates downstream UPR targets. XBP1 polymorphisms
have been show to be associated with increased risk of vitiligo. In this study, we investigated the
response of melanocytes to 4-tertiary butyl phenol (4-TBP), a known chemical trigger of vitiligo, in
order to establish whether oxidative stress is induced and the UPR activated. Melanocytes were
treated with 250μM 4-TBP for 4, 6 and 24h and induction of oxidative stress and the UPR moni-
tored by fluorescence microscopy, Western blot analysis, RT- and real-time PCR. Generation of reac-
tive oxygen species was observed by fluorescence microscopy indicating that 4-TBP induces oxida-
tive stress in melanocytes. In addition, expression of the antioxidant response regulator HO-1
increased, indicating that melanocytes mount an antioxidant response to 4-TBP. IRE1 expression
was upregulated within 3h of treatment with 4-TBP, leading to splicing of XBP1. Maximal splicing
of XBP1 was noted 4h after treatment with 4-TBP. Expression of UPR-related genes, including PERK
and ATF6, were also modulated at this time point. Thus, 4-TBP induces oxidative stress, elicits an
antioxidant response and may activate the UPR. These pathways may be dysfunctional in individ-
uals susceptible to vitiligo and provide novel targets for treatment of this condition.
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Linking UVB irradiation to pigmentation induction through FGF2-STAT3-PAX3 signaling in
melanocytes
Y Li, L Dong, E Pier and R Cui Boston University School of Medicine, Boston, MA
Excessive UV exposure induces skin damage, and in the long run, could lead to skin diseases includ-
ing the deadly malignant melanomas. Minimizing sun exposure represents an effective strategy to
prevent UV-related skin diseases. On the other hand, moderate sun exposure is beneficial to over-
all health. Therefore, it is important to be able to provide the public with effective therapeutic
strategies for enhancing pigmentation, especially to individuals with genetic defects in UV-induced
pigmentation pathways such as MSH/MC1R signaling. Towards this end, we will need to compre-
hensively understand the signaling network modulating this biological process. Here we have focused
our attention on PAX3, a key transcriptional regulator of the neural crest lineage, and aim to better
understand its function in pigment cells especially its role in regulating melanin synthesis. PAX3 is
known to play an important role in melanocyte development through modulation of MITF tran-
scription. Here we found that PAX3 transcriptional activity could be regulated through FGF2-
STAT3 signaling in the pigment cells. We further identified TBX2 as a direct transcriptional target of
PAX3 in melanocytes. To study its function in vivo, we have generated a transgenic mouse model
expressing PAX3 driven by tyrosinase promoter in a tissue-specific fashion. These animals exhibit
hyperpigmentation in epidermis, evident in the skin color of their ears and tails. We showed that
the darker skin color results from both increased melanocyte numbers and melanin synthesis. Together,
our study delineated a novel pathway in the melanocyte lineage, linking FGF2-STAT3 signaling to
increased TBX2 transcription through PAX3. Moreover, our results suggest that this pathway might
contribute to the regulation of melanocyte numbers and melanin levels, and thereby provide an
alternative strategy to induce pigmentation which could effectively reducing or even completely
preventing UV-induced skin damages.
723
WIPI1 coordinates melanogenic gene transcription and melanosome formation via TORC1
inhibition
H Ho, R Kapadia, S Al-Tahan, S Ahmad and A Ganesan Dermatology, University of California,
Irvine, Irvine, CA
Recent studies have implicated a role for WD repeat domain, phosphoinositide interacting 1 (WIPI1)
in the biogenesis of melanosomes, a cell type-specific lysosome-related organelle. In this study, we
determine that WIPI1, an ATG18 homologue that localizes to both autophagosomes and early endo-
somes, inhibits molecular Target Of Rapamycin (mTOR) signaling, leading to increased transcrip-
tion of melanogenic enzymes and the formation of mature melanosomes. WIPI1 suppresses the Tar-
get of Rapamycin Complex 1 (TORC1) activity, resulting in Glycogen Synthase Kinase 3β (GSK3β)
inhibition, β-Catenin stabilization, and increased transcription of Micropthalmia Transcription Fac-
tor (MITF) and MITF target genes. WIPI1 depleted cells accumulate stage I melanosomes, but lack
stage III-IV melanosomes. Inhibition of TORC1 by rapamycin treatment results in the accumulation
of stage IV melanosomes but not autophagosomes, while starvation results in the accumulation of
autophagosomes but not increased melanin. Taken together, our studies define a distinct role for
TORC1 signaling in controlling the transcription of melanogenic enzymes and melanosome matu-
ration, a process which is distinct from conventional autophagy.
725
The MEF2C transcription factor regulates melanocyte development, interacts directly with
SOX10 and is a candidate gene for Waardenburg Syndrome.
ML Wei,1,2 P Agarwal,1 M Verzi,1 T Nguyen,1,2 D McCulley,1 S Xu,1 E Dodou,1 J Anderson1 and
B Black1 1 Universitiy of California, San Francisco, CA and 2 Veterans Affairs Medical Center,
San Francisco, CA
Waardenburg syndromes are characterized by pigmentation and innervation defects, and mutations
in genes encoding transcription factors that control neural crest specification and differentiation
are often associated with Waardenburg and related disorders. For example, mutations in SOX10
result in a severe form of Waardenburg syndrome, Type IV, also known as Hirschsprung disease,
characterized by neural crest and pigmentation defects. Sox10 controls neural crest development
through interactions with other transcription factors. The MADS box transcription factor MEF2C is
an important regulator of brain, skeleton, lymphocyte, and cardiovascular development and is
required in the neural crest for craniofacial development. Here, we establish a novel role for MEF2C
in melanocyte development. Inactivation of Mef2c in the neural crest of mice results in reduced
expression of melanocyte genes during development and a significant loss of pigmentation at birth
due to defective differentiation and reduced abundance of melanocytes. We identify a novel tran-
scriptional enhancer from the Mef2c locus that directs expression to the neural crest and its deriv-
atives, including melanocytes, in transgenic mouse embryos. This novel Mef2c neural crest enhancer
contains three functional Sox10 binding sites and a single essential MEF2 site, and we demonstrate
that Mef2c is a direct transcriptional target of Sox10 and MEF2 via this evolutionarily conserved
enhancer. Furthermore, we show that Sox10 and MEF2C physically interact and function coopera-
tively to activate the Mef2c gene itself in a feed-forward transcriptional circuit, suggesting that MEF2C
may serve as a potentiator of the transcriptional pathways affected in Waardenburg syndromes.
724
Myeloid derived suppressor cells (MDSC) express DC-HIL, which is responsible for their potent
T cell-inhibitory and melanoma growth-promoting effects
J Chung,1 K Tamura,1 RR Sharma,2 PD Cruz1 and K Ariizumi1 1 Dermatology, University of Texas
Southwestern Medical Center, Dallas, TX and 2 Surgery, University of Texas Southwestern
Medical Center, Dallas, TX
MDSC are the most potent suppressors of T cell function and their exponential proliferation during
cancer progression severely restricts efficacy of immunotherapy. Having discovered DC-HIL as an
inhibitor of T cell activation, we asked whether MDSC express DC-HIL and whether it is required
for MDSC function. We found that DC-HIL is expressed by CD11b+/Gr-1+ MDSC from mice with
B16 melanoma, but not those without. Similarly, DC-HIL was expressed in the vast majority (86±10%)
of peripheral blood (CD14+/HLA-DR-/low) MDSC from 3 patients with metastatic melanoma, but
not (3.6±1%) healthy donors. We next examined the ability of MDSC from melanoma-bearing
mice to inhibit activation of gp100-TCR+ T cells in the presence of anti-DC-HIL Ab. MDSC abro-
gated T cell activation, which was reversed completely by addition of anti-DC-HIL (but not control)
Ab. For in vivo relevance, we generated DC-HIL-/- mice and confirmed null expression by MDSC.
In these mice, growth of subcutaneous melanoma (0.6±0.1 vs. 2.5±0.3 cm3) and metastases (194±105
vs. 1280±636 foci) were inhibited markedly. DC-HIL-/- MDSC failed to suppress T cell activation
and to promote tumor growth when co-implanted with B16 cells into naive mice. Having shown
that DC-HIL mediates inhibition by binding syndecan-4 (SD-4) on T cells, we blocked SD-4 func-
tion by gene deletion or specific Ab treatment. Either intervention neutralized MDSC function,
indicating that the inhibitory effect given by DC-HIL on MDSC is also mediated through SD-4. Finally,
we injected mice bearing melanoma with anti-DC-HIL every other day (i.p. 200 μg/mouse, 5 times).
Anti-DC-HIL Ab reduced circulating MDSC by 80% and markedly suppressed tumor growth. Thus,
DC-HIL expression by MDSC in mice with melanoma is responsible for their suppressive function.
We are testing the same hypothesis in humans, which if proved correct should make the DC-HIL/SD-
4 pathway a promising target for anti-melanoma therapy.
722
Identifying novel therapeutic agents for vitiligo
AU Tan, SJ Orlow and P Manga Dermatology, New York University School of Medicine, New
York, NY
Vitiligo is an acquired disorder characterized by depigmented skin lesions resulting from melanocyte
death. Vitiligo affects 1-2% of people worldwide. In most cases, the instigating factors are unknown
(idiopathic vitiligo). However a subset of individuals develop contact vitiligo following exposure to
certain chemicals such as 4-tertiary butyl phenol (4-TBP) and monobenzyl ether of hydroquinone
(MBEH), which are preferentially toxic to melanocytes. As there is currently no consistently effec-
tive treatment for vitiligo, this study is thus aimed at identifying compounds that prevent melanocyte
destruction as potential novel therapeutic agents. We have used chemically induced vitiligo as a
paradigm for idiopathic vitiligo since the two forms are indistinguishable after disease onset. We
performed a chemical library screen to determine whether any compounds from the 2320 com-
pound Spectrum Collection modulate the toxicity of 4-TBP and MBEH in mouse melanocytes.
Cells were treated with either 300μM 4-TBP or 250μM MBEH and 1μM of each library compound.
An MTT assay was performed to determine cell viability and lead compounds were selected based
on ability to increase viability by greater than 50% compared to cells treated with either 4-TBP or
MBEH alone. A number of compounds were identified by virtue of their ability to inhibit melanocyte
death induced by 4-TBP, MBEH or both. Additional mechanistic studies are being performed to
elucidate the means by which these compounds protect melanocytes from chemical induced death.
726
MAPK pathway regulates the expression of p18INK4c and p21Waf1/Cip1 cyclin-dependent
kinase inhibitors through the AP-1 transcription factor
A Jalili,1 C Wagner,1 KD Mertz,1 M Pashenkov,2 G Stingl,1 S Ramaswamy3 and SN Wagner1 1
DIAD, Department of Dermatology, Medical University of Vienna, Vienna, Austria, 2
Laboratory of Clinical Immunology, National Research Center Institute of Immunology,
Moscow, Russian Federation and 3 Massachusetts General Hospital Cancer Center, Boston,
MA
Gain-of-function mutations in upstream members of the MAPK pathway, BRAF and NRAS are among
the most common alterations in human melanoma. Single agent BRAF or MEK inhibitors only show
a very short-lasting or no meaningful clinical activity in human melanoma, respectively. MAPK activ-
ity is context-dependent as the result of a dynamic and complex regulatory network of diverse pro-
tein kinases. We therefore hypothesized that downstream effectors of MAPK pathway would be
better suited for therapeutic intervention. However, these downstream effectors are largely unde-
fined in melanoma. Here, we show that BRAFV600E can induce the AP-1 transcription factor. In
human melanoma cell lines interference with AP-1 activity by overexpressing dominant negative
AP-1 or c-Jun siRNAs resulted in G1 cell cycle arrest, reduced cell proliferation and induced apop-
totic cell death both in vitro and in vivo. Induction of G1 cell cycle arrest upon AP-1 deactivation
was mediated through combined induction of p18INK4c and p21Waf1/Cip1 cyclin-dependent
kinase (CDK) inhibitors. AP-1 repressed p18INK4c expression through direct binding to its promoter
and the p21Waf1/Cip1 indirectly through its upstream negative regulator Tbx2 but not p53 or c-
Myc. Combined silencing of p18INK4c and p21Waf1/Cip1 was able to completely rescue the human
melanoma cell death upon AP-1 deactivation. Interestingly, simultaneous pharmacological inhibi-
tion of p18INK4c and p21Waf1/Cip1 targets CDK2 and CDK4, in combination with or without
MAPK inhibitors resulted in decreased human melanoma cell viability in vitro and in vivo. Our
results demonstrate how MAPK activity can be linked to cell cycle control in a specific cellular
context (BRAF activating mutation) in human melanoma and identify novel therapeutic strategies.
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Targeting deregulated HIF1 signaling in human melanoma by conditional HIF1 knockdown
promotes tumor progression
KT Nash, AE Ayar, ME Verhaegen, TM Johnson and AA Dlugosz Dermatology, University of
Michigan, Ann Arbor, MI
Melanoma remains the most deadly cutaneous malignancy due to its potential to metastasize and
ability to resist therapy. Hypoxia-inducible factor-1 alpha (HIF1) is a tightly regulated transcriptional
activator of adaptive hypoxic gene expression but can drive normoxic gene expression in cancer
when deregulated by common oncogenic pathways. Although it is over expressed in many can-
cers, correlates with poor prognosis, and is being considered for targeted therapy, the role of HIF1
signaling in melanoma is unclear. In this study, we sought to confirm whether HIF1 signaling is
deregulated in melanoma and what role selective targeting of HIF1 has on tumorigenesis. Metasta-
tic human melanoma cell lines SK-Mel-103 and UACC-257 were stably transduced with a doxy-
cycline inducible lentiviral shRNA “knock-down” vector, containing either a scramble sequence or
two independent sequences targeting HIF1 (H1 or H2). Cells were grown in normoxic culture in
the presence or absence of doxycycline. In both cell lines expressing H1 or H2 shRNA, HIF1
mRNA levels were reduced by 66-82% (P<0.05), and target gene expression (VEGF, Glut-1, Glut-
3, HK-2 and PDK-1) was reduced by 18-66% (P<0.05). To assess the effects of HIF1 knock-down
on tumorigenesis, 1x10e6 shRNA transduced melanoma cells were injected into the subcutis of
athymic mice that were fed normal or doxycycline-containing chow. Surprisingly, by 12 or 14 days,
H1 or H2 expressing tumors were significantly larger (32-78%) than tumors in mice fed normal
chow (P<0.05). Importantly, analysis of RNA collected from H1 and H2-expressing xenografts at 14
days confirmed sustained HIF1 knockdown. In summary, we have shown that selective down reg-
ulation of HIF1 can promote, rather than inhibit, tumorigenesis of human melanoma cell lines that
harbor deregulated HIF1 activity. These data highlight the need for characterization of oncogenic
pathways in distinct tumor types before targeting these pathways in patients.
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Modeling combinational drug therapies in melanoma: A conundrum of monolayer versus
anchorage independent systems
SA Rosenberg, S Niglio, B Jeong, S Shin, Y Wen, J Li, J Fukui, J Chan and J Goydos Surgical
Oncology, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ
Questions have recently arisen about the effectiveness of assays that use monolayer cell culture
models to predict clinical response to single or combinatorial therapies. In this study we examine
the different responses of melanoma cell lines to either single or combinatorial therapies in mono-
layer (2-D) or anchorage independent (3-D) systems. Our group reported that the majority of human
melanomas (>60%) express the metabotropic glutamate receptor 1 (Grm1) and that the glutamate
release-inhibitor Riluzole, a drug currently used to treat ALS, can inhibit proliferation and induce
apoptosis in Grm1-expressing melanoma cells. We have continued our pre-clinical studies of Rilu-
zole and its effect on the melanoma cells alone and in combination with the mTOR inhibitor, Tem-
sirolimus. The melanoma cell lines C8161(GRM1+,Braf/NrasWT) and UACC903(GRM1+,BRAFV600E) were used
to compare a monolayer (MTT/MTS) versus an anchorage independent system (soft agar colony for-
mation/NCP) with single or combinational treatments. Single agent treatments had little effect on
cell viability or colony formation. However, Riluzole in combination with Temsirolimus showed a
significant inhibition of colony formation (3-D), while the effects of combinational therapy in the
2-D model were significantly less pronounced. Furthermore, combination drug treatment in the 3-
D model showed decreased Akt and ERK activation, while combinatorial therapy in the 2-D system
showed increased Akt activation and little effect on ERK activation. Results from our xenograft model
show Riluzole in combination with Temsirolimus is effective at halting melanoma progression,
consistent with the 3-D model results. We conclude that the combination of Riluzole and Tem-
sirolimus is a more effective treatment for melanoma than either agent alone. Our results show that
the anchorage independent (3-D) model more accurately reflects in vivo tumor biology and may
be a superior in vitro method for use in pre-clinical studies.
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Examination of skin lightening ingredients via genomic microarrays
JV Gruber1 and R Holtz2 1 Arch Personal Care, South Plainfield, NJ and 2 Bioinnovation
Laboratory, Jefferson, CO
Skin lightening remains a topic of extensive commercial and technical significance. It seems that
new skin lightening ingredients appear daily that are proposed to work better than stalwart indus-
try standards such as hydroquinone or kojic acid. While considerable research has been conducted
on mechanisms of skin lightening, broad examination of multiple skin lighteners in common mod-
els has not occurred. Human genomic microarrays allow for rapid examination of ingredients and
the influence such ingredients have on individual cell lines at the genomic level. Recently, a study
was commenced to examine how five ingredients reported to have skin lightening abilities function
when applied at sub-lethal doses to human melanoctyes (HM). These ingredients included Hydro-
quinone (HQ), Kojic Acid (KA), Niacinamide (NA), Glabridin (GB) and a glycosylated vitamin C
derivative (AA2G). Each of these ingredients was allow into come into contact with HM for 24 hours
and then gene transcription was analyzed using human microarrays (Agilent Technologies). It was
found, surprisingly, that in every case examined, the gene for Tyrosinase (TYR) was upregulated by
these ingredients within the 24 timeframe of the testing. This finding appears to be in contrast to
what would be anticipated. In addition, an important gene known to protect cells against sever iron
poisoning, ferritin (FTH1), was also strongly upregulated by each of these ingredients within the 24
hour timeframe of the test. The data for the iron binding protein gene upregulation is curious as it
suggests that the process of melanogenesis is creating a significant amount of toxic ferric ions (Fe+3).
Mechanisms by which iron might be playing a significant role in melanogenesis will be discussed.
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Possible involvement of shedding vesicle system in the melanosome transfer pathway
H Ando,1,2 Y Niki,1 M Ito,3 MS Matsui,4 DB Yarosh4 and M Ichihashi1,2 1 Kobe Skin Research
Institute, Kobe, Japan, 2 Skin Aging and Photo-aging Research Center, Doshisha University,
Kyoto, Japan, 3 Department of Dermatology, Niigata University, Niigata, Japan and 4 The
Estee Lauder Companies Inc., Melville, NY
Recent studies have shed light on the shedding vesicles as physiological conveyers of intracellular
components among neighboring cells. Here we report that melanosome is one of the examples for
the contents of shedding vesicles. The pigment vesicles surrounded by a plasma membrane of
melanocyte were observed to be released from various portions of cultured normal human
melanocytes. These vesicles contained multiple melanosomes and a small number of mitochondria.
The pigment vesicles were incorporated by cultured normal human keratinocytes in a PAR-2-depend-
ent manner, wherein surrounded by a double membrane. After the pigment vesicles were incorpo-
rated in keratinocytes, the double membrane that surrounds melanosome cluster was gradually
degraded and the melanosomes were spread into the cytosol and accumulated in the perinuclear
area of keratinocytes. These results suggest a new role of shedding vesicle in melanosome transfer
pathway, in which melanosomes are transferred from melanocytes to keratinocytes via the shed-
ding vesicle system.
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The comparative study in treatment of solar lentigines with trichloroacetic acid 40% vs.
cryotherapy
M Goldust, F Golforoushan, M Sadeghi and E Rezaee Tabriz University of medical sciences,
Tabriz, Islamic Republic of Iran
Solar lentigo is local and benign proliferation of melanocytes at dermo-epidermal junction. The
major concern on these lesions is related to cosmetic issues and most of the people may look for
treatment. Although there are different choices for treatment of these lesions such as photo selec-
tive lasers, cryotherapy and trichloroacetic acid (TCA) solution are inexpensive alternatives in the
treatment of solar lentigines. So the aim of this study was to comprise the efficiency and side effects
of TCA 40% vs. cryotherapy in treatment of solar lentigo. This study performed on 68 individuals
suffered from solar lentigo on their hands. One side was treated with cryotherapy and the other side
with TCA 40%, accidentally. This treatment was repeated after one month. Photographs of the hands
were taken prior to and 2 months following the treatment and degree of improvement (lightening)
of lesions and the resulted side effects were comprised. The results demonstrated that Cryosurgery
was more likely to produce lightening of the lentigines than 40% TCA solution but this difference
was not significant (P=0.32) Cryosurgery was more painful and took longer to heal. In concluion,
although Cryosurgery had better results than TCA 40% in lower Fitzpatrick skin types but this dif-
ference was no significant, wholly. In addition the side effects of Cryosurgery were more in com-
parison to TCA 40%.
720
Role of oxidative stress and unfolded protein response in development of vitiligo
S Toosi, SJ Orlow and P Manga Dermatology, New York University School of Medicine, New
York, NY
Vitiligo affects 1-2 % of the world’s population and significantly reduces quality of life due to char-
acteristic depigmented skin lesions. While the etiology of vitiligo is unclear, a number of studies
have implicated oxidative stress in disease onset. Sustained oxidative stress disrupts the Endoplas-
mic Reticulum (ER) where redox balance is critical for protein folding. Accumulation of immature
polypeptides triggers activation of the unfolded protein response (UPR). The UPR, consisting of three
pathways initiated by IRE1, PERK or ATF6 respectively, promotes restoration of ER homeostasis and
survival, but under sustained stress, can trigger apoptosis. IRE1 activation induces splicing of mRNA
encoding XBP1, a transcription factor that modulates downstream UPR targets. XBP1 polymorphisms
have been show to be associated with increased risk of vitiligo. In this study, we investigated the
response of melanocytes to 4-tertiary butyl phenol (4-TBP), a known chemical trigger of vitiligo, in
order to establish whether oxidative stress is induced and the UPR activated. Melanocytes were
treated with 250μM 4-TBP for 4, 6 and 24h and induction of oxidative stress and the UPR moni-
tored by fluorescence microscopy, Western blot analysis, RT- and real-time PCR. Generation of reac-
tive oxygen species was observed by fluorescence microscopy indicating that 4-TBP induces oxida-
tive stress in melanocytes. In addition, expression of the antioxidant response regulator HO-1
increased, indicating that melanocytes mount an antioxidant response to 4-TBP. IRE1 expression
was upregulated within 3h of treatment with 4-TBP, leading to splicing of XBP1. Maximal splicing
of XBP1 was noted 4h after treatment with 4-TBP. Expression of UPR-related genes, including PERK
and ATF6, were also modulated at this time point. Thus, 4-TBP induces oxidative stress, elicits an
antioxidant response and may activate the UPR. These pathways may be dysfunctional in individ-
uals susceptible to vitiligo and provide novel targets for treatment of this condition.
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Genetically determined ABCB5 functionality correlates with pigmentation phenotype and
melanoma risk
JY Lin,1 M Zhang,1 T Schatton,1 BJ Wilson,1,2 A Alloo,1,2 AA Qureshi,1 MH Frank,1,2 J Han1,3 and
NY Frank2,4 1 Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston,
MA, 2 Transplantation Research Center, Children’s Hospital Boston, Harvard Medical School,
Boston, MA, 3 Channing Laboratory, Brigham and Women’s Hospital, Boston, MA and 4
Division of Genetics, Brigham and Women’s Hospital, Boston, MA
ABCB5 is a multidrug resistance (MDR) member of the ATP-binding cassette (ABC) superfamily of
active transporters and represents a marker for chemoresistant malignant melanoma-initiating cells.
ABCB5 expression is closely linked to tumorigenicity and progression of human melanomas. Here,
we genotyped a large Caucasian cohort from the Nurses’ Health Study (NHS) comprised of 585
melanoma cases and 605 matched controls for 44 ABCB5 tagging single nucleotide polymor-
phisms (SNPs) to span a region covering 108.2kb of the gene on the 7p21.1 locus. The natural hair
color at age 20, mole count on the left arm, and childhood and adolescent tanning ability were
prospectively obtained through biennial surveys. We identified three SNPs that were associated with
a decreased melanoma risk after adjusting for melanoma risk factors in additive models: rs10231520
(OR, 0.83; 95% CI: 0.70–0.98), rs17817117 (OR, 0.82; 95% CI, 0.68–0.98), and rs2301641 (OR,
0.83; 95% CI, 0.69–0.98). Additionally, the rs2301641 SNP was associated with non-red com-
pared to red hair color (OR, 0.38; 95% CI, 0.14-1.03) in non-melanoma controls. Twelve human
melanoma cell lines were genotyped for the rs2301641 SNP, which encodes a non-synonymous
ABCB5 amino acid change (K115E). Functional studies revealed that the SNP associated with
lower melanoma risk correlated significantly with decreased ABCB5 transport capacity (P<0.01)
and increased melanin production (P<0.05). Furthermore, ABCB5 transport capacity correlated neg-
atively (P <0.05) with melanin production across this panel of melanoma cell lines. Our results iden-
tify novel associations of ABCB5 gene polymophisms with human pigmentation phenotype and
melanoma risk and point to potential functional roles of ABCB5 in melanomagenesis.
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Novel secosteroids regulate melanocytic activity
A Slominski,1 Z Janjetovic,1 RC Tuckey,2 W Li,1 T Kim,1 A Postethwaite,1 MA Zmijewski,3
T Sweatman,1 J Chen,1 J Zjawiony,4 MN Nguyen,2 TC Chen,5 MF Holick5 and D Miller1 1
University of Tennessee HSC, Memphis, TN, 2 The University of Western Australia, Crawley,
WA, Australia, 3 Medical University of Gdansk, Gdansk, Poland, 4 University of Mississippi,
University, MS and 5 Boston University, Boston, MA
Novel secosteroidogenic pathways initiated by CYP11A1 have been defined: 7DHC Ç22(OH)7DHC
Ç 20,22(OH)2-7DHC Ç 7DHP Ç 5,7-diene hydroxysteroids which can be photoconverted by
UVB to vitamin D analogs with a shortened side chain. These secosteroids are biologically active
and non-calcemic. CYP11A1 also hydroxylates vitamin D3 to produce 20(OH)D3, 20,23(OH)2D3
and 17,20,23(OH)3D3, and 1(OH)D3 to 1,20(OH)2D3. These compounds show differential antipro-
liferative and prodifferentiation activities in skin cells. 20(OH)D3 and 20,23(OH)2D3 are non-cal-
cemic at doses as high as 3 μg/kg, while 1,20(OH)2D3 is calcemic. We have analysed the biolog-
ical activities of the above novel secosteroids with a short or full-length side chain (compared to
1,25(OH)2D3) in normal melanocytes and melanoma cells. The novel secosteroids inhibited the
proliferation and behavior of normal and malignant melanocytes with a noted selectivity. In
melanocytes the inhibitory effect was potentiated by the addition of a 1αOH group to the secos-
teroid, while compounds with a shorter side chain were less or not effective. In melanomas there
was no difference between the novel secosteroids with or without an hydroxyl group at C1 and
they were of equal or greater potency than 1,25(OH)2D3 in inhibiting cell proliferation and colony
formation. However, some analogues with no side chain or a short one showed lower potency. No
effect on melanogenesis was observed. However, attenuation of dendrite formation in normal
melanocytes was seen only for 1,25(OH)2D3 and 1,20(OH)2D3. We conclude that above com-
pounds are excellent candidates for treatment of proliferative melanocytic disorders or melanoma.
Furthermore, we believe that we have identified vitamin D analogs that fulfill the definition of nat-
ural products and that retain the beneficial effects of 1,25(OH)2D3, while being non-toxic/non-cal-
cemic
737
Vascular features of cutaneous metastastic melanoma 
A Raymond,1 C Longo,4 G Pellacani,4 JY Tcheung,1 P Puri,1,2 A Selim,1,2 D Tyler3 and KC Nelson1
1 Dermatology, Duke University, Durham, NC, 2 Pathology, Duke University, Durham, NC, 3
Surgery, Duke University, Durham, NC and 4 Dermatology, University of Modena and Reggio
Emilia, Modena, Italy
Current methodologies for evaluating vascularity in cutaneous melanoma range from histologic
examination to investigational models requiring systemic contrast agents. Reflectance confocal
microscopy (RCM) is an FDA-approved dynamic in-vivo imaging technique which offers several
advantages over established methods: human tumors may be imaged in-vivo; small, nascent ves-
sels are easily appreciated; and the dynamic interaction of leukocytes, vascular endothelium and
tumor may be directly visualized. Thirteen biopsy-proven cutaneous metastatic melanoma lesions
demonstrating prominent vascularity on RCM imaging were selected for inclusion. Clinical, der-
moscopic, and RCM images including video capture of vascular flow were obtained. All lesions
were excised and submitted for standard histology processing, with CD31 staining for selected
lesions. RCM images were reviewed for correlation with histologic features. All cases demonstrated
at least one area with an intimate approximation of tumor and convoluted vessels, which we describe
as the vascular-tumor interface. Vessel morphology was categorized and the average vessel diame-
ter (measured as a representative vascular cross-section with VivaScan software) was 37.6 μm (range:
17 - 85 μm). Four lesions demonstrated prominent leukocyte rolling along the vascular endothe-
lium. The vascular features of cutaneous melanoma metastases may be easily visualized utilizing
RCM. The vessel diameter and morphology are readily appreciated, particularly for smaller vessels.
Several lesions demonstrated prominent leukocyte activity along the vascular endothelium. As vas-
cular transendothelial migration of melanoma cells is mediated by many interrelated factors, includ-
ing vascular flow dynamics and leukocyte activity, direct visualization and quantification of leuko-
cyte activity may offer unique insights into the biology of tumor metastasis.
736
Image color analysis method to quantify clinical efficacy of skin lightening product
D Qu and JV Scimeca Research and Development, Amway Corporation, Ada, MI
Quantification of clinical efficacy of skin lightening product is presented in this study. Convention-
ally skin lightening efficacy is assessed either by visual grading or by colorimetry. Subjectivity is a
concern with grading, while skin contact of colorimeter has caused large variation in the a* value.
Color analysis of digital photographs is a useful method which can achieve accurate measurement
if the color of a picture is properly corrected. Digital pictures were obtained from an in-use clini-
cal efficacy study in which thirty four Asian and Caucasian female volunteers participated. A test
product was applied to the face two times a week for 6 weeks. Facial pictures of each subject were
taken at baseline, and at weeks 2, 4 and 6 using VISIA-CR with embedded color standards. Color
values in RGB were measured on the forehead and cheeks, as well as on color standards, from
each picture. Color correction was carried out using in-house developed algorithms. Changes in
color were quantified from pictures before and after product application. The color correction step
significantly improved accuracy of color in clinical photos, with a reduction in %Error from 22.3%
to 4.0%. Skin lightening effects were hence detected, with statistical significance, from pictures
before and after the clinical study. The average L* value increased from 70.9 to 71.7 indicating the
subjects’ skin became whiter, with 76.5% of subjects showing improvement. The average a* value
decreased from 20.8 to 20.1 indicating their skin was less red, with 67.6% of subjects showing
improvement. The average b* was also decreased from 27.1 to 26.5 with 64.7% subjects showing
change indicating their skin was less yellow. The average skin tone, defined as ITA°, increased from
37.7 to 39.3, a 4.6% increase over the baseline with 79.4% of the volunteers showing improve-
ment. The image color analysis method can accurately measure changes in skin color due to prod-
uct application. Clinical efficacy of skin lightening product can therefore be quantitatively con-
firmed.
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A label-free indicator for melanoma cells based on the CH2-stretch ratio
S van den Driesche,2 W Witarski,3 S Pastorekova,3 H Breiteneder,1 MJ Vellekoop2 and C Hafner1,4
1 Department of Pathophysiology, Center of Pathophysiology, Infectiology and Immunology,
Medical University of Vienna, Vienna, Austria, 2 Institute of Sensor and Actuator Systems,
Vienna University of Technology, Vienna, Austria, 3 Institute of Virology, Slovak Academy of
Sciences, Bratislava, Slovakia and 4 Karl Landsteiner Institute for Dermatological Research,
St.Poelten, Austria
Infrared (IR) spectroscopy is a useful tool for the determination of global biochemical composition
of a sample. A number of recent cancer studies have suggested that the ratio of the CH2-symmetric
and CH2-antisymmetric stretching bands differs for normal and malignant cells and therefore may
be a potential marker for malignancy. A promising simple method for determining this ratio uses a
quadruple wavelength infrared system to probe the lipid region of the IR spectrum. For this study,
an adult primary human melanocyte cell line and three human melanoma cell lines were investi-
gated using this label-free measurement method for determination of CH2-symmetric to CH2-anti-
symmetric stretch ratios. To investigate whether the membrane stabilizing agent cholesterol had an
influence on this ratio, cell lines were exposed to the plasma membrane bound cholesterol reduc-
ing agent methyl-β–cyclodextrin. The CH2-stretch ratios of the three melanoma cell lines tested were
significantly increased compared to the adult human melanocytes. Measurement results of cells
exposed to methyl-β–cyclodextrin indicated that an increase in CH2-stretch ratio arises when there
is a decrease in, or a redistribution of, the membrane stabilizing agent cholesterol. This proof-of-
concept study shows that the proposed cell type discrimination method, based on the CH2-sym-
metric to CH2-antisymmetric stretch ratio, has the potential to be further developed into a label-free,
easy-to-use tool to improve the staging of suspicious cells or tissues.
738
AhR mediates FICZ-induced pigmentation
E Goyarts, L Ming, B Wolf, D Yarosh and N Pernodet Estee Lauder Research Laboratories,
Melville, NY
Activation of the aromatic hydrocarbon receptor (AhR) by xenobiotics has been proposed as a mech-
anism for inducing pigmentation. Here, we report our findings by using FICZ to induce AhR acti-
vation in keratinocytes (Fritsche et al., 2007) and the impact on melanogenesis. Normal human
keratinocytes were treated with FICZ and their conditioned media was then transferred to human
melanocytes. After 72h incubation, 25% increase of melanin content was measured with 100nM
FICZ. The increase in melanogenesis was dose-dependent. A 15% decrease in melanocyte prolif-
eration was measured during this time interval. However, human keratinocytes proliferation increased
by 15% after 72h with 100nM FICZ. Many signal transduction pathways contribute to the regula-
tion of melanogenesis. In this study, we activate AhR signaling in keratinocytes using nanomolar
amount of FICZ, which leads to an increase in melanin content.
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CCR7-expressing B16 melanoma cells down-regulate interferon (IFN)-γ-mediated inflamma-
tion and increase lymphangiogenesis in the tumor microenvironment
T Takekoshi,1 L Fang,2 R Sells1 and ST Hwang1 1 Dermatology, Medical College of Wisconsin,
Milwaukee, WI and 2 NCI, Bethesda, MD
The expression of the CC chemokine receptor-7 (CCR7) on cancers, including melanoma, augments
lymph node (LN) metastasis, but little is known about its role in lymphangiogenesis and anti-tumor
immunity. We injected control B16 murine melanoma cells (pLNCX2-B16) and CCR7-overexpressing
B16 cells (CCR7-B16) in murine footpads and compared resulting tumors at the protein and mRNA
level using immunostaining, Affymetrix gene microarray, and quantitative RT-PCR (qPCR). Although
control and CCR7-B16 primary tumors were of similar size, LN metastasis was dramatically enhanced
in CCR7-B16 tumors. Intratumoral CD45+ leukocytes and CD8+ T cells were diminished by >5 and
15 fold in CCR7-B16 (vs. control) tumors. Microarray analysis of leukocyte-depleted pLNCX2-B16
and CCR7-B16 tumor cell suspensions showed that 3 major groups of genes linked to IFN-γ sig-
naling pathways were down-regulated in the CCR7-B16 tumor microenvironment, including STAT1,
CXC chemokine receptors 9-11, CCL5 and CXCL10, MHC I, and MHC II, suggesting that activation
through CCR7 could down-regulate pathways critical for host anti-tumor immunity. In addition,
mRNA expression of the lymphatic marker podoplanin was up-regulated in CCR7-B16 tumors by
3.35 fold vs. control tumors. Anti-podoplanin mAb staining revealed a 3-fold increase in intratu-
moral lymphatic vessels (p<0.05) as well as a two-fold increase in invading tumor cells per lym-
phatic vessel (p<0.05) in CCR7-B16 vs. control tumors. Enhanced anti-VEGF-C staining was pres-
ent in CCR7-B16 vs. control tumors, suggesting that VEGF-C may play a role in CCR7-mediated
lymphangiogenesis. A subset of podoplanin+ vessels expressed CCR7 ligand (CCL21), explaining
the invasiveness of CCR7-B16 cells toward lymphatic vessels. In summary, CCR7-B16 tumors show
a dramatic decrease in IFN-γ-mediated inflammatory gene expression but increased expression of
VEGF-C, CCL21, and podoplanin. Enhanced lymphageogenesis may contribute to the dramatic
increase in LN metastasis in CCR7-expressing tumors.
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A simple assay method for melanosome transfer
H Kim, H Choi, S Park and K Park Dermatology, Seoul National University Bundang Hospital,
Seongnam-si, Republic of Korea
Pigmentation is achieved by production of melanin in specialized organelles termed melanosomes
and by transfer of these organelles from melanocytes to surrounding keratinocytes. The chemical
basis of melanogenesis is relatively well known but the mechanism of melanosome transfer is not
well studied. Especially, many Asian women desire to have a flawless skin. Thus, there is a need for
the development of skin lightening agents. Most of hypopigmenting agents are tyrosinase inhibitors
and only a few agents are known to inhibit transfer of melanosomes. However, standardized method
to study melanosome transfer is not established yet. In this study, we tried to develop a simple method
to study melanosome transfer by using flow cytometry. Importantly, normal human keratinocytes
and normal human melanocytes had been used. Furthermore, side scatter (SSC) was analyzed in
the cells which showed the positivity against the keratinocyte-specific marker keratin 14. SSC is
caused by granularity of cells. If melanosome is transported into keratinocytes, granularity of ker-
atinocytes will increase. Thus, changes of SSC were analyzed in keratinocytes instead specific
staining against melanosomal proteins. Our methods are easy to apply and short time consuming
compared to previous methods. Thus, we propose that this method will be applicable to screen
many possible agents. In literature, it is reported that melanocyte-keratinocyte interaction induces
calcium signaling and melanin transfer to keratinocytes. It is reported that pigment transfer was
decreased when intracellular calcium was inhibited by calcium chelators. To verify the applicabil-
ity of our method, CaCl2 and Ca2+ chelator were added to co-culture of keratinocytes and
melanocytes.
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Expressing matrix metalloproteinase-2,9 in reconstructed human skin melanoma model with
MV3 cells
H Lu, Y Lv and Y Ma Dept. of Dermatology, Affiliated Hospital of Guiyang Medical University,
Guiyang, China
A reconstructed skin malignant melanoma model in vitro with MV3 melanoma cells on de-epider-
mized dermis (DED) has been established before by us. Our previous studies have shown in the
model the growing MV3 cells was in adhesion and attachment to the surface of the DED which
aggregated at the concave parts and circularly gathered at cavity of the cutaneous appendages along
the basement membrane zone(BMZ). However, a few of melanoma cells was breaking through the
BMZ getting into the surrounding tissues of DED, which indicated the reconstructed skin melanoma
model could be used as studying the invasion of melanoma cells in vitro. The purpose of this study
is further to investigate whether the expression of matrix metalloproteinase (MMP)-2 and- 9, which
is considered the most important proteases of tumor invasion and metastasis because of MMP-2 and
MMP-9 degradation of the main component of basement membrane. The MV3 cells were seeded
onto the prepared acellular dermis and maintained at the air-liquid interface after submerged cul-
ture about 15 days. The reconstructed skin malignant melanoma tissue was examined with HE, and
immunohistochemical staining with S-100 protein and HMB45. The MMP-2, 9 expressions was
checked using immunohistochemistry and RT-RCR. The result revealed that MV3 cells were grow-
ing and gathered into groups-like tumor nests on DED. The S-100 protein was positive and HMB45
were weak positive. A strong positive expression of MMP-2,-9 has been observed in tumor distri-
bution of the MV3 attachment at the basement membrane. Semiquantitative RT-PCR also revealed
MMP-2, 9 genes express in the reconstructed skin melanoma model. These studies demonstrate
that MV3 cells expression of MMP-2, 9 can enhance the tumor invasion in vitro mode of human
skin melanoma model.
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Inhibition of pigmentation by keratinocyte-derived sFRP2
J Lee,1 M Kim,1 J Yoon,2 J Kim,2 Y Lee,1 C Kim,1 J Lee1 and T Yoon2 1 Dermatology, Chungnam
National University, Daejeon, Republic of Korea and 2 Dermatology, Gyeongsang National
University, Jinju, Republic of Korea
A link between Wnt/β-catenin signaling and melanocyte differentiation has been revealed by the
finding that β-catenin forms a complex with lymphocyte enhancer factor-1 to up-regulate expres-
sion of the MITF gene. Also, β-catenin directly interacts with the MITF protein itself and then acti-
vates MITF-specific target genes. Conversely, the inhibitor for Wnt/β-catenin such as DKK1 is known
to inhibit melanocyte growth and function. In this study, we found that another Wnt/β-catenin
inhibitor sFRP2 was increased in epidermis of vitiligo patient. To investigate the effect of sFRP2, we
set the co-culture model in which HaCaT keratinocytes and melanocytes were incubated using Boy-
den’s chamber. After transduction of HaCaT with the recombinant adenovirus expressing sFRP2,
cells were loaded into upper chamber, and melanocytes were seeded in lower chamber. Interestinlgy,
the β-catenin level was significantly decreased in melanocytes by co-culture with sFRP2 overex-
pressing HaCaT cells. In addition, the protein levels for pigmentation-related molecules including
MITF, TRP1 and TRP1 were also down-regulated by co-culture with sFRP2 overexpressing HaCaT.
These results suggest that increase of sFRP2 in epidermal keratinocytes of vitiligo patient may decrease
the melanogenic potential of melanocytes, contributing the depigmentation.
731
Nrf2 regulates melanogenesis by activating the PI3K/Akt pathway
J Shin,1 J Kim,1 H Kim,2 J Kim,2 M Im,1 C Kim,1 Y Seo,1 J Lee1 and T Yoon2 1 Dermatology,
Chungnam National University, Daejeon, Republic of Korea and 2 Dermatology, Gyeongsang
National University, Jinju, Republic of Korea
Nrf2 is a member of the “cap ‘n’ collar” family of transcription factors which encode detoxifying
enzymes and antioxidant proteins. Nrf2 is normally retained in the cytoplasm via interaction with
Keap1, an actin-binding protein, which also mediates its degradation via the ubiquitin–proteasome
pathway. Reactive oxygen species (ROS) has a paradoxical action on melanocytes because it not
only enhances depigmentation, but also increases pigmentation in the skin. We wondered if Nrf2
which regulates ROS detoxicification has an effect on melanogenesis. When normal epidermal
melanocytes were transduced with a recombinant adenovirus expressing Nrf2, tyorosinase activity
and total melanin production were significantly decreased. Consistent with these results, overex-
pression of Nrf2 led to marked decrease of pigmentation-related factors, such as MITF, tyrosinase,
TRP1 and DCT. Interestingly, overexpression of Nrf2 resulted in remarkable increase of phospho-
rylations of Akt, mTOR and S6 protein, suggesting Nrf2 modulates the PI3K/Akt pathway. Conversely,
inhibition of PI3K activity by treatment with Wortmannin reversed the Nrf2 effects on the expres-
sion of pigmentation-related molecules. These results strongly suggest that Nrf2 decreases the pig-
mentation through the activation of PI3K/Akt signaling pathway.
732
B7-H1 expression in benign and malignant melanocytic lesions and colocalization with infil-
trating T lymphocytes
J Taube,1,2 R Anders,2 H Xu,1 S Topalian3 and L Chen3 1 Dermatology, Johns Hopkins, Baltimore,
MD, 2 Pathology, Johns Hopkins, Baltimore, MD and 3 Oncology, Johns Hopkins, Baltimore,
MD
B7-H1 is an immune-inhibitory protein expressed by many human cancers. A significant propor-
tion of metastatic melanomas express B7-H1, and anti-B7-H1 immunotherapies are currently in
clinical trials for patients with stage IV disease. The purpose of this study was to determine whether
benign nevi, melanoma in situ, and primary invasive melanomas of various histologic subtypes
also express B7-H1, and the potential relationship to tumor infiltrating lymphocytes (TILs). B7-H1
immunohistochemistry was performed using mAb 5H1 on archived, paraffin-embedded tissue, and
cases demonstrating more than 5% melanocyte expression were considered positive. Benign
nevi(n=40), melanoma in situ(n=11), and invasive melanomas(superficial spreading,n=14; nodu-
lar,n=15; lentigo maligna,n=3; desmoplastic,n=4; acral lentiginous,n=7) were scored. The degree
of TILs was also scored as mild(rare), moderate(focal), or severe(diffuse). We found that 35%(14/40)
of benign nevi expressed B7-H1(mean melanocyte expression=30%). 100% (14/14) of the positive
cases were associated with at least mild TILs, compared to 15%(4/26) of B7-H1 negative cases
(p<0.05), suggesting B7-H1 induction by T cell secreted cytokines such as IFN-γ. 35%(19/54) of
malignant lesions were B7-H1 positive, and 100%(19/19) of the positive cases were associated
with at least mild TILs, compared to 43%(15/35) of B7-H1 negative cases (p<0.05). In 95%(18/19)
of B7-H1+ melanomas, expression was observed solely at the interface with TILs. 45%(13/29) of
superficial spreading and nodular melanomas were B7-H1 positive(mean melanocyte expression
=16%), while other subtypes were B7-H1 negative(0/14). Geographic co-localization of B7-H1+
melanoyctes with TILs suggests that TILs may paradoxically promote their own downregulation by
secreting B7-H1 inducing cytokines. Both the association with TILs and the difference in expres-
sion by histologic subtype may provide insight into currently unknown B7-H1 signaling mecha-
nisms.
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Genetically determined ABCB5 functionality correlates with pigmentation phenotype and
melanoma risk
JY Lin,1 M Zhang,1 T Schatton,1 BJ Wilson,1,2 A Alloo,1,2 AA Qureshi,1 MH Frank,1,2 J Han1,3 and
NY Frank2,4 1 Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston,
MA, 2 Transplantation Research Center, Children’s Hospital Boston, Harvard Medical School,
Boston, MA, 3 Channing Laboratory, Brigham and Women’s Hospital, Boston, MA and 4
Division of Genetics, Brigham and Women’s Hospital, Boston, MA
ABCB5 is a multidrug resistance (MDR) member of the ATP-binding cassette (ABC) superfamily of
active transporters and represents a marker for chemoresistant malignant melanoma-initiating cells.
ABCB5 expression is closely linked to tumorigenicity and progression of human melanomas. Here,
we genotyped a large Caucasian cohort from the Nurses’ Health Study (NHS) comprised of 585
melanoma cases and 605 matched controls for 44 ABCB5 tagging single nucleotide polymor-
phisms (SNPs) to span a region covering 108.2kb of the gene on the 7p21.1 locus. The natural hair
color at age 20, mole count on the left arm, and childhood and adolescent tanning ability were
prospectively obtained through biennial surveys. We identified three SNPs that were associated with
a decreased melanoma risk after adjusting for melanoma risk factors in additive models: rs10231520
(OR, 0.83; 95% CI: 0.70–0.98), rs17817117 (OR, 0.82; 95% CI, 0.68–0.98), and rs2301641 (OR,
0.83; 95% CI, 0.69–0.98). Additionally, the rs2301641 SNP was associated with non-red com-
pared to red hair color (OR, 0.38; 95% CI, 0.14-1.03) in non-melanoma controls. Twelve human
melanoma cell lines were genotyped for the rs2301641 SNP, which encodes a non-synonymous
ABCB5 amino acid change (K115E). Functional studies revealed that the SNP associated with
lower melanoma risk correlated significantly with decreased ABCB5 transport capacity (P<0.01)
and increased melanin production (P<0.05). Furthermore, ABCB5 transport capacity correlated neg-
atively (P <0.05) with melanin production across this panel of melanoma cell lines. Our results iden-
tify novel associations of ABCB5 gene polymophisms with human pigmentation phenotype and
melanoma risk and point to potential functional roles of ABCB5 in melanomagenesis.
735
Novel secosteroids regulate melanocytic activity
A Slominski,1 Z Janjetovic,1 RC Tuckey,2 W Li,1 T Kim,1 A Postethwaite,1 MA Zmijewski,3
T Sweatman,1 J Chen,1 J Zjawiony,4 MN Nguyen,2 TC Chen,5 MF Holick5 and D Miller1 1
University of Tennessee HSC, Memphis, TN, 2 The University of Western Australia, Crawley,
WA, Australia, 3 Medical University of Gdansk, Gdansk, Poland, 4 University of Mississippi,
University, MS and 5 Boston University, Boston, MA
Novel secosteroidogenic pathways initiated by CYP11A1 have been defined: 7DHC Ç22(OH)7DHC
Ç 20,22(OH)2-7DHC Ç 7DHP Ç 5,7-diene hydroxysteroids which can be photoconverted by
UVB to vitamin D analogs with a shortened side chain. These secosteroids are biologically active
and non-calcemic. CYP11A1 also hydroxylates vitamin D3 to produce 20(OH)D3, 20,23(OH)2D3
and 17,20,23(OH)3D3, and 1(OH)D3 to 1,20(OH)2D3. These compounds show differential antipro-
liferative and prodifferentiation activities in skin cells. 20(OH)D3 and 20,23(OH)2D3 are non-cal-
cemic at doses as high as 3 μg/kg, while 1,20(OH)2D3 is calcemic. We have analysed the biolog-
ical activities of the above novel secosteroids with a short or full-length side chain (compared to
1,25(OH)2D3) in normal melanocytes and melanoma cells. The novel secosteroids inhibited the
proliferation and behavior of normal and malignant melanocytes with a noted selectivity. In
melanocytes the inhibitory effect was potentiated by the addition of a 1αOH group to the secos-
teroid, while compounds with a shorter side chain were less or not effective. In melanomas there
was no difference between the novel secosteroids with or without an hydroxyl group at C1 and
they were of equal or greater potency than 1,25(OH)2D3 in inhibiting cell proliferation and colony
formation. However, some analogues with no side chain or a short one showed lower potency. No
effect on melanogenesis was observed. However, attenuation of dendrite formation in normal
melanocytes was seen only for 1,25(OH)2D3 and 1,20(OH)2D3. We conclude that above com-
pounds are excellent candidates for treatment of proliferative melanocytic disorders or melanoma.
Furthermore, we believe that we have identified vitamin D analogs that fulfill the definition of nat-
ural products and that retain the beneficial effects of 1,25(OH)2D3, while being non-toxic/non-cal-
cemic
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Vascular features of cutaneous metastastic melanoma 
A Raymond,1 C Longo,4 G Pellacani,4 JY Tcheung,1 P Puri,1,2 A Selim,1,2 D Tyler3 and KC Nelson1
1 Dermatology, Duke University, Durham, NC, 2 Pathology, Duke University, Durham, NC, 3
Surgery, Duke University, Durham, NC and 4 Dermatology, University of Modena and Reggio
Emilia, Modena, Italy
Current methodologies for evaluating vascularity in cutaneous melanoma range from histologic
examination to investigational models requiring systemic contrast agents. Reflectance confocal
microscopy (RCM) is an FDA-approved dynamic in-vivo imaging technique which offers several
advantages over established methods: human tumors may be imaged in-vivo; small, nascent ves-
sels are easily appreciated; and the dynamic interaction of leukocytes, vascular endothelium and
tumor may be directly visualized. Thirteen biopsy-proven cutaneous metastatic melanoma lesions
demonstrating prominent vascularity on RCM imaging were selected for inclusion. Clinical, der-
moscopic, and RCM images including video capture of vascular flow were obtained. All lesions
were excised and submitted for standard histology processing, with CD31 staining for selected
lesions. RCM images were reviewed for correlation with histologic features. All cases demonstrated
at least one area with an intimate approximation of tumor and convoluted vessels, which we describe
as the vascular-tumor interface. Vessel morphology was categorized and the average vessel diame-
ter (measured as a representative vascular cross-section with VivaScan software) was 37.6 μm (range:
17 - 85 μm). Four lesions demonstrated prominent leukocyte rolling along the vascular endothe-
lium. The vascular features of cutaneous melanoma metastases may be easily visualized utilizing
RCM. The vessel diameter and morphology are readily appreciated, particularly for smaller vessels.
Several lesions demonstrated prominent leukocyte activity along the vascular endothelium. As vas-
cular transendothelial migration of melanoma cells is mediated by many interrelated factors, includ-
ing vascular flow dynamics and leukocyte activity, direct visualization and quantification of leuko-
cyte activity may offer unique insights into the biology of tumor metastasis.
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Image color analysis method to quantify clinical efficacy of skin lightening product
D Qu and JV Scimeca Research and Development, Amway Corporation, Ada, MI
Quantification of clinical efficacy of skin lightening product is presented in this study. Convention-
ally skin lightening efficacy is assessed either by visual grading or by colorimetry. Subjectivity is a
concern with grading, while skin contact of colorimeter has caused large variation in the a* value.
Color analysis of digital photographs is a useful method which can achieve accurate measurement
if the color of a picture is properly corrected. Digital pictures were obtained from an in-use clini-
cal efficacy study in which thirty four Asian and Caucasian female volunteers participated. A test
product was applied to the face two times a week for 6 weeks. Facial pictures of each subject were
taken at baseline, and at weeks 2, 4 and 6 using VISIA-CR with embedded color standards. Color
values in RGB were measured on the forehead and cheeks, as well as on color standards, from
each picture. Color correction was carried out using in-house developed algorithms. Changes in
color were quantified from pictures before and after product application. The color correction step
significantly improved accuracy of color in clinical photos, with a reduction in %Error from 22.3%
to 4.0%. Skin lightening effects were hence detected, with statistical significance, from pictures
before and after the clinical study. The average L* value increased from 70.9 to 71.7 indicating the
subjects’ skin became whiter, with 76.5% of subjects showing improvement. The average a* value
decreased from 20.8 to 20.1 indicating their skin was less red, with 67.6% of subjects showing
improvement. The average b* was also decreased from 27.1 to 26.5 with 64.7% subjects showing
change indicating their skin was less yellow. The average skin tone, defined as ITA°, increased from
37.7 to 39.3, a 4.6% increase over the baseline with 79.4% of the volunteers showing improve-
ment. The image color analysis method can accurately measure changes in skin color due to prod-
uct application. Clinical efficacy of skin lightening product can therefore be quantitatively con-
firmed.
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A label-free indicator for melanoma cells based on the CH2-stretch ratio
S van den Driesche,2 W Witarski,3 S Pastorekova,3 H Breiteneder,1 MJ Vellekoop2 and C Hafner1,4
1 Department of Pathophysiology, Center of Pathophysiology, Infectiology and Immunology,
Medical University of Vienna, Vienna, Austria, 2 Institute of Sensor and Actuator Systems,
Vienna University of Technology, Vienna, Austria, 3 Institute of Virology, Slovak Academy of
Sciences, Bratislava, Slovakia and 4 Karl Landsteiner Institute for Dermatological Research,
St.Poelten, Austria
Infrared (IR) spectroscopy is a useful tool for the determination of global biochemical composition
of a sample. A number of recent cancer studies have suggested that the ratio of the CH2-symmetric
and CH2-antisymmetric stretching bands differs for normal and malignant cells and therefore may
be a potential marker for malignancy. A promising simple method for determining this ratio uses a
quadruple wavelength infrared system to probe the lipid region of the IR spectrum. For this study,
an adult primary human melanocyte cell line and three human melanoma cell lines were investi-
gated using this label-free measurement method for determination of CH2-symmetric to CH2-anti-
symmetric stretch ratios. To investigate whether the membrane stabilizing agent cholesterol had an
influence on this ratio, cell lines were exposed to the plasma membrane bound cholesterol reduc-
ing agent methyl-β–cyclodextrin. The CH2-stretch ratios of the three melanoma cell lines tested were
significantly increased compared to the adult human melanocytes. Measurement results of cells
exposed to methyl-β–cyclodextrin indicated that an increase in CH2-stretch ratio arises when there
is a decrease in, or a redistribution of, the membrane stabilizing agent cholesterol. This proof-of-
concept study shows that the proposed cell type discrimination method, based on the CH2-sym-
metric to CH2-antisymmetric stretch ratio, has the potential to be further developed into a label-free,
easy-to-use tool to improve the staging of suspicious cells or tissues.
738
AhR mediates FICZ-induced pigmentation
E Goyarts, L Ming, B Wolf, D Yarosh and N Pernodet Estee Lauder Research Laboratories,
Melville, NY
Activation of the aromatic hydrocarbon receptor (AhR) by xenobiotics has been proposed as a mech-
anism for inducing pigmentation. Here, we report our findings by using FICZ to induce AhR acti-
vation in keratinocytes (Fritsche et al., 2007) and the impact on melanogenesis. Normal human
keratinocytes were treated with FICZ and their conditioned media was then transferred to human
melanocytes. After 72h incubation, 25% increase of melanin content was measured with 100nM
FICZ. The increase in melanogenesis was dose-dependent. A 15% decrease in melanocyte prolif-
eration was measured during this time interval. However, human keratinocytes proliferation increased
by 15% after 72h with 100nM FICZ. Many signal transduction pathways contribute to the regula-
tion of melanogenesis. In this study, we activate AhR signaling in keratinocytes using nanomolar
amount of FICZ, which leads to an increase in melanin content.
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CCR7-expressing B16 melanoma cells down-regulate interferon (IFN)-γ-mediated inflamma-
tion and increase lymphangiogenesis in the tumor microenvironment
T Takekoshi,1 L Fang,2 R Sells1 and ST Hwang1 1 Dermatology, Medical College of Wisconsin,
Milwaukee, WI and 2 NCI, Bethesda, MD
The expression of the CC chemokine receptor-7 (CCR7) on cancers, including melanoma, augments
lymph node (LN) metastasis, but little is known about its role in lymphangiogenesis and anti-tumor
immunity. We injected control B16 murine melanoma cells (pLNCX2-B16) and CCR7-overexpressing
B16 cells (CCR7-B16) in murine footpads and compared resulting tumors at the protein and mRNA
level using immunostaining, Affymetrix gene microarray, and quantitative RT-PCR (qPCR). Although
control and CCR7-B16 primary tumors were of similar size, LN metastasis was dramatically enhanced
in CCR7-B16 tumors. Intratumoral CD45+ leukocytes and CD8+ T cells were diminished by >5 and
15 fold in CCR7-B16 (vs. control) tumors. Microarray analysis of leukocyte-depleted pLNCX2-B16
and CCR7-B16 tumor cell suspensions showed that 3 major groups of genes linked to IFN-γ sig-
naling pathways were down-regulated in the CCR7-B16 tumor microenvironment, including STAT1,
CXC chemokine receptors 9-11, CCL5 and CXCL10, MHC I, and MHC II, suggesting that activation
through CCR7 could down-regulate pathways critical for host anti-tumor immunity. In addition,
mRNA expression of the lymphatic marker podoplanin was up-regulated in CCR7-B16 tumors by
3.35 fold vs. control tumors. Anti-podoplanin mAb staining revealed a 3-fold increase in intratu-
moral lymphatic vessels (p<0.05) as well as a two-fold increase in invading tumor cells per lym-
phatic vessel (p<0.05) in CCR7-B16 vs. control tumors. Enhanced anti-VEGF-C staining was pres-
ent in CCR7-B16 vs. control tumors, suggesting that VEGF-C may play a role in CCR7-mediated
lymphangiogenesis. A subset of podoplanin+ vessels expressed CCR7 ligand (CCL21), explaining
the invasiveness of CCR7-B16 cells toward lymphatic vessels. In summary, CCR7-B16 tumors show
a dramatic decrease in IFN-γ-mediated inflammatory gene expression but increased expression of
VEGF-C, CCL21, and podoplanin. Enhanced lymphageogenesis may contribute to the dramatic
increase in LN metastasis in CCR7-expressing tumors.
728
A simple assay method for melanosome transfer
H Kim, H Choi, S Park and K Park Dermatology, Seoul National University Bundang Hospital,
Seongnam-si, Republic of Korea
Pigmentation is achieved by production of melanin in specialized organelles termed melanosomes
and by transfer of these organelles from melanocytes to surrounding keratinocytes. The chemical
basis of melanogenesis is relatively well known but the mechanism of melanosome transfer is not
well studied. Especially, many Asian women desire to have a flawless skin. Thus, there is a need for
the development of skin lightening agents. Most of hypopigmenting agents are tyrosinase inhibitors
and only a few agents are known to inhibit transfer of melanosomes. However, standardized method
to study melanosome transfer is not established yet. In this study, we tried to develop a simple method
to study melanosome transfer by using flow cytometry. Importantly, normal human keratinocytes
and normal human melanocytes had been used. Furthermore, side scatter (SSC) was analyzed in
the cells which showed the positivity against the keratinocyte-specific marker keratin 14. SSC is
caused by granularity of cells. If melanosome is transported into keratinocytes, granularity of ker-
atinocytes will increase. Thus, changes of SSC were analyzed in keratinocytes instead specific
staining against melanosomal proteins. Our methods are easy to apply and short time consuming
compared to previous methods. Thus, we propose that this method will be applicable to screen
many possible agents. In literature, it is reported that melanocyte-keratinocyte interaction induces
calcium signaling and melanin transfer to keratinocytes. It is reported that pigment transfer was
decreased when intracellular calcium was inhibited by calcium chelators. To verify the applicabil-
ity of our method, CaCl2 and Ca2+ chelator were added to co-culture of keratinocytes and
melanocytes.
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Expressing matrix metalloproteinase-2,9 in reconstructed human skin melanoma model with
MV3 cells
H Lu, Y Lv and Y Ma Dept. of Dermatology, Affiliated Hospital of Guiyang Medical University,
Guiyang, China
A reconstructed skin malignant melanoma model in vitro with MV3 melanoma cells on de-epider-
mized dermis (DED) has been established before by us. Our previous studies have shown in the
model the growing MV3 cells was in adhesion and attachment to the surface of the DED which
aggregated at the concave parts and circularly gathered at cavity of the cutaneous appendages along
the basement membrane zone(BMZ). However, a few of melanoma cells was breaking through the
BMZ getting into the surrounding tissues of DED, which indicated the reconstructed skin melanoma
model could be used as studying the invasion of melanoma cells in vitro. The purpose of this study
is further to investigate whether the expression of matrix metalloproteinase (MMP)-2 and- 9, which
is considered the most important proteases of tumor invasion and metastasis because of MMP-2 and
MMP-9 degradation of the main component of basement membrane. The MV3 cells were seeded
onto the prepared acellular dermis and maintained at the air-liquid interface after submerged cul-
ture about 15 days. The reconstructed skin malignant melanoma tissue was examined with HE, and
immunohistochemical staining with S-100 protein and HMB45. The MMP-2, 9 expressions was
checked using immunohistochemistry and RT-RCR. The result revealed that MV3 cells were grow-
ing and gathered into groups-like tumor nests on DED. The S-100 protein was positive and HMB45
were weak positive. A strong positive expression of MMP-2,-9 has been observed in tumor distri-
bution of the MV3 attachment at the basement membrane. Semiquantitative RT-PCR also revealed
MMP-2, 9 genes express in the reconstructed skin melanoma model. These studies demonstrate
that MV3 cells expression of MMP-2, 9 can enhance the tumor invasion in vitro mode of human
skin melanoma model.
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Inhibition of pigmentation by keratinocyte-derived sFRP2
J Lee,1 M Kim,1 J Yoon,2 J Kim,2 Y Lee,1 C Kim,1 J Lee1 and T Yoon2 1 Dermatology, Chungnam
National University, Daejeon, Republic of Korea and 2 Dermatology, Gyeongsang National
University, Jinju, Republic of Korea
A link between Wnt/β-catenin signaling and melanocyte differentiation has been revealed by the
finding that β-catenin forms a complex with lymphocyte enhancer factor-1 to up-regulate expres-
sion of the MITF gene. Also, β-catenin directly interacts with the MITF protein itself and then acti-
vates MITF-specific target genes. Conversely, the inhibitor for Wnt/β-catenin such as DKK1 is known
to inhibit melanocyte growth and function. In this study, we found that another Wnt/β-catenin
inhibitor sFRP2 was increased in epidermis of vitiligo patient. To investigate the effect of sFRP2, we
set the co-culture model in which HaCaT keratinocytes and melanocytes were incubated using Boy-
den’s chamber. After transduction of HaCaT with the recombinant adenovirus expressing sFRP2,
cells were loaded into upper chamber, and melanocytes were seeded in lower chamber. Interestinlgy,
the β-catenin level was significantly decreased in melanocytes by co-culture with sFRP2 overex-
pressing HaCaT cells. In addition, the protein levels for pigmentation-related molecules including
MITF, TRP1 and TRP1 were also down-regulated by co-culture with sFRP2 overexpressing HaCaT.
These results suggest that increase of sFRP2 in epidermal keratinocytes of vitiligo patient may decrease
the melanogenic potential of melanocytes, contributing the depigmentation.
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Nrf2 regulates melanogenesis by activating the PI3K/Akt pathway
J Shin,1 J Kim,1 H Kim,2 J Kim,2 M Im,1 C Kim,1 Y Seo,1 J Lee1 and T Yoon2 1 Dermatology,
Chungnam National University, Daejeon, Republic of Korea and 2 Dermatology, Gyeongsang
National University, Jinju, Republic of Korea
Nrf2 is a member of the “cap ‘n’ collar” family of transcription factors which encode detoxifying
enzymes and antioxidant proteins. Nrf2 is normally retained in the cytoplasm via interaction with
Keap1, an actin-binding protein, which also mediates its degradation via the ubiquitin–proteasome
pathway. Reactive oxygen species (ROS) has a paradoxical action on melanocytes because it not
only enhances depigmentation, but also increases pigmentation in the skin. We wondered if Nrf2
which regulates ROS detoxicification has an effect on melanogenesis. When normal epidermal
melanocytes were transduced with a recombinant adenovirus expressing Nrf2, tyorosinase activity
and total melanin production were significantly decreased. Consistent with these results, overex-
pression of Nrf2 led to marked decrease of pigmentation-related factors, such as MITF, tyrosinase,
TRP1 and DCT. Interestingly, overexpression of Nrf2 resulted in remarkable increase of phospho-
rylations of Akt, mTOR and S6 protein, suggesting Nrf2 modulates the PI3K/Akt pathway. Conversely,
inhibition of PI3K activity by treatment with Wortmannin reversed the Nrf2 effects on the expres-
sion of pigmentation-related molecules. These results strongly suggest that Nrf2 decreases the pig-
mentation through the activation of PI3K/Akt signaling pathway.
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B7-H1 expression in benign and malignant melanocytic lesions and colocalization with infil-
trating T lymphocytes
J Taube,1,2 R Anders,2 H Xu,1 S Topalian3 and L Chen3 1 Dermatology, Johns Hopkins, Baltimore,
MD, 2 Pathology, Johns Hopkins, Baltimore, MD and 3 Oncology, Johns Hopkins, Baltimore,
MD
B7-H1 is an immune-inhibitory protein expressed by many human cancers. A significant propor-
tion of metastatic melanomas express B7-H1, and anti-B7-H1 immunotherapies are currently in
clinical trials for patients with stage IV disease. The purpose of this study was to determine whether
benign nevi, melanoma in situ, and primary invasive melanomas of various histologic subtypes
also express B7-H1, and the potential relationship to tumor infiltrating lymphocytes (TILs). B7-H1
immunohistochemistry was performed using mAb 5H1 on archived, paraffin-embedded tissue, and
cases demonstrating more than 5% melanocyte expression were considered positive. Benign
nevi(n=40), melanoma in situ(n=11), and invasive melanomas(superficial spreading,n=14; nodu-
lar,n=15; lentigo maligna,n=3; desmoplastic,n=4; acral lentiginous,n=7) were scored. The degree
of TILs was also scored as mild(rare), moderate(focal), or severe(diffuse). We found that 35%(14/40)
of benign nevi expressed B7-H1(mean melanocyte expression=30%). 100% (14/14) of the positive
cases were associated with at least mild TILs, compared to 15%(4/26) of B7-H1 negative cases
(p<0.05), suggesting B7-H1 induction by T cell secreted cytokines such as IFN-γ. 35%(19/54) of
malignant lesions were B7-H1 positive, and 100%(19/19) of the positive cases were associated
with at least mild TILs, compared to 43%(15/35) of B7-H1 negative cases (p<0.05). In 95%(18/19)
of B7-H1+ melanomas, expression was observed solely at the interface with TILs. 45%(13/29) of
superficial spreading and nodular melanomas were B7-H1 positive(mean melanocyte expression
=16%), while other subtypes were B7-H1 negative(0/14). Geographic co-localization of B7-H1+
melanoyctes with TILs suggests that TILs may paradoxically promote their own downregulation by
secreting B7-H1 inducing cytokines. Both the association with TILs and the difference in expres-
sion by histologic subtype may provide insight into currently unknown B7-H1 signaling mecha-
nisms.
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Reduced expression of the tumor suppressor FBW7 in human melanoma
Y Cheng,1 M Martinka2 and G Li1 1 Dermatology and Skin Science, University of British
Columbia, Vancouver, BC, Canada and 2 Pathology, University of British Columbia,
Vancouver, BC, Canada
FBW7 (F-box and WD repeat domain-containing 7) is a member of the F-box family of proteins,
which function as interchangeable substrate recognition components of the SCF ubiquitin ligases.
FBW7 binds to key regulators of cell division and growth, including cyclin E, MYC, JUN and Notch.
Most FBW7 substrates are proto-oncogenes that are broadly implicated in the pathogenesis of human
cancers. FBW7 is widely considered as a tumor suppressor, and it has been reported that loss of
FBW7 function leads to chromosomal instability, probably owing to hyperactivation of its onco-
genic substrates. Recent studies have shown that FBW7 is mutated in a variety of human malig-
nancies. To investigate the role of FBW7 in human melanoma, we used tissue microarray technol-
ogy and immunohistochemistry to examine the expression of FBW7 in melanocytic lesions at different
stages and analyzed the correlation between FBW expression and clinicopathologic variables and
patient survival. The results showed that FBW7 expression is significantly reduced in primary
melanoma and metastatic melanoma, compared with normal and dysplastic nevi (p<0.05). We
also found significant lower expression in advanced primary melanoma (AJCC stage III-IV) than
melanoma at AJCC stage 1-II (p=0.027). Furthermore, we showed a strong correlation between
negative FBW7 expression and a worse 5-year survival in melanoma patients (p=0.031). Moreover,
we found the significant reduction (60%) of mRNA level of FBW7 in several melanoma cell lines
compared with normal melanocytes. Our in vitro studies showed that over-expression of Fbw7 in
MMRU melanoma cell line do not affect the cell proliferation. Interestingly, we found Fbw7-γ pro-
moted MMRU cell migration in wound healing assay. We also found that knockdown of Fbw7-α
and Fbw7-β by specific siRNA increased p53 and cyclin E expression by western blotting. Overall,
our data indicate that Fbw7 is a potential biomarker for melanoma progression.
747
MSH does not affect TNFα-induced NFκB activation in cultured human skin melanocytes
J Wan,1 F Lin,1,3 R Chang,2 N Kouttab,2 A Xu3 and Y Wan1 1 Providence College, Providence, RI,
2 The 3rd Hospital of Hangzhou, Hangzhou, China and 3 Boston University, Boston, MA
It has been suggested that cytokines, especially TNFα, play important roles in vitiligo. High con-
centrations of TNFα produced from the surrounding cells induce inflammatory activities and apop-
tosis of melanocytes, and inhibit differentiation of melanocyte stem cells. Limited studies have shown
that anti-TNFα antibodies have clinical benefits for vitiligo. However, the cell signaling pathways
are yet to be elucidated. We undertook this study to investigate the effect of TNFα on cultured human
skin melanocytes. Confocal microscopy data demonstrate that TNFα at the concentration of 10 ng/ml
induces NFκB p65 translocation from cytoplasm to nucleus in a time dependent manner. Western
blot analysis shows that TNFα induces IκB phosphorylation and degradation. Interestingly, but con-
trary to the report from other cells, MSH does not have any effect of TNFα-induced IκB degrada-
tion and p65 translocation in cultured human skin melanocytes. MSH, however, induces the acti-
vation of mTOR pathway as indicated by phosphorylation of S6 ribosomal protein. As expected,
TNFα induces p38 and AMPK in melanocytes. Collectively, our data provide insight into the molec-
ular mechanism of TNFα in melanocytes, supporting the notion that anti-TNFα antibodies could be
applied to treat vitiligo.
749
Time interval from diagnostic biopsy to surgical excision for melanoma at 4 institutions: Is it
acceptable?
LS Huff,1 CA Chang,2 P Blomquist,3 N Konnikov4 and RP Dellavalle1,5,6 1 University of Colorado
School of Medicine, Aurora, CO, 2 Dermatology, Tufts Medical Center, Boston, MA, 3 Health
Sciences Library, University of Colorado, Aurora, CO, 4 Dermatology Service, Department of
Veterans Affairs Medical Center, Boston, MA, 5 Dermatology Service, Department of Veterans
Affairs Medical Center, Denver, CO and 6 Department of Epidemiology, Colorado School of
Public Health, Aurora, CO
Early diagnosis and timely treatment matter for curing melanoma. The surgical interval is defined
as the time between diagnostic biopsy and surgical excision. This project measured surgical inter-
vals through retrospective chart review at 4 dermatology clinics (2 Veterans Affairs Dermatology
Clinics, 1 University Hospital Dermatology Clinic, and 1 University Hospital Melanoma Clinic). A
total of 205 melanoma cases were included. Median surgical intervals ranged from 23.5 to 38
days. There was a significant association between hospital and time between biopsy and pathology
report (time to diagnosis), time between pathology report and surgical excision (time to surgery),
and total surgical interval (p<0.0001, p=0.02, and p<0.0001 respectively). There was a significant
association between clinical department and time to surgery and total surgical interval (p<0.0001,
and p=0.001 respectively). Certain hospitals and departments had significantly longer time inter-
vals during pair-wise comparisons and the maximum difference was 68% (p<0.0001). It unclear
from the current literature what length of surgical interval adversely affects melanoma outcomes.
Based on current literature, a reasonable surgical interval appears to be 30 days and preliminary,
hypothesis-based, informal guidelines from expert opinion recommend treatment within 4-6 weeks.
At the 4 institutions measured in this study, the median surgical intervals varied significantly between
institutions and departments, but all were within a 6-week frame.
748
Novel cAMP signaling pathways in melanoma
JH Zippin, C Magro, L Levin and J Buck Dermatology, Weill Cornell Medical College, New York,
NY
The Ras/Raf/ERK signaling cascade is implicated in multiple aspects of melanoma, including
melanomagenesis, invasion, and metastasis. The cAMP pathway is a known modulator of the Ras
pathway, and while a key role for cAMP in melanoma pathogenesis is established, pinpointing the
source of cAMP has remained unclear. We study a distinct source of cAMP in mammalian cells
called soluble adenylyl cyclase (sAC). Unlike transmembrane adenylyl cyclases (tmACs), sAC is not
responsive to G proteins, and instead is regulated by calcium, bicarbonate ions, and ATP. In addi-
tion, sAC is present in the nucleus, mitochondria, and cytoplasm. We examined the role of cAMP
signaling microdomains initiated by soluble adenylyl cyclase in melanoma biology. We performed
sAC immunohistochemistry on over 140 cases of melanocytic proliferations; examined the expres-
sion level of sAC in human melanoma cell lines with distinct Ras pathway mutations; and, using
sAC-specific inhibitors, evaluated the role of sAC-dependent cAMP in melanoma proliferation. In
biopsied benign nevi, sAC is localized at the golgi. In dysplastic nevi, sAC begins to move into the
nucleus and the previously discrete golgi localization becomes diffusely cytoplasmic. In fully devel-
oped melanoma, sAC is almost exclusively nuclear. When comparing dysplastic nevi and melanoma,
the presence of nuclear sAC and absence of dot-like golgi staining is 92% sensitive and 88% spe-
cific for the diagnosis of melanoma. To examine the role of sAC in melanoma biology we have
studied human melanoma cell lines with Ras mutations, B-Raf mutations, and neither Ras nor B-
Raf mutations. sAC expression and responsiveness to sAC inhibition varies between different cell
lines in a Ras/Raf mutation specific manner. sAC activity is essential for the proliferation of melanoma
cell lines harboring Ras mutations or no mutations to either Ras or Raf. On the other hand, melanoma
cell lines with B-Raf mutation seem unaffected by sAC inhibitors. Soluble adenylyl cyclase repre-
sents a possible diagnostic adjunct for melanoma and sAC-dependent cAMP appears essential for
melanoma proliferation with certain mutational status.
746
MSH protects from H2O2-induced loss of melanocyte dendricity via activation of mTOR path-
way
F Lin,1,3 J Wan,1 R Chang,2 G Brum,1 N Kouttab,2 A Xu3 and Y Wan1 1 Providence College,
Providence, RI, 2 Boston University, Boston, MA and 3 The 3rd Hospital of Hangzhou,
Hangzhou, China
Vitiligo is a skin depigmentation disorder with increased prevalence. Among recognized mecha-
nisms is the oxidative stress that affects melanocytes. Accumulated studies have shown that high
concentrations of H2O2 induce apoptotic activities of melanocytes. Few studies have been done
with low doses of H2O2. We undertook this study to investigate the effect of moderate concentra-
tions of H2O2 on cultured human skin melanocytes. Our results show that H2O2 at the concen-
tration of 200 μM induces loss of dendricity of human skin melanocytes in a time dependent man-
ner, as indicated by actin and tubulin filaments observed by confocal microscopy. Western blot
analysis shows that H2O2 treatment activates p38 and AMPK pathways and inactivates AKT/mTOR
pathway. Our data demonstrate that MSH pretreatment protects from H2O2-induced loss of den-
dricity, while MSH alone enhances dendricity and activates AKT/mTOR pathway. PI3K/AKT inhibitor
LY 294002 and mTOR inhibitor Rapamycin inhibit MSH-induced dendricity. Collectively, our data
suggest that modulation of AKT/mTOR pathway may lead to better clinical management of vitiligo.
750
MKK6 increases the melanocyte dendricity through the regulation of Rho family GTPases
M Kim,1 J Lee,1 J Kim,1 J Kim,1 K Sohn,1 C Kim,1 J Lee1 and T Yoon2 1 Dermatology, School of
Medicine, Chungnam National University, Daejeon, Republic of Korea and 2 Department of
Dermatology, School of Medicine, Gyeongsang National University, Jinju, Republic of Korea
Melanocyte dendrites serve as the principal conduit for melanosome transfer. The dendrite forma-
tion requires actin polymerization mediated by Rho family GTPases including RhoA, Rac1 and
Cdc42. The aim of this study is to investigate and explore the involvement of p38 MAPK in melanocyte
dendrite formation. We transduced melanoma cells with adenovirus harboring the expression cas-
sette for constitutive active form of MKK6, an upstream MAPKK for p38 MAPK. We investigated the
effect of melanogenic inducers on melanocyte dendricity, using SK-mel-24 melanoma cells because
that this cell line is refractory to several melanogenic inducers in terms of melanogenesis. TPA-
induced the phosphorylation of p38 MAPK and the elongation of dendrite length, suggesting that
MKK6 may be involved in this process. Overexpression of the constitutive active formof MKK6
resulted in significant elongation of dendrites in the melanoma cell line SK-mel-24. Moreover,
overexpression of MKK6 ultimately led to the upregulation of Cdc42 and Rac1, suggesting that MKK6
acts as a crucial upstream signaling molecule for Rho family GTPases. When overexpressed in nor-
mal human epidermal melanocytes, MKK6 led also the increase of dendrite length. These results
suggest that MKK6 is an authentic regulator for melanocytes dendricity, through the modulation of
Rho family GTPases.
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Melanocytic nevus nests unexpectedly contain two cell populations – nevus cells and myeloid
(CD11c+) dendritic cells
N Gulati,1 F Kiecker,2 NS McNutt,1 H Mitsui1 and JG Krueger1 1 Laboratory for Investigative
Dermatology, The Rockefeller University, New York, NY and 2 Department of Dermatology
and Allergy, Charité – Universitatsmedizin, Berlin, Germany
Melanoma is a life-threatening malignant disease arising from melanocytes. It is known that
melanomas contain tumor-infiltrating leukocytes, and several therapeutic strategies attempt to take
advantage of this. However, little is known about the presence and activation states of dendritic cells
(DCs) and T lymphocytes infiltrating nevi, potential precursors of melanoma. We used immunohis-
tochemistry and immunofluorescence on frozen tissue sections to characterize the immune infil-
trates in 20 dysplastic nevi. We have found significant increases in both CD11c+ DCs (6.4-fold)
and CD3+ T lymphocytes (3.2-fold) in nevi as compared to normal skin by cell counts with NIH
ImageJ software (p<0.0001 for each comparison). The numbers of DCs and T lymphocytes had a
strong correlation (R = 0.71), perhaps implying a functional relationship between these two cell
types. Most of the DCs were identified as BDCA1- and DCLAMP-, therefore suggesting an inflam-
matory, immature phenotype. A subset of CD11c+ cells stained for TNF-related apoptosis-inducing
ligand (TRAIL), thus confirming the presence of inflammatory DCs. Dysplastic nevi have previously
been found to express HLA-D, but it has been assumed that this key immune molecule was induced
on melanocytes/nevus cells by inflammation, particularly since nevus nests appear as homogeneous
cell populations by conventional staining methods. However, our results demonstrate a marked
amount of DCs within nevi that are juxtaposed with nevus cells organized in nests, as evidenced
by double-label immunofluorescence. In addition, immunofluorescence showed much more co-
labeling of HLA-DR with CD11c compared to the melanocyte marker MLANA, thus implying that
the HLA-D positivity previously ascribed to melanocytes is in fact due to infiltrating DCs. These infil-
trating leukocytes warrant further investigation as they potentially affect tumor growth and/or reg-
ulate immune responses to abnormal melanocytes.
740
Genetic analysis of pre-malignant pigmented lesions in xeroderma pigmentosum patients
T Masaki,1 JJ DiGiovanna,1 Y Wang,1 SG Khan,1 T Hornyak,1 M Raffeld,2 C Lee2 and KH Kraemer1
1 Derm Br, NCI, Bethesda, MD and 2 Lab of Pathology, NCI, Bethesda, MD
We are examining early mutagenic changes in pigmented skin lesions in xeroderma pigmentosum
(XP) patients that may lead to melanoma. XP is a rare autosomal recessive disease, with sun sensi-
tivity and a high frequency of melanoma skin cancers. XP patients have defective post-UV DNA
nucleotide excision repair that leads to accumulations of DNA mutations. We reported previously
that mutations in the PTEN tumor suppressor gene were present in 56% of XP melanomas (PNAS
106:6279 (2009)). Further, 91% of these mutations were UV type. In the current study we analyzed
2 additional melanomas in situ (MIS), 1 invasive melanoma and 11 nevi from 3 XP patients who
had biopsies at the NIH Clinical Center as long ago as 1988. The paraffin blocks were recut and
melanoma cells and nevi on the biopsies were removed by laser capture microdissection. The DNA
was extracted and sequenced. The one MIS and 63 % of nevi had PTEN mutations. In the nevi, 69
% of PTEN mutations were UV type. We are currently investigating possible differences in muta-
tions in PTEN, BRAF and ERBB4 genes in benign pigmented lesions and melanomas in XP patients.
741
Agonistic signaling via neurokinin-1 receptor is required for anti-melanoma immunity elicited
by cutaneous genetic immunizations
AR Mathers,1,3 O Tkacheva,1 BM Janelsins,1,3 W Shufesky,2 AE Morelli2,3 and AT Larregina1,3 1
Dermatology, University of Pittsburgh, Pittsburgh, PA, 2 Surgery, University of Pittsburgh,
Pittsburgh, PA and 3 Immunology, University of Pittsburgh, Pittsburgh, PA
Tumor vaccines delivered to the skin constitute promising alternatives to current therapies for
melanomas. However, in spite of initial enthusiasm, melanoma vaccines have not generated the
beneficial results expected. Hence, there is a need for an in-depth understanding of the mechanisms
underlying effective cutaneous immunizations against melanocytic Ags. The immune function of
the skin, a richly innervated organ, is ideal for administration of efficient cancer vaccines. In fact,
agonistic signaling of skin cells via neurokinin-1 receptor (NK1R), by the pro-inflammatory neu-
ropeptide substance-P (SP) released by nerve endings, promotes T helper-1 (Th1) and T cytotoxic-1
(CTL-Tc1) immunity to foreign Ags. Here, we demonstrate in mice, that elicitation of cellular immu-
nity by cutaneous gene gun (GG) immunizations requires agonistic signaling via NK1R. Accord-
ingly, GG-immunization against the melanocyte self-Ag, tyrosine-related-protein-2 (TRP-2) (GG-
TRP-2), delivered to the skin of NK1R-/-KO mice failed to induce TRP-2-specific cellular immunity.
Conversely, the use of the NK1R agonist [Sar9Met O2)11]-SP (SarSP) used as adjuvant at the immu-
nization site in C57BL-6 WT mice significantly enhanced the ability of GG-TRP-2 to elicit TRP-2-
specific effector and memory Th1 and CTL-Tc1 immunity. This resulted in prevention of melanoma
growth and increased survival of mice challenged with melanoma cells, and overcame any poten-
tial effect of the neuropeptide on promotion of tumor growth. Our results are highly relevant for
development of effective tumor vaccines, as they shed light on the mechanisms involved in effi-
cient elicitation of cellular immunity through cutaneous delivery of weakly immunogenic tumor
Ags.
742
Melanoma classification based on dermoscopic features
MI Sanchez, HS Rabinovitz, M Oliviero and JM Grichnik Dermatology, University of Miami,
Miami, FL
Primary cutaneous melanomas are traditionally classified as acral lentiginous (ALM), lentigo maligna
(LMM), superficial spreading (SSM), and nodular melanoma (NM). Exclusion of nodular and acral
melanomas leaves just 2 categories LMM and SSM to describe the remaining melanomas on the
skin surface. The terms chronic sun damage and non chronic/intermittent sun damage have also
been applied to subcatergorize melanomas. Genetic analysis has revealed that BRAF, NRAS, and
KIT are the major growth promoting mutated genes in cutaneous melanoma. However, there is still
a significant fraction of melanomas for which the growth promoting mutation is unknown. There is
a correlation of increased KIT mutations with LMM / chronic sun damage melanomas and BRAF
mutations with SSM non-chronic/intermittent sun damage melanomas; however, there is not a pre-
cise correlation with tumor subtype. We hypothesize that the underlining growth promoting muta-
tion will drive a specific pattern of melanoma on the skin surface and that the current classification
system is insufficient to segregate the different melanoma types. Dermoscopy allows for improved
visualization of melanoma growth patterns and may yield better segregation of melanoma sub-
groups. We reviewed a collection of 100 dermoscopic images of melanomas removed at the Uni-
versity of Miami or in Plantation Florida for consistent patterns. These patterns were then reviewed
by two expert dermoscopists. We were able to define 10 primary patterns which include 1) multi-
color multicomponent, 2) negative network, 3) sparing of epidermal crease, 4) rhomboid, 5) polyg-
onal, 6) disorganized fine network, 7) perifollicular pigmented, 8) gray dot/ regression, 9) homoge-
neous, and 10) symmetrical pseudopods pattern. These patterns appear to define unique
subpopulations of primary cutaneous melanomas beyond that of the classical categories of SSM and
LMM. The presence of these multiple different definable dermoscopic patterns suggests that there
are more melanomas subtypes then previously defined and that these subtypes may reflect unique
underlying growth promoting mutations.
743
Transcriptome profiling of whole blood cells identifies PLEK2 and C1QB in human melanoma
Y Luo,1 S Robinson,2 J Fujita,1 L Siconolfi,3 J Magidson,4 CK Edwards,1 K Wassmann,3 K Storm,3
DA Norris,1 D Bankaitis-Davis,3 WA Robinson2 and M Fujita1 1 Dermatology, University of
Colorado Denver, Aurora, CO, 2 Medicine, University of Colorado Denver, Aurora, CO, 3
Source MDx, Boulder, CO and 4 Statistical Innovations, Belmont, MA
Peripheral whole blood is a “nucleic acid-rich” and “inflammatory cell-rich” information reservoir
and represents systemic processes altered by the presence of cancer cells. In order to identify bio-
markers for cancer, we conducted transcriptome profiling of peripheral whole blood cells from
melanoma patients. To overcome challenges associated with blood-based gene expression analy-
sis, we used a PAXgeneTM tube to instantly stabilize RNA from whole blood and NuGEN OvationTM
system to amplify non-globin RNA without the impact of globin RNA for microarray analysis. The
combined use of these systems resulted in the identification of 78 unique genes differentially expressed
in the blood of melanoma patients. Of these, 68 genes were further analyzed by quantitative RT-
PCR using whole blood samples from 45 newly diagnosed melanoma patients (stage I to IV) and
50 healthy control individuals. Thirty-nine genes were verified to be differentially expressed in blood
samples from melanoma patients. A stepwise logit analysis selected eighteen 2-gene signatures that
distinguish melanoma from healthy controls. Of these, a 2-gene signature consisting of PLEK2 and
C1QB led to the best result that correctly classified 93.3% melanoma patients and 90% healthy con-
trols. Both genes were upregulated in blood samples of melanoma patients from all stages. Further
analysis using blood fractionation showed that CD45- and CD45+ populations were responsible
for the altered expression levels of PLEK2 and C1QB, respectively and that C1QB expression was
upregualted by culturing with melanoma-conditioned-medium. The current study provides the first
analysis of whole blood-based transcriptome biomarkers for malignant melanoma. The expression
of PLEK2, the strongest gene to classify melanoma patients, in CD45- subsets illustrates the impor-
tance of analyzing whole blood cells for biomarker studies.
744
Meiosis protein REC8 is expressed in melanoma
AS Oriolo,1 MI Sanchez,1 J Li,1 Z Liu2 and JM Grichnik1 1 Dermatology, University of Miami,
Miami, FL and 2 Surgery, University of Miami, Miami, FL
Genomic instability is a hallmark of cancer. Three major areas are under investigation for contri-
butions to genomic instability: defects in DNA repair machinery, telomere crisis, and defective
mitotic spindle assembly defects. A fourth area worthy of consideration is the collision of meiosis
and mitosis pathways, meiomitosis. Both, mitosis and meiosis are preceded by an association of
sister chromatids which involves specific protein complexes known as cohesins. The cohesin com-
plex in mitosis includes SMC1, SMC3, and SCC1/RAD21. In meiosis SCC1/RAD21 is replaced by
REC8, a 547-aminoacid phosphoprotein that serves both to bind sister chromatids together and to
catalyze cross over events between homologous chromosomes. We examined the DM1N, DM2N,
and DM3N melanoma lines for REC8 by western blot analysis and found the meiosis protein was
present in all three tumor lines. Surprisingly, this protein was also found in a number of normal cell
lines suggesting REC8 expression is not restricted to germ cells undergoing meiosis or malignancy.
Immunohistochemistry of melanoma cell lines primarily revealed a cytoplasmic pattern with more
intense staining in polyploid cells. Immunohistochemistry of benign nevus, primary melanoma, and
metastatic melanoma tissues revealed significant heterogeneity with both nuclear and cytoplasmic
patterns of REC8 localization. Nuclear REC8 expression was predominant in 86% (18/21) of the
benign nevi, 64% (36/56) of the melanomas, and 42% (8/19) of the metastatic lesions. Thus, REC8
appears to be widely expressed in a number of somatic cell types pointing to a novel function of
this protein beyond meiosis. Both nuclear and cytoplasmic localization patterns were noted in tis-
sue suggesting the protein is shuttled between both compartments. The increased nuclear staining
in benign nevi may suggest a role in senescence, while the apparent increased cytoplamic staining
in some polyploid cells may suggest a role in abnormal nuclear division. The role and the regula-
tion of this protein in benign and malignant somatic cell types remains to be elucidated.
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Reduced expression of the tumor suppressor FBW7 in human melanoma
Y Cheng,1 M Martinka2 and G Li1 1 Dermatology and Skin Science, University of British
Columbia, Vancouver, BC, Canada and 2 Pathology, University of British Columbia,
Vancouver, BC, Canada
FBW7 (F-box and WD repeat domain-containing 7) is a member of the F-box family of proteins,
which function as interchangeable substrate recognition components of the SCF ubiquitin ligases.
FBW7 binds to key regulators of cell division and growth, including cyclin E, MYC, JUN and Notch.
Most FBW7 substrates are proto-oncogenes that are broadly implicated in the pathogenesis of human
cancers. FBW7 is widely considered as a tumor suppressor, and it has been reported that loss of
FBW7 function leads to chromosomal instability, probably owing to hyperactivation of its onco-
genic substrates. Recent studies have shown that FBW7 is mutated in a variety of human malig-
nancies. To investigate the role of FBW7 in human melanoma, we used tissue microarray technol-
ogy and immunohistochemistry to examine the expression of FBW7 in melanocytic lesions at different
stages and analyzed the correlation between FBW expression and clinicopathologic variables and
patient survival. The results showed that FBW7 expression is significantly reduced in primary
melanoma and metastatic melanoma, compared with normal and dysplastic nevi (p<0.05). We
also found significant lower expression in advanced primary melanoma (AJCC stage III-IV) than
melanoma at AJCC stage 1-II (p=0.027). Furthermore, we showed a strong correlation between
negative FBW7 expression and a worse 5-year survival in melanoma patients (p=0.031). Moreover,
we found the significant reduction (60%) of mRNA level of FBW7 in several melanoma cell lines
compared with normal melanocytes. Our in vitro studies showed that over-expression of Fbw7 in
MMRU melanoma cell line do not affect the cell proliferation. Interestingly, we found Fbw7-γ pro-
moted MMRU cell migration in wound healing assay. We also found that knockdown of Fbw7-α
and Fbw7-β by specific siRNA increased p53 and cyclin E expression by western blotting. Overall,
our data indicate that Fbw7 is a potential biomarker for melanoma progression.
747
MSH does not affect TNFα-induced NFκB activation in cultured human skin melanocytes
J Wan,1 F Lin,1,3 R Chang,2 N Kouttab,2 A Xu3 and Y Wan1 1 Providence College, Providence, RI,
2 The 3rd Hospital of Hangzhou, Hangzhou, China and 3 Boston University, Boston, MA
It has been suggested that cytokines, especially TNFα, play important roles in vitiligo. High con-
centrations of TNFα produced from the surrounding cells induce inflammatory activities and apop-
tosis of melanocytes, and inhibit differentiation of melanocyte stem cells. Limited studies have shown
that anti-TNFα antibodies have clinical benefits for vitiligo. However, the cell signaling pathways
are yet to be elucidated. We undertook this study to investigate the effect of TNFα on cultured human
skin melanocytes. Confocal microscopy data demonstrate that TNFα at the concentration of 10 ng/ml
induces NFκB p65 translocation from cytoplasm to nucleus in a time dependent manner. Western
blot analysis shows that TNFα induces IκB phosphorylation and degradation. Interestingly, but con-
trary to the report from other cells, MSH does not have any effect of TNFα-induced IκB degrada-
tion and p65 translocation in cultured human skin melanocytes. MSH, however, induces the acti-
vation of mTOR pathway as indicated by phosphorylation of S6 ribosomal protein. As expected,
TNFα induces p38 and AMPK in melanocytes. Collectively, our data provide insight into the molec-
ular mechanism of TNFα in melanocytes, supporting the notion that anti-TNFα antibodies could be
applied to treat vitiligo.
749
Time interval from diagnostic biopsy to surgical excision for melanoma at 4 institutions: Is it
acceptable?
LS Huff,1 CA Chang,2 P Blomquist,3 N Konnikov4 and RP Dellavalle1,5,6 1 University of Colorado
School of Medicine, Aurora, CO, 2 Dermatology, Tufts Medical Center, Boston, MA, 3 Health
Sciences Library, University of Colorado, Aurora, CO, 4 Dermatology Service, Department of
Veterans Affairs Medical Center, Boston, MA, 5 Dermatology Service, Department of Veterans
Affairs Medical Center, Denver, CO and 6 Department of Epidemiology, Colorado School of
Public Health, Aurora, CO
Early diagnosis and timely treatment matter for curing melanoma. The surgical interval is defined
as the time between diagnostic biopsy and surgical excision. This project measured surgical inter-
vals through retrospective chart review at 4 dermatology clinics (2 Veterans Affairs Dermatology
Clinics, 1 University Hospital Dermatology Clinic, and 1 University Hospital Melanoma Clinic). A
total of 205 melanoma cases were included. Median surgical intervals ranged from 23.5 to 38
days. There was a significant association between hospital and time between biopsy and pathology
report (time to diagnosis), time between pathology report and surgical excision (time to surgery),
and total surgical interval (p<0.0001, p=0.02, and p<0.0001 respectively). There was a significant
association between clinical department and time to surgery and total surgical interval (p<0.0001,
and p=0.001 respectively). Certain hospitals and departments had significantly longer time inter-
vals during pair-wise comparisons and the maximum difference was 68% (p<0.0001). It unclear
from the current literature what length of surgical interval adversely affects melanoma outcomes.
Based on current literature, a reasonable surgical interval appears to be 30 days and preliminary,
hypothesis-based, informal guidelines from expert opinion recommend treatment within 4-6 weeks.
At the 4 institutions measured in this study, the median surgical intervals varied significantly between
institutions and departments, but all were within a 6-week frame.
748
Novel cAMP signaling pathways in melanoma
JH Zippin, C Magro, L Levin and J Buck Dermatology, Weill Cornell Medical College, New York,
NY
The Ras/Raf/ERK signaling cascade is implicated in multiple aspects of melanoma, including
melanomagenesis, invasion, and metastasis. The cAMP pathway is a known modulator of the Ras
pathway, and while a key role for cAMP in melanoma pathogenesis is established, pinpointing the
source of cAMP has remained unclear. We study a distinct source of cAMP in mammalian cells
called soluble adenylyl cyclase (sAC). Unlike transmembrane adenylyl cyclases (tmACs), sAC is not
responsive to G proteins, and instead is regulated by calcium, bicarbonate ions, and ATP. In addi-
tion, sAC is present in the nucleus, mitochondria, and cytoplasm. We examined the role of cAMP
signaling microdomains initiated by soluble adenylyl cyclase in melanoma biology. We performed
sAC immunohistochemistry on over 140 cases of melanocytic proliferations; examined the expres-
sion level of sAC in human melanoma cell lines with distinct Ras pathway mutations; and, using
sAC-specific inhibitors, evaluated the role of sAC-dependent cAMP in melanoma proliferation. In
biopsied benign nevi, sAC is localized at the golgi. In dysplastic nevi, sAC begins to move into the
nucleus and the previously discrete golgi localization becomes diffusely cytoplasmic. In fully devel-
oped melanoma, sAC is almost exclusively nuclear. When comparing dysplastic nevi and melanoma,
the presence of nuclear sAC and absence of dot-like golgi staining is 92% sensitive and 88% spe-
cific for the diagnosis of melanoma. To examine the role of sAC in melanoma biology we have
studied human melanoma cell lines with Ras mutations, B-Raf mutations, and neither Ras nor B-
Raf mutations. sAC expression and responsiveness to sAC inhibition varies between different cell
lines in a Ras/Raf mutation specific manner. sAC activity is essential for the proliferation of melanoma
cell lines harboring Ras mutations or no mutations to either Ras or Raf. On the other hand, melanoma
cell lines with B-Raf mutation seem unaffected by sAC inhibitors. Soluble adenylyl cyclase repre-
sents a possible diagnostic adjunct for melanoma and sAC-dependent cAMP appears essential for
melanoma proliferation with certain mutational status.
746
MSH protects from H2O2-induced loss of melanocyte dendricity via activation of mTOR path-
way
F Lin,1,3 J Wan,1 R Chang,2 G Brum,1 N Kouttab,2 A Xu3 and Y Wan1 1 Providence College,
Providence, RI, 2 Boston University, Boston, MA and 3 The 3rd Hospital of Hangzhou,
Hangzhou, China
Vitiligo is a skin depigmentation disorder with increased prevalence. Among recognized mecha-
nisms is the oxidative stress that affects melanocytes. Accumulated studies have shown that high
concentrations of H2O2 induce apoptotic activities of melanocytes. Few studies have been done
with low doses of H2O2. We undertook this study to investigate the effect of moderate concentra-
tions of H2O2 on cultured human skin melanocytes. Our results show that H2O2 at the concen-
tration of 200 μM induces loss of dendricity of human skin melanocytes in a time dependent man-
ner, as indicated by actin and tubulin filaments observed by confocal microscopy. Western blot
analysis shows that H2O2 treatment activates p38 and AMPK pathways and inactivates AKT/mTOR
pathway. Our data demonstrate that MSH pretreatment protects from H2O2-induced loss of den-
dricity, while MSH alone enhances dendricity and activates AKT/mTOR pathway. PI3K/AKT inhibitor
LY 294002 and mTOR inhibitor Rapamycin inhibit MSH-induced dendricity. Collectively, our data
suggest that modulation of AKT/mTOR pathway may lead to better clinical management of vitiligo.
750
MKK6 increases the melanocyte dendricity through the regulation of Rho family GTPases
M Kim,1 J Lee,1 J Kim,1 J Kim,1 K Sohn,1 C Kim,1 J Lee1 and T Yoon2 1 Dermatology, School of
Medicine, Chungnam National University, Daejeon, Republic of Korea and 2 Department of
Dermatology, School of Medicine, Gyeongsang National University, Jinju, Republic of Korea
Melanocyte dendrites serve as the principal conduit for melanosome transfer. The dendrite forma-
tion requires actin polymerization mediated by Rho family GTPases including RhoA, Rac1 and
Cdc42. The aim of this study is to investigate and explore the involvement of p38 MAPK in melanocyte
dendrite formation. We transduced melanoma cells with adenovirus harboring the expression cas-
sette for constitutive active form of MKK6, an upstream MAPKK for p38 MAPK. We investigated the
effect of melanogenic inducers on melanocyte dendricity, using SK-mel-24 melanoma cells because
that this cell line is refractory to several melanogenic inducers in terms of melanogenesis. TPA-
induced the phosphorylation of p38 MAPK and the elongation of dendrite length, suggesting that
MKK6 may be involved in this process. Overexpression of the constitutive active formof MKK6
resulted in significant elongation of dendrites in the melanoma cell line SK-mel-24. Moreover,
overexpression of MKK6 ultimately led to the upregulation of Cdc42 and Rac1, suggesting that MKK6
acts as a crucial upstream signaling molecule for Rho family GTPases. When overexpressed in nor-
mal human epidermal melanocytes, MKK6 led also the increase of dendrite length. These results
suggest that MKK6 is an authentic regulator for melanocytes dendricity, through the modulation of
Rho family GTPases.
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Melanocytic nevus nests unexpectedly contain two cell populations – nevus cells and myeloid
(CD11c+) dendritic cells
N Gulati,1 F Kiecker,2 NS McNutt,1 H Mitsui1 and JG Krueger1 1 Laboratory for Investigative
Dermatology, The Rockefeller University, New York, NY and 2 Department of Dermatology
and Allergy, Charité – Universitatsmedizin, Berlin, Germany
Melanoma is a life-threatening malignant disease arising from melanocytes. It is known that
melanomas contain tumor-infiltrating leukocytes, and several therapeutic strategies attempt to take
advantage of this. However, little is known about the presence and activation states of dendritic cells
(DCs) and T lymphocytes infiltrating nevi, potential precursors of melanoma. We used immunohis-
tochemistry and immunofluorescence on frozen tissue sections to characterize the immune infil-
trates in 20 dysplastic nevi. We have found significant increases in both CD11c+ DCs (6.4-fold)
and CD3+ T lymphocytes (3.2-fold) in nevi as compared to normal skin by cell counts with NIH
ImageJ software (p<0.0001 for each comparison). The numbers of DCs and T lymphocytes had a
strong correlation (R = 0.71), perhaps implying a functional relationship between these two cell
types. Most of the DCs were identified as BDCA1- and DCLAMP-, therefore suggesting an inflam-
matory, immature phenotype. A subset of CD11c+ cells stained for TNF-related apoptosis-inducing
ligand (TRAIL), thus confirming the presence of inflammatory DCs. Dysplastic nevi have previously
been found to express HLA-D, but it has been assumed that this key immune molecule was induced
on melanocytes/nevus cells by inflammation, particularly since nevus nests appear as homogeneous
cell populations by conventional staining methods. However, our results demonstrate a marked
amount of DCs within nevi that are juxtaposed with nevus cells organized in nests, as evidenced
by double-label immunofluorescence. In addition, immunofluorescence showed much more co-
labeling of HLA-DR with CD11c compared to the melanocyte marker MLANA, thus implying that
the HLA-D positivity previously ascribed to melanocytes is in fact due to infiltrating DCs. These infil-
trating leukocytes warrant further investigation as they potentially affect tumor growth and/or reg-
ulate immune responses to abnormal melanocytes.
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Genetic analysis of pre-malignant pigmented lesions in xeroderma pigmentosum patients
T Masaki,1 JJ DiGiovanna,1 Y Wang,1 SG Khan,1 T Hornyak,1 M Raffeld,2 C Lee2 and KH Kraemer1
1 Derm Br, NCI, Bethesda, MD and 2 Lab of Pathology, NCI, Bethesda, MD
We are examining early mutagenic changes in pigmented skin lesions in xeroderma pigmentosum
(XP) patients that may lead to melanoma. XP is a rare autosomal recessive disease, with sun sensi-
tivity and a high frequency of melanoma skin cancers. XP patients have defective post-UV DNA
nucleotide excision repair that leads to accumulations of DNA mutations. We reported previously
that mutations in the PTEN tumor suppressor gene were present in 56% of XP melanomas (PNAS
106:6279 (2009)). Further, 91% of these mutations were UV type. In the current study we analyzed
2 additional melanomas in situ (MIS), 1 invasive melanoma and 11 nevi from 3 XP patients who
had biopsies at the NIH Clinical Center as long ago as 1988. The paraffin blocks were recut and
melanoma cells and nevi on the biopsies were removed by laser capture microdissection. The DNA
was extracted and sequenced. The one MIS and 63 % of nevi had PTEN mutations. In the nevi, 69
% of PTEN mutations were UV type. We are currently investigating possible differences in muta-
tions in PTEN, BRAF and ERBB4 genes in benign pigmented lesions and melanomas in XP patients.
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Agonistic signaling via neurokinin-1 receptor is required for anti-melanoma immunity elicited
by cutaneous genetic immunizations
AR Mathers,1,3 O Tkacheva,1 BM Janelsins,1,3 W Shufesky,2 AE Morelli2,3 and AT Larregina1,3 1
Dermatology, University of Pittsburgh, Pittsburgh, PA, 2 Surgery, University of Pittsburgh,
Pittsburgh, PA and 3 Immunology, University of Pittsburgh, Pittsburgh, PA
Tumor vaccines delivered to the skin constitute promising alternatives to current therapies for
melanomas. However, in spite of initial enthusiasm, melanoma vaccines have not generated the
beneficial results expected. Hence, there is a need for an in-depth understanding of the mechanisms
underlying effective cutaneous immunizations against melanocytic Ags. The immune function of
the skin, a richly innervated organ, is ideal for administration of efficient cancer vaccines. In fact,
agonistic signaling of skin cells via neurokinin-1 receptor (NK1R), by the pro-inflammatory neu-
ropeptide substance-P (SP) released by nerve endings, promotes T helper-1 (Th1) and T cytotoxic-1
(CTL-Tc1) immunity to foreign Ags. Here, we demonstrate in mice, that elicitation of cellular immu-
nity by cutaneous gene gun (GG) immunizations requires agonistic signaling via NK1R. Accord-
ingly, GG-immunization against the melanocyte self-Ag, tyrosine-related-protein-2 (TRP-2) (GG-
TRP-2), delivered to the skin of NK1R-/-KO mice failed to induce TRP-2-specific cellular immunity.
Conversely, the use of the NK1R agonist [Sar9Met O2)11]-SP (SarSP) used as adjuvant at the immu-
nization site in C57BL-6 WT mice significantly enhanced the ability of GG-TRP-2 to elicit TRP-2-
specific effector and memory Th1 and CTL-Tc1 immunity. This resulted in prevention of melanoma
growth and increased survival of mice challenged with melanoma cells, and overcame any poten-
tial effect of the neuropeptide on promotion of tumor growth. Our results are highly relevant for
development of effective tumor vaccines, as they shed light on the mechanisms involved in effi-
cient elicitation of cellular immunity through cutaneous delivery of weakly immunogenic tumor
Ags.
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Melanoma classification based on dermoscopic features
MI Sanchez, HS Rabinovitz, M Oliviero and JM Grichnik Dermatology, University of Miami,
Miami, FL
Primary cutaneous melanomas are traditionally classified as acral lentiginous (ALM), lentigo maligna
(LMM), superficial spreading (SSM), and nodular melanoma (NM). Exclusion of nodular and acral
melanomas leaves just 2 categories LMM and SSM to describe the remaining melanomas on the
skin surface. The terms chronic sun damage and non chronic/intermittent sun damage have also
been applied to subcatergorize melanomas. Genetic analysis has revealed that BRAF, NRAS, and
KIT are the major growth promoting mutated genes in cutaneous melanoma. However, there is still
a significant fraction of melanomas for which the growth promoting mutation is unknown. There is
a correlation of increased KIT mutations with LMM / chronic sun damage melanomas and BRAF
mutations with SSM non-chronic/intermittent sun damage melanomas; however, there is not a pre-
cise correlation with tumor subtype. We hypothesize that the underlining growth promoting muta-
tion will drive a specific pattern of melanoma on the skin surface and that the current classification
system is insufficient to segregate the different melanoma types. Dermoscopy allows for improved
visualization of melanoma growth patterns and may yield better segregation of melanoma sub-
groups. We reviewed a collection of 100 dermoscopic images of melanomas removed at the Uni-
versity of Miami or in Plantation Florida for consistent patterns. These patterns were then reviewed
by two expert dermoscopists. We were able to define 10 primary patterns which include 1) multi-
color multicomponent, 2) negative network, 3) sparing of epidermal crease, 4) rhomboid, 5) polyg-
onal, 6) disorganized fine network, 7) perifollicular pigmented, 8) gray dot/ regression, 9) homoge-
neous, and 10) symmetrical pseudopods pattern. These patterns appear to define unique
subpopulations of primary cutaneous melanomas beyond that of the classical categories of SSM and
LMM. The presence of these multiple different definable dermoscopic patterns suggests that there
are more melanomas subtypes then previously defined and that these subtypes may reflect unique
underlying growth promoting mutations.
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Transcriptome profiling of whole blood cells identifies PLEK2 and C1QB in human melanoma
Y Luo,1 S Robinson,2 J Fujita,1 L Siconolfi,3 J Magidson,4 CK Edwards,1 K Wassmann,3 K Storm,3
DA Norris,1 D Bankaitis-Davis,3 WA Robinson2 and M Fujita1 1 Dermatology, University of
Colorado Denver, Aurora, CO, 2 Medicine, University of Colorado Denver, Aurora, CO, 3
Source MDx, Boulder, CO and 4 Statistical Innovations, Belmont, MA
Peripheral whole blood is a “nucleic acid-rich” and “inflammatory cell-rich” information reservoir
and represents systemic processes altered by the presence of cancer cells. In order to identify bio-
markers for cancer, we conducted transcriptome profiling of peripheral whole blood cells from
melanoma patients. To overcome challenges associated with blood-based gene expression analy-
sis, we used a PAXgeneTM tube to instantly stabilize RNA from whole blood and NuGEN OvationTM
system to amplify non-globin RNA without the impact of globin RNA for microarray analysis. The
combined use of these systems resulted in the identification of 78 unique genes differentially expressed
in the blood of melanoma patients. Of these, 68 genes were further analyzed by quantitative RT-
PCR using whole blood samples from 45 newly diagnosed melanoma patients (stage I to IV) and
50 healthy control individuals. Thirty-nine genes were verified to be differentially expressed in blood
samples from melanoma patients. A stepwise logit analysis selected eighteen 2-gene signatures that
distinguish melanoma from healthy controls. Of these, a 2-gene signature consisting of PLEK2 and
C1QB led to the best result that correctly classified 93.3% melanoma patients and 90% healthy con-
trols. Both genes were upregulated in blood samples of melanoma patients from all stages. Further
analysis using blood fractionation showed that CD45- and CD45+ populations were responsible
for the altered expression levels of PLEK2 and C1QB, respectively and that C1QB expression was
upregualted by culturing with melanoma-conditioned-medium. The current study provides the first
analysis of whole blood-based transcriptome biomarkers for malignant melanoma. The expression
of PLEK2, the strongest gene to classify melanoma patients, in CD45- subsets illustrates the impor-
tance of analyzing whole blood cells for biomarker studies.
744
Meiosis protein REC8 is expressed in melanoma
AS Oriolo,1 MI Sanchez,1 J Li,1 Z Liu2 and JM Grichnik1 1 Dermatology, University of Miami,
Miami, FL and 2 Surgery, University of Miami, Miami, FL
Genomic instability is a hallmark of cancer. Three major areas are under investigation for contri-
butions to genomic instability: defects in DNA repair machinery, telomere crisis, and defective
mitotic spindle assembly defects. A fourth area worthy of consideration is the collision of meiosis
and mitosis pathways, meiomitosis. Both, mitosis and meiosis are preceded by an association of
sister chromatids which involves specific protein complexes known as cohesins. The cohesin com-
plex in mitosis includes SMC1, SMC3, and SCC1/RAD21. In meiosis SCC1/RAD21 is replaced by
REC8, a 547-aminoacid phosphoprotein that serves both to bind sister chromatids together and to
catalyze cross over events between homologous chromosomes. We examined the DM1N, DM2N,
and DM3N melanoma lines for REC8 by western blot analysis and found the meiosis protein was
present in all three tumor lines. Surprisingly, this protein was also found in a number of normal cell
lines suggesting REC8 expression is not restricted to germ cells undergoing meiosis or malignancy.
Immunohistochemistry of melanoma cell lines primarily revealed a cytoplasmic pattern with more
intense staining in polyploid cells. Immunohistochemistry of benign nevus, primary melanoma, and
metastatic melanoma tissues revealed significant heterogeneity with both nuclear and cytoplasmic
patterns of REC8 localization. Nuclear REC8 expression was predominant in 86% (18/21) of the
benign nevi, 64% (36/56) of the melanomas, and 42% (8/19) of the metastatic lesions. Thus, REC8
appears to be widely expressed in a number of somatic cell types pointing to a novel function of
this protein beyond meiosis. Both nuclear and cytoplasmic localization patterns were noted in tis-
sue suggesting the protein is shuttled between both compartments. The increased nuclear staining
in benign nevi may suggest a role in senescence, while the apparent increased cytoplamic staining
in some polyploid cells may suggest a role in abnormal nuclear division. The role and the regula-
tion of this protein in benign and malignant somatic cell types remains to be elucidated.
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Tumor stage-specific detection of ABCB5+ circulating malignant melanoma-initiating cells
A Alloo,1,2 JY Lin,2 J Ma,1,2 BJ Wilson,1,2 NY Frank,1,3 J Zhou,4 FS Hodi4 and MH Frank1,2 1
Transplantation Research Center, Children’s Hospital Boston, Boston, MA, 2 Department of
Dermatology, Brigham and Women’s Hospital, Boston, MA, 3 Division of Genetics, Brigham
and Women’s Hospital, Boston, MA and 4 Department of Medical Oncology, Dana-Farber
Cancer Institute, Boston, MA
ABCB5, a multidrug resistance mediator that belongs to the ATP-binding cassette (ABC) superfam-
ily of active transporters, is a marker of malignant melanoma-intiating cells (MMIC) and serves as
a unique link between chemoresistance, tumorgenicity and metastatic progression in human malig-
nant melanoma. Moreover, ABCB5 was recently shown to be overexpressed on circulating melanoma
cells (CMC) in human to mouse metastatic tumor xenotransplantation models. We hypothesized
that ABCB5 detection in the peripheral circulation of melanoma patients might correlate with tumor
stage, and that ABCB5+ circulating MMIC (cMMIC) might therefore represent a novel biomarker
for melanoma progression. We examined 38 peripheral blood mononuclear cell (PBMC) samples
from 33 melanoma patients using ABCB5 mRNA expression as a means for cMMIC detection. Using
real-time quantitative RT-PCR, we found ABCB5 expression significantly enhanced (151-fold) in
PBMC specimens of n=20 stage IV melanoma patients compared to those of n=13 stage I patients
(P<0.01), demonstrating that ABCB5 is a stage-specific marker for cMMIC detection in melanoma
patients. Additionally, the alternative MMIC marker CD271 (NGFR), recently shown to be co-
expressed with ABCB5 on the same melanoma subpopulation, was likewise up-regulated in stage
IV vs. stage I melanoma patient PBMC specimens (17-fold; P<0.05). Moreover, ABCB5 and CD271
mRNA expression correlated significantly across all melanoma patients examined (P<0.01). Our
results demonstrate that ABCB5+ cMMIC detection represents a novel biomarker for human
melanoma progression. Furthermore, our findings warrant investigation whether cMMIC detection
might represent a novel response-predictive/prognostic tool in metastatic melanoma patients under-
going promising emerging systemic treatment modalities.
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Chronic inflammatory demyelinating polyneuropathy (CIDP) heralding metastatic melanoma
FR Vleugels,1 SJ Huang,2 KM Collins,2 TJ Hollman3 and JY Lin2,4 1 University of Cincinnati
College of Medicine, Cincinnati, OH, 2 Dermatology, Brigham and Women’s Hospital, Boston,
MA, 3 Pathology, Brigham and Women’s Hospital, Boston, MA and 4 Dana Farber Cancer
Institute, Boston, MA
We report the first case of CIDP diagnosed in a patient with a known history of malignant melanoma
leading to the diagnosis of metastatic disease. A 62-year-old man with a history of melanoma of the
chest of 12mm Breslow thickness, treated with wide local excision and negative sentinel lymph
node biopsy two years prior, presented with a 3 month history of progressive weakness, paresthe-
sias, and back pain. On examination, neurology noted intact cranial nerves, widespread continu-
ous fasciculations, weakness of all four extremities, absent deep tendon reflexes, and decreased
sensation on the lower extremities. In addition to clinical criteria, the patient met electrophysiologic
criteria for a diagnosis of CIDP. On exam, dermatology discovered a firm 3cm mass in the right
axilla. FNA of the axillary mass was positive for malignant melanoma, and CT scan revealed mul-
tiple lung and splenic nodules consistent with metastases. Only 6 cases of CIDP associated with
melanoma have been reported to date. It is thought that these cases represent a rare paraneoplas-
tic phenomenon in which proteins expressed on the surface of tumor cells trigger an immune response
that cross reacts with similar proteins in the nervous system. Both melanocytes and Schwann cells
are derived from neural crest and share potential surface antigens such as MAG2 and gangliosides
GM2, GM3, GD3, and GD2. In a trial of monoclonal anti-GD2 antibody in metastatic melanoma,
4 patients developed an inflammatory demyelinating neuropathy, further supporting this associa-
tion. In several of the reported cases, a diagnosis of melanoma was made during the work-up of
CIDP, while the remaining cases occurred in patients with known metastatic melanoma undergo-
ing diverse therapies, including IFN-alpha. This is the first report of a patient with a history of
melanoma in which a diagnosis of CIDP led to evaluation and discovery of metastatic disease.
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Neuropilin-2: A novel biomarker for malignant melanoma
M Eller,1 E Rushing,2 M Stine,2 S Hahn,2 S Shea,2 A Naif,1 S Khanna,2 W Westra,2 A Jungbluth,3
K Busam,4 M Mahalingam1 and R Alani1 1 Boston University School of Medicine, Boston, MA,
2 Johns Hopkins University School of Medicine, Baltimore, MD, 3 Ludwig Institute for Cancer
Research, New York, NY and 4 Memorial Sloan-Kettering Cancer Center, New York, NY
Neuropilin-2 (NRP2), a cell surface receptor involved in angiogenesis and axonal guidance, is a
critical mediator of tumor-associated lymphangiogenesis. Given that lymphangiogenesis is a major
conduit of melanoma metastasis and that blocking NRP2 function in vivo inhibits tumor cell metas-
tasis, we sought to determine the clinical relevance of NRP2 expression in cutaneous melanoma.
Immunohistochemical analysis of NRP2 expression was evaluated in a tissue microarray and indi-
vidual histologic sections from samples of primary melanomas (PM) (n=42), metastatic melanomas
(MM) (n=30) and nevi (n=30), as well as normal human tissues and non-melanocytic tumors. NRP2
expression was estimated semi-quantitatively in terms of area stained (<20%, 20-60% and >60%
of tissue staining positively) and for intensity (from 0-3 with 3 being the highest and 0 the lowest
intensity). In nevomelanocytic proliferations, >20% staining for NRP2 was noted in 36/42 cases of
PM, in 27/30 cases of MM and in 9/30 cases of nevi with differences between melanoma (PM and
MM) and nevi achieving statistical significance (p<0.0001). A staining intensity of 2 or more was
noted in 36/42 cases of PM, in 17/30 cases of MM and in 7/23 of nevi with differences between
melanoma (PM and MM) and nevi achieving statistical significance (p<0.0001). In normal human
tissue, strong NRP2 staining was noted in kidney, skin (epidermal keratinocytes) and testes, while
in tumors, strong staining was noted only in renal cell carcinoma. Increased and enhanced expres-
sion of NRP2 staining in melanoma versus nevi argues in favor of the utility of NRP2 as a novel bio-
marker for melanocytic lesions.
758
SIRT1 is overexpressed in human melanoma cells and its inhibition imparts anti-proliferative
effects
M Nihal,1 M Ndiaye,1 GS Wood1,2 and N Ahmad1 1 Dermatology, University of Wisconsin,
Madison, WI and 2 Wm. S. Middleton VAMC, Madison, WI
Melanoma remains one of the most aggressive skin cancers, and is potentially lethal, if not diag-
nosed and treated early. Therefore, understanding of genetic control and mechanisms of melanoma
development and progression is critical. In this study, we tested the hypothesis that SIRT1 is differ-
entially expressed in melanoma and could serve as a target for designing novel approaches for the
management of this neoplasm. SIRT1 is a member of the Sirtuin (Sir2) family of enzymes, which are
nicotinamide adenine dinucleotide NAD(+)-dependent histone deacetylases, known to deacety-
late lysine residues on several proteins. SIRT1 has been shown to be critically involved in cellular
metabolism, stress response and aging via deacetylating a variety of substrates including p53, fork-
head-box transcription factors (FoxO), nuclear factor NF-κB, Ku70 and histones. To test our hypoth-
esis, we determined the expression of SIRT1 in a panel of melanoma cell lines (A375, Hs294T and
G361) and normal skin cells (normal human keratinocytes and normal human melanocytes). Our
data demonstrated that compared to normal skin cells, Sirt1 was significantly overexpressed at pro-
tein as well as mRNA levels in melanoma cells. Next, to understand the functional significance of
SIRT1 in human melanoma, we assessed the effects of small molecule inhibitor-mediated activity
inhibition as well as short hairpin RNA (shRNA)-mediated gene knockdown of SIRT1 in melanoma
cells. We found that SIRT1 inhibition resulted in a significant decrease in i) the growth and viabil-
ity, and ii) colony formation ability of melanoma cells. Taken together, our data suggested that
SIRT1 could be a contributing factor in melanoma development and/or progression. We suggest that
SIRT1 could serve as a potential target towards developing novel strategies for the management of
melanoma. Indeed, future studies in appropriate in vitro and in vivo systems are needed to sub-
stantiate our findings and to define the mechanism(s) by which SIRT1 imparts a growth advantage
to melanoma.
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Epigenetic control of gene expression programs in the skin: Distinct nuclear architecture and
higher order chromatin organization of cell-type specific genes in melanocytes and ker-
atinocytes
MR Gdula,2 TY Sharova,1 MY Fessing2 and AA Sharov1 1 Dermatology, Boston University,
Boston, MA and 2 Centre for Skin Sciences, University of Bradford, Bradford, United Kingdom
The mammalian nucleus is a complex and highly organized organelle that allows cells differenti-
ate and effectively fulfill their functions. Higher-order chromatin structure and nuclear compart-
mentalization of transcriptionally active and inactive domains and transcription machinery play an
important role in regulation of gene expression and can be altered in diseases. Melanocytes and
keratinocytes are highly specialized cells playing distinct functions in the skin controlled by the cell-
type specific gene expression programs. By three-dimensional fluorescence in situ hybridization
(3D-FISH) and confocal microscopy, we show that intra-nuclear positioning of the DNA loci con-
taining melanocyte specific genes tyrosinase (TYR), tyrosinase-related protein 1 (TYRP1) and the
melanoma antigen 1 recognized by T cells (MART1) in the primary human melanocytes differ very
substantially, compared to the primary keratinocytes. Analysis of the radial distributions of the genetic
loci showed that TYR locus (human chromosome 11), TYRP1 and MART1 loci (human chromosome
9) were occupied much more nuclear interior position in the melanocytes, while in primary ker-
atinocytes these loci were located significantly more peripherally in the nucleus (p<0.01) closer to
the nuclear membrane. Furthermore, primary melanocytes also showed the distinct spatial organ-
ization of the transcriptionally active nuclear domains depicted by phospho-serine-2 RNA Poly-
merase II and tri-methylated H3K4 staining, as well as the size, number and spatial distribution of
the nucleoli and nuclear speckles, as compared to keratinocytes. These data demonstrate for the first
time a distinct intra-nuclear organization of the pigment-specific genes, transcriptionally active
nuclear domains and nuclear bodies in melanocytes versus keratinocytes and suggest an involve-
ment of the distinct epigenetic mechanisms in the control of gene expression in pigment and epithe-
lial cells.
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Identification of EMMPRIN as a novel receptor for S100A9: Its involvement in melanoma
metastasis
T Hibino,1 S Miyamoto,1 M Sakaguchi,2 A Motoyama,1 M Yamamoto,3,1 R Tsuboi3 and N Huh2 1
Shiseido Research Center, Yokohama, Japan, 2 Department of Cell Biology, Okayama
University, Okayama, Japan and 3 Department of Dermatology, Tokyo Medical University,
Tokyo, Japan
S100A8 and S100A9 are thought to play important roles in inflammation and tumor cell invasion.
However, the precise mechanisms of S100-based biological reactions are still not fully understood.
Recently we reported the presence of a positive feedback loop between S100A8/A9 and inflam-
matory cytokines such as IL-6, IL-8 and TNF-alph in human epidermal keratinocytes. Using LC-
MS/MS shotgun proteomics, we found that S100A8/A9 could bind with EMMPRIN. Co-immuno-
precipitation assay revealed that S100A9, but not S100A8, specifically bonded with EMMPRIN.
Since EMMPRIN is associated with tumor cell invasion, we also examined a melanoma cell line,
Mel-2, a high EMMPRIN expresser. cDNA microarray and real-time PCR analyses demonstrated
induction of inflammatory cytokines at 3 h, and MMP-1 and MMP-10 at 24 h, after the addition of
S100A9. Induction of cytokines and MMPs by S100A9 was significantly suppressed by knocking
down with siRNA specific to EMMPRIN both in keratinocytes and Mel-2. Immunohistochemical
analyses showed that EMMPRIN was expressed in the invasive edge of a melanoma lesion and the
surrounding epidermis in vivo. S100A9 was strongly up-regulated only in the lesional epidermis. In
a pigmented nevus, however, both were completely negative. Furthermore we developed epider-
mis-specific S100A9 and S100A8 transgenic mice. Mel-2 or Mel-5, a low EMMPRIN expresser, was
injected into the tail vein and cell migration was investigated in the skin, lung and liver after 4 weeks.
Melanin-bearing, HMB-45-positive and MART-1 positive melanoma cells were detected only in
the skin of Mel-2-injected S100A9 transgenic mice. These lines of evidence indicated that EMM-
PRIN is a novel receptor for S100A9 and plays a critical role in melanoma cell migration. Our find-
ings may also provide a novel therapeutic target for this currently intractable metastatic cancer.
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In vivo melanoma phenotype switch from invasive to proliferative in the absence of the
extracellular matrix protein vitronectin
L Mesnard,1 A Prignon,2,3 M Halabi,2,3 S Hodgson,4 H Handoko,5 G Walker,5 B Hollier,6
E Rondeau,1 S Aractingi2,3 and K Khosrotehrani4,2,3 1 Nephrology, APHP-Hopital Tenon, Paris,
France, 2 Dermatology, APHP-Hopital Tenon, Paris, France, 3 Dermatology, UPMC Univ paris
VI, Paris, France, 4 Centre for Clinical Research, The university of Quensland, Brisbane, QLD,
Australia, 5 skin carcinogenesis, Queensland Institute of Medical Research, Brisbane, QLD,
Australia and 6 Queensland University of Technology, Brisbane, QLD, Australia
The transition of radial to vertical growth phase in melanoma is accompanied by the expression of
alpha-v and beta-3 (avb3) integrin. This integrin has been previously shown to be important for
melanoma invasion and metastasis. Recently, melanoma cells have been described to switch between
two phenotypes: proliferative or invasive. Our objective was to assess the role of vitronectin, the
main partner of avb3 integrin, in melanoma growth and metastasis. Age-matched wild type and vit-
ronectin deficient (VN-/-) mice were intradermally injected with B16-F10 melanoma cells. Tumour
volume was significantly increased in VN-/- animals from day 13 onwards (p<0.001). However,
fewer mice had metastases in the VN-/- group at day 16 (4/19 VN-/- vs 11/18 WT, p=0.02) result-
ing in a significant increase in survival if tumours were excised at day 10 post inoculation. This
change of phenotype could also be observed in vitro. B16 cells had dramatically reduced adhesion
when cultured with VN-/- serum. This was fully corrected by addition of vitronectin but only par-
tial correction was obtained by collagen IV. Unexpectedly, the absence of vitronectin also resulted
in increased cell proliferation in vitro that was reduced by addition of wild-type serum containing
vitronectin. Comparative microarray analysis of B16 cells in the presence or absence of vitronectin
highlighted modifications of TGF-beta signalling. In conclusions, vitronectin is a major component
of the extracellular matrix for melanoma cell adhesion and is essential for the change of phenotype
occurring during melanoma growth from proliferative to invasive.
753
The effect of E-cadherin loss on melanoma progression and markers of epithelial-mesenchy-
mal transition in a conditional mouse model
LE Rosenbaum, WE Damsky and M Bosenberg Dermatology, Yale University School of
Medicine, New Haven, CT
Melanoma is the most lethal form of skin cancer and accounts for the majority of skin cancer related
mortality. Early metastases are characteristic of melanoma and are an ominous sign, as current ther-
apeutic interventions have little effect on survival. The lack of accurate prognostic indicators and
effective therapies emphasize the need for a better understanding of the genetic and phenotypic
changes in melanoma formation and progression. One such change is the loss of E-cadherin, which
plays a central role in cell-cell adhesion and is thought to be a central feature of epithelial-mes-
enchymal transition (EMT). Maintenance of E-cadherin in melanoma may function to restrict
melanoma invasion, and loss of E-cadherin expression is associated with mesenchymal features and
melanoma metastasis. While several studies have suggested that loss of E-cadherin is associated
with cancer progression, functional evaluation of the effects of E-cadherin loss on metastasis has
not been well established. In order to evaluate these important issues on the role of E-cadherin in
melanoma formation and metastasis, we have utilized a well-characterized conditional mouse model
combining the activating Braf V600E mutation with Pten tumor suppressor loss. This model allows
us to alter these genes in mouse melanocytes in a spatially and temporally restricted manner, pro-
ducing melanoma specifically and reproducibly. We have combined this model with conditional
E-cadherin inactivation in order to evaluate the role of E-cadherin loss on melanoma formation, pro-
gression and metastasis as well as changes in cell morphology and signaling. Loss of E-cadherin
significantly decreases survival of mice in the Braf/Pten tumor model (p=0.024) and alters the expres-
sion of markers of EMT. These findings functionally delineate the role of E-cadherin loss in melanoma
formation, progression and metastasis.
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Melanocyte behaviors in C57BL/6 nu/nu mice
H Kato, M Nakamura, E Ito, O Taguchi and A Morita Department of Geriatric and Environmental
Dermatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
We generated nude mice in a C57BL/6 background. Mature hair growth is not observed in these
mice (C57BL/6 nu/nu). Their skin color is black and gradually decolorizes with age. Melanocyte
behavior with regard to this decolorization phenomenon is not clear. To test the melanocytes, skin
specimens of C57BL/6 nu/nu and wild-type C57BL/6 mice were obtained on postnatal days (PND)
0, 3, 6, 9, and 12. Immunohistochemistry was performed to analyze melanocytes. Next, a green-
fluorescent protein (GFP) transgenic C57BL/6 nu/nu mouse was generated. The skin of this mouse
was grafted to wild-type C57BL/6 mice to investigate melanocyte behavior. In the wild-type C57BL/6
and C57BL/6 nu/nu mice, melanocytes were present in both the epidermis and dermis on PND 0.
In the wild-type C57BL/6 mouse, there were no melanocytes after PND 3. In contrast, in the C57BL/6
nu/nu mouse, some melanocytes remained in the epidermis on PND 3, 6, and 9, and in the dermis
on PND 3, 6, 9, and 12. The numbers of melanocytes significantly differed between these mice in
the epidermis on PND 0, 6, and 9, and in the dermis on PND 3, 6, 9, and 12 (p<0.05, Wilcoxon
rank sum test). In the grafted mouse, the hairs around the graft site became blacker than the origi-
nal hair color. Immunohistochemistry analysis of the grafted skin revealed that GFP-positive and S-
100 protein-positive cells migrated to hairs around the grafted area, suggesting that dermal
melanocytes in C57BL/6 nu/nu mice were capable of migrating to hair follicles. In the C57BL/6
nu/nu mice, there were some immature hairs, but no mature hairs. Dermal melanocytes were pres-
ent by PND 12. In mice, melanocytes develop from the neural crest and migrate to the dermis and
epidermis to reach the follicular area; thus, no epidermal and dermal melanocytes are observed. In
C57BL/6 nu/nu mice, however, melanocyte migration was interrupted due to the lack of mature hair
formation. Interrupted melanocytes would remain in the dermis.
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Alternation of CYP27B1 expression during progression of pigmented lesions in the skin
AA Brozyna,1 W Jozwicki1 and A Slominski2 1 Department of Tumor Pathology and
Pathomorphology, The Lukaszczyk Oncology Center, Collegium Medicum, Nicolaus
Copernicus University, Bydgoszcz, Poland and 2 Department of Pathology and Laboratory
Medicine, University of Tennessee Health Science Center, Memphis, TN
There has been growing evidence that vitamin D-regulated pathways contribute to pathogenesis
and progression of tumors, including melanoma. Previously, we have shown that expression of
vitamin D receptor decreases during progression of melanocytic and melanoma lesions. CYP27B1,
1α-hydroxylase enzyme, is responsible for the synthesis of the biologically active form of vitamin
D (1,25-dihydroxyvitamin D; calcitriol) by hydroxylating of 25-hydroxyvitamin D. The main organ
producing active vitamin D is kidney, however, extrarenal activity of CYP27B1 is also documented
in other cell types including skin cells. Therefore, we decided to investigate possible changes in
CYP27B1 in melanocytic nevi and melanomas at different levels of progression. Thus, using immuno-
histochemistry we analyzed expression of CYP27B1 in 77 samples obtained form 64 patients includ-
ing 14 benign nevi, 39 primary cutaneous melanomas, 17 metastases, 1 re-excision and 6 normal
skin biopsies. The highest CYP27B1 expression was observed in skin and lymph node and tumor-
infiltrating lymphocytes. Cytoplasmic CYP27B1 was slightly elevated in nevi and melanomas when
compared to normal skin, however, nuclear immunoreactivity gradually decreased with progres-
sion of pigmented lesions. Also lymph node metastases showed the lowest level of CYP27B1. The
significant decrease of CYP27B1 expression in cytoplasm of melanoma cells at vertical growth phase
versus radial growth phase was also observed. In skin surrounding nevi cytoplasmic CYP27B1 was
higher in comparison to normal skin. In conclusion, our data suggests that local expression of
CYP27B1 may play a role in pathogenesis and progression of melanomas, and can affect behavior
of melanocytes.
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2,4,6-octatrienoic acid promotes melanogenesis in normal human melanocytes, through PPAR-
gamma
E Flori,2 A Mastrofrancesco,2 D Kovacs,2 G Giuliani,1 S Briganti2 and M Picardo2 1 R&D, Giuliani
SpA, Milan, Italy and 2 Laboratory of Cutaneous Physiopathology and Integrated Center of
Metabolomics Research, San Gallicano Dermatologic Institute (IRCCS ), Rome, Italy
Melanogenesis is a biosynthetic way controlled by several factors affecting intracellular signal trans-
duction pathways. Peroxisome-activated receptors (PPARs) are ligand-activated transcription factors
that regulate important functions in the skin including proliferation and differentiation. Evidence in
literature shows that activation of PPARγ, one of the three PPARs isoforms, can induce melanocytes
differentiation and melanogenesis. We have observed that Parrodienes, a class of compounds shar-
ing some structural features with carotenoids and retinoids, promote cell antioxidant defence and
counteract senescence-like phenotype in fibroblasts. Moreover we found that the same compounds
are able to promote PPARγ activation. On these basis we selected 2,4,6-octatrienoic acid (Octa), a
derivative of parrodienes, to study its ability to promote melanogenesis in normal human melanocytes
(NHM). We demonstrated that Octa up-regulated PPARγ mRNA expression and promoted its activ-
ity as a transcription factor in NHM. Moreover Octa induced melanogenesis through a significant
up-regulation of tyrosinase expression and activity, correlated with an increase of melanin content.
The observed increase in pigmentation was associated with the stimulation of microphthalmia-asso-
ciated transcription factor, the key transcription factor of melanocyte differentiation, proliferation
and survival. The PPARγ antagonist GW9662 or PPARγ silencing was able to abrogate the melanogenic
effect induced by Octa exposure, clearly indicating that the activation of PPARγ was necessary to
evoke the effects observed. These results suggest a regulatory role of Octa, through PPARγ activa-
tion, in melanogenesis of NHM, offering future perspectives of its employment to enhance skin pho-
toprotection and possibly for the treatment of pigmentary disorders.
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Tumor stage-specific detection of ABCB5+ circulating malignant melanoma-initiating cells
A Alloo,1,2 JY Lin,2 J Ma,1,2 BJ Wilson,1,2 NY Frank,1,3 J Zhou,4 FS Hodi4 and MH Frank1,2 1
Transplantation Research Center, Children’s Hospital Boston, Boston, MA, 2 Department of
Dermatology, Brigham and Women’s Hospital, Boston, MA, 3 Division of Genetics, Brigham
and Women’s Hospital, Boston, MA and 4 Department of Medical Oncology, Dana-Farber
Cancer Institute, Boston, MA
ABCB5, a multidrug resistance mediator that belongs to the ATP-binding cassette (ABC) superfam-
ily of active transporters, is a marker of malignant melanoma-intiating cells (MMIC) and serves as
a unique link between chemoresistance, tumorgenicity and metastatic progression in human malig-
nant melanoma. Moreover, ABCB5 was recently shown to be overexpressed on circulating melanoma
cells (CMC) in human to mouse metastatic tumor xenotransplantation models. We hypothesized
that ABCB5 detection in the peripheral circulation of melanoma patients might correlate with tumor
stage, and that ABCB5+ circulating MMIC (cMMIC) might therefore represent a novel biomarker
for melanoma progression. We examined 38 peripheral blood mononuclear cell (PBMC) samples
from 33 melanoma patients using ABCB5 mRNA expression as a means for cMMIC detection. Using
real-time quantitative RT-PCR, we found ABCB5 expression significantly enhanced (151-fold) in
PBMC specimens of n=20 stage IV melanoma patients compared to those of n=13 stage I patients
(P<0.01), demonstrating that ABCB5 is a stage-specific marker for cMMIC detection in melanoma
patients. Additionally, the alternative MMIC marker CD271 (NGFR), recently shown to be co-
expressed with ABCB5 on the same melanoma subpopulation, was likewise up-regulated in stage
IV vs. stage I melanoma patient PBMC specimens (17-fold; P<0.05). Moreover, ABCB5 and CD271
mRNA expression correlated significantly across all melanoma patients examined (P<0.01). Our
results demonstrate that ABCB5+ cMMIC detection represents a novel biomarker for human
melanoma progression. Furthermore, our findings warrant investigation whether cMMIC detection
might represent a novel response-predictive/prognostic tool in metastatic melanoma patients under-
going promising emerging systemic treatment modalities.
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Chronic inflammatory demyelinating polyneuropathy (CIDP) heralding metastatic melanoma
FR Vleugels,1 SJ Huang,2 KM Collins,2 TJ Hollman3 and JY Lin2,4 1 University of Cincinnati
College of Medicine, Cincinnati, OH, 2 Dermatology, Brigham and Women’s Hospital, Boston,
MA, 3 Pathology, Brigham and Women’s Hospital, Boston, MA and 4 Dana Farber Cancer
Institute, Boston, MA
We report the first case of CIDP diagnosed in a patient with a known history of malignant melanoma
leading to the diagnosis of metastatic disease. A 62-year-old man with a history of melanoma of the
chest of 12mm Breslow thickness, treated with wide local excision and negative sentinel lymph
node biopsy two years prior, presented with a 3 month history of progressive weakness, paresthe-
sias, and back pain. On examination, neurology noted intact cranial nerves, widespread continu-
ous fasciculations, weakness of all four extremities, absent deep tendon reflexes, and decreased
sensation on the lower extremities. In addition to clinical criteria, the patient met electrophysiologic
criteria for a diagnosis of CIDP. On exam, dermatology discovered a firm 3cm mass in the right
axilla. FNA of the axillary mass was positive for malignant melanoma, and CT scan revealed mul-
tiple lung and splenic nodules consistent with metastases. Only 6 cases of CIDP associated with
melanoma have been reported to date. It is thought that these cases represent a rare paraneoplas-
tic phenomenon in which proteins expressed on the surface of tumor cells trigger an immune response
that cross reacts with similar proteins in the nervous system. Both melanocytes and Schwann cells
are derived from neural crest and share potential surface antigens such as MAG2 and gangliosides
GM2, GM3, GD3, and GD2. In a trial of monoclonal anti-GD2 antibody in metastatic melanoma,
4 patients developed an inflammatory demyelinating neuropathy, further supporting this associa-
tion. In several of the reported cases, a diagnosis of melanoma was made during the work-up of
CIDP, while the remaining cases occurred in patients with known metastatic melanoma undergo-
ing diverse therapies, including IFN-alpha. This is the first report of a patient with a history of
melanoma in which a diagnosis of CIDP led to evaluation and discovery of metastatic disease.
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Neuropilin-2: A novel biomarker for malignant melanoma
M Eller,1 E Rushing,2 M Stine,2 S Hahn,2 S Shea,2 A Naif,1 S Khanna,2 W Westra,2 A Jungbluth,3
K Busam,4 M Mahalingam1 and R Alani1 1 Boston University School of Medicine, Boston, MA,
2 Johns Hopkins University School of Medicine, Baltimore, MD, 3 Ludwig Institute for Cancer
Research, New York, NY and 4 Memorial Sloan-Kettering Cancer Center, New York, NY
Neuropilin-2 (NRP2), a cell surface receptor involved in angiogenesis and axonal guidance, is a
critical mediator of tumor-associated lymphangiogenesis. Given that lymphangiogenesis is a major
conduit of melanoma metastasis and that blocking NRP2 function in vivo inhibits tumor cell metas-
tasis, we sought to determine the clinical relevance of NRP2 expression in cutaneous melanoma.
Immunohistochemical analysis of NRP2 expression was evaluated in a tissue microarray and indi-
vidual histologic sections from samples of primary melanomas (PM) (n=42), metastatic melanomas
(MM) (n=30) and nevi (n=30), as well as normal human tissues and non-melanocytic tumors. NRP2
expression was estimated semi-quantitatively in terms of area stained (<20%, 20-60% and >60%
of tissue staining positively) and for intensity (from 0-3 with 3 being the highest and 0 the lowest
intensity). In nevomelanocytic proliferations, >20% staining for NRP2 was noted in 36/42 cases of
PM, in 27/30 cases of MM and in 9/30 cases of nevi with differences between melanoma (PM and
MM) and nevi achieving statistical significance (p<0.0001). A staining intensity of 2 or more was
noted in 36/42 cases of PM, in 17/30 cases of MM and in 7/23 of nevi with differences between
melanoma (PM and MM) and nevi achieving statistical significance (p<0.0001). In normal human
tissue, strong NRP2 staining was noted in kidney, skin (epidermal keratinocytes) and testes, while
in tumors, strong staining was noted only in renal cell carcinoma. Increased and enhanced expres-
sion of NRP2 staining in melanoma versus nevi argues in favor of the utility of NRP2 as a novel bio-
marker for melanocytic lesions.
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SIRT1 is overexpressed in human melanoma cells and its inhibition imparts anti-proliferative
effects
M Nihal,1 M Ndiaye,1 GS Wood1,2 and N Ahmad1 1 Dermatology, University of Wisconsin,
Madison, WI and 2 Wm. S. Middleton VAMC, Madison, WI
Melanoma remains one of the most aggressive skin cancers, and is potentially lethal, if not diag-
nosed and treated early. Therefore, understanding of genetic control and mechanisms of melanoma
development and progression is critical. In this study, we tested the hypothesis that SIRT1 is differ-
entially expressed in melanoma and could serve as a target for designing novel approaches for the
management of this neoplasm. SIRT1 is a member of the Sirtuin (Sir2) family of enzymes, which are
nicotinamide adenine dinucleotide NAD(+)-dependent histone deacetylases, known to deacety-
late lysine residues on several proteins. SIRT1 has been shown to be critically involved in cellular
metabolism, stress response and aging via deacetylating a variety of substrates including p53, fork-
head-box transcription factors (FoxO), nuclear factor NF-κB, Ku70 and histones. To test our hypoth-
esis, we determined the expression of SIRT1 in a panel of melanoma cell lines (A375, Hs294T and
G361) and normal skin cells (normal human keratinocytes and normal human melanocytes). Our
data demonstrated that compared to normal skin cells, Sirt1 was significantly overexpressed at pro-
tein as well as mRNA levels in melanoma cells. Next, to understand the functional significance of
SIRT1 in human melanoma, we assessed the effects of small molecule inhibitor-mediated activity
inhibition as well as short hairpin RNA (shRNA)-mediated gene knockdown of SIRT1 in melanoma
cells. We found that SIRT1 inhibition resulted in a significant decrease in i) the growth and viabil-
ity, and ii) colony formation ability of melanoma cells. Taken together, our data suggested that
SIRT1 could be a contributing factor in melanoma development and/or progression. We suggest that
SIRT1 could serve as a potential target towards developing novel strategies for the management of
melanoma. Indeed, future studies in appropriate in vitro and in vivo systems are needed to sub-
stantiate our findings and to define the mechanism(s) by which SIRT1 imparts a growth advantage
to melanoma.
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Epigenetic control of gene expression programs in the skin: Distinct nuclear architecture and
higher order chromatin organization of cell-type specific genes in melanocytes and ker-
atinocytes
MR Gdula,2 TY Sharova,1 MY Fessing2 and AA Sharov1 1 Dermatology, Boston University,
Boston, MA and 2 Centre for Skin Sciences, University of Bradford, Bradford, United Kingdom
The mammalian nucleus is a complex and highly organized organelle that allows cells differenti-
ate and effectively fulfill their functions. Higher-order chromatin structure and nuclear compart-
mentalization of transcriptionally active and inactive domains and transcription machinery play an
important role in regulation of gene expression and can be altered in diseases. Melanocytes and
keratinocytes are highly specialized cells playing distinct functions in the skin controlled by the cell-
type specific gene expression programs. By three-dimensional fluorescence in situ hybridization
(3D-FISH) and confocal microscopy, we show that intra-nuclear positioning of the DNA loci con-
taining melanocyte specific genes tyrosinase (TYR), tyrosinase-related protein 1 (TYRP1) and the
melanoma antigen 1 recognized by T cells (MART1) in the primary human melanocytes differ very
substantially, compared to the primary keratinocytes. Analysis of the radial distributions of the genetic
loci showed that TYR locus (human chromosome 11), TYRP1 and MART1 loci (human chromosome
9) were occupied much more nuclear interior position in the melanocytes, while in primary ker-
atinocytes these loci were located significantly more peripherally in the nucleus (p<0.01) closer to
the nuclear membrane. Furthermore, primary melanocytes also showed the distinct spatial organ-
ization of the transcriptionally active nuclear domains depicted by phospho-serine-2 RNA Poly-
merase II and tri-methylated H3K4 staining, as well as the size, number and spatial distribution of
the nucleoli and nuclear speckles, as compared to keratinocytes. These data demonstrate for the first
time a distinct intra-nuclear organization of the pigment-specific genes, transcriptionally active
nuclear domains and nuclear bodies in melanocytes versus keratinocytes and suggest an involve-
ment of the distinct epigenetic mechanisms in the control of gene expression in pigment and epithe-
lial cells.
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Identification of EMMPRIN as a novel receptor for S100A9: Its involvement in melanoma
metastasis
T Hibino,1 S Miyamoto,1 M Sakaguchi,2 A Motoyama,1 M Yamamoto,3,1 R Tsuboi3 and N Huh2 1
Shiseido Research Center, Yokohama, Japan, 2 Department of Cell Biology, Okayama
University, Okayama, Japan and 3 Department of Dermatology, Tokyo Medical University,
Tokyo, Japan
S100A8 and S100A9 are thought to play important roles in inflammation and tumor cell invasion.
However, the precise mechanisms of S100-based biological reactions are still not fully understood.
Recently we reported the presence of a positive feedback loop between S100A8/A9 and inflam-
matory cytokines such as IL-6, IL-8 and TNF-alph in human epidermal keratinocytes. Using LC-
MS/MS shotgun proteomics, we found that S100A8/A9 could bind with EMMPRIN. Co-immuno-
precipitation assay revealed that S100A9, but not S100A8, specifically bonded with EMMPRIN.
Since EMMPRIN is associated with tumor cell invasion, we also examined a melanoma cell line,
Mel-2, a high EMMPRIN expresser. cDNA microarray and real-time PCR analyses demonstrated
induction of inflammatory cytokines at 3 h, and MMP-1 and MMP-10 at 24 h, after the addition of
S100A9. Induction of cytokines and MMPs by S100A9 was significantly suppressed by knocking
down with siRNA specific to EMMPRIN both in keratinocytes and Mel-2. Immunohistochemical
analyses showed that EMMPRIN was expressed in the invasive edge of a melanoma lesion and the
surrounding epidermis in vivo. S100A9 was strongly up-regulated only in the lesional epidermis. In
a pigmented nevus, however, both were completely negative. Furthermore we developed epider-
mis-specific S100A9 and S100A8 transgenic mice. Mel-2 or Mel-5, a low EMMPRIN expresser, was
injected into the tail vein and cell migration was investigated in the skin, lung and liver after 4 weeks.
Melanin-bearing, HMB-45-positive and MART-1 positive melanoma cells were detected only in
the skin of Mel-2-injected S100A9 transgenic mice. These lines of evidence indicated that EMM-
PRIN is a novel receptor for S100A9 and plays a critical role in melanoma cell migration. Our find-
ings may also provide a novel therapeutic target for this currently intractable metastatic cancer.
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In vivo melanoma phenotype switch from invasive to proliferative in the absence of the
extracellular matrix protein vitronectin
L Mesnard,1 A Prignon,2,3 M Halabi,2,3 S Hodgson,4 H Handoko,5 G Walker,5 B Hollier,6
E Rondeau,1 S Aractingi2,3 and K Khosrotehrani4,2,3 1 Nephrology, APHP-Hopital Tenon, Paris,
France, 2 Dermatology, APHP-Hopital Tenon, Paris, France, 3 Dermatology, UPMC Univ paris
VI, Paris, France, 4 Centre for Clinical Research, The university of Quensland, Brisbane, QLD,
Australia, 5 skin carcinogenesis, Queensland Institute of Medical Research, Brisbane, QLD,
Australia and 6 Queensland University of Technology, Brisbane, QLD, Australia
The transition of radial to vertical growth phase in melanoma is accompanied by the expression of
alpha-v and beta-3 (avb3) integrin. This integrin has been previously shown to be important for
melanoma invasion and metastasis. Recently, melanoma cells have been described to switch between
two phenotypes: proliferative or invasive. Our objective was to assess the role of vitronectin, the
main partner of avb3 integrin, in melanoma growth and metastasis. Age-matched wild type and vit-
ronectin deficient (VN-/-) mice were intradermally injected with B16-F10 melanoma cells. Tumour
volume was significantly increased in VN-/- animals from day 13 onwards (p<0.001). However,
fewer mice had metastases in the VN-/- group at day 16 (4/19 VN-/- vs 11/18 WT, p=0.02) result-
ing in a significant increase in survival if tumours were excised at day 10 post inoculation. This
change of phenotype could also be observed in vitro. B16 cells had dramatically reduced adhesion
when cultured with VN-/- serum. This was fully corrected by addition of vitronectin but only par-
tial correction was obtained by collagen IV. Unexpectedly, the absence of vitronectin also resulted
in increased cell proliferation in vitro that was reduced by addition of wild-type serum containing
vitronectin. Comparative microarray analysis of B16 cells in the presence or absence of vitronectin
highlighted modifications of TGF-beta signalling. In conclusions, vitronectin is a major component
of the extracellular matrix for melanoma cell adhesion and is essential for the change of phenotype
occurring during melanoma growth from proliferative to invasive.
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The effect of E-cadherin loss on melanoma progression and markers of epithelial-mesenchy-
mal transition in a conditional mouse model
LE Rosenbaum, WE Damsky and M Bosenberg Dermatology, Yale University School of
Medicine, New Haven, CT
Melanoma is the most lethal form of skin cancer and accounts for the majority of skin cancer related
mortality. Early metastases are characteristic of melanoma and are an ominous sign, as current ther-
apeutic interventions have little effect on survival. The lack of accurate prognostic indicators and
effective therapies emphasize the need for a better understanding of the genetic and phenotypic
changes in melanoma formation and progression. One such change is the loss of E-cadherin, which
plays a central role in cell-cell adhesion and is thought to be a central feature of epithelial-mes-
enchymal transition (EMT). Maintenance of E-cadherin in melanoma may function to restrict
melanoma invasion, and loss of E-cadherin expression is associated with mesenchymal features and
melanoma metastasis. While several studies have suggested that loss of E-cadherin is associated
with cancer progression, functional evaluation of the effects of E-cadherin loss on metastasis has
not been well established. In order to evaluate these important issues on the role of E-cadherin in
melanoma formation and metastasis, we have utilized a well-characterized conditional mouse model
combining the activating Braf V600E mutation with Pten tumor suppressor loss. This model allows
us to alter these genes in mouse melanocytes in a spatially and temporally restricted manner, pro-
ducing melanoma specifically and reproducibly. We have combined this model with conditional
E-cadherin inactivation in order to evaluate the role of E-cadherin loss on melanoma formation, pro-
gression and metastasis as well as changes in cell morphology and signaling. Loss of E-cadherin
significantly decreases survival of mice in the Braf/Pten tumor model (p=0.024) and alters the expres-
sion of markers of EMT. These findings functionally delineate the role of E-cadherin loss in melanoma
formation, progression and metastasis.
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Melanocyte behaviors in C57BL/6 nu/nu mice
H Kato, M Nakamura, E Ito, O Taguchi and A Morita Department of Geriatric and Environmental
Dermatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
We generated nude mice in a C57BL/6 background. Mature hair growth is not observed in these
mice (C57BL/6 nu/nu). Their skin color is black and gradually decolorizes with age. Melanocyte
behavior with regard to this decolorization phenomenon is not clear. To test the melanocytes, skin
specimens of C57BL/6 nu/nu and wild-type C57BL/6 mice were obtained on postnatal days (PND)
0, 3, 6, 9, and 12. Immunohistochemistry was performed to analyze melanocytes. Next, a green-
fluorescent protein (GFP) transgenic C57BL/6 nu/nu mouse was generated. The skin of this mouse
was grafted to wild-type C57BL/6 mice to investigate melanocyte behavior. In the wild-type C57BL/6
and C57BL/6 nu/nu mice, melanocytes were present in both the epidermis and dermis on PND 0.
In the wild-type C57BL/6 mouse, there were no melanocytes after PND 3. In contrast, in the C57BL/6
nu/nu mouse, some melanocytes remained in the epidermis on PND 3, 6, and 9, and in the dermis
on PND 3, 6, 9, and 12. The numbers of melanocytes significantly differed between these mice in
the epidermis on PND 0, 6, and 9, and in the dermis on PND 3, 6, 9, and 12 (p<0.05, Wilcoxon
rank sum test). In the grafted mouse, the hairs around the graft site became blacker than the origi-
nal hair color. Immunohistochemistry analysis of the grafted skin revealed that GFP-positive and S-
100 protein-positive cells migrated to hairs around the grafted area, suggesting that dermal
melanocytes in C57BL/6 nu/nu mice were capable of migrating to hair follicles. In the C57BL/6
nu/nu mice, there were some immature hairs, but no mature hairs. Dermal melanocytes were pres-
ent by PND 12. In mice, melanocytes develop from the neural crest and migrate to the dermis and
epidermis to reach the follicular area; thus, no epidermal and dermal melanocytes are observed. In
C57BL/6 nu/nu mice, however, melanocyte migration was interrupted due to the lack of mature hair
formation. Interrupted melanocytes would remain in the dermis.
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Alternation of CYP27B1 expression during progression of pigmented lesions in the skin
AA Brozyna,1 W Jozwicki1 and A Slominski2 1 Department of Tumor Pathology and
Pathomorphology, The Lukaszczyk Oncology Center, Collegium Medicum, Nicolaus
Copernicus University, Bydgoszcz, Poland and 2 Department of Pathology and Laboratory
Medicine, University of Tennessee Health Science Center, Memphis, TN
There has been growing evidence that vitamin D-regulated pathways contribute to pathogenesis
and progression of tumors, including melanoma. Previously, we have shown that expression of
vitamin D receptor decreases during progression of melanocytic and melanoma lesions. CYP27B1,
1α-hydroxylase enzyme, is responsible for the synthesis of the biologically active form of vitamin
D (1,25-dihydroxyvitamin D; calcitriol) by hydroxylating of 25-hydroxyvitamin D. The main organ
producing active vitamin D is kidney, however, extrarenal activity of CYP27B1 is also documented
in other cell types including skin cells. Therefore, we decided to investigate possible changes in
CYP27B1 in melanocytic nevi and melanomas at different levels of progression. Thus, using immuno-
histochemistry we analyzed expression of CYP27B1 in 77 samples obtained form 64 patients includ-
ing 14 benign nevi, 39 primary cutaneous melanomas, 17 metastases, 1 re-excision and 6 normal
skin biopsies. The highest CYP27B1 expression was observed in skin and lymph node and tumor-
infiltrating lymphocytes. Cytoplasmic CYP27B1 was slightly elevated in nevi and melanomas when
compared to normal skin, however, nuclear immunoreactivity gradually decreased with progres-
sion of pigmented lesions. Also lymph node metastases showed the lowest level of CYP27B1. The
significant decrease of CYP27B1 expression in cytoplasm of melanoma cells at vertical growth phase
versus radial growth phase was also observed. In skin surrounding nevi cytoplasmic CYP27B1 was
higher in comparison to normal skin. In conclusion, our data suggests that local expression of
CYP27B1 may play a role in pathogenesis and progression of melanomas, and can affect behavior
of melanocytes.
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2,4,6-octatrienoic acid promotes melanogenesis in normal human melanocytes, through PPAR-
gamma
E Flori,2 A Mastrofrancesco,2 D Kovacs,2 G Giuliani,1 S Briganti2 and M Picardo2 1 R&D, Giuliani
SpA, Milan, Italy and 2 Laboratory of Cutaneous Physiopathology and Integrated Center of
Metabolomics Research, San Gallicano Dermatologic Institute (IRCCS ), Rome, Italy
Melanogenesis is a biosynthetic way controlled by several factors affecting intracellular signal trans-
duction pathways. Peroxisome-activated receptors (PPARs) are ligand-activated transcription factors
that regulate important functions in the skin including proliferation and differentiation. Evidence in
literature shows that activation of PPARγ, one of the three PPARs isoforms, can induce melanocytes
differentiation and melanogenesis. We have observed that Parrodienes, a class of compounds shar-
ing some structural features with carotenoids and retinoids, promote cell antioxidant defence and
counteract senescence-like phenotype in fibroblasts. Moreover we found that the same compounds
are able to promote PPARγ activation. On these basis we selected 2,4,6-octatrienoic acid (Octa), a
derivative of parrodienes, to study its ability to promote melanogenesis in normal human melanocytes
(NHM). We demonstrated that Octa up-regulated PPARγ mRNA expression and promoted its activ-
ity as a transcription factor in NHM. Moreover Octa induced melanogenesis through a significant
up-regulation of tyrosinase expression and activity, correlated with an increase of melanin content.
The observed increase in pigmentation was associated with the stimulation of microphthalmia-asso-
ciated transcription factor, the key transcription factor of melanocyte differentiation, proliferation
and survival. The PPARγ antagonist GW9662 or PPARγ silencing was able to abrogate the melanogenic
effect induced by Octa exposure, clearly indicating that the activation of PPARγ was necessary to
evoke the effects observed. These results suggest a regulatory role of Octa, through PPARγ activa-
tion, in melanogenesis of NHM, offering future perspectives of its employment to enhance skin pho-
toprotection and possibly for the treatment of pigmentary disorders.
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Deficiency in IL-23, but not IL-12, promotes increased initiation and growth of melanocytic
nevi induced by exposure to carcinogenic polyaromatic hydrocarbons
T Nasti,1 N Yusuf,1,2 L Timares1,2 and C Elmets1,2 1 Dermatology, University of Alabama at
Birmingham, School of Medicine, Birmingham AL, AL and 2 Skin Diseases Research Center,
University of Alabama at Birmingham, School of Medicine, Birmingham AL, AL
To investigate genetic and environmental factors associated with nevus initiation, growth, and trans-
formation, we have established a mouse model that responds to topical application of the carcino-
genic polyaromatic hydrocarbon, 7,12-dimethylbenzanthracene (DMBA) followed by application
of the promotor 12-O-tetradecanoyl-phorbol-13-acetate (TPA) in pigmented C3H/HeN mice. After
several weeks, the number of pigmented macules that develop depends on the DMBA dose used;
however, melanoma progression has not been observed. To examine the role of immune modula-
tory cytokines on nevus formation, we backcrossed mice deficient in gene expression for IL-12 (p35-
/-), IL-23 (p19-/-), and both IL-12/23 (p40-/-) onto C3H/HeN mice for more than 11 generations.
Cohorts of 15 mice per strain were subjected to the DMBA/TPA protocol and assessd for latency,
number and size of induced nevi. We observed that IL-23 deficiency resulted in significant increases
in both number and size of nevi. After 17 weeks, the number of nevi increased 1.5-fold, from an
average of 16 nevi per WT mouse to 24 nevi per IL-23 p19-/- mouse (p≤0.001). In addition, the
radial growth spread was 2-fold greater; the total area covered measured 1007 vs 2017 mm2 for
the WT vs the IL-23 p19-/- cohort (p≤0.001). On the other hand, the number and size of nevi gen-
erated in IL-12 p35-/- mice was not significantly different from WT mice (p>0.1). Whereas the num-
ber and size of nevi in IL-12/IL-23 p40-/- mice was similar to that of IL-23 p19-/- mice (p>0.1). The
findings indicate that IL-12 did not contribute significantly to the modulation of nevus growth. The
results contrast with the prevailing paradigm that IL-23 promotes tumor growth, and reveals a novel
role for IL-23 in keeping the proliferation of nevus cells in check.
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Reconstructed human skin model to study melanoma at different stages of progression
M Klausner, Y Kaluzhny and S Ayehunie MatTek Corporation, Ashland, MA
The incidence of cutaneous melanoma (CM) has dramatically increased in the last few decades. The
changes leading from treatable radial growth phase (RGP) melanoma, to high risk vertical growth
phase (VGP), and finally to the metastatic melanoma (MM) phenotype are not well understood.
Development of specific RGP, VGP, and MM tissue models along with their specific microenviron-
ments and cell-matrix and cell-to-cell communication are crucial for understanding disease pro-
gression and for the development of CM therapies. A serum-free (SF) culture system, in which the
precise effects of growth factors and chemo-therapeutic compounds can be tested without inter-
ference from the many undetermined components in serum, is presented. The culture system is based
on the highly differentiated full thickness skin model system, EpiDermTM Full Thickness, which
exhibits a fully developed basement membrane zone. Single cell suspensions of normal human
epidermal keratinocytes and A375 or SK-Mel-28 melanoma cells were seeded on fibroblast-con-
taining collagen gels and induced to differentiate in SF medium. Initially, cultures adopted an RGP
phenotype in which small A375 melanoma nodes in the epidermis were detected as early as day
4. Between day 4 and 11, these nodes progressively grew at the dermal/epidermal junction, and
subsequently adopted VGP (day 18) and MM phenotypes (day 25). The progression of the less aggres-
sive SK-Mel-28 nodes lagged behind that of the A375 nodes. Expression of the adhesion molecule,
N-cadherin, by melanoma cells in the reconstructed skin model paralleled in vivo expression in
stage-specific melanoma. The development of three dimensional, serum-free tissue culture models,
containing melanoma cells at different stages of malignancy, will provide researchers with valuable
tools to study, understand, and develop preventative and therapeutic treatments for this serious malig-
nancy.
773
Effect of oral sulindac on biomarkers of drug bioavailability and carcinogenesis in melanocytic
nevi—A double-blind, randomized, placebo-controlled trial
C Curiel-Lewandrowski,1 S Swetter,2 J Einspahr,1 C Hsu,1 K Saboda,1 R Nagle,1 L LaPresto,1
P Sagerman,1 F Lian,1 J Tangrea,3 H Parnes3 and H Chow1 1 Arizona Cancer Center, University
of Arizona, Tucson, AZ, 2 Dermatology, Stanford University, Palo Alto, CA and 3 Cancer
Prevention, National Cancer Institute, Bethesda, MD
Some epidemiological and experimental publications suggest that regular use of NSAIDs may reduce
the risk of melanoma. A proposed mechanism of action includes VEGF downregulation and induc-
tion of apoptosis. Specific information on the ability of oral NSAIDs to modulate these mechanisms
in melanocytic nevi has not been evaluated. A phase IIa placebo controlled clinical trial was designed
with the primary end point to determine the bioavailability of oral sulindac in benign nevi (BN);
secondary end points were included to determine an effect on VEGF-A expression and apoptosis in
atypical nevi (AN). Fifty healthy subjects with ≥4 large AN and 1 BN were enrolled. Two AN were
randomized to be excised at baseline for biomarker evaluation and 2 AN and one BN to post-inter-
vention evaluation followed by randomization to receive 150 mg BID of sulindac or placebo for 8
weeks. The study intervention was well tolerated with only one subject reporting a persistent Grade
2 adverse event requiring study discontinuation. The interobserver diagnostic agreement between
2 pathologists was 73.5%(147/200 nevi). Sulindac sulfone, a pro-apoptotic active metabolite reached
the target melanocytic tissue at concentration levels (1.38 ± 2.86 μg/g) similar to the respective
plasma concentrations (1.65 ± 1.34 μg/ml). When VEGF-A expression was evaluated by IHC no sig-
nificant difference was observed between treatment groups. However, a loss of within-individual
correlation of VEGF-A expression was observed from baseline (> 0.7) to post-intervention (<0.5)
evaluation in the sulindac group. Current results demonstrate that active sulindac metabolites can
reach measurable levels in nevi. In addition, the present study further supports the notion that
melanoma chemoprevention studies in high-risk populations are feasible.
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Non-invasive genomic analysis discriminates invasive from in situ melanoma
W Wachsman,1,2 TJ Palmer,3 GB Schwartz3 and S Chang3 1 Research Service, VA San Diego,
Healthcare System, San Diego, CA, 2 Division of Hematology-Oncology and Moores Cancer
Center, University of California, San Diego, La Jolla, CA and 3 DermTech International, La Jolla,
CA
Current practice guidelines indicate that disease stage is a key factor for the management of melanoma.
The gold standard for the diagnosis and staging of melanoma is histopathologic evaluation of biopsy
material from suspicious lesions, a minority of which will be found to harbor disease. In previous
studies, we used RNA harvested by tape stripping stratum corneum overlying suspicious pigmented
lesions to identify a 17-gene genomic signature that is highly accurate for detection of both in situ
and invasive melanoma. The robustness of this technology, deemed epidermal genetic information
retrieval (EGIR), led us to ask whether it could be employed to distinguish invasive melanoma from
melanoma in situ. To address this objective, pigmented lesions suspicious for melanoma were tape
stripped and then biopsied as per standard of care. Each biopsy specimen was reviewed for
histopathology by two independent dermatopathologists. Lesions containing either melanoma in
situ or invasive melanoma were processed using the EGIR technology to harvest the RNA, which
was then amplified and expression profiled on Affymetrix U133 plus 2.0 GeneChip arrays. Super-
vised analysis of a training dataset, consisting of 22 in situ and 38 invasive melanomas, identified
427 differentially expressed genes (p<0.05, FDR<0.05). TreeNet-based class prediction modeling
of these 427 genes yielded a 20-gene classifier that discerns invasive from in situ melanoma. Upon
testing with an independent dataset, we found that this classifier separated invasive from in situ
melanoma with 100% sensitivity and 78% specificity, with a ROC AUC >0.972. These results demon-
strate that RNA present in stratum corneum overlying a melanoma lesion contains a genomic bio-
marker that can be used to accurately distinguish invasive from in situ disease and suggests that non-
invasive EGIR-based technology may be used to confirm or enhance histopathology findings for
melanoma staging.
770
Identification of microRNA-211 targets in melanocytes and their role in melanoma
N Maddodi,1 S Madhavan,1 S Devi,1 M Newton1,2 and V Setaluri1 1 Dermatology, University of
Wisconsin, Madison, WI and 2 Biostatistics, University of Wisconsin, Madison, WI
MicroRNAs (miRNAs) are regulatory RNAs that regulate gene expression. Evidence is accumulat-
ing that miRNAs are involved in almost all aspects of tumor biology including tumor cell survival,
proliferation and migration. Here, we report that miRNA-211, which maps to the sixth intron of
TRPM1 gene (a suppressor of melanoma metastasis), is highly expressed in melanocytes and its
expression is reduced in primary and metastatic melanoma cell lines. Expression of miRNA-211
correlates with expression of TRPM1, a transient receptor potential family member calcium chan-
nel protein that we showed to be involved in regulation of melanocyte calcium homeostasis and
melanin pigmentation. TRPM1and miRNA-211 expression are significantly lower in rapidly prolif-
erative melanocytes compared to the slow growing, differentiated melanocytes. Inhibition of miRNA-
211 expression by anti-miR211 inhibited the growth of rapidly growing melanocytes. Ectopic expres-
sion of miRNA-211in melanoma cells inhibit growth and reduced their migration. We show that
expression of RAB22A (member of the RAS family of small GTPases), a predicted RNA target of
miRNA-211, is inversely correlated with the expression of miRNA-211and TRPM1 in melanocytes.
RAB22A 3`UTR luciferase reporter and mutation of the miR-211 binding sites of RAB22A 3`UTR
confirmed that RAB22A is a direct target of miR-211. Since RAB22A is known to be involved in
vesicular trafficking, we also investigated the role of miR-211 on the trafficking of melanosomal pro-
tein TRP-1. We propose that activation of endogenous miRNA-211 expression or targeted delivery
of miR-211 in melanoma is a potential therapeutic option for treatment of cutaneous melanoma.
774
BMP-Smad signaling pathway inhibits proliferation and migration of melanoma cells
N Rungsimanond, T Sharova and A Sharov Dermatology, Boston University school of Medicine,
Boston, MA
Bone morphogenetic protein (BMP) signaling activates the BMP-Smad and BMP-MAPK pathways
and suppresses the development of epithelial tumors in the skin. To access a role of the BMP sig-
naling in the melanoma growth and metastasis, we examined the effect of Smad1 protein on the
proliferation and migration of melanoma cell lines. Malignant human melanoma cells express low
levels of active isoform of Smad1 protein and duration of its active signaling is reduced compared
to normal melanocytes. Marked decrease of the Smad1 activity in melanoma cells is caused, at least
in part, by its proteosomal degradation mediated by the MAPK/ERK-dependent phosphorylation of
the linker region of the Smad1 protein. Most of the primary and metastatic melanoma cell lines have
constitutively active MAPK/ERK signaling as a result of the gain-of-function mutations of the BRAF
or NRAS oncogenes. The lentiviral particles expressing Smad1 protein containing the mutated
MAPK/ERK binding sites were used to infect the melanoma cell lines and resulted in significant
increase of the extent of BMP-dependent activation of a Smad1 transcriptional reporter construct.
Furthermore, melanoma cells expressing constitutively active Smad1 protein containing mutated
MAPK/ERK binding sites showed significant inhibition of cell proliferation and migration compared
to non-infected cells. Growth inhibition in melanoma cells induced by Smad1 correlated with upreg-
ulation of the p16INK4a and p21Cip1 mRNA and protein expression. Thus, these data demonstrate
that MAPK-mediated degradation of Smad1 protein promotes growth of melanoma cells and sug-
gest that pharmacological modulation of the Smad1 protein stability may serve as a new strategy
for melanoma treatment.
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The dual role of IFN-α in TRAIL-induced apoptosis of melanoma cells
ML Kalb, A Glaser, F Koszik and G Stingl Department of Dermatology, DIAID, Medical
University of Vienna, Vienna, Austria
Recombinant IFN-α is used adjuvantly for treatment of stage II and III melanoma patients. It has
been shown that IFN-α therapy increases patient disease-free survival by directly inhibiting tumor
growth via its antiproliferative and cytotoxic properties. Additionally, IFN-α has strong immune-acti-
vating effects through which it may indirectly influence tumor progression. Using flow cytometry
we and others were able to show that the cytotoxic molecule TNF-related apoptosis-inducing lig-
and (TRAIL) is upregulated on monocytes, NK cells and plasmacytoid dendritic cells in response to
IFN-α treatment in vitro. We now observed that patients undergoing adjuvant IFN-α therapy exhibit
increased serum levels of soluble TRAIL as well as increased membrane levels of TRAIL on mono-
cytes, NK cells and, in one case, also on plasmacytoid dendritic cells. To investigate whether the
induction of TRAIL on immune cells may influence tumor growth we analyzed the susceptibility of
established melanoma cell lines and such generated from metastases of stage IV melanoma patients
to TRAIL-induced apoptosis. Over night treatment of melanoma cells with recombinant TRAIL
induced apoptosis ranging from 6-54%, as determined by Annexin V/PI staining. Interestingly, the
magnitude of TRAIL-induced apoptosis did not correlate with mRNA levels or protein surface expres-
sion of pro- and/or anti-apoptotic TRAIL receptors. Treatment of melanoma cells with IFN-α alone
inhibited proliferation but did not induce apoptosis. Importantly, however, IFN-α pre-treatment
enhanced subsequent TRAIL-induced apoptosis, suggesting effects of the cytokine on TRAIL-R expres-
sion or signalling molecules of the apoptotic cascade. In summary our findings suggest that the role
of IFN-α in melanoma therapy is a dual one, i.e. by induction of cytotoxic TRAIL on effector leuko-
cytes on the one hand and by enhancement of melanoma cell susceptibility to TRAIL on the other.
764
Temozolomide induces strong, synergistic apoptosis of melanoma cells when combined with
the BH3-mimetic ABT-737 in a Noxa-dependent fashion.
SN Reuland, NB Goldstein, KA Partyka, S Smith, M Fujita, YG Shellman and DA Norris
Dermatology, University Colorado Denver, Aurora, CO
Temozolomide (TMZ) is a common first-line treatment for metastatic melanoma, but its response
rate is notoriously poor. Agents that can be combined with TMZ to enhance its efficacy are highly
sought after and would have immediate clinical benefit. The BH3-only mimetic ABT-737 has shown
promise for inducing apoptosis in a number of cancers, but is only slightly effective as a single
agent in melanoma cell lines. We found that a combination of TMZ and ABT-737 induced strong
synergistic apoptosis in multiple human melanoma cell lines, while inducing little or no apoptosis
in normal melanocyte lines. The combination also greatly reduced tumor growth in a mouse model
at concentrations where the individual drugs were ineffective. Importantly, the drug combination
caused no observable adverse side-effects in mice. Further study revealed that synergy was depend-
ent on the BH3-only protein Noxa. Noxa is commonly induced by p53, and elevated p53 levels
were found in TMZ-treated cells. Induction of p53 by nutlin-3 was sufficient to induce synergistic
cell death with ABT-737. However, TMZ and ABT-737 caused synergistic cell death even in p53
mutant lines in which nutlin-3 had no effect. These results indicate that while p53 induction is suf-
ficient to cause synergy with ABT-737, the effect of Noxa is independent of p53, and the drug com-
bination should work regardless of p53 status. Our results show that TMZ and ABT-737 are a prom-
ising drug combination for clinical studies.
765
Pigmentary changes during pregnancy
S Baker, AC Haley, K Brown, B Nardone, DP West, JK Robinson and MK Martini Dermatology,
Northwestern University Feinberg School of Medicine, Chicago, IL
Various pigmentary changes have been reported during pregnancy including hyperpigmentation of
the areola, external genitalia, and body folds as well as development of a linea nigra and melasma.
The aim of our study was to evaluate women in each trimester of pregnancy for pigmentary changes
including the presence of melasma, linea nigra, nipple darkening and changes in their melanocytic
nevi. Sixteen patients completed this prospective study (ages 29-38; Fitzpatrick phototypes I-IV).
Subjects’ reported ethnicities were Caucasian (69%), Asian (12.5%), and Hispanic (19%). A major-
ity of patients were primagravid (75%). At initial screening visit during the first trimester, patients
were asked to provide a detailed history of sun exposure, and personal and family history of atyp-
ical nevi or skin cancer. Patients underwent total body skin examinations assessing pigment and
nevi. Two target regions on the back and thigh. If applicable, a target nevus greater than 2mm in
diameter was identified in each of these regions. These nevi were measured and evaluated with
dermoscopy. Patients underwent photographs documenting the face, nipple, abdomen, back, tar-
get regions and target nevi. Total body skin exams and photography were repeated at subsequent
visits during both second and third trimesters. The most common pigmentary changes were nipple
darkening (81%) and linea nigra (81%). Melasma typically presented by the second or third trimester
on the centrofacial and malar regions of the face (50%). Three patients (19%) developed a 1mm
increase in size of one of their target nevi. Changes in dermatoscopic features were also noted in
37.5% of patients. In conclusion, the most common pigmentary changes were the presence of
linea nigra and areolar darkening. Melasma was also noted in a smaller percent of patients. These
changes occurred throughout pregnancy; however they were most commonly noted in the second
and third trimesters. Subtle changes in size and dermatoscopic features of nevi were also evident.
766
Ultraviolet A radiation plays a role in the pathogenesis of malignant melanoma through involve-
ment of the Warburg effect in skin reconstructs
YP Kamenisch, E Maczey, M Röcken, F Meier and M Berneburg Department of Dermatology,
Eberhard-Karls University, Tuebingen, Germany
Malignant melanoma is a highly aggressive skin tumor. While recent studies elegantly demonstrated
a causative role for a single high dose of ultraviolet (UV)B (280-320nm) radiation in the develop-
ment of melanoma, the role of UVA (320-400nm) in the pathogenesis of human melanoma remains
unclear. We could previously show, that repetitive exposure of melanoma cell lines to UVA irradi-
ation increases lactate levels and increases levels of the transketolase-like-1 enzyme, which is an
important enzyme of the pentose phosphate pathway. These findings reason for an increase of aer-
obic glycolysis after repetitive UVA exposure. This phenomenon is characteristic for many carci-
nomas and is known as the Warburg effect. To gain more insight in the role of UVA in the patho-
genesis of melanoma it is important to focus investigations on model systems resembling the human
skin better than single cell cultures. To address this issue, we constructed in vitro models of human
skin, either employing melanocytes or melanoma cells of different malignancies and exposed them
to sublethal, repetitive UVA irradiation. During repetitive UVA irradiation, levels of lactate and glu-
cose were measured and upon completion of UVA treatment transketolase activity and the levels
of β Galactosidase associated senescence (β-Gal) was measured. We found, that UVA influences
glucose consumption and lactate production in skin models with melanocytes and melanoma cell
lines. Furthermore, UVA elevates transketolase activity in melanocytic skin models compared to
melanoma skin models. In addition to this, UVA alters β-Gal. These findings support the hypothe-
sis that repetitive doses of UVA may also play a role in the pathogenesis of melanoma.
767
Correlation between VEGF-A, VEGFR-1, pAkT, and pErk expression in melanocytic lesions and
degree of histological atypia
C Curiel-Lewandrowski,1,2 L LaPresto,3 C Hu,4 K Saboda,2 M Krutszch,2 R Nagle5 and J Einsphar2
1 Dermatology, University of Arizona, Tucson, AZ, 2 Arizona Cancer Center, University of
Arizona, Tucson, AZ, 3 Medicine, University of Arizona, Tucson, AZ, 4 Public Health,
University of Arizona, Tucson, AZ and 5 Pathology, University of Arizona, Tucson, AZ
The accurate diagnosis of atypical melanocytic lesions and their relevance in the clinical field rep-
resents a histological challenge. Relevant and reproducible melanocytic biomarkers that can accu-
rately identify higher risk melanocytic lesions are needed. The expression of vascular endothelial
growth factor-A (VEGF-A), VEGF Receptors 1 and 2, phosphorylated (p) AKT and pERK were assessed
by IHC in archival material from 23 benign nevi (BN), 46 dysplastic nevi (DN) with mild atypia
(DNM), 25 DN with severe atypia/melanoma in situ (DNS/MMIS), and 31 invasive melanoma (MM).
Each biomarker was evaluated within the junctional (JM) and dermal (DM) melanocytic compo-
nents, as well as in keratinocytes (KC), with respect to both the intensity of the IHC signal and per-
centage of positive cells at the nuclear (N) and cytoplasmic (C) level. By univariate analysis an
increased expression from BN/DN to DNS-MM was observed for the following markers: VEGF-A
DM-C (79.8 ± 55.8 vs 116 ± 69.3, p=0.004), VEGFR-1 KC-N (5.6 ± 18.2 vs 9.9 ± 20.4, p=0.024),
VEGFR-2 KC-N (1.1 ± 8 vs 16.6 ± 43.3, p=0.002), and pAKT DM-C (96.1 ± 43.7 vs 127.8 ± 45,
p=0.019). When age, gender, anatomic location and all biomarkers were evaluated by logistic regres-
sion analysis, VEGF-A DM-C was the only melanocytic biomarker demonstrating increased expres-
sion in MM compared to DN (OR 1.1, p=0.029) while VEGFR-1 KC-C and pAKT DM-N demon-
strated a decreased expression in MM (OR:0.95, p=0.023 and OR:0.94, p=0.019). Recursive
partitioning classification confirmed the findings by the logistic regression analysis. Current results
suggest that VEGF-A, and pAKT expression are modulated early on in the progression of melanoma
further suggesting the value of biomarker identification to optimize current histological diagnostic
criteria for atypical melanocytic proliferations.
768
SOX2 promotes human melanoma cell invasion
S Girouard,1 A Laga,2 Q Zhan2 and GF Murphy2 1 Harvard Medical School, Boston, MA and 2
Pathology, Brigham and Women’s Hospital, Boston, MA
The purpose of this study is to assess the role of expression of the embryonic neural crest stem cell
transcription factor, SOX2, in melanoma invasion. SOX2 is known physiologically to regulate stem
cell pluripotency and self-renewal. In melanoma, its expression correlates with primary tumor thick-
ness and experimental tumor growth in xenografts. In patient melanomas, we have observed its pref-
erential expression in more spindle-shaped melanoma cells that exhibit invasive relationships with
peritumoral stroma. Herein, we generated stable SOX2 knockdown (KD) clones in the melanoma
cell line A2058, and used an in vitro invasion assay and RT-PCR to examine potential alterations in
melanoma cell invasiveness and gene expression. By Western blotting, approximately 80% KD
efficiency was achieved using cells infected by lentiviral vectors containing non-target shRNA as
controls. There was a highly significant decrease in invasiveness of the SOX2-KD melanoma cell
line compared with controls (p<0.0001). RT-PCR analysis revealed the decreased invasiveness of
the SOX2-KD melanoma cell line to be associated with a marked decrease (55-fold) in mRNA expres-
sion for the matrix metalloproteinase-3 (MMP-3), an endopeptidase associated with cleavage of
components of the extracellular matrix during cancer cell invasion. These data implicate SOX2 gene
expression in melanoma invasion, and suggest a role for MMP-3 as a potential mediator of this
process.
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Deficiency in IL-23, but not IL-12, promotes increased initiation and growth of melanocytic
nevi induced by exposure to carcinogenic polyaromatic hydrocarbons
T Nasti,1 N Yusuf,1,2 L Timares1,2 and C Elmets1,2 1 Dermatology, University of Alabama at
Birmingham, School of Medicine, Birmingham AL, AL and 2 Skin Diseases Research Center,
University of Alabama at Birmingham, School of Medicine, Birmingham AL, AL
To investigate genetic and environmental factors associated with nevus initiation, growth, and trans-
formation, we have established a mouse model that responds to topical application of the carcino-
genic polyaromatic hydrocarbon, 7,12-dimethylbenzanthracene (DMBA) followed by application
of the promotor 12-O-tetradecanoyl-phorbol-13-acetate (TPA) in pigmented C3H/HeN mice. After
several weeks, the number of pigmented macules that develop depends on the DMBA dose used;
however, melanoma progression has not been observed. To examine the role of immune modula-
tory cytokines on nevus formation, we backcrossed mice deficient in gene expression for IL-12 (p35-
/-), IL-23 (p19-/-), and both IL-12/23 (p40-/-) onto C3H/HeN mice for more than 11 generations.
Cohorts of 15 mice per strain were subjected to the DMBA/TPA protocol and assessd for latency,
number and size of induced nevi. We observed that IL-23 deficiency resulted in significant increases
in both number and size of nevi. After 17 weeks, the number of nevi increased 1.5-fold, from an
average of 16 nevi per WT mouse to 24 nevi per IL-23 p19-/- mouse (p≤0.001). In addition, the
radial growth spread was 2-fold greater; the total area covered measured 1007 vs 2017 mm2 for
the WT vs the IL-23 p19-/- cohort (p≤0.001). On the other hand, the number and size of nevi gen-
erated in IL-12 p35-/- mice was not significantly different from WT mice (p>0.1). Whereas the num-
ber and size of nevi in IL-12/IL-23 p40-/- mice was similar to that of IL-23 p19-/- mice (p>0.1). The
findings indicate that IL-12 did not contribute significantly to the modulation of nevus growth. The
results contrast with the prevailing paradigm that IL-23 promotes tumor growth, and reveals a novel
role for IL-23 in keeping the proliferation of nevus cells in check.
771
Reconstructed human skin model to study melanoma at different stages of progression
M Klausner, Y Kaluzhny and S Ayehunie MatTek Corporation, Ashland, MA
The incidence of cutaneous melanoma (CM) has dramatically increased in the last few decades. The
changes leading from treatable radial growth phase (RGP) melanoma, to high risk vertical growth
phase (VGP), and finally to the metastatic melanoma (MM) phenotype are not well understood.
Development of specific RGP, VGP, and MM tissue models along with their specific microenviron-
ments and cell-matrix and cell-to-cell communication are crucial for understanding disease pro-
gression and for the development of CM therapies. A serum-free (SF) culture system, in which the
precise effects of growth factors and chemo-therapeutic compounds can be tested without inter-
ference from the many undetermined components in serum, is presented. The culture system is based
on the highly differentiated full thickness skin model system, EpiDermTM Full Thickness, which
exhibits a fully developed basement membrane zone. Single cell suspensions of normal human
epidermal keratinocytes and A375 or SK-Mel-28 melanoma cells were seeded on fibroblast-con-
taining collagen gels and induced to differentiate in SF medium. Initially, cultures adopted an RGP
phenotype in which small A375 melanoma nodes in the epidermis were detected as early as day
4. Between day 4 and 11, these nodes progressively grew at the dermal/epidermal junction, and
subsequently adopted VGP (day 18) and MM phenotypes (day 25). The progression of the less aggres-
sive SK-Mel-28 nodes lagged behind that of the A375 nodes. Expression of the adhesion molecule,
N-cadherin, by melanoma cells in the reconstructed skin model paralleled in vivo expression in
stage-specific melanoma. The development of three dimensional, serum-free tissue culture models,
containing melanoma cells at different stages of malignancy, will provide researchers with valuable
tools to study, understand, and develop preventative and therapeutic treatments for this serious malig-
nancy.
773
Effect of oral sulindac on biomarkers of drug bioavailability and carcinogenesis in melanocytic
nevi—A double-blind, randomized, placebo-controlled trial
C Curiel-Lewandrowski,1 S Swetter,2 J Einspahr,1 C Hsu,1 K Saboda,1 R Nagle,1 L LaPresto,1
P Sagerman,1 F Lian,1 J Tangrea,3 H Parnes3 and H Chow1 1 Arizona Cancer Center, University
of Arizona, Tucson, AZ, 2 Dermatology, Stanford University, Palo Alto, CA and 3 Cancer
Prevention, National Cancer Institute, Bethesda, MD
Some epidemiological and experimental publications suggest that regular use of NSAIDs may reduce
the risk of melanoma. A proposed mechanism of action includes VEGF downregulation and induc-
tion of apoptosis. Specific information on the ability of oral NSAIDs to modulate these mechanisms
in melanocytic nevi has not been evaluated. A phase IIa placebo controlled clinical trial was designed
with the primary end point to determine the bioavailability of oral sulindac in benign nevi (BN);
secondary end points were included to determine an effect on VEGF-A expression and apoptosis in
atypical nevi (AN). Fifty healthy subjects with ≥4 large AN and 1 BN were enrolled. Two AN were
randomized to be excised at baseline for biomarker evaluation and 2 AN and one BN to post-inter-
vention evaluation followed by randomization to receive 150 mg BID of sulindac or placebo for 8
weeks. The study intervention was well tolerated with only one subject reporting a persistent Grade
2 adverse event requiring study discontinuation. The interobserver diagnostic agreement between
2 pathologists was 73.5%(147/200 nevi). Sulindac sulfone, a pro-apoptotic active metabolite reached
the target melanocytic tissue at concentration levels (1.38 ± 2.86 μg/g) similar to the respective
plasma concentrations (1.65 ± 1.34 μg/ml). When VEGF-A expression was evaluated by IHC no sig-
nificant difference was observed between treatment groups. However, a loss of within-individual
correlation of VEGF-A expression was observed from baseline (> 0.7) to post-intervention (<0.5)
evaluation in the sulindac group. Current results demonstrate that active sulindac metabolites can
reach measurable levels in nevi. In addition, the present study further supports the notion that
melanoma chemoprevention studies in high-risk populations are feasible.
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Non-invasive genomic analysis discriminates invasive from in situ melanoma
W Wachsman,1,2 TJ Palmer,3 GB Schwartz3 and S Chang3 1 Research Service, VA San Diego,
Healthcare System, San Diego, CA, 2 Division of Hematology-Oncology and Moores Cancer
Center, University of California, San Diego, La Jolla, CA and 3 DermTech International, La Jolla,
CA
Current practice guidelines indicate that disease stage is a key factor for the management of melanoma.
The gold standard for the diagnosis and staging of melanoma is histopathologic evaluation of biopsy
material from suspicious lesions, a minority of which will be found to harbor disease. In previous
studies, we used RNA harvested by tape stripping stratum corneum overlying suspicious pigmented
lesions to identify a 17-gene genomic signature that is highly accurate for detection of both in situ
and invasive melanoma. The robustness of this technology, deemed epidermal genetic information
retrieval (EGIR), led us to ask whether it could be employed to distinguish invasive melanoma from
melanoma in situ. To address this objective, pigmented lesions suspicious for melanoma were tape
stripped and then biopsied as per standard of care. Each biopsy specimen was reviewed for
histopathology by two independent dermatopathologists. Lesions containing either melanoma in
situ or invasive melanoma were processed using the EGIR technology to harvest the RNA, which
was then amplified and expression profiled on Affymetrix U133 plus 2.0 GeneChip arrays. Super-
vised analysis of a training dataset, consisting of 22 in situ and 38 invasive melanomas, identified
427 differentially expressed genes (p<0.05, FDR<0.05). TreeNet-based class prediction modeling
of these 427 genes yielded a 20-gene classifier that discerns invasive from in situ melanoma. Upon
testing with an independent dataset, we found that this classifier separated invasive from in situ
melanoma with 100% sensitivity and 78% specificity, with a ROC AUC >0.972. These results demon-
strate that RNA present in stratum corneum overlying a melanoma lesion contains a genomic bio-
marker that can be used to accurately distinguish invasive from in situ disease and suggests that non-
invasive EGIR-based technology may be used to confirm or enhance histopathology findings for
melanoma staging.
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Identification of microRNA-211 targets in melanocytes and their role in melanoma
N Maddodi,1 S Madhavan,1 S Devi,1 M Newton1,2 and V Setaluri1 1 Dermatology, University of
Wisconsin, Madison, WI and 2 Biostatistics, University of Wisconsin, Madison, WI
MicroRNAs (miRNAs) are regulatory RNAs that regulate gene expression. Evidence is accumulat-
ing that miRNAs are involved in almost all aspects of tumor biology including tumor cell survival,
proliferation and migration. Here, we report that miRNA-211, which maps to the sixth intron of
TRPM1 gene (a suppressor of melanoma metastasis), is highly expressed in melanocytes and its
expression is reduced in primary and metastatic melanoma cell lines. Expression of miRNA-211
correlates with expression of TRPM1, a transient receptor potential family member calcium chan-
nel protein that we showed to be involved in regulation of melanocyte calcium homeostasis and
melanin pigmentation. TRPM1and miRNA-211 expression are significantly lower in rapidly prolif-
erative melanocytes compared to the slow growing, differentiated melanocytes. Inhibition of miRNA-
211 expression by anti-miR211 inhibited the growth of rapidly growing melanocytes. Ectopic expres-
sion of miRNA-211in melanoma cells inhibit growth and reduced their migration. We show that
expression of RAB22A (member of the RAS family of small GTPases), a predicted RNA target of
miRNA-211, is inversely correlated with the expression of miRNA-211and TRPM1 in melanocytes.
RAB22A 3`UTR luciferase reporter and mutation of the miR-211 binding sites of RAB22A 3`UTR
confirmed that RAB22A is a direct target of miR-211. Since RAB22A is known to be involved in
vesicular trafficking, we also investigated the role of miR-211 on the trafficking of melanosomal pro-
tein TRP-1. We propose that activation of endogenous miRNA-211 expression or targeted delivery
of miR-211 in melanoma is a potential therapeutic option for treatment of cutaneous melanoma.
774
BMP-Smad signaling pathway inhibits proliferation and migration of melanoma cells
N Rungsimanond, T Sharova and A Sharov Dermatology, Boston University school of Medicine,
Boston, MA
Bone morphogenetic protein (BMP) signaling activates the BMP-Smad and BMP-MAPK pathways
and suppresses the development of epithelial tumors in the skin. To access a role of the BMP sig-
naling in the melanoma growth and metastasis, we examined the effect of Smad1 protein on the
proliferation and migration of melanoma cell lines. Malignant human melanoma cells express low
levels of active isoform of Smad1 protein and duration of its active signaling is reduced compared
to normal melanocytes. Marked decrease of the Smad1 activity in melanoma cells is caused, at least
in part, by its proteosomal degradation mediated by the MAPK/ERK-dependent phosphorylation of
the linker region of the Smad1 protein. Most of the primary and metastatic melanoma cell lines have
constitutively active MAPK/ERK signaling as a result of the gain-of-function mutations of the BRAF
or NRAS oncogenes. The lentiviral particles expressing Smad1 protein containing the mutated
MAPK/ERK binding sites were used to infect the melanoma cell lines and resulted in significant
increase of the extent of BMP-dependent activation of a Smad1 transcriptional reporter construct.
Furthermore, melanoma cells expressing constitutively active Smad1 protein containing mutated
MAPK/ERK binding sites showed significant inhibition of cell proliferation and migration compared
to non-infected cells. Growth inhibition in melanoma cells induced by Smad1 correlated with upreg-
ulation of the p16INK4a and p21Cip1 mRNA and protein expression. Thus, these data demonstrate
that MAPK-mediated degradation of Smad1 protein promotes growth of melanoma cells and sug-
gest that pharmacological modulation of the Smad1 protein stability may serve as a new strategy
for melanoma treatment.
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The dual role of IFN-α in TRAIL-induced apoptosis of melanoma cells
ML Kalb, A Glaser, F Koszik and G Stingl Department of Dermatology, DIAID, Medical
University of Vienna, Vienna, Austria
Recombinant IFN-α is used adjuvantly for treatment of stage II and III melanoma patients. It has
been shown that IFN-α therapy increases patient disease-free survival by directly inhibiting tumor
growth via its antiproliferative and cytotoxic properties. Additionally, IFN-α has strong immune-acti-
vating effects through which it may indirectly influence tumor progression. Using flow cytometry
we and others were able to show that the cytotoxic molecule TNF-related apoptosis-inducing lig-
and (TRAIL) is upregulated on monocytes, NK cells and plasmacytoid dendritic cells in response to
IFN-α treatment in vitro. We now observed that patients undergoing adjuvant IFN-α therapy exhibit
increased serum levels of soluble TRAIL as well as increased membrane levels of TRAIL on mono-
cytes, NK cells and, in one case, also on plasmacytoid dendritic cells. To investigate whether the
induction of TRAIL on immune cells may influence tumor growth we analyzed the susceptibility of
established melanoma cell lines and such generated from metastases of stage IV melanoma patients
to TRAIL-induced apoptosis. Over night treatment of melanoma cells with recombinant TRAIL
induced apoptosis ranging from 6-54%, as determined by Annexin V/PI staining. Interestingly, the
magnitude of TRAIL-induced apoptosis did not correlate with mRNA levels or protein surface expres-
sion of pro- and/or anti-apoptotic TRAIL receptors. Treatment of melanoma cells with IFN-α alone
inhibited proliferation but did not induce apoptosis. Importantly, however, IFN-α pre-treatment
enhanced subsequent TRAIL-induced apoptosis, suggesting effects of the cytokine on TRAIL-R expres-
sion or signalling molecules of the apoptotic cascade. In summary our findings suggest that the role
of IFN-α in melanoma therapy is a dual one, i.e. by induction of cytotoxic TRAIL on effector leuko-
cytes on the one hand and by enhancement of melanoma cell susceptibility to TRAIL on the other.
764
Temozolomide induces strong, synergistic apoptosis of melanoma cells when combined with
the BH3-mimetic ABT-737 in a Noxa-dependent fashion.
SN Reuland, NB Goldstein, KA Partyka, S Smith, M Fujita, YG Shellman and DA Norris
Dermatology, University Colorado Denver, Aurora, CO
Temozolomide (TMZ) is a common first-line treatment for metastatic melanoma, but its response
rate is notoriously poor. Agents that can be combined with TMZ to enhance its efficacy are highly
sought after and would have immediate clinical benefit. The BH3-only mimetic ABT-737 has shown
promise for inducing apoptosis in a number of cancers, but is only slightly effective as a single
agent in melanoma cell lines. We found that a combination of TMZ and ABT-737 induced strong
synergistic apoptosis in multiple human melanoma cell lines, while inducing little or no apoptosis
in normal melanocyte lines. The combination also greatly reduced tumor growth in a mouse model
at concentrations where the individual drugs were ineffective. Importantly, the drug combination
caused no observable adverse side-effects in mice. Further study revealed that synergy was depend-
ent on the BH3-only protein Noxa. Noxa is commonly induced by p53, and elevated p53 levels
were found in TMZ-treated cells. Induction of p53 by nutlin-3 was sufficient to induce synergistic
cell death with ABT-737. However, TMZ and ABT-737 caused synergistic cell death even in p53
mutant lines in which nutlin-3 had no effect. These results indicate that while p53 induction is suf-
ficient to cause synergy with ABT-737, the effect of Noxa is independent of p53, and the drug com-
bination should work regardless of p53 status. Our results show that TMZ and ABT-737 are a prom-
ising drug combination for clinical studies.
765
Pigmentary changes during pregnancy
S Baker, AC Haley, K Brown, B Nardone, DP West, JK Robinson and MK Martini Dermatology,
Northwestern University Feinberg School of Medicine, Chicago, IL
Various pigmentary changes have been reported during pregnancy including hyperpigmentation of
the areola, external genitalia, and body folds as well as development of a linea nigra and melasma.
The aim of our study was to evaluate women in each trimester of pregnancy for pigmentary changes
including the presence of melasma, linea nigra, nipple darkening and changes in their melanocytic
nevi. Sixteen patients completed this prospective study (ages 29-38; Fitzpatrick phototypes I-IV).
Subjects’ reported ethnicities were Caucasian (69%), Asian (12.5%), and Hispanic (19%). A major-
ity of patients were primagravid (75%). At initial screening visit during the first trimester, patients
were asked to provide a detailed history of sun exposure, and personal and family history of atyp-
ical nevi or skin cancer. Patients underwent total body skin examinations assessing pigment and
nevi. Two target regions on the back and thigh. If applicable, a target nevus greater than 2mm in
diameter was identified in each of these regions. These nevi were measured and evaluated with
dermoscopy. Patients underwent photographs documenting the face, nipple, abdomen, back, tar-
get regions and target nevi. Total body skin exams and photography were repeated at subsequent
visits during both second and third trimesters. The most common pigmentary changes were nipple
darkening (81%) and linea nigra (81%). Melasma typically presented by the second or third trimester
on the centrofacial and malar regions of the face (50%). Three patients (19%) developed a 1mm
increase in size of one of their target nevi. Changes in dermatoscopic features were also noted in
37.5% of patients. In conclusion, the most common pigmentary changes were the presence of
linea nigra and areolar darkening. Melasma was also noted in a smaller percent of patients. These
changes occurred throughout pregnancy; however they were most commonly noted in the second
and third trimesters. Subtle changes in size and dermatoscopic features of nevi were also evident.
766
Ultraviolet A radiation plays a role in the pathogenesis of malignant melanoma through involve-
ment of the Warburg effect in skin reconstructs
YP Kamenisch, E Maczey, M Röcken, F Meier and M Berneburg Department of Dermatology,
Eberhard-Karls University, Tuebingen, Germany
Malignant melanoma is a highly aggressive skin tumor. While recent studies elegantly demonstrated
a causative role for a single high dose of ultraviolet (UV)B (280-320nm) radiation in the develop-
ment of melanoma, the role of UVA (320-400nm) in the pathogenesis of human melanoma remains
unclear. We could previously show, that repetitive exposure of melanoma cell lines to UVA irradi-
ation increases lactate levels and increases levels of the transketolase-like-1 enzyme, which is an
important enzyme of the pentose phosphate pathway. These findings reason for an increase of aer-
obic glycolysis after repetitive UVA exposure. This phenomenon is characteristic for many carci-
nomas and is known as the Warburg effect. To gain more insight in the role of UVA in the patho-
genesis of melanoma it is important to focus investigations on model systems resembling the human
skin better than single cell cultures. To address this issue, we constructed in vitro models of human
skin, either employing melanocytes or melanoma cells of different malignancies and exposed them
to sublethal, repetitive UVA irradiation. During repetitive UVA irradiation, levels of lactate and glu-
cose were measured and upon completion of UVA treatment transketolase activity and the levels
of β Galactosidase associated senescence (β-Gal) was measured. We found, that UVA influences
glucose consumption and lactate production in skin models with melanocytes and melanoma cell
lines. Furthermore, UVA elevates transketolase activity in melanocytic skin models compared to
melanoma skin models. In addition to this, UVA alters β-Gal. These findings support the hypothe-
sis that repetitive doses of UVA may also play a role in the pathogenesis of melanoma.
767
Correlation between VEGF-A, VEGFR-1, pAkT, and pErk expression in melanocytic lesions and
degree of histological atypia
C Curiel-Lewandrowski,1,2 L LaPresto,3 C Hu,4 K Saboda,2 M Krutszch,2 R Nagle5 and J Einsphar2
1 Dermatology, University of Arizona, Tucson, AZ, 2 Arizona Cancer Center, University of
Arizona, Tucson, AZ, 3 Medicine, University of Arizona, Tucson, AZ, 4 Public Health,
University of Arizona, Tucson, AZ and 5 Pathology, University of Arizona, Tucson, AZ
The accurate diagnosis of atypical melanocytic lesions and their relevance in the clinical field rep-
resents a histological challenge. Relevant and reproducible melanocytic biomarkers that can accu-
rately identify higher risk melanocytic lesions are needed. The expression of vascular endothelial
growth factor-A (VEGF-A), VEGF Receptors 1 and 2, phosphorylated (p) AKT and pERK were assessed
by IHC in archival material from 23 benign nevi (BN), 46 dysplastic nevi (DN) with mild atypia
(DNM), 25 DN with severe atypia/melanoma in situ (DNS/MMIS), and 31 invasive melanoma (MM).
Each biomarker was evaluated within the junctional (JM) and dermal (DM) melanocytic compo-
nents, as well as in keratinocytes (KC), with respect to both the intensity of the IHC signal and per-
centage of positive cells at the nuclear (N) and cytoplasmic (C) level. By univariate analysis an
increased expression from BN/DN to DNS-MM was observed for the following markers: VEGF-A
DM-C (79.8 ± 55.8 vs 116 ± 69.3, p=0.004), VEGFR-1 KC-N (5.6 ± 18.2 vs 9.9 ± 20.4, p=0.024),
VEGFR-2 KC-N (1.1 ± 8 vs 16.6 ± 43.3, p=0.002), and pAKT DM-C (96.1 ± 43.7 vs 127.8 ± 45,
p=0.019). When age, gender, anatomic location and all biomarkers were evaluated by logistic regres-
sion analysis, VEGF-A DM-C was the only melanocytic biomarker demonstrating increased expres-
sion in MM compared to DN (OR 1.1, p=0.029) while VEGFR-1 KC-C and pAKT DM-N demon-
strated a decreased expression in MM (OR:0.95, p=0.023 and OR:0.94, p=0.019). Recursive
partitioning classification confirmed the findings by the logistic regression analysis. Current results
suggest that VEGF-A, and pAKT expression are modulated early on in the progression of melanoma
further suggesting the value of biomarker identification to optimize current histological diagnostic
criteria for atypical melanocytic proliferations.
768
SOX2 promotes human melanoma cell invasion
S Girouard,1 A Laga,2 Q Zhan2 and GF Murphy2 1 Harvard Medical School, Boston, MA and 2
Pathology, Brigham and Women’s Hospital, Boston, MA
The purpose of this study is to assess the role of expression of the embryonic neural crest stem cell
transcription factor, SOX2, in melanoma invasion. SOX2 is known physiologically to regulate stem
cell pluripotency and self-renewal. In melanoma, its expression correlates with primary tumor thick-
ness and experimental tumor growth in xenografts. In patient melanomas, we have observed its pref-
erential expression in more spindle-shaped melanoma cells that exhibit invasive relationships with
peritumoral stroma. Herein, we generated stable SOX2 knockdown (KD) clones in the melanoma
cell line A2058, and used an in vitro invasion assay and RT-PCR to examine potential alterations in
melanoma cell invasiveness and gene expression. By Western blotting, approximately 80% KD
efficiency was achieved using cells infected by lentiviral vectors containing non-target shRNA as
controls. There was a highly significant decrease in invasiveness of the SOX2-KD melanoma cell
line compared with controls (p<0.0001). RT-PCR analysis revealed the decreased invasiveness of
the SOX2-KD melanoma cell line to be associated with a marked decrease (55-fold) in mRNA expres-
sion for the matrix metalloproteinase-3 (MMP-3), an endopeptidase associated with cleavage of
components of the extracellular matrix during cancer cell invasion. These data implicate SOX2 gene
expression in melanoma invasion, and suggest a role for MMP-3 as a potential mediator of this
process.
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Alteration of the dermal papillary fibroblast population: A new key to understand skin aging
– Beneficial effects of rhamnose
H Pageon, H Zucchi and D Asselineau Life Sciences, L’Oréal Research & Innovation, Clichy,
France
It is classical to address questions related to skin aging by considering alterations of the dermal
matrix because it is commonly admitted that changes occurring in the matrix are those which will
mostly contribute to skin aging by altering biomechanical properties. In fact the dermis is a com-
plex tissue which can be histologically divided into a superficial dermis close to epidermis and a
deep dermis which is much thicker and different. These two regions contain different fibroblast
populations (1): the superficial dermis or papillary dermis contains papillary fibroblasts (Fp) while
the deep dermis or reticular dermis contains reticular fibroblasts (Fr). Characteristics of matched
pairs of papillary and reticular fibroblasts were investigated throughout aging comparing morphol-
ogy, secretion of diffusible factors like cytokines, growth potential and interaction with epidermal
keratinocytes. Differences were observed which however became less important with increasing
age of the donors (2, 3). Using the reconstructed skin model we found that dermal equivalents con-
taining papillary fibroblasts were more efficient to promote epidermal morphogenesis as compared
to reticular fibroblasts provided young donors were used. We have also investigated the possibility
that Rhamnose added to cultured papillary fibroblasts either from young or old donors could stim-
ulate or restore the activity of these cells. Rhamnose seemed to improve several parameters which
change during aging suggesting that the treatment of aged papillary fibroblasts resulted to the
return to a young-like pattern of these cells. Our results suggest a new way to look at skin aging in
which marked alterations of papillary fibroblast may affect histological appearance of skin and new
opportunities to interfere with this process.
783
The bulge area is the major hair follicle source of nestin-expressing cells which can repair
the spinal cord compared to the dermal papilla
F Liu,1,2,3 A Uchugonova,1,4 H Kimura,1,2,5 C Zhang,3 M Zhao,1 L Zhang,1,2 K Koenig,4 J Duong,1
R Aki,1,6 N Saito,6 S Mii,1,6 Y Amoh,1,6 K Katsuoka6 and RM Hoffman1,2 1 AntiCancer Inc., San
Diego, CA, 2 Dept. of Surgery, University of California, San Diego, CA, 3 Dept. of Anatomy,
2nd Military Medical University, Shanghai, China, 4 Dept. of Biophot. & Laser Tech., Saarland
University, Saarbruecken, Germany, 5 Dept. of Orthopaedic Surg., Kanazawa University,
Kanazawa, Japan and 6 Dept. of Dermatology, Kitasato University, Kanagawa, Japan
Nestin-expressing cells of both the bulge area (BA) and dermal papilla (DP) have been previously
shown to be multipotent and be able to form hair follicle cells as well as neural and other non-fol-
licle cell types. The objective of the present study was to determine the major source of nestin-
expressing stem cells in the hair follicle and to compare the ability of the nestin-expressing stem
cells from the BA and DP to repair spinal cord injury. Transgenic mice in which the nestin promoter
drives GFP (ND-GFP) were used in order to observe nestin expression in the BA and DP. The expres-
sion of nestin in the DP depended on the phase of the hair follicle. Nestin-expressing DP cells were
found in early and middle anagen. The BA had nestin expression throughout the hair cycle and to
a greater extent than the DP. Nestin-expressing cells from both regions had essentially identical mor-
phology with very long processes extending from them as shown by two-photon confocal microscopy.
Nestin-expressing cells from both areas differentiated into neuronal cells at high frequency in vitro.
Matrices of cells from both the BA and DP were formed by culturing them on Gelfoam® which were
used to repair the injured spinal cord in nude mice. Both nestin-expressing DP and BA cells differ-
entiated into neuronal and glial cells after transplantation to the injured spinal cord and enhanced
injury repair and locomotor recovery within four weeks with the BA being the greater and more
constant source.
785
Compromised TGF-β signaling, reduced wound healing and spontaneous skin erosions char-
acterize CLIC4-/- mice
P Velayuthan Chellammal,1 M Stepp,2 K Speer,1 S Dengler,1 J Edwards,4 V Coppola,3 L Tessarollo3
and S Yuspa1 1 National Cancer Institute, Bethesda, MD, 2 GWU Medical School, Washington
DC, DC, 3 National Cancer Institute, Frederick, MD and 4 University of North Carolina,
Chapel Hill, NC
Cutaneous wound healing is a complex process that begins with blood clotting followed by inflam-
mation, migration of keratinocytes, angiogenesis and a combination of other effects that result in
tissue remodeling and wound closure. TGF-β signaling is one of the major signaling pathways
involved in the various aspects of wound healing. Defects in wound healing are a hallmark of genet-
ically modified mice ablated for components of TGF-β signaling. CLIC4, one of the seven members
of the chloride intracellular channel protein family, participates in TGF-β signaling in keratinocytes.
In vitro, CLIC4 modulates TGF-β signaling by inhibiting the phosphatase PPM1a thus prolonging p-
Smad signaling in the nucleus. In order to investigate the function of CLIC4 in vivo, we generated
null mice ablating the expression of CLIC4. CLIC4-/- mice are viable and fertile. CLIC4-/- mice in
CD-1 and C57/Bl6 backgrounds develop extensive skin erosions after about 3 to 6 months. TGF-β
signaling is defective in CLIC4-/- skin, fibroblasts and keratinocytes as evidenced by reduced Smad2
phosphorylation. Corneal wound healing is delayed in CLIC4-/- mice suggesting the skin erosions
might occur due to defects in wound healing. CLIC4-/- keratinocytes are less responsive to TGF-β
induced migration in vitro and adhere with less efficiency on plates coated with keratinocyte matrix.
CLIC4-/- keratinocytes and corneal epithelial cells express higher levels of α3 integrin. Reduced
responsiveness to TGF-β induced migration and altered attachement of CLIC4-/- keratinocytes cor-
relate with compromised wound healing observed in null mice. These results confirm that CLIC4
participates in TGF-β signaling in vivo and suggest that CLIC4 is an essential component of TGF-β
mediated wound healing.
784
Skin-derived precursors as a source of progenitors for cutaneous nerve regeneration
S Pradhan,1 C Liu1 and LQ Le1,2,3 1 Dermatology, UT Southwestern Medical Center, Dallas, TX,
2 Developmental Biology, UT Southwestern Medical Center, Dallas, TX and 3 Simmons
Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
Peripheral nerves have the potential to regenerate axons and reinnervate end organs. Chronic den-
ervation and disturbed nerve regeneration in the dermis contribute to the pathophysiologic mech-
anisms of peripheral neuropathy. The capacity of the denervated distal nerve to support axonal regen-
eration depends on proliferating Schwann cells, which are essential for guiding regenerating axons
to their denervated targets. However, adult peripheral nerve Schwann cells lack the capacity to sus-
tain their growth-permissive phenotype to produce new glia, therefore, it is believed that mature
Schwann cells dedifferentiate to a progenitor/stem cell and promote axonal regrowth upon injury.
In this study, we show that the Skin-derived precursors (SKPs), a recently identified neural crest-
related stem cell in the dermis, may be an alternative source of progenitors for cutaneous nerve
regeneration. Using both in vivo and in vitro 3-D cutaneous nerve regeneration models, we show
that SKPs are neurotropic to injured nerves and have the full capacity to differentiate into Schwann
cells and myelinate regenerating axons. The identification of adult stem cells as a physiologic source
of progenitors for cutaneous nerve regeneration has important implications for understanding early
cellular events that dictate peripheral nerve regeneration. It also provides fertile ground for the elu-
cidation of intrinsic and extrinsic factors within the nerve microenvironment that likely play essen-
tial roles in cutaneous neurogenesis.
782
Regulation of keratinocyte migration and cutaneous wound epithelialization by cholinergic
peptides involves modulation of integrin expression
AI Chernyavsky, M Kalantari-Dehaghi, C Phillips, S Marchenko and SA Grando Dermatology and
Biological Chemistry, University of California, Irvine, CA
It is well established that auto/paracrine acetylcholine (ACh) is essential for keratinocyte migration,
and that the mechanisms include regulation of expression of integrins via nicotinic ACh receptors
(nAChRs). Keratinocyte nAChRs can be activated by the non-canonical ligands termed secreted
mammalian Ly-6/urokinase-type plasminogen activator receptor-related protein (SLURP)-1 and -2.
In this study, we determined effects of recombinant (r)SLURP-1 and-2 on migration of human ker-
atinocytes under agarose and epithelialization of cutaneous wounds in mice, and also identified
the nAChR-mediated mechanism of SLURP actions. The rSLURPs exhibited differential regulation
of epithelialization, with rSLURP-1 decreasing and SLURP-2 increasing the rate of crawling loco-
motion. When combined, rSLURP-1 and -2 further accelerated epithelialization, indicating that
simultaneous signaling renders an additive physiologic response stimulating migration. To deter-
mine the type of nAChRs predominantly mediating biologic effect of each SLURP, we silenced the
receptor gene expression using shRNAs. SLURP-1 acted predominantly at the α7 nAChR coupled
to upregulation of the genes encoding sedentary integrins α2 and α3 at both mRNA and proteins
levels, whereas SLURP-2 activated both the α3-, and α9-made nAChRs coupled to upregulation of
the migratory integrins α5 and αV. The biologic effects of rSLURPs required the presence of endoge-
nous ACh, indicating that auto/paracrine SLURPs provide for a fine tuning of the physiologic regu-
lation of crawling locomotion through keratinocyte ACh axis. Since nAChRs have been previously
shown to regulate production and secretion of SLURPs, cholinergic regulation of keratinocyte migra-
tion appears to be mediated by a reciprocally arranged cholinergic network. The cholinergic pep-
tides, therefore, may become prototype drugs for the treatment of wounds that fail to heal.
786
Hair follicle neogenesis induced by fibroblast-like skin tumor cells from patients with tuber-
ous sclerosis complex
S Li,1 RL Thangapazham,1 J Wang,1 S Rajesh,1 T Kao,2 L Sperling,1 J Moss3 and TN Darling1 1
Department of Dermatology, USUHS, Bethesda, MD, 2 Preventive Medicine and Biometrics,
USUHS, Bethesda, MD and 3 Cardiovascular and Pulmonary Branch, NHLBI, NIH, Bethesda,
MD
Tuberous sclerosis complex (TSC) is a tumor syndrome cased by mutations of TSC1 or TSC2, which
lead to mTORC1 activation and hamartomas in multiple organs including skin. TSC angiofibromas
and forehead plaques are characterized by increased fibroblast-like cells and vessels; these abnor-
malities are accompanied by changes in the follicular epithelium. We have shown that certain TSC
skin tumors contain fibroblast-like cells with biallelic mutations in TSC2 and undetectable levels of
TSC2 protein, whereas no such changes were detectable in the overlying epithelium. To test the
hypothesis that TSC2-null cells are sufficient to induce morphological abnormalities of TSC skin
hamartomas, we grafted skin equivalents composed of TSC skin tumor cells (or patient normal skin
fibroblasts, control) and normal human neonatal foreskin keratinocytes onto immunodeficient mice.
In mice sacrificed 8 to 17 weeks after grafting, tumor xenografts recapitulated characteristics of TSC
skin hamartomas with increased mTORC1 activity, angiogenesis, and epidermal proliferation. Most
interestingly, grafts containing TSC2-null cells from certain TSC skin tumors formed hair follicles.
Follicles were complete with sebaceous glands, hair shafts, and inner and outer root sheaths, and
expressed markers of the companion layer and bulge region stem cells. Follicles were human ori-
gin as shown by immunohistochemistry for HLA-ABC and in situ hybridization for human Y-chro-
mosome. TSC2-null cells surrounding the hair bulb expressed markers of the dermal sheath and der-
mal papilla including nestin. Treatment with rapamycin, an mTORC1 inhibitor, reduced the number
of tumor cells without altering hair follicle size or density. These studies indicate that TSC skin hamar-
tomas contain TSC2-null cells with fetal cell-like morphogenic capacities, suggesting that studies
of hamartomas will provide insights into tissue morphogenesis and regeneration.
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An automated change detection image analysis system as an aid in the early identification of
skin cancer
K Seybold,1 F Mertz,2 R Pina,2 I Chou,2 L Morrison,3 C Bowersox,2 J Zirato,3 L De Paula,1 P Solima2
and C Curiel-Lewandrowski3 1 Raytheon Missle Systems, Tucson, AZ, 2 Photon Research
Associates, A Raytheon Company, San Diego, CA and 3 Arizona Cancer Center, University of
Arizona, Tucson, AZ
A higher rate of melanoma in situ and thinner cutaneous melanomas (CMs) have been detected
using total body digital photography (TBDP) when compared to those CMs identified without the
aid of photography. Barriers for adoption include the time, cost and complexity associated with the
manual image acquisition and comparison process. To overcome these barriers we have developed
a Proof-of-Concept Skin Change Detection (SCD) system to automatically map skin lesion changes
over time. The SCD system consists of 3 components: 1) Image acquisition – High resolution digi-
tal images covering approximately 85% of the body are captured using a repeatable subject posing
station; 2) Image alignment and change detection - Time sequences of images are automatically
aligned and analyzed to detect and report changes to the skin surface between image collections;
and 3) Graphical user interface (GUI) - Images for each change feature are displayed in a user-friendly
interface with detailed data (size, shape, color, texture, etc). To initially assess the registration and
change detection capabilities, simulated skin changes (SCs) in size, shape and color were intro-
duced to the study subjects skin surfaces. To date a total of 22 body poses have been defined with
85% of the images meeting the expected requirements. Image alignment results (from 6 males & 5
females) on 18 poses were scored by an image analyst (100=perfect score and 0=complete failure).
Overall, 67% of the poses scored >65 out of 100. The SCD system was effective at detecting the
smallest simulated changes (0.2-0.25mm). The resolution of each image ranged from 0.15 to 0.17mm
per pixel. Automated SCD systems are feasible and have the potential to advance early detection
of CM by aiding total body mapping with a tool that is automated, repeatable, and quantitative.
776
DNA methylation differences between melanomas and nevi
K Conway,1,6 SN Edmiston,6 ZS Khondker,2 PA Groben,3 X Zhou,2 H Chu,7 P Kuan,2,6 H Hao,4
C Carson,4 M Berwick,8,6 DW Ollila5 and NE Thomas4,6 1 Epidemiology, University of North
Carolina, Chapel Hill, NC, 2 Biostatistics, University of North Carolina, Chapel Hill, NC, 3
Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC, 4
Dermatology, University of North Carolina, Chapel Hill, NC, 5 Surgery, University of North
Carolina, Chapel Hill, NC, 6 Lineberger Comprehensive Cancer Center, University of North
Carolina, Chapel Hill, NC, 7 Biostatistics, University of Minnesota, Minneapolis, MN and 8
Medicine, University of New Mexico, Albuquerque, NM
Early diagnosis of melanoma is difficult due to its overlap in clinical and histologic appearance
with highly prevalent benign melanocytic nevi. We investigated whether DNA methylation could
be useful for molecular diagnosis of melanoma. Using the Illumina GoldenGate Cancer Panel I
Methylation array platform, we profiled formalin-fixed paraffin-embedded nevi (N=29) and
melanomas (N=22). Unsupervised hierarchical clustering distinguished melanomas from nevi; and
75 CpG loci were identified that differed significantly (P<0.05) between nevi and melanomas after
Bonferroni correction and had mean beta differences of at least 0.2. After further adjustment for age
and sex, 26 CpG loci in 22 genes differed significantly between melanomas and nevi. Of these
loci, 16 were hypomethylated while 6 were hypermethylated in melanomas relative to nevi. The
areas under the receiver operator curves ranged from 0.84 to 1.0. In Prediction Analysis for Microar-
rays (PAM) analyses, 12 CpG sites in 9 genes provided the most accurate discrimination, with no
misclassification. Of the 22 differentially methylated genes, 14 were significantly differentially methy-
lated in an independent dataset of 29 nevi (including dysplastic nevi) and 25 melanomas. Our results
suggest that DNA-methylation differences between melanomas and nevi may be useful for diag-
nosis.
777
Anti-tyrosinase related protein 1 antibody in combination with cyclophosphamide enhances
immunogenicity of established b16 melanoma
Y Saenger,1,2 M Pan,1 D Hashimoto,2 B Glodny,1 S Shah,1 T Merghoub,3 J Wolchok,3 M Lebwohl1
and M Merad2 1 Dermatology, Mount Sinai School of Medicine, New York, NY, 2 Medical
Oncology, Mount Sinai School of Medicine, New York, NY and 3 Medicine, Memorial Sloan
Kettering Cancer Institute, New York, NY
Monoclonal antibodies targeting tumor antigens are an effective anti-cancer immunotherapy when
given in combination with chemotherapy. Mechanisms underlying the efficacy of combination ther-
apy, however are poorly understood. Tyrosinase-related protein 1 (TRP1) is implicated in pigment
formation. An antibody targeting TRP1 is in clinical testing. In mice, anti-TRP1 prophylaxis protects
against B16 melanoma, but is not active as a single agent against established disease. We report
that anti-TRP1 enhances the immunogenicity of cyclophosphamide chemotherapy in the treatment
of established cutaneous B16 melanoma with treatment initiated at timepoints up to day 7 when
tumors are palpable with long term responses observed in some animals. Treatment efficacy is Fc
receptor dependent. Combination therapy increases infiltration of CD8+ T lymphocytes visualized
by immunofluorescence (IF) and flow cytometry. Therapeutic efficacy was abrogated in animals
depleted of CD8+ T cells through injection of anti-CD8 IgG. Surprisingly, although B16 is a non-
immunogenic tumor, mice treated with cyclophosphamide and ‘passive’ immunization with anti-
TRP1 remained resistant to rechallenge one month following the last antibody dose. Unlike other
models used to study monolonal antibody therapy, this is a poorly immunogenic treatment model
which is not manipulated through the expression of foreign antigens or the alteration of native anti-
gens. These data therefore strongly implicate a role for adaptive immunity in the therapeutic effi-
cacy of anti-tumor antibodies combined with chemotherapy in the treatment of poorly immuno-
genic tumors These findings have implications for design of future clinical trials using these agents
and for the development of novel strategies to induce adaptive anti-tumor immunity.
778
Ellagic acid induces apoptosis and cell cycle arrest through upregulation of p53
JD Jensen,1 Y Luo,1 W Liu,1 RP Dellavalle1,2,3 and M Fujita1 1 Dermatology, University of
Colorado Denver, Aurora, CO, 2 Dermatology, Denver Veterans Affairs Medical Center,
Denver, CO and 3 Epidemiology, Colorado School of Public Health, Aurora, CO
Ellagic acid is a polyphenolic compound that is found in strawberries, blueberries, and other fruit,
and is also a popular dietary supplement. It has anti-fibrotic and antioxidant properties, and has
been shown to exhibit antiproliferative properties in cancer cells in vitro. Ellagic acid has been
shown to modulate a variety of signaling pathways which result in increased apoptosis and decreased
proliferation in cancer cells, including NF-kB, iNOS, Wnt and others. There are few studies which
examine the effects of ellagic acid on metastatic melanoma. Even fewer identify a mechanism by
which ellagic acid exerts its antiproliferative and pro-apoptotic effects. In the present study, we iden-
tify a novel mechanism by which ellagic acid exerts antiproliferative and proapoptotic effects on
melanoma cells in vitro. Four metastatic human melanoma cell lines (1205LU, WM852c, A375
and HS294T) were examined in our study. MTS assay demonstrated that ellagic acid possesses an
inhibitory effect on cell proliferation at 25 to 100 micromolar concentrations over a period of 72
hours. Ellagic acid was also found to induce statistically significant G1 cell cycle arrest in WM852c
cells. Annexin V/PI staining and flow cytometry further revealed increased levels of apoptosis in
multiple cell lines treated with ellagic acid at 50-100 micromolar concentrations. Evaluation of 48
nuclear transcription factors revealed increases in p53 expression and decreases in AP2 expression
in cells treated with ellagic acid. Confirmatory studies quantifying mRNA expression of placental
TGF-beta and BCL-2 further suggest a mechanism by which ellagic acid may exert antiproliferative
and proapoptotic effects. Our findings support a potential role for ellagic acid as a therapeutic, adju-
vant, or chemopreventive agent for melanoma.
779
Dual role of apoptosis-associated speck-like protein containing a CARD (ASC) in human
melanoma cells
W Liu,1 CA Dinarello,2 DA Norris1 and M Fujita1 1 Dermatology, University of Colorado, School
of Medicine, Aurora, CO and 2 Medicine, University of Colorado, School of Medicine, Aurora,
CO
The adaptor protein ASC (apoptosis-associated speck-like protein containing a CARD) was origi-
nally reported to induce apoptosis when overexpressed in certain tumor cell lines. As an integral
component of the inflammasome, ASC also mediates inflammatory signals. We have previously
reported that inflammasome is consititutively active in human melanoma cells and that IL-1-medi-
ated autoinflammation contributes to the development and progression of human melanoma cells.
However, the role of ASC protein in tumorigenesis remains unclear. Here we showed that metasta-
tic melanoma cells (HS294T and 1205Lu) expressed less ASC than primary melanoma cells (WM35
and WM115). Immunoprecipitation revealed co-precipitation of ASC with NALP3 and IKK in all
melanoma cells. When ASC was silenced by stably transducing cells with ASC shRNA, caspase-1
activity was reduced and IL-1β secretion was decreased in all melanoma cells. However, IL-1α and
IL-1β production was increased in primary melanoma but not in metastatic melanoma after ASC
knockdown (ASC-KD). Although ASC-KD did not affect cell death, it increased DNA synthesis in
primary melanoma cells whereas it induced G1 cell cycle arrest in metastatic melanoma cells.
Likewise, cell proliferation analysis showed increased cell proliferation in primary melanoma cells
and decreased proliferation in metastatic melanoma cells after ASC-KD. Further analyses of phos-
pho-IκB Kinase, IκB and NF-κB activity revealed that NF-κB signaling was increased in primary
melanoma cells but was decreased in metastatic melanoma cells after ASC-KD. Along with these
data, nude mouse experiments confirmed enhanced tumorigenesis in primary melanoma cells with
ASC-KD and decreased tumorigenesis in metastatic melanoma cells with ASC-KD. These findings
implicate the dual role of ASC in tumorigenesis by mediating NF-κB activity and suggest that ASC
could be a promising target for cancer therapy in metastatic melanoma.
780
The redox antimalarial dihydroartemisinin targets human melanoma cells but not melanocytes
through induction of NOXA (PMAIP1)-dependent apoptosis that occurs as a function of intra-
cellular labile iron availability
CM Cabello, SD Lamore, WB Bair and GT Wondrak Pharmacology and Toxicology, College of
Pharmacy and Arizona Cancer Center, University of Arizona, Tucson, AZ
The proapoptotic BH3-only protein NOXA (encoded by PMAIP1) has recently emerged as a prom-
ising target for the chemotherapeutic induction of melanoma cell apoptosis. Using a differential
phenotypic drug screen for novel leads that selectively induce melanoma cell apoptosis without
compromising viability of primary human melanocytes, we have identified the redox antimalarial
drug dihydroartemisinin (DHA) as a NOXA-dependent experimental melanoma chemotherapeutic.
In cultured human metastatic melanoma cells (A375, G361) pronounced upregulation of NOXA
occurred within 3 h of DHA-exposure at the transcriptional and protein level followed by caspase-
dependent apoptotic execution. Genetic antagonism (PMAIP1-siRNA) rescued A375 cells from
DHA-induced apoptosis. Consistent with involvement of oxidative stress and iron-dependent acti-
vation of the endoperoxide-pharmacophore, DHA-induced cell death was antagonized by NAC or
deferoxamine cotreatment, respectively. Expression array analysis revealed DHA-induced upregu-
lation of oxidative and genotoxic stress response genes (GADD45A, GADD153, CDKN1A, HMOX1,
EGR1). Comet analysis demonstrated early induction of genotoxic stress by DHA, further substan-
tiated by detection of activational phosphorylation of p53 (Ser15) consistent with the established
role of activated p53 in PMAIP1 expression. In contrast, in primary human epidermal melanocytes,
viability, comet tail moment, NOXA expression, and cellular oxidative stress remained unaltered
by DHA. Flow cytometric analysis identified an increased intracellular labile iron pool in melanoma
cells versus melanocytes as a potential mechanistic determinant of differential DHA-sensitivity. Taken
together these data suggest that metastatic melanoma cells display a specific chemical vulnerabil-
ity to iron-mediated DHA cytotoxicity that causes NOXA upregulation upstream of caspase-depend-
ent cell death.
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Alteration of the dermal papillary fibroblast population: A new key to understand skin aging
– Beneficial effects of rhamnose
H Pageon, H Zucchi and D Asselineau Life Sciences, L’Oréal Research & Innovation, Clichy,
France
It is classical to address questions related to skin aging by considering alterations of the dermal
matrix because it is commonly admitted that changes occurring in the matrix are those which will
mostly contribute to skin aging by altering biomechanical properties. In fact the dermis is a com-
plex tissue which can be histologically divided into a superficial dermis close to epidermis and a
deep dermis which is much thicker and different. These two regions contain different fibroblast
populations (1): the superficial dermis or papillary dermis contains papillary fibroblasts (Fp) while
the deep dermis or reticular dermis contains reticular fibroblasts (Fr). Characteristics of matched
pairs of papillary and reticular fibroblasts were investigated throughout aging comparing morphol-
ogy, secretion of diffusible factors like cytokines, growth potential and interaction with epidermal
keratinocytes. Differences were observed which however became less important with increasing
age of the donors (2, 3). Using the reconstructed skin model we found that dermal equivalents con-
taining papillary fibroblasts were more efficient to promote epidermal morphogenesis as compared
to reticular fibroblasts provided young donors were used. We have also investigated the possibility
that Rhamnose added to cultured papillary fibroblasts either from young or old donors could stim-
ulate or restore the activity of these cells. Rhamnose seemed to improve several parameters which
change during aging suggesting that the treatment of aged papillary fibroblasts resulted to the
return to a young-like pattern of these cells. Our results suggest a new way to look at skin aging in
which marked alterations of papillary fibroblast may affect histological appearance of skin and new
opportunities to interfere with this process.
783
The bulge area is the major hair follicle source of nestin-expressing cells which can repair
the spinal cord compared to the dermal papilla
F Liu,1,2,3 A Uchugonova,1,4 H Kimura,1,2,5 C Zhang,3 M Zhao,1 L Zhang,1,2 K Koenig,4 J Duong,1
R Aki,1,6 N Saito,6 S Mii,1,6 Y Amoh,1,6 K Katsuoka6 and RM Hoffman1,2 1 AntiCancer Inc., San
Diego, CA, 2 Dept. of Surgery, University of California, San Diego, CA, 3 Dept. of Anatomy,
2nd Military Medical University, Shanghai, China, 4 Dept. of Biophot. & Laser Tech., Saarland
University, Saarbruecken, Germany, 5 Dept. of Orthopaedic Surg., Kanazawa University,
Kanazawa, Japan and 6 Dept. of Dermatology, Kitasato University, Kanagawa, Japan
Nestin-expressing cells of both the bulge area (BA) and dermal papilla (DP) have been previously
shown to be multipotent and be able to form hair follicle cells as well as neural and other non-fol-
licle cell types. The objective of the present study was to determine the major source of nestin-
expressing stem cells in the hair follicle and to compare the ability of the nestin-expressing stem
cells from the BA and DP to repair spinal cord injury. Transgenic mice in which the nestin promoter
drives GFP (ND-GFP) were used in order to observe nestin expression in the BA and DP. The expres-
sion of nestin in the DP depended on the phase of the hair follicle. Nestin-expressing DP cells were
found in early and middle anagen. The BA had nestin expression throughout the hair cycle and to
a greater extent than the DP. Nestin-expressing cells from both regions had essentially identical mor-
phology with very long processes extending from them as shown by two-photon confocal microscopy.
Nestin-expressing cells from both areas differentiated into neuronal cells at high frequency in vitro.
Matrices of cells from both the BA and DP were formed by culturing them on Gelfoam® which were
used to repair the injured spinal cord in nude mice. Both nestin-expressing DP and BA cells differ-
entiated into neuronal and glial cells after transplantation to the injured spinal cord and enhanced
injury repair and locomotor recovery within four weeks with the BA being the greater and more
constant source.
785
Compromised TGF-β signaling, reduced wound healing and spontaneous skin erosions char-
acterize CLIC4-/- mice
P Velayuthan Chellammal,1 M Stepp,2 K Speer,1 S Dengler,1 J Edwards,4 V Coppola,3 L Tessarollo3
and S Yuspa1 1 National Cancer Institute, Bethesda, MD, 2 GWU Medical School, Washington
DC, DC, 3 National Cancer Institute, Frederick, MD and 4 University of North Carolina,
Chapel Hill, NC
Cutaneous wound healing is a complex process that begins with blood clotting followed by inflam-
mation, migration of keratinocytes, angiogenesis and a combination of other effects that result in
tissue remodeling and wound closure. TGF-β signaling is one of the major signaling pathways
involved in the various aspects of wound healing. Defects in wound healing are a hallmark of genet-
ically modified mice ablated for components of TGF-β signaling. CLIC4, one of the seven members
of the chloride intracellular channel protein family, participates in TGF-β signaling in keratinocytes.
In vitro, CLIC4 modulates TGF-β signaling by inhibiting the phosphatase PPM1a thus prolonging p-
Smad signaling in the nucleus. In order to investigate the function of CLIC4 in vivo, we generated
null mice ablating the expression of CLIC4. CLIC4-/- mice are viable and fertile. CLIC4-/- mice in
CD-1 and C57/Bl6 backgrounds develop extensive skin erosions after about 3 to 6 months. TGF-β
signaling is defective in CLIC4-/- skin, fibroblasts and keratinocytes as evidenced by reduced Smad2
phosphorylation. Corneal wound healing is delayed in CLIC4-/- mice suggesting the skin erosions
might occur due to defects in wound healing. CLIC4-/- keratinocytes are less responsive to TGF-β
induced migration in vitro and adhere with less efficiency on plates coated with keratinocyte matrix.
CLIC4-/- keratinocytes and corneal epithelial cells express higher levels of α3 integrin. Reduced
responsiveness to TGF-β induced migration and altered attachement of CLIC4-/- keratinocytes cor-
relate with compromised wound healing observed in null mice. These results confirm that CLIC4
participates in TGF-β signaling in vivo and suggest that CLIC4 is an essential component of TGF-β
mediated wound healing.
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Skin-derived precursors as a source of progenitors for cutaneous nerve regeneration
S Pradhan,1 C Liu1 and LQ Le1,2,3 1 Dermatology, UT Southwestern Medical Center, Dallas, TX,
2 Developmental Biology, UT Southwestern Medical Center, Dallas, TX and 3 Simmons
Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
Peripheral nerves have the potential to regenerate axons and reinnervate end organs. Chronic den-
ervation and disturbed nerve regeneration in the dermis contribute to the pathophysiologic mech-
anisms of peripheral neuropathy. The capacity of the denervated distal nerve to support axonal regen-
eration depends on proliferating Schwann cells, which are essential for guiding regenerating axons
to their denervated targets. However, adult peripheral nerve Schwann cells lack the capacity to sus-
tain their growth-permissive phenotype to produce new glia, therefore, it is believed that mature
Schwann cells dedifferentiate to a progenitor/stem cell and promote axonal regrowth upon injury.
In this study, we show that the Skin-derived precursors (SKPs), a recently identified neural crest-
related stem cell in the dermis, may be an alternative source of progenitors for cutaneous nerve
regeneration. Using both in vivo and in vitro 3-D cutaneous nerve regeneration models, we show
that SKPs are neurotropic to injured nerves and have the full capacity to differentiate into Schwann
cells and myelinate regenerating axons. The identification of adult stem cells as a physiologic source
of progenitors for cutaneous nerve regeneration has important implications for understanding early
cellular events that dictate peripheral nerve regeneration. It also provides fertile ground for the elu-
cidation of intrinsic and extrinsic factors within the nerve microenvironment that likely play essen-
tial roles in cutaneous neurogenesis.
782
Regulation of keratinocyte migration and cutaneous wound epithelialization by cholinergic
peptides involves modulation of integrin expression
AI Chernyavsky, M Kalantari-Dehaghi, C Phillips, S Marchenko and SA Grando Dermatology and
Biological Chemistry, University of California, Irvine, CA
It is well established that auto/paracrine acetylcholine (ACh) is essential for keratinocyte migration,
and that the mechanisms include regulation of expression of integrins via nicotinic ACh receptors
(nAChRs). Keratinocyte nAChRs can be activated by the non-canonical ligands termed secreted
mammalian Ly-6/urokinase-type plasminogen activator receptor-related protein (SLURP)-1 and -2.
In this study, we determined effects of recombinant (r)SLURP-1 and-2 on migration of human ker-
atinocytes under agarose and epithelialization of cutaneous wounds in mice, and also identified
the nAChR-mediated mechanism of SLURP actions. The rSLURPs exhibited differential regulation
of epithelialization, with rSLURP-1 decreasing and SLURP-2 increasing the rate of crawling loco-
motion. When combined, rSLURP-1 and -2 further accelerated epithelialization, indicating that
simultaneous signaling renders an additive physiologic response stimulating migration. To deter-
mine the type of nAChRs predominantly mediating biologic effect of each SLURP, we silenced the
receptor gene expression using shRNAs. SLURP-1 acted predominantly at the α7 nAChR coupled
to upregulation of the genes encoding sedentary integrins α2 and α3 at both mRNA and proteins
levels, whereas SLURP-2 activated both the α3-, and α9-made nAChRs coupled to upregulation of
the migratory integrins α5 and αV. The biologic effects of rSLURPs required the presence of endoge-
nous ACh, indicating that auto/paracrine SLURPs provide for a fine tuning of the physiologic regu-
lation of crawling locomotion through keratinocyte ACh axis. Since nAChRs have been previously
shown to regulate production and secretion of SLURPs, cholinergic regulation of keratinocyte migra-
tion appears to be mediated by a reciprocally arranged cholinergic network. The cholinergic pep-
tides, therefore, may become prototype drugs for the treatment of wounds that fail to heal.
786
Hair follicle neogenesis induced by fibroblast-like skin tumor cells from patients with tuber-
ous sclerosis complex
S Li,1 RL Thangapazham,1 J Wang,1 S Rajesh,1 T Kao,2 L Sperling,1 J Moss3 and TN Darling1 1
Department of Dermatology, USUHS, Bethesda, MD, 2 Preventive Medicine and Biometrics,
USUHS, Bethesda, MD and 3 Cardiovascular and Pulmonary Branch, NHLBI, NIH, Bethesda,
MD
Tuberous sclerosis complex (TSC) is a tumor syndrome cased by mutations of TSC1 or TSC2, which
lead to mTORC1 activation and hamartomas in multiple organs including skin. TSC angiofibromas
and forehead plaques are characterized by increased fibroblast-like cells and vessels; these abnor-
malities are accompanied by changes in the follicular epithelium. We have shown that certain TSC
skin tumors contain fibroblast-like cells with biallelic mutations in TSC2 and undetectable levels of
TSC2 protein, whereas no such changes were detectable in the overlying epithelium. To test the
hypothesis that TSC2-null cells are sufficient to induce morphological abnormalities of TSC skin
hamartomas, we grafted skin equivalents composed of TSC skin tumor cells (or patient normal skin
fibroblasts, control) and normal human neonatal foreskin keratinocytes onto immunodeficient mice.
In mice sacrificed 8 to 17 weeks after grafting, tumor xenografts recapitulated characteristics of TSC
skin hamartomas with increased mTORC1 activity, angiogenesis, and epidermal proliferation. Most
interestingly, grafts containing TSC2-null cells from certain TSC skin tumors formed hair follicles.
Follicles were complete with sebaceous glands, hair shafts, and inner and outer root sheaths, and
expressed markers of the companion layer and bulge region stem cells. Follicles were human ori-
gin as shown by immunohistochemistry for HLA-ABC and in situ hybridization for human Y-chro-
mosome. TSC2-null cells surrounding the hair bulb expressed markers of the dermal sheath and der-
mal papilla including nestin. Treatment with rapamycin, an mTORC1 inhibitor, reduced the number
of tumor cells without altering hair follicle size or density. These studies indicate that TSC skin hamar-
tomas contain TSC2-null cells with fetal cell-like morphogenic capacities, suggesting that studies
of hamartomas will provide insights into tissue morphogenesis and regeneration.
www.jidonline.org   S131
SID11_Abstracts-5  2/28/11  9:27 AM  Page S131
ABSTRACTS
775
An automated change detection image analysis system as an aid in the early identification of
skin cancer
K Seybold,1 F Mertz,2 R Pina,2 I Chou,2 L Morrison,3 C Bowersox,2 J Zirato,3 L De Paula,1 P Solima2
and C Curiel-Lewandrowski3 1 Raytheon Missle Systems, Tucson, AZ, 2 Photon Research
Associates, A Raytheon Company, San Diego, CA and 3 Arizona Cancer Center, University of
Arizona, Tucson, AZ
A higher rate of melanoma in situ and thinner cutaneous melanomas (CMs) have been detected
using total body digital photography (TBDP) when compared to those CMs identified without the
aid of photography. Barriers for adoption include the time, cost and complexity associated with the
manual image acquisition and comparison process. To overcome these barriers we have developed
a Proof-of-Concept Skin Change Detection (SCD) system to automatically map skin lesion changes
over time. The SCD system consists of 3 components: 1) Image acquisition – High resolution digi-
tal images covering approximately 85% of the body are captured using a repeatable subject posing
station; 2) Image alignment and change detection - Time sequences of images are automatically
aligned and analyzed to detect and report changes to the skin surface between image collections;
and 3) Graphical user interface (GUI) - Images for each change feature are displayed in a user-friendly
interface with detailed data (size, shape, color, texture, etc). To initially assess the registration and
change detection capabilities, simulated skin changes (SCs) in size, shape and color were intro-
duced to the study subjects skin surfaces. To date a total of 22 body poses have been defined with
85% of the images meeting the expected requirements. Image alignment results (from 6 males & 5
females) on 18 poses were scored by an image analyst (100=perfect score and 0=complete failure).
Overall, 67% of the poses scored >65 out of 100. The SCD system was effective at detecting the
smallest simulated changes (0.2-0.25mm). The resolution of each image ranged from 0.15 to 0.17mm
per pixel. Automated SCD systems are feasible and have the potential to advance early detection
of CM by aiding total body mapping with a tool that is automated, repeatable, and quantitative.
776
DNA methylation differences between melanomas and nevi
K Conway,1,6 SN Edmiston,6 ZS Khondker,2 PA Groben,3 X Zhou,2 H Chu,7 P Kuan,2,6 H Hao,4
C Carson,4 M Berwick,8,6 DW Ollila5 and NE Thomas4,6 1 Epidemiology, University of North
Carolina, Chapel Hill, NC, 2 Biostatistics, University of North Carolina, Chapel Hill, NC, 3
Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC, 4
Dermatology, University of North Carolina, Chapel Hill, NC, 5 Surgery, University of North
Carolina, Chapel Hill, NC, 6 Lineberger Comprehensive Cancer Center, University of North
Carolina, Chapel Hill, NC, 7 Biostatistics, University of Minnesota, Minneapolis, MN and 8
Medicine, University of New Mexico, Albuquerque, NM
Early diagnosis of melanoma is difficult due to its overlap in clinical and histologic appearance
with highly prevalent benign melanocytic nevi. We investigated whether DNA methylation could
be useful for molecular diagnosis of melanoma. Using the Illumina GoldenGate Cancer Panel I
Methylation array platform, we profiled formalin-fixed paraffin-embedded nevi (N=29) and
melanomas (N=22). Unsupervised hierarchical clustering distinguished melanomas from nevi; and
75 CpG loci were identified that differed significantly (P<0.05) between nevi and melanomas after
Bonferroni correction and had mean beta differences of at least 0.2. After further adjustment for age
and sex, 26 CpG loci in 22 genes differed significantly between melanomas and nevi. Of these
loci, 16 were hypomethylated while 6 were hypermethylated in melanomas relative to nevi. The
areas under the receiver operator curves ranged from 0.84 to 1.0. In Prediction Analysis for Microar-
rays (PAM) analyses, 12 CpG sites in 9 genes provided the most accurate discrimination, with no
misclassification. Of the 22 differentially methylated genes, 14 were significantly differentially methy-
lated in an independent dataset of 29 nevi (including dysplastic nevi) and 25 melanomas. Our results
suggest that DNA-methylation differences between melanomas and nevi may be useful for diag-
nosis.
777
Anti-tyrosinase related protein 1 antibody in combination with cyclophosphamide enhances
immunogenicity of established b16 melanoma
Y Saenger,1,2 M Pan,1 D Hashimoto,2 B Glodny,1 S Shah,1 T Merghoub,3 J Wolchok,3 M Lebwohl1
and M Merad2 1 Dermatology, Mount Sinai School of Medicine, New York, NY, 2 Medical
Oncology, Mount Sinai School of Medicine, New York, NY and 3 Medicine, Memorial Sloan
Kettering Cancer Institute, New York, NY
Monoclonal antibodies targeting tumor antigens are an effective anti-cancer immunotherapy when
given in combination with chemotherapy. Mechanisms underlying the efficacy of combination ther-
apy, however are poorly understood. Tyrosinase-related protein 1 (TRP1) is implicated in pigment
formation. An antibody targeting TRP1 is in clinical testing. In mice, anti-TRP1 prophylaxis protects
against B16 melanoma, but is not active as a single agent against established disease. We report
that anti-TRP1 enhances the immunogenicity of cyclophosphamide chemotherapy in the treatment
of established cutaneous B16 melanoma with treatment initiated at timepoints up to day 7 when
tumors are palpable with long term responses observed in some animals. Treatment efficacy is Fc
receptor dependent. Combination therapy increases infiltration of CD8+ T lymphocytes visualized
by immunofluorescence (IF) and flow cytometry. Therapeutic efficacy was abrogated in animals
depleted of CD8+ T cells through injection of anti-CD8 IgG. Surprisingly, although B16 is a non-
immunogenic tumor, mice treated with cyclophosphamide and ‘passive’ immunization with anti-
TRP1 remained resistant to rechallenge one month following the last antibody dose. Unlike other
models used to study monolonal antibody therapy, this is a poorly immunogenic treatment model
which is not manipulated through the expression of foreign antigens or the alteration of native anti-
gens. These data therefore strongly implicate a role for adaptive immunity in the therapeutic effi-
cacy of anti-tumor antibodies combined with chemotherapy in the treatment of poorly immuno-
genic tumors These findings have implications for design of future clinical trials using these agents
and for the development of novel strategies to induce adaptive anti-tumor immunity.
778
Ellagic acid induces apoptosis and cell cycle arrest through upregulation of p53
JD Jensen,1 Y Luo,1 W Liu,1 RP Dellavalle1,2,3 and M Fujita1 1 Dermatology, University of
Colorado Denver, Aurora, CO, 2 Dermatology, Denver Veterans Affairs Medical Center,
Denver, CO and 3 Epidemiology, Colorado School of Public Health, Aurora, CO
Ellagic acid is a polyphenolic compound that is found in strawberries, blueberries, and other fruit,
and is also a popular dietary supplement. It has anti-fibrotic and antioxidant properties, and has
been shown to exhibit antiproliferative properties in cancer cells in vitro. Ellagic acid has been
shown to modulate a variety of signaling pathways which result in increased apoptosis and decreased
proliferation in cancer cells, including NF-kB, iNOS, Wnt and others. There are few studies which
examine the effects of ellagic acid on metastatic melanoma. Even fewer identify a mechanism by
which ellagic acid exerts its antiproliferative and pro-apoptotic effects. In the present study, we iden-
tify a novel mechanism by which ellagic acid exerts antiproliferative and proapoptotic effects on
melanoma cells in vitro. Four metastatic human melanoma cell lines (1205LU, WM852c, A375
and HS294T) were examined in our study. MTS assay demonstrated that ellagic acid possesses an
inhibitory effect on cell proliferation at 25 to 100 micromolar concentrations over a period of 72
hours. Ellagic acid was also found to induce statistically significant G1 cell cycle arrest in WM852c
cells. Annexin V/PI staining and flow cytometry further revealed increased levels of apoptosis in
multiple cell lines treated with ellagic acid at 50-100 micromolar concentrations. Evaluation of 48
nuclear transcription factors revealed increases in p53 expression and decreases in AP2 expression
in cells treated with ellagic acid. Confirmatory studies quantifying mRNA expression of placental
TGF-beta and BCL-2 further suggest a mechanism by which ellagic acid may exert antiproliferative
and proapoptotic effects. Our findings support a potential role for ellagic acid as a therapeutic, adju-
vant, or chemopreventive agent for melanoma.
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Dual role of apoptosis-associated speck-like protein containing a CARD (ASC) in human
melanoma cells
W Liu,1 CA Dinarello,2 DA Norris1 and M Fujita1 1 Dermatology, University of Colorado, School
of Medicine, Aurora, CO and 2 Medicine, University of Colorado, School of Medicine, Aurora,
CO
The adaptor protein ASC (apoptosis-associated speck-like protein containing a CARD) was origi-
nally reported to induce apoptosis when overexpressed in certain tumor cell lines. As an integral
component of the inflammasome, ASC also mediates inflammatory signals. We have previously
reported that inflammasome is consititutively active in human melanoma cells and that IL-1-medi-
ated autoinflammation contributes to the development and progression of human melanoma cells.
However, the role of ASC protein in tumorigenesis remains unclear. Here we showed that metasta-
tic melanoma cells (HS294T and 1205Lu) expressed less ASC than primary melanoma cells (WM35
and WM115). Immunoprecipitation revealed co-precipitation of ASC with NALP3 and IKK in all
melanoma cells. When ASC was silenced by stably transducing cells with ASC shRNA, caspase-1
activity was reduced and IL-1β secretion was decreased in all melanoma cells. However, IL-1α and
IL-1β production was increased in primary melanoma but not in metastatic melanoma after ASC
knockdown (ASC-KD). Although ASC-KD did not affect cell death, it increased DNA synthesis in
primary melanoma cells whereas it induced G1 cell cycle arrest in metastatic melanoma cells.
Likewise, cell proliferation analysis showed increased cell proliferation in primary melanoma cells
and decreased proliferation in metastatic melanoma cells after ASC-KD. Further analyses of phos-
pho-IκB Kinase, IκB and NF-κB activity revealed that NF-κB signaling was increased in primary
melanoma cells but was decreased in metastatic melanoma cells after ASC-KD. Along with these
data, nude mouse experiments confirmed enhanced tumorigenesis in primary melanoma cells with
ASC-KD and decreased tumorigenesis in metastatic melanoma cells with ASC-KD. These findings
implicate the dual role of ASC in tumorigenesis by mediating NF-κB activity and suggest that ASC
could be a promising target for cancer therapy in metastatic melanoma.
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The redox antimalarial dihydroartemisinin targets human melanoma cells but not melanocytes
through induction of NOXA (PMAIP1)-dependent apoptosis that occurs as a function of intra-
cellular labile iron availability
CM Cabello, SD Lamore, WB Bair and GT Wondrak Pharmacology and Toxicology, College of
Pharmacy and Arizona Cancer Center, University of Arizona, Tucson, AZ
The proapoptotic BH3-only protein NOXA (encoded by PMAIP1) has recently emerged as a prom-
ising target for the chemotherapeutic induction of melanoma cell apoptosis. Using a differential
phenotypic drug screen for novel leads that selectively induce melanoma cell apoptosis without
compromising viability of primary human melanocytes, we have identified the redox antimalarial
drug dihydroartemisinin (DHA) as a NOXA-dependent experimental melanoma chemotherapeutic.
In cultured human metastatic melanoma cells (A375, G361) pronounced upregulation of NOXA
occurred within 3 h of DHA-exposure at the transcriptional and protein level followed by caspase-
dependent apoptotic execution. Genetic antagonism (PMAIP1-siRNA) rescued A375 cells from
DHA-induced apoptosis. Consistent with involvement of oxidative stress and iron-dependent acti-
vation of the endoperoxide-pharmacophore, DHA-induced cell death was antagonized by NAC or
deferoxamine cotreatment, respectively. Expression array analysis revealed DHA-induced upregu-
lation of oxidative and genotoxic stress response genes (GADD45A, GADD153, CDKN1A, HMOX1,
EGR1). Comet analysis demonstrated early induction of genotoxic stress by DHA, further substan-
tiated by detection of activational phosphorylation of p53 (Ser15) consistent with the established
role of activated p53 in PMAIP1 expression. In contrast, in primary human epidermal melanocytes,
viability, comet tail moment, NOXA expression, and cellular oxidative stress remained unaltered
by DHA. Flow cytometric analysis identified an increased intracellular labile iron pool in melanoma
cells versus melanocytes as a potential mechanistic determinant of differential DHA-sensitivity. Taken
together these data suggest that metastatic melanoma cells display a specific chemical vulnerabil-
ity to iron-mediated DHA cytotoxicity that causes NOXA upregulation upstream of caspase-depend-
ent cell death.
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Survivin expression level and intra-cellular localization is regulated by the nuclear export pro-
tein Exportin 1 mediating nucleo-cytoplasmic repartition in keratinocytes
F Labarrade,1 J Botto,1 C Dal Farra2 and N Domloge1 1 ISP Global Skin Research center, ISP
Vincience, Sophia Antipolis, France and 2 ISP Corporate Research Center, ISP, Wayne, NJ
The information necessary for the nucleo-cytoplasmic transport of a protein is contained in specific
regions of its sequence. Exportin 1 (XPO1 or CRM1) is a receptor for Nuclear Export Sequence (NES)-
bearing proteins, associated with the Nuclear Pore Complex. NES-mediated nuclear export is a con-
served mechanism by which subcellular localization of proteins such as survivin, is controlled in
cells. In human epidermal keratinocytes, survivin possesses at least two roles depending on its local-
ization: when cytoplasmic, survivin regulates differentiation and apoptosis whereas in the nucleus,
as a member of the Chromosomal Passenger Complex (CPC), survivin regulates the mitosis process.
CRM1 controls the repartition of nuclear and cytoplasmic pools of survivin, which is critical for
keratinocytes homeostasis and skin renewal. Moreover, CRM1 is also directly implicated in the for-
mation of the kinetochore and hence regulates chromosomal segregation. In this work, we studied
the expression of CRM1 in the epidermis and in cultured keratinocytes, in relation with the expres-
sion of survivin. We also evaluated the effects of IV08.009, a compound developed to modulate
survivin expression. Interestingly, the treatment of both keratinocytes and skin biopsies with IV08.009
increased the expression of CRM1, and modulated survivin and CRM1 expression level in the basal
cells of epidermal pegs which corresponds to preferential sites of residence for keratinocytes stem
cells. Moreover, we investigated the relation between the expression of CPC proteins (survivin, bore-
alin, incenp and aurora B) and CRM1 by using CPC- and CRM1-specific siRNAs. In conclusion,
CRM1 seems to be tightly implicated in the regulation of cell division by finely tuning the level of
survivin and other CPC components; a process particularly important in the preservation of epi-
dermal KSCs pool and in natural skin renewal.
795
Stem cell rescuing effect of oligo-HA in the skin
K Park, H Choi, Y Kang and S Huh Dermatology, Seoul National University Bundang Hospital,
Seongnam-si,, Republic of Korea
The epidermis is constantly renewed and it is well accepted that epidermal stem cells can contribute
to the maintenance of the epidermis via their self-renewing ability. Previously, we reported that the
addition of IGFBP-2 induced a thicker and more mature epidermis and higher expressions of α6-
and β1-integrin in reconstructing of skin equivalent. Interestingly, IGFBP-2 only contributes to the
proliferation of less proliferative cells compared to more proliferative cells. This means that there
are some factors which maintain stemness from the terminal differentiation. In this presentation,
the effects of oligo-HA will be presentd. Hyaluronic acid (HA) is a linear glycosaminoglycan. HA
has a range of different physiological and biological functions in the skin. Increased epidermal HA
has been reported to support keratinocyte proliferation and to inhibit terminal differentiation. In sites
of tissue injury or inflammation, activated fibroblasts secrete hyaluronidases that degrade high-
molecular-weight HA into low-molecular-weight fragments. These oligosaccharides of HA (oligo-
HA) appear to have properties that affect wound healing and cell kinetics. However, the effects of
oligo-HA on keratinocytes have not been well studied. We examined the effects of oligo-HA by
using cultured keratinocytes and skin equivalent models. Results suggest that oligo-HA also affect
the proliferative potential of basal keratinocytes by modulating the expression of integrin and p63.
In addition, increased levels of p63, a putative stem cell marker of the skin, suggests that oligo-HA
promotes the survival of basal stem cells in the skin. Thus, we propose stem cell activation as a new
concept for the management of skin diseases or aging.
797
Quantitative hair plucking reveals stem cell activation is modulated by interactions with extra-
follicular macro-environment
CC Chen,1,2 M Plikus1 and CM Chuong1 1 Pathology, University of Southern California, Los
Angeles, CA and 2 Dermatology, Taipei Veterans General Hospital, Taipei, Taiwan
When hair is plucked, regeneration may occur via mechanism completely intrinsic to the follicle
or involve extra-follicular signaling events. Here, instead of large scale hair waxing we performed
careful quantitative plucking and accounted for the topological distribution of plucked hairs. We
found that plucking- induced hair regeneration 1) is a population behavior, i.e. regenerative response
is affected by neighboring plucked follicles in a dose dependent manner; 2) it is topologically depend-
ent, i.e. regeneration occurs when 200 hairs are plucked from a a round region with a diameter of
4mm, but not when 200 hairs are plucked from the diameter of 8mm; and 3) it does not behave lin-
early. Plucking of 200 hairs can lead to regeneration of up to 1200 hairs dependending on the pluck-
ing density, because plucking-induced regeneration elicits secondary regenerative response in the
surrounding un-plucked follicles. Cellular and molecular studies led us to propose that following
plucking injury, each injured follicle releases a “quantum” of first-level activating signal into the
dermal macro-environment. This activator stimulates cells in the dermal macro-environment to
secrete second-level paracrine activators that signal back to the neighboring telogen follicles (both
plucked and un-plucked) and induce them to regenerate. When enough macro-environmental
activators are accumulated in a certain region and reach the “threshold” level, regeneration begins.
Several macro-environmental modulators may be involved and here we identify a novel Tnf-alpha-
NF-kB-WNT/FGF signaling axis that appears to mediate plucking injury-induced regeneration, in a
mechanism distinct from physiological hair follicle regeneration. The importance of the macro-envi-
ronmental modulators demonstrated here also opens new possibilities for treating alopecia and
developing new organ regeneration strategies.
796
Platelet rich plasma promotes wound healing process through increased proliferation, migra-
tion, type I collagen production in human skin fibroblasts
J Cho, S Kim and K Lee Department of Dermatology, School of Medicine, Keimyung University,
Daegu, Republic of Korea
Platelet-rich plasma (PRP) contains a high concentration of thrombocytes. In -granules of platelets,
there are platelet-released growth factors that include molecules such as platelet-derived growth
factor (PDGF), transforming growth factor (TGF), and others, which stimulate cell roliferation and
cell differentiation for tissue regeneration. Thus in this study we have investigated the effect of PRP
on the proliferation, migration, expression of type I collagen in human skin fibroblasts. Further-
more activation of mitogen activated protein kinases (MAPKs; ERK, p38, JNK) and Smad2, 3 were
studied in PRP-treated fibroblasts. Our data clearly showed that PRP treatment induced the increased
proliferation rates, migration, and expression of type I collagen in skin fibroblasts. In addition ERK
and Smad 2 activaitons were observed in PRP-treated fibroblasts. Finally PRP treatment accelerated
the wound healing process in chronic wound such as diabetic foot ulcer and venous leg ulcer. Taken
together, our data indicated that PRP treatment accelerates wound healing process through increased
proliferation, migration, type I collagen production in human skin fibroblasts.
794
Epidermolysis bullosa simplex keratinocyte stem cells exhibit a growth disadvantage com-
pared to normal keratinocyte stem cells
L Li,1,3 W Buitrago,2 J Chen1 and DR Roop1 1 Department of Dermatology and Charles C. Gates
Center for Regenerative Medicine and Stem Cell Biology, University of Colorado Denver,
Aurora, CO, 2 Medical Scientist Training Program, Baylor College of Medicine, Houston, TX
and 3 Department of Dermatology, Peking Union Medical College Hospital, Beijing, China
Epidermolysis bullosa simplex (EBS) is an autosomal-dominant blistering genodermatosis. EBS is
caused by mutations in either the keratin 14 (KRT14) or keratin 5 (KRT5) gene, which affects basal
epidermal keratinocytes. Our previous studies demonstrated that EBS keratinocyte stem cells had a
reduced capacity to regenerate the epidermis. To directly compare the growth characteristics of nor-
mal and EBS keratinocyte stem cells, we performed skin reconstitution assays with these two pop-
ulations of cells. EBS keratinocytes contained an inducible form of mutant Krt14, an inducible lacZ
gene (Rosa26R), and an inducible form of Cre recombinase. Treatment of these trigenic EBS ker-
atinocytes with the inducer, RU486, resulted in the simultaneous expression of both mutant Krt14
and β-galactosidase; thus, providing a marker to distinguish induced EBS keratinocytes from nor-
mal (uninduced) keratinocytes in graft assays. We found that when equal amounts of both normal
and EBS keratinocytes were combined to form a chimeric skin, a basal blistering phenotype was
observed, and X-gal staining confirmed that blister formation was restricted to EBS keratinocytes.
In addition, we found that EBS keratinocytes were rapidly replaced by normal keratinocytes in the
same graft. Therefore, our findings establish a reliable in vivo assay that is able to mimic the EBS
blistering phenotype, and they document that EBS keratinocyte stem cells have a marked growth
disadvantage compared to normal keratinocyte stem cells. These observations suggest that the
introduction of a small population of genetically corrected EBS keratinocyte stem cells into areas
prone to blistering would result in the displacement of defective EBS keratinocyte stem cells and
provide a permanent corrective therapy for EBS patients.
798
Ganglioside depletion reverses the wound healing defect of diabetes
AS Paller,1 H Iordanov,1 A Whittington,1 A Sasman,1 M Vijayaraghavan,1 DL Chen,1 N Gatla,1
D Bach,1 D Zheng,2 D Giljohann,2 CA Mirkin2 and X Wang1 1 Dermatology, Northwestern Univ.,
Chicago, IL and 2 Chemistry, Northwestern Univ., Evanston, IL
Improved management of wound healing is a significant unmet need, particularly in individuals
with type 2 diabetes, a common complication of obesity. Recent studies suggest that ganglioside
GM3, a sialylated membrane glycosphingolipid, is a critical mediator of insulin resistance, as evi-
denced by improved insulin sensitivity after ganglioside depletion in cultured adipocytes and dia-
betic mouse models. We have found GM3 and GM3 synthase (GM3S) expression to be elevated in
the skin of mice with diet-induced and genetic diabetes. We hypothesized that GM3 promotes insulin
resistance in skin, leading to impaired wound healing. Using a GM3S knockout (KO) mouse with
diet-induced obesity, we showed marked acceleration in wound healing, despite their obesity, com-
pared with littermate controls. Cultured keratinocytes from KO mice showed greater proliferation
and directional migration in scratch assays and in single cell live imaging assays than cultured ker-
atinocytes from littermate controls, particularly in the presence of increased glucose, simulating
hyperglycemia. In normal human keratinocytes (HEKs), treatment with supplemental glucose or anti-
sense-gold nanoparticles to block GM3 metabolism increased membrane GM3, inhibited cell pro-
liferation and migration, and suppressed phosphorylation of the insulin growth factor-1 receptor
(both treatments) and of the insulin receptor (genetic blockade of GM3 metabolism). Depletion of
GM3 biochemically (inhibition of glucosylceramide synthase) or genetically (GM3S siRNA-Au NPs)
reversed the glucose-induced effects on proliferation, migration, and insulin signaling resistance.
These data provide strong evidence that cutaneous accumulation of ganglioside GM3 impairs dia-
betic wound healing. Furthermore, biochemical and genetic strategies to deplete cutaneous GM3
levels represent a novel direction in the treatment of diabetic ulcerations.
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Increased REG3A/RegIIIγ by Th17 cytokines promotes keratinocyte proliferation after skin
injury
Y Lai,1 D Li,1 Z Jiang,1 C Li,1 T Zhang,1 K Paul,2 TR Hata,2 M Shin2 and RL Gallo2 1 East China
Normal University, Shanghai, China and 2 University of California-San Diego, San Diego, CA
Proliferation of keratinocytes is essential for the process of wound repair. Here we describe the novel
discovery that a molecule previously known only in pancreas and gut epithelium termed: regener-
ating islet-derived protein 3 alpha (REG3A) is expressed in skin. We further hypothesized that REG3A
has a critical function in wound healing. This hypothesis was supported in a mouse model of injury
that showed expression of the mouse homolog of REG3A (Reg III-gamma) in skin surrounding the
wound edge was dramatically increased (3015±358 fold increase) compared to normal skin. To
identify if Th17 cytokines could regulate REG3A, normal human keratinocytes (NHEK) were treated
with IL-17A in culture. qPCR determined that IL-17A increased REG3A mRNA (10.75±0.92 fold
increase, p=0.0038), and combination of IL-22 with IL-17A induced a further increase in REG3A
(36.42±1.74 fold p=0.0003). When NHEK were directly exposed to recombinant REG3A they showed
a 41.4% increase entry into S phase as measured by FACS and increased reepithelialization in an
in vitro scratch wound assay by 75% over a 24-hour period compared to control. TLR2 is a nega-
tive regulator of RegIII-gamma in mouse skin as Tlr2-/- mice had increased IL-17a and IL-22 and
increased RegIII-gamma at the wound edges. In human psoriasis, REG3A was also observed to be
greatly elevated in both non-lesional (629.07 ±57.19 fold increase, n=11) and lesional skin
(45.88±4.59 fold increase, n=11) compared to skin of normal patients, n=15.) These findings sup-
port our novel discovery that REG3A is important to keratinocyte growth. Furthermore, induction
of REG3A may be important to wound reepithelialization and be a previously unknown key ele-
ment in the pathogenesis of psoriasis.
788
Management of irritant dermatitis by promoting a rapid and effective epidermal healing
C Baudouin, S Brédif, F Menu and P Msika Innovation R&D Direction, Laboratoires
Expanscience, Epernon, France
Skin is often exposed to aggressors that could alter epidermis and give rise to local irritation. An
emulsion for irritant contact dermatitis containing emollient, anti-irritant, anti-microbial and heal-
ing products has been evaluated for its epidermal repair efficacy. Firstly, we investigated the in vitro
effect of the [Cu-Zn-Mn] triad on the keratinocytes migration ability (scratch-Assay) and on the pro-
duction of migration and differentiation markers such as beta1 integrin and involucrin respectively
by ELISA analysis. Then, we analyzed the epidermal regeneration or re-epithelialization properties
of the emulsion by using a model of injury on reconstructed human epidermis (RHE). The trans
epithelial epidermal resistance (TEER), a functional parameter of barrier quality, was measured. Then
we analyzed by QRT-PCR gene expression of involucrin, involved in the epidermis maturation step
during re-epithelialization, and TGFbeta2, growth factor playing a key role in the first step of heal-
ing process. We have shown that the [Cu-Zn-Mn] triad was able to enhance keratinocytes migra-
tion in the wound and increased beta1 integrin and involucrin protein production (X3.2 and 2.3).
Topical application of the emulsion significantly increased the TEER (4500 ohmxcm2) 2h after the
mechanical injury at the RHE surface, reflecting the barrier recovery and the epidermal regenera-
tion ability of the emulsion. Moreover, the emulsion rapidly up-regulated TGFbeta2 (X3.4, 2h after
injury) and increased involucrin expression (X3, 2h+24h after injury), showing the fast repair activ-
ity of the emulsion but also its complete action until epidermis maturation. These results demon-
strate the rapid and optimized healing properties of this emulsion and support its cosmetic rele-
vance for the management of irritant contact dermatitis.
789
Impaired wound healing in SAD mice: A novel model to understand sickle cell ulcers
D Nassar,1 T Galaz,1 P Tharaux2 and S Aractingi1 1 UPMC Univ Paris 6 and INSERM
UMR_S938, Centre de Recherche Saint-Antoine, Paris, France and 2 INSERM U.970, Paris
Centre de Recherche Cardiovasculaire – PARCC, Paris, France
Leg ulcers are a major complication of sickle cell disease (SCD), a hemoglobin disorder causing
hemolytic anemia and vaso-occlusive events. They occur in 2.5-40% of patients, are large, long last-
ing and resistant to treatments. Pathogenesis of SCD ulcers remains unknown. The aim of our study
was to develop a murine model of SCD ulcers. SAD mice, a murine model of SCD, harbor hβ-glo-
bin transgene expressing human sickle cell hemoglobin along with mouse hemoglobin. SAD mice
do not present visible cutaneous abnormalities. Surgical wounds were realized on 6-8 week-old
SAD mice and their littermates. There was no difference in wound closure between the two groups.
Since leg ulcers in human SCD occur in severely anemic patients, after the age of 15 years, we
decided to repeat the experiment on older mice. We hypothesized that with aging, SAD mice would
develop features of SCD, especially hemolytic anemia and organ damage, and would then have
altered wound healing. Indeed surgical wounds on 6-8 month-old SAD mice appeared severely
necrotic, and wound closure strikingly altered when compared to their WT littermates. At that age,
SAD mice had hemolytic anemia and high circulating leukocyte counts. Interestingly, the surface
of the wounds correlated with the severity of anemia and hemolysis. On wound sections, lower
epidermization rates were found in old SAD mice compared to controls. Although wounds on SAD
mice appeared necrotic, there was no difference in wound bed vascularization measured by mor-
phometry. However, SAD wound beds where densely infiltrated with neutrophils, significantly more
than controls. Finally, wound edges of SAD mice were macroscopically more fibrotic than their lit-
termates. In conclusion, surgical wounds in old SAD mice lead to delayed healing that is similar to
the human disease since this abnormality develops only in old severely anemic animals and cor-
relates with hemolysis and anemia. We believe that it is a pertinent murine model to address ques-
tions about SCD ulcers.
790
p16 influences the aging phenotype in the living skin equivalent
J Adamus, JM Lee, S Aho, H Meldrum and C Bosko Unilever, Trumbull, CT
Aging skin has a reduced capacity for regeneration and an increase in senescent cells is seen in the
basal layer of the epidermis in both chronologically aged and photoaged skin. This results in a slower
cell cycle and a decrease in proliferation. Hypothesized to play a role in skin aging through its role
in cellular senescence, p16Ink4a (CDKN2A), an inhibitor of cyclin-dependent kinases (CDKs), has
recently been found to be a robust biomarker of aging in skin (Ressler et al. 2006). In order to bet-
ter understand the extent p16 plays in skin aging, we explored its expression in the genetically
modified adult and aged living skin equivalent (LSE) models. In these studies, our aim was 1) to build
a model of aging skin, reflected by a thinner epidermis, based upon the hypothesis that increased
p16 is integral to the aging skin process and 2) to reverse, or “rescue”, the aged phenotype to a
more structurally “younger”, or thicker, epidermis in vitro. To build our first model of aged skin we
targeted expression of the p16Ink4a gene, under control of a K14 truncated promoter, into the
basal layer of the adult LSE by lentiviral transduction. In two different donors, and dose-depend-
ently, increased expression resulted in models that mimicked an aged skin model, with a thinner
epidermis that, by immunochemistry and immunoblot, contained altered staining for markers of
proliferation (Ki67) and differentiation (caspase 14, filaggrin) as compared to the K14-lacZ lentivi-
ral control models. Our second aged LSE model, which also developed a thinner epidermis, used
aged human primary keratinocytes to simulate the aged skin phenotype in vitro. Transduction of
lentiviral miR against p16 led to a rescue of this phenotype in models made from several donors;
however, in normal adult donors, hyperproliferation into the dermal compartment was detected,
suggesting that other gene pathways may be involved. These studies further support the importance
of p16 in skin aging and in development of the atrophic phenotype.
791
Ultrastructural and three dimensional imaging analysis of perivascular cells in the dermis
H Yamanishi,1 S Fujiwara,1 Y Ishimatsu-Tsuji,1 Y Matsunaga,1 K Toida2 and T Soma1 1 Shiseido
Research Center, Yokohama, Japan and 2 Depertment of Anatomy, Kawasaki Medical School,
Kurashiki, Japan
Numerous studies show that stem cells in mammalian skin were characterized in epidermal basal
layer or hair follicular buldge, and they were involved in wound healing and regeneration. The
existence of stem cells in the dermis is still obscure, even though the number of reports describing
dermal stem cells has been increasing in recent years. CD34 is well known as a stem cell marker
of not only hematopoietic stem cells but also other stem cells such as epidermal stem cells, endothe-
lial progenitor cells and adipose-derived stem cells. Our previous study showed that CD34 positive
cells, isolated from human scalp tissue by magnetic cell sorting, had colony-forming ability and
mesenchymal multiple differentiating potency into smooth muscle cells, and adipocytes, osteocytes
and chondrocytes in vitro. We also visualized that CD34 positive cells were existed around the
microvascular of the dermis and hair follicles in human scalp by immunofluorescence confocal
microscopy. In this study, we applied immuno-transmittion electron microscopy to analyze the
microenvioroment of stem cells in the dermis. We found that the dermal microvascular with abun-
dant small collagen fibers were surrounded by CD34 positive cells which had fibroblast–like nucleus
and flattened cytoplasm. CD271 is well known as one of the mesenchymal stem cell markers of not
only adipose-derived stem cells but also bone marrow mesenchymal stem cells. Furthermore, by
immuno-transmittion electron microscopy, we recognized that CD271 was expressed at the cell
membrane of dermal vascular pericytes. These results suggested that cutaneous microcirculation
have a close relationship with the dermal stem cells and play an important role to maintain their
microenvironment.
792
Durable and reproducible murine splinted excisional wound model
MS Tuttle, LA Long, NL Ward and MA Ghannoum Dermatology, Case Western Reserve
University, Cleveland, OH
Existing murine splinted excisional wound (SEW) models are used to prevent wound contraction
and more effectively simulate human wound healing mechanisms. However, these models have sig-
nificant technical challenges due to inconsistent splint adherence to the skin, increasing experi-
mental variability. We describe a modified SEW model that is simple to create and durable through-
out wound healing. In this study, we compared three methods of wound splinting: A) silicone ring
(12 mm diameter and 0.5 mm thick) glued to the skin with cyanoacrylate and sutured in place with
interrupted 5-0 prolene sutures; B) silicone ring glued to the skin with cyanoacrylate and stapled in
place with 9 mm wound clips; and C) stainless steel wire ring (16 mm diameter and 19 gauge)
secured to the skin with wound clips. Photographs were used to determine the initial day of splint
compromise, which was when either the silicone splint was no longer intact or a suture or wound
clip was loose or missing. The initial day of splint compromise for method A was 5 days (95% con-
fidence interval (CI) 3.76, 6.24), for method B was 8 days (95% CI 5.42, 10.58), and for method C
was 11.3 days (95% CI 10.54, 12.06). These data indicate that method C is more durable than the
other two methods. Each splinting method was used to evaluate the effect on healing following inoc-
ulation of 106 cells of C. albicans into the wound bed on the day of wounding compared to unin-
fected control, demonstrating statistically significant delayed wound healing with method C only.
Delayed healing with method C was likely related to increased splint durability, leading to decreased
experimental variability and wound contraction. In addition, methods A and B had increased wound
surface to dressing contact, leading to debridement with each dressing change and further increas-
ing experimental variability. In this study, we describe a more durable SEW model that has partic-
ular utility in the study of the mechanisms of re-epithelialization, especially in the setting of micro-
bial biofilm formation.
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Survivin expression level and intra-cellular localization is regulated by the nuclear export pro-
tein Exportin 1 mediating nucleo-cytoplasmic repartition in keratinocytes
F Labarrade,1 J Botto,1 C Dal Farra2 and N Domloge1 1 ISP Global Skin Research center, ISP
Vincience, Sophia Antipolis, France and 2 ISP Corporate Research Center, ISP, Wayne, NJ
The information necessary for the nucleo-cytoplasmic transport of a protein is contained in specific
regions of its sequence. Exportin 1 (XPO1 or CRM1) is a receptor for Nuclear Export Sequence (NES)-
bearing proteins, associated with the Nuclear Pore Complex. NES-mediated nuclear export is a con-
served mechanism by which subcellular localization of proteins such as survivin, is controlled in
cells. In human epidermal keratinocytes, survivin possesses at least two roles depending on its local-
ization: when cytoplasmic, survivin regulates differentiation and apoptosis whereas in the nucleus,
as a member of the Chromosomal Passenger Complex (CPC), survivin regulates the mitosis process.
CRM1 controls the repartition of nuclear and cytoplasmic pools of survivin, which is critical for
keratinocytes homeostasis and skin renewal. Moreover, CRM1 is also directly implicated in the for-
mation of the kinetochore and hence regulates chromosomal segregation. In this work, we studied
the expression of CRM1 in the epidermis and in cultured keratinocytes, in relation with the expres-
sion of survivin. We also evaluated the effects of IV08.009, a compound developed to modulate
survivin expression. Interestingly, the treatment of both keratinocytes and skin biopsies with IV08.009
increased the expression of CRM1, and modulated survivin and CRM1 expression level in the basal
cells of epidermal pegs which corresponds to preferential sites of residence for keratinocytes stem
cells. Moreover, we investigated the relation between the expression of CPC proteins (survivin, bore-
alin, incenp and aurora B) and CRM1 by using CPC- and CRM1-specific siRNAs. In conclusion,
CRM1 seems to be tightly implicated in the regulation of cell division by finely tuning the level of
survivin and other CPC components; a process particularly important in the preservation of epi-
dermal KSCs pool and in natural skin renewal.
795
Stem cell rescuing effect of oligo-HA in the skin
K Park, H Choi, Y Kang and S Huh Dermatology, Seoul National University Bundang Hospital,
Seongnam-si,, Republic of Korea
The epidermis is constantly renewed and it is well accepted that epidermal stem cells can contribute
to the maintenance of the epidermis via their self-renewing ability. Previously, we reported that the
addition of IGFBP-2 induced a thicker and more mature epidermis and higher expressions of α6-
and β1-integrin in reconstructing of skin equivalent. Interestingly, IGFBP-2 only contributes to the
proliferation of less proliferative cells compared to more proliferative cells. This means that there
are some factors which maintain stemness from the terminal differentiation. In this presentation,
the effects of oligo-HA will be presentd. Hyaluronic acid (HA) is a linear glycosaminoglycan. HA
has a range of different physiological and biological functions in the skin. Increased epidermal HA
has been reported to support keratinocyte proliferation and to inhibit terminal differentiation. In sites
of tissue injury or inflammation, activated fibroblasts secrete hyaluronidases that degrade high-
molecular-weight HA into low-molecular-weight fragments. These oligosaccharides of HA (oligo-
HA) appear to have properties that affect wound healing and cell kinetics. However, the effects of
oligo-HA on keratinocytes have not been well studied. We examined the effects of oligo-HA by
using cultured keratinocytes and skin equivalent models. Results suggest that oligo-HA also affect
the proliferative potential of basal keratinocytes by modulating the expression of integrin and p63.
In addition, increased levels of p63, a putative stem cell marker of the skin, suggests that oligo-HA
promotes the survival of basal stem cells in the skin. Thus, we propose stem cell activation as a new
concept for the management of skin diseases or aging.
797
Quantitative hair plucking reveals stem cell activation is modulated by interactions with extra-
follicular macro-environment
CC Chen,1,2 M Plikus1 and CM Chuong1 1 Pathology, University of Southern California, Los
Angeles, CA and 2 Dermatology, Taipei Veterans General Hospital, Taipei, Taiwan
When hair is plucked, regeneration may occur via mechanism completely intrinsic to the follicle
or involve extra-follicular signaling events. Here, instead of large scale hair waxing we performed
careful quantitative plucking and accounted for the topological distribution of plucked hairs. We
found that plucking- induced hair regeneration 1) is a population behavior, i.e. regenerative response
is affected by neighboring plucked follicles in a dose dependent manner; 2) it is topologically depend-
ent, i.e. regeneration occurs when 200 hairs are plucked from a a round region with a diameter of
4mm, but not when 200 hairs are plucked from the diameter of 8mm; and 3) it does not behave lin-
early. Plucking of 200 hairs can lead to regeneration of up to 1200 hairs dependending on the pluck-
ing density, because plucking-induced regeneration elicits secondary regenerative response in the
surrounding un-plucked follicles. Cellular and molecular studies led us to propose that following
plucking injury, each injured follicle releases a “quantum” of first-level activating signal into the
dermal macro-environment. This activator stimulates cells in the dermal macro-environment to
secrete second-level paracrine activators that signal back to the neighboring telogen follicles (both
plucked and un-plucked) and induce them to regenerate. When enough macro-environmental
activators are accumulated in a certain region and reach the “threshold” level, regeneration begins.
Several macro-environmental modulators may be involved and here we identify a novel Tnf-alpha-
NF-kB-WNT/FGF signaling axis that appears to mediate plucking injury-induced regeneration, in a
mechanism distinct from physiological hair follicle regeneration. The importance of the macro-envi-
ronmental modulators demonstrated here also opens new possibilities for treating alopecia and
developing new organ regeneration strategies.
796
Platelet rich plasma promotes wound healing process through increased proliferation, migra-
tion, type I collagen production in human skin fibroblasts
J Cho, S Kim and K Lee Department of Dermatology, School of Medicine, Keimyung University,
Daegu, Republic of Korea
Platelet-rich plasma (PRP) contains a high concentration of thrombocytes. In -granules of platelets,
there are platelet-released growth factors that include molecules such as platelet-derived growth
factor (PDGF), transforming growth factor (TGF), and others, which stimulate cell roliferation and
cell differentiation for tissue regeneration. Thus in this study we have investigated the effect of PRP
on the proliferation, migration, expression of type I collagen in human skin fibroblasts. Further-
more activation of mitogen activated protein kinases (MAPKs; ERK, p38, JNK) and Smad2, 3 were
studied in PRP-treated fibroblasts. Our data clearly showed that PRP treatment induced the increased
proliferation rates, migration, and expression of type I collagen in skin fibroblasts. In addition ERK
and Smad 2 activaitons were observed in PRP-treated fibroblasts. Finally PRP treatment accelerated
the wound healing process in chronic wound such as diabetic foot ulcer and venous leg ulcer. Taken
together, our data indicated that PRP treatment accelerates wound healing process through increased
proliferation, migration, type I collagen production in human skin fibroblasts.
794
Epidermolysis bullosa simplex keratinocyte stem cells exhibit a growth disadvantage com-
pared to normal keratinocyte stem cells
L Li,1,3 W Buitrago,2 J Chen1 and DR Roop1 1 Department of Dermatology and Charles C. Gates
Center for Regenerative Medicine and Stem Cell Biology, University of Colorado Denver,
Aurora, CO, 2 Medical Scientist Training Program, Baylor College of Medicine, Houston, TX
and 3 Department of Dermatology, Peking Union Medical College Hospital, Beijing, China
Epidermolysis bullosa simplex (EBS) is an autosomal-dominant blistering genodermatosis. EBS is
caused by mutations in either the keratin 14 (KRT14) or keratin 5 (KRT5) gene, which affects basal
epidermal keratinocytes. Our previous studies demonstrated that EBS keratinocyte stem cells had a
reduced capacity to regenerate the epidermis. To directly compare the growth characteristics of nor-
mal and EBS keratinocyte stem cells, we performed skin reconstitution assays with these two pop-
ulations of cells. EBS keratinocytes contained an inducible form of mutant Krt14, an inducible lacZ
gene (Rosa26R), and an inducible form of Cre recombinase. Treatment of these trigenic EBS ker-
atinocytes with the inducer, RU486, resulted in the simultaneous expression of both mutant Krt14
and β-galactosidase; thus, providing a marker to distinguish induced EBS keratinocytes from nor-
mal (uninduced) keratinocytes in graft assays. We found that when equal amounts of both normal
and EBS keratinocytes were combined to form a chimeric skin, a basal blistering phenotype was
observed, and X-gal staining confirmed that blister formation was restricted to EBS keratinocytes.
In addition, we found that EBS keratinocytes were rapidly replaced by normal keratinocytes in the
same graft. Therefore, our findings establish a reliable in vivo assay that is able to mimic the EBS
blistering phenotype, and they document that EBS keratinocyte stem cells have a marked growth
disadvantage compared to normal keratinocyte stem cells. These observations suggest that the
introduction of a small population of genetically corrected EBS keratinocyte stem cells into areas
prone to blistering would result in the displacement of defective EBS keratinocyte stem cells and
provide a permanent corrective therapy for EBS patients.
798
Ganglioside depletion reverses the wound healing defect of diabetes
AS Paller,1 H Iordanov,1 A Whittington,1 A Sasman,1 M Vijayaraghavan,1 DL Chen,1 N Gatla,1
D Bach,1 D Zheng,2 D Giljohann,2 CA Mirkin2 and X Wang1 1 Dermatology, Northwestern Univ.,
Chicago, IL and 2 Chemistry, Northwestern Univ., Evanston, IL
Improved management of wound healing is a significant unmet need, particularly in individuals
with type 2 diabetes, a common complication of obesity. Recent studies suggest that ganglioside
GM3, a sialylated membrane glycosphingolipid, is a critical mediator of insulin resistance, as evi-
denced by improved insulin sensitivity after ganglioside depletion in cultured adipocytes and dia-
betic mouse models. We have found GM3 and GM3 synthase (GM3S) expression to be elevated in
the skin of mice with diet-induced and genetic diabetes. We hypothesized that GM3 promotes insulin
resistance in skin, leading to impaired wound healing. Using a GM3S knockout (KO) mouse with
diet-induced obesity, we showed marked acceleration in wound healing, despite their obesity, com-
pared with littermate controls. Cultured keratinocytes from KO mice showed greater proliferation
and directional migration in scratch assays and in single cell live imaging assays than cultured ker-
atinocytes from littermate controls, particularly in the presence of increased glucose, simulating
hyperglycemia. In normal human keratinocytes (HEKs), treatment with supplemental glucose or anti-
sense-gold nanoparticles to block GM3 metabolism increased membrane GM3, inhibited cell pro-
liferation and migration, and suppressed phosphorylation of the insulin growth factor-1 receptor
(both treatments) and of the insulin receptor (genetic blockade of GM3 metabolism). Depletion of
GM3 biochemically (inhibition of glucosylceramide synthase) or genetically (GM3S siRNA-Au NPs)
reversed the glucose-induced effects on proliferation, migration, and insulin signaling resistance.
These data provide strong evidence that cutaneous accumulation of ganglioside GM3 impairs dia-
betic wound healing. Furthermore, biochemical and genetic strategies to deplete cutaneous GM3
levels represent a novel direction in the treatment of diabetic ulcerations.
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Increased REG3A/RegIIIγ by Th17 cytokines promotes keratinocyte proliferation after skin
injury
Y Lai,1 D Li,1 Z Jiang,1 C Li,1 T Zhang,1 K Paul,2 TR Hata,2 M Shin2 and RL Gallo2 1 East China
Normal University, Shanghai, China and 2 University of California-San Diego, San Diego, CA
Proliferation of keratinocytes is essential for the process of wound repair. Here we describe the novel
discovery that a molecule previously known only in pancreas and gut epithelium termed: regener-
ating islet-derived protein 3 alpha (REG3A) is expressed in skin. We further hypothesized that REG3A
has a critical function in wound healing. This hypothesis was supported in a mouse model of injury
that showed expression of the mouse homolog of REG3A (Reg III-gamma) in skin surrounding the
wound edge was dramatically increased (3015±358 fold increase) compared to normal skin. To
identify if Th17 cytokines could regulate REG3A, normal human keratinocytes (NHEK) were treated
with IL-17A in culture. qPCR determined that IL-17A increased REG3A mRNA (10.75±0.92 fold
increase, p=0.0038), and combination of IL-22 with IL-17A induced a further increase in REG3A
(36.42±1.74 fold p=0.0003). When NHEK were directly exposed to recombinant REG3A they showed
a 41.4% increase entry into S phase as measured by FACS and increased reepithelialization in an
in vitro scratch wound assay by 75% over a 24-hour period compared to control. TLR2 is a nega-
tive regulator of RegIII-gamma in mouse skin as Tlr2-/- mice had increased IL-17a and IL-22 and
increased RegIII-gamma at the wound edges. In human psoriasis, REG3A was also observed to be
greatly elevated in both non-lesional (629.07 ±57.19 fold increase, n=11) and lesional skin
(45.88±4.59 fold increase, n=11) compared to skin of normal patients, n=15.) These findings sup-
port our novel discovery that REG3A is important to keratinocyte growth. Furthermore, induction
of REG3A may be important to wound reepithelialization and be a previously unknown key ele-
ment in the pathogenesis of psoriasis.
788
Management of irritant dermatitis by promoting a rapid and effective epidermal healing
C Baudouin, S Brédif, F Menu and P Msika Innovation R&D Direction, Laboratoires
Expanscience, Epernon, France
Skin is often exposed to aggressors that could alter epidermis and give rise to local irritation. An
emulsion for irritant contact dermatitis containing emollient, anti-irritant, anti-microbial and heal-
ing products has been evaluated for its epidermal repair efficacy. Firstly, we investigated the in vitro
effect of the [Cu-Zn-Mn] triad on the keratinocytes migration ability (scratch-Assay) and on the pro-
duction of migration and differentiation markers such as beta1 integrin and involucrin respectively
by ELISA analysis. Then, we analyzed the epidermal regeneration or re-epithelialization properties
of the emulsion by using a model of injury on reconstructed human epidermis (RHE). The trans
epithelial epidermal resistance (TEER), a functional parameter of barrier quality, was measured. Then
we analyzed by QRT-PCR gene expression of involucrin, involved in the epidermis maturation step
during re-epithelialization, and TGFbeta2, growth factor playing a key role in the first step of heal-
ing process. We have shown that the [Cu-Zn-Mn] triad was able to enhance keratinocytes migra-
tion in the wound and increased beta1 integrin and involucrin protein production (X3.2 and 2.3).
Topical application of the emulsion significantly increased the TEER (4500 ohmxcm2) 2h after the
mechanical injury at the RHE surface, reflecting the barrier recovery and the epidermal regenera-
tion ability of the emulsion. Moreover, the emulsion rapidly up-regulated TGFbeta2 (X3.4, 2h after
injury) and increased involucrin expression (X3, 2h+24h after injury), showing the fast repair activ-
ity of the emulsion but also its complete action until epidermis maturation. These results demon-
strate the rapid and optimized healing properties of this emulsion and support its cosmetic rele-
vance for the management of irritant contact dermatitis.
789
Impaired wound healing in SAD mice: A novel model to understand sickle cell ulcers
D Nassar,1 T Galaz,1 P Tharaux2 and S Aractingi1 1 UPMC Univ Paris 6 and INSERM
UMR_S938, Centre de Recherche Saint-Antoine, Paris, France and 2 INSERM U.970, Paris
Centre de Recherche Cardiovasculaire – PARCC, Paris, France
Leg ulcers are a major complication of sickle cell disease (SCD), a hemoglobin disorder causing
hemolytic anemia and vaso-occlusive events. They occur in 2.5-40% of patients, are large, long last-
ing and resistant to treatments. Pathogenesis of SCD ulcers remains unknown. The aim of our study
was to develop a murine model of SCD ulcers. SAD mice, a murine model of SCD, harbor hβ-glo-
bin transgene expressing human sickle cell hemoglobin along with mouse hemoglobin. SAD mice
do not present visible cutaneous abnormalities. Surgical wounds were realized on 6-8 week-old
SAD mice and their littermates. There was no difference in wound closure between the two groups.
Since leg ulcers in human SCD occur in severely anemic patients, after the age of 15 years, we
decided to repeat the experiment on older mice. We hypothesized that with aging, SAD mice would
develop features of SCD, especially hemolytic anemia and organ damage, and would then have
altered wound healing. Indeed surgical wounds on 6-8 month-old SAD mice appeared severely
necrotic, and wound closure strikingly altered when compared to their WT littermates. At that age,
SAD mice had hemolytic anemia and high circulating leukocyte counts. Interestingly, the surface
of the wounds correlated with the severity of anemia and hemolysis. On wound sections, lower
epidermization rates were found in old SAD mice compared to controls. Although wounds on SAD
mice appeared necrotic, there was no difference in wound bed vascularization measured by mor-
phometry. However, SAD wound beds where densely infiltrated with neutrophils, significantly more
than controls. Finally, wound edges of SAD mice were macroscopically more fibrotic than their lit-
termates. In conclusion, surgical wounds in old SAD mice lead to delayed healing that is similar to
the human disease since this abnormality develops only in old severely anemic animals and cor-
relates with hemolysis and anemia. We believe that it is a pertinent murine model to address ques-
tions about SCD ulcers.
790
p16 influences the aging phenotype in the living skin equivalent
J Adamus, JM Lee, S Aho, H Meldrum and C Bosko Unilever, Trumbull, CT
Aging skin has a reduced capacity for regeneration and an increase in senescent cells is seen in the
basal layer of the epidermis in both chronologically aged and photoaged skin. This results in a slower
cell cycle and a decrease in proliferation. Hypothesized to play a role in skin aging through its role
in cellular senescence, p16Ink4a (CDKN2A), an inhibitor of cyclin-dependent kinases (CDKs), has
recently been found to be a robust biomarker of aging in skin (Ressler et al. 2006). In order to bet-
ter understand the extent p16 plays in skin aging, we explored its expression in the genetically
modified adult and aged living skin equivalent (LSE) models. In these studies, our aim was 1) to build
a model of aging skin, reflected by a thinner epidermis, based upon the hypothesis that increased
p16 is integral to the aging skin process and 2) to reverse, or “rescue”, the aged phenotype to a
more structurally “younger”, or thicker, epidermis in vitro. To build our first model of aged skin we
targeted expression of the p16Ink4a gene, under control of a K14 truncated promoter, into the
basal layer of the adult LSE by lentiviral transduction. In two different donors, and dose-depend-
ently, increased expression resulted in models that mimicked an aged skin model, with a thinner
epidermis that, by immunochemistry and immunoblot, contained altered staining for markers of
proliferation (Ki67) and differentiation (caspase 14, filaggrin) as compared to the K14-lacZ lentivi-
ral control models. Our second aged LSE model, which also developed a thinner epidermis, used
aged human primary keratinocytes to simulate the aged skin phenotype in vitro. Transduction of
lentiviral miR against p16 led to a rescue of this phenotype in models made from several donors;
however, in normal adult donors, hyperproliferation into the dermal compartment was detected,
suggesting that other gene pathways may be involved. These studies further support the importance
of p16 in skin aging and in development of the atrophic phenotype.
791
Ultrastructural and three dimensional imaging analysis of perivascular cells in the dermis
H Yamanishi,1 S Fujiwara,1 Y Ishimatsu-Tsuji,1 Y Matsunaga,1 K Toida2 and T Soma1 1 Shiseido
Research Center, Yokohama, Japan and 2 Depertment of Anatomy, Kawasaki Medical School,
Kurashiki, Japan
Numerous studies show that stem cells in mammalian skin were characterized in epidermal basal
layer or hair follicular buldge, and they were involved in wound healing and regeneration. The
existence of stem cells in the dermis is still obscure, even though the number of reports describing
dermal stem cells has been increasing in recent years. CD34 is well known as a stem cell marker
of not only hematopoietic stem cells but also other stem cells such as epidermal stem cells, endothe-
lial progenitor cells and adipose-derived stem cells. Our previous study showed that CD34 positive
cells, isolated from human scalp tissue by magnetic cell sorting, had colony-forming ability and
mesenchymal multiple differentiating potency into smooth muscle cells, and adipocytes, osteocytes
and chondrocytes in vitro. We also visualized that CD34 positive cells were existed around the
microvascular of the dermis and hair follicles in human scalp by immunofluorescence confocal
microscopy. In this study, we applied immuno-transmittion electron microscopy to analyze the
microenvioroment of stem cells in the dermis. We found that the dermal microvascular with abun-
dant small collagen fibers were surrounded by CD34 positive cells which had fibroblast–like nucleus
and flattened cytoplasm. CD271 is well known as one of the mesenchymal stem cell markers of not
only adipose-derived stem cells but also bone marrow mesenchymal stem cells. Furthermore, by
immuno-transmittion electron microscopy, we recognized that CD271 was expressed at the cell
membrane of dermal vascular pericytes. These results suggested that cutaneous microcirculation
have a close relationship with the dermal stem cells and play an important role to maintain their
microenvironment.
792
Durable and reproducible murine splinted excisional wound model
MS Tuttle, LA Long, NL Ward and MA Ghannoum Dermatology, Case Western Reserve
University, Cleveland, OH
Existing murine splinted excisional wound (SEW) models are used to prevent wound contraction
and more effectively simulate human wound healing mechanisms. However, these models have sig-
nificant technical challenges due to inconsistent splint adherence to the skin, increasing experi-
mental variability. We describe a modified SEW model that is simple to create and durable through-
out wound healing. In this study, we compared three methods of wound splinting: A) silicone ring
(12 mm diameter and 0.5 mm thick) glued to the skin with cyanoacrylate and sutured in place with
interrupted 5-0 prolene sutures; B) silicone ring glued to the skin with cyanoacrylate and stapled in
place with 9 mm wound clips; and C) stainless steel wire ring (16 mm diameter and 19 gauge)
secured to the skin with wound clips. Photographs were used to determine the initial day of splint
compromise, which was when either the silicone splint was no longer intact or a suture or wound
clip was loose or missing. The initial day of splint compromise for method A was 5 days (95% con-
fidence interval (CI) 3.76, 6.24), for method B was 8 days (95% CI 5.42, 10.58), and for method C
was 11.3 days (95% CI 10.54, 12.06). These data indicate that method C is more durable than the
other two methods. Each splinting method was used to evaluate the effect on healing following inoc-
ulation of 106 cells of C. albicans into the wound bed on the day of wounding compared to unin-
fected control, demonstrating statistically significant delayed wound healing with method C only.
Delayed healing with method C was likely related to increased splint durability, leading to decreased
experimental variability and wound contraction. In addition, methods A and B had increased wound
surface to dressing contact, leading to debridement with each dressing change and further increas-
ing experimental variability. In this study, we describe a more durable SEW model that has partic-
ular utility in the study of the mechanisms of re-epithelialization, especially in the setting of micro-
bial biofilm formation.
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TSC2-null fibroblast-like cells recreate multiple niches in grafted skin equivalents including
dermal papilla
R Thangapazham,1 S Li,1 J Wang,1 S Rajesh,1 J Moss2 and TN Darling1 1 Dermatology, Uniformed
Services University of the Health Sciences, Bethesda, MD and 2 Cardiovascular and
Pulmonary Branch, National Heart Lung Blood Institute, NIH, Bethesda, MD
Angiofibromas and forehead plaques observed in tuberous sclerosis complex (TSC) are hamartomas
of dermis and hair follicles. We found that skin equivalents, composed of TSC2-null, fibroblast-like
cells from TSC skin hamartomas and normal neonatal foreskin keratinocytes, form hair follicles when
grafted to immunodeficient mice. Our objective in this study was to demonstrate the identity and
locations of tumor cells in the xenografts. An antibody reactive with human but not mouse COX IV
showed immunoreactivity to graft dermis and follicular and interfollicular epithelium, but not to
mouse skin. Human and mouse cells were identified using in situ hybridization with species-spe-
cific, pan-centromeric chromosome probes. Human cells were observed in the graft epidermis, fol-
licular epithelium, dermal papilla, perifollicular and interstitial dermis, and perivascular cells. Mouse
cells in grafts were located predominantly in vascular endothelial cells, with scattered mouse cells
in the interfollicular epidermis and interstitial dermis. To demonstrate the presence of TSC2-null cells
in the dermal papilla/lower dermal sheath regions of induced follicles, we investigated the genetic
identity of these cells. Analysis of TSC2-null cells from a fibrous forehead plaque revealed a non-
sense mutation in exon 10 of the TSC2 gene and loss of heterozygosity at three microsatellite mark-
ers flanking TSC2. Sections of xenografts were microdissected for restriction enzyme analysis that
revealed mutant DNA in cells from the region of the dermal papilla/lower dermal sheath and inter-
stitial dermis, but not in follicular epithelium. The presence of TSC2-null cells in these regions sug-
gests that TSC tumor fibroblast-like cells are oligopotent progenitor cells that can exhibit features
of interstitial dermal fibroblasts, perivascular cells, or dermal papilla/dermal sheath cells.
807
Gene correction of recessive dystrophic epidermolysis bullosa patient-specific induced pluripo-
tent stem cells by homologous recombination
M Itoh1 and AM Christiano1,2 1 Dermatology, Columbia University, New York, NY and 2
Genetics and Development, Columbia University, New York, NY
In recent years, generation of induced pluripotent stem cells (iPSCs) from patients with several human
diseases has been reported. Such cells are very useful tools to investigate unknown disease mech-
anisms and therapeutic testing. Moreover, autologous patient-specific iPSCs (PS-iPSCs) have great
potential to provide a source of cells for regenerative therapies for specific human diseases, because
they have unlimited proliferative capacity and extensive differentiation capability into required cell
types. We focused on recessive dystrophic epidermolysis bullosa (RDEB), an inherited blistering skin
disorder caused by mutations in the COL7A1 gene for developing iPSC-based therapy. We previ-
ously demonstrated that PS-iPSCs can be generated from a patient with compound heterozygous
COL7A1 mutations, and differentiated them into functional keratinocytes. For future clinical use,
the aim of this study is to correct the COL7A1 mutation in PS-iPSCs. We established RDEB PS-
iPSCs from a patient with a homozygous mutation (c2305-14del10ins2) in the splice junction of
exon/intron 17 border in the COL7A1 gene, and confirmed the authenticity of these iPSCs using
gene expression analysis by RT-PCR and immunostaining, transgene silencing, in vitro and vivo dif-
ferentiation capability by embryoid body and teratoma formation, karyotype analysis and NANOG
promoter methylation fingerprint. For gene correction by homologous recombination, a targeting
vector with neomycin-resistant selection cassette was generated based on BAC recombineering, and
nucleofected into PS-iPSCs. We obtained several iPSC lines which appear to be genetically cor-
rected after drug selection. We aim to develop iPSC-based cell therapy to advance to the next stage,
with the goal of establishing efficient therapy for RDEB.
809
High cell density markedly increases resistance to oxidative stress 
J Yahav,1 D Kim,1 L Maloney,2 F Lin,2,3 M McTigue3 and RA Clark2,3,4 1 School of Medicine, Stony
Brook University, Stony Brook, NY, 2 Dept. of Biomed Eng, Stony Brook University, Stony
Brook, NY, 3 Dept. of Dermatology, Stony Brook University, Stony Brook, NY and 4 Dept. of
Medicine, Stony Brook University, Stony Brook, NY
Oxidative stress is an important cause of cell death in skin trauma and inflammation. Here we
demonstrate that cell density increases resistance to oxidative stress by decreasing ROS in the
extracellular microenvironment. Adult human dermal fibroblasts were seeded at various densities
and treated with hydrogen peroxide (H2O2). Cell viability and levels of H2O2 remaining extracel-
lularly were compared at various cell densities by using the XTT (Roche Diagnostics, Mannheim,
Germany) and FOX (Pierce Biotechnology, Rockford, IL) assay kits, respectively. In both an H2O2
bolus system and a hypoxanthine/xanthine oxidase slow H2O2 generation system, cells seeded at
higher densities were increasingly more resistant (up to 4-fold) to the cytotoxic effects of high doses
of H2O2 (100-500 μM) over a 24-hour period. In both models, higher cell densities were also asso-
ciated with reduced levels of H2O2 remaining extracellularly by 2 hours after addition (reduced
almost completely at the highest cell density). We speculate that this is secondary to increased
absolute amounts of reducing agents like cellular catalase and/or glutathione in the system. These
findings have implications for in vitro assays and in vivo pathobiology. In vitro oxidative stress stud-
ies frequently fail to specify or even mention cell density. Our results show that cell density can
drastically alter results in such studies, and underscore the importance of proper in vitro experi-
mental design. In vivo, oxidative stress has been implicated in many pathological processes includ-
ing chronic skin ulcers. Our results suggest that once high cell density tissue such as stratified epi-
dermis or granulation tissue is established, wounds may become less susceptible to oxidative stress.
This may help explain why chronic wounds that begin to heal continue to do so fairly rapidly
unless an adverse event, like infection, occurs.
808
Epinephrine mediates impairment of wound healing via IL-6 dependent neutrophil traffick-
ing
M Kim,1,2 SI Simon1 and RR Isseroff2 1 Biomedical Engineering, UC Davis, Davis, CA and 2
Dermatology, UC Davis, Davis, CA
Epinephrine is endogenous stress hormone and is known to alter the inflammatory response to tis-
sue injury. However, precise mechanism by which epinephrine alters the inflammatory response
and wound healing is not well defined. Here we examined mechanistic interactions between the
systemic exposure of epinephrine, kinetics of neutrophil trafficking and the efficiency of local wound
repair. For this, sustained delivery of epinephrine (5 mg/kg/day) was achieved by subcutaneously
implanting osmotic pumps into mice following skin wounding. Neutrophil trafficking was non-inva-
sively observed during the entire time course of wound healing by real time tissue fluorescence
imaging technique that detect genetically tagged EGFP-neutrophil (EGFP-PMN) as previously reported
(J Invest Dermatol, 2008, 128: 1812-1820). Epinephrine treatment significantly delayed wound heal-
ing and increased wound PMN persistence in the wound for up to 8 days compared with saline-
treated mice. Inhibition of PMN infiltration into the wound following the 24 hr time point by injec-
tion of anti-neutrophil mAb Gr-1, significantly improved the rate of wound closure for
epinephrine-treated mice (by 57%, p<0.05 vs epinephrine only), but with negligible effect on saline-
treated mice. Multiplex cytokine assay revealed substantial increase in wound level of IL-6, while
other proinflammatory cytokines (IL-1β, TNF-α, IL-1α, and GM-CSF) were not altered as compared
with saline control. The subcutaneous injection of anti-IL-6 antibody into the wound periphery sig-
nificantly attenuated EGFP-PMN trafficking into the wound by 40% at day 8 post-wounding in epi-
nephrine-treated mice and accelerated the rate of wound closure by 2-fold compared with isotype
control. Our results suggest that prolonged exposure of epinephrine alters kinetics of neutrophil traf-
ficking to sites of wound via an IL-6 mediated mechanism and this in turn could delay wound repair.
806
Inhibiting beta-adrenergic receptors improves wound healing of combined injury of thermal
burning and irradiation
H Yang,1 H Albrecht,2 D Rocke2 and R Isseroff1 1 Dermatology, UC Davis School of Med., Davis,
CA and 2 Public Health Sci., UC Davis School of Med., Davis, CA
Previously we showed that keratinocyte migration and rate of wound healing are decreased in the
high stress and high epinephrine environment of a burn wound, by catecholamine activation the
beta-adrenergic receptors (β-AR). These impairments are reversed by treatment with a β-AR antag-
onist or depletion of β-AR in mice. In a “dirty bomb” scenario, both thermal and irradiation skin
wounding and impairment of healing are likely to ensue. Here we ask if suppressing β-AR activity
could improve the healing in the combined burn and irradiation wound injury. Explanted human
skin was irradiated by 1-10 Gy and then thermally wounded. Organ culture of the wounded skin
in serum-containing media and the re-epithelialization, mediated by keratinocyte migration, was
monitored by histochemistry and H&E staining 10 days post injury. The wounds in skin with the
irradiation and thermal injury re-epithelialized 14% over baseline, but treating the skin tissue with
timolol, a β-AR antagonist, increased re-epithelialization to 88%. The results suggest that treating
the combined injury by inhibiting β-AR could facilitate healing and may benefit the therapeutic
approaches. Since we have previously shown that timolol increase migration in cultured keratinocytes,
here we asked if irradiation suppresses healing by impairing cell migration and if treating cells with
timolol could improve migratory speed. Keratinocytes were examined 0, 24, 48 and 72 hours after
1-10 Gy exposure. The irradiated keratinocytes stopped proliferating with cell numbers at only
26% of control 72 hours post the exposure. However, the migration speed of keratinocyte did not
decrease, but surprisingly, increased by 15-30% after irradiation. Timolol treatment of irradiated
cells did not further increase the migration speed. These results suggest the effect of β-AR blocker
timolol on cell migration might be masked by irradiation. More experiments will be required to
elucidate the mechanism of how β-AR modulates healing in combined irradiation and thermal
injured skin.
810
Application of light emitting diode and Celecoxib (Cox-2 inhibitor) for the management of
wounds
ST Thng,1 K Manoj,2 M Tan,2 P Chow,3 SM Moochhala2 and J Lu2 1 Dermatology, National Skin
Centre, Singapore, Singapore, 2 Defence Medical and Environmental Research Institute,
Defense Science Organisation, Singapore, Singapore and 3 Department of Experimental
Surgery, Singapore General Hospital, Singapore, Singapore
Wound management, especially management of chronic wounds, have always been a challenge
for clinicians. Many factors come into play in order for wounds to heal properly and timely. These
factors include control of infection, inflammation, stimulation of keratinocytes and fibroblast growth
as well as adequacy of wound vascular bed. Of late, LEDs has been shown to upregulate keratinocyte
proliferation in cell culture studies through upregulation of growth factors. Our study aims to eval-
uate the efficacy of Light-Emitting Diodes (LEDs) combined with topical COX-2 inhibitor in the man-
agement of wounds, using burn wound as a model. We used a pig model of partial thickness burn
injury and studied efficacy of various treatment modalities by a) wound contraction, b) Laser Doppler
imaging, c) histology, and d) immunohistochemistry for Ki-67, proliferating cell nuclear antigen,
and laminin. The various treatment modalities studied include LED monotherapy, Celecoxib
monotherapy, LED + Celecoxib, Silverlon burn dressing and control group. Our findings show that
LED + Celecoxib combined treatment is very effective and achieved the best wound healing pro-
file among all treatment groups. The improvement of wound healing is significantly better when
compared to control as well as with the other treatment groups. Even when used alone, LED treat-
ment of burn wounds showed good healing when compared to control. In conclusion, our results
suggest that treatment of burn wounds with LED in combination with topical celecoxib signifi-
cantly improves wound healing. This combination showed potential to be used as a novel thera-
peutic intervention for the management of wounds, thus possibly opening up new avenues for the
management of difficult wounds.
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Automicroneedle therapy system combined with topical retinoid shows better regenerative
effects and fewer epidermal side effects compared with each individual treatment
J Kim,1,2 H Park,1,2 M Jung1,2 and E Choi1,2 1 Department of Dermatology, Yonsei University
Wonju College of Medicine, Wonju, Republic of Korea and 2 Korea and Healthy Woods Skin
Center, Yanggu, Republic of Korea
Regenerative therapy including anti-aging has become a new field for dermatologists. However, sev-
eral topical agents available for these kinds of skin problems have limitations in transdermal drug
delivery due to their high molecular weight and low liposolubility. Therefore, a more effective
transdermal drug delivery system is needed for better therapeutic effects of these agents. A recently
introduced microneedle therapy system (MTS) that makes multiple mechanical holes in the skin
improves transdermal delivery. Automicroneedle therapy system (AMTS) is a newly developed type
of MTS that has several advantages over traditional MTS. The objective of this study was designed
to evaluate the cutaneous effects of AMTS with topical retinoid. Cutaneous regenerative effects and
side effects were evaluated by functional assessment including transepidermal water loss and skin
hydration, and by histopathology including epidermal and dermal thickness and the density of col-
lagen fiber. Western blot and real time RT-PCR were also performed to determine protein and mRNA
expression of procollagen type I and matrix metalloproteinase-13. Compared with individual treat-
ments, ATMS with retinoid exhibited better dermal regenerative effects as a result of increased pro-
liferation of collagen fibers and reduced epidermal side effects associated with topical tretinoin. In
conclusion, we anticipate that AMTS combined with topical retinoid could be a new therapeutic
option for regenerative therapy with better regenerative effects and fewer side effects on the skin
compared with individual treatments.
800
Targeted genetic alteration in hyaluronan catabolism delays wound healing in mice
J Muto,1,2 AF Carlin,2 A Garcia,3 A Varki2 and RL Gallo1,2 1 Division of Dermatology, University
of California, San Diego, La Jolla, CA, 2 Department of Medicine, University of California, San
Diego, La Jolla, CA and 3 Department of Pathology, University of California, San Diego, La
Jolla, CA
Hyaluronan (HA) has been implicated in wound healing and inflammation, and its biological prop-
erties are thought to be dependent on its breakdown and molecular size, but direct evidence of the
physiological effects of HA catabolism in vivo have not been obtained. We sought to evaluate this
by altering expression of Hyaluronidase 1 (Hyal1), a major mammalian enzyme that acts intra- or
extracellularly to degrade HA. We constructed transgenic mice with a systemically-active promoter
containing loxP flanked eGFP reporter gene and stop codon upstream of Hyal1 (CAG-GFPfloxed-
Hyal1 Tg). Hyal1 is not expressed until targeted expression of Cre. Breeding of these mice with EIIa-
cre mice enabled initial production of EIIa-cre/CAG-Hyal1 Tg mice that then systemically over-
express Hyal1. HA in the skin of these mice was observed to be degraded when compared to controls
with shift in molecular weight from greater than 300 kDa to less than 30 kDa, but there were no
apparent morphological changes in structure of the skin. We next challenged these mice by full-
thickness 6 mm wounds and observed that wound closure in EIIa-cre/CAG-Hyal1 Tg mice was
delayed by approximately 2 days compared to control mice (CAG-GFPfloxed-Hyal1 Tg or Wt mice).
Wounds on day 4 showed more inflammatory cell infiltration and MIP-2 mRNA and protein levels
were significantly higher in EIIa-cre/CAG-Hyal1 Tg. Furthermore, we found that mRNA expression
of CD44, a receptor of HA, was significantly higher in EIIa-cre/CAG-Hyal1 Tg mice before wound-
ing and immunohistochemistry confirmed the higher expression of CD44 in endothelial cells. These
data show that hyaluronidase expression and abnormal degradation of endogenous hyaluronan
modulates wound healing by affecting the inflammatory status in skin. This confirms for the first time
an in vivo role for HA in inflammatory signaling and suggests modulation of its function can influ-
ence clinical outcome.
801
Liver X receptor (LXR) activator reverses psychological stress-induced delays in cutaneous
wound healing by inhibiting the activity and/or expression of 11β-hydroxysteroid dehydro-
genase type 1
J Youm, PM Elias, K Park, A Chan, Y Uchida and WM Holleran Dept. Dermatology, Univ.
California & Veterans Affairs Med. Center, San Francisco, CA
Psychological stress (PS) adversely affects cutaneous wound healing, evidenced by a slowing of the
recovery process. We recently demonstrated that inhibition of 11β-hydroxysteroid dehydrogenase
type 1 (11β-HSD1), an enzyme that converts relatively inactive GC (cortisone in humans, 11-dehy-
drocorticosterone in rodents) to more-active GC (cortisol in humans, corticosterone in rodents), with
topical carbenoxolone normalizes PS-induced delay of wound healing in mice. As reported that
both synthetic and natural liver X receptor (LXR) activators downregulate 11β-HSD1 expression
and activity in adipocytes and in mouse embryonic fibroblasts, here we assess the hypothesis that
LXR activator, TO901317, also attenuates the PS-induced delay in wound recovery, through down-
regulation of 11β-HSD1 expression and/or activity. We first confirmed that TO901317 not only
blocked the dexamethasone (Dex)-induced increases in both 11β-HSD1 mRNA and protein levels
in cultured human keratinocytes, but also inhibited the conversion of cortisone to cortisol in cul-
tured human keratinocytes. In addition, topical application of TO901317 to wound sites twice
daily (1mM in PG:EtOH [3:7] vehicle) attenuated the expected PS-induced delays in wound heal-
ing on days 2 through 6 following full thickness skin biopsy wounding of hairless mice. Further-
more, hairless mice were treated systemically with IP Dex (10μg in 0.5% DMSO) once daily for six
days after wounding, and topical TO901317 normalized the resultant GC-induced delay in wound
healing. Finally, the combined topical application of carbenoxolone and TO901317 ‘super’-nor-
malized wound healing in the face of PS. Together, these results indicate not only that the intracu-
taneous conversion of inactive-to-active GC accounts for PS-induced delay of wound healing, but
also that reduction of active GC through activation of the LXR nuclear hormone receptor can over-
ride the negative effects of PS on cutaneous wound healing.
802
Comparative analysis of two different polyurethane foam types for the use in NPWT treat-
ment in a porcine wound healing model
P Croizat,1 A Eckstein,1 U Fink1 and H Smola1,2 1 PAUL HARTMANN AG, Heidenheim,
Germany and 2 Department of Dermatology, University of Cologne, Cologne, Germany
Negative pressure wound therapy (NPWT) is highly effective in inducing granulation tissue in a vari-
ety of wound types ranging from acute and traumatic to chronic wounds. The V.A.C. System (KCI,
San Antonio, Texas) is predominant and this may explain the lack of comparative studies concern-
ing alternative systems. We analyzed the influence of the chemistry of two different polyurethane
foam dressings on the induction of granulation tissue. On the back of 15 pigs (87 kg + 3.9 kg) 8 full
thickness wounds (each extending to the fascia or adipose tissue) were created. The wounds were
treated with two different polyurethane foams (polyether-type polyurethane, Granufoam, KCI;
polyester-type polyurethane, VivanoMed, PAUL HARTMANN AG) for up to seven days. Negative
pressure was applied and after 3 days dressings were changed. The granulation tissue was evalu-
ated macroscopically, wound volume measured and inflammation analyzed by histology. Wound
healing proceeded in all wounds at the same speed. Granulation tissue increased, whereas wound
volume decreased and over 7 days all parameter showed no difference between ether-type and
esther-type polyurethane foams. Histology showed a marked increase in granulation tissue between
3 and 7 days. The subacute inflammation consisted of mild neutrophilic infiltration, fibrin exuda-
tion and lymphocytic cell infiltration. Foreign body cells and neutrophilic inflammation appeared
slightly more prominent in polyether-type polyurethane foam treated wounds. Our study in a highly
controlled, acute wound healing model shows that the chemistry of both, polyether-type and poly-
ester-type polyurethane foams, has excellent tissue tolerance. A robust granulation tissue is induced
whereas in polyester-type polyurethane foams inflammation was slightly reduced which may favor
a faster switch from NPWT to subsequent procedures.
803
Bioactivity of immobilized growth factor with polyelectrolyte multilayer assembly on ker-
atinocytes
F Gorouhi,1 N Shah,2 BL Wood,2 A Agarwal,3 J Covert,2 NL Abbott,3 CJ Murphy2 and RR Isseroff1
1 Dermatology, UC Davis, Davis, CA, 2 Surgical and Radiological Sciences, School of
Veterinary Medicine, UC Davis, Davis, CA and 3 Chemical and Biological Engineering,
University of Wisconsin–Madison, Madison, WI
Polyelectrolyte multilayer (PEM) films can serve as reservoirs of bioactive substances and allow for
prolonged controlled release. Here, we examined the bioactivity of epidermal growth factor (EGF)
covalently immobilized on PEMs. Tissue culture wells were coated by PEM layers, as described.1
Ten milliliter of 0.5 mg/ml EGF covalently modified with Texas Red succinimidyl ester and the
crosslinker sulfo-SANPAH was crosslinked to the PEM surface for 5 minutes using collimated UV
light (365 nm,10 mW/cm2). After rinsing, additional PEM bilayers (0, 2.5, 4.5, or 6.5) were deposited
over the EGF- crosslinked layer. Primary human keratinocytes cultured in serum and growth factor-
free Epilife medium were seeded in the same medium in PEM containing wells. Control keratinocytes
were plated on uncoated wells in the same medium, with or without addition of fluid phase EGF
(0.2 or 10 ng/ml). After 48 hours, cell proliferation was compared using the calcein-AM assay. Ker-
atinocytes attached and spread equally well on PEM control and EGF- crosslinked PEM layers. Ker-
atinocytes with direct access to immobilized, crosslinked EGF (no overlying PEMs) showed increased
proliferation compared to control surfaces of tissue culture polystyrene, unmodified PEMs, and PEMs
coated with BSA alone. Cells in direct contact with either the immobilized EGF, or the fluid phase
EGF demonstrated similar proliferative response. However, proliferation was decreased 30% in cells
plated on the immobilized EGF overlain by 4.5 PEM bilayers, and 40% when overlain by 6.5 bilay-
ers (p<0.05). Thus, we demonstrate that EGF bioactivity was preserved, despite of its structural
modification and surface immobilization, and that there is an inverse relationship between EGF
accessibility and/or bioavailability and number of PEMs coated over the immobilized EGF. These
findings will help design biomaterials for wound healing.
804
Organ regeneration in mammals: Development of a model for scarless wound healing using
amputated mouse vibrissae follicles
K Inoue,1 C Higgins,1 A Christiano1 and C Jahoda2 1 Columbia, New York, NY and 2 Durham,
Durham, United Kingdom
Within lower vertebrates, a form of robust tissue repair termed ‘epimorphic regeneration’ exists.
However, in mammals, the ability to regenerate lost organs is relatively limited. One observed exam-
ple of regeneration is seen in the hair follicle, where regeneration of an amputated end bulb can be
completed in a short period of time. Interestingly, this type of regeneration occurs without any scar
formation, and therefore we analyzed the molecular events that underlie this phenomenon. Based
on previously developed amputation techniques in the rat, we established a mouse model of hair
follicle amputation and regeneration. The mystacial pad of an adult Swiss Webster mouse was incised
to expose the base of hair follicle, followed by removal of the end bulb. Since innervation is required
for epimorphic regeneration in lower vertebrates, we also investigated the effect of nerve ablation
on regeneration. Follicle regeneration after amputation was examined by histology and immuno-
histochemistry, using markers to analyze both wound healing and regeneration events within the
follicle, as well as to label new hair follicle structures. Immediately after amputation, we observed
an inflammatory infiltrate at the site of injury, similar to normal skin wounds. However, SDC1 and
Sox2 immunofluorescence showed that by 4 days after amputation, the follicle mesenchyme starts
to reorganize around the amputated bulb, replacing the inflammatory response. By 7 days post
amputation, epithelial mesenchymal interactions were restored, indicated by p-cadherin expres-
sion, and the initiation of a new matrix and hair fibre had begun, coincident with labeling of
epithelial progenitors such as Sox9. We found that the follicle can regenerate without a require-
ment for innervation, making it distinct from the regeneration observed in lower vertebrates. We
hypothesize that the follicle is capable of intrinsically controlling the regenerative process, owing
to the unique plasticity of mesenchymal stem cells and their interaction with epithelial cells within
the follicle microenvironment.
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TSC2-null fibroblast-like cells recreate multiple niches in grafted skin equivalents including
dermal papilla
R Thangapazham,1 S Li,1 J Wang,1 S Rajesh,1 J Moss2 and TN Darling1 1 Dermatology, Uniformed
Services University of the Health Sciences, Bethesda, MD and 2 Cardiovascular and
Pulmonary Branch, National Heart Lung Blood Institute, NIH, Bethesda, MD
Angiofibromas and forehead plaques observed in tuberous sclerosis complex (TSC) are hamartomas
of dermis and hair follicles. We found that skin equivalents, composed of TSC2-null, fibroblast-like
cells from TSC skin hamartomas and normal neonatal foreskin keratinocytes, form hair follicles when
grafted to immunodeficient mice. Our objective in this study was to demonstrate the identity and
locations of tumor cells in the xenografts. An antibody reactive with human but not mouse COX IV
showed immunoreactivity to graft dermis and follicular and interfollicular epithelium, but not to
mouse skin. Human and mouse cells were identified using in situ hybridization with species-spe-
cific, pan-centromeric chromosome probes. Human cells were observed in the graft epidermis, fol-
licular epithelium, dermal papilla, perifollicular and interstitial dermis, and perivascular cells. Mouse
cells in grafts were located predominantly in vascular endothelial cells, with scattered mouse cells
in the interfollicular epidermis and interstitial dermis. To demonstrate the presence of TSC2-null cells
in the dermal papilla/lower dermal sheath regions of induced follicles, we investigated the genetic
identity of these cells. Analysis of TSC2-null cells from a fibrous forehead plaque revealed a non-
sense mutation in exon 10 of the TSC2 gene and loss of heterozygosity at three microsatellite mark-
ers flanking TSC2. Sections of xenografts were microdissected for restriction enzyme analysis that
revealed mutant DNA in cells from the region of the dermal papilla/lower dermal sheath and inter-
stitial dermis, but not in follicular epithelium. The presence of TSC2-null cells in these regions sug-
gests that TSC tumor fibroblast-like cells are oligopotent progenitor cells that can exhibit features
of interstitial dermal fibroblasts, perivascular cells, or dermal papilla/dermal sheath cells.
807
Gene correction of recessive dystrophic epidermolysis bullosa patient-specific induced pluripo-
tent stem cells by homologous recombination
M Itoh1 and AM Christiano1,2 1 Dermatology, Columbia University, New York, NY and 2
Genetics and Development, Columbia University, New York, NY
In recent years, generation of induced pluripotent stem cells (iPSCs) from patients with several human
diseases has been reported. Such cells are very useful tools to investigate unknown disease mech-
anisms and therapeutic testing. Moreover, autologous patient-specific iPSCs (PS-iPSCs) have great
potential to provide a source of cells for regenerative therapies for specific human diseases, because
they have unlimited proliferative capacity and extensive differentiation capability into required cell
types. We focused on recessive dystrophic epidermolysis bullosa (RDEB), an inherited blistering skin
disorder caused by mutations in the COL7A1 gene for developing iPSC-based therapy. We previ-
ously demonstrated that PS-iPSCs can be generated from a patient with compound heterozygous
COL7A1 mutations, and differentiated them into functional keratinocytes. For future clinical use,
the aim of this study is to correct the COL7A1 mutation in PS-iPSCs. We established RDEB PS-
iPSCs from a patient with a homozygous mutation (c2305-14del10ins2) in the splice junction of
exon/intron 17 border in the COL7A1 gene, and confirmed the authenticity of these iPSCs using
gene expression analysis by RT-PCR and immunostaining, transgene silencing, in vitro and vivo dif-
ferentiation capability by embryoid body and teratoma formation, karyotype analysis and NANOG
promoter methylation fingerprint. For gene correction by homologous recombination, a targeting
vector with neomycin-resistant selection cassette was generated based on BAC recombineering, and
nucleofected into PS-iPSCs. We obtained several iPSC lines which appear to be genetically cor-
rected after drug selection. We aim to develop iPSC-based cell therapy to advance to the next stage,
with the goal of establishing efficient therapy for RDEB.
809
High cell density markedly increases resistance to oxidative stress 
J Yahav,1 D Kim,1 L Maloney,2 F Lin,2,3 M McTigue3 and RA Clark2,3,4 1 School of Medicine, Stony
Brook University, Stony Brook, NY, 2 Dept. of Biomed Eng, Stony Brook University, Stony
Brook, NY, 3 Dept. of Dermatology, Stony Brook University, Stony Brook, NY and 4 Dept. of
Medicine, Stony Brook University, Stony Brook, NY
Oxidative stress is an important cause of cell death in skin trauma and inflammation. Here we
demonstrate that cell density increases resistance to oxidative stress by decreasing ROS in the
extracellular microenvironment. Adult human dermal fibroblasts were seeded at various densities
and treated with hydrogen peroxide (H2O2). Cell viability and levels of H2O2 remaining extracel-
lularly were compared at various cell densities by using the XTT (Roche Diagnostics, Mannheim,
Germany) and FOX (Pierce Biotechnology, Rockford, IL) assay kits, respectively. In both an H2O2
bolus system and a hypoxanthine/xanthine oxidase slow H2O2 generation system, cells seeded at
higher densities were increasingly more resistant (up to 4-fold) to the cytotoxic effects of high doses
of H2O2 (100-500 μM) over a 24-hour period. In both models, higher cell densities were also asso-
ciated with reduced levels of H2O2 remaining extracellularly by 2 hours after addition (reduced
almost completely at the highest cell density). We speculate that this is secondary to increased
absolute amounts of reducing agents like cellular catalase and/or glutathione in the system. These
findings have implications for in vitro assays and in vivo pathobiology. In vitro oxidative stress stud-
ies frequently fail to specify or even mention cell density. Our results show that cell density can
drastically alter results in such studies, and underscore the importance of proper in vitro experi-
mental design. In vivo, oxidative stress has been implicated in many pathological processes includ-
ing chronic skin ulcers. Our results suggest that once high cell density tissue such as stratified epi-
dermis or granulation tissue is established, wounds may become less susceptible to oxidative stress.
This may help explain why chronic wounds that begin to heal continue to do so fairly rapidly
unless an adverse event, like infection, occurs.
808
Epinephrine mediates impairment of wound healing via IL-6 dependent neutrophil traffick-
ing
M Kim,1,2 SI Simon1 and RR Isseroff2 1 Biomedical Engineering, UC Davis, Davis, CA and 2
Dermatology, UC Davis, Davis, CA
Epinephrine is endogenous stress hormone and is known to alter the inflammatory response to tis-
sue injury. However, precise mechanism by which epinephrine alters the inflammatory response
and wound healing is not well defined. Here we examined mechanistic interactions between the
systemic exposure of epinephrine, kinetics of neutrophil trafficking and the efficiency of local wound
repair. For this, sustained delivery of epinephrine (5 mg/kg/day) was achieved by subcutaneously
implanting osmotic pumps into mice following skin wounding. Neutrophil trafficking was non-inva-
sively observed during the entire time course of wound healing by real time tissue fluorescence
imaging technique that detect genetically tagged EGFP-neutrophil (EGFP-PMN) as previously reported
(J Invest Dermatol, 2008, 128: 1812-1820). Epinephrine treatment significantly delayed wound heal-
ing and increased wound PMN persistence in the wound for up to 8 days compared with saline-
treated mice. Inhibition of PMN infiltration into the wound following the 24 hr time point by injec-
tion of anti-neutrophil mAb Gr-1, significantly improved the rate of wound closure for
epinephrine-treated mice (by 57%, p<0.05 vs epinephrine only), but with negligible effect on saline-
treated mice. Multiplex cytokine assay revealed substantial increase in wound level of IL-6, while
other proinflammatory cytokines (IL-1β, TNF-α, IL-1α, and GM-CSF) were not altered as compared
with saline control. The subcutaneous injection of anti-IL-6 antibody into the wound periphery sig-
nificantly attenuated EGFP-PMN trafficking into the wound by 40% at day 8 post-wounding in epi-
nephrine-treated mice and accelerated the rate of wound closure by 2-fold compared with isotype
control. Our results suggest that prolonged exposure of epinephrine alters kinetics of neutrophil traf-
ficking to sites of wound via an IL-6 mediated mechanism and this in turn could delay wound repair.
806
Inhibiting beta-adrenergic receptors improves wound healing of combined injury of thermal
burning and irradiation
H Yang,1 H Albrecht,2 D Rocke2 and R Isseroff1 1 Dermatology, UC Davis School of Med., Davis,
CA and 2 Public Health Sci., UC Davis School of Med., Davis, CA
Previously we showed that keratinocyte migration and rate of wound healing are decreased in the
high stress and high epinephrine environment of a burn wound, by catecholamine activation the
beta-adrenergic receptors (β-AR). These impairments are reversed by treatment with a β-AR antag-
onist or depletion of β-AR in mice. In a “dirty bomb” scenario, both thermal and irradiation skin
wounding and impairment of healing are likely to ensue. Here we ask if suppressing β-AR activity
could improve the healing in the combined burn and irradiation wound injury. Explanted human
skin was irradiated by 1-10 Gy and then thermally wounded. Organ culture of the wounded skin
in serum-containing media and the re-epithelialization, mediated by keratinocyte migration, was
monitored by histochemistry and H&E staining 10 days post injury. The wounds in skin with the
irradiation and thermal injury re-epithelialized 14% over baseline, but treating the skin tissue with
timolol, a β-AR antagonist, increased re-epithelialization to 88%. The results suggest that treating
the combined injury by inhibiting β-AR could facilitate healing and may benefit the therapeutic
approaches. Since we have previously shown that timolol increase migration in cultured keratinocytes,
here we asked if irradiation suppresses healing by impairing cell migration and if treating cells with
timolol could improve migratory speed. Keratinocytes were examined 0, 24, 48 and 72 hours after
1-10 Gy exposure. The irradiated keratinocytes stopped proliferating with cell numbers at only
26% of control 72 hours post the exposure. However, the migration speed of keratinocyte did not
decrease, but surprisingly, increased by 15-30% after irradiation. Timolol treatment of irradiated
cells did not further increase the migration speed. These results suggest the effect of β-AR blocker
timolol on cell migration might be masked by irradiation. More experiments will be required to
elucidate the mechanism of how β-AR modulates healing in combined irradiation and thermal
injured skin.
810
Application of light emitting diode and Celecoxib (Cox-2 inhibitor) for the management of
wounds
ST Thng,1 K Manoj,2 M Tan,2 P Chow,3 SM Moochhala2 and J Lu2 1 Dermatology, National Skin
Centre, Singapore, Singapore, 2 Defence Medical and Environmental Research Institute,
Defense Science Organisation, Singapore, Singapore and 3 Department of Experimental
Surgery, Singapore General Hospital, Singapore, Singapore
Wound management, especially management of chronic wounds, have always been a challenge
for clinicians. Many factors come into play in order for wounds to heal properly and timely. These
factors include control of infection, inflammation, stimulation of keratinocytes and fibroblast growth
as well as adequacy of wound vascular bed. Of late, LEDs has been shown to upregulate keratinocyte
proliferation in cell culture studies through upregulation of growth factors. Our study aims to eval-
uate the efficacy of Light-Emitting Diodes (LEDs) combined with topical COX-2 inhibitor in the man-
agement of wounds, using burn wound as a model. We used a pig model of partial thickness burn
injury and studied efficacy of various treatment modalities by a) wound contraction, b) Laser Doppler
imaging, c) histology, and d) immunohistochemistry for Ki-67, proliferating cell nuclear antigen,
and laminin. The various treatment modalities studied include LED monotherapy, Celecoxib
monotherapy, LED + Celecoxib, Silverlon burn dressing and control group. Our findings show that
LED + Celecoxib combined treatment is very effective and achieved the best wound healing pro-
file among all treatment groups. The improvement of wound healing is significantly better when
compared to control as well as with the other treatment groups. Even when used alone, LED treat-
ment of burn wounds showed good healing when compared to control. In conclusion, our results
suggest that treatment of burn wounds with LED in combination with topical celecoxib signifi-
cantly improves wound healing. This combination showed potential to be used as a novel thera-
peutic intervention for the management of wounds, thus possibly opening up new avenues for the
management of difficult wounds.
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Automicroneedle therapy system combined with topical retinoid shows better regenerative
effects and fewer epidermal side effects compared with each individual treatment
J Kim,1,2 H Park,1,2 M Jung1,2 and E Choi1,2 1 Department of Dermatology, Yonsei University
Wonju College of Medicine, Wonju, Republic of Korea and 2 Korea and Healthy Woods Skin
Center, Yanggu, Republic of Korea
Regenerative therapy including anti-aging has become a new field for dermatologists. However, sev-
eral topical agents available for these kinds of skin problems have limitations in transdermal drug
delivery due to their high molecular weight and low liposolubility. Therefore, a more effective
transdermal drug delivery system is needed for better therapeutic effects of these agents. A recently
introduced microneedle therapy system (MTS) that makes multiple mechanical holes in the skin
improves transdermal delivery. Automicroneedle therapy system (AMTS) is a newly developed type
of MTS that has several advantages over traditional MTS. The objective of this study was designed
to evaluate the cutaneous effects of AMTS with topical retinoid. Cutaneous regenerative effects and
side effects were evaluated by functional assessment including transepidermal water loss and skin
hydration, and by histopathology including epidermal and dermal thickness and the density of col-
lagen fiber. Western blot and real time RT-PCR were also performed to determine protein and mRNA
expression of procollagen type I and matrix metalloproteinase-13. Compared with individual treat-
ments, ATMS with retinoid exhibited better dermal regenerative effects as a result of increased pro-
liferation of collagen fibers and reduced epidermal side effects associated with topical tretinoin. In
conclusion, we anticipate that AMTS combined with topical retinoid could be a new therapeutic
option for regenerative therapy with better regenerative effects and fewer side effects on the skin
compared with individual treatments.
800
Targeted genetic alteration in hyaluronan catabolism delays wound healing in mice
J Muto,1,2 AF Carlin,2 A Garcia,3 A Varki2 and RL Gallo1,2 1 Division of Dermatology, University
of California, San Diego, La Jolla, CA, 2 Department of Medicine, University of California, San
Diego, La Jolla, CA and 3 Department of Pathology, University of California, San Diego, La
Jolla, CA
Hyaluronan (HA) has been implicated in wound healing and inflammation, and its biological prop-
erties are thought to be dependent on its breakdown and molecular size, but direct evidence of the
physiological effects of HA catabolism in vivo have not been obtained. We sought to evaluate this
by altering expression of Hyaluronidase 1 (Hyal1), a major mammalian enzyme that acts intra- or
extracellularly to degrade HA. We constructed transgenic mice with a systemically-active promoter
containing loxP flanked eGFP reporter gene and stop codon upstream of Hyal1 (CAG-GFPfloxed-
Hyal1 Tg). Hyal1 is not expressed until targeted expression of Cre. Breeding of these mice with EIIa-
cre mice enabled initial production of EIIa-cre/CAG-Hyal1 Tg mice that then systemically over-
express Hyal1. HA in the skin of these mice was observed to be degraded when compared to controls
with shift in molecular weight from greater than 300 kDa to less than 30 kDa, but there were no
apparent morphological changes in structure of the skin. We next challenged these mice by full-
thickness 6 mm wounds and observed that wound closure in EIIa-cre/CAG-Hyal1 Tg mice was
delayed by approximately 2 days compared to control mice (CAG-GFPfloxed-Hyal1 Tg or Wt mice).
Wounds on day 4 showed more inflammatory cell infiltration and MIP-2 mRNA and protein levels
were significantly higher in EIIa-cre/CAG-Hyal1 Tg. Furthermore, we found that mRNA expression
of CD44, a receptor of HA, was significantly higher in EIIa-cre/CAG-Hyal1 Tg mice before wound-
ing and immunohistochemistry confirmed the higher expression of CD44 in endothelial cells. These
data show that hyaluronidase expression and abnormal degradation of endogenous hyaluronan
modulates wound healing by affecting the inflammatory status in skin. This confirms for the first time
an in vivo role for HA in inflammatory signaling and suggests modulation of its function can influ-
ence clinical outcome.
801
Liver X receptor (LXR) activator reverses psychological stress-induced delays in cutaneous
wound healing by inhibiting the activity and/or expression of 11β-hydroxysteroid dehydro-
genase type 1
J Youm, PM Elias, K Park, A Chan, Y Uchida and WM Holleran Dept. Dermatology, Univ.
California & Veterans Affairs Med. Center, San Francisco, CA
Psychological stress (PS) adversely affects cutaneous wound healing, evidenced by a slowing of the
recovery process. We recently demonstrated that inhibition of 11β-hydroxysteroid dehydrogenase
type 1 (11β-HSD1), an enzyme that converts relatively inactive GC (cortisone in humans, 11-dehy-
drocorticosterone in rodents) to more-active GC (cortisol in humans, corticosterone in rodents), with
topical carbenoxolone normalizes PS-induced delay of wound healing in mice. As reported that
both synthetic and natural liver X receptor (LXR) activators downregulate 11β-HSD1 expression
and activity in adipocytes and in mouse embryonic fibroblasts, here we assess the hypothesis that
LXR activator, TO901317, also attenuates the PS-induced delay in wound recovery, through down-
regulation of 11β-HSD1 expression and/or activity. We first confirmed that TO901317 not only
blocked the dexamethasone (Dex)-induced increases in both 11β-HSD1 mRNA and protein levels
in cultured human keratinocytes, but also inhibited the conversion of cortisone to cortisol in cul-
tured human keratinocytes. In addition, topical application of TO901317 to wound sites twice
daily (1mM in PG:EtOH [3:7] vehicle) attenuated the expected PS-induced delays in wound heal-
ing on days 2 through 6 following full thickness skin biopsy wounding of hairless mice. Further-
more, hairless mice were treated systemically with IP Dex (10μg in 0.5% DMSO) once daily for six
days after wounding, and topical TO901317 normalized the resultant GC-induced delay in wound
healing. Finally, the combined topical application of carbenoxolone and TO901317 ‘super’-nor-
malized wound healing in the face of PS. Together, these results indicate not only that the intracu-
taneous conversion of inactive-to-active GC accounts for PS-induced delay of wound healing, but
also that reduction of active GC through activation of the LXR nuclear hormone receptor can over-
ride the negative effects of PS on cutaneous wound healing.
802
Comparative analysis of two different polyurethane foam types for the use in NPWT treat-
ment in a porcine wound healing model
P Croizat,1 A Eckstein,1 U Fink1 and H Smola1,2 1 PAUL HARTMANN AG, Heidenheim,
Germany and 2 Department of Dermatology, University of Cologne, Cologne, Germany
Negative pressure wound therapy (NPWT) is highly effective in inducing granulation tissue in a vari-
ety of wound types ranging from acute and traumatic to chronic wounds. The V.A.C. System (KCI,
San Antonio, Texas) is predominant and this may explain the lack of comparative studies concern-
ing alternative systems. We analyzed the influence of the chemistry of two different polyurethane
foam dressings on the induction of granulation tissue. On the back of 15 pigs (87 kg + 3.9 kg) 8 full
thickness wounds (each extending to the fascia or adipose tissue) were created. The wounds were
treated with two different polyurethane foams (polyether-type polyurethane, Granufoam, KCI;
polyester-type polyurethane, VivanoMed, PAUL HARTMANN AG) for up to seven days. Negative
pressure was applied and after 3 days dressings were changed. The granulation tissue was evalu-
ated macroscopically, wound volume measured and inflammation analyzed by histology. Wound
healing proceeded in all wounds at the same speed. Granulation tissue increased, whereas wound
volume decreased and over 7 days all parameter showed no difference between ether-type and
esther-type polyurethane foams. Histology showed a marked increase in granulation tissue between
3 and 7 days. The subacute inflammation consisted of mild neutrophilic infiltration, fibrin exuda-
tion and lymphocytic cell infiltration. Foreign body cells and neutrophilic inflammation appeared
slightly more prominent in polyether-type polyurethane foam treated wounds. Our study in a highly
controlled, acute wound healing model shows that the chemistry of both, polyether-type and poly-
ester-type polyurethane foams, has excellent tissue tolerance. A robust granulation tissue is induced
whereas in polyester-type polyurethane foams inflammation was slightly reduced which may favor
a faster switch from NPWT to subsequent procedures.
803
Bioactivity of immobilized growth factor with polyelectrolyte multilayer assembly on ker-
atinocytes
F Gorouhi,1 N Shah,2 BL Wood,2 A Agarwal,3 J Covert,2 NL Abbott,3 CJ Murphy2 and RR Isseroff1
1 Dermatology, UC Davis, Davis, CA, 2 Surgical and Radiological Sciences, School of
Veterinary Medicine, UC Davis, Davis, CA and 3 Chemical and Biological Engineering,
University of Wisconsin–Madison, Madison, WI
Polyelectrolyte multilayer (PEM) films can serve as reservoirs of bioactive substances and allow for
prolonged controlled release. Here, we examined the bioactivity of epidermal growth factor (EGF)
covalently immobilized on PEMs. Tissue culture wells were coated by PEM layers, as described.1
Ten milliliter of 0.5 mg/ml EGF covalently modified with Texas Red succinimidyl ester and the
crosslinker sulfo-SANPAH was crosslinked to the PEM surface for 5 minutes using collimated UV
light (365 nm,10 mW/cm2). After rinsing, additional PEM bilayers (0, 2.5, 4.5, or 6.5) were deposited
over the EGF- crosslinked layer. Primary human keratinocytes cultured in serum and growth factor-
free Epilife medium were seeded in the same medium in PEM containing wells. Control keratinocytes
were plated on uncoated wells in the same medium, with or without addition of fluid phase EGF
(0.2 or 10 ng/ml). After 48 hours, cell proliferation was compared using the calcein-AM assay. Ker-
atinocytes attached and spread equally well on PEM control and EGF- crosslinked PEM layers. Ker-
atinocytes with direct access to immobilized, crosslinked EGF (no overlying PEMs) showed increased
proliferation compared to control surfaces of tissue culture polystyrene, unmodified PEMs, and PEMs
coated with BSA alone. Cells in direct contact with either the immobilized EGF, or the fluid phase
EGF demonstrated similar proliferative response. However, proliferation was decreased 30% in cells
plated on the immobilized EGF overlain by 4.5 PEM bilayers, and 40% when overlain by 6.5 bilay-
ers (p<0.05). Thus, we demonstrate that EGF bioactivity was preserved, despite of its structural
modification and surface immobilization, and that there is an inverse relationship between EGF
accessibility and/or bioavailability and number of PEMs coated over the immobilized EGF. These
findings will help design biomaterials for wound healing.
804
Organ regeneration in mammals: Development of a model for scarless wound healing using
amputated mouse vibrissae follicles
K Inoue,1 C Higgins,1 A Christiano1 and C Jahoda2 1 Columbia, New York, NY and 2 Durham,
Durham, United Kingdom
Within lower vertebrates, a form of robust tissue repair termed ‘epimorphic regeneration’ exists.
However, in mammals, the ability to regenerate lost organs is relatively limited. One observed exam-
ple of regeneration is seen in the hair follicle, where regeneration of an amputated end bulb can be
completed in a short period of time. Interestingly, this type of regeneration occurs without any scar
formation, and therefore we analyzed the molecular events that underlie this phenomenon. Based
on previously developed amputation techniques in the rat, we established a mouse model of hair
follicle amputation and regeneration. The mystacial pad of an adult Swiss Webster mouse was incised
to expose the base of hair follicle, followed by removal of the end bulb. Since innervation is required
for epimorphic regeneration in lower vertebrates, we also investigated the effect of nerve ablation
on regeneration. Follicle regeneration after amputation was examined by histology and immuno-
histochemistry, using markers to analyze both wound healing and regeneration events within the
follicle, as well as to label new hair follicle structures. Immediately after amputation, we observed
an inflammatory infiltrate at the site of injury, similar to normal skin wounds. However, SDC1 and
Sox2 immunofluorescence showed that by 4 days after amputation, the follicle mesenchyme starts
to reorganize around the amputated bulb, replacing the inflammatory response. By 7 days post
amputation, epithelial mesenchymal interactions were restored, indicated by p-cadherin expres-
sion, and the initiation of a new matrix and hair fibre had begun, coincident with labeling of
epithelial progenitors such as Sox9. We found that the follicle can regenerate without a require-
ment for innervation, making it distinct from the regeneration observed in lower vertebrates. We
hypothesize that the follicle is capable of intrinsically controlling the regenerative process, owing
to the unique plasticity of mesenchymal stem cells and their interaction with epithelial cells within
the follicle microenvironment.
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Microbiome and corresponding cutaneous defense response in chronic diabetic wounds
EA Grice,1 ES Snitkin,1 LJ Yockey,1 DM Bermudez,2 KW Liechty3 and JA Segre1 1 Genetics and
Molecular Biology Branch, NIH/NHGRI, Bethesda, MD, 2 Department of Surgery, University
of Pennsylvania, Philadelphia, PA and 3 Department of Surgery, University of Mississippi
Medical Center, Jackson, MS
The skin is not only the first line of defense to the external environment, but is also host to myriad
microbes (the “microbiome”). When the skin barrier is breached, the immune response must be
carefully calibrated to rapidly defend against microbial invasion and infection yet control poten-
tially damaging inflammation. Chronic and slow-healing skin wounds, especially prevalent in dia-
betic and elderly populations, are often characterized by excessive inflammation, microbial infec-
tion, and subsequent tissue necrosis and apoptosis. To elucidate the role of microbes and how their
products may influence the host cutaneous defense response in non-healing diabetic wounds, we
employ a diabetic model of impaired wound healing, the leptin receptor-deficient mouse, Lep-
rdb/db. By sequencing 16S ribosomal RNA genes to survey bacterial diversity, we previously deter-
mined that a longitudinal selective shift in skin and wound microbiota coincides with impaired heal-
ing in this model. We also demonstrated prolonged expression of cutaneous defense genes that
paralleled the shift in microbiota. Our current efforts are focused on the mechanism by which micro-
biota may cause impaired wound healing in Leprdb/db mice. Preliminary data indicates that decreased
bacterial diversity further impairs wound healing in our model. We are also examining how the
innate immune system modulates microbial colonization of wounds. Our long-term goal is to genet-
ically dissect the role of two intertwined components in impaired diabetic wound healing: the micro-
biome and the host innate immune response.
819
Hydrogels can reduce dermal temperatures and speed epithelialization of second degree
burns: Preliminary evaluations in a porcine model
SC Davis, J Gil, J Valdes and A Claro Dermatology & Cutaneous Surgery, University of Miami,
Miller School of Medicine, Miami, FL
Local cooling of a burn wound has been shown to increase the rate of healing. Hydrogel dressings
have been known to possess cooling properties. This study examines the effect of a novel hydrogel
dressing on burn wound temperature and rate of healing. A pilot study was conducted in four pigs.
Second-degree burns were created and randomly assigned to one of three treatment groups: 1)
untreated control, 2) hydrogel dressing [WaterJel, WaterJel Technologies], or 3) gauze [Surgical
Sponge, Dynarex Corporation]. Burns were treated within 1 minute of burn creation. After 90 min-
utes of treatment, the materials were removed and treated burns were then covered with a silver
dressing [Silverlon, Argentum Medical, LLC]. Burns were evaluated for healing at various time points
for epithelialization using a well established salt-split technique. In addition, a temperature probe
was used to assess papillary and reticular dermal temperatures. Burns treated with the hydrogel
dressing epithelized more rapidly than gauze and untreated wounds. On day 9 wounds treated
with the hydrogel dressing were 90% completely epithelialized as compared to 50% with gauze
treatment and 30% with untreated control. Complete epithelialization (100%) occurred four days
sooner than untreated controls. The hydrogel dressing also was able to reduce the papillary dermis
temperature by 4 degrees Fahrenheit. This study suggests that the hydrogel dressing we examined
was effective in increasing the re-epithelialization rate of second-degree burns. This increase in heal-
ing may be due to the hydrogel’s capacity to decrease the temperature of the dermis after burning
resulting in a reduction of burn progression. This is especially important since tissue necrosis in
burns can take 2-3 days to reach their deepest level. The ability of any material to diminish burn
progression would have significant clinical relevance.
821
Transregulation of α2 and α3 integrin expression by α6β4 integrin in migrating keratinocytes.
K Kligys, S Hopkinson and J Jones Cell and Molecular Biology, Northwestern University,
Chicago, IL
There is emerging evidence that α6β4 integrin, together with α3β1 and α2β1 integrins, regulate ker-
atinocyte migration during wound healing. To provide support for this notion, we generated human
keratinocytes exhibiting α6A integrin subunit deficiency using shRNA technology. Cells deficient
in α6 integrin expression fail to migrate directionally. Rather, they move in circular paths at a
slower rate than their normal keratinocyte counterparts. Interestingly, knockdown of α6 integrin is
accompanied by a decrease in surface expression of the α2, α3, β1, and β4 integrin subunits.
Moreover, the mRNA levels of the α2 integrin subunit are decreased in α6 integrin knockdown cells,
suggesting that α6 integrin, indirectly, regulates the transcription of the α2 integrin message. Con-
versely, α3, β1, and β4 integrin subunit mRNA levels are unaffected in the α6 knockdown cells,
implying that α6 integrin regulates the translation of these messages. Consistent with this hypothe-
sis, the phosphorylation state of the translational repressor protein 4E-binding protein (4E-BP1)
and, hence, its activity is decreased in keratinocytes exhibiting α6 integrin knockdown. Re-expres-
sion of the α6 integrin subunit leads to an increase in α3 and β4 integrin surface expression in the
α6 integrin-deficient keratinocytes. Interestingly, α2 integrin mRNA levels can be restored to that
of wild type cells by either induced expression of α6 integrin or α3 integrin in the α6 integrin-defi-
cient cells. Together our results suggest a sequential regulation of integrin expression in keratinocytes,
whereby α6β4 integrin regulates the translation of α3 integrin, which in turn, controls the tran-
scription of α2 integrin. Therefore, our data underscore the complexity of the integrin expression
profile required for the wound re-epithelialization process and indicate that α6 integrin is a key
translational and transcriptional modulator.
820
Characterization and quantification of wound-induced hair follicle neogenesis using in vivo
confocal scanning laser microscopy
C Fan,1 MA Luedtke,2 SM Prouty,3 M Burrows,4 N Kollias2 and G Cotsarelis4 1 School of
Biomedical Engineering, Science & Health Systems, Drexel University, Philadelphia, PA, 2
Consumer and Personal Products Worldwide, Johnson & Johnson, Skillman, NJ, 3 Follica, Inc,
Philadelphia, PA and 4 School of Medicine, University of Pennsylvania, Philadelphia, PA
In vivo confocal scanning laser microscopy (CSLM) is a recently-developed non-invasive technique
for visualizing microscopic structures within the skin. CSLM has been used to characterize several
skin diseases. In this study, we assessed the ability of CSLM to evaluate the formation of neogenic
hair follicles after a full thickness wound in mice. Full-thickness wounds were made on the dorsal
skin of 3-week old mice. After scab detachment, the number, width, length, space and volume of
neogenic hair follicles were analyzed using CSLM. The results were compared with those from
conventional methods, including staining for alkaline phosphatase (AP) and keratin 17 (K17) as well
as histology. We found that quantification of neogenic hair follicles using CSLM compared favor-
ably with results from direct measurements on isolated epidermal tissue after immunostaining for
K17, a marker for the epithelial portion of new hair follicles. CSLM detected 89% of K17-stained
follicles. CSLM more accurately quantitated the number of new follicles compared to AP staining,
which detects the dermal portion of the new follicle. The width and length measurement from CSLM
and histology were very close and correlated with each other. The minimum length of a neogenic
hair follicle that could be detected by CSLM was 21 μm. Measurements of spaces between neogenic
hair follicles using CSLM was more accurate than histological method, which caused shrinkage dur-
ing fixation. In conclusion, CSLM is an accurate and valuable method for counting and measuring
neogenic hair follicles non-invasively. In vivo visualization of developing follicles with CSLM per-
mits detection of serial changes in hair follicle formation, thus conserving numbers of mice required
for studies and improving detection of temporal changes in developing hair follicles.
818
Burn injury induces early erythrocyte occlusion of surrounding cutaneous microvasculature
prior to delayed microthrombus formation.
W Zhou,1 DA Hirth,1 MG Tonnesen,1,4 SA McClain,2 AJ Singer2 and RA Clark3,1 1 Dermatology,
Stony Brook Univ, Stony Brook, NY, 2 Emergency Medicine, Stony Brook Univ, Stony Brook,
NY, 3 Biomedical Engineering, Stony Brook Univ, Stony Brook, NY and 4 Medicine, VAMC,
Northport, NY
Progression of burn injury, with resultant scars and contractures, is a well-known, poorly delin-
eated phenomenon with no preventive therapy. This dynamic injury may progress due to compro-
mised blood supply. Blood vessel (BV) occlusion has long been noted in burns, but the cause debated.
Studies prior to 1975 on porcine models identified occlusions as densely packed erythrocytes (RBCs);
recent studies on rodent models attributed occlusion to thrombosis. Our previous analysis of fib-
rinogen in a porcine hot comb model of horizontal burn injury progression suggested that occlu-
sion by RBCs predominated early in the superficial vascular plexus (SVP), while thrombosis pre-
dominated later in the deep vascular plexus (DVP). To extend our study, full thickness 8mm skin
biopsies from interspaces between adjacent porcine burns at 1, 4, 24, and 48 hrs post injury were
probed for CD31, to delineate platelets and endothelial cells, and compared with previous fib-
rinogen staining. Hematoxylin stain revealed clumped, anuclear, small biconcave cells, consistent
with RBCs, in occluded SVP and DVP BVs at 4 and 24 hrs. CD31 outlined endothelium in SVP and
DVP at 1, 4, 24, and 48 hrs. CD31 staining of BV occlusions was minimal in DVP at 1 and 4 hrs,
moderate at 24 hrs, significant at 48 hrs. Fibrinogen/fibrin lined DVP lumens at 24 hrs but did not
occlude DVP BV until 48 hrs. Thus CD31 staining confirmed our previous fibrinogen results: RBC
aggregation predominated early (4 to 24 hrs) in the SVP, while fibrin-platelet thrombosis predomi-
nated later in the DVP causing significant occlusion by 48 hrs. The initial predominance of RBC
occlusion rather than thrombosis might explain historical ineffectiveness of anticoagulants to pre-
vent burn injury progression. We propose that early administration of cutaneous vasodilators might
reduce morbidity/mortality of burn injury.
822
The collagen XVII-binding protein actinin-4 regulates the directed migration of keratinocytes
KJ Hamill,1 O Skalli2 and JC Jones1 1 Cell and Molecular Biology, Northwestern University,
Chicago, IL and 2 University of Memphis, Memphis, TN
Our focus is to identify the molecules involved in determining the directed migration of keratinocytes,
an essential component of wound healing of the skin. To this end we recently presented evidence
that, in addition to their established location and role in hemidesmosomes, the bullous pemphigoid
antigens, BPAG1e and collagen XVII (Col XVII, BPAG2) regulate the migratory behavior and polar-
ity of motile keratinocytes. Both BPAG1e and Col XVII are found in the leading lamellipodia of
migrating skin cells, where they spatially interact with the actin cytoskeleton. However, neither
protein directly binds actin. Previous studies revealed that Col XVII possesses a site via which it can
interact with members of the actinin family of actin-binding proteins. Moreover, one actinin fam-
ily member, namely actinin-4, exhibits co-localization with Col XVII within the lamellipodia of
motile keratinoyctes. Thus, to begin to address whether actinin-4 is involved in regulating the migra-
tory behavior of keratinocytes, we induced actinin-4 knockdown in keratinocytes using lentiviral
delivery of shRNA. Skin cells exhibiting actinin-4 knockdown display a failure to migrate in a pro-
cessive manner in single cell motility assays although their overall migration rate is unaltered. This
phenotype mirrors that of BPAG1e and Col XVII-deficient keratinocytes. However, in contrast to
the latter cells, actinin-4-knockdown keratinocytes display numerous, large lamellipodia-like cell
surface extensions which demonstrate reduced dynamics as determined by kymographic analyses.
Intriguingly, confocal immunofluorescence analyses indicate that actinin-4 deficiency induces a
clustering of hemidesmosomal proteins in these large lamellipodial extensions. Together, our data
indicate that actinin-4 is required for the directed migration of skin cells through regulating the local-
ization of hemidesmosome components in the lamellipodia of actively migrating keratinocytes.
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Induced pluripotent stem cells from individuals with Lamellar Ichthyosis
J Teng,1 E McMillan,1 T Kawahara,1 A Martinsen,1 G Chen,3 J Thomson,4 V Setaluri1 and S Palecek2
1 Dept of Dermatology, University of Wisconsin Madison, Madison, WI, 2 College of
Engineering, University of Wisconsin Madison, Madison, WI, 3 Wisconsin Genome Center,
University of Wisconsin Madison, Madison, WI and 4 Morgridge Institute for Research,
University of Wisconsin Madison, Madison, WI
Lamellar ichthyosis (LI) is an autosomal recessive skin disorder with extensive scaling and hyperk-
eratosis caused by mutations in genes encoding cell envelop proteins. It is a severe form of con-
genital ichthyosis that not only results in disfiguring, but also complications such as electrolyte imbal-
ance, recurrent infections, and mal-nutrition from high epithelium turn over. The ophthalmologic
complications can also be extremely challenging. The enzyme that is most commonly affected in
LI is transglutaminase 1 (TG1). To date, there are no effective forms of therapy. The discovery of
human induced-pluripotent stem cells (iPSCs) provides a unique opportunity to study stem cell dif-
ferentiation and a revolutionary approach to create human models of diseases that can be studied
in tissue cultures. To establish a foundation for therapies using gene-corrected, patient-specific cell
transfer, we have generated iPSCs from subjects with confirmed diagnosis of LI (LI iPS) or carrying
a single allele mutation of TG1 (T2391C). We found that TG1 was not required for stem cell renewal
and that iPSCs derived from either LI patient or carrier control could be differentiated into ker-
atinocyte lineages following similar time course as wild-type iPS line, IMR90. The percentage of
K14+P63+ keratinocyte progenitors derived from IMR90 and LI iPS are also comparable following
two weeks of differentiation in vitro. Differentiated IMR90 and LI iPS cells were able to form organ-
otypic structures resembling epidermis derived from primary keratinocytes. These data identify the
potential of disease-specific iPSCs to generate gene-corrected autologous skin progenitors that could
offer new perspectives to our current therapeutic approaches and hopes to patients.
812
Prominent role of resident endothelial progenitors in skin wound angiogenesis
EJ Seppanen, M Rodero and K Khosrotehrani Centre for Clinical Research, University of
Queensland, Brisbane, QLD, Australia
Vessel formation in the granulation tissue is essential for skin wound healing. Although many stud-
ies have investigated factors that modify angiogenesis, the endothelial cells in this process have not
been clearly defined, especially within affected tissues. In particular, the respective role of resident
and bone marrow derived endothelial progenitors is not clear. We sought to quantitatively assess
endothelial populations in wounds, blood and bone marrow over time to determine hierarchy and
origin of the cells participating in wound angiogenesis. Excisional wounds were generated on
C57BL/6 mice and collected daily from day 1 to 5 after wounding. All tissues were analysed using
5-colour flow cytometry for CD45, CD11b, CD34, CD31 and VEGFR2. Unbiased analyses were
performed to establish hierarchy. Absolute number modifications in each compartment (wound,
blood, bone marrow) was calculated and considered for potential exchange between compartments.
Here, we propose a cell population defined as CD34+CD45loCD31loVEGFR2lo that exists as an
omnipresent endothelial progenitor cell (EPC). In skin wounds these putative EPCs proliferated
from day 1 and exhibited peak expansion on day 4 of healing. Within this expanded pool, a pop-
ulation of CD34+CD45loCD31hiVEGFR2hi cells appeared from day 2 and increased 3 fold in
absolute number between day 4 and 5 post wounding, suggesting terminal differentiation of pro-
genitors. The contribution of EPC or terminally differentiated cells from bone marrow or the circu-
lating blood was quantitatively small and occurred later than this initial local response. We pro-
pose that putative EPCs exist in local rather than distant pools and proliferate to give rise to the
neovascularisation. These data challenge the current paradigm for EPC recruitment during wound
healing and could have far reaching implications for developing more successful targeted cell ther-
apies to use in chronic wounds.
813
Maintenance of the epidermal progenitor state requires the long non-coding RNA Linc8D
C Lee, M Kretz, D Webster, R Flockhart, K Qu, A Mah, C Aros, H Chang, J Rinn and P Khavari
Veterans Affairs Palo Alto Healthcare System and Stanford University, Palo Alto, CA
Epidermal progenitors must sustain proliferation while suppressing exit into the terminal differenti-
ation pathway, however, the mechanism by which such genome-wide effects are sustained is not
fully understood. The human genome encodes >5,000 conserved large intergenic noncoding
(linc)RNAs with presumed biological functions that are not fully characterized yet represent candi-
date regulators of this process. A custom genomic tiling array for lincRNAs designed using bioin-
formatic filtering of chromatin domains was used to screen for actively transcribed but non-protein
coding genes and identified a new lincRNA on chromosome 8p12 (linc8D). We also identified
linc8D in a separate screen as up-regulated in a series of 5 primary human squamous cell carci-
nomas (SCC) compared to patient-matched, normal adjacent skin. Linc8D is strongly down-regu-
lated during epidermal differentiation, suggesting it may have a role in the undifferentiated cell state.
To test this possibility directly, we undertook loss-of-function experiments in both cultured primary
epidermal keratinocytes in vitro and in regenerated human organotypic tissue. Consistent with a
role for linc8D in preventing differentiation, linc8D depletion via multiple independent RNA-inter-
ference sequences induced differentiation in both settings. Efforts are underway to characterize
linc8D target genes and binding proteins as well as to study the effect of altering linc8D expression
in epidermal neoplasia. Linc8D represents the first long noncoding RNA identified to date that is
required to suppress differentiation and maintain the progenitor compartment in epidermis.
814
Epidermal IGF-1 receptor is important in the maintenance of bulge stem cell and their response
to skin wounds
E Roy,1 F Linay,2 M Holzenberger,2 M Oster,2 S Aractingi2 and K Khosrotehrani1 1 Centre for
Clinical Research, University of Queensland, Herston, QLD, Australia and 2 INSERM U 938,
UPMC Univ Paris 6, Paris, France
IGF-1 and its receptor are key regulators of growth, differentiation and metabolism. IGF-1 sig-
nalling is essential in epidermal development and interacts with the rho-GTPase Rac to maintain
the interfollicular epidermis (IFE). However its role in adult homeostasis of bulge stem cells and their
contribution to skin wound is unclear. To address this question, we used Keratin 14 and Keratin 15
driven conditional deletion of the IGF1 receptor (IGF1R) to abrogate IGF-1 signalling in the epi-
dermis and more specifically in the bulge stem cells in an inducible manner in adult mice. In
steady state, we did not observe any major histological changes in young mice (5 weeks old) and
aged mice (6 months old). Detailed quantitative analyses of epidermal subpopulations based on
CD34 and alpha-6 integrin staining using flow cytometry, revealed a significant reduction of IFE epi-
dermal cells in K14 driven deletion as opposed to an outer rout sheath (ORS) reduction in K15 driven
deletion suggesting the importance of IGF1 signalling in the maintenance of each compartment. In
both situations there was a reduction in the proportion of CD34 high bulge stem cells. To further
analyse the contribution of these different compartments to skin wound re-epidermisation, we per-
formed 6mm excisional wounds in young and aged mice. K14 driven IGF1R deletion resulted in
significant delay in wound closure at any age. In mice with IGF1R deficiency in bulge cells, wound
healing was normal in young animals but was significantly delayed at older age. In conclusion, our
results show the importance of IGF-1 signalling in adult skin homeostasis after the completion of
developmental processes of stratification and hair follicle formation. This pathway significantly
affected epidermal stem cell maintenance and activity both in the hair follicle bulge and presum-
ably in the IFE. In particular, our results show the reduced capacity of bulge stem cells deficient in
IGF1R to contribute to skin wound healing over time.
815
Dihydrodehydrodiisoeugenol (DDE) enhances adipocyte differentiation and decreases lipol-
ysis in murine and human cells
K Nehrenheim,1 I Meyer,2 J Krutmann1 and S Grether-Beck1 1 IUF-Leibniz Research Institute for
Environmental Medicine, Duesseldorf, Germany and 2 Symrise GmbH & Co KGAG,
Holzminden, Germany
During chronological aging, subcutaneous fat depots decrease while visceral fat depots increase.
Starting in the face, subcutaneous adipose tissue decreases resulting in facial lipoatrophy, probably
because (i) the preadipocytes in the subcutaneous fat tissue of the skin lose the capacity to differ-
entiate, (ii) TNF-α is secreted in elevated levels by adipocytes of elderly with diverse effects on the
fat storage capacity of adipose tissue by a) enhancing lipolysis, b) inhibiting the differentiation of
preadipocytes to adipocytes and c) maintaining the dedifferentiation of adipocytes. Accordingly, a
battery of compounds has been assessed for the endpoints (i) lipid accumulation and (ii) basal or
TNF-α induced lipolysis in a murine and a human cell culture system. In addition, induction of the
differentiation process was controlled for upregulation via measurement of specific transcription
factors such as PPARγ2 and C/EBPα, fatty acid binding protein 4 (FABP4), and adiponectin, and for
down-regulation via measurement of the preadipocyte marker pref1 using real time PCR. In the
murine system, the synthetic compound dihydrodehydrodiisoeugenol (DDE) resulted in a 30%
increase of lipid accumulation and was accompanied by an induction of the differentiation asso-
ciated markers mentioned above. In addition, DDE was able to diminish basal as well as TNF-α
induced lipolysis in a dose-dependent manner. In primary human subcutaneous preadipocytes using
an age-adopted hormone mix with reduced levels of insulin and dexamethasone, DDE was able to
significantly increase lipid accumulation above controls. In addition, DDE also induced upregula-
tion of PPARγ2 and adiponectin mRNA. Finally, the compound was able to inhibit basal lipolysis
in mature human subcutaneous adipocytes. Taken together, these studies indicate that DDE is well
suited to overcome age-associated lipoatrophy by a dual mode of action: (i) induction of adipocyte
differentiation and (ii) inhibition of lipolysis.
816
Induction of regulatory dendritic cells by artificial extracellular matrices used as coatings for
biomaterials
S Franz,1 I Forstreuter,1 V Hintze,2 S Möller,3 D Scharnweber,2 M Schnabelrauch3 and JC Simon1 1
Clinic for Dermatology, Venerology und Allergology, University Leipzig, Leipzig, Germany, 2
Max Bergmann Center for Biomaterials, Technical University Dresden, Dresden, Germany and
3 Biomaterials Department, INNOVENT e.V, Jena, Germany
Functionalization of biomaterials has evolved as a promising strategy to avoid detrimental immune
responses to biomaterial implants improving implant integration and performance. Here we address
the “immunomodulating” effects of artificial extracellular matrices (aECM) that are used as coatings
for biomaterials. Dendritic cells (DC) are key regulators of innate and adaptive immunity. They are
capable to downregulate immune responses. Since DC take an important part in biomaterial heal-
ing and integration we assessed DC responses resulting from interactions with different aECM. Arti-
ficial extracellular matrices are generated utilizing the natural self-assembly potential of collagen
type I in combination with either hyaluronic acid (HA) or chondroitin sulphate (CS) or specifically
sulfated derivates of both. Monocyte-derived immature DC are cultured on the aECM for 24h.
Induced DC phenotypes are determined by analyzing expression of DC maturation markers, cytokine
profile and allostimulatory ability in a mixed lymphocyte reaction. We find different DC responses
depending on the underlying aECM substrate. Whereas DC cultured on aECM containing HA derivates
do not mature and remain in their immature steady state phenotype, DC cultured on CS based aECM
show signs of activation. Up-regulation of co-stimulatory molecules, reduced phagocytic ability and
release of cytokines clearly indicate the maturation of these DC. However, the matured DC are not
capable to stimulate T cell proliferation. Our findings suggest the induction of a regulatory DC phe-
notype by aECM composed of collagen and CS derivates which is substantiated by the detected pro-
duction of IL-10 by these DC.
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Microbiome and corresponding cutaneous defense response in chronic diabetic wounds
EA Grice,1 ES Snitkin,1 LJ Yockey,1 DM Bermudez,2 KW Liechty3 and JA Segre1 1 Genetics and
Molecular Biology Branch, NIH/NHGRI, Bethesda, MD, 2 Department of Surgery, University
of Pennsylvania, Philadelphia, PA and 3 Department of Surgery, University of Mississippi
Medical Center, Jackson, MS
The skin is not only the first line of defense to the external environment, but is also host to myriad
microbes (the “microbiome”). When the skin barrier is breached, the immune response must be
carefully calibrated to rapidly defend against microbial invasion and infection yet control poten-
tially damaging inflammation. Chronic and slow-healing skin wounds, especially prevalent in dia-
betic and elderly populations, are often characterized by excessive inflammation, microbial infec-
tion, and subsequent tissue necrosis and apoptosis. To elucidate the role of microbes and how their
products may influence the host cutaneous defense response in non-healing diabetic wounds, we
employ a diabetic model of impaired wound healing, the leptin receptor-deficient mouse, Lep-
rdb/db. By sequencing 16S ribosomal RNA genes to survey bacterial diversity, we previously deter-
mined that a longitudinal selective shift in skin and wound microbiota coincides with impaired heal-
ing in this model. We also demonstrated prolonged expression of cutaneous defense genes that
paralleled the shift in microbiota. Our current efforts are focused on the mechanism by which micro-
biota may cause impaired wound healing in Leprdb/db mice. Preliminary data indicates that decreased
bacterial diversity further impairs wound healing in our model. We are also examining how the
innate immune system modulates microbial colonization of wounds. Our long-term goal is to genet-
ically dissect the role of two intertwined components in impaired diabetic wound healing: the micro-
biome and the host innate immune response.
819
Hydrogels can reduce dermal temperatures and speed epithelialization of second degree
burns: Preliminary evaluations in a porcine model
SC Davis, J Gil, J Valdes and A Claro Dermatology & Cutaneous Surgery, University of Miami,
Miller School of Medicine, Miami, FL
Local cooling of a burn wound has been shown to increase the rate of healing. Hydrogel dressings
have been known to possess cooling properties. This study examines the effect of a novel hydrogel
dressing on burn wound temperature and rate of healing. A pilot study was conducted in four pigs.
Second-degree burns were created and randomly assigned to one of three treatment groups: 1)
untreated control, 2) hydrogel dressing [WaterJel, WaterJel Technologies], or 3) gauze [Surgical
Sponge, Dynarex Corporation]. Burns were treated within 1 minute of burn creation. After 90 min-
utes of treatment, the materials were removed and treated burns were then covered with a silver
dressing [Silverlon, Argentum Medical, LLC]. Burns were evaluated for healing at various time points
for epithelialization using a well established salt-split technique. In addition, a temperature probe
was used to assess papillary and reticular dermal temperatures. Burns treated with the hydrogel
dressing epithelized more rapidly than gauze and untreated wounds. On day 9 wounds treated
with the hydrogel dressing were 90% completely epithelialized as compared to 50% with gauze
treatment and 30% with untreated control. Complete epithelialization (100%) occurred four days
sooner than untreated controls. The hydrogel dressing also was able to reduce the papillary dermis
temperature by 4 degrees Fahrenheit. This study suggests that the hydrogel dressing we examined
was effective in increasing the re-epithelialization rate of second-degree burns. This increase in heal-
ing may be due to the hydrogel’s capacity to decrease the temperature of the dermis after burning
resulting in a reduction of burn progression. This is especially important since tissue necrosis in
burns can take 2-3 days to reach their deepest level. The ability of any material to diminish burn
progression would have significant clinical relevance.
821
Transregulation of α2 and α3 integrin expression by α6β4 integrin in migrating keratinocytes.
K Kligys, S Hopkinson and J Jones Cell and Molecular Biology, Northwestern University,
Chicago, IL
There is emerging evidence that α6β4 integrin, together with α3β1 and α2β1 integrins, regulate ker-
atinocyte migration during wound healing. To provide support for this notion, we generated human
keratinocytes exhibiting α6A integrin subunit deficiency using shRNA technology. Cells deficient
in α6 integrin expression fail to migrate directionally. Rather, they move in circular paths at a
slower rate than their normal keratinocyte counterparts. Interestingly, knockdown of α6 integrin is
accompanied by a decrease in surface expression of the α2, α3, β1, and β4 integrin subunits.
Moreover, the mRNA levels of the α2 integrin subunit are decreased in α6 integrin knockdown cells,
suggesting that α6 integrin, indirectly, regulates the transcription of the α2 integrin message. Con-
versely, α3, β1, and β4 integrin subunit mRNA levels are unaffected in the α6 knockdown cells,
implying that α6 integrin regulates the translation of these messages. Consistent with this hypothe-
sis, the phosphorylation state of the translational repressor protein 4E-binding protein (4E-BP1)
and, hence, its activity is decreased in keratinocytes exhibiting α6 integrin knockdown. Re-expres-
sion of the α6 integrin subunit leads to an increase in α3 and β4 integrin surface expression in the
α6 integrin-deficient keratinocytes. Interestingly, α2 integrin mRNA levels can be restored to that
of wild type cells by either induced expression of α6 integrin or α3 integrin in the α6 integrin-defi-
cient cells. Together our results suggest a sequential regulation of integrin expression in keratinocytes,
whereby α6β4 integrin regulates the translation of α3 integrin, which in turn, controls the tran-
scription of α2 integrin. Therefore, our data underscore the complexity of the integrin expression
profile required for the wound re-epithelialization process and indicate that α6 integrin is a key
translational and transcriptional modulator.
820
Characterization and quantification of wound-induced hair follicle neogenesis using in vivo
confocal scanning laser microscopy
C Fan,1 MA Luedtke,2 SM Prouty,3 M Burrows,4 N Kollias2 and G Cotsarelis4 1 School of
Biomedical Engineering, Science & Health Systems, Drexel University, Philadelphia, PA, 2
Consumer and Personal Products Worldwide, Johnson & Johnson, Skillman, NJ, 3 Follica, Inc,
Philadelphia, PA and 4 School of Medicine, University of Pennsylvania, Philadelphia, PA
In vivo confocal scanning laser microscopy (CSLM) is a recently-developed non-invasive technique
for visualizing microscopic structures within the skin. CSLM has been used to characterize several
skin diseases. In this study, we assessed the ability of CSLM to evaluate the formation of neogenic
hair follicles after a full thickness wound in mice. Full-thickness wounds were made on the dorsal
skin of 3-week old mice. After scab detachment, the number, width, length, space and volume of
neogenic hair follicles were analyzed using CSLM. The results were compared with those from
conventional methods, including staining for alkaline phosphatase (AP) and keratin 17 (K17) as well
as histology. We found that quantification of neogenic hair follicles using CSLM compared favor-
ably with results from direct measurements on isolated epidermal tissue after immunostaining for
K17, a marker for the epithelial portion of new hair follicles. CSLM detected 89% of K17-stained
follicles. CSLM more accurately quantitated the number of new follicles compared to AP staining,
which detects the dermal portion of the new follicle. The width and length measurement from CSLM
and histology were very close and correlated with each other. The minimum length of a neogenic
hair follicle that could be detected by CSLM was 21 μm. Measurements of spaces between neogenic
hair follicles using CSLM was more accurate than histological method, which caused shrinkage dur-
ing fixation. In conclusion, CSLM is an accurate and valuable method for counting and measuring
neogenic hair follicles non-invasively. In vivo visualization of developing follicles with CSLM per-
mits detection of serial changes in hair follicle formation, thus conserving numbers of mice required
for studies and improving detection of temporal changes in developing hair follicles.
818
Burn injury induces early erythrocyte occlusion of surrounding cutaneous microvasculature
prior to delayed microthrombus formation.
W Zhou,1 DA Hirth,1 MG Tonnesen,1,4 SA McClain,2 AJ Singer2 and RA Clark3,1 1 Dermatology,
Stony Brook Univ, Stony Brook, NY, 2 Emergency Medicine, Stony Brook Univ, Stony Brook,
NY, 3 Biomedical Engineering, Stony Brook Univ, Stony Brook, NY and 4 Medicine, VAMC,
Northport, NY
Progression of burn injury, with resultant scars and contractures, is a well-known, poorly delin-
eated phenomenon with no preventive therapy. This dynamic injury may progress due to compro-
mised blood supply. Blood vessel (BV) occlusion has long been noted in burns, but the cause debated.
Studies prior to 1975 on porcine models identified occlusions as densely packed erythrocytes (RBCs);
recent studies on rodent models attributed occlusion to thrombosis. Our previous analysis of fib-
rinogen in a porcine hot comb model of horizontal burn injury progression suggested that occlu-
sion by RBCs predominated early in the superficial vascular plexus (SVP), while thrombosis pre-
dominated later in the deep vascular plexus (DVP). To extend our study, full thickness 8mm skin
biopsies from interspaces between adjacent porcine burns at 1, 4, 24, and 48 hrs post injury were
probed for CD31, to delineate platelets and endothelial cells, and compared with previous fib-
rinogen staining. Hematoxylin stain revealed clumped, anuclear, small biconcave cells, consistent
with RBCs, in occluded SVP and DVP BVs at 4 and 24 hrs. CD31 outlined endothelium in SVP and
DVP at 1, 4, 24, and 48 hrs. CD31 staining of BV occlusions was minimal in DVP at 1 and 4 hrs,
moderate at 24 hrs, significant at 48 hrs. Fibrinogen/fibrin lined DVP lumens at 24 hrs but did not
occlude DVP BV until 48 hrs. Thus CD31 staining confirmed our previous fibrinogen results: RBC
aggregation predominated early (4 to 24 hrs) in the SVP, while fibrin-platelet thrombosis predomi-
nated later in the DVP causing significant occlusion by 48 hrs. The initial predominance of RBC
occlusion rather than thrombosis might explain historical ineffectiveness of anticoagulants to pre-
vent burn injury progression. We propose that early administration of cutaneous vasodilators might
reduce morbidity/mortality of burn injury.
822
The collagen XVII-binding protein actinin-4 regulates the directed migration of keratinocytes
KJ Hamill,1 O Skalli2 and JC Jones1 1 Cell and Molecular Biology, Northwestern University,
Chicago, IL and 2 University of Memphis, Memphis, TN
Our focus is to identify the molecules involved in determining the directed migration of keratinocytes,
an essential component of wound healing of the skin. To this end we recently presented evidence
that, in addition to their established location and role in hemidesmosomes, the bullous pemphigoid
antigens, BPAG1e and collagen XVII (Col XVII, BPAG2) regulate the migratory behavior and polar-
ity of motile keratinocytes. Both BPAG1e and Col XVII are found in the leading lamellipodia of
migrating skin cells, where they spatially interact with the actin cytoskeleton. However, neither
protein directly binds actin. Previous studies revealed that Col XVII possesses a site via which it can
interact with members of the actinin family of actin-binding proteins. Moreover, one actinin fam-
ily member, namely actinin-4, exhibits co-localization with Col XVII within the lamellipodia of
motile keratinoyctes. Thus, to begin to address whether actinin-4 is involved in regulating the migra-
tory behavior of keratinocytes, we induced actinin-4 knockdown in keratinocytes using lentiviral
delivery of shRNA. Skin cells exhibiting actinin-4 knockdown display a failure to migrate in a pro-
cessive manner in single cell motility assays although their overall migration rate is unaltered. This
phenotype mirrors that of BPAG1e and Col XVII-deficient keratinocytes. However, in contrast to
the latter cells, actinin-4-knockdown keratinocytes display numerous, large lamellipodia-like cell
surface extensions which demonstrate reduced dynamics as determined by kymographic analyses.
Intriguingly, confocal immunofluorescence analyses indicate that actinin-4 deficiency induces a
clustering of hemidesmosomal proteins in these large lamellipodial extensions. Together, our data
indicate that actinin-4 is required for the directed migration of skin cells through regulating the local-
ization of hemidesmosome components in the lamellipodia of actively migrating keratinocytes.
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Induced pluripotent stem cells from individuals with Lamellar Ichthyosis
J Teng,1 E McMillan,1 T Kawahara,1 A Martinsen,1 G Chen,3 J Thomson,4 V Setaluri1 and S Palecek2
1 Dept of Dermatology, University of Wisconsin Madison, Madison, WI, 2 College of
Engineering, University of Wisconsin Madison, Madison, WI, 3 Wisconsin Genome Center,
University of Wisconsin Madison, Madison, WI and 4 Morgridge Institute for Research,
University of Wisconsin Madison, Madison, WI
Lamellar ichthyosis (LI) is an autosomal recessive skin disorder with extensive scaling and hyperk-
eratosis caused by mutations in genes encoding cell envelop proteins. It is a severe form of con-
genital ichthyosis that not only results in disfiguring, but also complications such as electrolyte imbal-
ance, recurrent infections, and mal-nutrition from high epithelium turn over. The ophthalmologic
complications can also be extremely challenging. The enzyme that is most commonly affected in
LI is transglutaminase 1 (TG1). To date, there are no effective forms of therapy. The discovery of
human induced-pluripotent stem cells (iPSCs) provides a unique opportunity to study stem cell dif-
ferentiation and a revolutionary approach to create human models of diseases that can be studied
in tissue cultures. To establish a foundation for therapies using gene-corrected, patient-specific cell
transfer, we have generated iPSCs from subjects with confirmed diagnosis of LI (LI iPS) or carrying
a single allele mutation of TG1 (T2391C). We found that TG1 was not required for stem cell renewal
and that iPSCs derived from either LI patient or carrier control could be differentiated into ker-
atinocyte lineages following similar time course as wild-type iPS line, IMR90. The percentage of
K14+P63+ keratinocyte progenitors derived from IMR90 and LI iPS are also comparable following
two weeks of differentiation in vitro. Differentiated IMR90 and LI iPS cells were able to form organ-
otypic structures resembling epidermis derived from primary keratinocytes. These data identify the
potential of disease-specific iPSCs to generate gene-corrected autologous skin progenitors that could
offer new perspectives to our current therapeutic approaches and hopes to patients.
812
Prominent role of resident endothelial progenitors in skin wound angiogenesis
EJ Seppanen, M Rodero and K Khosrotehrani Centre for Clinical Research, University of
Queensland, Brisbane, QLD, Australia
Vessel formation in the granulation tissue is essential for skin wound healing. Although many stud-
ies have investigated factors that modify angiogenesis, the endothelial cells in this process have not
been clearly defined, especially within affected tissues. In particular, the respective role of resident
and bone marrow derived endothelial progenitors is not clear. We sought to quantitatively assess
endothelial populations in wounds, blood and bone marrow over time to determine hierarchy and
origin of the cells participating in wound angiogenesis. Excisional wounds were generated on
C57BL/6 mice and collected daily from day 1 to 5 after wounding. All tissues were analysed using
5-colour flow cytometry for CD45, CD11b, CD34, CD31 and VEGFR2. Unbiased analyses were
performed to establish hierarchy. Absolute number modifications in each compartment (wound,
blood, bone marrow) was calculated and considered for potential exchange between compartments.
Here, we propose a cell population defined as CD34+CD45loCD31loVEGFR2lo that exists as an
omnipresent endothelial progenitor cell (EPC). In skin wounds these putative EPCs proliferated
from day 1 and exhibited peak expansion on day 4 of healing. Within this expanded pool, a pop-
ulation of CD34+CD45loCD31hiVEGFR2hi cells appeared from day 2 and increased 3 fold in
absolute number between day 4 and 5 post wounding, suggesting terminal differentiation of pro-
genitors. The contribution of EPC or terminally differentiated cells from bone marrow or the circu-
lating blood was quantitatively small and occurred later than this initial local response. We pro-
pose that putative EPCs exist in local rather than distant pools and proliferate to give rise to the
neovascularisation. These data challenge the current paradigm for EPC recruitment during wound
healing and could have far reaching implications for developing more successful targeted cell ther-
apies to use in chronic wounds.
813
Maintenance of the epidermal progenitor state requires the long non-coding RNA Linc8D
C Lee, M Kretz, D Webster, R Flockhart, K Qu, A Mah, C Aros, H Chang, J Rinn and P Khavari
Veterans Affairs Palo Alto Healthcare System and Stanford University, Palo Alto, CA
Epidermal progenitors must sustain proliferation while suppressing exit into the terminal differenti-
ation pathway, however, the mechanism by which such genome-wide effects are sustained is not
fully understood. The human genome encodes >5,000 conserved large intergenic noncoding
(linc)RNAs with presumed biological functions that are not fully characterized yet represent candi-
date regulators of this process. A custom genomic tiling array for lincRNAs designed using bioin-
formatic filtering of chromatin domains was used to screen for actively transcribed but non-protein
coding genes and identified a new lincRNA on chromosome 8p12 (linc8D). We also identified
linc8D in a separate screen as up-regulated in a series of 5 primary human squamous cell carci-
nomas (SCC) compared to patient-matched, normal adjacent skin. Linc8D is strongly down-regu-
lated during epidermal differentiation, suggesting it may have a role in the undifferentiated cell state.
To test this possibility directly, we undertook loss-of-function experiments in both cultured primary
epidermal keratinocytes in vitro and in regenerated human organotypic tissue. Consistent with a
role for linc8D in preventing differentiation, linc8D depletion via multiple independent RNA-inter-
ference sequences induced differentiation in both settings. Efforts are underway to characterize
linc8D target genes and binding proteins as well as to study the effect of altering linc8D expression
in epidermal neoplasia. Linc8D represents the first long noncoding RNA identified to date that is
required to suppress differentiation and maintain the progenitor compartment in epidermis.
814
Epidermal IGF-1 receptor is important in the maintenance of bulge stem cell and their response
to skin wounds
E Roy,1 F Linay,2 M Holzenberger,2 M Oster,2 S Aractingi2 and K Khosrotehrani1 1 Centre for
Clinical Research, University of Queensland, Herston, QLD, Australia and 2 INSERM U 938,
UPMC Univ Paris 6, Paris, France
IGF-1 and its receptor are key regulators of growth, differentiation and metabolism. IGF-1 sig-
nalling is essential in epidermal development and interacts with the rho-GTPase Rac to maintain
the interfollicular epidermis (IFE). However its role in adult homeostasis of bulge stem cells and their
contribution to skin wound is unclear. To address this question, we used Keratin 14 and Keratin 15
driven conditional deletion of the IGF1 receptor (IGF1R) to abrogate IGF-1 signalling in the epi-
dermis and more specifically in the bulge stem cells in an inducible manner in adult mice. In
steady state, we did not observe any major histological changes in young mice (5 weeks old) and
aged mice (6 months old). Detailed quantitative analyses of epidermal subpopulations based on
CD34 and alpha-6 integrin staining using flow cytometry, revealed a significant reduction of IFE epi-
dermal cells in K14 driven deletion as opposed to an outer rout sheath (ORS) reduction in K15 driven
deletion suggesting the importance of IGF1 signalling in the maintenance of each compartment. In
both situations there was a reduction in the proportion of CD34 high bulge stem cells. To further
analyse the contribution of these different compartments to skin wound re-epidermisation, we per-
formed 6mm excisional wounds in young and aged mice. K14 driven IGF1R deletion resulted in
significant delay in wound closure at any age. In mice with IGF1R deficiency in bulge cells, wound
healing was normal in young animals but was significantly delayed at older age. In conclusion, our
results show the importance of IGF-1 signalling in adult skin homeostasis after the completion of
developmental processes of stratification and hair follicle formation. This pathway significantly
affected epidermal stem cell maintenance and activity both in the hair follicle bulge and presum-
ably in the IFE. In particular, our results show the reduced capacity of bulge stem cells deficient in
IGF1R to contribute to skin wound healing over time.
815
Dihydrodehydrodiisoeugenol (DDE) enhances adipocyte differentiation and decreases lipol-
ysis in murine and human cells
K Nehrenheim,1 I Meyer,2 J Krutmann1 and S Grether-Beck1 1 IUF-Leibniz Research Institute for
Environmental Medicine, Duesseldorf, Germany and 2 Symrise GmbH & Co KGAG,
Holzminden, Germany
During chronological aging, subcutaneous fat depots decrease while visceral fat depots increase.
Starting in the face, subcutaneous adipose tissue decreases resulting in facial lipoatrophy, probably
because (i) the preadipocytes in the subcutaneous fat tissue of the skin lose the capacity to differ-
entiate, (ii) TNF-α is secreted in elevated levels by adipocytes of elderly with diverse effects on the
fat storage capacity of adipose tissue by a) enhancing lipolysis, b) inhibiting the differentiation of
preadipocytes to adipocytes and c) maintaining the dedifferentiation of adipocytes. Accordingly, a
battery of compounds has been assessed for the endpoints (i) lipid accumulation and (ii) basal or
TNF-α induced lipolysis in a murine and a human cell culture system. In addition, induction of the
differentiation process was controlled for upregulation via measurement of specific transcription
factors such as PPARγ2 and C/EBPα, fatty acid binding protein 4 (FABP4), and adiponectin, and for
down-regulation via measurement of the preadipocyte marker pref1 using real time PCR. In the
murine system, the synthetic compound dihydrodehydrodiisoeugenol (DDE) resulted in a 30%
increase of lipid accumulation and was accompanied by an induction of the differentiation asso-
ciated markers mentioned above. In addition, DDE was able to diminish basal as well as TNF-α
induced lipolysis in a dose-dependent manner. In primary human subcutaneous preadipocytes using
an age-adopted hormone mix with reduced levels of insulin and dexamethasone, DDE was able to
significantly increase lipid accumulation above controls. In addition, DDE also induced upregula-
tion of PPARγ2 and adiponectin mRNA. Finally, the compound was able to inhibit basal lipolysis
in mature human subcutaneous adipocytes. Taken together, these studies indicate that DDE is well
suited to overcome age-associated lipoatrophy by a dual mode of action: (i) induction of adipocyte
differentiation and (ii) inhibition of lipolysis.
816
Induction of regulatory dendritic cells by artificial extracellular matrices used as coatings for
biomaterials
S Franz,1 I Forstreuter,1 V Hintze,2 S Möller,3 D Scharnweber,2 M Schnabelrauch3 and JC Simon1 1
Clinic for Dermatology, Venerology und Allergology, University Leipzig, Leipzig, Germany, 2
Max Bergmann Center for Biomaterials, Technical University Dresden, Dresden, Germany and
3 Biomaterials Department, INNOVENT e.V, Jena, Germany
Functionalization of biomaterials has evolved as a promising strategy to avoid detrimental immune
responses to biomaterial implants improving implant integration and performance. Here we address
the “immunomodulating” effects of artificial extracellular matrices (aECM) that are used as coatings
for biomaterials. Dendritic cells (DC) are key regulators of innate and adaptive immunity. They are
capable to downregulate immune responses. Since DC take an important part in biomaterial heal-
ing and integration we assessed DC responses resulting from interactions with different aECM. Arti-
ficial extracellular matrices are generated utilizing the natural self-assembly potential of collagen
type I in combination with either hyaluronic acid (HA) or chondroitin sulphate (CS) or specifically
sulfated derivates of both. Monocyte-derived immature DC are cultured on the aECM for 24h.
Induced DC phenotypes are determined by analyzing expression of DC maturation markers, cytokine
profile and allostimulatory ability in a mixed lymphocyte reaction. We find different DC responses
depending on the underlying aECM substrate. Whereas DC cultured on aECM containing HA derivates
do not mature and remain in their immature steady state phenotype, DC cultured on CS based aECM
show signs of activation. Up-regulation of co-stimulatory molecules, reduced phagocytic ability and
release of cytokines clearly indicate the maturation of these DC. However, the matured DC are not
capable to stimulate T cell proliferation. Our findings suggest the induction of a regulatory DC phe-
notype by aECM composed of collagen and CS derivates which is substantiated by the detected pro-
duction of IL-10 by these DC.
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A Rho-kinase inhibitor promotes cutaneous wound-healing by enhancing keratinocyte growth
and migration in a JNK-dependent manner
V Gandham,1 M Rupa,2 V Rao,2 J Jin,1 D Epstein,2 R Hall1 and J Zhang1 1 Dermatology, Duke
University, Durham, NC and 2 Ophthalmology, Duke University, Durham, NC
Skin wound healing is an intricate process orchestrated by multiple cell types, including keratinocytes,
dermal fibroblasts and immune cells. Here, we demonstrate that the Rho-kinase inhibitor Y27632
promoted human keratinocyte cell proliferation and wound-closure in monolayer cell culture. This
effect appeared to be specific to normal keratinocyte as Y27632 induced a slower rate of cell growth
and migration of both dermal fibroblast and A431, a squamous carcinoma cell line. We also found
that Y27632 dramatically increased keratinocyte out-growth from human skin explants in culture.
Cells grown from skin explants in the presence of this reagent exhibited a small and shiny cell mor-
phology over a prolonged period of time, as compared to enlarged and dark-phased morphology
of the control cells. The treated cells expressed normal levels of cytokeratin 6 and 14. At a molec-
ular level, Y27632 reduced Rho-kinase activity as indicated by the decreased levels of phosphory-
lated myosin light chain regulatory protein (p-RLP). Because JNK/AP1 signaling pathway has been
associated with epithelial migration and wound-healing in various tissue models, we examined the
status of JNK activity following Y27632-treatment. We found that JNK activation was induced while
that of Erk was reduced by Y27632 as indicted by the increased and decreased levels of pJNK and
pErk, respectively. Consistently, pharmacological JNK inhibition abolished the growth and migra-
tion effects of Y27632 on keratinocytes. Our findings to date indicate that Rho-kinase inhibition with
Y27632 promotes wound-closure by promoting cell growth and migration in a keratinocyte-spe-
cific and JNK-dependent manner. Currently, we are in the process of analyzing the in vivo effects
of Y27632 on cutaneous wound-healing in mice.
831
The potential of a jasmonic acid derivative: A new anti ageing molecule
J Michelet,1 D Fagot,1 C Olive,1 E Rieux,1 A Minondo,2 Y Mahe,3 C Tacheau,3 A Colonna2 and
B Bernard3 1 L’OREAL, Research & Innovation, Department of Life Sciences, Aulnay sous Bois,
France, 2 L’OREAL, Research & Innovation, Department of Material Sciences, Aulnay sous
Bois, France and 3 L’OREAL, Research & Innovation, Department of Life Sciences, Clichy,
France
Ageing is a time–dependant biological process causing gradual and durable changes in all skin com-
partments. The decrease in basal keratinocyte proliferation leads to loss of epidermal thickness and
reduction of its renewal potential. An increase of matrix protein proteolysis combined with the
decrease in the number of fibroblasts is seen with ageing and generally leads to skin thinning and
impaired macromolecular proteins organization both in the dermis and dermal epidermal junction
(DEJ). Using REALSkin (a full thickness skin containing a dermis and epidermis) model, this study
demonstrates that a jasmonic acid derivative (JD) (3-hydroxy-2-pentylcyclopentyl)-acetic acid) stim-
ulates the induction of hyaluronasome signaling in the epidermis with beneficial effect on DEJ. An
Electron microscopy approach using ruthenium hexammine trichloride staining procedure reveals
an enhanced electron-density of the outer plasmalemmal surface, showing that upon JD treatment,
hyaluronan and proteoglycans’ network formation is stimulated. This response is thought to be
responsible for an improvement of epidermis/DEJ integrity since 10 μM JD induced laminin 332,
Collagen IV and VII in the DEJ. These in vitro results strongly argue for an anti-ageing potential of
jasmonic acid derivatives in cosmetic skin applications.
833
Germinative epithelium signature of the human hair follicle
CA Higgins,1 K Inoue,1 CA Jahoda2 and AM Christiano1,3 1 Dermatology, Columbia, New York,
NY, 2 Biological and Biomedical Sciences, Durham, Durham, United Kingdom and 3 Genetics
and Development, Columbia, New York, NY
Skin appendages, such as hair follicles are unique as they spend their lifetime growing and regress-
ing before regenerating again. This regeneration and subsequent growth occurs as a result of mes-
enchymal and epithelial interactions. At the base of the mature follicle resides the dermal papilla
(DP), a mesenchymal stem cell niche which is in direct contact with a specialized subpopulation
of cells termed the germinative epithelium (GE). A fundamental role for the DP has been demon-
strated in the regeneration/growth process, but when the DP is removed from its microenviron-
ment, and the cells are propagated in culture they gradually lose their ability to instruct hair growth.
We have previously shown that when non-inductive DP cells are grown with cells isolated from the
GE of the rodent hair follicle, their inductive ability is restored. Therefore, we hypothesized that the
cells of the GE create an instructive microenvironment for the DP. To characterize these cells within
the human hair follicle, we performed laser capture microdissection on human hair follicles taken
from the occipital scalp skin of 3 male donors and isolated RNA from GE cells, matrix cells, and
interfollicular epidermal cells. We generated biotin labeled cRNA and hybridized it to Hu133 Plus
2.0 affymetrix genechips. Using Genespring, we were able to determine significantly and differen-
tially regulated transcripts between each discrete epithelial population. This enabled us to identify
86 genes that were unique to the GE signature, including Id4 which we previously localized to
rodent GE cells. We are using semi-quantitative RT-PCR and immunofluorescence to validate the
expression of several transcripts. Interestingly, a significant number of genes were associated with
the extracellular matrix, or receptor-ECM interactions that may likely play a role in regulation of the
DP microenvironment. We are currently investigating the implications of the extracellular matrix
signals in DP maintenance.
832
Human keratinocytes have an immediate, autonomous response to injury that upregulates
protective and immune-enhancing gene expression
MK Crispin, E Billick, H Mitsui, H Fujita, M Suárez-Fariñas and JG Krueger Laboratory for
Investigative Dermatology, The Rockefeller University, New York, NY
Keratinocytes can synthesize inflammatory products in some conditions, such as cell culture or in
chronic immune-related diseases, but the autonomous, immediate response of uncultured ker-
atinocytes to injury is not known. This study aims to define the immediate alterations in protective
and inflammatory gene expression that occur in keratinocytes, independent from dermally-derived
signals. In prior wound healing studies, the dermis and epidermis were mechanically separated
and the specimens inevitably included residual dermal tissue. This study addressed this problem by
using dispase-separated epidermis and an 18-hour short-term culture as a model for cell injury.
Dispase digestion ensured complete removal of the dermis. We created a single-cell suspension of
the epidermal cells and removed melanocytes and Langerhans cells by fluorescence-activated cell
sorting (FACS) to obtain a pure population of keratinocytes. For a comparative model of uninjured
epidermis, we performed laser capture microdissection (LCM) on normal human skin. RNA was
extracted, quantified using RT-PCR, amplified by two-cycle cDNA synthesis, fragmented, and
hybridized to Human Genome U133 Plus 2.0 arrays. Microarray data was validated by quantita-
tive RT-PCR. Our results revealed an early burst of upregulated expression of IL1A (18-fold), IL8
(2000-fold), IL20 (22-fold), IL24 (30-fold), CXCL1 (59-fold), PI3 (35-fold), S100A7 (57-fold), S100A8
(129-fold), S100A9 (187-fold), LCN2 (40-fold), and RNASE7 (47-fold). In prior wound healing stud-
ies, these genes were shown to be downstream of EGFR activation. We also found upregulated
expression of EGFR ligands AREG (430-fold), HBEGF (341-fold), NRG1, and TGFA; the MMPs (1,
3 and 9) that shed these growth factors from the surface of the keratinocyte; and STAT3 (51-fold).
Thus, keratinocytes have the ability to initiate autonomously a high-level, protective immune response
to injury.
830
Elastin is essential for vascular development – A zebrafish model
Q Li,1 A Donahue,1 H Choi2 and J Uitto1 1 Jefferson Medical College, Philadelphia, PA and 2
School of Medicine, Ewha Woman’s University, Seoul, Democratic People’s Republic of Korea
Elastic fibers, consisting of elastin and the microfibrillar component, are responsible for tissue exten-
sibility and recoil in blood vessels, lung and skin. The specific role of elastin in contributing to these
properties is largely unknown, and information on elastin gene sequences and their developmen-
tal expression is limited to mammalian and avian species. In this study, we identified two tropoe-
lastin genes, elna and elnb, in zebrafish, a fresh water vertebrate. Although the homology of tropoe-
lastins across species at the primary sequence level is relatively low, the characteristic motifs of the
primary structure is preserved, consisting of hydrophobic domains alternating with crosslinking
domains. RT-PCR and in situ hybridization demonstrated that both zebrafish genes were expressed
and the corresponding proteins were deposited in blood vessels and the heart. 5’-UTR and splice
site morpholinos were designed to prevent translation of the elna and processing of pre-mRNA of
the elnb gene, respectively. A transgenic fish (vegfr2:g-rcfp) strain expressing green fluorescent pro-
tein in the vascular endothelial cells was used for morpholino targeting. Injection of morpholinos
into 1-4 cell stage embryos was performed, followed by morphologic observations of the pheno-
type of the blood vessels and assay of the mRNA target-gene expression. The elna morpholino
decreased the corresponding gene expression by >90% in the morphant fish, and development of
primary intersegmental vessel sprouts, critical features of angiogenesis, was disrupted. As a conse-
quence of the perturbed vascular development, the heartbeat and blood flow were reduced. Con-
versely, the elnb morpholino decreased the corresponding gene expression by 100%, but the inter-
segmental vessels of the morphant fish remained largely intact with no alterations in the cardiovascular
function. These results suggest that elna is an essential gene for normal zebrafish vascular develop-
ment and provide novel insight into the function of elastin in vertebrates.
834
Cutaneous antimicrobial barrier function is diminished in burn wounds following psycho-
logical stress
JK Plichta, S Droho, RL Gamelli and KA Radek Department of Surgery, Burn & Shock Trauma
Institute, Maywood, IL
Burn injured patients are highly susceptible to skin infection and graft rejection due to, in part, dimin-
ished skin barrier function. Neuroendocrine mediators released during stress negatively influence
skin barrier function by increasing epidermal permeability and reducing antimicrobial peptide (AMP)
production. Here, we sought to determine whether psychological stress (PS) prior to burn injury
impairs the local AMP and distal physical barrier response to injury. Male C57Bl/6 mice were exposed
to normal conditions or PS (i.e. chronic light, crowding, and radio static) for 72 hours, and then
subjected to a 15% scald burn injury or sham (immersion in 93°C or 22°C water, respectively). Skin
distal to the burn site underwent barrier disruption via tape stripping to assess barrier function and
recovery by transepidermal water loss (TEWL) and pH analysis, where a higher TEWL and pH after
tape stripping indicates an intact response to barrier disruption. Distal skin in burned mice failed
to respond to barrier disruption after 24 hours compared to sham mice as indicated by a lower
change in TEWL (sham 7±22% vs burn -28±9%, p<0.05) and higher in pH (6±7% vs 16±7%). This
effect in burn wounds was further exacerbated by PS (TEWL: unstressed -28±9% vs stressed -34±10%;
pH: 16±7% vs 2±4%, p<0.05). We further assessed the abundance and localization of β-defensin,
a major skin AMP, and Kallikrein 5 (KLK5), an epidermal proteolytic enzyme. β-defensin expres-
sion was reduced and differentially expressed within the epidermis in burn wounds from PS mice
compared to unstressed mice by immunohistochemistry. We also observed a robust increase in the
expression of KLK5 in burn wounds and in the surrounding tissue in PS mice compared to unstressed.
In summary, PS prior to scald burn injury acts as a double edged sword to compromise both the
local antimicrobial barrier and the distal barrier integrity. This provides a new perspective to explain
the high incidence of wound infection and graft failure in burn patients, particularly those sub-
jected to PS prior to injury.
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Natural products for epidermal barrier repair
B Rehal, R Sivamani and R Isseroff Dermatology, University of California, Davis, Sacramento,
CA
Natural products are often the source of development for medical therapies. In dermatology, natu-
ral products are used for antioxidant therapy, cosmetics, and skin barrier repair. Botanicals have
been used for wound care in Ayurvedic (traditional Indian) medicine for centuries, and many nat-
urally derived products are currently available over the counter. However, limited evidence-based
evaluation has been conducted for herbs in wound healing. Here we create a comparative data-
base of different botanicals in wound healing, using keratinocyte migration as an in vitro surrogate
for skin wound healing Herbs that have been used either anecdotally or in animal studies for
wound healing were chosen for analysis. The herbs were tested for contamination with bacteria,
yeast and mold and then extracted into liquid form. The herbs were extracted by heating the pow-
der or dried leaf formulations in deionized water to 80°F for thirty minutes. And finally, they were
sterile filtered. Normal human foreskin derived keratinocytes were treated with a range of doses
from 0-50% of herbal extract in media and their cell migration speeds were measured. Of the six
herbs tested, echinacea, turmeric and ginger increased cell migration by seventeen, fourteen and
thirty-five percent, respectively. This was statistically significant with a p-value of less than 0.05.
Interestingly, other herbs previously thought to improve healing— comfrey, aloe vera and gotu
kola, all decreased cell migration by sixteen, nineteen and fifteen percent, respectively, with a p-
value of less than 0.05. These studies show that keratinocyte migration can be used as a high through-
put screening assay for herbal substances and their ability to impact on healing. Ongoing studies
will evaluate the ability of the herbal extracts to modulate transepidermal water loss and skin con-
ductance. Our ultimate goal is to identify herbs that are both safe and efficacious for use in enhanc-
ing human skin repair.
824
Evidence for the existence of phenotypically distinct progenitors in epidermis
A Charruyer,1 LR Strachan,1 S Fong,1 L Yue,1 M Abdul,1 ML Mancianti3 and R Ghadially1,2 1
Dermatology, UCSF, San Francisco, CA, 2 Dermatology, VAMC, San Francisco, CA and 3
Pathology, Alta Bates Medical Center, Berkeley, CA
Epidermis is thought to be maintained by a hierarchy of progenitors, in which the epidermal stem
cell (EpiSC) divides to give rise to a daughter stem cell and a daughter transit amplifying cell (TAC),
which terminally differentiates after several cell divisions. Recently, however, some observations
indicate that only a single type of progenitor maintains normal epidermis. We addressed the possi-
ble existence of phenotypically distinct progenitor populations in both human and murine epider-
mis using short-term repopulation (STR) vs. long-term repopulation (LTR) in a quantitative trans-
plantation assay in vivo and clonogenic behavior in vitro. Putative EpiSCs and TACs were isolated
by FACS and injected into NOD/SCID mice. The epidermis produced was analyzed short-term (1
wk) and long-term (9 wks). Putative murine EpiSCs were isolated using CD133+ and putative human
EpiSCs using CD44+ALDH+ and integrin α6hiCD71lo. In murine epidermis, CD133+ keratinocytes
were enriched for LTR cells but lacked STR ability in vitro and in vivo, while CD133- keratinocytes
were depleted of LTR cells but showed STR ability in vitro and in vivo. These results suggest the
existence of phenotypically distinct progenitor populations in murine epidermis based on CD133
expression. In human epidermis, CD44+ALDH+ keratinocytes were enriched for LTR cells, but also
showed STR ability both in vitro and in vivo, in both KGM and embryonic stem cell media. Thus,
the CD44+ALDH+ population contains both LTR and STR progenitors. Integrin α6hiCD71lo ker-
atinocytes were enriched for LTR cells and showed STR ability in vitro in KGM (STR) but not in
embryonic stem cell media, suggesting that while both CD44+ALDH+ and α6hiCD71lo keratinocytes
contain LTR cells the CD44+ALDH+ population additionally contains a more primitive progenitor
capable of growth in embryonic stem cell medium. In conclusion, these results provide evidence
for phenotypically distinct groups of progenitors with different behaviors both in vivo and in vitro.
825
Drug allergy in hematopoietic stem cell transplantation
J Gordon,1 A Haryani,1 R Alfred,3 J Mehta2 and J Cotliar1 1 Dermatology, Northwestern
University, Chicago, IL, 2 Hematology/Oncology, Northwestern University, Chicago, IL and 3
Preventive Medicine, Northwestern University, Chicago, IL
There is a dearth of data on drug allergy and its effect on the post-transplant course of allogeneic
hematopoietic stem cell transplant (HSCT) patients. Reports suggest that recipients of HSCT can be
safely exposed to medications they were allergic to prior to transplant; however the interplay between
donor and recipient drug allergies and post-HSCT skin eruptions remains unknown. A retrospec-
tive chart review was performed on first-time allogeneic HSCT patients at Northwestern Medicine
in 2009. We assessed HSCT patients for exposure to medications that they or their donors were
known to be allergic to. Incidence and diagnosis of all skin eruptions early in the post-HSCT period
were also reviewed, including graft-versus-host disease (GVHD). We found 59 allogeneic HSCT
patients in 2009. Of these, 2 patients were exposed to medications that they were previously aller-
gic to, and both developed acute GVHD with skin involvement. One patient developed an erup-
tion on day +13 after HSCT, 3 days after starting piperacillin. The other patient developed a rash on
day +30, 31 days after starting vancomycin. There was 1 patient exposed to a medication the donor
was known to be allergic to(cefaclor). This patient developed urticaria on day +4, 3 days after start-
ing cefaclor; however, the patient did not develop GVHD. Despite reports of uneventful post-HSCT
exposures to medications previously known to cause allergies, we observed the development of
acute GVHD in 2/2 patients given medications that they were allergic to pre-HSCT. An urticarial
reaction was also observed in an HSCT recipient to a drug the donor was known to be allergic to;
suggesting donor allergies may also be important. Although acute GVHD is common after allo-
geneic HSCT, it is possible drug allergy may play a role in its development; larger studies are needed
to assess this concept. The potential of reversing drug allergy following allogeneic HSCT also needs
to be explored.
826
Bone marrow derived mesenchymal stem cells: Regenerative medicine for pseudoxanthoma
elasticum
Q Jiang, S Takahagi, B Reutemann, A Grand-Pierre, A Donahue and J Uitto Department of
Dermatology and Cutaneous Biology, Jefferson Medical College, Philadelphia, PA
Aberrant mineralization of peripheral connective tissues is a characteristic feature of pseudoxan-
thoma elasticum (PXE), a heritable metabolic disorder caused by mutations in the ABCC6 gene
which is primarily expressed in the liver. There is currently no effective treatment for PXE. In this
study, we characterized bone marrow derived mesenchymal stem cells (MSCs) and evaluated their
ability to contribute to liver regeneration, with the aim to rescue PXE phenotype. The marrow derived
stem cells were isolated from GFP-transgenic mice by magnetic cell sorting using a Lin- cocktail of
antibodies as well as stem cell antigen-1 (Sca-1) antibody for negative and positive selection, respec-
tively. Flow cytometric analyses of freshly isolated cells demonstrated the presence of two popula-
tions: (a) hematopoetic stem cells (HSCs), and (b) MSCs. A significant enrichment in MSCs was
gained during subsequent culturing of the cells, and the MSCs were shown to be MHC-1 positive
and have high potential for hepatic differentiation, with expression of Abcc6, in culture containing
hepatocyte growth factor and fibroblast growth factor. MSCs (0.5 x 106) at passage 4 were trans-
planted into the livers of 4-week old immunodeficient Abcc6-/- mice by intrasplenic injection one
day after partial hepatectomy, when peak expression of the stromal cell derived factor-1 (SDF-1) was
observed. On days 2 and 7 after engraftment, significant numbers of GFP-positive cells were noted
in the livers. Moreover, enhanced engraftment efficiency was observed with MSCs with high expres-
sion levels of the chemokine receptor CXCR4, a receptor for SDF-1. These data suggest that puri-
fied MSCs have the capability of differentiating into hepatic lineages and homing to the liver. The
interactions between SDF-1 and CXCR4 could be a critical mechanism to recruit MSCs for liver tar-
geting and regeneration. This therapeutic model provides the basis to investigate stem cell based
liver reconstitution as a means of regenerative treatment for PXE.
827
Laminin 332 expression and processing is altered in irradiated and wounded skin
A Lopez,1 EB Olasz,1 NE Duncan,1 A Schock,1 W Kittipongdaja,1 BL Fish,2 JE Moulder2 and
Z Lazarova1 1 Department of Dermatology, Medical College of Wisconsin, Milwaukee, WI and
2 Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI
Skin exposure to ionizing radiation affects the normal wound-healing process and has a great impact
on the prognosis of affected individuals. We investigated the effect of ionizing radiation on wound
healing. Six week old male WAG/RijCmcr rats (n=4 rats per time point) were irradiated with a sin-
gle 30 Gy dose of ionizing radiation with a steep dose gradient, wounded, and followed up to 30
days. Control rats were sham irradiated and wounded. Wound areas were measured and tissues
examined by quantitative RT-PCR, immunohistochemistry, and gelatin zymography at 3, 7, 14, and
30 days post-irradiation. Wound of non-irradiated animals underwent rapid wound closure within
14 days after wounding. In contrast, in irradiated animals, the unhealed area represented 60% of
the original wound size 30 days post-irradiation. RT-PCR revealed elevated expression of all laminin
332 genes within 7 days post-irradiation paralleled by elevated MMP 2 expression (cleavage enzyme
of rat γ2 subunit). Laminin 332 staining was significantly diminished in irradiated wound beds when
compared to controls (50±25 vs. 250±30 units per optical field; p<0.001). A quantitative immunoblot
analysis of laminin 332 deposition in irradiated cultured human keratinocytes revealed a dose-
dependent decreased synthesis of α3 (cell-associated 200 kD) and γ2 (processed105 kD) subunits.
Interestingly, incubation of normal or irradiated keratinocytes with metalloproteinase inhibitor (1,10-
phenanthroline) further decreased laminin 332 deposition. These data strongly suggest that laminin
332 synthesis and processing is negatively affected by ionizing radiation, which can be instrumen-
tal in delayed wound healing of irradiated skin.
828
Secreted Hsp90 carries two unique properties for effectiveness in skin wound healing that
are absent from conventional growth factor treatments
D Sahu, C Cheng, F Tsen, Y Kuang, J Fan, M Chen, D Woodley and W Li Dermatology and Norris
Comprehensive Cancer Center, University of Southern California, Los Angeles, CA
Chronic and non-healing wounds pose a health, economic and social problem worldwide. For
over two decades, the conventional wisdom pointed to growth factors as the driving force of skin
wound healing and, therefore, as the center for development of therapeutic treatments. However,
the only US FDA-approved growth factor therapy, Regranex gel (platelet-derived growth factor-
BB/PDGF-BB), has shown modest efficacy, high cost and higher risk of mortality secondary to malig-
nancy. This stem reality is surprising and the cause remains as a puzzle. We report here identifica-
tion of a novel 115-amino acid peptide (F-5) in heat shock protein 90-alpha (Hsp90α) protein secreted
by skin cells under various wound stress cues. F-5 equally promotes migration of both epidermal
and dermal cells through the universally expressed LRP-1 receptor and, more critically, overrides
the inhibition by TGFβ, present throughout wound healing. Topical application of F-5 enhances
wound closure three fold faster than Regranex. In contrast, Regranex only promotes dermal fibrob-
last migration and growth and is unable to overcome the inhibition of dermal cell migration by TGFβ
. Therefore, results of this study challenge the long-standing paradigm for developing wound-heal-
ing therapies and reveal a novel and more effective wound-healing agent.
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A Rho-kinase inhibitor promotes cutaneous wound-healing by enhancing keratinocyte growth
and migration in a JNK-dependent manner
V Gandham,1 M Rupa,2 V Rao,2 J Jin,1 D Epstein,2 R Hall1 and J Zhang1 1 Dermatology, Duke
University, Durham, NC and 2 Ophthalmology, Duke University, Durham, NC
Skin wound healing is an intricate process orchestrated by multiple cell types, including keratinocytes,
dermal fibroblasts and immune cells. Here, we demonstrate that the Rho-kinase inhibitor Y27632
promoted human keratinocyte cell proliferation and wound-closure in monolayer cell culture. This
effect appeared to be specific to normal keratinocyte as Y27632 induced a slower rate of cell growth
and migration of both dermal fibroblast and A431, a squamous carcinoma cell line. We also found
that Y27632 dramatically increased keratinocyte out-growth from human skin explants in culture.
Cells grown from skin explants in the presence of this reagent exhibited a small and shiny cell mor-
phology over a prolonged period of time, as compared to enlarged and dark-phased morphology
of the control cells. The treated cells expressed normal levels of cytokeratin 6 and 14. At a molec-
ular level, Y27632 reduced Rho-kinase activity as indicated by the decreased levels of phosphory-
lated myosin light chain regulatory protein (p-RLP). Because JNK/AP1 signaling pathway has been
associated with epithelial migration and wound-healing in various tissue models, we examined the
status of JNK activity following Y27632-treatment. We found that JNK activation was induced while
that of Erk was reduced by Y27632 as indicted by the increased and decreased levels of pJNK and
pErk, respectively. Consistently, pharmacological JNK inhibition abolished the growth and migra-
tion effects of Y27632 on keratinocytes. Our findings to date indicate that Rho-kinase inhibition with
Y27632 promotes wound-closure by promoting cell growth and migration in a keratinocyte-spe-
cific and JNK-dependent manner. Currently, we are in the process of analyzing the in vivo effects
of Y27632 on cutaneous wound-healing in mice.
831
The potential of a jasmonic acid derivative: A new anti ageing molecule
J Michelet,1 D Fagot,1 C Olive,1 E Rieux,1 A Minondo,2 Y Mahe,3 C Tacheau,3 A Colonna2 and
B Bernard3 1 L’OREAL, Research & Innovation, Department of Life Sciences, Aulnay sous Bois,
France, 2 L’OREAL, Research & Innovation, Department of Material Sciences, Aulnay sous
Bois, France and 3 L’OREAL, Research & Innovation, Department of Life Sciences, Clichy,
France
Ageing is a time–dependant biological process causing gradual and durable changes in all skin com-
partments. The decrease in basal keratinocyte proliferation leads to loss of epidermal thickness and
reduction of its renewal potential. An increase of matrix protein proteolysis combined with the
decrease in the number of fibroblasts is seen with ageing and generally leads to skin thinning and
impaired macromolecular proteins organization both in the dermis and dermal epidermal junction
(DEJ). Using REALSkin (a full thickness skin containing a dermis and epidermis) model, this study
demonstrates that a jasmonic acid derivative (JD) (3-hydroxy-2-pentylcyclopentyl)-acetic acid) stim-
ulates the induction of hyaluronasome signaling in the epidermis with beneficial effect on DEJ. An
Electron microscopy approach using ruthenium hexammine trichloride staining procedure reveals
an enhanced electron-density of the outer plasmalemmal surface, showing that upon JD treatment,
hyaluronan and proteoglycans’ network formation is stimulated. This response is thought to be
responsible for an improvement of epidermis/DEJ integrity since 10 μM JD induced laminin 332,
Collagen IV and VII in the DEJ. These in vitro results strongly argue for an anti-ageing potential of
jasmonic acid derivatives in cosmetic skin applications.
833
Germinative epithelium signature of the human hair follicle
CA Higgins,1 K Inoue,1 CA Jahoda2 and AM Christiano1,3 1 Dermatology, Columbia, New York,
NY, 2 Biological and Biomedical Sciences, Durham, Durham, United Kingdom and 3 Genetics
and Development, Columbia, New York, NY
Skin appendages, such as hair follicles are unique as they spend their lifetime growing and regress-
ing before regenerating again. This regeneration and subsequent growth occurs as a result of mes-
enchymal and epithelial interactions. At the base of the mature follicle resides the dermal papilla
(DP), a mesenchymal stem cell niche which is in direct contact with a specialized subpopulation
of cells termed the germinative epithelium (GE). A fundamental role for the DP has been demon-
strated in the regeneration/growth process, but when the DP is removed from its microenviron-
ment, and the cells are propagated in culture they gradually lose their ability to instruct hair growth.
We have previously shown that when non-inductive DP cells are grown with cells isolated from the
GE of the rodent hair follicle, their inductive ability is restored. Therefore, we hypothesized that the
cells of the GE create an instructive microenvironment for the DP. To characterize these cells within
the human hair follicle, we performed laser capture microdissection on human hair follicles taken
from the occipital scalp skin of 3 male donors and isolated RNA from GE cells, matrix cells, and
interfollicular epidermal cells. We generated biotin labeled cRNA and hybridized it to Hu133 Plus
2.0 affymetrix genechips. Using Genespring, we were able to determine significantly and differen-
tially regulated transcripts between each discrete epithelial population. This enabled us to identify
86 genes that were unique to the GE signature, including Id4 which we previously localized to
rodent GE cells. We are using semi-quantitative RT-PCR and immunofluorescence to validate the
expression of several transcripts. Interestingly, a significant number of genes were associated with
the extracellular matrix, or receptor-ECM interactions that may likely play a role in regulation of the
DP microenvironment. We are currently investigating the implications of the extracellular matrix
signals in DP maintenance.
832
Human keratinocytes have an immediate, autonomous response to injury that upregulates
protective and immune-enhancing gene expression
MK Crispin, E Billick, H Mitsui, H Fujita, M Suárez-Fariñas and JG Krueger Laboratory for
Investigative Dermatology, The Rockefeller University, New York, NY
Keratinocytes can synthesize inflammatory products in some conditions, such as cell culture or in
chronic immune-related diseases, but the autonomous, immediate response of uncultured ker-
atinocytes to injury is not known. This study aims to define the immediate alterations in protective
and inflammatory gene expression that occur in keratinocytes, independent from dermally-derived
signals. In prior wound healing studies, the dermis and epidermis were mechanically separated
and the specimens inevitably included residual dermal tissue. This study addressed this problem by
using dispase-separated epidermis and an 18-hour short-term culture as a model for cell injury.
Dispase digestion ensured complete removal of the dermis. We created a single-cell suspension of
the epidermal cells and removed melanocytes and Langerhans cells by fluorescence-activated cell
sorting (FACS) to obtain a pure population of keratinocytes. For a comparative model of uninjured
epidermis, we performed laser capture microdissection (LCM) on normal human skin. RNA was
extracted, quantified using RT-PCR, amplified by two-cycle cDNA synthesis, fragmented, and
hybridized to Human Genome U133 Plus 2.0 arrays. Microarray data was validated by quantita-
tive RT-PCR. Our results revealed an early burst of upregulated expression of IL1A (18-fold), IL8
(2000-fold), IL20 (22-fold), IL24 (30-fold), CXCL1 (59-fold), PI3 (35-fold), S100A7 (57-fold), S100A8
(129-fold), S100A9 (187-fold), LCN2 (40-fold), and RNASE7 (47-fold). In prior wound healing stud-
ies, these genes were shown to be downstream of EGFR activation. We also found upregulated
expression of EGFR ligands AREG (430-fold), HBEGF (341-fold), NRG1, and TGFA; the MMPs (1,
3 and 9) that shed these growth factors from the surface of the keratinocyte; and STAT3 (51-fold).
Thus, keratinocytes have the ability to initiate autonomously a high-level, protective immune response
to injury.
830
Elastin is essential for vascular development – A zebrafish model
Q Li,1 A Donahue,1 H Choi2 and J Uitto1 1 Jefferson Medical College, Philadelphia, PA and 2
School of Medicine, Ewha Woman’s University, Seoul, Democratic People’s Republic of Korea
Elastic fibers, consisting of elastin and the microfibrillar component, are responsible for tissue exten-
sibility and recoil in blood vessels, lung and skin. The specific role of elastin in contributing to these
properties is largely unknown, and information on elastin gene sequences and their developmen-
tal expression is limited to mammalian and avian species. In this study, we identified two tropoe-
lastin genes, elna and elnb, in zebrafish, a fresh water vertebrate. Although the homology of tropoe-
lastins across species at the primary sequence level is relatively low, the characteristic motifs of the
primary structure is preserved, consisting of hydrophobic domains alternating with crosslinking
domains. RT-PCR and in situ hybridization demonstrated that both zebrafish genes were expressed
and the corresponding proteins were deposited in blood vessels and the heart. 5’-UTR and splice
site morpholinos were designed to prevent translation of the elna and processing of pre-mRNA of
the elnb gene, respectively. A transgenic fish (vegfr2:g-rcfp) strain expressing green fluorescent pro-
tein in the vascular endothelial cells was used for morpholino targeting. Injection of morpholinos
into 1-4 cell stage embryos was performed, followed by morphologic observations of the pheno-
type of the blood vessels and assay of the mRNA target-gene expression. The elna morpholino
decreased the corresponding gene expression by >90% in the morphant fish, and development of
primary intersegmental vessel sprouts, critical features of angiogenesis, was disrupted. As a conse-
quence of the perturbed vascular development, the heartbeat and blood flow were reduced. Con-
versely, the elnb morpholino decreased the corresponding gene expression by 100%, but the inter-
segmental vessels of the morphant fish remained largely intact with no alterations in the cardiovascular
function. These results suggest that elna is an essential gene for normal zebrafish vascular develop-
ment and provide novel insight into the function of elastin in vertebrates.
834
Cutaneous antimicrobial barrier function is diminished in burn wounds following psycho-
logical stress
JK Plichta, S Droho, RL Gamelli and KA Radek Department of Surgery, Burn & Shock Trauma
Institute, Maywood, IL
Burn injured patients are highly susceptible to skin infection and graft rejection due to, in part, dimin-
ished skin barrier function. Neuroendocrine mediators released during stress negatively influence
skin barrier function by increasing epidermal permeability and reducing antimicrobial peptide (AMP)
production. Here, we sought to determine whether psychological stress (PS) prior to burn injury
impairs the local AMP and distal physical barrier response to injury. Male C57Bl/6 mice were exposed
to normal conditions or PS (i.e. chronic light, crowding, and radio static) for 72 hours, and then
subjected to a 15% scald burn injury or sham (immersion in 93°C or 22°C water, respectively). Skin
distal to the burn site underwent barrier disruption via tape stripping to assess barrier function and
recovery by transepidermal water loss (TEWL) and pH analysis, where a higher TEWL and pH after
tape stripping indicates an intact response to barrier disruption. Distal skin in burned mice failed
to respond to barrier disruption after 24 hours compared to sham mice as indicated by a lower
change in TEWL (sham 7±22% vs burn -28±9%, p<0.05) and higher in pH (6±7% vs 16±7%). This
effect in burn wounds was further exacerbated by PS (TEWL: unstressed -28±9% vs stressed -34±10%;
pH: 16±7% vs 2±4%, p<0.05). We further assessed the abundance and localization of β-defensin,
a major skin AMP, and Kallikrein 5 (KLK5), an epidermal proteolytic enzyme. β-defensin expres-
sion was reduced and differentially expressed within the epidermis in burn wounds from PS mice
compared to unstressed mice by immunohistochemistry. We also observed a robust increase in the
expression of KLK5 in burn wounds and in the surrounding tissue in PS mice compared to unstressed.
In summary, PS prior to scald burn injury acts as a double edged sword to compromise both the
local antimicrobial barrier and the distal barrier integrity. This provides a new perspective to explain
the high incidence of wound infection and graft failure in burn patients, particularly those sub-
jected to PS prior to injury.
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Natural products for epidermal barrier repair
B Rehal, R Sivamani and R Isseroff Dermatology, University of California, Davis, Sacramento,
CA
Natural products are often the source of development for medical therapies. In dermatology, natu-
ral products are used for antioxidant therapy, cosmetics, and skin barrier repair. Botanicals have
been used for wound care in Ayurvedic (traditional Indian) medicine for centuries, and many nat-
urally derived products are currently available over the counter. However, limited evidence-based
evaluation has been conducted for herbs in wound healing. Here we create a comparative data-
base of different botanicals in wound healing, using keratinocyte migration as an in vitro surrogate
for skin wound healing Herbs that have been used either anecdotally or in animal studies for
wound healing were chosen for analysis. The herbs were tested for contamination with bacteria,
yeast and mold and then extracted into liquid form. The herbs were extracted by heating the pow-
der or dried leaf formulations in deionized water to 80°F for thirty minutes. And finally, they were
sterile filtered. Normal human foreskin derived keratinocytes were treated with a range of doses
from 0-50% of herbal extract in media and their cell migration speeds were measured. Of the six
herbs tested, echinacea, turmeric and ginger increased cell migration by seventeen, fourteen and
thirty-five percent, respectively. This was statistically significant with a p-value of less than 0.05.
Interestingly, other herbs previously thought to improve healing— comfrey, aloe vera and gotu
kola, all decreased cell migration by sixteen, nineteen and fifteen percent, respectively, with a p-
value of less than 0.05. These studies show that keratinocyte migration can be used as a high through-
put screening assay for herbal substances and their ability to impact on healing. Ongoing studies
will evaluate the ability of the herbal extracts to modulate transepidermal water loss and skin con-
ductance. Our ultimate goal is to identify herbs that are both safe and efficacious for use in enhanc-
ing human skin repair.
824
Evidence for the existence of phenotypically distinct progenitors in epidermis
A Charruyer,1 LR Strachan,1 S Fong,1 L Yue,1 M Abdul,1 ML Mancianti3 and R Ghadially1,2 1
Dermatology, UCSF, San Francisco, CA, 2 Dermatology, VAMC, San Francisco, CA and 3
Pathology, Alta Bates Medical Center, Berkeley, CA
Epidermis is thought to be maintained by a hierarchy of progenitors, in which the epidermal stem
cell (EpiSC) divides to give rise to a daughter stem cell and a daughter transit amplifying cell (TAC),
which terminally differentiates after several cell divisions. Recently, however, some observations
indicate that only a single type of progenitor maintains normal epidermis. We addressed the possi-
ble existence of phenotypically distinct progenitor populations in both human and murine epider-
mis using short-term repopulation (STR) vs. long-term repopulation (LTR) in a quantitative trans-
plantation assay in vivo and clonogenic behavior in vitro. Putative EpiSCs and TACs were isolated
by FACS and injected into NOD/SCID mice. The epidermis produced was analyzed short-term (1
wk) and long-term (9 wks). Putative murine EpiSCs were isolated using CD133+ and putative human
EpiSCs using CD44+ALDH+ and integrin α6hiCD71lo. In murine epidermis, CD133+ keratinocytes
were enriched for LTR cells but lacked STR ability in vitro and in vivo, while CD133- keratinocytes
were depleted of LTR cells but showed STR ability in vitro and in vivo. These results suggest the
existence of phenotypically distinct progenitor populations in murine epidermis based on CD133
expression. In human epidermis, CD44+ALDH+ keratinocytes were enriched for LTR cells, but also
showed STR ability both in vitro and in vivo, in both KGM and embryonic stem cell media. Thus,
the CD44+ALDH+ population contains both LTR and STR progenitors. Integrin α6hiCD71lo ker-
atinocytes were enriched for LTR cells and showed STR ability in vitro in KGM (STR) but not in
embryonic stem cell media, suggesting that while both CD44+ALDH+ and α6hiCD71lo keratinocytes
contain LTR cells the CD44+ALDH+ population additionally contains a more primitive progenitor
capable of growth in embryonic stem cell medium. In conclusion, these results provide evidence
for phenotypically distinct groups of progenitors with different behaviors both in vivo and in vitro.
825
Drug allergy in hematopoietic stem cell transplantation
J Gordon,1 A Haryani,1 R Alfred,3 J Mehta2 and J Cotliar1 1 Dermatology, Northwestern
University, Chicago, IL, 2 Hematology/Oncology, Northwestern University, Chicago, IL and 3
Preventive Medicine, Northwestern University, Chicago, IL
There is a dearth of data on drug allergy and its effect on the post-transplant course of allogeneic
hematopoietic stem cell transplant (HSCT) patients. Reports suggest that recipients of HSCT can be
safely exposed to medications they were allergic to prior to transplant; however the interplay between
donor and recipient drug allergies and post-HSCT skin eruptions remains unknown. A retrospec-
tive chart review was performed on first-time allogeneic HSCT patients at Northwestern Medicine
in 2009. We assessed HSCT patients for exposure to medications that they or their donors were
known to be allergic to. Incidence and diagnosis of all skin eruptions early in the post-HSCT period
were also reviewed, including graft-versus-host disease (GVHD). We found 59 allogeneic HSCT
patients in 2009. Of these, 2 patients were exposed to medications that they were previously aller-
gic to, and both developed acute GVHD with skin involvement. One patient developed an erup-
tion on day +13 after HSCT, 3 days after starting piperacillin. The other patient developed a rash on
day +30, 31 days after starting vancomycin. There was 1 patient exposed to a medication the donor
was known to be allergic to(cefaclor). This patient developed urticaria on day +4, 3 days after start-
ing cefaclor; however, the patient did not develop GVHD. Despite reports of uneventful post-HSCT
exposures to medications previously known to cause allergies, we observed the development of
acute GVHD in 2/2 patients given medications that they were allergic to pre-HSCT. An urticarial
reaction was also observed in an HSCT recipient to a drug the donor was known to be allergic to;
suggesting donor allergies may also be important. Although acute GVHD is common after allo-
geneic HSCT, it is possible drug allergy may play a role in its development; larger studies are needed
to assess this concept. The potential of reversing drug allergy following allogeneic HSCT also needs
to be explored.
826
Bone marrow derived mesenchymal stem cells: Regenerative medicine for pseudoxanthoma
elasticum
Q Jiang, S Takahagi, B Reutemann, A Grand-Pierre, A Donahue and J Uitto Department of
Dermatology and Cutaneous Biology, Jefferson Medical College, Philadelphia, PA
Aberrant mineralization of peripheral connective tissues is a characteristic feature of pseudoxan-
thoma elasticum (PXE), a heritable metabolic disorder caused by mutations in the ABCC6 gene
which is primarily expressed in the liver. There is currently no effective treatment for PXE. In this
study, we characterized bone marrow derived mesenchymal stem cells (MSCs) and evaluated their
ability to contribute to liver regeneration, with the aim to rescue PXE phenotype. The marrow derived
stem cells were isolated from GFP-transgenic mice by magnetic cell sorting using a Lin- cocktail of
antibodies as well as stem cell antigen-1 (Sca-1) antibody for negative and positive selection, respec-
tively. Flow cytometric analyses of freshly isolated cells demonstrated the presence of two popula-
tions: (a) hematopoetic stem cells (HSCs), and (b) MSCs. A significant enrichment in MSCs was
gained during subsequent culturing of the cells, and the MSCs were shown to be MHC-1 positive
and have high potential for hepatic differentiation, with expression of Abcc6, in culture containing
hepatocyte growth factor and fibroblast growth factor. MSCs (0.5 x 106) at passage 4 were trans-
planted into the livers of 4-week old immunodeficient Abcc6-/- mice by intrasplenic injection one
day after partial hepatectomy, when peak expression of the stromal cell derived factor-1 (SDF-1) was
observed. On days 2 and 7 after engraftment, significant numbers of GFP-positive cells were noted
in the livers. Moreover, enhanced engraftment efficiency was observed with MSCs with high expres-
sion levels of the chemokine receptor CXCR4, a receptor for SDF-1. These data suggest that puri-
fied MSCs have the capability of differentiating into hepatic lineages and homing to the liver. The
interactions between SDF-1 and CXCR4 could be a critical mechanism to recruit MSCs for liver tar-
geting and regeneration. This therapeutic model provides the basis to investigate stem cell based
liver reconstitution as a means of regenerative treatment for PXE.
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Laminin 332 expression and processing is altered in irradiated and wounded skin
A Lopez,1 EB Olasz,1 NE Duncan,1 A Schock,1 W Kittipongdaja,1 BL Fish,2 JE Moulder2 and
Z Lazarova1 1 Department of Dermatology, Medical College of Wisconsin, Milwaukee, WI and
2 Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI
Skin exposure to ionizing radiation affects the normal wound-healing process and has a great impact
on the prognosis of affected individuals. We investigated the effect of ionizing radiation on wound
healing. Six week old male WAG/RijCmcr rats (n=4 rats per time point) were irradiated with a sin-
gle 30 Gy dose of ionizing radiation with a steep dose gradient, wounded, and followed up to 30
days. Control rats were sham irradiated and wounded. Wound areas were measured and tissues
examined by quantitative RT-PCR, immunohistochemistry, and gelatin zymography at 3, 7, 14, and
30 days post-irradiation. Wound of non-irradiated animals underwent rapid wound closure within
14 days after wounding. In contrast, in irradiated animals, the unhealed area represented 60% of
the original wound size 30 days post-irradiation. RT-PCR revealed elevated expression of all laminin
332 genes within 7 days post-irradiation paralleled by elevated MMP 2 expression (cleavage enzyme
of rat γ2 subunit). Laminin 332 staining was significantly diminished in irradiated wound beds when
compared to controls (50±25 vs. 250±30 units per optical field; p<0.001). A quantitative immunoblot
analysis of laminin 332 deposition in irradiated cultured human keratinocytes revealed a dose-
dependent decreased synthesis of α3 (cell-associated 200 kD) and γ2 (processed105 kD) subunits.
Interestingly, incubation of normal or irradiated keratinocytes with metalloproteinase inhibitor (1,10-
phenanthroline) further decreased laminin 332 deposition. These data strongly suggest that laminin
332 synthesis and processing is negatively affected by ionizing radiation, which can be instrumen-
tal in delayed wound healing of irradiated skin.
828
Secreted Hsp90 carries two unique properties for effectiveness in skin wound healing that
are absent from conventional growth factor treatments
D Sahu, C Cheng, F Tsen, Y Kuang, J Fan, M Chen, D Woodley and W Li Dermatology and Norris
Comprehensive Cancer Center, University of Southern California, Los Angeles, CA
Chronic and non-healing wounds pose a health, economic and social problem worldwide. For
over two decades, the conventional wisdom pointed to growth factors as the driving force of skin
wound healing and, therefore, as the center for development of therapeutic treatments. However,
the only US FDA-approved growth factor therapy, Regranex gel (platelet-derived growth factor-
BB/PDGF-BB), has shown modest efficacy, high cost and higher risk of mortality secondary to malig-
nancy. This stem reality is surprising and the cause remains as a puzzle. We report here identifica-
tion of a novel 115-amino acid peptide (F-5) in heat shock protein 90-alpha (Hsp90α) protein secreted
by skin cells under various wound stress cues. F-5 equally promotes migration of both epidermal
and dermal cells through the universally expressed LRP-1 receptor and, more critically, overrides
the inhibition by TGFβ, present throughout wound healing. Topical application of F-5 enhances
wound closure three fold faster than Regranex. In contrast, Regranex only promotes dermal fibrob-
last migration and growth and is unable to overcome the inhibition of dermal cell migration by TGFβ
. Therefore, results of this study challenge the long-standing paradigm for developing wound-heal-
ing therapies and reveal a novel and more effective wound-healing agent.
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Cutaneous wound healing in the EpiDerm-FT™ full-thickness in vitro human skin model: Role
of serum growth factors
AJ Armento, G Stolper, M Li, S Ayehunie, M Klausner and P Hayden MatTek Corp, Ashland, MA
Cutaneous wound healing involves interactions between dermal fibroblasts and epidermal ker-
atinocytes, as well as cell and extracellular matrix interactions. This poster describes new progress
in wound healing experiments conducted with a full−thickness in vitro human skin model (Epi-
Derm−FT™). Normal human epidermal keratinocytes (KC) and dermal fibroblasts (FB) were cul-
tured to produce the highly differentiated full−thickness skin model. Small wounds of several mm
diameter were induced in the epithelial model by means of a battery operated cauterizer or a der-
mal biopsy punch. The wounded EpiDerm−FT™ cultures were fixed at various time points and
H&E stained paraffin sections were prepared to evaluate the wound and the wound healing process.
The effect of human serum (HS) on the rate of wound healing was evaluated over a time course of
six days. Over the course of the 6 day experiment, KC migrated over the wounded area. FB prolif-
eration and dermal matrix repair were also observed. HS produced a concentration dependent
increase in the rate of cutaneous healing. Gene expression profiling of the wounded area by qPCR
showed temporally regulated increases in mRNA expression of basement membrane components,
collagens and genes involved in extracellular matrix remodeling. Increased FB proliferation in der-
mal areas directly adjacent to migrating KC was observed. FB proliferation and epidermal healing
were severely impaired in the presence of an EGFR tyrosine kinase inhibitor or a TGFα neutraliz-
ing antibody. Analysis of the role of other specific growth factors in the cutaneous wound healing
process is ongoing. These results demonstrate that EpiDerm−FT™ is a useful in vitro skin model for
investigating dermal−epidermal interactions during wound healing and evaluation of the role of spe-
cific growth factors or new therapeutics in the dermal wound healing process.
843
Laser assisted delivery of allogeneic porcine mesenchymal stem cells
S Davis,1 J Waibel,1 M Salgado,1,2 L Rodriguez-Menocal,1,2 D Ford1,2 and EV Badiavas1,2 1
Dermatology, University of Miami, Miami, FL and 2 Interdisciplinary Stem Cell Institute,
University of Miami, Miami, FL
Mesenchymal stem cells (MSCs) are multipotent cells that can differentiate into a variety of cell
types. Optimal delivery of stem cells that enable their viability is a current challenge to MSC research.
Fractional laser technology has revolutionized laser therapy. The fractional ablative tunnels can be
utilized for laser assisted delivery systems of a variety of drugs, topicals and other living tissue. This
is the first pilot study to test the hypothesis that ablative fractional laser could deliver mesenchymal
stem cells to skin using a porcine full thickness wound model. A porcine model was chosen due to
the morphological similarities between swine skin and human skin. Allogeneic cells were obtained
by bone marrow aspiration from a donor pig. Mesenchymal stem cells were isolated from the
donor bone marrow aspirate and transduced with a lentiviral vector containing a fluorescent marker
gene. One recipient pig was placed under general anesthesia and sixty full thickness skin wounds
were made using a 10 mm punch biopsy. The wounds were randomly assigned to two laser treat-
ment regimens: laser CO2/MSC and laser Er:YAG/MSC. After AFL the stem cells were pipetted into
the vertical channels. Wounds were covered with an occlusive polyurethane film dressing. Three
punch and wedge biopsies were taken from each group on days 5, 7 and 21. Labeled allogeneic
bone marrow cells were observed in papillary and reticular dermis on days 5 and 7 in both the
Er:YAG and CO2 laser treated wounds. Some labeled cells were noted in close proximity to the
ablated vertical channels created by laser treatment. Allogeneic cell showed persistence in the treated
wounds despite intense inflammation associated with the full thickness wounds created. In con-
clusion, preliminary study suggests that ablative fractional lasers may be useful technology to deliver
mesenchymal stem cells and this has broad implications for many branches of medicine.
845
Wound healing matrix displays properties useful for graft revascularization
WK Hoeffler and C Tapia 3-D Organ Modelling, Xgene Corporation, Sausalito, CA
Severe and chronic wounds can be effectively treated using in vitro synthesized skin grafts, but good
graft take rates depend upon wound bed preparation that involves both fastidious debridement,
and application of interim skin transplants. Exactly how short term application of transplanted native
skin prepares the wound bed is not fully understood. Here we describe a biomaterial derived from
living skin cells that has displayed properties suggesting that it might serve as a replacement for the
interim grafts, and that has the advantage of being readily absorbed by the body during healing.
Our approved mouse protocol for direct testing of the biomaterial in skin grafting applications, and
our success in also culturing canine skin cells for the preparation of the biomaterial for use in wound
treatments for dogs is preparing us for new collaborative studies in humans. The biomaterial is non-
living, protease resistant, and can be harvested from tissue cultured skin cells. We show that VEGF
populates the biomaterial by IHC and that the wound healing specific form of fibronectin contain-
ing extra domain A (EDA) is present, as indicated by RT-PCR. The spongy structure of the biomate-
rial suggests its use as an organizing structure for the support of vascularization and angiogenesis.
Although derived from skin cells the biomaterial does not contain typical markers of normal dif-
ferentiation, as determined by western blots. Also in preparation for human studies we are con-
ducting in vitro vascularization assays, and have so far obtained results indicating that nascent ves-
sels form in vitro from endothelial cells prepared from skin, and are currently evaluating how the
biomaterial can effect this system.
844
Laser assisted bone marrow transplantation
J Waibel,1 S Davis,1 L Rodriguez-Menocal,1,2 M Salgado,1,2 D Ford1,2 and EV Badiavas1,2 1
Dermatology, University of Miami, Miami, FL and 2 Interdisciplinary Stem Cell Institute,
University of Miami, Miami, FL
Fractional laser technology has greatly advanced the clinical use of light based ablation therapy.
While most often used for cosmetic purposes, these lasers appear to have the potential for the sys-
temic delivery of drugs and cell therapy. In this first pilot study, we have tested the hypothesis that
cells can be delivered through skin treated with the Er:YAG fractional laser and that the delivered
cells can enter the systemic circulation and remain functionally intact. A murine bone marrow trans-
plantation model was chosen for this study. Immune deficient NOD/SCID mice were recipients of
GFP positive bone marrow cells derived from a GFP expressing transgenic mice (C57BL/6-Tg(UBC-
GFP)30Scha/J). Recipient mice were either irradiated to create space in the bone marrow compart-
ment or not irradiated prior to fractional laser treatment and cell delivery. Cells were delivered in a
sealed plastic chamber that was secured to the mouse using an adhesive. 3 weeks following a sin-
gle administration of bone marrow cells to mice, chimerism could be detected by the presence of
circulating GFP positive blood cells in the recipient mice. Both irradiated and non-irradiated mice
had evidence of chimerism however irradiated mice had significantly higher levels. In conclusion,
these preliminary results demonstrate that using fractional laser technology, cells can be delivered
systemically through the skin and remain functional. These findings hold promise for the use of
fractional lasers for the treatment of a multitude of disorders using cell and drug based approaches.
842
Effects of claudin-2 knockdown in cultured keratinocytes
S Ellis, B Lu and D Telgenhoff Medical Laboratory Science, Tarleton State University, Fort
Worth, TX
The purpose of this study was to examine the effects of changes in claudin-2 protein in cell mono-
layers following knockdown with claudin-2 siRNA. Previous studies have shown that claudin-2 is
increased in wounded epidermis, both in vitro and in vivo. In order to investigate the role of claudin-
2 in wound healing we developed a model which was deficient in claudin-2. siRNA, transfection
medium, and control siRNA (nonsense siRNA) were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA). Human keratinocytes (Cascade Biologics, Oregon) were cultured to confluence
in 6 well plates. Multiple replicates were treated with either claudin-2 siRNA, nonsense siRNA, or
remained untreated at 37° C. Cultures were rinsed after 6 hours, fresh medium was added, and
plates were returned to the incubator. After 48 hours the cells were lysed and the lysate was assayed
for protein levels using the BCA assay (Thermo Scientific, Rockland IL). Equal amounts of protein
were loaded on an 8% acrylamide gel, electrophoresed, and transferred to nitrocellulose for West-
ern blot analysis. Claudin-2 antibody (abcam, Cambridge MA) was used for detection; bands were
quantified using the Kodak Imaging system. The bands in the knockdown cells were greatly decreased
compared to the two controls. Utilizing the same knockdown procedures we then analyzed the
effects of knockdown on cell migration using a scratch test assay. Monolayer keratinocyte cultures
showed a decrease in cell migration into scratch areas following claudin-2 knockdown. We have
developed a successful knockdown procedure for claudin-2 in keratinocytes, and have used this
method to show a relation between claudin-2 levels and wound healing in vitro.
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PPARγ-TGFβ-AGTR1 nexus modulates epithelial-mesenchymal transition and collagen syn-
thesis in scarring alopecia
SP Panicker,1 T Ganguly,1 MC Consolo,1 K Honda1,2 and P Karnik1,2 1 Dermatology, Case
Western Reserve Univ, Cleveland, OH and 2 Univ Hosp Case Med Ctr, Cleveland, OH
The mechanisms by which entire hair follicles are replaced by scar tissue in primary cicatricial alope-
cia (PCA), a group of rare inflammatory disorders of the pilosebaceous units, are not understood.
We previously showed that PPARγ and AhR play a crucial role in the pathogenesis of PCA. In order
to study these pathways and determine their importance in follicular scarring, we analyzed PCA
scalp biopsies, and the PPARγ and AhR mouse models with microarrays and siRNA technology.
Gene expression profiling of PCA tissue or mouse skin revealed that the TGFβ signaling and fibro-
sis genes are significantly up-regulated in affected tissue. Inhibition of PPARγ or activation of AhR
in mouse models or in hair follicle outer root sheath (HFORS) cells with specific agonists or antag-
onists induced TGFβ, AGTR1 and COL1A1 gene expression. These data suggest that PPARγ inhibi-
tion or AhR activation causes scarring by inducing TGFβ and AGTR1 signaling. Inhibition of TGFβ
with siRNA caused increased PPARγ expression and decreased collagen synthesis. Similarly, inhi-
bition of AGTR1 with specific siRNA also increased PPARγ expression and decreased collagen syn-
thesis. In contrast, PPARγ agonists inhibited TGFβ and AGTR1 expression and collagen synthesis.
These data suggest a complex regulatory nexus between PPARγ, TGFβ and AGTR1 in hair follicles
that controls collagen deposition and scarring. Intriguingly, modulation of TGFβ or AGTR1 induced
the expression of epithelial to mesenchymal transition (EMT) markers α-SMA, CDH1 and Snail 1.
Real-time PCR and immunohistochemistry revealed that EMT markers are also expressed in PCA
scalp biopsies. Whether and how EMT occurs during wound healing and fibrosis in human skin is
not known. Our novel data suggests that PPARγ-TGFβ-AGTR1 nexus modulates EMT and scarring
in hair follicle cells and in PCA. We conclude that PPARγ agonists in conjunction with AGTR1 antag-
onist Losartan, or TGFβ inhibitors may be an effective new approach to prevent EMT and scarring
in PCA.
836
A novel report of non-uremic calciphylaxis in the setting of excessive exogenous calcium
intake
S Gee,1 FR Vleugels2 and LS Winterfield3,4 1 Harvard Dermatology Residency Program, Boston,
MA, 2 University of Cincinnati College of Medicine, Cincinnati, OH, 3 Clinical Research
Program, Department of Dermatology, Brigham and Women’s Hospital, Boston, MA and 4
Wound Healing Center, Department of Dermatology, Brigham and Women’s Hospital, Boston,
MA
Calciphylaxis is a systemic microvascular occlusion syndrome primarily seen in patients with renal
failure, metabolic abnormalities, and hypercoagulable states. Although the pathogenesis is poorly
understood, the incidence of calciphylaxis is increasing. Exogenous oral calcium intake results in
an acute rise in serum calcium levels, the long term effects of which are unclear. The Aukland Cal-
cium Study does suggest, however, that oral calcium supplementation accelerates cardiac athero-
sclerosis. We present a case of a 64-year old woman with diabetes and normal renal function who
developed painful retiform purpura on her left calf. Biopsy of the involved area demonstrated cal-
ciphylaxis. Her history was notable for exogenous calcium supplementation for over 30 years. Med-
ications at the time of presentation included calcium intake of more than 2400mg per day, vitamin
C, hydrochlorothiazide, and naproxen. Laboratory workup revealed parathyroid hormone of <3
pg/mL, serum calcium of 11 mg/dL, normal renal function, and otherwise unremarkable results.
There was no other evidence of systemic vascular calcification. She was admitted to the hospital
and received sodium thiosulfate (STS) 25% solution 20g IV daily, which was discontinued after 5
days due to metabolic acidosis. Subsequently, she was treated with local wound care, including
sharp debridement and topical becaplermin gel. Six weeks after STS treatment and discontinuation
of all exogenous calcium supplementation, her ulcerations were healing with healthy granulation
tissue and her parathyroid hormone level returned to normal. While there have been cases of cal-
ciphylaxis reported in the setting of normal renal function, to our knowledge this is the first case of
calciphylaxis reported in the setting of excess calcium supplementation with resultant physiologic
hypoparathyroidism.
837
P12, a fibronectin-derived peptide, reduces burn injury progresion in a porcine burn model
RA Clark,1,2 F Lin,1 MG Tonnesen3,2 and AJ Singer4 1 Biomedical Engineering, Stony Brook
University, Stony Brook, NY, 2 Dermatology, Stony Brook University, Stony Brook, NY, 3
Medicine, VAMC, Northport, NY and 4 Emergency Medicine, Stony Brook University, Stony
Brook, NY
Burns are dynamic injuries that progress extensively in depth and size over the course of several
days post injury resulting in conversion of partial thickness 2nd degree burns to full-thickness 3rd
degree burns. Hence, limiting injury progression is a major goal of the therapy for burns. Previously
we reported that a 14mer, growth factor-binding peptide (P12), derived from the first fibronectin
type III repeat, enhanced adult human dermal fibroblast (AHDF) growth and protected AHDF from
necrosis and apoptosis secondary to oxidative and cytokine stress. We also showed that P12 reduced
injury progression in a rat hot comb burn model. Here, we report that P12 infusion 1hr after burn
effectively limits injury progression in a porcine burn model. Burns were created on the backs of
outbred, 20-25kg Yorkshire swine using a brass comb preheated in boiling water and applied for
30 seconds, resulting in four full thickness burns separated by three unburned interspaces. 20
burns with 60 unburned interspaces were created on each animal. Lactated Ringers (control) or
0.01, 0.1, 1, or 10mg/kg P12 was infused over 30 min intravenously at 1hr after burn using a peri-
stalsis pump. Injury progression was reduced in a bell-shaped, dose-response fashion. By macro-
scopic and microscopic analysis, >80% interspace necrosis was observed at 7 days in control ani-
mals and in animals treated with 10mg/kg P12, compared to 30% interspace necrosis in animals
treated with 1mg/kg P12 (P<0.001). Scrambled P12 peptide at 0.1, 1 or 10mg/kg showed no effect.
Thus, P12 has the potential to be the first effective therapy for limiting burn injury progression.
838
Oxidative damage fails to correlate spatiotemporally with cell necrosis during burn injury
progression
D Kim,1 S Lanier,1 S McClain,2,3 F Lin,2 M Tonnensen,5 A Singer4 and R Clark2,3 1 School of
Medicine, SBU, Stony Brook, NY, 2 Biomed Eng, SBU, Stony Brook, NY, 3 Dermatology, SBU,
Stony Brook, NY, 4 Emer Med, SBU, Stony Brook, NY and 5 Dermatology, VAMC, Northport,
NY
Burns are dynamic injuries that progress extensively in depth and breadth over the course of sev-
eral days post injury, sometimes resulting in conversion of partial thickness burns to full-thickness
burns. Understanding injury progression is a critical step toward developing novel therapies to
counter it. Recently we demonstrated that there is a moving gradient of necrosis and apoptosis out-
ward from the burn edge over a 1-2 day period. Here, we use immunohistochemical biomarkers of
oxidative stress, i.e. DNA oxidation and lipid peroxidation, to relate spatiotemporally to biomark-
ers of cell necrosis. Eight mm punch biopsies, taken at 1, 4, 24, and 48 hrs post-burn from the inter-
spaces in a porcine hot comb thermal burn model, were fixed, paraffin-embedded, and cut into 5μ
sections. Specimens were probed for high mobility group box-1 protein (HMGB-1), malondialde-
hyde (MDA), or 8-hydroxy-2’ deoxyguanosine (8-OHdG) to elucidate cell necrosis, DNA oxidation,
or lipid peroxidation, respectively. Nuclei were counterstained with hematoxylin. From the burn
edge, each tissue section was divided into five 0.5 mm intervals. DNA oxidative and lipid perox-
idative damage appeared across the entire interspace by 1hr, while cell necrosis progressed in a
step-wise fashion from 0.75 mm away from burn edge at 1 hr to 1.8 mm away from burn edge by
24 hours. In other words, although DNA oxidation and lipid peroxidation occurred across the entire
interspace by 1 hr, cell necrosis progressed as a moving-gradient over 24 hrs. Thus, oxidative dam-
age did not correlate spatiotemporally with cell necrosis. Careful studies of burn injury progression
with multiple biomarkers of toxic agents are needed to elucidate whether they are spatiotemporally
associated with cell necrosis, and whether they are predictive of ultimate tissue necrosis at 7 days.
Through such studies we believe that potential therapies to limit burn injury progression may be
elucidated.
839
In vivo assessment of wound induction and repair of a skin injury produced by liquid nitro-
gen
M Chu and N Kollias Johnson & Johnson Consumer Products, Inc., Skillman, NJ
The cascade of events following an injury that significantly alters epidermal structures and leads to
epidermal necrosis depends on the type of injury. We have studied epidermal necrosis caused by
solar simulated radiation, laser therapy and liquid nitrogen (N2) with reflectance laser scanning con-
focal microscopy in vivo. In the present study we investigated injuries produced with liquid N2, a
common therapeutic modality for solar lentigos, warts, and others. A 3 mm diameter skin site on
the forearm of 6 healthy human volunteers was brought in contact with a liquid N2 soaked cotton
swab for approximately 30 seconds, following written informed consent. The site was monitored by
confocal microscopy and digital imaging until the epidermis appeared clinically fully repaired (>4
weeks). Immediately following exposure to liquid N2 and for the first day, the epidermal cellular
organization appears slightly perturbed and capillaries are recruited showing increased blood flow.
On the second day the epidermal cellular architecture is lost and the capillaries become non-func-
tional. The pigment distribution in the keratinocytes that line the papillae maintains its appearance
and does not spread as the cell boundaries become imperceptible. The dead epidermis remains
intact for approximately 2 weeks and protects the new restructuring epidermis under it. The wound
repairs from the periphery towards the center, with large elongated keratinocytes and increased
blood flow present in the periphery. Approximately 2 weeks after injury, the new epidermis is infil-
trated by large dendritic cells, probably macrophages, localized in the area where papillae form.
The papillae appear to grow and produce the typical invaginations and surrounding structures of
the dermal-epidermal junction, and the enclosed capillaries are fully engorged with flowing ery-
throcytes. These giant dendritic cells disappear as the epidermis returns to normal appearance and
pigment. The giant dendritic cells appear to play a role in tissue restructuring post-injury, as they
are also present for a limited time following UV injury.
840
Agents that help protect epidermal stem cells from photodamage or induce differentiation
JE Anderson,1 YC Anderson,1 R Holtz,2 S Borchert3 and H van der Hoeven3 1 Actives
International, Allendale, NJ, 2 BioInnovation Labs, Lakewood, CO and 3 CLR, Berlin, Germany
Epidermal stem cells are responsible for tissue homeostasis and wound repair. They help maintain
a healthy skin barrier, but are susceptible to DNA damage that can accumulate. We have focused
on identifying materials that prevent DNA damage to epidermal stem cells and materials that can
stimulate differentiation of stem cells so as to improve barrier repair and tissue homeostasis. Human
neonatal keratinocytes were cultured with media which was designed to select epidermal stem cells
and then analyzed for the expression of stem cell markers. The expression of all three markers exam-
ined was significantly elevated compared to those in neonatal keratinocytes. Subsequently, epider-
mal stem cell enriched populations were cultured in stem cell selective, neutral, or differentiation
media. A population that was grown in differentiation media expressed an elevated level of cell dif-
ferentiation markers. Upon characterization of epidermal stem cells, we studied various ingredi-
ents for their ability 1) to protect stem cells from photodamage; 2) to induce differentiation. Epi-
dermal stem cells were treated with CB Extract, SP, and BL Extract that have shown in our previous
studies to protect or repair DNA damage in normal cells and skin models. Following the treatment,
the cells were exposed to UVB. The analysis of DNA revealed that all three materials significantly
decreased UVB-induced DNA damage as determined by the level of TT dimer content. In another
study, epidermal stem cells were treated with Yeast Extract PS or CB Extract and then analyzed for
the expression of differentiation markers. Yeast Extract PS significantly upregulated the expression
of DSG, PK, and K1. CB Extract also expressed a higher level of these markers. In these studies, we
have identified ingredients that offer photoprotection of epidermal stem cells and also identified
ingredients with an ability to induce differentiation of stem cells. These materials may be useful to
maintain homeostasis of the barrier function and prevent accelerated aging of the skin.
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Cutaneous wound healing in the EpiDerm-FT™ full-thickness in vitro human skin model: Role
of serum growth factors
AJ Armento, G Stolper, M Li, S Ayehunie, M Klausner and P Hayden MatTek Corp, Ashland, MA
Cutaneous wound healing involves interactions between dermal fibroblasts and epidermal ker-
atinocytes, as well as cell and extracellular matrix interactions. This poster describes new progress
in wound healing experiments conducted with a full−thickness in vitro human skin model (Epi-
Derm−FT™). Normal human epidermal keratinocytes (KC) and dermal fibroblasts (FB) were cul-
tured to produce the highly differentiated full−thickness skin model. Small wounds of several mm
diameter were induced in the epithelial model by means of a battery operated cauterizer or a der-
mal biopsy punch. The wounded EpiDerm−FT™ cultures were fixed at various time points and
H&E stained paraffin sections were prepared to evaluate the wound and the wound healing process.
The effect of human serum (HS) on the rate of wound healing was evaluated over a time course of
six days. Over the course of the 6 day experiment, KC migrated over the wounded area. FB prolif-
eration and dermal matrix repair were also observed. HS produced a concentration dependent
increase in the rate of cutaneous healing. Gene expression profiling of the wounded area by qPCR
showed temporally regulated increases in mRNA expression of basement membrane components,
collagens and genes involved in extracellular matrix remodeling. Increased FB proliferation in der-
mal areas directly adjacent to migrating KC was observed. FB proliferation and epidermal healing
were severely impaired in the presence of an EGFR tyrosine kinase inhibitor or a TGFα neutraliz-
ing antibody. Analysis of the role of other specific growth factors in the cutaneous wound healing
process is ongoing. These results demonstrate that EpiDerm−FT™ is a useful in vitro skin model for
investigating dermal−epidermal interactions during wound healing and evaluation of the role of spe-
cific growth factors or new therapeutics in the dermal wound healing process.
843
Laser assisted delivery of allogeneic porcine mesenchymal stem cells
S Davis,1 J Waibel,1 M Salgado,1,2 L Rodriguez-Menocal,1,2 D Ford1,2 and EV Badiavas1,2 1
Dermatology, University of Miami, Miami, FL and 2 Interdisciplinary Stem Cell Institute,
University of Miami, Miami, FL
Mesenchymal stem cells (MSCs) are multipotent cells that can differentiate into a variety of cell
types. Optimal delivery of stem cells that enable their viability is a current challenge to MSC research.
Fractional laser technology has revolutionized laser therapy. The fractional ablative tunnels can be
utilized for laser assisted delivery systems of a variety of drugs, topicals and other living tissue. This
is the first pilot study to test the hypothesis that ablative fractional laser could deliver mesenchymal
stem cells to skin using a porcine full thickness wound model. A porcine model was chosen due to
the morphological similarities between swine skin and human skin. Allogeneic cells were obtained
by bone marrow aspiration from a donor pig. Mesenchymal stem cells were isolated from the
donor bone marrow aspirate and transduced with a lentiviral vector containing a fluorescent marker
gene. One recipient pig was placed under general anesthesia and sixty full thickness skin wounds
were made using a 10 mm punch biopsy. The wounds were randomly assigned to two laser treat-
ment regimens: laser CO2/MSC and laser Er:YAG/MSC. After AFL the stem cells were pipetted into
the vertical channels. Wounds were covered with an occlusive polyurethane film dressing. Three
punch and wedge biopsies were taken from each group on days 5, 7 and 21. Labeled allogeneic
bone marrow cells were observed in papillary and reticular dermis on days 5 and 7 in both the
Er:YAG and CO2 laser treated wounds. Some labeled cells were noted in close proximity to the
ablated vertical channels created by laser treatment. Allogeneic cell showed persistence in the treated
wounds despite intense inflammation associated with the full thickness wounds created. In con-
clusion, preliminary study suggests that ablative fractional lasers may be useful technology to deliver
mesenchymal stem cells and this has broad implications for many branches of medicine.
845
Wound healing matrix displays properties useful for graft revascularization
WK Hoeffler and C Tapia 3-D Organ Modelling, Xgene Corporation, Sausalito, CA
Severe and chronic wounds can be effectively treated using in vitro synthesized skin grafts, but good
graft take rates depend upon wound bed preparation that involves both fastidious debridement,
and application of interim skin transplants. Exactly how short term application of transplanted native
skin prepares the wound bed is not fully understood. Here we describe a biomaterial derived from
living skin cells that has displayed properties suggesting that it might serve as a replacement for the
interim grafts, and that has the advantage of being readily absorbed by the body during healing.
Our approved mouse protocol for direct testing of the biomaterial in skin grafting applications, and
our success in also culturing canine skin cells for the preparation of the biomaterial for use in wound
treatments for dogs is preparing us for new collaborative studies in humans. The biomaterial is non-
living, protease resistant, and can be harvested from tissue cultured skin cells. We show that VEGF
populates the biomaterial by IHC and that the wound healing specific form of fibronectin contain-
ing extra domain A (EDA) is present, as indicated by RT-PCR. The spongy structure of the biomate-
rial suggests its use as an organizing structure for the support of vascularization and angiogenesis.
Although derived from skin cells the biomaterial does not contain typical markers of normal dif-
ferentiation, as determined by western blots. Also in preparation for human studies we are con-
ducting in vitro vascularization assays, and have so far obtained results indicating that nascent ves-
sels form in vitro from endothelial cells prepared from skin, and are currently evaluating how the
biomaterial can effect this system.
844
Laser assisted bone marrow transplantation
J Waibel,1 S Davis,1 L Rodriguez-Menocal,1,2 M Salgado,1,2 D Ford1,2 and EV Badiavas1,2 1
Dermatology, University of Miami, Miami, FL and 2 Interdisciplinary Stem Cell Institute,
University of Miami, Miami, FL
Fractional laser technology has greatly advanced the clinical use of light based ablation therapy.
While most often used for cosmetic purposes, these lasers appear to have the potential for the sys-
temic delivery of drugs and cell therapy. In this first pilot study, we have tested the hypothesis that
cells can be delivered through skin treated with the Er:YAG fractional laser and that the delivered
cells can enter the systemic circulation and remain functionally intact. A murine bone marrow trans-
plantation model was chosen for this study. Immune deficient NOD/SCID mice were recipients of
GFP positive bone marrow cells derived from a GFP expressing transgenic mice (C57BL/6-Tg(UBC-
GFP)30Scha/J). Recipient mice were either irradiated to create space in the bone marrow compart-
ment or not irradiated prior to fractional laser treatment and cell delivery. Cells were delivered in a
sealed plastic chamber that was secured to the mouse using an adhesive. 3 weeks following a sin-
gle administration of bone marrow cells to mice, chimerism could be detected by the presence of
circulating GFP positive blood cells in the recipient mice. Both irradiated and non-irradiated mice
had evidence of chimerism however irradiated mice had significantly higher levels. In conclusion,
these preliminary results demonstrate that using fractional laser technology, cells can be delivered
systemically through the skin and remain functional. These findings hold promise for the use of
fractional lasers for the treatment of a multitude of disorders using cell and drug based approaches.
842
Effects of claudin-2 knockdown in cultured keratinocytes
S Ellis, B Lu and D Telgenhoff Medical Laboratory Science, Tarleton State University, Fort
Worth, TX
The purpose of this study was to examine the effects of changes in claudin-2 protein in cell mono-
layers following knockdown with claudin-2 siRNA. Previous studies have shown that claudin-2 is
increased in wounded epidermis, both in vitro and in vivo. In order to investigate the role of claudin-
2 in wound healing we developed a model which was deficient in claudin-2. siRNA, transfection
medium, and control siRNA (nonsense siRNA) were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA). Human keratinocytes (Cascade Biologics, Oregon) were cultured to confluence
in 6 well plates. Multiple replicates were treated with either claudin-2 siRNA, nonsense siRNA, or
remained untreated at 37° C. Cultures were rinsed after 6 hours, fresh medium was added, and
plates were returned to the incubator. After 48 hours the cells were lysed and the lysate was assayed
for protein levels using the BCA assay (Thermo Scientific, Rockland IL). Equal amounts of protein
were loaded on an 8% acrylamide gel, electrophoresed, and transferred to nitrocellulose for West-
ern blot analysis. Claudin-2 antibody (abcam, Cambridge MA) was used for detection; bands were
quantified using the Kodak Imaging system. The bands in the knockdown cells were greatly decreased
compared to the two controls. Utilizing the same knockdown procedures we then analyzed the
effects of knockdown on cell migration using a scratch test assay. Monolayer keratinocyte cultures
showed a decrease in cell migration into scratch areas following claudin-2 knockdown. We have
developed a successful knockdown procedure for claudin-2 in keratinocytes, and have used this
method to show a relation between claudin-2 levels and wound healing in vitro.
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PPARγ-TGFβ-AGTR1 nexus modulates epithelial-mesenchymal transition and collagen syn-
thesis in scarring alopecia
SP Panicker,1 T Ganguly,1 MC Consolo,1 K Honda1,2 and P Karnik1,2 1 Dermatology, Case
Western Reserve Univ, Cleveland, OH and 2 Univ Hosp Case Med Ctr, Cleveland, OH
The mechanisms by which entire hair follicles are replaced by scar tissue in primary cicatricial alope-
cia (PCA), a group of rare inflammatory disorders of the pilosebaceous units, are not understood.
We previously showed that PPARγ and AhR play a crucial role in the pathogenesis of PCA. In order
to study these pathways and determine their importance in follicular scarring, we analyzed PCA
scalp biopsies, and the PPARγ and AhR mouse models with microarrays and siRNA technology.
Gene expression profiling of PCA tissue or mouse skin revealed that the TGFβ signaling and fibro-
sis genes are significantly up-regulated in affected tissue. Inhibition of PPARγ or activation of AhR
in mouse models or in hair follicle outer root sheath (HFORS) cells with specific agonists or antag-
onists induced TGFβ, AGTR1 and COL1A1 gene expression. These data suggest that PPARγ inhibi-
tion or AhR activation causes scarring by inducing TGFβ and AGTR1 signaling. Inhibition of TGFβ
with siRNA caused increased PPARγ expression and decreased collagen synthesis. Similarly, inhi-
bition of AGTR1 with specific siRNA also increased PPARγ expression and decreased collagen syn-
thesis. In contrast, PPARγ agonists inhibited TGFβ and AGTR1 expression and collagen synthesis.
These data suggest a complex regulatory nexus between PPARγ, TGFβ and AGTR1 in hair follicles
that controls collagen deposition and scarring. Intriguingly, modulation of TGFβ or AGTR1 induced
the expression of epithelial to mesenchymal transition (EMT) markers α-SMA, CDH1 and Snail 1.
Real-time PCR and immunohistochemistry revealed that EMT markers are also expressed in PCA
scalp biopsies. Whether and how EMT occurs during wound healing and fibrosis in human skin is
not known. Our novel data suggests that PPARγ-TGFβ-AGTR1 nexus modulates EMT and scarring
in hair follicle cells and in PCA. We conclude that PPARγ agonists in conjunction with AGTR1 antag-
onist Losartan, or TGFβ inhibitors may be an effective new approach to prevent EMT and scarring
in PCA.
836
A novel report of non-uremic calciphylaxis in the setting of excessive exogenous calcium
intake
S Gee,1 FR Vleugels2 and LS Winterfield3,4 1 Harvard Dermatology Residency Program, Boston,
MA, 2 University of Cincinnati College of Medicine, Cincinnati, OH, 3 Clinical Research
Program, Department of Dermatology, Brigham and Women’s Hospital, Boston, MA and 4
Wound Healing Center, Department of Dermatology, Brigham and Women’s Hospital, Boston,
MA
Calciphylaxis is a systemic microvascular occlusion syndrome primarily seen in patients with renal
failure, metabolic abnormalities, and hypercoagulable states. Although the pathogenesis is poorly
understood, the incidence of calciphylaxis is increasing. Exogenous oral calcium intake results in
an acute rise in serum calcium levels, the long term effects of which are unclear. The Aukland Cal-
cium Study does suggest, however, that oral calcium supplementation accelerates cardiac athero-
sclerosis. We present a case of a 64-year old woman with diabetes and normal renal function who
developed painful retiform purpura on her left calf. Biopsy of the involved area demonstrated cal-
ciphylaxis. Her history was notable for exogenous calcium supplementation for over 30 years. Med-
ications at the time of presentation included calcium intake of more than 2400mg per day, vitamin
C, hydrochlorothiazide, and naproxen. Laboratory workup revealed parathyroid hormone of <3
pg/mL, serum calcium of 11 mg/dL, normal renal function, and otherwise unremarkable results.
There was no other evidence of systemic vascular calcification. She was admitted to the hospital
and received sodium thiosulfate (STS) 25% solution 20g IV daily, which was discontinued after 5
days due to metabolic acidosis. Subsequently, she was treated with local wound care, including
sharp debridement and topical becaplermin gel. Six weeks after STS treatment and discontinuation
of all exogenous calcium supplementation, her ulcerations were healing with healthy granulation
tissue and her parathyroid hormone level returned to normal. While there have been cases of cal-
ciphylaxis reported in the setting of normal renal function, to our knowledge this is the first case of
calciphylaxis reported in the setting of excess calcium supplementation with resultant physiologic
hypoparathyroidism.
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P12, a fibronectin-derived peptide, reduces burn injury progresion in a porcine burn model
RA Clark,1,2 F Lin,1 MG Tonnesen3,2 and AJ Singer4 1 Biomedical Engineering, Stony Brook
University, Stony Brook, NY, 2 Dermatology, Stony Brook University, Stony Brook, NY, 3
Medicine, VAMC, Northport, NY and 4 Emergency Medicine, Stony Brook University, Stony
Brook, NY
Burns are dynamic injuries that progress extensively in depth and size over the course of several
days post injury resulting in conversion of partial thickness 2nd degree burns to full-thickness 3rd
degree burns. Hence, limiting injury progression is a major goal of the therapy for burns. Previously
we reported that a 14mer, growth factor-binding peptide (P12), derived from the first fibronectin
type III repeat, enhanced adult human dermal fibroblast (AHDF) growth and protected AHDF from
necrosis and apoptosis secondary to oxidative and cytokine stress. We also showed that P12 reduced
injury progression in a rat hot comb burn model. Here, we report that P12 infusion 1hr after burn
effectively limits injury progression in a porcine burn model. Burns were created on the backs of
outbred, 20-25kg Yorkshire swine using a brass comb preheated in boiling water and applied for
30 seconds, resulting in four full thickness burns separated by three unburned interspaces. 20
burns with 60 unburned interspaces were created on each animal. Lactated Ringers (control) or
0.01, 0.1, 1, or 10mg/kg P12 was infused over 30 min intravenously at 1hr after burn using a peri-
stalsis pump. Injury progression was reduced in a bell-shaped, dose-response fashion. By macro-
scopic and microscopic analysis, >80% interspace necrosis was observed at 7 days in control ani-
mals and in animals treated with 10mg/kg P12, compared to 30% interspace necrosis in animals
treated with 1mg/kg P12 (P<0.001). Scrambled P12 peptide at 0.1, 1 or 10mg/kg showed no effect.
Thus, P12 has the potential to be the first effective therapy for limiting burn injury progression.
838
Oxidative damage fails to correlate spatiotemporally with cell necrosis during burn injury
progression
D Kim,1 S Lanier,1 S McClain,2,3 F Lin,2 M Tonnensen,5 A Singer4 and R Clark2,3 1 School of
Medicine, SBU, Stony Brook, NY, 2 Biomed Eng, SBU, Stony Brook, NY, 3 Dermatology, SBU,
Stony Brook, NY, 4 Emer Med, SBU, Stony Brook, NY and 5 Dermatology, VAMC, Northport,
NY
Burns are dynamic injuries that progress extensively in depth and breadth over the course of sev-
eral days post injury, sometimes resulting in conversion of partial thickness burns to full-thickness
burns. Understanding injury progression is a critical step toward developing novel therapies to
counter it. Recently we demonstrated that there is a moving gradient of necrosis and apoptosis out-
ward from the burn edge over a 1-2 day period. Here, we use immunohistochemical biomarkers of
oxidative stress, i.e. DNA oxidation and lipid peroxidation, to relate spatiotemporally to biomark-
ers of cell necrosis. Eight mm punch biopsies, taken at 1, 4, 24, and 48 hrs post-burn from the inter-
spaces in a porcine hot comb thermal burn model, were fixed, paraffin-embedded, and cut into 5μ
sections. Specimens were probed for high mobility group box-1 protein (HMGB-1), malondialde-
hyde (MDA), or 8-hydroxy-2’ deoxyguanosine (8-OHdG) to elucidate cell necrosis, DNA oxidation,
or lipid peroxidation, respectively. Nuclei were counterstained with hematoxylin. From the burn
edge, each tissue section was divided into five 0.5 mm intervals. DNA oxidative and lipid perox-
idative damage appeared across the entire interspace by 1hr, while cell necrosis progressed in a
step-wise fashion from 0.75 mm away from burn edge at 1 hr to 1.8 mm away from burn edge by
24 hours. In other words, although DNA oxidation and lipid peroxidation occurred across the entire
interspace by 1 hr, cell necrosis progressed as a moving-gradient over 24 hrs. Thus, oxidative dam-
age did not correlate spatiotemporally with cell necrosis. Careful studies of burn injury progression
with multiple biomarkers of toxic agents are needed to elucidate whether they are spatiotemporally
associated with cell necrosis, and whether they are predictive of ultimate tissue necrosis at 7 days.
Through such studies we believe that potential therapies to limit burn injury progression may be
elucidated.
839
In vivo assessment of wound induction and repair of a skin injury produced by liquid nitro-
gen
M Chu and N Kollias Johnson & Johnson Consumer Products, Inc., Skillman, NJ
The cascade of events following an injury that significantly alters epidermal structures and leads to
epidermal necrosis depends on the type of injury. We have studied epidermal necrosis caused by
solar simulated radiation, laser therapy and liquid nitrogen (N2) with reflectance laser scanning con-
focal microscopy in vivo. In the present study we investigated injuries produced with liquid N2, a
common therapeutic modality for solar lentigos, warts, and others. A 3 mm diameter skin site on
the forearm of 6 healthy human volunteers was brought in contact with a liquid N2 soaked cotton
swab for approximately 30 seconds, following written informed consent. The site was monitored by
confocal microscopy and digital imaging until the epidermis appeared clinically fully repaired (>4
weeks). Immediately following exposure to liquid N2 and for the first day, the epidermal cellular
organization appears slightly perturbed and capillaries are recruited showing increased blood flow.
On the second day the epidermal cellular architecture is lost and the capillaries become non-func-
tional. The pigment distribution in the keratinocytes that line the papillae maintains its appearance
and does not spread as the cell boundaries become imperceptible. The dead epidermis remains
intact for approximately 2 weeks and protects the new restructuring epidermis under it. The wound
repairs from the periphery towards the center, with large elongated keratinocytes and increased
blood flow present in the periphery. Approximately 2 weeks after injury, the new epidermis is infil-
trated by large dendritic cells, probably macrophages, localized in the area where papillae form.
The papillae appear to grow and produce the typical invaginations and surrounding structures of
the dermal-epidermal junction, and the enclosed capillaries are fully engorged with flowing ery-
throcytes. These giant dendritic cells disappear as the epidermis returns to normal appearance and
pigment. The giant dendritic cells appear to play a role in tissue restructuring post-injury, as they
are also present for a limited time following UV injury.
840
Agents that help protect epidermal stem cells from photodamage or induce differentiation
JE Anderson,1 YC Anderson,1 R Holtz,2 S Borchert3 and H van der Hoeven3 1 Actives
International, Allendale, NJ, 2 BioInnovation Labs, Lakewood, CO and 3 CLR, Berlin, Germany
Epidermal stem cells are responsible for tissue homeostasis and wound repair. They help maintain
a healthy skin barrier, but are susceptible to DNA damage that can accumulate. We have focused
on identifying materials that prevent DNA damage to epidermal stem cells and materials that can
stimulate differentiation of stem cells so as to improve barrier repair and tissue homeostasis. Human
neonatal keratinocytes were cultured with media which was designed to select epidermal stem cells
and then analyzed for the expression of stem cell markers. The expression of all three markers exam-
ined was significantly elevated compared to those in neonatal keratinocytes. Subsequently, epider-
mal stem cell enriched populations were cultured in stem cell selective, neutral, or differentiation
media. A population that was grown in differentiation media expressed an elevated level of cell dif-
ferentiation markers. Upon characterization of epidermal stem cells, we studied various ingredi-
ents for their ability 1) to protect stem cells from photodamage; 2) to induce differentiation. Epi-
dermal stem cells were treated with CB Extract, SP, and BL Extract that have shown in our previous
studies to protect or repair DNA damage in normal cells and skin models. Following the treatment,
the cells were exposed to UVB. The analysis of DNA revealed that all three materials significantly
decreased UVB-induced DNA damage as determined by the level of TT dimer content. In another
study, epidermal stem cells were treated with Yeast Extract PS or CB Extract and then analyzed for
the expression of differentiation markers. Yeast Extract PS significantly upregulated the expression
of DSG, PK, and K1. CB Extract also expressed a higher level of these markers. In these studies, we
have identified ingredients that offer photoprotection of epidermal stem cells and also identified
ingredients with an ability to induce differentiation of stem cells. These materials may be useful to
maintain homeostasis of the barrier function and prevent accelerated aging of the skin.
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